Citrus Sinensis ID: 040604
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 582 | 2.2.26 [Sep-21-2011] | |||||||
| Q3ECH2 | 892 | Probable receptor-like pr | no | no | 0.931 | 0.607 | 0.412 | 1e-121 | |
| Q9FID5 | 806 | Probable receptor-like pr | no | no | 0.585 | 0.423 | 0.505 | 1e-98 | |
| Q9FID6 | 813 | Probable receptor-like pr | no | no | 0.554 | 0.397 | 0.521 | 4e-98 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.498 | 0.332 | 0.429 | 1e-63 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.517 | 0.363 | 0.419 | 4e-63 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.549 | 0.389 | 0.391 | 4e-61 | |
| C0LGH3 | 1033 | Probable LRR receptor-lik | no | no | 0.558 | 0.314 | 0.392 | 3e-59 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.486 | 0.341 | 0.412 | 1e-58 | |
| C0LGH2 | 1032 | Probable LRR receptor-lik | no | no | 0.537 | 0.303 | 0.395 | 4e-58 | |
| Q39202 | 832 | G-type lectin S-receptor- | no | no | 0.585 | 0.409 | 0.359 | 2e-55 |
| >sp|Q3ECH2|Y1670_ARATH Probable receptor-like protein kinase At1g67000 OS=Arabidopsis thaliana GN=At1g67000 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 434 bits (1117), Expect = e-121, Method: Compositional matrix adjust.
Identities = 257/623 (41%), Positives = 366/623 (58%), Gaps = 81/623 (13%)
Query: 16 RCTAPAPFHCANLRNIGYPFWGSNRPEHCGYPGFELDCAGDVPEITIMDRAYKVLHINNE 75
RC+ F C + R++ YP W R E CG+P F+L+C+G EI I +++L +
Sbjct: 253 RCSES--FSCGSQRDLNYPLWKPGR-EECGHPNFKLNCSGGFAEINIASVKFRIL----D 305
Query: 76 SWR--INVAREDYWDYNCPAN-LSNSLLN--FSIFNYASDTQNLTLYYSCPASFMNNISG 130
S+R I +AR DY CPAN L+ + + +T+ LTLYY C + ++I
Sbjct: 306 SYRSLIRLARSDYIGDLCPANPLTAPFIEKFLPVLELTGETELLTLYYGCRFN-SSDIPA 364
Query: 131 ILLPNRFNCSIDGKNTNSYYFSWD-SNSFNSSIRSAIGAYFRSCANSAVIPVWQSTLRYM 189
+ C +G+ SYY + + S+ S R + C + +P L +
Sbjct: 365 NIYVGELGCD-EGR---SYYVTRNLSSPLLDSSRGVLNNLREMCKRNVSVPASGPALFDL 420
Query: 190 VNNPNSVNLTCALRVGFGLQWHANNRLCEECKQSNGNCGYIAKTGEFICYCPNGA----Y 245
PN NL AL GF + ++ CE C+ S G CGY + F CYC +G Y
Sbjct: 421 QTRPNQDNLKMALDQGFRMLITSD---CERCRGSGGACGYNQTSSGFGCYCKDGKCGYEY 477
Query: 246 SSSC---HSRTV------------------------------IQALIKKKTREDDRNVEA 272
H R + +Q K+KT ++ R
Sbjct: 478 DDGFFRRHRRFIATLVRYTFIALGALTGVVIVFLVLLCPCFRVQIFRKRKTSDEVR---- 533
Query: 273 FIRNHESLAP-KRYSYSDVKRMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSR-C 330
++ ++L P K Y+Y++VK+MTKSF + +G+GG+G VY G L D +VAVKVLK+S+
Sbjct: 534 -LQKLKALIPLKHYTYAEVKKMTKSFTEVVGRGGFGIVYSGTLSDSSMVAVKVLKDSKGT 592
Query: 331 NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWK 390
+GE+FINEVAS+S+TSHVNIV+ LGFC E + A+IYE + NGSLDKFI + ++ L+ K
Sbjct: 593 DGEDFINEVASMSQTSHVNIVSLLGFCCEGSRRAIIYEFLGNGSLDKFISDKSSVNLDLK 652
Query: 391 TMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450
T+Y IA+G+ARGLEYLH GC+ RIVHFDIKPQN+LLD++ CPK+SDFGLAK +KKES +
Sbjct: 653 TLYGIALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLCPKVSDFGLAKLCEKKESIL 712
Query: 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNL---DDEVTDTSIC 507
S+L RGTIGYIAPE+ SR +G VSHKSDVYSYGM+++EM+G K + +D S
Sbjct: 713 SLLDTRGTIGYIAPEMISRLYGSVSHKSDVYSYGMLVLEMIGARKKERFDQNSRSDGSSI 772
Query: 508 H--NLIYERIEPGNDFQFD----------GVATEEEKKIAKMMILVGFWCIQTNPSERPS 555
+ IY+ +E N + G+++EEE +IA+ M LVG WCIQ++PS+RP
Sbjct: 773 YFPEWIYKDLEKANIKDIEKTENGGLIENGISSEEE-EIARKMTLVGLWCIQSSPSDRPP 831
Query: 556 MHKVLEMLEGSIENLQIPPKPSL 578
M+KV+EM+EGS++ L++PP+P L
Sbjct: 832 MNKVVEMMEGSLDALEVPPRPVL 854
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FID5|Y5393_ARATH Probable receptor-like protein kinase At5g39030 OS=Arabidopsis thaliana GN=At5g39030 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 360 bits (925), Expect = 1e-98, Method: Compositional matrix adjust.
Identities = 178/352 (50%), Positives = 252/352 (71%), Gaps = 11/352 (3%)
Query: 236 FICYCPNGAYSSSCHSRTVIQALIKKKTREDDRNVEAFIRNHESLAPKRYSYSDVKRMTK 295
FI P ++ + +K+K R+++R V F + Y+Y+++K++TK
Sbjct: 445 FIAVGPGTGLATFVVVLMLWMRQMKRKNRKEER-VVMFKK-----LLNMYTYAELKKITK 498
Query: 296 SFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLG 355
SF +G+GG+G VY G L +G+ VAVKVLK+ + + E+FINEVAS+S+TSHVNIV+ LG
Sbjct: 499 SFSYIIGKGGFGTVYGGNLSNGRKVAVKVLKDLKGSAEDFINEVASMSQTSHVNIVSLLG 558
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
FC+E K A++YE + NGSLD+F+ ++++ + T+Y IA+GIARGLEYLH GC+ RIV
Sbjct: 559 FCFEGSKRAIVYEFLENGSLDQFMSRNKSLTQDVTTLYGIALGIARGLEYLHYGCKTRIV 618
Query: 416 HFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVS 475
HFDIKPQNILLD + CPK+SDFGLAK +K+ES +S++ RGTIGYIAPEV+SR +G VS
Sbjct: 619 HFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGTIGYIAPEVFSRMYGRVS 678
Query: 476 HKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICH----NLIYERIEPGND-FQFDGVATEE 530
HKSDVYS+GM++I+M+G E D++ + IY+ +E G + F T+E
Sbjct: 679 HKSDVYSFGMLVIDMIGARSKEIVETVDSAASSTYFPDWIYKDLEDGEQTWIFGDEITKE 738
Query: 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQIPPKPSLFSAT 582
EK+IAK MI+VG WCIQ PS+RPSM++V+EM+EGS++ L+IPPKPS+ +T
Sbjct: 739 EKEIAKKMIVVGLWCIQPCPSDRPSMNRVVEMMEGSLDALEIPPKPSMHIST 790
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FID6|Y5392_ARATH Probable receptor-like protein kinase At5g39020 OS=Arabidopsis thaliana GN=At5g39020 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 358 bits (920), Expect = 4e-98, Method: Compositional matrix adjust.
Identities = 171/328 (52%), Positives = 242/328 (73%), Gaps = 5/328 (1%)
Query: 253 TVIQALIKKKTREDDRNVEAFIRNHESLAPKRYSYSDVKRMTKSFRDKLGQGGYGEVYKG 312
+I LI++ R+ ++ + I L K+Y Y+++K++TKSF +G+GG+G VY+G
Sbjct: 456 VIIMLLIRQMKRKKNKKENSVIMFK--LLLKQYIYAELKKITKSFSHTVGKGGFGTVYRG 513
Query: 313 ELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372
L +G+ VAVKVLK+ + NG++FINEV S+S+TSHVNIV+ LGFCYE K A+I E + +
Sbjct: 514 NLSNGRTVAVKVLKDLKGNGDDFINEVTSMSQTSHVNIVSLLGFCYEGSKRAIISEFLEH 573
Query: 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCP 432
GSLD+FI ++++ T+Y IA+GIARGLEYLH GC+ RIVHFDIKPQNILLD++FCP
Sbjct: 574 GSLDQFISRNKSLTPNVTTLYGIALGIARGLEYLHYGCKTRIVHFDIKPQNILLDDNFCP 633
Query: 433 KISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG 492
K++DFGLAK +K+ES +S++ RGTIGYIAPEV SR +GG+SHKSDVYSYGM++++M+G
Sbjct: 634 KVADFGLAKLCEKRESILSLIDTRGTIGYIAPEVVSRMYGGISHKSDVYSYGMLVLDMIG 693
Query: 493 CTKNLDDEVTDTSICH--NLIYERIEPGNDFQFDG-VATEEEKKIAKMMILVGFWCIQTN 549
++ + S + + IY+ +E G+ G EE+ KI K MILV WCI+
Sbjct: 694 ARNKVETTTCNGSTAYFPDWIYKDLENGDQTWIIGDEINEEDNKIVKKMILVSLWCIRPC 753
Query: 550 PSERPSMHKVLEMLEGSIENLQIPPKPS 577
PS+RP M+KV+EM+EGS++ L++PPKPS
Sbjct: 754 PSDRPPMNKVVEMIEGSLDALELPPKPS 781
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 244 bits (623), Expect = 1e-63, Method: Compositional matrix adjust.
Identities = 131/305 (42%), Positives = 188/305 (61%), Gaps = 15/305 (4%)
Query: 281 APKRYSYSDVKRMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGE-EFINEV 339
+P ++Y D++ T +F LG GG+G VYKG + LVAVK L + +GE EFI EV
Sbjct: 516 SPVSFTYRDLQNCTNNFSQLLGSGGFGTVYKGTVAGETLVAVKRLDRALSHGEREFITEV 575
Query: 340 ASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIK--LEWKTMYQIAI 397
+I H+N+V G+C E+ L+YE M NGSLDK+I + L+W+T ++IA+
Sbjct: 576 NTIGSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAV 635
Query: 398 GIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARG 457
A+G+ Y H C+ RI+H DIKP+NILLD++FCPK+SDFGLAK ++ S + + RG
Sbjct: 636 ATAQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHVVTM-IRG 694
Query: 458 TIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICH-NLIYERIE 516
T GY+APE S R ++ K+DVYSYGM+++E+VG +NLD + Y+ +
Sbjct: 695 TRGYLAPEWVSNR--PITVKADVYSYGMLLLEIVGGRRNLDMSYDAEDFFYPGWAYKELT 752
Query: 517 PGN-----DFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQ 571
G D + GVA EEE A + V FWCIQ S RPSM +V+++LEG+ + +
Sbjct: 753 NGTSLKAVDKRLQGVAEEEEVVKA---LKVAFWCIQDEVSMRPSMGEVVKLLEGTSDEIN 809
Query: 572 IPPKP 576
+PP P
Sbjct: 810 LPPMP 814
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 243 bits (619), Expect = 4e-63, Method: Compositional matrix adjust.
Identities = 130/310 (41%), Positives = 189/310 (60%), Gaps = 9/310 (2%)
Query: 277 HESLAPKRYSYSDVKRMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFI 336
+ S AP +++Y +++R TKSF++KLG GG+G VY+G L + +VAVK L+ ++F
Sbjct: 466 YASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGIEQGEKQFR 525
Query: 337 NEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIK-LEWKTMYQI 395
EVA+IS T H+N+V +GFC + + L+YE M NGSLD F+ + K L W+ + I
Sbjct: 526 MEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNI 585
Query: 396 AIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHA 455
A+G A+G+ YLH C+ IVH DIKP+NIL+D++F K+SDFGLAK K++ +M
Sbjct: 586 ALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSV 645
Query: 456 RGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLD-DEVTDTSICHNLIYER 514
RGT GY+APE + ++ KSDVYSYGM+++E+V +N D E T+ YE
Sbjct: 646 RGTRGYLAPEWLANL--PITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKFSIWAYEE 703
Query: 515 IEPGNDFQFDGVATEEEKKI----AKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENL 570
E GN E++ + M+ FWCIQ P +RP+M KV++MLEG I +
Sbjct: 704 FEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEG-ITEI 762
Query: 571 QIPPKPSLFS 580
+ P P S
Sbjct: 763 KNPLCPKTIS 772
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 236 bits (602), Expect = 4e-61, Method: Compositional matrix adjust.
Identities = 133/340 (39%), Positives = 197/340 (57%), Gaps = 20/340 (5%)
Query: 250 HSRTVIQALIKKKTREDDRNVEAFIRNHESLAPKRYSYSDVKRMTKSFRDKLGQGGYGEV 309
H R + +++ E+D F+ N + P R++Y D++ T +F KLGQGG+G V
Sbjct: 453 HKRKKMILEAPQESSEEDN----FLENLSGM-PIRFAYKDLQSATNNFSVKLGQGGFGSV 507
Query: 310 YKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369
Y+G LPDG +AVK L+ +EF EV+ I H+++V GFC E L YE
Sbjct: 508 YEGTLPDGSRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEF 567
Query: 370 MPNGSLDKFI--HNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLD 427
+ GSL+++I D ++ L+W T + IA+G A+GL YLH C RIVH DIKP+NILLD
Sbjct: 568 LSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLD 627
Query: 428 EDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMI 487
++F K+SDFGLAK +++S + RGT GY+APE + +S KSDVYSYGM++
Sbjct: 628 DNFNAKVSDFGLAKLMTREQSHV-FTTMRGTRGYLAPEWITNY--AISEKSDVYSYGMVL 684
Query: 488 IEMVGCTKNLDDEVTDTSICH--NLIYERIEPGN-----DFQFDGVATEEEKKIAKMMIL 540
+E++G KN D T + CH + ++++E G D + V +E+ + +
Sbjct: 685 LELIGGRKNYDPSET-SEKCHFPSFAFKKMEEGKLMDIVDGKMKNVDVTDER--VQRAMK 741
Query: 541 VGFWCIQTNPSERPSMHKVLEMLEGSIENLQIPPKPSLFS 580
WCIQ + RPSM KV++MLEG +Q P ++ S
Sbjct: 742 TALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPPSSSTMGS 781
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 229 bits (585), Expect = 3e-59, Method: Compositional matrix adjust.
Identities = 133/339 (39%), Positives = 198/339 (58%), Gaps = 14/339 (4%)
Query: 248 SCHSRTVIQALIKKKTR-EDDRNVEAFIRNHESLAPKRYSYSDVKRMTKSF--RDKLGQG 304
S S VI + K++ R DD + + + P ++YS++K T+ F +KLG+G
Sbjct: 648 SIISGVVIFIIRKRRKRYTDDEEILSM-----DVKPYTFTYSELKSATQDFDPSNKLGEG 702
Query: 305 GYGEVYKGELPDGQLVAVKVLK-NSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKN 363
G+G VYKG+L DG+ VAVK+L SR +F+ E+ +IS H N+V G CYE +
Sbjct: 703 GFGPVYKGKLNDGREVAVKLLSVGSRQGKGQFVAEIVAISAVQHRNLVKLYGCCYEGEHR 762
Query: 364 ALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQN 423
L+YE +PNGSLD+ + ++ + L+W T Y+I +G+ARGL YLH ++RIVH D+K N
Sbjct: 763 LLVYEYLPNGSLDQALFGEKTLHLDWSTRYEICLGVARGLVYLHEEARLRIVHRDVKASN 822
Query: 424 ILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSY 483
ILLD PK+SDFGLAK K++ IS A GTIGY+APE Y+ R G ++ K+DVY++
Sbjct: 823 ILLDSKLVPKVSDFGLAKLYDDKKTHISTRVA-GTIGYLAPE-YAMR-GHLTEKTDVYAF 879
Query: 484 GMMIIEMVGCTKNLDDEVTDTS-ICHNLIYERIEPGNDFQF-DGVATEEEKKIAKMMILV 541
G++ +E+V N D+ + D + E G + + D TE + K MI +
Sbjct: 880 GVVALELVSGRPNSDENLEDEKRYLLEWAWNLHEKGREVELIDHQLTEFNMEEGKRMIGI 939
Query: 542 GFWCIQTNPSERPSMHKVLEMLEGSIENLQIPPKPSLFS 580
C QT+ + RP M +V+ ML G +E + KP +
Sbjct: 940 ALLCTQTSHALRPPMSRVVAMLSGDVEVSDVTSKPGYLT 978
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 228 bits (580), Expect = 1e-58, Method: Compositional matrix adjust.
Identities = 130/315 (41%), Positives = 177/315 (56%), Gaps = 32/315 (10%)
Query: 285 YSYSDVKRMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISR 344
+SY +++ TK+F DKLG GG+G V+KG LPD +AVK L+ ++F EV +I
Sbjct: 483 FSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGISQGEKQFRTEVVTIGT 542
Query: 345 TSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFI---HNDRNIKLEWKTMYQIAIGIAR 401
HVN+V GFC E K L+Y+ MPNGSLD + + I L WK +QIA+G AR
Sbjct: 543 IQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTAR 602
Query: 402 GLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGY 461
GL YLH C+ I+H DIKP+NILLD FCPK++DFGLAK + S + + RGT GY
Sbjct: 603 GLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRV-LTTMRGTRGY 661
Query: 462 IAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDE---------------VTDTSI 506
+APE S ++ K+DVYSYGMM+ E+V +N + +T
Sbjct: 662 LAPEWISGV--AITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPSWAATILTKDGD 719
Query: 507 CHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGS 566
+L+ R+E D V EE + K V WCIQ S RP+M +V+++LEG
Sbjct: 720 IRSLVDPRLEG------DAVDIEEVTRACK----VACWCIQDEESHRPAMSQVVQILEGV 769
Query: 567 IENLQIPPKPSLFSA 581
+E + PP P A
Sbjct: 770 LE-VNPPPFPRSIQA 783
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 226 bits (576), Expect = 4e-58, Method: Compositional matrix adjust.
Identities = 129/326 (39%), Positives = 190/326 (58%), Gaps = 13/326 (3%)
Query: 260 KKKTREDDRNVEAFIRNHESLAPKRYSYSDVKRMTKSF--RDKLGQGGYGEVYKGELPDG 317
++K DD + + P ++YS++K T+ F +KLG+GG+G VYKG L DG
Sbjct: 662 RRKRYTDDEELLGM-----DVKPYIFTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDG 716
Query: 318 QLVAVKVLK-NSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLD 376
++VAVK+L SR +F+ E+ +IS H N+V G C+E + L+YE +PNGSLD
Sbjct: 717 RVVAVKLLSVGSRQGKGQFVAEIVAISSVLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLD 776
Query: 377 KFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISD 436
+ + D+ + L+W T Y+I +G+ARGL YLH VRIVH D+K NILLD P+ISD
Sbjct: 777 QALFGDKTLHLDWSTRYEICLGVARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISD 836
Query: 437 FGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKN 496
FGLAK K++ IS A GTIGY+APE Y+ R G ++ K+DVY++G++ +E+V N
Sbjct: 837 FGLAKLYDDKKTHISTRVA-GTIGYLAPE-YAMR-GHLTEKTDVYAFGVVALELVSGRPN 893
Query: 497 LDDEV-TDTSICHNLIYERIEPGNDFQF-DGVATEEEKKIAKMMILVGFWCIQTNPSERP 554
D+ + + + E D + D T+ + AK MI + C QT+ + RP
Sbjct: 894 SDENLEEEKKYLLEWAWNLHEKSRDIELIDDKLTDFNMEEAKRMIGIALLCTQTSHALRP 953
Query: 555 SMHKVLEMLEGSIENLQIPPKPSLFS 580
M +V+ ML G +E + KP S
Sbjct: 954 PMSRVVAMLSGDVEIGDVTSKPGYVS 979
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 217 bits (552), Expect = 2e-55, Method: Compositional matrix adjust.
Identities = 130/362 (35%), Positives = 195/362 (53%), Gaps = 21/362 (5%)
Query: 227 CGYIAKTGEFICYCPNGAYSSSCHSRTVIQALIKKKTREDDRNVEAFIRNHESLAPKRYS 286
C + T F+ + + +Y + S+ ++K + R+ R N +L + ++
Sbjct: 469 CSVLLGTSAFVIFDTSCSYRKTKKSKN----MMKNQARDIGRTTATTTANELNL--RVFT 522
Query: 287 YSDVKRMTKSFRDKLGQGGYGEVYKG--ELPDGQLVAVKVLKNSRC---NGEEFINEVAS 341
Y ++ T+ F ++LG+G +G VYKG E+ G V V V K R N +EF NEV
Sbjct: 523 YGELAEATRDFTEELGRGAFGIVYKGYLEVAGGSEVTVAVKKLDRLDLDNEKEFKNEVKV 582
Query: 342 ISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIAR 401
I + H N+V +GFC E + ++YE +P G+L F+ R + W+ IA+ IAR
Sbjct: 583 IGQIHHKNLVRLIGFCNEGQSQMIVYEFLPQGTLANFLF--RRPRPSWEDRKNIAVAIAR 640
Query: 402 GLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGY 461
G+ YLH C +I+H DIKPQNILLDE + P+ISDFGLAK ++ ++ + RGT GY
Sbjct: 641 GILYLHEECSEQIIHCDIKPQNILLDEYYTPRISDFGLAKLLLMNQT-YTLTNIRGTKGY 699
Query: 462 IAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPG--N 519
+APE + R ++ K DVYSYG+M++E+V C K +D E D I N Y+ G
Sbjct: 700 VAPEWF--RNSPITSKVDVYSYGVMLLEIVCCKKAVDLE--DNVILINWAYDCFRQGRLE 755
Query: 520 DFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQIPPKPSLF 579
D D + + + + + WCIQ RP+M V +MLEG I+ PP PS +
Sbjct: 756 DLTEDDSEAMNDMETVERYVKIAIWCIQEEHGMRPNMRNVTQMLEGVIQVFD-PPNPSPY 814
Query: 580 SA 581
S
Sbjct: 815 ST 816
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 582 | ||||||
| 224111934 | 661 | predicted protein [Populus trichocarpa] | 0.979 | 0.862 | 0.503 | 1e-168 | |
| 224127698 | 580 | predicted protein [Populus trichocarpa] | 0.960 | 0.963 | 0.514 | 1e-165 | |
| 255551426 | 638 | serine/threonine kinase, putative [Ricin | 0.943 | 0.860 | 0.511 | 1e-163 | |
| 296087257 | 584 | unnamed protein product [Vitis vinifera] | 0.812 | 0.809 | 0.514 | 1e-147 | |
| 297734241 | 667 | unnamed protein product [Vitis vinifera] | 0.962 | 0.839 | 0.466 | 1e-145 | |
| 359491461 | 1963 | PREDICTED: uncharacterized protein LOC10 | 0.962 | 0.285 | 0.466 | 1e-143 | |
| 356511307 | 669 | PREDICTED: probable receptor-like protei | 0.934 | 0.813 | 0.443 | 1e-139 | |
| 357508157 | 740 | Ser/Thr protein kinase [Medicago truncat | 0.917 | 0.721 | 0.443 | 1e-135 | |
| 62857020 | 691 | Ser/Thr protein kinase [Lotus japonicus] | 0.917 | 0.772 | 0.452 | 1e-134 | |
| 357508155 | 665 | Kinase R-like protein [Medicago truncatu | 0.919 | 0.804 | 0.446 | 1e-133 |
| >gi|224111934|ref|XP_002332866.1| predicted protein [Populus trichocarpa] gi|222833668|gb|EEE72145.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 598 bits (1543), Expect = e-168, Method: Compositional matrix adjust.
Identities = 313/622 (50%), Positives = 395/622 (63%), Gaps = 52/622 (8%)
Query: 2 CKTKPILA-----YFECSPRCTAPAPFHCANLRNIGYPFWGSNRPEHCGYPGFELDCAGD 56
C + P+ A Y C F C N++ +GYPF GS+RP++CGYPGFEL C+
Sbjct: 14 CGSAPVFADDDERYLNCMKS------FDCGNIKGVGYPFSGSDRPDYCGYPGFELGCSNQ 67
Query: 57 VPEITIMDRAYKVLHINNESWRINVAREDYWDYNCPANLSNSLLNFSIFNYASDTQNLTL 116
PEITIM YK+L INN+S +NV+R DY + CP LSN+ LN ++ Y SD +TL
Sbjct: 68 DPEITIMRSTYKLLGINNQSRTLNVSRSDYTENLCPTLLSNTSLNPNLLTYTSDHAEVTL 127
Query: 117 YYSCPASFMNNISGILLPNRFNCSIDGKNTNSYYFSWDSNSFNSSIRSAIGAYFRSCANS 176
YY CP+ +G +F C+I+ Y+ + + + + + S I +Y +C NS
Sbjct: 128 YYGCPSPSPALPAG--FSAQFACNINNTVMMGYFITANLSVISMTDPSFI-SYLTTCNNS 184
Query: 177 AVIPVWQSTLRYMVNNPNSVNLTCALRVGFGLQWHANNRLCEECKQSNGNCGYIAKTGEF 236
+P QS + ++ NP L A+ GF L W AN+ LC+ CK S G CGY T F
Sbjct: 185 VKVPALQSAVMPILANPTVAQLLGAINQGFELVWSANDSLCDTCKSSGGLCGYNQTTTAF 244
Query: 237 ICYCPNGAYSSSCHSR-------------------------------TVIQALIKKKTRE 265
CYC + C + VI + K +
Sbjct: 245 TCYCADQPQDFECSASPQVPSISAAAAAILTLSVITIYLTRREGSFSAVIAMTFRLKKPQ 304
Query: 266 DDRNVEAFIRNHESLAPKRYSYSDVKRMTKSFRDKLGQGGYGEVYKGELPD-GQLVAVKV 324
VE F+ ++ SL PKRYSYSD+K+MTKSF + LG+GG+G VY+G+LPD G+LVAVKV
Sbjct: 305 HVGRVETFMMDYHSLTPKRYSYSDIKKMTKSFVNTLGEGGFGNVYRGKLPDDGRLVAVKV 364
Query: 325 LKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHND-- 382
LK S+ +GEEF+NEVASISRTSHVN+VT LGFCYE K ALIYE MPNGSLD FI N
Sbjct: 365 LKESKGDGEEFMNEVASISRTSHVNVVTLLGFCYERNKRALIYEFMPNGSLDSFISNKGS 424
Query: 383 --RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLA 440
N +LEWK +Y+IA+GIARGLEYLHRGC RIVHFDIKP NILLDEDFCPKISDFGLA
Sbjct: 425 PHTNCRLEWKKLYEIAVGIARGLEYLHRGCNTRIVHFDIKPHNILLDEDFCPKISDFGLA 484
Query: 441 KQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDE 500
K + K S ISM+ ARGT GYIAPEV+ R FGGV++KSDVYSYGMM++EMVG +K+ D
Sbjct: 485 KLCKSKVSKISMIGARGTAGYIAPEVFCRSFGGVTYKSDVYSYGMMVLEMVGKSKDFDMG 544
Query: 501 VTDTSICH--NLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHK 558
+T+ + + Y ++PG F G TEEEK+I K MILVG WCIQT PS RPSM K
Sbjct: 545 SLETNELYFPDWFYMYLDPGEISTFHGGITEEEKEIVKKMILVGLWCIQTIPSHRPSMTK 604
Query: 559 VLEMLEGSIENLQIPPKPSLFS 580
V+EM EGS+++LQIPP+PSL S
Sbjct: 605 VVEMFEGSLQSLQIPPRPSLSS 626
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224127698|ref|XP_002329342.1| predicted protein [Populus trichocarpa] gi|222870796|gb|EEF07927.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 587 bits (1514), Expect = e-165, Method: Compositional matrix adjust.
Identities = 302/587 (51%), Positives = 391/587 (66%), Gaps = 28/587 (4%)
Query: 10 YFECSPRCTAPAPFHCANLRNIGYPFWGSNRPEHCGYPGFELDCAGDVPEITIMDRAYKV 69
Y CS F C N++NI YPFWG NRP++CGYPGF LDC+GD P I I + AY+V
Sbjct: 4 YLSCS------KSFECGNIQNITYPFWGVNRPQYCGYPGFHLDCSGDAPVIKISEVAYQV 57
Query: 70 LHINNESWRINVAREDYWDYNCPANLSNSLLNFSIFNYASDTQNLTLYYSCPASFMNNIS 129
L I + S R+++ +Y D C NS + F+YAS+T+N+ LYY CP +
Sbjct: 58 LEIKSMS-RVHLISTEYTDNICSIPPVNSTFDSDRFSYASNTKNIMLYYGCPTIPSQFLP 116
Query: 130 GILLPNRFNCSIDGKNTNSYYFSWD-SNSFNSSIRSAIGAYFRSCANSAVIPVWQSTLRY 188
+ L +F+C+I + YY + + S S S + I +Y SC +S +IP ++S +R
Sbjct: 117 TLGLSYQFSCNISRTDMVGYYLTRNLSMSATGSFAANISSYLESCNHSVLIPAYESAVRS 176
Query: 189 MVNNPNSVNLTCALRVGFGLQWHANNRLCEECKQSNGNCGYIAKTGEFICYCPNGAYSSS 248
+ ++P + NLT AL GF LQW AN+ LC +CK S G CGY T +F CY A +
Sbjct: 177 IESHPTAANLTNALHRGFWLQWTANDSLCNKCKFSGGQCGYNTDTSKFTCYFVTLAMYTM 236
Query: 249 --------CHSRTVIQALIKKKTREDDR---NVEAFIRNHESLAPKRYSYSDVKRMTKSF 297
C R + + + R++ + N+E I N SL PKRY+YS++K+MT SF
Sbjct: 237 IAVTIIVLCSRRGLSRGRMTSFWRQNAQHNLNIETIIMNSHSLTPKRYTYSEIKKMTNSF 296
Query: 298 RDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFC 357
DKLGQGG+G VYKGELPDG+ VAVKVLKNS+ +GEEF+NEV SISRTSHVNIVT LGFC
Sbjct: 297 VDKLGQGGFGGVYKGELPDGRPVAVKVLKNSKGDGEEFVNEVVSISRTSHVNIVTLLGFC 356
Query: 358 YENKKNALIYELMPNGSLDKFIHNDRNI----KLEWKTMYQIAIGIARGLEYLHRGCQVR 413
+E K ALIYE MPNGSLDKFI+ ++ L+W+ +Y+IA+GI RGLEYLHRGC R
Sbjct: 357 FERTKRALIYEYMPNGSLDKFIYRQTSLHGKYNLQWEKLYEIAVGIGRGLEYLHRGCNTR 416
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGG 473
IVHFDIKP NILLD DFCPKISDFGLAK +++ES +SM ARGT GYIAPEV+ + FGG
Sbjct: 417 IVHFDIKPHNILLDTDFCPKISDFGLAKLCKREESMVSMTGARGTAGYIAPEVFCKNFGG 476
Query: 474 VSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTS--ICHNLIYERIEPGNDFQFDGVATEEE 531
VS+KSDVYSYGMM++EMVG +N+D + +S N +YE E + GV T+E
Sbjct: 477 VSYKSDVYSYGMMVLEMVGGKRNIDIGESQSSEIFLPNCMYESEEVSS---LHGVITDET 533
Query: 532 KKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQIPPKPSL 578
++ K M+ VG WC+QTNP +RPSM KV+EMLEGS++ LQ PPKP L
Sbjct: 534 EETIKKMVTVGLWCVQTNPLDRPSMTKVVEMLEGSLQFLQTPPKPFL 580
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255551426|ref|XP_002516759.1| serine/threonine kinase, putative [Ricinus communis] gi|223544132|gb|EEF45657.1| serine/threonine kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 580 bits (1495), Expect = e-163, Method: Compositional matrix adjust.
Identities = 304/594 (51%), Positives = 389/594 (65%), Gaps = 45/594 (7%)
Query: 23 FHCANLRNIGYPFWGSNRPEHCGYPGFELDCAGDVPEITIMDRAYKVLHINNESWRINVA 82
F C N+ +IGYPFWGSNRP++CG+P FEL+C G IT+ + Y+VL IN+E + VA
Sbjct: 39 FKCGNIPDIGYPFWGSNRPQYCGHPEFELNCTGQTAVITVEELTYQVLEINSEEKTLKVA 98
Query: 83 REDYWDYNCPANLSNSLLNFSIFNYASDTQNLTLYYSCPASFMNNISGIL-LPNRFNCSI 141
R DY D CP+N ++ LNF+ F+Y SD Q +TLYY CP S N + + N+F+C+
Sbjct: 99 RTDYIDNICPSNPVSTTLNFNYFSYTSDIQIITLYYGCPQS--NPMPTLQDFTNQFSCN- 155
Query: 142 DGKNTNSYYFSWDSNSFNSSIRSAIGAYFRSCANSAVIPVWQSTLRYMVNNPNSVNLTCA 201
++N ++ + + S++ +A+ YFR+C ++P QS ++ + N PN NL A
Sbjct: 156 ---DSNGFFVTRNL----SNLTAALMTYFRTCDVEVIVPANQSAVQSLENRPNQENLVIA 208
Query: 202 LRVGFGLQWHANNRLCEECKQSNGNCGYIAKTGE-FICYCPNGAYSSSC----------- 249
L GFGL+W N+ CE C S G CG + F CYC NG SC
Sbjct: 209 LEQGFGLEWRENST-CETCNMSGGQCGSNSTDPSLFACYCTNGPDPFSCGRSQSSGLGAA 267
Query: 250 --------------HSRTVIQALIKKKTREDDRNVEAFIRNHESLAPKRYSYSDVKRMTK 295
R + + K + D +E FI N++S PKRYSYSD++RMT
Sbjct: 268 AAVLTICLGIYYCFTRRVRFLSDTRWKNVKKDEKIENFILNYQSFMPKRYSYSDIQRMTN 327
Query: 296 SFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLG 355
SF KLGQGG+G VYKG+L DG++VAVKVL S +GEEFINEVASISRTSH+N+VT LG
Sbjct: 328 SFNHKLGQGGFGGVYKGKLLDGRVVAVKVLSKSTGDGEEFINEVASISRTSHINVVTLLG 387
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDR----NIKLEWKTMYQIAIGIARGLEYLHRGCQ 411
FCYE K ALIYE MPNGSLDKFI++ N L+WKT+Y I +GIARGLEYLHRGC
Sbjct: 388 FCYERSKRALIYEYMPNGSLDKFIYDQGSQGVNKHLDWKTLYDITVGIARGLEYLHRGCN 447
Query: 412 VRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRF 471
RIVHFDIKP NILLD+DFCPK+SDFGLAK + KES I+ML ARGTIGYIAPE++ R F
Sbjct: 448 TRIVHFDIKPHNILLDKDFCPKVSDFGLAKLCKGKESIITMLGARGTIGYIAPEIFIRNF 507
Query: 472 GGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICH--NLIYERIEPGNDFQFDGVATE 529
GGVS+KSDVYSYGMMI+E+ G D V+ + + IY+ IE T+
Sbjct: 508 GGVSYKSDVYSYGMMILEICGGRNKSDVGVSHSGEVYFPECIYKYIESEQVSTLHEKITD 567
Query: 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG-SIENLQIPPKPSLFSAT 582
EE ++ + + +VG WCIQTNPS+RPSM KV+EMLEG S+E+LQIPPKPSLF+ T
Sbjct: 568 EEGEMVRRLTIVGLWCIQTNPSDRPSMTKVVEMLEGSSLESLQIPPKPSLFAPT 621
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296087257|emb|CBI33631.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 530 bits (1364), Expect = e-147, Method: Compositional matrix adjust.
Identities = 277/538 (51%), Positives = 349/538 (64%), Gaps = 65/538 (12%)
Query: 21 APFHCANLRNIGYPFWGSNRPEHCGYPGFELDCAGDVPEITIMDRAYKVLHINNESWRIN 80
A + C N+ I YPFWG +RP +CG+PGFEL C G+ PE T+ + +Y++L INN +
Sbjct: 36 AQYECGNMV-ISYPFWGGSRPPYCGHPGFELTCDGEAPEFTMKEASYRILDINNSFHTLT 94
Query: 81 VAREDYWDYNCPANLSNSLLNFSIFNYASDTQNLTLYYSCPASFMNNISGILLPNRFNCS 140
VAR DYWD CP N+ LN SIF+Y + ++TLYY CP I N+FNC+
Sbjct: 95 VARADYWDSYCPPTYVNTTLNESIFSYNATYTDVTLYYDCPQL------TIAPSNQFNCT 148
Query: 141 IDGKNTNSYYFSWDSNSFNSSIRSAIGAYFRSCANSAVIPVWQSTLRYMVNNPNSVNL-T 199
N YY + D N S+ SC +P++QS +V+ ++ L T
Sbjct: 149 ----NITGYYTTLD---LNLSVSPG------SCGVYVTVPIFQSAATAIVSGGGTLTLLT 195
Query: 200 CALRVGFGLQWHANNRLCEECKQSNGNCGYIAKTGEFICYCPNGAYSSSCHS-------- 251
AL+ GFGL+W+A+N LC EC +S G CGY + +F CYC NG SSC +
Sbjct: 196 EALKGGFGLEWNASNSLCTECVESGGQCGYTSN--QFTCYCRNGYPLSSCQTTRSGSNVL 253
Query: 252 RTVIQALIK------------------------------KKTREDDRNVEAFIRNHESLA 281
R +I ++ KK EDD NVEAFIRN+ SLA
Sbjct: 254 RKIIIGIVAGVATLILVLAMLGCLRIIKCPLACKTLVFWKKESEDDENVEAFIRNYGSLA 313
Query: 282 PKRYSYSDVKRMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVAS 341
PKRY+YSDVK+MT SF KLG+GG+G VYKG+LPDG+++AVK+L S+ NG++FINEVAS
Sbjct: 314 PKRYNYSDVKKMTNSFTSKLGEGGFGCVYKGKLPDGRMMAVKLLSKSKGNGQDFINEVAS 373
Query: 342 ISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHN----DRNIKLEWKTMYQIAI 397
ISRTSHVNIVTF+GFC+E + ALIYE MPNGSLDKFI+N + ++ LEWKTMYQIA+
Sbjct: 374 ISRTSHVNIVTFMGFCFERSRRALIYEFMPNGSLDKFIYNRGSSNESLNLEWKTMYQIAV 433
Query: 398 GIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARG 457
GIARGLEYL+RGC RI+HFDIKP NILLD++F PKISDFGLAK QK ES +SM HARG
Sbjct: 434 GIARGLEYLYRGCNTRILHFDIKPHNILLDQNFIPKISDFGLAKLCQKTESMVSMTHARG 493
Query: 458 TIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERI 515
T GYIAPEV+ R FGGVSHKSDVYSYGM+++EMVG KN+D +V + RI
Sbjct: 494 TTGYIAPEVFCRNFGGVSHKSDVYSYGMLVLEMVGGRKNIDVQVFQLGFISSFSQARI 551
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297734241|emb|CBI15488.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 522 bits (1344), Expect = e-145, Method: Compositional matrix adjust.
Identities = 290/621 (46%), Positives = 388/621 (62%), Gaps = 61/621 (9%)
Query: 10 YFECSPRCTAPAPFHCANLRNIGYPFWGSNRPEHCGYPGFELDCAGD-VPEITIMDRAYK 68
Y EC+ R + C +++ IGYPFWG RP+ CG GFEL C D P I I ++
Sbjct: 41 YEECTSRL-----YECGDMKGIGYPFWGDGRPQFCG-QGFELKCQDDDYPLIAIGSLEFR 94
Query: 69 VLHINNESWRINVAREDYWDYNCPANLSNSLLNFSIFNYASDTQNLTLYYSCPASFMNNI 128
VL+I+N ++ + +AR+D+WD CP ++ LN+++F+YA +NLTL+Y CP ++ +
Sbjct: 95 VLNISNSTYAMRIARKDFWDQTCPKEFQSTTLNYTLFDYAGTDRNLTLFYGCPDEVLSQL 154
Query: 129 SGIL-LPNRFNCSIDGKNTNSYYFSWDSNSFNSSIRSAIGAYFRSCANSAVIPVWQSTLR 187
+ N F S++G N + +++ D AI R+C + +PV + +
Sbjct: 155 PATWNISNNFTGSVEGINDTTVFYA-DEAFLGLDQHLAI---LRTCKINVTLPVLGAAID 210
Query: 188 YMVNN------PNSVNLTCALRVGFGLQWHANNRLCEECKQSNGNCGYIAKTGEFICYCP 241
+ N N L AL +GF + + LC +C S G CG + T +F C C
Sbjct: 211 ELNANRTGGEVSNGEGLEKALNMGFDVDYSVVTGLCVQCNASGGICGS-SSTSQFSCLCR 269
Query: 242 NGAYSSSCHS-------RTVIQALIK-----------------------------KKTRE 265
+ +Y SC +T++ A++ +K +
Sbjct: 270 DKSYPYSCQKSESANIPKTIMMAVVAAGVGTLFASILIIFCFKRKISKHRLMFIWRKRSD 329
Query: 266 DDRNVEAFIRNHESLAPKRYSYSDVKRMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVL 325
D+N+E F+RN+ S APKRYSYS+VK+MT +F+DKLGQGGYG VYKG+L DG LVAVKVL
Sbjct: 330 ADQNIEEFVRNYGSQAPKRYSYSNVKKMTNAFKDKLGQGGYGGVYKGKLGDGHLVAVKVL 389
Query: 326 KNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNI 385
S+ NG+EFINEVASISRTSHVNIV LGFC+E K ALIYE M NGSL+ F+ ++ +
Sbjct: 390 NTSKGNGDEFINEVASISRTSHVNIVRLLGFCFEGGKKALIYEFMSNGSLENFLGSENPL 449
Query: 386 K----LEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAK 441
K L W+ +YQIA+GIARGLEYLH GC+ +I+HFD+KP NILLD+DF PKISDFGLAK
Sbjct: 450 KVSKHLGWEKLYQIAVGIARGLEYLHCGCRTKILHFDVKPHNILLDQDFSPKISDFGLAK 509
Query: 442 QAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEV 501
KES ISM ARGTIGY+APEV+ R FG VSHKSDVYSYGMM++EMVG +N++ V
Sbjct: 510 LCPPKESIISMSAARGTIGYVAPEVFCRNFGQVSHKSDVYSYGMMVLEMVGGRQNVNGTV 569
Query: 502 TDTSICH--NLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKV 559
TS + + IY+ +E D +G+ +EE +I + MI+VG WCIQTNPS RP M KV
Sbjct: 570 GHTSETYFPHWIYKHLEQQEDLGLEGIENKEENEITRKMIVVGLWCIQTNPSHRPCMSKV 629
Query: 560 LEMLEGSIENLQIPPKPSLFS 580
+EMLEGSIE LQIPPKP L S
Sbjct: 630 IEMLEGSIEALQIPPKPFLSS 650
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491461|ref|XP_002277015.2| PREDICTED: uncharacterized protein LOC100261246 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 516 bits (1330), Expect = e-143, Method: Compositional matrix adjust.
Identities = 290/621 (46%), Positives = 388/621 (62%), Gaps = 61/621 (9%)
Query: 10 YFECSPRCTAPAPFHCANLRNIGYPFWGSNRPEHCGYPGFELDCAGD-VPEITIMDRAYK 68
Y EC+ R + C +++ IGYPFWG RP+ CG GFEL C D P I I ++
Sbjct: 1337 YEECTSRL-----YECGDMKGIGYPFWGDGRPQFCGQ-GFELKCQDDDYPLIAIGSLEFR 1390
Query: 69 VLHINNESWRINVAREDYWDYNCPANLSNSLLNFSIFNYASDTQNLTLYYSCPASFMNNI 128
VL+I+N ++ + +AR+D+WD CP ++ LN+++F+YA +NLTL+Y CP ++ +
Sbjct: 1391 VLNISNSTYAMRIARKDFWDQTCPKEFQSTTLNYTLFDYAGTDRNLTLFYGCPDEVLSQL 1450
Query: 129 SGIL-LPNRFNCSIDGKNTNSYYFSWDSNSFNSSIRSAIGAYFRSCANSAVIPVWQSTLR 187
+ N F S++G N + +++ D AI R+C + +PV + +
Sbjct: 1451 PATWNISNNFTGSVEGINDTTVFYA-DEAFLGLDQHLAI---LRTCKINVTLPVLGAAID 1506
Query: 188 YMVNN------PNSVNLTCALRVGFGLQWHANNRLCEECKQSNGNCGYIAKTGEFICYCP 241
+ N N L AL +GF + + LC +C S G CG + T +F C C
Sbjct: 1507 ELNANRTGGEVSNGEGLEKALNMGFDVDYSVVTGLCVQCNASGGICGS-SSTSQFSCLCR 1565
Query: 242 NGAYSSSCHS-------RTVIQALIK-----------------------------KKTRE 265
+ +Y SC +T++ A++ +K +
Sbjct: 1566 DKSYPYSCQKSESANIPKTIMMAVVAAGVGTLFASILIIFCFKRKISKHRLMFIWRKRSD 1625
Query: 266 DDRNVEAFIRNHESLAPKRYSYSDVKRMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVL 325
D+N+E F+RN+ S APKRYSYS+VK+MT +F+DKLGQGGYG VYKG+L DG LVAVKVL
Sbjct: 1626 ADQNIEEFVRNYGSQAPKRYSYSNVKKMTNAFKDKLGQGGYGGVYKGKLGDGHLVAVKVL 1685
Query: 326 KNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNI 385
S+ NG+EFINEVASISRTSHVNIV LGFC+E K ALIYE M NGSL+ F+ ++ +
Sbjct: 1686 NTSKGNGDEFINEVASISRTSHVNIVRLLGFCFEGGKKALIYEFMSNGSLENFLGSENPL 1745
Query: 386 K----LEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAK 441
K L W+ +YQIA+GIARGLEYLH GC+ +I+HFD+KP NILLD+DF PKISDFGLAK
Sbjct: 1746 KVSKHLGWEKLYQIAVGIARGLEYLHCGCRTKILHFDVKPHNILLDQDFSPKISDFGLAK 1805
Query: 442 QAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEV 501
KES ISM ARGTIGY+APEV+ R FG VSHKSDVYSYGMM++EMVG +N++ V
Sbjct: 1806 LCPPKESIISMSAARGTIGYVAPEVFCRNFGQVSHKSDVYSYGMMVLEMVGGRQNVNGTV 1865
Query: 502 TDTSICH--NLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKV 559
TS + + IY+ +E D +G+ +EE +I + MI+VG WCIQTNPS RP M KV
Sbjct: 1866 GHTSETYFPHWIYKHLEQQEDLGLEGIENKEENEITRKMIVVGLWCIQTNPSHRPCMSKV 1925
Query: 560 LEMLEGSIENLQIPPKPSLFS 580
+EMLEGSIE LQIPPKP L S
Sbjct: 1926 IEMLEGSIEALQIPPKPFLSS 1946
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356511307|ref|XP_003524368.1| PREDICTED: probable receptor-like protein kinase At1g67000-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 500 bits (1288), Expect = e-139, Method: Compositional matrix adjust.
Identities = 269/606 (44%), Positives = 368/606 (60%), Gaps = 62/606 (10%)
Query: 23 FHCANLRNIGYPFWGSNRPEHCGYPGFELDCAGDV-PEITIMDRAYKVLHINNESWRINV 81
F C LRNI YPFWG NRP+ CG GF+L C D + + + + VL+IN + + +
Sbjct: 59 FSCGTLRNISYPFWGGNRPQFCGRNGFKLTCMHDQNTSVQVGSQRFNVLNINQTASTLRM 118
Query: 82 AREDYWDYNCPANLSNSLLNFSIFNYASDTQNLTLYYSCPASFMNNISGILLPNRFNCSI 141
AR D C +N +N+ L+ S F++ S QN+T++Y CP+ +N++ G N F C
Sbjct: 119 ARTDLVYDRCSSNFTNTSLSVSPFSFPSTVQNVTIFYECPSG-INSVVG----NNFTCQN 173
Query: 142 DGKNTNSYYFSWDSNSFNSSIRSAIGAYFRSCANSAVIPVWQSTLRYMVNNPNSVNLTCA 201
D N +++Y + G + + V VW S L A
Sbjct: 174 DSNNKHAFYVVNGTQLKQFPGLQKCGVSVQMQVSEGV--VWDS-------EGGIGALEKA 224
Query: 202 LRVGFGLQWHAN-NRLCEECKQSNGNCGYIA-KTGEFICYCPNGAYSSSCHSRT------ 253
L GF +++ A + C C+ S G CG +F CYC G + S C +
Sbjct: 225 LEKGFDVRYDAELSSQCTACRDSGGACGTNENDLAQFSCYCSGGTHGSLCSTHKSQRKNR 284
Query: 254 ----------------VIQALIKK--------------KTREDDRNVEAFIRNHESLAPK 283
+I +I + K +++D+ +EAF+ + SL K
Sbjct: 285 VLKLVLGFVATGFALPLIAVIICRNKARIWKFILVQVGKIKKNDQVIEAFLESQGSLGLK 344
Query: 284 RYSYSDVKRMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASIS 343
RYS+SD+K++T SF+ KLG+GGYG VYKG+L +G VAVK+L S+ NGEEFINEVASIS
Sbjct: 345 RYSFSDIKKITNSFKIKLGEGGYGSVYKGKLLNGCSVAVKILNESKENGEEFINEVASIS 404
Query: 344 RTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNI------KLEWKTMYQIAI 397
+TSHVNIV+ LGFC + + ALIYE M NGSL+K+IH L W+ ++QIAI
Sbjct: 405 KTSHVNIVSLLGFCLDGSRKALIYEFMSNGSLEKYIHEKTAETKTTTPSLSWERLHQIAI 464
Query: 398 GIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARG 457
GIARGLEYLH+GC RI+HFDIKP NILLDE + PKISDFGLAK + + ES ISM +ARG
Sbjct: 465 GIARGLEYLHKGCNTRILHFDIKPHNILLDEAYRPKISDFGLAKLSTRDESIISMSNARG 524
Query: 458 TIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTS---ICHNLIYER 514
T+GY+APEV+S+ FGGVSHKSDVYSYGMM++EMVG KN+D E + +S +IY++
Sbjct: 525 TVGYVAPEVFSKSFGGVSHKSDVYSYGMMLLEMVGGQKNMDVEASRSSEIYFPQLVIYKK 584
Query: 515 IEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQIPP 574
+E GND DG+ + EE +IAK M +VG WCIQT PS RP++ +V++MLEGS+++L++PP
Sbjct: 585 LEQGNDLGLDGILSGEENEIAKRMTMVGLWCIQTIPSHRPTISRVIDMLEGSVDSLEMPP 644
Query: 575 KPSLFS 580
KP L S
Sbjct: 645 KPFLSS 650
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357508157|ref|XP_003624367.1| Ser/Thr protein kinase [Medicago truncatula] gi|355499382|gb|AES80585.1| Ser/Thr protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 489 bits (1260), Expect = e-135, Method: Compositional matrix adjust.
Identities = 276/623 (44%), Positives = 374/623 (60%), Gaps = 89/623 (14%)
Query: 23 FHC--ANLRNIGYPFWGSNRPEHCGY---PGFELDCAGDVPEITIMDRAYKVLHINNESW 77
F C +++ N+ YP+WG NR ++CG P EL C G VP+ITI Y++L +N +
Sbjct: 116 FTCESSSISNLKYPYWGGNREKYCGVSGDPKMELVCEGSVPKITINLVKYRILEWDNTTQ 175
Query: 78 RINVAREDYWDYNCPANLSNSLLNF-----------SIFNYASDTQNLTLYYSCPASFMN 126
R+ VAR+DYW C N+ ++++N ++F +Q +TL Y C + +
Sbjct: 176 RLRVARDDYWSGICAVNVRDNIMNVGENPKNSTFGNTLFQRDGSSQ-VTLLYGCVENQQS 234
Query: 127 NISGILLPNRFNCSIDGKNTNSYYFSWDSNSFNSSIRSAIGAYFRSCANSAVIPVWQSTL 186
+ GI G+ T+ Y D++S + S I VIP+ +
Sbjct: 235 MVYGITC---------GEYTDVLYTVADADSALPCVSSFI----------IVIPILGTQA 275
Query: 187 RYMVNNPNSVNLTCALRVGFGLQWHANNRLCEECKQSNGNCGYIAKTGEFICYCPNGAYS 246
++VN S L AL+ GF L+W N C+ C S G CG T +F C+C +G+ +
Sbjct: 276 AHVVN---SNGLNQALKNGFELRWTGNYGECQRCIDSGGVCGNDGGT-QFRCFCKDGSNT 331
Query: 247 SSCHSR-------------TVIQA-----------------------------LIKKKTR 264
+SC+S VI A + +K+ +
Sbjct: 332 TSCNSEKATTSRSKRNRRFIVIGASVAGFGVTMFFIIMISCYFKKGIRRQEMTIFRKRRK 391
Query: 265 EDDRNVEAFIRNHESLAPKRYSYSDVKRMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKV 324
D NVE F++++ +RYSY++VKR+T SFRDKLG GGYG VYK L DG+ VAVKV
Sbjct: 392 HVDSNVEVFMQSYNLSIARRYSYTEVKRITNSFRDKLGHGGYGVVYKASLTDGRQVAVKV 451
Query: 325 LKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHN--- 381
+ S+ NGEEFINEVASISRTSH+NIV+ LGFCYE K ALIYE MP GSLDKFI+
Sbjct: 452 INESKGNGEEFINEVASISRTSHLNIVSLLGFCYEVNKRALIYEYMPKGSLDKFIYKSGF 511
Query: 382 -DRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLA 440
D +W T++Q+AIGIARGLEYLH+GC RI+H DIKPQNILLDEDFCPKISDFGLA
Sbjct: 512 PDAVCDFDWNTLFQVAIGIARGLEYLHQGCSSRILHLDIKPQNILLDEDFCPKISDFGLA 571
Query: 441 KQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDE 500
K Q+K+S +S+L RGTIGY+APEV+SR FGGVS+KSDVYSYGM+I+EM+G KN D
Sbjct: 572 KICQRKDSIVSILGTRGTIGYMAPEVFSRAFGGVSYKSDVYSYGMLILEMIGGRKNYDTG 631
Query: 501 VTDTSICH--NLIYERIEPGNDFQFDGVA-TEEEKKIAKMMILVGFWCIQTNPSERPSMH 557
+ TS + + IY+ +E GN +G+ + EE + + + +V WCIQTNPS+RP M+
Sbjct: 632 GSCTSEMYFPDWIYKDLEQGNHTVLNGLTISTEENDMVRKITMVSLWCIQTNPSDRPPMN 691
Query: 558 KVLEMLEGSIENLQIPPKPSLFS 580
KV+EML+G + ++ PPKP LFS
Sbjct: 692 KVIEMLQGPLSSVSYPPKPVLFS 714
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|62857020|dbj|BAD95895.1| Ser/Thr protein kinase [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 486 bits (1250), Expect = e-134, Method: Compositional matrix adjust.
Identities = 278/615 (45%), Positives = 368/615 (59%), Gaps = 81/615 (13%)
Query: 23 FHC--ANLRNIGYPFWGSNRPEHCGYPGFELDCAGDVPEITIMDRAYKVLHINNESWRIN 80
F C +++ N+ YPFWG NR E+CG EL C +ITI Y+V+ + + ++
Sbjct: 60 FSCDGSSVGNLKYPFWGGNRTEYCGQSQLELVCEDRAAKITINSITYRVVKWEDSTQKLT 119
Query: 81 VAREDYWDYNCP-ANLSNSLLNFSIFNYA-SDTQNLTLYYSCPASFMNNISGILLPNRFN 138
VAR+D+W C ++ NS + S F Y S N+TL Y+C + ++ SG +
Sbjct: 120 VARDDFWGGVCAVSDYQNSSFDNSPFQYDFSGDNNVTLLYNCGS--IDPPSGF-----YR 172
Query: 139 CSIDGKNTNSYYFSWDSNSFNSSIRSAIGAY-FRSCANSAVIPVWQSTLRYMVNNPNSVN 197
S DG + YY +G F S S V+PV S + + + N
Sbjct: 173 SSCDGGSRVVYYIV------------GVGPLSFASACTSVVVPVLASQVSALASTAG--N 218
Query: 198 LTCALRVGFGLQWHANNRLCEECKQSNGNCGYIAKTGEFICYCPNGAYSSSCHS------ 251
+ L GFGL+W N + C C + G CG+ G+F C+C +G + SSC S
Sbjct: 219 IDEVLNEGFGLRWSGNYQECTGCLDTRGACGF---DGKFRCFCEDGPHQSSCISDRAPAP 275
Query: 252 --------RTVI------------------------------QALI-KKKTREDDRNVEA 272
R ++ Q +I +K++ + +VEA
Sbjct: 276 DKRRGSTTRNIVIGVAASCVGGLVAIISIAIYIRRKFKSLSGQTMISRKRSTFVEHDVEA 335
Query: 273 FIRNHESLAPKRYSYSDVKRMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNG 332
F++++ SLAP+RYSYS+VKR+T SF KLGQGGYG VYK LPDG+LVAVKV+ S +G
Sbjct: 336 FMQSYGSLAPRRYSYSEVKRITNSFVHKLGQGGYGVVYKATLPDGRLVAVKVISESGGSG 395
Query: 333 EEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIK----LE 388
E+FINEV+SISRTSHVNIV+ LGFCY+ + LIYE MPNGSLD FI+ + +
Sbjct: 396 EDFINEVSSISRTSHVNIVSLLGFCYDKNRRVLIYEFMPNGSLDNFINGMGSPNAICCFD 455
Query: 389 WKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448
W T+Y++AIGIARGLEYLH+GC RI+H DIKPQNILLDED CPKI+DFGLAK ++KES
Sbjct: 456 WNTLYKVAIGIARGLEYLHQGCNTRILHLDIKPQNILLDEDLCPKIADFGLAKICKRKES 515
Query: 449 AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTS--- 505
+SML RGT GYIAPEV+SR FGGVSHKSDVYS+GM+I+EMVG KN D S
Sbjct: 516 IVSMLGTRGTPGYIAPEVFSRAFGGVSHKSDVYSFGMLILEMVGGRKNYDSGGGSQSSEM 575
Query: 506 ICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565
+ IY+ +E G+ V TEEE ++A+ MILV WCIQT SERPSM+KV+EMLEG
Sbjct: 576 FFPDWIYKDLEQGDVHTNFLVITEEEHEMARKMILVSLWCIQTRSSERPSMNKVVEMLEG 635
Query: 566 SIENLQIPPKPSLFS 580
++E++ PPKP L S
Sbjct: 636 TLESVPYPPKPILHS 650
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357508155|ref|XP_003624366.1| Kinase R-like protein [Medicago truncatula] gi|355499381|gb|AES80584.1| Kinase R-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 481 bits (1238), Expect = e-133, Method: Compositional matrix adjust.
Identities = 275/616 (44%), Positives = 366/616 (59%), Gaps = 81/616 (13%)
Query: 23 FHC-ANLRNIGYPFWGSNRPEHCGY----PGFELDCAGDVPEITIMDRAYKVLHINNESW 77
F+C +++ NI YPFWG NR ++CG P +L C VP+I I D Y++L N+
Sbjct: 47 FNCGSSIANIKYPFWGENRDKYCGGVSSDPNMDLTCEESVPKININDVKYRILDWNDTIQ 106
Query: 78 RINVAREDYWDYNCPANLS----NSLLNFSIFNYASDTQ-NLTLYYSCPASFMNNISGIL 132
++ VARED W C N+S NS + ++F D N++L Y+C S N S
Sbjct: 107 KLTVAREDCWSGICAVNVSSNPKNSTFDNTMFQRDGDVSYNVSLLYNCETSITNIFST-- 164
Query: 133 LPNRFNCSIDGKNTNSYYFSWDSNSFNSSIRSAIGAYFRSCANSAVIPVWQSTLRYMVNN 192
C NT Y D S + + ++ F P+ +R +
Sbjct: 165 -----TCG----NTKVSYTIVDPASASLTCTPSVIVEF---------PILAVQVR-QIAT 205
Query: 193 PNSVNLTCALRVGFGLQWHANNRLCEECKQSNGNCGYIAKTGEFICYCPNGAYSSSC--- 249
N +N AL+ GF L+W N C++C S+G CG EF C+C +G++++SC
Sbjct: 206 LNDINK--ALQGGFDLKWTGNYGECQKCVDSDGVCGSNDGGNEFRCFCKDGSHTTSCASQ 263
Query: 250 ------------HSRTVIQALI---------------------------KKKTREDDRNV 270
SRTVI A++ +K+ + D NV
Sbjct: 264 KVLTSNNSTERNRSRTVIGAIVAGFGVTIIIMISCYFNKGNGRPNMSIFRKRRKVVDHNV 323
Query: 271 EAFIRNHESLAPKRYSYSDVKRMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRC 330
E F++++ S P+RYSY ++KR+T SFR KLGQGGYG VYK L DG+ VAVKV+ S+
Sbjct: 324 EVFMQSYNSSMPRRYSYKEIKRITNSFRVKLGQGGYGVVYKASLIDGRQVAVKVINESKG 383
Query: 331 NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHN----DRNIK 386
NGEEFINEVASISRTSH+NIV+ LGFCYE K ALIYE MPNGSLDKFI+ +
Sbjct: 384 NGEEFINEVASISRTSHMNIVSLLGFCYEVDKRALIYEFMPNGSLDKFIYKSEFPNAICD 443
Query: 387 LEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446
+W T++QIAIGIARGLEYLH+GC RI+H DIKPQNILLD+DFCPKISDFGLAK QKK
Sbjct: 444 FDWNTLFQIAIGIARGLEYLHQGCSSRILHLDIKPQNILLDDDFCPKISDFGLAKICQKK 503
Query: 447 ESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSI 506
+S +S+L ARGTIGY+APE ++R FGGVS+KSDVYSYGM+I+EM+G KN D + TS
Sbjct: 504 DSIVSILGARGTIGYMAPEAFNRSFGGVSYKSDVYSYGMLILEMIGGRKNYDTGGSCTSE 563
Query: 507 CH--NLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564
+ + IY+ +E GN +EEE + + + LV W IQT S+RP M+KV+EML+
Sbjct: 564 MYFPDWIYKDLEQGNTLLNCSTVSEEENDMVRKITLVSLWRIQTKLSDRPPMNKVIEMLQ 623
Query: 565 GSIENLQIPPKPSLFS 580
G + + PPKP L+S
Sbjct: 624 GPLSTISYPPKPVLYS 639
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 582 | ||||||
| TAIR|locus:2019688 | 674 | AT1G66930 [Arabidopsis thalian | 0.946 | 0.817 | 0.433 | 5.2e-120 | |
| TAIR|locus:2204480 | 666 | AT1G66910 [Arabidopsis thalian | 0.560 | 0.489 | 0.528 | 5.9e-120 | |
| TAIR|locus:2019713 | 892 | AT1G67000 [Arabidopsis thalian | 0.546 | 0.356 | 0.536 | 2.2e-118 | |
| TAIR|locus:2176717 | 638 | AT5G38260 [Arabidopsis thalian | 0.969 | 0.884 | 0.418 | 3.4e-116 | |
| TAIR|locus:2020583 | 799 | AT1G70250 [Arabidopsis thalian | 0.558 | 0.406 | 0.601 | 1.9e-104 | |
| TAIR|locus:2176707 | 579 | AT5G38250 [Arabidopsis thalian | 0.486 | 0.488 | 0.548 | 3.4e-101 | |
| TAIR|locus:2141862 | 853 | AT4G18250 [Arabidopsis thalian | 0.537 | 0.366 | 0.592 | 7.9e-101 | |
| TAIR|locus:2176737 | 665 | PR5K "PR5-like receptor kinase | 0.554 | 0.485 | 0.585 | 2.2e-98 | |
| TAIR|locus:2176697 | 588 | AT5G38240 [Arabidopsis thalian | 0.469 | 0.464 | 0.555 | 4.8e-95 | |
| TAIR|locus:2177142 | 813 | AT5G39020 [Arabidopsis thalian | 0.561 | 0.402 | 0.518 | 3.4e-94 |
| TAIR|locus:2019688 AT1G66930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1181 (420.8 bits), Expect = 5.2e-120, P = 5.2e-120
Identities = 255/588 (43%), Positives = 364/588 (61%)
Query: 12 ECSPRCTAPAPFHCANLRNIGYPFWGSNRPEHCGYPGFELDCAGDVPEITIMDRAYKVLH 71
E RC+ F C N RN+ YPFW R E+CG+P F+LDC+G E+ I +++L+
Sbjct: 66 ELRRRCSER--FSCGNQRNLYYPFWIPGR-EYCGHPDFKLDCSGGFAELNIASVNFRILN 122
Query: 72 INNESWRINVAREDYWDYNCPAN-LSNSLLNFSIFNYASDTQNLTLYYSCPASFMNNISG 130
++ +S +AR DY + CP N L++ L ++ +++DT+ LTLYY C +N+ +
Sbjct: 123 MSYDSSNKRLARSDYLNDLCPPNPLNDEPLIETVLQFSADTELLTLYYDCQ---LNSSAT 179
Query: 131 ILLPNRFNCSIDGKNTNSYYFSWD-SNSFNSSIRSAIGAYFRSCANSAVIPVWQSTLRYM 189
P+ + + SYY + + S+ R + C +P L +
Sbjct: 180 SPFPSSYFGELGCDEGRSYYVTRNLSSPLLDRFRGVLNNLREMCKRKVSVPASGPALNTL 239
Query: 190 VNNPNSVNLTCALRVGFGLQWHANNRLCEECKQSNGNCGYIAKT-----GEFICYCPNGA 244
NPNS NL AL GF LQ ++N C C S G+CGY + G F+ C G
Sbjct: 240 QTNPNSNNLKMALEHGFELQDNSN---CSMCVLSGGSCGYNQNSMAIIIGIFVALCTIGG 296
Query: 245 YSSS----CHSRTVIQALIKKKTREDDRNVEAFIRNHESLAP-KRYSYSDVKRMTKSFRD 299
+ + C V + + + DDR E ++L P K Y+Y+ VKRMTKSF +
Sbjct: 297 FIAFLVLLCPCCKV--RIFRNRKTSDDRRQEKL----KALIPLKHYTYAQVKRMTKSFAE 350
Query: 300 KLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNG-EEFINEVASISRTSHVNIVTFLGFCY 358
+G+GG+G VY+G L DG++VAVKVLK S+ N E+FINEV+S+S+TSHVNIV+ LGFC
Sbjct: 351 VVGRGGFGIVYRGTLCDGRMVAVKVLKESKGNNSEDFINEVSSMSQTSHVNIVSLLGFCS 410
Query: 359 ENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFD 418
E + A+IYE + NGSLDKFI ++ L+ +Y IA+G+ARGLEYLH GC+ RIVHFD
Sbjct: 411 EGSRRAIIYEFLENGSLDKFISEKTSVILDLTALYGIALGVARGLEYLHYGCKTRIVHFD 470
Query: 419 IKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKS 478
IKPQN+LLD++ PK+SDFGLAK +KKES +S++ RGTIGYIAPE+ SR +G VSHKS
Sbjct: 471 IKPQNVLLDDNLSPKVSDFGLAKLCEKKESVMSLMDTRGTIGYIAPEMISRVYGSVSHKS 530
Query: 479 DVYSYGMMIIEMVGCTKNL---DDEVTDTSICH-NLIYERIEPGNDFQFD----GVATEE 530
DVYSYGM++ EM+G K + +S+ IY+ +E ++ + G+++EE
Sbjct: 531 DVYSYGMLVFEMIGARKKERFGQNSANGSSMYFPEWIYKDLEKADNGDLEHIEIGISSEE 590
Query: 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQIPPKPSL 578
E+ IAK M LVG WCIQ++PS+RP M+KV+EM+EGS++ L++PP+P L
Sbjct: 591 EE-IAKKMTLVGLWCIQSSPSDRPPMNKVVEMMEGSLDALEVPPRPVL 637
|
|
| TAIR|locus:2204480 AT1G66910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 912 (326.1 bits), Expect = 5.9e-120, Sum P(2) = 5.9e-120
Identities = 178/337 (52%), Positives = 247/337 (73%)
Query: 253 TVIQALIKK--KTREDDR---NVEAFIRNHESLAP-KRYSYSDVKRMTKSFRDKLGQGGY 306
T + LI++ KT D R + ++ +N ++L P K YSY+ V +TKSF + +G+GG+
Sbjct: 300 TCLNCLIRRQRKTLNDPRMRTSDDSRQQNLKALIPLKHYSYAQVTSITKSFAEVIGKGGF 359
Query: 307 GEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALI 366
G VY+G L DG+ VAVKVLK S+ NGE+FINEVAS+S+TSHVNIVT LGFC E K A+I
Sbjct: 360 GTVYRGTLYDGRSVAVKVLKESQGNGEDFINEVASMSQTSHVNIVTLLGFCSEGYKRAII 419
Query: 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL 426
YE M NGSLDKFI + ++ ++W+ +Y IA+G+ARGLEYLH GC+ RIVHFDIKPQN+LL
Sbjct: 420 YEFMENGSLDKFISSKKSSTMDWRELYGIALGVARGLEYLHHGCRTRIVHFDIKPQNVLL 479
Query: 427 DEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMM 486
D++ PK+SDFGLAK ++KES +S++ RGTIGYIAPEV+SR +G VSHKSDVYSYGM+
Sbjct: 480 DDNLSPKVSDFGLAKLCERKESILSLMDTRGTIGYIAPEVFSRVYGRVSHKSDVYSYGML 539
Query: 487 IIEMVGCTK--NLDDEVTDTSICH--NLIYERIEPG-NDFQFDGVATEEEKKIAKMMILV 541
+++++G + +D + TS + IY +E N + + EE +IAK M LV
Sbjct: 540 VLDIIGARNKTSTEDTTSSTSSMYFPEWIYRDLEKAHNGKSIETAISNEEDEIAKKMTLV 599
Query: 542 GFWCIQTNPSERPSMHKVLEMLEGSIENLQIPPKPSL 578
G WCIQ P +RP+M++V+EM+EG+++ L++PP+P L
Sbjct: 600 GLWCIQPWPLDRPAMNRVVEMMEGNLDALEVPPRPVL 636
|
|
| TAIR|locus:2019713 AT1G67000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 914 (326.8 bits), Expect = 2.2e-118, Sum P(2) = 2.2e-118
Identities = 183/341 (53%), Positives = 253/341 (74%)
Query: 255 IQALIKKKTREDDRNVEAFIRNHESLAP-KRYSYSDVKRMTKSFRDKLGQGGYGEVYKGE 313
+Q K+KT ++ R ++ ++L P K Y+Y++VK+MTKSF + +G+GG+G VY G
Sbjct: 520 VQIFRKRKTSDEVR-----LQKLKALIPLKHYTYAEVKKMTKSFTEVVGRGGFGIVYSGT 574
Query: 314 LPDGQLVAVKVLKNSR-CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372
L D +VAVKVLK+S+ +GE+FINEVAS+S+TSHVNIV+ LGFC E + A+IYE + N
Sbjct: 575 LSDSSMVAVKVLKDSKGTDGEDFINEVASMSQTSHVNIVSLLGFCCEGSRRAIIYEFLGN 634
Query: 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCP 432
GSLDKFI + ++ L+ KT+Y IA+G+ARGLEYLH GC+ RIVHFDIKPQN+LLD++ CP
Sbjct: 635 GSLDKFISDKSSVNLDLKTLYGIALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLCP 694
Query: 433 KISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG 492
K+SDFGLAK +KKES +S+L RGTIGYIAPE+ SR +G VSHKSDVYSYGM+++EM+G
Sbjct: 695 KVSDFGLAKLCEKKESILSLLDTRGTIGYIAPEMISRLYGSVSHKSDVYSYGMLVLEMIG 754
Query: 493 CTKN--LDDEV-TDTSICH--NLIYERIEPGN--DFQF--------DGVATEEEKKIAKM 537
K D +D S + IY+ +E N D + +G+++EEE+ IA+
Sbjct: 755 ARKKERFDQNSRSDGSSIYFPEWIYKDLEKANIKDIEKTENGGLIENGISSEEEE-IARK 813
Query: 538 MILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQIPPKPSL 578
M LVG WCIQ++PS+RP M+KV+EM+EGS++ L++PP+P L
Sbjct: 814 MTLVGLWCIQSSPSDRPPMNKVVEMMEGSLDALEVPPRPVL 854
|
|
| TAIR|locus:2176717 AT5G38260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1145 (408.1 bits), Expect = 3.4e-116, P = 3.4e-116
Identities = 250/598 (41%), Positives = 368/598 (61%)
Query: 7 ILAYFECSPRCTAPAPFHCANLRNIGYPFWGSNRPEHCGYPGFELDCAGDVPEITIMDRA 66
+L+ E C+ P F C ++ YPFW +R E CG+P F+++C+GD E TI
Sbjct: 27 VLSVDERQKHCS-PT-FRCGKQTDLYYPFWSPDR-EECGHPVFKVNCSGDFAEFTISTVK 83
Query: 67 YKVLHINNESWRINVAREDYWDYNCPANLSNSLLNFSIFNYASDTQNLTLYYSCPASFMN 126
+ VL +N ES I + R +Y + CP + N +N + + DT+ T YY+C ++
Sbjct: 84 FHVLEMNYESRIIRLVRTEYLNNLCPWHPENRSINQEVLPFLQDTELGTFYYNCSGPTVD 143
Query: 127 NISGILLPNRFNCS--IDGKNTNSYYFSWDSNSFNSSIRSAIGAYFRSCANSAVIPVWQS 184
++ + + C + GK SY+ S S+ N +I + A SC + IPV +S
Sbjct: 144 ELANGYI-RQLGCDEEVGGK---SYFVSSPSHPGNRAILDGLSA---SCERNVDIPVSRS 196
Query: 185 TLRYMVNNPNSVNLTCALRVGFGLQWHANNRLCEECKQSNG-N-------CGYIAKTGEF 236
+ N + + L VGF L ++++ LC K + G N C + E
Sbjct: 197 AMETTATNQSLEAIKKVLDVGFELGFNSDCSLCVASKGACGFNQSSKAFVCYCKDEPHEH 256
Query: 237 ICYCPNGAYSSSCH--SRTVIQALIKK---KTREDDRNVEAFIRNHESLAP-KRYSYSDV 290
C C T+I + + R ++ N + L K+YSY++V
Sbjct: 257 TCGKMGIGIGLGCGFLGATLITVCLLCFFFQKRRTSHHLRPRDNNLKGLVQLKQYSYAEV 316
Query: 291 KRMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNI 350
+++TK F LG+GG+G VY G L DG+ VAVK+LK+ + NGE+FINEVAS+S+TSHVNI
Sbjct: 317 RKITKLFSHTLGKGGFGTVYGGNLCDGRKVAVKILKDFKSNGEDFINEVASMSQTSHVNI 376
Query: 351 VTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGC 410
V+ LGFCYE K A++YE + NGSLD+F+ +++ L+ T+Y+IA+G+ARGL+YLH GC
Sbjct: 377 VSLLGFCYEGSKRAIVYEFLENGSLDQFLSEKKSLNLDVSTLYRIALGVARGLDYLHHGC 436
Query: 411 QVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRR 470
+ RIVHFDIKPQNILLD+ FCPK+SDFGLAK +K+ES +S+L ARGTIGYIAPEV+S
Sbjct: 437 KTRIVHFDIKPQNILLDDTFCPKVSDFGLAKLCEKRESILSLLDARGTIGYIAPEVFSGM 496
Query: 471 FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVT---DTSICH--NLIYERIEPGND-FQFD 524
+G VSHKSDVYSYGM+++EM+G KN + E T ++S + + IY+ +E G D ++F
Sbjct: 497 YGRVSHKSDVYSYGMLVLEMIGA-KNKEIEETAASNSSSAYFPDWIYKNLENGEDTWKFG 555
Query: 525 GVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQIPPKPSL-FSA 581
+ E+K++AK M LVG WCIQ +P RP M++++EM+EGS++ L++PPKPS+ +SA
Sbjct: 556 DEISREDKEVAKKMTLVGLWCIQPSPLNRPPMNRIVEMMEGSLDVLEVPPKPSIHYSA 613
|
|
| TAIR|locus:2020583 AT1G70250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1013 (361.7 bits), Expect = 1.9e-104, Sum P(2) = 1.9e-104
Identities = 202/336 (60%), Positives = 255/336 (75%)
Query: 253 TVIQALIKKKTREDD-RNVEAFIRNHESLAP-KRYSYSDVKRMTKSFRDKLGQGGYGEVY 310
T+I +I K R ++ R + +N E++ KR+SY VK+MTKSF + LG+GG+G VY
Sbjct: 415 TMIIIVIVGKVRANNMRKSDLNEKNMEAVVMLKRFSYVQVKKMTKSFENVLGKGGFGTVY 474
Query: 311 KGELPDGQL-VAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369
KG+LPDG VAVK+LK S +GE+FINE+AS+SRTSH NIV+ LGFCYE +K A+IYEL
Sbjct: 475 KGKLPDGSRDVAVKILKESNEDGEDFINEIASMSRTSHANIVSLLGFCYEGRKKAIIYEL 534
Query: 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED 429
MPNGSLDKFI + + K+EWKT+Y IA+G++ GLEYLH C RIVHFDIKPQNIL+D D
Sbjct: 535 MPNGSLDKFISKNMSAKMEWKTLYNIAVGVSHGLEYLHSHCVSRIVHFDIKPQNILIDGD 594
Query: 430 FCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIE 489
CPKISDFGLAK + ES ISMLHARGTIGYIAPEV+S+ FGGVSHKSDVYSYGM+++E
Sbjct: 595 LCPKISDFGLAKLCKNNESIISMLHARGTIGYIAPEVFSQNFGGVSHKSDVYSYGMVVLE 654
Query: 490 MVGCTKNL----DDEVTDTSICH-NLIYERIEPGNDFQF--DGVATEEEKKIAKMMILVG 542
M+G +N+ + ++TS+ + IY+ +E G F D + EE++KI K M+LVG
Sbjct: 655 MIGA-RNIGRAQNAGSSNTSMYFPDWIYKDLEKGEIMSFLADQITEEEDEKIVKKMVLVG 713
Query: 543 FWCIQTNPSERPSMHKVLEMLEGSIENLQIPPKPSL 578
WCIQTNP +RP M KV+EMLEGS+E LQIPPKP L
Sbjct: 714 LWCIQTNPYDRPPMSKVVEMLEGSLEALQIPPKPLL 749
|
|
| TAIR|locus:2176707 AT5G38250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 801 (287.0 bits), Expect = 3.4e-101, Sum P(3) = 3.4e-101
Identities = 164/299 (54%), Positives = 219/299 (73%)
Query: 287 YSDVKRMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTS 346
Y + +R+ K+ R + + G + G L DG+ VAVKVLK+S+ N E+FINEVAS+S+TS
Sbjct: 266 YLNERRIAKAARIQHLEA-LGTLRGGRLRDGRKVAVKVLKDSKGNCEDFINEVASMSQTS 324
Query: 347 HVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYL 406
HVNIVT LGFCYE K A+IYE + NGSLD+ ++ L+ T+Y IA+G+ARGLEYL
Sbjct: 325 HVNIVTLLGFCYEGSKRAIIYEFLENGSLDQ------SLNLDVSTLYGIALGVARGLEYL 378
Query: 407 HRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEV 466
H GC+ RIVHFDIKPQN+LLDE+ PK++DFGLAK +K+ES +S+L RGTIGYIAPE+
Sbjct: 379 HYGCKTRIVHFDIKPQNVLLDENLRPKVADFGLAKLCEKQESILSLLDTRGTIGYIAPEL 438
Query: 467 YSRRFGGVSHKSDVYSYGMMIIEMVGC-----TKNLDDEVTDTSICHNLIYERIEPGNDF 521
+SR +G VSHKSDVYSYGM+++EM+G +N D ++ + IY+ +E ++
Sbjct: 439 FSRMYGSVSHKSDVYSYGMLVLEMIGARNKERVQNADPN-NSSAYFPDWIYKDLENFDNT 497
Query: 522 QF--DGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQIPPKPSL 578
+ DG+ EEEK AK MILVG WCIQ PS+RPSM+KV+EM+EGS+++L PPKP L
Sbjct: 498 RLLGDGLTREEEKN-AKKMILVGLWCIQFRPSDRPSMNKVVEMMEGSLDSLDPPPKPLL 555
|
|
| TAIR|locus:2141862 AT4G18250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1000 (357.1 bits), Expect = 7.9e-101, P = 7.9e-101
Identities = 195/329 (59%), Positives = 247/329 (75%)
Query: 260 KKKTREDDRNVEAFIRNHESLAPKRYSYSDVKRMTKSFRDKLGQGGYGEVYKGELPD--G 317
K+K+ +D N+EA + KRYS+ VK+MT SF +G+GG+G VYKG+LPD G
Sbjct: 490 KRKSELNDENIEAVVML------KRYSFEKVKKMTNSFDHVIGKGGFGTVYKGKLPDASG 543
Query: 318 QLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDK 377
+ +A+K+LK S+ NGEEFINE+ S+SR SHVNIV+ GFCYE + A+IYE MPNGSLDK
Sbjct: 544 RDIALKILKESKGNGEEFINELVSMSRASHVNIVSLFGFCYEGSQRAIIYEFMPNGSLDK 603
Query: 378 FIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDF 437
FI + + K+EWKT+Y IA+G+ARGLEYLH C +IVHFDIKPQNIL+DED CPKISDF
Sbjct: 604 FISENMSTKIEWKTLYNIAVGVARGLEYLHNSCVSKIVHFDIKPQNILIDEDLCPKISDF 663
Query: 438 GLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKN- 496
GLAK +KKES ISML ARGT+GYIAPE++S+ +GGVSHKSDVYSYGM+++EM+G TK
Sbjct: 664 GLAKLCKKKESIISMLDARGTVGYIAPEMFSKNYGGVSHKSDVYSYGMVVLEMIGATKRE 723
Query: 497 -LDDEVTDTSICH--NLIYERIEPGNDFQF--DGVATEEEK-KIAKMMILVGFWCIQTNP 550
++ TD S + + +YE +E + D + EEE+ KI K M LVG WCIQTNP
Sbjct: 724 EVETSATDKSSMYFPDWVYEDLERKETMRLLEDHIIEEEEEEKIVKRMTLVGLWCIQTNP 783
Query: 551 SERPSMHKVLEMLEGS-IENLQIPPKPSL 578
S+RP M KV+EMLEGS +E LQ+PPKP L
Sbjct: 784 SDRPPMRKVVEMLEGSRLEALQVPPKPLL 812
|
|
| TAIR|locus:2176737 PR5K "PR5-like receptor kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 977 (349.0 bits), Expect = 2.2e-98, P = 2.2e-98
Identities = 196/335 (58%), Positives = 250/335 (74%)
Query: 254 VIQALIKKKTREDDRNVEAFIRNHESLAP-KRYSYSDVKRMTKSFRDKLGQGGYGEVYKG 312
V+ +++ K RN E +N E++A KRYSY+ VK+MT SF LG+GG+G VYKG
Sbjct: 292 VVVIIVRTKNM---RNSEWNDQNVEAVAMLKRYSYTRVKKMTNSFAHVLGKGGFGTVYKG 348
Query: 313 ELPD-GQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371
+L D G+ VAVK+LK S NGEEFINEVAS+SRTSHVNIV+ LGFCYE K A+IYE MP
Sbjct: 349 KLADSGRDVAVKILKVSEGNGEEFINEVASMSRTSHVNIVSLLGFCYEKNKRAIIYEFMP 408
Query: 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFC 431
NGSLDK+I + + K+EW+ +Y +A+GI+RGLEYLH C RIVHFDIKPQNIL+DE+ C
Sbjct: 409 NGSLDKYISANMSTKMEWERLYDVAVGISRGLEYLHNRCVTRIVHFDIKPQNILMDENLC 468
Query: 432 PKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMV 491
PKISDFGLAK + KES ISMLH RGT GYIAPE++S+ FG VSHKSDVYSYGM+++EM+
Sbjct: 469 PKISDFGLAKLCKNKESIISMLHMRGTFGYIAPEMFSKNFGAVSHKSDVYSYGMVVLEMI 528
Query: 492 GCTKNLDD-EVTDTS----ICHNLIYERIEPGNDFQFDGVA-TEEEKKIAKMMILVGFWC 545
G KN++ E + ++ +Y+ E G + G + T+EE+KIAK ++LV WC
Sbjct: 529 GA-KNIEKVEYSGSNNGSMYFPEWVYKDFEKGEITRIFGDSITDEEEKIAKKLVLVALWC 587
Query: 546 IQTNPSERPSMHKVLEMLEGSIENLQIPPKPSLFS 580
IQ NPS+RP M KV+EMLEG++E LQ+PP P LFS
Sbjct: 588 IQMNPSDRPPMIKVIEMLEGNLEALQVPPNPLLFS 622
|
|
| TAIR|locus:2176697 AT5G38240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 810 (290.2 bits), Expect = 4.8e-95, Sum P(2) = 4.8e-95
Identities = 160/288 (55%), Positives = 216/288 (75%)
Query: 298 RDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFC 357
++ +G+GG+G VYKG L DG+ VAVK+LK+S N E+FINEVASIS+TSHVNIV+ LGFC
Sbjct: 284 QEVVGRGGFGTVYKGNLRDGRKVAVKILKDSNGNCEDFINEVASISQTSHVNIVSLLGFC 343
Query: 358 YENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHF 417
+E K A++YE + NGSLD+ + L+ T+Y IA+G+ARG+EYLH GC+ RIVHF
Sbjct: 344 FEKSKRAIVYEFLENGSLDQ------SSNLDVSTLYGIALGVARGIEYLHFGCKKRIVHF 397
Query: 418 DIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHK 477
DIKPQN+LLDE+ PK++DFGLAK +K+ES +S+L RGTIGYIAPE++SR +G VSHK
Sbjct: 398 DIKPQNVLLDENLKPKVADFGLAKLCEKQESILSLLDTRGTIGYIAPELFSRVYGNVSHK 457
Query: 478 SDVYSYGMMIIEMVGC-----TKNLDDEVTDTSICHNLIYERIEPGNDFQF--DGVATEE 530
SDVYSYGM+++EM G +N D ++ + I++ +E G+ + DG+ T E
Sbjct: 458 SDVYSYGMLVLEMTGARNKERVQNADSN-NSSAYFPDWIFKDLENGDYVKLLADGL-TRE 515
Query: 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQIPPKPSL 578
E+ IAK MILVG WCIQ PS+RPSM+KV+ M+EG++++L PPKP L
Sbjct: 516 EEDIAKKMILVGLWCIQFRPSDRPSMNKVVGMMEGNLDSLDPPPKPLL 563
|
|
| TAIR|locus:2177142 AT5G39020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 906 (324.0 bits), Expect = 3.4e-94, Sum P(2) = 3.4e-94
Identities = 172/332 (51%), Positives = 244/332 (73%)
Query: 254 VIQALIKKKTREDDRNVEAFIRNHESLAPKRYSYSDVKRMTKSFRDKLGQGGYGEVYKGE 313
+I LI++ R+ ++ + I L K+Y Y+++K++TKSF +G+GG+G VY+G
Sbjct: 457 IIMLLIRQMKRKKNKKENSVIMF--KLLLKQYIYAELKKITKSFSHTVGKGGFGTVYRGN 514
Query: 314 LPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNG 373
L +G+ VAVKVLK+ + NG++FINEV S+S+TSHVNIV+ LGFCYE K A+I E + +G
Sbjct: 515 LSNGRTVAVKVLKDLKGNGDDFINEVTSMSQTSHVNIVSLLGFCYEGSKRAIISEFLEHG 574
Query: 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPK 433
SLD+FI ++++ T+Y IA+GIARGLEYLH GC+ RIVHFDIKPQNILLD++FCPK
Sbjct: 575 SLDQFISRNKSLTPNVTTLYGIALGIARGLEYLHYGCKTRIVHFDIKPQNILLDDNFCPK 634
Query: 434 ISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGC 493
++DFGLAK +K+ES +S++ RGTIGYIAPEV SR +GG+SHKSDVYSYGM++++M+G
Sbjct: 635 VADFGLAKLCEKRESILSLIDTRGTIGYIAPEVVSRMYGGISHKSDVYSYGMLVLDMIGA 694
Query: 494 TKNLDDEVTDTSICH--NLIYERIEPGNDFQFDG-VATEEEKKIAKMMILVGFWCIQTNP 550
++ + S + + IY+ +E G+ G EE+ KI K MILV WCI+ P
Sbjct: 695 RNKVETTTCNGSTAYFPDWIYKDLENGDQTWIIGDEINEEDNKIVKKMILVSLWCIRPCP 754
Query: 551 SERPSMHKVLEMLEGSIENLQIPPKPSLFSAT 582
S+RP M+KV+EM+EGS++ L++PPKPS +T
Sbjct: 755 SDRPPMNKVVEMIEGSLDALELPPKPSRHIST 786
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 582 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-53 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-52 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-51 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-51 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-50 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-47 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-43 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-37 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-31 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-28 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-27 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-27 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-27 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-26 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-26 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-25 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-23 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-23 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-22 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-21 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-20 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-19 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-19 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-18 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-18 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-18 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-17 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-17 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-16 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-16 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-16 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-15 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-15 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-15 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-15 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-14 | |
| pfam14380 | 94 | pfam14380, WAK_assoc, Wall-associated receptor kin | 1e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-10 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 8e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-04 | |
| pfam13947 | 106 | pfam13947, GUB_WAK_bind, Wall-associated receptor | 6e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.001 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.003 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.003 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.003 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.003 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 180 bits (460), Expect = 8e-53
Identities = 86/268 (32%), Positives = 127/268 (47%), Gaps = 23/268 (8%)
Query: 300 KLGQGGYGEVYKG-ELPDGQLVAVKVLKNSR---CNGEEFINEVASISRTSHVNIVTFLG 355
KLG G +G VYK G++VAVK+LK + E+ + R SH NIV +
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
+ L+ E G L ++ R L +IA+ I RGLEYLH I+
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLS--RGGPLSEDEAKKIALQILRGLEYLHS---NGII 120
Query: 416 HFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVS 475
H D+KP+NILLDE+ KI+DFGLAK+ K S S+ GT Y+APEV G
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSS--SLTTFVGTPWYMAPEVLLGGN-GYG 177
Query: 476 HKSDVYSYGMMIIEMVGCTKNL--DDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKK 533
K DV+S G+++ E+ T E + LI + P +F +
Sbjct: 178 PKVDVWSLGVILYEL--LTGKPPFSGENILDQL--QLIRRILGPPLEFDE-----PKWSS 228
Query: 534 IAKMMILVGFWCIQTNPSERPSMHKVLE 561
++ + C+ +PS+RP+ ++L+
Sbjct: 229 GSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 2e-52
Identities = 73/270 (27%), Positives = 121/270 (44%), Gaps = 29/270 (10%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNG--EEFINEVASISRTSHVNIVTFLG 355
+KLG+G +G+VY + G+LVA+KV+K + E + E+ + + H NIV
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEW--KTMYQIAIGIARGLEYLHRGCQVR 413
+ K L+ E G L + + + + QI LEYLH
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQIL----SALEYLH---SKG 117
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGG 473
IVH D+KP+NILLDED K++DFGLA+Q E + + GT Y+APEV + G
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV---GTPEYMAPEVLLGK--G 172
Query: 474 VSHKSDVYSYGMMIIEMVGCTKNL-DDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532
D++S G+++ E++ K + + + + + + E
Sbjct: 173 YGKAVDIWSLGVILYELL-TGKPPFPGDDQLLELFKKIGKPKPPF---PPPEWDISPE-- 226
Query: 533 KIAKMMILVGFWCIQTNPSERPSMHKVLEM 562
AK +I + +P +R + + L+
Sbjct: 227 --AKDLIR---KLLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 2e-52
Identities = 78/267 (29%), Positives = 118/267 (44%), Gaps = 56/267 (20%)
Query: 301 LGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNG--EEFINEVASISRTSHVNIVTFLGFC 357
LG+GG+G VY G+ VA+K++K + EE + E+ + + +H NIV G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 358 YENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHF 417
+ L+ E GSL + KL + +I + I GLEYLH I+H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKE-NEGKLSEDEILRILLQILEGLEYLH---SNGIIHR 116
Query: 418 DIKPQNILLDED-FCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSH 476
D+KP+NILLD D K++DFGL+K +S + GT Y+APEV + G S
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGK-GYYSE 173
Query: 477 KSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAK 536
KSD++S G+++ E+ +LI
Sbjct: 174 KSDIWSLGVILYEL--------------PELKDLI------------------------- 194
Query: 537 MMILVGFWCIQTNPSERPSMHKVLEML 563
+Q +P +RPS ++LE L
Sbjct: 195 ------RKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 1e-51
Identities = 79/277 (28%), Positives = 133/277 (48%), Gaps = 29/277 (10%)
Query: 296 SFRDKLGQGGYGEVYKGEL-----PDGQLVAVKVLKN--SRCNGEEFINEVASISRTSHV 348
+ KLG+G +GEVYKG L VAVK LK S EEF+ E + + H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 349 NIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHR 408
NIV LG C E + ++ E MP G L ++ +R +L + A+ IARG+EYL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 409 GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVY- 467
+H D+ +N L+ E+ KISDFGL++ + + + I ++APE
Sbjct: 122 ---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-YKVKGGKLPIRWMAPESLK 177
Query: 468 SRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIY-ERIEPGNDFQFDGV 526
+F + KSDV+S+G+++ E+ + +++ + L R+ +
Sbjct: 178 EGKF---TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNC----- 229
Query: 527 ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEML 563
++ K+M+ C +P +RP+ +++E+L
Sbjct: 230 ----PPELYKLML----QCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 1e-51
Identities = 78/277 (28%), Positives = 131/277 (47%), Gaps = 30/277 (10%)
Query: 296 SFRDKLGQGGYGEVYKGEL-----PDGQLVAVKVLKN--SRCNGEEFINEVASISRTSHV 348
+ KLG+G +GEVYKG+L VAVK LK S EEF+ E + + H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 349 NIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHR 408
N+V LG C E + ++ E M G L ++ +R KL + A+ IARG+EYL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP-KLSLSDLLSFALQIARGMEYLES 120
Query: 409 GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVY- 467
+H D+ +N L+ E+ KISDFGL++ + + I ++APE
Sbjct: 121 ---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-YRKRGGKLPIRWMAPESLK 176
Query: 468 SRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIY-ERIEPGNDFQFDGV 526
+F + KSDV+S+G+++ E+ + +++ + L R+ +
Sbjct: 177 EGKF---TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPN------ 227
Query: 527 ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEML 563
E + +M+ C +P +RP+ +++E+L
Sbjct: 228 CPPE---LYDLML----QCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 6e-50
Identities = 87/287 (30%), Positives = 137/287 (47%), Gaps = 51/287 (17%)
Query: 297 FRDKLGQGGYGEVYKGEL-----PDGQLVAVKVLKN--SRCNGEEFINEVASISRTSHVN 349
KLG+G +GEVYKG L VAVK LK S EEF+ E + + + SH N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 350 IVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRG 409
IV LG C + + ++ E MP G L F+ KL K + Q+A+ IA+G+EYL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLR-KHGEKLTLKDLLQMALQIAKGMEYLES- 120
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSR 469
VH D+ +N L+ E+ KISDFGL++ + + + I ++APE S
Sbjct: 121 --KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPE--SL 176
Query: 470 RFGGVSHKSDVYSYGMMIIEMVGCT------KNLDDEVTDTSICHNLIYERIEPGNDFQF 523
+ G + KSDV+S+G+++ E+ T + +E + E +E
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEI--FTLGEQPYPGMSNE---------EVLELLE------- 218
Query: 524 DG-------VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEML 563
DG +E + ++M+ C +P +RP+ +++E L
Sbjct: 219 DGYRLPRPENCPDE---LYELMLQ----CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 8e-47
Identities = 85/284 (29%), Positives = 132/284 (46%), Gaps = 40/284 (14%)
Query: 299 DKLGQGGYGEVYKGELPDGQ----LVAVKVLKNSRCNGE--EFINEVASISRTSHVNIVT 352
KLG+G +GEVYKG+L VAVK LK E +F+ E + + H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 353 FLGFCYENKKNALIYELMPNGSLDKFIHNDRNI-------KLEWKTMYQIAIGIARGLEY 405
LG C E + L+ E M G L ++ R + L K + AI IA+G+EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 406 LHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPE 465
L + VH D+ +N L+ ED KISDFGL++ + + I ++APE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 466 V-YSRRFGGVSHKSDVYSYGMMIIEMV--GCT--KNLDDEVTDTSICHNLIYERIEPGND 520
F + KSDV+S+G+++ E+ G T L +E + E + G
Sbjct: 178 SLKDGIF---TSKSDVWSFGVLLWEIFTLGATPYPGLSNE---------EVLEYLRKGYR 225
Query: 521 FQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564
+E + ++M+ C Q +P +RP+ +++E LE
Sbjct: 226 LPKPEYCPDE---LYELML----SCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 1e-43
Identities = 69/197 (35%), Positives = 98/197 (49%), Gaps = 13/197 (6%)
Query: 300 KLGQGGYGEVYKGELPD-GQLVAVKVLKNSRCNGEE---FINEVASISRTSHVNIVTFLG 355
LG+G +G VY D G+L+AVK ++ S + EE E+ +S H NIV + G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 356 FCYENKKNAL-IY-ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVR 413
+ +KN L I+ E + GSL + + KL + + I GL YLH
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLK--KFGKLPEPVIRKYTRQILEGLAYLHSN---G 121
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGG 473
IVH DIK NIL+D D K++DFG AK+ E+ RGT ++APEV
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG--EE 179
Query: 474 VSHKSDVYSYGMMIIEM 490
+D++S G +IEM
Sbjct: 180 YGRAADIWSLGCTVIEM 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 4e-37
Identities = 65/195 (33%), Positives = 103/195 (52%), Gaps = 11/195 (5%)
Query: 299 DKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGF 356
+K+G+GG+GEVYK G+ VA+KV+K E+ INE+ + + H NIV + G
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 357 CYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVH 416
+ + ++ E GSL + + N L + + + +GLEYLH I+H
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLLKS-TNQTLTESQIAYVCKELLKGLEYLH---SNGIIH 121
Query: 417 FDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSH 476
DIK NILL D K+ DFGL+ Q ++ +M+ GT ++APEV + +
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVING--KPYDY 176
Query: 477 KSDVYSYGMMIIEMV 491
K+D++S G+ IE+
Sbjct: 177 KADIWSLGITAIELA 191
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 7e-34
Identities = 85/276 (30%), Positives = 118/276 (42%), Gaps = 22/276 (7%)
Query: 300 KLGQGGYGEVYKGELPDGQLVAVKVLKNSRCN----GEEFINEVASISRTSH-VNIVTFL 354
KLG+G +GEVY D +LVA+KVL + E F+ E+ ++ +H NIV
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 355 GFCYENKKNALIYELMPNGSLDKFIHND-RNIKLEWKTMYQIAIGIARGLEYLHRGCQVR 413
F + L+ E + GSL+ + R L I I LEYLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---G 121
Query: 414 IVHFDIKPQNILLDED-FCPKISDFGLAKQAQKKESAISMLHAR----GTIGYIAPEVYS 468
I+H DIKP+NILLD D K+ DFGLAK S S+ GT GY+APEV
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 469 RRFGG-VSHKSDVYSYGMMIIEMV-GCT-KNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525
S SD++S G+ + E++ G + + TS +I E P
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP 241
Query: 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561
E K A ++ + +P R S L
Sbjct: 242 SNPELISKAASDLLKK---LLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 4e-31
Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 23/201 (11%)
Query: 299 DKLGQGGYGEVYKGEL-PDGQLVAVKVLK-NSRCNGEEFI-NEVASISRTSHVNIVTFLG 355
LGQG G VYK P G++ A+K + + + + E+ ++ +V G
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
Y+ + +++ E M GSL + I E Y IA I +GL+YLH + I+
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLLKKVGKIP-EPVLAY-IARQILKGLDYLHT--KRHII 122
Query: 416 HFDIKPQNILLDEDFCPKISDFGLAKQ----AQKKESAISMLHARGTIGYIAPEVYSRRF 471
H DIKP N+L++ KI+DFG++K + + + GT+ Y++PE R
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV------GTVTYMSPE----RI 172
Query: 472 GG--VSHKSDVYSYGMMIIEM 490
G S+ +D++S G+ ++E
Sbjct: 173 QGESYSYAADIWSLGLTLLEC 193
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 7e-31
Identities = 68/282 (24%), Positives = 128/282 (45%), Gaps = 50/282 (17%)
Query: 299 DKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEE---FINEVASISRTSHVNIVTFL 354
++G+G +G+VY DG+L +K + S + +E +NEV + + +H NI+ +
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 355 GFCYENKKNALIYELMPNGSLDKFIHNDR--NIKLE----WKTMYQIAIGIARGLEYLHR 408
E K ++ E G L + I + Q+ + L+YLH
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA----LKYLHS 121
Query: 409 GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ-KKESAISMLHARGTIGYIAPEVY 467
+I+H DIKPQNI L + K+ DFG++K + A +++ GT Y++PE+
Sbjct: 122 R---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV---GTPYYLSPELC 175
Query: 468 SRRFGGVSHKSDVYSYGMMIIEMVGCT-------KNLDDEVTDTSICHNLIYERIEPGND 520
+ ++KSD++S G ++ E+ CT +NL + ++ + P
Sbjct: 176 QNK--PYNYKSDIWSLGCVLYEL--CTLKHPFEGENLL------ELALKILKGQYPPIPS 225
Query: 521 FQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562
Q+ ++ ++ +Q +P ERPS+ ++L+
Sbjct: 226 -QYS-------SELRNLV----SSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 7e-31
Identities = 73/275 (26%), Positives = 128/275 (46%), Gaps = 37/275 (13%)
Query: 297 FRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGF 356
+G+G +G+V G+ GQ VAVK LK+ + F+ E + ++ H N+V LG
Sbjct: 10 LGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 357 CYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVH 416
+ ++ E M GSL ++ + + A+ + G+EYL + VH
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVH 125
Query: 417 FDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSH 476
D+ +N+L+ ED K+SDFGLAK+A + + + + + + APE + R S
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAKEASQGQDS-----GKLPVKWTAPE--ALREKKFST 178
Query: 477 KSDVYSYGMMIIEMVGCTKN------LDDEVTDTSICHNLIYERIEPGNDFQF-DGVATE 529
KSDV+S+G+++ E+ + L D V +E G + +G E
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-----------PHVEKGYRMEAPEGCPPE 227
Query: 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564
+ K+M C + +P++RP+ ++ E L
Sbjct: 228 ----VYKVMKD----CWELDPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 64/197 (32%), Positives = 105/197 (53%), Gaps = 14/197 (7%)
Query: 301 LGQGGYGEVYKGE-LPDGQL----VAVKVLKN--SRCNGEEFINEVASISRTSHVNIVTF 353
LG G +G VYKG +P+G+ VA+KVL+ S +E ++E ++ H ++V
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 354 LGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVR 413
LG C + + LI +LMP G L ++ N ++ + + + + IA+G+ YL + R
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLE---EKR 129
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGG 473
+VH D+ +N+L+ KI+DFGLAK E + I ++A E S
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE--SILHRI 187
Query: 474 VSHKSDVYSYGMMIIEM 490
+HKSDV+SYG+ + E+
Sbjct: 188 YTHKSDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 66/206 (32%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 299 DKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGE---EFINEVASISRTSHVNIVTFL 354
D +G+G +G VYKG L G VA+K + + E + E+ + H NIV ++
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 355 GFCYENKKN-ALIYELMPNGSLDKFI--HNDRNIKLEWKTMYQIAIGIARGLEYLHR-GC 410
G E + +I E NGSL + I L +YQ+ +GL YLH G
Sbjct: 66 GS-IETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL----QGLAYLHEQG- 119
Query: 411 QVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRR 470
++H DIK NIL +D K++DFG+A + + + GT ++APEV
Sbjct: 120 ---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV--VGTPYWMAPEVIEMS 174
Query: 471 FGGVSHKSDVYSYGMMIIEMVGCTKN 496
G S SD++S G +IE++ T N
Sbjct: 175 --GASTASDIWSLGCTVIELL--TGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 69/209 (33%), Positives = 101/209 (48%), Gaps = 36/209 (17%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFIN-----EVASISRTSHVNIVT 352
+KLG+G YG VYK + G++VA+K ++ N EE I E++ + H NIV
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRL--DNEEEGIPSTALREISLLKELKHPNIVK 62
Query: 353 FLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKT----MYQIAIGIARGLEYLHR 408
L + +K L++E L K++ R L MYQ+ RGL Y H
Sbjct: 63 LLDVIHTERKLYLVFEYCDM-DLKKYLDK-RPGPLSPNLIKSIMYQLL----RGLAYCH- 115
Query: 409 GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEV-- 466
RI+H D+KPQNIL++ D K++DFGLA+ + H T+ Y APE+
Sbjct: 116 --SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT--HEVVTLWYRAPEILL 171
Query: 467 ----YSRRFGGVSHKSDVYSYGMMIIEMV 491
YS V D++S G + EM+
Sbjct: 172 GSKHYS---TAV----DIWSVGCIFAEMI 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 87/289 (30%), Positives = 129/289 (44%), Gaps = 70/289 (24%)
Query: 301 LGQGGYGEVYKG-ELPDGQLVAVKV--LKNSRCNGEEFIN----EVASISRTSHVNIVTF 353
LG G +G VY+G L DG AVK L + G+E + E+A +S+ H NIV +
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 354 LGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMY--QIAIGIARGLEYLHRGCQ 411
LG E + EL+P GSL K + + +Y QI +G LEYLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYLHDR-- 121
Query: 412 VRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRF 471
VH DIK NIL+D + K++DFG+AKQ + A S +G+ ++APEV +++
Sbjct: 122 -NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF---KGSPYWMAPEVIAQQ- 176
Query: 472 GGVSHKSDVYSYGMMIIEM------------------VGCTKNLDDEVTDTSICHNLIYE 513
GG +D++S G ++EM +G +K I +
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE-----------LPPIPD 225
Query: 514 RIEP-GNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561
+ DF I K C+Q +PS RP+ ++LE
Sbjct: 226 HLSDEAKDF------------ILK--------CLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 65/212 (30%), Positives = 104/212 (49%), Gaps = 21/212 (9%)
Query: 291 KRMTKSFRDKLGQGGYGEVYKGE---LPDGQ--LVAVKVLKNSRCNGE---EFINEVASI 342
KR K + LG+G +G+V L D VAVK L +S + +F E+ +
Sbjct: 3 KRHLKFIKQ-LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS-GEEQHRSDFEREIEIL 60
Query: 343 SRTSHVNIVTFLGFCYENKKNA--LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIA 400
H NIV + G C + + LI E +P+GSL ++ R+ ++ K + + I
Sbjct: 61 RTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQIC 119
Query: 401 RGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQA-QKKESAISMLHARGTI 459
+G++YL R +H D+ +NIL++ + KISDFGLAK + K+ I
Sbjct: 120 KGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI 176
Query: 460 GYIAPEVYS-RRFGGVSHKSDVYSYGMMIIEM 490
+ APE +F S SDV+S+G+ + E+
Sbjct: 177 FWYAPECLRTSKF---SSASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 63/192 (32%), Positives = 97/192 (50%), Gaps = 6/192 (3%)
Query: 300 KLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYE 359
KLG G +GEV+ G VAVK LK + E F+ E + + H +V C E
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 360 NKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDI 419
+ ++ E M GSL F+ + KL + +A IA G+ YL +H D+
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDL 129
Query: 420 KPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSD 479
+NIL+ E+ KI+DFGLA+ + E A+ I + APE + +G + KSD
Sbjct: 130 AARNILVGENLVCKIADFGLARLIEDDEYTARE-GAKFPIKWTAPE--AANYGRFTIKSD 186
Query: 480 VYSYGMMIIEMV 491
V+S+G+++ E+V
Sbjct: 187 VWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 9e-27
Identities = 76/279 (27%), Positives = 134/279 (48%), Gaps = 23/279 (8%)
Query: 289 DVKRMTKSFRDKLGQGGYGEVYKGELPD-GQLVAVKVLKNSRCNGEEFINEVASISRTSH 347
+++R + + KLG G YGEVY+G VAVK LK EEF+ E A + H
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 61
Query: 348 VNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH 407
N+V LG C +I E M G+L ++ ++ + +A I+ +EYL
Sbjct: 62 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 121
Query: 408 RGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVY 467
+ +H D+ +N L+ E+ K++DFGL++ ++ + A+ I + APE
Sbjct: 122 KK---NFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPE-- 175
Query: 468 SRRFGGVSHKSDVYSYGMMIIEMV--GCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525
S + S KSDV+++G+++ E+ G + +++ +YE +E ++ +
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLE--KGYRMER 226
Query: 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564
K+ ++M C Q NPS+RPS ++ + E
Sbjct: 227 PEGCPP-KVYELMRA----CWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 72/204 (35%), Positives = 104/204 (50%), Gaps = 23/204 (11%)
Query: 296 SFRDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFL 354
+K+G+G GEVYK + G+ VA+K ++ + N E INE+ + H NIV +
Sbjct: 22 KNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYY 81
Query: 355 GFCYENKKNAL--IYELMPNGSL-DKFIHNDRNIKLEWKTMYQIAI---GIARGLEYLHR 408
Y + L + E M GSL D N + QIA + +GLEYLH
Sbjct: 82 D-SYL-VGDELWVVMEYMDGGSLTDIITQNFVRMNEP-----QIAYVCREVLQGLEYLHS 134
Query: 409 GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ-AQKKESAISMLHARGTIGYIAPEVY 467
++H DIK NILL +D K++DFG A Q ++K S++ GT ++APEV
Sbjct: 135 Q---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV---GTPYWMAPEVI 188
Query: 468 SRRFGGVSHKSDVYSYGMMIIEMV 491
R+ G K D++S G+M IEM
Sbjct: 189 KRKDYG--PKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 81/285 (28%), Positives = 122/285 (42%), Gaps = 50/285 (17%)
Query: 299 DKLGQGGYGEVYKGEL--PDGQL--VAVKVLKNSRCNG--EEFINEVASISRTSHVNIVT 352
KLG G +G V +GE G++ VAVK LK+ + + ++F+ E A + H N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 353 FLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQV 412
G ++ EL P GSL + D T+ A+ IA G+ YL
Sbjct: 61 LYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SK 116
Query: 413 RIVHFDIKPQNILLDEDFCPKISDFGLAKQ-AQKKESAISMLHARGTIGYIAPEVYSRRF 471
R +H D+ +NILL D KI DFGL + Q ++ + H + + APE S R
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE--SLRT 174
Query: 472 GGVSHKSDVYSYGMMIIEM--------VGCT-----KNLDDEVTDTSICHNLIYERIEPG 518
SH SDV+ +G+ + EM G + K +D E ER+E
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE-----------GERLERP 223
Query: 519 NDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEML 563
D I +M+ C NP++RP+ + E L
Sbjct: 224 EACPQD---------IYNVMLQ----CWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 65/268 (24%), Positives = 124/268 (46%), Gaps = 19/268 (7%)
Query: 296 SFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLG 355
+F +LG G +G V+ G+ VA+K+++ + ++FI E + + SH N+V G
Sbjct: 7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
C + + ++ E M NG L ++ + KL + + + + +EYL +
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNG---FI 122
Query: 416 HFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVS 475
H D+ +N L+ ED K+SDFGLA+ + S + + + PEV+ + S
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ-GTKFPVKWAPPEVFD--YSRFS 179
Query: 476 HKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIA 535
KSDV+S+G+++ E+ K + +++ + E + G ++ ++
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV-----ESVSAG--YRLYR-PKLAPTEVY 231
Query: 536 KMMILVGFWCIQTNPSERPSMHKVLEML 563
+M C P +RP+ K+L L
Sbjct: 232 TIMYS----CWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 73/274 (26%), Positives = 132/274 (48%), Gaps = 40/274 (14%)
Query: 299 DKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNG---EEFINEVASISRTSHVNIVTFL 354
KLG+G YG VYK + L D Q A+K + + E+ +NE+ ++ +H NI+++
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK 65
Query: 355 GFCYENKKNALIYELMPNGSLDKFIHNDRNIK--LEWKTMYQIAIGIARGLEYLHRGCQV 412
+ K ++ E P G L K I + + + + +++I I + RGL+ LH +
Sbjct: 66 EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQ 122
Query: 413 RIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR-GTIGYIAPEVYSRRF 471
+I+H D+K NILL + KI D G++K +K +M + GT Y+APEV+ R
Sbjct: 123 KILHRDLKSANILLVANDLVKIGDLGISKVLKK-----NMAKTQIGTPHYMAPEVWKGR- 176
Query: 472 GGVSHKSDVYSYGMMIIEMVGCT-----KNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526
S+KSD++S G ++ EM +++ D + +++ G ++ +
Sbjct: 177 -PYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-----------LRYKVQRG---KYPPI 221
Query: 527 ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVL 560
+ + + +Q P RP+ K+L
Sbjct: 222 PPIYSQDLQNFIR----SMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 68/226 (30%), Positives = 112/226 (49%), Gaps = 35/226 (15%)
Query: 290 VKRMTKSFRDKLGQGGYGEVYKGEL----PDGQ--LVAVKVLKNSRCNG--EEFINEVAS 341
V+R T + +LG+G +G+V+ GE P+ LVAVK LK + N ++F E
Sbjct: 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAEL 61
Query: 342 ISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIH-NDRNIK-----------LEW 389
++ H NIV F G C E +++E M +G L+KF+ + + L
Sbjct: 62 LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121
Query: 390 KTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK---- 445
+ QIA+ IA G+ YL VH D+ +N L+ D KI DFG+++
Sbjct: 122 SQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY 178
Query: 446 KESAISMLHARGTIGYIAPE-VYSRRFGGVSHKSDVYSYGMMIIEM 490
+ +ML R ++ PE + R+F + +SDV+S+G+++ E+
Sbjct: 179 RVGGHTMLPIR----WMPPESIMYRKF---TTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 8e-26
Identities = 62/195 (31%), Positives = 101/195 (51%), Gaps = 8/195 (4%)
Query: 298 RDKLGQGGYGEVYKGELPDGQLVAVKVLK-NSRCNGEEFINEVASISRTSHVNIVTFLGF 356
KLG G +GEV++G + VA+K+LK + ++F EV ++ R H ++++
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAV 70
Query: 357 CYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVH 416
C + +I ELM GSL F+ + L ++ +A +A G+ YL + +H
Sbjct: 71 CSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIH 127
Query: 417 FDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSH 476
D+ +NIL+ ED K++DFGLA+ KE + + APE S G S
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYKWTAPEAASH--GTFST 183
Query: 477 KSDVYSYGMMIIEMV 491
KSDV+S+G+++ EM
Sbjct: 184 KSDVWSFGILLYEMF 198
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 8e-26
Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 41/211 (19%)
Query: 301 LGQGGYGEVYKG--ELPDGQL--VAVKVLKNSR--CNGEEFINEVASISRTSHVNIVTFL 354
LG G +G V KG + G+ VAVK LK +EF+ E + +++ H IV +
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 355 GFCYENKKNALIYELMPNGSLDKFIHNDRNIK----LEWKTMYQIAIGIARGLEYLHRGC 410
G C + + L+ EL P G L K++ R I E +Q+A G+ YL
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL--AHQVA----MGMAYLE--- 112
Query: 411 QVRIVHFDIKPQNILLDEDFCPKISDFGLAK---------QAQKKESAISMLHARGTIGY 461
VH D+ +N+LL KISDFG+++ +A R + +
Sbjct: 113 SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT--------AGRWPLKW 164
Query: 462 IAPE-VYSRRFGGVSHKSDVYSYGMMIIEMV 491
APE + +F S KSDV+SYG+ + E
Sbjct: 165 YAPECINYGKF---SSKSDVWSYGVTLWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 8e-26
Identities = 80/268 (29%), Positives = 133/268 (49%), Gaps = 29/268 (10%)
Query: 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGF 356
+ +G+G +G V +GE GQ VAVK +K C+ + F+ E A +++ H N+V LG
Sbjct: 12 EIIGEGEFGAVLQGEYT-GQKVAVKNIK---CDVTAQAFLEETAVMTKLHHKNLVRLLGV 67
Query: 357 CYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVH 416
N ++ ELM G+L F+ + + Q ++ +A G+EYL ++VH
Sbjct: 68 ILHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVH 123
Query: 417 FDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSH 476
D+ +NIL+ ED K+SDFGLA+ S L + T APE + + S
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLPVKWT----APE--ALKHKKFSS 176
Query: 477 KSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAK 536
KSDV+SYG+++ E+ + +++ + E +E G ++ + E
Sbjct: 177 KSDVWSYGVLLWEVFSYGRAPYPKMS-----LKEVKECVEKG--YRME---PPEGCPADV 226
Query: 537 MMILVGFWCIQTNPSERPSMHKVLEMLE 564
+++ W +T P +RPS HK+ E LE
Sbjct: 227 YVLMTSCW--ETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 62/194 (31%), Positives = 110/194 (56%), Gaps = 10/194 (5%)
Query: 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNS--RCNGEEFINEVASISRTSHVNIVTFLGF 356
+K+G+G +G+VYKG L VAVK +++ +F+ E + + H NIV +G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 357 CYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH-RGCQVRIV 415
C + + ++ EL+P GSL F+ +N +L K + Q+++ A G+EYL + C +
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESKNC----I 115
Query: 416 HFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVS 475
H D+ +N L+ E+ KISDFG++++ + +S + I + APE + +G +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPE--ALNYGRYT 173
Query: 476 HKSDVYSYGMMIIE 489
+SDV+SYG+++ E
Sbjct: 174 SESDVWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 298 RDKLGQGGYGEVYKG-ELPDGQLVAVKVLK---NSRCNGEEFINEVASISRTSHVNIVTF 353
+K+G G +G+VY L G+L+AVK ++ N +E +E+ + H N+V +
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 354 LGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVR 413
G +K + E G+L++ + + R + +Y + + GL YLH
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVY--TLQLLEGLAYLH---SHG 119
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI--SMLHARGTIGYIAPEVYSRRF 471
IVH DIKP NI LD + K+ DFG A + + + + + GT Y+APEV +
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG-- 177
Query: 472 GGVSHK---SDVYSYGMMIIEMV 491
G +D++S G +++EM
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMA 200
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 68/208 (32%), Positives = 109/208 (52%), Gaps = 30/208 (14%)
Query: 295 KSFR--DKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIV 351
+ F +KLG+G YG VYK GQ+VA+KV+ +E I E++ + + IV
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL-QEIIKEISILKQCDSPYIV 61
Query: 352 TFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTM--YQIAI---GIARGLEYL 406
+ G ++N ++ E GS+ +D +K+ KT+ +IA +GLEYL
Sbjct: 62 KYYGSYFKNTDLWIVMEYCGAGSV-----SDI-MKITNKTLTEEEIAAILYQTLKGLEYL 115
Query: 407 HRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ----KKESAISMLHARGTIGYI 462
H + +H DIK NILL+E+ K++DFG++ Q K+ + I GT ++
Sbjct: 116 H---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI------GTPFWM 166
Query: 463 APEVYSRRFGGVSHKSDVYSYGMMIIEM 490
APEV G ++K+D++S G+ IEM
Sbjct: 167 APEVIQEI--GYNNKADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 63/197 (31%), Positives = 108/197 (54%), Gaps = 16/197 (8%)
Query: 301 LGQGGYGEVYKG--ELPDGQ--LVAVKVLKNSRCNGE--EFINEVASISRTSHVNIVTFL 354
+G G +GEV +G +LP + VA+K LK + + +F+ E + + + H NI+
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 355 GFCYENKKNALIYELMPNGSLDKFI-HNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVR 413
G +++ +I E M NGSLDKF+ ND K + + GIA G++YL
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMN--- 126
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYS-RRFG 472
VH D+ +NIL++ + K+SDFGL+++ + E+ + + I + APE + R+F
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKF- 185
Query: 473 GVSHKSDVYSYGMMIIE 489
+ SDV+S+G+++ E
Sbjct: 186 --TSASDVWSFGIVMWE 200
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 65/216 (30%), Positives = 107/216 (49%), Gaps = 27/216 (12%)
Query: 297 FRDKLGQGGYGEVYKGEL--PDG----QLVAVKVLK--NSRCNGEEFINEVASISRTSHV 348
F ++LG+G +G+VYKGEL P+ VA+K LK +EF E +S H
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 349 NIVTFLGFCYENKKNALIYELMPNGSLDKFI------------HNDRNIK--LEWKTMYQ 394
NIV LG C + + +++E + +G L +F+ D +K L+
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 395 IAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLH 454
IAI IA G+EYL VH D+ +N L+ E KISDFGL++ +
Sbjct: 129 IAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 455 ARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEM 490
+ + ++ PE + +G + +SD++S+G+++ E+
Sbjct: 186 SLLPVRWMPPE--AILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 9e-25
Identities = 65/274 (23%), Positives = 122/274 (44%), Gaps = 31/274 (11%)
Query: 296 SFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLG 355
+ ++G G +G V+ G + + VA+K ++ + E+FI E + + SH +V G
Sbjct: 7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
C E L++E M +G L ++ R K +T+ + + + G+ YL ++
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLESSN---VI 122
Query: 416 HFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVS 475
H D+ +N L+ E+ K+SDFG+ + + S + + + +PEV+S F S
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SSTGTKFPVKWSSPEVFS--FSKYS 179
Query: 476 HKSDVYSYGMMIIEMVGCTKNLDDE------VTDTSICHNLIYERIEPGNDFQFDGVATE 529
KSDV+S+G+++ E+ K + V + L R+
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLAS------------ 227
Query: 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEML 563
+ + ++M C + P +RPS +L L
Sbjct: 228 --QSVYELMQ----HCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 74/261 (28%), Positives = 118/261 (45%), Gaps = 34/261 (13%)
Query: 301 LGQGGYGEVYK-GELPDGQLVAVKVLKNSRC---NGEEF-INEVASISRTSHVNIVTFLG 355
LG+G +G+V + G+L A+KVLK + E + E +SR +H IV L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK-LH 59
Query: 356 FCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRI 414
+ ++ ++ L+ E P G L + + E Y A I LEYLH + I
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFY--AAEIVLALEYLHS---LGI 114
Query: 415 VHFDIKPQNILLDEDFCPKISDFGLAKQA-QKKESAISMLHARGTIGYIAPEVYSRRFGG 473
++ D+KP+NILLD D K++DFGLAK+ + + GT Y+APEV G
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC---GTPEYLAPEVLLG--KG 169
Query: 474 VSHKSDVYSYGMMIIEM-VGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532
D +S G+++ EM G ++ IYE+I +F + E +
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPPFYAED-------RKEIYEKILKD-PLRFPEFLSPEAR 221
Query: 533 KIAKMMILVGFWCIQTNPSER 553
+ +Q +P++R
Sbjct: 222 DLISG-------LLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 65/202 (32%), Positives = 104/202 (51%), Gaps = 20/202 (9%)
Query: 297 FRDKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEFIN-----EVASISRTSHVNI 350
+ +LG G G V K P G+++AVK + R E I E+ + + + I
Sbjct: 5 YLGELGAGNSGVVSKVLHRPTGKIMAVKTI---RLEINEAIQKQILRELDILHKCNSPYI 61
Query: 351 VTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGC 410
V F G Y N ++ E M GSLDK + + E + + +IA+ + +GL YLH
Sbjct: 62 VGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPE-RILGKIAVAVLKGLTYLHE-- 118
Query: 411 QVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRR 470
+ +I+H D+KP NIL++ K+ DFG++ Q ++++ GT Y+APE R
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV---NSLAKTFV-GTSSYMAPE---RI 171
Query: 471 FGGV-SHKSDVYSYGMMIIEMV 491
G S KSD++S G+ +IE+
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELA 193
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 79/284 (27%), Positives = 132/284 (46%), Gaps = 38/284 (13%)
Query: 301 LGQGGYGEVYKG----ELPDG---QLVAVKVLKNSRCNGE--EFINEVASISRTSHVNIV 351
LG G +GEVY+G L G VAVK L+ + E EF+ E +S +H NIV
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 352 TFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIK-----LEWKTMYQIAIGIARGLEYL 406
LG C N+ +I ELM G L ++ + R + L K + I + +A+G YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 407 HRGCQVRIVHFDIKPQNILLDED--FCP---KISDFGLAKQAQKKESAISMLHARGTIGY 461
Q+ +H D+ +N L+ E KI DFGLA+ K + + +
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 462 IAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYE-RIEPGND 520
+APE S G + +SDV+S+G+++ E++ + + + + ++ R++ +
Sbjct: 180 MAPE--SLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237
Query: 521 FQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564
KI ++M C +PSERP+ ++ E+L+
Sbjct: 238 C---------PDKIYQLMTN----CWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 8/204 (3%)
Query: 289 DVKRMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHV 348
++ R + KLG G +GEV++G + VAVK LK + ++F+ E + + H
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHP 61
Query: 349 NIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHR 408
++ C + ++ ELM GSL +++ L+ + +A +A G+ YL
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE- 120
Query: 409 GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPE-VY 467
+H D+ +N+L+ E+ K++DFGLA+ K++ + A+ I + APE
Sbjct: 121 --AQNYIHRDLAARNVLVGENNICKVADFGLAR-VIKEDIYEAREGAKFPIKWTAPEAAL 177
Query: 468 SRRFGGVSHKSDVYSYGMMIIEMV 491
RF S KSDV+S+G+++ E+V
Sbjct: 178 YNRF---SIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 70/202 (34%), Positives = 103/202 (50%), Gaps = 25/202 (12%)
Query: 300 KLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFI-NEVASISRTSHVNIVTFLGFC 357
++G G YG+VYK ++ G+LVA+KV+K + E I E++ + H NIV + G
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY 69
Query: 358 YENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIAR----GLEYLHRGCQVR 413
K ++ E GSL I+ L QIA + R GL YLH +
Sbjct: 70 LRRDKLWIVMEYCGGGSLQD-IYQVTRGPLS---ELQIAY-VCRETLKGLAYLH---ETG 121
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQ----AQKKESAISMLHARGTIGYIAPEVYS- 468
+H DIK NILL ED K++DFG++ Q K++S I GT ++APEV +
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI------GTPYWMAPEVAAV 175
Query: 469 RRFGGVSHKSDVYSYGMMIIEM 490
R GG K D+++ G+ IE+
Sbjct: 176 ERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 3e-23
Identities = 67/203 (33%), Positives = 103/203 (50%), Gaps = 7/203 (3%)
Query: 289 DVKRMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHV 348
+V R T KLG G +GEV+ G VA+K LK + E F+ E + + H
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHP 61
Query: 349 NIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHR 408
+V L + +I E M NGSL F+ IKL + +A IA G+ ++ R
Sbjct: 62 RLVR-LYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER 120
Query: 409 GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYS 468
+H D++ NIL+ E C KI+DFGLA+ + E + A+ I + APE +
Sbjct: 121 ---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAIN 176
Query: 469 RRFGGVSHKSDVYSYGMMIIEMV 491
+G + KSDV+S+G+++ E+V
Sbjct: 177 --YGTFTIKSDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 3e-23
Identities = 73/276 (26%), Positives = 126/276 (45%), Gaps = 38/276 (13%)
Query: 300 KLGQGGYGEVYKGE-LPDGQLVAVKVLK---------NSRCNGEEFINEVASISRTSHVN 349
K+G+G + VYK L DG++VA+K ++ C + E+ + + H N
Sbjct: 9 KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDC-----LKEIDLLKQLDHPN 63
Query: 350 IVTFL-GFCYENKKNALIYELMPNGSLDKFIHNDRNIK--LEWKTMYQIAIGIARGLEYL 406
++ +L F N+ N ++ EL G L + I + + K + +T+++ + + LE++
Sbjct: 64 VIKYLASFIENNELN-IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHM 122
Query: 407 HRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEV 466
H RI+H DIKP N+ + K+ D GL + K +A L GT Y++PE
Sbjct: 123 H---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMSPER 177
Query: 467 YSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLD-DEVTDTSICHNLIYERIEPGNDFQFDG 525
G + KSD++S G ++ EM D++ S+C IE D
Sbjct: 178 I--HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK-----IEKC-----DY 225
Query: 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561
+ ++ LV CI +P +RP + VL+
Sbjct: 226 PPLPADHYSEELRDLVSR-CINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 70/213 (32%), Positives = 99/213 (46%), Gaps = 38/213 (17%)
Query: 301 LGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFINEVASISRTS-HVNIVTFLGFCY 358
+G+G YG+VYK GQLVA+K++ EE E + + S H NI TF G +
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG-AF 72
Query: 359 ENKKNA-------LIYELMPNGS----LDKFIHNDRNIKLEWKTMYQIAI---GIARGLE 404
K L+ EL GS + + +K EW IA RGL
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-----IAYILRETLRGLA 127
Query: 405 YLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGT-IG--- 460
YLH +++H DIK QNILL ++ K+ DFG++ Q L R T IG
Sbjct: 128 YLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST------LGRRNTFIGTPY 178
Query: 461 YIAPEVYS---RRFGGVSHKSDVYSYGMMIIEM 490
++APEV + + +SDV+S G+ IE+
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIEL 211
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 3e-22
Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 301 LGQGGYGEVYKG-ELPDGQLVAVK-VLKNSRCNG----------EEFINEVASISRTSHV 348
+G+G YG VY + G+++AVK V + G + +E+ ++ H+
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 349 NIVTFLGFCYENKKNAL-IY-ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYL 406
NIV +LGF E + L I+ E +P GS+ + + E + + + GL YL
Sbjct: 69 NIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYL 124
Query: 407 HRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEV 466
H I+H D+K N+L+D D KISDFG++K++ + +G++ ++APEV
Sbjct: 125 HSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 467 YSRRFGGVSHKSDVYSYGMMIIEM 490
G S K D++S G +++EM
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEM 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 4e-22
Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 43/225 (19%)
Query: 297 FRDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFINEVASISR--------TSH 347
F +G+G + V E + A+K+L + E +V + H
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE---KKVKYVKIEKEVLTRLNGH 61
Query: 348 VNIVTFLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMY--QIAIGIARGLE 404
I+ L + +++++N + E PNG L ++I ++ + Y +I + LE
Sbjct: 62 PGIIK-LYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLA----LE 116
Query: 405 YLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAK-------------QAQKKESAIS 451
YLH I+H D+KP+NILLD+D KI+DFG AK A +S I
Sbjct: 117 YLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 452 MLHAR-----GTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMV 491
R GT Y++PE+ + SD+++ G +I +M+
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQML 216
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 4e-22
Identities = 74/276 (26%), Positives = 130/276 (47%), Gaps = 19/276 (6%)
Query: 289 DVKRMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHV 348
++ R + KLG G +GEV+ G VAVK LK + E F+ E + + H
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHD 61
Query: 349 NIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHR 408
+V E + ++ E M GSL F+ + L+ + +A +A G+ Y+ R
Sbjct: 62 KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER 120
Query: 409 GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYS 468
+ +H D++ NIL+ + KI+DFGLA+ + E + A+ I + APE +
Sbjct: 121 ---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPE--A 174
Query: 469 RRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528
+G + KSDV+S+G+++ E+V TK V + + + E++E G
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELV--TKG---RVPYPGMNNREVLEQVERGYRMPCPQ--- 226
Query: 529 EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564
+ + ++M+ C + +P ERP+ + LE
Sbjct: 227 DCPISLHELML----QCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 7e-22
Identities = 66/286 (23%), Positives = 122/286 (42%), Gaps = 51/286 (17%)
Query: 299 DKLGQGGYGEVYK-GELPDGQLVAVKVLKNSRCNGEE---FINEVASISRTSHVNIVTFL 354
+ +G+G +G V K DG+++ K + +E ++EV + H NIV +
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRY- 64
Query: 355 GFCYE---NKKNALIYELMP---NGSLDKFIHNDRNIK--LEWKTMYQIAIGIARGLEYL 406
Y+ ++ N +Y +M G L + I + + +E + +++I + L
Sbjct: 65 ---YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121
Query: 407 HRGCQV--RIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR-------- 456
H ++H D+KP NI LD + K+ DFGLAK +L
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK----------ILGHDSSFAKTYV 171
Query: 457 GTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIE 516
GT Y++PE + KSD++S G +I E+ C + + + +I+
Sbjct: 172 GTPYYMSPEQLNHM--SYDEKSDIWSLGCLIYEL--CALSPPFTARN----QLQLASKIK 223
Query: 517 PGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562
G + + E ++ K M+ V +P +RPS ++L++
Sbjct: 224 EGKFRRIPYRYSSELNEVIKSMLNV-------DPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 9e-22
Identities = 75/284 (26%), Positives = 125/284 (44%), Gaps = 44/284 (15%)
Query: 297 FRDKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNG--EEFINEVASISRTSHVNIVTF 353
+ +G G VY LP+ + VA+K + +C +E EV ++S+ +H N+V +
Sbjct: 5 LIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY 64
Query: 354 LGFCYENKKNALIYELMPNGS-LDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQV 412
+ L+ + GS LD + L+ + + + +GLEYLH Q+
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI 124
Query: 413 RIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR----GTIGYIAPEVYS 468
H DIK NILL ED KI+DFG++ A + R GT ++APEV
Sbjct: 125 ---HRDIKAGNILLGEDGSVKIADFGVS--ASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 469 RRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHN--------LIYERIEPGND 520
+ G K+D++S+G+ IE+ T + L + P +
Sbjct: 180 QV-HGYDFKADIWSFGITAIEL----------ATGAAPYSKYPPMKVLMLTLQNDPPSLE 228
Query: 521 FQFDGVATEEEKKIAKM---MILVGFWCIQTNPSERPSMHKVLE 561
+ KK +K MI + C+Q +PS+RP+ ++L+
Sbjct: 229 ------TGADYKKYSKSFRKMISL---CLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 9e-22
Identities = 76/281 (27%), Positives = 131/281 (46%), Gaps = 23/281 (8%)
Query: 289 DVKRMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHV 348
++ R + KLGQG +GEV+ G VA+K LK + E F+ E + + H
Sbjct: 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 61
Query: 349 NIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHR 408
+V E + ++ E M GSL F+ + L + +A IA G+ Y+ R
Sbjct: 62 KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 120
Query: 409 GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYS 468
+ VH D++ NIL+ E+ K++DFGLA+ + E + A+ I + APE +
Sbjct: 121 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPE--A 174
Query: 469 RRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528
+G + KSDV+S+G+++ E+ TK V + + + +++E G
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELT--TKG---RVPYPGMVNREVLDQVERGYRMP---CPP 226
Query: 529 EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIEN 569
E + + +M C + P ERP+ E L+ +E+
Sbjct: 227 ECPESLHDLMC----QCWRKEPEERPT----FEYLQAFLED 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 28/214 (13%)
Query: 301 LGQGGYGEVYKGEL------PDGQLVAVKVLKNSRCNGE--EFINEVASISRT-SHVNIV 351
LG+G +G+V K E + VAVK+LK+ + + ++E+ + H NI+
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 352 TFLGFCYENKKNALIYELMPNGSLDKFIHNDRNI--------------KLEWKTMYQIAI 397
LG C + ++ E +G+L F+ R L K + A
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 398 GIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARG 457
+ARG+E+L + +H D+ +N+L+ ED KI+DFGLA+ + + R
Sbjct: 140 QVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196
Query: 458 TIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMV 491
+ ++APE R +H+SDV+S+G+++ E+
Sbjct: 197 PVKWMAPEALFDRV--YTHQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 2e-21
Identities = 77/276 (27%), Positives = 130/276 (47%), Gaps = 19/276 (6%)
Query: 289 DVKRMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHV 348
++ R + KLGQG +GEV+ G VA+K LK E F+ E + + H
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHD 61
Query: 349 NIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHR 408
+V E + ++ E M GSL F+ L+ + +A IA G+ Y+ R
Sbjct: 62 KLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER 120
Query: 409 GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYS 468
+ +H D++ NIL+ ++ KI+DFGLA+ + E + A+ I + APE +
Sbjct: 121 ---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPE--A 174
Query: 469 RRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528
+G + KSDV+S+G+++ E+V TK V + + + E++E G
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELV--TKG---RVPYPGMVNREVLEQVERGYRMPCPQGCP 229
Query: 529 EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564
E + ++M L C + +P ERP+ + LE
Sbjct: 230 ES---LHELMKL----CWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 3e-21
Identities = 63/192 (32%), Positives = 105/192 (54%), Gaps = 11/192 (5%)
Query: 301 LGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEE--FINEVASISRTSHVNIVTFLGFCY 358
LG+G +GEV+KG L D VAVK K + F++E + + H NIV +G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 359 ENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH-RGCQVRIVHF 417
+ + ++ EL+P G F+ ++ +L+ K + + A+ A G+ YL + C +H
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKD-ELKTKQLVKFALDAAAGMAYLESKNC----IHR 117
Query: 418 DIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHK 477
D+ +N L+ E+ KISDFG+++Q + S L + I + APE + +G S +
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK-QIPIKWTAPEALN--YGRYSSE 174
Query: 478 SDVYSYGMMIIE 489
SDV+SYG+++ E
Sbjct: 175 SDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 67/204 (32%), Positives = 103/204 (50%), Gaps = 17/204 (8%)
Query: 297 FRDKLGQGGYGEVYK---GELPD--GQLVAVKVLKNSRCNG-EEFINEVASISRTSHVNI 350
F +LG+G +G V L D G++VAVK L++S +F E+ + H NI
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 351 VTFLGFCYENKKNA--LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHR 408
V + G CY + L+ E +P GSL ++ R +L+ + + A I +G+EYL
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRE-RLDHRKLLLYASQICKGMEYLG- 125
Query: 409 GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAK-QAQKKESAISMLHARGTIGYIAPEVY 467
R VH D+ +NIL++ + KI DFGL K Q KE I + APE
Sbjct: 126 --SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183
Query: 468 SR-RFGGVSHKSDVYSYGMMIIEM 490
+ +F S SDV+S+G+++ E+
Sbjct: 184 TESKF---SVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 5e-21
Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCN-GEEFIN--EVASISRTSHVNIVTFL 354
K+G+G YG VYK + G++VA+K +K + G E+ + +H NI+ L
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 355 GFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRI 414
L++E M + L K I DR L + + +GL + H I
Sbjct: 65 DVFRHKGDLYLVFEFM-DTDLYKLI-KDRQRGLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 415 VHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGV 474
+H D+KP+N+L++ + K++DFGLA+ H T Y APE+ G
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP--YTHYVVTRWYRAPELLLGD-KGY 176
Query: 475 SHKSDVYSYGMMIIEMV 491
S D++S G + E++
Sbjct: 177 STPVDIWSVGCIFAELL 193
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 6e-21
Identities = 63/200 (31%), Positives = 113/200 (56%), Gaps = 18/200 (9%)
Query: 301 LGQGGYGEVYKG-ELPDGQLV----AVKVLKNS---RCNGEEFINEVASISRTSHVNIVT 352
LG G +G VYKG +P+G+ V A+K+L + + N EF++E ++ H ++V
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN-VEFMDEALIMASMDHPHLVR 73
Query: 353 FLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQV 412
LG C + L+ +LMP+G L ++H ++ + + + + IA+G+ YL +
Sbjct: 74 LLGVCL-SPTIQLVTQLMPHGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYLE---ER 128
Query: 413 RIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPE-VYSRRF 471
R+VH D+ +N+L+ KI+DFGLA+ + E + + I ++A E ++ R+F
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188
Query: 472 GGVSHKSDVYSYGMMIIEMV 491
+H+SDV+SYG+ I E++
Sbjct: 189 ---THQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 8e-21
Identities = 67/201 (33%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 301 LGQGGYGEVYKGELPDGQLVAVK--VLKNSRCNGEE-----FINEVASISRTSHVNIVTF 353
LG+G YG VY G GQL+AVK L S E EV + HVNIV +
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 354 LGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVR 413
LG C ++ ++ E +P GS+ + +R L + I G+ YLH C
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQILDGVAYLHNNC--- 122
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQ---AQKKESAISMLHA-RGTIGYIAPEVYSR 469
+VH DIK N++L + K+ DFG A++ + +ML + GT ++APEV
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI-- 180
Query: 470 RFGGVSHKSDVYSYGMMIIEM 490
G KSD++S G + EM
Sbjct: 181 NESGYGRKSDIWSIGCTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 54/202 (26%), Positives = 88/202 (43%), Gaps = 20/202 (9%)
Query: 300 KLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGE---EFINEVASISRTSHVNIVTFLGF 356
+LG+G G V K L + ++ + N + + + E+ IV + G
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 357 CYENKKN--ALIYELMPNGSLDKFIHN--DRNIKLEWKTMYQIAIGIARGLEYLHRGCQV 412
+ + + E GSLD R ++ K + +IA + +GL YLH
Sbjct: 68 FLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SR 124
Query: 413 RIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFG 472
+I+H DIKP NILL K+ DFG++ + + GT Y+APE R
Sbjct: 125 KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSFYMAPE----RIQ 176
Query: 473 GVSH--KSDVYSYGMMIIEMVG 492
G + SDV+S G+ ++E+
Sbjct: 177 GKPYSITSDVWSLGLTLLEVAQ 198
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 60/192 (31%), Positives = 97/192 (50%), Gaps = 6/192 (3%)
Query: 300 KLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYE 359
KLG G +GEV+ G + VAVK LK + + F+ E + H +V +
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 360 NKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDI 419
+ +I E M GSL F+ +D K+ + + IA G+ Y+ R +H D+
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDL 129
Query: 420 KPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSD 479
+ N+L+ E KI+DFGLA+ + E + A+ I + APE + FG + KSD
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAIN--FGSFTIKSD 186
Query: 480 VYSYGMMIIEMV 491
V+S+G+++ E+V
Sbjct: 187 VWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 58/192 (30%), Positives = 99/192 (51%), Gaps = 15/192 (7%)
Query: 301 LGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYEN 360
+G+G +G+V G+ G VAVK +KN + F+ E + +++ H N+V LG E
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 361 KKNALIY-ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDI 419
K I E M GSL ++ + L + + ++ + +EYL VH D+
Sbjct: 72 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDL 128
Query: 420 KPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPE-VYSRRFGGVSHKS 478
+N+L+ ED K+SDFGL K+A + + + + APE + ++F S KS
Sbjct: 129 AARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREKKF---STKS 180
Query: 479 DVYSYGMMIIEM 490
DV+S+G+++ E+
Sbjct: 181 DVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 3e-20
Identities = 68/211 (32%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 285 YSYSDVKRMTKSFRDKLGQGGYGEVYKGELPDGQL-VAVKVL--KNSRCNGEEFINEVAS 341
Y Y + R LG+G YG VY Q+ +A+K + ++SR + E+A
Sbjct: 5 YEYDENGE-----RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR-YVQPLHEEIAL 58
Query: 342 ISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRN-IKLEWKTMYQIAIGIA 400
S H NIV +LG EN + E +P GSL + + +K +T+ I
Sbjct: 59 HSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL 118
Query: 401 RGLEYLHRGCQVRIVHFDIKPQNILLDE-DFCPKISDFGLAKQAQKKESAISMLHARGTI 459
GL+YLH +IVH DIK N+L++ KISDFG +K+ GT+
Sbjct: 119 EGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF--TGTL 173
Query: 460 GYIAPEVYSRRFGGVSHKSDVYSYGMMIIEM 490
Y+APEV + G +D++S G I+EM
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEM 204
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 68/200 (34%), Positives = 98/200 (49%), Gaps = 21/200 (10%)
Query: 301 LGQGGYGEVYKGELPD-GQLVAVKVLKNSRCN---GEEF-INEVASISRTSHVNIVTFLG 355
LG+GG+GEV ++ G++ A K L R GE+ +NE + + S IV+ L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVS-LA 59
Query: 356 FCYENKKN-ALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRI 414
+ +E K + L+ LM G L I+N A I GLE+LH Q RI
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRI 116
Query: 415 VHFDIKPQNILLDEDFCPKISDFGLAKQ--AQKKESAISMLHAR-GTIGYIAPEVYSRRF 471
V+ D+KP+N+LLD+ +ISD GLA + KK + R GT GY+APEV
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK------IKGRAGTPGYMAPEVLQG-- 168
Query: 472 GGVSHKSDVYSYGMMIIEMV 491
D ++ G + EM+
Sbjct: 169 EVYDFSVDWFALGCTLYEMI 188
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 3e-20
Identities = 56/194 (28%), Positives = 102/194 (52%), Gaps = 9/194 (4%)
Query: 299 DKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLG 355
+++G+G +GEV+ G L D VAVK + + +F+ E + + SH NIV +G
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
C + + ++ EL+ G F+ + +L+ K + Q+ A G+EYL +
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 416 HFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVS 475
H D+ +N L+ E KISDFG++++ + A + + + + APE + +G S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALN--YGRYS 174
Query: 476 HKSDVYSYGMMIIE 489
+SDV+S+G+++ E
Sbjct: 175 SESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 75/296 (25%), Positives = 130/296 (43%), Gaps = 61/296 (20%)
Query: 299 DKLGQGGYGEVYKG---ELPDGQL---VAVKVLKNSRCNGE--EFINEVASISR--TSHV 348
+LGQG +G VY+G + G+ VA+K + + E EF+NE AS+ + H
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNE-ASVMKEFNCH- 69
Query: 349 NIVTFLGFCYENKKNALIYELMPNGSLDKFI--------HNDRNIKLEWKTMYQIAIGIA 400
++V LG + ++ ELM G L ++ +N + Q+A IA
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 401 RGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAK----QAQKKESAISMLHAR 456
G+ YL + VH D+ +N ++ ED KI DFG+ + ++ +L R
Sbjct: 130 DGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 457 GTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMV--------GCTKNLDDEVTDTSICH 508
++APE S + G + KSDV+S+G+++ EM G + ++EV +
Sbjct: 187 ----WMAPE--SLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS---NEEVLKF-VID 236
Query: 509 NLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564
+ E K+ ++M + C Q NP RP+ +++ L+
Sbjct: 237 GGHLDLPE------------NCPDKLLELMRM----CWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 5e-20
Identities = 73/283 (25%), Positives = 129/283 (45%), Gaps = 39/283 (13%)
Query: 299 DKLGQGGYGEVYKGELPDG--QLVAVKVL-----------KNSRCNGEEFINEVASISRT 345
+ LG G +G VYK + L+A+K + + + + ++EV I
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 346 -SHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHN--DRNIKLEWKTMYQIAIGIARG 402
H NIV + EN + ++ +L+ L + ++ ++ + + ++ I + +
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 403 LEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYI 462
L YLH+ + RIVH D+ P NI+L ED I+DFGLAKQ Q + S++ GTI Y
Sbjct: 126 LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVV---GTILYS 180
Query: 463 APE-VYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDT-SICHNLIYERIEPGND 520
PE V + +G K+DV+++G ++ +M CT T+ S+ ++ EP +
Sbjct: 181 CPEIVKNEPYG---EKADVWAFGCILYQM--CTLQPPFYSTNMLSLATKIVEAVYEPLPE 235
Query: 521 FQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEML 563
+ T V C+ + RP + +V M+
Sbjct: 236 GMYSEDVT-----------DVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 6e-20
Identities = 61/201 (30%), Positives = 106/201 (52%), Gaps = 16/201 (7%)
Query: 299 DKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEE---FINEVASISRTSH-VNIVTF 353
++LG+G YG V K +P G ++AVK ++ + N +E + ++ R+ VTF
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRAT-VNSQEQKRLLMDLDISMRSVDCPYTVTF 65
Query: 354 LGFCYENKKNALIYELMPNGSLDKFIHN--DRNIKLEWKTMYQIAIGIARGLEYLHRGCQ 411
G + + E+M + SLDKF D+ + + + +IA+ I + LEYLH +
Sbjct: 66 YGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS--K 122
Query: 412 VRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYS--R 469
+ ++H D+KP N+L++ + K+ DFG++ +S + A G Y+APE +
Sbjct: 123 LSVIHRDVKPSNVLINRNGQVKLCDFGIS--GYLVDSVAKTIDA-GCKPYMAPERINPEL 179
Query: 470 RFGGVSHKSDVYSYGMMIIEM 490
G KSDV+S G+ +IE+
Sbjct: 180 NQKGYDVKSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 9e-20
Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 29/207 (14%)
Query: 300 KLGQGGYGEVYK-GELPDGQLVAVKVLKNSRCNG---EEFINEVASISRTSHVNIVTFLG 355
++G+G +G V+K + G+ VA+K + R G + + E+ ++ H +V L
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRN------IKLEWKTMYQIAIGIARGLEYLHRG 409
L+ E MP L + + ++ +K M + +G+ Y+H
Sbjct: 67 VFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVK---SYMRMLL----KGVAYMH-- 116
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVY-- 467
I+H D+KP N+L+ D KI+DFGLA+ +E H T Y APE+
Sbjct: 117 -ANGIMHRDLKPANLLISADGVLKIADFGLAR-LFSEEEPRLYSHQVATRWYRAPELLYG 174
Query: 468 SRRFG-GVSHKSDVYSYGMMIIEMVGC 493
+R++ GV D+++ G + E++
Sbjct: 175 ARKYDPGV----DLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 9e-20
Identities = 67/277 (24%), Positives = 129/277 (46%), Gaps = 23/277 (8%)
Query: 290 VKRMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVN 349
+ +F +LG G +G V G+ VA+K++K + +EFI E + + SH
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEK 60
Query: 350 IVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRG 409
+V G C + + ++ E M NG L ++ + + + ++ + G+ YL
Sbjct: 61 LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESK 119
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEV--Y 467
+ +H D+ +N L+D+ C K+SDFGL++ E S+ ++ + + PEV Y
Sbjct: 120 ---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLLY 175
Query: 468 SRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527
S+ S KSDV+++G+++ E+ K + ++ E++ G +A
Sbjct: 176 SK----FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETV-----EKVSQGLRLYRPHLA 226
Query: 528 TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564
+E K+ +M + C ERP+ ++L +E
Sbjct: 227 SE---KVYAIM----YSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 68/203 (33%), Positives = 100/203 (49%), Gaps = 25/203 (12%)
Query: 299 DKLGQGGYGEVYKGE-LPDGQLVAVKVLK-NSRCNGEEFIN-----EVASISRTSHVNIV 351
KLG+G Y VYK G++VA+K +K R ++ IN E+ + H NI+
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 352 TFLGFCYENKKN-ALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGC 410
L + +K N L++E M L+K I D++I L + + RGLEYLH
Sbjct: 66 GLLD-VFGHKSNINLVFEFME-TDLEKVIK-DKSIVLTPADIKSYMLMTLRGLEYLHSN- 121
Query: 411 QVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ-AQKKESAISMLHARGTIGYIAPEVY-- 467
I+H D+KP N+L+ D K++DFGLA+ M H T Y APE+
Sbjct: 122 --WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR---KMTHQVVTRWYRAPELLFG 176
Query: 468 SRRFG-GVSHKSDVYSYGMMIIE 489
+R +G GV D++S G + E
Sbjct: 177 ARHYGVGV----DMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (221), Expect = 1e-19
Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 28/204 (13%)
Query: 300 KLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFIN--EVASISR-TSHVNIVTFLG 355
+LG G +G VY G+LVA+K +K + EE +N EV S+ + H NIV
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKE 65
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKT----MYQIAIGIARGLEYLHR-GC 410
EN + ++E M G+L + + + + +YQI +GL ++H+ G
Sbjct: 66 VFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQIL----QGLAHIHKHG- 119
Query: 411 QVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE---SAISMLHARGTIGYIAPEVY 467
H D+KP+N+L+ KI+DFGLA++ + + +S T Y APE+
Sbjct: 120 ---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVS------TRWYRAPEIL 170
Query: 468 SRRFGGVSHKSDVYSYGMMIIEMV 491
R S D+++ G ++ E+
Sbjct: 171 LRS-TSYSSPVDIWALGCIMAELY 193
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 62/201 (30%), Positives = 95/201 (47%), Gaps = 19/201 (9%)
Query: 301 LGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGE------EFINEVASISRTSHVNIVTF 353
LGQG +G VY ++ G+ +AVK + + E E+ + H IV +
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 354 LGFCYENKKNALIYELMPNGSLDKFI--HNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQ 411
G +++ ++ E MP GS+ + + + K QI G+EYLH
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGVEYLHSN-- 123
Query: 412 VRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS-MLHARGTIGYIAPEVYSRR 470
IVH DIK NIL D K+ DFG +K+ Q S+ + M GT +++PEV S
Sbjct: 124 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 471 FGGVSHKSDVYSYGMMIIEMV 491
G K+DV+S G ++EM+
Sbjct: 183 --GYGRKADVWSVGCTVVEML 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 68/201 (33%), Positives = 113/201 (56%), Gaps = 22/201 (10%)
Query: 301 LGQGGYGEVY---KGELPD-GQLVAVKVLKNSRCNGEEFI---NEVASISRTSHVNIVTF 353
LGQG +G+V+ K PD GQL A+KVLK + + + E ++ +H IV
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK- 62
Query: 354 LGFCYENK-KNALIYELMPNGSLDKFIHNDRNIKL-EWKTMYQIAIGIARGLEYLHRGCQ 411
L + ++ + K LI + + G L F + + E + +A +A L++LH
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLA-ELALALDHLHS--- 116
Query: 412 VRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES-AISMLHARGTIGYIAPEVYSRR 470
+ I++ D+KP+NILLDE+ K++DFGL+K++ E A S GT+ Y+APEV +RR
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC---GTVEYMAPEVVNRR 173
Query: 471 FGGVSHKSDVYSYGMMIIEMV 491
G + +D +S+G+++ EM+
Sbjct: 174 --GHTQSADWWSFGVLMFEML 192
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 13/208 (6%)
Query: 286 SYSDVKRMTKSFRDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFI-NEVASIS 343
S D K+ F +K+GQG G VY ++ GQ VA+K + + +E I NE+ +
Sbjct: 13 SVGDPKKKYTRF-EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMR 71
Query: 344 RTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGL 403
H NIV +L + ++ E + GSL + ++ + + + L
Sbjct: 72 ENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQAL 128
Query: 404 EYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIA 463
E+LH +++H DIK NILL D K++DFG Q ++S S + GT ++A
Sbjct: 129 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYWMA 183
Query: 464 PEVYSRRFGGVSHKSDVYSYGMMIIEMV 491
PEV +R+ G K D++S G+M IEMV
Sbjct: 184 PEVVTRKAYG--PKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 35/213 (16%)
Query: 301 LGQGGYGEVYKGEL------PDGQLVAVKVLKN--SRCNGEEFINEVASISRTSHVNIVT 352
LG G +GEVY+G VAVK L S + +F+ E +S+ +H NIV
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 353 FLGFCYENKKNALIYELMPNGSLDKFIHNDRN-----IKLEWKTMYQIAIGIARGLEYLH 407
+G +E ++ ELM G L F+ +R L K + A +A+G +YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 408 RGCQVRIVHFDIKPQNILLDEDFCP------KISDFGLAKQAQKKE----SAISMLHARG 457
+ +H DI +N LL C KI+DFG+A+ + +ML
Sbjct: 134 ---ENHFIHRDIAARNCLLT---CKGPGRVAKIADFGMARDIYRASYYRKGGRAML---- 183
Query: 458 TIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEM 490
I ++ PE + G + K+DV+S+G+++ E+
Sbjct: 184 PIKWMPPEAFLD--GIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 60/198 (30%), Positives = 100/198 (50%), Gaps = 14/198 (7%)
Query: 301 LGQGGYGEVYKG-ELPDGQL----VAVKVLKN--SRCNGEEFINEVASISRTSHVNIVTF 353
LG G +G V+KG +P+G VA+K +++ R +E + + ++ H IV
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 354 LGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVR 413
LG C L+ +L P GSL + R+ L+ + + + IA+G+ YL
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMYYLEEHR--- 129
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGG 473
+VH ++ +NILL D +I+DFG+A + + I ++A E S FG
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE--SILFGR 187
Query: 474 VSHKSDVYSYGMMIIEMV 491
+H+SDV+SYG+ + EM+
Sbjct: 188 YTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 62/199 (31%), Positives = 108/199 (54%), Gaps = 16/199 (8%)
Query: 301 LGQGGYGEVYKG-ELPDGQ----LVAVKVLK--NSRCNGEEFINEVASISRTSHVNIVTF 353
LG G +G VYKG +PDG+ VA+KVL+ S +E ++E ++ +
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 354 LGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVR 413
LG C + L+ +LMP G L ++ +++ ++ + + + IA+G+ YL +VR
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKD-RIGSQDLLNWCVQIAKGMSYLE---EVR 129
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPE-VYSRRFG 472
+VH D+ +N+L+ KI+DFGLA+ E+ + I ++A E + RRF
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF- 188
Query: 473 GVSHKSDVYSYGMMIIEMV 491
+H+SDV+SYG+ + E++
Sbjct: 189 --THQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 7e-19
Identities = 68/215 (31%), Positives = 115/215 (53%), Gaps = 25/215 (11%)
Query: 291 KRMTKSFRDKLGQGGYGEV----YKGELPD-GQLVAVKVLKNSRCNGEEFIN----EVAS 341
KR K RD LG+G +G+V Y E + G+ VAVK LK +G I E+
Sbjct: 3 KRFLKRIRD-LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEIEI 59
Query: 342 ISRTSHVNIVTFLGFCYENKKNA--LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGI 399
+ H NIV + G C E+ N LI E +P+GSL +++ ++N K+ K + A+ I
Sbjct: 60 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKN-KINLKQQLKYAVQI 118
Query: 400 ARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGT- 458
+G++YL G + + VH D+ +N+L++ + KI DFGL K + + ++ +
Sbjct: 119 CKGMDYL--GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSP 175
Query: 459 IGYIAPE--VYSRRFGGVSHKSDVYSYGMMIIEMV 491
+ + APE + S+ + SDV+S+G+ + E++
Sbjct: 176 VFWYAPECLIQSKFY----IASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 8e-19
Identities = 64/226 (28%), Positives = 113/226 (50%), Gaps = 35/226 (15%)
Query: 290 VKRMTKSFRDKLGQGGYGEVYKGE----LPDGQ--LVAVKVLKNSRCNG-EEFINEVASI 342
+KR + +LG+G +G+V+ E LP+ LVAVK LK + + ++F E +
Sbjct: 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 61
Query: 343 SRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHN---DRNI----------KLEW 389
+ H +IV F G C E + +++E M +G L++F+ + D I +L
Sbjct: 62 TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121
Query: 390 KTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE-- 447
M IA IA G+ YL + VH D+ +N L+ + KI DFG+++ +
Sbjct: 122 GQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 178
Query: 448 --SAISMLHARGTIGYIAPE-VYSRRFGGVSHKSDVYSYGMMIIEM 490
+ML R ++ PE + R+F + +SD++S+G+++ E+
Sbjct: 179 RVGGRTMLPIR----WMPPESILYRKF---TTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 62/202 (30%), Positives = 110/202 (54%), Gaps = 19/202 (9%)
Query: 301 LGQGGYGEVYKGEL--PDGQLVAVKVLKNSRCNG----EEFINEVASISRTSHVNIVTFL 354
+G+G +G VY G L DGQ + V +R E+F+ E + SH N+++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 355 GFCYENKKNALI-YELMPNGSLDKFIHND-RNIKLEWKTMYQIAIGIARGLEYLHRGCQV 412
G C ++ + L+ M +G L FI ++ N + K + + +A+G+EYL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTV--KDLIGFGLQVAKGMEYL---ASK 117
Query: 413 RIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE--SAISMLHARGTIGYIAPE-VYSR 469
+ VH D+ +N +LDE F K++DFGLA+ KE S + A+ + ++A E + ++
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177
Query: 470 RFGGVSHKSDVYSYGMMIIEMV 491
+F + KSDV+S+G+++ E++
Sbjct: 178 KF---TTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 80/273 (29%), Positives = 130/273 (47%), Gaps = 38/273 (13%)
Query: 301 LGQGGYGEVYKG-ELPDGQ----LVAVKVLK--NSRCNGEEFINEVASISRTSHVNIVTF 353
LG G +G VYKG +P+G+ VA+K L+ S +E ++E ++ + ++
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 354 LGFCYENKKNALIYELMPNGSLDKFI-HNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQV 412
LG C + LI +LMP G L ++ + NI ++ + + IA+G+ YL +
Sbjct: 75 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQY--LLNWCVQIAKGMNYLE---ER 128
Query: 413 RIVHFDIKPQNILLDEDFCPKISDFGLAK--QAQKKESAISMLHARG---TIGYIAPEVY 467
R+VH D+ +N+L+ KI+DFGLAK A +KE HA G I ++A E
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE-----YHAEGGKVPIKWMALESI 183
Query: 468 SRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527
R +H+SDV+SYG+ + E++ D + + I L E G +
Sbjct: 184 LHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-----EKGERLPQPPIC 236
Query: 528 TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVL 560
T I MI+V W I + RP +++
Sbjct: 237 T-----IDVYMIMVKCWMI--DADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 68/267 (25%), Positives = 125/267 (46%), Gaps = 28/267 (10%)
Query: 300 KLGQGGYGEVYKG-ELPDGQLVAVK---VLKNSRCNGEEFINEVASISRTSHVNIVTFLG 355
K+G+G +G V+K D ++ A+K + K +R EE I+E +++ I+ +
Sbjct: 7 KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
+ K ++ E NG L K + R L +++ I I GL +LH +I+
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KIL 123
Query: 416 HFDIKPQNILLDEDFCPKISDFGLAKQAQKKES-AISMLHARGTIGYIAPEVYSRRFGGV 474
H DIK N+ LD KI D G+AK + A +++ GT Y++PE+ +
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV---GTPYYLSPELCEDK--PY 178
Query: 475 SHKSDVYSYGMMIIEMVGCT-KNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKK 533
+ KSDV++ G+++ E CT K+ D ++ +I P V+ ++
Sbjct: 179 NEKSDVWALGVVLYEC--CTGKHPFDANNQGALILKIIRGVFPP--------VSQMYSQQ 228
Query: 534 IAKMMILVGFWCIQTNPSERPSMHKVL 560
+A+++ C+ + +RP ++L
Sbjct: 229 LAQLIDQ----CLTKDYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-18
Identities = 56/195 (28%), Positives = 96/195 (49%), Gaps = 7/195 (3%)
Query: 296 SFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLG 355
+F +LG G +G V+ G+ VA+K + + E+FI E + + SH +V G
Sbjct: 7 TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
C + K ++ E M NG L ++ + KL + + + G+EYL R +
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERN---SFI 122
Query: 416 HFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVS 475
H D+ +N L+ K+SDFG+ + E S A+ + + PEV++ F S
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWSPPEVFN--FSKYS 179
Query: 476 HKSDVYSYGMMIIEM 490
KSDV+S+G+++ E+
Sbjct: 180 SKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 65/220 (29%), Positives = 108/220 (49%), Gaps = 29/220 (13%)
Query: 294 TKSFRDKLGQGGYGEVYKGEL------PDGQLVAVKVLKNSRCNG---EEFINEVASISR 344
T F ++LG+ +G+VYKG L Q VA+K LK+ + G EEF +E SR
Sbjct: 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKD-KAEGPLREEFKHEAMMRSR 64
Query: 345 TSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFI------------HNDRNIK--LEWK 390
H NIV LG + + ++I+ + L +F+ +D+ +K LE
Sbjct: 65 LQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPA 124
Query: 391 TMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450
I IA G+E+L +VH D+ +N+L+ + KISD GL ++ +
Sbjct: 125 DFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYK 181
Query: 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEM 490
M ++ I +++PE +G S SD++SYG+++ E+
Sbjct: 182 LMGNSLLPIRWMSPEAIM--YGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 78/283 (27%), Positives = 137/283 (48%), Gaps = 38/283 (13%)
Query: 301 LGQGGYGEVYKGEL--PDG--QLVAVKVLK---NSRCNGEEFINEVASISRTSHVNIVTF 353
LG+G +G V +G+L DG VAVK +K ++ EEF++E A + H N++
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 354 LGFCYENK------KNALIYELMPNGSLDKFIHNDR----NIKLEWKTMYQIAIGIARGL 403
+G C+E K +I M +G L F+ R KL +T+ + + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 404 EYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIA 463
EYL +H D+ +N +L ED ++DFGL+K+ + A+ + +IA
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 464 PEVYSRRFGGVSHKSDVYSYGMMIIEMV--GCTKNLDDEVTDTSICHNLIYERIEPGNDF 521
E + R + KSDV+++G+ + E+ G T + ++ IY+ + GN
Sbjct: 184 IESLADRV--YTSKSDVWAFGVTMWEIATRGQTPY-------PGVENHEIYDYLRHGNRL 234
Query: 522 QFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564
+ + E + ++ L+ C + +P +RP+ K+ E+LE
Sbjct: 235 K------QPEDCLDELYDLMYS-CWRADPKDRPTFTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-18
Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 13/205 (6%)
Query: 301 LGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEE---FINEVASISRTSHVNIVTFLGF 356
+G+G +G V+ D +LV +K + + +E NE + SH NI+ +
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 357 CYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVH 416
E+K ++ E P G+L ++I N L+ T+ + I L ++H I+H
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILH 124
Query: 417 FDIKPQNILLDE-DFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVS 475
D+K QNILLD+ KI DFG++K K A +++ GT YI+PE+ + +
Sbjct: 125 RDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV---GTPCYISPELCEGK--PYN 179
Query: 476 HKSDVYSYGMMIIEMVGCTKNLDDE 500
KSD+++ G ++ E+ + +
Sbjct: 180 QKSDIWALGCVLYELASLKRAFEAA 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 1e-18
Identities = 68/201 (33%), Positives = 102/201 (50%), Gaps = 16/201 (7%)
Query: 301 LGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEFINEVASISRTSH-VNIVTFLG-FC 357
+G G YG+VYKG + GQL A+KV+ + EE E+ + + SH NI T+ G F
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 358 YENKKNA-----LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQV 412
+N L+ E GS+ I N + L+ + + I I RGL +LH Q
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QH 130
Query: 413 RIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYS---R 469
+++H DIK QN+LL E+ K+ DFG++ Q + + GT ++APEV +
Sbjct: 131 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF--IGTPYWMAPEVIACDEN 188
Query: 470 RFGGVSHKSDVYSYGMMIIEM 490
KSD++S G+ IEM
Sbjct: 189 PDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-18
Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 25/205 (12%)
Query: 301 LGQGGYGEVYKGEL-PDG---QLVAVKVLKNSRCNGE--EFINEVASISRTSHVNIVTFL 354
+G G +GEV +G L G VA+K LK+ + +F++E + + + H NI+
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 355 GFCYENKKNALIYELMPNGSLDKFIH-NDRNIKLEWKTMYQIA---IGIARGLEYLHRGC 410
G +++ +I E M NG+LD F+ ND T+ Q+ GIA G++YL
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQF-----TVIQLVGMLRGIAAGMKYL---S 123
Query: 411 QVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES---AISMLHARGTIGYIAPEVY 467
++ VH D+ +NIL++ + K+SDFGL++ + S S L + I + APE
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 468 S-RRFGGVSHKSDVYSYGMMIIEMV 491
+ R+F + SDV+SYG+++ E++
Sbjct: 184 AYRKF---TSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 58/195 (29%), Positives = 95/195 (48%), Gaps = 17/195 (8%)
Query: 302 GQGGYGEVYKGELPD-GQLVAVKVLKNSRCNGEE----FINEVASISRTSHVNIVTFLGF 356
G+G +G+V + D ++ A+K + +C + +NE + +H +V L +
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVN-LWY 67
Query: 357 CYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
+++++N L+ +L+ G L ++ H + +K + + I LEYLH I+
Sbjct: 68 SFQDEENMYLVVDLLLGGDL-RY-HLSQKVKFSEEQVKFWICEIVLALEYLH---SKGII 122
Query: 416 HFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVS 475
H DIKP NILLDE I+DF +A + S GT GY+APEV R+ G S
Sbjct: 123 HRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST---SGTPGYMAPEVLCRQ--GYS 177
Query: 476 HKSDVYSYGMMIIEM 490
D +S G+ E
Sbjct: 178 VAVDWWSLGVTAYEC 192
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 72/276 (26%), Positives = 123/276 (44%), Gaps = 19/276 (6%)
Query: 289 DVKRMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHV 348
++ R + KLG G +GEV+ VAVK +K + E F+ E + H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 61
Query: 349 NIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHR 408
+V L + +I E M GSL F+ +D K + + IA G+ ++
Sbjct: 62 KLVK-LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE- 119
Query: 409 GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYS 468
Q +H D++ NIL+ KI+DFGLA+ + E + A+ I + APE +
Sbjct: 120 --QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAIN 176
Query: 469 RRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528
FG + KSDV+S+G++++E+V + +++ + L E G
Sbjct: 177 --FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-----ERGYRMPRPENCP 229
Query: 529 EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564
EE + +M+ C + P ERP+ + +L+
Sbjct: 230 EE---LYNIMMR----CWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 60/199 (30%), Positives = 107/199 (53%), Gaps = 15/199 (7%)
Query: 301 LGQGGYGEVYKGELP----DGQLVAVKVLKNSRCNGE--EFINEVASISRTSHVNIVTFL 354
+G G +GEV++G L VA+K LK + +F++E + + + SH NI+
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 355 GFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRI 414
G + K +I E M NG+LDK++ D + + + + GIA G++YL +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLR-DHDGEFSSYQLVGMLRGIAAGMKYL---SDMNY 128
Query: 415 VHFDIKPQNILLDEDFCPKISDFGLAKQAQK-KESAISMLHARGTIGYIAPEVYS-RRFG 472
VH D+ +NIL++ + K+SDFGL++ + E + + I + APE + R+F
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF- 187
Query: 473 GVSHKSDVYSYGMMIIEMV 491
+ SDV+S+G+++ E++
Sbjct: 188 --TSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 78/302 (25%), Positives = 139/302 (46%), Gaps = 45/302 (14%)
Query: 287 YSDVKRMTKSFRDKLGQGGYGEVYKGELPDGQL---VAVKVLKN--SRCNGEEFINEVAS 341
++D+K F+D +G+G +G+V K + L A+K +K S+ + +F E+
Sbjct: 6 WNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 60
Query: 342 ISRTS-HVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIK-------------- 386
+ + H NI+ LG C L E P+G+L F+ R ++
Sbjct: 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120
Query: 387 LEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446
L + + A +ARG++YL Q + +H D+ +NIL+ E++ KI+DFGL++ +
Sbjct: 121 LSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQ 174
Query: 447 ESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSI 506
E + R + ++A E S + + SDV+SYG+++ E+V +L
Sbjct: 175 EVYVKKTMGRLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIV----SLGGTPYCGMT 228
Query: 507 CHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGS 566
C L YE++ G + +E + + C + P ERPS ++L L
Sbjct: 229 CAEL-YEKLPQGYRLEKPLNCDDEVYDLMRQ-------CWREKPYERPSFAQILVSLNRM 280
Query: 567 IE 568
+E
Sbjct: 281 LE 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 70/198 (35%), Positives = 102/198 (51%), Gaps = 17/198 (8%)
Query: 301 LGQGGYGEVYKGEL-PDGQLVAVKVLKNSRC---NGEEF-INEVASISRTSHVNIVTFLG 355
LG+GG+GEV ++ G++ A K L+ R GE +NE + + + +V+ L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS-LA 66
Query: 356 FCYENKKN-ALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRI 414
+ YE K L+ LM G L I+N N + + A I GLE LHR RI
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RI 123
Query: 415 VHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR-GTIGYIAPEVYSRRFGG 473
V+ D+KP+NILLD+ +ISD GLA + + E+ + R GT+GY+APEV
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVEIPEGET----IRGRVGTVGYMAPEVVKNERYT 179
Query: 474 VSHKSDVYSYGMMIIEMV 491
S D + G +I EM+
Sbjct: 180 FS--PDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 301 LGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNG-------EEFINEVASISRTSHVNIVT 352
LG G + Y+ ++ G L+AVK + R E E+ ++R +H +I+
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 353 FLGFCYENKKNALIYELMPNGSLDKFIHN----DRNIKLEWKTMYQIAIGIARGLEYLHR 408
LG E+ L E M GS+ + + + + Q + RGL YLH
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINY--TEQ----LLRGLSYLHE 121
Query: 409 GCQVRIVHFDIKPQNILLD---EDFCPKISDFGLAKQAQKKESAISMLHAR--GTIGYIA 463
+I+H D+K N+L+D + +I+DFG A + K + + GTI ++A
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 464 PEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTK 495
PEV G S DV+S G +IIEM K
Sbjct: 177 PEVLRGEQYGRS--CDVWSVGCVIIEMA-TAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 69/276 (25%), Positives = 126/276 (45%), Gaps = 42/276 (15%)
Query: 301 LGQGGYGE--VYKGELPDGQLVAVKVLKNSRCNGEE---FINEVASISRTSHVNIVTFLG 355
LG+G +GE +Y+ D LV K + +R + +E +NE+ +S H NI+ +
Sbjct: 8 LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 356 FCYENKKNALIYELMPNGSL-DKFIHNDRNIKLE----WKTMYQIAIGIARGLEYLHRGC 410
++ + E G+L DK + + E W ++QI ++ Y+H
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-YLFQIVSAVS----YIH--- 118
Query: 411 QVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ-AQKKESAISMLHARGTIGYIAPEVYSR 469
+ I+H DIK NI L + K+ DFG++K + A +++ GT Y++PE+
Sbjct: 119 KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV---GTPYYMSPELCQ- 174
Query: 470 RFGGVSH--KSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527
GV + KSD+++ G ++ E++ K D ++ +I GN V
Sbjct: 175 ---GVKYNFKSDIWALGCVLYELL-TLKRTFDATNPLNLV-----VKIVQGNYTPVVSVY 225
Query: 528 TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEML 563
+ E +I + +Q +P +RP+ +VL+
Sbjct: 226 SSE-------LISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 65/205 (31%), Positives = 103/205 (50%), Gaps = 31/205 (15%)
Query: 301 LGQGGYGEVYKGELPD-GQLVAVKVLK-NSRCNGEEFINEVASISRTSHVNIVTFL-GFC 357
LG G +G+VYK + + G A K+++ S E+F+ E+ +S H NIV +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 358 YENKKNALIYELMPNGSLDKFIHNDRNIKLEWK-TMYQIAIGIAR----GLEYLHRGCQV 412
YENK LI E G+LD + ++LE T QI + R L +LH
Sbjct: 73 YENKLWILI-EFCDGGALDSIM-----LELERGLTEPQIRY-VCRQMLEALNFLHSH--- 122
Query: 413 RIVHFDIKPQNILLDEDFCPKISDFG----LAKQAQKKESAISMLHARGTIGYIAPEVY- 467
+++H D+K NILL D K++DFG QK+++ I GT ++APEV
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI------GTPYWMAPEVVA 176
Query: 468 --SRRFGGVSHKSDVYSYGMMIIEM 490
+ + +K+D++S G+ +IE+
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 59/194 (30%), Positives = 94/194 (48%), Gaps = 13/194 (6%)
Query: 300 KLGQGGYGEVYKG-ELPDGQLVAVKV--LKNSRCNGEEFINEVASISRTSHVNIVTFLGF 356
+G+G +GEVYK + Q+VA+KV L+ + E+ E+ +S+ I + G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 357 CYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVH 416
+ K +I E GS + + KL+ + I + GLEYLH +H
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLL---KPGKLDETYIAFILREVLLGLEYLHEE---GKIH 121
Query: 417 FDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSH 476
DIK NILL E+ K++DFG++ Q + GT ++APEV + G
Sbjct: 122 RDIKAANILLSEEGDVKLADFGVS--GQLTSTMSKRNTFVGTPFWMAPEVIKQ--SGYDE 177
Query: 477 KSDVYSYGMMIIEM 490
K+D++S G+ IE+
Sbjct: 178 KADIWSLGITAIEL 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 65/220 (29%), Positives = 107/220 (48%), Gaps = 25/220 (11%)
Query: 290 VKRMTKSFRDKLGQGGYGEVYKGEL------PDGQLVAVKVLKNSRCNG-EEFINEVASI 342
+KR + +LG+G +G+V+ E D LVAVK LK++ N ++F E +
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 61
Query: 343 SRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFI-----------HNDRNIKLEWKT 391
+ H +IV F G C E +++E M +G L+KF+ +R +L
Sbjct: 62 TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ 121
Query: 392 MYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451
M IA IA G+ YL VH D+ +N L+ E+ KI DFG+++ +
Sbjct: 122 MLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV 178
Query: 452 MLHARGTIGYIAPE-VYSRRFGGVSHKSDVYSYGMMIIEM 490
H I ++ PE + R+F + +SDV+S G+++ E+
Sbjct: 179 GGHTMLPIRWMPPESIMYRKF---TTESDVWSLGVVLWEI 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 71/285 (24%), Positives = 125/285 (43%), Gaps = 43/285 (15%)
Query: 301 LGQGGYGEVYKGELPDGQL---VAVKVLKNSRCNG---EEFINEVASISRTSHVNIVTFL 354
LG+G +G V +G+L VAVK +K + C E+F++E + H N++ +
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 355 GFCYENKKN------ALIYELMPNGSLDKFIH----NDRNIKLEWKTMYQIAIGIARGLE 404
G C + ++ +I M +G L F+ D L + + + IA G+E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 405 YLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAP 464
YL +H D+ +N +L+E+ ++DFGL+K+ + A+ + +IA
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 465 EVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQ-- 522
E + R + KSDV+S+G+ + E+ + V ++ IY+ + GN +
Sbjct: 184 ESLADRV--YTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-----IYDYLRQGNRLKQP 236
Query: 523 ---FDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564
DG + +M C NP +RPS + LE
Sbjct: 237 PDCLDG--------LYSLM----SSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 68/197 (34%), Positives = 97/197 (49%), Gaps = 15/197 (7%)
Query: 301 LGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGF 356
LG+GG+GEV ++ G++ A K L+ R GE I + V L +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 357 CYENKKN-ALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
YE K L+ +M G L I+N N E + A I GLE LHR V
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTV 124
Query: 416 HFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR-GTIGYIAPEVYSRRFGGV 474
+ D+KP+NILLD+ +ISD GLA + + ES + R GT+GY+APEV + + +
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGLAVKIPEGES----IRGRVGTVGYMAPEVLNNQRYTL 180
Query: 475 SHKSDVYSYGMMIIEMV 491
S D + G +I EM+
Sbjct: 181 S--PDYWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 6e-18
Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 37/210 (17%)
Query: 299 DKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEF----INEVASISRTSHVNIVTF 353
++G+G YG+VYK G+LVA+K ++ E F I E+ + + H NIV
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEK-EGFPITAIREIKLLQKLRHPNIVRL 63
Query: 354 LGFCYENKKNA--LIYELMPNGSLDKFIHNDRNIKLEWKTMYQI---AIGIARGLEYLHR 408
K + +++E M + L + + +K T QI + GL+YLH
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDH-DLTGLLDS-PEVKF---TESQIKCYMKQLLEGLQYLHS 118
Query: 409 GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA------ISMLHARGTIGYI 462
I+H DIK NIL++ D K++DFGLA+ K+ SA I T+ Y
Sbjct: 119 N---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-------TLWYR 168
Query: 463 APEVY--SRRFGGVSHKSDVYSYGMMIIEM 490
PE+ + R+G + D++S G ++ E+
Sbjct: 169 PPELLLGATRYGP---EVDMWSVGCILAEL 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 7e-18
Identities = 75/299 (25%), Positives = 128/299 (42%), Gaps = 45/299 (15%)
Query: 285 YSYSDVKRMTKSFRDKLGQGGYGEVYKGELP------DGQLVAVKVLKNSRCNG--EEFI 336
+ S+++ +T LG+G +GEV+ + LV VK L+ ++ EF
Sbjct: 2 FPRSNLQEITT-----LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFR 56
Query: 337 NEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFI----HNDRNIK---LEW 389
E+ + SH N+V LG C E + + +I E G L +F+ D +K L
Sbjct: 57 RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116
Query: 390 KTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449
K + IA G+++L R VH D+ +N L+ K+S L+K E
Sbjct: 117 KQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE-- 171
Query: 450 ISMLHARGT---IGYIAPE-VYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTS 505
R + ++APE V F S KSDV+S+G+++ E+ + ++D
Sbjct: 172 --YYKLRNALIPLRWLAPEAVQEDDF---STKSDVWSFGVLMWEVFTQGELPFYGLSDEE 226
Query: 506 ICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564
+ R++ G + V ++ K+M C NP +RPS +++ L
Sbjct: 227 VL-----NRLQAG-KLELP-VPEGCPSRLYKLMTR----CWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 7e-18
Identities = 72/296 (24%), Positives = 134/296 (45%), Gaps = 41/296 (13%)
Query: 289 DVKRMTKSFRDKLGQGGYGEVYKGELPD---GQL---VAVKVLKNSRCNGE--EFINEVA 340
+V R + +LGQG +G VY+G D G+ VAVK + S E EF+NE +
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 341 SISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFI--------HNDRNIKLEWKTM 392
+ + ++V LG + + ++ ELM +G L ++ +N + M
Sbjct: 62 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121
Query: 393 YQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK----KES 448
Q+A IA G+ YL+ + VH D+ +N ++ DF KI DFG+ + + ++
Sbjct: 122 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 449 AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICH 508
+L R +APE S + G + SD++S+G+++ E+ + +++ +
Sbjct: 179 GKGLLPVRW----MAPE--SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL- 231
Query: 509 NLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564
F DG ++ + + + C Q NP RP+ +++ +L+
Sbjct: 232 -----------KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 8e-18
Identities = 66/215 (30%), Positives = 102/215 (47%), Gaps = 47/215 (21%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEE------FINEVASISRTSHVNIV 351
+K+G+G YG VYK + G++VA LK R E+ I E++ + +H NIV
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVA---LKKIRLETEDEGVPSTAIREISLLKELNHPNIV 61
Query: 352 TFLGFCYENKKNALIYELMPNGSLDKFIH-------NDRNIKLEWKTMYQIAIGIARGLE 404
L + K L++E + + L K++ + IK +YQ+ GIA
Sbjct: 62 RLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIK---SYLYQLLQGIA---- 113
Query: 405 YLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM-----LHARGTI 459
Y H R++H D+KPQN+L+D + K++DFGLA+ A + H T+
Sbjct: 114 YCH---SHRVLHRDLKPQNLLIDREGALKLADFGLAR-------AFGVPVRTYTHEVVTL 163
Query: 460 GYIAPEVYSRRFGGVSHKS---DVYSYGMMIIEMV 491
Y APE+ G S D++S G + EMV
Sbjct: 164 WYRAPEI----LLGSRQYSTPVDIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 71/301 (23%), Positives = 129/301 (42%), Gaps = 61/301 (20%)
Query: 301 LGQGGYGEVYKGE------LPDGQLVAVKVLKNSRCNGE--EFINEVASISRTSHVNIVT 352
LG+G +G+V K VAVK+LK + + E + ++E + + +H +++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 353 FLGFCYENKKNALIYELMPNGSLDKFIHNDRNIK----------------------LEWK 390
G C ++ LI E GSL F+ R + L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 391 TMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450
+ A I+RG++YL ++++VH D+ +N+L+ E KISDFGL++ +++S +
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 451 SMLHARGTIGYIAPE-----VYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTS 505
R + ++A E +Y+ +SDV+S+G+++ E+V N
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTT-------QSDVWSFGVLLWEIVTLGGN--------- 228
Query: 506 ICHNLIYERIEPGNDFQF--DGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEML 563
Y I P F G E + ++ M + C + P +RP+ + + L
Sbjct: 229 -----PYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283
Query: 564 E 564
E
Sbjct: 284 E 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 27/216 (12%)
Query: 297 FRDKLGQGGYGEVYKGEL-----PDGQLVAVKVLK--NSRCNGEEFINEVASISRTSHVN 349
F ++LG+ +G++YKG L QLVA+K LK N+ EF E + ++ H N
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68
Query: 350 IVTFLGFCYENKKNALIYELMPNGSLDKFI-----HNDRNIK----------LEWKTMYQ 394
IV LG + + +++E + G L +F+ H+D L+
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 395 IAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLH 454
IAI IA G+EYL VH D+ +NIL+ E KISD GL+++ +
Sbjct: 129 IAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 455 ARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEM 490
+ I ++ PE +G S SD++S+G+++ E+
Sbjct: 186 SLLPIRWMPPEAIM--YGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 75/296 (25%), Positives = 133/296 (44%), Gaps = 40/296 (13%)
Query: 290 VKRMTKSFRDKLGQGGYGEVYKGE------LPDGQLVAVKVLKNSRCNG-EEFINEVASI 342
+KR + +LG+G +G+V+ E D LVAVK LK+ ++F E +
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELL 61
Query: 343 SRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHN--------------DRNIKLE 388
+ H +IV F G C + +++E M +G L+KF+ +L
Sbjct: 62 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 121
Query: 389 WKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448
M IA IA G+ YL VH D+ +N L+ + KI DFG+++ +
Sbjct: 122 LSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 178
Query: 449 AISMLHARGTIGYIAPE-VYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSIC 507
H I ++ PE + R+F + +SDV+S+G+++ E+ K ++++T
Sbjct: 179 YRVGGHTMLPIRWMPPESIMYRKF---TTESDVWSFGVILWEIFTYGKQPWFQLSNT--- 232
Query: 508 HNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEML 563
+ E I G + V +E I++G W Q P +R ++ ++ ++L
Sbjct: 233 --EVIECITQGRVLERPRVCPKEVYD-----IMLGCW--QREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 73/277 (26%), Positives = 127/277 (45%), Gaps = 40/277 (14%)
Query: 301 LGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEFINEVAS----ISRTSHVNIVTFLG 355
+ +G YG V+ + G + A+KV+K + + +++V + +S+ +V
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 356 FCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMY--QIAIGIARGLEYLHRGCQV 412
+ ++ KKN L+ E +P G L + N ++ + +Y +I + LEYLH
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLA----LEYLH---SN 112
Query: 413 RIVHFDIKPQNILLDEDFCPKISDFGLAK----QAQKKESAISMLHAR--GTIGYIAPEV 466
I+H D+KP NIL+D + K++DFGL+K + Q + R GT YIAPEV
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 467 YSRRFGGVSHKSDVYSYGMMIIE-MVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525
+ G S D +S G ++ E +VG + T I N++ +IE D
Sbjct: 173 ILGQ--GHSKTVDWWSLGCILYEFLVGIPPFHGE--TPEEIFQNILNGKIEWPEDV---- 224
Query: 526 VATEEEKK-IAKMMILVGFWCIQTNPSERPSMHKVLE 561
++E I+K++ +P +R + E
Sbjct: 225 EVSDEAIDLISKLL--------VPDPEKRLGAKSIEE 253
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 62/216 (28%), Positives = 111/216 (51%), Gaps = 23/216 (10%)
Query: 285 YSYSDVKRMTKSFRDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEE---FINEVA 340
++ D+K + ++G+G +G V K P G ++AVK ++ S + +E + ++
Sbjct: 1 FTAEDLKDL-----GEIGRGAFGTVNKMLHKPSGTIMAVKRIR-STVDEKEQKRLLMDLD 54
Query: 341 SISRTSH-VNIVTFLGFCYENKKNALI-YELMPNGSLDKF---IHNDRNIKLEWKTMYQI 395
+ R+S IV F G + + + I ELM + SLDKF ++ + + + +I
Sbjct: 55 VVMRSSDCPYIVKFYGALF-REGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKI 112
Query: 396 AIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHA 455
A+ + L YL +++I+H D+KP NILLD + K+ DFG++ Q +I+
Sbjct: 113 AVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTRD 167
Query: 456 RGTIGYIAPE-VYSRRFGGVSHKSDVYSYGMMIIEM 490
G Y+APE + G +SDV+S G+ + E+
Sbjct: 168 AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 29/206 (14%)
Query: 301 LGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEE-----FINEVA---SISRTSHVNIV 351
+G+G YG VYK +L G+ VA+K K EE + E+A + H NIV
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALK--KVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 352 TFLGFCYENK-----KNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYL 406
L C+ + K L++E + + L ++ L +T+ + + RG+++L
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFL 123
Query: 407 HRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEV 466
H RIVH D+KPQNIL+ D KI+DFGLA+ +++ T+ Y APEV
Sbjct: 124 HSH---RIVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTSVVVTLWYRAPEV 177
Query: 467 YSRRFGGVSHKS--DVYSYGMMIIEM 490
S+ + D++S G + E+
Sbjct: 178 ----LLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 67/300 (22%), Positives = 124/300 (41%), Gaps = 63/300 (21%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFINEVASI----SRTSHVNIVTF 353
K+G+G + EV K G+ A+K +K E +N + I + H NI+
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKK-HFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 354 LGFCYENKKN--ALIYELMPNGSLDKFIHNDRNIKLEWKT---MYQIAIGIARGLEYLHR 408
+ ++ K AL++ELM + +L + I + E + MYQ+ + L+++HR
Sbjct: 64 IEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLL----KSLDHMHR 118
Query: 409 -GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE---SAISMLHARGTIGYIAP 464
G I H DIKP+NIL+ +D K++DFG + K IS T Y AP
Sbjct: 119 NG----IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYIS------TRWYRAP 167
Query: 465 E------VYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNL---DDEVTDTSICHNL----- 510
E Y K D+++ G + E++ L +E+ + H++
Sbjct: 168 ECLLTDGYY-------GPKMDIWAVGCVFFEILS-LFPLFPGTNELDQIAKIHDVLGTPD 219
Query: 511 --IYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQT-------NPSERPSMHKVLE 561
+ ++ ++ +++ + K++ + +P ER + + L
Sbjct: 220 AEVLKKFRKSRHMNYN-FPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 63/201 (31%), Positives = 108/201 (53%), Gaps = 21/201 (10%)
Query: 300 KLGQGGYGEVYKGELPD-GQLVAVKVLKN-SRCNGEEFINEVASISRTSHVNIVTFLGFC 357
+LG G +G+VYK + + G L A KV++ S E+++ E+ ++ +H IV LG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 358 YENKKNALIYELMPNGSLDK-FIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVH 416
Y + K ++ E P G++D + DR + T QI + + LE L ++I+H
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGL-----TEPQIQVICRQMLEALQYLHSMKIIH 133
Query: 417 FDIKPQNILLDEDFCPKISDFGLA----KQAQKKESAISMLHARGTIGYIAPEVY---SR 469
D+K N+LL D K++DFG++ K Q+++S I GT ++APEV +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI------GTPYWMAPEVVMCETM 187
Query: 470 RFGGVSHKSDVYSYGMMIIEM 490
+ +K+D++S G+ +IEM
Sbjct: 188 KDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 63/201 (31%), Positives = 111/201 (55%), Gaps = 19/201 (9%)
Query: 301 LGQGGYGEVYKG--ELPDGQ--LVAVKVLKNSRCNGE--EFINEVASISRTSHVNIVTFL 354
+G G +GEV G +LP + VA+K LK + +F++E + + + H NI+
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 355 GFCYENKKNALIYELMPNGSLDKFI--HNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQV 412
G ++K ++ E M NGSLD F+ H+ + ++ M + GIA G++YL +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR---GIASGMKYL---SDM 125
Query: 413 RIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK-ESAISMLHARGTIGYIAPEVYS-RR 470
VH D+ +NIL++ + K+SDFGL++ + E+A + + I + APE + R+
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185
Query: 471 FGGVSHKSDVYSYGMMIIEMV 491
F + SDV+SYG+++ E++
Sbjct: 186 F---TSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 73/298 (24%), Positives = 138/298 (46%), Gaps = 45/298 (15%)
Query: 289 DVKRMTKSFRDKLGQGGYGEVYKG-------ELPDGQLVAVKVLKNSRCNGE--EFINEV 339
+V R + +LGQG +G VY+G + P+ + VA+K + + E EF+NE
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEA 60
Query: 340 ASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLE---------WK 390
+ + + ++V LG + + +I ELM G L ++ + R ++E K
Sbjct: 61 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRP-EMENNPVQAPPSLK 119
Query: 391 TMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK----K 446
M Q+A IA G+ YL+ + VH D+ +N ++ EDF KI DFG+ + + +
Sbjct: 120 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 176
Query: 447 ESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSI 506
+ +L R +++PE S + G + SDV+S+G+++ E+ + +++ +
Sbjct: 177 KGGKGLLPVR----WMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV 230
Query: 507 CHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564
F +G ++ M+ + C Q NP RPS +++ ++
Sbjct: 231 LR------------FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 40/212 (18%)
Query: 299 DKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEE------FINEVASISRTSHVNIV 351
+K+G+G YG VYKG GQ+VA +K R EE I E++ + H NIV
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVA---MKKIRLESEEEGVPSTAIREISLLKELQHPNIV 62
Query: 352 TFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIK-LEWKTM----YQIAIGIARGLEYL 406
+ + LI+E + + L K++ + + ++ + + YQI GI +
Sbjct: 63 CLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGIL----FC 117
Query: 407 HRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM-----LHARGTIGY 461
H R++H D+KPQN+L+D K++DFGLA+ A + H T+ Y
Sbjct: 118 HSR---RVLHRDLKPQNLLIDNKGVIKLADFGLAR-------AFGIPVRVYTHEVVTLWY 167
Query: 462 IAPEVY--SRRFGGVSHKSDVYSYGMMIIEMV 491
APEV S R+ S D++S G + EM
Sbjct: 168 RAPEVLLGSPRY---STPVDIWSIGTIFAEMA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 66/225 (29%), Positives = 110/225 (48%), Gaps = 40/225 (17%)
Query: 297 FRDKLGQGGYGEV----------YKGELP---DGQ--LVAVKVL-----KNSRCNGEEFI 336
++KLG+G +GEV + GE DGQ LVAVK+L K +R +F+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTAR---NDFL 65
Query: 337 NEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIK---------- 386
E+ +SR + NI+ LG C + +I E M NG L++F+ + R I+
Sbjct: 66 KEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL-SQREIESTFTHANNIP 124
Query: 387 -LEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445
+ + +A+ IA G++YL + VH D+ +N L+ + KI+DFG+++
Sbjct: 125 SVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYS 181
Query: 446 KESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEM 490
+ A I ++A E S G + SDV+++G+ + EM
Sbjct: 182 GDYYRIQGRAVLPIRWMAWE--SILLGKFTTASDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 5e-17
Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 301 LGQGGYGEVYKG-ELPDGQLVAVKVL----------KNSRCNGEEFINEVASISRTSHVN 349
+G G +G VY G G+L+AVK + R + E+A + H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 350 IVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH-R 408
IV +LG + + E +P GS+ ++N E + I +GL YLH R
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNR 125
Query: 409 GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR----GTIGYIAP 464
G I+H DIK NIL+D KISDFG++K+ + + AR G++ ++AP
Sbjct: 126 G----IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 465 EVYSRRFGGVSHKSDVYSYGMMIIEM 490
EV + + K+D++S G +++EM
Sbjct: 182 EVVKQTS--YTRKADIWSLGCLVVEM 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 6e-17
Identities = 78/294 (26%), Positives = 120/294 (40%), Gaps = 37/294 (12%)
Query: 291 KRMTKSFRDKLGQGGYGEV----YKGELPD-GQLVAVKVLK--NSRCNGEEFINEVASIS 343
KR K R LG+G +G+V Y G++VAVK LK + N + E+ +
Sbjct: 3 KRYLKKIRV-LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILK 61
Query: 344 RTSHVNIVTFLGFCYE--NKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIAR 401
H NIV + G C E K LI E +P GSL ++ KL + A I
Sbjct: 62 TLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICE 118
Query: 402 GLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLH-ARGTIG 460
G+ YLH +H D+ +N+LLD D KI DFGLAK + + +
Sbjct: 119 GMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 175
Query: 461 YIAPEVYSR-RFGGVSHKSDVYSYGMMIIEMVG-CTKNLDD--------EVTDTSICHNL 510
+ A E +F S+ SDV+S+G+ + E++ C +
Sbjct: 176 WYAVECLKENKF---SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR 232
Query: 511 IYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564
+ E +E G +E + K C +T RP+ ++ +L+
Sbjct: 233 LIELLERGMRLPCPKNCPQEVYILMKN-------CWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 6e-17
Identities = 59/197 (29%), Positives = 102/197 (51%), Gaps = 15/197 (7%)
Query: 300 KLGQGGYGEVYKG---ELPDGQLVAVKVLKNSRCNG---EEFINEVASISRTSHVNIVTF 353
+LG G +G V KG + VAVK+LKN + +E + E + + + IV
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 354 LGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVR 413
+G C E + L+ EL G L+KF+ ++++ K + ++ ++ G++YL +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTE--KNITELVHQVSMGMKYLE---ETN 115
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI-SMLHARGTIGYIAPEVYSRRFG 472
VH D+ +N+LL KISDFGL+K E+ + H + + + APE + +
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN--YY 173
Query: 473 GVSHKSDVYSYGMMIIE 489
S KSDV+S+G+++ E
Sbjct: 174 KFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 65/198 (32%), Positives = 102/198 (51%), Gaps = 17/198 (8%)
Query: 301 LGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCN---GEEF-INEVASISRTSHVNIVTFLG 355
LG+GG+GEV ++ G++ A K L+ R GE +NE + + + +V+ L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVS-LA 66
Query: 356 FCYENKKN-ALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRI 414
+ YE K L+ LM G L I++ E A I GLE LH+ RI
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RI 123
Query: 415 VHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVY-SRRFGG 473
V+ D+KP+NILLD+ +ISD GLA + ++ + GT+GY+APEV + R+
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV---GTVGYMAPEVVKNERY-- 178
Query: 474 VSHKSDVYSYGMMIIEMV 491
+ D ++ G ++ EM+
Sbjct: 179 -TFSPDWWALGCLLYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 8e-17
Identities = 63/215 (29%), Positives = 108/215 (50%), Gaps = 30/215 (13%)
Query: 301 LGQGGYGEVYKGEL-------PDGQL-VAVKVLKNSRCNGE--EFINEVASISRTS-HVN 349
LG+G +G+V + E PD + VAVK+LK++ + + + I+E+ + H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 350 IVTFLGFCYENKKNALIYELMPNGSLDKFIHNDR--------------NIKLEWKTMYQI 395
I+ LG C + +I E G+L +F+ R +L +K +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 396 AIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHA 455
A +ARG+EYL R +H D+ +N+L+ ED KI+DFGLA+ + +
Sbjct: 140 AYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 456 RGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEM 490
R + ++APE R +H+SDV+S+G+++ E+
Sbjct: 197 RLPVKWMAPEALFDRV--YTHQSDVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 9e-17
Identities = 65/196 (33%), Positives = 95/196 (48%), Gaps = 13/196 (6%)
Query: 301 LGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGF 356
LG+GG+GEV ++ G++ A K L+ R GE I + V L +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 357 CYENKKN-ALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
YE K L+ +M G L I+N N + + A + GLE L R RIV
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIV 124
Query: 416 HFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVS 475
+ D+KP+NILLD+ +ISD GLA Q + E+ + GT+GY+APEV + +
Sbjct: 125 YRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV---GTVGYMAPEVINNE--KYT 179
Query: 476 HKSDVYSYGMMIIEMV 491
D + G +I EM+
Sbjct: 180 FSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 9e-17
Identities = 64/208 (30%), Positives = 103/208 (49%), Gaps = 13/208 (6%)
Query: 286 SYSDVKRMTKSFRDKLGQGGYGEVYKG-ELPDGQLVAVKVLK-NSRCNGEEFINEVASIS 343
S D K+ F +K+GQG G VY ++ GQ VA+K + + E INE+ +
Sbjct: 13 SVGDPKKKYTRF-EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMR 71
Query: 344 RTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGL 403
+ NIV +L + ++ E + GSL + ++ + + + L
Sbjct: 72 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQAL 128
Query: 404 EYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIA 463
++LH +++H DIK NILL D K++DFG Q ++S S + GT ++A
Sbjct: 129 DFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYWMA 183
Query: 464 PEVYSRRFGGVSHKSDVYSYGMMIIEMV 491
PEV +R+ G K D++S G+M IEMV
Sbjct: 184 PEVVTRKAYG--PKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 59/198 (29%), Positives = 101/198 (51%), Gaps = 16/198 (8%)
Query: 300 KLGQGGYGEVYKG--ELPDGQL--VAVKVLKN--SRCNGEEFINEVASISRTSHVNIVTF 353
+G+G +G+VY+G P+ + VAVK KN S E+F+ E + + H +IV
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 354 LGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVR 413
+G EN ++ EL P G L ++ ++ L+ ++ + ++ L YL R
Sbjct: 73 IGVITENPV-WIVMELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLE---SKR 127
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPE-VYSRRFG 472
VH DI +N+L+ C K+ DFGL++ + ES + I ++APE + RRF
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWMAPESINFRRF- 185
Query: 473 GVSHKSDVYSYGMMIIEM 490
+ SDV+ +G+ + E+
Sbjct: 186 --TSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 301 LGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEFINEVASISRTSH-VNIVTFLGFCY 358
+G G YG+VYKG + GQL A+KV+ + EE E+ + + SH NI T+ G +
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYG-AF 82
Query: 359 ENKKNA-------LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQ 411
K L+ E GS+ + N + L+ + I I RGL +LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH-- 140
Query: 412 VRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYS--- 468
+++H DIK QN+LL E+ K+ DFG++ Q + + GT ++APEV +
Sbjct: 141 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF--IGTPYWMAPEVIACDE 197
Query: 469 RRFGGVSHKSDVYSYGMMIIEM 490
++SD++S G+ IEM
Sbjct: 198 NPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 71/279 (25%), Positives = 121/279 (43%), Gaps = 37/279 (13%)
Query: 301 LGQGGYGEVYKGEL-PDGQLVAVKVLKNS---RCNGEEFI-NEVASISRTSHVNIVTFLG 355
LG GG+G V ++ + A+K +K +E I +E + +H IV
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
+ K ++ E G L + DR + E+ + IA + EYLH I+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILR-DRGLFDEYTARFYIA-CVVLAFEYLHN---RGII 115
Query: 416 HFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVS 475
+ D+KP+N+LLD + K+ DFG AK+ + + + GT Y+APE+ + G
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC---GTPEYVAPEIILNK--GYD 170
Query: 476 HKSDVYSYGMMIIE-MVGCTKNLDDEVTDTSICHNLIYERIEPGNDF-QFDGVATEEEKK 533
D +S G+++ E + G +D+ IY I GN +F + K
Sbjct: 171 FSVDYWSLGILLYELLTGRPPFGEDDEDPME-----IYNDILKGNGKLEFPNYIDKAAKD 225
Query: 534 -IAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQ 571
I +++ + NP ER L L+G I++++
Sbjct: 226 LIKQLL--------RRNPEER------LGNLKGGIKDIK 250
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 1e-16
Identities = 65/228 (28%), Positives = 99/228 (43%), Gaps = 31/228 (13%)
Query: 297 FRDKLGQGGYGEV----YKGELPDGQLVAVKVLKNS---RCNGEEFI-NEVASISRTSHV 348
F LG G +G V +K G+ A+K+L + + E + NE + H
Sbjct: 5 FIKTLGTGSFGRVMLVRHK---GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHP 61
Query: 349 NIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHR 408
+V G ++ L+ E +P G L + Y A + LEYLH
Sbjct: 62 FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFY--AAQVVLALEYLH- 118
Query: 409 GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYS 468
+ IV+ D+KP+N+LLD D KI+DFG AK+ + + + GT Y+APE+
Sbjct: 119 --SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC-----GTPEYLAPEIIL 171
Query: 469 RRFGGVSHKSDVYSYGMMIIEM-VGCTKNLDDEVTDTSICHNLIYERI 515
+ G D ++ G++I EM G DD IYE+I
Sbjct: 172 SK--GYGKAVDWWALGILIYEMLAGYPPFFDDN-------PIQIYEKI 210
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 70/253 (27%), Positives = 119/253 (47%), Gaps = 48/253 (18%)
Query: 297 FRDKLGQGGYGEVYKGELPDGQ-----------------LVAVKVL-----KNSRCNGEE 334
F++KLG+G +GEV+ E+ + Q LVAVK+L KN+R +
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNAR---ND 65
Query: 335 FINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIH-----------NDR 383
F+ EV +SR NI+ LG C + +I E M NG L++F+ ND
Sbjct: 66 FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDA 125
Query: 384 NIK------LEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDF 437
+ + ++ +A+ IA G++YL + VH D+ +N L+ E+ KI+DF
Sbjct: 126 VPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADF 182
Query: 438 GLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKN 496
G+++ + A I ++A E G + SDV+++G+ + E++ C +
Sbjct: 183 GMSRNLYAGDYYRIQGRAVLPIRWMAWECI--LMGKFTTASDVWAFGVTLWEILMLCKEQ 240
Query: 497 LDDEVTDTSICHN 509
E+TD + N
Sbjct: 241 PYGELTDEQVIEN 253
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 2e-16
Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 13/208 (6%)
Query: 286 SYSDVKRMTKSFRDKLGQGGYGEVYKG-ELPDGQLVAVKVLK-NSRCNGEEFINEVASIS 343
S D K+ F +K+GQG G VY ++ GQ VA++ + + E INE+ +
Sbjct: 14 SVGDPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72
Query: 344 RTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGL 403
+ NIV +L + ++ E + GSL + ++ + + + L
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQAL 129
Query: 404 EYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIA 463
E+LH +++H DIK NILL D K++DFG Q ++S S + GT ++A
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYWMA 184
Query: 464 PEVYSRRFGGVSHKSDVYSYGMMIIEMV 491
PEV +R+ G K D++S G+M IEM+
Sbjct: 185 PEVVTRKAYG--PKVDIWSLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 61/203 (30%), Positives = 103/203 (50%), Gaps = 23/203 (11%)
Query: 299 DKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEE-----FINEVASISRTSHVNIVT 352
+KLG+G Y VYKG G++VA+K + + EE I E++ + H NIV
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEI---HLDAEEGTPSTAIREISLMKELKHENIVR 62
Query: 353 FLGFCYENKKNALIYELMPNGSLDKF--IHNDRNIKLEWKTMYQIAIGIARGLEYLHRGC 410
+ K L++E M + L K+ H R L+ T+ + +G+ + H
Sbjct: 63 LHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRG-ALDPNTVKSFTYQLLKGIAFCH--- 117
Query: 411 QVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVY--S 468
+ R++H D+KPQN+L+++ K++DFGLA+ + S + T+ Y AP+V S
Sbjct: 118 ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS--NEVVTLWYRAPDVLLGS 175
Query: 469 RRFGGVSHKSDVYSYGMMIIEMV 491
R + S D++S G ++ EM+
Sbjct: 176 RTY---STSIDIWSVGCIMAEMI 195
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 58/215 (26%), Positives = 107/215 (49%), Gaps = 30/215 (13%)
Query: 301 LGQGGYGEVYKGEL-------PDGQL-VAVKVLKNSRCNGE--EFINEVASISRT-SHVN 349
LG+G +G+V E P+ + VAVK+LK+ + + + ++E+ + H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 350 IVTFLGFCYENKKNALIYELMPNGSLDKFIHNDR--------------NIKLEWKTMYQI 395
I+ LG C ++ ++ E G+L +++ R +L +K +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 396 AIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHA 455
A +ARG+EYL + +H D+ +N+L+ ED KI+DFGLA+ + +
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 456 RGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEM 490
R + ++APE R +H+SDV+S+G+++ E+
Sbjct: 197 RLPVKWMAPEALFDRV--YTHQSDVWSFGVLLWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 69/272 (25%), Positives = 128/272 (47%), Gaps = 28/272 (10%)
Query: 300 KLGQGGYGEVYKGE-LPDGQLVAVKV-----LKNSRCNGEEFINEVASISRTSHVNIVTF 353
K+G+G + EVY+ L DG VA+K L +++ + I E+ + + +H N++ +
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKAR-ADCIKEIDLLKQLNHPNVIKY 67
Query: 354 LGFCYENKKNALIYELMPNGSLDKFIHNDRNIK--LEWKTMYQIAIGIARGLEYLHRGCQ 411
E+ + ++ EL G L + I + + K + KT+++ + + LE++H
Sbjct: 68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---S 124
Query: 412 VRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRF 471
R++H DIKP N+ + K+ D GL + K +A L GT Y++PE
Sbjct: 125 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMSPERIHE-- 180
Query: 472 GGVSHKSDVYSYGMMIIEMVGCTKNL-DDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530
G + KSD++S G ++ EM D++ S+C + P + +EE
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHY----SEE 236
Query: 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562
+++ M CI +P +RP + V ++
Sbjct: 237 LRQLVNM-------CINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-16
Identities = 69/272 (25%), Positives = 130/272 (47%), Gaps = 28/272 (10%)
Query: 300 KLGQGGYGEVYKGE-LPDGQLVAVKVLK-----NSRCNGEEFINEVASISRTSHVNIVTF 353
K+G+G + EVY+ L D + VA+K ++ +++ ++ + E+ + + +H N++ +
Sbjct: 9 KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKAR-QDCVKEIDLLKQLNHPNVIKY 67
Query: 354 LGFCYENKKNALIYELMPNGSLDKFIHNDRNIK--LEWKTMYQIAIGIARGLEYLHRGCQ 411
L E+ + ++ EL G L + I + K + +T+++ + + +E++H
Sbjct: 68 LDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---S 124
Query: 412 VRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRF 471
R++H DIKP N+ + K+ D GL + K +A L GT Y++PE
Sbjct: 125 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMSPERIHE-- 180
Query: 472 GGVSHKSDVYSYGMMIIEMVGCTKNL-DDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530
G + KSD++S G ++ EM D++ S+C +IE Q D
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQ-----KIE-----QCDYPPLPT 230
Query: 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562
E K+ LV CI +P +RP + V ++
Sbjct: 231 EHYSEKLRELVSM-CIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 5e-16
Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 26/201 (12%)
Query: 300 KLGQGGYGEVYKG-ELPDGQLVAVK---VLKNSRCNGEEFINEVASISRTSHVNIVTFLG 355
K+G+G G V + G+ VAVK + K R E NEV + H NIV
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQR--RELLFNEVVIMRDYQHPNIVEMYS 83
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH-RGCQVRI 414
+ ++ E + G+L + + R + + + + + + + L +LH +G +
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLAVLKALSFLHAQG----V 136
Query: 415 VHFDIKPQNILLDEDFCPKISDFG----LAKQAQKKESAISMLHARGTIGYIAPEVYSRR 470
+H DIK +ILL D K+SDFG ++K+ +++S + GT ++APEV SR
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV------GTPYWMAPEVISRL 190
Query: 471 FGGVSHKSDVYSYGMMIIEMV 491
G + D++S G+M+IEMV
Sbjct: 191 PYGT--EVDIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-16
Identities = 68/202 (33%), Positives = 102/202 (50%), Gaps = 24/202 (11%)
Query: 301 LGQGGYGEVYKGELPD-GQLVAVKVLKNSRC---NGEEF-INE--VASISRTSHVNIVTF 353
+G+GG+GEVY D G++ A+K L R GE +NE + S+ T +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 354 LGFCYEN-KKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH-RGCQ 411
+ + + K + I +LM G L H ++ M A I GLE++H R
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF-- 117
Query: 412 VRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRF 471
+V+ D+KP NILLDE +ISD GLA KK+ S+ GT GY+APEV +
Sbjct: 118 --VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQK-- 169
Query: 472 GGVSHKS--DVYSYGMMIIEMV 491
GV++ S D +S G M+ +++
Sbjct: 170 -GVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 60/215 (27%), Positives = 105/215 (48%), Gaps = 30/215 (13%)
Query: 301 LGQGGYGEVYKGEL-------PDG-QLVAVKVLKNSRCNGE--EFINEVASISRT-SHVN 349
LG+G +G+V E P+ VAVK+LK+ + + I+E+ + H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 350 IVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEW--------------KTMYQI 395
I+ LG C ++ +I E G+L +++ R +E+ K +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 396 AIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHA 455
A +ARG+EYL + +H D+ +N+L+ ED KI+DFGLA+ + +
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 456 RGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEM 490
R + ++APE R +H+SDV+S+G+++ E+
Sbjct: 203 RLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEI 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 8e-16
Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 296 SFRDKLGQGGYGEVYKGE---LPDGQL---VAVKVLKNS--RCNGEEFINEVASISRT-S 346
SF LG G +G+V + L VAVK+LK + E ++E+ +S +
Sbjct: 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN 97
Query: 347 HVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYL 406
H NIV LG C +I E G L F+ R L + + + +A+G+ +L
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL 157
Query: 407 -HRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPE 465
+ C +H D+ +N+LL KI DFGLA+ + + +AR + ++APE
Sbjct: 158 ASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 213
Query: 466 VYSRRFGGV-SHKSDVYSYGMMIIEM 490
F V + +SDV+SYG+++ E+
Sbjct: 214 SI---FNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 9e-16
Identities = 71/248 (28%), Positives = 124/248 (50%), Gaps = 23/248 (9%)
Query: 301 LGQGGYGEVYKGELPD-GQLVAVKVLKNSRCN---GEEF-INEVASISRTSHVNIVTFLG 355
LG+GG+GEV ++ + G++ A K L R GE+ + E + + + IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVN-LA 59
Query: 356 FCYENKKN-ALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRI 414
+ +E+K + L+ LM G L I+N LE + + + I G+ +LH + I
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDI 116
Query: 415 VHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGV 474
V+ D+KP+N+LLD+ ++SD GLA + + + ++ GT GY+APE+
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILKEE--PY 171
Query: 475 SHKSDVYSYGMMIIEMV-GCT--KNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531
S+ D ++ G I EMV G T K+ ++V + + + ++ F+ TEE
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK----FEHQNF-TEES 226
Query: 532 KKIAKMMI 539
K I ++ +
Sbjct: 227 KDICRLFL 234
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 9e-16
Identities = 54/155 (34%), Positives = 81/155 (52%), Gaps = 26/155 (16%)
Query: 299 DKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEE-----FINEVASISRTSHVNIVT 352
DKLG+G Y VYKG GQLVA+K + R EE I E + + H NIVT
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEI---RLEHEEGAPFTAIREASLLKDLKHANIVT 67
Query: 353 FLGFCYENKKNALIYELMPNGSLDKFIH------NDRNIKLEWKTMYQIAIGIARGLEYL 406
+ K L++E + + L +++ + N++L ++Q+ RGL Y
Sbjct: 68 LHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRL---FLFQLL----RGLAYC 119
Query: 407 HRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAK 441
H Q R++H D+KPQN+L+ E K++DFGLA+
Sbjct: 120 H---QRRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-15
Identities = 81/325 (24%), Positives = 140/325 (43%), Gaps = 59/325 (18%)
Query: 273 FIRNHESLAPKRYSYSD--------VKRMTKSF-----------RDKLGQGGYGEVYKGE 313
FIR +L KR D +++KS + + +G G YKG+
Sbjct: 651 FIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGK 710
Query: 314 LPDGQL-VAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372
+ VK + + +E+A + + H NIV +G C K LI+E +
Sbjct: 711 SIKNGMQFVVKEINDVNSIPS---SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG 767
Query: 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCP 432
+L + + N L W+ +IAIGIA+ L +LH C +V ++ P+ I++D P
Sbjct: 768 KNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEP 822
Query: 433 K--ISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEM 490
+S GL K + + Y+APE +R ++ KSD+Y +G+++IE+
Sbjct: 823 HLRLSLPGLLCTDTKCFISSA---------YVAPE--TRETKDITEKSDIYGFGLILIEL 871
Query: 491 V--GCTKNLDDEVTDT---------SICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMI 539
+ + + V + S CH ++ D G + + +I ++M
Sbjct: 872 LTGKSPADAEFGVHGSIVEWARYCYSDCH------LDMWIDPSIRGDVSVNQNEIVEVMN 925
Query: 540 LVGFWCIQTNPSERPSMHKVLEMLE 564
L C T+P+ RP + VL+ LE
Sbjct: 926 L-ALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 65/225 (28%), Positives = 101/225 (44%), Gaps = 57/225 (25%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEE------FINEVASISRTSHVN-I 350
+K+G+G YG+VYK + G+LVA LK +R +E + E++ + S I
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVA---LKKTRLEMDEEGIPPTALREISLLQMLSESIYI 63
Query: 351 VTFLGFCYENKKNA-------LIYELMPNGSLDKFI-------HNDRNIKLEWKTMYQIA 396
V L E+ + L++E + + L KF+ K MYQ+
Sbjct: 64 VRLL--DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120
Query: 397 IGIARGLEYLH-RGCQVRIVHFDIKPQNILLDED-FCPKISDFGLAKQAQKKESAISM-- 452
G+A + H G ++H D+KPQN+L+D+ KI+D GL + A S+
Sbjct: 121 KGVA----HCHKHG----VMHRDLKPQNLLVDKQKGLLKIADLGLGR-------AFSIPV 165
Query: 453 ---LHARGTIGYIAPEVYSRRFGGVSHKS---DVYSYGMMIIEMV 491
H T+ Y APEV G +H S D++S G + EM
Sbjct: 166 KSYTHEIVTLWYRAPEV----LLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 300 KLGQGGYGEVY--KGELPDGQLV--AVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLG 355
K+G+G +G++Y K + V + + K E EV +++ H NIVTF
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
EN + ++ E G L K I+ R + + + I+ GL+++H +I+
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKIL 123
Query: 416 HFDIKPQNILLDED-FCPKISDFGLAKQAQKKESAISMLHARGTIG---YIAPEVYSRRF 471
H DIK QNI L ++ K+ DFG+A+Q SM A +G Y++PE+ R
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIARQLND-----SMELAYTCVGTPYYLSPEICQNR- 177
Query: 472 GGVSHKSDVYSYGMMIIEMVGCT 494
++K+D++S G ++ E+ CT
Sbjct: 178 -PYNNKTDIWSLGCVLYEL--CT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 39/211 (18%)
Query: 299 DKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEE------FINEVASISRTSHVNIV 351
+K+G+G YG VYK G++VA LK R + E I E++ + +H NIV
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVA---LKKIRLDTETEGVPSTAIREISLLKELNHPNIV 62
Query: 352 TFLGFCYENKKNALIYELMPNGSLDKF--IHNDRNIKLEW--KTMYQIAIGIARGLEYLH 407
L + K L++E + + L KF I L ++Q+ G+A + H
Sbjct: 63 KLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA----FCH 117
Query: 408 RGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI-----SMLHARGTIGYI 462
R++H D+KPQN+L++ + K++DFGLA+ A + H T+ Y
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-------AFGVPVRTYTHEVVTLWYR 167
Query: 463 APEVY--SRRFGGVSHKSDVYSYGMMIIEMV 491
APE+ + + S D++S G + EMV
Sbjct: 168 APEILLGCKYY---STAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 2e-15
Identities = 60/195 (30%), Positives = 99/195 (50%), Gaps = 12/195 (6%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFI-NEVASISRTSHVNIVTFLGF 356
+K+GQG G V+ ++ GQ VA+K + + +E I NE+ + + NIV FL
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 357 CYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVH 416
+ ++ E + GSL + ++ + + + LE+LH +++H
Sbjct: 85 FLVGDELFVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECLQALEFLHAN---QVIH 138
Query: 417 FDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSH 476
DIK N+LL D K++DFG Q ++S S + GT ++APEV +R+ G
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYWMAPEVVTRKAYG--P 194
Query: 477 KSDVYSYGMMIIEMV 491
K D++S G+M IEMV
Sbjct: 195 KVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 59/224 (26%), Positives = 106/224 (47%), Gaps = 36/224 (16%)
Query: 298 RDKL------GQGGYGEVYKGEL--------PDGQLVAVKVLKNSRCNGE--EFINEVAS 341
RDKL G+G +G+V E + VAVK+LK+ + + ++E+
Sbjct: 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM 73
Query: 342 ISRTS-HVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEW----------- 389
+ H NI+ LG C ++ +I E G+L +++ R +E+
Sbjct: 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133
Query: 390 ---KTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446
K + +ARG+EYL + +H D+ +N+L+ E+ KI+DFGLA+
Sbjct: 134 MTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNI 190
Query: 447 ESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEM 490
+ + R + ++APE R +H+SDV+S+G+++ E+
Sbjct: 191 DYYKKTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 54/200 (27%), Positives = 99/200 (49%), Gaps = 19/200 (9%)
Query: 301 LGQGGYGEVYKG--ELPDGQ--LVAVKVLKNSRCNGEE---FINEVASISRTSHVNIVTF 353
LG G +GE+ +G +LP + VA+ L+ C+ ++ F+ E ++ + H NIV
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAG-CSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 354 LGFCYENKKNALIYELMPNGSLDKFI--HNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQ 411
G ++ E M NG+LD F+ H + + + M G+A G++YL +
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLP---GLASGMKYL---SE 125
Query: 412 VRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRF 471
+ VH + +L++ D KIS F Q K E+ + + + + + APE ++
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFRRL-QEDKSEAIYTTMSGKSPVLWAAPEAI--QY 182
Query: 472 GGVSHKSDVYSYGMMIIEMV 491
S SDV+S+G+++ E++
Sbjct: 183 HHFSSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 64/222 (28%), Positives = 108/222 (48%), Gaps = 36/222 (16%)
Query: 298 RDKLGQGGYGEVYK----GELPDGQ--LVAVKVLKN--SRCNGEEFINEVASISRTSHVN 349
RD +GQG +G V++ G LP +VAVK+LK S +F E A ++ H N
Sbjct: 11 RD-IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPN 69
Query: 350 IVTFLGFCYENKKNALIYELMPNGSLDKFI------------HNDRNI------KLEWKT 391
IV LG C K L++E M G L++F+ H+ + L
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 392 MYQIAIG--IARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449
Q+ I +A G+ YL + + VH D+ +N L+ E+ KI+DFGL++ +
Sbjct: 130 TEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 450 ISMLHARGTIGYIAPE-VYSRRFGGVSHKSDVYSYGMMIIEM 490
+ + I ++ PE ++ R+ + +SDV++YG+++ E+
Sbjct: 187 KASENDAIPIRWMPPESIFYNRY---TTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 3e-15
Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 300 KLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGE-----EFINEVASISRTSHVNIVTFL 354
++G G +G+V GE+ G A V+K R + +F+ E H N++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 355 GFCYENKKNALIYELMPNGSLDKFIHNDR---NIKLEWKTMYQIAIGIARGLEYLHRGCQ 411
G C E L+ E P G L ++ + R + + T+ ++A IA GL +LH+
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN-- 119
Query: 412 VRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRF 471
+H D+ +N LL D KI D+GL+ K++ ++ + +IAPE+
Sbjct: 120 -NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 472 GGV-----SHKSDVYSYGMMIIEM 490
G + + +S+V+S G+ I E+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 3e-15
Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 13/195 (6%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKV--LKNSRCNGEEFINEVASISRTSHVNIVTFLG 355
+++G+G +GEVYKG + ++VA+K+ L+ + E+ E+ +S+ I + G
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
+ K +I E + GS + + LE + I I +GL+YLH R +
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDYLH---SERKI 123
Query: 416 HFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVS 475
H DIK N+LL E K++DFG+A Q ++ I GT ++APEV +
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQ--SAYD 179
Query: 476 HKSDVYSYGMMIIEM 490
K+D++S G+ IE+
Sbjct: 180 FKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 67/201 (33%), Positives = 100/201 (49%), Gaps = 22/201 (10%)
Query: 301 LGQGGYGEVYKGELPD-GQLVAVKVLKNSRC---NGEEF-INE--VASISRTSHVNIVTF 353
+G+GG+GEVY D G++ A+K L R GE +NE + S+ T +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 354 LGFCYEN-KKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQV 412
+ + + K I +LM G L H ++ K M A I GLE++H
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLH--YHLSQHGVFSEKEMRFYATEIILGLEHMHNRF-- 117
Query: 413 RIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFG 472
+V+ D+KP NILLDE +ISD GLA KK+ S+ GT GY+APEV +
Sbjct: 118 -VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQK--- 169
Query: 473 GVSHKS--DVYSYGMMIIEMV 491
G ++ S D +S G M+ +++
Sbjct: 170 GTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 23/208 (11%)
Query: 301 LGQGGYGEVY----KGELPDGQLVAVKVLKNSRCNGEEFINEVASISRT--SHVNIVTFL 354
LG G YG+V+ G G+L A+KVLK + + E R V FL
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 355 -----GFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRG 409
F + K + LI + + G L ++ + +Y I +A L++LH
Sbjct: 68 VTLHYAFQTDTKLH-LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLA--LDHLH-- 122
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ--AQKKESAISMLHARGTIGYIAPEVY 467
Q+ I++ DIK +NILLD + ++DFGL+K+ A+++E A S GTI Y+APEV
Sbjct: 123 -QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC---GTIEYMAPEVI 178
Query: 468 SRRFGGVSHKSDVYSYGMMIIEMV-GCT 494
GG D +S G++ E++ G +
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGAS 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 6e-15
Identities = 57/197 (28%), Positives = 103/197 (52%), Gaps = 18/197 (9%)
Query: 297 FRDKLGQGGYGEVYKG-ELPDGQLVAVKV--LKNSRCNGEEFINEVASISRTSHVNIVTF 353
+++ LG G G VYK L +++AVKV L + ++ ++E+ + + I+ F
Sbjct: 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 354 LGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVR 413
G + + ++ E M GSLD + K+ + +IA+ + +GL YL ++
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYL---WSLK 115
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGG 473
I+H D+KP N+L++ K+ DFG++ Q ++I+ + GT Y+APE S G
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTYV-GTNAYMAPERISGEQYG 171
Query: 474 VSHKSDVYSYGMMIIEM 490
+ SDV+S G+ +E+
Sbjct: 172 I--HSDVWSLGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 6e-15
Identities = 63/246 (25%), Positives = 117/246 (47%), Gaps = 40/246 (16%)
Query: 296 SFRDKLGQGGYGEVYKGELPDGQ-----------------LVAVKVL-----KNSRCNGE 333
+F++KLG+G +GEV+ E + LVAVK+L KN+R
Sbjct: 8 TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNAR---N 64
Query: 334 EFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDR---------N 384
+F+ E+ +SR NI+ L C + +I E M NG L++F+
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 385 IKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444
+ + + T+ +A IA G++YL + VH D+ +N L+ +++ KI+DFG+++
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 445 KKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTD 503
+ A I +++ E S G + SDV+++G+ + E++ C + +++D
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWE--SILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239
Query: 504 TSICHN 509
+ N
Sbjct: 240 EQVIEN 245
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 9e-15
Identities = 74/252 (29%), Positives = 122/252 (48%), Gaps = 46/252 (18%)
Query: 296 SFRDKLGQGGYGEVY------------KGELPDGQ-----LVAVKVL-----KNSRCNGE 333
+F +KLG+G +GEV+ K + LVAVKVL N+R E
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAR---E 64
Query: 334 EFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFI--HNDR------NI 385
+F+ EV +SR S NI LG C + +I E M NG L++F+ H N
Sbjct: 65 DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNS 124
Query: 386 K-LEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444
K L + T+ +A IA G+ YL + VH D+ +N L+ +++ KI+DFG+++
Sbjct: 125 KSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 445 KKESAISMLHARGT--IGYIAPE-VYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDE 500
+ + R I ++A E V +F + KSDV+++G+ + E++ C + +
Sbjct: 182 SSD--YYRVQGRAPLPIRWMAWESVLLGKF---TTKSDVWAFGVTLWEILTLCREQPYEH 236
Query: 501 VTDTSICHNLIY 512
+TD + N +
Sbjct: 237 LTDQQVIENAGH 248
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 9e-15
Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 27/204 (13%)
Query: 299 DKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEF--INEVASISRTSHVNIVTFLG 355
+KLG+G Y VYKG+ +G+LVA+KV++ G F I E + + H NIV
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHD 70
Query: 356 FCYENKKNALIYELMPNG---SLDKF---IHNDRNIKLEWKTMYQIAIGIARGLEYLHRG 409
+ + L++E + +DK +H + N+KL ++Q+ RGL Y+H
Sbjct: 71 IIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPE-NVKL---FLFQLL----RGLSYIH-- 120
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSR 469
Q I+H D+KPQN+L+ + K++DFGLA+ S + T+ Y P+V
Sbjct: 121 -QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS--NEVVTLWYRPPDVL-- 175
Query: 470 RFGGVSHKS--DVYSYGMMIIEMV 491
G + + D++ G + +EM+
Sbjct: 176 -LGSTEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 22/200 (11%)
Query: 300 KLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFI---NEVASISRTSHVNIVTFLG 355
++G G YG+VYK L G+L AVK++K G++F E+ + H NIV + G
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
+K + E GSL H + E + Y + +GL YLH ++
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHVTGPLS-ELQIAY-VCRETLQGLAYLHSKGKM--- 128
Query: 416 HFDIKPQNILLDEDFCPKISDFGLAKQ----AQKKESAISMLHARGTIGYIAPEVYS-RR 470
H DIK NILL ++ K++DFG+A + K++S I GT ++APEV + +
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI------GTPYWMAPEVAAVEK 182
Query: 471 FGGVSHKSDVYSYGMMIIEM 490
GG + D+++ G+ IE+
Sbjct: 183 NGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 70/278 (25%), Positives = 117/278 (42%), Gaps = 34/278 (12%)
Query: 297 FRDKLGQGGYGEVYKG-ELPDGQLVAVK----VLKNSRCNGEEFINEVASISRTSHVNIV 351
D+LG+G YG VYK P G +A+K L S+ N I E+ + + IV
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQ--IIMELDILHKAVSPYIV 62
Query: 352 TFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIK-LEWKTMYQIAIGIARGLEYLHRGC 410
F G + + E M GSLDK + + + +I + +GL++L
Sbjct: 63 DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE-- 120
Query: 411 QVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRR 470
+ I+H D+KP N+L++ + K+ DFG++ + ++ G Y+APE +
Sbjct: 121 EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI----GCQSYMAPE--RIK 174
Query: 471 FGGVSH------KSDVYSYGMMIIEMVGCTKNLDDEVTDTSICH-NLIYERIEPGNDFQF 523
GG + +SDV+S G+ I+EM E + I + P +
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234
Query: 524 DGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561
A + K C+ P+ RP+ ++LE
Sbjct: 235 SDDAQDFVAK-----------CLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 23/201 (11%)
Query: 300 KLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNG---EEFINEVASISRTSHVNIVTFLG 355
+G+G YG V K G++VA+K K S + + + EV + + H NIV
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEW--KTMYQIAIGIARGLEYLHRGCQVR 413
+ L++E + L+ + + + ++Q+ IA Y H
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIA----YCHSH---N 120
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQ-AQKKESAISMLHARGTIGYIAPE--VYSRR 470
I+H DIKP+NIL+ E K+ DFG A+ + S ++ A T Y APE V
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA--TRWYRAPELLVGDTN 178
Query: 471 FG-GVSHKSDVYSYGMMIIEM 490
+G V DV++ G ++ E+
Sbjct: 179 YGKPV----DVWAIGCIMAEL 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 22/200 (11%)
Query: 300 KLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEFI---NEVASISRTSHVNIVTFLG 355
++G G YG+VYK + G+L A+KV+K GE+F E+ + H NIV + G
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFG 73
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
K + E GSL H + E + Y ++ +GL YLH ++
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVTGPLS-ESQIAY-VSRETLQGLYYLHSKGKM--- 128
Query: 416 HFDIKPQNILLDEDFCPKISDFGLAKQAQ----KKESAISMLHARGTIGYIAPEVYS-RR 470
H DIK NILL ++ K++DFG++ Q K++S I GT ++APEV + R
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI------GTPYWMAPEVAAVER 182
Query: 471 FGGVSHKSDVYSYGMMIIEM 490
GG + D+++ G+ IE+
Sbjct: 183 KGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 22/201 (10%)
Query: 300 KLGQGGYGEVYKGELPD-GQLVAVKVLKNSRCNGEE---FINEVASISRTSHVNIVTFLG 355
+G+G YG V K + + GQ+VA+K S + + E+ + + H N+V +
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEW--KTMYQIAIGIARGLEYLHRGCQVR 413
K+ L++E + + LD + K ++QI RG+E+ H
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQIL----RGIEFCHSH---N 120
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQ-AQKKESAISMLHARGTIGYIAPE--VYSRR 470
I+H DIKP+NIL+ + K+ DFG A+ A E + R Y APE V +
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR---WYRAPELLVGDTK 177
Query: 471 FGGVSHKSDVYSYGMMIIEMV 491
+G D+++ G ++ EM+
Sbjct: 178 YG---RAVDIWAVGCLVTEML 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 23/207 (11%)
Query: 299 DKLGQGGYGEVYK-GELPDGQLVAVKVLKNSRCNGEEFINEVASI-SRTSHVNIVTFLGF 356
+ +G+G YG+VYK DG L AVK+L EE E + S +H N+V F G
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGM 87
Query: 357 CYENKKNA-----LIYELMPNGSLDKFIHN--DRNIKLEWKTMYQIAIGIARGLEYLHRG 409
Y+ K L+ EL GS+ + + +L+ + I G GL++LH
Sbjct: 88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN 147
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEV--- 466
RI+H D+K NILL + K+ DFG++ AQ + + + GT ++APEV
Sbjct: 148 ---RIIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTSVGTPFWMAPEVIAC 202
Query: 467 ---YSRRFGGVSHKSDVYSYGMMIIEM 490
Y + + DV+S G+ IE+
Sbjct: 203 EQQYDYSYDA---RCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 64/202 (31%), Positives = 97/202 (48%), Gaps = 22/202 (10%)
Query: 301 LGQGGYGEVYKGEL-PDGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGF 356
LG+GG+GEV ++ G+L A K L R G E I H + L +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 357 CYENKKN-ALIYELMPNGSLDKFIHN--DRNIKL-EWKTMYQIAIGIARGLEYLHRGCQV 412
++ K + L+ +M G L I+N + N E + + A I GLE+LH Q
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTA-QIISGLEHLH---QR 116
Query: 413 RIVHFDIKPQNILLDEDFCPKISDFGLA---KQAQKKESAISMLHARGTIGYIAPEVYSR 469
RI++ D+KP+N+LLD D +ISD GLA K Q K + GT G++APE+
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-----GTPGFMAPELL-- 169
Query: 470 RFGGVSHKSDVYSYGMMIIEMV 491
+ D ++ G+ + EM+
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 32/208 (15%)
Query: 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEE------FINEVASISRTSHVNIVT 352
+K+G+G YG VYK D LK R E+ I E++ + H NIV
Sbjct: 8 EKIGEGTYGVVYKAR--DRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVR 65
Query: 353 FLGFCYENKKNALIYELMPNGSLDKFIHND------RNIKLEWKTMYQIAIGIARGLEYL 406
+ K+ L++E + LD H D +N +L +YQI RG+ Y
Sbjct: 66 LQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQIL----RGIAYC 118
Query: 407 HRGCQVRIVHFDIKPQNILLDEDFCP-KISDFGLAKQAQKKESAISMLHARGTIGYIAPE 465
H R++H D+KPQN+L+D K++DFGLA+ + H T+ Y APE
Sbjct: 119 HSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT--HEVVTLWYRAPE 173
Query: 466 VY--SRRFGGVSHKSDVYSYGMMIIEMV 491
+ SR + S D++S G + EMV
Sbjct: 174 ILLGSRHY---STPVDIWSVGCIFAEMV 198
|
Length = 294 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 299 DKLGQGGYGEVYKGELPDGQLVA---VKVLKNSRCNGEE--FINEVASISRTSHVNIVTF 353
D++G G +G+V GE G A VK L+ S E+ F+ EV +H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 354 LGFCYENKKNALIYELMPNGSLDKFIHNDRNIKL---EWKTMYQIAIGIARGLEYLHRGC 410
LG C E+ L+ E P G L ++ ++R + + + ++A +A GL +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117
Query: 411 QVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRR 470
Q +H D+ +N L D KI D+GLA + ++ I+ + ++APE+ R
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 471 FGGV-----SHKSDVYSYGMMIIEM 490
+ + KS+++S G+ + E+
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 67/214 (31%), Positives = 107/214 (50%), Gaps = 46/214 (21%)
Query: 301 LGQGGYGEVYKGELPDG----QLVAVKVLKNSRCNGEEFINEVASISR----TSHV---- 348
LG+GGYG+V++ G ++ A+KVLK A+I R T+H
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKK------------ATIVRNQKDTAHTKAER 51
Query: 349 NI--------VTFLGFCYENK-KNALIYELMPNGSLDKFIHNDRN-IKLEWKTMYQIAIG 398
NI + L + ++ K LI E + G L F+H +R I +E + ++
Sbjct: 52 NILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLS-E 108
Query: 399 IARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR-G 457
I+ LE+LH Q I++ D+KP+NILLD K++DFGL K++ + ++ H G
Sbjct: 109 ISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG---TVTHTFCG 162
Query: 458 TIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMV 491
TI Y+APE+ R G D +S G ++ +M+
Sbjct: 163 TIEYMAPEILMR--SGHGKAVDWWSLGALMYDML 194
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 71/286 (24%), Positives = 127/286 (44%), Gaps = 44/286 (15%)
Query: 301 LGQGGYGEVYKGELP----DGQLVAVKVLK---NSRCNGEEFINEVASISRTSHVNIVTF 353
LG+G +G V + +L Q VAVK+LK S + EEF+ E A + H N++
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 354 LGFCYENKKNA------LIYELMPNGSLDKFIHNDR----NIKLEWKTMYQIAIGIARGL 403
+G ++ +I M +G L F+ R L +T+ + I IA G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 404 EYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK----KESAISMLHARG-T 458
EYL +H D+ +N +L+E+ ++DFGL+K+ ++ S L +
Sbjct: 127 EYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 459 IGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPG 518
+ +A VY+ SDV+++G+ + E++ T+ + + ++ IY + G
Sbjct: 184 LESLADNVYTTH-------SDVWAFGVTMWEIM--TRG---QTPYAGVENSEIYNYLIKG 231
Query: 519 NDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564
N + E+ + ++M C P RPS + + LE
Sbjct: 232 NRLKQPPDCLED---VYELM----CQCWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 33/207 (15%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEF--INEVASISRTSHVNIVTFLG 355
+KLG+G Y VYKG +GQLVA+KV+ G F I E + + H NIV
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 356 FCYENKKNALIYELMPNGSLDKFIHN-----DRNIKLEWKTMYQIAIGIARGLEYLHRGC 410
+ + ++E M I + N++L M+Q+ RGL Y+H
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL---FMFQLL----RGLAYIHGQ- 122
Query: 411 QVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ----AQKKESAISMLHARGTIGYIAPEV 466
I+H D+KPQN+L+ K++DFGLA+ +Q S + T+ Y P+V
Sbjct: 123 --HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV------TLWYRPPDV 174
Query: 467 YSRRFGGVSHKS--DVYSYGMMIIEMV 491
G + S D++ G + IEM+
Sbjct: 175 L---LGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 57/156 (36%), Positives = 83/156 (53%), Gaps = 28/156 (17%)
Query: 299 DKLGQGGYGEVYKG--ELPDGQLVAVKVLKNSRCNGEE-----FINEVASISRTSHVNIV 351
DKLG+G Y VYKG +L D LVA LK R EE I EV+ + H NIV
Sbjct: 12 DKLGEGTYATVYKGRSKLTD-NLVA---LKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 352 TFLGFCYENKKNALIYELMPNGSLDKFIH------NDRNIKLEWKTMYQIAIGIARGLEY 405
T + K L++E + + L +++ N N+KL ++Q+ RGL Y
Sbjct: 68 TLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKL---FLFQLL----RGLNY 119
Query: 406 LHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAK 441
HR +++H D+KPQN+L++E K++DFGLA+
Sbjct: 120 CHRR---KVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 5e-14
Identities = 59/194 (30%), Positives = 93/194 (47%), Gaps = 12/194 (6%)
Query: 300 KLGQGGYGEV-YKGELPDGQLVAVKVLKNSRCNGEEFI-NEVASISRTSHVNIVTFLGFC 357
K+G+G G V E G+ VAVK + + E + NEV + H N+V
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 358 YENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHF 417
+ ++ E + G+L + + R + + + + + + R L YLH ++H
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYLH---NQGVIHR 142
Query: 418 DIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHK 477
DIK +ILL D K+SDFG Q K+ L GT ++APEV SR G +
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL--VGTPYWMAPEVISRLPYGT--E 198
Query: 478 SDVYSYGMMIIEMV 491
D++S G+M+IEM+
Sbjct: 199 VDIWSLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 61/217 (28%), Positives = 110/217 (50%), Gaps = 30/217 (13%)
Query: 296 SFRDKLGQGGYGEVYKGELP-DGQLV--AVKVLKN--SRCNGEEFINEVASISRTS-HVN 349
F D +G+G +G+V + + DG + A+K+LK S + +F E+ + + H N
Sbjct: 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64
Query: 350 IVTFLGFCYENKKNALI-YELMPNGSLDKFIHNDRNIK--------------LEWKTMYQ 394
I+ LG C EN+ I E P G+L F+ R ++ L + + Q
Sbjct: 65 IINLLGAC-ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123
Query: 395 IAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLH 454
A +A G++YL + + +H D+ +N+L+ E+ KI+DFGL++ +E +
Sbjct: 124 FASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTM 177
Query: 455 ARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMV 491
R + ++A E S + + KSDV+S+G+++ E+V
Sbjct: 178 GRLPVRWMAIE--SLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 5e-14
Identities = 63/200 (31%), Positives = 105/200 (52%), Gaps = 21/200 (10%)
Query: 300 KLGQGGYGEVYKG--ELPDGQL-VAVKVLK--NSRCNGEEFINEVASISRTSHVNIVTFL 354
+LG G +G V KG ++ Q+ VA+KVLK N + +E + E + + + IV +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 355 GFCYENKKNALIYELMPNGSLDKFIHNDRN-IKLE--WKTMYQIAIGIARGLEYLHRGCQ 411
G C E + L+ E+ G L+KF+ ++ I + + M+Q+++G ++YL
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMG----MKYLE---G 113
Query: 412 VRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHA-RGTIGYIAPE-VYSR 469
VH D+ +N+LL KISDFGL+K +S A + + + APE + R
Sbjct: 114 KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 470 RFGGVSHKSDVYSYGMMIIE 489
+F S +SDV+SYG+ + E
Sbjct: 174 KF---SSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 29/204 (14%)
Query: 299 DKLGQGGYGEVYKG--ELPDGQLVAVKVLKNSRCNGEE-----FINEVASISRTSHVNIV 351
+KLG+G Y V+KG +L + LVA LK R EE I EV+ + H NIV
Sbjct: 12 EKLGEGTYATVFKGRSKLTE-NLVA---LKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 352 TFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAI---GIARGLEYLHR 408
T + +K L++E + + L +++ + NI +M+ + I I RGL Y HR
Sbjct: 68 TLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIM----SMHNVKIFLYQILRGLAYCHR 122
Query: 409 GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVY- 467
+++H D+KPQN+L++E K++DFGLA+ S + T+ Y P+V
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYS--NEVVTLWYRPPDVLL 177
Query: 468 -SRRFGGVSHKSDVYSYGMMIIEM 490
S + S + D++ G + EM
Sbjct: 178 GSSEY---STQIDMWGVGCIFFEM 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-14
Identities = 56/195 (28%), Positives = 99/195 (50%), Gaps = 13/195 (6%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKV--LKNSRCNGEEFINEVASISRTSHVNIVTFLG 355
+++G+G +GEV+KG + Q+VA+K+ L+ + E+ E+ +S+ + + G
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
+ K +I E + GS + + + TM + I +GL+YLH + +
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLH---SEKKI 123
Query: 416 HFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVS 475
H DIK N+LL E K++DFG+A Q ++ I GT ++APEV +
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQ--SAYD 179
Query: 476 HKSDVYSYGMMIIEM 490
K+D++S G+ IE+
Sbjct: 180 SKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 6e-14
Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 27/204 (13%)
Query: 299 DKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEE-----FINEVASISRTSHVNIVT 352
DKLG+G Y V+KG LVA LK R EE I EV+ + H NIVT
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVA---LKEIRLEHEEGAPCTAIREVSLLKNLKHANIVT 67
Query: 353 FLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAI---GIARGLEYLHRG 409
+ + L++E + + L +++ N N+ +M+ + I + RGL Y H+
Sbjct: 68 LHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLM----SMHNVKIFMFQLLRGLSYCHKR 122
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSR 469
+I+H D+KPQN+L++E K++DFGLA+ S + T+ Y P+V
Sbjct: 123 ---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYS--NEVVTLWYRPPDVL-- 175
Query: 470 RFGGVSHKS--DVYSYGMMIIEMV 491
G + + D++ G ++ EM
Sbjct: 176 -LGSTEYSTPIDMWGVGCILYEMA 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 66/202 (32%), Positives = 107/202 (52%), Gaps = 23/202 (11%)
Query: 300 KLGQGGYGEVYKGELPD-GQLVAVKVLKN-SRCNGEEFINEVASISRTSHVNIVTFL-GF 356
+LG G +G+VYK + + G L A KV+ S E+++ E+ ++ H NIV L F
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 357 CYENKKNALIYELMPNGSLDKFIHNDRNIKLEWK-TMYQIAIGIARGLEYLHRGCQVRIV 415
YEN LI E G++D + ++LE T QI + + LE L+ + +I+
Sbjct: 72 YYENNLWILI-EFCAGGAVDAVM-----LELERPLTEPQIRVVCKQTLEALNYLHENKII 125
Query: 416 HFDIKPQNILLDEDFCPKISDFGLA----KQAQKKESAISMLHARGTIGYIAPEVY---S 468
H D+K NIL D K++DFG++ + Q+++S I GT ++APEV +
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI------GTPYWMAPEVVMCET 179
Query: 469 RRFGGVSHKSDVYSYGMMIIEM 490
+ +K+DV+S G+ +IEM
Sbjct: 180 SKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 7e-14
Identities = 66/223 (29%), Positives = 109/223 (48%), Gaps = 34/223 (15%)
Query: 279 SLAPKRYSYSDVKRMTKSFRDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFI- 336
S S S+++R+ +++G G G VYK P G+L A+KV+ N E+ +
Sbjct: 65 SAPSAAKSLSELERV-----NRIGSGAGGTVYKVIHRPTGRLYALKVIYG---NHEDTVR 116
Query: 337 ----NEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTM 392
E+ + +H N+V N + ++ E M GSL+ +I E + +
Sbjct: 117 RQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE-----GTHIADE-QFL 170
Query: 393 YQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAK-QAQKKESAIS 451
+A I G+ YLHR IVH DIKP N+L++ KI+DFG+++ AQ + S
Sbjct: 171 ADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNS 227
Query: 452 MLHARGTIGYIAPE-----VYSRRFGGVSHKSDVYSYGMMIIE 489
+ GTI Y++PE + + G + D++S G+ I+E
Sbjct: 228 SV---GTIAYMSPERINTDLNHGAYDG--YAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 9e-14
Identities = 68/226 (30%), Positives = 103/226 (45%), Gaps = 29/226 (12%)
Query: 301 LGQGGYGEVYKG-ELPDGQLVAVKVLKNS---RCNGEEFI-NEVASISRTSHVNIVTFLG 355
+G G +G V+ + A+KV+ R E+ + NE + SH I+
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66
Query: 356 FCYENKKNAL--IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVR 413
F E+ + L + E +P G L ++ N Y A I LEYLH
Sbjct: 67 FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFY--ASEIVCALEYLH---SKE 121
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGG 473
IV+ D+KP+NILLD++ K++DFG AK+ + + + GT Y+APEV + G
Sbjct: 122 IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC-----GTPEYLAPEVIQSK--G 174
Query: 474 VSHKSDVYSYGMMIIEM-VGCTKNLDDEVTDTSICHNLIYERIEPG 518
+ D ++ G++I EM VG DD IYE+I G
Sbjct: 175 HNKAVDWWALGILIYEMLVGYPPFFDDNPFG-------IYEKILAG 213
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|222721 pfam14380, WAK_assoc, Wall-associated receptor kinase C-terminal | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-13
Identities = 33/107 (30%), Positives = 48/107 (44%), Gaps = 14/107 (13%)
Query: 137 FNCSIDGKNTNSYYFSWDSNSFNSSIRSAIGAYFRSCANSAVIPVWQSTLRYMVNNPNSV 196
+CS D + +SY+ S + S C+ S V+PV S L + +
Sbjct: 1 LSCSGDSGDYSSYF---VFPSDDLS---------GGCSRSVVVPVLGSALGADLGS--GD 46
Query: 197 NLTCALRVGFGLQWHANNRLCEECKQSNGNCGYIAKTGEFICYCPNG 243
LR GF L+W+ + C EC+ S G CGY + F C CP+G
Sbjct: 47 GYEEVLREGFELEWNVDPGDCSECEASGGRCGYDQTSEFFGCLCPDG 93
|
This WAK_assoc domain is cysteine-rich and lies C-terminal to the binding domain, GUB_WAK_bind, pfam13947. Length = 94 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 22/199 (11%)
Query: 300 KLGQGGYGEV-YKGELPDGQLVAVKVLKNSRCNGEEFI-NEVASISRTSHVNIVTFLGFC 357
K+G+G G V E G+ VAVK++ + E + NEV + H N+V
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 358 YENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH-RGCQVRIVH 416
++ ++ E + G+L + +L + + + + + L YLH +G ++H
Sbjct: 88 LVGEELWVLMEFLQGGALTDIV---SQTRLNEEQIATVCESVLQALCYLHSQG----VIH 140
Query: 417 FDIKPQNILLDEDFCPKISDFG----LAKQAQKKESAISMLHARGTIGYIAPEVYSRRFG 472
DIK +ILL D K+SDFG ++K K++S + GT ++APEV SR
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV------GTPYWMAPEVISRTPY 194
Query: 473 GVSHKSDVYSYGMMIIEMV 491
G + D++S G+M+IEMV
Sbjct: 195 GT--EVDIWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 62/257 (24%), Positives = 110/257 (42%), Gaps = 29/257 (11%)
Query: 303 QGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVN----IVTFLGFC 357
+G +G VY + G A+KVLK S + + V + + V L +
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 358 YENKKN-ALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVH 416
+++K L+ E + G I + +W Y + G+E LH Q I+H
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY--IAEVVLGVEDLH---QRGIIH 120
Query: 417 FDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSH 476
DIKP+N+L+D+ K++DFGL++ + + + GT Y+APE G
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV------GTPDYLAPETILGV--GDDK 172
Query: 477 KSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAK 536
SD +S G +I E + E D ++ N++ RI + + + E I +
Sbjct: 173 MSDWWSLGCVIFEFLFGYPPFHAETPD-AVFDNILSRRIN-WPEEVKEFCSPEAVDLINR 230
Query: 537 MMILVGFWCIQTNPSER 553
++ + +P++R
Sbjct: 231 LLCM--------DPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 31/209 (14%)
Query: 301 LGQGGYGEVYKGEL---PDGQL--------VAVKVLKNSRCNGEEFINEVASISRTSHVN 349
LGQG + +YKG L D + V +KVL + + F + +S+ SH +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 350 IVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRN-IKLEWKTMYQIAIGIARGLEYLHR 408
+V G C + +N ++ E + G LD F+H ++N + L WK +A +A L YL
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLE- 118
Query: 409 GCQVRIVHFDIKPQNILL----DEDFCP---KISDFGLAKQAQKKESAISMLHARGTIGY 461
++VH ++ +NIL+ + K+SD G+ +E + I +
Sbjct: 119 --DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE------RIPW 170
Query: 462 IAPEVYSRRFGGVSHKSDVYSYGMMIIEM 490
IAPE ++ +D +S+G ++E+
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 61/197 (30%), Positives = 101/197 (51%), Gaps = 19/197 (9%)
Query: 300 KLGQGGYGEVYKGE-LPDGQLVAVKV--LKNSRCNGEEFINEVASISRTSHVNIVTFLGF 356
+LG G G V K + P G ++A K+ L+ + I E+ + + IV F G
Sbjct: 12 ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 357 CYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVH 416
Y + + ++ E M GSLD+ + + I E + +++I + RGL YL Q I+H
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVLKEAKRIPEE--ILGKVSIAVLRGLAYLREKHQ--IMH 127
Query: 417 FDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHA-RGTIGYIAPEVYSRRFGGV- 474
D+KP NIL++ K+ DFG++ Q SM ++ GT Y++PE R G
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPE----RLQGTH 178
Query: 475 -SHKSDVYSYGMMIIEM 490
S +SD++S G+ ++E+
Sbjct: 179 YSVQSDIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 56/195 (28%), Positives = 99/195 (50%), Gaps = 13/195 (6%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKV--LKNSRCNGEEFINEVASISRTSHVNIVTFLG 355
+K+G+G +GEV+KG + ++VA+K+ L+ + E+ E+ +S+ + + G
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
++ K +I E + GS + L+ + I I +GL+YLH + +
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLH---SEKKI 123
Query: 416 HFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVS 475
H DIK N+LL E K++DFG+A Q ++ I GT ++APEV +
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQ--SAYD 179
Query: 476 HKSDVYSYGMMIIEM 490
K+D++S G+ IE+
Sbjct: 180 SKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 29/160 (18%)
Query: 300 KLGQGGYGEVYKG-ELPDGQLVAVK--VLKNSRCNGEEF----INEVASISRTSHVNIVT 352
KLG+G +GEVYK ++ G++VA+K ++ N + + F + E+ + + H N+V
Sbjct: 15 KLGEGTFGEVYKARQIKTGRVVALKKILMHNEK---DGFPITALREIKILKKLKHPNVVP 71
Query: 353 FLGFCYENKKNAL-----IYELMP--NGSLDKFIHNDRNIKLEWKT----MYQIAIGIAR 401
+ E + +Y + P + L + N +KL M Q+
Sbjct: 72 LIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPS-VKLTESQIKCYMLQLL----E 126
Query: 402 GLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAK 441
G+ YLH I+H DIK NIL+D KI+DFGLA+
Sbjct: 127 GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 57/199 (28%), Positives = 100/199 (50%), Gaps = 22/199 (11%)
Query: 300 KLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNGEEFI-NEVASISRTSHVNIVTFLGFC 357
K+G+G G V + G+LVAVK + + E + NEV + H N+V
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 358 YENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH-RGCQVRIVH 416
+ ++ E + G+L + + R + + + + + + + L LH +G ++H
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLKALSVLHAQG----VIH 139
Query: 417 FDIKPQNILLDEDFCPKISDFG----LAKQAQKKESAISMLHARGTIGYIAPEVYSRRFG 472
DIK +ILL D K+SDFG ++K+ +++S + GT ++APE+ SR
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV------GTPYWMAPELISRLPY 193
Query: 473 GVSHKSDVYSYGMMIIEMV 491
G + D++S G+M+IEMV
Sbjct: 194 G--PEVDIWSLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 56/201 (27%), Positives = 97/201 (48%), Gaps = 25/201 (12%)
Query: 300 KLGQGGYGEVYKGELPD-GQLVAVKVLKNSRCNGEEFINEVASISR-------TSHVNIV 351
++GQGGYG+V+ + D G++VA+K +K S +NEV + T +V
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL---FKLNEVRHVLTERDILTTTKSEWLV 64
Query: 352 TFLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGC 410
L + +++ + L E +P G ++N + + Y + A ++ LH
Sbjct: 65 KLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEA--VDALHE-- 119
Query: 411 QVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRR 470
+ +H D+KP+N L+D K++DFGL+K A S++ G+ Y+APEV +
Sbjct: 120 -LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY--ANSVV---GSPDYMAPEVLRGK 173
Query: 471 FGGVSHKSDVYSYGMMIIEMV 491
G D +S G M+ E +
Sbjct: 174 --GYDFTVDYWSLGCMLYEFL 192
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 59/213 (27%), Positives = 105/213 (49%), Gaps = 28/213 (13%)
Query: 299 DKLGQGGYGEVYKGELPDGQL---VAVKVLKN--SRCNGEEFINEVASISRTSH-VNIVT 352
D +G+G +G+V K + L A+K +K S+ + +F E+ + + H NI+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 353 FLGFCYENKKNALIYELMPNGSLDKFIHNDRNIK--------------LEWKTMYQIAIG 398
LG C L E P+G+L F+ R ++ L + + A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 399 IARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGT 458
+ARG++YL Q + +H D+ +NIL+ E++ KI+DFGL++ +E + R
Sbjct: 121 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174
Query: 459 IGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMV 491
+ ++A E S + + SDV+SYG+++ E+V
Sbjct: 175 VRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 8e-13
Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 51/218 (23%)
Query: 300 KLGQGGYGEVYKGELPD-GQLVAVKVLKNSRC-NGEE-----FINEVASISRTS---HVN 349
++G G YG VYK P G VA LK+ R E+ + EVA + R H N
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVA---LKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPN 63
Query: 350 IVTFLGFCYENK-----KNALIYELMPNGSLDKFIHNDRNIK----------LEWKTMYQ 394
IV + C ++ K L++E H D++++ L +T+
Sbjct: 64 IVRLMDVCATSRTDRETKVTLVFE-----------HVDQDLRTYLDKVPPPGLPAETIKD 112
Query: 395 IAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAK--QAQKKESAISM 452
+ RGL++LH C IVH D+KP+NIL+ K++DFGLA+ Q + + +
Sbjct: 113 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV 169
Query: 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEM 490
T+ Y APEV + + D++S G + EM
Sbjct: 170 -----TLWYRAPEVLLQ--STYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 67/204 (32%), Positives = 102/204 (50%), Gaps = 23/204 (11%)
Query: 301 LGQGGYGEVY---KGELPD-GQLVAVKVLKNSRCNGEEFINEVASISRT--SHVNIVTFL 354
LG G YG+V+ K D G+L A+KVL+ + + E R HV FL
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 355 -----GFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRG 409
F E K + LI + + G + ++ N + Y I +A LE+LH+
Sbjct: 68 VTLHYAFQTEAKLH-LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILA--LEHLHK- 123
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ--AQKKESAISMLHARGTIGYIAPEVY 467
+ IV+ DIK +NILLD + ++DFGL+K+ +++KE S GTI Y+APE+
Sbjct: 124 --LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC---GTIEYMAPEII 178
Query: 468 SRRFGGVSHKSDVYSYGMMIIEMV 491
R GG D +S G++I E++
Sbjct: 179 -RGKGGHGKAVDWWSLGILIFELL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 300 KLGQGGYGE-VYKGELPDGQLVAVKVLKNSRCNG---EEFINEVASISRTSHVNIVTFLG 355
K+G+G +G+ + DG+ +K + S+ + EE EVA +S H NIV +
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
EN ++ + G L K I+ R + + + I L+++H +I+
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKIL 123
Query: 416 HFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIG---YIAPEVYSRRFG 472
H DIK QNI L +D K+ DFG+A+ ++ AR IG Y++PE+ R
Sbjct: 124 HRDIKSQNIFLTKDGTIKLGDFGIARVLNS-----TVELARTCIGTPYYLSPEICENR-- 176
Query: 473 GVSHKSDVYSYGMMIIEMVGCT 494
++KSD+++ G ++ EM CT
Sbjct: 177 PYNNKSDIWALGCVLYEM--CT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 21/200 (10%)
Query: 301 LGQGGYGEVYKG-ELPDGQLVAVKV--LKNSRCNGEEFINEVASISRTSHV---NIVTFL 354
+G+G YG VY+G +P G++VA+K+ L + + EVA +S+ NI +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 355 GFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVR 413
G Y +I E GS+ + + + K + I + L+Y+H+ V
Sbjct: 69 G-SYLKGPRLWIIMEYAEGGSVRTLM---KAGPIAEKYISVIIREVLVALKYIHK---VG 121
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGG 473
++H DIK NIL+ K+ DFG+A + S S GT ++APEV + G
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF--VGTPYWMAPEVIT---EG 176
Query: 474 VSH--KSDVYSYGMMIIEMV 491
+ K+D++S G+ I EM
Sbjct: 177 KYYDTKADIWSLGITIYEMA 196
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 19/199 (9%)
Query: 301 LGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEVASISRTSHVNIVTFLG 355
LG+G +G+V+ EL Q A+K LK + E + E +S +T L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 356 FCYENKKNAL-IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH-RGCQVR 413
++ K+N + E + G L I + L T Y A I GL++LH +G
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY--AAEIICGLQFLHSKG---- 116
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEV-YSRRFG 472
IV+ D+K NILLD D KI+DFG+ K+ ++ GT YIAPE+ +++
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC--GTPDYIAPEILLGQKYN 174
Query: 473 GVSHKSDVYSYGMMIIEMV 491
D +S+G+++ EM+
Sbjct: 175 ---TSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 61/194 (31%), Positives = 98/194 (50%), Gaps = 15/194 (7%)
Query: 301 LGQGGYGEVYKGE-LPDGQLVAVKV--LKNSRCNGEEFINEVASISRTSHVNIVTFLGFC 357
LG G G V K + +P G ++A KV + ++ + E+ + IV+F G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG-A 71
Query: 358 YENKKNALI-YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVH 416
+ N+ N + E M GSLD+ I +E + +IA+ + GL YL+ RI+H
Sbjct: 72 FLNENNICMCMEFMDCGSLDRIYKKGGPIPVE--ILGKIAVAVVEGLTYLYN--VHRIMH 127
Query: 417 FDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSH 476
DIKP NIL++ K+ DFG++ + + + GT Y++PE + G +
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV----GTSTYMSPE--RIQGGKYTV 181
Query: 477 KSDVYSYGMMIIEM 490
KSDV+S G+ IIE+
Sbjct: 182 KSDVWSLGISIIEL 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 32/211 (15%)
Query: 300 KLGQGGYGEVYKG-ELPDGQLVAVK-VLKNSRCNGEEF----INEVASISRTSHVNIVTF 353
K+GQG +GEV+K Q+VA+K VL + G F + E+ + H N+V
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG--FPITALREIKILQLLKHENVVNL 76
Query: 354 LGFCY-----ENKKNALIYELMP--NGSLDKFIHNDRNIKL---EWKTMYQIAIGIARGL 403
+ C N+ Y + L + N +N+K E K + ++ + GL
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSN-KNVKFTLSEIKKVMKM---LLNGL 132
Query: 404 EYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ-AQKKESAISMLHAR-GTIGY 461
Y+HR +I+H D+K NIL+ +D K++DFGLA+ + K S + R T+ Y
Sbjct: 133 YYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWY 189
Query: 462 IAPEVY--SRRFGGVSHKSDVYSYGMMIIEM 490
PE+ R +G D++ G ++ EM
Sbjct: 190 RPPELLLGERDYG---PPIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 37/213 (17%)
Query: 300 KLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFINEVASISRT----------SHV 348
+G G YG V + G+ VA+K + ++ + RT H
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHA-------FDVPTLAKRTLRELKILRHFKHD 64
Query: 349 NIVTFLGFCYENKKNA----LIYELMPNGSLDKFIHNDRNIKLEWKT--MYQIAIGIARG 402
NI+ + ++ +LM + L IH+D+ + E +YQ+ RG
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLL----RG 119
Query: 403 LEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK--ESAISMLHARGTIG 460
L+Y+H ++H D+KP N+L++ED +I DFG+A+ E M T
Sbjct: 120 LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 461 YIAPEV-YSRRFGGVSHKSDVYSYGMMIIEMVG 492
Y APE+ S + D++S G + EM+G
Sbjct: 177 YRAPELLLS--LPEYTTAIDMWSVGCIFAEMLG 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 58/197 (29%), Positives = 103/197 (52%), Gaps = 19/197 (9%)
Query: 300 KLGQGGYGEVYK-GELPDGQLVAVKV--LKNSRCNGEEFINEVASISRTSHVNIVTFLGF 356
+LG G G V+K P G ++A K+ L+ + I E+ + + IV F G
Sbjct: 12 ELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 357 CYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVH 416
Y + + ++ E M GSLD+ + + ++ + + +++I + +GL YL + +I+H
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMH 127
Query: 417 FDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHA-RGTIGYIAPEVYSRRFGGV- 474
D+KP NIL++ K+ DFG++ Q SM ++ GT Y++PE R G
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPE----RLQGTH 178
Query: 475 -SHKSDVYSYGMMIIEM 490
S +SD++S G+ ++EM
Sbjct: 179 YSVQSDIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 24/205 (11%)
Query: 301 LGQGGYGEVY---KGELPD-GQLVAVKVLKNSRCNGEEFINEVASISRT--SHVNIVTFL 354
LG G YG+V+ K D G+L A+KVLK + + E R H+ FL
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 355 -----GFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIG-IARGLEYLHR 408
F + K + LI + + G L F H + + + + + QI G I LE+LH+
Sbjct: 68 VTLHYAFQTDTKLH-LILDYINGGEL--FTHLSQRERFKEQEV-QIYSGEIVLALEHLHK 123
Query: 409 GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ--AQKKESAISMLHARGTIGYIAPEV 466
+ I++ DIK +NILLD + ++DFGL+K+ + E A S GTI Y+AP++
Sbjct: 124 ---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC---GTIEYMAPDI 177
Query: 467 YSRRFGGVSHKSDVYSYGMMIIEMV 491
GG D +S G+++ E++
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 41/223 (18%)
Query: 301 LGQGGYGEVYKG-ELPDGQLVAVKVLKNS---RCNGEEFINEVASISRTSHVNIVTFLGF 356
+G+G +GEV+ + GQ+ A+KVL+ S + N + I + + L +
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYY 68
Query: 357 CYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHR-GCQVRI 414
++++++ L+ E MP G L + E Y + +A L+ +H+ G
Sbjct: 69 SFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA--LDSVHKLGF---- 122
Query: 415 VHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR------------------ 456
+H DIKP NIL+D D K++DFGL K+ K + L+
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182
Query: 457 ---------GTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEM 490
GT YIAPEV + D +S G+++ EM
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEM 223
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 42/210 (20%)
Query: 301 LGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNGEEFI---NEVASI----------SRTS 346
LG+G +G+V E G+L A+K LK + I +EV S+ +
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALK------KGDIIARDEVESLMCEKRIFETANSER 60
Query: 347 HVNIVTFLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEY 405
H +V C++ + + + E G L IH D E + ++ A + GL+Y
Sbjct: 61 HPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVF--SEPRAVFYAAC-VVLGLQY 116
Query: 406 LHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPE 465
LH + +IV+ D+K N+LLD + KI+DFGL K+ S GT ++APE
Sbjct: 117 LH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC--GTPEFLAPE 171
Query: 466 V-----YSRRFGGVSHKSDVYSYGMMIIEM 490
V Y+R D + G++I EM
Sbjct: 172 VLTETSYTRAV-------DWWGLGVLIYEM 194
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 6e-12
Identities = 67/267 (25%), Positives = 111/267 (41%), Gaps = 43/267 (16%)
Query: 298 RDKLGQGGYGEV----YKGELPDGQLVAVKVLKNS---RCNGEEFINEVASI-SRTSHVN 349
+ LG G +G V +KG G+ A+K LK + + + + SI SH
Sbjct: 23 GETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 350 IVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKL--EWKTMYQIAIGIARGLEYLH 407
IV + + + + E + G L F H + + + Y + +A EYLH
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGEL--FTHLRKAGRFPNDVAKFYHAELVLA--FEYLH 135
Query: 408 RGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVY 467
I++ D+KP+N+LLD K++DFG AK+ + + GT Y+APEV
Sbjct: 136 ---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC-----GTPEYLAPEVI 187
Query: 468 SRRFGGVSHKSDVYSYGMMIIEM-VGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526
+ G D ++ G+++ E G DD YE+I G +F
Sbjct: 188 QSK--GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI-------YEKILAGR-LKFPNW 237
Query: 527 ATEEEKKIAKMMILVGFWCIQTNPSER 553
+ + K G +QT+ ++R
Sbjct: 238 FDGRARDLVK-----GL--LQTDHTKR 257
|
Length = 329 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 62/203 (30%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 301 LGQGGYGEVYKGELPD-GQLVAVKVLK--------NSRCNGEEFINEVASISRTSHVNIV 351
LGQG +G VY D G+ +AVK ++ + N E E+ + H IV
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALEC--EIQLLKNLLHERIV 67
Query: 352 TFLGFCYENKKNAL--IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRG 409
+ G + + L E MP GS+ + + L + I G+ YLH
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSN 125
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK-ESAISMLHARGTIGYIAPEVYS 468
IVH DIK NIL D K+ DFG +K+ Q S M GT +++PEV S
Sbjct: 126 ---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182
Query: 469 RRFGGVSHKSDVYSYGMMIIEMV 491
G K+D++S G ++EM+
Sbjct: 183 GE--GYGRKADIWSVGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 59/197 (29%), Positives = 91/197 (46%), Gaps = 17/197 (8%)
Query: 301 LGQGGYGEVYKGELPD-GQLVAVKVLKNSRCNGEEFI----NEVASISRTSHVNIVTFLG 355
LG+G +G+V EL +L AVKVLK ++ + E ++ +T L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 356 FCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH-RGCQVR 413
C++ K + E + G L I Y A I GL++LH RG
Sbjct: 63 SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFY--AAEIVLGLQFLHERG---- 116
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGG 473
I++ D+K N+LLD + KI+DFG+ K+ S GT YIAPE+ S + G
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC--GTPDYIAPEILSYQPYG 174
Query: 474 VSHKSDVYSYGMMIIEM 490
+ D ++ G+++ EM
Sbjct: 175 PA--VDWWALGVLLYEM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 48/145 (33%), Positives = 78/145 (53%), Gaps = 18/145 (12%)
Query: 350 IVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRG 409
IV F G Y + + ++ E M GSLD+ + I + +I+I + RGL YL
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP--ENILGKISIAVLRGLTYLRE- 117
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHA-RGTIGYIAPEVYS 468
+ +I+H D+KP NIL++ K+ DFG++ Q SM ++ GT Y++PE
Sbjct: 118 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPE--- 168
Query: 469 RRFGGVSH---KSDVYSYGMMIIEM 490
R G +H +SD++S G+ ++EM
Sbjct: 169 -RLQG-THYTVQSDIWSLGLSLVEM 191
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 32/209 (15%)
Query: 300 KLGQGGYGEVYKG-ELPDG-QLVAVKVLKNSRCNGEE------FINEVASISRTS---HV 348
++G+G YG+V+K +L +G + VA LK R E I EVA + H
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVA---LKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 64
Query: 349 NIVTFLGFCYENK-----KNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGL 403
N+V C ++ K L++E + + L ++ + +T+ + + RGL
Sbjct: 65 NVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 123
Query: 404 EYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAK--QAQKKESAISMLHARGTIGY 461
++LH R+VH D+KPQNIL+ K++DFGLA+ Q +++ + T+ Y
Sbjct: 124 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-----TLWY 175
Query: 462 IAPEVYSRRFGGVSHKSDVYSYGMMIIEM 490
APEV + + D++S G + EM
Sbjct: 176 RAPEVLLQ--SSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 39/103 (37%), Positives = 55/103 (53%), Gaps = 13/103 (12%)
Query: 392 MYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451
+YQI RGL+YLH I+H DIKP N+L++ + KI DFGLA+ + ES
Sbjct: 109 LYQIL----RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKH- 160
Query: 452 MLHARGTIGYIAPEVY--SRRFGGVSHKSDVYSYGMMIIEMVG 492
M T Y APE+ SR + D++S G + E++G
Sbjct: 161 MTQEVVTQYYRAPEILMGSRHYTS---AVDIWSVGCIFAELLG 200
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 295 KSFRD--KLGQGGYGEVY-KGELPDGQLVAVKVL----KNSRCNGEEFINEVASISRTSH 347
K F D ++G G +G VY ++ ++VA+K + K S ++ I EV + R H
Sbjct: 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84
Query: 348 VNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH 407
N + + G CY + A + GS + + L+ + I G +GL YLH
Sbjct: 85 PNSIEYKG-CYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLH 142
Query: 408 RGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEV- 466
++H DIK NILL E K++DFG A A S + GT ++APEV
Sbjct: 143 SH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV------GTPYWMAPEVI 193
Query: 467 YSRRFGGVSHKSDVYSYGMMIIEM 490
+ G K DV+S G+ IE+
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 31/210 (14%)
Query: 295 KSFRD--KLGQGGYGEVYKG-ELPDGQLVAVKVL----KNSRCNGEEFINEVASISRTSH 347
K F D ++G G +G VY ++ ++VA+K + K S ++ I EV + + H
Sbjct: 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74
Query: 348 VNIVTFLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAI-----GIAR 401
N + + G CY + A L+ E + D +++ K + ++ I G +
Sbjct: 75 PNTIEYKG-CYLREHTAWLVMEYCLGSASDI-------LEVHKKPLQEVEIAAICHGALQ 126
Query: 402 GLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGY 461
GL YLH ++ H DIK NILL E K++DFG A S + GT +
Sbjct: 127 GLAYLHSHERI---HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYW 177
Query: 462 IAPEV-YSRRFGGVSHKSDVYSYGMMIIEM 490
+APEV + G K DV+S G+ IE+
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 15/227 (6%)
Query: 300 KLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNG-----EEFINEVASISRTSHVNIVTFL 354
++G G +G+V E+ VA V+K + N EF+ + H NI+ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 355 GFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMY--QIAIGIARGLEYLHRGCQV 412
G C E L++E G L ++ ++ + + + ++A IA G+ ++H+
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---H 118
Query: 413 RIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFG 472
+H D+ +N L D K+ D+G+ K++ + + ++APE+ G
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHG 178
Query: 473 GV-----SHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYER 514
G+ + S+V++ G+ + E+ ++D + +++I ++
Sbjct: 179 GLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQ 225
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 51/173 (29%), Positives = 90/173 (52%), Gaps = 32/173 (18%)
Query: 399 IARGLEYL-HRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARG 457
+ARG+E+L R C +H D+ +NILL E+ KI DFGLA+ K + AR
Sbjct: 182 VARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237
Query: 458 TIGYIAPE-VYSRRFGGVSHKSDVYSYGMMIIEM--VGCTK----NLDDEVTDTSICHNL 510
+ ++APE ++ + + + +SDV+S+G+++ E+ +G + +D+E C
Sbjct: 238 PLKWMAPESIFDKVY---TTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-----FC--- 286
Query: 511 IYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEML 563
R++ G + AT E I +M+ C NP +RP+ +++E+L
Sbjct: 287 --RRLKEGTRMRAPEYATPE---IYSIMLD----CWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 8e-11
Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 18/205 (8%)
Query: 298 RDKLGQGGYGEVY-KGELPDGQLVAVKVLKNSRCNGEE---FINEVASISRTSHVNIVTF 353
+ +G+G +GEV E G + A+KV+K S +E F E I S+ +
Sbjct: 6 KSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQ 65
Query: 354 LGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQV 412
L + +++K N L+ E P G L ++ + E M Q + A + +H Q+
Sbjct: 66 LQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDE--DMAQFYL--AELVLAIHSVHQM 121
Query: 413 RIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEV------ 466
VH DIKP+N+L+D K++DFG A + + S L GT YIAPEV
Sbjct: 122 GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEVLTTMNG 180
Query: 467 YSRRFGGVSHKSDVYSYGMMIIEMV 491
+ GV D +S G++ EM+
Sbjct: 181 DGKGTYGVE--CDWWSLGVIAYEMI 203
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 30/210 (14%)
Query: 299 DKLGQGGYGEVYKG---ELPD-GQL----VAVKVLKNSRCNGEEFINEVASI-SRTSHVN 349
+ LGQG + +++KG E+ D G+L V +KVL S N E E AS+ S+ SH +
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 350 IVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRN-IKLEWKTMYQIAIGIARGLEYLHR 408
+V G C ++ ++ E + GSLD ++ ++N I + WK ++A +A L +L
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK--LEVAKQLAWALHFLE- 117
Query: 409 GCQVRIVHFDIKPQNILL--DEDFCP------KISDFGLAKQAQKKESAISMLHARGTIG 460
+ H ++ +N+LL +ED K+SD G++ KE +L R I
Sbjct: 118 --DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE----ILLER--IP 169
Query: 461 YIAPEVYSRRFGGVSHKSDVYSYGMMIIEM 490
++ PE +S +D +S+G + E+
Sbjct: 170 WVPPECIENP-QNLSLAADKWSFGTTLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 17/197 (8%)
Query: 300 KLGQGGYGEVY-KGELPDGQLVAVKVL----KNSRCNGEEFINEVASISRTSHVNIVTFL 354
++G G +G VY ++VAVK + K + ++ I EV + + H N + +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 355 GFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRI 414
G CY + A + GS + + L+ + I G +GL YLH +
Sbjct: 88 G-CYLKEHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSHN---M 142
Query: 415 VHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEV-YSRRFGG 473
+H DIK NILL E K++DFG A ++ S + GT ++APEV + G
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEVILAMDEGQ 196
Query: 474 VSHKSDVYSYGMMIIEM 490
K DV+S G+ IE+
Sbjct: 197 YDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 65/203 (32%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 301 LGQGGYGEVYKGELPD-GQLVAVKVLK---NSRCNGEEFIN----EVASISRTSHVNIVT 352
LG+G +GEVY D G+ +AVK + +S+ +E +N E+ + H IV
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE-VNALECEIQLLKNLRHDRIVQ 68
Query: 353 FLGFC---YENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRG 409
+ G C E KK ++ E MP GS+ + L + I +G+ YLH
Sbjct: 69 YYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSN 125
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK-KESAISMLHARGTIGYIAPEVYS 468
IVH DIK NIL D K+ DFG +K+ Q S + GT +++PEV S
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182
Query: 469 RRFGGVSHKSDVYSYGMMIIEMV 491
G K+DV+S ++EM+
Sbjct: 183 GE--GYGRKADVWSVACTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (153), Expect = 1e-10
Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 35/211 (16%)
Query: 301 LGQGGYGEVYKGE-LPDGQLVAVKVLKN---SRCNGEEFINEVASISRTSHVNIVTFLGF 356
+G G YG V G+ VA+K + N + + + E+ + H NI+ L
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDI 67
Query: 357 CYENKKNA-----LIYELMPNGSLDKFIHNDRNIKLE-WKT-MYQIAIGIARGLEYLHRG 409
++ ELM L K I + + + + + +YQI RGL+YLH
Sbjct: 68 LRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQIL----RGLKYLHSA 122
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIG-----YIAP 464
++H D+KP NIL++ + KI DFGLA+ E L T Y AP
Sbjct: 123 ---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL----TEYVVTRWYRAP 175
Query: 465 EV---YSRRFGGVSHKSDVYSYGMMIIEMVG 492
E+ SR + D++S G + E++
Sbjct: 176 ELLLSSSRYTKAI----DIWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 44/169 (26%), Positives = 78/169 (46%), Gaps = 27/169 (15%)
Query: 293 MTKSFRDK---LGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEF------------- 335
+++ + K LG+G YG+V K G++VA+K +K + +
Sbjct: 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHF 65
Query: 336 --INEVASISRTSHVNIVTFLG-FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTM 392
+ E+ ++ H NI+ + + + N L+ ++M L K + DR I+L +
Sbjct: 66 TTLRELKIMNEIKHENIMGLVDVYVEGDFIN-LVMDIM-ASDLKKVV--DRKIRLTESQV 121
Query: 393 YQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAK 441
I + I GL LH+ +H D+ P NI ++ KI+DFGLA+
Sbjct: 122 KCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLAR 167
|
Length = 335 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 29/212 (13%)
Query: 298 RDKLGQGGYGEVYKG-ELPDGQLVAVKVL----KNSRCNGEEFINEVASISRTSHVNIVT 352
+G+G YG V P G VA+K + + C + + E+ + R H NI+
Sbjct: 10 LSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFC--QRTLREIKILRRFKHENIIG 67
Query: 353 FLGF----CYENKKNA-LIYELMPNGSLDKFIH----NDRNIKLEWKTMYQIAIGIARGL 403
L +E+ + ++ ELM L K I ++ +I+ +YQI RGL
Sbjct: 68 ILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQY---FLYQIL----RGL 119
Query: 404 EYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR-GTIGYI 462
+Y+H V +H D+KP N+LL+ + KI DFGLA+ A + L T Y
Sbjct: 120 KYIH-SANV--LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176
Query: 463 APEVYSRRFGGVSHKSDVYSYGMMIIEMVGCT 494
APE+ G + D++S G ++ EM+
Sbjct: 177 APEIM-LNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 43/155 (27%), Positives = 78/155 (50%), Gaps = 25/155 (16%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEE------FINEVASISRTSHVNIV 351
+K+G+G YG V+K ++VA LK R + ++ + E+ + H NIV
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVA---LKRVRLDDDDEGVPSSALREICLLKELKHKNIV 62
Query: 352 TFLGFCYENKKNALIYELMPNGSLDKFIHN-----DRNIKLEWKTMYQIAIGIARGLEYL 406
+ +KK L++E + L K+ + D I + M+Q+ +GL +
Sbjct: 63 RLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSF--MFQLL----KGLAFC 115
Query: 407 HRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAK 441
H ++H D+KPQN+L++++ K++DFGLA+
Sbjct: 116 H---SHNVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 295 KSFRD--KLGQGGYGEVYKG-ELPDGQLVAVKVL----KNSRCNGEEFINEVASISRTSH 347
K F D ++G G +G VY ++ + ++VA+K + K S ++ I EV + + H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 348 VNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH 407
N + + G CY + A + GS + + L+ + + G +GL YLH
Sbjct: 75 PNTIQYRG-CYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLH 132
Query: 408 RGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEV- 466
++H D+K NILL E K+ DFG A + GT ++APEV
Sbjct: 133 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVI 183
Query: 467 YSRRFGGVSHKSDVYSYGMMIIEM 490
+ G K DV+S G+ IE+
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 17/204 (8%)
Query: 299 DKLGQGGYGEVYK-GELPDGQLVAVKVLKNSRCNGEEFINEVASISRTS-HVNIVTFLGF 356
+ +G+G YG+V+K +G AVK+L EE E + S H N+V F G
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83
Query: 357 CYE-NKKNA----LIYELMPNGSLDKFIHN--DRNIKLEWKTMYQIAIGIARGLEYLHRG 409
Y+ + KN L+ EL GS+ + R ++E + I GL++LH
Sbjct: 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN 143
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYS- 468
+ +H D+K NILL + K+ DFG++ AQ + + + GT ++APEV +
Sbjct: 144 ---KTIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTSVGTPFWMAPEVIAC 198
Query: 469 --RRFGGVSHKSDVYSYGMMIIEM 490
+ + DV+S G+ IE+
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 68/297 (22%), Positives = 118/297 (39%), Gaps = 60/297 (20%)
Query: 301 LGQGGYGEVYKGEL--------PDGQLVAVKVLKNSRCNGEE------------------ 334
LGQG +Y G L + ++ L NG E
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62
Query: 335 FINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDR-NIKLEWKTMY 393
F + +S+ SH+++ G C +N ++ E + +G LD + ++ + + WK
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWK--I 120
Query: 394 QIAIGIARGLEYLHRGCQVRIVHFDIKPQNIL-----LDEDFCP--KISDFGLAKQAQKK 446
+A +A L YL +VH ++ +NIL L E P K+SD G++ A +
Sbjct: 121 TVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR 177
Query: 447 ESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSI 506
E + I +IAPE +S +D +S+G ++E+ C D EV
Sbjct: 178 EERVE------RIPWIAPECV-PGGNSLSTAADKWSFGTTLLEI--C---FDGEVP---- 221
Query: 507 CHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEML 563
+ ER + ++ E ++ L+ C+ P++RPS +L L
Sbjct: 222 ----LKERTPSEKERFYEKKHRLPEPSCKELATLIS-QCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 50/169 (29%), Positives = 91/169 (53%), Gaps = 24/169 (14%)
Query: 399 IARGLEYL-HRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARG 457
+ARG+E+L R C +H D+ +NILL E+ KI DFGLA+ K + AR
Sbjct: 183 VARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238
Query: 458 TIGYIAPE-VYSRRFGGVSHKSDVYSYGMMIIEM--VGCTKNLDDEVTDTSICHNLIYER 514
+ ++APE ++ + + + +SDV+S+G+++ E+ +G + ++ + C +R
Sbjct: 239 PLKWMAPESIFDKVY---TTQSDVWSFGVLLWEIFSLGASPYPGVQI-NEEFC-----QR 289
Query: 515 IEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEML 563
++ G + AT E I ++M+ C Q +P ERP+ ++E+L
Sbjct: 290 LKDGTRMRAPENATPE---IYRIMLA----CWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 70/267 (26%), Positives = 121/267 (45%), Gaps = 29/267 (10%)
Query: 301 LGQGGYGEV--YKGELPDGQLVAVKV-LKN-SRCNGEEFINEVASISRTSHVNIVTFLGF 356
+G+G YGEV + Q V K+ L+N SR + E +S+ H NIV +
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE- 66
Query: 357 CYENKKNALIYELM---PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVR 413
+E + + L+Y +M G L + + L + + + IA L+YLH +
Sbjct: 67 SWEGE-DGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKH 122
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGG 473
I+H D+K QN+ L K+ D G+A+ + + S L GT Y++PE++S +
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTL--IGTPYYMSPELFSNK--P 178
Query: 474 VSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKK 533
++KSDV++ G + EM + + ++ L+Y RI G + E +
Sbjct: 179 YNYKSDVWALGCCVYEMATLKHAFNAKDMNS-----LVY-RIIEGKLPPMPKDYSPELGE 232
Query: 534 IAKMMILVGFWCIQTNPSERPSMHKVL 560
+ M + P +RPS+ +L
Sbjct: 233 LIATM-------LSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 49/192 (25%), Positives = 75/192 (39%), Gaps = 39/192 (20%)
Query: 300 KLGQGGYGEVYKG---ELPDGQLVAVKVLKNSRCNGEEF----INEVASISRTSHVNIVT 352
+G+G YG VYK DG+ A+K K + E+A + H N+V+
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 353 FLGFCYEN--KKNALIYELMPNGSLDKFIH----------NDRNIKLEWKTMYQIAIGIA 400
+ E+ K L+++ + L + I +K ++QI G+
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVK---SLLWQILNGVH 122
Query: 401 RGLEYLHRGCQVRIVHFDIKPQNILL----DEDFCPKISDFGLAKQAQKKESAISMLHAR 456
YLH ++H D+KP NIL+ E KI D GLA+ +
Sbjct: 123 ----YLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA--PLKPLADLD 173
Query: 457 G---TIGYIAPE 465
TI Y APE
Sbjct: 174 PVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 6e-10
Identities = 62/198 (31%), Positives = 98/198 (49%), Gaps = 18/198 (9%)
Query: 301 LGQGGYGEV-YKGELPDGQLVAVKVLKNSRCNGEEFINEVASISR----TSHVNIVTFLG 355
LG+G +G+V E G+ A+K+LK ++ + + SR T H +T L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRH-PFLTSLK 61
Query: 356 FCYENKKN-ALIYELMPNGSLDKFIHNDRN-IKLEWKTMYQIAIGIARGLEYLHRGCQVR 413
+ ++ K + E + G L F H R + E +T + A I L+YLH G +
Sbjct: 62 YSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGA-EIVSALDYLHSG---K 115
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGG 473
IV+ D+K +N++LD+D KI+DFGL K+ A +M GT Y+APEV G
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 474 VSHKSDVYSYGMMIIEMV 491
D + G+++ EM+
Sbjct: 174 --RAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 57/221 (25%), Positives = 102/221 (46%), Gaps = 29/221 (13%)
Query: 290 VKRMTKSFRDKLGQGGYGEVYKGELPDG-----QLVAVKVLKN--SRCNGEEFINEVASI 342
+ R + D L +G +G ++ G L D + V VK +K+ S + E +
Sbjct: 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLL 62
Query: 343 SRTSHVNIVTFLGFCYEN-KKNALIYELMPNGSLDKFIHNDRNIK------LEWKTMYQI 395
SH NI+ L C E+ + ++Y M G+L F+ R + L + + +
Sbjct: 63 YGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHM 122
Query: 396 AIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHA 455
AI IA G+ YLH+ ++H DI +N ++DE+ KI+D L++ + H
Sbjct: 123 AIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD-----YHC 174
Query: 456 RGT-----IGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMV 491
G + ++A E + S SDV+S+G+++ E++
Sbjct: 175 LGDNENRPVKWMALESLVNKE--YSSASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 62/230 (26%), Positives = 101/230 (43%), Gaps = 26/230 (11%)
Query: 296 SFRDKLGQGGYGEVYKGELPDGQL--VAVKVLKNSRCNGEEFINEVAS----ISRTSHVN 349
+F LG G +G V + VA+K + S+ ++ ++ V S ++ +H
Sbjct: 33 NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPF 92
Query: 350 IVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRG 409
V G + L+ E + G F+ ++ + Y A I EYL
Sbjct: 93 CVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFY--AAQIVLIFEYLQ-- 148
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSR 469
+ IV+ D+KP+N+LLD+D K++DFG AK + + GT YIAPE+
Sbjct: 149 -SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC-----GTPEYIAPEILLN 202
Query: 470 RFGGVSHKSDVYSYGMMIIEM-VGCTKNLDDEVTDTSICHNLIYERIEPG 518
G +D ++ G+ I E+ VGC +E LIY++I G
Sbjct: 203 V--GHGKAADWWTLGIFIYEILVGCPPFYANEPL-------LIYQKILEG 243
|
Length = 340 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 8e-10
Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 26/219 (11%)
Query: 301 LGQGGYGEVYKGELPD-GQLVAVKVLKNSRCNGEEFINEVAS----ISRTSHVNIVTFLG 355
+G+G Y +V L ++ A+KV+K N +E I+ V + + S+ + L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 356 FCYENKKNAL-IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH-RGCQVR 413
C++ + + E + G L + R + E Y I +A L YLH RG
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNYLHERG---- 116
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGG 473
I++ D+K N+LLD + K++D+G+ K+ + S GT YIAPE+ G
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC--GTPNYIAPEILRGEDYG 174
Query: 474 VSHKSDVYSYGMMIIEM---------VGCTKNLDDEVTD 503
S D ++ G+++ EM VG + N D D
Sbjct: 175 FS--VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED 211
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 9e-10
Identities = 61/209 (29%), Positives = 91/209 (43%), Gaps = 33/209 (15%)
Query: 301 LGQGGYGEVYKG-ELPDGQLVAVKVLK---NSRCNGEEFIN---EVASISRTSHVNIVTF 353
LGQG +G VY ++ G+ +A K ++ S +E E+ + H IV +
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 354 LGFCYENKKNAL--IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIAR--------GL 403
G + + L E MP GS +K + K + + R G+
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGS----------VKDQLKAYGALTESVTRKYTRQILEGM 119
Query: 404 EYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK-ESAISMLHARGTIGYI 462
YLH IVH DIK NIL D K+ DFG +K+ Q S + GT ++
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176
Query: 463 APEVYSRRFGGVSHKSDVYSYGMMIIEMV 491
+PEV S G K+DV+S G ++EM+
Sbjct: 177 SPEVISGE--GYGRKADVWSLGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-09
Identities = 52/192 (27%), Positives = 79/192 (41%), Gaps = 32/192 (16%)
Query: 317 GQLVAVKVLKNSRCNGEE----FINEVASISRTSHVNIVTFL--GFCYENKKNALIYELM 370
G VA+K+L+ E F E A +R H NIV L G A ++E +
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFA-VFEYV 61
Query: 371 PNGSLDKFIHNDRNIKLE--WKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL-- 426
P +L + + D + + M Q+ +A H IVH D+KPQNI++
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACA----HNQ---GIVHRDLKPQNIMVSQ 114
Query: 427 -DEDFCPKISDFGL--------AKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHK 477
K+ DFG+ +L GT Y APE R V+
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVL---GTPTYCAPE--QLRGEPVTPN 169
Query: 478 SDVYSYGMMIIE 489
SD+Y++G++ +E
Sbjct: 170 SDLYAWGLIFLE 181
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 64/228 (28%), Positives = 100/228 (43%), Gaps = 38/228 (16%)
Query: 301 LGQGGYGEVYKGELPD-GQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLG---- 355
LG+G +G+V EL + A+K LK ++ + E + T V L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALK------KDVVLEDDDVECTMVERRVLALAWEHP 56
Query: 356 -----FCYENKKNALIY--ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHR 408
FC K L + E + G L I + Y A I GL++LH+
Sbjct: 57 FLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFY--AAEIICGLQFLHK 114
Query: 409 GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYS 468
I++ D+K N+LLD+D KI+DFG+ K+ E S GT YIAPE+
Sbjct: 115 K---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC--GTPDYIAPEILK 169
Query: 469 RRFGGVSHKSDVYSYGMMIIEMV-------GCTKNLDDEVTDTSICHN 509
+ + D +S+G+++ EM+ G +DE+ D SI ++
Sbjct: 170 GQ--KYNESVDWWSFGVLLYEMLIGQSPFHGED---EDELFD-SILND 211
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 17/205 (8%)
Query: 301 LGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVAS----ISRTSHVNIVTFLG 355
+G+G Y +V L + Q+ A+KV+K + +E I+ V + + S + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 356 FCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH-RGCQVR 413
C++ L+ E + G L + R + E Y I IA L +LH RG
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA--LNFLHERG---- 116
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGG 473
I++ D+K N+LLD D K++D+G+ K+ S GT YIAPE+ G
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC--GTPNYIAPEILRGEEYG 174
Query: 474 VSHKSDVYSYGMMIIEMVGCTKNLD 498
S D ++ G+++ EM+ D
Sbjct: 175 FS--VDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 25/227 (11%)
Query: 301 LGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFIN----EVASISRTSHVNIVTFLG 355
LG+G +G+V E +L A+K+LK ++ + E ++ +T L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 356 FCYEN-KKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRI 414
C++ + + E + G L I K Y A I+ GL +LHR I
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY--AAEISVGLFFLHRR---GI 122
Query: 415 VHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR---GTIGYIAPEVYSRRF 471
++ D+K N++LD + KI+DFG+ KE + + R GT YIAPE+ + +
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMC-----KEHMVDGVTTRTFCGTPDYIAPEIIAYQP 177
Query: 472 GGVSHKSDVYSYGMMIIEMVGCTKNLD----DEVTDTSICHNLIYER 514
G S D ++YG+++ EM+ D DE+ + + HN+ Y +
Sbjct: 178 YGKS--VDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK 222
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 62/232 (26%), Positives = 107/232 (46%), Gaps = 51/232 (21%)
Query: 301 LGQGGYGEVYKGELPD-GQLVAVKVLKNSRCNGEEFINEVASISRTSHVNI------VTF 353
+G+G +GEV + D G + A+K+L+ + +E +VA I + + V
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKE---QVAHIRAERDILVEADGAWVVK 65
Query: 354 LGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQV 412
+ + +++K+N LI E +P G + + + E T + IA + ++ +H Q+
Sbjct: 66 MFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLS-EEATQFYIAETVL-AIDAIH---QL 120
Query: 413 RIVHFDIKPQNILLDEDFCPKISDFGLA---KQAQKKESAISMLH--------------- 454
+H DIKP N+LLD K+SDFGL K+A + E ++ H
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 455 ------------ARGTIG---YIAPEVYSRRFGGVSHKSDVYSYGMMIIEMV 491
A T+G YIAPEV+ + G + D +S G+++ EM+
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 30/74 (40%), Positives = 39/74 (52%), Gaps = 12/74 (16%)
Query: 393 YQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452
YQI RGL+Y+H I+H D+KP NI ++ED KI DFGLA+ + M
Sbjct: 125 YQIL----RGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----M 172
Query: 453 LHARGTIGYIAPEV 466
T Y APE+
Sbjct: 173 TGYVATRWYRAPEI 186
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 26/219 (11%)
Query: 301 LGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNGEEFINEVAS----ISRTSHVNIVTFLG 355
+G+G Y +V EL ++ A+KV+K N +E I+ V + S+ + L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 356 FCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH-RGCQVR 413
C++ + + E + G L + R + E Y I +A L +LH RG
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNFLHERG---- 116
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGG 473
I++ D+K N+LLD + K++D+G+ K+ + S GT YIAPE+ G
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC--GTPNYIAPEILRGEDYG 174
Query: 474 VSHKSDVYSYGMMIIEM---------VGCTKNLDDEVTD 503
S D ++ G+++ EM VG + N D D
Sbjct: 175 FS--VDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTED 211
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 33/210 (15%)
Query: 298 RDKLGQGGYGEVYKGELPDGQLVA---VKVLKN---SRCNGEEFIN---EVASISRTSHV 348
+ +LG+G +G VY + D + VA +KVLK N E + E +S+ H
Sbjct: 5 QQRLGKGSFGTVYL--VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62
Query: 349 NIVTFLGFCYENKKNALIYELMPNGSLD----KFIHNDRNIK----LEWKTMYQIAIGIA 400
IV F E +I E LD + H + + EW Q+ +G+
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW--FIQLLLGV- 119
Query: 401 RGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIG 460
Y+H Q RI+H D+K +NI L + KI DFG+++ + GT
Sbjct: 120 ---HYMH---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTF--TGTPY 170
Query: 461 YIAPEVYSRRFGGVSHKSDVYSYGMMIIEM 490
Y++PE + G KSD++S G ++ EM
Sbjct: 171 YMSPEALKHQ--GYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 64/254 (25%), Positives = 113/254 (44%), Gaps = 32/254 (12%)
Query: 267 DRNVEAFIRNHESLAPKRYSYSDVKRMTKSFRDK-----LGQGGYGEVYKGELPDGQLV- 320
++N++ F+ +E + K ++++ D +G+G +GEV Q V
Sbjct: 18 NKNIDNFLNRYEKIVRK------IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVY 71
Query: 321 AVKVLKN----SRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLD 376
A+K+L R + F E ++ + +V ++K ++ E MP G L
Sbjct: 72 AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLV 131
Query: 377 KFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISD 436
+ N ++ +W Y + +A L+ +H + ++H D+KP N+LLD+ K++D
Sbjct: 132 NLMSN-YDVPEKWAKFYTAEVVLA--LDAIH---SMGLIHRDVKPDNMLLDKHGHLKLAD 185
Query: 437 FGLAKQAQKKESAISMLH---ARGTIGYIAPEVYSRRFGG--VSHKSDVYSYGMMIIEM- 490
FG K M+ A GT YI+PEV + G + D +S G+ + EM
Sbjct: 186 FGTC----MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241
Query: 491 VGCTKNLDDEVTDT 504
VG T D + T
Sbjct: 242 VGDTPFYADSLVGT 255
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 4e-09
Identities = 55/228 (24%), Positives = 89/228 (39%), Gaps = 47/228 (20%)
Query: 300 KLGQGGYGEVYKGELPD-GQLVAVKVLKNSRCNGE----EFINEVASISRTSHVNIVTFL 354
+G+GG GEVY P + VA+K ++ F+ E + H IV
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 355 GFCYENKKNALIYELMP---NGSLDKFIHN---------DRNIKLEWKTMYQIAIGIARG 402
C + +Y MP +L + + + K I I
Sbjct: 69 SICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 403 LEYLH-RGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR----- 456
+EY+H +G ++H D+KP NILL I D+G A + +E + +
Sbjct: 126 IEYVHSKG----VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 457 -----------GTIGYIAPEVYSRRFGGV--SHKSDVYSYGMMIIEMV 491
GT Y+APE R GV S +D+Y+ G+++ +M+
Sbjct: 182 YSSMTIPGKIVGTPDYMAPE----RLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 60/202 (29%), Positives = 92/202 (45%), Gaps = 25/202 (12%)
Query: 301 LGQGGYGEVYKGELP-DGQLVAVKVLK--------NSRCNGEEFINEVASISRTSHVNIV 351
LG+G +G+V L G+L AVKVLK + C E + S++R +H +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTE--KRILSLAR-NH-PFL 58
Query: 352 TFLGFCYENKKNAL-IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH-RG 409
T L C++ + E + G L I R Y A I L +LH +G
Sbjct: 59 TQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFY--AAEITSALMFLHDKG 116
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSR 469
I++ D+K N+LLD + K++DFG+ K+ S GT YIAPE+
Sbjct: 117 ----IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC--GTPDYIAPEILQE 170
Query: 470 RFGGVSHKSDVYSYGMMIIEMV 491
G S D ++ G+++ EM+
Sbjct: 171 MLYGPS--VDWWAMGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 33/102 (32%), Positives = 53/102 (51%), Gaps = 8/102 (7%)
Query: 399 IARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGT 458
I GL YLH RI+H D+K +NI +++ I D G AQ A + L GT
Sbjct: 166 ILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLG---AAQFPVVAPAFLGLAGT 219
Query: 459 IGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDE 500
+ APEV +R + K+D++S G+++ EM+ + ++
Sbjct: 220 VETNAPEVLAR--DKYNSKADIWSAGIVLFEMLAYPSTIFED 259
|
Length = 357 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 57/197 (28%), Positives = 93/197 (47%), Gaps = 15/197 (7%)
Query: 301 LGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEVASISRTSHVNIVTFLG 355
LG+G +G+V EL G+ AVK LK + E + E ++ +T L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 356 FCYENKKNAL-IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRI 414
++ K++ + E + G L I + L T Y A I GL++LH I
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFY--AAEIVCGLQFLHSK---GI 117
Query: 415 VHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGV 474
++ D+K N++LD D KI+DFG+ K+ ++ S GT YIAPE+
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC--GTPDYIAPEILQGL--KY 173
Query: 475 SHKSDVYSYGMMIIEMV 491
+ D +S+G+++ EM+
Sbjct: 174 TFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 62/219 (28%), Positives = 93/219 (42%), Gaps = 46/219 (21%)
Query: 300 KLGQGGYGEVYKG---ELPDGQLVAVKVLKN--------SRCNGE----EFINEVASISR 344
+LGQG YG V E + + VA+K + N R E +I+
Sbjct: 7 ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 345 TSHVNIVTFLGF----CYENKKNALIYELMPNGSLDKFIHN-----DRNIKLEWKTMYQI 395
++IV F YE ELM L + I + D + + +YQI
Sbjct: 67 LYDMDIVFPGNFNELYLYE--------ELM-EADLHQIIRSGQPLTDAHFQ---SFIYQI 114
Query: 396 AIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAK--QAQKKESAISML 453
GL+Y+H ++H D+KP N+L++ D KI DFGLA+ E+A M
Sbjct: 115 L----CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT 167
Query: 454 HARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG 492
T Y APE+ F + DV+S G ++ E++G
Sbjct: 168 EYVATRWYRAPEIM-LSFQSYTKAIDVWSVGCILAELLG 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 48/168 (28%), Positives = 84/168 (50%), Gaps = 22/168 (13%)
Query: 399 IARGLEYL-HRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARG 457
+A+G+E+L R C +H D+ +NILL E+ KI DFGLA+ K + AR
Sbjct: 188 VAKGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 458 TIGYIAPE-VYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEV-TDTSICHNLIYERI 515
+ ++APE ++ R + + +SDV+S+G+++ E+ + V D C R+
Sbjct: 244 PLKWMAPETIFDRVY---TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC-----RRL 295
Query: 516 EPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEML 563
+ G + T E + + M+ C PS+RP+ +++E L
Sbjct: 296 KEGTRMRAPDYTTPE---MYQTMLD----CWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 68/245 (27%), Positives = 99/245 (40%), Gaps = 60/245 (24%)
Query: 295 KSFR--DKLGQGGYGEVYKGELPD-GQLVAVKVL---------KNSRCNGEEFINEVASI 342
K F+ LG+G G V+ L G+L A+KVL K R E+ I +
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEI-----L 55
Query: 343 SRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFI--HNDRNIKLEWKTMYQIAIGIA 400
+ H + T L+ + P G L + + + + E Y + +A
Sbjct: 56 ATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA 115
Query: 401 RGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR---- 456
LEYLH IV+ D+KP+NILL E +SDF L+KQ+ + +S R
Sbjct: 116 --LEYLH--LL-GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSK-ALRKGSR 169
Query: 457 ------------------------GTIGYIAPEVYSRRFGGVSHKSDV--YSYGMMIIEM 490
GT YIAPEV S G H S V ++ G+++ EM
Sbjct: 170 RSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS----GDGHGSAVDWWTLGILLYEM 225
Query: 491 V-GCT 494
+ G T
Sbjct: 226 LYGTT 230
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 36/103 (34%), Positives = 56/103 (54%), Gaps = 19/103 (18%)
Query: 392 MYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAK-QAQKKESAI 450
+YQI RGL+Y+H +VH D+KP NIL++E+ KI DFGLA+ Q + +
Sbjct: 114 LYQIL----RGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYV 166
Query: 451 SMLHARGTIGYIAPEVYS--RRFGGVSHKSDVYSYGMMIIEMV 491
S T Y APE+ +++ + D++S G + EM+
Sbjct: 167 S------TRYYRAPEIMLTWQKYD---VEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 54/178 (30%), Positives = 83/178 (46%), Gaps = 26/178 (14%)
Query: 301 LGQGGYGEV-YKGELPDGQLVAVKVLKNSRCNGEEFI---NEVASISRTSHV------NI 350
LG+G +G+V E G+ A+K+LK +E I +EVA S V
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILK------KEVIIAKDEVAHTLTESRVLQNTRHPF 56
Query: 351 VTFLGFCY-ENKKNALIYELMPNGSLDKFIHNDR-NIKLEWKTMYQIAIGIARGLEYLHR 408
+T L + + + + + E G L F H R + E + + A I L YLH
Sbjct: 57 LTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGA-EIVSALGYLHS 113
Query: 409 GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEV 466
+V+ D+K +N++LD+D KI+DFGL K+ + + GT Y+APEV
Sbjct: 114 C---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC--GTPEYLAPEV 166
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 59/229 (25%), Positives = 106/229 (46%), Gaps = 45/229 (19%)
Query: 301 LGQGGYGEVYKGELPD-GQLVAVKVLKNSRCNGEEFINEVAS---ISRTSHVNIVTFLGF 356
+G+G +GEV + D G + A+K+L+ + +E + + + I + V + +
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY 68
Query: 357 CYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
+++K N LI E +P G + + ++ E +T + IA + ++ +H Q+ +
Sbjct: 69 SFQDKLNLYLIMEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVL-AIDSIH---QLGFI 123
Query: 416 HFDIKPQNILLDEDFCPKISDFGLA---KQAQKKESAISMLHAR---------------- 456
H DIKP N+LLD K+SDFGL K+A + E ++ H+
Sbjct: 124 HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAE 183
Query: 457 --------------GTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMV 491
GT YIAPEV+ + G + D +S G+++ EM+
Sbjct: 184 TWKRNRRQLAFSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 18/199 (9%)
Query: 301 LGQGGYGEVYKGELPD-GQLVAVKVL-KNSRCNGEEF---INEVASISRTSHVN--IVTF 353
+G+G +G+VY+ D ++ A+KVL K +E I E + RT +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 354 LGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKL-EWKTMYQIAIGIARGLEYLHRGCQ 411
L F ++ + L+ + M G L F H + + E + + IA + LE+LH+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGEL--FWHLQKEGRFSEDRAKFYIA-ELVLALEHLHKY-- 115
Query: 412 VRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRF 471
IV+ D+KP+NILLD + DFGL+K + GT Y+APEV
Sbjct: 116 -DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC--GTTEYLAPEVLLDEK 172
Query: 472 GGVSHKSDVYSYGMMIIEM 490
G H D +S G+++ EM
Sbjct: 173 GYTKH-VDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 50/175 (28%), Positives = 76/175 (43%), Gaps = 19/175 (10%)
Query: 301 LGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTF------ 353
+G+G +G+V + DG+ AVKVL+ + E I +V +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK---KEQKHIMAERNVLLKNVKHPFLV 59
Query: 354 -LGFCYENK-KNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQ 411
L + ++ K + + + G L F H R A IA L YLH
Sbjct: 60 GLHYSFQTADKLYFVLDYVNGGEL--FFHLQRERSFPEPRARFYAAEIASALGYLH---S 114
Query: 412 VRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEV 466
+ I++ D+KP+NILLD ++DFGL K+ + S GT Y+APEV
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC--GTPEYLAPEV 167
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 70/255 (27%), Positives = 113/255 (44%), Gaps = 36/255 (14%)
Query: 268 RNVEAFIRNHESLAPK----RYSYSDVKRMTKSFRDKLGQGGYGEVYKGELPDGQLV-AV 322
+N++ F+ +E A K R D + +G+G +GEV + V A+
Sbjct: 19 KNIDNFLSRYEKAAEKITKLRMKAEDFDVIKV-----IGRGAFGEVQLVRHKSSKQVYAM 73
Query: 323 KVL------KNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNA-LIYELMPNGSL 375
K+L K S F E I ++ + L + +++ K ++ E MP G L
Sbjct: 74 KLLSKFEMIKRSD---SAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDL 130
Query: 376 DKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKIS 435
+ N +I +W Y + +A L+ +H + +H D+KP N+LLD+ K++
Sbjct: 131 VNLMSN-YDIPEKWARFYTAEVVLA--LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLA 184
Query: 436 DFGLAKQAQKKESAISMLH---ARGTIGYIAPEVY-SRRFGGVSHKS-DVYSYGMMIIEM 490
DFG K A M+ A GT YI+PEV S+ G + D +S G+ + EM
Sbjct: 185 DFGTC----MKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240
Query: 491 -VGCTKNLDDEVTDT 504
VG T D + T
Sbjct: 241 LVGDTPFYADSLVGT 255
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 45/132 (34%), Positives = 66/132 (50%), Gaps = 23/132 (17%)
Query: 365 LIYELMPNGSLDKFIHNDRNIKLEWKTM----YQIAIGIARGLEYLHRGCQVRIVHFDIK 420
L+ ELM + +L + I D L+ + M YQ+ GI ++LH I+H D+K
Sbjct: 98 LVMELM-DANLCQVIQMD----LDHERMSYLLYQMLCGI----KHLH---SAGIIHRDLK 145
Query: 421 PQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFG-GVSHKSD 479
P NI++ D KI DFGLA+ A ++ M T Y APEV G G D
Sbjct: 146 PSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVI---LGMGYKENVD 199
Query: 480 VYSYGMMIIEMV 491
++S G ++ EM+
Sbjct: 200 IWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 60/232 (25%), Positives = 102/232 (43%), Gaps = 48/232 (20%)
Query: 301 LGQGGYGEVYKGELPD-GQLVAVKVLKNSRCNGEEFINEVAS---ISRTSHVNIVTFLGF 356
+G+G +GEV + D G + A+K L+ S +E + V + I + V L +
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYY 68
Query: 357 CYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
++++ LI E +P G + + ++ E +T + IA I ++ +H ++ +
Sbjct: 69 SFQDENYLYLIMEYLPGGDMMTLLMK-KDTFTEEETRFYIAETIL-AIDSIH---KLGYI 123
Query: 416 HFDIKPQNILLDEDFCPKISDFGL----------------------------AKQAQKKE 447
H DIKP N+LLD K+SDFGL +K K
Sbjct: 124 HRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKR 183
Query: 448 SAISMLHAR--------GTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMV 491
A + R GT YIAPEV+ + G + + D +S G+++ EM+
Sbjct: 184 KAETWKRNRRALAYSTVGTPDYIAPEVFLQT--GYNKECDWWSLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 46/215 (21%)
Query: 300 KLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEE------FINEVASISRTSHVNIV- 351
++G+G YG VY+ + G++VA LK R + E + E+ + H NIV
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVA---LKKVRMDNERDGIPISSLREITLLLNLRHPNIVE 70
Query: 352 ------------TFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGI 399
FL Y + A + + MP F ++ +K + + +
Sbjct: 71 LKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPT----PF--SESQVKC-------LMLQL 117
Query: 400 ARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTI 459
RGL+YLH I+H D+K N+LL + C KI+DFGLA+ A M T+
Sbjct: 118 LRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG--LPAKPMTPKVVTL 172
Query: 460 GYIAPEVYSRRFGGVSHKS--DVYSYGMMIIEMVG 492
Y APE+ G ++ + D+++ G ++ E++
Sbjct: 173 WYRAPELL---LGCTTYTTAIDMWAVGCILAELLA 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 31/220 (14%)
Query: 301 LGQGGYGEVYKGELPDGQLV---------AVKVLKN---SRCNGEEFINEVASISRTSHV 348
+G+G +GEV QLV A+K+L + + F E I ++
Sbjct: 51 IGRGAFGEV--------QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 349 NIVTFLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH 407
V L + +++ + ++ E MP G L + N ++ +W Y + +A L+ +H
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLA--LDAIH 159
Query: 408 RGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVY 467
+ +H D+KP N+LLD+ K++DFG + KE + A GT YI+PEV
Sbjct: 160 ---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK-MNKEGMVRCDTAVGTPDYISPEVL 215
Query: 468 SRRFGG--VSHKSDVYSYGMMIIEM-VGCTKNLDDEVTDT 504
+ G + D +S G+ + EM VG T D + T
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT 255
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 38/152 (25%), Positives = 74/152 (48%), Gaps = 21/152 (13%)
Query: 300 KLGQGGYGEVYKGELPD-GQLVAVKVLKNSRCNGEE-------FINEVASISRTSHVNIV 351
K+G+G YG V+K + GQ+VA+K S E+ + E+ + + H N+V
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVES----EDDPVIKKIALREIRMLKQLKHPNLV 63
Query: 352 TFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIK-LEWKTMYQIAIGIARGLEYLHR-G 409
+ +K L++E + L++ ++N + + + +I + + + H+
Sbjct: 64 NLIEVFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHKHN 120
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAK 441
C +H D+KP+NIL+ + K+ DFG A+
Sbjct: 121 C----IHRDVKPENILITKQGQIKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 53/196 (27%), Positives = 92/196 (46%), Gaps = 13/196 (6%)
Query: 301 LGQGGYGEV-YKGELPDGQLVAVKVLKNSRCNGEEFINEVASISR---TSHVNIVTFLGF 356
LG+G +G+V E G+ A+K+LK ++ + + +R S +T L +
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 357 CYE-NKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
++ + + + E G L + +R + Y I L+YLH + +V
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY--GAEIVSALDYLH--SEKNVV 118
Query: 416 HFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVS 475
+ D+K +N++LD+D KI+DFGL K+ K +M GT Y+APEV G
Sbjct: 119 YRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCGTPEYLAPEVLEDNDYG-- 174
Query: 476 HKSDVYSYGMMIIEMV 491
D + G+++ EM+
Sbjct: 175 RAVDWWGLGVVMYEMM 190
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 42/199 (21%), Positives = 81/199 (40%), Gaps = 14/199 (7%)
Query: 301 LGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFI---NEVASISRTSHVNIVTFLGFC 357
+ K + P LVAVK + C+ E+ E+ + + H NI+ ++
Sbjct: 10 FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 358 YENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHR-GCQVRIVH 416
+ + ++ LM GS + + L + I + L+Y+H G +H
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGF----IH 124
Query: 417 FDIKPQNILLDEDFCPKISDF----GLAKQAQKKESAISM-LHARGTIGYIAPEVYSRRF 471
+K +ILL D +S + K +++ + + +++PEV +
Sbjct: 125 RSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNL 184
Query: 472 GGVSHKSDVYSYGMMIIEM 490
G + KSD+YS G+ E+
Sbjct: 185 QGYNEKSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 48/200 (24%), Positives = 92/200 (46%), Gaps = 20/200 (10%)
Query: 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYL-HRGCQVRIVHFDIKPQNIL 425
Y+ + + + +D + L + +ARG+E+L + C VH D+ +N+L
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNVL 269
Query: 426 LDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPE-VYSRRFGGVSHKSDVYSYG 484
L + KI DFGLA+ + +S + ++APE ++ + + SDV+SYG
Sbjct: 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTL---SDVWSYG 326
Query: 485 MMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFW 544
+++ E+ +L I + Y +I+ G AT+E + +M+
Sbjct: 327 ILLWEIF----SLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQE---VYDIMVK---- 375
Query: 545 CIQTNPSERPSMHKVLEMLE 564
C + P +RPS + +++E
Sbjct: 376 CWNSEPEKRPSFLHLSDIVE 395
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 15/150 (10%)
Query: 413 RIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFG 472
++H DIK NILL + K+ DFG +K S GT Y+APE++ R+
Sbjct: 163 HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK-- 220
Query: 473 GVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532
S K+D++S G+++ E++ + D E + + H + R +P
Sbjct: 221 PYSKKADMFSLGVLLYELLTLKRPFDGENME-EVMHKTLAGRYDPLPP------------ 267
Query: 533 KIAKMMILVGFWCIQTNPSERPSMHKVLEM 562
I+ M + + ++P RPS K+L M
Sbjct: 268 SISPEMQEIVTALLSSDPKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 7e-08
Identities = 47/187 (25%), Positives = 90/187 (48%), Gaps = 34/187 (18%)
Query: 387 LEWKTMYQIAIGIARGLEYL-HRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445
L+ + + + +A+G+++L + C +H D+ +N+LL + KI DFGLA+
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMN 264
Query: 446 KESAISMLHARGTIGYIAPE-----VYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDE 500
+ + +AR + ++APE VY+ +SDV+SYG+++ E+ K+
Sbjct: 265 DSNYVVKGNARLPVKWMAPESIFDCVYTV-------QSDVWSYGILLWEIFSLGKSPYPG 317
Query: 501 VTDTSICHNLI---YERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMH 557
+ S + ++ Y+ P DF A E I KM C P+ERP+
Sbjct: 318 ILVNSKFYKMVKRGYQMSRP--DF-----APPEIYSIMKM-------CWNLEPTERPTFS 363
Query: 558 KVLEMLE 564
++ ++++
Sbjct: 364 QISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 16/197 (8%)
Query: 301 LGQGGYGEV-YKGELPDGQLVAVKVLKNSRCNGEEFINEVASISR----TSHVNIVTFLG 355
LG+G +G+V E G+ A+K+L+ ++ + + SR T H +T L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALK 61
Query: 356 FCYENKKN-ALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRI 414
+ ++ + E G L F H R + I LEYLH +
Sbjct: 62 YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH---SRDV 116
Query: 415 VHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGV 474
V+ DIK +N++LD+D KI+DFGL K+ + +M GT Y+APEV G
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYG- 173
Query: 475 SHKSDVYSYGMMIIEMV 491
D + G+++ EM+
Sbjct: 174 -RAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 8e-08
Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 46/218 (21%)
Query: 300 KLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFIN---------EVASISR-TSHV 348
KLG+G YG V+K + ++VA+K + ++ F N E+ + H
Sbjct: 14 KLGKGAYGIVWKAIDRRTKEVVALKKIFDA------FRNATDAQRTFREIMFLQELGDHP 67
Query: 349 NIVTFLG-FCYENKKNA-LIYELMPNGSLDKFIHN--DRNIKLEWK---TMYQIAIGIAR 401
NIV L EN K+ L++E M + +H NI + MYQ+ +
Sbjct: 68 NIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRYIMYQLL----K 118
Query: 402 GLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAK---QAQKKESAISMLHARGT 458
L+Y+H G ++H D+KP NILL+ D K++DFGLA+ + ++ + T
Sbjct: 119 ALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175
Query: 459 IGYIAPEVY--SRRFG-GVSHKSDVYSYGMMIIEMVGC 493
Y APE+ S R+ GV D++S G ++ EM+
Sbjct: 176 RWYRAPEILLGSTRYTKGV----DMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 60/257 (23%), Positives = 106/257 (41%), Gaps = 28/257 (10%)
Query: 311 KGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370
+G P ++VA V+ N +E+ ++ H IV + K LI E
Sbjct: 88 RGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147
Query: 371 PNGSLDKFIHNDRNIKLEWKT------MYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNI 424
G L+K I L ++ YQI + L+ +H ++H D+K NI
Sbjct: 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLA----LDEVHSRK---MMHRDLKSANI 200
Query: 425 LLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYG 484
L K+ DFG +KQ S GT Y+APE++ R+ S K+D++S G
Sbjct: 201 FLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERK--RYSKKADMWSLG 258
Query: 485 MMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFW 544
+++ E++ + + I ++Y + +P G+ + ++K
Sbjct: 259 VILYELLTLHRPFKGP-SQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSK-------- 309
Query: 545 CIQTNPSERPSMHKVLE 561
NP+ RP+ ++L
Sbjct: 310 ----NPALRPTTQQLLH 322
|
Length = 478 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 8e-08
Identities = 71/278 (25%), Positives = 120/278 (43%), Gaps = 48/278 (17%)
Query: 299 DKLGQGGYGEVYKGELPDGQ-------------LVAVKVLKNSRCNGEEFINEVASISR- 344
+ LG+G ++Y G L V +KVL S + E AS+ R
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60
Query: 345 TSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRN-IKLEWKTMYQIAIGIARGL 403
SH +IV G C + +N ++ E + G LD F+H + + WK +++A +A L
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWK--FKVAKQLASAL 118
Query: 404 EYLHRGCQVRIVHFDIKPQNILL-----DEDFCP--KISDFGLAKQAQKKESAISMLHAR 456
YL +VH ++ +NILL D + P K+SD G+ ++ +
Sbjct: 119 SYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE----- 170
Query: 457 GTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIE 516
I +IAPE +S +D +S+G + E+ C N + + D ++ ER
Sbjct: 171 -RIPWIAPECVEDS-KNLSIAADKWSFGTTLWEI--CY-NGEIPLKDKTLAEK---ERFY 222
Query: 517 PGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERP 554
G + T K++A +M C+ +P++RP
Sbjct: 223 EGQ-CM---LVTPSCKELADLMT----HCMNYDPNQRP 252
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 9e-08
Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 50/215 (23%)
Query: 300 KLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEF----INEVASISRTSHVNIVTFL 354
++ +G YG VY+ + G++VA+K LK + E F + E+ + + H NIVT
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEK-EKEGFPITSLREINILLKLQHPNIVT-- 68
Query: 355 GFCYENKKNALIYELMPNGSLDK------FIHNDRNIKL----------EWKT-MYQIAI 397
+ E++ +LDK ++ +D + E K M Q+
Sbjct: 69 -----------VKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLS 117
Query: 398 GIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARG 457
G+A +LH I+H D+K N+LL+ KI DFGLA++
Sbjct: 118 GVA----HLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYG--SPLKPYTQLVV 168
Query: 458 TIGYIAPEVYSRRFGG--VSHKSDVYSYGMMIIEM 490
T+ Y APE+ G S D++S G + E+
Sbjct: 169 TLWYRAPELL---LGAKEYSTAIDMWSVGCIFAEL 200
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 56/211 (26%), Positives = 85/211 (40%), Gaps = 41/211 (19%)
Query: 301 LGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEFIN-----EVASISRTSHVNIVTFL 354
+G G G+VYK G ++AVK ++ + N EE +V S IV
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTG-NKEENKRILMDLDVVLKSHDCP-YIVKCY 80
Query: 355 GFCYENKKNALI-YELMPNGSLDKFIHNDRNIKLEWKTMYQ---------IAIGIARGLE 404
G + + I ELM LDK + K + + + I + L
Sbjct: 81 G-YFITDSDVFICMELMST-CLDKLL----------KRIQGPIPEDILGKMTVAIVKALH 128
Query: 405 YLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR--GTIGYI 462
YL V +H D+KP NILLD K+ DFG++ + S R G Y+
Sbjct: 129 YLKEKHGV--IHRDVKPSNILLDASGNVKLCDFGISGRLVD-----SKAKTRSAGCAAYM 181
Query: 463 APEVYS--RRFGGVSHKSDVYSYGMMIIEMV 491
APE ++DV+S G+ ++E+
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELA 212
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 37/215 (17%)
Query: 356 FC-YENKKN-ALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVR 413
FC +E K++ ++ E + G + N + ++ MY +A LEYLH
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLA--LEYLH---NYG 121
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAK-------------QAQKKESAISMLHARGTIG 460
IVH D+KP N+L+ K++DFGL+K +K GT
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181
Query: 461 YIAPEVYSRRFGGVSHKSDVYSYGMMIIE-MVGCTKNLDDEVTDTSICHNLIYERIE-PG 518
YIAPEV R+ G D ++ G+++ E +VGC D T + +I + IE P
Sbjct: 182 YIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGD--TPEELFGQVISDDIEWPE 237
Query: 519 NDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSER 553
D + + + + I++++ + NP ER
Sbjct: 238 GD---EALPADAQDLISRLL--------RQNPLER 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 290 VKRMTKSFRDKLGQGGYGEVY---KGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTS 346
V RM + L G GEV+ K + V VK + + G E I+ + +IS +
Sbjct: 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGRE-IDILKTISHRA 147
Query: 347 HVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYL 406
+N++ Y K + + +MP D F + DR+ L + I + L YL
Sbjct: 148 IINLIH----AYRWK--STVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYL 201
Query: 407 H-RGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPE 465
H RG I+H D+K +NI LDE + DFG A + GT+ +PE
Sbjct: 202 HGRG----IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPE 257
Query: 466 VYSRRFGGVSHKSDVYSYGMMIIEM 490
+ + K+D++S G+++ EM
Sbjct: 258 LLA--LDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 60/221 (27%), Positives = 109/221 (49%), Gaps = 30/221 (13%)
Query: 288 SDVKRM-TKSFR--DKLGQGGYGEVYKGELPD-GQLVAVK-VLKNSRCNGEEFINEVASI 342
+D+ R KS++ + +G G +G VY+ D + VA+K VL++ + E + +
Sbjct: 58 NDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IM 113
Query: 343 SRTSHVNIVTFLGFCY-----ENKKNA---LIYELMP---NGSLDKFIHNDRNIKLEWKT 391
+H+NI+ + Y +N+KN ++ E +P + + + N+ + L
Sbjct: 114 KNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVK 173
Query: 392 MYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED-FCPKISDFGLAKQAQKKESAI 450
+Y + + R L Y+H I H D+KPQN+L+D + K+ DFG AK + ++
Sbjct: 174 LY--SYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV 228
Query: 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMV 491
S + +R Y APE+ +H D++S G +I EM+
Sbjct: 229 SYICSR---FYRAPELMLGATNYTTH-IDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 44/142 (30%), Positives = 67/142 (47%), Gaps = 27/142 (19%)
Query: 392 MYQI--------------AIGIARGLEYLH-RGCQVRIVHFDIKPQNILLDEDFCPKISD 436
MY I A IA GL +LH +G I++ D+K N++LD + KI+D
Sbjct: 89 MYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG----IIYRDLKLDNVMLDAEGHIKIAD 144
Query: 437 FGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKN 496
FG+ K+ GT YIAPE+ + + G S D +++G+++ EM+
Sbjct: 145 FGMCKENIFGGKTTRTFC--GTPDYIAPEIIAYQPYGKS--VDWWAFGVLLYEMLAGQPP 200
Query: 497 LDDEVTD---TSIC-HNLIYER 514
D E D SI HN+ Y +
Sbjct: 201 FDGEDEDELFQSIMEHNVSYPK 222
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 54/183 (29%), Positives = 87/183 (47%), Gaps = 26/183 (14%)
Query: 320 VAVKVLK---NSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNA------LIYELM 370
VAVK L ++ + + E+ + +H NI++ L K L+ ELM
Sbjct: 49 VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 108
Query: 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF 430
+ +L + IH + + + +YQ+ GI ++LH I+H D+KP NI++ D
Sbjct: 109 -DANLCQVIHMELDHERMSYLLYQMLCGI----KHLH---SAGIIHRDLKPSNIVVKSDC 160
Query: 431 CPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKS--DVYSYGMMII 488
KI DFGLA+ A + M T Y APEV G+ +K D++S G ++
Sbjct: 161 TLKILDFGLARTAC---TNFMMTPYVVTRYYRAPEV----ILGMGYKENVDIWSVGCIMG 213
Query: 489 EMV 491
E+V
Sbjct: 214 ELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 59/225 (26%), Positives = 106/225 (47%), Gaps = 21/225 (9%)
Query: 301 LGQGGYGEVYKGELPDG-QLVAVKVLKNSRCNGEEFIN----EVASISRTSHVNIVTFLG 355
LG+G +G+V E +L A+K+LK ++ + E ++ + +T L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 356 FCYEN-KKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH-RGCQVR 413
C++ + + E + G L I K Y A IA GL +LH +G
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY--AAEIAIGLFFLHSKG---- 121
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGG 473
I++ D+K N++LD + KI+DFG+ K + ++ GT YIAPE+ + + G
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEIIAYQPYG 179
Query: 474 VSHKSDVYSYGMMIIEMVGCTKNLD----DEVTDTSICHNLIYER 514
S D +++G+++ EM+ + DE+ + + HN+ Y +
Sbjct: 180 KS--VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK 222
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 45/217 (20%)
Query: 297 FRD--KLGQGGYGEV-YKGELPDGQLVAVKVLK---NSRCNGEEFINEVASISRTSHVNI 350
+RD ++G G YG V + G VA+K L S + E+ + H N+
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76
Query: 351 VTFLGFCYENKKNALIYELMPNGSLDKFIHND----------------RNIKLEWKTMYQ 394
+ L+ P+ SLD+F +D ++ KL +
Sbjct: 77 I------------GLLDVFTPDLSLDRF--HDFYLVMPFMGTDLGKLMKHEKLSEDRIQF 122
Query: 395 IAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLH 454
+ + +GL+Y+H I+H D+KP N+ ++ED KI DFGLA+Q + + +
Sbjct: 123 LVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV-- 177
Query: 455 ARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMV 491
T Y APEV + + D++S G ++ EM+
Sbjct: 178 ---TRWYRAPEVI-LNWMHYTQTVDIWSVGCIMAEML 210
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 46/195 (23%), Positives = 89/195 (45%), Gaps = 28/195 (14%)
Query: 379 IHNDRNIKLEWKTMYQIAIGIARGLEYL-HRGCQVRIVHFDIKPQNILLDEDFCPKISDF 437
I + + L+ + + + +A+G+ +L + C +H D+ +NILL KI DF
Sbjct: 203 ILEEDELALDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDF 258
Query: 438 GLAKQAQKKESAISMLHARGTIGYIAPE-----VYSRRFGGVSHKSDVYSYGMMIIEMVG 492
GLA+ + + + +AR + ++APE VY + +SDV+SYG+++ E+
Sbjct: 259 GLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVY-------TFESDVWSYGILLWEIF- 310
Query: 493 CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSE 552
+L + Y+ I+ G A E I K C +P +
Sbjct: 311 ---SLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKS-------CWDADPLK 360
Query: 553 RPSMHKVLEMLEGSI 567
RP+ ++++++E +
Sbjct: 361 RPTFKQIVQLIEQQL 375
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 20/203 (9%)
Query: 301 LGQGGYGEVYKG-ELPDGQLVAVKVLKN---SRCNGEEFINEVASISRTSHVNIVTFLGF 356
+G+G YG V + G+ VA+K + + + + E+ + H +IV
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 357 CYENKKNA-----LIYELMPNGSLDKFIHNDRNIKLEWKT--MYQIAIGIARGLEYLHRG 409
+ +++ELM L + I + ++ E +YQ+ R L+Y+H
Sbjct: 68 MLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLL----RALKYIHTA 122
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQA-QKKESAISMLHARGTIGYIAPEVYS 468
+ H D+KP+NIL + D KI DFGLA+ A +AI T Y APE+
Sbjct: 123 ---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 179
Query: 469 RRFGGVSHKSDVYSYGMMIIEMV 491
F + D++S G + E++
Sbjct: 180 SFFSKYTPAIDIWSIGCIFAEVL 202
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 8e-07
Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 23/201 (11%)
Query: 301 LGQGGYGEVYKGELP-DGQLVAVKVLK--------NSRCNGEEFINEVASISRTSHVNIV 351
LG+G +G+V EL ++ A+KVLK + C E + +++ H +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTE--KRILALAA-KH-PFL 58
Query: 352 TFLGFCYENKKNAL-IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGC 410
T L C++ K + E + G L I R Y + +A L +LHR
Sbjct: 59 TALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLA--LMFLHRH- 115
Query: 411 QVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRR 470
+++ D+K NILLD + K++DFG+ K+ + GT YIAPE+
Sbjct: 116 --GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC--GTPDYIAPEILQEL 171
Query: 471 FGGVSHKSDVYSYGMMIIEMV 491
G S D ++ G+++ EM+
Sbjct: 172 EYGPS--VDWWALGVLMYEMM 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 8e-07
Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 14/198 (7%)
Query: 301 LGQGGYGE--VYKGELPDGQLVAVKV-LKNSRCNGEEFINEVASISRTSHVNIVTFLGFC 357
+G+G +G + + D + ++ L S E+ E +++ H NIV F
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 358 YENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHF 417
+ ++ E G L + I R T+ Q + + G++++H R++H
Sbjct: 68 EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHR 124
Query: 418 DIKPQNILLDEDFCPKISDFGLAK-QAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSH 476
DIK +NI L ++ K+ DFG A+ A + + GT Y+ PE++ ++
Sbjct: 125 DIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV---GTPYYVPPEIWENM--PYNN 179
Query: 477 KSDVYSYGMMIIEMVGCT 494
KSD++S G ++ E+ CT
Sbjct: 180 KSDIWSLGCILYEL--CT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 52/197 (26%), Positives = 94/197 (47%), Gaps = 15/197 (7%)
Query: 301 LGQGGYGEVYKGELP-DGQLVAVKVLKN----SRCNGEEFINEVASISRTSHVNIVTFLG 355
+G+G +G+V + DG+ AVKVL+ +R + + E + + + L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 356 FCYEN-KKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRI 414
+ ++ +K + + + G L + +R+ E + + A IA L YLH + I
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFP-EPRARFYAA-EIASALGYLH---SINI 117
Query: 415 VHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGV 474
V+ D+KP+NILLD ++DFGL K+ + + GT Y+APEV ++
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC--GTPEYLAPEVIRKQ--PY 173
Query: 475 SHKSDVYSYGMMIIEMV 491
+ D + G ++ EM+
Sbjct: 174 DNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 36/206 (17%)
Query: 301 LGQGGYGEVYKGELPD-GQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVT---- 352
+G+G YG V K + ++VA+K K+S N E + E+ + NIV
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 353 -------FLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEY 405
+L F Y K + E MPNG + + + +YQ+ + + +
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRS---------YIYQLI----KAIHW 115
Query: 406 LHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPE 465
H+ IVH DIKP+N+L+ + K+ DFG A+ + +A + T Y +PE
Sbjct: 116 CHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-NYTEYVATRWYRSPE 171
Query: 466 VYSRRFGGVSHKS-DVYSYGMMIIEM 490
+ G K+ D++S G ++ E+
Sbjct: 172 LL---LGAPYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 301 LGQGGYGEVYKGELP-DGQLVAVKVL-KNSRCNGEEFINEVAS----ISRTSHVNIVTFL 354
+G+G +G+V + DG AVKVL K + +E + +A + H +V L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG-L 61
Query: 355 GFCYEN-KKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVR 413
+ ++ +K + + + G L F H R A +A + YLH +
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAEVASAIGYLH---SLN 116
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGG 473
I++ D+KP+NILLD ++DFGL K+ + E S GT Y+APEV +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC--GTPEYLAPEVLRKE--P 172
Query: 474 VSHKSDVYSYGMMIIEMV 491
D + G ++ EM+
Sbjct: 173 YDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 47/185 (25%), Positives = 75/185 (40%), Gaps = 13/185 (7%)
Query: 315 PDGQLVAVKVLKNSRCNGEEF---INEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371
P G LV V++ C E NEV H NI+T +I M
Sbjct: 23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82
Query: 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHR-GCQVRIVHFDIKPQNILLDEDF 430
GS + + + + I G RGL YLH+ G +H +IK +IL+ D
Sbjct: 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY----IHRNIKASHILISGDG 138
Query: 431 CPKISD----FGLAKQAQKKESAISMLH-ARGTIGYIAPEVYSRRFGGVSHKSDVYSYGM 485
+S + L + QK + + + +++PE+ + G + KSD+YS G+
Sbjct: 139 LVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGI 198
Query: 486 MIIEM 490
E+
Sbjct: 199 TACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 51/200 (25%), Positives = 86/200 (43%), Gaps = 22/200 (11%)
Query: 301 LGQGGYGEVYKG-ELPDGQLVAVKVLK---NSRCNGEEFINEVASISRTSHVNIVTFL-- 354
+G G YG V + G+ VA+K L S + E+ + H N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 355 ---GFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQ 411
+ ++ Y +MP D + L + + + GL+Y+H
Sbjct: 83 FTSAVSGDEFQD--FYLVMPYMQTD--LQKIMGHPLSEDKVQYLVYQMLCGLKYIHSA-- 136
Query: 412 VRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRF 471
I+H D+KP N+ ++ED KI DFGLA+ A + + + T Y APEV +
Sbjct: 137 -GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV-----TRWYRAPEVI-LNW 189
Query: 472 GGVSHKSDVYSYGMMIIEMV 491
+ D++S G ++ EM+
Sbjct: 190 MHYNQTVDIWSVGCIMAEML 209
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 65/216 (30%), Positives = 102/216 (47%), Gaps = 41/216 (18%)
Query: 299 DKLGQGGYGEVYKGELPD-GQLVAVKV--LKNSRCNGEEF----INEVASISRTSHVNIV 351
++G+G YG+VYK D G+LVA+K L N + E F I E+ + + +H NIV
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK---EGFPITAIREIKILRQLNHRNIV 69
Query: 352 TF----------LGFCYENKKNALIYELMPN---GSLD-KFIH-NDRNIKLEWKTMYQIA 396
L F + L++E M + G L+ +H ++ +IK K + +
Sbjct: 70 NLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLE-- 127
Query: 397 IGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR 456
GL Y H+ +H DIK NILL+ K++DFGLA+ +ES +
Sbjct: 128 -----GLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR-PYTNKV 178
Query: 457 GTIGYIAPEVY--SRRFGGVSHKSDVYSYGMMIIEM 490
T+ Y PE+ R+G DV+S G ++ E+
Sbjct: 179 ITLWYRPPELLLGEERYGPA---IDVWSCGCILGEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 26/205 (12%)
Query: 301 LGQGGYGEVYKG-ELPDGQLVAVKVLKNS---RCNGEEFINEVASISRTSHVNIVTFLGF 356
+G+G YG V + VA+K + N+ R + + + E+ + H N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 357 CYENKKNA-----LIYELMPNGSLDKFIHNDRNIKLEWKT--MYQIAIGIARGLEYLHRG 409
+ A ++YELM + L + I + + + + +YQ+ RGL+Y+H
Sbjct: 73 MPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLL----RGLKYIH-- 125
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVY-- 467
++H D+KP N+LL+ + KI DFGLA+ +K M T Y APE+
Sbjct: 126 -SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDF--MTEYVVTRWYRAPELLLN 182
Query: 468 SRRFGGVSHKSDVYSYGMMIIEMVG 492
+ DV+S G + E++G
Sbjct: 183 CSEYTTA---IDVWSVGCIFAELLG 204
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 9/91 (9%)
Query: 401 RGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIG 460
RGL+Y+H I+H D+KP N+ ++ED +I DFGLA+QA + M T
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRW 180
Query: 461 YIAPEVYSRRFGGVSHKSDVYSYGMMIIEMV 491
Y APE+ + + D++S G ++ E++
Sbjct: 181 YRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 34/96 (35%), Positives = 49/96 (51%), Gaps = 7/96 (7%)
Query: 396 AIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHA 455
A IA L YLH + IV+ D+KP+NILLD ++DFGL K+ + S
Sbjct: 102 AAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC- 157
Query: 456 RGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMV 491
GT Y+APEV ++ D + G ++ EM+
Sbjct: 158 -GTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 6e-06
Identities = 51/197 (25%), Positives = 94/197 (47%), Gaps = 16/197 (8%)
Query: 301 LGQGGYGEVYKGELPDGQLV-AVKVLKNSR-CNGEEFINEVASISRTSHVN--IVTFLGF 356
+G+G +G+V + D Q + A+K ++ + + E + +A + + VN + L F
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 357 CYENK-KNALIYELMPNGSLDKFIHNDRNIKL-EWKTMYQIAIGIARGLEYLHRGCQVRI 414
+++ K L+ + G L F H R + + + A + LE LH + +
Sbjct: 61 SFQSPEKLYLVLAFINGGEL--FHHLQREGRFDLSRARFYTA-ELLCALENLH---KFNV 114
Query: 415 VHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGV 474
++ D+KP+NILLD + DFGL K K + + GT Y+APE+ G
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC--GTPEYLAPELLLGH--GY 170
Query: 475 SHKSDVYSYGMMIIEMV 491
+ D ++ G+++ EM+
Sbjct: 171 TKAVDWWTLGVLLYEML 187
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 7e-06
Identities = 41/144 (28%), Positives = 58/144 (40%), Gaps = 47/144 (32%)
Query: 403 LEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGL---------AKQAQK-------- 445
+E +H+ + +H DIKP NIL+D D K++DFGL +K QK
Sbjct: 114 IESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170
Query: 446 -------------KESAISMLHAR-----------GTIGYIAPEVYSRRFGGVSHKSDVY 481
+ + R GT YIAPEV R G + D +
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWW 228
Query: 482 SYGMMIIEM-VGCTKNLDDEVTDT 504
S G+++ EM VG L D +T
Sbjct: 229 SVGVILYEMLVGQPPFLADTPAET 252
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 9e-06
Identities = 53/182 (29%), Positives = 86/182 (47%), Gaps = 24/182 (13%)
Query: 320 VAVKVLK---NSRCNGEEFINEVASISRTSHVNIVTFLGF------CYENKKNALIYELM 370
VA+K L ++ + + E+ + +H NI++ L E + L+ ELM
Sbjct: 45 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 104
Query: 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF 430
+ +L + I + + + +YQ+ GI ++LH I+H D+KP NI++ D
Sbjct: 105 -DANLCQVIQMELDHERMSYLLYQMLCGI----KHLH---SAGIIHRDLKPSNIVVKSDC 156
Query: 431 CPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFG-GVSHKSDVYSYGMMIIE 489
KI DFGLA+ A ++ M T Y APEV G G D++S G ++ E
Sbjct: 157 TLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVI---LGMGYKENVDIWSVGCIMGE 210
Query: 490 MV 491
MV
Sbjct: 211 MV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 399 IARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGT 458
I RGL+Y+H I+H D+KP N+ ++ED KI DFGLA+ + M T
Sbjct: 129 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 180
Query: 459 IGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMV 491
Y APE+ + + D++S G ++ E++
Sbjct: 181 RWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 212
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (115), Expect = 9e-06
Identities = 62/242 (25%), Positives = 97/242 (40%), Gaps = 40/242 (16%)
Query: 282 PKRYSYSDVKRMTKSFRDKLGQGGYGEVY------KGELPDGQLVAVKVLKNSRCNGEEF 335
P +Y + + K+G G +GEV+ E + ++ + LK +
Sbjct: 2 PGKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKERE--KSQL 59
Query: 336 INEVASISRTSHVNIVTFLGFCYENKKNALIYELMP---NGSLDKFIHNDRNI--KLEWK 390
+ EV + H NIV ++ + NK N +Y LM G L + I + K+E
Sbjct: 60 VIEVNVMRELKHKNIVRYIDR-FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEH 118
Query: 391 TMYQIAIGIARGLEYLHR----GCQVRIVHFDIKPQNILLDEDF---------------- 430
+ I + L Y H R++H D+KPQNI L
Sbjct: 119 AIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGR 178
Query: 431 -CPKISDFGLAKQAQKKESAISMLHA-RGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMII 488
KI DFGL+K + SM H+ GT Y +PE+ KSD+++ G +I
Sbjct: 179 PIAKIGDFGLSKNIGIE----SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234
Query: 489 EM 490
E+
Sbjct: 235 EL 236
|
Length = 1021 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 55/265 (20%), Positives = 110/265 (41%), Gaps = 32/265 (12%)
Query: 309 VYKGELPDGQLVAVKVLK----NSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKN- 363
+YKG + + V ++ K + + NE+ ++ R NI+ GF + +
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 364 ---ALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIK 420
+LI E G L + + +++ L +KT +AI +GL L++ + ++
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEKD--LSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLT 150
Query: 421 PQNILLDEDFCPKISDFGLAKQAQKKESA-ISMLHARGTIGYIAPEVYSRRFGGVSHKSD 479
+ L+ E++ KI GL K ++ + Y + ++ + F + K D
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSSPPFKNVNFM------VYFSYKMLNDIFSEYTIKDD 204
Query: 480 VYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMI 539
+YS G+++ E+ T + E T ++LI I N + E K I +
Sbjct: 205 IYSLGVVLWEIF--TGKIPFENLTTKEIYDLI---INKNNSLKLPLDCPLEIKCIVEA-- 257
Query: 540 LVGFWCIQTNPSERPSMHKVLEMLE 564
C + +RP++ ++L L
Sbjct: 258 -----CTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 17/186 (9%)
Query: 406 LHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPE 465
+H Q+ VH DIKP N+LLD + +++DFG + + + S + A GT YI+PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV-AVGTPDYISPE 173
Query: 466 VYSRRFGGVSH---KSDVYSYGMMIIEMV-GCTKNLDDEVTDTSICHNLIYERIEPGND- 520
+ G+ + D +S G+ + EM+ G T + + +T Y +I +
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-------YGKIMNHEER 226
Query: 521 FQFD---GVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE-GSIENLQIPPKP 576
FQF +EE K + + +I + N E H E ++ +I NL+ P P
Sbjct: 227 FQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENIRNLEAPYIP 286
Query: 577 SLFSAT 582
+ S +
Sbjct: 287 DVSSPS 292
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 28/83 (33%), Positives = 44/83 (53%), Gaps = 4/83 (4%)
Query: 411 QVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRR 470
Q+ VH DIKP N+LLD++ +++DFG + + S + A GT YI+PE+
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV-AVGTPDYISPEILQAM 178
Query: 471 FGGVSH---KSDVYSYGMMIIEM 490
G + D +S G+ + EM
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEM 201
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 22/51 (43%), Positives = 32/51 (62%), Gaps = 8/51 (15%)
Query: 392 MYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLD-EDFCPKISDFGLAK 441
MYQ+ RGL+Y+H ++H D+KP N+ ++ ED KI DFGLA+
Sbjct: 120 MYQLL----RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLAR 163
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 45/168 (26%), Positives = 72/168 (42%), Gaps = 21/168 (12%)
Query: 336 INEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQI 395
E + +H +I+ G NK LI +P D + + + + I
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAI 187
Query: 396 AIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE--DFCPKISDFGLA----KQAQKKESA 449
+ R ++YLH RI+H DIK +NI ++ D C + DFG A K
Sbjct: 188 ERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVC--LGDFGAACFPVDINANKYYG 242
Query: 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNL 497
+ GTI APE+ +R G + D++S G+++ EM C +L
Sbjct: 243 WA-----GTIATNAPELLARDPYGPA--VDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 37/138 (26%), Positives = 56/138 (40%), Gaps = 47/138 (34%)
Query: 392 MYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451
+YQ+ GI ++LH I+H D+KP NI++ D KI DFGLA+ A
Sbjct: 132 LYQMLCGI----KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-------- 176
Query: 452 MLHARGTIGYIAPEVYSRRFG--------GVSHKSDVYSYGMMIIEMVGCTKNLDDEVTD 503
GT + P V +R + G D++S G ++ EM
Sbjct: 177 -----GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM------------- 218
Query: 504 TSICHNLIYERIEPGNDF 521
I +++ PG D
Sbjct: 219 --IKGGVLF----PGTDH 230
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 29/94 (30%), Positives = 54/94 (57%), Gaps = 9/94 (9%)
Query: 399 IARGLEYL-HRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARG 457
+A G+E+L + C VH D+ +N+L+ E KI DFGLA+ + + IS
Sbjct: 248 VANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 458 TIGYIAPE-VYSRRFGGVSHKSDVYSYGMMIIEM 490
+ ++APE +++ + + SDV+S+G+++ E+
Sbjct: 304 PLKWMAPESIFNNLYTTL---SDVWSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 41/150 (27%), Positives = 76/150 (50%), Gaps = 10/150 (6%)
Query: 303 QGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENK 361
+G +G+VY G + + +L AVKV+K + + +++V + ++ F+ Y +
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 362 KNA----LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHF 417
++A L+ E + G + +H E Y + +A L+YLHR I+H
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALA--LDYLHRH---GIIHR 128
Query: 418 DIKPQNILLDEDFCPKISDFGLAKQAQKKE 447
D+KP N+L+ + K++DFGL+K +E
Sbjct: 129 DLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 25/210 (11%)
Query: 300 KLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEF--INEVASISRTSHVNIVTF--LG 355
K+G+G YG VYK + DG+ LK G E+A + H N++ +
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 356 FCYENKKNALIYELMPNG--SLDKFIH----NDRNIKLEWKTMYQIAIGIARGLEYLHRG 409
+ ++K L+++ + + KF N + ++L + + I G+ YLH
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 410 CQVRIVHFDIKPQNILL----DEDFCPKISDFGLAKQAQKKESAISMLH-ARGTIGYIAP 464
++H D+KP NIL+ E KI+D G A+ ++ L T Y AP
Sbjct: 128 W---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 465 EVYSRRFGGVSHKS---DVYSYGMMIIEMV 491
E+ G H + D+++ G + E++
Sbjct: 185 EL----LLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 300 KLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEF--INEVASISRTSHVNIVTF--LG 355
K+G+G YG VYK + DG+ LK G E+A + H N+++ +
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 356 FCYENKKNALIYELMPNG--SLDKFIH----NDRNIKLEWKTMYQIAIGIARGLEYLHRG 409
+ ++K L+++ + + KF N + ++L + + I G+ YLH
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 410 CQVRIVHFDIKPQNILL----DEDFCPKISDFGLAKQAQKKESAISMLH-ARGTIGYIAP 464
++H D+KP NIL+ E KI+D G A+ ++ L T Y AP
Sbjct: 128 W---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 465 EVYSRRFGGVSHKS---DVYSYGMMIIEMV 491
E+ G H + D+++ G + E++
Sbjct: 185 EL----LLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 2e-04
Identities = 53/230 (23%), Positives = 91/230 (39%), Gaps = 39/230 (16%)
Query: 300 KLGQGGYGEVY--KGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFC 357
KL G +G+V K + P +L K++K N E + V + + + N +
Sbjct: 23 KLIDGKFGKVSVLKHK-PTQKLFVQKIIKAKNFNAIEPM--VHQLMK-DNPNFIKLYYSV 78
Query: 358 YENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHF 417
K + LI + + +G L + + KL + +I + L LH+ I+H
Sbjct: 79 TTLKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKH---NIIHN 133
Query: 418 DIKPQNILLDEDFCPK----ISDFGLAKQAQKKESAISMLHARGTIGYIAPE-----VYS 468
DIK +N+L D K + D+GL K S GT+ Y +PE Y
Sbjct: 134 DIKLENVLYDR---AKDRIYLCDYGLC----KIIGTPSCY--DGTLDYFSPEKIKGHNYD 184
Query: 469 RRFGGVSHKSDVYSYGMMIIEMVGCT---KNLDDEVTDTSICHNLIYERI 515
F D ++ G++ E++ K +DE D +++
Sbjct: 185 VSF-------DWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKL 227
|
Length = 267 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 47/182 (25%), Positives = 71/182 (39%), Gaps = 56/182 (30%)
Query: 299 DKLGQGGYGEVYKGEL------PDGQLV--------AVKVLKNSR----CNGE------E 334
KLG+G +G VYK L +G+ V AV++ N R C
Sbjct: 138 KKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYG 197
Query: 335 FINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNG----SLDKFIHND-------- 382
F+ V+S + +L + YE + + + +LM + +++ ++
Sbjct: 198 FLEPVSSKKEDEY-----WLVWRYEGE--STLADLMQSKEFPYNVEPYLLGKVQDLPKGL 250
Query: 383 -RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED---FCPKISDFG 438
R K+ M QI L L IVH D+KPQNI+ E F KI D G
Sbjct: 251 ERENKIIQTIMRQI-------LFALDGLHSTGIVHRDVKPQNIIFSEGSGSF--KIIDLG 301
Query: 439 LA 440
A
Sbjct: 302 AA 303
|
Length = 566 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 56/244 (22%), Positives = 94/244 (38%), Gaps = 63/244 (25%)
Query: 301 LGQGGYGEV-YKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHV------NIVTF 353
LG G +GEV ++ L A+K L+ N+VA + + V
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNR---NQVAHVKAERDILAEADNEWVVK 65
Query: 354 LGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQV 412
L + +++K N + + +P G + + Y + +A +E +H+ +
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLA--IESVHK---M 120
Query: 413 RIVHFDIKPQNILLDEDFCPKISDFGLA-------------------------------- 440
+H DIKP NIL+D D K++DFGL
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 441 ------------KQAQKKESAISMLHAR-GTIGYIAPEVYSRRFGGVSHKSDVYSYGMMI 487
+Q K+ + H+ GT YIAPEV R+ G + D +S G+++
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK--GYTQLCDWWSVGVIL 238
Query: 488 IEMV 491
EM+
Sbjct: 239 FEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|222467 pfam13947, GUB_WAK_bind, Wall-associated receptor kinase galacturonan-binding | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 6e-04
Identities = 29/114 (25%), Positives = 44/114 (38%), Gaps = 13/114 (11%)
Query: 14 SPRCTAPAPFHCANLRNIGYPFWGSNRPEHCGY-PGFELDC--AGDVPEITIMDRAYKVL 70
P C P C N+ +I YPF C PGFEL C P + + + Y+VL
Sbjct: 1 LPGC----PDRCGNV-SIPYPFGIGP---GCARDPGFELTCNNTTSPPRLLLGNGNYEVL 52
Query: 71 HINNESWRINVAREDYWD-YNCPAN-LSNSLLNFSIFNYASDTQNLTLYYSCPA 122
I+ + + V + YN N L+ + S ++N + C
Sbjct: 53 SISLANGTVRVLDPISSNCYNSSGKRTDNGSLSLGGPFFFSSSRNKFVVVGCNT 106
|
This cysteine-rich GUB_WAK_bind domain is the extracellular part of this serine/threonine kinase that binds to the cell-wall pectins. Length = 106 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 31/90 (34%), Positives = 47/90 (52%), Gaps = 11/90 (12%)
Query: 403 LEYLHRGCQVRIVHFDIKPQNILLD--EDFCPKISDFGLAKQAQKKESAISMLHARGTIG 460
++Y+H I+H DIK +N+L++ ED C + DFG A A+ S GT+
Sbjct: 273 IDYIHGE---GIIHRDIKTENVLVNGPEDIC--LGDFGAACFARGSWSTPFHYGIAGTVD 327
Query: 461 YIAPEVYSRRFGGVSHKS-DVYSYGMMIIE 489
APEV + G S D++S G++I E
Sbjct: 328 TNAPEVLA---GDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 8e-04
Identities = 28/84 (33%), Positives = 45/84 (53%), Gaps = 4/84 (4%)
Query: 411 QVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRR 470
Q+ VH DIKP NIL+D + +++DFG + + + S + A GT YI+PE+
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGTPDYISPEILQAM 178
Query: 471 FGGVSH---KSDVYSYGMMIIEMV 491
G + D +S G+ + EM+
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 46/182 (25%), Positives = 85/182 (46%), Gaps = 21/182 (11%)
Query: 318 QLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTF--------LGFCYENKKNALIYEL 369
+L+A +V SR + NE+ ++ R +H NI+ + K + +Y
Sbjct: 194 RLIAKRVKAGSRA-AIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSF 252
Query: 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED 429
M + + D DR L +T I + +EY+H +++H DIK +NI L+ D
Sbjct: 253 MYDEAFD---WKDR--PLLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCD 303
Query: 430 FCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIE 489
+ DFG A +K+ A GT+ +PE+ + G +D++S G+++++
Sbjct: 304 GKIVLGDFGTAMPFEKEREAFDYGWV-GTVATNSPEILAG--DGYCEITDIWSCGLILLD 360
Query: 490 MV 491
M+
Sbjct: 361 ML 362
|
Length = 501 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 25/76 (32%), Positives = 37/76 (48%), Gaps = 5/76 (6%)
Query: 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNI 424
LI E +P G L + + Y +A +E +H+ + +H DIKP NI
Sbjct: 78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLA--IEAVHK---LGFIHRDIKPDNI 132
Query: 425 LLDEDFCPKISDFGLA 440
L+D K+SDFGL+
Sbjct: 133 LIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 40/184 (21%), Positives = 75/184 (40%), Gaps = 11/184 (5%)
Query: 315 PDGQLVAVKVLKNSRCNGE--EFINEVASISRT-SHVNIVTFLGFCYENKKNALIYELMP 371
P G+ V V+ + C E F+ +S+ +H NIV + + + ++ M
Sbjct: 23 PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82
Query: 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED-- 429
GS I + + I G+ + L+Y+H + VH +K +IL+ D
Sbjct: 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGK 139
Query: 430 --FCPKISDFGLAKQAQKKESAISM-LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMM 486
S+ + Q+ ++ + +++PEV + G KSD+YS G+
Sbjct: 140 VYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGIT 199
Query: 487 IIEM 490
E+
Sbjct: 200 ACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.003
Identities = 25/65 (38%), Positives = 35/65 (53%), Gaps = 7/65 (10%)
Query: 376 DKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKIS 435
D + R+I + M Q+ G+ + LHR + IVH DIKP+N+L+ D KI
Sbjct: 299 DNMPQDKRDINVIKGVMRQVLTGLRK----LHR---IGIVHRDIKPENLLVTVDGQVKII 351
Query: 436 DFGLA 440
DFG A
Sbjct: 352 DFGAA 356
|
Length = 507 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 57/244 (23%), Positives = 91/244 (37%), Gaps = 63/244 (25%)
Query: 301 LGQGGYGEVYKGELPD-GQLVAVKVLKNSRCNGEEFINEVASISRTSHV------NIVTF 353
LG G +GEV D L A+K L+ N+VA + + V
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDV---LLRNQVAHVKAERDILAEADNEWVVR 65
Query: 354 LGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQV 412
L + +++K N + + +P G + + + Y + A +E +H+ +
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCA--VESVHK---M 120
Query: 413 RIVHFDIKPQNILLDEDFCPKISDFGL--------------------------------- 439
+H DIKP NIL+D D K++DFGL
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180
Query: 440 -----AKQAQKKESAISMLHAR-------GTIGYIAPEVYSRRFGGVSHKSDVYSYGMMI 487
+ + E + H R GT YIAPEV R G + D +S G+++
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVGVIL 238
Query: 488 IEMV 491
EM+
Sbjct: 239 YEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 582 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| PF13947 | 106 | GUB_WAK_bind: Wall-associated receptor kinase gala | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.77 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.72 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.64 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.62 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.49 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.42 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.39 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.39 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.32 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.28 | |
| PF14380 | 94 | WAK_assoc: Wall-associated receptor kinase C-termi | 99.26 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.26 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.18 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.16 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.16 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.08 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.06 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.99 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.99 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.92 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.89 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.77 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.67 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.58 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.56 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.54 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.49 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.47 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.39 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.32 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.27 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.27 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.19 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.13 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.13 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.04 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.02 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.02 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.01 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.99 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.87 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.79 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.72 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.71 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.58 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.51 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.47 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.32 | |
| PLN02236 | 344 | choline kinase | 97.11 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.11 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.04 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.74 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.7 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.65 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.58 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.46 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.42 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.42 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.36 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.3 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.26 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.24 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.15 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.14 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.88 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 95.85 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.73 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.51 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.24 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-53 Score=434.61 Aligned_cols=285 Identities=41% Similarity=0.713 Sum_probs=237.9
Q ss_pred CCCcccHHHHHHHHHHhh--hhcCccCceEEEEEEeCCCcEEEEEEeccCCCC-HHHHHHHHHHHhccCCCceEEEEeEE
Q 040604 281 APKRYSYSDVKRMTKSFR--DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCN-GEEFINEVASISRTSHVNIVTFLGFC 357 (582)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~--~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~ 357 (582)
....|++.+++++|++|. ..||+|+||.||+|.+.+|..||||++...... ..+|.+|+.++.+++|||+|+|+|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 456799999999999998 589999999999999999999999998876655 66799999999999999999999999
Q ss_pred EeCC-eeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEee
Q 040604 358 YENK-KNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISD 436 (582)
Q Consensus 358 ~~~~-~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~D 436 (582)
.+.+ ...||||||++|+|.++++.....+++|..+++||.++|+||+|||..+.++||||||||+|||||+++.+||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9998 599999999999999999876433889999999999999999999999888999999999999999999999999
Q ss_pred ccccccccc-cccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcc-cchhhHHHHHh
Q 040604 437 FGLAKQAQK-KESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTD-TSICHNLIYER 514 (582)
Q Consensus 437 FGla~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~-~~~~~~~~~~~ 514 (582)
||+|+.... ....... . .||.+|+|||++.. +.++.|+|||||||+|+||+||+++.+..... ...+..|....
T Consensus 221 FGLa~~~~~~~~~~~~~-~-~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTT-V-MGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred ccCcccCCccccceeee-c-CCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 999977655 3222211 1 69999999999976 68999999999999999999999998865422 22356666555
Q ss_pred hcCCCCC-CCCCcC--cHHH-HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCC
Q 040604 515 IEPGNDF-QFDGVA--TEEE-KKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIEN 569 (582)
Q Consensus 515 i~~~~~~-~~~~~~--~~~~-~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~ 569 (582)
+..+... .+++.. .... .+...+++.++.+|++.+|.+||+|.||+++|+.....
T Consensus 297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 5554221 122221 1111 15677799999999999999999999999999765443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=391.53 Aligned_cols=258 Identities=33% Similarity=0.527 Sum_probs=212.9
Q ss_pred HhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEeCC-eeeEEEEecC
Q 040604 296 SFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYENK-KNALIYELMP 371 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~E~~~ 371 (582)
.+.+.||+|+||+||+|.+.....||||++...... .+.|.+|+.+|.+++|||||+++|+|.+.. ...+||||++
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 345669999999999999965555999999765433 458999999999999999999999999887 7899999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCc-eEecCCCCCCEEEcCCC-ceEEeeccccccccccccc
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVR-IVHFDIKPQNILLDEDF-CPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~-ivH~Dikp~NILl~~~~-~vkl~DFGla~~~~~~~~~ 449 (582)
+|+|.++++......+++..+++|+.|||+||+|||++ + ||||||||+|||++.++ ++||+|||+++......
T Consensus 124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-- 198 (362)
T KOG0192|consen 124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-- 198 (362)
T ss_pred CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc--
Confidence 99999999875456899999999999999999999998 6 99999999999999997 99999999998765432
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
...+...||+.|||||++.+.-..++.|+|||||||+||||+||+.||..... .. ........+..+.++..
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~----~~~~v~~~~~Rp~~p~~--- 270 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQ----VASAVVVGGLRPPIPKE--- 270 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HH----HHHHHHhcCCCCCCCcc---
Confidence 22333579999999999984214799999999999999999999999987654 22 22233333333333222
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCC
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENL 570 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~ 570 (582)
....+..|+.+||+.||+.||++.+++..|+......
T Consensus 271 ----~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 271 ----CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred ----CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 4566778888899999999999999999999765544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=380.15 Aligned_cols=251 Identities=27% Similarity=0.399 Sum_probs=208.6
Q ss_pred HHHhhhhcCccCceEEEEEE-eCCCcEEEEEEeccCCCC--------HHHHHHHHHHHhccCCCceEEEEeEEEeCCeee
Q 040604 294 TKSFRDKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCN--------GEEFINEVASISRTSHVNIVTFLGFCYENKKNA 364 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 364 (582)
.+-+.+.||+|+||.|-+|. .++|+.||||++++.... ...+.+|+++|++|+|||||++++++...+..|
T Consensus 173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Y 252 (475)
T KOG0615|consen 173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSY 252 (475)
T ss_pred eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceE
Confidence 34456889999999999995 558999999999754321 233579999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC---CceEEeeccccc
Q 040604 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED---FCPKISDFGLAK 441 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~---~~vkl~DFGla~ 441 (582)
|||||++||+|.+.+..++ .+.+.....++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+|||+|+
T Consensus 253 mVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 253 MVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred EEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchhh
Confidence 9999999999999998665 566677788899999999999998 99999999999999766 789999999999
Q ss_pred cccccccceeeecccCCcccccccccccccCC-CCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCC
Q 040604 442 QAQKKESAISMLHARGTIGYIAPEVYSRRFGG-VSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND 520 (582)
Q Consensus 442 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~ 520 (582)
...... .+...+|||.|.|||++...... +..|+|+||+||+||-+|+|.+||........ +.++|..+..
T Consensus 328 ~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-----l~eQI~~G~y 399 (475)
T KOG0615|consen 328 VSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-----LKEQILKGRY 399 (475)
T ss_pred ccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-----HHHHHhcCcc
Confidence 976433 23456899999999999764223 34589999999999999999999987755543 4566666643
Q ss_pred CCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 521 FQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 521 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
. ..+....++.++.++|+.|||..||++|||+.|+++
T Consensus 400 ~----f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 400 A----FGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred c----ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 2 223456778888999999999999999999999874
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=364.34 Aligned_cols=247 Identities=27% Similarity=0.372 Sum_probs=205.0
Q ss_pred hhhcCccCceEEEEEEeC-CCcEEEEEEeccCC--CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCe-eeEEEEecCCC
Q 040604 298 RDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR--CNGEEFINEVASISRTSHVNIVTFLGFCYENKK-NALIYELMPNG 373 (582)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~E~~~~g 373 (582)
.+.||+|..|+||++.++ +++.+|+|++.... ...+++.+|+++++..+||+||++||.|..+.. ..++||||.+|
T Consensus 84 ~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgG 163 (364)
T KOG0581|consen 84 LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGG 163 (364)
T ss_pred hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCC
Confidence 478999999999999765 79999999994332 235678999999999999999999999999984 99999999999
Q ss_pred ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeee
Q 040604 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISML 453 (582)
Q Consensus 374 sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 453 (582)
+|++++...+ .+++..+-+|+.+|++||.|||.. ..||||||||+|||++..|.|||+|||.++.+.+.. ..
T Consensus 164 SLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~----a~ 235 (364)
T KOG0581|consen 164 SLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSI----AN 235 (364)
T ss_pred CHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhhh----cc
Confidence 9999998653 689999999999999999999963 399999999999999999999999999999876652 12
Q ss_pred cccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHH
Q 040604 454 HARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKK 533 (582)
Q Consensus 454 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 533 (582)
...||..|||||.+.+. .|+.++||||||++++|+++|+-|+...........+ +...|-.+..+.++.. .
T Consensus 236 tfvGT~~YMsPERi~g~--~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~-Ll~~Iv~~ppP~lP~~------~ 306 (364)
T KOG0581|consen 236 TFVGTSAYMSPERISGE--SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFE-LLCAIVDEPPPRLPEG------E 306 (364)
T ss_pred cccccccccChhhhcCC--cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHH-HHHHHhcCCCCCCCcc------c
Confidence 35699999999999884 8999999999999999999999999775332222222 2334444444444432 3
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 534 IAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 534 ~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
...++..++..||++||++||+++|+++
T Consensus 307 fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 307 FSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 4556777788899999999999999974
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=380.31 Aligned_cols=264 Identities=28% Similarity=0.450 Sum_probs=224.2
Q ss_pred cHHHHHHHHHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeE
Q 040604 286 SYSDVKRMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNAL 365 (582)
Q Consensus 286 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 365 (582)
...++.+....+.++||+|.||+||.|.++....||+|.++......+.|.+|+.+|++|+|+|||+|+|+|..++.++|
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI 278 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI 278 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence 33456667777889999999999999999888899999999988889999999999999999999999999999889999
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
|||||+.|+|.++++...+..+...+.+.++.|||+||+||+++ ++|||||...|||++++..+||+|||||+....
T Consensus 279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCC
Confidence 99999999999999986667899999999999999999999998 999999999999999999999999999995544
Q ss_pred cccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCC-CCCCCCCcccchhhHHHHHhhcCCCCCCCC
Q 040604 446 KESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCT-KNLDDEVTDTSICHNLIYERIEPGNDFQFD 524 (582)
Q Consensus 446 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 524 (582)
+... ......-.+.|.|||.+.. +.++.|||||||||+||||+|-. .|+..+... -+.+.+++|..+.-+
T Consensus 356 ~~Y~-~~~~~kfPIkWtAPEa~~~--~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~------ev~~~le~GyRlp~P 426 (468)
T KOG0197|consen 356 DEYT-ASEGGKFPIKWTAPEALNY--GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE------EVLELLERGYRLPRP 426 (468)
T ss_pred Ccee-ecCCCCCCceecCHHHHhh--CCcccccceeehhhhHHHHhccCCCCCCCCCHH------HHHHHHhccCcCCCC
Confidence 4332 2233445678999999975 68999999999999999999854 455544332 256778887765554
Q ss_pred CcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 525 GVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 525 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
... +..+-+|+..||+.+|++|||++.+...|+....
T Consensus 427 ~~C-------P~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 427 EGC-------PDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCC-------CHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 443 4556667778999999999999999999887544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=383.79 Aligned_cols=246 Identities=29% Similarity=0.433 Sum_probs=207.4
Q ss_pred HHHHhhhhcCccCceEEEEEEe-CCCcEEEEEEecc----CCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEE
Q 040604 293 MTKSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKN----SRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 367 (582)
.+|...+.||+|||+++|.++. .+|+.||+|++.+ .....+.+.+|+++.++|+|||||+++++|.+.++.|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 3455668899999999999976 7899999999976 4446678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
|+|..++|.+++++ ..++++.+++.++.||+.||.|||+. +|+|||||..|+||+++.+|||+|||||..+....
T Consensus 98 ELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 99999999999984 45899999999999999999999998 99999999999999999999999999999988653
Q ss_pred cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcC
Q 040604 448 SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 527 (582)
.... ..+|||.|+|||++.+. ..+..+||||+|||+|.||.|++||....-.+ .+++|.... ..++...
T Consensus 173 Erk~--TlCGTPNYIAPEVl~k~--gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke------ty~~Ik~~~-Y~~P~~l 241 (592)
T KOG0575|consen 173 ERKK--TLCGTPNYIAPEVLNKS--GHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE------TYNKIKLNE-YSMPSHL 241 (592)
T ss_pred cccc--eecCCCcccChhHhccC--CCCCchhhhhhhhHHHhhhhCCCCcccchHHH------HHHHHHhcC-ccccccc
Confidence 3322 34799999999999864 78999999999999999999999998653222 344554432 2233333
Q ss_pred cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 528 TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 528 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.....+|+..+|+.||.+|||+++|++
T Consensus 242 -------s~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 242 -------SAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -------CHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 333455566678999999999999984
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=363.22 Aligned_cols=197 Identities=29% Similarity=0.450 Sum_probs=175.3
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
.+.++||+|+||+||+|+++ ++..||||.+..... ..+.+..|+.+|+.++|||||+|++++..++..+||||||.
T Consensus 13 ~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~ 92 (429)
T KOG0595|consen 13 ELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCN 92 (429)
T ss_pred eehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCC
Confidence 44567999999999999765 689999999976543 34567899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC------CceEEeeccccccccc
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED------FCPKISDFGLAKQAQK 445 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~------~~vkl~DFGla~~~~~ 445 (582)
||+|.++|+..+ .+++..+..++.|+|.||++||++ +||||||||+||||+.. -.+||+|||+|+.+..
T Consensus 93 gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 93 GGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 999999998765 699999999999999999999998 99999999999999765 4689999999999886
Q ss_pred cccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCc
Q 040604 446 KESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVT 502 (582)
Q Consensus 446 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~ 502 (582)
+.... ..+|+|-|||||++.. .+|+.|+|+||+|++||||++|+.||+....
T Consensus 168 ~~~a~---tlcGSplYMAPEV~~~--~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 168 GSMAE---TLCGSPLYMAPEVIMS--QQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred hhHHH---HhhCCccccCHHHHHh--ccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 55432 4579999999999975 4899999999999999999999999986543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-47 Score=352.91 Aligned_cols=256 Identities=27% Similarity=0.429 Sum_probs=208.9
Q ss_pred HHHHhhhhcCccCceEEEEEE-eCCCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEe-EEEe-CCeeeEE
Q 040604 293 MTKSFRDKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLG-FCYE-NKKNALI 366 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~-~~~~-~~~~~lv 366 (582)
+.+.+.++||+|.||+||++. ..+|..+|.|.++-...+ .+....|+.+|++|+|||||++++ .+.+ .+..+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 446677999999999999994 569999999998744333 346789999999999999999998 4433 3458999
Q ss_pred EEecCCCChhhhhhcC--CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCc--eEecCCCCCCEEEcCCCceEEeecccccc
Q 040604 367 YELMPNGSLDKFIHND--RNIKLEWKTMYQIAIGIARGLEYLHRGCQVR--IVHFDIKPQNILLDEDFCPKISDFGLAKQ 442 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~--ivH~Dikp~NILl~~~~~vkl~DFGla~~ 442 (582)
||+|.+|+|...|+.. ....++++.+|+++.|++.||+.+|+.. ++ |+||||||.||+|+.+|.|||+|||+++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999999753 4456999999999999999999999842 24 99999999999999999999999999999
Q ss_pred ccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCC
Q 040604 443 AQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQ 522 (582)
Q Consensus 443 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~ 522 (582)
+....+... ..+|||.||+||.+.+. .++.||||||+||++|||...+.||...+-. -+.++|.++..+.
T Consensus 178 l~s~~tfA~--S~VGTPyYMSPE~i~~~--~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~------~L~~KI~qgd~~~ 247 (375)
T KOG0591|consen 178 LSSKTTFAH--SLVGTPYYMSPERIHES--GYNFKSDIWSLGCLLYEMCALQSPFYGDNLL------SLCKKIEQGDYPP 247 (375)
T ss_pred hcchhHHHH--hhcCCCcccCHHHHhcC--CCCcchhHHHHHHHHHHHHhcCCCcccccHH------HHHHHHHcCCCCC
Confidence 887665432 34699999999999874 8999999999999999999999999876221 1456777775444
Q ss_pred CCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 523 FDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 523 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
++ .......+..|+..|+..||+.||+.-.++..+..
T Consensus 248 ~p------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 248 LP------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred Cc------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 43 23456677778888999999999986555554443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=359.18 Aligned_cols=239 Identities=27% Similarity=0.392 Sum_probs=200.5
Q ss_pred HHHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCC----CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRC----NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 368 (582)
.+++.+.||+|+||+|+.++. ++++.+|+|++++... ..+...+|..+|.+++||.||+|+-.|++.+.+|||+|
T Consensus 26 dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld 105 (357)
T KOG0598|consen 26 DFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLD 105 (357)
T ss_pred heeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEe
Confidence 345678999999999999954 5799999999987543 34678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
|+.||.|..+|++++ .+++..+.-.+.+|+.||.|||+. +||||||||+|||||++|+++|+||||++.......
T Consensus 106 ~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 106 YLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred ccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence 999999999998765 688888889999999999999998 999999999999999999999999999996554433
Q ss_pred ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc
Q 040604 449 AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528 (582)
Q Consensus 449 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 528 (582)
.. ...+||+.|||||++.+. .++.++|+||||+++|||++|.+||...+... +++.|..+.....+...+
T Consensus 181 ~t--~tfcGT~eYmAPEil~~~--gy~~~vDWWsLGillYeML~G~pPF~~~~~~~------~~~~I~~~k~~~~p~~ls 250 (357)
T KOG0598|consen 181 AT--RTFCGTPEYMAPEILLGK--GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK------MYDKILKGKLPLPPGYLS 250 (357)
T ss_pred cc--ccccCCccccChHHHhcC--CCCcccchHhHHHHHHHHhhCCCCCcCccHHH------HHHHHhcCcCCCCCccCC
Confidence 22 236899999999999884 89999999999999999999999998765432 455666655444444455
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCC
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERP 554 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RP 554 (582)
.+..++++. .|+.||++|.
T Consensus 251 ~~ardll~~-------LL~rdp~~RL 269 (357)
T KOG0598|consen 251 EEARDLLKK-------LLKRDPRQRL 269 (357)
T ss_pred HHHHHHHHH-------HhccCHHHhc
Confidence 555554444 5689999996
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=333.62 Aligned_cols=238 Identities=29% Similarity=0.455 Sum_probs=202.1
Q ss_pred ccHHHHHHHHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC----CHHHHHHHHHHHhccCCCceEEEEeEEEe
Q 040604 285 YSYSDVKRMTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEVASISRTSHVNIVTFLGFCYE 359 (582)
Q Consensus 285 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 359 (582)
+++++. ++.+.||.|+||+|.+++.+ +|..+|+|++++.+. +.+...+|..+|+.+.||.+++|++.+.+
T Consensus 41 ~~l~df-----e~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d 115 (355)
T KOG0616|consen 41 YSLQDF-----ERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD 115 (355)
T ss_pred cchhhh-----hheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence 666554 45688999999999999765 789999999976432 45678899999999999999999999999
Q ss_pred CCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccc
Q 040604 360 NKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGL 439 (582)
Q Consensus 360 ~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGl 439 (582)
....+|||||++||.|..++++.+ ++++..+.-+|.||+.||+|||+. +|++|||||+|||||.+|.+||+|||.
T Consensus 116 ~~~lymvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGF 190 (355)
T KOG0616|consen 116 NSNLYMVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGF 190 (355)
T ss_pred CCeEEEEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccc
Confidence 999999999999999999998654 688899999999999999999998 999999999999999999999999999
Q ss_pred cccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCC
Q 040604 440 AKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGN 519 (582)
Q Consensus 440 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~ 519 (582)
|+...... ...+|||.|+|||+++.+ .++.++|+|||||++|||+.|.+||.+..... ++++|..+.
T Consensus 191 AK~v~~rT-----~TlCGTPeYLAPEii~sk--~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~------iY~KI~~~~ 257 (355)
T KOG0616|consen 191 AKRVSGRT-----WTLCGTPEYLAPEIIQSK--GYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ------IYEKILEGK 257 (355)
T ss_pred eEEecCcE-----EEecCCccccChHHhhcC--CCCcchhHHHHHHHHHHHHcCCCCCcCCChHH------HHHHHHhCc
Confidence 99876542 245799999999999875 78999999999999999999999998876633 566666653
Q ss_pred CCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCC
Q 040604 520 DFQFDGVATEEEKKIAKMMILVGFWCIQTNPSER 553 (582)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~R 553 (582)
..++.....+.++++..|+ +.|-.+|
T Consensus 258 -v~fP~~fs~~~kdLl~~LL-------~vD~t~R 283 (355)
T KOG0616|consen 258 -VKFPSYFSSDAKDLLKKLL-------QVDLTKR 283 (355)
T ss_pred -ccCCcccCHHHHHHHHHHH-------hhhhHhh
Confidence 4456666666666666554 6676777
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=357.22 Aligned_cols=248 Identities=26% Similarity=0.354 Sum_probs=201.9
Q ss_pred HHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCC----HHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeeeEEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCN----GEEFINEVASISRT-SHVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 368 (582)
+.|.+.||+|+|++|++|.. .+++.||||++.+.... .+-+..|-.+|.+| .||.|++|+-.|+++..+|+|+|
T Consensus 75 F~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe 154 (604)
T KOG0592|consen 75 FKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLE 154 (604)
T ss_pred cchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEE
Confidence 45789999999999999954 48999999999765432 34567888999999 89999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
|+++|+|.++|++.+ .+++...+..+.||+.||+|||+. |||||||||+|||||+++++||+|||.|+.+.....
T Consensus 155 ~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 155 YAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred ecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence 999999999998765 688899999999999999999998 999999999999999999999999999998764322
Q ss_pred c---------ee--eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcC
Q 040604 449 A---------IS--MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEP 517 (582)
Q Consensus 449 ~---------~~--~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~ 517 (582)
. .. ....+||..|.+||++.+ +..+..+|+|+||||||+|+.|.+||.+.++-. +.++|..
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~--~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl------iFqkI~~ 301 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLND--SPAGPSSDLWALGCILYQMLAGQPPFRAANEYL------IFQKIQA 301 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcC--CCCCcccchHHHHHHHHHHhcCCCCCccccHHH------HHHHHHH
Confidence 2 01 123679999999999987 478899999999999999999999998765422 2233322
Q ss_pred CCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 040604 518 GNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEML 563 (582)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L 563 (582)
. ...+....++.. .+|+.+.|..||.+|+|.++|-+..
T Consensus 302 l-~y~fp~~fp~~a-------~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 302 L-DYEFPEGFPEDA-------RDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred h-cccCCCCCCHHH-------HHHHHHHHccCccccccHHHHhhCc
Confidence 1 223444444333 4444556688999999999987653
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=355.67 Aligned_cols=261 Identities=26% Similarity=0.371 Sum_probs=212.0
Q ss_pred HHHHHhhhhcCccCceEEEEEE-eCCCcEEEEEEeccCCCCHHHH--HHHHHHHhccC-CCceEEEEeEEEeCC-eeeEE
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEF--INEVASISRTS-HVNIVTFLGFCYENK-KNALI 366 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~--~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~lv 366 (582)
..+|...++||.|.||+||+|+ ..+|..||||.+++.-..-++. ++|+..|++|+ |||||+|.+++.+.+ .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 4567888999999999999996 4579999999998766555543 68999999999 999999999999988 89999
Q ss_pred EEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccc
Q 040604 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~ 446 (582)
|||| ..+|+++++.. +..+++..+..|+.||++||+|+|.+ |+.|||+||+|||+..+..+||+|||+|+.....
T Consensus 89 fE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 89 FEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred HHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccC
Confidence 9999 78999999876 67899999999999999999999998 9999999999999999999999999999987665
Q ss_pred ccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCC--------
Q 040604 447 ESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPG-------- 518 (582)
Q Consensus 447 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~-------- 518 (582)
.. .+....|.+|.|||++.+. +.|+.+.|+||+|||++|+.+.++.|.+..+....+. +.+.+...
T Consensus 164 pP---YTeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~K--Ic~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 164 PP---YTEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYK--ICEVLGTPDKDSWPEG 237 (538)
T ss_pred CC---cchhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHH--HHHHhCCCccccchhH
Confidence 43 3445689999999999876 7899999999999999999999999877655433110 11122111
Q ss_pred ------CCCCCCCcCcHH----HHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 040604 519 ------NDFQFDGVATEE----EKKIAKMMILVGFWCIQTNPSERPSMHKVLEML 563 (582)
Q Consensus 519 ------~~~~~~~~~~~~----~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L 563 (582)
..+.++...... ........+.|+.+|++.||++||||+|.+++-
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 112222211111 112445678888899999999999999998753
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=334.52 Aligned_cols=257 Identities=21% Similarity=0.317 Sum_probs=202.0
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
.|+...++|+|+||.||+++.+ +|+.||||.+..+..+ .+-.++|+.+|++++|+|+|.|+.+|.....++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 3455678999999999999765 7999999999776553 25578999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
|+. ++.+-+.... ..++...+.+++.|++.|+.|+|++ ++|||||||+||||+.+|.+||+|||+|+.+.....
T Consensus 83 ~dh-TvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd- 156 (396)
T KOG0593|consen 83 CDH-TVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD- 156 (396)
T ss_pred cch-HHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCcc-
Confidence 954 4444444433 3688899999999999999999998 999999999999999999999999999999875332
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhh--HH----H---HHhhcCCCC
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICH--NL----I---YERIEPGND 520 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~--~~----~---~~~i~~~~~ 520 (582)
..+....|.+|.|||.+.+. .+|...+||||+||++.||++|.+.|.........+. .. + .+.....
T Consensus 157 -~YTDYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N-- 232 (396)
T KOG0593|consen 157 -NYTDYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN-- 232 (396)
T ss_pred -hhhhhhhhhhccChhhhccc-CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC--
Confidence 23455689999999999886 5899999999999999999999998877654332110 00 0 0011111
Q ss_pred CCCCCcC----------cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 040604 521 FQFDGVA----------TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVL 560 (582)
Q Consensus 521 ~~~~~~~----------~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl 560 (582)
..+.++. ......+...+++++..||++||++|++-++++
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 1111111 111224556789999999999999999999887
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=340.80 Aligned_cols=260 Identities=25% Similarity=0.411 Sum_probs=216.0
Q ss_pred HHHhhhhcCccCceEEEEEE-eCCCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 294 TKSFRDKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
.|++.+.||.|.-++||+|. ...++.||||++...+. ..+.+.+|+..|+.++||||++++..|..+..+++||.||
T Consensus 27 ~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfM 106 (516)
T KOG0582|consen 27 DYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFM 106 (516)
T ss_pred ceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhh
Confidence 35667899999999999996 45789999999975543 3467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc-cc
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE-SA 449 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~-~~ 449 (582)
.+|++.++++..-...+++..+..|+.++++||.|||++ |-||||||+.||||+.+|.|||+|||.+-.+.... ..
T Consensus 107 a~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~ 183 (516)
T KOG0582|consen 107 AGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ 183 (516)
T ss_pred cCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence 999999999877666799999999999999999999998 99999999999999999999999999876544332 22
Q ss_pred eee-ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCC-CCCcC
Q 040604 450 ISM-LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQ-FDGVA 527 (582)
Q Consensus 450 ~~~-~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~-~~~~~ 527 (582)
... ....||+.|||||++..+...|+.|+||||||+...||.+|..||....+.. ++...+....... .....
T Consensus 184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk-----vLl~tLqn~pp~~~t~~~~ 258 (516)
T KOG0582|consen 184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK-----VLLLTLQNDPPTLLTSGLD 258 (516)
T ss_pred eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH-----HHHHHhcCCCCCcccccCC
Confidence 222 3457999999999977666789999999999999999999999998765433 3444454443211 11233
Q ss_pred cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 528 TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 528 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.++.+...+.+.+++..||+.||++|||++++++
T Consensus 259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 3455667778889999999999999999999984
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=343.55 Aligned_cols=253 Identities=30% Similarity=0.409 Sum_probs=199.3
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCC--eeeEEEEecC
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENK--KNALIYELMP 371 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~E~~~ 371 (582)
...+.||+|+||+||++... +|+..|||.+..... ..+.+.+|+.+|++++|||||+.+|.....+ ...+.|||++
T Consensus 20 ~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~ 99 (313)
T KOG0198|consen 20 SKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAP 99 (313)
T ss_pred hhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccC
Confidence 45578999999999999765 599999999865422 2466889999999999999999999855444 5889999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-CCceEEeeccccccccc-cccc
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE-DFCPKISDFGLAKQAQK-KESA 449 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~-~~~vkl~DFGla~~~~~-~~~~ 449 (582)
+|+|.+++.+.++ ++++..+.....||++||+|||++ +|||+||||+|||++. ++.+||+|||+++.... ....
T Consensus 100 ~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~ 175 (313)
T KOG0198|consen 100 GGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS 175 (313)
T ss_pred CCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence 9999999998776 899999999999999999999998 9999999999999999 79999999999987664 1111
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
......+||+.|||||++... .....++|||||||+++||+||+.||..... ...++.........+.++..
T Consensus 176 ~~~~~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~----~~~~~~~ig~~~~~P~ip~~--- 247 (313)
T KOG0198|consen 176 DSELSVQGTPNYMAPEVIRNG-EVARRESDIWSLGCTVVEMLTGKPPWSEFFE----EAEALLLIGREDSLPEIPDS--- 247 (313)
T ss_pred cccccccCCccccCchhhcCC-CcCCccchhhhcCCEEEeccCCCCcchhhcc----hHHHHHHHhccCCCCCCCcc---
Confidence 223346799999999999851 2333599999999999999999999976311 11122222222222233332
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le 564 (582)
+.....+++..|++.||++||||+++++..-
T Consensus 248 ----ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 248 ----LSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred ----cCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 3444556666799999999999999997654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=347.38 Aligned_cols=262 Identities=23% Similarity=0.315 Sum_probs=209.2
Q ss_pred HHHHHHhhhhcCccCceEEEEEE-eCCCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeC--Ceee
Q 040604 291 KRMTKSFRDKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYEN--KKNA 364 (582)
Q Consensus 291 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 364 (582)
....++..++||+|.||.||+|+ ..+|+.||+|.++.... ...-..+||.+|++|+||||++|.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 34456667899999999999995 55899999999876543 334568999999999999999999999887 6889
Q ss_pred EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccc
Q 040604 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~ 444 (582)
||+||| .-+|.-++.. ....+++.++.-++.|+++||+|+|++ +|+|||||.+|||||.+|.+||+|||||+++.
T Consensus 195 lVFeYM-dhDL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 195 LVFEYM-DHDLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEEecc-cchhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence 999999 5678777764 456899999999999999999999998 99999999999999999999999999999877
Q ss_pred ccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCC----
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND---- 520 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~---- 520 (582)
...... ++..+-|.+|.|||.+.+. ..|+.++|+||.||||.||++|++.+....+.+.. +.+.+.......
T Consensus 270 ~~~~~~-~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl--~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 270 PSGSAP-YTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQL--HKIFKLCGSPTEDYWP 345 (560)
T ss_pred CCCCcc-cccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHHHH--HHHHHHhCCCChhccc
Confidence 665443 3455689999999999986 58999999999999999999999998776543321 111211111100
Q ss_pred -------------CCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 521 -------------FQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 521 -------------~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
........+..+.+....++|+..+|..||++|.|+.++++
T Consensus 346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 00111222334556677888999999999999999998874
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=355.43 Aligned_cols=260 Identities=26% Similarity=0.452 Sum_probs=203.5
Q ss_pred HHHHHhhhhcCccCceEEEEEEe------CCCcEEEEEEeccCCCC--HHHHHHHHHHHhcc-CCCceEEEEeEEEeCC-
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGEL------PDGQLVAVKVLKNSRCN--GEEFINEVASISRT-SHVNIVTFLGFCYENK- 361 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~- 361 (582)
+..+.+.++||+|+||.||+|.. .+++.||||+++..... .+.+.+|+.++.++ +||||+++++++....
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 34566778999999999999963 24578999999754332 35688999999999 8999999999987654
Q ss_pred eeeEEEEecCCCChhhhhhcCC----------------------------------------------------------
Q 040604 362 KNALIYELMPNGSLDKFIHNDR---------------------------------------------------------- 383 (582)
Q Consensus 362 ~~~lv~E~~~~gsL~~~i~~~~---------------------------------------------------------- 383 (582)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 5789999999999999986432
Q ss_pred --CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeecccCCccc
Q 040604 384 --NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGY 461 (582)
Q Consensus 384 --~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y 461 (582)
..++++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++...............+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 12477889999999999999999998 9999999999999999999999999999876443322222234467899
Q ss_pred ccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHH
Q 040604 462 IAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMIL 540 (582)
Q Consensus 462 ~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~ 540 (582)
+|||++.+ ..++.++||||||+++|||++ |..||........ +...+..+....... .....+.+
T Consensus 243 ~aPE~~~~--~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~~-------~~~~~l~~ 308 (338)
T cd05102 243 MAPESIFD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-----FCQRLKDGTRMRAPE-------NATPEIYR 308 (338)
T ss_pred cCcHHhhc--CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-----HHHHHhcCCCCCCCC-------CCCHHHHH
Confidence 99999876 368999999999999999997 8889876433221 122233322222221 22345778
Q ss_pred HHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 541 VGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 541 l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
|+.+||+.||++|||+.+|++.|+..++
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 8899999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=355.69 Aligned_cols=267 Identities=30% Similarity=0.451 Sum_probs=214.7
Q ss_pred HHHHHHHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeE
Q 040604 289 DVKRMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYENKKNAL 365 (582)
Q Consensus 289 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 365 (582)
++.-....+.+.||+|.||+||+|.+. | .||||+++..... .+.|.+|+..+++.+|.||+-+.|+|..... ++
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI 464 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI 464 (678)
T ss_pred ccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence 343344456789999999999999884 2 6999999876554 3679999999999999999999999988877 99
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
|.-+|+|.+|+.+++-.+ .+++..+.++||.||++||.|||.+ +|||||||..||++.+++.|||+||||+.....
T Consensus 465 iTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred eehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeee
Confidence 999999999999998654 5799999999999999999999998 999999999999999999999999999986554
Q ss_pred cccceeeecccCCcccccccccccc-cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCC
Q 040604 446 KESAISMLHARGTIGYIAPEVYSRR-FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFD 524 (582)
Q Consensus 446 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 524 (582)
...........|...|||||++... ...|+..+||||||+++|||++|..|+.....+... -.+..|. +.
T Consensus 541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi------fmVGrG~---l~ 611 (678)
T KOG0193|consen 541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII------FMVGRGY---LM 611 (678)
T ss_pred eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE------EEecccc---cC
Confidence 4333333455688899999998532 246899999999999999999999999854433321 1222221 11
Q ss_pred CcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCC
Q 040604 525 GVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQ 571 (582)
Q Consensus 525 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~ 571 (582)
...........++|.+|+..||..++++||.+.+|+..|+..+.+++
T Consensus 612 pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~p 658 (678)
T KOG0193|consen 612 PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLP 658 (678)
T ss_pred ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccc
Confidence 11122234556788888899999999999999999999988777553
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=352.48 Aligned_cols=243 Identities=30% Similarity=0.419 Sum_probs=204.2
Q ss_pred hhhcCccCceEEEEEE-eCCCcEEEEEEeccCCCC-HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCCh
Q 040604 298 RDKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCN-GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSL 375 (582)
Q Consensus 298 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 375 (582)
.++||+|+.|.||.+. ..+++.||||.+...... .+.+++|+.+|+..+|+|||.+++.+...+.++.|||||+||+|
T Consensus 278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL 357 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL 357 (550)
T ss_pred hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence 3689999999999995 557899999999766554 46678999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeecc
Q 040604 376 DKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHA 455 (582)
Q Consensus 376 ~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 455 (582)
.+++... .+++.++..|+.+++.||+|||.+ +|+|||||.+|||++.+|.+||+|||++.++....... ...
T Consensus 358 TDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR--~Tm 429 (550)
T KOG0578|consen 358 TDVVTKT---RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR--STM 429 (550)
T ss_pred hhhhhcc---cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc--ccc
Confidence 9999754 489999999999999999999998 99999999999999999999999999999887665432 234
Q ss_pred cCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHH
Q 040604 456 RGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIA 535 (582)
Q Consensus 456 ~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 535 (582)
.|||.|||||++.++ .|.+|.||||||+|++||+-|++|+-....... ++ +|.....+.+. ....+.
T Consensus 430 VGTPYWMAPEVvtrk--~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA-----ly-LIa~ng~P~lk-----~~~klS 496 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTRK--PYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-----LY-LIATNGTPKLK-----NPEKLS 496 (550)
T ss_pred cCCCCccchhhhhhc--ccCccccchhhhhHHHHHhcCCCCccCCChHHH-----HH-HHhhcCCCCcC-----CccccC
Confidence 699999999999874 899999999999999999999999986443221 11 22222222221 223455
Q ss_pred HHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 536 KMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 536 ~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
..+.+++.+||+.|+++||+++|+|+
T Consensus 497 ~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 497 PELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred HHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 66778888899999999999999986
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=315.03 Aligned_cols=268 Identities=24% Similarity=0.337 Sum_probs=208.5
Q ss_pred HHHhhhhcCccCceEEEEEE-eCCCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 294 TKSFRDKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+|...++||+|.||.||+|. ..+|+.||||.++..... ....++|+..|+.++|+||+.|+++|-..+...||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 34556889999999999995 458999999999865433 45689999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
| ..+|..+|+.+ ...++...+..++.++++||+|||++ .|+||||||+|+|++++|.+||+|||+|+.+......
T Consensus 83 m-~tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 83 M-PTDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred c-cccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9 68999988764 46799999999999999999999998 9999999999999999999999999999998766543
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCC---------
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND--------- 520 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~--------- 520 (582)
.. ...-|.+|.|||.+.+. ..|+..+|+||+||++.||+-|.+-+.+....+. +. .+...+.....
T Consensus 158 ~~--~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ-L~-~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 158 QT--HQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ-LS-KIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred cc--cceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH-HH-HHHHHcCCCCcccCcccccc
Confidence 32 23578999999999875 6899999999999999999988876665433221 11 11112211111
Q ss_pred -----------CCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCCCCCCCC
Q 040604 521 -----------FQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQIPPKPS 577 (582)
Q Consensus 521 -----------~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~~p~~p~ 577 (582)
..+....+ ......++++..++..||.+|++++|++++ ..+.+++.|..|.
T Consensus 233 pdY~~~~~~P~~~~~~lf~----aas~d~ldLl~~m~~ynP~~Rita~qaL~~--~yf~~~P~pt~~~ 294 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFP----AASSDALDLLSKMLTYNPKKRITASQALKH--PYFKSLPLPTPPS 294 (318)
T ss_pred ccHHHHhcCCCCccccccc----cccHHHHHHHHhhhccCchhcccHHHHhcc--hhhhcCCCCCChh
Confidence 11111111 123445788888999999999999998864 3344444444443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=349.08 Aligned_cols=247 Identities=25% Similarity=0.359 Sum_probs=201.8
Q ss_pred HHHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccC----CC--CHHHHHHHHHHHhccC-CCceEEEEeEEEeCCeeeE
Q 040604 294 TKSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNS----RC--NGEEFINEVASISRTS-HVNIVTFLGFCYENKKNAL 365 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 365 (582)
.+.+.+.||+|+||+|+.|.. .+++.||+|++.+. .. ..+.+.+|+.++++++ ||||++++.++......++
T Consensus 18 ~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~i 97 (370)
T KOG0583|consen 18 KYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYI 97 (370)
T ss_pred ceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEE
Confidence 455678999999999999954 47899999987653 11 2345668999999999 9999999999999999999
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-CceEEeecccccccc
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED-FCPKISDFGLAKQAQ 444 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~-~~vkl~DFGla~~~~ 444 (582)
||||+.||+|.+++.+. .++.+..+..++.|++.|++|+|+. +|+||||||+|||+|.+ +.+||+|||++....
T Consensus 98 vmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 98 VMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred EEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 99999999999999873 4688899999999999999999998 99999999999999999 999999999999874
Q ss_pred ccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCC
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFD 524 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 524 (582)
.... .....+||+.|+|||++.+....-..++||||+||+||.|++|+.||++..... ++..|..+.. .++
T Consensus 173 ~~~~--~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~------l~~ki~~~~~-~~p 243 (370)
T KOG0583|consen 173 GEDG--LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN------LYRKIRKGEF-KIP 243 (370)
T ss_pred CCCC--cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH------HHHHHhcCCc-cCC
Confidence 2111 223467999999999998852133589999999999999999999999843322 3334444432 233
Q ss_pred CcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 040604 525 GVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVL 560 (582)
Q Consensus 525 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl 560 (582)
.... ...+..|+.+||+.||.+|+|+.+++
T Consensus 244 ~~~~------S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 244 SYLL------SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred CCcC------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 3221 45566777789999999999999998
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=364.82 Aligned_cols=263 Identities=29% Similarity=0.468 Sum_probs=215.1
Q ss_pred HHHHHHHhhhhcCccCceEEEEEEeC------CCcEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeCC
Q 040604 290 VKRMTKSFRDKLGQGGYGEVYKGELP------DGQLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYENK 361 (582)
Q Consensus 290 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 361 (582)
+.+....+.++||+|+||+||+|+.. +...||||.++..... ..+|.+|+++++.++|||||+|+|+|.+++
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 44444567789999999999999653 3467999999876554 468999999999999999999999999999
Q ss_pred eeeEEEEecCCCChhhhhhcCC--------Cc----CCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC
Q 040604 362 KNALIYELMPNGSLDKFIHNDR--------NI----KLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED 429 (582)
Q Consensus 362 ~~~lv~E~~~~gsL~~~i~~~~--------~~----~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~ 429 (582)
-.+||+|||..|+|.++|.... +. +++..+.+.||.|||.||+||-++ .+|||||-.+|.|+.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccc
Confidence 9999999999999999987431 22 388999999999999999999998 89999999999999999
Q ss_pred CceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhh
Q 040604 430 FCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICH 508 (582)
Q Consensus 430 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~ 508 (582)
..|||+|||+++..-..+.........-.++|||||.+.- +.+|.+||||||||+|||+++ |+.|+......+
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly--~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E---- 713 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY--GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE---- 713 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc--CcccchhhhhhhhhhhhhhhccccCcccccchHH----
Confidence 9999999999987544333221112234578999999875 699999999999999999997 666776654433
Q ss_pred HHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCC
Q 040604 509 NLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENL 570 (582)
Q Consensus 509 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~ 570 (582)
+.+.++.+.-.. ..+..+..+..|+..||+.+|++||+++||-..|+...++-
T Consensus 714 --VIe~i~~g~lL~-------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 714 --VIECIRAGQLLS-------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred --HHHHHHcCCccc-------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 666777664322 23445677888888999999999999999999999865543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=343.98 Aligned_cols=248 Identities=24% Similarity=0.314 Sum_probs=194.9
Q ss_pred HHhhhhcCccCceEEEEEE-eCCCcEEEEEEeccCCC----CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRC----NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+++...||+|+||.||+++ ..+|..+|+|+++++.. +.+.+..|-.+|....+++||+|+-.|++.+.+||||||
T Consensus 143 Fe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEy 222 (550)
T KOG0605|consen 143 FELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEY 222 (550)
T ss_pred chhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEe
Confidence 3455789999999999995 45899999999988654 456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccc---
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK--- 446 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~--- 446 (582)
++||++..+|...+ .|++..+...+.+++.|++-||+. |+|||||||+|+|||..|++||+||||+..+...
T Consensus 223 lPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 223 LPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred cCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 99999999998765 688888888999999999999998 9999999999999999999999999998533210
Q ss_pred ------------------ccce------e------------------eecccCCcccccccccccccCCCCccchhHHHH
Q 040604 447 ------------------ESAI------S------------------MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYG 484 (582)
Q Consensus 447 ------------------~~~~------~------------------~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlG 484 (582)
.... . .....|||.|||||++.+. .++..+|+||||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k--gY~~~cDwWSLG 375 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK--GYGKECDWWSLG 375 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC--CCCccccHHHHH
Confidence 0000 0 0012499999999999985 689999999999
Q ss_pred HHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCC---HHHHH
Q 040604 485 MMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPS---MHKVL 560 (582)
Q Consensus 485 vil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt---~~evl 560 (582)
||+||||.|-+||......+. +...+.-+. ...++. ...+..+..+|+.+||. ||++|.- ++||-
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T-~rkI~nwr~----~l~fP~-----~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQET-YRKIVNWRE----TLKFPE-----EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK 443 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHH-HHHHHHHhh----hccCCC-----cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence 999999999999987765543 111111110 111111 11222455666777777 9999986 45543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=339.78 Aligned_cols=262 Identities=25% Similarity=0.389 Sum_probs=197.9
Q ss_pred HHHHhhhhcCccCceEEEEEEeC-----------------CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEE
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELP-----------------DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTF 353 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l 353 (582)
..+.+.++||+|+||.||++.+. ++..||+|+++.... ...++.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 34556789999999999999653 234799999876432 23568999999999999999999
Q ss_pred EeEEEeCCeeeEEEEecCCCChhhhhhcCC-----------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 040604 354 LGFCYENKKNALIYELMPNGSLDKFIHNDR-----------------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVH 416 (582)
Q Consensus 354 ~~~~~~~~~~~lv~E~~~~gsL~~~i~~~~-----------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH 416 (582)
++++.+....++||||+++|+|.+++.... ...+++..+++++.||+.||.|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 999999999999999999999999886431 12467888999999999999999998 9999
Q ss_pred cCCCCCCEEEcCCCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcC--C
Q 040604 417 FDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGC--T 494 (582)
Q Consensus 417 ~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg--~ 494 (582)
|||||+|||++.++.+||+|||+++...............++..|+|||++.. +.++.++||||||+++|||+++ .
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM--GKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc--CCCCchhhhHHHHHHHHHHHHccCC
Confidence 99999999999999999999999987654433222223446889999999865 4789999999999999999874 4
Q ss_pred CCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 495 KNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 495 ~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
.|+....... . ...+.+............. ....+..+.+++.+||+.||++|||+++|.+.|+.
T Consensus 240 ~p~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 240 QPYGELTDEQ-V-IENAGEFFRDQGRQVYLFR----PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCcCCHHH-H-HHHHHHHhhhccccccccC----CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 5555432211 1 1111111111110000000 01223567888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=347.90 Aligned_cols=258 Identities=27% Similarity=0.456 Sum_probs=202.4
Q ss_pred HHHHHhhhhcCccCceEEEEEEe------CCCcEEEEEEeccCCC--CHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCe
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGEL------PDGQLVAVKVLKNSRC--NGEEFINEVASISRT-SHVNIVTFLGFCYENKK 362 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 362 (582)
+..+.+.++||+|+||.||+|.. .++..||||+++.... ..+.+.+|+.+++.+ +||||+++++++.+...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34466789999999999999853 2467899999975433 335688999999999 89999999999999999
Q ss_pred eeEEEEecCCCChhhhhhcCC-----------------------------------------------------------
Q 040604 363 NALIYELMPNGSLDKFIHNDR----------------------------------------------------------- 383 (582)
Q Consensus 363 ~~lv~E~~~~gsL~~~i~~~~----------------------------------------------------------- 383 (582)
.++||||+++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999886432
Q ss_pred --------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 384 --------------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 384 --------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
...+++..+++++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 12478889999999999999999997 9999999999999999999999999999876543322
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 528 (582)
.......++..|+|||++.+ ..++.++||||||+++|||++ |..|+........ ..+.+..+........
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~--~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~-- 341 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-----FYKMIKEGYRMLSPEC-- 341 (375)
T ss_pred cccCCCCCCcceeChhHhcC--CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH-----HHHHHHhCccCCCCCC--
Confidence 21222345678999999876 478999999999999999998 7778765432221 1122222211111111
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGS 566 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~ 566 (582)
....+.+|+.+||+.||++||++++|+++|++.
T Consensus 342 -----~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 342 -----APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred -----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 234577888999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=332.26 Aligned_cols=246 Identities=20% Similarity=0.280 Sum_probs=199.5
Q ss_pred hhcCccCceEEEEEEeCCCcEEEEEEeccCCCC----HHHHHHHHHHHhccCCCceEEEEeEEEe----CCeeeEEEEec
Q 040604 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCN----GEEFINEVASISRTSHVNIVTFLGFCYE----NKKNALIYELM 370 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~E~~ 370 (582)
..||+|++|.||+|.+ +|+.||||+++..... .+.+.+|+.+|++++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 3689999999999988 7899999999765433 3567799999999999999999999977 34678999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
++|+|.+++...+ .+++...++++.|++.||.|||+. .+++||||||+|||+++++.+||+|||+++.......
T Consensus 105 ~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~-- 178 (283)
T PHA02988 105 TRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPF-- 178 (283)
T ss_pred CCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhccccc--
Confidence 9999999997643 688899999999999999999974 2788999999999999999999999999987544321
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHH
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 530 (582)
...||+.|+|||++.+....++.++|||||||++|||++|+.||....... .....+.......++.
T Consensus 179 ---~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~-----~~~~i~~~~~~~~~~~----- 245 (283)
T PHA02988 179 ---KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE-----IYDLIINKNNSLKLPL----- 245 (283)
T ss_pred ---cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH-----HHHHHHhcCCCCCCCC-----
Confidence 235899999999987644578999999999999999999999997653221 1112222222222221
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 040604 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGS 566 (582)
Q Consensus 531 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~ 566 (582)
.....+.+++.+||+.||++|||++||++.|+..
T Consensus 246 --~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 246 --DCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred --cCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 1244577888899999999999999999999863
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=343.85 Aligned_cols=243 Identities=24% Similarity=0.381 Sum_probs=204.3
Q ss_pred hhhhcCccCceEEEEEEe-CCCcEEEEEEeccCC----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 297 FRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSR----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 297 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
+.+.||.|+-|.|.+|++ .+|+.+|||++.+.. .....+.+|+.+|+.+.||||++||+++.+..++|||.||++
T Consensus 16 LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~ 95 (786)
T KOG0588|consen 16 LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVP 95 (786)
T ss_pred ccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecC
Confidence 457899999999999965 489999999996542 234567899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
||.|.+++..++ ++++.++.+++.||+.|+.|+|.. +|+||||||+|+|||..+.+||+|||+|.....+.-
T Consensus 96 gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl--- 167 (786)
T KOG0588|consen 96 GGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL--- 167 (786)
T ss_pred CchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCCcc---
Confidence 999999998765 688899999999999999999997 999999999999999999999999999987655432
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHH
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 531 (582)
...-+|+|-|.+||++.+. ..-..++||||.|||||.||||+.||++.+... ++.++..|. +.++..++.+.
T Consensus 168 LeTSCGSPHYA~PEIV~G~-pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~------LLlKV~~G~-f~MPs~Is~ea 239 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGR-PYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV------LLLKVQRGV-FEMPSNISSEA 239 (786)
T ss_pred ccccCCCcccCCchhhcCC-CCCCCccccchhHHHHHHHHhCCCCCCCccHHH------HHHHHHcCc-ccCCCcCCHHH
Confidence 2245799999999999986 456789999999999999999999999664432 445666654 33445555444
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 532 KKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
++ |+.+||..||++|.|++||++.
T Consensus 240 Qd-------LLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 240 QD-------LLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HH-------HHHHHhccCccccccHHHHhhC
Confidence 44 4455678899999999999875
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=325.67 Aligned_cols=248 Identities=23% Similarity=0.343 Sum_probs=208.9
Q ss_pred HHHHHHhhhhcCccCceEEEEEE-eCCCcEEEEEEeccCCCCHH----HHHHHHHHHhccCCCceEEEEeEEEeCCeeeE
Q 040604 291 KRMTKSFRDKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGE----EFINEVASISRTSHVNIVTFLGFCYENKKNAL 365 (582)
Q Consensus 291 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~----~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 365 (582)
.+-+|+|.+.||+|.||.|-+|. ...|+.||||.+++.....+ .+.+|+++|+.|+||||+.++.+|...+.+++
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 35577889999999999999995 46899999999987765443 46799999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
||||..+|.|++++...+ .+++.++..++.||..|+.|+|.+ +++|||||.+|||+|.|+++||+|||++..+..
T Consensus 131 vMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 999999999999998654 699999999999999999999998 999999999999999999999999999998876
Q ss_pred cccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCC
Q 040604 446 KESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525 (582)
Q Consensus 446 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 525 (582)
+.... ..+|+|-|.+||++.+. ..-.+.+|-|||||+||.|+.|..||+..+. ..+..+|..+....-
T Consensus 206 ~kfLq---TFCGSPLYASPEIvNG~-PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh------k~lvrQIs~GaYrEP-- 273 (668)
T KOG0611|consen 206 KKFLQ---TFCGSPLYASPEIVNGT-PYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH------KRLVRQISRGAYREP-- 273 (668)
T ss_pred ccHHH---HhcCCcccCCccccCCC-CCCCCccchhhHHHHHHHHhhcccccCCchH------HHHHHHhhcccccCC--
Confidence 65432 45799999999999886 3557899999999999999999999987532 223445555533221
Q ss_pred cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 526 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
.. +....-|+.|||..+|++|.|+++|...
T Consensus 274 ~~-------PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 274 ET-------PSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred CC-------CchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 11 1223456778999999999999999754
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=349.39 Aligned_cols=262 Identities=29% Similarity=0.480 Sum_probs=209.0
Q ss_pred HHHHHHHHhhhhcCccCceEEEEEEeC--CC--cE-EEEEEeccC----CCCHHHHHHHHHHHhccCCCceEEEEeEEEe
Q 040604 289 DVKRMTKSFRDKLGQGGYGEVYKGELP--DG--QL-VAVKVLKNS----RCNGEEFINEVASISRTSHVNIVTFLGFCYE 359 (582)
Q Consensus 289 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~--~~-vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 359 (582)
++......+.++||+|+||.||+|.+. ++ .. ||||..+.+ .....+|++|+.+|++++|||||+++|+...
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 333444456689999999999999654 33 23 899998852 2345689999999999999999999999999
Q ss_pred CCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccc
Q 040604 360 NKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGL 439 (582)
Q Consensus 360 ~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGl 439 (582)
.+-+++|||+|.||+|.++++..+. .++..+...++.+.|.||+|||++ ++|||||-.+|+|++.++.+||+|||+
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGL 308 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGL 308 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcccc
Confidence 9999999999999999999997654 689999999999999999999998 999999999999999999999999999
Q ss_pred cccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhh-cC
Q 040604 440 AKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERI-EP 517 (582)
Q Consensus 440 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i-~~ 517 (582)
++........ .....-...|+|||.+.. +.++.++|||||||++||+.+ |..|+...... .+...+ ..
T Consensus 309 s~~~~~~~~~--~~~~klPirWLAPEtl~~--~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------~v~~kI~~~ 378 (474)
T KOG0194|consen 309 SRAGSQYVMK--KFLKKLPIRWLAPETLNT--GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------EVKAKIVKN 378 (474)
T ss_pred ccCCcceeec--cccccCcceecChhhhcc--CccccccchhheeeeEEeeeccCCCCCCCCCHH------HHHHHHHhc
Confidence 9876421111 111134578999999986 589999999999999999998 77787765432 234444 44
Q ss_pred CCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCC
Q 040604 518 GNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQ 571 (582)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~ 571 (582)
+.....+. ..+..+..++.+||..+|++||+|.++.+.|+.......
T Consensus 379 ~~r~~~~~-------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 379 GYRMPIPS-------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred CccCCCCC-------CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 43333332 224455666778999999999999999999988666544
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=332.05 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=198.2
Q ss_pred HHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC---------------CHHHHHHHHHHHhccCCCceEEEEeE
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC---------------NGEEFINEVASISRTSHVNIVTFLGF 356 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------------~~~~~~~E~~~l~~l~h~niv~l~~~ 356 (582)
+.|.+.+.||+|.||.|-+|... +++.||||++.+... ..+...+|+.+|++++|||||+|+.+
T Consensus 97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv 176 (576)
T KOG0585|consen 97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV 176 (576)
T ss_pred hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence 45567789999999999999654 799999999965321 22578899999999999999999999
Q ss_pred EEeC--CeeeEEEEecCCCChhhhhhcCCCcC-CCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceE
Q 040604 357 CYEN--KKNALIYELMPNGSLDKFIHNDRNIK-LEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPK 433 (582)
Q Consensus 357 ~~~~--~~~~lv~E~~~~gsL~~~i~~~~~~~-l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vk 433 (582)
..+. +..|||+|||..|.+...- ...+ +++.++++++.++..||+|||.+ +||||||||+|+||+++|+||
T Consensus 177 LDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 177 LDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred ecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEE
Confidence 9864 5789999999988876543 2234 89999999999999999999998 999999999999999999999
Q ss_pred Eeeccccccccccc---cceeeecccCCccccccccccccc--CCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhh
Q 040604 434 ISDFGLAKQAQKKE---SAISMLHARGTIGYIAPEVYSRRF--GGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICH 508 (582)
Q Consensus 434 l~DFGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~ 508 (582)
|+|||.+....... .........|||.|+|||...... ...+.+.||||+||+||-|+-|+.||.+.....
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~---- 326 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE---- 326 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH----
Confidence 99999998763221 111122357999999999987621 234678899999999999999999997653322
Q ss_pred HHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 040604 509 NLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEML 563 (582)
Q Consensus 509 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L 563 (582)
++.+|... .+...+..++...+.+|++++|++||++|.+..+|....
T Consensus 327 --l~~KIvn~------pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 327 --LFDKIVND------PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred --HHHHHhcC------cccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 23333322 111122235566778888899999999999999987654
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=337.42 Aligned_cols=263 Identities=27% Similarity=0.381 Sum_probs=211.0
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCH---HHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNG---EEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
.|.+.+.||+|+||+||+|+.+ +.+.||+|.+.+..... ..+.+|+++++.++|||||.++++|....+.++|.||
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 3456688999999999999654 78999999997765544 3477899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+.| +|..++...+ .++++.++.|+.++..||.|||+. +|+|||+||.|||++.+|++|++|||+|+.+..+...
T Consensus 83 a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 83 AVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred hhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence 965 9999998655 799999999999999999999998 9999999999999999999999999999998876543
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
.+...|||.|||||.+.+ ..++..+|.||+||++|||.+|++||.... +.+.+. .|.... ...+...
T Consensus 157 --ltsikGtPlYmAPElv~e--~pyd~~sDlWslGcilYE~~~G~PPF~a~s-----i~~Lv~-~I~~d~-v~~p~~~-- 223 (808)
T KOG0597|consen 157 --LTSIKGTPLYMAPELVEE--QPYDHTSDLWSLGCILYELYVGQPPFYARS-----ITQLVK-SILKDP-VKPPSTA-- 223 (808)
T ss_pred --eeeccCcccccCHHHHcC--CCccchhhHHHHHHHHHHHhcCCCCchHHH-----HHHHHH-HHhcCC-CCCcccc--
Confidence 345689999999999986 489999999999999999999999997542 222232 222211 1122222
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcccCCCCCCCCCCCCC
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLE--MLEGSIENLQIPPKPSLFS 580 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~--~Le~~~~~~~~p~~p~~~~ 580 (582)
......++...|++||.+|.|-.+++. ..++.+.-.+.|..|.+.+
T Consensus 224 -----S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~s 271 (808)
T KOG0597|consen 224 -----SSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFDS 271 (808)
T ss_pred -----cHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccccC
Confidence 333444455567999999999999874 3455555555555555544
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=325.75 Aligned_cols=254 Identities=26% Similarity=0.415 Sum_probs=207.4
Q ss_pred HHHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
..+.+.++||+|+||.||+|...++..||+|.+.......+.+.+|+.++++++|+||+++++.+.+....+++|||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK 85 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence 34456789999999999999887888999999887666678899999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
++|.+++.......+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++......... ..
T Consensus 86 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~ 161 (261)
T cd05072 86 GSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AR 161 (261)
T ss_pred CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee-cc
Confidence 9999999876556789999999999999999999987 9999999999999999999999999999876543221 11
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 531 (582)
....++..|+|||++.. +.++.++||||||+++|+|++ |+.|+....... ....+.........
T Consensus 162 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~------~~~~~~~~~~~~~~------- 226 (261)
T cd05072 162 EGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD------VMSALQRGYRMPRM------- 226 (261)
T ss_pred CCCccceecCCHHHhcc--CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH------HHHHHHcCCCCCCC-------
Confidence 22346778999999865 468899999999999999998 888886532211 12222222111111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 532 KKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
..+...+.+++.+||+.+|++||+++++++.|+.
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1233557788899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=324.87 Aligned_cols=256 Identities=25% Similarity=0.426 Sum_probs=208.2
Q ss_pred HHHHHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 291 KRMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 291 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
.+..+++.+.||+|++|.||+|...+++.||+|.++......+++.+|+.++++++|+||+++++++......++||||+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 34556677899999999999998877889999999877666788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
++++|.+++.......+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE- 159 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-
Confidence 999999999766555789999999999999999999988 9999999999999999999999999999876532211
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
......++..|+|||++.. ..++.++||||||++++||++ |+.|+....... +...+.........
T Consensus 160 ~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~~----- 226 (261)
T cd05068 160 AREGAKFPIKWTAPEAALY--NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE------VLQQVDQGYRMPCP----- 226 (261)
T ss_pred ccCCCcCceeccCcccccc--CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHHcCCCCCCC-----
Confidence 1111223468999998875 468899999999999999999 888886542211 12222222111111
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
......+.+++.+||+.+|++||++++|++.||.
T Consensus 227 --~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 227 --PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred --CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1234567888899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=322.92 Aligned_cols=250 Identities=26% Similarity=0.446 Sum_probs=203.2
Q ss_pred HHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCC
Q 040604 295 KSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGS 374 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 374 (582)
+.+.++||+|+||.||++...++..+|+|.++......+.+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~ 85 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGC 85 (256)
T ss_pred cEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCc
Confidence 45568899999999999988888899999988766667889999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeec
Q 040604 375 LDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLH 454 (582)
Q Consensus 375 L~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 454 (582)
|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++........ ....
T Consensus 86 L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~~~ 160 (256)
T cd05114 86 LLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSG 160 (256)
T ss_pred HHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee-ccCC
Confidence 999987543 2588999999999999999999988 9999999999999999999999999999875433221 1122
Q ss_pred ccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHH
Q 040604 455 ARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKK 533 (582)
Q Consensus 455 ~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 533 (582)
..++..|+|||++.. ..++.++||||||+++|||++ |+.|+....... ....+..+.....+..
T Consensus 161 ~~~~~~y~aPE~~~~--~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~------~~~~i~~~~~~~~~~~------- 225 (256)
T cd05114 161 AKFPVKWSPPEVFNF--SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE------VVEMISRGFRLYRPKL------- 225 (256)
T ss_pred CCCchhhCChhhccc--CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHHCCCCCCCCCC-------
Confidence 335678999999875 368899999999999999999 888886543211 1222222222111111
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 040604 534 IAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564 (582)
Q Consensus 534 ~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le 564 (582)
....+.+++.+||+.+|++||+++++++.|.
T Consensus 226 ~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 2346788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=334.39 Aligned_cols=248 Identities=27% Similarity=0.374 Sum_probs=198.5
Q ss_pred HhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCC----CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 296 SFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRC----NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
...+.||+|+||+||++.. .+|+.||+|.+..... ....+.+|+.++++++|+||+++++.+.++...++||||+
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05631 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIM 82 (285)
T ss_pred eEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEec
Confidence 4457899999999999965 5799999999865332 2245789999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
++|+|..++.......+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++........
T Consensus 83 ~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 157 (285)
T cd05631 83 NGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-- 157 (285)
T ss_pred CCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe--
Confidence 999999888755555689999999999999999999998 999999999999999999999999999987643322
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHH
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 530 (582)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...+...+.... ..+.
T Consensus 158 -~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~-~~~~------ 225 (285)
T cd05631 158 -VRGRVGTVGYMAPEVINN--EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK--REEVDRRVKEDQ-EEYS------ 225 (285)
T ss_pred -ecCCCCCCCccCHhhhcC--CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh--HHHHHHHhhccc-ccCC------
Confidence 123469999999999976 4789999999999999999999999976543211 111222222111 1111
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 040604 531 EKKIAKMMILVGFWCIQTNPSERPS-----MHKVLE 561 (582)
Q Consensus 531 ~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~evl~ 561 (582)
..+...+.+|+.+||+.||++||+ ++++++
T Consensus 226 -~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 226 -EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 123455677888899999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=338.67 Aligned_cols=246 Identities=29% Similarity=0.470 Sum_probs=200.8
Q ss_pred hhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCChhhh
Q 040604 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKF 378 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~ 378 (582)
+-||.|+.|.||+|++ .++.||||+++.-+ .-+++-|++|+|+||+.+.|+|.....+++|||||+.|-|..+
T Consensus 130 eWlGSGaQGAVF~Grl-~netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V 202 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRL-HNETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV 202 (904)
T ss_pred hhhccCcccceeeeec-cCceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence 5699999999999999 67899999875422 2367889999999999999999999999999999999999999
Q ss_pred hhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeecccCC
Q 040604 379 IHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGT 458 (582)
Q Consensus 379 i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt 458 (582)
++..+ ++....+.+|..+||.||.|||.+ .|||||||.-||||..+..|||+|||.++......+.. ..+||
T Consensus 203 Lka~~--~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkM---SFaGT 274 (904)
T KOG4721|consen 203 LKAGR--PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKM---SFAGT 274 (904)
T ss_pred HhccC--ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhhhhh---hhhhh
Confidence 98654 688899999999999999999998 99999999999999999999999999999877664332 35699
Q ss_pred cccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHH
Q 040604 459 IGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMM 538 (582)
Q Consensus 459 ~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l 538 (582)
..|||||++... ..++|+|||||||+|||||||.-|+.+.....- +...-.+...+.. ....++.+
T Consensus 275 VaWMAPEvIrne--PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-----IwGVGsNsL~Lpv-------PstcP~Gf 340 (904)
T KOG4721|consen 275 VAWMAPEVIRNE--PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-----IWGVGSNSLHLPV-------PSTCPDGF 340 (904)
T ss_pred HhhhCHHHhhcC--CcccccceehhHHHHHHHHhcCCCccccchhee-----EEeccCCcccccC-------cccCchHH
Confidence 999999999874 789999999999999999999999987654331 1111111111111 12234556
Q ss_pred HHHHHhccccCCCCCCCHHHHHHHHhc-ccCCCCCC
Q 040604 539 ILVGFWCIQTNPSERPSMHKVLEMLEG-SIENLQIP 573 (582)
Q Consensus 539 ~~l~~~Cl~~dp~~RPt~~evl~~Le~-~~~~~~~p 573 (582)
..|+++||+-.|.+||++++++..|+- .-+-|++|
T Consensus 341 klL~Kqcw~sKpRNRPSFrqil~HldIa~pell~~t 376 (904)
T KOG4721|consen 341 KLLLKQCWNSKPRNRPSFRQILLHLDIASPELLSTT 376 (904)
T ss_pred HHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhccc
Confidence 777888999999999999999999973 33334443
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.68 Aligned_cols=259 Identities=25% Similarity=0.431 Sum_probs=202.2
Q ss_pred HHHHHhhhhcCccCceEEEEEEeC------CCcEEEEEEeccCCCC--HHHHHHHHHHHhcc-CCCceEEEEeEEEeCCe
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELP------DGQLVAVKVLKNSRCN--GEEFINEVASISRT-SHVNIVTFLGFCYENKK 362 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 362 (582)
...+.+.+.||+|+||.||+|... ++..||||+++..... .+.+.+|+.+++.+ +|+||+++++.+.+...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 334567789999999999998632 3458999999754332 35688999999999 89999999999999999
Q ss_pred eeEEEEecCCCChhhhhhcCC-----------------------------------------------------------
Q 040604 363 NALIYELMPNGSLDKFIHNDR----------------------------------------------------------- 383 (582)
Q Consensus 363 ~~lv~E~~~~gsL~~~i~~~~----------------------------------------------------------- 383 (582)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999885421
Q ss_pred ---------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeec
Q 040604 384 ---------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLH 454 (582)
Q Consensus 384 ---------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 454 (582)
..++++..+++++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++.............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 12478889999999999999999998 999999999999999999999999999987644332211122
Q ss_pred ccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHH
Q 040604 455 ARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKK 533 (582)
Q Consensus 455 ~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 533 (582)
..+++.|+|||++.+ ..++.++|||||||++|||++ |+.||........ ....+..+........
T Consensus 274 ~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-----~~~~~~~~~~~~~~~~------- 339 (374)
T cd05106 274 ARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-----FYKMVKRGYQMSRPDF------- 339 (374)
T ss_pred CCCccceeCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-----HHHHHHcccCccCCCC-------
Confidence 345678999999875 478999999999999999997 9999876433221 1122222211111111
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 040604 534 IAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSI 567 (582)
Q Consensus 534 ~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~ 567 (582)
....+.+++.+||+.||++|||+.+|+++|++++
T Consensus 340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 2355777888999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=323.37 Aligned_cols=253 Identities=28% Similarity=0.447 Sum_probs=205.6
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCC
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNG 373 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 373 (582)
+.+.++||+|+||.||+|... +++.+|+|+++......+++.+|+.++++++|+||+++++++......++||||++++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (263)
T cd05052 8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 87 (263)
T ss_pred eEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCC
Confidence 456688999999999999654 6889999999876656678999999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeee
Q 040604 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISML 453 (582)
Q Consensus 374 sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 453 (582)
+|.+++.......+++..++.++.|+++||+|||+. +++||||||+|||+++++.+||+|||++......... ...
T Consensus 88 ~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~ 163 (263)
T cd05052 88 NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHA 163 (263)
T ss_pred cHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee-ccC
Confidence 999999766556789999999999999999999988 9999999999999999999999999999876543221 111
Q ss_pred cccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 454 HARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 454 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
...+++.|+|||.+.. ..++.++||||||+++|||++ |..|+....... ....+......... .
T Consensus 164 ~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~~-------~ 228 (263)
T cd05052 164 GAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKGYRMERP-------E 228 (263)
T ss_pred CCCCccccCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHHCCCCCCCC-------C
Confidence 2235678999998865 468899999999999999998 888876542211 12222222111111 1
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 040604 533 KIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGS 566 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~ 566 (582)
..+..+.+++.+||+.+|++||++.+++++|+..
T Consensus 229 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 229 GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 2345677888899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=323.97 Aligned_cols=255 Identities=22% Similarity=0.387 Sum_probs=202.5
Q ss_pred HHHHHhhhhcCccCceEEEEEEeC----CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeE
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELP----DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNAL 365 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 365 (582)
...+.+.+.||+|+||.||+|.+. .+..||+|.++.... ..+.+.+|+.++++++||||+++++++..+...++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 345567789999999999999653 467899999976532 23568899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+|||++.++.+|++|||.+.....
T Consensus 84 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999987643 3689999999999999999999988 999999999999999999999999998765432
Q ss_pred cccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCC
Q 040604 446 KESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFD 524 (582)
Q Consensus 446 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 524 (582)
.... ......++..|+|||.+.+ ..++.++||||||+++|||++ |+.||....... +.+.+..+......
T Consensus 160 ~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~------~~~~~~~~~~~~~~ 230 (266)
T cd05064 160 EAIY-TTMSGKSPVLWAAPEAIQY--HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD------VIKAVEDGFRLPAP 230 (266)
T ss_pred cchh-cccCCCCceeecCHHHHhh--CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH------HHHHHHCCCCCCCC
Confidence 2111 1112335678999999876 478999999999999999775 898986543221 22233332221111
Q ss_pred CcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 040604 525 GVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGS 566 (582)
Q Consensus 525 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~ 566 (582)
...+..+.+++..||+.+|++||++++|++.|++.
T Consensus 231 -------~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 231 -------RNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -------CCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 12345677888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=333.03 Aligned_cols=243 Identities=27% Similarity=0.374 Sum_probs=203.6
Q ss_pred hhhhcCccCceEEEEEEe-CCCcEEEEEEeccCC--CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCC
Q 040604 297 FRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSR--CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNG 373 (582)
Q Consensus 297 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 373 (582)
-.+.||+|.||.||+|.+ .+++.||+|++.... ...+++.+|+.+|.+++++||.++||.+..+..+.++||||.||
T Consensus 17 ~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gG 96 (467)
T KOG0201|consen 17 KLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGG 96 (467)
T ss_pred cchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCc
Confidence 347899999999999965 479999999987544 45578899999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeee
Q 040604 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISML 453 (582)
Q Consensus 374 sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 453 (582)
++.++++... .+++....-|+++++.||.|||.+ +.+|||||+.|||+..+|.+||+|||.+-++....... .
T Consensus 97 sv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr--~ 169 (467)
T KOG0201|consen 97 SVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR--K 169 (467)
T ss_pred chhhhhccCC--CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc--c
Confidence 9999997543 347777778899999999999998 99999999999999999999999999998876654432 3
Q ss_pred cccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHH
Q 040604 454 HARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKK 533 (582)
Q Consensus 454 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 533 (582)
...|||.|||||++.. ..|+.|+||||||++.+||++|.+|+....+..- .-.|.+...+.+++ .
T Consensus 170 tfvGTPfwMAPEVI~~--~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv------lflIpk~~PP~L~~-------~ 234 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQ--SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV------LFLIPKSAPPRLDG-------D 234 (467)
T ss_pred cccccccccchhhhcc--ccccchhhhhhhhHHHHHHhcCCCCCcccCcceE------EEeccCCCCCcccc-------c
Confidence 4579999999999986 4899999999999999999999999987655331 11233333444444 3
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 534 IAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 534 ~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
..+.+.+++..||+.||+.||+|.++++
T Consensus 235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 235 FSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 3455667777799999999999999984
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=320.66 Aligned_cols=250 Identities=24% Similarity=0.462 Sum_probs=203.3
Q ss_pred HHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCC
Q 040604 295 KSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGS 374 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 374 (582)
+.+.+.||+|+||+||+|...++..+|+|.++......+.+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05113 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGC 85 (256)
T ss_pred eEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCc
Confidence 45668899999999999988777789999998766667889999999999999999999999998888999999999999
Q ss_pred hhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeec
Q 040604 375 LDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLH 454 (582)
Q Consensus 375 L~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 454 (582)
|.+++..... .+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++........ ....
T Consensus 86 l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~ 160 (256)
T cd05113 86 LLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SSVG 160 (256)
T ss_pred HHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCcee-ecCC
Confidence 9999976433 689999999999999999999988 9999999999999999999999999999866443221 1122
Q ss_pred ccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHH
Q 040604 455 ARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKK 533 (582)
Q Consensus 455 ~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 533 (582)
..++..|+|||++.. ..++.++||||||+++|||++ |..|+....... +...+..+........
T Consensus 161 ~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~------- 225 (256)
T cd05113 161 SKFPVRWSPPEVLLY--SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE------TVEKVSQGLRLYRPHL------- 225 (256)
T ss_pred CccChhhCCHHHHhc--CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH------HHHHHhcCCCCCCCCC-------
Confidence 346678999999875 368899999999999999998 888886543211 2222322222111111
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 040604 534 IAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564 (582)
Q Consensus 534 ~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le 564 (582)
....+.+++.+||+.+|++||++.+|++.|+
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 226 ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 2356778888999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=319.72 Aligned_cols=251 Identities=25% Similarity=0.458 Sum_probs=203.2
Q ss_pred HHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCC
Q 040604 294 TKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNG 373 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 373 (582)
.+.+.+.||+|+||.||++...++..+|+|++.......+.+.+|+.++++++|+||+++++++.+....++||||++++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 34577899999999999998877788999999876666778999999999999999999999999988999999999999
Q ss_pred ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeee
Q 040604 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISML 453 (582)
Q Consensus 374 sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 453 (582)
+|.+++..... .+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++........ ...
T Consensus 85 ~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~~ 159 (256)
T cd05059 85 CLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQ 159 (256)
T ss_pred CHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc-ccC
Confidence 99999876433 689999999999999999999998 9999999999999999999999999999876433221 111
Q ss_pred cccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 454 HARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 454 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
...++..|+|||.+.+ ..++.++||||||+++|||++ |+.|+....... ....+..........
T Consensus 160 ~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~------- 224 (256)
T cd05059 160 GTKFPVKWAPPEVFDY--SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE------VVESVSAGYRLYRPK------- 224 (256)
T ss_pred CCCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH------HHHHHHcCCcCCCCC-------
Confidence 2234568999999876 368899999999999999999 777876533221 122222222111111
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 040604 533 KIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le 564 (582)
.....+.+++.+||+.+|++|||+++|++.|.
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 13456788899999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=305.71 Aligned_cols=246 Identities=27% Similarity=0.404 Sum_probs=207.5
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC----CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 368 (582)
.+++.+.||+|-||.||.|+.+ ++..||+|++.+++. ...++.+|+++.+.|+||||+++|++|.+....||++|
T Consensus 23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE 102 (281)
T KOG0580|consen 23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE 102 (281)
T ss_pred hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence 3467899999999999999654 788999999977653 23568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
|.++|+|...+...+...+++.....++.|+|.||.|+|.. +||||||||+|+|++..+.+||+|||.+...+.+..
T Consensus 103 ya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~kR 179 (281)
T KOG0580|consen 103 YAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNKR 179 (281)
T ss_pred ecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCCCCc
Confidence 99999999999987777899999999999999999999997 999999999999999999999999999987653332
Q ss_pred ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc
Q 040604 449 AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528 (582)
Q Consensus 449 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 528 (582)
. ..+||..|++||...+. ..+.++|+|++|++.+|++.|.+||......+ .+.+|..-. ..++..
T Consensus 180 ~----tlcgt~dyl~pEmv~~~--~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e------tYkrI~k~~-~~~p~~-- 244 (281)
T KOG0580|consen 180 K----TLCGTLDYLPPEMVEGR--GHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE------TYKRIRKVD-LKFPST-- 244 (281)
T ss_pred e----eeecccccCCHhhcCCC--CccchhhHHHHHHHHHHHHhcCCchhhhhhHH------HHHHHHHcc-ccCCcc--
Confidence 2 34699999999999874 77899999999999999999999998765333 334443321 222222
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
+.....+++.+|+..+|.+|.+..|+++.
T Consensus 245 -----is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 245 -----ISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -----cChhHHHHHHHHhccCccccccHHHHhhh
Confidence 34556677788999999999999998764
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=320.14 Aligned_cols=256 Identities=29% Similarity=0.473 Sum_probs=209.1
Q ss_pred HHHHHHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 290 VKRMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 290 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.+.++++.++||+|+||.||+|...+++.+|+|.+.......+.+.+|+.++++++|+||+++++++. ....+++|||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 445677888999999999999999888999999999887777889999999999999999999999864 4568999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++++|.+++.......+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999999876666789999999999999999999987 9999999999999999999999999999876532211
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 528 (582)
......++..|+|||++.. +.++.++||||||++++||++ |+.||....... +...+..+.......
T Consensus 159 -~~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~--- 226 (260)
T cd05067 159 -AREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE------VIQNLERGYRMPRPD--- 226 (260)
T ss_pred -cccCCcccccccCHHHhcc--CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH------HHHHHHcCCCCCCCC---
Confidence 1112346778999999875 467899999999999999998 888886543221 122222221111111
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
.....+.+++.+||+.+|++||+++++++.|+.
T Consensus 227 ----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 227 ----NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ----CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 123467888899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=339.78 Aligned_cols=239 Identities=23% Similarity=0.349 Sum_probs=193.9
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhccC-CCceEEEEeEEEeCCeeeEEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISRTS-HVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 367 (582)
.+.|.+.||+|+||+|+++..+ +++.+|||++++.. .+.+..+.|..++.... ||.++.|+..|+..++.++||
T Consensus 369 ~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvm 448 (694)
T KOG0694|consen 369 DFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVM 448 (694)
T ss_pred ceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEE
Confidence 3456689999999999999766 68899999998754 34567788888887765 999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
||+.||++..+.+. ..+++.++.-++.+|+.||.|||++ +||+||||.+|||||.+|++||+|||+++..-...
T Consensus 449 ey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 449 EYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG 522 (694)
T ss_pred EecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCCC
Confidence 99999995555443 3699999999999999999999998 99999999999999999999999999999754332
Q ss_pred cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcC
Q 040604 448 SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 527 (582)
. .+...+|||.|||||++.+. .|+.++|+|||||+|||||.|..||...++++ .+.. |... +..++...
T Consensus 523 ~--~TsTfCGTpey~aPEil~e~--~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-~Fds-----I~~d-~~~yP~~l 591 (694)
T KOG0694|consen 523 D--RTSTFCGTPEFLAPEVLTEQ--SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-VFDS-----IVND-EVRYPRFL 591 (694)
T ss_pred C--ccccccCChhhcChhhhccC--cccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHH-----HhcC-CCCCCCcc
Confidence 2 23456899999999999884 89999999999999999999999998765543 2222 2211 12233333
Q ss_pred cHHHHHHHHHHHHHHHhccccCCCCCCCH
Q 040604 528 TEEEKKIAKMMILVGFWCIQTNPSERPSM 556 (582)
Q Consensus 528 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~ 556 (582)
..+.+.++.++|..+|++|.-+
T Consensus 592 -------s~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 592 -------SKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -------cHHHHHHHHHHhccCcccccCC
Confidence 3444555666779999999866
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=318.53 Aligned_cols=254 Identities=27% Similarity=0.454 Sum_probs=205.6
Q ss_pred HHHHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
...+++.++||+|+||.||+|...++..+|+|.++......+.+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 3456778899999999999998888888999999877667788999999999999999999999875 456789999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
+++|.+++.......+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++......... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~ 159 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-A 159 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-c
Confidence 99999999875555689999999999999999999998 9999999999999999999999999999876543221 1
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHH
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 530 (582)
.....++..|+|||++.. ..++.++||||||++++||++ |..|+....... ..+.+.........
T Consensus 160 ~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~------ 225 (260)
T cd05070 160 RQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE------VLEQVERGYRMPCP------ 225 (260)
T ss_pred ccCCCCCccccChHHHhc--CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHHcCCCCCCC------
Confidence 112235678999998865 468899999999999999999 788886543211 12222222111111
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 531 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
......+.+++.+||+.+|++|||++++++.|++
T Consensus 226 -~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 226 -QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1233567888999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=323.50 Aligned_cols=254 Identities=27% Similarity=0.475 Sum_probs=203.1
Q ss_pred HHHhhhhcCccCceEEEEEEeCC------CcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELPD------GQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNAL 365 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 365 (582)
.+.+.+.||+|+||.||+|.... ...+|+|.++.... ..+.+.+|+.++++++||||+++++++.+....++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 34567899999999999996532 25799999875432 23568899999999999999999999998889999
Q ss_pred EEEecCCCChhhhhhcCCC--------------cCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc
Q 040604 366 IYELMPNGSLDKFIHNDRN--------------IKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFC 431 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~ 431 (582)
+|||+++++|.+++..... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCc
Confidence 9999999999999875421 4578899999999999999999998 9999999999999999999
Q ss_pred eEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHH
Q 040604 432 PKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNL 510 (582)
Q Consensus 432 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~ 510 (582)
+||+|||+++...............+++.|+|||++.. +.++.++|||||||++|||++ |..|+.......
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~------ 234 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY--GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE------ 234 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhcc--CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH------
Confidence 99999999986544332222223457889999999875 478999999999999999998 888887543321
Q ss_pred HHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 511 IYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 511 ~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
+.+.+..+..... ....+..+.+|+.+||+.||++||++++|++.|++
T Consensus 235 ~~~~i~~~~~~~~-------~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 VIEMIRSRQLLPC-------PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCcCCC-------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 2233333221111 12345678888899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=325.06 Aligned_cols=249 Identities=35% Similarity=0.578 Sum_probs=194.0
Q ss_pred hhhhcCccCceEEEEEEeC-----CCcEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 297 FRDKLGQGGYGEVYKGELP-----DGQLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 297 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.+.||.|.||.||+|.+. .+..|+||+++..... .+.+.+|+..+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999765 3678999999664332 47899999999999999999999999988889999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++|+|.+++.......+++..++.|+.|+++||+|||+. +++|+||+++|||+++++.+||+|||++.........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999987556799999999999999999999998 9999999999999999999999999999887433322
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 528 (582)
.......+...|+|||.+... .++.++||||||+++|||++ |+.|+....... +.+.+..+........
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~--~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~------~~~~~~~~~~~~~~~~-- 229 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDG--EYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE------IIEKLKQGQRLPIPDN-- 229 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHS--EESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH------HHHHHHTTEETTSBTT--
T ss_pred ccccccccccccccccccccc--ccccccccccccccccccccccccccccccccc------ccccccccccceeccc--
Confidence 222334577899999998763 58999999999999999999 567775542211 2233333322222211
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEML 563 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L 563 (582)
....+..++.+||+.+|++|||+++|++.|
T Consensus 230 -----~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 230 -----CPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -----SBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -----hhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 235567788889999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=342.36 Aligned_cols=260 Identities=26% Similarity=0.419 Sum_probs=204.6
Q ss_pred HHHHHhhhhcCccCceEEEEEEeC------CCcEEEEEEeccCCC--CHHHHHHHHHHHhccC-CCceEEEEeEEEeCCe
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELP------DGQLVAVKVLKNSRC--NGEEFINEVASISRTS-HVNIVTFLGFCYENKK 362 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 362 (582)
+..+.+.++||+|+||.||+|... .+..||||+++.... ..+.+.+|+.+++++. ||||+++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 334567789999999999999642 235799999975433 2457899999999996 9999999999999999
Q ss_pred eeEEEEecCCCChhhhhhcCC-----------------------------------------------------------
Q 040604 363 NALIYELMPNGSLDKFIHNDR----------------------------------------------------------- 383 (582)
Q Consensus 363 ~~lv~E~~~~gsL~~~i~~~~----------------------------------------------------------- 383 (582)
.+|||||+++|+|.+++....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999998886431
Q ss_pred -----------------------------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC
Q 040604 384 -----------------------------------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE 428 (582)
Q Consensus 384 -----------------------------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~ 428 (582)
...+++..++.++.|++.||+|||+. +|+||||||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 12477888899999999999999997 9999999999999999
Q ss_pred CCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchh
Q 040604 429 DFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSIC 507 (582)
Q Consensus 429 ~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~ 507 (582)
++.+||+|||+++...............+++.|+|||.+.+ ..++.++|||||||++|||++ |+.|+........
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~-- 348 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD--NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-- 348 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--
Confidence 99999999999987654333222223457788999999876 368899999999999999997 8888875433221
Q ss_pred hHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 508 HNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 508 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
+...+..+...... ..+...+.+++.+||+.||++||++.+|+++|+..+.
T Consensus 349 ---~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 349 ---FYNKIKSGYRMAKP-------DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ---HHHHHhcCCCCCCC-------ccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 22223332221111 1234567888899999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=334.82 Aligned_cols=240 Identities=23% Similarity=0.319 Sum_probs=193.8
Q ss_pred hhcCccCceEEEEEEe-CCCcEEEEEEeccCC----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCC
Q 040604 299 DKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSR----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNG 373 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 373 (582)
+.||+|+||.||++.. .+|+.||||+++... .....+.+|+.++++++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999965 479999999997532 22346788999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeee
Q 040604 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISML 453 (582)
Q Consensus 374 sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 453 (582)
+|.+++...+ .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........ ..
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~ 153 (323)
T cd05571 81 ELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MK 153 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc--cc
Confidence 9999987543 688999999999999999999998 9999999999999999999999999999764322211 12
Q ss_pred cccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHH
Q 040604 454 HARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKK 533 (582)
Q Consensus 454 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 533 (582)
...||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... +.+.+... ...++. .
T Consensus 154 ~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~------~~~~~~~~-~~~~p~-------~ 217 (323)
T cd05571 154 TFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILME-EIRFPR-------T 217 (323)
T ss_pred ceecCccccChhhhcC--CCCCccccCcccchhhhhhhcCCCCCCCCCHHH------HHHHHHcC-CCCCCC-------C
Confidence 3469999999999876 368999999999999999999999997543211 11222211 112222 2
Q ss_pred HHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 040604 534 IAKMMILVGFWCIQTNPSERP-----SMHKVLE 561 (582)
Q Consensus 534 ~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~ 561 (582)
+...+.+++.+||+.||++|| +++++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 345567788889999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=322.32 Aligned_cols=256 Identities=29% Similarity=0.469 Sum_probs=204.6
Q ss_pred HHHHHhhhhcCccCceEEEEEEeC------CCcEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeCCee
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELP------DGQLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYENKKN 363 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 363 (582)
..++.+.+.||+|+||.||+|... +++.||||.++..... .+.+.+|+.++++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 455678899999999999999653 3578999999765443 46789999999999999999999999999999
Q ss_pred eEEEEecCCCChhhhhhcCC------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc
Q 040604 364 ALIYELMPNGSLDKFIHNDR------------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFC 431 (582)
Q Consensus 364 ~lv~E~~~~gsL~~~i~~~~------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~ 431 (582)
++||||+++++|.+++...+ ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 99999999999999997542 23478899999999999999999998 9999999999999999999
Q ss_pred eEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHH
Q 040604 432 PKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNL 510 (582)
Q Consensus 432 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~ 510 (582)
+||+|||+++...............+++.|+|||++.+ +.++.++||||||+++|||++ |..|+.......
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~------ 232 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE------ 232 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhcc--CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH------
Confidence 99999999986543322111123346788999999876 478999999999999999998 998886543322
Q ss_pred HHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 511 IYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 511 ~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
..+.+..+...... ......+.+++.+||+.||++||+++||++.|++
T Consensus 233 ~~~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 233 VIECITQGRLLQRP-------RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHHHcCCcCCCC-------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 12222222211111 1234567788889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=338.77 Aligned_cols=250 Identities=22% Similarity=0.289 Sum_probs=199.3
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.+.++||+|+||.||+|... +++.||||+++... .....+.+|+.++.+++||||+++++.+.+....++||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 345688999999999999765 68999999997542 2335688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~--- 154 (333)
T cd05600 83 VPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY--- 154 (333)
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCcccccc---
Confidence 99999999997543 588899999999999999999998 9999999999999999999999999999875441
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... . ...+..............
T Consensus 155 --~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~-----~~~i~~~~~~~~~~~~~~ 224 (333)
T cd05600 155 --ANSVVGSPDYMAPEVLRGK--GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-T-----WENLKYWKETLQRPVYDD 224 (333)
T ss_pred --cCCcccCccccChhHhcCC--CCCCccceecchHHHhhhhhCCCCCCCCCHHH-H-----HHHHHhccccccCCCCCc
Confidence 1234599999999999764 78999999999999999999999997543322 1 111111100000001111
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
....+...+.+++.+||+.+|++||+++++++.
T Consensus 225 ~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 225 PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 112345567788889999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=318.46 Aligned_cols=254 Identities=28% Similarity=0.484 Sum_probs=208.0
Q ss_pred HHHHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
+..+.+.++||.|+||.||+|...+++.+|+|+++.... ..+.+.+|+.++++++|+||+++++++.+....++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 344677899999999999999888899999999976654 4567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
++++|.+++.......+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~- 160 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL- 160 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcccc-
Confidence 999999999876666789999999999999999999987 9999999999999999999999999999876443221
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
.....++..|+|||.+.. ..++.++||||||+++++|++ |+.|+....... +...+..+......
T Consensus 161 -~~~~~~~~~~~~PE~~~~--~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~----- 226 (261)
T cd05148 161 -SSDKKIPYKWTAPEAASH--GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE------VYDQITAGYRMPCP----- 226 (261)
T ss_pred -ccCCCCceEecCHHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH------HHHHHHhCCcCCCC-----
Confidence 113346788999999876 468899999999999999998 788886543211 11122222111111
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
......+.+++.+||+.||++|||++++++.|+.
T Consensus 227 --~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 227 --AKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred --CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1223557788889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=332.24 Aligned_cols=260 Identities=25% Similarity=0.443 Sum_probs=203.5
Q ss_pred HHHHHhhhhcCccCceEEEEEEeC------CCcEEEEEEeccCCCC--HHHHHHHHHHHhcc-CCCceEEEEeEEEeC-C
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELP------DGQLVAVKVLKNSRCN--GEEFINEVASISRT-SHVNIVTFLGFCYEN-K 361 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 361 (582)
..++++.+.||+|+||.||+|... +++.||+|+++..... .+.+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 345678899999999999999532 3578999999754332 24577899999999 899999999988754 4
Q ss_pred eeeEEEEecCCCChhhhhhcCCC---------------------------------------------------------
Q 040604 362 KNALIYELMPNGSLDKFIHNDRN--------------------------------------------------------- 384 (582)
Q Consensus 362 ~~~lv~E~~~~gsL~~~i~~~~~--------------------------------------------------------- 384 (582)
..+++|||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999998864321
Q ss_pred --cCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeecccCCcccc
Q 040604 385 --IKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYI 462 (582)
Q Consensus 385 --~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 462 (582)
..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 2578999999999999999999998 99999999999999999999999999998765443332223345678899
Q ss_pred cccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHH
Q 040604 463 APEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILV 541 (582)
Q Consensus 463 aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l 541 (582)
|||++.+ ..++.++|||||||+++||++ |..|+........ ....+..+.....+ ......+.++
T Consensus 243 aPE~~~~--~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~-------~~~~~~~~~l 308 (337)
T cd05054 243 APESIFD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-----FCRRLKEGTRMRAP-------EYATPEIYSI 308 (337)
T ss_pred CcHHhcC--CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-----HHHHHhccCCCCCC-------ccCCHHHHHH
Confidence 9999876 478999999999999999997 8888865432221 12222222221111 1223557788
Q ss_pred HHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 542 GFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 542 ~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
+.+||+.+|++||++.||+++|+..++
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=313.25 Aligned_cols=262 Identities=26% Similarity=0.338 Sum_probs=204.6
Q ss_pred HHHHHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCc-eEEEEeEEEeCC-----
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVN-IVTFLGFCYENK----- 361 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~----- 361 (582)
...+...++||+|+||+||+|+. .+|+.||+|+++.... .....++|+.+|++++|+| ||+|++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34455668899999999999964 4899999999976543 3456789999999999999 999999999877
Q ss_pred -eeeEEEEecCCCChhhhhhcCCC--cCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecc
Q 040604 362 -KNALIYELMPNGSLDKFIHNDRN--IKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFG 438 (582)
Q Consensus 362 -~~~lv~E~~~~gsL~~~i~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFG 438 (582)
..+||+||+ ..+|..++..... ..++...+..++.||+.||+|||++ +|+||||||+||||+++|.+||+|||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence 788999999 7899999986543 3677788999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCC
Q 040604 439 LAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPG 518 (582)
Q Consensus 439 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~ 518 (582)
+|+...-.... .+...+|.+|.|||++.+. ..|+...||||+||++.||++++..|.......... .+.+.+...
T Consensus 166 lAra~~ip~~~--yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~--~If~~lGtP 240 (323)
T KOG0594|consen 166 LARAFSIPMRT--YTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLF--RIFRLLGTP 240 (323)
T ss_pred hHHHhcCCccc--ccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHH--HHHHHcCCC
Confidence 99976543332 3355699999999999886 469999999999999999999998887665432211 122222222
Q ss_pred CCCCCCC-------------cC-c----HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 519 NDFQFDG-------------VA-T----EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 519 ~~~~~~~-------------~~-~----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
....+++ .. . ...........+++.+||+.+|.+|.|++.++++
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1111111 10 0 0111111356788889999999999999999875
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=320.20 Aligned_cols=255 Identities=27% Similarity=0.437 Sum_probs=205.6
Q ss_pred HHHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
..+.+.++||+|+||.||+|...+...||+|+++......+.+.+|+.++++++|+||+++++.+. ....++||||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK 84 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCC
Confidence 446778899999999999998776677999999876666778999999999999999999999874 4567899999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
|+|.+++.......+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||.++......... .
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~-~ 160 (262)
T cd05071 85 GSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-R 160 (262)
T ss_pred CcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccccc-c
Confidence 9999999865555689999999999999999999998 99999999999999999999999999998765433211 1
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 531 (582)
....++..|+|||+..+ +.++.++||||||+++|||++ |..|+....... +...+........ .
T Consensus 161 ~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~------~~~~~~~~~~~~~-------~ 225 (262)
T cd05071 161 QGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVERGYRMPC-------P 225 (262)
T ss_pred cCCcccceecCHhHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH------HHHHHhcCCCCCC-------c
Confidence 12346778999998865 468999999999999999999 777776443211 2222222211111 1
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 040604 532 KKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSI 567 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~ 567 (582)
..+...+.+++.+||+.+|++||+++++++.|+..+
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 226 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 234566788999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=330.60 Aligned_cols=242 Identities=26% Similarity=0.328 Sum_probs=196.5
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+++.++||+|+||.||+|... +|+.||+|++.... ...+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 345688999999999999765 78999999986532 1335688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~- 156 (291)
T cd05612 83 VPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW- 156 (291)
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCcc-
Confidence 99999999997643 688899999999999999999998 999999999999999999999999999987643221
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
...||+.|+|||++.+. .++.++|||||||++|||++|+.||....... +.+.+..+. ..++...
T Consensus 157 ----~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~------~~~~i~~~~-~~~~~~~-- 221 (291)
T cd05612 157 ----TLCGTPEYLAPEVIQSK--GHNKAVDWWALGILIYEMLVGYPPFFDDNPFG------IYEKILAGK-LEFPRHL-- 221 (291)
T ss_pred ----cccCChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC-cCCCccC--
Confidence 23599999999998763 67899999999999999999999997643211 222222221 1122211
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPS-----MHKVLEM 562 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~evl~~ 562 (582)
...+.+++.+||+.||.+||+ ++++++.
T Consensus 222 -----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 222 -----DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -----CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 345677888899999999995 8888754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=331.10 Aligned_cols=238 Identities=21% Similarity=0.321 Sum_probs=191.1
Q ss_pred cCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCCh
Q 040604 301 LGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSL 375 (582)
Q Consensus 301 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 375 (582)
||+|+||.||++... +++.||+|+++... .....+.+|+.++++++||||+++++.+.+....++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999765 68899999986532 2345678899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeecc
Q 040604 376 DKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHA 455 (582)
Q Consensus 376 ~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 455 (582)
.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........ ....
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~--~~~~ 153 (312)
T cd05585 81 FHHLQREG--RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTF 153 (312)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCc--cccc
Confidence 99987643 588999999999999999999998 9999999999999999999999999999864332221 1234
Q ss_pred cCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHH
Q 040604 456 RGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIA 535 (582)
Q Consensus 456 ~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 535 (582)
.||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... +.+.+... ...++. .+.
T Consensus 154 ~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~~~~~~~~-~~~~~~-------~~~ 217 (312)
T cd05585 154 CGTPEYLAPELLLG--HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------MYRKILQE-PLRFPD-------GFD 217 (312)
T ss_pred cCCcccCCHHHHcC--CCCCCccceechhHHHHHHHhCCCCcCCCCHHH------HHHHHHcC-CCCCCC-------cCC
Confidence 69999999999976 368999999999999999999999997543221 12222221 112222 233
Q ss_pred HHHHHHHHhccccCCCCCCC---HHHHHH
Q 040604 536 KMMILVGFWCIQTNPSERPS---MHKVLE 561 (582)
Q Consensus 536 ~~l~~l~~~Cl~~dp~~RPt---~~evl~ 561 (582)
..+.+++.+||+.||++||+ +++++.
T Consensus 218 ~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 218 RDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 45677888899999999985 555543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=307.38 Aligned_cols=247 Identities=27% Similarity=0.385 Sum_probs=206.6
Q ss_pred hhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCC-----CH----HHHHHHHHHHhcc-CCCceEEEEeEEEeCCeeeE
Q 040604 297 FRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRC-----NG----EEFINEVASISRT-SHVNIVTFLGFCYENKKNAL 365 (582)
Q Consensus 297 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~----~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 365 (582)
-++.||.|..++|.++.. .+|...|+|++..... .. +.-.+|+.+|+++ .||+|++|.+++..+...++
T Consensus 21 pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~Fl 100 (411)
T KOG0599|consen 21 PKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFL 100 (411)
T ss_pred hHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhh
Confidence 357899999999999854 4789999999864321 12 3346799999997 59999999999999999999
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
|+|.|+.|.|.+++.+. ..+++++..+|+.|+.+|++|||.. +||||||||+|||+|++..+||+|||+|..+..
T Consensus 101 VFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 101 VFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred hhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccCC
Confidence 99999999999999764 4799999999999999999999998 999999999999999999999999999999888
Q ss_pred cccceeeecccCCccccccccccc----ccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCC
Q 040604 446 KESAISMLHARGTIGYIAPEVYSR----RFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDF 521 (582)
Q Consensus 446 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~ 521 (582)
+... ...+|||+|+|||.+.- ....|+..+|+||+||++|.||.|.+||...... ++...|..|..
T Consensus 176 GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm------lMLR~ImeGky- 245 (411)
T KOG0599|consen 176 GEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM------LMLRMIMEGKY- 245 (411)
T ss_pred chhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH------HHHHHHHhccc-
Confidence 7654 34679999999998742 2347899999999999999999999999764321 23444555532
Q ss_pred CCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 522 QFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 522 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
...+++..++.....+|+.+||+.||++|.|++|+++
T Consensus 246 ---qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 246 ---QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred ---ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 2334566778888899999999999999999999984
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=335.92 Aligned_cols=243 Identities=24% Similarity=0.352 Sum_probs=197.9
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 368 (582)
.+.+.+.||+|+||.||+|... +++.||+|+++... ...+.+.+|+.++++++||||+++++.+.++...++|||
T Consensus 19 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 98 (329)
T PTZ00263 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE 98 (329)
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence 3456789999999999999765 68999999997532 234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
|+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 99 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 173 (329)
T PTZ00263 99 FVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF 173 (329)
T ss_pred CCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCcc
Confidence 999999999987643 578889999999999999999998 999999999999999999999999999987644321
Q ss_pred ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc
Q 040604 449 AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528 (582)
Q Consensus 449 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 528 (582)
...||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ..+.+..+. ..++...
T Consensus 174 -----~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~~~~i~~~~-~~~p~~~- 238 (329)
T PTZ00263 174 -----TLCGTPEYLAPEVIQSK--GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR------IYEKILAGR-LKFPNWF- 238 (329)
T ss_pred -----eecCChhhcCHHHHcCC--CCCCcceeechHHHHHHHHcCCCCCCCCCHHH------HHHHHhcCC-cCCCCCC-
Confidence 23599999999999764 67899999999999999999999997543211 223333322 2222222
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERPS-----MHKVLEM 562 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~evl~~ 562 (582)
...+.+++.+||+.||++||+ +++++..
T Consensus 239 ------~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 239 ------DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ------CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 244667888899999999997 6777633
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=364.47 Aligned_cols=261 Identities=28% Similarity=0.473 Sum_probs=208.3
Q ss_pred HHHHHHhhhhcCccCceEEEEEEeC--CCc----EEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCe
Q 040604 291 KRMTKSFRDKLGQGGYGEVYKGELP--DGQ----LVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKK 362 (582)
Q Consensus 291 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~----~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 362 (582)
.+....+.+.||+|+||.||.|... +|. .||||.++.... ...+|++|..+|++++|||||+++|+|.+...
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 3444456678999999999999654 444 489999976533 45789999999999999999999999999999
Q ss_pred eeEEEEecCCCChhhhhhcCC-----CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeec
Q 040604 363 NALIYELMPNGSLDKFIHNDR-----NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDF 437 (582)
Q Consensus 363 ~~lv~E~~~~gsL~~~i~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DF 437 (582)
.++++|||++|+|..+|++.+ ...++...++.++.|||+|+.||+++ .+|||||..+|+||+....|||+||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEccc
Confidence 999999999999999998752 34689999999999999999999998 9999999999999999999999999
Q ss_pred cccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCC-CCCCCCcccchhhHHHHH-hh
Q 040604 438 GLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTK-NLDDEVTDTSICHNLIYE-RI 515 (582)
Q Consensus 438 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~-p~~~~~~~~~~~~~~~~~-~i 515 (582)
|+|+.+.+.+.........-...|||||.+.+ +.++.|+|||||||+|||++|... |+....+ .+ +.. .+
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n-~~-----v~~~~~ 918 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-FE-----VLLDVL 918 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcch-HH-----HHHHHH
Confidence 99995544433222222234468999999987 589999999999999999999655 5554332 22 222 22
Q ss_pred cCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCC
Q 040604 516 EPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENL 570 (582)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~ 570 (582)
..+ .+..+ ..++..+.+|+..||+.+|++||++..|++.++..+..+
T Consensus 919 ~gg-RL~~P-------~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 919 EGG-RLDPP-------SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred hCC-ccCCC-------CCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 333 22222 234566778888999999999999999999998876654
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=321.75 Aligned_cols=256 Identities=27% Similarity=0.396 Sum_probs=202.0
Q ss_pred HHHHHhhhhcCccCceEEEEEEeC------CCcEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeCCee
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELP------DGQLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYENKKN 363 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 363 (582)
..++.+.++||+|+||.||+|... ++..||+|+++..... .+.+.+|+.++.+++||||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 345677899999999999999653 3578999999754432 35688999999999999999999999999999
Q ss_pred eEEEEecCCCChhhhhhcCC--------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC
Q 040604 364 ALIYELMPNGSLDKFIHNDR--------------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED 429 (582)
Q Consensus 364 ~lv~E~~~~gsL~~~i~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~ 429 (582)
++++||+++++|.+++.... ...+++..+++++.|++.||+|||+. +|+||||||+|||++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCC
Confidence 99999999999999985321 23478889999999999999999988 99999999999999999
Q ss_pred CceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhh
Q 040604 430 FCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICH 508 (582)
Q Consensus 430 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~ 508 (582)
+.+||+|||+++...............+++.|+|||.+.. +.++.++||||||+++|||++ |..|+......
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----- 233 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ----- 233 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-----
Confidence 9999999999987654332222223446789999999865 468899999999999999998 66677543221
Q ss_pred HHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 509 NLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 509 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
.+.+.+..+....... .....+.+++..||+.+|++||++++|++.|+.
T Consensus 234 -~~~~~i~~~~~~~~~~-------~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 234 -DVIEMIRNRQVLPCPD-------DCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -HHHHHHHcCCcCCCCC-------CCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1223333332211111 234557788889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=318.15 Aligned_cols=254 Identities=26% Similarity=0.455 Sum_probs=203.3
Q ss_pred HHHhhhhcCccCceEEEEEEeC----CCcEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP----DGQLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 367 (582)
.+.+.+.||+|+||+||+|.+. +...||||+++..... ...|.+|+.++++++|+||+++++++.+....++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 84 (266)
T cd05033 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIIT 84 (266)
T ss_pred HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEE
Confidence 3456789999999999999764 2457999998754432 356889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+|+||||+|||+++++.+||+|||+++......
T Consensus 85 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 85 EYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999997643 3689999999999999999999997 99999999999999999999999999999875333
Q ss_pred cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCc
Q 040604 448 SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 526 (582)
.........+++.|+|||.+.. ..++.++||||||++++||++ |..|+....... +...+..+......
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~--~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~-- 230 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD------VIKAVEDGYRLPPP-- 230 (266)
T ss_pred cceeccCCCCCccccChhhhcc--CCCccccchHHHHHHHHHHHccCCCCCCCCCHHH------HHHHHHcCCCCCCC--
Confidence 2222223346678999999876 468899999999999999998 888886543211 22223222111111
Q ss_pred CcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 040604 527 ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGS 566 (582)
Q Consensus 527 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~ 566 (582)
......+.+++.+||+.+|++||++++|++.|++.
T Consensus 231 -----~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 231 -----MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 12245678889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=323.80 Aligned_cols=260 Identities=27% Similarity=0.429 Sum_probs=205.5
Q ss_pred HHHHHhhhhcCccCceEEEEEEe------CCCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeee
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGEL------PDGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENKKNA 364 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 364 (582)
+..+.+.+.||+|+||.||++.. .++..+|+|.+..... ..+.+.+|+.++++++|+||+++++++......+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 33455678899999999999964 2356799999875432 3457899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCC-----------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceE
Q 040604 365 LIYELMPNGSLDKFIHNDR-----------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPK 433 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~-----------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vk 433 (582)
+||||+++++|.+++...+ ...+++..++.++.|++.||+|||+. +++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 9999999999999987432 23489999999999999999999988 999999999999999999999
Q ss_pred EeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHH
Q 040604 434 ISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIY 512 (582)
Q Consensus 434 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 512 (582)
|+|||+++...............+++.|+|||++.. ..++.++||||||++++||++ |..|+....... ..
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~------~~ 232 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------VI 232 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HH
Confidence 999999987644332222223346788999999875 478899999999999999998 888876543211 22
Q ss_pred HhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCC
Q 040604 513 ERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIEN 569 (582)
Q Consensus 513 ~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~ 569 (582)
+.+..+........ ....+.+++.+||+.+|.+|||+++|++.|++..+.
T Consensus 233 ~~i~~~~~~~~~~~-------~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 233 ECITQGRVLQRPRT-------CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHcCCcCCCCCC-------CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 23333322222211 234578888999999999999999999999986654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=320.97 Aligned_cols=256 Identities=25% Similarity=0.436 Sum_probs=199.4
Q ss_pred HHHHHhhhhcCccCceEEEEEEeC------CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCee
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELP------DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKN 363 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 363 (582)
...+++.++||+|+||.||+|... ++..||+|+++.... ...++.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~ 84 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 84 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence 344566789999999999998642 356799999865332 235688999999999999999999999998999
Q ss_pred eEEEEecCCCChhhhhhcCC--------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEe
Q 040604 364 ALIYELMPNGSLDKFIHNDR--------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKIS 435 (582)
Q Consensus 364 ~lv~E~~~~gsL~~~i~~~~--------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~ 435 (582)
++||||+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+|||+++++.+||+
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEEC
Confidence 99999999999999987532 12467888999999999999999997 99999999999999999999999
Q ss_pred eccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHh
Q 040604 436 DFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYER 514 (582)
Q Consensus 436 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 514 (582)
|||+++...............+++.|+|||++.+ +.++.++||||||+++|||++ |..|+....... ..+.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~------~~~~ 233 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ------VLRF 233 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHH
Confidence 9999986544322211122346788999999876 468999999999999999999 677775432211 1122
Q ss_pred hcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 515 IEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 515 i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
+.......... .....+.+++.+||+.+|++|||+.|+++.|+.
T Consensus 234 ~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCcCCCCC-------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 22211111111 223567888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=324.57 Aligned_cols=257 Identities=24% Similarity=0.336 Sum_probs=195.8
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC--CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR--CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
+.+.++||+|+||+||+|... +++.||+|+++... .....+.+|+.++++++||||+++++++......++||||++
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD 86 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence 456689999999999999764 78999999987543 234567899999999999999999999999889999999996
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 87 -~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~-- 159 (288)
T cd07871 87 -SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT-- 159 (288)
T ss_pred -cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc--
Confidence 58988886543 3578899999999999999999998 9999999999999999999999999999765432221
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCC----------
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDF---------- 521 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~---------- 521 (582)
.....||+.|+|||++.+. ..++.++||||+||++|||++|+.||........ .. .+...+......
T Consensus 160 ~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE-LH-LIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred ccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HH-HHHHHhCCCChHHhhccccchh
Confidence 1234589999999998653 4678999999999999999999999975433221 11 111111110000
Q ss_pred ----CCCCcCc----HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 522 ----QFDGVAT----EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 522 ----~~~~~~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.++.... .....+.....+++.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000 000122345678899999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=328.07 Aligned_cols=258 Identities=25% Similarity=0.423 Sum_probs=201.6
Q ss_pred HHHHHhhhhcCccCceEEEEEEeC-CCc----EEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeee
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELP-DGQ----LVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNA 364 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 364 (582)
...++..+.||+|+||.||+|.+. ++. .||+|+++.... ..+++.+|+.+++.++||||++++|++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 344556688999999999999753 343 489999875432 346788999999999999999999999764 567
Q ss_pred EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccc
Q 040604 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~ 444 (582)
+|+||+++|+|.+++.... ..+++..+++++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 85 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccccc
Confidence 9999999999999987643 3588899999999999999999998 99999999999999999999999999999876
Q ss_pred ccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCC
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQF 523 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~ 523 (582)
............++..|+|||++.+ ..++.++||||||+++|||++ |+.|+....... +.+.+..+.....
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~ 232 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------ISSILEKGERLPQ 232 (316)
T ss_pred CCCcceeccCCccceeecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHhCCCCCCC
Confidence 5443332223345678999999876 478999999999999999998 888886542211 1222222222212
Q ss_pred CCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCC
Q 040604 524 DGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIEN 569 (582)
Q Consensus 524 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~ 569 (582)
... ....+.+++.+||+.+|++||++.+++..|......
T Consensus 233 ~~~-------~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 233 PPI-------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred CCC-------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 221 123467788899999999999999999999876553
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=306.29 Aligned_cols=256 Identities=20% Similarity=0.268 Sum_probs=198.9
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCH---HHHHHHHHHHhccCCCceEEEEeEEEeC--CeeeEEEEe
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNG---EEFINEVASISRTSHVNIVTFLGFCYEN--KKNALIYEL 369 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~E~ 369 (582)
+...+|++|+||.||+|+++ +++.||+|.++...... =.-++|+.+|.+++|||||.+-.+.... +..||||||
T Consensus 79 e~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~ 158 (419)
T KOG0663|consen 79 EKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEY 158 (419)
T ss_pred HHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHH
Confidence 34578999999999999765 79999999998655321 2458999999999999999999888643 478999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
| .-+|..++..-+ .++...++.-+..|+++|++|||.. .|+||||||+|+|+...|.+||+|||+|+.+.....
T Consensus 159 ~-EhDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k- 232 (419)
T KOG0663|consen 159 V-EHDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK- 232 (419)
T ss_pred H-HhhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCcc-
Confidence 9 578999988654 5788899999999999999999998 899999999999999999999999999999877633
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcC--
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA-- 527 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~-- 527 (582)
.++..+-|.+|.|||.+.+. ..|+.+.|+||+|||+.||+++++.|........ +. .+...+.......+++..
T Consensus 233 -~~T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ-l~-~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 233 -PYTPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ-LD-KIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred -cCcceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH-HH-HHHHHhCCCccccCCCcccc
Confidence 23445688999999999885 6899999999999999999999998876544332 11 122222222111111110
Q ss_pred ------------cHHH----H--HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 528 ------------TEEE----K--KIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 528 ------------~~~~----~--~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.... . .+.+.-.+|+...|..||.+|.|+++.++
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 0000 0 13355567777889999999999999875
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=336.63 Aligned_cols=253 Identities=21% Similarity=0.235 Sum_probs=193.6
Q ss_pred HHHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 294 TKSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
.|.+.++||+|+||.||++.. .+++.||+|... .+.+.+|+.++++++||||+++++++......++|||++ +
T Consensus 93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~ 166 (391)
T PHA03212 93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-K 166 (391)
T ss_pred CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-C
Confidence 456678999999999999965 478999999753 345688999999999999999999999999999999999 5
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
++|..++.... .+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+........ ..
T Consensus 167 ~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~-~~ 240 (391)
T PHA03212 167 TDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN-KY 240 (391)
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccc-cc
Confidence 78888886543 588999999999999999999998 9999999999999999999999999999754322111 11
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCccc------chhhHHHHHhhcC---------
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDT------SICHNLIYERIEP--------- 517 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~------~~~~~~~~~~i~~--------- 517 (582)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.|+....... ..+.. +......
T Consensus 241 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~-i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 241 YGWAGTIATNAPELLAR--DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKL-IIRRSGTHPNEFPIDA 317 (391)
T ss_pred ccccCccCCCChhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHH-HHHHhcCChhhcCcch
Confidence 23469999999999876 368999999999999999999998765332110 00000 1111000
Q ss_pred -------------CCCCC-CCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 518 -------------GNDFQ-FDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 518 -------------~~~~~-~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
..... ...........+...+.+|+.+||+.||++|||++|+++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000 000011122345567888999999999999999999985
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=330.91 Aligned_cols=258 Identities=23% Similarity=0.334 Sum_probs=198.7
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
.+++.++||+|+||.||++... ++..+|+|+++.... ..+.+.+|+.++++++||||+++++++..+...++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 85 (331)
T cd06649 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 85 (331)
T ss_pred cceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecC
Confidence 4456688999999999999765 788999999875432 2356889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
++++|.+++.... .+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 159 (331)
T cd06649 86 DGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-- 159 (331)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccccccc--
Confidence 9999999997643 588999999999999999999985 2699999999999999999999999999986543221
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCC--------
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQ-------- 522 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~-------- 522 (582)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+......+....
T Consensus 160 --~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 160 --NSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred --ccCCCCcCcCCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccccCCccccCccc
Confidence 23459999999999876 368999999999999999999999996532211 0000000000000000
Q ss_pred -----------CCCc----------------Cc-HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 040604 523 -----------FDGV----------------AT-EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEML 563 (582)
Q Consensus 523 -----------~~~~----------------~~-~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L 563 (582)
.... .. .........+.+++.+||+.||++|||+++|++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0000 00 00012345678899999999999999999998653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=327.44 Aligned_cols=259 Identities=23% Similarity=0.326 Sum_probs=195.7
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
.+++.++||+|+||+||+|... +++.||||+++.... ....+.+|+.++++++||||+++++++.+....++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (303)
T cd07869 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV 85 (303)
T ss_pred cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence 3456789999999999999765 789999999875432 2346789999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
.++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 86 -~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 158 (303)
T cd07869 86 -HTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH-- 158 (303)
T ss_pred -CcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--
Confidence 577877776432 3588899999999999999999998 999999999999999999999999999876433221
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCC---------
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDF--------- 521 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~--------- 521 (582)
......||+.|+|||++.+. ..++.++||||+||++|||++|+.||.............. ..+......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIF-LVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred cCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHH-HHhCCCChhhccchhhcc
Confidence 11234589999999998653 3578899999999999999999999976533222111111 111100000
Q ss_pred -----CCCCcCcHHHH------HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 522 -----QFDGVATEEEK------KIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 522 -----~~~~~~~~~~~------~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.+....+.... .....+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000000000 12245678889999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=313.58 Aligned_cols=248 Identities=27% Similarity=0.452 Sum_probs=195.3
Q ss_pred hhcCccCceEEEEEEeC-CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCCh
Q 040604 299 DKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSL 375 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 375 (582)
++||+|+||.||+|... +++.+|+|.+..... ....+.+|+.++++++|+||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999764 789999998864432 235689999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeecc
Q 040604 376 DKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHA 455 (582)
Q Consensus 376 ~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 455 (582)
.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...............
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99987543 3588999999999999999999988 9999999999999999999999999998765432211111111
Q ss_pred cCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHH
Q 040604 456 RGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKI 534 (582)
Q Consensus 456 ~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 534 (582)
.++..|+|||.+.+ +.++.++||||||+++|||++ |..|+....... ....+.......... ..
T Consensus 157 ~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~------~~~~~~~~~~~~~~~-------~~ 221 (252)
T cd05084 157 QIPVKWTAPEALNY--GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ------TREAIEQGVRLPCPE-------LC 221 (252)
T ss_pred CCceeecCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH------HHHHHHcCCCCCCcc-------cC
Confidence 23567999999876 468899999999999999997 777775432211 112222221111111 22
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 535 AKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 535 ~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
...+.+++.+||+.+|++|||+.+|+++|+.
T Consensus 222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 4567888899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=330.21 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=208.7
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCCe-eeEEEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENKK-NALIYE 368 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~E 368 (582)
.|...+++|+|+||.++..+.+ +...+++|.+..... ..+...+|+.++++++|||||.+.+.|.+++. .++||+
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence 3566789999999999998654 678999999865443 33467899999999999999999999999888 899999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
|++||+|.+.|.++++..++++.+..++.|++.|+.|||+. .|+|||||+.||++..++.|||+|||+|+.+.....
T Consensus 85 Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred ecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 99999999999988888899999999999999999999987 999999999999999999999999999999888763
Q ss_pred ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc
Q 040604 449 AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528 (582)
Q Consensus 449 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 528 (582)
... ...|||.||.||.+.+. .|..|+|||||||++|||++-+++|...+... +..++..+....++.
T Consensus 162 ~a~--tvvGTp~YmcPEil~d~--pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~------Li~ki~~~~~~Plp~--- 228 (426)
T KOG0589|consen 162 LAS--TVVGTPYYMCPEILSDI--PYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE------LILKINRGLYSPLPS--- 228 (426)
T ss_pred hhh--eecCCCcccCHHHhCCC--CCCccCcchhhcchHHHHHhcccccCccchHH------HHHHHhhccCCCCCc---
Confidence 322 35699999999999885 89999999999999999999999998765433 222333322222222
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
.....+..++..||+.+|+.||++.+++..
T Consensus 229 ----~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 229 ----MYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ----cccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 234556667777999999999999999865
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=317.80 Aligned_cols=252 Identities=26% Similarity=0.429 Sum_probs=196.2
Q ss_pred hhhhcCccCceEEEEEEeCC-Cc--EEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeC------Ceee
Q 040604 297 FRDKLGQGGYGEVYKGELPD-GQ--LVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYEN------KKNA 364 (582)
Q Consensus 297 ~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 364 (582)
+.++||+|+||.||+|.+.. +. .+|+|.++.... ..+.+.+|+.++++++|+||+++++.+... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 56789999999999997653 33 689999876432 345688999999999999999999987532 2458
Q ss_pred EEEEecCCCChhhhhhcC----CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccc
Q 040604 365 LIYELMPNGSLDKFIHND----RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLA 440 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla 440 (582)
++|||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence 999999999999887432 233589999999999999999999997 9999999999999999999999999999
Q ss_pred ccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCC
Q 040604 441 KQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGN 519 (582)
Q Consensus 441 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~ 519 (582)
+...............+++.|+|||++.+ ..++.++||||||+++|||++ |+.|+...... .+.+.+..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~~~~~~ 231 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLAD--RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS------EIYDYLRQGN 231 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccC--CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHHcCC
Confidence 87654332211122346778999999876 368999999999999999999 77787643221 1223333332
Q ss_pred CCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 040604 520 DFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGS 566 (582)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~ 566 (582)
...... .....+.+++.+||+.||++|||+++|++.|+..
T Consensus 232 ~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RLKQPP-------DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 222211 2234577888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=323.32 Aligned_cols=257 Identities=26% Similarity=0.421 Sum_probs=204.3
Q ss_pred HHhhhhcCccCceEEEEEEeC------CCcEEEEEEeccCCCC-HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP------DGQLVAVKVLKNSRCN-GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 367 (582)
+.+.+.||+|+||.||+|... ++..+++|.++..... .+.+.+|+.++++++|+||+++++++......++||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (291)
T cd05094 7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVF 86 (291)
T ss_pred eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEE
Confidence 445678999999999999642 3567999998755432 356889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCC--------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceE
Q 040604 368 ELMPNGSLDKFIHNDR--------------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPK 433 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vk 433 (582)
||+++++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+|
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 87 EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred ecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 9999999999997532 23478999999999999999999998 999999999999999999999
Q ss_pred EeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHH
Q 040604 434 ISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIY 512 (582)
Q Consensus 434 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 512 (582)
|+|||++................|+..|+|||++.. ..++.++||||||+++|||++ |+.|+....... +.
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~~ 235 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------VI 235 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HH
Confidence 999999986544332222223457889999999876 368899999999999999998 888876543221 22
Q ss_pred HhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCC
Q 040604 513 ERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIEN 569 (582)
Q Consensus 513 ~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~ 569 (582)
+.+..+....... ..+..+.+++.+||+.+|++||++++|+++|++....
T Consensus 236 ~~~~~~~~~~~~~-------~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 236 ECITQGRVLERPR-------VCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHhCCCCCCCCc-------cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 2233322221111 2345678889999999999999999999999997553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=315.80 Aligned_cols=253 Identities=28% Similarity=0.448 Sum_probs=203.7
Q ss_pred HHHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
..+.+.++||+|++|.||++....+..+|+|.+.......+.+.+|+.++++++|+|++++++++. ....+++|||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 345667899999999999998877778999998776666678999999999999999999999875 4567899999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
++|.+++.......+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++........ ..
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~~ 160 (260)
T cd05069 85 GSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-AR 160 (260)
T ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc-cc
Confidence 9999999865555689999999999999999999987 9999999999999999999999999999876433211 11
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 531 (582)
....++..|+|||+..+ ...+.++||||||+++|||++ |+.|+....... ..+.+.........
T Consensus 161 ~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~~------- 225 (260)
T cd05069 161 QGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE------VLEQVERGYRMPCP------- 225 (260)
T ss_pred CCCccchhhCCHHHhcc--CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCCCCC-------
Confidence 12346778999998865 468899999999999999999 888886543221 11222222111111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 532 KKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
......+.+++.+||+.||++||++++|++.|+.
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 2334667888899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=325.31 Aligned_cols=256 Identities=25% Similarity=0.371 Sum_probs=192.5
Q ss_pred HHhhhhcCccCceEEEEEEeC--CCcEEEEEEeccCCC---CHHHHHHHHHHHhcc---CCCceEEEEeEEEe-----CC
Q 040604 295 KSFRDKLGQGGYGEVYKGELP--DGQLVAVKVLKNSRC---NGEEFINEVASISRT---SHVNIVTFLGFCYE-----NK 361 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~ 361 (582)
|++.++||+|+||+||+|... +++.||+|+++.... ....+.+|+.+++++ +||||+++++++.. ..
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 456788999999999999753 578899999865432 234566777777665 69999999999852 34
Q ss_pred eeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccc
Q 040604 362 KNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAK 441 (582)
Q Consensus 362 ~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~ 441 (582)
..++||||++ ++|.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 6789999995 7999998766555689999999999999999999998 99999999999999999999999999998
Q ss_pred cccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCC-
Q 040604 442 QAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND- 520 (582)
Q Consensus 442 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~- 520 (582)
....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .....+ +.+.....
T Consensus 159 ~~~~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~-~~~~~~~~~ 231 (290)
T cd07862 159 IYSFQMA---LTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKIL-DVIGLPGEE 231 (290)
T ss_pred eccCCcc---cccccccccccChHHHhC--CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHH-HHhCCCChh
Confidence 7654321 123458999999999875 468899999999999999999999997653322 111111 11110000
Q ss_pred ----------CCCCCcCc----HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 521 ----------FQFDGVAT----EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 521 ----------~~~~~~~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
..+..... .....+...+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000000 001123456778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=329.60 Aligned_cols=241 Identities=23% Similarity=0.335 Sum_probs=194.2
Q ss_pred hhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCC
Q 040604 299 DKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNG 373 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 373 (582)
+.||+|+||.||++... +|+.||+|+++... .....+.+|+.++++++||||+++++.+......++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999754 78999999997532 23356788999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeee
Q 040604 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISML 453 (582)
Q Consensus 374 sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 453 (582)
+|..++...+ .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........ ..
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~--~~ 153 (328)
T cd05593 81 ELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT--MK 153 (328)
T ss_pred CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccc--cc
Confidence 9998887543 688999999999999999999998 9999999999999999999999999998764332211 12
Q ss_pred cccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHH
Q 040604 454 HARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKK 533 (582)
Q Consensus 454 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 533 (582)
...||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... +.+.+... ...++. .
T Consensus 154 ~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~------~~~~~~~~-~~~~p~-------~ 217 (328)
T cd05593 154 TFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILME-DIKFPR-------T 217 (328)
T ss_pred cccCCcCccChhhhcC--CCCCccCCccccchHHHHHhhCCCCCCCCCHHH------HHHHhccC-CccCCC-------C
Confidence 3469999999999876 368899999999999999999999997543221 11222111 111222 2
Q ss_pred HHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 040604 534 IAKMMILVGFWCIQTNPSERP-----SMHKVLEM 562 (582)
Q Consensus 534 ~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~~ 562 (582)
+...+.+++.+||+.||++|| +++++++.
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 334567788889999999997 88988754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=324.07 Aligned_cols=259 Identities=20% Similarity=0.259 Sum_probs=197.1
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
+.+.+.||+|+||+||++... +++.||+|+++.... ..+.+.+|+.++++++|+||+++++++.+++..++||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 456688999999999999775 688999999875432 3456889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
+++.|..+... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 156 (287)
T cd07848 83 EKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA- 156 (287)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc-
Confidence 88877665443 23688999999999999999999988 9999999999999999999999999999876443221
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhh----------HHHHHhhcCCC-
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICH----------NLIYERIEPGN- 519 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~----------~~~~~~i~~~~- 519 (582)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||........... ...........
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGA--PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccCCcHHHcCC--CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 11234589999999998763 688999999999999999999999976433221100 00000000000
Q ss_pred -CCCCCCc--Cc----HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 520 -DFQFDGV--AT----EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 520 -~~~~~~~--~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
....... .. .....+...+.+++.+||+.||++|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 00 011124567889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=319.66 Aligned_cols=254 Identities=28% Similarity=0.439 Sum_probs=200.4
Q ss_pred HHHhhhhcCccCceEEEEEEe-----CCCcEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGEL-----PDGQLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYENKKNALI 366 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 366 (582)
.+++.++||+|+||.||+|.. .+++.+|+|.++..... ...+.+|+.++++++|+||+++++++......++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence 446678999999999999964 25678999999754332 25688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcCC---------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc
Q 040604 367 YELMPNGSLDKFIHNDR---------------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFC 431 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~---------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~ 431 (582)
|||+++++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+|||+++++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCc
Confidence 99999999999985321 23478899999999999999999998 9999999999999999999
Q ss_pred eEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHH
Q 040604 432 PKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNL 510 (582)
Q Consensus 432 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~ 510 (582)
+||+|||+++...............++..|+|||++.+ +.++.++||||||++++||++ |..|+...... .
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~------~ 234 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY--GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ------E 234 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH------H
Confidence 99999999987644332222223346778999999875 468999999999999999998 88887653221 1
Q ss_pred HHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 511 IYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 511 ~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
+.+.+.......... .....+.+++.+||+.||++||++.+|++.|.+
T Consensus 235 ~~~~~~~~~~~~~~~-------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKRQLLPCSE-------DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCcCCCCC-------CCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 223333322222222 123456778889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=314.56 Aligned_cols=256 Identities=23% Similarity=0.308 Sum_probs=198.9
Q ss_pred hhhcCccCceEEEEEEeC-CCcEEEEEEecc---CCCCHHHHHHHHHHHhccCCCceEEEEeEEEe-----CCeeeEEEE
Q 040604 298 RDKLGQGGYGEVYKGELP-DGQLVAVKVLKN---SRCNGEEFINEVASISRTSHVNIVTFLGFCYE-----NKKNALIYE 368 (582)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~~lv~E 368 (582)
.+.||+|+||.|..+... +|+.||||.+.. .....+.-.+|+.+|++++|+||+.+++++.. -...|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 477999999999999654 899999999863 33345678899999999999999999999875 346799999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
+| +.+|...|+.+. .++...+.-++.|+++||.|+|+. +|+||||||.|+|++.+..+||+|||+|+.......
T Consensus 107 lM-etDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~ 180 (359)
T KOG0660|consen 107 LM-ETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFE 180 (359)
T ss_pred HH-hhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccccCc
Confidence 99 889999998654 589999999999999999999998 999999999999999999999999999999865433
Q ss_pred ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccch--------------h----hHH
Q 040604 449 AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSI--------------C----HNL 510 (582)
Q Consensus 449 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~--------------~----~~~ 510 (582)
...++...-|.+|.|||++... ..++.+.||||+|||+.||++|++.|.+....... + ...
T Consensus 181 ~~~mTeYVaTRWYRAPElll~~-~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ 259 (359)
T KOG0660|consen 181 DGFMTEYVATRWYRAPELLLNS-SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK 259 (359)
T ss_pred ccchhcceeeeeecCHHHHhcc-ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence 3334556789999999998764 68999999999999999999999998765443220 0 000
Q ss_pred HHHhhcCCCCCCCCCc-CcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 511 IYERIEPGNDFQFDGV-ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 511 ~~~~i~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
....+..-.. .+.. ............++|+.+||..||.+|+|++|.++.
T Consensus 260 ar~yi~slp~--~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 260 ARPYIKSLPQ--IPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHhCCC--CCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1111111100 0000 011111223456778888999999999999999853
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=328.76 Aligned_cols=240 Identities=23% Similarity=0.328 Sum_probs=192.8
Q ss_pred hhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCC
Q 040604 299 DKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNG 373 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 373 (582)
+.||+|+||.||++... +|+.||+|+++... .....+.+|+.++++++||||+++++.+......++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999754 78999999997532 22345778999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeee
Q 040604 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISML 453 (582)
Q Consensus 374 sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 453 (582)
+|..++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........ ..
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--~~ 153 (323)
T cd05595 81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MK 153 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc--cc
Confidence 9998887543 688999999999999999999998 9999999999999999999999999998764332211 12
Q ss_pred cccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHH
Q 040604 454 HARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKK 533 (582)
Q Consensus 454 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 533 (582)
...||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..+.+... ...++. .
T Consensus 154 ~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~~~~~-~~~~p~-------~ 217 (323)
T cd05595 154 TFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELILME-EIRFPR-------T 217 (323)
T ss_pred cccCCcCcCCcccccC--CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHhcC-CCCCCC-------C
Confidence 3469999999999876 478999999999999999999999997543221 11111111 111222 2
Q ss_pred HHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 040604 534 IAKMMILVGFWCIQTNPSERP-----SMHKVLE 561 (582)
Q Consensus 534 ~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~ 561 (582)
+...+.+++.+||+.||++|| ++.++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 234567788889999999998 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=333.09 Aligned_cols=260 Identities=22% Similarity=0.318 Sum_probs=193.6
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC---CCHHHHHHHHHHHhccCCCceEEEEeEEEeC-----CeeeE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR---CNGEEFINEVASISRTSHVNIVTFLGFCYEN-----KKNAL 365 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~l 365 (582)
+.+.++||+|+||.||+|... +|+.||||+++... .....+.+|+.++++++||||+++++++... ...++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 345688999999999999754 78999999986432 2234688999999999999999999988643 24789
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
||||+ +++|.+++.... .+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 82 v~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 82 VFELM-ESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEecC-CCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 99999 578988887543 589999999999999999999998 999999999999999999999999999986543
Q ss_pred ccc-ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCC-----
Q 040604 446 KES-AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGN----- 519 (582)
Q Consensus 446 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~----- 519 (582)
... ........||+.|+|||++.+....++.++|||||||++|||++|+.||........ ...+...+....
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ--LDLITDLLGTPSPETIS 233 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH--HHHHHHHhCCCCHHHHH
Confidence 221 111223469999999999865334688999999999999999999999865432110 000000000000
Q ss_pred --------------CCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 520 --------------DFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 520 --------------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
..................+.+++.+||+.||++|||++|+++.
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000111223456788999999999999999999854
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=314.55 Aligned_cols=255 Identities=29% Similarity=0.476 Sum_probs=207.5
Q ss_pred HHHHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
+..+.+.++||+|+||.||+|...+++.+|||.+.......+++.+|+.++++++|+|++++++++......++||||++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 44556778999999999999988788899999998777777889999999999999999999999998888999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
+++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++........ .
T Consensus 85 ~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~ 160 (261)
T cd05034 85 KGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT-A 160 (261)
T ss_pred CCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhh-h
Confidence 99999999876656789999999999999999999998 9999999999999999999999999999876532211 1
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHH
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 530 (582)
.....++..|+|||.+.+ ..++.++|+||||++++||++ |+.|+....... ..+.+..+.......
T Consensus 161 ~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~------~~~~~~~~~~~~~~~----- 227 (261)
T cd05034 161 REGAKFPIKWTAPEAANY--GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE------VLEQVERGYRMPRPP----- 227 (261)
T ss_pred hhccCCCccccCHHHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCCCCCC-----
Confidence 112235678999999876 368899999999999999998 888885432211 122222221111111
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 531 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
.....+.+++.+||+.+|++||+++++++.|+.
T Consensus 228 --~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 228 --NCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 113467788889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=319.20 Aligned_cols=245 Identities=25% Similarity=0.344 Sum_probs=193.9
Q ss_pred cCccCceEEEEEEeC-CCcEEEEEEeccCCC----CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCCh
Q 040604 301 LGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSL 375 (582)
Q Consensus 301 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 375 (582)
||+|+||.||++... +|+.||+|.+..... ....+..|+.++++++||||+++++.+.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999754 799999999864322 233456799999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeecc
Q 040604 376 DKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHA 455 (582)
Q Consensus 376 ~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 455 (582)
..++.......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......... ...
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~---~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCcee---ecc
Confidence 9988766656789999999999999999999998 9999999999999999999999999999876543221 234
Q ss_pred cCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHH
Q 040604 456 RGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIA 535 (582)
Q Consensus 456 ~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 535 (582)
.||+.|+|||++.+. .++.++||||+||++|||++|+.|+........ ...+......... .. ....+.
T Consensus 155 ~~~~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~-~~------~~~~~~ 223 (277)
T cd05607 155 AGTNGYMAPEILKEE--PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLEDEV-KF------EHQNFT 223 (277)
T ss_pred CCCCCccCHHHHccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhcccc-cc------ccccCC
Confidence 599999999998764 589999999999999999999999865432211 1111111111110 00 011234
Q ss_pred HHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 536 KMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 536 ~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
..+.+++..||+.||++||+++|+++.
T Consensus 224 ~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 224 EESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred HHHHHHHHHHhccCHhhCCCCccchhh
Confidence 556788888999999999999776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=343.96 Aligned_cols=249 Identities=21% Similarity=0.276 Sum_probs=197.6
Q ss_pred HHhhhhcCccCceEEEEEEeC-C-CcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-D-GQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
+.+.+.||+|++|.||+|... + ++.||+|.+..... ....+.+|+.+++.++|||||++++++...+..+|||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 456688999999999999543 4 67889997754332 23457789999999999999999999999999999999999
Q ss_pred CCChhhhhhcC--CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 372 NGSLDKFIHND--RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 372 ~gsL~~~i~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+|+|.+++... ...++++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99999988642 344688999999999999999999998 9999999999999999999999999999876543322
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+ ..+..+....+..
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~-----~~-~~~~~~~~~~~~~---- 293 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWER--KRYSKKADMWSLGVILYELLTLHRPFKGPSQRE-----IM-QQVLYGKYDPFPC---- 293 (478)
T ss_pred ccccccCCCccccCHhHhCC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-----HH-HHHHhCCCCCCCc----
Confidence 12233469999999999876 478999999999999999999999996543211 11 2222221111111
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.+...+.+++.+||+.||++||++++++.
T Consensus 294 ---~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 294 ---PVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ---cCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 23355778888999999999999998864
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=304.97 Aligned_cols=247 Identities=24% Similarity=0.337 Sum_probs=199.5
Q ss_pred HHHhhhhcCccCceEEEEE-EeCCCcEEEEEEeccC---CCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 294 TKSFRDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNS---RCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
.+++.+.||+|.|+.||++ ...+|+.+|+|++... ....+++.+|+.+.+.|+|||||+|.+...+....+||+|+
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~ 91 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 91 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEec
Confidence 4567789999999999998 4558999999988543 33567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---CCceEEeecccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE---DFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~---~~~vkl~DFGla~~~~~~ 446 (582)
|.|++|..-|... .-.++..+-..+.||++||.|+|.+ +|||||+||+|+|+.. .-.+||+|||+|..+..+
T Consensus 92 m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g 166 (355)
T KOG0033|consen 92 VTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG 166 (355)
T ss_pred ccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence 9999997655433 3467788888999999999999998 9999999999999953 456999999999998843
Q ss_pred ccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCc
Q 040604 447 ESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526 (582)
Q Consensus 447 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 526 (582)
.. .....|||+|||||++.+. .++..+|||+.||+||-||.|..||.+..... ++++|..+... +++
T Consensus 167 ~~---~~G~~GtP~fmaPEvvrkd--py~kpvDiW~cGViLfiLL~G~~PF~~~~~~r------lye~I~~g~yd-~~~- 233 (355)
T KOG0033|consen 167 EA---WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQHR------LYEQIKAGAYD-YPS- 233 (355)
T ss_pred cc---cccccCCCcccCHHHhhcC--CCCCcchhhhhhHHHHHHHhCCCCCCCccHHH------HHHHHhccccC-CCC-
Confidence 32 2356799999999999874 79999999999999999999999998754433 56776665421 111
Q ss_pred CcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 040604 527 ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVL 560 (582)
Q Consensus 527 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl 560 (582)
.+...+.....+|+.+||..||.+|.|+.|.+
T Consensus 234 --~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 234 --PEWDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred --cccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 11222333445566668899999999999887
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=331.52 Aligned_cols=244 Identities=25% Similarity=0.319 Sum_probs=197.5
Q ss_pred HHHHhhhhcCccCceEEEEEEeC-C-CcEEEEEEeccCC----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEE
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELP-D-GQLVAVKVLKNSR----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALI 366 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 366 (582)
..+.+.+.||+|+||.||+|... + +..||+|++.... ...+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 34566789999999999999654 3 4689999986432 2345688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccc
Q 040604 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~ 446 (582)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 99999999999997654 588999999999999999999998 9999999999999999999999999999876432
Q ss_pred ccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCc
Q 040604 447 ESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526 (582)
Q Consensus 447 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 526 (582)
. ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .+.+.+..+. ..++..
T Consensus 185 ~-----~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~~i~~~~-~~~p~~ 250 (340)
T PTZ00426 185 T-----YTLCGTPEYIAPEILLN--VGHGKAADWWTLGIFIYEILVGCPPFYANEPL------LIYQKILEGI-IYFPKF 250 (340)
T ss_pred c-----ceecCChhhcCHHHHhC--CCCCccccccchhhHHHHHhcCCCCCCCCCHH------HHHHHHhcCC-CCCCCC
Confidence 2 13469999999999976 36789999999999999999999999764321 1223333322 112222
Q ss_pred CcHHHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 040604 527 ATEEEKKIAKMMILVGFWCIQTNPSERP-----SMHKVLEM 562 (582)
Q Consensus 527 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~~ 562 (582)
. ...+.+++.+||+.||++|+ +++++++.
T Consensus 251 ~-------~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 251 L-------DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred C-------CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 2 23456777889999999995 89988764
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=320.88 Aligned_cols=258 Identities=25% Similarity=0.450 Sum_probs=202.7
Q ss_pred HHHHHhhhhcCccCceEEEEEEeC------CCcEEEEEEeccCCCC--HHHHHHHHHHHhcc-CCCceEEEEeEEEeCCe
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELP------DGQLVAVKVLKNSRCN--GEEFINEVASISRT-SHVNIVTFLGFCYENKK 362 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 362 (582)
+..+++.+.||+|+||.||++... +...+|+|.++..... ...+.+|+.+++++ +|+||+++++++..+..
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 334556688999999999999653 3468999998754332 24688999999999 89999999999999989
Q ss_pred eeEEEEecCCCChhhhhhcC--------------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC
Q 040604 363 NALIYELMPNGSLDKFIHND--------------RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE 428 (582)
Q Consensus 363 ~~lv~E~~~~gsL~~~i~~~--------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~ 428 (582)
.+++|||+++|+|.+++... ....+++..++.++.|++.||.|||+. +|+||||||+|||+++
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcC
Confidence 99999999999999998642 234688999999999999999999987 9999999999999999
Q ss_pred CCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchh
Q 040604 429 DFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSIC 507 (582)
Q Consensus 429 ~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~ 507 (582)
++.+||+|||+++...............++..|+|||++.+ ..++.++|||||||++|||++ |..|+.......
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--- 242 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--- 242 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc--CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH---
Confidence 99999999999987654332222223346678999998865 368899999999999999997 888876543211
Q ss_pred hHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 040604 508 HNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSI 567 (582)
Q Consensus 508 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~ 567 (582)
+.+.+..+....... .....+.+++.+||+.+|++||||+++++.|+..+
T Consensus 243 ---~~~~~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 ---LFKLLKEGYRMEKPQ-------NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ---HHHHHHcCCcCCCCC-------CCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 122222222111111 22345778889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=319.80 Aligned_cols=258 Identities=26% Similarity=0.417 Sum_probs=204.5
Q ss_pred HHHHHhhhhcCccCceEEEEEEe------CCCcEEEEEEeccCCCC--HHHHHHHHHHHhcc-CCCceEEEEeEEEeCCe
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGEL------PDGQLVAVKVLKNSRCN--GEEFINEVASISRT-SHVNIVTFLGFCYENKK 362 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 362 (582)
...+.+.+.||+|+||.||++.. ..+..+|||+++..... .+.+.+|+.+++++ +|+||+++++++.....
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 44566778999999999999953 13568999998764332 35688999999999 79999999999999999
Q ss_pred eeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccc
Q 040604 363 NALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ 442 (582)
Q Consensus 363 ~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~ 442 (582)
.++||||+++|+|.+++.......+++.++..++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||+++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccccc
Confidence 99999999999999999865544589999999999999999999998 999999999999999999999999999987
Q ss_pred ccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCC
Q 040604 443 AQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDF 521 (582)
Q Consensus 443 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~ 521 (582)
..............++..|+|||.+.. +.++.++||||+|+++|||++ |..|+........ ..+.+..+...
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-----~~~~~~~~~~~ 263 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-----FYKLIKEGYRM 263 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhcc--CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-----HHHHHHcCCcC
Confidence 654432222222346788999999876 368899999999999999998 8888865433221 12222222111
Q ss_pred CCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 040604 522 QFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGS 566 (582)
Q Consensus 522 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~ 566 (582)
.... .....+.+++.+||+.+|++|||+.+|++.|++.
T Consensus 264 ~~~~-------~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 264 AQPE-------HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCC-------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1111 1234678888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=313.70 Aligned_cols=253 Identities=28% Similarity=0.469 Sum_probs=198.2
Q ss_pred HhhhhcCccCceEEEEEEeC-C---CcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEeCCe------
Q 040604 296 SFRDKLGQGGYGEVYKGELP-D---GQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYENKK------ 362 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 362 (582)
.+.+.||+|+||.||+|... + +..||+|.++..... .+.+.+|+..++.++|+||+++++++.+...
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 35678999999999999753 2 478999998754332 3568899999999999999999999876554
Q ss_pred eeEEEEecCCCChhhhhhcC----CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecc
Q 040604 363 NALIYELMPNGSLDKFIHND----RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFG 438 (582)
Q Consensus 363 ~~lv~E~~~~gsL~~~i~~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFG 438 (582)
.+++|||+++|+|..++... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCcc
Confidence 68999999999999988543 223689999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcC
Q 040604 439 LAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEP 517 (582)
Q Consensus 439 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~ 517 (582)
+++...............++..|+|||++.. ..++.++||||||+++|||++ |..|+....... +.+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~------~~~~~~~ 230 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE------IYDYLRH 230 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHc
Confidence 9987654432211122335678999999865 468899999999999999999 777875543221 2222222
Q ss_pred CCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 040604 518 GNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGS 566 (582)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~ 566 (582)
+....... .....+.+++.+||+.||++|||+.||++.|++.
T Consensus 231 ~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNRLKQPE-------DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCCCCc-------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 22222211 2345678888899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=317.76 Aligned_cols=256 Identities=25% Similarity=0.426 Sum_probs=201.8
Q ss_pred HHHHHhhhhcCccCceEEEEEEeC------CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCee
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELP------DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKN 363 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 363 (582)
+..+.+.+.||+|+||.||+|... ++..||+|.+..... ....+.+|+.++++++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 445566789999999999999653 246899999865432 234688999999999999999999999999999
Q ss_pred eEEEEecCCCChhhhhhcCC--------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEe
Q 040604 364 ALIYELMPNGSLDKFIHNDR--------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKIS 435 (582)
Q Consensus 364 ~lv~E~~~~gsL~~~i~~~~--------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~ 435 (582)
++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 99999999999999987532 12478889999999999999999987 99999999999999999999999
Q ss_pred eccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHh
Q 040604 436 DFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYER 514 (582)
Q Consensus 436 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 514 (582)
|||+++...............+|..|+|||.+.. +.++.++||||||+++|||++ |+.|+....... ..+.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~~~~ 233 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD--GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE------VLKF 233 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhc--CCCCcccchHHHHHHHHHhhccCCCCCccCCHHH------HHHH
Confidence 9999986544332212223347889999999865 468999999999999999998 888876432211 1122
Q ss_pred hcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 515 IEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 515 i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
+..+........ ....+.+++.+||+.+|++|||+.++++.|+.
T Consensus 234 ~~~~~~~~~~~~-------~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 234 VIDGGHLDLPEN-------CPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HhcCCCCCCCCC-------CCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 222222222221 24567888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=323.69 Aligned_cols=200 Identities=27% Similarity=0.390 Sum_probs=172.2
Q ss_pred HHHHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEE
Q 040604 291 KRMTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 291 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 367 (582)
....+++.++||+|+||.||++... ++..+|+|+++.... ..+.+.+|+.++++++|+||+++++++.++...++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3456677889999999999999765 688999999875432 2356889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
||+++|+|.+++...+ .+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++.......
T Consensus 83 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 83 EHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 9999999999997643 588899999999999999999974 279999999999999999999999999997654322
Q ss_pred cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCC
Q 040604 448 SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDE 500 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~ 500 (582)
. ....||..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 159 ~----~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 159 A----NSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred c----ccCCCCccccCHHHhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 1 23459999999999876 36889999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=333.61 Aligned_cols=250 Identities=20% Similarity=0.260 Sum_probs=190.7
Q ss_pred HhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCC----CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 296 SFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRC----NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
.+.++||+|+||+||+|.. .+++.||||++..... ..+.+.+|+.++++++|+||+++++.+.+....++||||+
T Consensus 4 ~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~ 83 (381)
T cd05626 4 VKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI 83 (381)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecC
Confidence 4567899999999999965 4789999999975432 2356889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc-
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA- 449 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~- 449 (582)
++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 84 PGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 9999999987643 588889999999999999999998 9999999999999999999999999997643210000
Q ss_pred --------------------------------------------eeeecccCCcccccccccccccCCCCccchhHHHHH
Q 040604 450 --------------------------------------------ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGM 485 (582)
Q Consensus 450 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGv 485 (582)
.......||+.|+|||++.+ ..++.++|||||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSlG~ 236 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR--KGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC--CCCCCccceeehhh
Confidence 00012369999999999876 36889999999999
Q ss_pred HHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCC--cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 486 MIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG--VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 486 il~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
++|||++|+.||........ ....+........+. ..+.+..+++.+|+ |+..++..||+++++++.
T Consensus 237 il~elltG~~Pf~~~~~~~~-----~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll-----~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTET-----QLKVINWENTLHIPPQVKLSPEAVDLITKLC-----CSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHH-----HHHHHccccccCCCCCCCCCHHHHHHHHHHc-----cCcccccCCCCHHHHhcC
Confidence 99999999999976543221 111111111111111 12233333333322 667788889999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=309.73 Aligned_cols=245 Identities=28% Similarity=0.446 Sum_probs=195.8
Q ss_pred hcCccCceEEEEEEe---CCCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCC
Q 040604 300 KLGQGGYGEVYKGEL---PDGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNG 373 (582)
Q Consensus 300 ~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 373 (582)
+||+|+||.||+|.+ .++..+|+|+++..... .+++.+|+.++++++|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 699999999999954 36789999998754432 357889999999999999999999875 45678999999999
Q ss_pred ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce-ee
Q 040604 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI-SM 452 (582)
Q Consensus 374 sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~-~~ 452 (582)
+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||.||++++++.+||+|||+++......... ..
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 9999997543 688999999999999999999998 99999999999999999999999999998765443221 11
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 531 (582)
....++..|+|||.+.. ..++.++||||||+++|||++ |+.||....... +.+.+..+.....+..
T Consensus 156 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~i~~~~~~~~~~~----- 222 (257)
T cd05116 156 THGKWPVKWYAPECMNY--YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE------VTQMIESGERMECPQR----- 222 (257)
T ss_pred CCCCCCccccCHhHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHCCCCCCCCCC-----
Confidence 22335679999998865 468889999999999999998 888987543221 2233333332222222
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 532 KKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
....+.+++.+||+.||++||++.+|.+.|++
T Consensus 223 --~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 223 --CPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred --CCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 23456778889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=325.98 Aligned_cols=235 Identities=25% Similarity=0.332 Sum_probs=188.9
Q ss_pred hhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 299 DKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISRT-SHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
+.||+|+||+||+|... +++.||||+++... ...+.+..|..++..+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999765 68999999987532 2345677888888776 699999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........ .
T Consensus 81 g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~--~ 153 (320)
T cd05590 81 GDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--T 153 (320)
T ss_pred chHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc--c
Confidence 99999887543 688999999999999999999998 9999999999999999999999999998764332221 1
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... +.+.+.... ..++..
T Consensus 154 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~-~~~~~~------ 218 (320)
T cd05590 154 STFCGTPDYIAPEILQE--MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD------LFEAILNDE-VVYPTW------ 218 (320)
T ss_pred cccccCccccCHHHHcC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH------HHHHHhcCC-CCCCCC------
Confidence 23469999999999876 368899999999999999999999997643221 223332221 112221
Q ss_pred HHHHHHHHHHHhccccCCCCCCCH
Q 040604 533 KIAKMMILVGFWCIQTNPSERPSM 556 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RPt~ 556 (582)
+...+.+++.+||+.||++||++
T Consensus 219 -~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 219 -LSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred -CCHHHHHHHHHHcccCHHHCCCC
Confidence 23456778888999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=327.01 Aligned_cols=261 Identities=25% Similarity=0.438 Sum_probs=201.5
Q ss_pred HHHHHhhhhcCccCceEEEEEEe------CCCcEEEEEEeccCCCC--HHHHHHHHHHHhcc-CCCceEEEEeEEEeCC-
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGEL------PDGQLVAVKVLKNSRCN--GEEFINEVASISRT-SHVNIVTFLGFCYENK- 361 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~- 361 (582)
..++.+.+.||+|+||.||+|.. .+++.||||+++..... ...+.+|+.++.++ +|+||+++++++....
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 44567889999999999999963 35789999999764332 34688999999999 6899999999887544
Q ss_pred eeeEEEEecCCCChhhhhhcCCC---------------------------------------------------------
Q 040604 362 KNALIYELMPNGSLDKFIHNDRN--------------------------------------------------------- 384 (582)
Q Consensus 362 ~~~lv~E~~~~gsL~~~i~~~~~--------------------------------------------------------- 384 (582)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 56899999999999999864321
Q ss_pred --------cCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeeccc
Q 040604 385 --------IKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR 456 (582)
Q Consensus 385 --------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 456 (582)
..+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 2367888899999999999999998 99999999999999999999999999998754332222222234
Q ss_pred CCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHH
Q 040604 457 GTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIA 535 (582)
Q Consensus 457 gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 535 (582)
+++.|+|||.+.. ..++.++||||||+++|||++ |..|+........ ....+..+.....+.. ..
T Consensus 243 ~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~-------~~ 308 (343)
T cd05103 243 LPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-----FCRRLKEGTRMRAPDY-------TT 308 (343)
T ss_pred CCcceECcHHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-----HHHHHhccCCCCCCCC-------CC
Confidence 6778999999865 368899999999999999996 8888865432221 1222222222222211 12
Q ss_pred HHHHHHHHhccccCCCCCCCHHHHHHHHhcccCC
Q 040604 536 KMMILVGFWCIQTNPSERPSMHKVLEMLEGSIEN 569 (582)
Q Consensus 536 ~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~ 569 (582)
..+.+++.+||+.+|++|||+.+|++.|+..+++
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 3567788899999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=327.69 Aligned_cols=268 Identities=25% Similarity=0.374 Sum_probs=211.1
Q ss_pred HHHHHHHHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeE
Q 040604 288 SDVKRMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYENKKNAL 365 (582)
Q Consensus 288 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 365 (582)
.|+-+....|+++||+|-||.|.++....+..||||.++..... ..+|.+|+++|.+++|||||+|+|+|..++.+.+
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 34445556788999999999999999877899999999876543 3689999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
|+|||++|+|.+++.......+.-....+|+.||+.||+||.+. ++|||||.+.|+|+|.++++||+|||+++.+-.
T Consensus 613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccccc
Confidence 99999999999999876432345566778999999999999997 999999999999999999999999999997666
Q ss_pred cccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc--CCCCCCCCCcccchhhHHHHHhhcCCCCCCC
Q 040604 446 KESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG--CTKNLDDEVTDTSICHNLIYERIEPGNDFQF 523 (582)
Q Consensus 446 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt--g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~ 523 (582)
++....-....-.+.|||+|.+.- ++++.++|||+|||.+||+++ ..+|+.....+. ..+..-+.+..+....
T Consensus 690 g~yy~vqgr~vlpiRwmawEsill--gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--vven~~~~~~~~~~~~- 764 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--VVENAGEFFRDQGRQV- 764 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHh--ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--HHHhhhhhcCCCCcce-
Confidence 554433333445689999999875 689999999999999999864 667776543322 1111112222221111
Q ss_pred CCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 040604 524 DGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGS 566 (582)
Q Consensus 524 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~ 566 (582)
......-.+..+.+++++||+.|.++||++++|...|...
T Consensus 765 ---~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 ---VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ---eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1111223445677888899999999999999999988764
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=317.31 Aligned_cols=255 Identities=25% Similarity=0.423 Sum_probs=200.6
Q ss_pred HhhhhcCccCceEEEEEEeC------CCcEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEE
Q 040604 296 SFRDKLGQGGYGEVYKGELP------DGQLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 367 (582)
.+.+.||+|+||.||+|... ....+|+|.+...... .+.+.+|+.++++++||||+++++.+......+++|
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV 82 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence 45678999999999999642 2357999988754432 356889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCC----------------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEE
Q 040604 368 ELMPNGSLDKFIHNDR----------------------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNIL 425 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~----------------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NIL 425 (582)
||+.+++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+|||
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nil 159 (290)
T cd05045 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVL 159 (290)
T ss_pred EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEE
Confidence 9999999999876421 23578999999999999999999987 9999999999999
Q ss_pred EcCCCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCccc
Q 040604 426 LDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDT 504 (582)
Q Consensus 426 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~ 504 (582)
+++++.+||+|||+++...............++..|+|||++.+ ..++.++||||||++++||++ |+.|+.......
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc--CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999999999986544332222223456778999998865 368899999999999999998 888886543211
Q ss_pred chhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 505 SICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 505 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
+.+.+........+ ......+.+++.+||+.+|++||+++++++.|++.+.
T Consensus 238 ------~~~~~~~~~~~~~~-------~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 ------LFNLLKTGYRMERP-------ENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred ------HHHHHhCCCCCCCC-------CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 22222222111111 1223567788899999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=317.22 Aligned_cols=258 Identities=24% Similarity=0.429 Sum_probs=200.6
Q ss_pred HHHHHhhhhcCccCceEEEEEEeC------CCcEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeCCee
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELP------DGQLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYENKKN 363 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 363 (582)
..++.+.++||+|+||.||+|... .+..||+|.++..... ...+.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 445667789999999999998542 3558999998654432 24578899999999999999999999999999
Q ss_pred eEEEEecCCCChhhhhhcCC--------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEe
Q 040604 364 ALIYELMPNGSLDKFIHNDR--------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKIS 435 (582)
Q Consensus 364 ~lv~E~~~~gsL~~~i~~~~--------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~ 435 (582)
++||||+++|+|.+++.... ....++..+.+++.|++.||.|||+. +|+||||||+|||+++++.+||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEEC
Confidence 99999999999999997532 12356778899999999999999988 99999999999999999999999
Q ss_pred eccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHh
Q 040604 436 DFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYER 514 (582)
Q Consensus 436 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 514 (582)
|||+++...............++..|+|||.+.+ +.++.++||||||++++||++ |..|+....... +...
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~------~~~~ 233 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD--GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ------VLKF 233 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhcc--CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHH
Confidence 9999986544322222222345778999999876 468999999999999999998 677775432211 1222
Q ss_pred hcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 040604 515 IEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSI 567 (582)
Q Consensus 515 i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~ 567 (582)
+..+....... .....+.+++.+||+.||++|||+.++++.|+..+
T Consensus 234 ~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 234 VMDGGYLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHcCCCCCCCC-------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 22221111111 22356888899999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=320.79 Aligned_cols=262 Identities=27% Similarity=0.414 Sum_probs=199.8
Q ss_pred HHHHhhhhcCccCceEEEEEEeCC-----------------CcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEE
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELPD-----------------GQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTF 353 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l 353 (582)
..+++.++||+|+||.||++.... +..||+|.+..... ..+.+.+|+.++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 345677899999999999986532 35689999875542 34678899999999999999999
Q ss_pred EeEEEeCCeeeEEEEecCCCChhhhhhcCC---------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCE
Q 040604 354 LGFCYENKKNALIYELMPNGSLDKFIHNDR---------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNI 424 (582)
Q Consensus 354 ~~~~~~~~~~~lv~E~~~~gsL~~~i~~~~---------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NI 424 (582)
++++..+...+++||++++++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhce
Confidence 999999999999999999999999987543 12589999999999999999999987 999999999999
Q ss_pred EEcCCCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc--CCCCCCCCCc
Q 040604 425 LLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG--CTKNLDDEVT 502 (582)
Q Consensus 425 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt--g~~p~~~~~~ 502 (582)
+++.++.+||+|||+++...............+++.|+|||++.. +.++.++||||||+++|||++ +..|+.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc--CCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 999999999999999987544332222233457889999999876 468999999999999999998 5556643321
Q ss_pred ccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 503 DTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 503 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
...+.. +.............. .....+..+.+++.+||+.||++|||+.+|++.|+.
T Consensus 240 -~~~~~~-~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 -QQVIEN-AGHFFRDDGRQIYLP----RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred -HHHHHH-HHhccccccccccCC----CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111111 111111100000000 011233567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=316.40 Aligned_cols=259 Identities=24% Similarity=0.361 Sum_probs=205.1
Q ss_pred HHHHHhhhhcCccCceEEEEEEeCC-----CcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEe-CCee
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELPD-----GQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYE-NKKN 363 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 363 (582)
+.++.+.+.||+|+||.||+|...+ +..|++|.++.... ..+.+.+|+.++++++|+||+++++++.+ +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4455667899999999999997654 78899999875432 24568899999999999999999998876 4677
Q ss_pred eEEEEecCCCChhhhhhcCCC------cCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeec
Q 040604 364 ALIYELMPNGSLDKFIHNDRN------IKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDF 437 (582)
Q Consensus 364 ~lv~E~~~~gsL~~~i~~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DF 437 (582)
++++||+++++|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 899999999999999875422 4589999999999999999999987 9999999999999999999999999
Q ss_pred cccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhc
Q 040604 438 GLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIE 516 (582)
Q Consensus 438 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~ 516 (582)
|+++.+.............++..|+|||++.. ..++.++||||||+++|||++ |+.|+....... +...+.
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~ 233 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVN--KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE------MAAYLK 233 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhc--CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH------HHHHHH
Confidence 99987654433322223346778999999876 368899999999999999999 888886543211 222222
Q ss_pred CCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 517 PGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
.+....... .....+.+++.+||+.||++|||+.+|++.|+....
T Consensus 234 ~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 234 DGYRLAQPI-------NCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred cCCCCCCCC-------cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 222211111 123457888999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=330.13 Aligned_cols=249 Identities=22% Similarity=0.334 Sum_probs=189.9
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
++.++||+|+||+||++... +++.||||+++... ...+.+.+|+.++.+++|+||+++++.+.+....++||||+
T Consensus 4 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~ 83 (363)
T cd05628 4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFL 83 (363)
T ss_pred eEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCC
Confidence 45688999999999999654 68999999997532 22346788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc-
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA- 449 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~- 449 (582)
++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 84 PGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 9999999997643 689999999999999999999998 9999999999999999999999999999764321100
Q ss_pred --------------------------------eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCC
Q 040604 450 --------------------------------ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNL 497 (582)
Q Consensus 450 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~ 497 (582)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC--CCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 00113469999999999976 36889999999999999999999999
Q ss_pred CCCCcccchhhHHHHHhhcC-CCCCCCCCc--CcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 498 DDEVTDTSICHNLIYERIEP-GNDFQFDGV--ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 498 ~~~~~~~~~~~~~~~~~i~~-~~~~~~~~~--~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
....... ....+.. .....++.. ..++..++...| .|...++..||+++||++.
T Consensus 237 ~~~~~~~------~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l-----~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 237 CSETPQE------TYKKVMNWKETLIFPPEVPISEKAKDLILRF-----CCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCHHH------HHHHHHcCcCcccCCCcCCCCHHHHHHHHHH-----cCChhhcCCCCCHHHHhCC
Confidence 7643322 1122221 111222221 222333332222 1433455567999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=324.90 Aligned_cols=240 Identities=27% Similarity=0.364 Sum_probs=192.2
Q ss_pred hhcCccCceEEEEEEe----CCCcEEEEEEeccCC-----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 299 DKLGQGGYGEVYKGEL----PDGQLVAVKVLKNSR-----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
++||+|+||.||++.. .+++.||||+++... .....+.+|+.++++++||||+++++.+..+...++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999964 368899999987532 2234577899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++++|.+++...+ .+.+..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 156 (323)
T cd05584 82 LSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV 156 (323)
T ss_pred CCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCc
Confidence 99999999987643 578888889999999999999998 9999999999999999999999999998754332221
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ....+..+. ..++..
T Consensus 157 --~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------~~~~~~~~~-~~~~~~--- 222 (323)
T cd05584 157 --THTFCGTIEYMAPEILMRS--GHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------TIDKILKGK-LNLPPY--- 222 (323)
T ss_pred --ccccCCCccccChhhccCC--CCCCcceecccHHHHHHHhcCCCCCCCCCHHH------HHHHHHcCC-CCCCCC---
Confidence 1234699999999998763 67899999999999999999999997643221 112222221 112222
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERP-----SMHKVLE 561 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~ 561 (582)
+...+.+++.+||+.||++|| +++++++
T Consensus 223 ----~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 223 ----LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred ----CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 234567788889999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=312.86 Aligned_cols=254 Identities=26% Similarity=0.437 Sum_probs=205.6
Q ss_pred HHHHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
+.++.+.++||+|+||.||++...++..+|+|.++......+.+.+|+.++++++|+||+++++.+.+ ...+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 44566778999999999999987778889999988766566789999999999999999999999887 77899999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
+++|.+++.......+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++......... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~ 159 (260)
T cd05073 84 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-A 159 (260)
T ss_pred CCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcc-c
Confidence 99999999876556789999999999999999999987 9999999999999999999999999999865433221 1
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHH
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 530 (582)
.....++..|+|||++.. +.++.++|+||||+++++|++ |+.|+....... +.+.+..+......
T Consensus 160 ~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~------~~~~~~~~~~~~~~------ 225 (260)
T cd05073 160 REGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE------VIRALERGYRMPRP------ 225 (260)
T ss_pred ccCCcccccccCHhHhcc--CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHhCCCCCCCc------
Confidence 122346678999999875 468899999999999999998 888886532211 12222222111111
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 531 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
......+.+++.+||+.+|++||++.++++.|+.
T Consensus 226 -~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 226 -ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 2234567788889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=325.52 Aligned_cols=241 Identities=23% Similarity=0.324 Sum_probs=192.1
Q ss_pred hhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 299 DKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISRT-SHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
++||+|+||.||+|... +++.||+|+++... ...+.+..|..++..+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999765 68899999997532 2334577888888765 799999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
|+|..++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........ .
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~--~ 153 (321)
T cd05591 81 GDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--T 153 (321)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCcc--c
Confidence 99998887543 588899999999999999999998 9999999999999999999999999998764332221 1
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..+.+.... ..++..
T Consensus 154 ~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~------~~~~i~~~~-~~~p~~------ 218 (321)
T cd05591 154 TTFCGTPDYIAPEILQE--LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD------LFESILHDD-VLYPVW------ 218 (321)
T ss_pred cccccCccccCHHHHcC--CCCCCccceechhHHHHHHhcCCCCCCCCCHHH------HHHHHHcCC-CCCCCC------
Confidence 23469999999999876 368899999999999999999999997654322 122222221 112211
Q ss_pred HHHHHHHHHHHhccccCCCCCC-------CHHHHHHH
Q 040604 533 KIAKMMILVGFWCIQTNPSERP-------SMHKVLEM 562 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RP-------t~~evl~~ 562 (582)
+...+.+++..||+.||++|| +++++++.
T Consensus 219 -~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 219 -LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred -CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 234566778889999999999 78888743
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=325.15 Aligned_cols=246 Identities=25% Similarity=0.350 Sum_probs=191.1
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
++.++||+|+||+||+|... +++.||||++...... .+.+.+|+.++++++|+||+++++++.+....++||||+++
T Consensus 77 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 156 (353)
T PLN00034 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDG 156 (353)
T ss_pred hhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCC
Confidence 34578999999999999764 7899999999654322 35688999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
|+|.... ..++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++........ .
T Consensus 157 ~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~--~ 225 (353)
T PLN00034 157 GSLEGTH------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--C 225 (353)
T ss_pred Ccccccc------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccccc--c
Confidence 9986532 346678889999999999999998 9999999999999999999999999999876433211 1
Q ss_pred ecccCCccccccccccccc---CCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 453 LHARGTIGYIAPEVYSRRF---GGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~---~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
....||..|+|||++.... ...+.++|||||||++|||++|+.||....... ....+.. +.........
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~-~~~~~~~~~~----- 297 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASLMCA-ICMSQPPEAP----- 297 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHH-HhccCCCCCC-----
Confidence 2346999999999875321 234568999999999999999999997433222 1111111 1111111111
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
..+...+.+++.+||+.||++|||++||++.
T Consensus 298 --~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 298 --ATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred --CccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1234567788889999999999999999865
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=323.59 Aligned_cols=263 Identities=25% Similarity=0.390 Sum_probs=197.2
Q ss_pred HHHHHhhhhcCccCceEEEEEEeCC---------------CcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEE
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELPD---------------GQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFL 354 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~ 354 (582)
+..+++.++||+|+||.||++...+ ...||+|.++.... ..+.+.+|+.++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4456777899999999999986532 23589999875432 235688999999999999999999
Q ss_pred eEEEeCCeeeEEEEecCCCChhhhhhcCC----------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCE
Q 040604 355 GFCYENKKNALIYELMPNGSLDKFIHNDR----------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNI 424 (582)
Q Consensus 355 ~~~~~~~~~~lv~E~~~~gsL~~~i~~~~----------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NI 424 (582)
+++......++||||+++++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 99999999999999999999999986432 12368889999999999999999998 999999999999
Q ss_pred EEcCCCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcC--CCCCCCCCc
Q 040604 425 LLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGC--TKNLDDEVT 502 (582)
Q Consensus 425 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg--~~p~~~~~~ 502 (582)
++++++.+||+|||++................++..|+|||++.. +.++.++||||||++++||+++ ..|+.....
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc--CCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 999999999999999986543322212222345778999999875 4689999999999999999984 445544322
Q ss_pred ccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 503 DTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 503 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
.. .... +.+............ .....+..+.+++.+||+.||++||++++|++.|+.
T Consensus 239 ~~-~~~~-~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 239 EQ-VIEN-TGEFFRNQGRQIYLS----QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HH-HHHH-HHHhhhhccccccCC----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 11 1111 111111100000000 011134578889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=329.70 Aligned_cols=261 Identities=23% Similarity=0.381 Sum_probs=203.4
Q ss_pred HHHHHHHhhhhcCccCceEEEEEEeC------CCcEEEEEEeccCCCC--HHHHHHHHHHHhccC-CCceEEEEeEEEeC
Q 040604 290 VKRMTKSFRDKLGQGGYGEVYKGELP------DGQLVAVKVLKNSRCN--GEEFINEVASISRTS-HVNIVTFLGFCYEN 360 (582)
Q Consensus 290 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 360 (582)
+....+.+.++||+|+||.||+|.+. .++.||||+++..... .+.+.+|+.+|.++. ||||+++++++...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 34444556789999999999999753 3568999999764332 346889999999997 99999999999998
Q ss_pred CeeeEEEEecCCCChhhhhhcCCC--------------------------------------------------------
Q 040604 361 KKNALIYELMPNGSLDKFIHNDRN-------------------------------------------------------- 384 (582)
Q Consensus 361 ~~~~lv~E~~~~gsL~~~i~~~~~-------------------------------------------------------- 384 (582)
...++||||+++|+|.++++..+.
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 899999999999999999865321
Q ss_pred ----------------------------------------cCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCE
Q 040604 385 ----------------------------------------IKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNI 424 (582)
Q Consensus 385 ----------------------------------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NI 424 (582)
..+++..++.++.|++.||+|||+. +++||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceE
Confidence 1367778899999999999999987 999999999999
Q ss_pred EEcCCCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcc
Q 040604 425 LLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTD 503 (582)
Q Consensus 425 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~ 503 (582)
|+++++.+||+|||+++...............+++.|+|||.+.. ..++.++||||||+++|||++ |+.|+......
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN--NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC--CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 999999999999999986543322212222357889999999876 367899999999999999998 78887654322
Q ss_pred cchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 040604 504 TSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSI 567 (582)
Q Consensus 504 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~ 567 (582)
. ...+.+..+.....+. .....+.+++.+||+.+|++||++++|++.|++.+
T Consensus 349 ~-----~~~~~~~~~~~~~~p~-------~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 E-----QFYNAIKRGYRMAKPA-------HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred H-----HHHHHHHcCCCCCCCC-------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 2 1222233322222211 12356778888999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=327.40 Aligned_cols=241 Identities=22% Similarity=0.322 Sum_probs=192.9
Q ss_pred hhcCccCceEEEEEEe-CCCcEEEEEEeccCC----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCC
Q 040604 299 DKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSR----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNG 373 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 373 (582)
+.||+|+||.||++.. .+|+.||+|+++... .....+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999965 478999999997532 22356778999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHR-GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 374 sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
+|..++...+ .+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++........ .
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--~ 153 (325)
T cd05594 81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--M 153 (325)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc--c
Confidence 9998887543 68999999999999999999997 5 9999999999999999999999999998764322221 1
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..+.+... ...++..
T Consensus 154 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~------~~~~i~~~-~~~~p~~------ 218 (325)
T cd05594 154 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILME-EIRFPRT------ 218 (325)
T ss_pred ccccCCcccCCHHHHcc--CCCCCccccccccceeeeeccCCCCCCCCCHHH------HHHHHhcC-CCCCCCC------
Confidence 23459999999999876 478899999999999999999999997543221 11222111 1112222
Q ss_pred HHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 040604 533 KIAKMMILVGFWCIQTNPSERP-----SMHKVLEM 562 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~~ 562 (582)
+...+.+++.+||+.||++|+ +++++++.
T Consensus 219 -~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 219 -LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred -CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 234566778889999999996 89998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=326.30 Aligned_cols=249 Identities=25% Similarity=0.313 Sum_probs=194.8
Q ss_pred HhhhhcCccCceEEEEEEe----CCCcEEEEEEeccCC-----CCHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeeeE
Q 040604 296 SFRDKLGQGGYGEVYKGEL----PDGQLVAVKVLKNSR-----CNGEEFINEVASISRT-SHVNIVTFLGFCYENKKNAL 365 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 365 (582)
++.++||+|+||.||+++. .+++.||+|++++.. ...+.+.+|+.+++++ +|+||+++++++.+....++
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (332)
T cd05614 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL 82 (332)
T ss_pred eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence 4568899999999999864 368899999986432 2235678899999999 59999999999999999999
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 83 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 83 ILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 999999999999987543 588999999999999999999998 999999999999999999999999999986543
Q ss_pred cccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCC
Q 040604 446 KESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525 (582)
Q Consensus 446 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 525 (582)
..... .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||........ ...+...+.... ..+..
T Consensus 158 ~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~~~~~~~~~~-~~~~~ 232 (332)
T cd05614 158 EEKER-TYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNT--QSEVSRRILKCD-PPFPS 232 (332)
T ss_pred cCCCc-cccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCCCC--HHHHHHHHhcCC-CCCCC
Confidence 32221 1234699999999998753 3578899999999999999999999965432221 111222222211 11221
Q ss_pred cCcHHHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 040604 526 VATEEEKKIAKMMILVGFWCIQTNPSERP-----SMHKVLE 561 (582)
Q Consensus 526 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~ 561 (582)
. +...+.+++.+||+.||++|| +++++++
T Consensus 233 ~-------~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 233 F-------IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred C-------CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1 234566778889999999999 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=314.00 Aligned_cols=254 Identities=25% Similarity=0.392 Sum_probs=197.4
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCc----EEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQ----LVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 367 (582)
+++.+.||+|+||+||+|.+. +++ .+++|.+..... ...++..|+..+++++||||+++++++. ....++++
T Consensus 9 ~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~ 87 (279)
T cd05111 9 LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVT 87 (279)
T ss_pred ceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEE
Confidence 345678999999999999764 454 477777754322 2356778888999999999999999875 45678999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
||+++|+|.+++.... ..+++..+..|+.|++.||+|||+. +++||||||+|||+++++.+||+|||+++......
T Consensus 88 e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 88 QLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred EeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 9999999999997543 3689999999999999999999998 99999999999999999999999999998765433
Q ss_pred cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCc
Q 040604 448 SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 526 (582)
.........++..|+|||++.. +.++.++||||||+++|||++ |+.|+....... +.+.+..+........
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~ 235 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESILF--GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE------VPDLLEKGERLAQPQI 235 (279)
T ss_pred cccccCCCCCcccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHHCCCcCCCCCC
Confidence 3222234457889999999875 468999999999999999998 888886543211 2222333322222222
Q ss_pred CcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 527 ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 527 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
. ...+..++.+||..||++|||++|+++.|+.+..
T Consensus 236 ~-------~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 236 C-------TIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred C-------CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 1 2345667788999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=319.34 Aligned_cols=250 Identities=27% Similarity=0.361 Sum_probs=199.4
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC----CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
++..++||+|+||+||++... +++.||+|++..... ....+.+|+.++++++|+||+++++.+.++...++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 445678999999999999754 789999999865332 224577899999999999999999999998999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++|+|.+++.......+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||+++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI 158 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc
Confidence 9999999988765555689999999999999999999998 9999999999999999999999999999876433221
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
....||+.|+|||++.+ ..++.++||||+|+++|||++|+.||....... ....+...+..... ..
T Consensus 159 ---~~~~~~~~y~aPE~~~~--~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~-~~------ 224 (285)
T cd05605 159 ---RGRVGTVGYMAPEVVKN--ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV--KREEVERRVKEDQE-EY------ 224 (285)
T ss_pred ---ccccCCCCccCcHHhcC--CCCCccccchhHHHHHHHHHHCCCCCCCCchhh--HHHHHHHHhhhccc-cc------
Confidence 23358999999999876 468899999999999999999999997543221 11112222222111 11
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERP-----SMHKVLEM 562 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~~ 562 (582)
...+...+.+++.+||+.||++|| +++++++.
T Consensus 225 -~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 225 -SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 122445677888899999999999 88888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=322.72 Aligned_cols=239 Identities=25% Similarity=0.341 Sum_probs=188.1
Q ss_pred hhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhc-cCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 299 DKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISR-TSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
+.||+|+||.||+|... +++.||+|+++... ...+.+..|..++.. .+||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999764 68899999997532 223445667766664 5899999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
|+|..++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........ .
T Consensus 81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~--~ 153 (316)
T cd05592 81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--A 153 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCc--c
Confidence 99999987543 588899999999999999999998 9999999999999999999999999999865433221 1
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... +...+... ...++..
T Consensus 154 ~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~~-~~~~~~~------ 218 (316)
T cd05592 154 STFCGTPDYIAPEILKGQ--KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE------LFDSILND-RPHFPRW------ 218 (316)
T ss_pred ccccCCccccCHHHHcCC--CCCCcccchhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHcC-CCCCCCC------
Confidence 234699999999998763 68899999999999999999999997643221 11222221 1112222
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 040604 533 KIAKMMILVGFWCIQTNPSERPSMH-KVL 560 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RPt~~-evl 560 (582)
+...+.+++.+||+.||++||++. +++
T Consensus 219 -~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 219 -ISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred -CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 234456778889999999999875 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=309.68 Aligned_cols=248 Identities=31% Similarity=0.529 Sum_probs=202.9
Q ss_pred hhcCccCceEEEEEEeCC----CcEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 299 DKLGQGGYGEVYKGELPD----GQLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
+.||+|+||.||+|.... +..+|+|+++..... .+.+.+|+..+++++|+|++++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999997653 889999999865544 57789999999999999999999999998899999999999
Q ss_pred CChhhhhhcCC-------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 373 GSLDKFIHNDR-------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 373 gsL~~~i~~~~-------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
++|.+++.... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999998642 35689999999999999999999997 999999999999999999999999999988765
Q ss_pred cccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCC
Q 040604 446 KESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFD 524 (582)
Q Consensus 446 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 524 (582)
...........+++.|+|||.+... .++.++||||+|++++||++ |..|+...... .+.+.+..+......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~~~~ 229 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDG--IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE------EVLEYLRKGYRLPKP 229 (262)
T ss_pred ccccccccCCCcCccccCHHHhccC--CcchhhccHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHcCCCCCCC
Confidence 4322222344588999999998763 78899999999999999998 58888665221 122233322222222
Q ss_pred CcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 040604 525 GVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564 (582)
Q Consensus 525 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le 564 (582)
. .....+.+++.+||+.+|++|||++++++.|+
T Consensus 230 ~-------~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 230 E-------YCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred c-------cCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1 22456778888999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=333.37 Aligned_cols=249 Identities=24% Similarity=0.324 Sum_probs=199.7
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.+.++||+|+||+||+|... +++.||||+++... .....+.+|+.++..++|+||+++++.+.++...++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 345688999999999999765 79999999997532 3345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc--
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE-- 447 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~-- 447 (582)
+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 83 MPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 9999999999765 4689999999999999999999997 99999999999999999999999999998765433
Q ss_pred -------------------------cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCc
Q 040604 448 -------------------------SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVT 502 (582)
Q Consensus 448 -------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~ 502 (582)
.........||+.|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCC--CCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 00111234699999999999774 789999999999999999999999976542
Q ss_pred ccchhhHHHHHhhcC-CCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCC-HHHHHHH
Q 040604 503 DTSICHNLIYERIEP-GNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPS-MHKVLEM 562 (582)
Q Consensus 503 ~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-~~evl~~ 562 (582)
.. ....+.. .....++... .+...+.+++.+||+ ||.+||+ ++++++.
T Consensus 236 ~~------~~~~i~~~~~~~~~p~~~-----~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 QE------TYNKIINWKESLRFPPDP-----PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HH------HHHHHhccCCcccCCCCC-----CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 21 1112211 1111111111 134556777788997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=307.03 Aligned_cols=250 Identities=24% Similarity=0.283 Sum_probs=202.5
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC----HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN----GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+++.++||+|.-|+||+++++ ++..+|+|++.+.... .....-|-+||+.++||.++.||+.+..+...+|+|||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey 158 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY 158 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence 355689999999999999876 4689999999765433 23456788999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc--
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE-- 447 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~-- 447 (582)
|+||+|..+++++.+..+++..+.-.+.+|+.||+|||-. |||.|||||+||||-++|++.|+||.|+.......
T Consensus 159 CpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 159 CPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred CCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence 9999999999999988999999999999999999999988 99999999999999999999999999875432100
Q ss_pred -------------------------------cc---------------------eeeecccCCcccccccccccccCCCC
Q 040604 448 -------------------------------SA---------------------ISMLHARGTIGYIAPEVYSRRFGGVS 475 (582)
Q Consensus 448 -------------------------------~~---------------------~~~~~~~gt~~y~aPE~~~~~~~~~s 475 (582)
.. ......+||-.|+|||++.+. ..+
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~--GHg 313 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE--GHG 313 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC--CCC
Confidence 00 000123599999999999985 678
Q ss_pred ccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCC
Q 040604 476 HKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPS 555 (582)
Q Consensus 476 ~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt 555 (582)
.++|||+|||+|||||.|+.||......+.. .+.+.+.. .+++. ..+.....+|+.+.|.+||++|..
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl-----~NIv~~~l--~Fp~~-----~~vs~~akDLIr~LLvKdP~kRlg 381 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETL-----RNIVGQPL--KFPEE-----PEVSSAAKDLIRKLLVKDPSKRLG 381 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhhH-----HHHhcCCC--cCCCC-----CcchhHHHHHHHHHhccChhhhhc
Confidence 8999999999999999999999887766542 23333322 22221 144556677777788999999998
Q ss_pred ----HHHHHH
Q 040604 556 ----MHKVLE 561 (582)
Q Consensus 556 ----~~evl~ 561 (582)
+.||-+
T Consensus 382 ~~rGA~eIK~ 391 (459)
T KOG0610|consen 382 SKRGAAEIKR 391 (459)
T ss_pred cccchHHhhc
Confidence 777754
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=309.18 Aligned_cols=248 Identities=27% Similarity=0.465 Sum_probs=204.1
Q ss_pred HHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCC
Q 040604 294 TKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNG 373 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 373 (582)
.+++.+.||+|+||.||+|.. .|+.||+|.++......+.+.+|+.++++++|+||+++++++.+....++||||++++
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 85 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKG 85 (256)
T ss_pred hccceeeeecCCCceEEEEEe-cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCC
Confidence 446678999999999999987 4889999999876555678999999999999999999999999888999999999999
Q ss_pred ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeee
Q 040604 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISML 453 (582)
Q Consensus 374 sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 453 (582)
+|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||.++.......
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~----- 157 (256)
T cd05039 86 SLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD----- 157 (256)
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc-----
Confidence 999999876555789999999999999999999998 999999999999999999999999999987643222
Q ss_pred cccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 454 HARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 454 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
...++..|+|||++.. +.++.++||||||++++||++ |..|+...... .+.+.+......... .
T Consensus 158 ~~~~~~~~~ape~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~~~~-------~ 222 (256)
T cd05039 158 SGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DVVPHVEKGYRMEAP-------E 222 (256)
T ss_pred cCCCcccccCchhhcC--CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHhcCCCCCCc-------c
Confidence 2235678999999865 478899999999999999997 88887644221 122222222111111 1
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 533 KIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
..+..+.+++.+||+.+|++||++++|+++|+.
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 223 GCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 234567788889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=311.56 Aligned_cols=254 Identities=26% Similarity=0.384 Sum_probs=190.4
Q ss_pred hhcCccCceEEEEEEeC---CCcEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCC
Q 040604 299 DKLGQGGYGEVYKGELP---DGQLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNG 373 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 373 (582)
+.||+|+||.||+|... ++..+|+|.++..... ...+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 36999999999999654 3467999998765432 246889999999999999999999999888899999999999
Q ss_pred ChhhhhhcCC---CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 374 SLDKFIHNDR---NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 374 sL~~~i~~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
+|.+++.... ....++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999987532 23467788889999999999999998 99999999999999999999999999997644332222
Q ss_pred eeecccCCcccccccccccccC-----CCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCC
Q 040604 451 SMLHARGTIGYIAPEVYSRRFG-----GVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFD 524 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~-----~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 524 (582)
......|+..|+|||++....+ .++.++||||||+++|||++ |+.||........ ....+...........+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 236 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-LTYTVREQQLKLPKPRLK 236 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-HHHHhhcccCCCCCCccC
Confidence 2223457889999999864211 35789999999999999996 9989865433221 111111100000001111
Q ss_pred CcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 040604 525 GVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564 (582)
Q Consensus 525 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le 564 (582)
......+.+++..|+ .+|++|||++||++.|+
T Consensus 237 -------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 237 -------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred -------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 112234566777898 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=323.96 Aligned_cols=246 Identities=21% Similarity=0.299 Sum_probs=193.0
Q ss_pred hhcCccCceEEEEEEeC-CCcEEEEEEeccCCC----CHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 299 DKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEVASISRT-SHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
+.||+|+||.||++... +++.||+|+++.... ..+.+.+|..++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999764 789999999975432 234577899999888 799999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........ .
T Consensus 81 g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~--~ 153 (329)
T cd05588 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--T 153 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCc--c
Confidence 99998886543 689999999999999999999998 9999999999999999999999999998753222111 1
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCccc---chhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDT---SICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~---~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .....++.+.+.... ..++..
T Consensus 154 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~--- 227 (329)
T cd05588 154 STFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ-IRIPRS--- 227 (329)
T ss_pred ccccCCccccCHHHHcC--CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC-CCCCCC---
Confidence 23469999999999976 368899999999999999999999996432211 112223333333221 122222
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCC------HHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPS------MHKVLE 561 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt------~~evl~ 561 (582)
+...+.+++.+||+.||.+||+ ++++++
T Consensus 228 ----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 228 ----LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred ----CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 2345677888899999999997 567763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=316.63 Aligned_cols=245 Identities=25% Similarity=0.339 Sum_probs=193.5
Q ss_pred cCccCceEEEEEEeC-CCcEEEEEEeccCCC----CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCCh
Q 040604 301 LGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSL 375 (582)
Q Consensus 301 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 375 (582)
||+|+||+||++... +++.+|+|.+..... ..+.+..|+.++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999654 789999999865432 224577899999999999999999999999999999999999999
Q ss_pred hhhhhcC--CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeee
Q 040604 376 DKFIHND--RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISML 453 (582)
Q Consensus 376 ~~~i~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 453 (582)
..++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......... ..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence 9887542 334689999999999999999999998 9999999999999999999999999999876543322 12
Q ss_pred cccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHH
Q 040604 454 HARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKK 533 (582)
Q Consensus 454 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 533 (582)
...||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ...+...+.... ..+. ..
T Consensus 156 ~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~-~~~~-------~~ 223 (280)
T cd05608 156 GYAGTPGFMAPELLQG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRILNDS-VTYP-------DK 223 (280)
T ss_pred ccCCCcCccCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhhcccC-CCCc-------cc
Confidence 3469999999999976 4788999999999999999999999975433211 111111111111 1111 12
Q ss_pred HHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 040604 534 IAKMMILVGFWCIQTNPSERP-----SMHKVLEM 562 (582)
Q Consensus 534 ~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~~ 562 (582)
+...+.+++.+||+.||++|| +++++++.
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 345677788889999999999 77888753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=307.67 Aligned_cols=247 Identities=27% Similarity=0.463 Sum_probs=196.4
Q ss_pred hhcCccCceEEEEEEeC-C---CcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 299 DKLGQGGYGEVYKGELP-D---GQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
++||+|+||.||+|.+. . +..+|+|.+..... ..+.+.+|+.++++++|+||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999643 2 36899999986654 3467899999999999999999999875 4567999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce-e
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI-S 451 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~-~ 451 (582)
++|.+++.... .+++..+..++.|++.||+|||.. +++|+||||+|||++.++.+||+|||+++......... .
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999997654 689999999999999999999988 99999999999999999999999999998765433221 1
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHH
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 530 (582)
.....++..|+|||.+.. ..++.++||||||+++|||++ |..|+....... +...+..........
T Consensus 155 ~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~----- 221 (257)
T cd05060 155 TTAGRWPLKWYAPECINY--GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE------VIAMLESGERLPRPE----- 221 (257)
T ss_pred ccCccccccccCHHHhcC--CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH------HHHHHHcCCcCCCCC-----
Confidence 112234578999999865 468999999999999999998 888886543221 122222222111111
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 040604 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGS 566 (582)
Q Consensus 531 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~ 566 (582)
.....+.+++.+||+.+|++||++.+|++.|++.
T Consensus 222 --~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 222 --ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred --CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 2235677888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=332.71 Aligned_cols=249 Identities=21% Similarity=0.257 Sum_probs=193.8
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.+.+.||+|+||+||++... +|+.||||+++... .....+.+|+.++..++|+||+++++.+.++...++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY 82 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence 345688999999999999765 78999999997532 2234578899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 83 ~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 83 LPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 99999999987643 589999999999999999999998 9999999999999999999999999998764322110
Q ss_pred e------------------------------------eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcC
Q 040604 450 I------------------------------------SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGC 493 (582)
Q Consensus 450 ~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg 493 (582)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--TGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC--CCCCCeeeeecchhHHHHhhcC
Confidence 0 0012359999999999876 4689999999999999999999
Q ss_pred CCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCC---HHHHHH
Q 040604 494 TKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPS---MHKVLE 561 (582)
Q Consensus 494 ~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt---~~evl~ 561 (582)
..||....... .....+.......++.. ..+...+.+++.+|+. +|.+|++ ++++++
T Consensus 236 ~~Pf~~~~~~~-----~~~~i~~~~~~~~~~~~-----~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 236 YPPFCSDNPQE-----TYRKIINWKETLQFPDE-----VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCHHH-----HHHHHHcCCCccCCCCC-----CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99997653321 11111111111111111 1123445566667776 9999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=312.99 Aligned_cols=253 Identities=28% Similarity=0.441 Sum_probs=197.3
Q ss_pred HHhhhhcCccCceEEEEEEeC------CCcEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP------DGQLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYENKKNALI 366 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 366 (582)
+.+.+.||+|++|.||+|.+. .+..||+|.+...... ...|.+|+.++++++|+||+++++++.+....++|
T Consensus 8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 87 (277)
T cd05036 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFIL 87 (277)
T ss_pred cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEE
Confidence 445688999999999999764 3568999988654332 35689999999999999999999999998899999
Q ss_pred EEecCCCChhhhhhcCCC-----cCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC---ceEEeecc
Q 040604 367 YELMPNGSLDKFIHNDRN-----IKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF---CPKISDFG 438 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~---~vkl~DFG 438 (582)
|||+++++|.+++...+. ..+++..+++++.||+.||+|||+. +++||||||+|||++.++ .+||+|||
T Consensus 88 ~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg 164 (277)
T cd05036 88 LELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFG 164 (277)
T ss_pred EecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCc
Confidence 999999999999876432 2589999999999999999999998 999999999999998765 59999999
Q ss_pred ccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcC
Q 040604 439 LAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEP 517 (582)
Q Consensus 439 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~ 517 (582)
+++................+..|+|||++.+ ..++.++|||||||++|||++ |..||....... +...+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~ 236 (277)
T cd05036 165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLD--GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE------VMEFVTG 236 (277)
T ss_pred cccccCCccceecCCCCCccHhhCCHHHHhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHHc
Confidence 9987643322111112234568999999876 468999999999999999997 888886543221 1122222
Q ss_pred CCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 518 GNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
....... ..+...+.+++.+||+.+|++||++.+|++.|+.
T Consensus 237 ~~~~~~~-------~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 237 GGRLDPP-------KGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred CCcCCCC-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 2111111 1223567788899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=323.42 Aligned_cols=241 Identities=21% Similarity=0.301 Sum_probs=188.6
Q ss_pred hhcCccCceEEEEEEeC-CCcEEEEEEeccCCC----CHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 299 DKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEVASISRT-SHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
+.||+|+||.||++... +++.+|+|++++... ..+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999765 688999999975422 234567888888776 899999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
|+|..++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........ .
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~--~ 153 (329)
T cd05618 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--T 153 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc--c
Confidence 99998886543 689999999999999999999998 9999999999999999999999999999764322211 1
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCccc---chhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDT---SICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~---~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
....||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... .....++.+.+.... ..++..
T Consensus 154 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-~~~p~~--- 227 (329)
T cd05618 154 STFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-IRIPRS--- 227 (329)
T ss_pred ccccCCccccCHHHHcC--CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC-CCCCCC---
Confidence 23469999999999976 368899999999999999999999996322111 112223333332221 122222
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSM 556 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~ 556 (582)
+...+.+++.+||+.||++||++
T Consensus 228 ----~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 228 ----LSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred ----CCHHHHHHHHHHhcCCHHHcCCC
Confidence 23456678888999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=322.22 Aligned_cols=239 Identities=24% Similarity=0.325 Sum_probs=189.4
Q ss_pred hhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhc-cCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 299 DKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISR-TSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
+.||+|+||.||+|... +|+.||+|+++... ...+.+..|..++.. .+||||+++++++.+....++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999765 78999999997532 234556778877765 5899999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
|+|..++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........ .
T Consensus 81 g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~ 153 (316)
T cd05620 81 GDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--A 153 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCc--e
Confidence 99999887543 588899999999999999999998 9999999999999999999999999998753322211 2
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... +.+.+.... ..++..
T Consensus 154 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~------~~~~~~~~~-~~~~~~------ 218 (316)
T cd05620 154 STFCGTPDYIAPEILQG--LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE------LFESIRVDT-PHYPRW------ 218 (316)
T ss_pred eccCCCcCccCHHHHcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC-CCCCCC------
Confidence 23469999999999976 378899999999999999999999997543221 222222211 112222
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 040604 533 KIAKMMILVGFWCIQTNPSERPSMH-KVL 560 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RPt~~-evl 560 (582)
+...+.+++.+||+.||++||++. +++
T Consensus 219 -~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 219 -ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 234566778889999999999984 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=308.14 Aligned_cols=250 Identities=24% Similarity=0.480 Sum_probs=202.0
Q ss_pred HHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCC
Q 040604 295 KSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGS 374 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 374 (582)
+.+.+.||+|+||.||++.+.++..+|+|.++......+.+.+|+.++++++|||++++++++......++||||+++++
T Consensus 6 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (256)
T cd05112 6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGC 85 (256)
T ss_pred eEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCc
Confidence 34568899999999999987778899999998776667889999999999999999999999999889999999999999
Q ss_pred hhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeec
Q 040604 375 LDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLH 454 (582)
Q Consensus 375 L~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 454 (582)
|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.......... ...
T Consensus 86 L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~-~~~ 160 (256)
T cd05112 86 LSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STG 160 (256)
T ss_pred HHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccc-cCC
Confidence 999987543 3578999999999999999999988 99999999999999999999999999988654332211 112
Q ss_pred ccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHH
Q 040604 455 ARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKK 533 (582)
Q Consensus 455 ~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 533 (582)
..++.+|+|||.+.+ +.++.++||||||+++|||++ |+.|+....... +.+.+..+........
T Consensus 161 ~~~~~~~~aPe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~------- 225 (256)
T cd05112 161 TKFPVKWSSPEVFSF--SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE------VVETINAGFRLYKPRL------- 225 (256)
T ss_pred CccchhhcCHhHhcc--CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH------HHHHHhCCCCCCCCCC-------
Confidence 235678999999875 478899999999999999998 888886533211 2222222211111111
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 040604 534 IAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564 (582)
Q Consensus 534 ~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le 564 (582)
....+.+++.+||+.+|++||+++++++.|.
T Consensus 226 ~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 2356788899999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=331.66 Aligned_cols=252 Identities=22% Similarity=0.280 Sum_probs=198.6
Q ss_pred HHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEE
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 367 (582)
..+.+.++||+|+||.||++... +++.||+|+++... ...+.+.+|+.+++.++||||+++++++.++...++||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 34566789999999999999765 78999999996432 23345778999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 123 Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 123 EYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred cCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 999999999998653 478888999999999999999998 99999999999999999999999999998764332
Q ss_pred cceeeecccCCccccccccccccc--CCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcC-CCCCCCC
Q 040604 448 SAISMLHARGTIGYIAPEVYSRRF--GGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEP-GNDFQFD 524 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~-~~~~~~~ 524 (582)
.. ......||+.|+|||++.... ..++.++|||||||++|||++|+.||....... .+..+.. .....++
T Consensus 197 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~~~~~~~~ 269 (370)
T cd05596 197 MV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMDHKNSLTFP 269 (370)
T ss_pred cc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH------HHHHHHcCCCcCCCC
Confidence 21 112346999999999986531 247899999999999999999999997643321 1222222 1112222
Q ss_pred CcCcHHHHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 040604 525 GVATEEEKKIAKMMILVGFWCIQTNPSE--RPSMHKVLEM 562 (582)
Q Consensus 525 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPt~~evl~~ 562 (582)
. ...+...+.+++.+||+.+|++ ||+++++++.
T Consensus 270 ~-----~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 270 D-----DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred C-----cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1 1123455667788899999988 9999999754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=321.05 Aligned_cols=239 Identities=25% Similarity=0.325 Sum_probs=189.4
Q ss_pred hhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhc-cCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 299 DKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISR-TSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
+.||+|+||+||+|... +++.||||+++... ...+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999765 68899999997542 234556678888775 5999999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........ .
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~ 153 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--T 153 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc--e
Confidence 9999998754 3588899999999999999999998 9999999999999999999999999998754322221 1
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... +.+.+.... ..++..
T Consensus 154 ~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~~~~i~~~~-~~~~~~------ 218 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQ--KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE------LFQSIRMDN-PCYPRW------ 218 (316)
T ss_pred eeecCCccccCHHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC-CCCCcc------
Confidence 234699999999998763 68999999999999999999999997543221 122222211 112221
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 040604 533 KIAKMMILVGFWCIQTNPSERPSMH-KVL 560 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RPt~~-evl 560 (582)
+...+.+++.+||+.||++||++. ++.
T Consensus 219 -~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 219 -LTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred -CCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 234466778889999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=318.81 Aligned_cols=260 Identities=26% Similarity=0.462 Sum_probs=202.1
Q ss_pred HHHHhhhhcCccCceEEEEEEeC--------CCcEEEEEEeccCCCC--HHHHHHHHHHHhcc-CCCceEEEEeEEEeCC
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELP--------DGQLVAVKVLKNSRCN--GEEFINEVASISRT-SHVNIVTFLGFCYENK 361 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 361 (582)
..+.+.++||+|+||.||++... ....+|+|.++..... .+++.+|+.+++++ +||||+++++++.+..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 34556789999999999999641 3457999998754332 35688999999999 6999999999999888
Q ss_pred eeeEEEEecCCCChhhhhhcCC--------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc
Q 040604 362 KNALIYELMPNGSLDKFIHNDR--------------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLD 427 (582)
Q Consensus 362 ~~~lv~E~~~~gsL~~~i~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~ 427 (582)
..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence 8999999999999999996532 23588999999999999999999987 999999999999999
Q ss_pred CCCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccch
Q 040604 428 EDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSI 506 (582)
Q Consensus 428 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~ 506 (582)
+++.+||+|||+++...............++..|+|||++.+ +.++.++||||||+++|||++ |..|+.......
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-- 244 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD--RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE-- 244 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHcc--CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 999999999999987654322211122235568999999876 468899999999999999998 777875432211
Q ss_pred hhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCC
Q 040604 507 CHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENL 570 (582)
Q Consensus 507 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~ 570 (582)
+.+.+..+....... .....+.+++.+||+.+|++|||++++++.|++....+
T Consensus 245 ----~~~~~~~~~~~~~~~-------~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 245 ----LFKLLREGHRMDKPS-------NCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred ----HHHHHHcCCCCCCCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 222333322111111 12345677888999999999999999999999866443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=338.81 Aligned_cols=251 Identities=25% Similarity=0.308 Sum_probs=197.8
Q ss_pred HHHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEeCC--------
Q 040604 294 TKSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYENK-------- 361 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 361 (582)
+|.+.+.||+|+||+||+|.. .+|+.||||++...... ...+.+|+.++..++|+|+++++..+....
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~ 112 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL 112 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence 455678999999999999965 47999999999765433 345788999999999999999988775432
Q ss_pred eeeEEEEecCCCChhhhhhcC--CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccc
Q 040604 362 KNALIYELMPNGSLDKFIHND--RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGL 439 (582)
Q Consensus 362 ~~~lv~E~~~~gsL~~~i~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGl 439 (582)
..++||||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 357999999999999998653 234689999999999999999999998 999999999999999999999999999
Q ss_pred cccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCC
Q 040604 440 AKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGN 519 (582)
Q Consensus 440 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~ 519 (582)
++...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+. .+..+.
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~-----~~~~-~~~~~~ 261 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGENME-----EVMH-KTLAGR 261 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-----HHHH-HHhcCC
Confidence 987654322222234569999999999976 46899999999999999999999999754321 1122 222221
Q ss_pred CCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 520 DFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
...++. .+...+.+++.+||+.||++||++.++++.
T Consensus 262 ~~~~~~-------~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 262 YDPLPP-------SISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCC-------CCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111221 234557788889999999999999999763
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=313.78 Aligned_cols=254 Identities=25% Similarity=0.402 Sum_probs=199.4
Q ss_pred HHHhhhhcCccCceEEEEEEeC------CCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP------DGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALI 366 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 366 (582)
...+.++||+|+||.||++... ++..+|+|.++.... ..+.+.+|+.++++++|+||+++++++.+....+++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV 85 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence 3456789999999999999532 466899998865432 346789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCC-------------cCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceE
Q 040604 367 YELMPNGSLDKFIHNDRN-------------IKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPK 433 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~-------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vk 433 (582)
|||+++++|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+|||+++++.+|
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEE
Confidence 999999999999875431 3478999999999999999999988 999999999999999999999
Q ss_pred EeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHH
Q 040604 434 ISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIY 512 (582)
Q Consensus 434 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 512 (582)
|+|||++................+++.|+|||++.+ ..++.++|||||||++|||++ |+.||....... ..
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~ 234 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY--RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE------AI 234 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH------HH
Confidence 999999976543322111122346788999999876 368999999999999999998 788875433221 11
Q ss_pred HhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 513 ERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 513 ~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
..+..+....... .+...+.+++.+||+.||++||++++|++.|++
T Consensus 235 ~~~~~~~~~~~~~-------~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 235 ECITQGRELERPR-------TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHcCccCCCCC-------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 2222221111111 223557788889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=319.24 Aligned_cols=259 Identities=26% Similarity=0.440 Sum_probs=201.8
Q ss_pred HHHHHhhhhcCccCceEEEEEEeC--------CCcEEEEEEeccCCC--CHHHHHHHHHHHhcc-CCCceEEEEeEEEeC
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELP--------DGQLVAVKVLKNSRC--NGEEFINEVASISRT-SHVNIVTFLGFCYEN 360 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 360 (582)
...+.+.++||+|+||.||++... ++..+|+|.++.... ...++.+|+.+++++ +|+||+++++++.+.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 445667789999999999999642 235799999976432 235688899999999 799999999999999
Q ss_pred CeeeEEEEecCCCChhhhhhcCCC--------------cCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE
Q 040604 361 KKNALIYELMPNGSLDKFIHNDRN--------------IKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL 426 (582)
Q Consensus 361 ~~~~lv~E~~~~gsL~~~i~~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl 426 (582)
...++||||+++|+|.+++...+. ..+++.++++++.|++.||+|||+. +++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 999999999999999999975421 2488999999999999999999987 99999999999999
Q ss_pred cCCCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccc
Q 040604 427 DEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTS 505 (582)
Q Consensus 427 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~ 505 (582)
+.++.+||+|||+++...............+++.|+|||++.+ ..++.++||||||+++|||++ |..|+..... .
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-~- 249 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-E- 249 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc--CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-H-
Confidence 9999999999999986643322111222235578999999876 368899999999999999998 7777754321 1
Q ss_pred hhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 506 ICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 506 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
.+.+.+......... ......+.+++.+||+.+|++||||++|++.|+..+.
T Consensus 250 ----~~~~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 250 ----ELFKLLKEGHRMDKP-------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred ----HHHHHHHcCCCCCCC-------CcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 122222222211111 1234567778889999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=308.75 Aligned_cols=247 Identities=25% Similarity=0.360 Sum_probs=201.7
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC---CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR---CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
.+.+.||+|++|.||++... +++.|++|.+.... ...+.+.+|+.++++++|||++++++.+.+....++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE 82 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCC
Confidence 45678999999999999764 78999999986543 234678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
+++|.+++.......+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~- 158 (256)
T cd08529 83 NGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA- 158 (256)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccchh-
Confidence 99999999876556789999999999999999999987 99999999999999999999999999998765433221
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHH
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 531 (582)
....|++.|+|||++.+ ..++.++|+||||++++||++|+.|+....... ....+..+....+.
T Consensus 159 -~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~------- 222 (256)
T cd08529 159 -NTIVGTPYYLSPELCED--KPYNEKSDVWALGVVLYECCTGKHPFDANNQGA------LILKIIRGVFPPVS------- 222 (256)
T ss_pred -hccccCccccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHcCCCCCCc-------
Confidence 22358899999999876 368899999999999999999999997543211 11222222111111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 532 KKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
..+...+.+++.+||+.+|++||++.++++.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 223 QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1344667888899999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=312.21 Aligned_cols=254 Identities=26% Similarity=0.361 Sum_probs=199.2
Q ss_pred HHHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 294 TKSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
.+++.++||+|+||.||+|.. .+++.||+|+++.... ..+.+.+|+.++++++||||+++++.+......++||||++
T Consensus 10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~ 89 (267)
T cd06646 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCG 89 (267)
T ss_pred hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCC
Confidence 456778999999999999975 4789999999975432 34567889999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
+++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 90 ~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~-- 162 (267)
T cd06646 90 GGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK-- 162 (267)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccccc--
Confidence 999999987543 688999999999999999999987 9999999999999999999999999999876432211
Q ss_pred eecccCCcccccccccccc-cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHH
Q 040604 452 MLHARGTIGYIAPEVYSRR-FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 530 (582)
.....|++.|+|||.+... ...++.++||||||++++||++|+.|+......... ..+... ...... ...
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~------~~~~~~-~~~~~~--~~~ 233 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------FLMSKS-NFQPPK--LKD 233 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh------eeeecC-CCCCCC--Ccc
Confidence 1234588999999987431 235788999999999999999999998644322110 011110 000000 011
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 040604 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVLEML 563 (582)
Q Consensus 531 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L 563 (582)
...+...+.+++.+||+.+|++|||+++|++.|
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 234 KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 123345678889999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=310.86 Aligned_cols=255 Identities=22% Similarity=0.392 Sum_probs=202.9
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC----CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.+.++||+|+||.||+|... +++.||||.++.... ....+.+|+.++++++||||+++++++.+....++||||
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence 456688999999999999754 789999998864322 234688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcC--CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 370 MPNGSLDKFIHND--RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 370 ~~~gsL~~~i~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
+++++|.+++... ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 9999999888642 234578899999999999999999998 99999999999999999999999999988765433
Q ss_pred cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcC
Q 040604 448 SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 527 (582)
.. .....|++.|+|||.+.+. .++.++|+||||+++|||++|+.|+........ . +...+...... ..
T Consensus 161 ~~--~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~---~-~~~~~~~~~~~---~~- 228 (267)
T cd08228 161 TA--AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF---S-LCQKIEQCDYP---PL- 228 (267)
T ss_pred HH--HhcCCCCccccChhhhccC--CCCchhhHHHHHHHHHHHhcCCCCCccccccHH---H-HHHHHhcCCCC---CC-
Confidence 21 1123588999999998763 678899999999999999999999865432211 1 11222222111 11
Q ss_pred cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 040604 528 TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGS 566 (582)
Q Consensus 528 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~ 566 (582)
........+.+++.+||+.+|++||++++|++.|++.
T Consensus 229 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 229 --PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred --ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1123446678888999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=322.60 Aligned_cols=249 Identities=27% Similarity=0.329 Sum_probs=206.6
Q ss_pred HHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC----CHHHHHHHHHHHhccC-CCceEEEEeEEEeCCeeeEE
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEVASISRTS-HVNIVTFLGFCYENKKNALI 366 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 366 (582)
..|.+.++||+|.||.||++..+ +|+.+|+|++.+... ..+.+.+|+.+|+++. |||||.+++++.+....++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 34566789999999999999765 599999999976544 3368899999999999 99999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC----CceEEeecccccc
Q 040604 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED----FCPKISDFGLAKQ 442 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~----~~vkl~DFGla~~ 442 (582)
||++.||.|.+.|... .+++..+..++.|++.|++|||+. +|+||||||+|+|+... +.+|++|||+|..
T Consensus 115 mEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 9999999999999876 399999999999999999999997 99999999999999543 5799999999998
Q ss_pred ccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCC
Q 040604 443 AQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQ 522 (582)
Q Consensus 443 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~ 522 (582)
..... .....+||+.|+|||++.. ..++.++||||+||++|.|++|..||......... ..+..+.. .
T Consensus 189 ~~~~~---~~~~~~Gtp~y~APEvl~~--~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~------~~i~~~~~-~ 256 (382)
T KOG0032|consen 189 IKPGE---RLHTIVGTPEYVAPEVLGG--RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF------LAILRGDF-D 256 (382)
T ss_pred ccCCc---eEeeecCCccccCchhhcC--CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH------HHHHcCCC-C
Confidence 87722 2345679999999999985 37899999999999999999999999876543321 12222221 1
Q ss_pred CCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 523 FDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 523 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
+ ..+....+.....+++..+|..||.+|+|++++++.
T Consensus 257 f---~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 257 F---TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred C---CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1 122233445666777888999999999999999985
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=323.30 Aligned_cols=242 Identities=25% Similarity=0.373 Sum_probs=189.8
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHH---hccCCCceEEEEeEEEeCCeeeEEE
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASI---SRTSHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv~ 367 (582)
++.+.||+|+||.||+|... +++.||||+++... ...+.+.+|+.++ ++++||||+++++++.+....++||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 35678999999999999754 78999999997532 2234566666554 5678999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
||+++++|..++... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 82 EYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred cCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 999999999888642 589999999999999999999998 99999999999999999999999999987543222
Q ss_pred cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcC
Q 040604 448 SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 527 (582)
.. .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... +...+.... ..++..
T Consensus 156 ~~--~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~------~~~~i~~~~-~~~p~~- 223 (324)
T cd05589 156 DR--TSTFCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE------VFDSIVNDE-VRYPRF- 223 (324)
T ss_pred Cc--ccccccCccccCHhHhcC--CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC-CCCCCC-
Confidence 11 123469999999999876 368899999999999999999999997543221 112222211 112111
Q ss_pred cHHHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 040604 528 TEEEKKIAKMMILVGFWCIQTNPSERP-----SMHKVLE 561 (582)
Q Consensus 528 ~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~ 561 (582)
+...+.+++.+||+.||++|| +++++++
T Consensus 224 ------~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 224 ------LSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ------CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 234567788889999999999 5666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=311.95 Aligned_cols=251 Identities=30% Similarity=0.415 Sum_probs=198.6
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhcc-CCCceEEEEeEEEeC------CeeeE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRT-SHVNIVTFLGFCYEN------KKNAL 365 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~~~~l 365 (582)
.+++.+.||+|+||.||+|... +++.+|+|++.........+.+|+.+++++ +|+||+++++.+... ...++
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i 86 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 86 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEE
Confidence 3556688999999999999754 688999999987666677889999999998 799999999998753 35789
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
||||+++++|.+++.......+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++.....
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~ 163 (272)
T cd06637 87 VMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 163 (272)
T ss_pred EEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence 99999999999999876556789999999999999999999998 999999999999999999999999999986543
Q ss_pred cccceeeecccCCcccccccccccc---cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCC
Q 040604 446 KESAISMLHARGTIGYIAPEVYSRR---FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQ 522 (582)
Q Consensus 446 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~ 522 (582)
.... .....|++.|+|||++... ...++.++|||||||++|||++|+.|+......... . .+.......
T Consensus 164 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~-----~-~~~~~~~~~ 235 (272)
T cd06637 164 TVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-----F-LIPRNPAPR 235 (272)
T ss_pred cccc--CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-----H-HHhcCCCCC
Confidence 2221 1234589999999998532 135788999999999999999999998654322111 1 111111100
Q ss_pred CCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 523 FDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 523 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.. .......+.+++.+||+.+|.+|||++++++
T Consensus 236 ~~------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 236 LK------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CC------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 10 0123355778889999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=317.73 Aligned_cols=261 Identities=24% Similarity=0.447 Sum_probs=204.3
Q ss_pred HHHHHHHhhhhcCccCceEEEEEEeC--------CCcEEEEEEeccCCC--CHHHHHHHHHHHhcc-CCCceEEEEeEEE
Q 040604 290 VKRMTKSFRDKLGQGGYGEVYKGELP--------DGQLVAVKVLKNSRC--NGEEFINEVASISRT-SHVNIVTFLGFCY 358 (582)
Q Consensus 290 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 358 (582)
+....+.+.+.||+|+||.||++... ++..+|+|.++.... ..+.+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 44555667789999999999999631 345799999875432 235688999999999 8999999999999
Q ss_pred eCCeeeEEEEecCCCChhhhhhcCC--------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCE
Q 040604 359 ENKKNALIYELMPNGSLDKFIHNDR--------------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNI 424 (582)
Q Consensus 359 ~~~~~~lv~E~~~~gsL~~~i~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NI 424 (582)
.....++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 9999999999999999999987642 13478889999999999999999998 999999999999
Q ss_pred EEcCCCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcc
Q 040604 425 LLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTD 503 (582)
Q Consensus 425 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~ 503 (582)
|+++++.+||+|||+++...............+++.|+|||++.+ ..++.++||||||+++|||++ |..|+......
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 999999999999999987654333222223346788999999876 368899999999999999998 66776543211
Q ss_pred cchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 504 TSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 504 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
.+.+.+......... ......+.+++.+||+.+|++|||+.+|++.|++++.
T Consensus 247 ------~~~~~~~~~~~~~~~-------~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 247 ------ELFKLLKEGHRMDKP-------ANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred ------HHHHHHHcCCcCCCC-------CCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 122233322221111 1234567778889999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=321.56 Aligned_cols=240 Identities=24% Similarity=0.339 Sum_probs=192.5
Q ss_pred hhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 299 DKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISRT-SHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
+.||+|+||+||++... +++.||||++++.. ...+.+.+|..++..+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999765 68899999997542 2345577888888877 699999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
|+|..++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++........ .
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~ 153 (318)
T cd05570 81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--T 153 (318)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc--c
Confidence 99999887543 689999999999999999999998 9999999999999999999999999998753322221 1
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... +...+.... ..++.
T Consensus 154 ~~~~g~~~y~aPE~~~~--~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~------~~~~i~~~~-~~~~~------- 217 (318)
T cd05570 154 STFCGTPDYIAPEILSY--QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE------LFQSILEDE-VRYPR------- 217 (318)
T ss_pred cceecCccccCHHHhcC--CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH------HHHHHHcCC-CCCCC-------
Confidence 23459999999999976 378899999999999999999999997543211 122222211 11211
Q ss_pred HHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 040604 533 KIAKMMILVGFWCIQTNPSERPSM-----HKVLE 561 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RPt~-----~evl~ 561 (582)
.+...+.+++.+||+.||++||++ .++++
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 218 WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 223556788889999999999999 88765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=321.38 Aligned_cols=238 Identities=24% Similarity=0.326 Sum_probs=189.1
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhccCCC-ceEEEEeEEEeCCeeeEEEEe
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISRTSHV-NIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~E~ 369 (582)
.+.+.||+|+||.||+|... +++.||||+++... ...+.+..|+.++..++|+ +|+++++++.+.+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 82 (324)
T ss_pred eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence 45688999999999999765 67899999997532 2345678899999999765 588899999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 83 VNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 99999999987543 588899999999999999999998 9999999999999999999999999998753322211
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+.... ..++..
T Consensus 158 --~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~------~~~~i~~~~-~~~~~~--- 223 (324)
T cd05587 158 --TRTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE------LFQSIMEHN-VSYPKS--- 223 (324)
T ss_pred --eeeecCCccccChhhhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHcCC-CCCCCC---
Confidence 123469999999999976 367899999999999999999999997543221 122222211 112221
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSM 556 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~ 556 (582)
+...+.+++.+||+.||++|++.
T Consensus 224 ----~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 224 ----LSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ----CCHHHHHHHHHHhhcCHHHcCCC
Confidence 23456778888999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=319.56 Aligned_cols=261 Identities=25% Similarity=0.409 Sum_probs=197.0
Q ss_pred HHHHhhhhcCccCceEEEEEEeC-----------------CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEE
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELP-----------------DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTF 353 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l 353 (582)
..+.+.++||+|+||.||++... ++..+|+|+++.... ..+.+.+|+.++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 34567789999999999998432 244699999975432 23578999999999999999999
Q ss_pred EeEEEeCCeeeEEEEecCCCChhhhhhcCCC---------cCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCE
Q 040604 354 LGFCYENKKNALIYELMPNGSLDKFIHNDRN---------IKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNI 424 (582)
Q Consensus 354 ~~~~~~~~~~~lv~E~~~~gsL~~~i~~~~~---------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NI 424 (582)
++++......++||||+++++|.+++..... ..+++..++.++.|++.||+|||+. +++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 9999999999999999999999999875421 2467889999999999999999998 999999999999
Q ss_pred EEcCCCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc--CCCCCCCCCc
Q 040604 425 LLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG--CTKNLDDEVT 502 (582)
Q Consensus 425 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt--g~~p~~~~~~ 502 (582)
|++.++.+||+|||+++.+.............+++.|+|||.... +.++.++|||||||++|||++ |..|+.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL--GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc--CCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 999999999999999987544322111122335678999998765 478999999999999999998 5567654322
Q ss_pred ccchhhHHHHHhhcCC-CCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 503 DTSICHNLIYERIEPG-NDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 503 ~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
.. .... ..+..... ....++. .......+.+++.+||+.||++||++.+|++.|+.
T Consensus 240 ~~-~~~~-~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 EQ-VIEN-TGEFFRDQGRQVYLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HH-HHHH-HHHHHhhccccccCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 21 1111 11111110 0000100 01123567888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=305.42 Aligned_cols=247 Identities=27% Similarity=0.398 Sum_probs=195.0
Q ss_pred hcCccCceEEEEEEeC---CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCC
Q 040604 300 KLGQGGYGEVYKGELP---DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGS 374 (582)
Q Consensus 300 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 374 (582)
.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999653 456799999876532 2356889999999999999999999875 457799999999999
Q ss_pred hhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce-eee
Q 040604 375 LDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI-SML 453 (582)
Q Consensus 375 L~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~-~~~ 453 (582)
|.+++.... ..+++..+++++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++......... ...
T Consensus 81 L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 999987533 3689999999999999999999998 99999999999999999999999999998654433221 112
Q ss_pred cccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 454 HARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 454 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
...+++.|+|||.+.. ..++.++||||||+++|||++ |..|+....... +...+..+.....+..
T Consensus 157 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~------ 222 (257)
T cd05115 157 AGKWPLKWYAPECINF--RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE------VMSFIEQGKRLDCPAE------ 222 (257)
T ss_pred CCCCCcccCCHHHHcc--CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH------HHHHHHCCCCCCCCCC------
Confidence 2234678999999865 368899999999999999996 888987553321 2233333332222222
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 040604 533 KIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGS 566 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~ 566 (582)
....+.+++.+||+.+|++||++.+|.+.|+..
T Consensus 223 -~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 223 -CPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred -CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 235566788889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=327.46 Aligned_cols=251 Identities=21% Similarity=0.236 Sum_probs=197.7
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC----CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.+.++||+|+||+||++... +|+.||+|+++.... ..+.+.+|+.++++++|+||+++++++.+....++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 345688999999999999754 789999999975432 345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 83 ~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 83 QPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 99999999997642 3689999999999999999999998 9999999999999999999999999999876543322
Q ss_pred eeeecccCCcccccccccccc----cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCC
Q 040604 450 ISMLHARGTIGYIAPEVYSRR----FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~----~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 525 (582)
......||+.|+|||++... ...++.++|||||||++|||++|+.||....... .....+.......++.
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-----~~~~i~~~~~~~~~~~ 232 (330)
T cd05601 159 -NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-----TYNNIMNFQRFLKFPE 232 (330)
T ss_pred -eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-----HHHHHHcCCCccCCCC
Confidence 12234699999999998631 1357889999999999999999999997643322 1111111111111111
Q ss_pred cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 526 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
. ..+...+.+|+..||+ +|++||++++++.
T Consensus 233 ~-----~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 233 D-----PKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred C-----CCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 1 1233456677777888 9999999999885
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=325.28 Aligned_cols=237 Identities=27% Similarity=0.360 Sum_probs=190.1
Q ss_pred hhcCccCceEEEEEEe----CCCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 299 DKLGQGGYGEVYKGEL----PDGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
+.||+|+||.||++.. .+|+.+|+|+++.... ....+.+|+.++++++||||+++++++.++...++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999854 3688999999975432 23456789999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
+|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~-- 154 (318)
T cd05582 82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-- 154 (318)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc--
Confidence 99999998654 3689999999999999999999998 9999999999999999999999999999875443221
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHH
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 531 (582)
.....||+.|+|||.+.+. .++.++||||||+++|||++|+.||....... ....+.... ..++..
T Consensus 155 ~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~~------~~~~i~~~~-~~~p~~----- 220 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE------TMTMILKAK-LGMPQF----- 220 (318)
T ss_pred eecccCChhhcCHHHHcCC--CCCCccceeccceEeeeeccCCCCCCCCCHHH------HHHHHHcCC-CCCCCC-----
Confidence 1234699999999998763 67899999999999999999999997543211 112222211 112111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHH
Q 040604 532 KKIAKMMILVGFWCIQTNPSERPSMHK 558 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RPt~~e 558 (582)
+...+.+++.+||+.||++||++.+
T Consensus 221 --~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 221 --LSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred --CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 2345667888899999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=330.37 Aligned_cols=253 Identities=21% Similarity=0.270 Sum_probs=195.3
Q ss_pred HHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEE
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 367 (582)
..+++.++||+|+||.||++... +++.+|+|++.+.. ...+.+.+|+.+++.++||||+++++.+.++...++||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 34566789999999999999765 68899999986422 23345788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
||+++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++.......
T Consensus 123 Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 123 EYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred cCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 999999999998653 478889999999999999999998 99999999999999999999999999998764332
Q ss_pred cceeeecccCCccccccccccccc--CCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCC
Q 040604 448 SAISMLHARGTIGYIAPEVYSRRF--GGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 525 (582)
.. ......||+.|+|||++.+.. +.++.++||||+||++|||++|+.||....... .....+.......++.
T Consensus 197 ~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~-----~~~~i~~~~~~~~~p~ 270 (370)
T cd05621 197 MV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG-----TYSKIMDHKNSLNFPE 270 (370)
T ss_pred ce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH-----HHHHHHhCCcccCCCC
Confidence 21 112356999999999986532 247889999999999999999999997543221 1111121111111111
Q ss_pred cCcHHHHHHHHHHHHHHHhccccCCC--CCCCHHHHHHH
Q 040604 526 VATEEEKKIAKMMILVGFWCIQTNPS--ERPSMHKVLEM 562 (582)
Q Consensus 526 ~~~~~~~~~~~~l~~l~~~Cl~~dp~--~RPt~~evl~~ 562 (582)
...+...+.+++.+||+.++. .|++++|+++.
T Consensus 271 -----~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 271 -----DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -----cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 122344556666777875554 38899999876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=314.21 Aligned_cols=254 Identities=26% Similarity=0.446 Sum_probs=199.0
Q ss_pred HHHhhhhcCccCceEEEEEEeC------CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP------DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNAL 365 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 365 (582)
.+++.++||+|+||.||++... ++..+|+|+++.... ...++.+|+.++++++||||+++++++.++...++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~l 85 (288)
T cd05050 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCL 85 (288)
T ss_pred hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEE
Confidence 4456689999999999999753 467899999875432 23568899999999999999999999999889999
Q ss_pred EEEecCCCChhhhhhcCC--------------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEE
Q 040604 366 IYELMPNGSLDKFIHNDR--------------------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNIL 425 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~--------------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NIL 425 (582)
||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||+
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil 162 (288)
T cd05050 86 LFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCL 162 (288)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheE
Confidence 999999999999986421 12478889999999999999999987 9999999999999
Q ss_pred EcCCCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCccc
Q 040604 426 LDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDT 504 (582)
Q Consensus 426 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~ 504 (582)
+++++.+||+|||++................++..|+|||.+.+ ..++.++|||||||++|||++ |..|+.......
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999886543322111112235678999998865 478999999999999999997 777775432211
Q ss_pred chhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 505 SICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 505 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
+...+..+...... ......+.+++.+||+.+|++|||+.||++.|++
T Consensus 241 ------~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 ------VIYYVRDGNVLSCP-------DNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ------HHHHHhcCCCCCCC-------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 12223222211111 1234567889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=303.45 Aligned_cols=247 Identities=28% Similarity=0.460 Sum_probs=198.0
Q ss_pred hhcCccCceEEEEEEeCCCcEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCChh
Q 040604 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLD 376 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 376 (582)
+.||+|+||.||+|...++..+|+|+++..... ...+.+|+.++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 469999999999998888999999998754332 346889999999999999999999999999999999999999999
Q ss_pred hhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeeccc
Q 040604 377 KFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR 456 (582)
Q Consensus 377 ~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 456 (582)
+++.... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......... .....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~ 155 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGLKQ 155 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccccccc-CCCCC
Confidence 9987543 3578999999999999999999987 99999999999999999999999999997644322111 11123
Q ss_pred CCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHH
Q 040604 457 GTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIA 535 (582)
Q Consensus 457 gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 535 (582)
+++.|+|||++.. +.++.++||||||+++|||++ |..||....... ....+..+....... .+.
T Consensus 156 ~~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~-------~~~ 220 (250)
T cd05085 156 IPIKWTAPEALNY--GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ------AREQVEKGYRMSCPQ-------KCP 220 (250)
T ss_pred CcccccCHHHhcc--CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH------HHHHHHcCCCCCCCC-------CCC
Confidence 5678999999865 478899999999999999998 888886542221 122222222211111 234
Q ss_pred HHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 536 KMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 536 ~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
..+.+++.+||+.+|++||++.+++++|.+
T Consensus 221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 250 (250)
T cd05085 221 DDVYKVMQRCWDYKPENRPKFSELQKELAA 250 (250)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHHHhcC
Confidence 567888899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=306.49 Aligned_cols=247 Identities=27% Similarity=0.461 Sum_probs=198.7
Q ss_pred HHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEE-eCCeeeEEEEecCC
Q 040604 294 TKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCY-ENKKNALIYELMPN 372 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~E~~~~ 372 (582)
.+.+.+.||+|+||.||++.. .|..+|+|.++... ..+.+.+|+.++++++|+|++++++++. ++...++||||+++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred hCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 455678999999999999976 47889999986543 4567899999999999999999999765 44578999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
++|.+++.......+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~---- 157 (256)
T cd05082 85 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---- 157 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccCC----
Confidence 9999999876555689999999999999999999988 999999999999999999999999999886543221
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 531 (582)
...++..|+|||++.. ..++.++||||||+++|||++ |+.|+....... +...+..+......
T Consensus 158 -~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~------- 221 (256)
T cd05082 158 -TGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYKMDAP------- 221 (256)
T ss_pred -CCccceeecCHHHHcc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHhcCCCCCCC-------
Confidence 2235678999999865 468899999999999999997 888876432211 12222222211111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 532 KKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
......+.+++.+||+.+|++|||++++++.|+.
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 222 DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1234567788889999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=332.83 Aligned_cols=248 Identities=23% Similarity=0.289 Sum_probs=190.3
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
.+.++||+|+||+||++... +++.||||++.... ...+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 4 ~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 83 (377)
T cd05629 4 HTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFL 83 (377)
T ss_pred eEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCC
Confidence 45688999999999999654 78999999986532 12356788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc-
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA- 449 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~- 449 (582)
++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 84 PGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 9999999987543 588899999999999999999998 9999999999999999999999999999643211000
Q ss_pred -----------e---------------------------------eeecccCCcccccccccccccCCCCccchhHHHHH
Q 040604 450 -----------I---------------------------------SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGM 485 (582)
Q Consensus 450 -----------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGv 485 (582)
. ......||+.|+|||++.+. .++.++|||||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGv 236 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ--GYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC--CCCCceeeEecch
Confidence 0 00013599999999998763 6899999999999
Q ss_pred HHHHHhcCCCCCCCCCcccchhhHHHHHhhcC-CCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCC---CCHHHHHH
Q 040604 486 MIIEMVGCTKNLDDEVTDTSICHNLIYERIEP-GNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSER---PSMHKVLE 561 (582)
Q Consensus 486 il~elltg~~p~~~~~~~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~R---Pt~~evl~ 561 (582)
++|||++|+.||....... ....+.. .....++.. ..+...+.+++.+||+ +|.+| +++.++++
T Consensus 237 il~elltG~~Pf~~~~~~~------~~~~i~~~~~~~~~p~~-----~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~ 304 (377)
T cd05629 237 IMFECLIGWPPFCSENSHE------TYRKIINWRETLYFPDD-----IHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS 304 (377)
T ss_pred hhhhhhcCCCCCCCCCHHH------HHHHHHccCCccCCCCC-----CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence 9999999999997543321 1111211 111112111 1123445667777887 66665 59999886
Q ss_pred H
Q 040604 562 M 562 (582)
Q Consensus 562 ~ 562 (582)
.
T Consensus 305 h 305 (377)
T cd05629 305 H 305 (377)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=323.34 Aligned_cols=236 Identities=24% Similarity=0.314 Sum_probs=186.3
Q ss_pred hhcCccCceEEEEEEeC-CCcEEEEEEeccCCC----CHHHHHHHHH-HHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 299 DKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEVA-SISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
+.||+|+||+||+|... +|+.||+|++..... ....+.+|.. +++.++||||+++++.+.+....++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999765 799999999865321 2234555554 56789999999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
|+|..++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~ 153 (323)
T cd05575 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TT 153 (323)
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--cc
Confidence 99999887543 688899999999999999999998 999999999999999999999999999876432221 12
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... +.+.+.... ..+...
T Consensus 154 ~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~~~i~~~~-~~~~~~------ 218 (323)
T cd05575 154 STFCGTPEYLAPEVLRK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE------MYDNILNKP-LRLKPN------ 218 (323)
T ss_pred ccccCChhhcChhhhcC--CCCCccccccccchhhhhhhcCCCCCCCCCHHH------HHHHHHcCC-CCCCCC------
Confidence 23469999999999876 468899999999999999999999997543211 122222221 112111
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHH
Q 040604 533 KIAKMMILVGFWCIQTNPSERPSMH 557 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RPt~~ 557 (582)
+...+.+++.+||+.||++||+++
T Consensus 219 -~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 219 -ISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -CCHHHHHHHHHHhhcCHHhCCCCC
Confidence 234567778889999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=303.63 Aligned_cols=248 Identities=29% Similarity=0.495 Sum_probs=198.1
Q ss_pred hhcCccCceEEEEEEeCCCcEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCChh
Q 040604 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLD 376 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 376 (582)
++||+|+||.||++...+++.||+|.++..... .+.+.+|+.++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999998767999999998765443 457899999999999999999999999999999999999999999
Q ss_pred hhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeeccc
Q 040604 377 KFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR 456 (582)
Q Consensus 377 ~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 456 (582)
+++.... ..+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++...............
T Consensus 81 ~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 9987543 3678999999999999999999988 99999999999999999999999999998654322221111223
Q ss_pred CCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHH
Q 040604 457 GTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIA 535 (582)
Q Consensus 457 gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 535 (582)
++..|+|||.+.+ +.++.++|+||||++++||++ |..|+....... ....+......... ....
T Consensus 157 ~~~~y~~PE~~~~--~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~------~~~~~~~~~~~~~~-------~~~~ 221 (251)
T cd05041 157 IPIKWTAPEALNY--GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ------TRERIESGYRMPAP-------QLCP 221 (251)
T ss_pred ceeccCChHhhcc--CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH------HHHHHhcCCCCCCC-------ccCC
Confidence 4667999999865 468899999999999999998 777775543211 12222222111111 1234
Q ss_pred HHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 536 KMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 536 ~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
..+.+++.+||+.+|++|||++||++.|+.
T Consensus 222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 222 EEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 567888899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=310.48 Aligned_cols=253 Identities=26% Similarity=0.436 Sum_probs=199.7
Q ss_pred HHhhhhcCccCceEEEEEEeC-CC---cEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DG---QLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 368 (582)
++..+.||+|+||.||+|... ++ ..+|+|.++.... ..+.+.+|+.++++++|+|++++++++.+....++|||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (268)
T cd05063 7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITE 86 (268)
T ss_pred ceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEE
Confidence 345678999999999999764 33 3799999876532 24568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
|+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 87 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 162 (268)
T cd05063 87 YMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE 162 (268)
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence 999999999987543 4689999999999999999999998 999999999999999999999999999987654322
Q ss_pred cee-eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCc
Q 040604 449 AIS-MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526 (582)
Q Consensus 449 ~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 526 (582)
... ......++.|+|||++.. ..++.++||||||+++|||++ |+.|+....... +...+..+......
T Consensus 163 ~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~------~~~~i~~~~~~~~~-- 232 (268)
T cd05063 163 GTYTTSGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE------VMKAINDGFRLPAP-- 232 (268)
T ss_pred cceeccCCCcCceecCHHHhhc--CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhcCCCCCCC--
Confidence 211 111223567999999875 467899999999999999997 999986543211 12222222111111
Q ss_pred CcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 040604 527 ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGS 566 (582)
Q Consensus 527 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~ 566 (582)
......+.+++.+||+.+|++||++++|++.|++.
T Consensus 233 -----~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 233 -----MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 12345678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=325.60 Aligned_cols=265 Identities=26% Similarity=0.416 Sum_probs=222.3
Q ss_pred cHHHHHHHHHHhhhhcCccCceEEEEEEeCC-CcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeee
Q 040604 286 SYSDVKRMTKSFRDKLGQGGYGEVYKGELPD-GQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNA 364 (582)
Q Consensus 286 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 364 (582)
.-.|+++.......+||-|.||.||.|.++. .-.||||.++...+..++|+.|+.+|+.++|||+|+|+|+|....-.|
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 3345555555567899999999999998864 567999999999999999999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccc
Q 040604 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~ 444 (582)
+|.|||..|+|.+++.+-....++...++.++.||+.||+||..+ .+|||||...|.|+.++..|||+||||++++.
T Consensus 340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 999999999999999877666788888999999999999999988 99999999999999999999999999999987
Q ss_pred ccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCC-CCCCCCcccchhhHHHHHhhcCCCCCCC
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTK-NLDDEVTDTSICHNLIYERIEPGNDFQF 523 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~-p~~~~~~~~~~~~~~~~~~i~~~~~~~~ 523 (582)
.+... ......-.+.|.|||-+.- ..++.|+|||+|||+|||+.|-.. |+.... ...+++.++++..+.-
T Consensus 417 gDTYT-AHAGAKFPIKWTAPEsLAy--NtFSiKSDVWAFGVLLWEIATYGMsPYPGid------lSqVY~LLEkgyRM~~ 487 (1157)
T KOG4278|consen 417 GDTYT-AHAGAKFPIKWTAPESLAY--NTFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYGLLEKGYRMDG 487 (1157)
T ss_pred CCcee-cccCccCcccccCcccccc--cccccchhhHHHHHHHHHHHhcCCCCCCCcc------HHHHHHHHhccccccC
Confidence 65432 1223345678999999864 479999999999999999998554 554432 2347788887755443
Q ss_pred CCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCC
Q 040604 524 DGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIEN 569 (582)
Q Consensus 524 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~ 569 (582)
+ +.++.++.+|+..||+..|.+||++.|+-+.+|.++.+
T Consensus 488 P-------eGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 488 P-------EGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred C-------CCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 3 33456778888899999999999999999998876653
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=310.20 Aligned_cols=255 Identities=25% Similarity=0.447 Sum_probs=199.3
Q ss_pred HHHhhhhcCccCceEEEEEEe-CCCc----EEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGEL-PDGQ----LVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALI 366 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 366 (582)
.+++.++||+|+||+||+|.+ .+++ .||+|+++.... ..+++.+|+.+++.++|+||+++++++.. ...+++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~ 86 (279)
T cd05109 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLV 86 (279)
T ss_pred heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEE
Confidence 345668999999999999964 3454 489999875433 24568899999999999999999999875 456899
Q ss_pred EEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccc
Q 040604 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~ 446 (582)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 87 ~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 87 TQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 99999999999987543 3689999999999999999999998 9999999999999999999999999999877544
Q ss_pred ccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCC
Q 040604 447 ESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525 (582)
Q Consensus 447 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 525 (582)
..........+++.|+|||.+.+ ..++.++||||||+++|||++ |..|+....... +...+..+.......
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~~~ 234 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILH--RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE------IPDLLEKGERLPQPP 234 (279)
T ss_pred cceeecCCCccchhhCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHHCCCcCCCCc
Confidence 33322223346778999999865 468999999999999999998 788876432211 122222222211111
Q ss_pred cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 526 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
.....+.+++.+||+.||++||++.++++.|+....
T Consensus 235 -------~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 235 -------ICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred -------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 123456778889999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=308.62 Aligned_cols=248 Identities=27% Similarity=0.472 Sum_probs=193.9
Q ss_pred hhcCccCceEEEEEEeC-CCc--EEEEEEeccCC--CCHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 299 DKLGQGGYGEVYKGELP-DGQ--LVAVKVLKNSR--CNGEEFINEVASISRT-SHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
+.||+|+||.||+|.+. ++. .+|+|.++... ...+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999764 444 47888887533 2345788999999999 899999999999999999999999999
Q ss_pred CChhhhhhcCC--------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecc
Q 040604 373 GSLDKFIHNDR--------------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFG 438 (582)
Q Consensus 373 gsL~~~i~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFG 438 (582)
|+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999987532 12478899999999999999999987 99999999999999999999999999
Q ss_pred ccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcC
Q 040604 439 LAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEP 517 (582)
Q Consensus 439 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~ 517 (582)
++........ ......+..|+|||++.. ..++.++||||||++++||++ |..||....... ..+.+..
T Consensus 158 l~~~~~~~~~---~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~------~~~~~~~ 226 (270)
T cd05047 158 LSRGQEVYVK---KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEKLPQ 226 (270)
T ss_pred Cccccchhhh---ccCCCCccccCChHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH------HHHHHhC
Confidence 9864322111 111234667999999865 368899999999999999997 888886532211 1222222
Q ss_pred CCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 040604 518 GNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSI 567 (582)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~ 567 (582)
+....... .....+.+++.+||+.+|.+|||+.+++..|++++
T Consensus 227 ~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 GYRLEKPL-------NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCCCCCC-------cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 21111111 12345778889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=308.49 Aligned_cols=248 Identities=29% Similarity=0.439 Sum_probs=197.6
Q ss_pred hhcCccCceEEEEEEeC--CC--cEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 299 DKLGQGGYGEVYKGELP--DG--QLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
++||+|++|.||+|.+. ++ ..+|||.++.... ..+.+.+|+.++++++|+||+++++.+.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 46899999999999754 23 3699999977654 34578899999999999999999999988 888999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce-e
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI-S 451 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~-~ 451 (582)
++|.+++.......+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++......... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 9999999765435689999999999999999999998 99999999999999999999999999998765532221 1
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHH
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 530 (582)
.....++..|+|||++.. ..++.++||||||++++||++ |+.|+....... ...............
T Consensus 157 ~~~~~~~~~y~~pE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~------ 223 (257)
T cd05040 157 EEHLKVPFAWCAPESLRT--RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-----ILKKIDKEGERLERP------ 223 (257)
T ss_pred ccCCCCCceecCHHHhcc--cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHhcCCcCCCC------
Confidence 123457889999999876 368899999999999999998 999986442221 111111111111111
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 040604 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564 (582)
Q Consensus 531 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le 564 (582)
...+..+.+++.+||+.+|++||++++|++.|.
T Consensus 224 -~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 224 -EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 123456788899999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=308.05 Aligned_cols=254 Identities=25% Similarity=0.420 Sum_probs=187.7
Q ss_pred hhcCccCceEEEEEEeCC---CcEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCC
Q 040604 299 DKLGQGGYGEVYKGELPD---GQLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNG 373 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 373 (582)
++||+|+||+||+|...+ ...+|+|.+...... ...+.+|+.+++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999996433 456888887644322 346889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCC---cCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 374 SLDKFIHNDRN---IKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 374 sL~~~i~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
+|.+++..... ...++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999976432 2346788899999999999999998 99999999999999999999999999987644332222
Q ss_pred eeecccCCcccccccccccc-----cCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCC
Q 040604 451 SMLHARGTIGYIAPEVYSRR-----FGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFD 524 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~-----~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 524 (582)
......+++.|+|||++... ...++.++||||||+++|||++ |..|+....... . ....+.... ..+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~----~~~~~~~~~-~~~~ 231 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-V----LKQVVREQD-IKLP 231 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-H----HHHHhhccC-ccCC
Confidence 22233467789999987531 1356889999999999999998 667775443221 1 112222211 1111
Q ss_pred CcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 040604 525 GVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564 (582)
Q Consensus 525 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le 564 (582)
.. .........+.+++..|+ .||++|||+++|++.|.
T Consensus 232 ~~--~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KP--QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CC--cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 00 011123344455666677 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=317.30 Aligned_cols=261 Identities=19% Similarity=0.273 Sum_probs=195.1
Q ss_pred hhhhcCcc--CceEEEEEEe-CCCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 297 FRDKLGQG--GYGEVYKGEL-PDGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 297 ~~~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
+.++||+| +|++||++.. .+|+.||+|.++..... .+.+.+|+.+++.++||||+++++++..+...++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 7899999965 47999999999754322 245678999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
++|+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||++.++.++++||+.+..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999999765445689999999999999999999998 99999999999999999999999998654432211100
Q ss_pred -----eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcC--------
Q 040604 451 -----SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEP-------- 517 (582)
Q Consensus 451 -----~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~-------- 517 (582)
......++..|+|||++.+....++.++|||||||++|||++|+.||......... .......+..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML-LEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH-HHHhcCCccccccccchh
Confidence 01123467889999998764346889999999999999999999999754321110 0000000000
Q ss_pred -----------CCCCCC--------------CCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 518 -----------GNDFQF--------------DGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 518 -----------~~~~~~--------------~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
+.+..+ ..............+.+++.+||+.||++|||++||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000000 00000112234457888999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=310.89 Aligned_cols=249 Identities=29% Similarity=0.497 Sum_probs=196.3
Q ss_pred hhcCccCceEEEEEEeCC-------CcEEEEEEeccCC--CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 299 DKLGQGGYGEVYKGELPD-------GQLVAVKVLKNSR--CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.||+|+||.||+|...+ ++.+|+|.+.... .....+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999996532 3679999886543 3456788999999999999999999999998999999999
Q ss_pred cCCCChhhhhhcCC-----CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-----ceEEeeccc
Q 040604 370 MPNGSLDKFIHNDR-----NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF-----CPKISDFGL 439 (582)
Q Consensus 370 ~~~gsL~~~i~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~-----~vkl~DFGl 439 (582)
+++++|.+++.... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++ .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999987532 23478899999999999999999987 999999999999999887 899999999
Q ss_pred cccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCC
Q 040604 440 AKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPG 518 (582)
Q Consensus 440 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~ 518 (582)
++...............++..|+|||++.+ +.++.++||||||+++|||++ |+.|+....... ....+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~ 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLD--GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE------VLQHVTAG 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHcc--CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH------HHHHHhcC
Confidence 986544322211122346788999999876 478999999999999999998 888886443211 11222222
Q ss_pred CCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 519 NDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
...... ..++..+.+++.+||+.+|++||++++|++.|+.
T Consensus 230 ~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 GRLQKP-------ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred CccCCc-------ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111111 2234567788999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=316.79 Aligned_cols=254 Identities=27% Similarity=0.481 Sum_probs=196.8
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCc--EEEEEEeccCCC--CHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeeeEEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQ--LVAVKVLKNSRC--NGEEFINEVASISRT-SHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 367 (582)
.+.+.+.||+|+||.||+|.+. ++. .+|+|.++.... ..+.+.+|+.++.++ +|+||+++++++.+....++||
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 87 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 87 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEE
Confidence 3456789999999999999754 454 457777764322 235688999999999 8999999999999999999999
Q ss_pred EecCCCChhhhhhcCC--------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceE
Q 040604 368 ELMPNGSLDKFIHNDR--------------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPK 433 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vk 433 (582)
||+++++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+|||+++++.+|
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~k 164 (303)
T cd05088 88 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 164 (303)
T ss_pred EeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEE
Confidence 9999999999987542 13578999999999999999999987 999999999999999999999
Q ss_pred EeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHH
Q 040604 434 ISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIY 512 (582)
Q Consensus 434 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 512 (582)
|+|||+++....... .....++..|+|||++... .++.++||||||++++||+| |..||....... ..
T Consensus 165 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~ 233 (303)
T cd05088 165 IADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LY 233 (303)
T ss_pred eCccccCcccchhhh---cccCCCcccccCHHHHhcc--CCcccccchhhhhHHHHHHhcCCCCcccCChHH------HH
Confidence 999999864322111 1112346789999988653 67899999999999999998 888886443221 12
Q ss_pred HhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 513 ERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 513 ~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
+.+..+...... ......+.+++.+||+.+|++||+++++++.|+..+.
T Consensus 234 ~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 234 EKLPQGYRLEKP-------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred HHHhcCCcCCCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 222222111111 1123457788899999999999999999999887554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=315.64 Aligned_cols=261 Identities=25% Similarity=0.433 Sum_probs=201.6
Q ss_pred HHhhhhcCccCceEEEEEEeC-CC--cEEEEEEeccCCC--CHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeeeEEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DG--QLVAVKVLKNSRC--NGEEFINEVASISRT-SHVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~--~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 368 (582)
+.+.+.||+|+||.||+|... ++ ..+++|.++.... ..+.+.+|+.++.++ +||||+++++++.+....++|||
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 83 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE 83 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence 346688999999999999764 33 3578888874322 235788999999999 79999999999999889999999
Q ss_pred ecCCCChhhhhhcCC--------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEE
Q 040604 369 LMPNGSLDKFIHNDR--------------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKI 434 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl 434 (582)
|+++++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEE
Confidence 999999999986532 12478899999999999999999987 9999999999999999999999
Q ss_pred eeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHH
Q 040604 435 SDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYE 513 (582)
Q Consensus 435 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 513 (582)
+|||++........ ......+..|+|||++.. ..++.++|||||||++|||++ |+.||....... +.+
T Consensus 161 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~------~~~ 229 (297)
T cd05089 161 ADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNY--SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE------LYE 229 (297)
T ss_pred CCcCCCccccceec---cCCCCcCccccCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HHH
Confidence 99999864322111 111223567999999865 368899999999999999997 888986543221 122
Q ss_pred hhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCCCCCCC
Q 040604 514 RIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQIPPKP 576 (582)
Q Consensus 514 ~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~~p~~p 576 (582)
.+..+....... .+...+.+++.+||+.+|.+||+++++++.|+..+...+...++
T Consensus 230 ~~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~~~ 285 (297)
T cd05089 230 KLPQGYRMEKPR-------NCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYVNM 285 (297)
T ss_pred HHhcCCCCCCCC-------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcccccc
Confidence 222221111111 23355778888999999999999999999999888766544433
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=319.27 Aligned_cols=241 Identities=22% Similarity=0.299 Sum_probs=189.2
Q ss_pred hhcCccCceEEEEEEeC-CCcEEEEEEeccCCC----CHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 299 DKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEVASISRT-SHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
+.||+|+||+||++... +++.||+|+++.... ..+.+.+|+.++.++ +|+||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999764 688999999976432 234577899998887 699999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
|+|..++...+ .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........ .
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~--~ 153 (327)
T cd05617 81 GDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--T 153 (327)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc--e
Confidence 99998886543 689999999999999999999998 9999999999999999999999999999753322211 1
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccc-hhhHHHHHhhcCCCCCCCCCcCcHHH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTS-ICHNLIYERIEPGNDFQFDGVATEEE 531 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~i~~~~~~~~~~~~~~~~ 531 (582)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .....+.+.+... ...++..
T Consensus 154 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~p~~----- 225 (327)
T cd05617 154 STFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK-PIRIPRF----- 225 (327)
T ss_pred ecccCCcccCCHHHHCC--CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC-CCCCCCC-----
Confidence 23469999999999876 4788999999999999999999999964322211 1122233333222 1122222
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCH
Q 040604 532 KKIAKMMILVGFWCIQTNPSERPSM 556 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RPt~ 556 (582)
+...+.+++.+||+.||++|+++
T Consensus 226 --~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 226 --LSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred --CCHHHHHHHHHHhccCHHHcCCC
Confidence 22445677788999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=320.43 Aligned_cols=238 Identities=23% Similarity=0.326 Sum_probs=189.0
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC----CHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeeeEEEEe
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEVASISRT-SHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
++.+.||+|+||+||+|... +++.||||++++... ..+.+..|..++..+ +|++|+++++++.+.+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY 82 (323)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence 45678999999999999765 678999999975422 234566788887776 588999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 83 ~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 83 VNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 99999999887543 588899999999999999999998 9999999999999999999999999999764322211
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... +...+.... ..++.
T Consensus 158 --~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~------~~~~i~~~~-~~~p~---- 222 (323)
T cd05616 158 --TKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------LFQSIMEHN-VAYPK---- 222 (323)
T ss_pred --cccCCCChhhcCHHHhcC--CCCCCccchhchhHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC-CCCCC----
Confidence 123469999999999976 478999999999999999999999997643321 122222211 11221
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSM 556 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~ 556 (582)
.+...+.+++.+||+.||++|++.
T Consensus 223 ---~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 223 ---SMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ---cCCHHHHHHHHHHcccCHHhcCCC
Confidence 233556778888999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=322.43 Aligned_cols=239 Identities=23% Similarity=0.300 Sum_probs=186.4
Q ss_pred hhcCccCceEEEEEEeC-CCcEEEEEEeccCCC----CHHHHHHHH-HHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 299 DKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEV-ASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
+.||+|+||+||++... +++.||+|++..... ....+..|. .+++.++|+||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999765 678999999875321 223344444 456789999999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
|+|.+++.... .+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++........ .
T Consensus 81 ~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~--~ 153 (325)
T cd05602 81 GELFYHLQRER--CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--T 153 (325)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCC--c
Confidence 99999987643 577888889999999999999998 9999999999999999999999999999764332221 2
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..+.+.... ..+..
T Consensus 154 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~~~-~~~~~------- 217 (325)
T cd05602 154 STFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MYDNILNKP-LQLKP------- 217 (325)
T ss_pred ccccCCccccCHHHHcC--CCCCCccccccccHHHHHHhcCCCCCCCCCHHH------HHHHHHhCC-cCCCC-------
Confidence 23469999999999876 468899999999999999999999997543322 112221111 11111
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHH
Q 040604 533 KIAKMMILVGFWCIQTNPSERPSMHKVL 560 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl 560 (582)
.+...+.+++.+||+.||.+||++.+.+
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 218 NITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 2234566777889999999999987443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.70 Aligned_cols=257 Identities=21% Similarity=0.228 Sum_probs=193.5
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
.+.+.++||+|+||.||++... .++.||||... ...+.+|+.+|++++|+|||++++++......++|||++ .
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~ 243 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-R 243 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-C
Confidence 3556688999999999999765 58899999642 234678999999999999999999999999999999999 5
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
++|..++.... ..+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...........
T Consensus 244 ~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 244 SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence 78888876532 3689999999999999999999998 9999999999999999999999999999876443222222
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCccc--chhhHHHHHhhcCCCCC--CCCCc--
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDT--SICHNLIYERIEPGNDF--QFDGV-- 526 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~--~~~~~~~~~~i~~~~~~--~~~~~-- 526 (582)
....||+.|+|||++.+. .++.++|||||||+||||++|..++....... ......+.+.+...... .+...
T Consensus 320 ~~~~GT~~Y~APE~~~~~--~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 320 YGIAGTVDTNAPEVLAGD--PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred cccCCCcCCcCHHHHcCC--CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 234699999999999763 68999999999999999999887654322111 11111122222111100 00000
Q ss_pred ----------------------CcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 527 ----------------------ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 527 ----------------------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
.......+...+.+|+.+||+.||++|||+.|+++.
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000011223357788999999999999999999874
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=314.63 Aligned_cols=256 Identities=27% Similarity=0.394 Sum_probs=196.9
Q ss_pred HhhhhcCccCceEEEEEEe-----CCCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeC--CeeeEE
Q 040604 296 SFRDKLGQGGYGEVYKGEL-----PDGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYEN--KKNALI 366 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 366 (582)
.+.+.||+|+||+||++.. .+++.||+|+++.... ..+.+.+|+.++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 4568899999999988642 3678999999976533 346788999999999999999999988754 357899
Q ss_pred EEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccc
Q 040604 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~ 446 (582)
|||+++++|.+++... .+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 87 ~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 87 MEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred ecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 9999999999999753 489999999999999999999998 9999999999999999999999999999876543
Q ss_pred cccee-eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchh---------hHHHHHhhc
Q 040604 447 ESAIS-MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSIC---------HNLIYERIE 516 (582)
Q Consensus 447 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~---------~~~~~~~i~ 516 (582)
..... .....++..|+|||.+.. ..++.++||||||++++||++|..|+.......... ...+.+.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKE--NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcc--cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 32111 112235667999999875 468899999999999999999999875432211000 000001111
Q ss_pred CCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 040604 517 PGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGS 566 (582)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~ 566 (582)
..... .........+.+++.+||+.+|++|||+++|++.|+..
T Consensus 239 ~~~~~-------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 239 RGMRL-------PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred cCCCC-------CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11000 00122346788889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=319.81 Aligned_cols=258 Identities=26% Similarity=0.468 Sum_probs=212.8
Q ss_pred HHHHHHHhhhhcCccCceEEEEEEeC---CC--cEEEEEEeccCC--CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCe
Q 040604 290 VKRMTKSFRDKLGQGGYGEVYKGELP---DG--QLVAVKVLKNSR--CNGEEFINEVASISRTSHVNIVTFLGFCYENKK 362 (582)
Q Consensus 290 ~~~~~~~~~~~lG~G~~g~Vy~~~~~---~~--~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 362 (582)
+.++...+.++||.|.||.||+|.+. .| -.||||..+... .+.+.|+.|..+|++++|||||+|+|+|.+ .-
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 45555667789999999999999653 23 358999998743 346889999999999999999999999965 45
Q ss_pred eeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccc
Q 040604 363 NALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ 442 (582)
Q Consensus 363 ~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~ 442 (582)
.++|||.++-|.|..+++.++ ..++...+...+.||..||+|||+. .+|||||...|||+.....|||+|||+++.
T Consensus 465 ~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred eeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhh
Confidence 689999999999999998765 3688889999999999999999998 999999999999999999999999999999
Q ss_pred ccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCC
Q 040604 443 AQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDF 521 (582)
Q Consensus 443 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~ 521 (582)
+......... ...-.+.|||||.+.- ..++.+||||.|||.+||++. |.+||....+.. +..++++|..+
T Consensus 541 ~ed~~yYkaS-~~kLPIKWmaPESINf--RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD------VI~~iEnGeRl 611 (974)
T KOG4257|consen 541 LEDDAYYKAS-RGKLPIKWMAPESINF--RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD------VIGHIENGERL 611 (974)
T ss_pred ccccchhhcc-ccccceeecCccccch--hcccchhhHHHHHHHHHHHHHhcCCccccccccc------eEEEecCCCCC
Confidence 8765443222 3345678999998854 589999999999999999885 888997765443 45577787776
Q ss_pred CCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 522 QFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 522 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
..++..+ ..+..|+.+||..+|.+||+..|+...|+..++
T Consensus 612 P~P~nCP-------p~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 612 PCPPNCP-------PALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCCCC-------hHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 6665544 455667788999999999999999888766544
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=307.76 Aligned_cols=255 Identities=24% Similarity=0.403 Sum_probs=203.4
Q ss_pred HHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCC----CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRC----NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+++.+.||+|+||.||++.. .+++.+|||.+..... ..+++.+|+.++++++|+||+++++++.++...+++|||
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 83 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence 45678899999999999975 4899999998865332 235688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcC--CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 370 MPNGSLDKFIHND--RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 370 ~~~gsL~~~i~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
+++++|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 9999999988642 234689999999999999999999998 99999999999999999999999999988765433
Q ss_pred cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcC
Q 040604 448 SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 527 (582)
... ....|+..|+|||.+.+. .++.++|+||||+++|+|++|..|+......... ....+.........
T Consensus 161 ~~~--~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~--- 229 (267)
T cd08229 161 TAA--HSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS----LCKKIEQCDYPPLP--- 229 (267)
T ss_pred ccc--ccccCCcCccCHHHhcCC--CccchhhHHHHHHHHHHHHhCCCCcccccchHHH----HhhhhhcCCCCCCC---
Confidence 221 123589999999998763 6888999999999999999999998654322111 11122211111111
Q ss_pred cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 040604 528 TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGS 566 (582)
Q Consensus 528 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~ 566 (582)
.......+.+++.+||+.+|++||||.+|++.+++.
T Consensus 230 ---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 230 ---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 122445678888899999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=305.82 Aligned_cols=240 Identities=25% Similarity=0.411 Sum_probs=190.1
Q ss_pred hhcCccCceEEEEEEeCC-C----------cEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEE
Q 040604 299 DKLGQGGYGEVYKGELPD-G----------QLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~-~----------~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 367 (582)
+.||+|+||.||+|.+.+ + ..+++|+++........+.+|+.++++++|+||+++++++.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 469999999999997653 3 257888876655446789999999999999999999999988 7789999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-------ceEEeecccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF-------CPKISDFGLA 440 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~-------~vkl~DFGla 440 (582)
||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||++
T Consensus 80 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 80 EYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999976543 688999999999999999999987 999999999999999887 7999999999
Q ss_pred ccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcC-CCCCCCCCcccchhhHHHHHhhcCCC
Q 040604 441 KQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGC-TKNLDDEVTDTSICHNLIYERIEPGN 519 (582)
Q Consensus 441 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~i~~~~ 519 (582)
....... ...++..|+|||++......++.++||||||+++|||++| ..|+....... . .. ......
T Consensus 156 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~-~-~~----~~~~~~ 223 (259)
T cd05037 156 ITVLSRE------ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-K-ER----FYQDQH 223 (259)
T ss_pred ccccccc------ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-H-HH----HHhcCC
Confidence 8754421 2347788999999876323688999999999999999995 55665443211 1 11 111111
Q ss_pred CCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 040604 520 DFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564 (582)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le 564 (582)
...... ...+.+++.+||+.+|++|||+.+|++.|+
T Consensus 224 ~~~~~~---------~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 224 RLPMPD---------CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCCCCC---------chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 110100 156778889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=308.60 Aligned_cols=261 Identities=25% Similarity=0.398 Sum_probs=200.2
Q ss_pred HHHHhhhhcCccCceEEEEEEe-----CCCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeC--Cee
Q 040604 293 MTKSFRDKLGQGGYGEVYKGEL-----PDGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYEN--KKN 363 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 363 (582)
.++.+.++||+|+||.||++.. .++..||+|.++.... ..+.+.+|+.++++++|+|++++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3456678899999999999963 3578999999875432 235788999999999999999999999875 567
Q ss_pred eEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccc
Q 040604 364 ALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQA 443 (582)
Q Consensus 364 ~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~ 443 (582)
++||||+++++|.+++.+.. ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccc
Confidence 89999999999999986543 3589999999999999999999998 9999999999999999999999999999876
Q ss_pred cccccce-eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcc---------cchhhHHHHH
Q 040604 444 QKKESAI-SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTD---------TSICHNLIYE 513 (582)
Q Consensus 444 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~---------~~~~~~~~~~ 513 (582)
....... ......|+..|+|||++.+ ..++.++||||||++++||++++.|....... ..........
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQ--SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhcc--CCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 5433221 1123346778999999876 36889999999999999999987654321110 0000011111
Q ss_pred hhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 040604 514 RIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGS 566 (582)
Q Consensus 514 ~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~ 566 (582)
.+..+...... ..+...+.+++.+||+.+|++|||++++++.|+++
T Consensus 238 ~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGKRLPRP-------PNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCccCCCC-------CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 12221111111 12345688899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=310.07 Aligned_cols=253 Identities=26% Similarity=0.443 Sum_probs=198.8
Q ss_pred HHhhhhcCccCceEEEEEEeC-CC---cEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DG---QLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 368 (582)
+++.+.||+|+||.||+|... ++ ..||||+++.... ..+.|.+|+.++++++||||+++++++.++...++|||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 85 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE 85 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence 456789999999999999764 33 3699999876432 24578999999999999999999999999899999999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
|+++++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 86 FMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred cCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 999999999987643 3689999999999999999999998 999999999999999999999999999886654332
Q ss_pred ceeeeccc---CCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCC
Q 040604 449 AISMLHAR---GTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFD 524 (582)
Q Consensus 449 ~~~~~~~~---gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 524 (582)
........ .+..|+|||++.. ..++.++||||||+++|||++ |..|+....... +.+.+.........
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~------~~~~i~~~~~~~~~ 233 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD------VINAIEQDYRLPPP 233 (269)
T ss_pred ccccccccCCCcceeecCHhHhcc--CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH------HHHHHHcCCcCCCc
Confidence 21111111 2457999999875 478899999999999999886 888886543221 12222221111111
Q ss_pred CcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 040604 525 GVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGS 566 (582)
Q Consensus 525 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~ 566 (582)
.+.+..+.+++.+||+.+|++||++++|+..|++.
T Consensus 234 -------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 234 -------MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 12234567888899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=316.44 Aligned_cols=196 Identities=23% Similarity=0.356 Sum_probs=160.9
Q ss_pred hhcCccCceEEEEEEeC---CCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEe--CCeeeEEEEecCCC
Q 040604 299 DKLGQGGYGEVYKGELP---DGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYE--NKKNALIYELMPNG 373 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E~~~~g 373 (582)
++||+|+||+||+|... +++.+|+|.++... ....+.+|+.++++++||||+++++++.. +...++||||+ ++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~-~~ 84 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-EH 84 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-CC
Confidence 58999999999999754 56889999997554 33567899999999999999999999864 34678999999 56
Q ss_pred ChhhhhhcC-------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE----cCCCceEEeecccccc
Q 040604 374 SLDKFIHND-------RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL----DEDFCPKISDFGLAKQ 442 (582)
Q Consensus 374 sL~~~i~~~-------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl----~~~~~vkl~DFGla~~ 442 (582)
+|.+++... ....+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 888776532 223588999999999999999999998 99999999999999 4567899999999987
Q ss_pred ccccccc-eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCC
Q 040604 443 AQKKESA-ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDE 500 (582)
Q Consensus 443 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~ 500 (582)
....... .......||+.|+|||++.+. ..++.++||||+||+++||++|+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 6543211 122234689999999998763 35789999999999999999999999644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=328.36 Aligned_cols=254 Identities=22% Similarity=0.286 Sum_probs=196.1
Q ss_pred HHHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEE
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALI 366 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 366 (582)
...+.+.+.||+|+||.||++... +++.+|+|++.... ...+.+.+|+.+++.++||||+++++.+.++...++|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 121 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 345566789999999999999765 78899999986422 2234577899999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccc
Q 040604 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~ 446 (582)
|||+++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 122 ~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 122 MEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 9999999999998653 478888999999999999999998 9999999999999999999999999999876543
Q ss_pred ccceeeecccCCccccccccccccc--CCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCC-CCCCC
Q 040604 447 ESAISMLHARGTIGYIAPEVYSRRF--GGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPG-NDFQF 523 (582)
Q Consensus 447 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~-~~~~~ 523 (582)
... ......||+.|+|||++.... +.++.++|||||||++|||++|+.||....... ....+... ....+
T Consensus 196 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~~~~~~~ 268 (371)
T cd05622 196 GMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMNHKNSLTF 268 (371)
T ss_pred Ccc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH------HHHHHHcCCCcccC
Confidence 221 112346999999999986531 237899999999999999999999997643221 11222211 11111
Q ss_pred CCcCcHHHHHHHHHHHHHHHhccccCCCC--CCCHHHHHHHH
Q 040604 524 DGVATEEEKKIAKMMILVGFWCIQTNPSE--RPSMHKVLEML 563 (582)
Q Consensus 524 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPt~~evl~~L 563 (582)
.. ...+...+.+++.+||+.++.+ ||+++++++..
T Consensus 269 ~~-----~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 269 PD-----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CC-----cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 11 1233455666777788844433 77999988753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=316.64 Aligned_cols=258 Identities=24% Similarity=0.370 Sum_probs=196.1
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
++.+.++||+|+||+||+|... +++.||+|.++.... ....+.+|+.++++++|+||+++++++..+...++||||+
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 86 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL 86 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence 3455688999999999999765 788999999875432 3356789999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
+ ++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 87 ~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 160 (309)
T cd07872 87 D-KDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT- 160 (309)
T ss_pred C-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCccc-
Confidence 6 58888776543 3578899999999999999999998 9999999999999999999999999999765433221
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCC----------
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND---------- 520 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~---------- 520 (582)
.....+|+.|+|||++.+. ..++.++||||||++++||++|+.||........ .. .+...+.....
T Consensus 161 -~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 161 -YSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-LH-LIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred -cccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HH-HHHHHhCCCCHHHHhhhcchh
Confidence 1223589999999998653 4678999999999999999999999976533221 11 11111110000
Q ss_pred ----CCCCCcCc----HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 521 ----FQFDGVAT----EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 521 ----~~~~~~~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
........ .....+...+.+++.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000 011123456778899999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=318.57 Aligned_cols=262 Identities=25% Similarity=0.463 Sum_probs=203.6
Q ss_pred HHHHHHHHhhhhcCccCceEEEEEEeC--------CCcEEEEEEeccCCC--CHHHHHHHHHHHhcc-CCCceEEEEeEE
Q 040604 289 DVKRMTKSFRDKLGQGGYGEVYKGELP--------DGQLVAVKVLKNSRC--NGEEFINEVASISRT-SHVNIVTFLGFC 357 (582)
Q Consensus 289 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~ 357 (582)
++...++.+.+.||+|+||.||++... ++..||+|+++.... ..+++.+|+.+++++ +|+||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 344556778899999999999999532 234789998875432 235788999999999 799999999999
Q ss_pred EeCCeeeEEEEecCCCChhhhhhcCC--------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCC
Q 040604 358 YENKKNALIYELMPNGSLDKFIHNDR--------------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQN 423 (582)
Q Consensus 358 ~~~~~~~lv~E~~~~gsL~~~i~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~N 423 (582)
.+....+++|||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 99889999999999999999987532 23478899999999999999999997 99999999999
Q ss_pred EEEcCCCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCc
Q 040604 424 ILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVT 502 (582)
Q Consensus 424 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~ 502 (582)
||++.++.+||+|||+++...............++..|+|||++.+ ..++.++||||||+++|||++ |..|+.....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc--CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999987654332222222345678999999876 368899999999999999998 7777754322
Q ss_pred ccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 503 DTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 503 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
.. +...+.......... .....+.+++.+||+.+|++||++.|+++.|+....
T Consensus 243 ~~------~~~~~~~~~~~~~~~-------~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 243 EE------LFKLLKEGHRMDKPA-------NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HH------HHHHHHcCCCCCCCC-------CCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 11 112222221111111 223457788889999999999999999999998663
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=306.58 Aligned_cols=255 Identities=24% Similarity=0.414 Sum_probs=204.4
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.+.++||+|+||.||+|... +|+.||+|.++... ...+.+.+|+.++++++|+|++++++.+.+....++||||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence 456788999999999999766 89999999986422 1245788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcC--CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 370 MPNGSLDKFIHND--RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 370 ~~~gsL~~~i~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
+++++|.+++... ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 9999999988642 234589999999999999999999998 99999999999999999999999999988755433
Q ss_pred cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcC
Q 040604 448 SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 527 (582)
... ....|++.|+|||.+.+ ..++.++||||||+++|+|++|+.|+....... .. +.+.+..+......
T Consensus 161 ~~~--~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~-~~~~~~~~~~~~~~--- 229 (267)
T cd08224 161 TAA--HSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---YS-LCKKIEKCDYPPLP--- 229 (267)
T ss_pred ccc--ceecCCccccCHHHhcc--CCCCchhcHHHHHHHHHHHHHCCCCcccCCccH---HH-HHhhhhcCCCCCCC---
Confidence 221 22358999999999875 368899999999999999999999986543221 11 11222222111111
Q ss_pred cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 040604 528 TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGS 566 (582)
Q Consensus 528 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~ 566 (582)
.......+.+++.+||+.+|++|||+.+|+++|++.
T Consensus 230 ---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 230 ---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred ---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 123445677888999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=331.97 Aligned_cols=250 Identities=20% Similarity=0.248 Sum_probs=189.9
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.+.++||+|+||.||++... +++.||||++.... ...+.+.+|+.++++++|+||+++++.+.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 345688999999999999754 68999999986432 2345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc--
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE-- 447 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~-- 447 (582)
+++|+|.+++...+ .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 83 ~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 83 IPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 99999999997643 578889999999999999999998 99999999999999999999999999975321000
Q ss_pred ---------------------------------------cceeeecccCCcccccccccccccCCCCccchhHHHHHHHH
Q 040604 448 ---------------------------------------SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMII 488 (582)
Q Consensus 448 ---------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ 488 (582)
.........||+.|+|||++.+. .++.++|||||||++|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvily 235 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC--CCCcceeeeeccceee
Confidence 00001123699999999999763 6889999999999999
Q ss_pred HHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCC---CHHHHHHH
Q 040604 489 EMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERP---SMHKVLEM 562 (582)
Q Consensus 489 elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP---t~~evl~~ 562 (582)
||++|+.||........ ............+... ..+...+.+++.+|+ .+|.+|+ ++.++++.
T Consensus 236 ell~G~~Pf~~~~~~~~-----~~~i~~~~~~~~~~~~-----~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 236 EMLVGQPPFLADTPAET-----QLKVINWETTLHIPSQ-----AKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred ehhhCCCCCCCCCHHHH-----HHHHhccCccccCCCC-----CCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999999976543221 1111111111111110 112233344444554 4999999 88888754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=305.23 Aligned_cols=240 Identities=26% Similarity=0.395 Sum_probs=186.6
Q ss_pred hhcCccCceEEEEEEeCC-------------CcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeee
Q 040604 299 DKLGQGGYGEVYKGELPD-------------GQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENKKNA 364 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 364 (582)
+.||+|+||.||+|.... ...+|+|++..... ....+.+|+.++++++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999996431 23589998865433 2346788999999999999999999999988999
Q ss_pred EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc-------eEEeec
Q 040604 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFC-------PKISDF 437 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~-------vkl~DF 437 (582)
+||||+++|+|..++.... ..+++..+++++.||++||+|||+. +|+||||||+|||++.++. +|++||
T Consensus 81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999887543 3589999999999999999999998 9999999999999987664 899999
Q ss_pred cccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHh-cCCCCCCCCCcccchhhHHHHHhhc
Q 040604 438 GLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMV-GCTKNLDDEVTDTSICHNLIYERIE 516 (582)
Q Consensus 438 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ell-tg~~p~~~~~~~~~~~~~~~~~~i~ 516 (582)
|++....... ...|+..|+|||.+... ..++.++|||||||++|||+ +|..|+....... . ..+.
T Consensus 157 g~~~~~~~~~------~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~-~~~~ 222 (262)
T cd05077 157 GIPITVLSRQ------ECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE------K-ERFY 222 (262)
T ss_pred CCCccccCcc------cccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH------H-HHHH
Confidence 9987654322 23488899999988643 46889999999999999998 5777765432111 0 1111
Q ss_pred CCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 040604 517 PGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564 (582)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le 564 (582)
.... ... .. ....+.+|+.+||+.||++||++++|++.|+
T Consensus 223 ~~~~-~~~---~~----~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EGQC-MLV---TP----SCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hcCc-cCC---CC----ChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 1110 010 01 1245678888999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=314.71 Aligned_cols=249 Identities=26% Similarity=0.343 Sum_probs=197.1
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC----HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN----GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
++..+.||+|+||.||++... +++.||+|.+...... .+.+.+|+.++++++|+|++++++.+.+....++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 344578999999999999654 7899999998654322 24577899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++++|.+++.......+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 158 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc
Confidence 9999999998765555789999999999999999999987 9999999999999999999999999999765443321
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||........ ........... ...+.
T Consensus 159 ---~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~--~~~~~~~~~~~-~~~~~----- 225 (285)
T cd05630 159 ---KGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REEVERLVKEV-QEEYS----- 225 (285)
T ss_pred ---cCCCCCccccChHHHcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCccch--HHHHHhhhhhh-hhhcC-----
Confidence 23369999999999876 4689999999999999999999999976432211 00111111110 00111
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPS-----MHKVLE 561 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~evl~ 561 (582)
..+...+.+++..||+.||++||| ++|+++
T Consensus 226 --~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 226 --EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred --ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 122345677888899999999999 888886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=330.31 Aligned_cols=199 Identities=23% Similarity=0.304 Sum_probs=167.9
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC----CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
.+.++||+|+||+||+|... +++.||+|++..... ..+.+.+|+.++++++|+||+++++.+.+....++||||+
T Consensus 4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (382)
T cd05625 4 VKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYI 83 (382)
T ss_pred EEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCC
Confidence 45678999999999999654 788999999875422 2356788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc--
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES-- 448 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~-- 448 (582)
++|+|.+++.+.+ .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 84 ~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 84 PGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 9999999987643 578889999999999999999998 999999999999999999999999999753211000
Q ss_pred -------------------------------------------ceeeecccCCcccccccccccccCCCCccchhHHHHH
Q 040604 449 -------------------------------------------AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGM 485 (582)
Q Consensus 449 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGv 485 (582)
........||+.|+|||++.+. .++.++|||||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlGv 236 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC--CCCCeeeEEechH
Confidence 0000123599999999998763 6889999999999
Q ss_pred HHHHHhcCCCCCCCCC
Q 040604 486 MIIEMVGCTKNLDDEV 501 (582)
Q Consensus 486 il~elltg~~p~~~~~ 501 (582)
++|||++|+.||....
T Consensus 237 il~elltG~~Pf~~~~ 252 (382)
T cd05625 237 ILYEMLVGQPPFLAQT 252 (382)
T ss_pred HHHHHHhCCCCCCCCC
Confidence 9999999999997653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=313.17 Aligned_cols=256 Identities=26% Similarity=0.355 Sum_probs=191.6
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC---CHHHHHHHHHHHhcc---CCCceEEEEeEEEeC-----Ce
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC---NGEEFINEVASISRT---SHVNIVTFLGFCYEN-----KK 362 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~~ 362 (582)
+++.++||+|+||+||+|... +++.||+|.++.... ....+.+|+.+++++ +||||+++++++... ..
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 345678999999999999665 789999999875322 224566777776655 799999999988642 35
Q ss_pred eeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccc
Q 040604 363 NALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ 442 (582)
Q Consensus 363 ~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~ 442 (582)
.++||||++ ++|.+++.......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 82 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 82 VTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred EEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcccc
Confidence 789999996 5898888765555689999999999999999999998 999999999999999999999999999987
Q ss_pred ccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCC--
Q 040604 443 AQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND-- 520 (582)
Q Consensus 443 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~-- 520 (582)
....... ....||+.|+|||++.+ ..++.++||||+||+++||++|+.||........ ... +...+.....
T Consensus 158 ~~~~~~~---~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~-~~~-~~~~~~~~~~~~ 230 (288)
T cd07863 158 YSCQMAL---TPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-LGK-IFDLIGLPPEDD 230 (288)
T ss_pred ccCcccC---CCccccccccCchHhhC--CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH-HHH-HHHHhCCCChhh
Confidence 6543221 23458999999999876 4689999999999999999999999865433221 111 1111100000
Q ss_pred ---------CCCCCcC----cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 521 ---------FQFDGVA----TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 521 ---------~~~~~~~----~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
..+.... ......+...+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000 0111234566788999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=305.57 Aligned_cols=247 Identities=21% Similarity=0.297 Sum_probs=199.8
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC--CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR--CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
.+.++||+|+||.||++... +++.+|+|.++... ...+.+.+|+.++++++|+||+++++.+.+....++||||+++
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDG 82 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence 45688999999999999754 78999999986433 2346788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
++|.+++.......+++..++.++.|++.||.|||+. +|+|+||||+||++++++.++|+|||++......... .
T Consensus 83 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--~ 157 (255)
T cd08219 83 GDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY--A 157 (255)
T ss_pred CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccccc--c
Confidence 9999998765556789999999999999999999988 9999999999999999999999999999866443221 1
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
....|++.|+|||++.+ ..++.++|+||||+++|+|++|+.||....... ....+..+....+..
T Consensus 158 ~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~------- 222 (255)
T cd08219 158 CTYVGTPYYVPPEIWEN--MPYNNKSDIWSLGCILYELCTLKHPFQANSWKN------LILKVCQGSYKPLPS------- 222 (255)
T ss_pred ccccCCccccCHHHHcc--CCcCchhhhhhhchhheehhhccCCCCCCCHHH------HHHHHhcCCCCCCCc-------
Confidence 23458999999999876 368899999999999999999999997543211 112222222111111
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 533 KIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
.+...+.+++.+||+.||++||++++|+..
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 223456778889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=336.21 Aligned_cols=253 Identities=28% Similarity=0.464 Sum_probs=211.7
Q ss_pred hhcCccCceEEEEEEeC----CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 299 DKLGQGGYGEVYKGELP----DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
+.||.|.||.|++|+++ ....||||.+|.... +..+|+.|+.||.+.+||||++|.|+.....-..+|.|||++
T Consensus 635 ~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMEN 714 (996)
T KOG0196|consen 635 KVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMEN 714 (996)
T ss_pred EEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhC
Confidence 57999999999999775 235799999997654 456899999999999999999999999988889999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc-ee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA-IS 451 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~-~~ 451 (582)
|+|+.+|+.+.+ .+++.++..+++.||.||.||-+. +.|||||..+|||++.+...|++|||+++.+..+... .+
T Consensus 715 GsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~yt 790 (996)
T KOG0196|consen 715 GSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT 790 (996)
T ss_pred CcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCCCcccc
Confidence 999999987654 589999999999999999999988 9999999999999999999999999999988665522 22
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHH
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 530 (582)
.....=.+.|.|||.+.- ..+|.+||||||||++||.++ |.+|+.++.+.+ +.+.|+++.. ++.
T Consensus 791 t~GGKIPiRWTAPEAIa~--RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd------VIkaIe~gyR--LPp----- 855 (996)
T KOG0196|consen 791 TLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD------VIKAIEQGYR--LPP----- 855 (996)
T ss_pred ccCCccceeecChhHhhh--cccCchhhccccceEEEEecccCCCcccccchHH------HHHHHHhccC--CCC-----
Confidence 222223468999999975 589999999999999999775 889988765433 5566666543 322
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCC
Q 040604 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENL 570 (582)
Q Consensus 531 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~ 570 (582)
..+.+..|-.|+++|||+|..+||.+.+|+..|.+++-+.
T Consensus 856 PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 856 PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 2345677888999999999999999999999999866543
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=314.95 Aligned_cols=255 Identities=23% Similarity=0.371 Sum_probs=204.3
Q ss_pred HHHHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCC---CHHHHHHHHHHHhccC-CCceEEEEeEEEeCCeeeEEE
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRC---NGEEFINEVASISRTS-HVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 367 (582)
.-.|++.++||+||.++||++...+.+.||+|.+..... ...-|.+|+..|.+|+ |.+||.|+++-..++.+||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 334677789999999999999988888899887754333 2356999999999995 899999999999999999999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
|+- ..+|.++|.+.......| .+..+..|++.|+.++|++ ||||-||||.|+|+-+ |.+||+|||+|..+..+.
T Consensus 440 E~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT 513 (677)
T ss_pred ecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence 998 789999998876555555 7778899999999999998 9999999999999974 689999999999999888
Q ss_pred cceeeecccCCcccccccccccccC---------CCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCC
Q 040604 448 SAISMLHARGTIGYIAPEVYSRRFG---------GVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPG 518 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~~~---------~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~ 518 (582)
+.+.....+||+.||+||.+..... ..+.++||||+|||||+|+.|+.||....... ..+......+
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~----aKl~aI~~P~ 589 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI----AKLHAITDPN 589 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH----HHHHhhcCCC
Confidence 8777777889999999999854211 27789999999999999999999997542211 1111112222
Q ss_pred CCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 519 NDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
..+.++...... .++++++.||+.||.+||+..|||+.
T Consensus 590 ~~Iefp~~~~~~------~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 590 HEIEFPDIPEND------ELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ccccccCCCCch------HHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 223343332221 27888899999999999999999853
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=344.48 Aligned_cols=258 Identities=22% Similarity=0.287 Sum_probs=199.9
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC----CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+++.++||+|+||.||+|... +|+.||||+++.... ..+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY 83 (932)
T PRK13184 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY 83 (932)
T ss_pred eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence 345688999999999999765 689999999975422 235688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCC---------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccc
Q 040604 370 MPNGSLDKFIHNDR---------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLA 440 (582)
Q Consensus 370 ~~~gsL~~~i~~~~---------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla 440 (582)
++||+|.+++.... ....++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcc
Confidence 99999999886421 12456778899999999999999998 9999999999999999999999999999
Q ss_pred ccccccccc----------------eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCccc
Q 040604 441 KQAQKKESA----------------ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDT 504 (582)
Q Consensus 441 ~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~ 504 (582)
+........ .......||+.|+|||++.+ ..++.++|||||||+++||++|+.||.......
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g--~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG--VPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC--CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 876211100 00112359999999999876 368999999999999999999999996532211
Q ss_pred chhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhcccC
Q 040604 505 SICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERP-SMHKVLEMLEGSIE 568 (582)
Q Consensus 505 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-t~~evl~~Le~~~~ 568 (582)
.. ....+..... . .....++..+.+++.+||+.||++|| +++++++.|+..++
T Consensus 239 i~----~~~~i~~P~~--~-----~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 IS----YRDVILSPIE--V-----APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hh----hhhhccChhh--c-----cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 10 0011111100 0 01123456677888999999999996 57888888877655
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=317.91 Aligned_cols=236 Identities=22% Similarity=0.292 Sum_probs=185.2
Q ss_pred hhcCccCceEEEEEEeC-CCcEEEEEEeccCCC----CHHHHHHHHH-HHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 299 DKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEVA-SISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
+.||+|+||.||+|... +++.||+|++..... ....+.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999764 789999999865321 2234555554 67889999999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
|+|...+... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........ .
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~ 153 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--T 153 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCc--c
Confidence 9999888654 3578888999999999999999987 9999999999999999999999999998764322221 1
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... +.+.+.... ..++..
T Consensus 154 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~~~-~~~~~~------ 218 (321)
T cd05603 154 STFCGTPEYLAPEVLRK--EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ------MYDNILHKP-LQLPGG------ 218 (321)
T ss_pred ccccCCcccCCHHHhcC--CCCCCcCcccccchhhhhhhcCCCCCCCCCHHH------HHHHHhcCC-CCCCCC------
Confidence 23469999999999876 368899999999999999999999997643211 222222221 112211
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHH
Q 040604 533 KIAKMMILVGFWCIQTNPSERPSMH 557 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RPt~~ 557 (582)
....+.+++.+||+.||++||++.
T Consensus 219 -~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 219 -KTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -CCHHHHHHHHHHccCCHhhcCCCC
Confidence 134567788889999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=326.35 Aligned_cols=257 Identities=25% Similarity=0.303 Sum_probs=194.0
Q ss_pred HhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCC-----eeeEE
Q 040604 296 SFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENK-----KNALI 366 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv 366 (582)
++.++||+|+||.||++.. .+|+.||||++..... ..+.+.+|+.+++.++|+||+++++++.... ..++|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 3567899999999999975 4799999999865322 2356889999999999999999999998766 78999
Q ss_pred EEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccc
Q 040604 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~ 446 (582)
|||+. ++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 83 TELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred eeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 99995 6788877643 3689999999999999999999998 9999999999999999999999999999875433
Q ss_pred ccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHh------------
Q 040604 447 ESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYER------------ 514 (582)
Q Consensus 447 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~------------ 514 (582)
... ......+|+.|+|||++.+. ..++.++|||||||+++||++|+.||........ . ..+.+.
T Consensus 157 ~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~-~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 157 ESK-HMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ-L-DLITDLLGTPSLEAMRSA 232 (372)
T ss_pred ccc-cCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH-H-HHHHHHcCCCCHHHHHHh
Confidence 221 12234589999999998763 3578999999999999999999999976533211 0 001000
Q ss_pred -------hcC-CCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 515 -------IEP-GNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 515 -------i~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
+.. ....................+.+++.+||+.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000 000000000000001124567788999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=321.51 Aligned_cols=239 Identities=23% Similarity=0.280 Sum_probs=186.3
Q ss_pred hhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHH-HHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 299 DKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVA-SISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
+.||+|+||+||++... +|+.+|+|++.... .....+..|.. +++.++||||+++++.+......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999654 79999999996532 12234555554 56779999999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
|+|..++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........ .
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~--~ 153 (325)
T cd05604 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--T 153 (325)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCC--c
Confidence 99998886543 689999999999999999999998 9999999999999999999999999998754322211 1
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... +...+.... ..+...
T Consensus 154 ~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~~~~~~~~~-~~~~~~------ 218 (325)
T cd05604 154 TTFCGTPEYLAPEVIRK--QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE------MYDNILHKP-LVLRPG------ 218 (325)
T ss_pred ccccCChhhCCHHHHcC--CCCCCcCccccccceehhhhcCCCCCCCCCHHH------HHHHHHcCC-ccCCCC------
Confidence 23469999999999876 468899999999999999999999997543221 112222211 111111
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHH
Q 040604 533 KIAKMMILVGFWCIQTNPSERPSMHKVL 560 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl 560 (582)
....+.+++.+||+.+|.+||++++.+
T Consensus 219 -~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 219 -ASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred -CCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 223456677789999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=330.09 Aligned_cols=254 Identities=22% Similarity=0.315 Sum_probs=188.9
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeC--------CeeeE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYEN--------KKNAL 365 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~~~~l 365 (582)
+.+.++||+|+||.||+|... +++.||||++.... ....+|+.++++++|+||+++++++... ...++
T Consensus 68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l 144 (440)
T PTZ00036 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144 (440)
T ss_pred EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence 456789999999999999764 78999999886432 2345799999999999999999887532 23568
Q ss_pred EEEecCCCChhhhhhc--CCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-ceEEeecccccc
Q 040604 366 IYELMPNGSLDKFIHN--DRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF-CPKISDFGLAKQ 442 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~-~vkl~DFGla~~ 442 (582)
||||++ ++|.+++.. .....+++..++.++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+|+.
T Consensus 145 vmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~~ 220 (440)
T PTZ00036 145 VMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220 (440)
T ss_pred EEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence 999996 577776653 2344689999999999999999999998 999999999999999664 799999999987
Q ss_pred ccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCC----
Q 040604 443 AQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPG---- 518 (582)
Q Consensus 443 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~---- 518 (582)
........ ...||+.|+|||++.+. ..++.++|||||||++|||++|..||........ +... .+.+...
T Consensus 221 ~~~~~~~~---~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~-~~~i-~~~~~~p~~~~ 294 (440)
T PTZ00036 221 LLAGQRSV---SYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ-LVRI-IQVLGTPTEDQ 294 (440)
T ss_pred ccCCCCcc---cCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHH-HHHhCCCCHHH
Confidence 65443322 24589999999998653 3689999999999999999999999976533221 1111 1111000
Q ss_pred --------CCCCCCCcCcHHHH-----HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 519 --------NDFQFDGVATEEEK-----KIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 519 --------~~~~~~~~~~~~~~-----~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
....++........ .....+.+|+.+||+.||.+|||+.|+++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00111111111111 12356788999999999999999999983
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=313.58 Aligned_cols=248 Identities=27% Similarity=0.350 Sum_probs=196.9
Q ss_pred hhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC----HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 297 FRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN----GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 297 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
..+.||+|+||+||++... +++.+|+|.+...... .+.+.+|+.++++++|+||+++++.+..++..++||||++
T Consensus 4 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05632 4 QYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEecc
Confidence 4478999999999999654 7899999998654322 2457889999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
+++|.+++...+...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++.........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-- 158 (285)
T cd05632 84 GGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI-- 158 (285)
T ss_pred CccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc--
Confidence 99999988765555799999999999999999999988 9999999999999999999999999999765433221
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHH
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 531 (582)
....|+..|+|||++.+ ..++.++|+||||+++|||++|+.||........ ...+...+..... ...
T Consensus 159 -~~~~g~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~~~~~~~~~~~-~~~------- 225 (285)
T cd05632 159 -RGRVGTVGYMAPEVLNN--QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REEVDRRVLETEE-VYS------- 225 (285)
T ss_pred -cCCCCCcCccChHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhhhcccc-ccC-------
Confidence 23459999999999876 4688999999999999999999999975433211 1112222222111 111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 040604 532 KKIAKMMILVGFWCIQTNPSERPS-----MHKVLEM 562 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RPt-----~~evl~~ 562 (582)
..+...+.+++.+||+.||++||+ +++++..
T Consensus 226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 226 AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 122345677888899999999999 6677653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=305.94 Aligned_cols=252 Identities=26% Similarity=0.369 Sum_probs=198.0
Q ss_pred HHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
..+.+.++||+|+||.||+|... +++.||+|+++.... ....+.+|+.+++.++||||+++++.+.+....++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 35667789999999999999654 789999999876532 2356788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
++++|.+++...+ .+++.+++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.........
T Consensus 89 ~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~- 162 (267)
T cd06645 89 GGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK- 162 (267)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc-
Confidence 9999999987544 688999999999999999999998 9999999999999999999999999998765432211
Q ss_pred eeecccCCccccccccccc-ccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCC-CCCCCCCcCc
Q 040604 451 SMLHARGTIGYIAPEVYSR-RFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPG-NDFQFDGVAT 528 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~-~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~-~~~~~~~~~~ 528 (582)
.....|++.|+|||++.. ....++.++|||||||++|+|++|+.|+......... ....... ......
T Consensus 163 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~-----~~~~~~~~~~~~~~---- 232 (267)
T cd06645 163 -RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-----FLMTKSNFQPPKLK---- 232 (267)
T ss_pred -cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH-----HhhhccCCCCCccc----
Confidence 123469999999998742 1245788999999999999999999998654332211 0000010 000010
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
....+...+.+++.+||+.+|++||++++|++
T Consensus 233 -~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 233 -DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred -ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 01122345678888999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=303.60 Aligned_cols=251 Identities=26% Similarity=0.431 Sum_probs=191.8
Q ss_pred hhcCccCceEEEEEEeC----CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEe-CCeeeEEEEecC
Q 040604 299 DKLGQGGYGEVYKGELP----DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYE-NKKNALIYELMP 371 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~E~~~ 371 (582)
+.||+|+||.||+|... ++..+|+|.+..... ..+.+.+|+.+++.++||||+++++++.. +...++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999653 245799999864332 24578899999999999999999998764 456789999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc--
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA-- 449 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~-- 449 (582)
+|+|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999997543 2467788889999999999999987 9999999999999999999999999999865432211
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCC-CCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTK-NLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~-p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 528 (582)
.......++..|+|||.+.. ..++.++||||||+++|||++|+. |+..... . . +...+..+.......
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~----~-~~~~~~~~~~~~~~~--- 225 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-F----D-ITVYLLQGRRLLQPE--- 225 (262)
T ss_pred cccccCcCCccccChhHhcc--CccchHHHHHHHHHHHHHHHcCCCCCCCCCCH-H----H-HHHHHhcCCCCCCCC---
Confidence 11112346778999999865 478899999999999999999655 4443221 1 1 112222222221111
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
..+..+.+++.+||+.+|++||++.+|++.|+....
T Consensus 226 ----~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 226 ----YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 123457788889999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=307.10 Aligned_cols=260 Identities=26% Similarity=0.439 Sum_probs=202.7
Q ss_pred HHHhhhhcCccCceEEEEEEeC-----CCcEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEe--CCeee
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-----DGQLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYE--NKKNA 364 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 364 (582)
.+.+.+.||+|+||.||++... ++..+|||+++..... .+.+.+|+.++++++|+||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 3456688999999999999753 4789999999876553 5689999999999999999999999887 55789
Q ss_pred EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccc
Q 040604 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~ 444 (582)
+||||+++++|.+++..... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 85 lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 99999999999999976432 589999999999999999999987 99999999999999999999999999998876
Q ss_pred cccccee-eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccc---------hhhHHHHHh
Q 040604 445 KKESAIS-MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTS---------ICHNLIYER 514 (582)
Q Consensus 445 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~---------~~~~~~~~~ 514 (582)
....... .....++..|+|||.+.. ..++.++||||||++++||++|+.|+........ .....+.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRT--SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHcc--CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 3322211 112235667999999866 3688999999999999999999988754322110 001111122
Q ss_pred hcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 040604 515 IEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGS 566 (582)
Q Consensus 515 i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~ 566 (582)
+........ .......+.+++.+||+.+|++||||.||+++|+++
T Consensus 239 ~~~~~~~~~-------~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGERLPR-------PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCcCCC-------CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 222111111 112235678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=346.43 Aligned_cols=258 Identities=23% Similarity=0.335 Sum_probs=199.1
Q ss_pred HHHHHHHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEeC--C
Q 040604 288 SDVKRMTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYEN--K 361 (582)
Q Consensus 288 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~ 361 (582)
.+.....+.+.++||+|+||+||++... ++..+|+|++...... ...+..|+.++++++|||||++++++.+. .
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 3344445667789999999999999764 6789999998754332 35688999999999999999999988653 4
Q ss_pred eeeEEEEecCCCChhhhhhcC--CCcCCCHHHHHHHHHHHHHHHHHHHhCCC----CceEecCCCCCCEEEcC-------
Q 040604 362 KNALIYELMPNGSLDKFIHND--RNIKLEWKTMYQIAIGIARGLEYLHRGCQ----VRIVHFDIKPQNILLDE------- 428 (582)
Q Consensus 362 ~~~lv~E~~~~gsL~~~i~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~----~~ivH~Dikp~NILl~~------- 428 (582)
..+|||||+++|+|.++|... ....+++..++.|+.||+.||.|||+... .+||||||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 688999999999999998753 23469999999999999999999998521 25999999999999964
Q ss_pred ----------CCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCC
Q 040604 429 ----------DFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLD 498 (582)
Q Consensus 429 ----------~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~ 498 (582)
.+.+||+|||++......... ....||+.|+|||++......++.++|||||||+||||++|+.||.
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~---~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMA---HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccccc---cccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 345899999999876443221 2346999999999986543468899999999999999999999997
Q ss_pred CCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 499 DEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 499 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
...... . +...+.......+. .....+.+|+.+||+.+|.+||++.+++.
T Consensus 245 ~~~~~~----q-li~~lk~~p~lpi~--------~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 245 KANNFS----Q-LISELKRGPDLPIK--------GKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cCCcHH----H-HHHHHhcCCCCCcC--------CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 543221 1 22222222221111 12345777888999999999999999983
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=304.53 Aligned_cols=254 Identities=26% Similarity=0.431 Sum_probs=200.9
Q ss_pred HHHhhhhcCccCceEEEEEEeC----CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP----DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 367 (582)
.+.+.+.||+|+||.||+|... .+..+|+|.++.... ..+.+.+|+.++++++||||+++++++..+...++||
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (267)
T cd05066 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVT 84 (267)
T ss_pred HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence 3456689999999999999653 234799999875432 2357889999999999999999999999989999999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||++.......
T Consensus 85 e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 85 EYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999997643 3589999999999999999999998 99999999999999999999999999998765543
Q ss_pred ccee-eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCC
Q 040604 448 SAIS-MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525 (582)
Q Consensus 448 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 525 (582)
.... .....++..|+|||++.. ..++.++|+||||++++||++ |+.|+....... ....+..+......
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~------~~~~~~~~~~~~~~- 231 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD------VIKAIEEGYRLPAP- 231 (267)
T ss_pred ceeeecCCCccceeecCHhHhcc--CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH------HHHHHhCCCcCCCC-
Confidence 2211 112234568999999876 368999999999999999886 998986543221 11222222111111
Q ss_pred cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 040604 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGS 566 (582)
Q Consensus 526 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~ 566 (582)
...+..+.+++.+||+.+|++||+|.++++.|++.
T Consensus 232 ------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 232 ------MDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ------CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 12245567888899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=304.85 Aligned_cols=254 Identities=20% Similarity=0.342 Sum_probs=184.9
Q ss_pred hhcCccCceEEEEEEeCCC---cEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCC
Q 040604 299 DKLGQGGYGEVYKGELPDG---QLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNG 373 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 373 (582)
++||+|+||+||+|...++ ..+++|.++.... ..+.+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999965433 3566777654432 3467899999999999999999999999988999999999999
Q ss_pred ChhhhhhcCC--CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 374 SLDKFIHNDR--NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 374 sL~~~i~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
+|.+++.+.. ....++..++.++.||+.||+|||+. +++||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999997642 23467778889999999999999987 999999999999999999999999999865332211111
Q ss_pred eecccCCccccccccccccc-----CCCCccchhHHHHHHHHHHhcC-CCCCCCCCcccchhhHHHHHhhcCCCCCCCCC
Q 040604 452 MLHARGTIGYIAPEVYSRRF-----GGVSHKSDVYSYGMMIIEMVGC-TKNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~-----~~~s~~~DvwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 525 (582)
.....|+..|+|||++.... ..++.++||||||+++|||+++ ..|+..... ....... +..........
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~~~~----~~~~~~~~~~~ 232 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-REVLNHV----IKDQQVKLFKP 232 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHH----HhhcccccCCC
Confidence 12345889999999875321 2357899999999999999975 456643322 1111111 11111110111
Q ss_pred cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 040604 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564 (582)
Q Consensus 526 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le 564 (582)
... ......+.+++..|| .+|++||++++|++.|.
T Consensus 233 ~~~---~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 233 QLE---LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccC---CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 111 112344556667788 57999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=325.02 Aligned_cols=256 Identities=20% Similarity=0.243 Sum_probs=195.0
Q ss_pred HHHHhhhhcCccCceEEEEEEeC---CCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELP---DGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
..+.+.++||+|+||.||++... .++.||+|.+... ..+.+|+.++++++||||+++++++......++|||+
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK 167 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence 34567789999999999999643 4678999988653 2356899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+ +++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 168 ~-~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 168 Y-KCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred c-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 9 57888888433 4689999999999999999999998 9999999999999999999999999999876544332
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccc--hhhHHHHHhhcCCCCCCCCC--
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTS--ICHNLIYERIEPGNDFQFDG-- 525 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~--~~~~~~~~~i~~~~~~~~~~-- 525 (582)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||........ .+.. +.+.+.... ..++.
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~-i~~~~~~~~-~~~~~~~ 317 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLAL--DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRS-IIRCMQVHP-LEFPQNG 317 (392)
T ss_pred ccccccccccCccCHhHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHH-HHHHhccCc-cccCCcc
Confidence 22234569999999999876 4688999999999999999999999865433221 1111 111111000 00000
Q ss_pred ------------------c-CcHH--HHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 526 ------------------V-ATEE--EKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 526 ------------------~-~~~~--~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
. .+.. .......+.+++.+||+.||++|||+.|++..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 0000 01123456678889999999999999999865
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=305.52 Aligned_cols=256 Identities=27% Similarity=0.456 Sum_probs=201.8
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCc----EEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQ----LVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALI 366 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 366 (582)
.+++.++||+|+||.||+|... +|+ .+|+|+++.... ..+++.+|+.++++++|+||+++++++.. ...++|
T Consensus 8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v 86 (279)
T cd05057 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLI 86 (279)
T ss_pred HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEE
Confidence 4456689999999999999754 333 689998876543 23578899999999999999999999987 788999
Q ss_pred EEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccc
Q 040604 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~ 446 (582)
|||+++|+|.+++.... ..+++..+++++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++.....
T Consensus 87 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 87 TQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999997643 2589999999999999999999997 9999999999999999999999999999876644
Q ss_pred ccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCC
Q 040604 447 ESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525 (582)
Q Consensus 447 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 525 (582)
..........++..|+|||.+.. ..++.++|+||||++++||++ |+.|+....... +...+..+.....+.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~ 234 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILH--RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE------IPDLLEKGERLPQPP 234 (279)
T ss_pred ccceecCCCcccccccCHHHhhc--CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH------HHHHHhCCCCCCCCC
Confidence 33222222334678999998865 478899999999999999998 999986543211 222333322222222
Q ss_pred cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCC
Q 040604 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIEN 569 (582)
Q Consensus 526 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~ 569 (582)
... ..+.+++.+||..+|.+||++.++++.|+.....
T Consensus 235 ~~~-------~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 235 ICT-------IDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred CCC-------HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 211 3456777889999999999999999999987553
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=302.78 Aligned_cols=248 Identities=30% Similarity=0.533 Sum_probs=199.6
Q ss_pred hhhhcCccCceEEEEEEeCC-----CcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 297 FRDKLGQGGYGEVYKGELPD-----GQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 297 ~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.+.||.|+||.||++...+ +..+|+|+++.... ..+.+.+|+..+++++|+||+++++++.+....+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 56789999999999997653 48899999976654 356789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++++|.+++.......+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 9999999999865543389999999999999999999998 9999999999999999999999999999876654322
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 528 (582)
... ...+++.|+|||.+.. ..++.++||||+|+++++|++ |+.|+....... +.+.+...........
T Consensus 160 ~~~-~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~-- 228 (258)
T smart00219 160 KKK-GGKLPIRWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE------VLEYLKKGYRLPKPEN-- 228 (258)
T ss_pred ccc-cCCCcccccChHHhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHhcCCCCCCCCc--
Confidence 111 2347889999999854 478999999999999999998 667765432211 1222222222211111
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEML 563 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L 563 (582)
....+.+++.+||+.+|++|||+.++++.|
T Consensus 229 -----~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 229 -----CPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -----CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 345677888999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=310.08 Aligned_cols=257 Identities=25% Similarity=0.356 Sum_probs=195.4
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
.+.++||+|++|.||+|... +++.||+|+++.... ..+.+.+|+.++++++||||+++++++.++...++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (285)
T cd07861 3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS 82 (285)
T ss_pred eEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC
Confidence 45678999999999999764 789999999865322 34678899999999999999999999999999999999996
Q ss_pred CCChhhhhhcCC-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 372 NGSLDKFIHNDR-NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 372 ~gsL~~~i~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
++|.+++.... ...+++..++.++.|+++||+|||+. +++||||||+|||++.++.+||+|||++.........
T Consensus 83 -~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~- 157 (285)
T cd07861 83 -MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV- 157 (285)
T ss_pred -CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCccc-
Confidence 68888886543 35689999999999999999999998 9999999999999999999999999999765433211
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCC---------
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDF--------- 521 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~--------- 521 (582)
.....+++.|+|||++.+. ..++.++||||||++++||++|+.|+........... . .+.+......
T Consensus 158 -~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 158 -YTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFR-I-FRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred -ccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-H-HHHhCCCChhhhhcchhhH
Confidence 1233578999999988653 3578899999999999999999999875432211100 0 0000000000
Q ss_pred ----CCC----CcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 522 ----QFD----GVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 522 ----~~~----~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
... .........+...+.+++.+||+.||++|||+++|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 0000111123456778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=305.20 Aligned_cols=259 Identities=27% Similarity=0.448 Sum_probs=195.8
Q ss_pred HHhhhhcCccCceEEEEEEe-----CCCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeC--CeeeEE
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-----PDGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYEN--KKNALI 366 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 366 (582)
+.+.+.||+|+||+||++.. .+++.||+|.++.... ..+.+.+|+.++++++||||+++++++... ...++|
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 85 (284)
T cd05081 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLV 85 (284)
T ss_pred ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEE
Confidence 34568899999999999864 2588999999875443 245788999999999999999999987543 467899
Q ss_pred EEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccc
Q 040604 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~ 446 (582)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 86 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 86 MEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred EEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 99999999999997543 3589999999999999999999998 9999999999999999999999999999876543
Q ss_pred ccceee-ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCccc----------chhhHHHHHhh
Q 040604 447 ESAISM-LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDT----------SICHNLIYERI 515 (582)
Q Consensus 447 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~----------~~~~~~~~~~i 515 (582)
...... ....++..|+|||++.+ ..++.++||||||++++||++|..++....... ......+.+.+
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhcc--CCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 322111 11124456999999875 468899999999999999999877653321100 00000011111
Q ss_pred cCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 040604 516 EPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGS 566 (582)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~ 566 (582)
........ ...+...+.+++.+||+.+|++||||++|++.|+.+
T Consensus 240 ~~~~~~~~-------~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 240 KNNGRLPA-------PPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hcCCcCCC-------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11111111 112345678889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=302.33 Aligned_cols=246 Identities=30% Similarity=0.507 Sum_probs=198.1
Q ss_pred HHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCC
Q 040604 294 TKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNG 373 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 373 (582)
.+.+.+.||+|+||.||++.. +++.+|+|.++... ..+.+.+|+.++++++|||++++++++..+ ..++||||++++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~ 83 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKG 83 (254)
T ss_pred HceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCC
Confidence 355678999999999999975 77889999986543 456789999999999999999999998654 479999999999
Q ss_pred ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeee
Q 040604 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISML 453 (582)
Q Consensus 374 sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 453 (582)
+|.+++.......+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 84 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~----- 155 (254)
T cd05083 84 NLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD----- 155 (254)
T ss_pred CHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccCC-----
Confidence 999999876555689999999999999999999987 999999999999999999999999999876433211
Q ss_pred cccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 454 HARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 454 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
....+..|+|||++.. +.++.++|+||||++++||++ |+.|+....... ....+..+...... .
T Consensus 156 ~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~-------~ 220 (254)
T cd05083 156 NSKLPVKWTAPEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE------VKECVEKGYRMEPP-------E 220 (254)
T ss_pred CCCCCceecCHHHhcc--CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH------HHHHHhCCCCCCCC-------C
Confidence 2235678999999865 478899999999999999997 888886543211 12222222111111 1
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 533 KIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
.++..+.+++.+||+.+|++||++++|++.|+.
T Consensus 221 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 221 GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 234567788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=306.67 Aligned_cols=250 Identities=27% Similarity=0.354 Sum_probs=191.1
Q ss_pred hhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCC-----eeeEEEEecCC
Q 040604 299 DKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENK-----KNALIYELMPN 372 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~E~~~~ 372 (582)
+.+|.|+||.||+|... +++.||||..-.... .-.+|+.+|+.++|||||+|.-+|.... ...|||||| .
T Consensus 30 ~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym-P 105 (364)
T KOG0658|consen 30 RLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM-P 105 (364)
T ss_pred EEEeecccceEEEEEEcCCCceeEEEEecCCCC---cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc-h
Confidence 68999999999999765 678999998754432 2246899999999999999999887532 234899999 5
Q ss_pred CChhhhhhcC--CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-CceEEeeccccccccccccc
Q 040604 373 GSLDKFIHND--RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED-FCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 373 gsL~~~i~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~-~~vkl~DFGla~~~~~~~~~ 449 (582)
.+|.++++.. .+..++...+.-+..||.+||.|||+. +|+||||||.|+|+|.+ |.+||+|||.|+.+..++..
T Consensus 106 ~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn 182 (364)
T KOG0658|consen 106 ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN 182 (364)
T ss_pred HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc
Confidence 7898888742 234567777777899999999999997 99999999999999976 99999999999999888776
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCC--------C--
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPG--------N-- 519 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~--------~-- 519 (582)
.+.- -|..|.|||.+.+. ..|+.+.||||.||++.||+-|++.|.+...... +... .+.+... .
T Consensus 183 iSYi---cSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ-L~eI-ik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 183 ISYI---CSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ-LVEI-IKVLGTPTREDIKSMNPN 256 (364)
T ss_pred eeEE---EeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH-HHHH-HHHhCCCCHHHHhhcCcc
Confidence 6543 67899999999875 5899999999999999999999999977544322 1111 1111110 0
Q ss_pred --CCCCCCcCcH-----HHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 520 --DFQFDGVATE-----EEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 520 --~~~~~~~~~~-----~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
...++..... ....+....++++.++|+.+|.+|.++.|++.
T Consensus 257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 0111111100 12234456788889999999999999998873
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=308.80 Aligned_cols=251 Identities=31% Similarity=0.475 Sum_probs=196.3
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHH---HHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEE---FINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~---~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
++.+.||+|+||+||+++.. +++.+|+|++......... ..+|+.++++++|+||+++++++.+....++|||+++
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 81 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP 81 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence 35688999999999999765 6779999999876544332 3569999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
+++|.+++.. ...+++..++.++.|+++||++||+. +++|+||||+||++++++.++|+|||.+....... ..
T Consensus 82 ~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~--~~ 154 (260)
T PF00069_consen 82 GGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN--EN 154 (260)
T ss_dssp TEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT--SE
T ss_pred cccccccccc--cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc--cc
Confidence 9999999983 23689999999999999999999998 99999999999999999999999999998642211 12
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHH
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 531 (582)
.....+|..|+|||++... ...+.++||||+|+++++|++|..|+........ ...+............ ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~-----~~~ 226 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQG-KKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ--LEIIEKILKRPLPSSS-----QQS 226 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTT-SSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH--HHHHHHHHHTHHHHHT-----TSH
T ss_pred ccccccccccccccccccc-ccccccccccccccccccccccccccccccchhh--hhhhhhcccccccccc-----ccc
Confidence 2345699999999998722 4789999999999999999999999986521111 0111111110000000 000
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 532 KKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
......+.+++.+||+.||++||++.++++
T Consensus 227 ~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 227 REKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred chhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011267888899999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=306.04 Aligned_cols=239 Identities=25% Similarity=0.389 Sum_probs=186.2
Q ss_pred hcCccCceEEEEEEeC-------------------------CCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEE
Q 040604 300 KLGQGGYGEVYKGELP-------------------------DGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTF 353 (582)
Q Consensus 300 ~lG~G~~g~Vy~~~~~-------------------------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l 353 (582)
+||+|+||.||+|.+. ....||+|++..... ....+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999998642 113589998865433 23568889999999999999999
Q ss_pred EeEEEeCCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC---
Q 040604 354 LGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF--- 430 (582)
Q Consensus 354 ~~~~~~~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~--- 430 (582)
++++.+....++||||+++|+|..++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCccc
Confidence 999999999999999999999999986533 3688899999999999999999987 999999999999997644
Q ss_pred ----ceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHh-cCCCCCCCCCcccc
Q 040604 431 ----CPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMV-GCTKNLDDEVTDTS 505 (582)
Q Consensus 431 ----~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ell-tg~~p~~~~~~~~~ 505 (582)
.+|++|||++....... ...++..|+|||.+.+. ..++.++||||||+++|||+ +|+.|+........
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSRE------ERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred CccceeeecCCcccccccccc------ccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 48999999886543322 22478889999988653 46899999999999999994 78888865432211
Q ss_pred hhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 040604 506 ICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564 (582)
Q Consensus 506 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le 564 (582)
.. .+.... .+... ....+.+++.+||+.+|++|||+++|++.|.
T Consensus 231 --~~----~~~~~~--~~~~~-------~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 --ER----FYEKKH--RLPEP-------SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred --HH----HHHhcc--CCCCC-------CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11 111110 11111 1235778888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=316.84 Aligned_cols=239 Identities=25% Similarity=0.334 Sum_probs=188.9
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhccC-CCceEEEEeEEEeCCeeeEEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISRTS-HVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E 368 (582)
+++.+.||+|+||+||+|... +|+.||+|+++... ...+.+..|..++..+. |++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 456688999999999999754 78999999987532 23355778888888875 5678889999999999999999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
|+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 82 y~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 82 YVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 999999999987543 589999999999999999999998 999999999999999999999999999876433221
Q ss_pred ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc
Q 040604 449 AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528 (582)
Q Consensus 449 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 528 (582)
. .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... +.+.+.... ..++.
T Consensus 157 ~--~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~------~~~~i~~~~-~~~p~--- 222 (323)
T cd05615 157 T--TRTFCGTPDYIAPEIIAY--QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE------LFQSIMEHN-VSYPK--- 222 (323)
T ss_pred c--ccCccCCccccCHHHHcC--CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC-CCCCc---
Confidence 1 123459999999999876 368899999999999999999999997643221 112222111 11111
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCCCH
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERPSM 556 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~ 556 (582)
.+...+.+++.+||+.+|++|++.
T Consensus 223 ----~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 223 ----SLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ----cCCHHHHHHHHHHcccCHhhCCCC
Confidence 123456778888999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=292.87 Aligned_cols=263 Identities=23% Similarity=0.324 Sum_probs=205.1
Q ss_pred HHHHhhhhcCccCceEEEEEE-eCCCcEEEEEEeccCC-CCHHHHHHHHHHHhccCCCceEEEEeEEEeCC-----eeeE
Q 040604 293 MTKSFRDKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSR-CNGEEFINEVASISRTSHVNIVTFLGFCYENK-----KNAL 365 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l 365 (582)
.+|.+.++||+|||+-||+++ ..+++.||+|++.-.. .+.+..++|++..++++||||++++++...+. ..||
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl 100 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL 100 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence 345678899999999999996 6689999999986443 56678899999999999999999998876544 3799
Q ss_pred EEEecCCCChhhhhhcC--CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccc
Q 040604 366 IYELMPNGSLDKFIHND--RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQA 443 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~ 443 (582)
+++|...|+|.+.+... ++..+++.+.+.|+.+|.+||++||+. .++.+||||||.|||+.+.+.++|.|||.+...
T Consensus 101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQA 179 (302)
T ss_pred EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcccc
Confidence 99999999999998754 344699999999999999999999997 346999999999999999999999999999875
Q ss_pred cccccc-------eeeecccCCcccccccccccc-cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhh
Q 040604 444 QKKESA-------ISMLHARGTIGYIAPEVYSRR-FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERI 515 (582)
Q Consensus 444 ~~~~~~-------~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i 515 (582)
...-.. .......-|..|.|||.+.-+ ...+++++|||||||+||+|+-|..||+........+.-.+
T Consensus 180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv---- 255 (302)
T KOG2345|consen 180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAV---- 255 (302)
T ss_pred ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEee----
Confidence 432110 111123478899999998543 23578999999999999999999999975433221111001
Q ss_pred cCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 040604 516 EPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGS 566 (582)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~ 566 (582)
..+ ...++ ......+.+..++.+||+.||.+||++.+++..++..
T Consensus 256 ~n~-q~s~P-----~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 256 QNA-QISIP-----NSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ecc-ccccC-----CCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 000 01111 1122567888999999999999999999999998864
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=302.33 Aligned_cols=249 Identities=24% Similarity=0.335 Sum_probs=201.3
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC---CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR---CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
|++.+.||.|+||.||.++.. +++.+++|.+.... .....+.+|+.++++++|+||+++++++.+....+++|||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 345688999999999998654 68899999986543 23456889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
++++|.+++.......+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++.........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~- 157 (256)
T cd08221 82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM- 157 (256)
T ss_pred CCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccccc-
Confidence 999999999876556789999999999999999999987 9999999999999999999999999999876544321
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHH
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 530 (582)
.....|++.|+|||.+.+. .++.++||||||++++||++|+.|+....... .... +..+......
T Consensus 158 -~~~~~~~~~y~ape~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-----~~~~-~~~~~~~~~~------ 222 (256)
T cd08221 158 -AETVVGTPYYMSPELCQGV--KYNFKSDIWALGCVLYELLTLKRTFDATNPLN-----LVVK-IVQGNYTPVV------ 222 (256)
T ss_pred -ccccCCCccccCHhhcCCC--CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH-----HHHH-HHcCCCCCCc------
Confidence 1234589999999998763 57889999999999999999999986543211 1112 2222111111
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 040604 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVLEML 563 (582)
Q Consensus 531 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L 563 (582)
......+.+++.+||+.+|++||+++++++.+
T Consensus 223 -~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 223 -SVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -cccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 23345677888899999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=309.21 Aligned_cols=241 Identities=22% Similarity=0.331 Sum_probs=187.1
Q ss_pred hhcCccCceEEEEEEeC-C-------CcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 299 DKLGQGGYGEVYKGELP-D-------GQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~-------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.||+|+||.||+|... . ...+|+|.+..... ..+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 46999999999999653 2 23488888754432 246788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc--------eEEeeccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFC--------PKISDFGLAK 441 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~--------vkl~DFGla~ 441 (582)
+++|+|.+++...+ ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++. +|++|||++.
T Consensus 81 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999997654 2688999999999999999999998 9999999999999987765 6999999987
Q ss_pred cccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCC
Q 040604 442 QAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDF 521 (582)
Q Consensus 442 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~ 521 (582)
...... ...+++.|+|||++.+. ..++.++||||||+++|||++|..++......... . ...... .
T Consensus 157 ~~~~~~------~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~----~~~~~~--~ 222 (258)
T cd05078 157 TVLPKE------ILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-L----QFYEDR--H 222 (258)
T ss_pred ccCCch------hccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-H----HHHHcc--c
Confidence 654322 23488899999998753 35788999999999999999996443322221110 0 111111 1
Q ss_pred CCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 040604 522 QFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564 (582)
Q Consensus 522 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le 564 (582)
.++... ...+.+++.+||+.||++|||++++++.|+
T Consensus 223 ~~~~~~-------~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 223 QLPAPK-------WTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred cCCCCC-------cHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 111111 235678888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=305.77 Aligned_cols=256 Identities=25% Similarity=0.426 Sum_probs=200.5
Q ss_pred HHHHHhhhhcCccCceEEEEEEeCC----CcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeE
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELPD----GQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNAL 365 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 365 (582)
+.++.+.++||+|+||.||+|...+ ...||||....... ..+.+.+|+.++++++|+||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3445667899999999999997543 34699998865442 34578999999999999999999998865 45789
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+|||++.++.+||+|||+++....
T Consensus 84 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 84 VMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999997643 3589999999999999999999987 999999999999999999999999999987654
Q ss_pred cccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCC
Q 040604 446 KESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFD 524 (582)
Q Consensus 446 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 524 (582)
..... .....++..|+|||.+.. ..++.++||||||++++||++ |..||....... ....+..+......
T Consensus 160 ~~~~~-~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~~~~ 230 (270)
T cd05056 160 ESYYK-ASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND------VIGRIENGERLPMP 230 (270)
T ss_pred cccee-cCCCCccccccChhhhcc--CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHcCCcCCCC
Confidence 42211 112335578999998865 368899999999999999986 999986553322 11222332222221
Q ss_pred CcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 525 GVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 525 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
. .+...+.+++.+|+..+|++|||+.++++.|++..+
T Consensus 231 ~-------~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 231 P-------NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred C-------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1 223567778889999999999999999999988543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=319.26 Aligned_cols=240 Identities=25% Similarity=0.317 Sum_probs=186.5
Q ss_pred cCccCceEEEEEEeC-CCcEEEEEEeccCCC----CHHHHHHHHHHHhcc---CCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 301 LGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEVASISRT---SHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 301 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
||+|+||+||+|... +++.||||++..... ....+..|..++.++ +||||+++++.+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999764 689999999864322 123455666666655 699999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
|+|..++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........ .
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~--~ 153 (330)
T cd05586 81 GELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--T 153 (330)
T ss_pred ChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC--c
Confidence 99999887543 688999999999999999999998 9999999999999999999999999998764332221 1
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
....||+.|+|||++.+. ..++.++|||||||++|||++|+.||....... +.+.+..+.. .+.. .
T Consensus 154 ~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~------~~~~i~~~~~-~~~~------~ 219 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ------MYRNIAFGKV-RFPK------N 219 (330)
T ss_pred cCccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCHHH------HHHHHHcCCC-CCCC------c
Confidence 234699999999998653 357899999999999999999999997643221 2222322211 1111 1
Q ss_pred HHHHHHHHHHHhccccCCCCCC----CHHHHHH
Q 040604 533 KIAKMMILVGFWCIQTNPSERP----SMHKVLE 561 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RP----t~~evl~ 561 (582)
.+...+.+++.+||+.||++|| +++++++
T Consensus 220 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1234566778889999999998 4566654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=305.29 Aligned_cols=246 Identities=24% Similarity=0.376 Sum_probs=192.9
Q ss_pred HhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 296 SFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
++.+.||+|+||.||+|.. .+++.||+|++..... ...++.+|+.++++++||||+++++.+......++||||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 83 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG 83 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence 4568899999999999965 4789999999865432 235688999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
++|..+. .+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||++........
T Consensus 84 ~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~---- 150 (279)
T cd06619 84 GSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA---- 150 (279)
T ss_pred CChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccccc----
Confidence 9997652 467888999999999999999998 999999999999999999999999999986543321
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccch-hhHHHHHhhcCCCCCCCCCcCcHHH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSI-CHNLIYERIEPGNDFQFDGVATEEE 531 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~ 531 (582)
....||..|+|||++.+. .++.++||||||+++|+|++|+.||......... ......+.+.......+..
T Consensus 151 ~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 222 (279)
T cd06619 151 KTYVGTNAYMAPERISGE--QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV------ 222 (279)
T ss_pred cCCCCChhhcCceeecCC--CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCC------
Confidence 234689999999999763 6889999999999999999999998653322111 0001111111111111110
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 532 KKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
......+.+++.+||+.+|++||+++++++.
T Consensus 223 ~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 223 GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1123456778888999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=307.23 Aligned_cols=256 Identities=25% Similarity=0.336 Sum_probs=203.0
Q ss_pred HHHHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEE
Q 040604 291 KRMTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 291 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 367 (582)
+...+++.++||+|+||+||++... +++.+|+|++..... ..+.+.+|+.+++.++||||+++++.+......++||
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 4456778899999999999999654 689999999865432 3467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
||+++++|.+++...+ .+++..+..++.|++.||.|||+. .+++||||||+||++++++.++|+|||++.......
T Consensus 83 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 83 EFMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred ecCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 9999999999987643 589999999999999999999973 289999999999999999999999999987643322
Q ss_pred cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccc------hhhHHHHHhhcCCCCC
Q 040604 448 SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTS------ICHNLIYERIEPGNDF 521 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~------~~~~~~~~~i~~~~~~ 521 (582)
. ....|+..|+|||++.+ +.++.++|||||||++++|++|+.||........ .....+...+. ....
T Consensus 159 ~----~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 231 (284)
T cd06620 159 A----DTFVGTSTYMSPERIQG--GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-EPPP 231 (284)
T ss_pred c----CccccCcccCCHHHHcc--CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh-ccCC
Confidence 1 13468999999999875 4788999999999999999999999976543210 11112222221 1111
Q ss_pred CCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 040604 522 QFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEML 563 (582)
Q Consensus 522 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~L 563 (582)
.+. ...+...+.+++.+||+.||++|||++||+++.
T Consensus 232 ~~~------~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 232 RLP------SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCC------chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 111 112445678888999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=310.19 Aligned_cols=248 Identities=26% Similarity=0.386 Sum_probs=198.7
Q ss_pred HHHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 294 TKSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
++.+.++||+|+||.||+|.. .+++.+|+|.+..... ..+.+.+|+.+++.++|+||+++++.+..+...++||||++
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~ 100 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence 344567899999999999975 4789999999875443 34678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
+++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..........
T Consensus 101 ~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~- 173 (296)
T cd06654 101 GGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR- 173 (296)
T ss_pred CCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccccc-
Confidence 99999998643 478899999999999999999998 99999999999999999999999999988654332211
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHH
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 531 (582)
....|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||........ ......... .... ..
T Consensus 174 -~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-----~~~~~~~~~-~~~~-----~~ 239 (296)
T cd06654 174 -STMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-----LYLIATNGT-PELQ-----NP 239 (296)
T ss_pred -CcccCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-----HHHHhcCCC-CCCC-----Cc
Confidence 12358999999999876 3678999999999999999999999975533221 111111111 1110 11
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 532 KKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
..+...+.+++.+||+.+|++||+++++++.
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred cccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 2344567788899999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=319.03 Aligned_cols=253 Identities=26% Similarity=0.304 Sum_probs=190.3
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC---CCHHHHHHHHHHHhccCCCceEEEEeEEEeCC------ee
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR---CNGEEFINEVASISRTSHVNIVTFLGFCYENK------KN 363 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~ 363 (582)
.+.+.+.||+|+||.||++... +|+.||||++.... .....+.+|+.+++.++||||+++++++.... ..
T Consensus 22 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 101 (359)
T cd07876 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDV 101 (359)
T ss_pred ceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccccee
Confidence 3455689999999999999754 68999999996532 23456789999999999999999999986543 46
Q ss_pred eEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccc
Q 040604 364 ALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQA 443 (582)
Q Consensus 364 ~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~ 443 (582)
++||||++ ++|...+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 102 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 102 YLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred EEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 89999995 566666542 478889999999999999999998 9999999999999999999999999999765
Q ss_pred cccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhH--------------
Q 040604 444 QKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHN-------------- 509 (582)
Q Consensus 444 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~-------------- 509 (582)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ +..
T Consensus 174 ~~~~~---~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 174 CTNFM---MTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ-WNKVIEQLGTPSAEFMN 247 (359)
T ss_pred ccCcc---CCCCcccCCCCCchhccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCcHHHHH
Confidence 43221 123458999999999976 4788999999999999999999999975432110 000
Q ss_pred ----HHHHhhcCCCCCCCCCcC-------------cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 510 ----LIYERIEPGNDFQFDGVA-------------TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 510 ----~~~~~i~~~~~~~~~~~~-------------~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
.+....... ....... ..........+.+++.+||+.||++|||++|+++.
T Consensus 248 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 248 RLQPTVRNYVENR--PQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHhhC--CCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000001100 0000000 00111223557788899999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=312.92 Aligned_cols=196 Identities=23% Similarity=0.354 Sum_probs=160.0
Q ss_pred hhcCccCceEEEEEEeC---CCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEe--CCeeeEEEEecCCC
Q 040604 299 DKLGQGGYGEVYKGELP---DGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYE--NKKNALIYELMPNG 373 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E~~~~g 373 (582)
.+||+|+||+||+|... ++..||+|.++... ....+.+|+.++++++||||+++++++.. +...++||||++ +
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-H 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-C
Confidence 57999999999999754 45789999987554 33567899999999999999999999864 456789999995 6
Q ss_pred ChhhhhhcC-------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE----cCCCceEEeecccccc
Q 040604 374 SLDKFIHND-------RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL----DEDFCPKISDFGLAKQ 442 (582)
Q Consensus 374 sL~~~i~~~-------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl----~~~~~vkl~DFGla~~ 442 (582)
+|.+++... ....+++..++.++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 777776422 223588999999999999999999998 99999999999999 5668999999999987
Q ss_pred ccccccc-eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCC
Q 040604 443 AQKKESA-ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDE 500 (582)
Q Consensus 443 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~ 500 (582)
....... .......||+.|+|||++.+. ..++.++|||||||++|||++|+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 6543221 112234589999999998653 35789999999999999999999998644
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=322.59 Aligned_cols=199 Identities=25% Similarity=0.360 Sum_probs=169.4
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
++.+.||+|+||+||++... +++.||||+++... ...+.+.+|+.++.+++|+||+++++.+.+....++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~ 83 (360)
T cd05627 4 ESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFL 83 (360)
T ss_pred eEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence 45578999999999999765 78999999996432 23456788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc-
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA- 449 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~- 449 (582)
++|+|.+++.+.+ .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 84 PGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred CCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 9999999997643 588999999999999999999998 9999999999999999999999999998754321100
Q ss_pred --------------------------------eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCC
Q 040604 450 --------------------------------ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNL 497 (582)
Q Consensus 450 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~ 497 (582)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC--CCCCCcceeccccceeeecccCCCCC
Confidence 00112469999999999876 36889999999999999999999999
Q ss_pred CCCC
Q 040604 498 DDEV 501 (582)
Q Consensus 498 ~~~~ 501 (582)
....
T Consensus 237 ~~~~ 240 (360)
T cd05627 237 CSET 240 (360)
T ss_pred CCCC
Confidence 7653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=299.59 Aligned_cols=249 Identities=27% Similarity=0.330 Sum_probs=197.2
Q ss_pred HHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCC------HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCN------GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 367 (582)
+...+.||+|++|.||++.. .+++.+|+|.+...... .+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 34568899999999999965 47899999998654321 245788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 84 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 84 EYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 9999999999987643 578899999999999999999998 99999999999999999999999999998654322
Q ss_pred ccee-eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCc
Q 040604 448 SAIS-MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526 (582)
Q Consensus 448 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 526 (582)
.... .....|+..|+|||++.+. .++.++||||||+++|||++|+.|+........ ............++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~- 230 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGE--GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA-----IFKIATQPTNPQLPS- 230 (263)
T ss_pred cccccccCCCcCccccCcceeccC--CCCchhhhHHHHHHHHHHHhCCCCccccchHHH-----HHHHhccCCCCCCCc-
Confidence 1111 1234588899999999774 588999999999999999999999865432211 111111111111221
Q ss_pred CcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 527 ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 527 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
.....+.+++.+||+.+|++|||++++++.
T Consensus 231 ------~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 231 ------HVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ------cCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 233456778888999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=309.19 Aligned_cols=254 Identities=27% Similarity=0.463 Sum_probs=196.7
Q ss_pred HhhhhcCccCceEEEEEEeC-CCc----EEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEE
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQ----LVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 368 (582)
+..+.||+|+||.||+|... +|+ .+|+|.+...... ..++.+|+.++++++|+||+++++++... ...+++|
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e 88 (303)
T cd05110 10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQ 88 (303)
T ss_pred eeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeeh
Confidence 44578999999999999653 444 5788988654332 34688999999999999999999998754 4679999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
|+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 89 LMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164 (303)
T ss_pred hcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCccc
Confidence 999999999987543 3588999999999999999999998 999999999999999999999999999987654333
Q ss_pred ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcC
Q 040604 449 AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527 (582)
Q Consensus 449 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 527 (582)
........++..|+|||++.+ ..++.++||||||+++|||++ |+.|+....... +.+.+..+........
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~- 235 (303)
T cd05110 165 EYNADGGKMPIKWMALECIHY--RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE------IPDLLEKGERLPQPPI- 235 (303)
T ss_pred ccccCCCccccccCCHHHhcc--CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHCCCCCCCCCC-
Confidence 222223346778999999865 468899999999999999997 888886542211 1222222222211111
Q ss_pred cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCC
Q 040604 528 TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIEN 569 (582)
Q Consensus 528 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~ 569 (582)
....+.+++..||..+|++||+++++++.|+....+
T Consensus 236 ------~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 236 ------CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 123467788889999999999999999999875543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=302.90 Aligned_cols=251 Identities=23% Similarity=0.321 Sum_probs=196.6
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
+++.++||+|+||.||+|... ++..+++|.+..... ..+.+.+|+.+++.++|+||+++++.+......++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 456688999999999999765 678899999865432 345688999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
++|..++.... .++++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++......... .
T Consensus 87 ~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~ 160 (282)
T cd06643 87 GAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--R 160 (282)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccccc--c
Confidence 99998876532 3689999999999999999999998 9999999999999999999999999998765432211 1
Q ss_pred ecccCCccccccccccc---ccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 453 LHARGTIGYIAPEVYSR---RFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~---~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
....||+.|+|||++.. ....++.++|||||||++|||++|+.|+....... .+.... ........
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-----~~~~~~-~~~~~~~~----- 229 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-----VLLKIA-KSEPPTLA----- 229 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-----HHHHHh-hcCCCCCC-----
Confidence 23458999999999842 12357789999999999999999999986543211 111111 11111110
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
....+...+.+++.+||+.+|++||++.++++.
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 230 QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011234567788889999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=314.45 Aligned_cols=254 Identities=20% Similarity=0.222 Sum_probs=191.3
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+++.+.||+|+||+||++... +++.||+|++.+.. ...+.+.+|+.++..++|+||+++++++.++...++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 456688999999999999765 68999999986422 2335588899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++|+|.+++.+. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 83 ~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 83 YVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred CCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 9999999999753 23688999999999999999999998 9999999999999999999999999998765443221
Q ss_pred eeeecccCCcccccccccccc---cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCc
Q 040604 450 ISMLHARGTIGYIAPEVYSRR---FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 526 (582)
. .....||+.|+|||++... .+.++.++|||||||++|||++|+.||....... .....+.......+...
T Consensus 159 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~-----~~~~i~~~~~~~~~~~~ 232 (331)
T cd05597 159 Q-SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-----TYGKIMNHKEHFQFPPD 232 (331)
T ss_pred c-ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH-----HHHHHHcCCCcccCCCc
Confidence 1 1123599999999998631 2357889999999999999999999997543221 11111111111112111
Q ss_pred CcHHHHHHHHHHHHHHHhcc--ccCCCCCCCHHHHHHH
Q 040604 527 ATEEEKKIAKMMILVGFWCI--QTNPSERPSMHKVLEM 562 (582)
Q Consensus 527 ~~~~~~~~~~~l~~l~~~Cl--~~dp~~RPt~~evl~~ 562 (582)
. ..+...+.+++.+|| ..++..||+++++++.
T Consensus 233 ~----~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 233 V----TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred c----CCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 1 112233444444444 4455558899998865
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=329.91 Aligned_cols=254 Identities=17% Similarity=0.228 Sum_probs=186.5
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhccCC------CceEEEEeEEEeC-CeeeE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRTSH------VNIVTFLGFCYEN-KKNAL 365 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~~-~~~~l 365 (582)
.+.+.++||+|+||+||+|... +++.||||+++.......++..|+.+++.++| .+++++++++... .+.++
T Consensus 130 ~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~i 209 (467)
T PTZ00284 130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCI 209 (467)
T ss_pred cEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEE
Confidence 3456689999999999999754 68899999997654444556677777777654 4589999988765 46789
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC---------------
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF--------------- 430 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~--------------- 430 (582)
|||++ +++|.+++...+ .+++..+..|+.||+.||+|||+. .+||||||||+|||++.++
T Consensus 210 v~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 210 VMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred EEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 99998 888988887543 689999999999999999999973 2899999999999998765
Q ss_pred -ceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhH
Q 040604 431 -CPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHN 509 (582)
Q Consensus 431 -~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~ 509 (582)
.+||+|||++....... ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..
T Consensus 285 ~~vkl~DfG~~~~~~~~~-----~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~-~~- 355 (467)
T PTZ00284 285 CRVRICDLGGCCDERHSR-----TAIVSTRHYRSPEVVLG--LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH-LH- 355 (467)
T ss_pred ceEEECCCCccccCcccc-----ccccCCccccCcHHhhc--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HH-
Confidence 49999999876432221 23469999999999976 3789999999999999999999999976443211 00
Q ss_pred HHHHhhcCCC------------------CCCCCCcCc------------HHHHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 040604 510 LIYERIEPGN------------------DFQFDGVAT------------EEEKKIAKMMILVGFWCIQTNPSERPSMHKV 559 (582)
Q Consensus 510 ~~~~~i~~~~------------------~~~~~~~~~------------~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev 559 (582)
.+.+.+.... ...+..... .........+.+|+.+||+.||++|||++|+
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 0101000000 000000000 0000112456789999999999999999999
Q ss_pred HH
Q 040604 560 LE 561 (582)
Q Consensus 560 l~ 561 (582)
++
T Consensus 436 L~ 437 (467)
T PTZ00284 436 TT 437 (467)
T ss_pred hc
Confidence 86
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=300.51 Aligned_cols=248 Identities=29% Similarity=0.411 Sum_probs=200.8
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
.+++.++||+|+||.||+|... +++.+|+|.++.... .+++.+|+.++++++|+||+++++.+.+....++++||+++
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 82 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence 3556788999999999999776 488999999976543 67899999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++......... .
T Consensus 83 ~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~--~ 156 (256)
T cd06612 83 GSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK--R 156 (256)
T ss_pred CcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCccc--c
Confidence 99999986533 4689999999999999999999998 9999999999999999999999999999876543321 1
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
....|+..|+|||++.+. .++.++||||||+++|+|++|+.|+........ + ..+.......+ ....
T Consensus 157 ~~~~~~~~y~~PE~~~~~--~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-----~-~~~~~~~~~~~-----~~~~ 223 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEI--GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-----I-FMIPNKPPPTL-----SDPE 223 (256)
T ss_pred ccccCCccccCHHHHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-----h-hhhccCCCCCC-----Cchh
Confidence 223488999999998763 688999999999999999999999875433211 0 01111100001 1122
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 533 KIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.+...+.+++.+||+.+|++|||+++|++
T Consensus 224 ~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 224 KWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 34456788888999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=303.85 Aligned_cols=247 Identities=26% Similarity=0.363 Sum_probs=198.3
Q ss_pred HHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
..+...+.||+|+||.||+|... +++.||+|.++.... ..+.+.+|+.++++++|+||+++++.+..+...++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 44566788999999999999654 688999999875432 235688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++.........
T Consensus 84 ~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06642 84 LGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred cCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcchh
Confidence 999999998864 3588999999999999999999987 9999999999999999999999999999876543221
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
.....|+..|+|||++.+. .++.++||||||++++||++|+.|+....... ....+.......+.
T Consensus 158 --~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~------~~~~~~~~~~~~~~----- 222 (277)
T cd06642 158 --RNTFVGTPFWMAPEVIKQS--AYDFKADIWSLGITAIELAKGEPPNSDLHPMR------VLFLIPKNSPPTLE----- 222 (277)
T ss_pred --hhcccCcccccCHHHhCcC--CCchhhhHHHHHHHHHHHHhCCCCCcccchhh------HHhhhhcCCCCCCC-----
Confidence 1123588999999998763 68899999999999999999999986443221 11111111111111
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
......+.+++.+||+.+|++||+|.+|++.
T Consensus 223 --~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 223 --GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred --cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1234567788899999999999999999873
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=305.55 Aligned_cols=253 Identities=25% Similarity=0.340 Sum_probs=195.6
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhcc-CCCceEEEEeEEE-----eCCeeeEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRT-SHVNIVTFLGFCY-----ENKKNALI 366 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-----~~~~~~lv 366 (582)
++++.+.||+|+||.||++... +++.+|+|+++......+.+.+|+.+++++ +|+||+++++++. .+...++|
T Consensus 19 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv 98 (286)
T cd06638 19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLV 98 (286)
T ss_pred ceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEE
Confidence 4456688999999999999664 688999999876555567788999999999 6999999999885 33567999
Q ss_pred EEecCCCChhhhhhcC--CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccc
Q 040604 367 YELMPNGSLDKFIHND--RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~ 444 (582)
|||+++++|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++...
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 175 (286)
T cd06638 99 LELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175 (286)
T ss_pred EeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence 9999999999987632 234688899999999999999999998 99999999999999999999999999998764
Q ss_pred ccccceeeecccCCcccccccccccc---cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCC
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRR---FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDF 521 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~ 521 (582)
..... .....|++.|+|||++... ...++.++||||+||++|||++|+.|+........ +. .+......
T Consensus 176 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-----~~-~~~~~~~~ 247 (286)
T cd06638 176 STRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-----LF-KIPRNPPP 247 (286)
T ss_pred cCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-----Hh-hccccCCC
Confidence 33211 1234599999999987531 13578899999999999999999999875432211 11 11111111
Q ss_pred CCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 522 QFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 522 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
.+.. .......+..++.+||+.||++|||++||++.
T Consensus 248 ~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 248 TLHQ-----PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred cccC-----CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 1100 01123457778889999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=301.91 Aligned_cols=245 Identities=30% Similarity=0.398 Sum_probs=199.1
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC--CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR--CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
+++.+.||.|++|.||+|... +++.+|+|++.... .....+.+|+.+++.++|+||+++++.+.++...++|+||++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG 82 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence 456788999999999999765 78999999986543 234568899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
+++|.+++... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++........
T Consensus 83 ~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-- 154 (274)
T cd06609 83 GGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK-- 154 (274)
T ss_pred CCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccccc--
Confidence 99999998754 689999999999999999999987 9999999999999999999999999999877544221
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHH
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 531 (582)
.....|++.|+|||++.+. .++.++||||||+++|+|++|+.|+....... ....+.......+...
T Consensus 155 ~~~~~~~~~y~~PE~~~~~--~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~~~~~~~~~~~~~~~~----- 221 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQS--GYDEKADIWSLGITAIELAKGEPPLSDLHPMR------VLFLIPKNNPPSLEGN----- 221 (274)
T ss_pred cccccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCcccCchHH------HHHHhhhcCCCCCccc-----
Confidence 1234588999999998764 58999999999999999999999986543211 1112222211111111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 532 KKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.+...+.+++.+||+.+|++|||++++++
T Consensus 222 -~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 -KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred -ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 13445777888899999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=307.08 Aligned_cols=256 Identities=23% Similarity=0.323 Sum_probs=195.8
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
+++.++||+|+||.||++... ++..+|+|.++.... ..+.+.+|+.++++++||||+++++.+.++...++||||++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 345678999999999999754 688999999875432 23568899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
+++|.+++... ..+++..+..++.|+++||.|||+. .+++|+||||+|||++.++.+||+|||++........
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--- 155 (308)
T cd06615 83 GGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--- 155 (308)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccccc---
Confidence 99999999765 3688999999999999999999973 2899999999999999999999999999876533221
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCC--------CC
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDF--------QF 523 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~--------~~ 523 (582)
....|++.|+|||.+.+ ..++.++|+||||+++++|++|+.|+....... ............... ..
T Consensus 156 -~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 156 -NSFVGTRSYMSPERLQG--THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE--LEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred -ccCCCCcCccChhHhcC--CCCCccchHHHHHHHHHHHHhCCCCCCCcchhh--HHHhhcCccccccccCCcccccCCC
Confidence 23458999999999865 368899999999999999999999986433211 000000000000000 00
Q ss_pred CCc-Cc----H-------------HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 524 DGV-AT----E-------------EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 524 ~~~-~~----~-------------~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
... .. + ........+.+++.+||+.+|++|||+++|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00 0 000134457889999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=309.81 Aligned_cols=258 Identities=23% Similarity=0.348 Sum_probs=196.4
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC--CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR--CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
.+.+.++||+|+||.||+|... +++.||+|.++... .....+.+|+.++++++|+||+++++++.+....++||||+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 86 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 86 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence 3456688999999999999765 68899999986543 23456789999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
+ ++|.+++.... ..+++..+..++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||++.........
T Consensus 87 ~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~- 160 (301)
T cd07873 87 D-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT- 160 (301)
T ss_pred c-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc-
Confidence 5 68988886543 3588999999999999999999998 9999999999999999999999999999765433221
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCC-----------
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGN----------- 519 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~----------- 519 (582)
.....+++.|+|||++.+. ..++.++||||||+++|||++|+.||........ . ..+...+....
T Consensus 161 -~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 161 -YSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ-L-HFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred -ccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-H-HHHHHHcCCCChhhchhhhccc
Confidence 1223578999999998653 3578899999999999999999999875432211 0 00111110000
Q ss_pred ---CCCCCCcCc----HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 520 ---DFQFDGVAT----EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 520 ---~~~~~~~~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
...+..... .....+...+.+|+.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000111000 011123456788999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=303.93 Aligned_cols=253 Identities=25% Similarity=0.417 Sum_probs=197.5
Q ss_pred hhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC-----------CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeee
Q 040604 297 FRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC-----------NGEEFINEVASISRTSHVNIVTFLGFCYENKKNA 364 (582)
Q Consensus 297 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 364 (582)
..+.||+|+||.||+|... +|+.+|+|.++.... ..+.+.+|+.++++++|+|++++++++......+
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (272)
T cd06629 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLS 84 (272)
T ss_pred ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceE
Confidence 3578999999999999654 789999998853211 1235778999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccc
Q 040604 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~ 444 (582)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 85 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 85 IFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred EEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 999999999999998765 3688899999999999999999987 99999999999999999999999999998754
Q ss_pred ccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCC
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFD 524 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 524 (582)
............|+..|+|||.+......++.++|+||||++++||++|..|+........ +.+.........+.
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~ 234 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA-----MFKLGNKRSAPPIP 234 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH-----HHHhhccccCCcCC
Confidence 4322222223458999999999876422478999999999999999999999864332211 11111111111111
Q ss_pred CcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 525 GVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 525 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
......+...+.+++.+||+.+|++||++++|++.
T Consensus 235 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 235 ---PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ---ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11122345677888889999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=303.31 Aligned_cols=248 Identities=27% Similarity=0.367 Sum_probs=193.1
Q ss_pred hhcCccCceEEEEEEeC-CCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCChh
Q 040604 299 DKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLD 376 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 376 (582)
..||+|+||.||+|... ++..||+|.+..... ..+.+.+|+.++++++|+||+++++++..+...++||||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 47999999999999754 688999999875543 3457889999999999999999999999999999999999999999
Q ss_pred hhhhcCC-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-CCceEEeeccccccccccccceeeec
Q 040604 377 KFIHNDR-NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE-DFCPKISDFGLAKQAQKKESAISMLH 454 (582)
Q Consensus 377 ~~i~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~-~~~vkl~DFGla~~~~~~~~~~~~~~ 454 (582)
+++.... ....++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++......... ...
T Consensus 94 ~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~--~~~ 168 (268)
T cd06624 94 ALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC--TET 168 (268)
T ss_pred HHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc--ccc
Confidence 9997542 22237888899999999999999988 9999999999999976 679999999998765432221 112
Q ss_pred ccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHH
Q 040604 455 ARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKI 534 (582)
Q Consensus 455 ~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 534 (582)
..|++.|+|||++......++.++||||||+++|+|++|+.|+......... ............++ ..+
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~-------~~~ 237 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA----MFKVGMFKIHPEIP-------ESL 237 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh----HhhhhhhccCCCCC-------ccc
Confidence 3489999999998654335788999999999999999999998654322110 01110000111111 123
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 535 AKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 535 ~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
...+.+++.+||+.+|++|||++++++.
T Consensus 238 ~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 238 SAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 4557778889999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=299.07 Aligned_cols=248 Identities=24% Similarity=0.340 Sum_probs=197.4
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeC-CeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYEN-KKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~E~ 369 (582)
|++.+.||+|++|.||++... +++.+|+|.+..... ..+.+.+|+.++++++|+|++++++.+... ...+++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 456788999999999999754 678999999865432 335688999999999999999999987643 467899999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++++|.+++.......+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM 158 (257)
T ss_pred cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence 9999999999865555689999999999999999999998 9999999999999999999999999999876443221
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
.....|++.|+|||++.+ ..++.++||||||+++++|++|+.|+....... .... +..+......
T Consensus 159 --~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-----~~~~-~~~~~~~~~~----- 223 (257)
T cd08223 159 --ASTLIGTPYYMSPELFSN--KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS-----LVYR-IIEGKLPPMP----- 223 (257)
T ss_pred --cccccCCcCccChhHhcC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-----HHHH-HHhcCCCCCc-----
Confidence 123458999999999876 467889999999999999999999986543211 1111 1111111111
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
......+.+++.+||+.+|++||++.++++.
T Consensus 224 --~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 224 --KDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred --cccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 2344567888999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=300.77 Aligned_cols=253 Identities=25% Similarity=0.409 Sum_probs=195.2
Q ss_pred HhhhhcCccCceEEEEEEeC----CCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCC------e
Q 040604 296 SFRDKLGQGGYGEVYKGELP----DGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENK------K 362 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 362 (582)
.+.+.||+|+||.||+|.+. +++.+|||+++.... ..+++.+|+.++++++||||+++++++.... .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 35678999999999999643 468999999876432 2356889999999999999999999886532 2
Q ss_pred eeEEEEecCCCChhhhhhcC----CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecc
Q 040604 363 NALIYELMPNGSLDKFIHND----RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFG 438 (582)
Q Consensus 363 ~~lv~E~~~~gsL~~~i~~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFG 438 (582)
.++++||+++|+|..++... ....+++..+++++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECccc
Confidence 36889999999998887532 223578899999999999999999988 99999999999999999999999999
Q ss_pred ccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcC
Q 040604 439 LAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEP 517 (582)
Q Consensus 439 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~ 517 (582)
+++...............+++.|++||.+.. ..++.++||||||+++|||++ |+.|+....... +...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~------~~~~~~~ 230 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLAD--NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE------IYNYLIK 230 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhc--CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH------HHHHHHc
Confidence 9987654332222222346678999999876 367889999999999999999 777775432211 1222222
Q ss_pred CCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 040604 518 GNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGS 566 (582)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~ 566 (582)
........ .....+.+++.+||+.+|++||++.++++.|++.
T Consensus 231 ~~~~~~~~-------~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNRLKQPP-------DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCcCCCCC-------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 22211111 2345678889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=302.54 Aligned_cols=247 Identities=29% Similarity=0.423 Sum_probs=195.5
Q ss_pred HhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCC-------HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEE
Q 040604 296 SFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCN-------GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 368 (582)
...+.||+|+||+||+|...+++.+|+|.++..... .+.+.+|+.++++++|+||+++++++.+....++|||
T Consensus 3 ~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (265)
T cd06631 3 TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME 82 (265)
T ss_pred cccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEe
Confidence 345789999999999998878999999998654321 2457889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
|+++++|.+++.+.. .+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++........
T Consensus 83 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 83 FVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 999999999997643 578899999999999999999987 999999999999999999999999999886532111
Q ss_pred ----ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcC-CCCCCC
Q 040604 449 ----AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEP-GNDFQF 523 (582)
Q Consensus 449 ----~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~-~~~~~~ 523 (582)
........|+..|+|||++.+ ..++.++||||||+++++|++|+.||......... ...... .....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~ 230 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINE--SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM-----FYIGAHRGLMPRL 230 (265)
T ss_pred cccccccccccCCCccccChhhhcC--CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH-----HHhhhccCCCCCC
Confidence 111123458999999999876 36789999999999999999999999754322211 111100 111111
Q ss_pred CCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 524 DGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 524 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
. ......+.+++.+||+.+|++||++.++++
T Consensus 231 ~-------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 231 P-------DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred C-------CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1 123455677888999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=305.60 Aligned_cols=251 Identities=30% Similarity=0.405 Sum_probs=197.5
Q ss_pred HHHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCCHHHHHHHHHHHhcc-CCCceEEEEeEEEe------CCeeeE
Q 040604 294 TKSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNGEEFINEVASISRT-SHVNIVTFLGFCYE------NKKNAL 365 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~~~~~l 365 (582)
.+.+.+.||+|+||.||+|.. .+++.+|+|++........++..|+.+++++ +|+||+++++++.. ....++
T Consensus 17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i 96 (282)
T cd06636 17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWL 96 (282)
T ss_pred hhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEE
Confidence 455668999999999999976 4788999999876655566788999999998 79999999999863 356789
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
+|||+++|+|.+++.......+++..++.++.|++.||.|||+. +|+|+||||+||++++++.+||+|||++.....
T Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~ 173 (282)
T cd06636 97 VMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173 (282)
T ss_pred EEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence 99999999999999876656788999999999999999999998 999999999999999999999999999876543
Q ss_pred cccceeeecccCCcccccccccccc---cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCC
Q 040604 446 KESAISMLHARGTIGYIAPEVYSRR---FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQ 522 (582)
Q Consensus 446 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~ 522 (582)
.... .....|++.|+|||.+... ...++.++|||||||++|||++|+.||......... .. +.......
T Consensus 174 ~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~-----~~-~~~~~~~~ 245 (282)
T cd06636 174 TVGR--RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL-----FL-IPRNPPPK 245 (282)
T ss_pred cccC--CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-----hh-HhhCCCCC
Confidence 2211 1234589999999987531 135788999999999999999999999654322211 11 11111111
Q ss_pred CCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 523 FDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 523 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
. ........+.+++.+||+.||++|||+.||++
T Consensus 246 ~------~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 246 L------KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred C------cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 1 11223456788889999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=319.57 Aligned_cols=243 Identities=28% Similarity=0.432 Sum_probs=198.1
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEec---cCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeCCe--eeEEE
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLK---NSRCN--GEEFINEVASISRTSHVNIVTFLGFCYENKK--NALIY 367 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~ 367 (582)
.|.++||+|+|-+||+|.+. +|..||--.++ ..+.. .+.|..|+.+|+.|+|+|||+++..|.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 35578999999999999554 68777753332 22333 3789999999999999999999999988765 67899
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-CceEEeecccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED-FCPKISDFGLAKQAQKK 446 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~-~~vkl~DFGla~~~~~~ 446 (582)
|.+..|+|..|+++.+ .++.+.+..|++||++||.|||++ +++|||||||-+||+|+.+ |.|||+|+|||......
T Consensus 123 EL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999998765 678899999999999999999997 6799999999999999864 89999999999987655
Q ss_pred ccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCC-CCCC
Q 040604 447 ESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDF-QFDG 525 (582)
Q Consensus 447 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~-~~~~ 525 (582)
... .+.|||.|||||++.. .|++.+||||||+.++||+|+..|+....... .+|+++..|..+ .+..
T Consensus 200 ~ak----svIGTPEFMAPEmYEE---~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A-----QIYKKV~SGiKP~sl~k 267 (632)
T KOG0584|consen 200 HAK----SVIGTPEFMAPEMYEE---NYNELVDVYAFGMCMLEMVTSEYPYSECTNPA-----QIYKKVTSGIKPAALSK 267 (632)
T ss_pred ccc----eeccCccccChHHHhh---hcchhhhhhhhhHHHHHHHhccCChhhhCCHH-----HHHHHHHcCCCHHHhhc
Confidence 432 2569999999999975 68999999999999999999999998765544 356665555432 2222
Q ss_pred cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 526 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
+.. ..+.+++.+||.. .++|||+.|+|.
T Consensus 268 V~d-------Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 268 VKD-------PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred cCC-------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 222 3456677789999 999999999985
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=316.26 Aligned_cols=189 Identities=23% Similarity=0.351 Sum_probs=160.9
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
.+.+.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++|+||+++++++.+....++|||++ .
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~ 140 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-S 140 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-C
Confidence 4566789999999999999765 6789999985433 2356899999999999999999999999999999999 5
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
++|.+++... ...+++..+..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 141 ~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~--- 213 (357)
T PHA03209 141 SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF--- 213 (357)
T ss_pred CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCccc---
Confidence 7888887653 34689999999999999999999998 9999999999999999999999999999754332221
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCC
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNL 497 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~ 497 (582)
....||+.|+|||++.+ ..++.++|||||||++|||+++..++
T Consensus 214 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 214 LGLAGTVETNAPEVLAR--DKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccccCCeecCC--CCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 23459999999999976 36899999999999999999876655
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=319.70 Aligned_cols=198 Identities=26% Similarity=0.371 Sum_probs=174.1
Q ss_pred HHHhhhhcCccCceEEEEEE-eCCCcEEEEEEeccCCCCHHHHHHHHHHHhccC-C-----CceEEEEeEEEeCCeeeEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEFINEVASISRTS-H-----VNIVTFLGFCYENKKNALI 366 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~lv 366 (582)
+|.+.+.||+|+||.|-+|. ..+++.||||++++...-..+...|+.+|..|+ | -|+|+++++|.-..+.+||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 55677899999999999995 558999999999988777777888999999987 3 3799999999999999999
Q ss_pred EEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC--CceEEeecccccccc
Q 040604 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED--FCPKISDFGLAKQAQ 444 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~--~~vkl~DFGla~~~~ 444 (582)
+|.+ .-+|.++++.++..+++...+..|+.||+.||..||+. +|||+||||+||||.+- ..|||+|||.|....
T Consensus 267 fELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 267 FELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred ehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccccC
Confidence 9999 89999999999888999999999999999999999987 99999999999999654 379999999998865
Q ss_pred ccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCc
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVT 502 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~ 502 (582)
.... ...-+..|.|||++.+ ..|+.+.||||||||+.||++|.+.|.+.+.
T Consensus 343 q~vy-----tYiQSRfYRAPEVILG--lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 343 QRVY-----TYIQSRFYRAPEVILG--LPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred Ccce-----eeeeccccccchhhcc--CCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 5432 1235678999999998 4899999999999999999999877765543
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=302.10 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=199.4
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
.+.+.++||.|+||.||++... ++..+|+|+++.... ..+.+.+|+.++++++|+||+++++.+.++...++||||++
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD 85 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccC
Confidence 4677889999999999999764 689999999875432 34578899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
+++|.+++.... ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-- 159 (280)
T cd06611 86 GGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK-- 159 (280)
T ss_pred CCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccccc--
Confidence 999999987533 3689999999999999999999998 9999999999999999999999999998765432221
Q ss_pred eecccCCcccccccccccc---cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc
Q 040604 452 MLHARGTIGYIAPEVYSRR---FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 528 (582)
.....||+.|+|||.+... ...++.++|+||||+++|||++|+.|+....... ....+..+....+.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~---- 229 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR------VLLKILKSEPPTLD---- 229 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH------HHHHHhcCCCCCcC----
Confidence 1234589999999997531 1346789999999999999999999987543221 11122222111111
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
....+...+.+++.+||+.+|++||++++|++.
T Consensus 230 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 230 -QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 011233456778889999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=302.27 Aligned_cols=251 Identities=26% Similarity=0.352 Sum_probs=196.9
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
.+++.++||+|+||.||+|... +++.+|+|++..... ..+.+.+|+.++++++|+||+++++.+..+...++||||++
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCP 92 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCC
Confidence 4567789999999999999765 589999999875432 34568889999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
+++|..++.+.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 93 ~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~-- 166 (292)
T cd06644 93 GGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR-- 166 (292)
T ss_pred CCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccccc--
Confidence 999988876533 3689999999999999999999987 9999999999999999999999999998764332111
Q ss_pred eecccCCcccccccccccc---cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc
Q 040604 452 MLHARGTIGYIAPEVYSRR---FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 528 (582)
.....+++.|+|||++... ...++.++|||||||++|||++|+.|+....... .. ..+.........
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~~-~~~~~~~~~~~~---- 236 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-----VL-LKIAKSEPPTLS---- 236 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-----HH-HHHhcCCCccCC----
Confidence 1233588999999998531 1356889999999999999999999986543211 11 111111111110
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
....+...+.+++.+||+.+|++||+++++++
T Consensus 237 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 237 -QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 01123345677888999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=299.34 Aligned_cols=255 Identities=25% Similarity=0.375 Sum_probs=202.9
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
+++.+.||.|+||+||+|... ++..+|+|++..... ..+.+.+|+.+++.++|+|++++++.+......++|||+++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 456688999999999999754 788999999865432 34678999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCC-cCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 372 NGSLDKFIHNDRN-IKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 372 ~gsL~~~i~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
+++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++..........
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred CCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 9999999976432 4689999999999999999999987 99999999999999999999999999998765543221
Q ss_pred --eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc
Q 040604 451 --SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528 (582)
Q Consensus 451 --~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 528 (582)
......|+..|+|||++... ...+.++|+||||++++||++|+.|+........ ..+.+.. ....+...
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-----~~~~~~~-~~~~~~~~-- 230 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-----LMLTLQN-DPPSLETG-- 230 (267)
T ss_pred ccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhhh-----HHHHhcC-CCCCcCCc--
Confidence 11233589999999998764 3688999999999999999999999975433221 1111221 11111111
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.....+...+.+++.+||+.||++||++++|++
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111244567788889999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=317.17 Aligned_cols=255 Identities=24% Similarity=0.278 Sum_probs=191.0
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC---CCHHHHHHHHHHHhccCCCceEEEEeEEEeC------Cee
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR---CNGEEFINEVASISRTSHVNIVTFLGFCYEN------KKN 363 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 363 (582)
.+.+.+.||+|+||.||++... .++.||||++.... .....+.+|+.+++.++||||+++++++... ...
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~ 104 (364)
T cd07875 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 104 (364)
T ss_pred ceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeE
Confidence 4556688999999999999654 68899999987532 2345678999999999999999999987543 356
Q ss_pred eEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccc
Q 040604 364 ALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQA 443 (582)
Q Consensus 364 ~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~ 443 (582)
++||||++ ++|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 105 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 105 YIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred EEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 89999995 577776643 478889999999999999999998 9999999999999999999999999999875
Q ss_pred cccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHH-----------
Q 040604 444 QKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIY----------- 512 (582)
Q Consensus 444 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~----------- 512 (582)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ....+.
T Consensus 177 ~~~~~---~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 177 GTSFM---MTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFMK 250 (364)
T ss_pred CCCCc---ccCCcccCCcCCHHHHhC--CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHH
Confidence 43321 123458999999999976 4789999999999999999999999975432211 111000
Q ss_pred -------HhhcCCCCC---CCC----C----cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 513 -------ERIEPGNDF---QFD----G----VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 513 -------~~i~~~~~~---~~~----~----~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
......... .+. . ............+.+++.+||+.||++|||++++++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000 000 0 0001111123467889999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.87 Aligned_cols=254 Identities=19% Similarity=0.217 Sum_probs=192.4
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.+.++||+|+||+||+++.. +++.||+|++.... ...+.+.+|+.++..++|+||+++++++.+....++||||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 345688999999999999765 68899999986522 2234578899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
++||+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 83 YVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred CCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 99999999997632 3688899999999999999999998 9999999999999999999999999999876543322
Q ss_pred eeeecccCCcccccccccccc---cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCc
Q 040604 450 ISMLHARGTIGYIAPEVYSRR---FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 526 (582)
. .....||+.|+|||++.+. .+.++.++|||||||++|||++|+.||....... .............++..
T Consensus 159 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-----~~~~i~~~~~~~~~p~~ 232 (331)
T cd05624 159 Q-SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-----TYGKIMNHEERFQFPSH 232 (331)
T ss_pred e-eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH-----HHHHHHcCCCcccCCCc
Confidence 1 1234699999999998642 1357889999999999999999999997543221 11111111111112211
Q ss_pred CcHHHHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 040604 527 ATEEEKKIAKMMILVGFWCIQTNPSE--RPSMHKVLEM 562 (582)
Q Consensus 527 ~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPt~~evl~~ 562 (582)
. ..+...+.+++.+||..++++ |++++++++.
T Consensus 233 ~----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 233 I----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred c----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 1 123345566666677755443 5688888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=314.33 Aligned_cols=254 Identities=22% Similarity=0.278 Sum_probs=191.0
Q ss_pred HHHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeC------Cee
Q 040604 294 TKSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYEN------KKN 363 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 363 (582)
++.+.+.||+|+||.||+|.. .+++.||||++..... ..+.+.+|+.++++++|+||+++++++... ...
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07878 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV 95 (343)
T ss_pred hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcE
Confidence 455668899999999999965 4788999999875422 235677899999999999999999987543 346
Q ss_pred eEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccc
Q 040604 364 ALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQA 443 (582)
Q Consensus 364 ~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~ 443 (582)
+++||++ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 96 YLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred EEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccceec
Confidence 8999998 8899888754 3589999999999999999999998 9999999999999999999999999999875
Q ss_pred cccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCC---
Q 040604 444 QKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND--- 520 (582)
Q Consensus 444 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~--- 520 (582)
.... ....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||........ ... +.+.......
T Consensus 169 ~~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~-~~~~~~~~~~~~~ 240 (343)
T cd07878 169 DDEM-----TGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ-LKR-IMEVVGTPSPEVL 240 (343)
T ss_pred CCCc-----CCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHH-HHHHhCCCCHHHH
Confidence 4432 233589999999998753 3678999999999999999999999865432111 000 0000000000
Q ss_pred ------------CCCCCcCcHHH----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 521 ------------FQFDGVATEEE----KKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 521 ------------~~~~~~~~~~~----~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
..+........ ......+.+++.+||+.||++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 241 KKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000 0112346788999999999999999999854
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=315.64 Aligned_cols=241 Identities=27% Similarity=0.388 Sum_probs=197.6
Q ss_pred hhcCccCceEEEEEEe-CCCcEEEEEEeccCCCCH----HHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCC
Q 040604 299 DKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNG----EEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNG 373 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 373 (582)
+.||.|+||.||.|.+ .+.+.||||.+.-+..+. .+++.|+..|++++|||++.+.|++..+...+|||||| -|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lG 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LG 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hc
Confidence 5799999999999965 478899999986443322 46889999999999999999999999999999999999 67
Q ss_pred ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeee
Q 040604 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISML 453 (582)
Q Consensus 374 sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 453 (582)
+-.+++.-. ..++.+.++..|..+.+.||+|||+. +.||||||..|||+.+.|.|||+|||.|....+..+
T Consensus 111 SAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAns----- 181 (948)
T KOG0577|consen 111 SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANS----- 181 (948)
T ss_pred cHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchhc-----
Confidence 777776432 24788899999999999999999998 999999999999999999999999999988766543
Q ss_pred cccCCccccccccccc-ccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 454 HARGTIGYIAPEVYSR-RFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 454 ~~~gt~~y~aPE~~~~-~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
..|||.|||||++.. ..|+|+-|+||||||+...||...++|...++..+. ++. |.....+.+. ..
T Consensus 182 -FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA-----LYH-IAQNesPtLq------s~ 248 (948)
T KOG0577|consen 182 -FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYH-IAQNESPTLQ------SN 248 (948)
T ss_pred -ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH-----HHH-HHhcCCCCCC------Cc
Confidence 359999999999853 237899999999999999999999999887755442 232 3333333332 23
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 533 KIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
+....+..++..||++-|.+|||.+++++.
T Consensus 249 eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 249 EWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred hhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 445667778888999999999999988753
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=304.81 Aligned_cols=245 Identities=22% Similarity=0.332 Sum_probs=203.5
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
|.+.+.||+|.|..|-+|++. +|+.||||++.+.+.+ ...+.+|+..|+.++|||||+||.+......+|||+|.-
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 456688999999999999654 8999999999876654 367889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE-cCCCceEEeeccccccccccccc
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL-DEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl-~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
.+|+|.++|.+.. ..+.+..+.+.+.||+.|+.|+|+. -+|||||||+||.+ .+-|-|||.|||++..+.+++..
T Consensus 100 D~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL 175 (864)
T KOG4717|consen 100 DGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKL 175 (864)
T ss_pred CCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcchh
Confidence 9999999997643 4689999999999999999999987 89999999999976 56689999999999888776543
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
+..+|+..|-|||++.+. ..-.+++||||||||||.|++|+.||...+..+.. ..|.... +..+
T Consensus 176 ---~TsCGSLAYSAPEILLGD-sYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL------TmImDCK-YtvP----- 239 (864)
T KOG4717|consen 176 ---TTSCGSLAYSAPEILLGD-SYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL------TMIMDCK-YTVP----- 239 (864)
T ss_pred ---hcccchhhccCchhhhcC-ccCCcchhhhHHHHHHHHHHhCCCccccccchhhh------hhhhccc-ccCc-----
Confidence 345799999999999886 34567899999999999999999999876554421 1222221 1122
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
..+.....+|+..||..||.+|.+.+||+.
T Consensus 240 --shvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 240 --SHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred --hhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 334566677777889999999999999974
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=298.25 Aligned_cols=246 Identities=25% Similarity=0.359 Sum_probs=199.0
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
.+...++||+|+||.||+|... ++..||+|+++.... ..+.+.+|+.+++++.|+||+++++.+.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 3455678999999999999764 688999999875432 2456889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
++++|.+++... ++++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.........
T Consensus 85 ~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06640 85 GGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK- 157 (277)
T ss_pred CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCccc-
Confidence 999999998643 578899999999999999999987 9999999999999999999999999999876543321
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHH
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 530 (582)
.....++..|+|||++.+ ..++.++|+||||+++|||++|+.|+....... ....+...... ..
T Consensus 158 -~~~~~~~~~y~apE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~------~~~~~~~~~~~-------~~ 221 (277)
T cd06640 158 -RNTFVGTPFWMAPEVIQQ--SAYDSKADIWSLGITAIELAKGEPPNSDMHPMR------VLFLIPKNNPP-------TL 221 (277)
T ss_pred -cccccCcccccCHhHhcc--CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh------HhhhhhcCCCC-------CC
Confidence 122358889999999876 368899999999999999999999987543221 11111111111 11
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 531 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
.......+.+++.+||+.+|++||++++++..
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 22345667888999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=318.26 Aligned_cols=255 Identities=25% Similarity=0.286 Sum_probs=190.9
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeC------Cee
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYEN------KKN 363 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 363 (582)
.+.+.+.||+|+||.||++... .++.||||++..... ....+.+|+.+++.++||||+++++++... ...
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 97 (355)
T cd07874 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDV 97 (355)
T ss_pred ceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccccee
Confidence 3455688999999999999654 689999999875432 235678899999999999999999988643 246
Q ss_pred eEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccc
Q 040604 364 ALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQA 443 (582)
Q Consensus 364 ~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~ 443 (582)
++||||++ ++|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 98 ~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 98 YLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred EEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 89999995 567666643 478889999999999999999998 9999999999999999999999999999865
Q ss_pred cccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHH-------------
Q 040604 444 QKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNL------------- 510 (582)
Q Consensus 444 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~------------- 510 (582)
..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ....
T Consensus 170 ~~~~~---~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 170 GTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMK 243 (355)
T ss_pred CCccc---cCCccccCCccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHH
Confidence 43322 1234589999999998763 688999999999999999999999975432111 0000
Q ss_pred -----HHHhhcCCCC---CCCCCc--------CcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 511 -----IYERIEPGND---FQFDGV--------ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 511 -----~~~~i~~~~~---~~~~~~--------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
+...+..... ..+... ...........+.+++.+||+.||++|||++|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000000 000000 001111234567889999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=329.35 Aligned_cols=256 Identities=24% Similarity=0.315 Sum_probs=200.7
Q ss_pred HhhhhcCccCceEEEEEEeCCC-cEEEEEEeccCCC-CHHHHHHHHHHHhccC-CCceEEEEeEE-Ee----C--CeeeE
Q 040604 296 SFRDKLGQGGYGEVYKGELPDG-QLVAVKVLKNSRC-NGEEFINEVASISRTS-HVNIVTFLGFC-YE----N--KKNAL 365 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~-~~----~--~~~~l 365 (582)
.+.+.|.+|||+.||.|.+..+ ..||+|++-..+. .-+...+|+.+|++|+ |+|||.+++.. .. . -...|
T Consensus 40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evll 119 (738)
T KOG1989|consen 40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLL 119 (738)
T ss_pred EEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEe
Confidence 3557899999999999987765 9999999765433 3466889999999998 99999999932 21 1 24468
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
.||||+||.|-+++.......|++.++++|+.|+++|+++||.. .++|||||||-|||||+.++..||||||.|.....
T Consensus 120 LmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~ 198 (738)
T KOG1989|consen 120 LMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKIL 198 (738)
T ss_pred ehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccC
Confidence 99999999999999876556699999999999999999999986 67899999999999999999999999999875433
Q ss_pred cc-cceee------ecccCCcccccccccccc-cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcC
Q 040604 446 KE-SAISM------LHARGTIGYIAPEVYSRR-FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEP 517 (582)
Q Consensus 446 ~~-~~~~~------~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~ 517 (582)
.. ..... -...-|+.|.|||++.-. .-.+++|+|||||||+||-|.-...||+...... |..
T Consensus 199 ~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la----------Iln 268 (738)
T KOG1989|consen 199 SPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA----------ILN 268 (738)
T ss_pred CCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee----------EEe
Confidence 22 11000 012378999999997421 1368999999999999999999999998764322 122
Q ss_pred CCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 518 GNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
+. +.++.. ......|..|+..||+.||++||++-+|++.+..+..
T Consensus 269 g~-Y~~P~~-----p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 269 GN-YSFPPF-----PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred cc-ccCCCC-----ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 21 122221 3456778888889999999999999999988876444
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=297.06 Aligned_cols=249 Identities=26% Similarity=0.368 Sum_probs=205.9
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
-+.+.++||+|+||.||++.++ .|+.+|||.+.... +-.+++.|+.+|.+.+.|+||++||.+.....+++|||||..
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 3567789999999999999654 79999999986543 567889999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
|++.+.+.. ++.++++.++..|+...++||+|||.. .-+|||||..|||++.+|.+||+|||.|.++...-.. .
T Consensus 113 GSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK--R 186 (502)
T KOG0574|consen 113 GSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK--R 186 (502)
T ss_pred CcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHh--h
Confidence 999999875 446899999999999999999999987 8899999999999999999999999999876543222 1
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
..+.|||-|||||++.. -.|..++||||||+...||..|++|+.+..+....+ .|...+.+.+ ....
T Consensus 187 NTVIGTPFWMAPEVI~E--IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF------MIPT~PPPTF-----~KPE 253 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEE--IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF------MIPTKPPPTF-----KKPE 253 (502)
T ss_pred CccccCcccccHHHHHH--hccchhhhHhhhcchhhhhhcCCCCcccccccceeE------eccCCCCCCC-----CChH
Confidence 24569999999999986 378999999999999999999999997764433211 1111111111 1234
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 533 KIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
.....+.+++..||-.+|++|-|+.++++.
T Consensus 254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 254 EWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 456677888899999999999999888754
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=303.70 Aligned_cols=257 Identities=22% Similarity=0.297 Sum_probs=197.5
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
+++.+.||+|++|.||+|... +|+.||+|++..... ..+.+.+|+.++++++|+|++++++++......++||||+
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 445678999999999999765 689999999865432 2356789999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
++++|..++.... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~- 156 (286)
T cd07847 83 DHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD- 156 (286)
T ss_pred CccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCccc-
Confidence 9988888775433 589999999999999999999997 9999999999999999999999999999876554321
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhc-----------CCC
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIE-----------PGN 519 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~-----------~~~ 519 (582)
.....++..|+|||++.+. ..++.++||||||++++||++|+.||......... .. +...+. ...
T Consensus 157 -~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 157 -YTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQL-YL-IRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred -ccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH-HH-HHHHhCCCChHHhhhccccc
Confidence 1123478899999998653 35788999999999999999999999754332211 00 000000 000
Q ss_pred ------CCCCCCcCc--HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 520 ------DFQFDGVAT--EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 520 ------~~~~~~~~~--~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
......... .....+...+.+++.+||+.+|++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000000 111234567888999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=305.47 Aligned_cols=258 Identities=26% Similarity=0.355 Sum_probs=197.6
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC------HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN------GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 367 (582)
+++.+.||+|++|.||+|... +++.||||.++..... ...+.+|+.++++++|+||+++++++.+....++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 345678999999999999764 7899999999765432 345678999999999999999999999989999999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
||+ +++|.+++.... ..+++..+..++.||++||.|||+. +++|+||||+||+++.++.+||+|||+++......
T Consensus 82 e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 82 EFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred ccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 999 999999997644 3689999999999999999999998 99999999999999999999999999998765432
Q ss_pred cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCC--------
Q 040604 448 SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGN-------- 519 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~-------- 519 (582)
.. .....+++.|+|||.+.+. ..++.++||||||++++||++|..++....... ..... ...+....
T Consensus 157 ~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 157 RK--MTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKI-FEALGTPTEENWPGVT 231 (298)
T ss_pred cc--ccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHH-HHHcCCCchhhhhhcc
Confidence 21 1223578899999988543 467899999999999999999977765433211 11111 11110000
Q ss_pred ---CC-CCCC--c--CcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 520 ---DF-QFDG--V--ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 520 ---~~-~~~~--~--~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
.. .... . ...........+.+++.+||+.+|++|||++||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00 0000 0 001112335678889999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=300.44 Aligned_cols=251 Identities=26% Similarity=0.415 Sum_probs=196.8
Q ss_pred HHhhhhcCccCceEEEEEEeCC--CcEEEEEEeccCC-----------CCHHHHHHHHHHHhc-cCCCceEEEEeEEEeC
Q 040604 295 KSFRDKLGQGGYGEVYKGELPD--GQLVAVKVLKNSR-----------CNGEEFINEVASISR-TSHVNIVTFLGFCYEN 360 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~-----------~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~ 360 (582)
+.+.+.||+|+||.||+|.... ++.+|+|.+.... ....++.+|+.++.+ ++|+||+++++++.++
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 3566889999999999997654 7889999875321 112456788887765 7999999999999999
Q ss_pred CeeeEEEEecCCCChhhhhhc--CCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecc
Q 040604 361 KKNALIYELMPNGSLDKFIHN--DRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFG 438 (582)
Q Consensus 361 ~~~~lv~E~~~~gsL~~~i~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFG 438 (582)
...++||||+++++|.+++.. .....+++..+++++.|++.||.|||+. .+++|+||||+|||++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEeccc
Confidence 999999999999999988753 2334689999999999999999999963 289999999999999999999999999
Q ss_pred ccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCC
Q 040604 439 LAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPG 518 (582)
Q Consensus 439 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~ 518 (582)
++........ .....|+..|+|||.+.+ +.++.++||||||+++|||++|+.|+....... ....+...
T Consensus 160 ~~~~~~~~~~---~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~------~~~~~~~~ 228 (269)
T cd08528 160 LAKQKQPESK---LTSVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS------LATKIVEA 228 (269)
T ss_pred ceeecccccc---cccccCcccCcChhhhcC--CCCchHHHHHHHHHHHHHHHhCCCcccccCHHH------HHHHHhhc
Confidence 9987655431 223458999999999876 468999999999999999999999986542211 11112111
Q ss_pred CCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 040604 519 NDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564 (582)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le 564 (582)
...... .......+.+++.+||+.||++||++.||.++|+
T Consensus 229 ~~~~~~------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 VYEPLP------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCCcCC------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111010 1123356778888999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=311.66 Aligned_cols=254 Identities=20% Similarity=0.219 Sum_probs=191.5
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccC----CCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNS----RCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.+.++||+|+||+||++... +++.+|+|++.+. ......+.+|+.++..++|+||+++++.+.+....++||||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 345688999999999999765 6788999998642 22234578899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++|+|.+++.+.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 83 ~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 83 YVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred cCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 99999999997532 3688999999999999999999998 9999999999999999999999999999765433221
Q ss_pred eeeecccCCcccccccccccc---cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCc
Q 040604 450 ISMLHARGTIGYIAPEVYSRR---FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 526 (582)
......||+.|+|||++... ...++.++|||||||++|||++|+.||....... .....+.......++..
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~-----~~~~i~~~~~~~~~p~~ 232 (332)
T cd05623 159 -QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-----TYGKIMNHKERFQFPAQ 232 (332)
T ss_pred -eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH-----HHHHHhCCCccccCCCc
Confidence 11234699999999998631 1357889999999999999999999997543221 11111111111112111
Q ss_pred CcHHHHHHHHHHHHHHHhccc--cCCCCCCCHHHHHHH
Q 040604 527 ATEEEKKIAKMMILVGFWCIQ--TNPSERPSMHKVLEM 562 (582)
Q Consensus 527 ~~~~~~~~~~~l~~l~~~Cl~--~dp~~RPt~~evl~~ 562 (582)
...+...+.+++.+|+. .++..|++++++++.
T Consensus 233 ----~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 233 ----VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ----cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 11223344455555554 444557899998766
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=301.23 Aligned_cols=252 Identities=29% Similarity=0.401 Sum_probs=199.6
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhcc-CCCceEEEEeEEEeCC------eeeE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRT-SHVNIVTFLGFCYENK------KNAL 365 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------~~~l 365 (582)
.+++.+.||+|++|.||+|... +++.+++|++.......+.+.+|+.+++++ .|+||+++++++.+.. ..++
T Consensus 7 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~l 86 (275)
T cd06608 7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWL 86 (275)
T ss_pred heeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEE
Confidence 4556789999999999999765 688999999987766667899999999998 7999999999997644 4789
Q ss_pred EEEecCCCChhhhhhcCC--CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccc
Q 040604 366 IYELMPNGSLDKFIHNDR--NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQA 443 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~ 443 (582)
||||+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 163 (275)
T cd06608 87 VMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL 163 (275)
T ss_pred EEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccceec
Confidence 999999999999987533 45789999999999999999999998 9999999999999999999999999998765
Q ss_pred cccccceeeecccCCcccccccccccc---cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCC
Q 040604 444 QKKESAISMLHARGTIGYIAPEVYSRR---FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND 520 (582)
Q Consensus 444 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~ 520 (582)
...... .....|+..|+|||++... ...++.++||||||+++++|++|+.||........ +.+ +.....
T Consensus 164 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~-~~~~~~ 235 (275)
T cd06608 164 DSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA-----LFK-IPRNPP 235 (275)
T ss_pred ccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH-----HHH-hhccCC
Confidence 433221 1234589999999987532 13467899999999999999999999965422211 111 111111
Q ss_pred CCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 521 FQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 521 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
..+ .........+.+++.+||+.||++|||+++|++
T Consensus 236 ~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 236 PTL-----KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CCC-----CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111 111234567788999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=299.95 Aligned_cols=250 Identities=28% Similarity=0.402 Sum_probs=200.8
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
+++.+.||+|++|.||++... +++.+|+|.+..... ..+.+.+|+.++++++||||+++++.+......++++||++
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 456789999999999999765 689999999876533 33568899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHR-GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
+++|.+++.... ..+++..+.+++.|++.||+|||+ . +++|+||||+||++++++.+||+|||.+..........
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 158 (265)
T cd06605 83 GGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT 158 (265)
T ss_pred CCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhc
Confidence 999999997643 468899999999999999999998 6 99999999999999999999999999987654332211
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHH
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 530 (582)
..|+..|+|||.+.+. .++.++||||||+++++|++|+.|+.............+...+ ......+. .
T Consensus 159 ----~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~- 226 (265)
T cd06605 159 ----FVGTSSYMAPERIQGN--DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV-NEPPPRLP----S- 226 (265)
T ss_pred ----ccCChhccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh-cCCCCCCC----h-
Confidence 4588999999998764 7889999999999999999999999765322222222222222 21111111 1
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 531 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
..+...+.+++.+||..+|++|||+.++++
T Consensus 227 -~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 227 -GKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred -hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 114556788888999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=306.89 Aligned_cols=258 Identities=21% Similarity=0.282 Sum_probs=195.2
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
+.+.++||+|+||.||+|... +|+.+|+|.++.... ....+.+|+.++++++|+||+++++++.+....++|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 345678999999999999765 789999999865322 2356788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
+ ++|.+++.... ..+++..++.++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 82 ~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~- 155 (284)
T cd07839 82 D-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC- 155 (284)
T ss_pred C-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC-
Confidence 5 67887776532 3689999999999999999999998 9999999999999999999999999999865433221
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCC-----------C
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPG-----------N 519 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~-----------~ 519 (582)
.....+++.|+|||++.+. ..++.++||||||+++|||++|+.|+............ +...+... .
T Consensus 156 -~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 156 -YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR-IFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred -cCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHH-HHHHhCCCChHHhHHhhhcc
Confidence 1233578999999998653 35788999999999999999999987544332211111 11111000 0
Q ss_pred C-CCCCCcC-----cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 520 D-FQFDGVA-----TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 520 ~-~~~~~~~-----~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
. ....... ......+...+.+++.+||+.||++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0 0000000 0111234567788999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=299.73 Aligned_cols=252 Identities=28% Similarity=0.395 Sum_probs=199.9
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
+++.+.||+|+||.||+|... +++.+|+|++..... ..+.+.+|+.++++++||||+++++.+.+....+++|||+++
T Consensus 5 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~ 84 (262)
T cd06613 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGG 84 (262)
T ss_pred eEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCC
Confidence 456688999999999999764 688999999875433 356788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++......... .
T Consensus 85 ~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~--~ 158 (262)
T cd06613 85 GSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK--R 158 (262)
T ss_pred CcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhhc--c
Confidence 99999987642 3688999999999999999999987 9999999999999999999999999999875543211 1
Q ss_pred ecccCCcccccccccccc-cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHH
Q 040604 453 LHARGTIGYIAPEVYSRR-FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 531 (582)
....|+..|+|||.+... ...++.++||||||+++|||++|+.|+........ ........ +........
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-----~~~~~~~~----~~~~~~~~~ 229 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-----LFLISKSN----FPPPKLKDK 229 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhcc----CCCccccch
Confidence 234588899999998642 12678899999999999999999999875432221 11111110 001111122
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 532 KKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
......+.+++.+||+.+|++|||+++|+.
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 230 EKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred hhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 334566888999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=299.02 Aligned_cols=246 Identities=26% Similarity=0.379 Sum_probs=197.2
Q ss_pred HHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCC--CCHHHHHHHHHHHhccC---CCceEEEEeEEEeCCeeeEEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSR--CNGEEFINEVASISRTS---HVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~E 368 (582)
+++.+.||+|+||.||+|.. .+++.+|+|+++... ...+++.+|+.++++++ |+|++++++++.++...++|||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 44568899999999999975 478999999986542 23467889999999987 9999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
|+++++|.+++... .+++..++.++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 83 YAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred cCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 99999999998653 689999999999999999999988 999999999999999999999999999987655432
Q ss_pred ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc
Q 040604 449 AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528 (582)
Q Consensus 449 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 528 (582)
. .....|+..|+|||.+.+. ..++.++|+||||+++|+|++|+.|+....... .. ..+.......+..
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-----~~-~~~~~~~~~~~~~--- 224 (277)
T cd06917 157 K--RSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-----AM-MLIPKSKPPRLED--- 224 (277)
T ss_pred c--cccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChhh-----hh-hccccCCCCCCCc---
Confidence 2 1234589999999988653 356889999999999999999999997543221 11 1111111111111
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
......+.+++.+||+.||++||++.++++
T Consensus 225 ---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 225 ---NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred ---ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 013456778888999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=297.74 Aligned_cols=246 Identities=27% Similarity=0.431 Sum_probs=194.9
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC----------HHHHHHHHHHHhccCCCceEEEEeEEEeCCeee
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN----------GEEFINEVASISRTSHVNIVTFLGFCYENKKNA 364 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 364 (582)
.+.+.||+|++|.||+|... +++.+|+|.+...... .+.+.+|+.++++++||||+++++++.+....+
T Consensus 3 ~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (267)
T cd06628 3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLN 82 (267)
T ss_pred cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccE
Confidence 35578999999999999654 6889999988653321 145778999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccc
Q 040604 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~ 444 (582)
+||||+++++|.+++...+ .+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||+++...
T Consensus 83 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 83 IFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred EEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 9999999999999997643 578889999999999999999987 99999999999999999999999999998765
Q ss_pred ccccce----eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCC
Q 040604 445 KKESAI----SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND 520 (582)
Q Consensus 445 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~ 520 (582)
...... ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||........ +.. +.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~-~~~~~~ 229 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQ--TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA-----IFK-IGENAS 229 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhcc--CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH-----HHH-HhccCC
Confidence 321110 1112358899999999876 3678899999999999999999999975432211 111 111111
Q ss_pred CCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 521 FQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 521 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
..++ ......+.+++.+||+.||++||++.+|++
T Consensus 230 ~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 230 PEIP-------SNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CcCC-------cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1111 123456677888999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=303.37 Aligned_cols=252 Identities=25% Similarity=0.346 Sum_probs=198.3
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
+++.+.||+|+||.||++... +++.+|+|.++.... ..+.+.+|+.++++++|+||+++++.+......++||||++
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD 82 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence 567789999999999999765 789999999875422 23578899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCC-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 372 NGSLDKFIHNDR-NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 372 ~gsL~~~i~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
+++|..++.... ...+++..+..++.|++.||.|||+. .+|+|+||||+||+++.++.+||+|||++........
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 158 (286)
T cd06622 83 AGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA-- 158 (286)
T ss_pred CCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc--
Confidence 999999887532 23689999999999999999999963 2899999999999999999999999999976543222
Q ss_pred eeecccCCccccccccccccc----CCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCc
Q 040604 451 SMLHARGTIGYIAPEVYSRRF----GGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~----~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 526 (582)
....|++.|+|||.+.+.. ..++.++|+|||||++|+|++|+.||....... .. ..+ ..+..+....+.
T Consensus 159 --~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~-~~~-~~~~~~~~~~~~-- 231 (286)
T cd06622 159 --KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-IF-AQL-SAIVDGDPPTLP-- 231 (286)
T ss_pred --ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-HH-HHH-HHHhhcCCCCCC--
Confidence 1235888999999985421 235889999999999999999999996543221 11 111 112222111111
Q ss_pred CcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 527 ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 527 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
..+...+.+++.+||+.+|++||++++++..
T Consensus 232 -----~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 232 -----SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -----cccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1244567788889999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=305.44 Aligned_cols=247 Identities=26% Similarity=0.388 Sum_probs=197.9
Q ss_pred HHHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 294 TKSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
.+.+.++||+|+||.||++.. .+++.||+|.+..... ..+.+.+|+.+++.++|+||+++++.+..+...++||||++
T Consensus 20 ~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (297)
T cd06656 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 99 (297)
T ss_pred hceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccC
Confidence 445668899999999999975 4799999999875443 34668899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
+++|.+++.+. .+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++..........
T Consensus 100 ~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~- 172 (297)
T cd06656 100 GGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR- 172 (297)
T ss_pred CCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCccCc-
Confidence 99999998643 478899999999999999999998 99999999999999999999999999988654432211
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHH
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 531 (582)
....|++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||......... ......+ .... ...
T Consensus 173 -~~~~~~~~y~aPE~~~~--~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~-----~~~~~~~-~~~~-----~~~ 238 (297)
T cd06656 173 -STMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-----YLIATNG-TPEL-----QNP 238 (297)
T ss_pred -CcccCCccccCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe-----eeeccCC-CCCC-----CCc
Confidence 12358899999999876 46789999999999999999999999654332211 0001111 0010 011
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 532 KKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
..+...+.+++.+||+.+|++||++++|++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 233455677888999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=302.28 Aligned_cols=252 Identities=26% Similarity=0.414 Sum_probs=196.8
Q ss_pred HHhhhhcCccCceEEEEEEeC------CCcEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP------DGQLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYENKKNALI 366 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 366 (582)
+...++||+|+||.||+|... +.+.+++|.+...... .+.+.+|+.++++++|+||+++++++.+....++|
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 86 (275)
T cd05046 7 LQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMI 86 (275)
T ss_pred ceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEE
Confidence 345578999999999999753 3467999998654433 46789999999999999999999999988899999
Q ss_pred EEecCCCChhhhhhcCCC-------cCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccc
Q 040604 367 YELMPNGSLDKFIHNDRN-------IKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGL 439 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~-------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGl 439 (582)
|||+++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||+
T Consensus 87 ~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~ 163 (275)
T cd05046 87 LEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSL 163 (275)
T ss_pred EEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccccc
Confidence 999999999999976542 2589999999999999999999988 999999999999999999999999999
Q ss_pred cccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCC
Q 040604 440 AKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPG 518 (582)
Q Consensus 440 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~ 518 (582)
++....... .......++..|+|||.+.+ +..+.++||||||+++++|++ |..|+....... +...+..+
T Consensus 164 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~------~~~~~~~~ 234 (275)
T cd05046 164 SKDVYNSEY-YKLRNALIPLRWLAPEAVQE--DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE------VLNRLQAG 234 (275)
T ss_pred ccccCcccc-cccCCceeEEeecChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccchHH------HHHHHHcC
Confidence 875432221 11122346778999998875 367889999999999999998 667775432211 11122111
Q ss_pred CC-CCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 519 ND-FQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 519 ~~-~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
.. .... ......+.+++.+||+.+|++|||+.++++.|.+
T Consensus 235 ~~~~~~~-------~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 235 KLELPVP-------EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CcCCCCC-------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 10 1111 1233567788899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=314.23 Aligned_cols=249 Identities=27% Similarity=0.439 Sum_probs=205.3
Q ss_pred HHHhhhhcCccCceEEEEEEeC--CCc--EEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP--DGQ--LVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 367 (582)
...+.|+||+|.||.|++|.+. +|+ .||||.++.... ...+|++|+.+|.+|+|+|+++|||+..+ ....|||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 3456689999999999999765 444 689999987654 35789999999999999999999999987 6778999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
|.++.|+|.+.++......+-...+-.++.|||.||.||.++ ++|||||...|+|+-....|||+||||.+.+...+
T Consensus 190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 999999999999886666788888999999999999999998 99999999999999999999999999999988776
Q ss_pred cceeeecc-cCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCC
Q 040604 448 SAISMLHA-RGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525 (582)
Q Consensus 448 ~~~~~~~~-~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 525 (582)
....+... .-...|.|||.+.. ..++.++|||+|||.+|||+| |..||...... .+.+.|..+..+.-
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh--~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~------qIL~~iD~~erLpR-- 336 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRH--RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI------QILKNIDAGERLPR-- 336 (1039)
T ss_pred cceEecCCCcCcccccCHhHhcc--ccccccchhhhhhhhHHhhhccCCCCCCCCCHH------HHHHhccccccCCC--
Confidence 65444322 24567999999975 589999999999999999998 45677654332 25556654433322
Q ss_pred cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 526 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.+...+.+.++++.||..+|++|||+..|.+
T Consensus 337 -----Pk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 337 -----PKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred -----CCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 2344567778888999999999999999973
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=317.96 Aligned_cols=246 Identities=28% Similarity=0.415 Sum_probs=199.7
Q ss_pred hcCccCceEEEEEEeC-CCcEEEEEEeccCC-CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCChhh
Q 040604 300 KLGQGGYGEVYKGELP-DGQLVAVKVLKNSR-CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDK 377 (582)
Q Consensus 300 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~ 377 (582)
.||+|.||+||.|++. +....|||-+.... ....-+.+|+..-++|+|.|||+++|.+.+++..-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999765 66789999986543 344567899999999999999999999999999999999999999999
Q ss_pred hhhcC-CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc-CCCceEEeeccccccccccccceeeecc
Q 040604 378 FIHND-RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLD-EDFCPKISDFGLAKQAQKKESAISMLHA 455 (582)
Q Consensus 378 ~i~~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~-~~~~vkl~DFGla~~~~~~~~~~~~~~~ 455 (582)
++... +..+-.+.++-....||++||.|||.. .|||||||-+|||++ ..|.+||+|||.++.+..-... +...
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~--TETF 736 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC--TETF 736 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcc--cccc
Confidence 99875 333347888888999999999999998 999999999999996 5799999999999886543222 2234
Q ss_pred cCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHH
Q 040604 456 RGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIA 535 (582)
Q Consensus 456 ~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 535 (582)
.||..|||||++......|..++|||||||.+.||.||++||........ .+ ..-|.. ...+.+ ..++.
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA----AM---FkVGmy-KvHP~i---Peels 805 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA----AM---FKVGMY-KVHPPI---PEELS 805 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH----hh---hhhcce-ecCCCC---cHHHH
Confidence 59999999999987777899999999999999999999999976554332 11 111111 112222 34556
Q ss_pred HHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 536 KMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 536 ~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.+...++++|+.+||.+||+++++++
T Consensus 806 aeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 806 AEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHcCCCcccCccHHHhcc
Confidence 66677888999999999999999984
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=305.64 Aligned_cols=249 Identities=25% Similarity=0.320 Sum_probs=198.6
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC----HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN----GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
++.+.||+|++|+||++... +++.+|+|.+...... .+.+.+|+.++++++|+||+++++.+.+....++||||+
T Consensus 4 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (316)
T cd05574 4 KKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYC 83 (316)
T ss_pred EEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEec
Confidence 44578999999999999765 5899999999765432 346889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
.+++|.+++.......+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++..........
T Consensus 84 ~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 84 PGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred CCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999866556799999999999999999999998 99999999999999999999999999987653321110
Q ss_pred ---------------------------eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcc
Q 040604 451 ---------------------------SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTD 503 (582)
Q Consensus 451 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~ 503 (582)
......||..|+|||++.+ ..++.++||||||+++|+|++|+.||......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG--DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC--CCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0112358899999999876 36789999999999999999999999754332
Q ss_pred cchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCC----HHHHHH
Q 040604 504 TSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPS----MHKVLE 561 (582)
Q Consensus 504 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt----~~evl~ 561 (582)
.. ..+.+... ..+.. ...+...+.+++.+||+.||++||+ +++++.
T Consensus 239 ~~-----~~~~~~~~--~~~~~-----~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 239 ET-----FSNILKKE--VTFPG-----SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HH-----HHHHhcCC--ccCCC-----ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 21 11112111 11111 1114567888889999999999999 777765
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=295.30 Aligned_cols=248 Identities=26% Similarity=0.366 Sum_probs=200.3
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
+.+.++||+|+||.||++... +|+.+|+|.+..... ..+++.+|+.++++++|+||+++++++.+....++||||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 345688999999999999654 789999999865322 3357889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
++++|.+++.......+++..+++++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++..........
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 158 (256)
T cd08218 82 EGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA 158 (256)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhh
Confidence 999999999765555689999999999999999999987 99999999999999999999999999998764432211
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHH
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 530 (582)
....|++.|+|||++.+ ...+.++|+||||+++++|++|+.|+...... ..+.+.+. +.....
T Consensus 159 --~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~~~~~-~~~~~~------- 221 (256)
T cd08218 159 --RTCIGTPYYLSPEICEN--RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-----NLVLKIIR-GSYPPV------- 221 (256)
T ss_pred --hhccCCccccCHHHhCC--CCCCCccchhHHHHHHHHHHcCCCCccCCCHH-----HHHHHHhc-CCCCCC-------
Confidence 12348899999999876 36788999999999999999999998654322 12222222 111111
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 531 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
.......+.+++.+||+.+|++||++++|++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 222 SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred cccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 12234567888889999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=303.28 Aligned_cols=257 Identities=24% Similarity=0.346 Sum_probs=196.1
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
+..+.||.|++|.||+|... +|+.||||.++.... ..+.+.+|+.++++++||||+++++++.+....++||||+.
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (284)
T cd07860 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH 82 (284)
T ss_pred eeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc
Confidence 44578999999999999764 789999999865332 23578899999999999999999999999999999999995
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
++|.+++.......+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.........
T Consensus 83 -~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~-- 156 (284)
T cd07860 83 -QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-- 156 (284)
T ss_pred -cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc--
Confidence 6899988766556789999999999999999999988 9999999999999999999999999998865433221
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCC----------
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDF---------- 521 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~---------- 521 (582)
.....+++.|+|||++.+. ..++.++||||||+++|||+||+.||.......... .. .+........
T Consensus 157 ~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RI-FRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred cccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH-HH-HHHhCCCChhhhhhhhHHHH
Confidence 1223478899999988653 346889999999999999999999986543322111 10 0111100000
Q ss_pred ---CCCCcCc----HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 522 ---QFDGVAT----EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 522 ---~~~~~~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.+..... .....+...+.+++.+||+.||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000 001123455678899999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=305.88 Aligned_cols=258 Identities=23% Similarity=0.370 Sum_probs=197.0
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
+++.++||+|+||.||+|... +++.||+|++..... ..+.+.+|+.++++++|+||+++++++.++...++||||+
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (286)
T cd07846 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV 82 (286)
T ss_pred eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence 345688999999999999765 689999999865332 2456889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
++++|..+..... .+++..++.++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.........
T Consensus 83 ~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~- 156 (286)
T cd07846 83 DHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV- 156 (286)
T ss_pred CccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc-
Confidence 9999988776433 489999999999999999999998 9999999999999999999999999999876443322
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHH----------HHhhcCCC-
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLI----------YERIEPGN- 519 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~----------~~~i~~~~- 519 (582)
.....++..|+|||++.+. ..++.++||||||++++||++|+.|+........ ..... .+......
T Consensus 157 -~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 157 -YTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQ-LYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred -cCcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHH-HHHHHHHhCCCchhhHHHhccchH
Confidence 1223588999999998653 3578899999999999999999988865432111 00000 00000000
Q ss_pred --CCCCCCcCc-----HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 520 --DFQFDGVAT-----EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 520 --~~~~~~~~~-----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
......... .....+...+.+++.+||+.+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000 001134567888999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=304.40 Aligned_cols=245 Identities=27% Similarity=0.397 Sum_probs=196.3
Q ss_pred HhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCC
Q 040604 296 SFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNG 373 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 373 (582)
.+.++||.|++|.||+|.. .+++.||+|.+..... ..+.+.+|+.++++++|+|++++++++.+....++||||++++
T Consensus 22 ~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 101 (296)
T cd06655 22 TRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGG 101 (296)
T ss_pred EEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCC
Confidence 4557899999999999965 4789999999865433 4567889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeee
Q 040604 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISML 453 (582)
Q Consensus 374 sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 453 (582)
+|.+++... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......... .
T Consensus 102 ~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~--~ 173 (296)
T cd06655 102 SLTDVVTET---CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR--S 173 (296)
T ss_pred cHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccccC--C
Confidence 999988643 589999999999999999999998 99999999999999999999999999988655433221 1
Q ss_pred cccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHH
Q 040604 454 HARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKK 533 (582)
Q Consensus 454 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 533 (582)
...|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||......... ....... ...+. ....
T Consensus 174 ~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~-----~~~~~~~-~~~~~-----~~~~ 240 (296)
T cd06655 174 TMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-----YLIATNG-TPELQ-----NPEK 240 (296)
T ss_pred CcCCCccccCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHhcC-CcccC-----Cccc
Confidence 2358899999999876 36789999999999999999999999765432211 1111111 11110 0112
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 534 IAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 534 ~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
+...+.+++.+||+.||++||++.+|++
T Consensus 241 ~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 241 LSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 3445677888999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=301.11 Aligned_cols=259 Identities=22% Similarity=0.290 Sum_probs=199.6
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
+.+.+.||+|++|.||+|... +|+.||+|++..... ..+.+.+|+.++++++|+||+++++++.+....++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 346688999999999999764 789999999875442 3467899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
+++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++........ .
T Consensus 82 -~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (286)
T cd07832 82 -PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R 155 (286)
T ss_pred -CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence 999999987543 4689999999999999999999998 999999999999999999999999999987654432 1
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCC-----------
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGN----------- 519 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~----------- 519 (582)
......|+..|+|||++.+. ..++.++||||+|++++||++|..++....... .+.. +...+....
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE-QLAI-VFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred ccccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH-HHHH-HHHHcCCCChHHHhhccCcc
Confidence 12234689999999998653 356899999999999999999977775433211 1111 111111100
Q ss_pred ---CCCCCCcCc----HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 520 ---DFQFDGVAT----EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 520 ---~~~~~~~~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
...+..... ....+....+.+++.+||+.+|++||+++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 0111234778889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=349.61 Aligned_cols=254 Identities=25% Similarity=0.443 Sum_probs=198.3
Q ss_pred hhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCChh
Q 040604 298 RDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLD 376 (582)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 376 (582)
.+.||+|+||.||+|.. .+++.||||.++...... .+|+..+++++|||||+++|++.+....++||||+++|+|.
T Consensus 695 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~ 771 (968)
T PLN00113 695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP---SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLS 771 (968)
T ss_pred ccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc---HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHH
Confidence 35799999999999976 489999999987544322 34688999999999999999999999999999999999999
Q ss_pred hhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeeccc
Q 040604 377 KFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR 456 (582)
Q Consensus 377 ~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 456 (582)
++++ .++|..+.+|+.|+++||+|||..+..+|+||||||+||+++.++..++. ||.+....... ...
T Consensus 772 ~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~------~~~ 839 (968)
T PLN00113 772 EVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDT------KCF 839 (968)
T ss_pred HHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCC------Ccc
Confidence 9995 37899999999999999999997666799999999999999999888876 66654432211 225
Q ss_pred CCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCC-----CCCCCCcCcHHH
Q 040604 457 GTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGN-----DFQFDGVATEEE 531 (582)
Q Consensus 457 gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~-----~~~~~~~~~~~~ 531 (582)
||+.|+|||++.+ ..++.++|||||||++|||++|+.|++...........|......... +..+.... ...
T Consensus 840 ~t~~y~aPE~~~~--~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 916 (968)
T PLN00113 840 ISSAYVAPETRET--KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV-SVN 916 (968)
T ss_pred ccccccCcccccC--CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC-Ccc
Confidence 8899999999876 478999999999999999999999986543333333333322221110 11111111 112
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCC
Q 040604 532 KKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIEN 569 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~ 569 (582)
.+....+.+++.+||+.||++||||+||++.|++....
T Consensus 917 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 917 QNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred HHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 33455678899999999999999999999999987653
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=300.33 Aligned_cols=252 Identities=28% Similarity=0.373 Sum_probs=196.3
Q ss_pred HHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCCHHHHHHHHHHHhcc-CCCceEEEEeEEEeC-----CeeeEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNGEEFINEVASISRT-SHVNIVTFLGFCYEN-----KKNALIY 367 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-----~~~~lv~ 367 (582)
+.+.+.||+|+||.||++.. .+++.+|+|++.......+.+.+|+.+++++ +|+|++++++++... ...++||
T Consensus 24 y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ 103 (291)
T cd06639 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVL 103 (291)
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEE
Confidence 34557899999999999976 4789999999976655567788999999998 899999999998754 3578999
Q ss_pred EecCCCChhhhhhcC--CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 368 ELMPNGSLDKFIHND--RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 368 E~~~~gsL~~~i~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
||+++++|.++++.. ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++.....
T Consensus 104 ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~ 180 (291)
T cd06639 104 ELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180 (291)
T ss_pred EECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhccc
Confidence 999999999988642 334689999999999999999999987 999999999999999999999999999887543
Q ss_pred cccceeeecccCCccccccccccccc---CCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCC
Q 040604 446 KESAISMLHARGTIGYIAPEVYSRRF---GGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQ 522 (582)
Q Consensus 446 ~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~ 522 (582)
..... ....|+..|+|||.+.... ..++.++|||||||++|||++|+.|+........ +. .+.......
T Consensus 181 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-----~~-~~~~~~~~~ 252 (291)
T cd06639 181 TRLRR--NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-----LF-KIPRNPPPT 252 (291)
T ss_pred ccccc--cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-----HH-HHhcCCCCC
Confidence 32211 1245889999999975421 1368899999999999999999999875432221 11 111111111
Q ss_pred CCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 523 FDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 523 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
+. . .......+.+++.+||+.+|++||+++|+++.
T Consensus 253 ~~---~--~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 253 LL---H--PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CC---c--ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 10 0 11233467888999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=302.26 Aligned_cols=253 Identities=25% Similarity=0.382 Sum_probs=193.3
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC--CHHHHHHHHHHHhccC-CCceEEEEeEEEeCCeeeEEEEecC
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC--NGEEFINEVASISRTS-HVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
.+.++||+|+||.||++... +++.+|+|.+..... ....+.+|+.++.++. |+||+++++++......+++|||+.
T Consensus 7 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~ 86 (288)
T cd06616 7 KDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD 86 (288)
T ss_pred HHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc
Confidence 34578999999999999654 689999999875432 2356889999999996 9999999999998889999999984
Q ss_pred CCChhhhh---hcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 372 NGSLDKFI---HNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 372 ~gsL~~~i---~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
++|.++. .......+++..+..++.|++.||+|||+. .+++||||||+||+++.++.+||+|||+++.......
T Consensus 87 -~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 163 (288)
T cd06616 87 -ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163 (288)
T ss_pred -CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence 5655443 333345689999999999999999999974 3899999999999999999999999999976543322
Q ss_pred ceeeecccCCccccccccccccc-CCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcC
Q 040604 449 AISMLHARGTIGYIAPEVYSRRF-GGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527 (582)
Q Consensus 449 ~~~~~~~~gt~~y~aPE~~~~~~-~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 527 (582)
. ....|++.|+|||++.... ..++.++||||||+++|||++|+.||...... ...+.+.. .+....+..
T Consensus 164 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~-~~~~~~~~~-- 233 (288)
T cd06616 164 K---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV----FDQLTQVV-KGDPPILSN-- 233 (288)
T ss_pred c---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH----HHHHhhhc-CCCCCcCCC--
Confidence 1 1235899999999986531 25788999999999999999999998754311 11111211 111111111
Q ss_pred cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 528 TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 528 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
.....+...+.+++.+||+.+|++|||+++|++.
T Consensus 234 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 234 -SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1113355678889999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=302.05 Aligned_cols=258 Identities=25% Similarity=0.352 Sum_probs=193.7
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
+++.+.||+|++|.||+|... +++.||||.+..... ....+.+|+.++++++|+||+++++++.+....++||||++
T Consensus 7 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07844 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD 86 (291)
T ss_pred eeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC
Confidence 445688999999999999765 789999999865432 23557789999999999999999999999999999999996
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
++|.+++..... .+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 87 -~~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-- 159 (291)
T cd07844 87 -TDLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT-- 159 (291)
T ss_pred -CCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCcc--
Confidence 589988875433 688999999999999999999998 9999999999999999999999999998764322111
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCC----------
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDF---------- 521 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~---------- 521 (582)
.....++..|+|||++.+. ..++.++||||+|+++|||++|+.||............ +.+.+......
T Consensus 160 ~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHK-IFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHH-HHHhcCCCChhhhhhhhhccc
Confidence 1123478899999988653 35788999999999999999999998654321111111 11111110000
Q ss_pred ----CCCCcCcHHH----HHH--HHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 522 ----QFDGVATEEE----KKI--AKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 522 ----~~~~~~~~~~----~~~--~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.......... ..+ ...+.+++.+||+.+|++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000000 011 155678889999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=293.57 Aligned_cols=247 Identities=25% Similarity=0.389 Sum_probs=197.9
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
+++.+.||+|+||.||++... +++.+|+|.+..... ..+.+.+|+.++++++|+||+++++.+......++||||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 345678999999999999654 788999999865432 3456889999999999999999999999899999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-CceEEeeccccccccccccc
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED-FCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~-~~vkl~DFGla~~~~~~~~~ 449 (582)
++++|.+++.......+++..+.+++.|++.||+|||+. +++|+||||+||+++++ +.+||+|||++.........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (256)
T cd08220 82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA 158 (256)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccc
Confidence 999999999876556689999999999999999999998 99999999999999855 46899999999876543322
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
....|+..|+|||.+.+ ...+.++||||||+++|+|++|+.|+....... ....... .....+..
T Consensus 159 ---~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-----~~~~~~~-~~~~~~~~---- 223 (256)
T cd08220 159 ---YTVVGTPCYISPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANLPA-----LVLKIMS-GTFAPISD---- 223 (256)
T ss_pred ---cccccCCcccCchhccC--CCCCcccchHHHHHHHHHHHhCCCCcccCchHH-----HHHHHHh-cCCCCCCC----
Confidence 12358899999999876 367899999999999999999999986543221 1111111 11111111
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
.....+.+++.+||+.+|++|||++|+++.
T Consensus 224 ---~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 224 ---RYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ---CcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 134456788889999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=303.25 Aligned_cols=244 Identities=26% Similarity=0.366 Sum_probs=193.6
Q ss_pred hhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCCh
Q 040604 298 RDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSL 375 (582)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 375 (582)
..+||+|+||.||++... ++..||||.+..... ..+.+.+|+.++++++|+||+++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 367999999999999754 688999999865432 345688999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeecc
Q 040604 376 DKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHA 455 (582)
Q Consensus 376 ~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 455 (582)
.+++... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++......... ....
T Consensus 107 ~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~~ 178 (292)
T cd06658 107 TDIVTHT---RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSL 178 (292)
T ss_pred HHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc--Ccee
Confidence 9988543 488899999999999999999998 9999999999999999999999999998765432221 1123
Q ss_pred cCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHH
Q 040604 456 RGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIA 535 (582)
Q Consensus 456 ~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 535 (582)
.|++.|+|||.+.+ ..++.++||||||++++||++|+.|+........ ...+.......+.. .....
T Consensus 179 ~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~-----~~~~~ 245 (292)
T cd06658 179 VGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA------MRRIRDNLPPRVKD-----SHKVS 245 (292)
T ss_pred ecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhcCCCcccc-----ccccC
Confidence 58999999999865 3678999999999999999999999875432111 11111111111111 11233
Q ss_pred HHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 536 KMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 536 ~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
..+..++.+||+.||.+|||++++++.
T Consensus 246 ~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 246 SVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 456677888999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=299.00 Aligned_cols=255 Identities=25% Similarity=0.329 Sum_probs=196.7
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeC--CeeeEEEEec
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYEN--KKNALIYELM 370 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~E~~ 370 (582)
++.++||.|++|.||++... +++.+|+|.+..... ..+.+.+|+.++++++||||+++++++.+. ...++||||+
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 83 (287)
T cd06621 4 VELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYC 83 (287)
T ss_pred EEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEec
Confidence 34578999999999999764 688999999875443 346789999999999999999999998654 3679999999
Q ss_pred CCCChhhhhhcC--CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 371 PNGSLDKFIHND--RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 371 ~~gsL~~~i~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++........
T Consensus 84 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (287)
T cd06621 84 EGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160 (287)
T ss_pred CCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence 999999887542 334588899999999999999999998 999999999999999999999999999876543221
Q ss_pred ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc
Q 040604 449 AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528 (582)
Q Consensus 449 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 528 (582)
. ...++..|+|||.+.+ ..++.++||||||+++|+|++|+.|+...........+ ....+.......+....
T Consensus 161 ~----~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~- 232 (287)
T cd06621 161 G----TFTGTSFYMAPERIQG--KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIE-LLSYIVNMPNPELKDEP- 232 (287)
T ss_pred c----cccCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHH-HHHHHhcCCchhhccCC-
Confidence 1 2347889999999875 46889999999999999999999999765321111111 11222221111111111
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.........+.+++.+||+.+|++|||+.||++
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 233 GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 111123466788999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=305.03 Aligned_cols=255 Identities=22% Similarity=0.318 Sum_probs=194.8
Q ss_pred hhcCcc--CceEEEEEEeC-CCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 299 DKLGQG--GYGEVYKGELP-DGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 299 ~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
++||+| +||+||++... +|+.||+|++...... .+.+.+|+.+++.++||||+++++++..+...++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 457776 99999999764 7999999998754433 35678899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce--
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI-- 450 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~-- 450 (582)
++|.+++.+.....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999999876555689999999999999999999987 99999999999999999999999998654332211100
Q ss_pred e---eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCC--------
Q 040604 451 S---MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGN-------- 519 (582)
Q Consensus 451 ~---~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~-------- 519 (582)
. .....++..|+|||++.+....++.++||||||++++||++|+.|+......... .+.+....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML-----LQKLKGPPYSPLDITT 235 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH-----HHHhcCCCCCCccccc
Confidence 0 0012356679999998765446789999999999999999999999764322111 01110000
Q ss_pred ------------------------------CCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 520 ------------------------------DFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 520 ------------------------------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
..................+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000001112223445677899999999999999999999973
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=294.87 Aligned_cols=251 Identities=24% Similarity=0.355 Sum_probs=198.4
Q ss_pred HHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEe--CCeeeEEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYE--NKKNALIYE 368 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E 368 (582)
+++.+.||.|+||.||++.. .+++.+|+|+++..... .+.+.+|+.++++++|+||+++++.+.. ....+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 34567899999999999965 47889999998754432 3467889999999999999999998764 346789999
Q ss_pred ecCCCChhhhhhcC--CCcCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecCCCCCCEEEcCCCceEEeecccccccc
Q 040604 369 LMPNGSLDKFIHND--RNIKLEWKTMYQIAIGIARGLEYLHRGC--QVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 369 ~~~~gsL~~~i~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~--~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~ 444 (582)
|+++++|.+++... ....+++..++.++.|++.||.|||..+ ..+++|+||||+||+++.++.+||+|||++....
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~ 161 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG 161 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence 99999999998653 2356899999999999999999999321 2399999999999999999999999999998876
Q ss_pred ccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCC
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFD 524 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 524 (582)
...... ....|++.|+|||++.. ..++.++|+||||+++++|++|+.|+...... .+.+.+..+....+.
T Consensus 162 ~~~~~~--~~~~~~~~~~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~ 231 (265)
T cd08217 162 HDSSFA--KTYVGTPYYMSPEQLNH--MSYDEKSDIWSLGCLIYELCALSPPFTARNQL------QLASKIKEGKFRRIP 231 (265)
T ss_pred CCcccc--cccccCCCccChhhhcC--CCCCchhHHHHHHHHHHHHHHCCCcccCcCHH------HHHHHHhcCCCCCCc
Confidence 543211 23458999999999876 36889999999999999999999998764321 122333333222121
Q ss_pred CcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 525 GVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 525 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
......+.+++.+||+.+|++||++++|++.
T Consensus 232 -------~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 232 -------YRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -------cccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1334567888889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=301.92 Aligned_cols=243 Identities=26% Similarity=0.369 Sum_probs=194.3
Q ss_pred hhcCccCceEEEEEEeC-CCcEEEEEEeccCC-CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCChh
Q 040604 299 DKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR-CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLD 376 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 376 (582)
.+||+|+||.||++... +++.||+|++.... ...+.+.+|+.+++.++||||+++++++..+...++||||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 47999999999999764 78999999986533 33467889999999999999999999999999999999999999999
Q ss_pred hhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeeccc
Q 040604 377 KFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR 456 (582)
Q Consensus 377 ~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 456 (582)
.++.. ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......... .....
T Consensus 107 ~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~~~ 178 (297)
T cd06659 107 DIVSQ---TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLV 178 (297)
T ss_pred HHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccccc--cccee
Confidence 98754 3588999999999999999999988 9999999999999999999999999998765433221 12245
Q ss_pred CCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHH
Q 040604 457 GTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAK 536 (582)
Q Consensus 457 gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 536 (582)
|++.|+|||++.+ ..++.++||||||++++||++|+.|+........ ...+......... ....+..
T Consensus 179 ~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~~~~-----~~~~~~~ 245 (297)
T cd06659 179 GTPYWMAPEVISR--TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA------MKRLRDSPPPKLK-----NAHKISP 245 (297)
T ss_pred cCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHhccCCCCcc-----ccCCCCH
Confidence 8999999999876 3678999999999999999999999875432211 1122211111110 0112334
Q ss_pred HHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 537 MMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 537 ~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
.+.+++.+||+.+|++||++++|++.
T Consensus 246 ~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 246 VLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 56778888999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=293.58 Aligned_cols=246 Identities=27% Similarity=0.346 Sum_probs=189.2
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC------CHHHHHHHHHHHhccCCCceEEEEeEEEeC--CeeeEE
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC------NGEEFINEVASISRTSHVNIVTFLGFCYEN--KKNALI 366 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 366 (582)
...+.||+|+||.||+|... +++.||+|.++.... ..+.+.+|+.++++++|+||+++++++.+. ...+++
T Consensus 5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~ 84 (266)
T cd06651 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF 84 (266)
T ss_pred cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence 44578999999999999654 689999999864321 124578899999999999999999998753 567899
Q ss_pred EEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccc
Q 040604 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~ 446 (582)
|||+++++|.+++.... .+++...+.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 85 MEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 99999999999997543 578899999999999999999987 9999999999999999999999999999865432
Q ss_pred cc-ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCC
Q 040604 447 ES-AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525 (582)
Q Consensus 447 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 525 (582)
.. ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .+...........++
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~- 231 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISG--EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA-----AIFKIATQPTNPQLP- 231 (266)
T ss_pred cccCCccccCCccccccCHHHhCC--CCCCchhhhHHHHHHHHHHHHCCCCccccchHH-----HHHHHhcCCCCCCCc-
Confidence 11 111123458899999999876 368899999999999999999999987543221 111222221112121
Q ss_pred cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 526 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
..+...+..++ +||..+|++||+++||++
T Consensus 232 ------~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 232 ------SHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ------hhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 12223344444 588889999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=292.77 Aligned_cols=247 Identities=26% Similarity=0.382 Sum_probs=198.4
Q ss_pred HHHHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 293 MTKSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
..+.+.++||+|+||.||+|.. .+++.+|+|++..... ..+.+.+|+.++++++|+||+++++.+.++...++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 3455668899999999999965 4789999999865433 235688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++++|.+++... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.........
T Consensus 84 ~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06641 84 LGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchhh
Confidence 9999999998642 588999999999999999999987 9999999999999999999999999998776443221
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
.....|+..|+|||.+.. ..++.++|+||||+++++|++|..|+....... ....+.......+..
T Consensus 158 --~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~---- 223 (277)
T cd06641 158 --RNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPHSELHPMK------VLFLIPKNNPPTLEG---- 223 (277)
T ss_pred --hccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCccchHH------HHHHHhcCCCCCCCc----
Confidence 112358899999999865 367889999999999999999999986533211 112222222222221
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
.+...+.+++.+||+.+|++||+++++++.
T Consensus 224 ---~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 224 ---NYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ---ccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 234556778889999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=294.13 Aligned_cols=242 Identities=28% Similarity=0.341 Sum_probs=186.2
Q ss_pred hcCccCceEEEEEEeC-CCcEEEEEEeccCCCC----HHHHHHHHHHH---hccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 300 KLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN----GEEFINEVASI---SRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 300 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
.||+|+||.||++... +++.+|+|.+...... ...+.+|..++ ...+|+||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999764 6899999998654321 22344554433 33579999999999999899999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
+++|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++........
T Consensus 81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~--- 152 (279)
T cd05633 81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--- 152 (279)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc---
Confidence 999999887543 589999999999999999999998 999999999999999999999999999876543322
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHH
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 531 (582)
....||+.|+|||.+... ..++.++||||+||+++||++|+.||......... .+.... ......+.
T Consensus 153 -~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~-~~~~~~~~------- 219 (279)
T cd05633 153 -HASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMT-LTVNVELP------- 219 (279)
T ss_pred -cCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH---HHHHHh-hcCCcCCc-------
Confidence 123599999999988642 35789999999999999999999999654332211 111111 11111111
Q ss_pred HHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 040604 532 KKIAKMMILVGFWCIQTNPSERP-----SMHKVLEM 562 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~~ 562 (582)
..+...+.+++.+||+.||++|| +++++++.
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 220 DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 12345667778889999999999 69999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=297.06 Aligned_cols=255 Identities=22% Similarity=0.334 Sum_probs=192.6
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC--CHHHHHHHHHHHhccC-CCceEEEEeEEEeC--CeeeEEEEe
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC--NGEEFINEVASISRTS-HVNIVTFLGFCYEN--KKNALIYEL 369 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~E~ 369 (582)
.+.++||+|+||.||+|... +++.+|+|+++.... ......+|+.++.++. |+|++++++++.+. +..++||||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 35678999999999999754 789999999876432 2334567888998885 99999999999987 888999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
++ ++|.+.+.... ..+++..++.++.|++.||+|||+. +++||||||+||+++. +.+||+|||+++........
T Consensus 82 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 82 MD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred CC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence 95 68887776533 3689999999999999999999998 9999999999999999 99999999999876543322
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHH----------HHHhhcCCC
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNL----------IYERIEPGN 519 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~----------~~~~i~~~~ 519 (582)
....++..|+|||++... +.++.++|||||||++|||++|..||........ .... +.+......
T Consensus 156 ---~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 156 ---TEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ-IAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred ---CCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH-HHHHHHHcCCCCHHHHHhhcccc
Confidence 123488999999987543 4578899999999999999999999965432211 0000 011111100
Q ss_pred --CCCCCCcC----cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 520 --DFQFDGVA----TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 520 --~~~~~~~~----~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
...+.... ......+...+.+++.+||+.+|++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 01111111 1112245678899999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=297.86 Aligned_cols=258 Identities=23% Similarity=0.269 Sum_probs=191.1
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
+.+.++||+|+||.||+|... +|+.||+|++..... ....+.+|+.++++++|+||+++++++.++...++||||+.
T Consensus 7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07870 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH 86 (291)
T ss_pred eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence 345678999999999999654 789999999865432 23467899999999999999999999999999999999995
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
++|.+++.... ..+++..+..++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||+++........
T Consensus 87 -~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-- 159 (291)
T cd07870 87 -TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT-- 159 (291)
T ss_pred -CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC--
Confidence 77777665432 3577888899999999999999998 9999999999999999999999999999764332211
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhc--------------C
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIE--------------P 517 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~--------------~ 517 (582)
.....+++.|+|||++.+. ..++.++||||||+++|||++|+.||.........+...+ ..+. .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW-TVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHH-HHcCCCChhhhhhhhhccc
Confidence 1223478999999998653 3578899999999999999999999975543221111110 0000 0
Q ss_pred CCCCCCCCcCcHHHH------HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 518 GNDFQFDGVATEEEK------KIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 518 ~~~~~~~~~~~~~~~------~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.....+......... .....+.+++.+|++.||++|||+++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000000 11345677888999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=300.05 Aligned_cols=257 Identities=24% Similarity=0.353 Sum_probs=197.1
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
++.++||.|++|.||+|... +|..||+|++..... ..+.+.+|+.++++++|+|++++++++.+....+++|||+
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~- 80 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL- 80 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc-
Confidence 35678999999999999754 799999999865432 2357889999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
+++|.+++.......+++..++.++.|+++||+|||+. +++||||+|+||+++.++.+||+|||++.........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-- 155 (283)
T cd07835 81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-- 155 (283)
T ss_pred CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc--
Confidence 57999998766545789999999999999999999997 9999999999999999999999999999765433221
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCC-----------C
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGN-----------D 520 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~-----------~ 520 (582)
.....+++.|+|||++.+. ..++.++||||||+++|+|++|+.||......... ...... ..... .
T Consensus 156 ~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQL-FRIFRT-LGTPDEDVWPGVTSLPD 232 (283)
T ss_pred cCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHH-hCCCChHHhhhhhhchh
Confidence 1223478899999988653 35688999999999999999999998654322111 111100 00000 0
Q ss_pred --CCCCC----cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 521 --FQFDG----VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 521 --~~~~~----~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
..+.. ........+...+.+++.+||+.+|++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000 000111223466788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=303.45 Aligned_cols=260 Identities=25% Similarity=0.310 Sum_probs=195.1
Q ss_pred HHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccC---CCCHHHHHHHHHHHhcc-CCCceEEEEeEEEeC--CeeeE
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNS---RCNGEEFINEVASISRT-SHVNIVTFLGFCYEN--KKNAL 365 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~~l 365 (582)
..+.+.+.||+|+||.||+|... +++.+|+|++... ......+.+|+.+++++ +|+||+++++++... ...++
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 45667789999999999999765 6889999988542 22335677899999999 999999999998654 36799
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
||||++ ++|..++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 87 v~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 87 VFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred Eecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 999995 6998888653 678889999999999999999987 999999999999999999999999999987654
Q ss_pred cccc---eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHH----------
Q 040604 446 KESA---ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIY---------- 512 (582)
Q Consensus 446 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---------- 512 (582)
.... .......||+.|+|||++.+. ..++.++||||||+++|+|++|+.||........ ......
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHH
Confidence 3221 122234589999999988653 4678899999999999999999999865432211 000000
Q ss_pred ---------HhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 513 ---------ERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 513 ---------~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
..+........ .........+...+.+++.+||+.+|++|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPR-KPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccc-cchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000000 00011111245678889999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=290.54 Aligned_cols=245 Identities=29% Similarity=0.418 Sum_probs=196.0
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC------CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEE
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC------NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 368 (582)
...+.||+|++|.||+|... +++.|++|.+..... ..+.+.+|+.++++++|+||+++++++.+....+++||
T Consensus 3 ~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (258)
T cd06632 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLE 82 (258)
T ss_pred cccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEE
Confidence 34578999999999999765 799999999865431 23568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
|+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~ 157 (258)
T cd06632 83 LVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF 157 (258)
T ss_pred ecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecccccc
Confidence 999999999997643 588999999999999999999998 999999999999999999999999999887544331
Q ss_pred ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc
Q 040604 449 AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528 (582)
Q Consensus 449 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 528 (582)
.....|++.|++||.+... ..++.++|+||||+++|+|++|+.|+....... .+...........+..
T Consensus 158 ---~~~~~~~~~y~~pe~~~~~-~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~--- 225 (258)
T cd06632 158 ---AKSFKGSPYWMAPEVIAQQ-GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA-----AVFKIGRSKELPPIPD--- 225 (258)
T ss_pred ---ccccCCCcceeCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH-----HHHHHHhcccCCCcCC---
Confidence 1234589999999998653 238899999999999999999999987654211 1111111111111111
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.+...+.+++.+||+.+|++||+++++++
T Consensus 226 ----~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 226 ----HLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ----CcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 22355667788899999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=303.08 Aligned_cols=252 Identities=20% Similarity=0.264 Sum_probs=195.6
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC----CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
.+.+.||+|+||.||++... +++.||+|.+..... ..+.+.+|+.+++.++||||+++++.+..+...++||||+
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (305)
T cd05609 4 ETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYV 83 (305)
T ss_pred eEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecC
Confidence 45678999999999999765 688999999865432 2346789999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc---
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE--- 447 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~--- 447 (582)
+|++|.+++...+ .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 84 ~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 84 EGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 9999999997643 588999999999999999999997 99999999999999999999999999987421110
Q ss_pred ----------cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcC
Q 040604 448 ----------SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEP 517 (582)
Q Consensus 448 ----------~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~ 517 (582)
.........|+..|+|||.+.. ..++.++|+||||+++|||++|..|+....... +...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~------~~~~~~~ 230 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQVIS 230 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh
Confidence 0001112357889999999876 368899999999999999999999986542211 1122111
Q ss_pred CCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 518 GNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
+.. .... ........+.+++.+||+.+|++||++.++.+.|+.
T Consensus 231 ~~~-~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 231 DDI-EWPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ccc-CCCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 110 0000 011234557788889999999999997667666665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=298.27 Aligned_cols=258 Identities=20% Similarity=0.260 Sum_probs=195.3
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeC--CeeeEEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYEN--KKNALIY 367 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 367 (582)
.+.+.+.||+|+||.||+|... +++.+|+|.++.... ....+.+|+.++++++||||+++++++... ...++||
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 3566789999999999999765 688999999975432 234567899999999999999999999877 7899999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
||++ ++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+|||++.++.+||+|||++.......
T Consensus 86 e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 86 EYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred hhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 9996 59988887543 3689999999999999999999998 99999999999999999999999999998765542
Q ss_pred cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhc-----------
Q 040604 448 SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIE----------- 516 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~----------- 516 (582)
.. .....+++.|+|||.+.+. ..++.++|+||||++++||++|+.|+........ .... .....
T Consensus 161 ~~--~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 161 KP--YTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ-LNKI-FKLLGTPTEKIWPGFS 235 (293)
T ss_pred cc--cccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHH-HHHhCCCchHHHHHhh
Confidence 21 1223578899999998653 3468899999999999999999999875433211 1100 00000
Q ss_pred ---CCCCCCCCCcCc----HHHHH--HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 517 ---PGNDFQFDGVAT----EEEKK--IAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 517 ---~~~~~~~~~~~~----~~~~~--~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
............ ..... +...+.+++.+||+.+|++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000000 00001 3556778889999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=298.39 Aligned_cols=240 Identities=27% Similarity=0.393 Sum_probs=195.3
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.+.+.||+|+||.||++... +++.+|+|+++... ...+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 345688999999999999765 68999999986533 2345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+|||++.++.+||+|||+++......
T Consensus 83 ~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~-- 155 (290)
T cd05580 83 VPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT-- 155 (290)
T ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCCC--
Confidence 9999999999765 3688999999999999999999997 99999999999999999999999999998765442
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
....|++.|+|||.+... ..+.++||||||+++++|++|+.|+...... ...+.+..+. ..++..
T Consensus 156 ---~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~-~~~~~~--- 220 (290)
T cd05580 156 ---YTLCGTPEYLAPEIILSK--GYGKAVDWWALGILIYEMLAGYPPFFDDNPI------QIYEKILEGK-VRFPSF--- 220 (290)
T ss_pred ---CCCCCCccccChhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhcCC-ccCCcc---
Confidence 234589999999998763 6788999999999999999999998654321 1122222221 112221
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCC-----CHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERP-----SMHKVL 560 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl 560 (582)
+...+.+++.+||+.||++|| ++++++
T Consensus 221 ----~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 221 ----FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred ----CCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 234566778889999999999 777776
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=297.36 Aligned_cols=245 Identities=27% Similarity=0.361 Sum_probs=193.7
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC----CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.+.++||+|+||+||+|... +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 96 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY 96 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence 556688999999999999764 789999999864332 124688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+. |+|.+++.... ..+++..+..++.|++.||.|||+. +|+||||+|+||++++++.+||+|||++.......
T Consensus 97 ~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~-- 169 (307)
T cd06607 97 CL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN-- 169 (307)
T ss_pred hC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCCC--
Confidence 95 67777765432 3689999999999999999999987 99999999999999999999999999987654332
Q ss_pred eeeecccCCccccccccccc-ccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc
Q 040604 450 ISMLHARGTIGYIAPEVYSR-RFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~-~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 528 (582)
...|++.|+|||++.. ..+.++.++||||||+++|||++|+.|+....... .+.. +.......+.
T Consensus 170 ----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~-----~~~~-~~~~~~~~~~---- 235 (307)
T cd06607 170 ----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----ALYH-IAQNDSPTLS---- 235 (307)
T ss_pred ----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH-----HHHH-HhcCCCCCCC----
Confidence 2348889999998742 12468889999999999999999999986543221 1111 1111111111
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
.......+.+++.+||+.+|++||++.+|+..
T Consensus 236 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 236 --SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 11244567888899999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=293.21 Aligned_cols=247 Identities=24% Similarity=0.393 Sum_probs=198.1
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC---CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR---CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
.+.+.||+|+||.||++... +|..+|+|.+.... ...+.+.+|+.++++++|+||+++++.+.+....++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (257)
T cd08225 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCD 82 (257)
T ss_pred eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCC
Confidence 45678999999999999765 68899999986542 234578899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-ceEEeeccccccccccccce
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF-CPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~-~vkl~DFGla~~~~~~~~~~ 450 (582)
+++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||++++++ .+||+|||.+..........
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (257)
T cd08225 83 GGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA 159 (257)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence 99999999876555689999999999999999999998 999999999999999885 46999999998765433221
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHH
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 530 (582)
....|++.|+|||++.. ..++.++|+||||++++||++|+.|+...... ..+.+..... .....
T Consensus 160 --~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~-~~~~~------ 223 (257)
T cd08225 160 --YTCVGTPYYLSPEICQN--RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH-----QLVLKICQGY-FAPIS------ 223 (257)
T ss_pred --cccCCCccccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHhccc-CCCCC------
Confidence 12358999999998875 36889999999999999999999998654221 1222222211 11111
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 531 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
......+.+++.+||+.+|++|||+++|++.
T Consensus 224 -~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 224 -PNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1223457788889999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=299.89 Aligned_cols=257 Identities=19% Similarity=0.243 Sum_probs=194.6
Q ss_pred hhhhcCccCceEEEEEEeCCCcEEEEEEeccC---CCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCC
Q 040604 297 FRDKLGQGGYGEVYKGELPDGQLVAVKVLKNS---RCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNG 373 (582)
Q Consensus 297 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 373 (582)
+.+.+|.|+++.|+++.. +++.||||+++.. ....+.+.+|+.++++++|+||+++++++.+.+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 345566666666666655 7999999998754 223467889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc----
Q 040604 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA---- 449 (582)
Q Consensus 374 sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~---- 449 (582)
+|.+++.......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+.........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 999999876555789999999999999999999998 9999999999999999999999999988765432111
Q ss_pred -eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCC------
Q 040604 450 -ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQ------ 522 (582)
Q Consensus 450 -~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~------ 522 (582)
.......++..|+|||++......++.++||||||+++|||++|+.||......... .+.+.......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML-----LEKVRGTVPCLLDKSTY 236 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHhccCccccccCch
Confidence 111223478899999998764346789999999999999999999999754322211 11111000000
Q ss_pred -------------------CCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 523 -------------------FDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 523 -------------------~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
...........+...+.+++.+||+.||++|||++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000111122344567889999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=292.57 Aligned_cols=252 Identities=25% Similarity=0.443 Sum_probs=199.2
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
+...+.||+|+||.||+|... +++.+|+|+++.... ..+.+.+|+.++++++|+||+++++.+......++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 345678999999999999754 789999999976654 3467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
++++|.+++.... .+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.+||+|||++..........
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 82 SGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 9999999997643 478889999999999999999998 99999999999999999999999999998765433221
Q ss_pred e--eecccCCccccccccccccc-CCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcC
Q 040604 451 S--MLHARGTIGYIAPEVYSRRF-GGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527 (582)
Q Consensus 451 ~--~~~~~gt~~y~aPE~~~~~~-~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 527 (582)
. .....+++.|+|||++.... ...+.++||||||++++||++|+.||........ ... .+..+....++.
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~----~~~-~~~~~~~~~~~~-- 229 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ----IMF-HVGAGHKPPIPD-- 229 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH----HHH-HHhcCCCCCCCc--
Confidence 1 11245889999999987642 2378899999999999999999999965432211 111 111121222211
Q ss_pred cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 528 TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 528 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.......+.+++.+||+.+|++||++.+++.
T Consensus 230 ---~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 230 ---SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ---ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1122455667888999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=302.43 Aligned_cols=262 Identities=22% Similarity=0.319 Sum_probs=193.9
Q ss_pred HHhhhhcCccCceEEEEEEeC---CCcEEEEEEeccCC----CCHHHHHHHHHHHhccCCCceEEEEeEEEeC--CeeeE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP---DGQLVAVKVLKNSR----CNGEEFINEVASISRTSHVNIVTFLGFCYEN--KKNAL 365 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 365 (582)
+.+.++||+|+||.||+|... +++.||+|.+.... ...+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 345678999999999999764 47899999997632 2346678899999999999999999999988 78899
Q ss_pred EEEecCCCChhhhhhcC---CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC----CCceEEeecc
Q 040604 366 IYELMPNGSLDKFIHND---RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE----DFCPKISDFG 438 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~----~~~vkl~DFG 438 (582)
||||++ ++|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 999995 5676666432 223688999999999999999999998 9999999999999999 9999999999
Q ss_pred cccccccccc-ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccc----hhhHH---
Q 040604 439 LAKQAQKKES-AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTS----ICHNL--- 510 (582)
Q Consensus 439 la~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~----~~~~~--- 510 (582)
+++....... ........+|+.|+|||++.+. ..++.++||||||+++++|++|+.|+........ .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 9987644322 1112234588999999987653 3578899999999999999999999875433220 00000
Q ss_pred HHHhhcCCC------------------CCCCCCcCcHHHH-------HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 511 IYERIEPGN------------------DFQFDGVATEEEK-------KIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 511 ~~~~i~~~~------------------~~~~~~~~~~~~~-------~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
+.+.+.... ............. .....+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 001110000 0000000000000 23346788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=306.70 Aligned_cols=271 Identities=24% Similarity=0.318 Sum_probs=199.0
Q ss_pred HHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCC--CCHHHHHHHHHHHhccCCCceEEEEeEEEeCC-----eeeEE
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSR--CNGEEFINEVASISRTSHVNIVTFLGFCYENK-----KNALI 366 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv 366 (582)
+.+.++||+|+||.||+|.. .+|+.||+|+++... .....+.+|+.++++++|+||+++++++.... ..++|
T Consensus 7 y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 86 (336)
T cd07849 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIV 86 (336)
T ss_pred eEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEE
Confidence 44568899999999999965 478999999986432 23456888999999999999999999876543 47899
Q ss_pred EEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccc
Q 040604 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~ 446 (582)
|||+. ++|..++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 87 ~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 87 QELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred ehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 99995 688877754 3589999999999999999999998 9999999999999999999999999999875433
Q ss_pred ccce-eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCC-----
Q 040604 447 ESAI-SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND----- 520 (582)
Q Consensus 447 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~----- 520 (582)
.... ......||+.|+|||.+.+. ..++.++||||||+++++|++|+.||........ . ..+...+.....
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~-~-~~~~~~~~~~~~~~~~~ 236 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ-L-NLILGVLGTPSQEDLNC 236 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-H-HHHHHHcCCCCHHHHHH
Confidence 2211 11234589999999987543 4678999999999999999999999865422110 0 001111110000
Q ss_pred ------------CCCCCcCc--HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcccCCCCCCCC
Q 040604 521 ------------FQFDGVAT--EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM--LEGSIENLQIPPK 575 (582)
Q Consensus 521 ------------~~~~~~~~--~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~--Le~~~~~~~~p~~ 575 (582)
........ .........+.+++.+||+.+|++|||+.++++. ++...+....|..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~ 307 (336)
T cd07849 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVA 307 (336)
T ss_pred hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccC
Confidence 00000000 0011234668899999999999999999999986 7766554443433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=294.69 Aligned_cols=248 Identities=30% Similarity=0.429 Sum_probs=200.7
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCC
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNG 373 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 373 (582)
+.+.+.||+|++|.||+|... ++..+|+|+++......+.+.+|+..+++++|+|++++++.+......++|+||++++
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 100 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGG 100 (286)
T ss_pred chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCC
Confidence 445678999999999999776 6889999999765545677899999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeee
Q 040604 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISML 453 (582)
Q Consensus 374 sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 453 (582)
+|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++......... ..
T Consensus 101 ~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~ 174 (286)
T cd06614 101 SLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK--RN 174 (286)
T ss_pred cHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh--hc
Confidence 9999998654 4689999999999999999999997 9999999999999999999999999998765443221 11
Q ss_pred cccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHH
Q 040604 454 HARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKK 533 (582)
Q Consensus 454 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 533 (582)
...+++.|++||++.+. .++.++|+||||+++|+|++|+.|+........ .. .+........ .....
T Consensus 175 ~~~~~~~y~~PE~~~~~--~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~-----~~-~~~~~~~~~~-----~~~~~ 241 (286)
T cd06614 175 SVVGTPYWMAPEVIKRK--DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA-----LF-LITTKGIPPL-----KNPEK 241 (286)
T ss_pred cccCCcccCCHhHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH-----HH-HHHhcCCCCC-----cchhh
Confidence 23488999999998763 678999999999999999999999865433211 11 1111111111 11122
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 534 IAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 534 ~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
+...+.+++.+||+.+|.+||++.+|++
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 242 WSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 4456788899999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=292.80 Aligned_cols=246 Identities=25% Similarity=0.321 Sum_probs=189.0
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC------CHHHHHHHHHHHhccCCCceEEEEeEEEeC--CeeeEE
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC------NGEEFINEVASISRTSHVNIVTFLGFCYEN--KKNALI 366 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 366 (582)
.+.+.||+|+||.||+|... +++.||||.+..... ..+.+.+|+.++++++|+||+++++++.+. ...+++
T Consensus 5 ~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (265)
T cd06652 5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIF 84 (265)
T ss_pred eEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEE
Confidence 34578999999999999764 689999998853221 124678899999999999999999998764 457899
Q ss_pred EEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccc
Q 040604 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~ 446 (582)
|||+++++|.+++.... .+++....+++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 85 MEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 99999999999987543 578888999999999999999998 9999999999999999999999999999865432
Q ss_pred ccc-eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCC
Q 040604 447 ESA-ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525 (582)
Q Consensus 447 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 525 (582)
... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.|+........ +.+..........
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~-- 230 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISG--EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA-----IFKIATQPTNPVL-- 230 (265)
T ss_pred cccccccccCCCCccccChhhhcC--CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH-----HHHHhcCCCCCCC--
Confidence 111 11123458999999999876 3678999999999999999999999865422111 1111111111111
Q ss_pred cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 526 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
...+...+.+++.+|+. +|++||++++|++
T Consensus 231 -----~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 231 -----PPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -----chhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 12334455666677774 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=298.98 Aligned_cols=258 Identities=23% Similarity=0.328 Sum_probs=194.5
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
+++.++||+|++|+||+|... +|+.||+|.+..... ..+.+.+|+.++++++|+||+++++++.+....++||||+
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence 345678999999999999765 789999999865432 2356889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-CCceEEeeccccccccccccc
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE-DFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~-~~~vkl~DFGla~~~~~~~~~ 449 (582)
+ ++|.+++.......+++..+..++.||+.||+|||+. +++|+||||+||+++. ++.+||+|||++.........
T Consensus 84 ~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 84 D-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (294)
T ss_pred c-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence 5 6888887665555578889999999999999999998 9999999999999985 567999999999765432211
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCC------
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQF------ 523 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~------ 523 (582)
.....|++.|+|||++.+. ..++.++||||||+++|+|++|+.|+.......... ... ..+.......+
T Consensus 160 --~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 160 --FTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF-KIF-RILGTPNEETWPGVTSL 234 (294)
T ss_pred --cccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHH-HHhCCCChhhccccccc
Confidence 1223578999999988653 357889999999999999999999987543322111 110 11111000000
Q ss_pred -------CCcCc----HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 524 -------DGVAT----EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 524 -------~~~~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
..... .....+...+.+++.+||+.+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 001123456788899999999999999999986
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=298.89 Aligned_cols=258 Identities=23% Similarity=0.312 Sum_probs=193.4
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC---CHHHHHHHHHHHhccC-CCceEEEEeEEEeCCe-----ee
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC---NGEEFINEVASISRTS-HVNIVTFLGFCYENKK-----NA 364 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----~~ 364 (582)
+++.+.||+|+||.||+|... +++.||+|+++.... ....+.+|+.++++++ |+||+++++++...+. .+
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 345678999999999999764 789999999865432 2357888999999995 6999999999987665 79
Q ss_pred EEEEecCCCChhhhhhcCC---CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-CCceEEeecccc
Q 040604 365 LIYELMPNGSLDKFIHNDR---NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE-DFCPKISDFGLA 440 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~-~~~vkl~DFGla 440 (582)
+||||+++ +|.+++.... ...+++..++.++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccc
Confidence 99999974 8888876532 34689999999999999999999998 9999999999999998 899999999999
Q ss_pred ccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCC
Q 040604 441 KQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND 520 (582)
Q Consensus 441 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~ 520 (582)
+........ .....+++.|+|||++.+. ..++.++||||||+++|+|++|..||.......... . +...+.....
T Consensus 159 ~~~~~~~~~--~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~-~-~~~~~~~~~~ 233 (295)
T cd07837 159 RAFSIPVKS--YTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL-H-IFKLLGTPTE 233 (295)
T ss_pred eecCCCccc--cCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH-H-HHHHhCCCCh
Confidence 865432221 1223478899999988653 357899999999999999999999987543322111 1 1111111100
Q ss_pred CCC------------CCcC----cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 521 FQF------------DGVA----TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 521 ~~~------------~~~~----~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
... .... ......+...+.+++.+||+.||++||+++|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 0000 0111234567888999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=295.07 Aligned_cols=249 Identities=26% Similarity=0.392 Sum_probs=191.1
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC--HHHHHHHHHH-HhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN--GEEFINEVAS-ISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
.+.+.||+|+||.||++... +|+.||+|.++..... ...+..|+.+ ++.++||||+++++++..+...+++|||++
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (283)
T cd06617 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD 83 (283)
T ss_pred eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc
Confidence 45678999999999999765 7999999998765332 3345566664 666799999999999999999999999995
Q ss_pred CCChhhhhhcC--CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 372 NGSLDKFIHND--RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 372 ~gsL~~~i~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
|+|.+++... ....+++..++.++.|++.||+|||++ .+++||||||+|||++.++.+||+|||++........
T Consensus 84 -~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (283)
T cd06617 84 -TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA- 159 (283)
T ss_pred -ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccccc-
Confidence 7888877542 234689999999999999999999974 3899999999999999999999999999987543221
Q ss_pred eeeecccCCcccccccccccc--cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcC
Q 040604 450 ISMLHARGTIGYIAPEVYSRR--FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~--~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 527 (582)
.....|+..|+|||.+.+. ...++.++|+||||+++|||++|+.|+......... +...+. .....+.
T Consensus 160 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~-~~~~~~~--- 229 (283)
T cd06617 160 --KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ----LKQVVE-EPSPQLP--- 229 (283)
T ss_pred --cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHH----HHHHHh-cCCCCCC---
Confidence 1224588999999988542 134688999999999999999999998654322111 111111 1111111
Q ss_pred cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 528 TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 528 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
...+...+.+++.+||+.+|++||++++|++
T Consensus 230 ---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 230 ---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0123456778888999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=294.91 Aligned_cols=257 Identities=25% Similarity=0.322 Sum_probs=197.0
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC---CCHHHHHHHHHHHhccCCCceEEEEeEEEeC--CeeeEEEEe
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR---CNGEEFINEVASISRTSHVNIVTFLGFCYEN--KKNALIYEL 369 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~E~ 369 (582)
++.++||+|++|.||+|... +++.+|+|++.... .....+.+|+.++++++|+|++++++++.+. ...++||||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 34578999999999999765 58899999997653 2345688999999999999999999999988 789999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
++ ++|.+++.... ..+++..++.++.|+++||+|||+. +++|+||||+||++++++.+||+|||++.........
T Consensus 82 ~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 82 MD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred cc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 96 58888886542 4689999999999999999999997 9999999999999999999999999999876554321
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCC------
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQF------ 523 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~------ 523 (582)
......++..|+|||.+.+. ..++.++||||||+++|||++|+.|+........ .. .+.+..........
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 157 -DYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ-LE-KIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred -cccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HH-HHHHHhCCCchhhccccccc
Confidence 12234578899999987653 3578999999999999999999999875543211 11 11111110000000
Q ss_pred ------------CCcCcHHHHH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 524 ------------DGVATEEEKK-IAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 524 ------------~~~~~~~~~~-~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.....+.... +...+.+++.+||+.+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000011112 2567889999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=292.06 Aligned_cols=250 Identities=26% Similarity=0.415 Sum_probs=195.7
Q ss_pred HhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCC-------CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEE
Q 040604 296 SFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRC-------NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 367 (582)
...+.||+|++|.||++.. .+++.+|+|++..... ..+.+.+|+.++++++|+||+++++++.+.+..++||
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 82 (268)
T cd06630 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82 (268)
T ss_pred cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEE
Confidence 3457899999999999965 5789999999865331 1356889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-ceEEeecccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF-CPKISDFGLAKQAQKK 446 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~-~vkl~DFGla~~~~~~ 446 (582)
||+++++|.+++...+ ++++..+..++.|++.||+|||+. +++|+||||+||+++.++ .+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 83 EWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred eccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 9999999999997543 688999999999999999999998 999999999999998776 5999999999876543
Q ss_pred ccce--eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCC
Q 040604 447 ESAI--SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFD 524 (582)
Q Consensus 447 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 524 (582)
.... ......||..|+|||.+.+ ..++.++||||+|+++++|++|+.|+........ ...+.+........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~--- 230 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRG--EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH--LALIFKIASATTAP--- 230 (268)
T ss_pred cccCCccccccccccceeCHhHhcc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch--HHHHHHHhccCCCC---
Confidence 2111 1112358899999999865 3678999999999999999999999864432211 11111111111111
Q ss_pred CcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 525 GVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 525 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.....+...+.+++.+||+.+|++||++.+++.
T Consensus 231 ----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 231 ----SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ----CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 111234566778888999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=293.85 Aligned_cols=243 Identities=28% Similarity=0.345 Sum_probs=192.1
Q ss_pred cCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCCh
Q 040604 301 LGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSL 375 (582)
Q Consensus 301 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 375 (582)
||+|+||+||++... +|+.+|+|++.... .....+.+|+.++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 799999999999654 78999999986532 1234567899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeecc
Q 040604 376 DKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHA 455 (582)
Q Consensus 376 ~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 455 (582)
.+++.......+++..++.++.|++.||.|||+. +++||||+|+||++++++.+||+|||++......... ...
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI---KGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcc---ccc
Confidence 9999876555789999999999999999999998 9999999999999999999999999998865442221 123
Q ss_pred cCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHH
Q 040604 456 RGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIA 535 (582)
Q Consensus 456 ~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 535 (582)
.++..|+|||++.+. .++.++||||||+++++|++|+.||........ ...+.+.+... ..... ..+.
T Consensus 155 ~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~-~~~~~-------~~~~ 222 (277)
T cd05577 155 AGTPGYMAPEVLQGE--VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE--KEELKRRTLEM-AVEYP-------DKFS 222 (277)
T ss_pred cCCCCcCCHHHhcCC--CCCchhhhHHHHHHHHHHhhCCCCCCCCccccc--HHHHHhccccc-cccCC-------ccCC
Confidence 588899999998763 588999999999999999999999965443211 11111111111 11111 1224
Q ss_pred HHHHHHHHhccccCCCCCC-----CHHHHHH
Q 040604 536 KMMILVGFWCIQTNPSERP-----SMHKVLE 561 (582)
Q Consensus 536 ~~l~~l~~~Cl~~dp~~RP-----t~~evl~ 561 (582)
..+.+++.+||+.+|++|| ++.++++
T Consensus 223 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 223 PEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 5567788889999999999 7777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=287.35 Aligned_cols=247 Identities=28% Similarity=0.398 Sum_probs=200.7
Q ss_pred hhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeC--CeeeEEEEec
Q 040604 297 FRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYEN--KKNALIYELM 370 (582)
Q Consensus 297 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~E~~ 370 (582)
..+.||+|++|.||+|... +++.+++|++..... ..+.+.+|+.++++++|+||+++++.+.+. ...++||||+
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 83 (260)
T cd06606 4 RGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYV 83 (260)
T ss_pred eeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEec
Confidence 4478999999999999766 799999999876553 356788999999999999999999999988 8899999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
++++|.+++.... .+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||.+..........
T Consensus 84 ~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 84 SGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence 9999999997654 789999999999999999999997 99999999999999999999999999998876554311
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHH
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 530 (582)
......++..|+|||.+... ..+.++||||||+++++|++|..|+....... ..+...........+.
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~------ 226 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGE--EYGRAADIWSLGCTVIEMATGKPPWSELGNPM----AALYKIGSSGEPPEIP------ 226 (260)
T ss_pred cccCCCCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCchH----HHHHhccccCCCcCCC------
Confidence 12234588999999998763 58899999999999999999999997654211 1111111111111111
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 531 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
..+...+.+++.+||+.+|++||++.+++.
T Consensus 227 -~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 227 -EHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred -cccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 122566788888999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=289.09 Aligned_cols=249 Identities=25% Similarity=0.370 Sum_probs=201.8
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
++.+.||+|++|.||++... +++.+|||++..... ..+.+.+|+..+.+++|+|++++++++......++||||+++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDG 83 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCC
Confidence 45688999999999999765 599999999876543 356789999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHR-GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
++|.+++... ..+++..++.++.|+++||+|||+ . +++|+||+|+||+++.++.++|+|||++..........
T Consensus 84 ~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~- 157 (264)
T cd06623 84 GSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC- 157 (264)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc-
Confidence 9999999764 468999999999999999999998 7 99999999999999999999999999998765443321
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHH
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 531 (582)
....++..|+|||.+.. ..++.++|+||||+++|+|++|+.|+....... ..+.+ +.+.......+...
T Consensus 158 -~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~-~~~~~~~~~~~~~~----- 226 (264)
T cd06623 158 -NTFVGTVTYMSPERIQG--ESYSYAADIWSLGLTLLECALGKFPFLPPGQPS--FFELM-QAICDGPPPSLPAE----- 226 (264)
T ss_pred -cceeecccccCHhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCccccccC--HHHHH-HHHhcCCCCCCCcc-----
Confidence 12358899999999876 378899999999999999999999987654211 11112 12222111111111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 532 KKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
.+...+.+++.+||+.+|++||++.++++.
T Consensus 227 -~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 227 -EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 144667888888999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=297.48 Aligned_cols=248 Identities=27% Similarity=0.392 Sum_probs=198.5
Q ss_pred HHHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCC-CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 294 TKSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSR-CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
++.+.+.||+|+||.||++.. .++..+|+|.+.... ...+.+.+|+.++++++||||+++++.+...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 99 (293)
T cd06647 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLA 99 (293)
T ss_pred hceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCC
Confidence 455668899999999999965 478899999986433 334678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
+++|.+++.+. .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++..........
T Consensus 100 ~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~- 172 (293)
T cd06647 100 GGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR- 172 (293)
T ss_pred CCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccccc-
Confidence 99999998653 478899999999999999999998 99999999999999999999999999987654433221
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHH
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 531 (582)
....|++.|+|||.+.. ..++.++||||||+++|+|++|+.||......... ......+ ...+. ..
T Consensus 173 -~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~-----~~~~~~~-~~~~~-----~~ 238 (293)
T cd06647 173 -STMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-----YLIATNG-TPELQ-----NP 238 (293)
T ss_pred -ccccCChhhcCchhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe-----eehhcCC-CCCCC-----Cc
Confidence 22358899999999876 46789999999999999999999999754332211 0001111 11110 11
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 532 KKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
..+...+.+++.+||+.+|++||++.+++..
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2344567788899999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=296.83 Aligned_cols=248 Identities=26% Similarity=0.351 Sum_probs=195.0
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC----HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN----GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+...+.||+|+||.||++... ++..+|+|++...... ...+.+|+.++++++|+|++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 455678999999999999754 7899999998654322 24678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
++ |+|.+++... ..++++..+..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||++.......
T Consensus 107 ~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~-- 179 (317)
T cd06635 107 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN-- 179 (317)
T ss_pred CC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCcc--
Confidence 96 5777776543 23689999999999999999999998 99999999999999999999999999987644322
Q ss_pred eeeecccCCccccccccccc-ccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc
Q 040604 450 ISMLHARGTIGYIAPEVYSR-RFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~-~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 528 (582)
...|++.|+|||++.. ..+.++.++|||||||++|||++|+.|+........ ........ .....
T Consensus 180 ----~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-----~~~~~~~~-~~~~~---- 245 (317)
T cd06635 180 ----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQNE-SPTLQ---- 245 (317)
T ss_pred ----cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-----HHHHHhcc-CCCCC----
Confidence 2358899999999742 124678999999999999999999999865432211 11111111 11111
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
.......+.+++.+||+.+|.+||++.+|++.+..
T Consensus 246 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 246 --SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred --CccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 11234557788889999999999999999986654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=297.81 Aligned_cols=254 Identities=19% Similarity=0.264 Sum_probs=183.2
Q ss_pred HHHhhhhcCccCceEEEEEEeCC----CcEEEEEEeccCCCCH--H----------HHHHHHHHHhccCCCceEEEEeEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELPD----GQLVAVKVLKNSRCNG--E----------EFINEVASISRTSHVNIVTFLGFC 357 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~--~----------~~~~E~~~l~~l~h~niv~l~~~~ 357 (582)
.+.+.++||+|+||+||+|...+ +..+|+|+........ + ....+...+..+.|+|++++++.+
T Consensus 13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~ 92 (294)
T PHA02882 13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG 92 (294)
T ss_pred ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence 45567899999999999997653 4567777654322211 1 123344556678999999999977
Q ss_pred EeCC----eeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceE
Q 040604 358 YENK----KNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPK 433 (582)
Q Consensus 358 ~~~~----~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vk 433 (582)
.... ..++++|++ ..++.+.+.... ..++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+|
T Consensus 93 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 93 SFKRCRMYYRFILLEKL-VENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred eEecCCceEEEEEEehh-ccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEE
Confidence 6543 336788887 456666665432 357788899999999999999998 999999999999999999999
Q ss_pred Eeeccccccccccccc-----eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhh
Q 040604 434 ISDFGLAKQAQKKESA-----ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICH 508 (582)
Q Consensus 434 l~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~ 508 (582)
|+|||+|+........ .......||+.|+|||++.+ ..++.++|||||||+++||++|+.||...........
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~--~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG--ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 9999999876432211 11122359999999999876 3689999999999999999999999976543332221
Q ss_pred HHH---HHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 040604 509 NLI---YERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564 (582)
Q Consensus 509 ~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le 564 (582)
... ...+..+.. .. ....+.+.+++..|++.+|++||+++++++.|+
T Consensus 245 ~~~~~~~~~~~~~~~-~~--------~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 245 AAKCDFIKRLHEGKI-KI--------KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HhHHHHHHHhhhhhh-cc--------CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 111 122222111 01 112455777888899999999999999998874
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=297.94 Aligned_cols=260 Identities=22% Similarity=0.306 Sum_probs=197.2
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
+++.++||+|+||.||+|... +++.||+|+++.... ..+.+.+|+.++++++|+||+++++++..+...++||||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 456688999999999999765 688999999875432 3467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
+++.|..++... ..+++..++.++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++..........
T Consensus 83 ~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 83 ERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 887777665543 3589999999999999999999998 99999999999999999999999999998766543211
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhH-HHH--------HhhcCCCC-
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHN-LIY--------ERIEPGND- 520 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~-~~~--------~~i~~~~~- 520 (582)
.....++..|+|||++.+. ..++.++||||||+++|+|++|+.|+............ ... ........
T Consensus 158 -~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 158 -LTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred -ccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 1234588999999998763 36789999999999999999999988654322110000 000 00000000
Q ss_pred --CCCCCcC-cHH-----HHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 521 --FQFDGVA-TEE-----EKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 521 --~~~~~~~-~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
..+.... ... ...+...+.+++.+||+.+|++||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000000 000 0123577889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=292.95 Aligned_cols=242 Identities=26% Similarity=0.362 Sum_probs=194.5
Q ss_pred hhcCccCceEEEEEEe-CCCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCChh
Q 040604 299 DKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLD 376 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 376 (582)
++||+|++|.||++.. .+++.+|+|+++.... ..+.+.+|+.++++++|+||+++++++......++|+||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~ 104 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence 6899999999999975 4788999999865432 3456889999999999999999999999999999999999999999
Q ss_pred hhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeeccc
Q 040604 377 KFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR 456 (582)
Q Consensus 377 ~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 456 (582)
+++.. ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||.+......... .....
T Consensus 105 ~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~ 176 (285)
T cd06648 105 DIVTH---TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RKSLV 176 (285)
T ss_pred HHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc--ccccc
Confidence 99876 3588999999999999999999998 9999999999999999999999999988765433221 11235
Q ss_pred CCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHH
Q 040604 457 GTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAK 536 (582)
Q Consensus 457 gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 536 (582)
|++.|+|||.+.+ ..++.++||||||++++||++|+.|+....... ....+......... ....+..
T Consensus 177 ~~~~y~aPE~~~~--~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~------~~~~~~~~~~~~~~-----~~~~~~~ 243 (285)
T cd06648 177 GTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ------AMKRIRDNLPPKLK-----NLHKVSP 243 (285)
T ss_pred CCccccCHHHhcC--CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH------HHHHHHhcCCCCCc-----ccccCCH
Confidence 8999999999876 367899999999999999999999986533211 11122222111111 1112345
Q ss_pred HHHHHHHhccccCCCCCCCHHHHHH
Q 040604 537 MMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 537 ~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.+.+++.+||+.+|++||+++++++
T Consensus 244 ~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 244 RLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHHHHcccChhhCcCHHHHcc
Confidence 6788889999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=288.39 Aligned_cols=241 Identities=23% Similarity=0.356 Sum_probs=193.5
Q ss_pred cCccCceEEEEEEeC-CCcEEEEEEeccCCC----CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCCh
Q 040604 301 LGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSL 375 (582)
Q Consensus 301 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 375 (582)
||.|++|.||++... +++.+|+|++..... ..+.+.+|+.++++++|+||+++++.+.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999765 589999999875432 335688999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeecc
Q 040604 376 DKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHA 455 (582)
Q Consensus 376 ~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 455 (582)
.+++.+.. .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++........ ...
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~---~~~ 152 (262)
T cd05572 81 WTILRDRG--LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT---WTF 152 (262)
T ss_pred HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccccc---ccc
Confidence 99997643 588899999999999999999997 9999999999999999999999999999877554311 223
Q ss_pred cCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHH
Q 040604 456 RGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIA 535 (582)
Q Consensus 456 ~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 535 (582)
.|++.|++||.+.. ..++.++|+||||+++|+|++|..|+........ ...............+.. ..
T Consensus 153 ~~~~~~~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~-------~~ 220 (262)
T cd05572 153 CGTPEYVAPEIILN--KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM---EIYNDILKGNGKLEFPNY-------ID 220 (262)
T ss_pred cCCcCccChhHhcC--CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH---HHHHHHhccCCCCCCCcc-------cC
Confidence 58999999999865 3678999999999999999999999976543221 111111211111111111 14
Q ss_pred HHHHHHHHhccccCCCCCCC-----HHHHHH
Q 040604 536 KMMILVGFWCIQTNPSERPS-----MHKVLE 561 (582)
Q Consensus 536 ~~l~~l~~~Cl~~dp~~RPt-----~~evl~ 561 (582)
..+.+++.+||+.+|++||+ ++|+++
T Consensus 221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 56788888999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=276.33 Aligned_cols=249 Identities=22% Similarity=0.366 Sum_probs=197.0
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCH--HHHHHHHHHHhccC-CCceEEEEeEEEeCCeeeEEEEecC
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNG--EEFINEVASISRTS-HVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
++...||.|+.|.||++... +|...|||.+....... ..++..+.++..-+ .|.||+.+|+|..+....+.||.|
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM- 173 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM- 173 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-
Confidence 45578999999999999654 79999999997765332 34566676665554 899999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
...+++++.+-. .++++..+-++...+..||.||..+ ++|+|||+||+|||+|+.|.+|++|||++..+.....+
T Consensus 174 s~C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh-- 248 (391)
T KOG0983|consen 174 STCAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH-- 248 (391)
T ss_pred HHHHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeeccccc--
Confidence 566777766433 3688888889999999999999987 49999999999999999999999999999887654433
Q ss_pred eecccCCcccccccccccc-cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHH
Q 040604 452 MLHARGTIGYIAPEVYSRR-FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 530 (582)
+...|-+.|||||.+.-. ...|..++||||||+.|+||+||+.|+.....+-+. ..++.+...+.+++..
T Consensus 249 -trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~-----ltkvln~ePP~L~~~~--- 319 (391)
T KOG0983|consen 249 -TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV-----LTKVLNEEPPLLPGHM--- 319 (391)
T ss_pred -ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH-----HHHHHhcCCCCCCccc---
Confidence 234599999999998643 357888999999999999999999999887665432 2233333334443322
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 531 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.+...+.+++..||+.|+.+||...++++
T Consensus 320 --gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 320 --GFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred --CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 15566677778899999999999998875
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=293.21 Aligned_cols=245 Identities=24% Similarity=0.337 Sum_probs=197.9
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+++.+.||.|+||.||++... +++.+|+|++.... ...+.+.+|+.++++++||||+++++.+.+....++||||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 345688999999999999765 68999999997543 2346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++++|.+++... ..+++..+..++.|+++||.|||+. +++|+||||+||++++++.++|+|||++.........
T Consensus 82 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 82 LLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT 156 (258)
T ss_pred CCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCccc
Confidence 9999999999765 4688999999999999999999987 9999999999999999999999999999876544221
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
....|+..|+|||.+... .++.++|+||||+++|+|++|+.|+....... ...+.+.... ......
T Consensus 157 ---~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~-~~~~~~----- 222 (258)
T cd05578 157 ---TSTSGTPGYMAPEVLCRQ--GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI---RDQIRAKQET-ADVLYP----- 222 (258)
T ss_pred ---cccCCChhhcCHHHHccc--CCCCcccchhhHHHHHHHHhCCCCCCCCCccH---HHHHHHHhcc-ccccCc-----
Confidence 234589999999998764 58899999999999999999999997654321 1111122221 111111
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCH--HHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSM--HKVL 560 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~--~evl 560 (582)
......+.+++.+||+.||++||++ +|++
T Consensus 223 --~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 223 --ATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred --ccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1234667788889999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=293.33 Aligned_cols=258 Identities=25% Similarity=0.373 Sum_probs=196.4
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC--CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR--CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
++.++||.|++|.||+|... +|+.||||+++... ...+.+.+|+.++++++|+||+++++.+.+.+..++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~- 81 (284)
T cd07836 3 KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD- 81 (284)
T ss_pred eEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC-
Confidence 45678999999999999765 68999999987543 234677899999999999999999999999999999999996
Q ss_pred CChhhhhhcCC-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 373 GSLDKFIHNDR-NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 373 gsL~~~i~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
++|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||++.........
T Consensus 82 ~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~-- 156 (284)
T cd07836 82 KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-- 156 (284)
T ss_pred ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc--
Confidence 58888876543 34689999999999999999999987 9999999999999999999999999999765433221
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHH----------HHhhcCCCCC
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLI----------YERIEPGNDF 521 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~----------~~~i~~~~~~ 521 (582)
.....+|+.|++||++.+. ..++.++||||||+++|+|++|+.|+........ ..... .+.+......
T Consensus 157 ~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ-LLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred cccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhHHHHhcCchh
Confidence 1223578999999998653 3578899999999999999999999875533221 11110 0001100000
Q ss_pred --CCCCcCcHH----HHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 522 --QFDGVATEE----EKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 522 --~~~~~~~~~----~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
......... .......+.+++.+||+.||++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000011 1123466788999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=285.08 Aligned_cols=247 Identities=29% Similarity=0.455 Sum_probs=199.7
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCC
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNG 373 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 373 (582)
...+.||+|++|.||++... +++.+++|++..... ..+.+.+|+..+++++|+|++++++++......++++||++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 82 (253)
T cd05122 3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGG 82 (253)
T ss_pred eeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCC
Confidence 34578999999999999775 789999999976554 4577899999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeee
Q 040604 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISML 453 (582)
Q Consensus 374 sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 453 (582)
+|.+++.... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||.+........ ..
T Consensus 83 ~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~ 155 (253)
T cd05122 83 SLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RN 155 (253)
T ss_pred cHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc---cc
Confidence 9999987643 4689999999999999999999997 999999999999999999999999999987665432 12
Q ss_pred cccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHH
Q 040604 454 HARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKK 533 (582)
Q Consensus 454 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 533 (582)
...|+..|+|||.+... ..+.++||||||+++++|++|+.|+........ +..... .....+.. ...
T Consensus 156 ~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~-~~~~~~~~-----~~~ 222 (253)
T cd05122 156 TMVGTPYWMAPEVINGK--PYDYKADIWSLGITAIELAEGKPPYSELPPMKA-----LFKIAT-NGPPGLRN-----PEK 222 (253)
T ss_pred ceecCCcccCHHHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCchHHH-----HHHHHh-cCCCCcCc-----ccc
Confidence 34588999999998763 578999999999999999999999875432211 111111 11111111 111
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 534 IAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 534 ~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
....+.+++.+||+.||++|||+.++++.
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 223 WSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 24567788889999999999999998863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=319.79 Aligned_cols=263 Identities=19% Similarity=0.235 Sum_probs=182.5
Q ss_pred HHHHhhhhcCccCceEEEEEEeC--CCcEEEEE------------------EeccCCCCHHHHHHHHHHHhccCCCceEE
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELP--DGQLVAVK------------------VLKNSRCNGEEFINEVASISRTSHVNIVT 352 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK------------------~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 352 (582)
..|.+.++||+|+||+||++..+ .+...++| .++........+.+|+.+|++++|+|||+
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 34667789999999999998543 23223322 11111122345789999999999999999
Q ss_pred EEeEEEeCCeeeEEEEecCCCChhhhhhcCC---CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC
Q 040604 353 FLGFCYENKKNALIYELMPNGSLDKFIHNDR---NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED 429 (582)
Q Consensus 353 l~~~~~~~~~~~lv~E~~~~gsL~~~i~~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~ 429 (582)
+++++......++|+|++ +++|.+++.... ........+..|+.||+.||+|||+. +|+||||||+|||++.+
T Consensus 228 l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 228 IEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCD 303 (501)
T ss_pred EeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCC
Confidence 999999999999999999 567777765432 11234566778999999999999998 99999999999999999
Q ss_pred CceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCC-CCCCccc-chh
Q 040604 430 FCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNL-DDEVTDT-SIC 507 (582)
Q Consensus 430 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~-~~~~~~~-~~~ 507 (582)
+.+||+|||+++.+....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.++ ....... ..+
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAG--DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 999999999998765433221 123469999999999976 36899999999999999999988644 3222111 111
Q ss_pred hHHHH-----------------HhhcCCCCCCCCCcCcHHH--HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 508 HNLIY-----------------ERIEPGNDFQFDGVATEEE--KKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 508 ~~~~~-----------------~~i~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
...+. +.+................ ..+...+.+++.+||+.||.+|||+.|+++.
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11110 0000000000000000000 0122345667888999999999999999863
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=296.04 Aligned_cols=259 Identities=24% Similarity=0.356 Sum_probs=197.0
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC--HHHHHHHHHHHhccC-CCceEEEEeEEEeCCeeeEEEEecC
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN--GEEFINEVASISRTS-HVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
.+.+.||+|++|+||+|... +++.||||.+...... .....+|+..+++++ |+|++++++++.++...++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 45678999999999999875 5889999998765432 234567999999999 999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
+|+|.+++.......+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 155 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-- 155 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc--
Confidence 88999988766545789999999999999999999998 9999999999999999999999999999876543322
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhh-----------HHHHH-hhcCCC
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICH-----------NLIYE-RIEPGN 519 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~-----------~~~~~-~i~~~~ 519 (582)
....|+..|+|||++.+. ..++.++|+||||++++||++|+.|+........... .|... .+....
T Consensus 156 -~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 156 -TDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred -CCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 123488899999988653 4678999999999999999999988865433221100 00000 000000
Q ss_pred CCCCCCcCcHH----HHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 520 DFQFDGVATEE----EKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 520 ~~~~~~~~~~~----~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
...+....... .......+.+++.+||+.+|++|||++|++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00111111000 01123568899999999999999999998753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=291.46 Aligned_cols=246 Identities=26% Similarity=0.394 Sum_probs=196.4
Q ss_pred cCccCceEEEEEEeC-CCcEEEEEEeccCCC----CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCCh
Q 040604 301 LGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSL 375 (582)
Q Consensus 301 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 375 (582)
||+|+||.||++... +|+.+|+|++..... ..+.+.+|+.++++++|+||+++++.+......+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 699999999999776 599999999976443 345688999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc------c
Q 040604 376 DKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES------A 449 (582)
Q Consensus 376 ~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~------~ 449 (582)
.+++.+.. .+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++........ .
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99997644 689999999999999999999987 999999999999999999999999999886543321 1
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
.......++..|+|||.+... ..+.++||||||+++++|++|..|+....... ....+..+. ......
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~~~-~~~~~~--- 223 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQ--GHSKTVDWWSLGCILYEFLVGIPPFHGETPEE------IFQNILNGK-IEWPED--- 223 (265)
T ss_pred ccccCcccCccccCHHHhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHhcCC-cCCCcc---
Confidence 112234588899999998763 57889999999999999999999987543221 112222211 111111
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
......+..++.+||+.+|++|||++++.+.|+.
T Consensus 224 --~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 224 --VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred --ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 1135667788889999999999999777776653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=295.42 Aligned_cols=259 Identities=21% Similarity=0.304 Sum_probs=190.3
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCC--------e
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENK--------K 362 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------~ 362 (582)
+.+.++||+|+||.||+|... +++.||||.+..... ....+.+|+.++++++||||+++++++.... .
T Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 93 (310)
T cd07865 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS 93 (310)
T ss_pred eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence 456688999999999999764 789999999864322 2345678999999999999999999987654 3
Q ss_pred eeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccc
Q 040604 363 NALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ 442 (582)
Q Consensus 363 ~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~ 442 (582)
.++||||+. ++|.+++... ...+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++..
T Consensus 94 ~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 94 FYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred EEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 489999995 6888877643 24689999999999999999999998 999999999999999999999999999987
Q ss_pred ccccccc--eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCC
Q 040604 443 AQKKESA--ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND 520 (582)
Q Consensus 443 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~ 520 (582)
....... .......++..|+|||.+.+. ..++.++||||||++++||++|+.|+........ ...+.........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~--~~~~~~~~~~~~~ 245 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ--LTLISQLCGSITP 245 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCh
Confidence 6443221 111234578899999988653 3468899999999999999999998865432211 0111111100000
Q ss_pred --------------CCCCCcCc-HHHHH-----HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 521 --------------FQFDGVAT-EEEKK-----IAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 521 --------------~~~~~~~~-~~~~~-----~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
..+..... ..... ....+.+++.+||+.||++|||++++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000000 00000 1245678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=283.12 Aligned_cols=245 Identities=24% Similarity=0.338 Sum_probs=196.4
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC----HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN----GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 368 (582)
.++|.+.||+|.||.|.+++.+ +++.+|+|++++.... ...-+-|-.+|+..+||.+..|.-.|+..+++++|||
T Consensus 169 dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMe 248 (516)
T KOG0690|consen 169 DFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVME 248 (516)
T ss_pred hhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEE
Confidence 3567899999999999999654 8999999999875432 2334568889999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
|..||.|.-++.+.+ .+++.+....-.+|..||.|||++ +||.||||.+|+|+|.+|++||+|||+.+.-.....
T Consensus 249 yanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~ 323 (516)
T KOG0690|consen 249 YANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD 323 (516)
T ss_pred EccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcccccc
Confidence 999999998887654 678888888899999999999998 999999999999999999999999999987443322
Q ss_pred ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc
Q 040604 449 AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528 (582)
Q Consensus 449 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 528 (582)
.+...+|||.|+|||++..+ .|..++|+|-+||++|||++|+.||....... +.+.|.. .+..++....
T Consensus 324 --t~kTFCGTPEYLAPEVleDn--DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k------LFeLIl~-ed~kFPr~ls 392 (516)
T KOG0690|consen 324 --TTKTFCGTPEYLAPEVLEDN--DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK------LFELILM-EDLKFPRTLS 392 (516)
T ss_pred --eeccccCChhhcCchhhccc--cccceeehhhhhHHHHHHHhccCcccccchhH------HHHHHHh-hhccCCccCC
Confidence 23356899999999999874 89999999999999999999999998754432 2222222 1234555555
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERP-----SMHKVLE 561 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~ 561 (582)
.+.+.+... .|..||.+|. .++||.+
T Consensus 393 ~eAktLLsG-------LL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 393 PEAKTLLSG-------LLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred HHHHHHHHH-------HhhcChHhhcCCCchhHHHHHh
Confidence 555544444 4588999996 4566653
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=290.45 Aligned_cols=255 Identities=25% Similarity=0.351 Sum_probs=194.2
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC---HHHHHHHHHHHhcc---CCCceEEEEeEEEeCCe-----e
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN---GEEFINEVASISRT---SHVNIVTFLGFCYENKK-----N 363 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----~ 363 (582)
++.+.||+|+||.||+|... +++.+|+|+++..... ...+.+|+.+++++ +|+|++++++++.+.+. .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 34578999999999999876 5899999999754322 34566788777665 69999999999988776 8
Q ss_pred eEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccc
Q 040604 364 ALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQA 443 (582)
Q Consensus 364 ~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~ 443 (582)
+++|||+. ++|.+++.......+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++...
T Consensus 82 ~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 82 TLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred EEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceec
Confidence 99999995 5898888765545689999999999999999999998 9999999999999999999999999999876
Q ss_pred cccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCC---
Q 040604 444 QKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND--- 520 (582)
Q Consensus 444 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~--- 520 (582)
...... ....+++.|+|||++.+ ..++.++|+||||++++||++|+.|+....... ...... +.......
T Consensus 158 ~~~~~~---~~~~~~~~~~~PE~~~~--~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~ 230 (287)
T cd07838 158 SFEMAL---TSVVVTLWYRAPEVLLQ--SSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QLDKIF-DVIGLPSEEEW 230 (287)
T ss_pred cCCccc---ccccccccccChHHhcc--CCCCCcchhhhHHHHHHHHHhCCCcccCCChHH-HHHHHH-HHcCCCChHhc
Confidence 543221 12347889999999876 368899999999999999999988887543322 111111 11100000
Q ss_pred --------CCCCC----cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 521 --------FQFDG----VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 521 --------~~~~~----~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
..+.. ........+...+.+++.+||+.||++||++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000 111222345677788999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=296.88 Aligned_cols=258 Identities=22% Similarity=0.316 Sum_probs=193.6
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEeC--CeeeEEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYEN--KKNALIYE 368 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~E 368 (582)
+++.++||+|+||.||+|... +|+.||+|+++..... ...+.+|+.++++++|+|++++++++.+. ...++|||
T Consensus 9 y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (309)
T cd07845 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVME 88 (309)
T ss_pred eeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEe
Confidence 445678999999999999764 6999999998654322 23567899999999999999999998765 46799999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
|+. ++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++........
T Consensus 89 ~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 89 YCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163 (309)
T ss_pred cCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence 995 58888876533 4689999999999999999999998 999999999999999999999999999987654322
Q ss_pred ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCC---------
Q 040604 449 AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGN--------- 519 (582)
Q Consensus 449 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~--------- 519 (582)
. .....+++.|+|||.+.+. ..++.++||||||+++|||++|+.|+....... .+.. +.+.+....
T Consensus 164 ~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 164 P--MTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE-QLDL-IIQLLGTPNESIWPGFSD 238 (309)
T ss_pred C--CCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHHhcCCCChhhchhhhc
Confidence 1 1223468889999998653 357899999999999999999999987543221 1111 111111000
Q ss_pred -----CCCCCCcC----cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 520 -----DFQFDGVA----TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 520 -----~~~~~~~~----~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
...+.... ..........+.+++.+||+.||++|||++++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000 00111235567788999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=294.34 Aligned_cols=261 Identities=23% Similarity=0.267 Sum_probs=195.2
Q ss_pred HHHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC---CCHHHHHHHHHHHhccCCCceEEEEeEEEeCC------
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR---CNGEEFINEVASISRTSHVNIVTFLGFCYENK------ 361 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 361 (582)
...+.+.++||+|+||.||+|... +|+.||+|+++... .....+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 345566789999999999999765 68999999996532 23356788999999999999999999987654
Q ss_pred ----eeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeec
Q 040604 362 ----KNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDF 437 (582)
Q Consensus 362 ----~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DF 437 (582)
..++||||+++ +|..++... ...+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+||
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCcc
Confidence 78899999965 777766643 33689999999999999999999998 9999999999999999999999999
Q ss_pred cccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcC
Q 040604 438 GLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEP 517 (582)
Q Consensus 438 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~ 517 (582)
|++......... ......++..|+|||.+.+. ...+.++|||||||+++||++|+.|+....... .... +.+....
T Consensus 161 g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~-~~~~-~~~~~~~ 236 (302)
T cd07864 161 GLARLYNSEESR-PYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELA-QLEL-ISRLCGS 236 (302)
T ss_pred cccccccCCccc-ccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHH-HHHHhCC
Confidence 999876543321 11223467889999988653 356889999999999999999999887543211 1111 1111111
Q ss_pred CCCCCCC------------------CcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 518 GNDFQFD------------------GVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 518 ~~~~~~~------------------~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.....++ .........++..+.+++.+||+.+|++||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000000 0000111224567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=289.01 Aligned_cols=243 Identities=23% Similarity=0.308 Sum_probs=188.5
Q ss_pred hhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCH----HHHHHHHHH-HhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 299 DKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNG----EEFINEVAS-ISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
+.||+|+||.||+|... +++.||+|+++...... ..+..|..+ ..+.+|+|++++++.+.+++..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999664 68999999987543221 233445443 4556899999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
++|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||+++.....
T Consensus 82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~------ 150 (260)
T cd05611 82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN------ 150 (260)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceecccc------
Confidence 99999997543 588899999999999999999998 9999999999999999999999999998765432
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
....|++.|+|||.+.+. .++.++||||||++++||++|..|+....... +...+..... .... ....
T Consensus 151 ~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~-~~~~---~~~~ 218 (260)
T cd05611 151 KKFVGTPDYLAPETILGV--GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA------VFDNILSRRI-NWPE---EVKE 218 (260)
T ss_pred ccCCCCcCccChhhhcCC--CCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhccc-CCCC---cccc
Confidence 123588999999998764 47899999999999999999999996543221 1111111110 0100 0111
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 040604 533 KIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le 564 (582)
.+...+.+++.+||+.+|++||++.++.+.|+
T Consensus 219 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 219 FCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 34566788889999999999998876666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=296.71 Aligned_cols=240 Identities=29% Similarity=0.391 Sum_probs=195.1
Q ss_pred hhhhcCccCceEEEEEE-eCCCcEEEEEEeccCCCC----HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 297 FRDKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCN----GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 297 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
.-+.||+||||.|+-+. ..+|+.+|.|.+.+.+.. ....++|-.+|.+++.+.||.|--.+...+.++|||..|.
T Consensus 189 ~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMN 268 (591)
T KOG0986|consen 189 VYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMN 268 (591)
T ss_pred eeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeec
Confidence 34689999999999985 448999999998654332 3457899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
||+|.-+|.+.++..+++.++.-.+.+|+.||++||+. +||.||+||+|||||+.|+++|+|.|||..+..++...
T Consensus 269 GGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~- 344 (591)
T KOG0986|consen 269 GGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIR- 344 (591)
T ss_pred CCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCccc-
Confidence 99999999888877899999999999999999999998 99999999999999999999999999999988876543
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHH
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 531 (582)
...||.+|||||++.+. .|+...|+|||||+||||+.|+.||........ .+-+..++.. ....+.+-.+++.
T Consensus 345 --~rvGT~GYMAPEvl~ne--~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk--~eEvdrr~~~-~~~ey~~kFS~ea 417 (591)
T KOG0986|consen 345 --GRVGTVGYMAPEVLQNE--VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK--REEVDRRTLE-DPEEYSDKFSEEA 417 (591)
T ss_pred --cccCcccccCHHHHcCC--cccCCccHHHHHhHHHHHHcccCchhhhhhhhh--HHHHHHHHhc-chhhcccccCHHH
Confidence 33699999999999874 699999999999999999999999975433221 1112222222 1122333344444
Q ss_pred HHHHHHHHHHHHhccccCCCCCC
Q 040604 532 KKIAKMMILVGFWCIQTNPSERP 554 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RP 554 (582)
+.+.+ ..|+.||.+|.
T Consensus 418 kslc~-------~LL~Kdp~~RL 433 (591)
T KOG0986|consen 418 KSLCE-------GLLTKDPEKRL 433 (591)
T ss_pred HHHHH-------HHHccCHHHhc
Confidence 44443 35689999996
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=296.00 Aligned_cols=251 Identities=20% Similarity=0.352 Sum_probs=192.4
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC--CHHHHHHHHHHHhccC-CCceEEEEeEEEeCCeeeEEEEec
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC--NGEEFINEVASISRTS-HVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
+.+.+.||+|++|.||+|... +++.||||.++.... ...++..|+.++.++. |+||+++++++.+....+++|||+
T Consensus 17 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 96 (296)
T cd06618 17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM 96 (296)
T ss_pred heeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc
Confidence 456789999999999999876 489999999976433 2345667777666665 999999999999999999999998
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
+++|.+++.... ..+++..+..++.|++.||+|||+. .+|+||||+|+||++++++.+||+|||++.........
T Consensus 97 -~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~- 171 (296)
T cd06618 97 -STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK- 171 (296)
T ss_pred -CcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc-
Confidence 567777765533 3789999999999999999999973 28999999999999999999999999999775433222
Q ss_pred eeecccCCccccccccccccc--CCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc
Q 040604 451 SMLHARGTIGYIAPEVYSRRF--GGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~--~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 528 (582)
....+++.|+|||.+.+.. +.++.++||||||+++|||++|+.|+........ .+...+... .......
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~~-~~~~~~~-- 242 (296)
T cd06618 172 --TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE----VLTKILQEE-PPSLPPN-- 242 (296)
T ss_pred --cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH----HHHHHhcCC-CCCCCCC--
Confidence 1234888999999986532 3478899999999999999999999865322211 111112111 1111110
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
......+.+++.+||+.||++||+++++++.
T Consensus 243 ---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 243 ---EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ---CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1234567888899999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=291.72 Aligned_cols=255 Identities=23% Similarity=0.318 Sum_probs=198.3
Q ss_pred hhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 297 FRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 297 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
..+.||+|++|.||++... +++.+|+|.++..... .+.+.+|+.++++++|+||+++++++..+...++||||++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~- 81 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD- 81 (283)
T ss_pred cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC-
Confidence 4578999999999999764 7899999998765433 4678899999999999999999999999999999999996
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
++|.+++.... ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||.+........ ..
T Consensus 82 ~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~~ 155 (283)
T cd05118 82 TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--PY 155 (283)
T ss_pred CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--cc
Confidence 58888876543 4789999999999999999999998 999999999999999999999999999987655431 11
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCC-----------
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDF----------- 521 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~----------- 521 (582)
....++..|+|||.+.+. ...+.++|+||||+++++|++|+.||........ ... +.+.+......
T Consensus 156 ~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 156 THYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ-LFK-IFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred cCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH-HHHHcCCCchHhcccchhhhhh
Confidence 223588899999998763 3688999999999999999999998865433221 100 11111110000
Q ss_pred ---CCC----CcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 522 ---QFD----GVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 522 ---~~~----~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.+. .............+.+++.+||+.||.+||++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 0011122345678899999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=285.64 Aligned_cols=247 Identities=26% Similarity=0.404 Sum_probs=200.1
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
.+.+.||.|+||.||++... +++.+|+|++..... ..+.+.+|+.++++++|+|++++++.+......++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~ 82 (258)
T cd08215 3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYAD 82 (258)
T ss_pred eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecC
Confidence 45578999999999999765 689999999976543 34568899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCC--CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 372 NGSLDKFIHNDR--NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 372 ~gsL~~~i~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||.+.........
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (258)
T cd08215 83 GGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL 159 (258)
T ss_pred CCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence 999999997643 45799999999999999999999998 9999999999999999999999999999876554311
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
.....|++.|+|||.+... .++.++|+||+|+++++|++|+.|+....... +...+.......+..
T Consensus 160 --~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~---- 225 (258)
T cd08215 160 --AKTVVGTPYYLSPELCQNK--PYNYKSDIWSLGCVLYELCTLKHPFEGENLLE------LALKILKGQYPPIPS---- 225 (258)
T ss_pred --ecceeeeecccChhHhccC--CCCccccHHHHHHHHHHHHcCCCCCCCCcHHH------HHHHHhcCCCCCCCC----
Confidence 1223589999999988763 68899999999999999999999986543211 111121211111211
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
.....+.+++.+||+.+|++|||+.++++.
T Consensus 226 ---~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 226 ---QYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ---CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 234567778889999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=303.00 Aligned_cols=255 Identities=25% Similarity=0.303 Sum_probs=191.4
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC---CCHHHHHHHHHHHhccCCCceEEEEeEEEeC------Cee
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR---CNGEEFINEVASISRTSHVNIVTFLGFCYEN------KKN 363 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 363 (582)
.+...+.||+|+||.||+|... +|+.||+|.+.... ...+.+.+|+.++++++|+||+++++++... ...
T Consensus 17 ~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 96 (353)
T cd07850 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDV 96 (353)
T ss_pred ceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcE
Confidence 3445678999999999999754 79999999986432 2235677899999999999999999988643 346
Q ss_pred eEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccc
Q 040604 364 ALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQA 443 (582)
Q Consensus 364 ~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~ 443 (582)
++||||+ .++|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 97 ~lv~e~~-~~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 97 YLVMELM-DANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred EEEEecc-CCCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 8999999 5688887754 278899999999999999999998 9999999999999999999999999999876
Q ss_pred cccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHH------------
Q 040604 444 QKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLI------------ 511 (582)
Q Consensus 444 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~------------ 511 (582)
..... .....||+.|+|||.+.+ ..++.++||||||+++++|++|+.||........ ....+
T Consensus 169 ~~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 169 GTSFM---MTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ-WNKIIEQLGTPSDEFMS 242 (353)
T ss_pred CCCCC---CCCCcccccccCHHHHhC--CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHH
Confidence 44322 122358899999999876 4789999999999999999999999865432110 00000
Q ss_pred ------HHhhcCCCC---CCCCC---------cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 512 ------YERIEPGND---FQFDG---------VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 512 ------~~~i~~~~~---~~~~~---------~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
......... ..+.. ............+.+++.+||+.||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 00000 0000112345567889999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=321.80 Aligned_cols=271 Identities=24% Similarity=0.301 Sum_probs=212.0
Q ss_pred HHHHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEecc----CCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeE
Q 040604 291 KRMTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKN----SRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNAL 365 (582)
Q Consensus 291 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 365 (582)
++..+++.+.||+|+||.|..++.+ +++.||+|++.+ .+....-|..|-.+|..-+.+.|+.|+-.|+++.++||
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 3456778899999999999999765 789999999976 24455678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
|||||+||+|-.++.+.. +++++.+...+.+|..||.-||+. |+|||||||+|||||..|++||+|||.+-.+..
T Consensus 153 VMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred EEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 999999999999998765 688888888899999999999998 999999999999999999999999999988876
Q ss_pred cccceeeecccCCcccccccccccc---cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcC-CCCC
Q 040604 446 KESAISMLHARGTIGYIAPEVYSRR---FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEP-GNDF 521 (582)
Q Consensus 446 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~-~~~~ 521 (582)
+....+ ...+|||.|++||++... .+.|...+|+||+||++|||+.|..||+...-...+ .+|.. ...+
T Consensus 228 dG~V~s-~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY------~KIm~hk~~l 300 (1317)
T KOG0612|consen 228 DGTVRS-SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETY------GKIMNHKESL 300 (1317)
T ss_pred CCcEEe-ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHH------HHHhchhhhc
Confidence 655443 356899999999998532 257899999999999999999999999876444322 22222 1223
Q ss_pred CCC--CcCcHHHHHHHHHHHHHHHhccccCCCCCCC---HHHHHHHH--hc----ccCCCCCCCCCCCCCC
Q 040604 522 QFD--GVATEEEKKIAKMMILVGFWCIQTNPSERPS---MHKVLEML--EG----SIENLQIPPKPSLFSA 581 (582)
Q Consensus 522 ~~~--~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt---~~evl~~L--e~----~~~~~~~p~~p~~~~~ 581 (582)
.++ ..++++.++++..++ -+|+.|.. ++++-..- ++ .+-+...|=.|.+.|+
T Consensus 301 ~FP~~~~VSeeakdLI~~ll--------~~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd 363 (1317)
T KOG0612|consen 301 SFPDETDVSEEAKDLIEALL--------CDREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSD 363 (1317)
T ss_pred CCCcccccCHHHHHHHHHHh--------cChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCC
Confidence 333 234555666665554 27888887 77776432 22 1223344555555554
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=322.26 Aligned_cols=248 Identities=26% Similarity=0.375 Sum_probs=184.6
Q ss_pred hhhcCccCceEEEEEEeC-CCcEEEEEEeccCC--CCHHHHHHHHHHHhccCCCceEEEEeEEEe---------------
Q 040604 298 RDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR--CNGEEFINEVASISRTSHVNIVTFLGFCYE--------------- 359 (582)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------------- 359 (582)
.+.||+||||.||+++.+ +|+.||||++.... ..-..+.+|+..|++|+|||||+++..|.+
T Consensus 484 L~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~ 563 (1351)
T KOG1035|consen 484 LELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDS 563 (1351)
T ss_pred HHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccch
Confidence 368999999999999766 99999999997653 233567899999999999999998622110
Q ss_pred --------------------------------------------------------------------------------
Q 040604 360 -------------------------------------------------------------------------------- 359 (582)
Q Consensus 360 -------------------------------------------------------------------------------- 359 (582)
T Consensus 564 ~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d 643 (1351)
T KOG1035|consen 564 ESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILD 643 (1351)
T ss_pred hhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccC
Confidence
Q ss_pred ----------------C--------CeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceE
Q 040604 360 ----------------N--------KKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415 (582)
Q Consensus 360 ----------------~--------~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iv 415 (582)
. ..+|+-||||+..+|.+++.++.... .....|+++.||++||.|+|++ |||
T Consensus 644 ~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~~---giI 719 (1351)
T KOG1035|consen 644 DTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHDQ---GII 719 (1351)
T ss_pred cchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHhC---cee
Confidence 0 12467899998888888887654221 4678899999999999999998 999
Q ss_pred ecCCCCCCEEEcCCCceEEeecccccccc----------------ccccceeeecccCCcccccccccccccC-CCCccc
Q 040604 416 HFDIKPQNILLDEDFCPKISDFGLAKQAQ----------------KKESAISMLHARGTIGYIAPEVYSRRFG-GVSHKS 478 (582)
Q Consensus 416 H~Dikp~NILl~~~~~vkl~DFGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~s~~~ 478 (582)
||||||.||+||++..|||+|||+|+... ........+...||.-|+|||++.+... .|+.|+
T Consensus 720 HRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~Ki 799 (1351)
T KOG1035|consen 720 HRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKI 799 (1351)
T ss_pred eccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchh
Confidence 99999999999999999999999998621 0111123345679999999999987532 699999
Q ss_pred hhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHH
Q 040604 479 DVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHK 558 (582)
Q Consensus 479 DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~e 558 (582)
|+|||||||+||+. ||....+.. .+...++.+..+...+. .......-+.++.|+++.||++||||.|
T Consensus 800 DmYSLGIVlFEM~y---PF~TsMERa-----~iL~~LR~g~iP~~~~f----~~~~~~~e~slI~~Ll~hdP~kRPtA~e 867 (1351)
T KOG1035|consen 800 DMYSLGIVLFEMLY---PFGTSMERA-----SILTNLRKGSIPEPADF----FDPEHPEEASLIRWLLSHDPSKRPTATE 867 (1351)
T ss_pred hhHHHHHHHHHHhc---cCCchHHHH-----HHHHhcccCCCCCCccc----ccccchHHHHHHHHHhcCCCccCCCHHH
Confidence 99999999999983 354433222 23334444432222111 1112223356778899999999999999
Q ss_pred HHH
Q 040604 559 VLE 561 (582)
Q Consensus 559 vl~ 561 (582)
++.
T Consensus 868 LL~ 870 (1351)
T KOG1035|consen 868 LLN 870 (1351)
T ss_pred Hhh
Confidence 874
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=291.49 Aligned_cols=243 Identities=25% Similarity=0.348 Sum_probs=192.8
Q ss_pred hhhcCccCceEEEEEEe-CCCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCCh
Q 040604 298 RDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSL 375 (582)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 375 (582)
..+||+|+||.||++.. .+++.||||++..... ..+.+.+|+.++++++|+|++++++.+...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 36899999999999976 4789999999864332 345688999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeecc
Q 040604 376 DKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHA 455 (582)
Q Consensus 376 ~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 455 (582)
.+++... .+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.......... ...
T Consensus 105 ~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~--~~~ 176 (292)
T cd06657 105 TDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KSL 176 (292)
T ss_pred HHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccccc--ccc
Confidence 9987543 478899999999999999999998 99999999999999999999999999987654432211 223
Q ss_pred cCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHH
Q 040604 456 RGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIA 535 (582)
Q Consensus 456 ~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 535 (582)
.|++.|+|||++.+ ..++.++|+||+|+++|+|++|..|+........ ...+.......+.. ...+.
T Consensus 177 ~~~~~y~~pE~~~~--~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~------~~~~~~~~~~~~~~-----~~~~~ 243 (292)
T cd06657 177 VGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA------MKMIRDNLPPKLKN-----LHKVS 243 (292)
T ss_pred ccCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhhCCcccCC-----cccCC
Confidence 58999999998865 3678999999999999999999999865322211 11111111111111 11123
Q ss_pred HHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 536 KMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 536 ~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
..+.+++.+||+.+|.+||++.++++
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 45667788899999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=309.63 Aligned_cols=254 Identities=29% Similarity=0.466 Sum_probs=209.9
Q ss_pred hhhcCccCceEEEEEEe-CCC----cEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 298 RDKLGQGGYGEVYKGEL-PDG----QLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~-~~~----~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
.++||+|+||+||+|.+ .+| .+||||++...... ..++++|+.+|.+++|||++||+|+|.... ..||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 36899999999999964 343 47999998765543 678999999999999999999999998665 78999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
+.|+|.++++.++ ..+..+..+.|..|||+||.|||.+ +++||||-.+|||+.+-..+||.|||+|+.........
T Consensus 780 P~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 780 PLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred ccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 9999999998754 4688899999999999999999988 99999999999999999999999999999988776665
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
......-.+.|||-|.+.. ..++.++|||||||.+||++| |.+|++.....+ +.+.++.+.++..++..+
T Consensus 856 ~~~~gK~pikwmale~i~~--~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e------I~dlle~geRLsqPpiCt- 926 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRI--RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE------IPDLLEKGERLSQPPICT- 926 (1177)
T ss_pred cccccccCcHHHHHHHhhc--cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH------hhHHHhccccCCCCCCcc-
Confidence 5544455678999998876 589999999999999999998 677877654433 455666666544444332
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCC
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQ 571 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~ 571 (582)
..+..++.+||..|+..||+++++...+.....+++
T Consensus 927 ------iDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq 962 (1177)
T KOG1025|consen 927 ------IDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ 962 (1177)
T ss_pred ------HHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence 234455667999999999999999999988776655
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=286.19 Aligned_cols=242 Identities=27% Similarity=0.318 Sum_probs=186.2
Q ss_pred hcCccCceEEEEEEe-CCCcEEEEEEeccCCCC----HHHHHHHHH---HHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 300 KLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCN----GEEFINEVA---SISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 300 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
.||+|+||.||++.. .+++.||+|.+...... ...+.+|.. .++...||||+++++.+.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999965 46899999998654321 122344443 4445689999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
|++|..++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~-- 153 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH-- 153 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCc--
Confidence 99999988654 3689999999999999999999997 9999999999999999999999999998765432221
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHH
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 531 (582)
...|+..|+|||++.+. ..++.++||||+|++++||++|+.||......... ....... .....++..
T Consensus 154 --~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~-~~~~~~~~~----- 221 (278)
T cd05606 154 --ASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMTL-TMAVELPDS----- 221 (278)
T ss_pred --CcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH---HHHHHhh-ccCCCCCCc-----
Confidence 23599999999998653 25789999999999999999999999765322211 1111111 111112211
Q ss_pred HHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 040604 532 KKIAKMMILVGFWCIQTNPSERP-----SMHKVLEM 562 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~~ 562 (582)
....+.+++.+||+.+|++|| +++++++.
T Consensus 222 --~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 222 --FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred --CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 235567777889999999999 99999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=299.29 Aligned_cols=257 Identities=24% Similarity=0.291 Sum_probs=193.6
Q ss_pred hhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCH---------------HHHHHHHHHHhccCCCceEEEEeEEEeC
Q 040604 297 FRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNG---------------EEFINEVASISRTSHVNIVTFLGFCYEN 360 (582)
Q Consensus 297 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---------------~~~~~E~~~l~~l~h~niv~l~~~~~~~ 360 (582)
+.+.||+|+||+||+|... +++.||||+++...... ..+.+|+.++++++|+||+++++++...
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 3467999999999999754 78999999986543221 2477899999999999999999999999
Q ss_pred CeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccc
Q 040604 361 KKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLA 440 (582)
Q Consensus 361 ~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla 440 (582)
...++||||+. |+|.+++.... .+++.....++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCccce
Confidence 99999999995 78998886543 588899999999999999999987 9999999999999999999999999999
Q ss_pred ccccccc------------cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhh
Q 040604 441 KQAQKKE------------SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICH 508 (582)
Q Consensus 441 ~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~ 508 (582)
+...... .........+++.|+|||.+.+. ..++.++||||||++++||++|+.|+........ .
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-~- 243 (335)
T PTZ00024 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ-L- 243 (335)
T ss_pred eecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-H-
Confidence 8655111 00111223478899999998653 3578899999999999999999999875543221 1
Q ss_pred HHHHHhhcCCCCCC------------CCCcCc----HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 509 NLIYERIEPGNDFQ------------FDGVAT----EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 509 ~~~~~~i~~~~~~~------------~~~~~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
..+.+.+....... ...... .........+.+++.+||+.+|++||++++++..
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 11111111111000 000000 1111234567889999999999999999999864
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=301.14 Aligned_cols=263 Identities=23% Similarity=0.323 Sum_probs=196.0
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccC---CCCHHHHHHHHHHHhccCCCceEEEEeEEEeC-----CeeeE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNS---RCNGEEFINEVASISRTSHVNIVTFLGFCYEN-----KKNAL 365 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~l 365 (582)
+.+.+.||+|+||+||++... +++.||||.++.. ......+.+|+.+++.++|+||+++++++... ...++
T Consensus 7 y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 86 (337)
T cd07858 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYI 86 (337)
T ss_pred eeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEE
Confidence 344578999999999999654 7899999998653 22345677899999999999999999988654 24799
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
||||+ +++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 87 v~e~~-~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 87 VYELM-DTDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEeCC-CCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 99999 578988887543 689999999999999999999998 999999999999999999999999999987654
Q ss_pred cccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCC---
Q 040604 446 KESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQ--- 522 (582)
Q Consensus 446 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~--- 522 (582)
.... .....++..|+|||.+... ..++.++||||||+++++|++|+.||........ . ..+.+.+.......
T Consensus 161 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~-~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 161 KGDF--MTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ-L-KLITELLGSPSEEDLGF 235 (337)
T ss_pred Cccc--ccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH-H-HHHHHHhCCCChHHhhh
Confidence 3211 1223588999999988643 3588999999999999999999999865422110 0 00000000000000
Q ss_pred ------------C----CCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcccC
Q 040604 523 ------------F----DGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM--LEGSIE 568 (582)
Q Consensus 523 ------------~----~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~--Le~~~~ 568 (582)
. ..........+...+.+++.+||+.+|++|||++++++. ++...+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 0 000001112345667899999999999999999999876 665433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=286.84 Aligned_cols=245 Identities=28% Similarity=0.422 Sum_probs=198.7
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
++.++||+|+||.||++... +++.+|+|.+..... ...++.+|+.++++++|+||+++++++.+....++||||++
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd08530 3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAP 82 (256)
T ss_pred eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcC
Confidence 45678999999999999654 788999999876432 34567889999999999999999999999999999999999
Q ss_pred CCChhhhhhcC--CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 372 NGSLDKFIHND--RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 372 ~gsL~~~i~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++|.+++... ....+++..++.++.|++.||+|||+. +++|+||+|+||++++++.+||+|||+++.......
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~- 158 (256)
T cd08530 83 FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA- 158 (256)
T ss_pred CCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCCc-
Confidence 99999998652 234689999999999999999999988 999999999999999999999999999987655421
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
....|++.|++||.+.+ ..++.++|+||||++++||++|+.|+....... ....+.......+
T Consensus 159 ---~~~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~------ 221 (256)
T cd08530 159 ---KTQIGTPHYMAPEVWKG--RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD------LRYKVQRGKYPPI------ 221 (256)
T ss_pred ---ccccCCccccCHHHHCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHhcCCCCCC------
Confidence 12358899999999876 367889999999999999999999986543211 1112222111111
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
.......+.+++.+||+.+|++||++.++++.
T Consensus 222 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 222 -PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 12345668889999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=282.72 Aligned_cols=245 Identities=27% Similarity=0.405 Sum_probs=198.9
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
+.+.+.||+|++|.||++... +++.+|+|.+..... ..+.+.+|+.++++++|+|++++++++.+....+++|||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 345688999999999999655 688999999976653 3467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
++++|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 82 ~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 82 ENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred CCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 999999998765 4689999999999999999999988 9999999999999999999999999999876554332
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHH
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 530 (582)
.....|+..|+|||.+.+. ..+.++||||+|+++++|++|+.|+........ ..... ......+..
T Consensus 156 -~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~-----~~~~~-~~~~~~~~~----- 221 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMS--GASTASDIWSLGCTVIELLTGNPPYYDLNPMAA-----LFRIV-QDDHPPLPE----- 221 (254)
T ss_pred -ccccccchhhcCHhhhcCC--CCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH-----HHHHh-ccCCCCCCC-----
Confidence 1234589999999998764 478899999999999999999999875432111 11111 111112221
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 531 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.+...+.+++.+||+.+|++||++.+++.
T Consensus 222 --~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 222 --GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred --CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 22455677888999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=304.12 Aligned_cols=250 Identities=23% Similarity=0.330 Sum_probs=197.5
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccC-CCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNS-RCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
.++...||.|+||.||+|..+ ++-..|-|++... ...-++++-|+.||....||+||+|++.|+-...++++.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 456678999999999999665 4566788888643 33457899999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
|.++.++-.-+ ..+.+.++.-++.|++.||.|||++ .|||||||..|||+.-+|.++|+|||.+-....... ..
T Consensus 114 GAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q--kR 187 (1187)
T KOG0579|consen 114 GAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ--KR 187 (1187)
T ss_pred chHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHHh--hh
Confidence 99999887543 4799999999999999999999998 999999999999999999999999998754322111 11
Q ss_pred ecccCCcccccccccccc---cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 453 LHARGTIGYIAPEVYSRR---FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
....|||+|||||+..-. ...|..++||||||+.|.||..+.+|....+... ++ -++.+...+.+.
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR-----Vl-lKiaKSePPTLl----- 256 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-----VL-LKIAKSEPPTLL----- 256 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH-----HH-HHHhhcCCCccc-----
Confidence 234699999999997432 1368899999999999999999999876654322 22 233333222221
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
........+.+++.+||..||+.||++.++++
T Consensus 257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 11223455667778899999999999999875
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=284.34 Aligned_cols=234 Identities=21% Similarity=0.290 Sum_probs=182.1
Q ss_pred cCccCceEEEEEEe-CCCcEEEEEEeccCCCCHHHHHHHHHHHhc-cCCCceEEEEeEEEeCCeeeEEEEecCCCChhhh
Q 040604 301 LGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNGEEFINEVASISR-TSHVNIVTFLGFCYENKKNALIYELMPNGSLDKF 378 (582)
Q Consensus 301 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~ 378 (582)
||+|+||.||++.. .+++.+|+|++........ |+..... .+|+||+++++.+......++||||+++++|.++
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~ 99 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDL 99 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHH
Confidence 59999999999965 4789999999876433221 2222221 2799999999999999999999999999999999
Q ss_pred hhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-ceEEeeccccccccccccceeeecccC
Q 040604 379 IHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF-CPKISDFGLAKQAQKKESAISMLHARG 457 (582)
Q Consensus 379 i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~-~vkl~DFGla~~~~~~~~~~~~~~~~g 457 (582)
+.... .+++..+..++.|+++||.|||+. +++||||||+||+++.++ .++|+|||+++...... ...|
T Consensus 100 l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~------~~~~ 168 (267)
T PHA03390 100 LKKEG--KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS------CYDG 168 (267)
T ss_pred HHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc------cCCC
Confidence 97654 789999999999999999999998 999999999999999998 99999999988654332 2358
Q ss_pred CcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHH
Q 040604 458 TIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKM 537 (582)
Q Consensus 458 t~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 537 (582)
+..|+|||++.+ ..++.++||||||++++||++|+.|+............+. ..... ..... ......
T Consensus 169 ~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~--~~~~~-------~~~~~~ 236 (267)
T PHA03390 169 TLDYFSPEKIKG--HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLL-KRQQK--KLPFI-------KNVSKN 236 (267)
T ss_pred CCcccChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHH-Hhhcc--cCCcc-------cccCHH
Confidence 999999999976 3678999999999999999999999974432221111111 11111 11111 134456
Q ss_pred HHHHHHhccccCCCCCCC-HHHHHH
Q 040604 538 MILVGFWCIQTNPSERPS-MHKVLE 561 (582)
Q Consensus 538 l~~l~~~Cl~~dp~~RPt-~~evl~ 561 (582)
+.+++.+||+.+|.+||+ ++++++
T Consensus 237 ~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 237 ANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHHHhccChhhCCchHHHHhc
Confidence 777888899999999996 588874
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=305.47 Aligned_cols=199 Identities=27% Similarity=0.429 Sum_probs=171.4
Q ss_pred hhhcCccCceEEEEEEe-CCCcEEEEEEeccCC--CCHHHHHHHHHHHhccCCCceEEEEeEEEeCC------eeeEEEE
Q 040604 298 RDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSR--CNGEEFINEVASISRTSHVNIVTFLGFCYENK------KNALIYE 368 (582)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv~E 368 (582)
.+.||+||||.||+|+. .+|+.||||.++... ...+...+|+++|++++|+|||+++++=.+.. ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 47899999999999984 589999999997643 35678899999999999999999999865433 5679999
Q ss_pred ecCCCChhhhhhcC-CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC--CC--ceEEeeccccccc
Q 040604 369 LMPNGSLDKFIHND-RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE--DF--CPKISDFGLAKQA 443 (582)
Q Consensus 369 ~~~~gsL~~~i~~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~--~~--~vkl~DFGla~~~ 443 (582)
||.||+|...+.+- ...++++.+++.++.++..||.|||+. +|+||||||.||++-. +| .-||+|||.|+.+
T Consensus 98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 99999999999864 345799999999999999999999987 9999999999999842 23 4799999999998
Q ss_pred cccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcc
Q 040604 444 QKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTD 503 (582)
Q Consensus 444 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~ 503 (582)
..+.... ...||..|++||.+.++ +.++..+|.|||||++||.+||..||......
T Consensus 175 ~d~s~~~---S~vGT~~YLhPel~E~q-~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 175 DDNSLFT---SLVGTEEYLHPELYERQ-KKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred CCCCeee---eecCchhhcChHHHhhc-cCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 8876443 45699999999999853 57899999999999999999999999765544
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=331.28 Aligned_cols=249 Identities=27% Similarity=0.387 Sum_probs=197.6
Q ss_pred hhcCccCceEEEEEE-eCCCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCC
Q 040604 299 DKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGS 374 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 374 (582)
.+||.|.||.||.|. ..+|+..|+|-++--.. ....+.+|+.++..++|||+|+++|+-...+..+|.||||++|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 479999999999995 56899999998864332 23457889999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce--ee
Q 040604 375 LDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI--SM 452 (582)
Q Consensus 375 L~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~--~~ 452 (582)
|.+++...+ .+++.....+-.|++.|+.|||++ |||||||||+||||+.+|.+|++|||.|..+....... ..
T Consensus 1321 La~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el 1395 (1509)
T KOG4645|consen 1321 LASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGEL 1395 (1509)
T ss_pred HHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHH
Confidence 999997654 355555566789999999999998 99999999999999999999999999999876653111 11
Q ss_pred ecccCCccccccccccccc-CCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHH
Q 040604 453 LHARGTIGYIAPEVYSRRF-GGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~-~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 531 (582)
....||+.|||||++.+.. .+-..++||||+||+++||+||++||......-. .++ +...+..+.++..
T Consensus 1396 ~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a----IMy-~V~~gh~Pq~P~~----- 1465 (1509)
T KOG4645|consen 1396 QSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA----IMY-HVAAGHKPQIPER----- 1465 (1509)
T ss_pred HhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH----HHh-HHhccCCCCCchh-----
Confidence 2346999999999997642 2345689999999999999999999976544321 122 3344444444322
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 040604 532 KKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le 564 (582)
+..+-.+++.+||+.||++|.++.|+++.--
T Consensus 1466 --ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f 1496 (1509)
T KOG4645|consen 1466 --LSSEGRDFLEHCLEQDPKMRWTASQLLEHAF 1496 (1509)
T ss_pred --hhHhHHHHHHHHHhcCchhhhHHHHHHHhhc
Confidence 5555667778899999999999888776543
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=300.08 Aligned_cols=243 Identities=23% Similarity=0.351 Sum_probs=199.2
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCH---HHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNG---EEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
.+.++||+|.|+.|.+|... ++..||||.+.++..+. ..+.+|+.+|..++|||||+|+.+......+|+||||+.
T Consensus 59 ~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~ 138 (596)
T KOG0586|consen 59 VIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYAS 138 (596)
T ss_pred eeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEecc
Confidence 45678999999999999654 79999999998876543 457899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
+|.+.+++.+.+ ...+..+..++.|+..|++|||++ .|+|||||++||||+.+..+||+|||++..+.......
T Consensus 139 ~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lq- 212 (596)
T KOG0586|consen 139 GGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQ- 212 (596)
T ss_pred CchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeeccccccc-
Confidence 999999998765 344578888999999999999998 99999999999999999999999999999887544332
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHH
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 531 (582)
..+|++.|.|||++.+. ....+++|+||+|++||.|+.|..||+...-... .++...+ .++++-.+..+.
T Consensus 213 --t~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L------r~rvl~g-k~rIp~~ms~dc 282 (596)
T KOG0586|consen 213 --TFCGSPPYAAPELFNGK-KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL------RPRVLRG-KYRIPFYMSCDC 282 (596)
T ss_pred --ccCCCCCccChHhhcCc-ccCCcceehhhhhhhheeeeecccccCCcccccc------cchheee-eecccceeechh
Confidence 35799999999999886 4678999999999999999999999987644321 1111111 123334444455
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 532 KKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
++++++ +|-.+|.+|++++++.+
T Consensus 283 e~lLrk-------~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 283 EDLLRK-------FLVLNPSKRGPCDQIMK 305 (596)
T ss_pred HHHHHH-------hhccCccccCCHHHhhh
Confidence 555444 55789999999999874
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=277.21 Aligned_cols=245 Identities=24% Similarity=0.291 Sum_probs=200.4
Q ss_pred hhcCccCceEEEEEEe-CCCcEEEEEEeccCCCCHHHHHHHHHHHhc-cCCCceEEEEeEEEe----CCeeeEEEEecCC
Q 040604 299 DKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNGEEFINEVASISR-TSHVNIVTFLGFCYE----NKKNALIYELMPN 372 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~~lv~E~~~~ 372 (582)
++||-|-.|.|-.+.. .+|+.+|+|++..+ ....+|++.--. -.|+|||.+++++.+ ...+.+|||.|+|
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meG 143 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEG 143 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccc
Confidence 6899999999999954 48999999999654 345677776433 469999999998864 3455789999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---CCceEEeeccccccccccccc
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE---DFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~---~~~vkl~DFGla~~~~~~~~~ 449 (582)
|.|...|+.++...+++.++.+|+.||..|+.|||+. +|.||||||+|+|... |..+||+|||+|+......
T Consensus 144 GeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~-- 218 (400)
T KOG0604|consen 144 GELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG-- 218 (400)
T ss_pred hHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCCCc--
Confidence 9999999999988999999999999999999999998 9999999999999964 5679999999999865432
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
....++-||.|.|||++... .+....|+||+||++|-||+|-+||....... +..-+..+|..+.. ....+
T Consensus 219 -~L~TPc~TPyYvaPevlg~e--KydkscdmwSlgVimYIlLCGyPPFYS~hg~a--ispgMk~rI~~gqy----~FP~p 289 (400)
T KOG0604|consen 219 -DLMTPCFTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--ISPGMKRRIRTGQY----EFPEP 289 (400)
T ss_pred -cccCCcccccccCHHHhCch--hcCCCCCccchhHHHHHhhcCCCcccccCCcc--CChhHHhHhhccCc----cCCCh
Confidence 33457899999999999764 68888999999999999999999998664422 22335566666542 23345
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
+...+.+...+++...|+.+|++|.|++++++
T Consensus 290 EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 290 EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred hHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 55677777788888899999999999999875
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=291.25 Aligned_cols=248 Identities=25% Similarity=0.347 Sum_probs=193.5
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC----CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 368 (582)
++...+.||+|+||.||+|... +++.+|+|.+..... ....+.+|+.++++++|+|++++++++.+....++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3455678999999999999764 688999999864321 23467889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
|+. |+|.+++.... ..+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++.......
T Consensus 96 ~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~- 169 (308)
T cd06634 96 YCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN- 169 (308)
T ss_pred ccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCcc-
Confidence 995 68877765432 3588999999999999999999987 99999999999999999999999999987654322
Q ss_pred ceeeecccCCccccccccccc-ccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcC
Q 040604 449 AISMLHARGTIGYIAPEVYSR-RFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527 (582)
Q Consensus 449 ~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 527 (582)
...|++.|+|||.+.. ..+.++.++|||||||++|||++|+.|+....... .... +........
T Consensus 170 -----~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~-~~~~~~~~~---- 234 (308)
T cd06634 170 -----XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----ALYH-IAQNESPAL---- 234 (308)
T ss_pred -----cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-----HHHH-HhhcCCCCc----
Confidence 2358899999999753 11357889999999999999999999986543221 1111 111111111
Q ss_pred cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 040604 528 TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564 (582)
Q Consensus 528 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le 564 (582)
........+.+++.+||+.+|++||++++|++...
T Consensus 235 --~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 235 --QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred --CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 01123456778889999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=289.33 Aligned_cols=260 Identities=23% Similarity=0.337 Sum_probs=201.5
Q ss_pred HHHHHHHhhhhcCccCceEEEEE-EeCCCcEEEEEEeccCCCCH--------HHHHHHHHHHhccCCCceEEEEeEEE-e
Q 040604 290 VKRMTKSFRDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNG--------EEFINEVASISRTSHVNIVTFLGFCY-E 359 (582)
Q Consensus 290 ~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~--------~~~~~E~~~l~~l~h~niv~l~~~~~-~ 359 (582)
....+|-+...||+|||+.||+| .+..++.||||+-...+.+. +...+|..+-+.|.||.||++|+++. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 44556677789999999999999 56678999999976554433 23678999999999999999999996 4
Q ss_pred CCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---CCceEEee
Q 040604 360 NKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE---DFCPKISD 436 (582)
Q Consensus 360 ~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~---~~~vkl~D 436 (582)
.+..+-|+|||+|.+|+-+++..+ .++++++..|+.||+.||.||... .++|||-||||.||||.. .|.+||.|
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 556789999999999999998654 689999999999999999999986 679999999999999954 47899999
Q ss_pred ccccccccccccc-----eeeecccCCccccccccccc--ccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhH
Q 040604 437 FGLAKQAQKKESA-----ISMLHARGTIGYIAPEVYSR--RFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHN 509 (582)
Q Consensus 437 FGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~ 509 (582)
|||++.+...... ..+....||.+|++||.+.- .+..++.|+||||+|||+|+-+.|++||.......+.+..
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe 696 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE 696 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence 9999988754322 22335679999999998753 3567899999999999999999999999876544332211
Q ss_pred HHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 040604 510 LIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVL 560 (582)
Q Consensus 510 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl 560 (582)
+.|.+.....++. ...+..+..+++.+||+..-++|....++.
T Consensus 697 ---NTIlkAtEVqFP~-----KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 697 ---NTILKATEVQFPP-----KPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred ---hchhcceeccCCC-----CCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 2222222222221 112223344566779999999998887775
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=288.97 Aligned_cols=250 Identities=24% Similarity=0.326 Sum_probs=194.1
Q ss_pred HhhhhcCccCceEEEEEEe----CCCcEEEEEEeccCC-----CCHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeeeE
Q 040604 296 SFRDKLGQGGYGEVYKGEL----PDGQLVAVKVLKNSR-----CNGEEFINEVASISRT-SHVNIVTFLGFCYENKKNAL 365 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 365 (582)
++.+.||+|+||.||++.. .+|+.||+|+++... ...+.+.+|+.++.++ +|+||+++++.+..+...++
T Consensus 3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (290)
T cd05613 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL 82 (290)
T ss_pred eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence 4567899999999999965 378999999987532 2236678899999999 59999999999998888999
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++....
T Consensus 83 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 83 ILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 999999999999987643 578899999999999999999997 999999999999999999999999999987544
Q ss_pred cccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCC
Q 040604 446 KESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525 (582)
Q Consensus 446 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 525 (582)
.... ......|+..|+|||.+.......+.++||||||+++|+|++|+.|+........ ... +...+..... ...
T Consensus 158 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-~~~-~~~~~~~~~~-~~~- 232 (290)
T cd05613 158 DEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS-QAE-ISRRILKSEP-PYP- 232 (290)
T ss_pred cccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc-HHH-HHHHhhccCC-CCC-
Confidence 3221 1123458999999999875434578899999999999999999999864322211 111 1122211111 111
Q ss_pred cCcHHHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 040604 526 VATEEEKKIAKMMILVGFWCIQTNPSERP-----SMHKVLE 561 (582)
Q Consensus 526 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~ 561 (582)
..+...+.+++.+||+.||++|| ++++++.
T Consensus 233 ------~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 233 ------QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ------ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 12345667788899999999997 6677765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=275.89 Aligned_cols=255 Identities=24% Similarity=0.387 Sum_probs=205.4
Q ss_pred hhhcCccCceEEEEE-EeCCCcEEEEEEeccCCC-CHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeeeEEEEecCCCC
Q 040604 298 RDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRC-NGEEFINEVASISRT-SHVNIVTFLGFCYENKKNALIYELMPNGS 374 (582)
Q Consensus 298 ~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~gs 374 (582)
.+.||+|+|+.|-.+ .+.+|..||||++.+... ....+.+|++++.+. .|+||+.|+++|.+++..|||||.|.||.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 368999999999998 467999999999976544 346788999999997 49999999999999999999999999999
Q ss_pred hhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC---ceEEeecccccccccc-----
Q 040604 375 LDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF---CPKISDFGLAKQAQKK----- 446 (582)
Q Consensus 375 L~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~---~vkl~DFGla~~~~~~----- 446 (582)
|..+|++.+ .+++.++.++..+|+.||.+||.+ ||.||||||+|||-.+.. -|||+||.+.......
T Consensus 163 lLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 163 LLSHIQKRK--HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 999998654 689999999999999999999998 999999999999986543 4899999887653321
Q ss_pred ccceeeecccCCccccccccc---ccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcc---------cchhhHHHHHh
Q 040604 447 ESAISMLHARGTIGYIAPEVY---SRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTD---------TSICHNLIYER 514 (582)
Q Consensus 447 ~~~~~~~~~~gt~~y~aPE~~---~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~---------~~~~~~~~~~~ 514 (582)
.+......++|+..|||||+. .+.-..|..+.|.||||||||-||+|-+||...-.. -..+.+.+.+.
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 122334457899999999985 333346889999999999999999999999643221 11566777788
Q ss_pred hcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 515 IEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 515 i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
|+.+... + ...+...+..+..+++...|-.|+.+|.++.+++.
T Consensus 318 IQEGkYe-F---PdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 318 IQEGKYE-F---PDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HhccCCc-C---ChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 8877532 2 22344456666667777778899999999998876
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=298.76 Aligned_cols=258 Identities=23% Similarity=0.322 Sum_probs=193.7
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC---CCHHHHHHHHHHHhccCCCceEEEEeEEEe----CCeeeEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR---CNGEEFINEVASISRTSHVNIVTFLGFCYE----NKKNALI 366 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv 366 (582)
+.+.+.||+|++|.||+|... +|+.||+|++.... .....+.+|+.++++++|+||+++++++.. ....++|
T Consensus 7 y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 86 (334)
T cd07855 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVV 86 (334)
T ss_pred eeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEE
Confidence 445678999999999999654 79999999987542 234567789999999999999999998763 3467899
Q ss_pred EEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccc
Q 040604 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~ 446 (582)
|||+ +++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 87 ~e~~-~~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 87 MDLM-ESDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred Eehh-hhhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 9999 578988886543 589999999999999999999997 9999999999999999999999999999865433
Q ss_pred ccc--eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCC-----
Q 040604 447 ESA--ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGN----- 519 (582)
Q Consensus 447 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~----- 519 (582)
... .......|+..|+|||.+.+. ..++.++||||||+++|||++|+.||........ . ..+........
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~-~-~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ-L-KLILSVLGSPSEEVLN 237 (334)
T ss_pred CcCCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHH-H-HHHHHHhCCChhHhhh
Confidence 221 111234689999999998653 4578999999999999999999999965432211 0 00001000000
Q ss_pred -------------CCCCCCcC-cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 520 -------------DFQFDGVA-TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 520 -------------~~~~~~~~-~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
........ ..........+.+++.+||+.+|++||++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00000000 0111234567888999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=289.45 Aligned_cols=266 Identities=25% Similarity=0.374 Sum_probs=201.9
Q ss_pred HhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhc--cCCCceEEEEeEEEeCC----eeeEEEEe
Q 040604 296 SFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISR--TSHVNIVTFLGFCYENK----KNALIYEL 369 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~lv~E~ 369 (582)
++.+.||+|.||.||+|.+ +++.||||++... +.+.|.+|-.+.+. ++|+||+++++.-.... .+.||+||
T Consensus 213 ~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~--~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ--EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hhHHHhhcCccceeehhhc-cCceeEEEecCHH--HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 4568899999999999998 5699999999643 35678888777665 68999999998876544 77899999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhC------CCCceEecCCCCCCEEEcCCCceEEeeccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRG------CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQA 443 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~------~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~ 443 (582)
.+.|+|.+++..+ .++|....+|+..+++||+|||+. +.++|+|||||..|||+..+++.-|+|||+|..+
T Consensus 290 h~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 290 HPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL 366 (534)
T ss_pred ccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence 9999999999865 599999999999999999999974 3578999999999999999999999999999988
Q ss_pred cccccceeeecccCCcccccccccccccCCCC-----ccchhHHHHHHHHHHhcCCCCCCCCCcccc------------h
Q 040604 444 QKKESAISMLHARGTIGYIAPEVYSRRFGGVS-----HKSDVYSYGMMIIEMVGCTKNLDDEVTDTS------------I 506 (582)
Q Consensus 444 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s-----~~~DvwSlGvil~elltg~~p~~~~~~~~~------------~ 506 (582)
............+||.+|||||++.+.. .+. .+.||||+|.+||||+++-...+.....+. .
T Consensus 367 ~p~~~~~d~~~qVGT~RYMAPEvLEgai-nl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 367 EPGKPQGDTHGQVGTRRYMAPEVLEGAI-NLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred cCCCCCcchhhhhhhhhhcCHHHHhhhc-ccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 7665554444567999999999997642 233 367999999999999987765542111110 1
Q ss_pred hhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCC
Q 040604 507 CHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENL 570 (582)
Q Consensus 507 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~ 570 (582)
+.++..-...+..++.++..-. ...-++.+.+.+..||..|++-|.|+.=|.+.+......-
T Consensus 446 ~e~mq~~VV~kK~RP~~p~~W~--~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 446 LEEMQELVVRKKQRPKIPDAWR--KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred HHHHHHHHHhhccCCCChhhhh--cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 1111111122222222322111 1134567888889999999999999988887777644433
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=289.08 Aligned_cols=242 Identities=27% Similarity=0.388 Sum_probs=190.0
Q ss_pred hhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC----CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 298 RDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
.++||+|+||+||+|... +++.||+|++..... ..+.+.+|+.++++++|+|++++++++.+....++||||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 467999999999999764 789999999864322 22467889999999999999999999999999999999995
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
|+|.+++.... .++++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 105 ~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~----- 175 (313)
T cd06633 105 GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN----- 175 (313)
T ss_pred CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCCC-----
Confidence 67777775432 3689999999999999999999988 99999999999999999999999999986533221
Q ss_pred ecccCCccccccccccc-ccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHH
Q 040604 453 LHARGTIGYIAPEVYSR-RFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~-~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 531 (582)
...|+..|+|||++.. ..+.++.++||||||+++|||++|..|+........ +........ .... .
T Consensus 176 -~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~-----~~~~~~~~~-~~~~------~ 242 (313)
T cd06633 176 -SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQNDS-PTLQ------S 242 (313)
T ss_pred -CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHhcCC-CCCC------c
Confidence 2358899999999853 124678899999999999999999999876533221 111111111 1110 1
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 532 KKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
..+...+.+++.+||+.+|.+||++.++++.
T Consensus 243 ~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 243 NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1223457778889999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=289.46 Aligned_cols=254 Identities=24% Similarity=0.270 Sum_probs=196.6
Q ss_pred HhhhhcCccCceEEEEEEe----CCCcEEEEEEeccCC-----CCHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeeeE
Q 040604 296 SFRDKLGQGGYGEVYKGEL----PDGQLVAVKVLKNSR-----CNGEEFINEVASISRT-SHVNIVTFLGFCYENKKNAL 365 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 365 (582)
.+.+.||+|++|.||++.. .+++.+|||+++... ...+.+.+|+.++.++ +|+||+++++.+..+...++
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l 82 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL 82 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence 4567899999999999864 357899999987532 2235678999999999 59999999999998889999
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
||||+++|+|.+++... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 83 ILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 99999999999998754 3588999999999999999999987 999999999999999999999999999887554
Q ss_pred cccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCC
Q 040604 446 KESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525 (582)
Q Consensus 446 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 525 (582)
..... .....|+..|+|||.+.+.....+.++||||||++++||++|..|+........ ............ .....
T Consensus 158 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~--~~~~~ 233 (288)
T cd05583 158 EEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS-QSEISRRILKSK--PPFPK 233 (288)
T ss_pred ccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch-HHHHHHHHHccC--CCCCc
Confidence 32211 112358999999999876433478899999999999999999999864322111 111111111111 11111
Q ss_pred cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 526 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
.+...+.+++.+||+.+|++|||++++.+.|+.
T Consensus 234 -------~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 234 -------TMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -------ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 123456778888999999999999988888765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=294.91 Aligned_cols=256 Identities=21% Similarity=0.274 Sum_probs=189.0
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC---CCHHHHHHHHHHHhccCCCceEEEEeEEEeCC------eeeE
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR---CNGEEFINEVASISRTSHVNIVTFLGFCYENK------KNAL 365 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l 365 (582)
...+.||+|+||.||+|... +|+.||||+++... .....+.+|+.++++++|+||+++++++.... ..++
T Consensus 18 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 97 (342)
T cd07879 18 TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYL 97 (342)
T ss_pred EEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEE
Confidence 34578999999999999754 78999999986532 22356789999999999999999999987542 4589
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
|+||+. .+|..++. ..+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++....
T Consensus 98 v~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 98 VMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred Eecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 999995 57766652 2588899999999999999999998 999999999999999999999999999986543
Q ss_pred cccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHH----------Hhh
Q 040604 446 KESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIY----------ERI 515 (582)
Q Consensus 446 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~----------~~i 515 (582)
.. ....||+.|+|||.+.+. ..++.++||||||+++|||++|+.||........ ....+. +.+
T Consensus 170 ~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07879 170 EM-----TGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKVTGVPGPEFVQKL 242 (342)
T ss_pred CC-----CCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHHh
Confidence 22 123578899999998653 3578899999999999999999999975432111 111000 000
Q ss_pred cCCCC----CCCCCcCcHH----HHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--Hhcc
Q 040604 516 EPGND----FQFDGVATEE----EKKIAKMMILVGFWCIQTNPSERPSMHKVLEM--LEGS 566 (582)
Q Consensus 516 ~~~~~----~~~~~~~~~~----~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~--Le~~ 566 (582)
..... .......... .......+.+++.+||+.||++||++++++.. +++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00000 0000000000 01223557789999999999999999999944 6653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=293.76 Aligned_cols=260 Identities=23% Similarity=0.320 Sum_probs=191.1
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCC--------
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENK-------- 361 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 361 (582)
.+.+.++||+|+||.||+|... +++.+|+|++..... ....+.+|+.++++++|+||+++++++.+..
T Consensus 9 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 88 (311)
T cd07866 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRG 88 (311)
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCc
Confidence 3455688999999999999754 689999999854322 2346788999999999999999999876543
Q ss_pred eeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccc
Q 040604 362 KNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAK 441 (582)
Q Consensus 362 ~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~ 441 (582)
..++||||+. ++|...+... ...+++..+..++.|+++||+|||+. +|+|+||||+||++++++.+||+|||+++
T Consensus 89 ~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 89 SVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred eEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccch
Confidence 3589999995 5677766543 34689999999999999999999998 99999999999999999999999999998
Q ss_pred cccccccc---------eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHH
Q 040604 442 QAQKKESA---------ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIY 512 (582)
Q Consensus 442 ~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 512 (582)
........ ...+...|++.|+|||.+.+. ..++.++||||||++++||++|+.|+........ .. .+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~-~~-~~~ 240 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ-LH-LIF 240 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH-HH-HHH
Confidence 65432211 111223578899999987653 3578899999999999999999999865433221 11 111
Q ss_pred HhhcCC--------------CC-CC---CCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 513 ERIEPG--------------ND-FQ---FDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 513 ~~i~~~--------------~~-~~---~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
...... .. .. ...............+.+++.+||+.||++|||+.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 111000 00 00 000000111123356788999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=285.07 Aligned_cols=246 Identities=25% Similarity=0.337 Sum_probs=191.7
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC------CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR------CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 367 (582)
+.+.++||+|+||.||++... .+..+++|+++... .....+..|+.++++++||||+++++.+.+....++||
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 456789999999999999764 45556677665321 12345678999999999999999999999989999999
Q ss_pred EecCCCChhhhhhcC--CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 368 ELMPNGSLDKFIHND--RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 368 E~~~~gsL~~~i~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
||+++++|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+||++++ +.+||+|||+++....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999999988642 334689999999999999999999987 9999999999999975 5699999999987644
Q ss_pred cccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCC
Q 040604 446 KESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525 (582)
Q Consensus 446 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 525 (582)
.... .....|++.|+|||.+.. ..++.++|+||||+++|+|++|..|+...... . ....+..+....+
T Consensus 158 ~~~~--~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~-~~~~~~~~~~~~~-- 225 (260)
T cd08222 158 SCDL--ATTFTGTPYYMSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL-----S-VVLRIVEGPTPSL-- 225 (260)
T ss_pred Cccc--ccCCCCCcCccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----H-HHHHHHcCCCCCC--
Confidence 3221 123458899999998865 36788999999999999999999998643211 1 1122222222211
Q ss_pred cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 526 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.......+.+++.+||+.+|++||++.++++
T Consensus 226 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 226 -----PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -----cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1234456788889999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=280.56 Aligned_cols=247 Identities=25% Similarity=0.310 Sum_probs=191.2
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC------CCHHHHHHHHHHHhccCCCceEEEEeEEEeC--CeeeE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR------CNGEEFINEVASISRTSHVNIVTFLGFCYEN--KKNAL 365 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 365 (582)
+.+.+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.++++++|+||+++++++.+. ...++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 345688999999999999754 68999999875321 1224678899999999999999999998764 45789
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
+|||+++++|.+++.... .+++....+++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++....
T Consensus 84 v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 84 FVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 999999999999987543 478899999999999999999988 999999999999999999999999999986543
Q ss_pred ccc-ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCC
Q 040604 446 KES-AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFD 524 (582)
Q Consensus 446 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 524 (582)
... ........|+..|+|||++.+. .++.++|+||||+++++|++|+.||....... .+.+.........++
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~p 231 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGE--GYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-----AIFKIATQPTKPMLP 231 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccCHHH-----HHHHHHcCCCCCCCC
Confidence 211 1111234589999999998763 67899999999999999999999987542221 112222222122222
Q ss_pred CcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 525 GVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 525 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
..+.+.+.+++.+||+ +|..||++.+++.
T Consensus 232 -------~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 232 -------DGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -------cccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 2234556677778888 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=287.28 Aligned_cols=246 Identities=24% Similarity=0.347 Sum_probs=196.1
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC----CHHHHHHHHHHHhccC-CCceEEEEeEEEeCCeeeEEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEVASISRTS-HVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E 368 (582)
+.+.+.||+|+||.||++... +++.+|+|++..... ..+.+.+|+.++++++ |+||+++++++......++|||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 345678999999999999765 799999999876322 2356788999999999 9999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
++++++|.+++...+ .+++..++.|+.|++.||.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 83 YAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 999999999997654 689999999999999999999987 999999999999999999999999999986544321
Q ss_pred c------------------eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHH
Q 040604 449 A------------------ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNL 510 (582)
Q Consensus 449 ~------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~ 510 (582)
. .......|+..|+|||.+.. ...+.++|+||||+++++|++|+.|+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------ 229 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL------ 229 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCC--CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH------
Confidence 1 11123357899999998876 368899999999999999999999987553211
Q ss_pred HHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCH----HHHHH
Q 040604 511 IYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSM----HKVLE 561 (582)
Q Consensus 511 ~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~----~evl~ 561 (582)
..+.+.... ..+. ..+...+.+++.+||+.+|++||++ +++++
T Consensus 230 ~~~~~~~~~-~~~~-------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 230 TFQKILKLE-YSFP-------PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHHhcC-CCCC-------CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111111110 1111 1224567788889999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=275.83 Aligned_cols=201 Identities=26% Similarity=0.351 Sum_probs=168.0
Q ss_pred HHhhhhcCccCceEEEEEEeC---C--CcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEe-CCeeeE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP---D--GQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYE-NKKNAL 365 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l 365 (582)
++...+||+|.||.||+|... + .+.+|||.++..+. -.....+|+.+++.++|+||+.|..++.. +...+|
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l 105 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL 105 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence 455678999999999999443 2 23799999976532 33568899999999999999999999988 678899
Q ss_pred EEEecCCCChhhhhhcC---CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC----CceEEeecc
Q 040604 366 IYELMPNGSLDKFIHND---RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED----FCPKISDFG 438 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~----~~vkl~DFG 438 (582)
++||. .-+|.++|+.. ....++...+..|+.||+.|+.|||+. =|+||||||.|||+..+ |.|||+|||
T Consensus 106 ~fdYA-EhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 106 LFDYA-EHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred Eehhh-hhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeeccc
Confidence 99999 56888888643 234688899999999999999999998 79999999999999877 899999999
Q ss_pred ccccccccccc-eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCC
Q 040604 439 LAKQAQKKESA-ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDE 500 (582)
Q Consensus 439 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~ 500 (582)
+++.+...-.. .+...+.-|++|.|||.+.+. ..||.+.||||+|||+.||+|.++.|...
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccch
Confidence 99987654322 233345689999999999886 68999999999999999999999888543
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=293.25 Aligned_cols=258 Identities=21% Similarity=0.273 Sum_probs=192.7
Q ss_pred HHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCC------eee
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENK------KNA 364 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~ 364 (582)
+.+.+.||+|+||.||++.. .+++.||||++..... ..+.+.+|+.++++++|+||+++++++.... ..+
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07880 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFY 96 (343)
T ss_pred eEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEE
Confidence 44557899999999999965 4799999999865322 2346789999999999999999999987543 348
Q ss_pred EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccc
Q 040604 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~ 444 (582)
+||||+ +++|.+++.. ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 97 lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 97 LVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred EEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 999999 8899888864 2589999999999999999999998 99999999999999999999999999998754
Q ss_pred ccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHH----------HHh
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLI----------YER 514 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~----------~~~ 514 (582)
.... ...+++.|+|||.+.+. ..++.++|+||||+++++|++|+.||........ ..... .+.
T Consensus 170 ~~~~-----~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07880 170 SEMT-----GYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ-LMEIMKVTGTPSKEFVQK 242 (343)
T ss_pred cCcc-----ccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHh
Confidence 3221 23578999999998653 3578999999999999999999999875432111 00000 000
Q ss_pred hcCCCC----CCCCCcCcH----HHHHHHHHHHHHHHhccccCCCCCCCHHHHH--HHHhcc
Q 040604 515 IEPGND----FQFDGVATE----EEKKIAKMMILVGFWCIQTNPSERPSMHKVL--EMLEGS 566 (582)
Q Consensus 515 i~~~~~----~~~~~~~~~----~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl--~~Le~~ 566 (582)
+..... ..+...... ........+.+++.+||+.||++|||+.+++ ..++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 000000 000000000 0112344578899999999999999999998 444443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=290.12 Aligned_cols=255 Identities=24% Similarity=0.301 Sum_probs=188.0
Q ss_pred HHhhhhcCccCceEEEEEEeC-C--CcEEEEEEeccCC---CCHHHHHHHHHHHhcc-CCCceEEEEeEEEeC----Cee
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-D--GQLVAVKVLKNSR---CNGEEFINEVASISRT-SHVNIVTFLGFCYEN----KKN 363 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~~ 363 (582)
+.+.+.||+|+||.||++... . +..||+|.+.... ...+.+.+|+.+++++ +|+||+++++.+... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 345678999999999999764 4 7899999986432 2245678899999999 599999999875432 356
Q ss_pred eEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccc
Q 040604 364 ALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQA 443 (582)
Q Consensus 364 ~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~ 443 (582)
++++|++ +++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 82 ~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 82 YLYEELM-EADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEecc-cCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 7889998 57898888654 3688999999999999999999998 9999999999999999999999999999865
Q ss_pred cccccc--eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHH----------
Q 040604 444 QKKESA--ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLI---------- 511 (582)
Q Consensus 444 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~---------- 511 (582)
...... .......||+.|+|||++.+. ..++.++||||+|+++++|++|+.|+....... .+...+
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQVLGTPDEET 233 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHHHhCCCCHHH
Confidence 432211 111234689999999987653 357899999999999999999999886543211 000000
Q ss_pred HHhh------------cCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 512 YERI------------EPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 512 ~~~i------------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
...+ .......+. .........+.+++.+||+.||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFE----SIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchH----hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000 000000000 000112456788999999999999999999863
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=284.26 Aligned_cols=255 Identities=27% Similarity=0.357 Sum_probs=196.3
Q ss_pred hhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC---CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 297 FRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR---CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 297 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
+.+.||+|++|.||+|... +++.+|+|++.... ...+.+.+|+.++++++|+|++++++++.+....++||||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD- 81 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence 4578999999999999765 69999999997643 234678899999999999999999999999999999999996
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||+|+||++++++.+||+|||+++........ .
T Consensus 82 ~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~ 155 (282)
T cd07829 82 MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT--Y 155 (282)
T ss_pred cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc--c
Confidence 69999997643 3689999999999999999999998 9999999999999999999999999999876543321 1
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhc-----------CC--C
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIE-----------PG--N 519 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~-----------~~--~ 519 (582)
....++..|+|||.+... ..++.++||||||++++||++|+.|+........ ... +.+... .. .
T Consensus 156 ~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 156 THEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ-LFK-IFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred CccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHH-HHHHhCCCcHHHHHhhcccccc
Confidence 123467889999998653 3678999999999999999999988865432211 000 000000 00 0
Q ss_pred CCCCCCcCc----HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 520 DFQFDGVAT----EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 520 ~~~~~~~~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
...+..... .....+...+.+++.+||+.+|++||++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000111000 111123567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=291.31 Aligned_cols=262 Identities=23% Similarity=0.297 Sum_probs=199.3
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC---CCHHHHHHHHHHHhccCCCceEEEEeEEEeCC-----eeeE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR---CNGEEFINEVASISRTSHVNIVTFLGFCYENK-----KNAL 365 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l 365 (582)
+.+.+.||.|++|.||+|... +++.+|||++.... ...+.+.+|+.++++++|+||+++++++.... ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 345688999999999999765 58999999987643 23467889999999999999999999998765 7899
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
||||++ ++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++.....
T Consensus 82 v~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 82 VTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred Eecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 999996 68988887543 789999999999999999999998 999999999999999999999999999987655
Q ss_pred cccc-eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCC-
Q 040604 446 KESA-ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQF- 523 (582)
Q Consensus 446 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~- 523 (582)
.... .......+|+.|+|||++.+. ..++.++|+||||+++++|++|+.||........ .. .+...........+
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~-~~-~i~~~~~~~~~~~~~ 232 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-LN-LIVEVLGTPSEEDLK 232 (330)
T ss_pred cccccccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH-HH-HHHHhcCCCChhHhh
Confidence 4310 111233588999999998764 3688999999999999999999999876543211 00 01111100000000
Q ss_pred --------------CCc----CcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--Hhc
Q 040604 524 --------------DGV----ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM--LEG 565 (582)
Q Consensus 524 --------------~~~----~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~--Le~ 565 (582)
... .......+...+.+++.+||+.+|++||+++++++. +++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence 000 000011245667889999999999999999999974 544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=290.97 Aligned_cols=253 Identities=21% Similarity=0.264 Sum_probs=188.4
Q ss_pred HHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeC------Ceee
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYEN------KKNA 364 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 364 (582)
+.+.+.||+|+||.||+|.. .+++.||+|+++.... ..+.+.+|+.++++++|+||+++++++... ...+
T Consensus 19 y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 98 (345)
T cd07877 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 98 (345)
T ss_pred eEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEE
Confidence 33457899999999999965 4789999999875322 245678899999999999999999988643 2357
Q ss_pred EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccc
Q 040604 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~ 444 (582)
+++|++ +++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 99 lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 99 LVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred EEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 888887 88998887643 489999999999999999999998 99999999999999999999999999988654
Q ss_pred ccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCC
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFD 524 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 524 (582)
... ....||+.|+|||.+.+. ..++.++||||||++++||++|+.|+........ ....+. ...........
T Consensus 172 ~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~-~~~~~~~~~~~ 243 (345)
T cd07877 172 DEM-----TGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILR-LVGTPGAELLK 243 (345)
T ss_pred ccc-----cccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH-HhCCCCHHHHh
Confidence 321 123588999999988653 3578899999999999999999999865432211 111100 00000000000
Q ss_pred CcC-------------------cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 525 GVA-------------------TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 525 ~~~-------------------~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
... ..........+.+++.+||+.||++||++.++++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000 00000123457789999999999999999998854
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=275.77 Aligned_cols=235 Identities=31% Similarity=0.392 Sum_probs=190.9
Q ss_pred cCccCceEEEEEEeC-CCcEEEEEEeccCCC----CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCCh
Q 040604 301 LGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSL 375 (582)
Q Consensus 301 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 375 (582)
||+|+||.||++... +++.+|+|+++.... ..+.+.+|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 799999999999765 689999999876443 345788999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeecc
Q 040604 376 DKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHA 455 (582)
Q Consensus 376 ~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 455 (582)
.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTF 153 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCC
Confidence 99997654 589999999999999999999997 999999999999999999999999999987654321 11234
Q ss_pred cCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHH
Q 040604 456 RGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIA 535 (582)
Q Consensus 456 ~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 535 (582)
.|+..|++||.+.+. ..+.++|+||||+++|+|++|+.|+....... ....+... ...++... .
T Consensus 154 ~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~~-~~~~~~~~-------~ 217 (250)
T cd05123 154 CGTPEYLAPEVLLGK--GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE------IYEKILKD-PLRFPEFL-------S 217 (250)
T ss_pred cCCccccChHHhCCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHhcC-CCCCCCCC-------C
Confidence 588999999998763 57889999999999999999999996543211 12222221 12222222 4
Q ss_pred HHHHHHHHhccccCCCCCCCHHH
Q 040604 536 KMMILVGFWCIQTNPSERPSMHK 558 (582)
Q Consensus 536 ~~l~~l~~~Cl~~dp~~RPt~~e 558 (582)
..+.+++.+||..||++||++++
T Consensus 218 ~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 218 PEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHHhcCCHhhCCCccc
Confidence 55677888899999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=286.58 Aligned_cols=253 Identities=23% Similarity=0.285 Sum_probs=190.4
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC---CCHHHHHHHHHHHhccCCCceEEEEeEEEe-CCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR---CNGEEFINEVASISRTSHVNIVTFLGFCYE-NKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~E~ 369 (582)
+.+.+.||.|+||.||++... +++.||+|.+.... ...+.+.+|+.++++++||||+++++++.. ....++||||
T Consensus 12 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~ 91 (328)
T cd07856 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL 91 (328)
T ss_pred eEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeeh
Confidence 445688999999999999654 89999999885422 234667899999999999999999999876 4578899999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+ +++|..++... .+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 92 ~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~-- 162 (328)
T cd07856 92 L-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQM-- 162 (328)
T ss_pred h-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCCc--
Confidence 9 67898888643 478888889999999999999998 99999999999999999999999999987643321
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcC-----------C
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEP-----------G 518 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~-----------~ 518 (582)
....++..|+|||.+.+. ..++.++||||||+++++|++|+.||........ . ..+.+.+.. .
T Consensus 163 ---~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd07856 163 ---TGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQ-F-SIITDLLGTPPDDVINTICSE 236 (328)
T ss_pred ---CCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-H-HHHHHHhCCCCHHHHHhccch
Confidence 123478899999987542 3678999999999999999999999865432111 0 000011000 0
Q ss_pred CC------CCCCCcCc--HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 519 ND------FQFDGVAT--EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 519 ~~------~~~~~~~~--~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
.. .......+ .....+...+.+++.+||+.+|++||++++++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 00000000 1111234678888999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=291.13 Aligned_cols=257 Identities=20% Similarity=0.225 Sum_probs=188.6
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeC------------
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYEN------------ 360 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------------ 360 (582)
+.+.+.||.|+||.||+|... +|+.||+|.+..... ..+.+.+|+.++++++||||+++++.+...
T Consensus 7 y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 86 (342)
T cd07854 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLT 86 (342)
T ss_pred eEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccccc
Confidence 445688999999999999654 789999999865443 346688999999999999999999776543
Q ss_pred --CeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc-CCCceEEeec
Q 040604 361 --KKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLD-EDFCPKISDF 437 (582)
Q Consensus 361 --~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~-~~~~vkl~DF 437 (582)
...++||||++ ++|.+++... .+++..+..++.|+++||.|||+. +|+||||||+||+++ +++.+||+||
T Consensus 87 ~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 87 ELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred ccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCc
Confidence 35689999995 6888887542 588999999999999999999988 999999999999997 4567999999
Q ss_pred cccccccccccce-eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHH----
Q 040604 438 GLAKQAQKKESAI-SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIY---- 512 (582)
Q Consensus 438 Gla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---- 512 (582)
|+++......... ......|+..|+|||.+.+. ..++.++|||||||++|||++|+.||........ ......
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~ 237 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILESVPV 237 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCC
Confidence 9997654321111 11123578899999987543 3578899999999999999999999975433211 000000
Q ss_pred --------------HhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 513 --------------ERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 513 --------------~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
..+....... ..........+...+.+++.+||+.||++|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEP-RRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CChHHhhhhhhhhhhhhhhccccc-CCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000000000 00000001124456778999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=287.86 Aligned_cols=241 Identities=28% Similarity=0.389 Sum_probs=192.7
Q ss_pred hhcCccCceEEEEEEe-CCCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCC
Q 040604 299 DKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGS 374 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 374 (582)
+.||+|.||+||-|+. ++|+.||||++.+.+. +.+.+.+|++||.+++||.||.|--.|...+..+.|||.+ .|+
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HGD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cch
Confidence 6899999999999965 4899999999976543 3467889999999999999999999999999999999999 566
Q ss_pred hhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC---CceEEeecccccccccccccee
Q 040604 375 LDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED---FCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 375 L~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~---~~vkl~DFGla~~~~~~~~~~~ 451 (582)
..+.|-......+++..-..++.||+.||.|||-+ +|+|.||||+|||+.+. -.+||+|||.|+.+..+....
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRr- 724 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRR- 724 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhhhh-
Confidence 55555544445788888888999999999999988 99999999999999754 469999999999987765432
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHH
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 531 (582)
.+.|||.|+|||++..+ .|+..-|+||+|||+|--|+|.-||..... +.++|+.... .++ +...
T Consensus 725 --sVVGTPAYLaPEVLrnk--GyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--------IndQIQNAaF-MyP---p~PW 788 (888)
T KOG4236|consen 725 --SVVGTPAYLAPEVLRNK--GYNRSLDMWSVGVIIYVSLSGTFPFNEDED--------INDQIQNAAF-MYP---PNPW 788 (888)
T ss_pred --hhcCCccccCHHHHhhc--cccccccceeeeEEEEEEecccccCCCccc--------hhHHhhcccc-ccC---CCch
Confidence 35699999999999874 789999999999999999999999965433 2233433221 111 1223
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 040604 532 KKIAKMMILVGFWCIQTNPSERPSMHKVL 560 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl 560 (582)
.++....++|+...||..-++|-|.++-+
T Consensus 789 ~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 789 SEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred hhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 45555566677777788888888776543
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=293.32 Aligned_cols=252 Identities=23% Similarity=0.286 Sum_probs=191.8
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC---CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCe------ee
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR---CNGEEFINEVASISRTSHVNIVTFLGFCYENKK------NA 364 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~ 364 (582)
+.+.+.||+|++|.||+|... +++.||||++.... ...+.+.+|+.++++++|+|++++++++...+. .+
T Consensus 17 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07851 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVY 96 (343)
T ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEE
Confidence 345578999999999999765 68899999986532 223567789999999999999999988766554 79
Q ss_pred EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccc
Q 040604 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~ 444 (582)
+|+||+ +++|.+++.. ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 97 lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 97 LVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred EEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 999999 7899998875 3589999999999999999999998 99999999999999999999999999998764
Q ss_pred ccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCC----
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND---- 520 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~---- 520 (582)
... ....++..|+|||.+.+. ..++.++||||||++++||++|+.||........ ... +.+.......
T Consensus 170 ~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~-~~~-i~~~~~~~~~~~~~ 241 (343)
T cd07851 170 DEM-----TGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ-LKR-IMNLVGTPDEELLQ 241 (343)
T ss_pred ccc-----cCCcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHH-HHHhcCCCCHHHHh
Confidence 432 223588899999998653 3678899999999999999999999865433211 110 1010000000
Q ss_pred ---------------CCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 521 ---------------FQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 521 ---------------~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.................+.+++.+||+.+|++|||+++|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000000111123567889999999999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=294.50 Aligned_cols=237 Identities=24% Similarity=0.297 Sum_probs=191.1
Q ss_pred HHHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCCHHHHHHHHHHHh-ccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 294 TKSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNGEEFINEVASIS-RTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
.+.+...+|.|+|+.|-++.. .+++..++|++.+... +-.+|+.++. .-+|+|++++.+.+.++.+.++|||.+.
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~---~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~ 399 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD---DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD 399 (612)
T ss_pred hhccccccCCCCccceeeeeccccccchhheecccccc---ccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence 345667899999999999854 4788999999976622 2234664444 4579999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE-cCCCceEEeeccccccccccccce
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL-DEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl-~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
|+-|.+.+...+ .....+..|+.+|+.|+.|||++ |||||||||+|||+ ++.++++|+|||.++.....
T Consensus 400 g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---- 469 (612)
T KOG0603|consen 400 GGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---- 469 (612)
T ss_pred ccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh----
Confidence 999888887654 22267778999999999999998 99999999999999 68999999999999987665
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHH
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 530 (582)
...++-|..|.|||++.. ..+++++||||||++||+||+|+.|+...... ..++.++..+.. .
T Consensus 470 -~~tp~~t~~y~APEvl~~--~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----~ei~~~i~~~~~---s------ 532 (612)
T KOG0603|consen 470 -CDTPALTLQYVAPEVLAI--QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----IEIHTRIQMPKF---S------ 532 (612)
T ss_pred -hcccchhhcccChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCccccCCch-----HHHHHhhcCCcc---c------
Confidence 223467889999999985 48999999999999999999999999765433 224455554421 1
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 531 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
..+.+...+|+.+||+.||.+||+|.++..
T Consensus 533 -~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 533 -ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred -cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 344555667777899999999999999864
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=272.21 Aligned_cols=220 Identities=20% Similarity=0.186 Sum_probs=174.7
Q ss_pred cCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCChhhhhhcC
Q 040604 304 GGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHND 382 (582)
Q Consensus 304 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~i~~~ 382 (582)
|.+|.||++... +++.+|+|+++... .+.+|...+....|||++++++++.+....++||||+++|+|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 899999999654 78999999997643 2344555566667999999999999999999999999999999998754
Q ss_pred CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeecccCCcccc
Q 040604 383 RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYI 462 (582)
Q Consensus 383 ~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 462 (582)
. .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++++|||.+....... ....++..|+
T Consensus 80 ~--~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~ 149 (237)
T cd05576 80 L--NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYC 149 (237)
T ss_pred c--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcccc
Confidence 3 589999999999999999999997 99999999999999999999999999887654321 1234677899
Q ss_pred cccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHH
Q 040604 463 APEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVG 542 (582)
Q Consensus 463 aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~ 542 (582)
|||.+.. ..++.++||||+|++++||++|+.++....... .......++. .+...+.+++
T Consensus 150 aPE~~~~--~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------~~~~~~~~~~-------~~~~~~~~li 209 (237)
T cd05576 150 APEVGGI--SEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------NTHTTLNIPE-------WVSEEARSLL 209 (237)
T ss_pred CCcccCC--CCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------ccccccCCcc-------cCCHHHHHHH
Confidence 9998865 367889999999999999999998765321110 0000111111 1335567788
Q ss_pred HhccccCCCCCCCHH
Q 040604 543 FWCIQTNPSERPSMH 557 (582)
Q Consensus 543 ~~Cl~~dp~~RPt~~ 557 (582)
.+||+.||++||++.
T Consensus 210 ~~~l~~dp~~R~~~~ 224 (237)
T cd05576 210 QQLLQFNPTERLGAG 224 (237)
T ss_pred HHHccCCHHHhcCCC
Confidence 899999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=275.41 Aligned_cols=264 Identities=23% Similarity=0.358 Sum_probs=198.1
Q ss_pred HhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhc--cCCCceEEEEeEEEeC----CeeeEEEEe
Q 040604 296 SFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISR--TSHVNIVTFLGFCYEN----KKNALIYEL 369 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~lv~E~ 369 (582)
.+.+.||+|.||.||+|++ -|+.||||++...+ .+.+.+|.++.+. |+|+||+.+++.=..+ .+++||.+|
T Consensus 214 ~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd--E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdY 290 (513)
T KOG2052|consen 214 VLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD--ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDY 290 (513)
T ss_pred EEEEEecCccccceeeccc-cCCceEEEEecccc--hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeec
Confidence 3457899999999999999 68899999997553 5567777777665 7999999998865432 366899999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHh-----CCCCceEecCCCCCCEEEcCCCceEEeecccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHR-----GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-----~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~ 444 (582)
.+.|+|.+++.++ .++....++++..+|.||++||. +..+.|.|||||+.|||+.+++..-|+|+|||....
T Consensus 291 He~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~ 367 (513)
T KOG2052|consen 291 HEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 367 (513)
T ss_pred ccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEec
Confidence 9999999999874 58999999999999999999995 346789999999999999999999999999998766
Q ss_pred ccccc--eeeecccCCcccccccccccccCC--C--CccchhHHHHHHHHHHhcC----------CCCCCCCCcccchhh
Q 040604 445 KKESA--ISMLHARGTIGYIAPEVYSRRFGG--V--SHKSDVYSYGMMIIEMVGC----------TKNLDDEVTDTSICH 508 (582)
Q Consensus 445 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~--~--s~~~DvwSlGvil~elltg----------~~p~~~~~~~~~~~~ 508 (582)
..... ......+||..|||||++...... + -..+||||||.++||++.+ +.||.+..+....+.
T Consensus 368 ~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~e 447 (513)
T KOG2052|consen 368 SDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFE 447 (513)
T ss_pred ccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHH
Confidence 55322 223345799999999999753211 1 1357999999999998642 346655544433333
Q ss_pred HHHHHhhc-CCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 509 NLIYERIE-PGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 509 ~~~~~~i~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
++ .+.+- +...+.++. . ....+....|.+|+..||..+|.-|-|+=.+-+.|.+..+
T Consensus 448 eM-rkVVCv~~~RP~ipn-r-W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 448 EM-RKVVCVQKLRPNIPN-R-WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred HH-hcceeecccCCCCCc-c-cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 22 11111 111111111 1 1233567788899999999999999999888888877554
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=242.40 Aligned_cols=255 Identities=22% Similarity=0.307 Sum_probs=192.7
Q ss_pred hhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCC
Q 040604 298 RDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNG 373 (582)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 373 (582)
.++||+|.||+||+|+. .+++.||+|.++..+.+ ....++|+-+++.++|+|||++++....+....||+||| ..
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-dq 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQ 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hH
Confidence 47899999999999965 47899999998765433 357899999999999999999999999999999999999 77
Q ss_pred ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeee
Q 040604 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISML 453 (582)
Q Consensus 374 sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 453 (582)
+|.++...-. ..++.+.+..++.|+++||.++|++ .++|||+||.|.||+.+|++|++|||+++.+.-..... .
T Consensus 86 dlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrcy--s 159 (292)
T KOG0662|consen 86 DLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY--S 159 (292)
T ss_pred HHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEee--e
Confidence 8888876533 3689999999999999999999998 99999999999999999999999999999876654322 2
Q ss_pred cccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCC-----------CCC
Q 040604 454 HARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGN-----------DFQ 522 (582)
Q Consensus 454 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~-----------~~~ 522 (582)
...-|.+|.+|+++-+. ..++...|+||-||++.|+.....|........+.+.... ..+.... +..
T Consensus 160 aevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfpg~dvddqlkrif-~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF-RLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred ceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHH-HHhCCCccccCCccccCCCCc
Confidence 34578999999999775 5789999999999999999976666554444333222211 1111111 111
Q ss_pred CCCcCc--HHHHHHH----HHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 523 FDGVAT--EEEKKIA----KMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 523 ~~~~~~--~~~~~~~----~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.-+..+ ....++. ..=.++....|.-+|.+|.++++.++
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 001111 1111222 22244555566779999999998775
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=307.91 Aligned_cols=142 Identities=26% Similarity=0.400 Sum_probs=126.9
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC----HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN----GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.+.++||+|+||+||+|... +++.||||+++..... ...+.+|+.+++.++|+||+++++.+......++||||
T Consensus 6 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy 85 (669)
T cd05610 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEY 85 (669)
T ss_pred EEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeC
Confidence 345688999999999999765 7899999999754322 25678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAK 441 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~ 441 (582)
+.+++|.+++...+ .+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 86 LIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999997543 578899999999999999999997 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=302.58 Aligned_cols=262 Identities=27% Similarity=0.433 Sum_probs=207.6
Q ss_pred HHHHHHHHHhhhhcCccCceEEEEEEeC----C----CcEEEEEEeccCCCC--HHHHHHHHHHHhcc-CCCceEEEEeE
Q 040604 288 SDVKRMTKSFRDKLGQGGYGEVYKGELP----D----GQLVAVKVLKNSRCN--GEEFINEVASISRT-SHVNIVTFLGF 356 (582)
Q Consensus 288 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~~~ 356 (582)
.++.+....+.+.||+|+||.|++|... . ...||||.++..... .+.+..|+.+|+.+ +|+||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 3444444456679999999999999532 1 457999999865544 56789999999998 59999999999
Q ss_pred EEeCCeeeEEEEecCCCChhhhhhcCC------------C--cCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCC
Q 040604 357 CYENKKNALIYELMPNGSLDKFIHNDR------------N--IKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQ 422 (582)
Q Consensus 357 ~~~~~~~~lv~E~~~~gsL~~~i~~~~------------~--~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~ 422 (582)
|......++|+||+..|+|.+++...+ . ..++...++.++.|||.|++||++. ++|||||-.+
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhh
Confidence 999889999999999999999998655 0 1388899999999999999999998 8999999999
Q ss_pred CEEEcCCCceEEeeccccccccccccceeeecccC--CcccccccccccccCCCCccchhHHHHHHHHHHhcCCC-CCCC
Q 040604 423 NILLDEDFCPKISDFGLAKQAQKKESAISMLHARG--TIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTK-NLDD 499 (582)
Q Consensus 423 NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~-p~~~ 499 (582)
|||+.++..+||+|||+|+........... ...| ...|||||.+.. ..++.|+|||||||+||||+|... |+..
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~--~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFD--RVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhcc--CcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 999999999999999999976554433211 1122 235999999987 489999999999999999998555 5544
Q ss_pred CCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 040604 500 EVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSI 567 (582)
Q Consensus 500 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~ 567 (582)
..... -+.+.+..|.....+... ..++..++..||+.+|++||+..++++.|+..+
T Consensus 525 ~~~~~-----~l~~~l~~G~r~~~P~~c-------~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 525 IPPTE-----ELLEFLKEGNRMEQPEHC-------SDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred CCcHH-----HHHHHHhcCCCCCCCCCC-------CHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 22122 134567777665554443 345567777899999999999999999999854
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=277.89 Aligned_cols=242 Identities=24% Similarity=0.334 Sum_probs=188.1
Q ss_pred HHHHHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC----CHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCee
Q 040604 290 VKRMTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEVASISRT-SHVNIVTFLGFCYENKKN 363 (582)
Q Consensus 290 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 363 (582)
++...++|...||+|+||.|-+|..+ +.+.+|||++++... +.+--+.|-.+|... +-|.++.|+.+|+.-+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 45556789999999999999999665 678899999987532 234445677777765 466789999999999999
Q ss_pred eEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccc
Q 040604 364 ALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQA 443 (582)
Q Consensus 364 ~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~ 443 (582)
|+||||+.||+|.-+|++.+ .+.+..+.-.|.+||-||-+||++ +||.||||.+||+||.+|++||+|||+.+.-
T Consensus 426 yFVMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eeEEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999999999998765 455667777899999999999998 9999999999999999999999999999864
Q ss_pred cccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCC
Q 040604 444 QKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQF 523 (582)
Q Consensus 444 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~ 523 (582)
.-... ++...+|||.|+|||++.- ..|+..+|+|||||+|||||.|++||+...+.+ .+.... ++ ...+
T Consensus 501 i~~~~--TTkTFCGTPdYiAPEIi~Y--qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e-lF~aI~-eh-----nvsy 569 (683)
T KOG0696|consen 501 IFDGV--TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-LFQAIM-EH-----NVSY 569 (683)
T ss_pred ccCCc--ceeeecCCCcccccceEEe--cccccchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHH-Hc-----cCcC
Confidence 33222 2335689999999999875 478999999999999999999999999875544 222221 11 1112
Q ss_pred CCcCcHHHHHHHHHHHHHHHhccccCCCCCC
Q 040604 524 DGVATEEEKKIAKMMILVGFWCIQTNPSERP 554 (582)
Q Consensus 524 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP 554 (582)
+.. +.++...+....|..+|.+|.
T Consensus 570 PKs-------lSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 570 PKS-------LSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ccc-------ccHHHHHHHHHHhhcCCcccc
Confidence 222 233334444455688999885
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=271.55 Aligned_cols=250 Identities=24% Similarity=0.344 Sum_probs=196.3
Q ss_pred hhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC--HHHHHHHHHH-HhccCCCceEEEEeEEEeCCeeeEEEEecCCCC
Q 040604 299 DKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN--GEEFINEVAS-ISRTSHVNIVTFLGFCYENKKNALIYELMPNGS 374 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 374 (582)
..||.|+||+|++-.++ .|+..|||.++..... ..+++.|.+. ++.-+.||||+++|.+..++..++.||.| ..+
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DIS 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhh
Confidence 57999999999998654 7999999999865543 3457777765 55567999999999999999999999999 788
Q ss_pred hhhhhh---cCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 375 LDKFIH---NDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 375 L~~~i~---~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
|+.+.+ ......+++..+-.|......||.||... ..||||||||+|||+|..|.+||+|||++..+...-.
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA--- 223 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA--- 223 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHHH---
Confidence 876643 33445688888889999999999999976 5899999999999999999999999999887654321
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHH
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 531 (582)
.+...|-..|||||.+......+.-+|||||||+.|+|+.||+-|+......-+.+. .+-.+..+.+. .+.+.
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~-----~Vv~gdpp~l~--~~~~~ 296 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLC-----QVVIGDPPILL--FDKEC 296 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHH-----HHHcCCCCeec--Ccccc
Confidence 223458889999999976645689999999999999999999999977654222111 12223223322 12233
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 532 KKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.+....|...+..||.+|.++||...++.+
T Consensus 297 ~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 297 VHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred cccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 456677888888999999999999998864
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=292.18 Aligned_cols=251 Identities=29% Similarity=0.389 Sum_probs=207.9
Q ss_pred HHhhhhcCccCceEEEEEE-eCCCcEEEEEEeccCCCCHHHHHHHHHHHhcc-CCCceEEEEeEEEe-----CCeeeEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEFINEVASISRT-SHVNIVTFLGFCYE-----NKKNALIY 367 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-----~~~~~lv~ 367 (582)
.+|.+.||.|.+|.||+++ .++++.+|+|+........++...|..+|+.. +|||++.++|++.- ++.++|||
T Consensus 21 ~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVM 100 (953)
T KOG0587|consen 21 FEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVM 100 (953)
T ss_pred cEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEe
Confidence 4567899999999999995 45899999999988888888889999999887 69999999999973 56889999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
|||.||+..++++...+..+.|..+.-|+..++.||.+||.. .++|||||-.|||++.++.|||.|||.+.++....
T Consensus 101 EfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~ 177 (953)
T KOG0587|consen 101 EFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV 177 (953)
T ss_pred eccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeeccc
Confidence 999999999999987778899999999999999999999998 89999999999999999999999999998866543
Q ss_pred cceeeecccCCcccccccccccc---cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCC
Q 040604 448 SAISMLHARGTIGYIAPEVYSRR---FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFD 524 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 524 (582)
... ....|||.|||||++... ...++.++|+||||++..||..|.+|+.++.+.... -.|...+.+.+
T Consensus 178 grR--nT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL------F~IpRNPPPkL- 248 (953)
T KOG0587|consen 178 GRR--NTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL------FLIPRNPPPKL- 248 (953)
T ss_pred ccc--cCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh------ccCCCCCCccc-
Confidence 221 234699999999998542 235778999999999999999999999887554321 12222222222
Q ss_pred CcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 525 GVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 525 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.....-.+++.+.+..||.+|..+||++.++++
T Consensus 249 ----krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 249 ----KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ----cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 223455677888899999999999999998874
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=285.35 Aligned_cols=242 Identities=25% Similarity=0.344 Sum_probs=197.1
Q ss_pred hhhhcCccCceEEEEEEeCCCc-EEEEEEeccCC----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 297 FRDKLGQGGYGEVYKGELPDGQ-LVAVKVLKNSR----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 297 ~~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
....||-||||.|-++.....+ .+|+|++++.. .+.+.+..|-.+|...+.|.||+||..|.+....|+.||-|-
T Consensus 424 ~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaCl 503 (732)
T KOG0614|consen 424 RIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACL 503 (732)
T ss_pred hhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhc
Confidence 3467999999999999775443 48999987643 345678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
||.|+..+...+ .++..+...++..+++|++|||++ +||.|||||+|.++|.+|-+||.|||+|+.+..+...
T Consensus 504 GGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT-- 576 (732)
T KOG0614|consen 504 GGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT-- 576 (732)
T ss_pred CchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCCce--
Confidence 999999998654 688888888999999999999998 9999999999999999999999999999998776543
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCC-CCCCCcCcHH
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND-FQFDGVATEE 530 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~ 530 (582)
...+|||.|.|||++..+ ....++|.||||++++|||+|.+||...++.. .++.|-++.+ ..++
T Consensus 577 -wTFcGTpEYVAPEIILnK--GHD~avDyWaLGIli~ELL~G~pPFs~~dpmk------tYn~ILkGid~i~~P------ 641 (732)
T KOG0614|consen 577 -WTFCGTPEYVAPEIILNK--GHDRAVDYWALGILIYELLTGSPPFSGVDPMK------TYNLILKGIDKIEFP------ 641 (732)
T ss_pred -eeecCCcccccchhhhcc--CcchhhHHHHHHHHHHHHHcCCCCCCCCchHH------HHHHHHhhhhhhhcc------
Confidence 346799999999999875 66889999999999999999999998776544 3444444432 2222
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 040604 531 EKKIAKMMILVGFWCIQTNPSERPS-----MHKVLE 561 (582)
Q Consensus 531 ~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~evl~ 561 (582)
..+.+...+|+.+..+.+|.+|.. +.+|-+
T Consensus 642 -r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 642 -RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred -cccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 233344445555555889999985 555543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=274.46 Aligned_cols=263 Identities=22% Similarity=0.309 Sum_probs=205.9
Q ss_pred ccHHHHHHHHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhccC--CCc----eEEEEeEE
Q 040604 285 YSYSDVKRMTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRTS--HVN----IVTFLGFC 357 (582)
Q Consensus 285 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~--h~n----iv~l~~~~ 357 (582)
|...+....++.+.+.+|+|.||.|-.+.+. .+..||||+++....-.+..+-|+.+|.++. .|+ +|.+.++|
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 4555666777888899999999999999543 5789999999887666677788999999984 232 78888999
Q ss_pred EeCCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---------
Q 040604 358 YENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE--------- 428 (582)
Q Consensus 358 ~~~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~--------- 428 (582)
.-.++.++|+|.+ |-++.+++..+...+++...+..++.|+++++++||+. +++|.||||+|||+.+
T Consensus 161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~ 236 (415)
T KOG0671|consen 161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNP 236 (415)
T ss_pred hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEecc
Confidence 9999999999999 88999999998888999999999999999999999998 9999999999999831
Q ss_pred -----------CCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCC
Q 040604 429 -----------DFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNL 497 (582)
Q Consensus 429 -----------~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~ 497 (582)
+..|||+|||.|+......+. ...|..|.|||++.+- .++.++||||+||||.||.+|...|
T Consensus 237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~-----iVsTRHYRAPEViLgL--GwS~pCDvWSiGCIL~ElytG~~LF 309 (415)
T KOG0671|consen 237 KKKVCFIRPLKSTAIKVIDFGSATFDHEHHST-----IVSTRHYRAPEVILGL--GWSQPCDVWSIGCILVELYTGETLF 309 (415)
T ss_pred CCccceeccCCCcceEEEecCCcceeccCcce-----eeeccccCCchheecc--CcCCccCceeeeeEEEEeeccceec
Confidence 346899999999886655532 3478899999999984 7999999999999999999999988
Q ss_pred CCCCcccchhhHHHHHhhcCCC-----------------CCCCCCc-------------Cc-----HHHHHHHHHHHHHH
Q 040604 498 DDEVTDTSICHNLIYERIEPGN-----------------DFQFDGV-------------AT-----EEEKKIAKMMILVG 542 (582)
Q Consensus 498 ~~~~~~~~~~~~~~~~~i~~~~-----------------~~~~~~~-------------~~-----~~~~~~~~~l~~l~ 542 (582)
....+.+.. .+.+++-... .+..+.. .+ .........+.+|+
T Consensus 310 qtHen~EHL---aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl 386 (415)
T KOG0671|consen 310 QTHENLEHL---AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLL 386 (415)
T ss_pred ccCCcHHHH---HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence 655432211 1112111100 0000000 00 00112345689999
Q ss_pred HhccccCCCCCCCHHHHHH
Q 040604 543 FWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 543 ~~Cl~~dp~~RPt~~evl~ 561 (582)
.+||..||.+|+|+.|++.
T Consensus 387 ~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 387 RRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHccCccccccHHHHhc
Confidence 9999999999999999885
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=278.97 Aligned_cols=200 Identities=24% Similarity=0.350 Sum_probs=168.0
Q ss_pred hhcCccCceEEEEE-EeCCCcEEEEEEeccCC----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCC
Q 040604 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSR----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNG 373 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 373 (582)
+.||-|+||+|-++ +.++...||+|.+++.+ .+...+..|-.||.....+.||+||-.|++.+.+|+||+|++||
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 46999999999999 45567889999997643 34567888999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccc---------
Q 040604 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ--------- 444 (582)
Q Consensus 374 sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~--------- 444 (582)
++-.+|.+.+ -+.+..+...+.++..|+++.|.. |+|||||||+|||||.+|++||.||||..-+.
T Consensus 715 DmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq 789 (1034)
T KOG0608|consen 715 DMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 789 (1034)
T ss_pred cHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence 9999887654 577788888899999999999998 99999999999999999999999999975221
Q ss_pred cccc--c-----------------------------eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcC
Q 040604 445 KKES--A-----------------------------ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGC 493 (582)
Q Consensus 445 ~~~~--~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg 493 (582)
.+.. . .......||+.|+|||++.+. .++.-+|+||.||||+||+.|
T Consensus 790 ~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~--g~~q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 790 EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART--GYTQLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc--CccccchhhHhhHHHHHHhhC
Confidence 1000 0 000012499999999999874 789999999999999999999
Q ss_pred CCCCCCCCcccc
Q 040604 494 TKNLDDEVTDTS 505 (582)
Q Consensus 494 ~~p~~~~~~~~~ 505 (582)
+.||.+......
T Consensus 868 ~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 868 QPPFLADTPGET 879 (1034)
T ss_pred CCCccCCCCCcc
Confidence 999987655443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=259.06 Aligned_cols=237 Identities=29% Similarity=0.402 Sum_probs=192.1
Q ss_pred CceEEEEEEeC-CCcEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCChhhhhhc
Q 040604 305 GYGEVYKGELP-DGQLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHN 381 (582)
Q Consensus 305 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~i~~ 381 (582)
+||.||+|... +|+.+|+|++...... .+.+.+|+..+++++|+||+++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999876 5899999999765433 57899999999999999999999999999999999999999999999876
Q ss_pred CCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeecccCCccc
Q 040604 382 DRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGY 461 (582)
Q Consensus 382 ~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y 461 (582)
.. .+++..++.++.+++.++.|||+. +++|+||+|.||++++++.++|+|||.+........ .....++..|
T Consensus 81 ~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~ 152 (244)
T smart00220 81 RG--RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGL---LTTFVGTPEY 152 (244)
T ss_pred cc--CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeeccccc---cccccCCcCC
Confidence 44 288999999999999999999998 999999999999999999999999999988665431 1234588999
Q ss_pred ccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHH
Q 040604 462 IAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILV 541 (582)
Q Consensus 462 ~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l 541 (582)
++||.+.. ..++.++||||||+++++|++|..|+....... .+.+.+......... ....+...+.++
T Consensus 153 ~~pE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-----~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 220 (244)
T smart00220 153 MAPEVLLG--KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-----ELFKKIGKPKPPFPP-----PEWKISPEAKDL 220 (244)
T ss_pred CCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-----HHHHHHhccCCCCcc-----ccccCCHHHHHH
Confidence 99999875 467889999999999999999999986532221 122222222111100 000134567888
Q ss_pred HHhccccCCCCCCCHHHHHH
Q 040604 542 GFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 542 ~~~Cl~~dp~~RPt~~evl~ 561 (582)
+.+||..+|++||++.++++
T Consensus 221 i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 221 IRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHccCCchhccCHHHHhh
Confidence 89999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-32 Score=243.86 Aligned_cols=204 Identities=29% Similarity=0.413 Sum_probs=169.1
Q ss_pred hhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCC--HHHHHHHHHHHhc-cCCCceEEEEeEEEeCCeeeEEEEecCCC
Q 040604 298 RDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCN--GEEFINEVASISR-TSHVNIVTFLGFCYENKKNALIYELMPNG 373 (582)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~E~~~~g 373 (582)
.+.||+|++|.|-+-++ .+|...|+|.++.+-.. ....++|+.+..+ ...|.+|.++|...+....++.||.| ..
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~t 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DT 129 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hh
Confidence 46799999999988865 48999999999765443 3457788877555 57999999999999999999999999 78
Q ss_pred Chhhhhhc--CCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 374 SLDKFIHN--DRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 374 sL~~~i~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
+|+.+..+ ..+..+++..+-+|+..+.+||.|||++ ..++|||+||+||||+.+|+||++|||++..+...-..
T Consensus 130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk-- 205 (282)
T KOG0984|consen 130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK-- 205 (282)
T ss_pred hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH--
Confidence 88887654 2456789999999999999999999997 68999999999999999999999999999876543221
Q ss_pred eecccCCcccccccccccc--cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchh
Q 040604 452 MLHARGTIGYIAPEVYSRR--FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSIC 507 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~--~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~ 507 (582)
+...|-..|||||.+... ...|+-|+||||||+.+.||.+++.|++...+.-..+
T Consensus 206 -t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qL 262 (282)
T KOG0984|consen 206 -TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQL 262 (282)
T ss_pred -HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHH
Confidence 223488899999998543 2368899999999999999999999998876655433
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-33 Score=255.94 Aligned_cols=259 Identities=21% Similarity=0.336 Sum_probs=190.5
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEecc---CCCCHHHHHHHHHHHhccCCCceEEEEeEEEe--------CCe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKN---SRCNGEEFINEVASISRTSHVNIVTFLGFCYE--------NKK 362 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~~~ 362 (582)
++-..+||+|.||.||+|+.. +|+.||+|++-. ...-....++|+.+|..++|+|++.++.+|.. ...
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 344578999999999999654 678889987532 22334567899999999999999999988863 234
Q ss_pred eeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccc
Q 040604 363 NALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ 442 (582)
Q Consensus 363 ~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~ 442 (582)
.+|||.+| .-+|.-++.. ....++..++.+++.+++.||.|+|+. .|+|||+|++|+||+.+|.+||+|||+++.
T Consensus 99 ~ylVf~~c-ehDLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 99 FYLVFDFC-EHDLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred eeeeHHHh-hhhHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 68999999 5677777754 345789999999999999999999998 999999999999999999999999999987
Q ss_pred ccccccc--eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCC
Q 040604 443 AQKKESA--ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND 520 (582)
Q Consensus 443 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~ 520 (582)
+...... ...+...-|.+|.+||.+.+. ..++++.|||.-||++.||.|+.+.+....+... .+.+.........
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimqgnteqqq--l~~Is~LcGs~tk 250 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQ--LHLISQLCGSITK 250 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcc-cccCCcchhHhHHHHHHHHHccCccccCChHHHH--HHHHHHHhccCCc
Confidence 6543322 223344569999999999885 6899999999999999999999988765433221 1111111111100
Q ss_pred ---CC-----------CCCcCcHH---HHHHHH------HHHHHHHhccccCCCCCCCHHHHHH
Q 040604 521 ---FQ-----------FDGVATEE---EKKIAK------MMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 521 ---~~-----------~~~~~~~~---~~~~~~------~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
+. ++++.... .++..+ ..++|+..++..||.+|+++.+++.
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 00 01110001 111112 4567888899999999999988874
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=254.49 Aligned_cols=197 Identities=23% Similarity=0.333 Sum_probs=167.2
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCH----HHHHHHHHHHhc-cCCCceEEEEeEEEeCCeeeEEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNG----EEFINEVASISR-TSHVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~E 368 (582)
+.+...||+|+|.+|-.+++. +.+.+|+|++++.-... +=+.-|-.+..+ -+||.+|-|+.+|+....+++|.|
T Consensus 252 f~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvie 331 (593)
T KOG0695|consen 252 FDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIE 331 (593)
T ss_pred ceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEE
Confidence 345678999999999999765 67899999998643322 223445555544 479999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
|++||+|.-++++++ +++++.+.....+|..||.|||++ |||.||||..|+|+|..|++||.|+|+.+.-.....
T Consensus 332 yv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~gd 406 (593)
T KOG0695|consen 332 YVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD 406 (593)
T ss_pred EecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCCCc
Confidence 999999988887665 689999999999999999999998 999999999999999999999999999987554433
Q ss_pred ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCC
Q 040604 449 AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDE 500 (582)
Q Consensus 449 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~ 500 (582)
. +...+|||.|+|||++.+. .|...+|+|+|||+++||+.|+.||+..
T Consensus 407 ~--tstfcgtpnyiapeilrge--eygfsvdwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 407 T--TSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred c--cccccCCCcccchhhhccc--ccCceehHHHHHHHHHHHHcCCCCccee
Confidence 2 2346899999999999885 7888999999999999999999999753
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=242.01 Aligned_cols=255 Identities=17% Similarity=0.266 Sum_probs=194.4
Q ss_pred HHHHhhhhcCccCceEEEEEE-eCCCcEEEEEEeccCCCCHHHHHHHHHHHhccC-CCceEEEEeEEEeCC--eeeEEEE
Q 040604 293 MTKSFRDKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEFINEVASISRTS-HVNIVTFLGFCYENK--KNALIYE 368 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~lv~E 368 (582)
..+++.+++|+|-++.||.|. ..+++.++||++++.+ .+.+.+|+.+|..|. ||||++|+++..+.. .+.||+|
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 456778999999999999995 5678899999998753 567889999999998 999999999998764 5689999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-CceEEeeccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED-FCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~-~~vkl~DFGla~~~~~~~ 447 (582)
|+.+.+...+.. .++...+...+.|++.||.|+|++ ||+|||+||+|++||.. ..++|+|+|+|.+...+.
T Consensus 116 ~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 116 YVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 998877766543 466677888899999999999998 99999999999999864 579999999999987765
Q ss_pred cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHH------------HHH--
Q 040604 448 SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNL------------IYE-- 513 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~------------~~~-- 513 (582)
.... ...+..|--||.+..- ..+...-|+|||||+|.+|+..+.||.......+.+... +..
T Consensus 188 eYnV---RVASRyfKGPELLVdy-~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 188 EYNV---RVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred eeee---eeehhhcCCchheeec-hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 5322 2356678899998763 578888999999999999999999997654433321111 100
Q ss_pred ---------hhcCCCCCCCCCcCcHHHHHHH-HHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 514 ---------RIEPGNDFQFDGVATEEEKKIA-KMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 514 ---------~i~~~~~~~~~~~~~~~~~~~~-~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.+.......+......+...+. .+.++++...|+.|-.+|||++|.+.
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 0001111111112222233333 56677888889999999999999874
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=278.50 Aligned_cols=257 Identities=21% Similarity=0.237 Sum_probs=173.3
Q ss_pred HHHhhhhcCccCceEEEEEEe-----------------CCCcEEEEEEeccCCC-CH--------------HHHHHHHHH
Q 040604 294 TKSFRDKLGQGGYGEVYKGEL-----------------PDGQLVAVKVLKNSRC-NG--------------EEFINEVAS 341 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~-~~--------------~~~~~E~~~ 341 (582)
.+.+.++||+|+||+||+|.+ ..++.||||.++.... .. +....|+..
T Consensus 146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~ 225 (507)
T PLN03224 146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM 225 (507)
T ss_pred CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence 345668999999999999953 2456899999865322 11 223457777
Q ss_pred HhccCCCce-----EEEEeEEEe--------CCeeeEEEEecCCCChhhhhhcCC----------------------CcC
Q 040604 342 ISRTSHVNI-----VTFLGFCYE--------NKKNALIYELMPNGSLDKFIHNDR----------------------NIK 386 (582)
Q Consensus 342 l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~E~~~~gsL~~~i~~~~----------------------~~~ 386 (582)
+.+++|.++ ++++++|.. ....+|||||+++++|.++++... ...
T Consensus 226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~ 305 (507)
T PLN03224 226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK 305 (507)
T ss_pred HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence 777777654 677777753 346789999999999999887421 113
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeecccCCcccccccc
Q 040604 387 LEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEV 466 (582)
Q Consensus 387 l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 466 (582)
+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......... ......+|+.|+|||.
T Consensus 306 ~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 306 RDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPEE 381 (507)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChhh
Confidence 46778899999999999999998 9999999999999999999999999999765433211 1112345899999998
Q ss_pred ccccc--------------------CCCCccchhHHHHHHHHHHhcCCC-CCCCCCcccc-------hhhHHHHHhhcCC
Q 040604 467 YSRRF--------------------GGVSHKSDVYSYGMMIIEMVGCTK-NLDDEVTDTS-------ICHNLIYERIEPG 518 (582)
Q Consensus 467 ~~~~~--------------------~~~s~~~DvwSlGvil~elltg~~-p~~~~~~~~~-------~~~~~~~~~i~~~ 518 (582)
+.... .....+.||||+||+++||+++.. |+.....-.. ....|. .. ..
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r--~~-~~ 458 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR--MY-KG 458 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH--hh-cc
Confidence 75321 011235799999999999999875 5542211000 011111 11 11
Q ss_pred CCCCCCCcCcHHHHHHHHHHHHHHHhccccCC---CCCCCHHHHHHH
Q 040604 519 NDFQFDGVATEEEKKIAKMMILVGFWCIQTNP---SERPSMHKVLEM 562 (582)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp---~~RPt~~evl~~ 562 (582)
....+. ..........+++.++|..+| .+|+|++|+++.
T Consensus 459 ~~~~~~-----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 459 QKYDFS-----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cCCCcc-----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 111111 111223445556666777655 789999999863
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=286.24 Aligned_cols=254 Identities=22% Similarity=0.228 Sum_probs=162.9
Q ss_pred HHhhhhcCccCceEEEEEEeC-C----CcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeE------EEeCCee
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-D----GQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGF------CYENKKN 363 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~~~~~~ 363 (582)
+.+.++||+|+||.||+|.+. + +..||||.+.... ..+.+.+|. +.+..+.+++.++.. .......
T Consensus 134 y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-~~e~~~~e~--l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (566)
T PLN03225 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-AVEIWMNER--VRRACPNSCADFVYGFLEPVSSKKEDEY 210 (566)
T ss_pred eEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-hhHHHHHHH--HHhhchhhHHHHHHhhhcccccccCCce
Confidence 455689999999999999765 5 7899999886433 222222221 222222222222211 2345678
Q ss_pred eEEEEecCCCChhhhhhcCCCc------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEE
Q 040604 364 ALIYELMPNGSLDKFIHNDRNI------------------KLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNIL 425 (582)
Q Consensus 364 ~lv~E~~~~gsL~~~i~~~~~~------------------~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NIL 425 (582)
++||||+++++|.+++...... ......+..++.|++.||+|||+. +|+||||||+|||
T Consensus 211 ~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NIL 287 (566)
T PLN03225 211 WLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNII 287 (566)
T ss_pred EEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHEE
Confidence 9999999999999988753210 112334567999999999999998 9999999999999
Q ss_pred EcC-CCceEEeeccccccccccccceeeecccCCccccccccccccc--------------------CCCCccchhHHHH
Q 040604 426 LDE-DFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRF--------------------GGVSHKSDVYSYG 484 (582)
Q Consensus 426 l~~-~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------------------~~~s~~~DvwSlG 484 (582)
++. ++.+||+|||+|+......... .....||+.|+|||.+.... ..++.++||||||
T Consensus 288 l~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 288 FSEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred EeCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 986 6899999999998654332221 12346899999999653211 1244567999999
Q ss_pred HHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCC-CCC-----CCCCcCcHHHH-------HHHHHHHHHHHhccccCCC
Q 040604 485 MMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPG-NDF-----QFDGVATEEEK-------KIAKMMILVGFWCIQTNPS 551 (582)
Q Consensus 485 vil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~-~~~-----~~~~~~~~~~~-------~~~~~l~~l~~~Cl~~dp~ 551 (582)
|+||||+++..+.+.... .+. ..+... .+. ........+.. .......+|+.+||+.||+
T Consensus 367 viL~el~~~~~~~~~~~~---~~~----~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 367 LIFLQMAFPNLRSDSNLI---QFN----RQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred HHHHHHHhCcCCCchHHH---HHH----HHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 999999987665432100 000 000000 000 00000000000 0112344788999999999
Q ss_pred CCCCHHHHHHH
Q 040604 552 ERPSMHKVLEM 562 (582)
Q Consensus 552 ~RPt~~evl~~ 562 (582)
+|||++++++.
T Consensus 440 kR~ta~e~L~H 450 (566)
T PLN03225 440 QRISAKAALAH 450 (566)
T ss_pred cCCCHHHHhCC
Confidence 99999999874
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=277.43 Aligned_cols=241 Identities=27% Similarity=0.353 Sum_probs=183.9
Q ss_pred hhhcCccCceE-EEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeeeEEEEecCCCCh
Q 040604 298 RDKLGQGGYGE-VYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRT-SHVNIVTFLGFCYENKKNALIYELMPNGSL 375 (582)
Q Consensus 298 ~~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 375 (582)
.+.+|.|+.|+ ||+|.. +|+.||||.+-..- .+-..+|+..|+.- .|||||++++.-.+.+..|+..|.| ..+|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL 589 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSL 589 (903)
T ss_pred HHHcccCCCCcEEEEEee-CCceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhH
Confidence 36799999986 699988 78999999874322 23456899998886 5999999999999999999999999 7899
Q ss_pred hhhhhcC--CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---C--CceEEeecccccccccccc
Q 040604 376 DKFIHND--RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE---D--FCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 376 ~~~i~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~---~--~~vkl~DFGla~~~~~~~~ 448 (582)
++++... ..........+.++.|+++||++||+. +||||||||.||||+. + ..++|+|||+++.+..+..
T Consensus 590 ~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 590 QDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred HHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 9999873 111111134567889999999999997 9999999999999975 2 5799999999999887765
Q ss_pred cee-eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcC-CCCCCCCCcccchhhHHHHHhhcCCCCCCCCCc
Q 040604 449 AIS-MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGC-TKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526 (582)
Q Consensus 449 ~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 526 (582)
... .....||-+|+|||++... .-+.++||||+||++|..++| ..||.+....+.. |..+.. .+...
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~--~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N--------Il~~~~-~L~~L 735 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLRED--RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN--------ILTGNY-TLVHL 735 (903)
T ss_pred hhhcccCCCCcccccCHHHHhcc--ccCcccchhhcCceEEEEecCCccCCCchHHhhhh--------hhcCcc-ceeee
Confidence 433 3445699999999999874 456799999999999998876 6798875443221 111111 11111
Q ss_pred CcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 040604 527 ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVL 560 (582)
Q Consensus 527 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl 560 (582)
.+.... ...+|+.+|++++|..||++.+|+
T Consensus 736 ~~~~d~----eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 736 EPLPDC----EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred ccCchH----HHHHHHHHhcCCCcccCCCHHHHh
Confidence 111111 456788889999999999999997
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=254.06 Aligned_cols=258 Identities=21% Similarity=0.303 Sum_probs=204.1
Q ss_pred HHHHHHHhhhhcCccCceEEEEEEeC------CCcEEEEEEeccC--CCCHHHHHHHHHHHhccCCCceEEEEeEEEeC-
Q 040604 290 VKRMTKSFRDKLGQGGYGEVYKGELP------DGQLVAVKVLKNS--RCNGEEFINEVASISRTSHVNIVTFLGFCYEN- 360 (582)
Q Consensus 290 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 360 (582)
+.+.+......+-+|.||+||+|.+. +.+.|.+|.++.. ..+...++.|...+..++|||+..+.+++.++
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY 360 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence 34445555678899999999999553 4566788888653 34557789999999999999999999999765
Q ss_pred CeeeEEEEecCCCChhhhhhcC------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEE
Q 040604 361 KKNALIYELMPNGSLDKFIHND------RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKI 434 (582)
Q Consensus 361 ~~~~lv~E~~~~gsL~~~i~~~------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl 434 (582)
..++.+|.++.-|+|..++..- ....++-.+...++.|++.|++|||+. +|||.||..+|.+||+...+||
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEe
Confidence 4678899999999999998721 223466777888999999999999998 9999999999999999999999
Q ss_pred eeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHH
Q 040604 435 SDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYE 513 (582)
Q Consensus 435 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 513 (582)
+|=.+++.+-+.+.+...........||+||.+... .++.++|||||||+||||+| |+.|+...++-+ +..
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~--~yssasDvWsfGVllWELmtlg~~PyaeIDPfE------m~~ 509 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS--HYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE------MEH 509 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHHhhh--hhcchhhhHHHHHHHHHHHhcCCCCccccCHHH------HHH
Confidence 999999987766554433333456789999999874 89999999999999999998 555665433322 444
Q ss_pred hhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 514 RIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 514 ~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
.+.+|.+...+ ...++++..++.-||..+|++||+.++++.-|..
T Consensus 510 ylkdGyRlaQP-------~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 510 YLKDGYRLAQP-------FNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred HHhccceecCC-------CCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 55666554443 3345667778888999999999999999988864
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=254.52 Aligned_cols=131 Identities=27% Similarity=0.462 Sum_probs=116.0
Q ss_pred HHHHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCCHHHHHHHHHHHhccC-----C---CceEEEEeEEEe----
Q 040604 293 MTKSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNGEEFINEVASISRTS-----H---VNIVTFLGFCYE---- 359 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~---- 359 (582)
.+|...++||.|.|++||++.+ .+.+.||+|+.+....-.+..+.|+.+|++++ | .+||+|++.|.-
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 4556678999999999999954 47889999999987777788899999999874 3 359999999974
Q ss_pred CCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE
Q 040604 360 NKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL 426 (582)
Q Consensus 360 ~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl 426 (582)
+.+.+||+|++ |.+|..+|.......++...+.+|+.||+.||.|||+.| +|||-||||+|||+
T Consensus 158 G~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 158 GQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 56889999999 999999998877778999999999999999999999985 99999999999999
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=263.73 Aligned_cols=194 Identities=24% Similarity=0.329 Sum_probs=167.1
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHH---------HHHHHHHHhccC---CCceEEEEeEEEeCC
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEE---------FINEVASISRTS---HVNIVTFLGFCYENK 361 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~---------~~~E~~~l~~l~---h~niv~l~~~~~~~~ 361 (582)
+...+.||.|+||.|+.+.++ +...|+||.+.+.+.-.+. +-.|+.||..++ |+||+|++++|.+++
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd 642 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD 642 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence 334578999999999999765 5678999999887654433 345999999997 999999999999999
Q ss_pred eeeEEEEec-CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccc
Q 040604 362 KNALIYELM-PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLA 440 (582)
Q Consensus 362 ~~~lv~E~~-~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla 440 (582)
..||+||.- +|-+|.++|..++ .+++.++.-|+.||+.|+++||++ +|||||||-+|+.++.+|-+||+|||.|
T Consensus 643 ~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred eeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccch
Confidence 999999985 4667889997655 588899999999999999999998 9999999999999999999999999999
Q ss_pred ccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCC
Q 040604 441 KQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLD 498 (582)
Q Consensus 441 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~ 498 (582)
.....+... ..+||.+|.|||++.+. .......|||++|++||.++-...|+.
T Consensus 718 a~~ksgpfd----~f~gtv~~aapevl~g~-~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 718 AYTKSGPFD----VFVGTVDYAAPEVLGGE-KYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhcCCCcc----eeeeeccccchhhhCCC-ccCCCcchhhhhhheeeEEEeccCCCc
Confidence 887665543 34699999999999876 466788999999999999998887775
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-32 Score=250.54 Aligned_cols=197 Identities=27% Similarity=0.399 Sum_probs=166.3
Q ss_pred hhhcCccCceEEEEEEe-CCCcEEEEEEeccCC---CCHHHHHHHHHHHhccCCCceEEEEeEEEeC-----CeeeEEEE
Q 040604 298 RDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSR---CNGEEFINEVASISRTSHVNIVTFLGFCYEN-----KKNALIYE 368 (582)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~E 368 (582)
.+.||-|+||.||...+ ++|+.||+|++.+.. ...+.+.+|+++|.-.+|.||+..+++.+-. +.+|.+.|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 36799999999999865 489999999885432 2346788999999999999999999887643 34567889
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
.| ..+|.++|.. ..+++.+.+.-++.||++||.|||+. +|+||||||.|.|++.|..+||+|||+|+....++.
T Consensus 138 Lm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 138 LM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 88 6888888865 34788889999999999999999998 999999999999999999999999999998665543
Q ss_pred ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCc
Q 040604 449 AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVT 502 (582)
Q Consensus 449 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~ 502 (582)
. .++...-|..|.|||++.+. ..|+.+.||||+||++.||+.++-.|.....
T Consensus 212 ~-hMTqEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQAq~P 263 (449)
T KOG0664|consen 212 L-NMTHEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQAAGP 263 (449)
T ss_pred h-hhHHHHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhccCh
Confidence 3 34455678899999999886 6899999999999999999988877765544
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=233.74 Aligned_cols=211 Identities=36% Similarity=0.575 Sum_probs=182.1
Q ss_pred cCccCceEEEEEEeC-CCcEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCChhh
Q 040604 301 LGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDK 377 (582)
Q Consensus 301 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~ 377 (582)
||+|++|.||++... +++.+++|++...... .+.+.+|+..++.++|++|+++++++......+++||++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999775 4899999999876543 5778999999999999999999999999899999999999999999
Q ss_pred hhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-CCceEEeeccccccccccccceeeeccc
Q 040604 378 FIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE-DFCPKISDFGLAKQAQKKESAISMLHAR 456 (582)
Q Consensus 378 ~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~-~~~vkl~DFGla~~~~~~~~~~~~~~~~ 456 (582)
++.... ..+++..++.++.+++.+|.+||+. +++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~ 154 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIV 154 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhccc
Confidence 987542 3688999999999999999999998 9999999999999999 89999999999987655431 112245
Q ss_pred CCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHH
Q 040604 457 GTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAK 536 (582)
Q Consensus 457 gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 536 (582)
+...|++||.+... ...+.+.|+|++|+++++| .
T Consensus 155 ~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l---------------------------------------------~ 188 (215)
T cd00180 155 GTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL---------------------------------------------P 188 (215)
T ss_pred CCCCccChhHhccc-CCCCchhhhHHHHHHHHHH---------------------------------------------H
Confidence 78899999998653 3678899999999999999 4
Q ss_pred HHHHHHHhccccCCCCCCCHHHHHHHH
Q 040604 537 MMILVGFWCIQTNPSERPSMHKVLEML 563 (582)
Q Consensus 537 ~l~~l~~~Cl~~dp~~RPt~~evl~~L 563 (582)
.+.+++..|++.+|++||++.++++.|
T Consensus 189 ~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 189 ELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 466777789999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=232.47 Aligned_cols=250 Identities=24% Similarity=0.296 Sum_probs=186.0
Q ss_pred hhcCccCceEEEEEE-eCCCcEEEEEEeccC---CCCHHHHHHHHHHHhccCCCceEEEEeEEEeC------CeeeEEEE
Q 040604 299 DKLGQGGYGEVYKGE-LPDGQLVAVKVLKNS---RCNGEEFINEVASISRTSHVNIVTFLGFCYEN------KKNALIYE 368 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv~E 368 (582)
..+|.|+- .|-.+. .-.+++||+|..... ....+...+|...+..+.|+||++++.++.-. ...|+|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 46788887 555553 337899999987543 23346678999999999999999999999643 35589999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
+| ..+|...+.. .++-.++..|..|++.|++|||+. +|+||||||+||++..+..+||.|||+|+.....
T Consensus 102 ~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~-- 171 (369)
T KOG0665|consen 102 LM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD-- 171 (369)
T ss_pred hh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc--
Confidence 99 7899998873 577889999999999999999998 9999999999999999999999999999875443
Q ss_pred ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccch-------------hhH----HH
Q 040604 449 AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSI-------------CHN----LI 511 (582)
Q Consensus 449 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~-------------~~~----~~ 511 (582)
..++....|..|.|||++.+. .+.+.+||||+||++.||++|+--|.+......+ +.. ..
T Consensus 172 -~~mtpyVvtRyyrapevil~~--~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~ 248 (369)
T KOG0665|consen 172 -FMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV 248 (369)
T ss_pred -cccCchhheeeccCchheecc--CCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence 334456688999999999985 4899999999999999999999877643221110 000 00
Q ss_pred HHhhcCCCC---C----CCCCc----CcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 512 YERIEPGND---F----QFDGV----ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 512 ~~~i~~~~~---~----~~~~~----~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
....+..+. . .+++. ..+..+.-.....+++.+||-.||++|.+++++++.
T Consensus 249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000000000 0 01110 011112234556778899999999999999999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-29 Score=259.78 Aligned_cols=250 Identities=27% Similarity=0.371 Sum_probs=195.1
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
+++...+|.|.||.||++++. ++++.|+|+++.... ...-..+|+-+++.-+|+|||.++|.+...+..++.||||.|
T Consensus 17 yellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgg 96 (829)
T KOG0576|consen 17 YELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGG 96 (829)
T ss_pred hhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCC
Confidence 345678999999999999654 899999999987544 335567899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
|+|++..+-. .++++.++..+.++.++||+|||++ +-+|||||-.|||+++.|.+|++|||.+-.+...-. ..
T Consensus 97 gslQdiy~~T--gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati~--Kr 169 (829)
T KOG0576|consen 97 GSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA--KR 169 (829)
T ss_pred Ccccceeeec--ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhhh--hh
Confidence 9999987643 4789999999999999999999998 889999999999999999999999999876554211 11
Q ss_pred ecccCCcccccccccc-cccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHH
Q 040604 453 LHARGTIGYIAPEVYS-RRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~-~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 531 (582)
....||+.|||||+.. ++-+.+..++|||++|+...|+-..++|..+....... ..+.+. .+.+....+.
T Consensus 170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l------~LmTkS---~~qpp~lkDk 240 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL------FLMTKS---GFQPPTLKDK 240 (829)
T ss_pred hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH------HHhhcc---CCCCCcccCC
Confidence 2346999999999862 23378999999999999999998888776554332211 111111 0111111222
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 040604 532 KKIAKMMILVGFWCIQTNPSERPSMHKVL 560 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl 560 (582)
..-...+-++++.||..+|.+||+++.++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 23344556677779999999999998776
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-27 Score=227.40 Aligned_cols=197 Identities=34% Similarity=0.511 Sum_probs=169.2
Q ss_pred hhhhcCccCceEEEEEEeCC-CcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCC
Q 040604 297 FRDKLGQGGYGEVYKGELPD-GQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNG 373 (582)
Q Consensus 297 ~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 373 (582)
+.+.||+|++|.||++...+ ++.+|+|.+..... ..+.+.+|+..+++++|+|++++++++......++++|+++++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 82 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG 82 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence 45789999999999997764 89999999976544 3567889999999999999999999999989999999999999
Q ss_pred ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeee
Q 040604 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISML 453 (582)
Q Consensus 374 sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 453 (582)
+|.+++..... .+++..+..++.+++.++.+||+. +++|+||+|.||+++.++.++|+|||.+......... ...
T Consensus 83 ~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~~ 157 (225)
T smart00221 83 DLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LLK 157 (225)
T ss_pred CHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-ccc
Confidence 99999976542 178899999999999999999998 9999999999999999999999999999887654311 111
Q ss_pred cccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCC
Q 040604 454 HARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDD 499 (582)
Q Consensus 454 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~ 499 (582)
...++..|++||.+. ....++.++|||+||++++||++|+.||..
T Consensus 158 ~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 234788999999984 224678899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-28 Score=246.62 Aligned_cols=268 Identities=20% Similarity=0.269 Sum_probs=206.5
Q ss_pred cccHHHHHHHHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhccC------CCceEEEEeE
Q 040604 284 RYSYSDVKRMTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRTS------HVNIVTFLGF 356 (582)
Q Consensus 284 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~ 356 (582)
++.+.|+...+|.+....|+|-|++|-+|.+. -|..||||+|.+...-...=+.|+.+|++|. --|.++|+..
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 44556777777777788999999999999654 5779999999876654455578999999985 3478999999
Q ss_pred EEeCCeeeEEEEecCCCChhhhhhcC-CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-CceEE
Q 040604 357 CYENKKNALIYELMPNGSLDKFIHND-RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED-FCPKI 434 (582)
Q Consensus 357 ~~~~~~~~lv~E~~~~gsL~~~i~~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~-~~vkl 434 (582)
|....+++||+|-+ ..+|.++++.. .+..|....+...+.|+..||..|... +|+|.||||.|||++++ ..+||
T Consensus 503 F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKL 578 (752)
T KOG0670|consen 503 FKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKL 578 (752)
T ss_pred hhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeee
Confidence 99999999999999 78999999865 456788899999999999999999987 99999999999999876 56899
Q ss_pred eeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccc--hh-----
Q 040604 435 SDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTS--IC----- 507 (582)
Q Consensus 435 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~--~~----- 507 (582)
||||.|.....+.... ..-+..|.|||++.+- .|+...|+||+||.||||.||+-.|.+...... ++
T Consensus 579 CDfGSA~~~~eneitP----YLVSRFYRaPEIiLG~--~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG 652 (752)
T KOG0670|consen 579 CDFGSASFASENEITP----YLVSRFYRAPEIILGL--PYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG 652 (752)
T ss_pred ccCccccccccccccH----HHHHHhccCcceeecC--cccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence 9999998876654321 2244579999999985 788899999999999999999998876533221 00
Q ss_pred --hH-------HHHHhhcCCCCCC----------------------------C--CCcCcHHHHHHHHHHHHHHHhcccc
Q 040604 508 --HN-------LIYERIEPGNDFQ----------------------------F--DGVATEEEKKIAKMMILVGFWCIQT 548 (582)
Q Consensus 508 --~~-------~~~~~i~~~~~~~----------------------------~--~~~~~~~~~~~~~~l~~l~~~Cl~~ 548 (582)
+. +..+++.....+. + ....+.+...+...+.+|+..||..
T Consensus 653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L 732 (752)
T KOG0670|consen 653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL 732 (752)
T ss_pred CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence 00 0001111100000 0 0113344556778899999999999
Q ss_pred CCCCCCCHHHHHH
Q 040604 549 NPSERPSMHKVLE 561 (582)
Q Consensus 549 dp~~RPt~~evl~ 561 (582)
||++|.|..++|.
T Consensus 733 dP~KRit~nqAL~ 745 (752)
T KOG0670|consen 733 DPEKRITVNQALK 745 (752)
T ss_pred ChhhcCCHHHHhc
Confidence 9999999998875
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-27 Score=230.65 Aligned_cols=257 Identities=22% Similarity=0.350 Sum_probs=190.0
Q ss_pred HHhhhhcCccCceEEEEEEeC----CCcEEEEEEeccCCCCHHHHHHHHHHHhccC-CCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP----DGQLVAVKVLKNSRCNGEEFINEVASISRTS-HVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+...++||+|.|++||++.+. ..+.||+|.+.... ....+.+|++.|..+. +.||+++.+++..++...+||||
T Consensus 38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~ 116 (418)
T KOG1167|consen 38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPY 116 (418)
T ss_pred hhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecc
Confidence 445589999999999999543 46789999987654 3456889999999985 88999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-CCceEEeeccccccccccc-
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE-DFCPKISDFGLAKQAQKKE- 447 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~-~~~vkl~DFGla~~~~~~~- 447 (582)
++...-.++... ++...+...+..++.||+++|.. |||||||||.|+|.+. -+.-.|.|||+|.......
T Consensus 117 ~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 117 FEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred cCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 999888888753 66778888899999999999998 9999999999999975 4667899999997211000
Q ss_pred -----c---------------------------c---------eeeecccCCcccccccccccccCCCCccchhHHHHHH
Q 040604 448 -----S---------------------------A---------ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMM 486 (582)
Q Consensus 448 -----~---------------------------~---------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvi 486 (582)
. . .......||+||.|||++.+- +..+.++||||.|||
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCcCCccceeeccce
Confidence 0 0 000122499999999999864 678999999999999
Q ss_pred HHHHhcCCCCCCCCCcccchhhHHH--------HHh-hcCCC-------C-CC-------CCCc-------------CcH
Q 040604 487 IIEMVGCTKNLDDEVTDTSICHNLI--------YER-IEPGN-------D-FQ-------FDGV-------------ATE 529 (582)
Q Consensus 487 l~elltg~~p~~~~~~~~~~~~~~~--------~~~-i~~~~-------~-~~-------~~~~-------------~~~ 529 (582)
++.+++++.||.....+...+.+.+ .+. ...+. . +. +... ...
T Consensus 268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~ 347 (418)
T KOG1167|consen 268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE 347 (418)
T ss_pred eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence 9999999999976544433221111 000 00000 0 00 0000 000
Q ss_pred HH-HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 530 EE-KKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 530 ~~-~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.. ......+.++..+||..||.+|.|+++.|+
T Consensus 348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 348 IGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 01 112336788999999999999999999884
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=214.85 Aligned_cols=250 Identities=15% Similarity=0.236 Sum_probs=185.2
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhcc-CCCceEEEEeE-EEeCCeeeEEEEec
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRT-SHVNIVTFLGF-CYENKKNALIYELM 370 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~E~~ 370 (582)
.+++.+.||+|-||.+-+++++ .+..+++|.+........+|.+|..---.| .|.||+.-|+. |+..+..++++||+
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~a 104 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFA 104 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccC
Confidence 3567789999999999999766 678899999998888899999998765555 58899987764 45566778999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc--CCCceEEeecccccccccccc
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLD--EDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~--~~~~vkl~DFGla~~~~~~~~ 448 (582)
+.|+|..-+.. ..+.+....+++.|++.|+.|||+. ++||||||.+||||- +...|||+|||+.+..+....
T Consensus 105 P~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~ 178 (378)
T KOG1345|consen 105 PRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK 178 (378)
T ss_pred ccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence 99999988764 3577888899999999999999998 999999999999993 334799999999876543221
Q ss_pred ceeeecccCCcccccccccccc---cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCC
Q 040604 449 AISMLHARGTIGYIAPEVYSRR---FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525 (582)
Q Consensus 449 ~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 525 (582)
...-+-.|.+||..... .-...+.+|+|.||++++..|||..||............ +.....+....++
T Consensus 179 -----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~--~~~w~~rk~~~~P- 250 (378)
T KOG1345|consen 179 -----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWE--WEQWLKRKNPALP- 250 (378)
T ss_pred -----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHH--HHHHhcccCccCc-
Confidence 12245679999976431 123567789999999999999999999754333332222 2233333333332
Q ss_pred cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 040604 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVL 560 (582)
Q Consensus 526 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl 560 (582)
...+.+...+.++..+-|..++.+|--..++.
T Consensus 251 ---~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~k 282 (378)
T KOG1345|consen 251 ---KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAK 282 (378)
T ss_pred ---hhhcccCHHHHHHHHHhcCCcccccchhHHHH
Confidence 22334445566666778889999994444443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=266.04 Aligned_cols=196 Identities=18% Similarity=0.281 Sum_probs=137.5
Q ss_pred ccCC-CceEEEEeEE-------EeCCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceE
Q 040604 344 RTSH-VNIVTFLGFC-------YENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415 (582)
Q Consensus 344 ~l~h-~niv~l~~~~-------~~~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iv 415 (582)
.++| .||+++++.+ .+....+++||++ +++|.+++... ...+++.+++.++.||++||+|||++ +|+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQ---GIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 4556 5888888877 2334567889988 77999999753 34689999999999999999999998 999
Q ss_pred ecCCCCCCEEEcC-------------------CCceEEeecccccccccccc--------------ceeeecccCCcccc
Q 040604 416 HFDIKPQNILLDE-------------------DFCPKISDFGLAKQAQKKES--------------AISMLHARGTIGYI 462 (582)
Q Consensus 416 H~Dikp~NILl~~-------------------~~~vkl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~ 462 (582)
||||||+||||+. ++.+|++|||+++....... ........||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 44566667776654211000 00011235899999
Q ss_pred cccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHH
Q 040604 463 APEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVG 542 (582)
Q Consensus 463 aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~ 542 (582)
|||++.+ ..++.++|||||||+||||++|..|+..... ..... .... ++. ...........++
T Consensus 183 APE~~~~--~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~-~~~~-------~~~----~~~~~~~~~~~~~ 245 (793)
T PLN00181 183 SPEEDNG--SSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSL-RHRV-------LPP----QILLNWPKEASFC 245 (793)
T ss_pred Chhhhcc--CCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHH-HHhh-------cCh----hhhhcCHHHHHHH
Confidence 9999876 3689999999999999999998877543211 11111 1111 000 0001122345677
Q ss_pred HhccccCCCCCCCHHHHHH
Q 040604 543 FWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 543 ~~Cl~~dp~~RPt~~evl~ 561 (582)
.+||+++|.+||+|.||++
T Consensus 246 ~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 246 LWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHhCCCChhhCcChHHHhh
Confidence 8899999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=206.60 Aligned_cols=167 Identities=20% Similarity=0.236 Sum_probs=126.8
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
|+|.+++... +..+++..++.|+.|++.||+|||+. + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc-----
Confidence 7899999753 34699999999999999999999987 4 999999999999999 99988754422
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
..||+.|+|||++.+ ..++.++|||||||++|||++|+.|+............+... .... ... ......
T Consensus 64 --~~g~~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~----~~~-~~~~~~ 133 (176)
T smart00750 64 --SRVDPYFMAPEVIQG--QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNG-MPAD----DPR-DRSNLE 133 (176)
T ss_pred --CCCcccccChHHhcC--CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHH-hccC----Ccc-ccccHH
Confidence 258999999999976 468899999999999999999999986554333222222211 1111 000 001122
Q ss_pred HHHH--HHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 040604 533 KIAK--MMILVGFWCIQTNPSERPSMHKVLEMLEGS 566 (582)
Q Consensus 533 ~~~~--~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~ 566 (582)
.+.. .+.+++.+||+.+|++||++.++++.+...
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 2333 588999999999999999999999988653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-26 Score=213.61 Aligned_cols=253 Identities=23% Similarity=0.411 Sum_probs=198.4
Q ss_pred HHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 294 TKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
..++.-+|.+...|..|+|++. |..+++|+++.... ..++|..|.-.|+-..||||+.++|.|....++.++..||
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 3456678999999999999995 44566687765443 3467999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
+-|+|..+++...+..++..++.+++.++++|++|||+. .+-|.-.-|....+++|++.+++|+- +-+++. .
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfs------f 341 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFS------F 341 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceee------e
Confidence 999999999998888889999999999999999999997 33455557899999999998888751 111110 0
Q ss_pred eeecccCCcccccccccccccCCC-CccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGV-SHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~-s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
........|.||+||.+++..... -.++|+|||.++||||.|...||.+..+.+ -+....+++....
T Consensus 342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme------------cgmkialeglrv~ 409 (448)
T KOG0195|consen 342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME------------CGMKIALEGLRVH 409 (448)
T ss_pred eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh------------hhhhhhhcccccc
Confidence 111223578999999998764333 346899999999999999999998764432 1222233344333
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSI 567 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~ 567 (582)
-...+...|.+|+.-|++.||.+||.+..|+-.||++.
T Consensus 410 ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 34456778888999999999999999999999999854
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-23 Score=212.92 Aligned_cols=261 Identities=20% Similarity=0.245 Sum_probs=189.5
Q ss_pred HHHhhhhcCccCceEEEEEEeCC--CcEEEEEEeccCCCC-HHHHHHHHHHHhccCC----CceEEEEeEE-EeCCeeeE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELPD--GQLVAVKVLKNSRCN-GEEFINEVASISRTSH----VNIVTFLGFC-YENKKNAL 365 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 365 (582)
.+.+.++||+|+||.||++.... ...+|+|+....... ...+..|+.++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 45567899999999999997654 358999998764322 2267788888888863 5899999998 47778899
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-----CceEEeecccc
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED-----FCPKISDFGLA 440 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~-----~~vkl~DFGla 440 (582)
||+.+ |.+|.++........++..++++|+.|++.+|++||+. |++||||||+|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999 99999988766667899999999999999999999998 99999999999999865 46999999999
Q ss_pred c--cccccccc------eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHH
Q 040604 441 K--QAQKKESA------ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIY 512 (582)
Q Consensus 441 ~--~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 512 (582)
+ ........ ......+||..|.++....+ ...+.+.|+||++.++.||+.|..||........ .... .
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~--~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~-~ 250 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG--IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKF-E 250 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCC--CccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHH-H
Confidence 9 43222111 00123469999999999877 4789999999999999999999999865433221 0111 0
Q ss_pred HhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCC
Q 040604 513 ERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIEN 569 (582)
Q Consensus 513 ~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~ 569 (582)
+.........+....+.+ +..+..-+-..+..++|....+...|++....
T Consensus 251 ~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 251 KDPRKLLTDRFGDLKPEE-------FAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred HHhhhhccccccCCChHH-------HHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 000000000011112222 22222223357999999999999988765443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-24 Score=218.81 Aligned_cols=172 Identities=21% Similarity=0.202 Sum_probs=129.4
Q ss_pred HHHhhhhcCccCceEEEEEEeC--CCcEEEEEEeccCC------CCHHHHHHHHHHHhccCCCceEE-EEeEEEeCCeee
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP--DGQLVAVKVLKNSR------CNGEEFINEVASISRTSHVNIVT-FLGFCYENKKNA 364 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~ 364 (582)
.|.+.+.||+|+||+||+|... +++.+|||++.... ...+.+.+|+.+|++++|+|++. +++. ...+
T Consensus 19 ~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~ 94 (365)
T PRK09188 19 RFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKDG 94 (365)
T ss_pred CceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCcE
Confidence 3556788999999999999654 57888999875321 12356889999999999999985 5432 4579
Q ss_pred EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCC-CCCCEEEcCCCceEEeeccccccc
Q 040604 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDI-KPQNILLDEDFCPKISDFGLAKQA 443 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Di-kp~NILl~~~~~vkl~DFGla~~~ 443 (582)
|||||++|++|... .. .. ...++.|+++||.|||+. +|+|||| ||+|||++.++.+||+|||+|+..
T Consensus 95 LVmE~~~G~~L~~~-~~-----~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 95 LVRGWTEGVPLHLA-RP-----HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred EEEEccCCCCHHHh-Cc-----cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 99999999999632 11 11 146788999999999998 9999999 999999999999999999999976
Q ss_pred ccccccee------eecccCCccccccccccccc----CCCCccchhH
Q 040604 444 QKKESAIS------MLHARGTIGYIAPEVYSRRF----GGVSHKSDVY 481 (582)
Q Consensus 444 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~~----~~~s~~~Dvw 481 (582)
........ .....+++.|+|||++.... ...+..+|-|
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 55432111 13456889999999985431 1233446666
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=193.79 Aligned_cols=261 Identities=20% Similarity=0.281 Sum_probs=193.0
Q ss_pred HHhhhhcCccCceEEEEEE-eCCCcEEEEEEeccCCCCHHHHHHHHHHHhccC-CCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 295 KSFRDKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEFINEVASISRTS-HVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
+.+.++||+|+||.++.|. +-++++||||.-... ...-++..|....+.|. .+.|...+-|..++.+..||||.+ |
T Consensus 30 yrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G 107 (449)
T KOG1165|consen 30 YRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G 107 (449)
T ss_pred ceeccccccCcceeeecccccccCceEEEEecccc-CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence 4567899999999999994 569999999976433 24456777888888775 678999999999999999999999 9
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-----CceEEeeccccccccccc
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED-----FCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~-----~~vkl~DFGla~~~~~~~ 447 (582)
-+|.++..-- +..++.+++..||.|++.-++|+|++ .+|.|||||+|+||..- ..+.|+|||+|+.+....
T Consensus 108 PSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~ 183 (449)
T KOG1165|consen 108 PSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK 183 (449)
T ss_pred cCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence 9999987632 34699999999999999999999998 99999999999999643 458999999999876554
Q ss_pred cceee-----ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCC
Q 040604 448 SAISM-----LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQ 522 (582)
Q Consensus 448 ~~~~~-----~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~ 522 (582)
+..-. ....||..||+-....++ ..+.+.|+=|||=|++..|.|..||.....+.. ..-+++|.......
T Consensus 184 TkqHIPYrE~KSLsGTARYMSINTHlGr--EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn---K~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 184 TKQHIPYREHKSLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN---KEKYEKIGETKRST 258 (449)
T ss_pred ccccCccccccccccceeeeEeeccccc--hhhhhhhHHHhhhhhhhhccCCCccccccCcch---HHHHHHhccccccC
Confidence 32111 112499999999888774 778999999999999999999999987654432 22345554432211
Q ss_pred CCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCC
Q 040604 523 FDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIEN 569 (582)
Q Consensus 523 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~ 569 (582)
.+.+....++.++..-+.---+.+-++-|..+-+...+...++.
T Consensus 259 ---~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 259 ---PIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred ---CHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 11111222333333333223356777888887766666555443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-21 Score=197.77 Aligned_cols=259 Identities=31% Similarity=0.388 Sum_probs=192.5
Q ss_pred HhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCC----CHHHHHHHHHHHhccCCC-ceEEEEeEEEeCCeeeEEEEec
Q 040604 296 SFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRC----NGEEFINEVASISRTSHV-NIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~E~~ 370 (582)
.+.+.||.|+||.||++... ..+++|.+..... ....+.+|+.+++.+.|+ +++++.+.+......++++|++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 3 RILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred eeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 34578999999999999876 8899999876443 256789999999999988 7999999997777789999999
Q ss_pred CCCChhhhhhcCCC-cCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-ceEEeecccccccccccc
Q 040604 371 PNGSLDKFIHNDRN-IKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF-CPKISDFGLAKQAQKKES 448 (582)
Q Consensus 371 ~~gsL~~~i~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~-~vkl~DFGla~~~~~~~~ 448 (582)
.+++|.+++..... ..+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||+++.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 99999977664322 2688899999999999999999998 899999999999999988 799999999986554432
Q ss_pred ce----eeecccCCccccccccccccc-CCCCccchhHHHHHHHHHHhcCCCCCCCCCcc--cchhhHHHHHhhcCCCCC
Q 040604 449 AI----SMLHARGTIGYIAPEVYSRRF-GGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTD--TSICHNLIYERIEPGNDF 521 (582)
Q Consensus 449 ~~----~~~~~~gt~~y~aPE~~~~~~-~~~s~~~DvwSlGvil~elltg~~p~~~~~~~--~~~~~~~~~~~i~~~~~~ 521 (582)
.. ......||..|+|||.+.... ...+...|+||+|++++++++|..|+...... .......+..........
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence 21 123456999999999987631 36788999999999999999999996655431 111111111111110000
Q ss_pred CCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 522 QFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 522 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
....... ......+.+++..++..+|..|.++.+....
T Consensus 238 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 238 PLSPSNP---ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccCcccc---chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0100000 1222455666777888899999998877653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-23 Score=227.69 Aligned_cols=251 Identities=22% Similarity=0.232 Sum_probs=187.1
Q ss_pred hhhcCccCceEEEEEEe-CCCcEEEEEEecc---CCCCHH----HHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 298 RDKLGQGGYGEVYKGEL-PDGQLVAVKVLKN---SRCNGE----EFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~----~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
...+|.|++|.|+.... ......+.|..+. ...... .+..|+.+-..++|+|++..+..+++.....-+|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 46799999998887743 3444455554431 111111 255677788889999998888877776666666999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
|++ +|..++.... .+...++..++.|++.|+.|||+. ||.|||||++|+++..+|.+||+|||.+.........
T Consensus 403 ~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 403 CPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred ccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 999 9999997652 577788888999999999999998 9999999999999999999999999999876655443
Q ss_pred --eeeecccCCcccccccccccccCCC-CccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCc
Q 040604 450 --ISMLHARGTIGYIAPEVYSRRFGGV-SHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526 (582)
Q Consensus 450 --~~~~~~~gt~~y~aPE~~~~~~~~~-s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 526 (582)
.......|+..|+|||++.+. .| ....||||.|+++..|++|+.||.........+.. ............
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~--~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~-----~~~~~~~~~~~~ 549 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGK--EYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT-----NNYSDQRNIFEG 549 (601)
T ss_pred hhhhhcCcccCCcCcCccccccc--ccCcchhhhhhccceEEEEecCCCccccccccccchhh-----hccccccccccC
Confidence 334456799999999999774 44 45689999999999999999999765444322100 111111111122
Q ss_pred CcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 527 ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 527 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.......++.....++.++|+.||.+|.||++|++
T Consensus 550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 22344567788888999999999999999999975
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.7e-22 Score=186.34 Aligned_cols=138 Identities=19% Similarity=0.185 Sum_probs=107.8
Q ss_pred hhcCccCceEEEEEEeCCCcEEEEEEeccCCCC---H-------H-----------------HHHHHHHHHhccCCCceE
Q 040604 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCN---G-------E-----------------EFINEVASISRTSHVNIV 351 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~-------~-----------------~~~~E~~~l~~l~h~niv 351 (582)
+.||+|++|.||+|...+|+.||||+++..... . . ...+|+..+.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 579999999999998878999999999754211 0 1 123499999999877764
Q ss_pred EEEeEEEeCCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEecCCCCCCEEEcCCC
Q 040604 352 TFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYL-HRGCQVRIVHFDIKPQNILLDEDF 430 (582)
Q Consensus 352 ~l~~~~~~~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yL-H~~~~~~ivH~Dikp~NILl~~~~ 430 (582)
....+.. ...+|||||++|++|...+... .++++..+.+++.|++.+|.|| |+. +|+||||||+|||++ ++
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-CC
Confidence 3332221 2348999999888776543322 3688899999999999999999 676 999999999999998 47
Q ss_pred ceEEeecccccccc
Q 040604 431 CPKISDFGLAKQAQ 444 (582)
Q Consensus 431 ~vkl~DFGla~~~~ 444 (582)
.++|+|||+|....
T Consensus 155 ~v~LiDFG~a~~~~ 168 (190)
T cd05147 155 KLYIIDVSQSVEHD 168 (190)
T ss_pred cEEEEEccccccCC
Confidence 89999999997643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-22 Score=185.23 Aligned_cols=254 Identities=21% Similarity=0.278 Sum_probs=182.4
Q ss_pred HHHhhhhcCccCceEEEEEE-eCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCC-CceEEEEeEEEeCCeeeEEEEecC
Q 040604 294 TKSFRDKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEFINEVASISRTSH-VNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
.+.+.++||.|+||.+|.|. ..+|+.||||+-+.... ..++..|..+.+.|++ ..|..+..+..+....+|||+.+
T Consensus 16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL- 93 (341)
T KOG1163|consen 16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL- 93 (341)
T ss_pred ceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-
Confidence 45567899999999999995 56899999999865432 3456778888888875 46778888888888999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC---CceEEeecccccccccccc
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED---FCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~---~~vkl~DFGla~~~~~~~~ 448 (582)
|.+|.++..-- ...++.++++-++-|++.-++|+|.+ ++|||||||+|+|+.-+ ..+.++|||+|+.+....+
T Consensus 94 GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t 169 (341)
T KOG1163|consen 94 GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT 169 (341)
T ss_pred CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence 99999987532 23688999999999999999999998 99999999999999644 4689999999998755433
Q ss_pred ce-----eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCC
Q 040604 449 AI-----SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQF 523 (582)
Q Consensus 449 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~ 523 (582)
.. ......||..|.+-....+. ..+.+.|+=|+|.+|..+..|..||.+...... ..-+++|.... .
T Consensus 170 ~~HIpyre~r~ltGTaRYASinAh~g~--eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk---~QKyEkI~EkK---~ 241 (341)
T KOG1163|consen 170 RQHIPYREDRNLTGTARYASINAHLGI--EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK---KQKYEKISEKK---M 241 (341)
T ss_pred cccCccccCCccceeeeehhhhhhhhh--hhhhhhhhhhhcceeeeeecCCCcccccchhhH---HHHHHHHHHhh---c
Confidence 21 11123499999998776652 567889999999999999999999987644332 11223332211 0
Q ss_pred CCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 524 DGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 524 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.-....-....+.+....+.-|-...-++-|...-+-+
T Consensus 242 s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrq 279 (341)
T KOG1163|consen 242 STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQ 279 (341)
T ss_pred CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHH
Confidence 00011111223334444444566666666676544433
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.6e-21 Score=181.17 Aligned_cols=140 Identities=22% Similarity=0.228 Sum_probs=110.8
Q ss_pred hhhcCccCceEEEEEEeCCCcEEEEEEeccCCCC---------------------------HHHHHHHHHHHhccCCCce
Q 040604 298 RDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCN---------------------------GEEFINEVASISRTSHVNI 350 (582)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------------~~~~~~E~~~l~~l~h~ni 350 (582)
.+.||+|++|.||+|...+|+.||||+++..... ...+.+|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3679999999999998778999999998764211 1123578899999999987
Q ss_pred EEEEeEEEeCCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCCEEEcCC
Q 040604 351 VTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHR-GCQVRIVHFDIKPQNILLDED 429 (582)
Q Consensus 351 v~l~~~~~~~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~ivH~Dikp~NILl~~~ 429 (582)
.....+... ..+|||||++|+++....... ..++.....+++.|++.+|.+||+ . ||+||||||+|||++ +
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-C
Confidence 544443332 348999999888654432222 357788999999999999999999 7 999999999999999 8
Q ss_pred CceEEeeccccccccc
Q 040604 430 FCPKISDFGLAKQAQK 445 (582)
Q Consensus 430 ~~vkl~DFGla~~~~~ 445 (582)
+.++|+|||++.....
T Consensus 154 ~~~~liDFG~a~~~~~ 169 (190)
T cd05145 154 GKPYIIDVSQAVELDH 169 (190)
T ss_pred CCEEEEEcccceecCC
Confidence 8999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-21 Score=185.85 Aligned_cols=170 Identities=13% Similarity=0.126 Sum_probs=129.9
Q ss_pred HHHHHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHH----------HHHHHHHHhccCCCceEEEEeEEEeC
Q 040604 291 KRMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEE----------FINEVASISRTSHVNIVTFLGFCYEN 360 (582)
Q Consensus 291 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~ 360 (582)
...+++..+.||.|+||.||+... ++..+|||+++......+. +.+|+..+.++.|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 344455668899999999999766 5778999999754433222 57899999999999999998886643
Q ss_pred --------CeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCce
Q 040604 361 --------KKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCP 432 (582)
Q Consensus 361 --------~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~v 432 (582)
...+|||||++|.+|.++.. ++. ....+++.+|..+|+. |++|||+||+||+++.+| +
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-E
Confidence 35789999999999988732 222 2456899999999998 999999999999999988 9
Q ss_pred EEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHh
Q 040604 433 KISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMV 491 (582)
Q Consensus 433 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ell 491 (582)
+|+|||..+......... .++..+ .+..++|+||||+.+..+.
T Consensus 174 ~liDfg~~~~~~e~~a~d--------------~~vler--~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAKD--------------RIDLER--HYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhHH--------------HHHHHh--HhcccccccceeEeehHHH
Confidence 999999887653322110 022222 4557899999999987653
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.8e-21 Score=176.76 Aligned_cols=185 Identities=15% Similarity=0.087 Sum_probs=141.7
Q ss_pred hhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHH-----HHHHHHHHHhccC-CCceEEEEeEEEeCCeeeEEEEecC
Q 040604 298 RDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGE-----EFINEVASISRTS-HVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
...|++|+||+||.+.. .+..++.+.+.......+ .+.+|+.+|++|+ |+++++++++ ...+++|||+.
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 35799999999998766 788888888877665433 5789999999995 5789999886 35699999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCC-CCCCEEEcCCCceEEeeccccccccccccc-
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDI-KPQNILLDEDFCPKISDFGLAKQAQKKESA- 449 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Di-kp~NILl~~~~~vkl~DFGla~~~~~~~~~- 449 (582)
|.+|...+.. ....++.|++.+|+++|+. ||+|||| ||+|||++.++.++|+|||+|.........
T Consensus 82 G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 82 GAAMYQRPPR---------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred CccHHhhhhh---------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 9998754321 1134678999999999998 9999999 799999999999999999999865543311
Q ss_pred ----------eeeecccCCcccccccccccccCCCC-ccchhHHHHHHHHHHhcCCCCCCCC
Q 040604 450 ----------ISMLHARGTIGYIAPEVYSRRFGGVS-HKSDVYSYGMMIIEMVGCTKNLDDE 500 (582)
Q Consensus 450 ----------~~~~~~~gt~~y~aPE~~~~~~~~~s-~~~DvwSlGvil~elltg~~p~~~~ 500 (582)
.......+++.|++|+.-.-- ...+ ...++++-|..+|.++|++.+....
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l-~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVL-KRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhh-ccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 001123478899999854221 1222 4569999999999999999876544
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.1e-20 Score=192.75 Aligned_cols=220 Identities=23% Similarity=0.395 Sum_probs=166.6
Q ss_pred HhccCCCceEEEEeEEEeCCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCce-EecCCC
Q 040604 342 ISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRI-VHFDIK 420 (582)
Q Consensus 342 l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~i-vH~Dik 420 (582)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ....+++.....++.+++.||+|||.. +| .|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeec
Confidence 4678999999999999999999999999999999999986 456789999999999999999999987 44 999999
Q ss_pred CCCEEEcCCCceEEeeccccccccccccceeeecccCCcccccccccccc--cCC---CCccchhHHHHHHHHHHhcCCC
Q 040604 421 PQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRR--FGG---VSHKSDVYSYGMMIIEMVGCTK 495 (582)
Q Consensus 421 p~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~---~s~~~DvwSlGvil~elltg~~ 495 (582)
+.|.++|..+.+||+|||+.................-..-|.|||.+... ... .+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998876431000000111233469999998653 111 5788999999999999999999
Q ss_pred CCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 496 NLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 496 p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
||+........ .+.+.. +..+....+.+...... +....+..++..||..+|++||++++|-..++....
T Consensus 157 ~~~~~~~~~~~-~eii~~-~~~~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 157 PFDLRNLVEDP-DEIILR-VKKGGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccccCCh-HHHHHH-HHhcCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 99875544432 222222 33322222222222222 455578889999999999999999999988876544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.5e-21 Score=201.57 Aligned_cols=184 Identities=28% Similarity=0.338 Sum_probs=155.4
Q ss_pred cCccCceEEEEEE----eCCCcEEEEEEeccCCCC---HHHHHHHHHHHhccC-CCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 301 LGQGGYGEVYKGE----LPDGQLVAVKVLKNSRCN---GEEFINEVASISRTS-HVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 301 lG~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
+|+|.||.|+++. ...|..+|+|++++.... ......|..++...+ ||.+|++...++.+...++++++..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7999999999762 336788999998754321 124556778888887 99999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
|.|...+.... .+++.........++.|++++|+. +|+|||+|++||+++.+|++|+.|||+++........
T Consensus 82 g~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 82 GDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred chhhhccccCC--chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc---
Confidence 99988876543 456666677788999999999998 9999999999999999999999999999986554432
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCC
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDD 499 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~ 499 (582)
+||..|||||++.+ ...++|+||||++++||+||..||..
T Consensus 154 ---cgt~eymApEI~~g----h~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIING----HLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ---ccchhhhhhHhhhc----cCCcccchhhhhhHHHHhhCCCCCch
Confidence 69999999999863 46789999999999999999999976
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-18 Score=165.93 Aligned_cols=132 Identities=23% Similarity=0.309 Sum_probs=103.0
Q ss_pred hhcCccCceEEEEEEeCCCcEEEEEEeccCC-CCHHHHHHHHHHHhcc-----CCCceEEEEeEEEeCC---eee-EEEE
Q 040604 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSR-CNGEEFINEVASISRT-----SHVNIVTFLGFCYENK---KNA-LIYE 368 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~-lv~E 368 (582)
+.||+|+||.||. .-.++.. +||++.... ...+.+.+|+.+++++ .||||++++|++.++. ..+ +|||
T Consensus 8 ~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 5799999999996 2224444 799886542 3456789999999999 5799999999998864 323 7899
Q ss_pred e--cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHH-HHHHhCCCCceEecCCCCCCEEEcC----CCceEEeecccc
Q 040604 369 L--MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGL-EYLHRGCQVRIVHFDIKPQNILLDE----DFCPKISDFGLA 440 (582)
Q Consensus 369 ~--~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL-~yLH~~~~~~ivH~Dikp~NILl~~----~~~vkl~DFGla 440 (582)
| +.+|+|.+++.+. .+++. ..++.|++.++ +|||+. +|+||||||+|||++. ++.++|+||+.+
T Consensus 86 ~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 86 FDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred CCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 9 5579999999653 35544 35577888777 999998 9999999999999974 347999995544
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.7e-19 Score=173.54 Aligned_cols=229 Identities=19% Similarity=0.259 Sum_probs=145.8
Q ss_pred hhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC----HHHHHHHHHHHhccCC----------CceEEEEeEEE----
Q 040604 298 RDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN----GEEFINEVASISRTSH----------VNIVTFLGFCY---- 358 (582)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h----------~niv~l~~~~~---- 358 (582)
.+.||.|+++.||.+.+. +|+.+|||++...... .+.+.+|......+.+ -.++.-++...
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 367999999999999776 6999999997543322 3456666655544322 12222222221
Q ss_pred -----eCC--------eeeEEEEecCCCChhhhhhc---C--CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC
Q 040604 359 -----ENK--------KNALIYELMPNGSLDKFIHN---D--RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIK 420 (582)
Q Consensus 359 -----~~~--------~~~lv~E~~~~gsL~~~i~~---~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dik 420 (582)
... +.+++|+-+ .++|.+++.. . ....+....++.+..|+++.+++||+. |++|+|||
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-S
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccc
Confidence 111 335788888 7888887642 1 122344556667779999999999998 99999999
Q ss_pred CCCEEEcCCCceEEeeccccccccccccceeeecccCCcccccccccccc------cCCCCccchhHHHHHHHHHHhcCC
Q 040604 421 PQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRR------FGGVSHKSDVYSYGMMIIEMVGCT 494 (582)
Q Consensus 421 p~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~s~~~DvwSlGvil~elltg~ 494 (582)
|+|+|++.+|.++|+||+........... ...+..|.+||..... .-.++.+.|.|++|+++|.|.+++
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred eeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 99999999999999999877665442221 2356789999976432 124788999999999999999999
Q ss_pred CCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCC
Q 040604 495 KNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSER 553 (582)
Q Consensus 495 ~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~R 553 (582)
.|++........- + .+. ... ++++.+..|+..+|+.+|.+|
T Consensus 248 lPf~~~~~~~~~~--~-----------~f~----~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPE--W-----------DFS----RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSG--G-----------GGT----TSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCcccccc--c-----------cch----hcC-CcCHHHHHHHHHHccCCcccC
Confidence 9998654332110 0 111 112 567778888889999999988
|
|
| >PF13947 GUB_WAK_bind: Wall-associated receptor kinase galacturonan-binding | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.9e-19 Score=149.71 Aligned_cols=97 Identities=36% Similarity=0.642 Sum_probs=76.5
Q ss_pred CCCCCCCCCCCCCCCCcccCCCccCCCCCCCCC-CCcEEeccCC--CceEEEcCcceEEEEEecCCcEEEEEecCCCCCC
Q 040604 14 SPRCTAPAPFHCANLRNIGYPFWGSNRPEHCGY-PGFELDCAGD--VPEITIMDRAYKVLHINNESWRINVAREDYWDYN 90 (582)
Q Consensus 14 ~~~c~~~~~~~CG~~~~I~yPF~~~~~p~~Cg~-p~f~l~C~~~--~~~~~~~~~~~~V~~I~y~~~~~~v~~~~~~~~~ 90 (582)
++.| |.+||| ++|+||||++. +|++ |+|+|+|+++ .+++.+.+++|+|++|+|.+++++|.++.. ..
T Consensus 1 ~~~C----~~~CGn-v~IpYPFgi~~---~C~~~~~F~L~C~~~~~~~~l~l~~~~~~V~~I~~~~~~i~v~~~~~--~~ 70 (106)
T PF13947_consen 1 KPGC----PSSCGN-VSIPYPFGIGP---GCGRDPGFELTCNNNTSPPKLLLSSGNYEVLSISYENGTIRVSDPIS--SN 70 (106)
T ss_pred CCCC----CCccCC-EeecCCCccCC---CCCCCCCcEEECCCCCCCceeEecCCcEEEEEEecCCCEEEEEeccc--cc
Confidence 4677 379999 89999999987 8999 9999999988 578888889999999999999999999642 23
Q ss_pred CCCCCC------CCccCCcccccccCCCceEEEEcCCC
Q 040604 91 CPANLS------NSLLNFSIFNYASDTQNLTLYYSCPA 122 (582)
Q Consensus 91 C~~~~~------~~~~~~~~f~~s~~~~~~~~~~~C~~ 122 (582)
|..... +.++.. +|.+++..|.+++ +||++
T Consensus 71 ~~~~~~~~~~~~~~~~~~-~~~~s~~~N~~~~-~GC~t 106 (106)
T PF13947_consen 71 CYSSSSSNSSNSNLSLNG-PFFFSSSSNKFTV-VGCNT 106 (106)
T ss_pred eecCCCCcccccEEeecC-CceEccCCcEEEE-ECCCC
Confidence 442221 113333 7888888888776 89974
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.4e-18 Score=167.73 Aligned_cols=141 Identities=18% Similarity=0.217 Sum_probs=110.2
Q ss_pred HHhhhhcCccCceEEEEEE--eCCCcEEEEEEeccCCCC-------------------------HHHHHHHHHHHhccCC
Q 040604 295 KSFRDKLGQGGYGEVYKGE--LPDGQLVAVKVLKNSRCN-------------------------GEEFINEVASISRTSH 347 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~-------------------------~~~~~~E~~~l~~l~h 347 (582)
+.+.+.||+|++|.||+|. ..+|+.||||+++..... ...+.+|+.++.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 4566899999999999997 568999999998754210 0124679999999976
Q ss_pred Cc--eEEEEeEEEeCCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCc-eEecCCCCCCE
Q 040604 348 VN--IVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVR-IVHFDIKPQNI 424 (582)
Q Consensus 348 ~n--iv~l~~~~~~~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~-ivH~Dikp~NI 424 (582)
.. +.+.++. ...++||||++|++|....... ..+.......++.|++.+|++||+. + |+||||||+||
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NI 180 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNI 180 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhE
Confidence 33 4455543 2358999999988887665332 2455667788999999999999998 8 99999999999
Q ss_pred EEcCCCceEEeeccccccccc
Q 040604 425 LLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 425 Ll~~~~~vkl~DFGla~~~~~ 445 (582)
+++ ++.++|+|||.+.....
T Consensus 181 li~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EEE-CCCEEEEEChhhhccCC
Confidence 999 88999999999876433
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.8e-19 Score=196.53 Aligned_cols=245 Identities=21% Similarity=0.231 Sum_probs=171.5
Q ss_pred HhhhhcCccCceEEEEEEeCCCcEEEEEEeccCC--CCHHHHHHHHHH--HhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 296 SFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSR--CNGEEFINEVAS--ISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
.+.+.||.+.|=+|.+|++++|. |+||++-+.. ..-+.|.+++.- ...++|||++.+.-+-..+...|||-+|.
T Consensus 26 ~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv- 103 (1431)
T KOG1240|consen 26 HYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV- 103 (1431)
T ss_pred eeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH-
Confidence 45678999999999999998887 9999985543 233444443332 55578999999877766666778888888
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccc---cc
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK---ES 448 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~---~~ 448 (582)
.-+|.+.+.-.. -+...+..-|+.|++.||.-+|.. +|+|||||.+||||+.-.=+.|+||..-+..--. ..
T Consensus 104 khnLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 104 KHNLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred hhhhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 678888886543 355666777899999999999998 9999999999999998888999999876543211 11
Q ss_pred cee--eecccCCccccccccccccc---------CCCCccchhHHHHHHHHHHhcC-CCCCCCC-----CcccchhhHHH
Q 040604 449 AIS--MLHARGTIGYIAPEVYSRRF---------GGVSHKSDVYSYGMMIIEMVGC-TKNLDDE-----VTDTSICHNLI 511 (582)
Q Consensus 449 ~~~--~~~~~gt~~y~aPE~~~~~~---------~~~s~~~DvwSlGvil~elltg-~~p~~~~-----~~~~~~~~~~~ 511 (582)
... ....+.-..|+|||.+.... +.++++.||||+||++.||++- +++|.-. ........+.+
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~ 258 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL 258 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence 111 01112223699999885421 1268899999999999999875 5555321 00001111222
Q ss_pred HHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 512 YERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 512 ~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
.+.|+. ..+..++..|++.||++|.++++.++.-.+
T Consensus 259 Le~Ied------------------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 259 LEKIED------------------VSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred HHhCcC------------------ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 222211 135666777999999999999999987544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.4e-18 Score=162.51 Aligned_cols=133 Identities=21% Similarity=0.297 Sum_probs=113.3
Q ss_pred hhcCccCceEEEEEEeCCCcEEEEEEeccCCCC---------HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCN---------GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.||+|++|.||+|.. +|..+++|+....... .+.+.+|+.++.++.|+++.....++.+....++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 7778999987543321 13577899999999999988777777777888999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ 442 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~ 442 (582)
++|++|.+++.... + .+..++.+++.+|.+||+. +++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986432 2 7788999999999999998 999999999999999 78999999998865
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.5e-18 Score=159.71 Aligned_cols=136 Identities=21% Similarity=0.235 Sum_probs=108.4
Q ss_pred HHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCC-----------------------HHHHHHHHHHHhccCCC--c
Q 040604 295 KSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCN-----------------------GEEFINEVASISRTSHV--N 349 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~E~~~l~~l~h~--n 349 (582)
+.+.+.||+|+||.||++...+|+.||||++...... ...+..|..++..+.|+ .
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 5566889999999999998888999999987643210 11356788889988887 4
Q ss_pred eEEEEeEEEeCCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC
Q 040604 350 IVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED 429 (582)
Q Consensus 350 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~ 429 (582)
+...++. ...++||||++|++|..+... .....++.+++.++.++|+. +|+||||||+||+++++
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~ 161 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDD 161 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCC
Confidence 4555442 355899999999999776431 23457889999999999997 99999999999999999
Q ss_pred CceEEeeccccccccc
Q 040604 430 FCPKISDFGLAKQAQK 445 (582)
Q Consensus 430 ~~vkl~DFGla~~~~~ 445 (582)
+.++|+|||++.....
T Consensus 162 ~~~~liDfg~~~~~~~ 177 (198)
T cd05144 162 EKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcEEEEECCccccCCC
Confidence 9999999999966544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-17 Score=158.61 Aligned_cols=129 Identities=23% Similarity=0.328 Sum_probs=106.0
Q ss_pred hcCccCceEEEEEEeCCCcEEEEEEeccCCC--C-------HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 300 KLGQGGYGEVYKGELPDGQLVAVKVLKNSRC--N-------GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 300 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
.||+|+||.||+|.. +|..+++|+...... . .+.+.+|+.++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 678899998654221 1 245678999999999887655555555666779999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccc
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ 442 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~ 442 (582)
+|++|.+++..... .++.+++.+|.+||+. +++|+|++|.||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND---------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH---------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999988754221 7899999999999998 999999999999999 88999999998876
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.3e-18 Score=188.11 Aligned_cols=195 Identities=23% Similarity=0.247 Sum_probs=151.5
Q ss_pred HHHHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccC---CCceEEEEeEEEeCCeeeEEEE
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTS---HVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~E 368 (582)
..++.+.+.||+|+||+||+|...+|+.||+|+-+..... +|.--..++.+|+ -+-|..+.....-.+.-+||+|
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W--EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~e 774 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW--EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSE 774 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce--eeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeee
Confidence 3455666789999999999998888999999998876533 2222233444444 1223334444444566789999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc-------CCCceEEeeccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLD-------EDFCPKISDFGLAK 441 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~-------~~~~vkl~DFGla~ 441 (582)
|.+.|+|.+++. .....+|.....++.|++..++.||.. +|||+||||+|+||. ++-.++|+|||-+-
T Consensus 775 y~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 775 YSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred ccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 999999999997 344688899999999999999999998 999999999999993 24569999999886
Q ss_pred cccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCC
Q 040604 442 QAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTK 495 (582)
Q Consensus 442 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~ 495 (582)
-+.--.........++|-.+--+|+..++ .++...|.|-++.+++-||.|+.
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~gr--pWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREGR--PWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcCC--CCchhhhhHHHHHHHHHHHHHHH
Confidence 54433333334456789999999999884 89999999999999999998874
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.2e-19 Score=179.99 Aligned_cols=173 Identities=26% Similarity=0.367 Sum_probs=128.5
Q ss_pred eeeEEEEecCCCChhhhhhcC-CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccc
Q 040604 362 KNALIYELMPNGSLDKFIHND-RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLA 440 (582)
Q Consensus 362 ~~~lv~E~~~~gsL~~~i~~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla 440 (582)
..++.|++|.-.+|.++|.+. .....++...+.++.|++.|++| + +.+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 568999999999999999744 34467888999999999999999 4 8999999999999999999999999999
Q ss_pred ccccccc----cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhh
Q 040604 441 KQAQKKE----SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERI 515 (582)
Q Consensus 441 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i 515 (582)
....... .....+...||..||+||.+.++ .++.|+||||||++|+||+. -...+...... ..+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~--~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~---------~d~ 472 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ--QYSEKVDIYALGLILAELLIQFSTQFERIATL---------TDI 472 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhh--hhhhhcchhhHHHHHHHHHHHhccHHHHHHhh---------hhh
Confidence 8776554 22334456799999999999885 89999999999999999986 33232221111 112
Q ss_pred cCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHH
Q 040604 516 EPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHK 558 (582)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~e 558 (582)
+. +..++....-...=..+..+++.+.|.+||++.+
T Consensus 473 r~-------g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 473 RD-------GIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred hc-------CCCChHHhhcCcHHHHHHHHhcCCCcccCchHHH
Confidence 22 2222122111122245667889999999994433
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.1e-18 Score=188.12 Aligned_cols=208 Identities=25% Similarity=0.333 Sum_probs=139.4
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCC
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGS 374 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 374 (582)
+..+.|..|+||.||..+++ +.+.+|+|+-++..... + ++.....|.+| |+
T Consensus 86 ~~IklisngAygavylvrh~~trqrfa~kiNkq~lilR----n---ilt~a~npfvv---------------------gD 137 (1205)
T KOG0606|consen 86 NTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLILR----N---ILTFAGNPFVV---------------------GD 137 (1205)
T ss_pred ceeEeeccCCCCceeeeeccccccchhhcccccchhhh----c---cccccCCccee---------------------ch
Confidence 44578999999999999776 46678885443322110 0 22222333333 44
Q ss_pred hhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccc--------
Q 040604 375 LDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK-------- 446 (582)
Q Consensus 375 L~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~-------- 446 (582)
-..+++.-+..+. +++.|++|||+. +|+|||+||+|.||..-|++|+.|||+++.....
T Consensus 138 c~tllk~~g~lPv----------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg 204 (1205)
T KOG0606|consen 138 CATLLKNIGPLPV----------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEG 204 (1205)
T ss_pred hhhhcccCCCCcc----------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhc
Confidence 4444443332222 237789999998 9999999999999999999999999998753211
Q ss_pred -----ccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCC
Q 040604 447 -----ESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDF 521 (582)
Q Consensus 447 -----~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~ 521 (582)
.......+++|||.|+|||++..+ .|...+|||++|+|+||.+-|..||+....+ ..+.+++...+.-
T Consensus 205 ~I~k~t~Ef~dKqvcgTPeyiaPeVilrq--gygkpvdwwamGiIlyeFLVgcvpffGdtpe-elfg~visd~i~w---- 277 (1205)
T KOG0606|consen 205 HIEKDTHEFQDKQVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-ELFGQVISDDIEW---- 277 (1205)
T ss_pred chHHHHHHhhhccccCCccccChhhhhhh--ccCCCccHHHHHHHHHHHheeeeeccCCCHH-HHHhhhhhhhccc----
Confidence 011122345799999999999874 7899999999999999999999999875443 3444444333221
Q ss_pred CCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHH
Q 040604 522 QFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMH 557 (582)
Q Consensus 522 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ 557 (582)
++.......+..+++.+.|+.+|.+|--..
T Consensus 278 ------pE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 278 ------PEEDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred ------cccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 112223334455566667788999997433
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.4e-17 Score=158.44 Aligned_cols=199 Identities=20% Similarity=0.237 Sum_probs=134.1
Q ss_pred CCCceEEEEeEEEe---------------------------CCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHH
Q 040604 346 SHVNIVTFLGFCYE---------------------------NKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIG 398 (582)
Q Consensus 346 ~h~niv~l~~~~~~---------------------------~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~q 398 (582)
+|||||++.++|.+ +...|+||... ..+|..++..+ ..+.....-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~---~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR---HRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC---CCchHHHHHHHHH
Confidence 59999999887753 23557888877 67888888654 3566677778999
Q ss_pred HHHHHHHHHhCCCCceEecCCCCCCEEE--cCCC--ceEEeeccccccccccccc----eeeecccCCcccccccccccc
Q 040604 399 IARGLEYLHRGCQVRIVHFDIKPQNILL--DEDF--CPKISDFGLAKQAQKKESA----ISMLHARGTIGYIAPEVYSRR 470 (582)
Q Consensus 399 i~~aL~yLH~~~~~~ivH~Dikp~NILl--~~~~--~vkl~DFGla~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~ 470 (582)
+++|+.|||++ +|.|||+|.+|||+ |+++ .+.|+|||.+-......-. ......-|.-.-||||+....
T Consensus 350 lLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 99999999998 99999999999998 3443 4788999976433221100 001112377789999998665
Q ss_pred cCCC----CccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhcc
Q 040604 471 FGGV----SHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCI 546 (582)
Q Consensus 471 ~~~~----s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl 546 (582)
.|.. -.|+|.|+.|.+.||+++...||.......-.... -++.+-+.+++..+... .+|+...|
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-----Yqe~qLPalp~~vpp~~-------rqlV~~lL 494 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-----YQESQLPALPSRVPPVA-------RQLVFDLL 494 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh-----hhhhhCCCCcccCChHH-------HHHHHHHh
Confidence 4432 24899999999999999999999874332211111 11111223333333333 34444467
Q ss_pred ccCCCCCCCHHHHHHHH
Q 040604 547 QTNPSERPSMHKVLEML 563 (582)
Q Consensus 547 ~~dp~~RPt~~evl~~L 563 (582)
+.||++|++..-....|
T Consensus 495 ~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 495 KRDPSKRVSPNIAANVL 511 (598)
T ss_pred cCCccccCCccHHHhHH
Confidence 99999999876554444
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.9e-17 Score=177.41 Aligned_cols=131 Identities=20% Similarity=0.282 Sum_probs=107.4
Q ss_pred hhhcCccCceEEEEEEeCCCcEEEEEEe-ccC-CC-------CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEE
Q 040604 298 RDKLGQGGYGEVYKGELPDGQLVAVKVL-KNS-RC-------NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~-~~~-~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 368 (582)
.++||+|+||+||+|.+... .+++|+. .+. .. ..+.+.+|+.++++++|++++....++.+....++|||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E 416 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME 416 (535)
T ss_pred cceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence 57899999999999987544 3444432 221 11 12457899999999999999888888777778899999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQA 443 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~ 443 (582)
|++|++|.+++. ....++.|++++|.|||+. +++||||||+|||+ +++.++|+|||+++..
T Consensus 417 ~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 417 YIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred ecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 999999998875 3467899999999999998 99999999999999 5789999999998763
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=9.2e-17 Score=151.38 Aligned_cols=136 Identities=23% Similarity=0.290 Sum_probs=99.2
Q ss_pred hhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCH---HHH----------------------HHHHHHHhccCCCc--e
Q 040604 298 RDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNG---EEF----------------------INEVASISRTSHVN--I 350 (582)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~----------------------~~E~~~l~~l~h~n--i 350 (582)
.+.||+|+||+||+|...+++.||||+++...... ..+ ..|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999988789999999987543211 111 34556666664443 4
Q ss_pred EEEEeEEEeCCeeeEEEEecCCCChhh-hhhcCCCcCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCCEEEcC
Q 040604 351 VTFLGFCYENKKNALIYELMPNGSLDK-FIHNDRNIKLEWKTMYQIAIGIARGLEYLHR-GCQVRIVHFDIKPQNILLDE 428 (582)
Q Consensus 351 v~l~~~~~~~~~~~lv~E~~~~gsL~~-~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~ivH~Dikp~NILl~~ 428 (582)
.+.++. ...++||||++++.+.. .+.... .. .....++.+++.++.++|+ . +|+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-
Confidence 455543 24689999999855432 121111 11 5677899999999999998 6 999999999999999
Q ss_pred CCceEEeeccccccccc
Q 040604 429 DFCPKISDFGLAKQAQK 445 (582)
Q Consensus 429 ~~~vkl~DFGla~~~~~ 445 (582)
++.++|+|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 89999999999976443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.6e-16 Score=138.94 Aligned_cols=135 Identities=23% Similarity=0.198 Sum_probs=114.5
Q ss_pred hhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCC--CceEEEEeEEEeCCeeeEEEEecCCCCh
Q 040604 298 RDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSH--VNIVTFLGFCYENKKNALIYELMPNGSL 375 (582)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~E~~~~gsL 375 (582)
.+.||+|.++.||++...+ ..+++|....... ...+.+|+..++.++| .++++++++....+..+++|||++++.+
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 3679999999999998744 7899999876543 5678899999999987 4899999888877789999999988877
Q ss_pred hhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccc
Q 040604 376 DKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQA 443 (582)
Q Consensus 376 ~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~ 443 (582)
..+ +......++.+++++|++||.....+++|+|++|+||++++.+.++++|||.+...
T Consensus 81 ~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 81 DEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 654 44566778999999999999864457999999999999999999999999988753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.2e-17 Score=180.40 Aligned_cols=253 Identities=23% Similarity=0.236 Sum_probs=187.0
Q ss_pred HHhhhhcCccCceEEEEEEeC--CCcEEEEEEeccCCC---CHHHHHHHHHHHhccC-CCceEEEEeEEEeCCeeeEEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP--DGQLVAVKVLKNSRC---NGEEFINEVASISRTS-HVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E 368 (582)
+++.+.||+|+|+.|-..... ....+|+|.+..... ..+....|..+-..+. |.|++.+++...+.+..++++|
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 344567999999999988543 455677777654432 2233445777777776 9999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHH-hCCCCceEecCCCCCCEEEcCCC-ceEEeeccccccccc-
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH-RGCQVRIVHFDIKPQNILLDEDF-CPKISDFGLAKQAQK- 445 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~~~~~ivH~Dikp~NILl~~~~-~vkl~DFGla~~~~~- 445 (582)
|..|+++.+.+........+.......+.|+..++.|+| .. ++.|+||||+|.+++..+ .+|++|||+|..+..
T Consensus 102 ~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 102 YSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred cccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 999999999883222214455566677999999999999 66 999999999999999999 999999999998877
Q ss_pred cccceeeecccC-CcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCC
Q 040604 446 KESAISMLHARG-TIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFD 524 (582)
Q Consensus 446 ~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 524 (582)
..........+| ++.|+|||...+. ....+..|+||.|+++..+++|..|+.........+..|....-. ..
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~----~~-- 251 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGR----FT-- 251 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCccccccccccceeecccccc----cc--
Confidence 444444555678 9999999998774 355778899999999999999999997765544333333222100 00
Q ss_pred CcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 040604 525 GVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVL 560 (582)
Q Consensus 525 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl 560 (582)
......+......+...++..+|+.|.+.+++.
T Consensus 252 ---~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 252 ---QLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ---cCccccCChhhhhcccccccCCchhcccccccc
Confidence 001122334445555667788999999988764
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.2e-15 Score=145.23 Aligned_cols=133 Identities=15% Similarity=0.176 Sum_probs=104.5
Q ss_pred hhcC-ccCceEEEEEEeCCCcEEEEEEeccCC--------------CCHHHHHHHHHHHhccCCCce--EEEEeEEEeCC
Q 040604 299 DKLG-QGGYGEVYKGELPDGQLVAVKVLKNSR--------------CNGEEFINEVASISRTSHVNI--VTFLGFCYENK 361 (582)
Q Consensus 299 ~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~ 361 (582)
..|| .||.|+||++.. ++..++||.+.... .....+.+|+.++.++.|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4688 899999999987 47788999875321 122457889999999998874 67777654332
Q ss_pred ----eeeEEEEecCC-CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEee
Q 040604 362 ----KNALIYELMPN-GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISD 436 (582)
Q Consensus 362 ----~~~lv~E~~~~-gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~D 436 (582)
..++|||+++| .+|.+++... .++.. .+.|++.+|.+||+. ||+||||||+|||++.++.++|+|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEE
Confidence 23599999997 6898887642 34543 356899999999998 999999999999999999999999
Q ss_pred cccccc
Q 040604 437 FGLAKQ 442 (582)
Q Consensus 437 FGla~~ 442 (582)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998876
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.6e-13 Score=145.66 Aligned_cols=140 Identities=24% Similarity=0.274 Sum_probs=99.7
Q ss_pred hhcCccCceEEEEEEeCCCcEEEEEEeccCCCC---------------------------H----H----------HHHH
Q 040604 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCN---------------------------G----E----------EFIN 337 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------------~----~----------~~~~ 337 (582)
+.||.|++|.||+|.+.+|+.||||+.+..... . + +|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 469999999999999999999999998653210 0 0 1445
Q ss_pred HHHHHhccC----CCceEEEEeEEE-eCCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHH-HHHHHHhCCC
Q 040604 338 EVASISRTS----HVNIVTFLGFCY-ENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIAR-GLEYLHRGCQ 411 (582)
Q Consensus 338 E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~-aL~yLH~~~~ 411 (582)
|+..+.++. |.+-+.+-.++. .....+|||||++|++|.++...... ..+ ..+++.+++. .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~~-- 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLRD-- 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHhC--
Confidence 665555542 333333333332 24457999999999999887653211 122 3456666665 46778876
Q ss_pred CceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 412 VRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 412 ~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
|++|+|+||.||++++++.++++|||++..+..
T Consensus 277 -g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 -GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred -CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.42 E-value=8.5e-13 Score=122.08 Aligned_cols=130 Identities=22% Similarity=0.159 Sum_probs=97.3
Q ss_pred hhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCce-EEEEeEEEeCCeeeEEEEecCCCChhh
Q 040604 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNI-VTFLGFCYENKKNALIYELMPNGSLDK 377 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~gsL~~ 377 (582)
+.|+.|.++.||++.. .++.+++|+..........+.+|+.+++.+.+.++ .+++.+. ....++||||++|.++..
T Consensus 4 ~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEE-CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence 5689999999999987 47789999986654333456789999998876554 4455443 334689999999988765
Q ss_pred hhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecCCCCCCEEEcCCCceEEeecccccc
Q 040604 378 FIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGC--QVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ 442 (582)
Q Consensus 378 ~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~ 442 (582)
.. . ....++.+++++|+.||+.. ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 81 ~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 ED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 30 0 11235678999999999872 22369999999999999 66899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=6.4e-13 Score=128.51 Aligned_cols=203 Identities=21% Similarity=0.263 Sum_probs=137.3
Q ss_pred HHHHhccCCCceEEEEeEEEeCC-----eeeEEEEecCCCChhhhhhcC--CCcCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 040604 339 VASISRTSHVNIVTFLGFCYENK-----KNALIYELMPNGSLDKFIHND--RNIKLEWKTMYQIAIGIARGLEYLHRGCQ 411 (582)
Q Consensus 339 ~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~E~~~~gsL~~~i~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~ 411 (582)
...|.++.|.|+|+++.++.+.. ...++.|||..|+|..+|++. ....+....+.+|+.||+.||.|||+. .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 45677788999999999987543 457899999999999999764 234578888899999999999999985 7
Q ss_pred CceEecCCCCCCEEEcCCCceEEeecccccccc--ccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHH
Q 040604 412 VRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ--KKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIE 489 (582)
Q Consensus 412 ~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~e 489 (582)
+.|+|+++..+-|++..+|-+|+.--.-..... ............|-++|.+||+-.. .+.+.++|||+||+..+|
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~--tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT--TNTTGASDIYKFGMCALE 274 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc--cccccchhhhhhhHHHHH
Confidence 899999999999999999999875321111000 0000001112347889999997433 467889999999999999
Q ss_pred HhcCCCCCCCCCcccchhh-HHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 490 MVGCTKNLDDEVTDTSICH-NLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 490 lltg~~p~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
|..+.--..... ..... ..+...+....+ ... +.++..|++..|..||+|++++.
T Consensus 275 mailEiq~tnse--S~~~~ee~ia~~i~~len--------~lq-------r~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 275 MAILEIQSTNSE--SKVEVEENIANVIIGLEN--------GLQ-------RGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHHheeccCCCc--ceeehhhhhhhheeeccC--------ccc-------cCcCcccccCCCCCCcchhhhhc
Confidence 987764322111 11111 111111111000 000 12334599999999999998863
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=4.4e-13 Score=140.42 Aligned_cols=247 Identities=21% Similarity=0.205 Sum_probs=179.3
Q ss_pred HHHHhhhhcCc--cCceEEEEEEe---CCCcEEEEEEeccCC---CCHHHHHHHHHHHhccC-CCceEEEEeEEEeCCee
Q 040604 293 MTKSFRDKLGQ--GGYGEVYKGEL---PDGQLVAVKVLKNSR---CNGEEFINEVASISRTS-HVNIVTFLGFCYENKKN 363 (582)
Q Consensus 293 ~~~~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 363 (582)
.+..+.+.+|. |.+|.||.+.. .++..+|+|.-+... .....-++|+.....++ |+|.++.+..+.+.+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34455677899 99999999865 368889999844321 12223345666666664 99999999999999999
Q ss_pred eEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHH----HHHHHHhCCCCceEecCCCCCCEEEcCC-CceEEeecc
Q 040604 364 ALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIAR----GLEYLHRGCQVRIVHFDIKPQNILLDED-FCPKISDFG 438 (582)
Q Consensus 364 ~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~----aL~yLH~~~~~~ivH~Dikp~NILl~~~-~~vkl~DFG 438 (582)
++-+|++ +.+|..+.+... ..++...++.+..+... ||.++|+. .++|-|+||.||++..+ ...+++|||
T Consensus 194 fiqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcc
Confidence 9999999 688888887532 34777888888888888 99999998 99999999999999999 889999999
Q ss_pred cccccccccccee---eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhh
Q 040604 439 LAKQAQKKESAIS---MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERI 515 (582)
Q Consensus 439 la~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i 515 (582)
+...+....-... .....|...|++||...+ .++.++|+|++|.+.++..++-.......... |. .+
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-----W~--~~ 338 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLPSVGKNSS-----WS--QL 338 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhcc---ccchHhhhcchhhhhHhhHhhcccccCCCCCC-----cc--cc
Confidence 9988776542211 123358889999999875 67889999999999999988776554331111 11 11
Q ss_pred cCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 040604 516 EPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVL 560 (582)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl 560 (582)
+.+. ...+........+..+...+++.+|..|++.+.+.
T Consensus 339 r~~~------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 339 RQGY------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred cccc------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 1111 11111222233344466778999999999987665
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=4.2e-12 Score=136.34 Aligned_cols=137 Identities=20% Similarity=0.251 Sum_probs=92.9
Q ss_pred hhcCccCceEEEEEEeCC-CcEEEEEEeccCCC---------------------------CH----H----------HHH
Q 040604 299 DKLGQGGYGEVYKGELPD-GQLVAVKVLKNSRC---------------------------NG----E----------EFI 336 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---------------------------~~----~----------~~~ 336 (582)
+.||+|++|.||+|.+++ |+.||||+.++... .. + ++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 479999999999999876 99999999975310 00 0 144
Q ss_pred HHHHHHhccC----CCceEEEEeEEEe-CCeeeEEEEecCCCChhhhh--hcCCC--cCCCHHHHHHHHHHHHHHHHHHH
Q 040604 337 NEVASISRTS----HVNIVTFLGFCYE-NKKNALIYELMPNGSLDKFI--HNDRN--IKLEWKTMYQIAIGIARGLEYLH 407 (582)
Q Consensus 337 ~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~E~~~~gsL~~~i--~~~~~--~~l~~~~~~~i~~qi~~aL~yLH 407 (582)
+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.|.++. ...+. ..+....+..++.|+.
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif------- 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF------- 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------
Confidence 5555555543 4444554444443 45678999999999998753 22110 0122222233333332
Q ss_pred hCCCCceEecCCCCCCEEEcCCC----ceEEeeccccccccc
Q 040604 408 RGCQVRIVHFDIKPQNILLDEDF----CPKISDFGLAKQAQK 445 (582)
Q Consensus 408 ~~~~~~ivH~Dikp~NILl~~~~----~vkl~DFGla~~~~~ 445 (582)
.. |++|+|+||.||+++.++ .+++.|||++..+..
T Consensus 278 ~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33 999999999999999888 999999999987754
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.4e-11 Score=112.68 Aligned_cols=135 Identities=17% Similarity=0.188 Sum_probs=98.9
Q ss_pred hhcCccCceEEEEEEeCC-------CcEEEEEEeccCCC----------------------C-HHHH----HHHHHHHhc
Q 040604 299 DKLGQGGYGEVYKGELPD-------GQLVAVKVLKNSRC----------------------N-GEEF----INEVASISR 344 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~----------------------~-~~~~----~~E~~~l~~ 344 (582)
..||.|--+.||.|...+ +..+|||+.+.+.. . ...+ .+|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999996543 47999998753210 0 1122 379999998
Q ss_pred cCC--CceEEEEeEEEeCCeeeEEEEecCCCChhh-hhhcCCCcCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEecCCC
Q 040604 345 TSH--VNIVTFLGFCYENKKNALIYELMPNGSLDK-FIHNDRNIKLEWKTMYQIAIGIARGLEYL-HRGCQVRIVHFDIK 420 (582)
Q Consensus 345 l~h--~niv~l~~~~~~~~~~~lv~E~~~~gsL~~-~i~~~~~~~l~~~~~~~i~~qi~~aL~yL-H~~~~~~ivH~Dik 420 (582)
+.. -++.+++++ ...+|||||+.+..+.. .+.. ..++.....++..+++.+|..| |+. +|+|+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 864 466777765 46789999996654422 2221 2345566778889999999998 776 99999999
Q ss_pred CCCEEEcCCCceEEeecccccccc
Q 040604 421 PQNILLDEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 421 p~NILl~~~~~vkl~DFGla~~~~ 444 (582)
+.|||++ ++.+.|+|||.+....
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCC
Confidence 9999997 4679999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF14380 WAK_assoc: Wall-associated receptor kinase C-terminal | Back alignment and domain information |
|---|
Probab=99.26 E-value=2e-11 Score=100.52 Aligned_cols=94 Identities=36% Similarity=0.765 Sum_probs=72.6
Q ss_pred ccCCCCCCCCcceEeecCCCCccccccccccccccCCceeEEEeecccccccccCCCCCchhhhhhhcceEEEecCCCcc
Q 040604 137 FNCSIDGKNTNSYYFSWDSNSFNSSIRSAIGAYFRSCANSAVIPVWQSTLRYMVNNPNSVNLTCALRVGFGLQWHANNRL 216 (582)
Q Consensus 137 ~~C~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~C~~~~~vp~~~~~~~~~~~~~~~~~~~~~l~~gf~L~W~~~~~~ 216 (582)
++|.+++.....+|+... ......|+..+.|||....... ...+..+|.++|+.||+|+|.+....
T Consensus 1 ~~C~~~~~~~~~~~v~~~------------~~~~~~C~~~v~vPV~~~~~~~--~~~~~~~~~~~L~~GF~L~w~~~~~~ 66 (94)
T PF14380_consen 1 INCSINSGNSVSYFVFRS------------SDLAGSCQKSVVVPVLGSAVDS--IDGSSGNYEEVLKKGFELEWNADSGD 66 (94)
T ss_pred CccccCCCCceeEEEeCC------------cccCCcCCEEEEEEECchhhhc--cccchhHHHHHHhcCcEEEEeCCCCc
Confidence 467766655455665433 3356799999999998642211 12366789999999999999976789
Q ss_pred ccccccCCCcccccCCCCceEEeCCCCC
Q 040604 217 CEECKQSNGNCGYIAKTGEFICYCPNGA 244 (582)
Q Consensus 217 C~~C~~~~~~C~~~~~~~~~~C~c~~G~ 244 (582)
|.+|+.++|.|+++.+...+.|+|++|.
T Consensus 67 C~~C~~SgG~Cgy~~~~~~f~C~C~dg~ 94 (94)
T PF14380_consen 67 CRECEASGGRCGYDSNSEQFTCFCSDGP 94 (94)
T ss_pred CcChhcCCCEeCCCCCCceEEEECCCCC
Confidence 9999999999999998889999999873
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.26 E-value=5.8e-11 Score=114.76 Aligned_cols=141 Identities=16% Similarity=0.171 Sum_probs=111.4
Q ss_pred hhcCccCceEEEEEEeCCCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCC--ceEEEEeEEEeCC---eeeEEEEecC
Q 040604 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRC--NGEEFINEVASISRTSHV--NIVTFLGFCYENK---KNALIYELMP 371 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~---~~~lv~E~~~ 371 (582)
+.||.|..+.||++...+|+.+++|+...... ....+.+|+.+++.+.+. ++.+++.+..+.. ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999877778999999865443 356788999999998764 4577777766542 5689999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGC----------------------------------------- 410 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~----------------------------------------- 410 (582)
|.++.+.+.. ..++......++.+++++|..||+..
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9988876542 24677778888889999999998531
Q ss_pred ------------CCceEecCCCCCCEEEcC--CCceEEeecccccc
Q 040604 411 ------------QVRIVHFDIKPQNILLDE--DFCPKISDFGLAKQ 442 (582)
Q Consensus 411 ------------~~~ivH~Dikp~NILl~~--~~~vkl~DFGla~~ 442 (582)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 67789999997765
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.1e-11 Score=130.05 Aligned_cols=242 Identities=20% Similarity=0.231 Sum_probs=168.8
Q ss_pred HHhhhhcCccCceEEEEEEe--CCCcEEEEEEeccCCCC-HHH--HHHHHHHHhcc-CCCceEEEEeEEEeCCeeeEEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGEL--PDGQLVAVKVLKNSRCN-GEE--FINEVASISRT-SHVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~-~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 368 (582)
+.+...||.|.|+.|+.... .++..|++|.+.+.... .++ -..|+.+...+ .|.++++.+..|....+.++-.|
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e 346 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLE 346 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchh
Confidence 34557899999999999854 36889999988654332 222 24566665555 58899999988888888899999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-CceEEeeccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED-FCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~-~~vkl~DFGla~~~~~~~ 447 (582)
|++++++...+. -...+++...+++..|++.++.++|+. .++|+|+||+||++..+ +.-++.|||.+..+.-..
T Consensus 347 ~~~~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~ 421 (524)
T KOG0601|consen 347 FCEGGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS 421 (524)
T ss_pred hhcCcchhhhhH--HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccceec
Confidence 999999876662 223577788899999999999999987 99999999999999876 788999999987532211
Q ss_pred cceeeecccCCcccc-cccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCc
Q 040604 448 SAISMLHARGTIGYI-APEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~-aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 526 (582)
. ...++-++. .+|++... ..+-.+.|++|||.-+.|.+++..-........ .+..+........
T Consensus 422 ~-----~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~---------~i~~~~~p~~~~~ 486 (524)
T KOG0601|consen 422 G-----VFHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSPLSESGVQSL---------TIRSGDTPNLPGL 486 (524)
T ss_pred c-----cccccccccccchhhccc-cccccccccccccccccccccCcccCcccccce---------eeecccccCCCch
Confidence 1 111333444 35655554 467789999999999999998886443321111 2222222222221
Q ss_pred CcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 040604 527 ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564 (582)
Q Consensus 527 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le 564 (582)
. +.+..++..++.+++..||.+.++..+.+
T Consensus 487 ~--------~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 487 K--------LQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred H--------HhhhhhhhhhcCCccccchhhhhhcccch
Confidence 1 22333444467899999999888776554
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.8e-10 Score=102.07 Aligned_cols=130 Identities=19% Similarity=0.247 Sum_probs=98.4
Q ss_pred hhcCccCceEEEEEEeCCCcEEEEEEe-ccCCCCH--------HHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 299 DKLGQGGYGEVYKGELPDGQLVAVKVL-KNSRCNG--------EEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~vavK~~-~~~~~~~--------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.+++|+-+.+|.+.+ -|.++++|.- ++..... +.-.+|+.++.+++--.|...+=+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 4578999999999977 3445666653 3322221 2356899999998766655555555577788899999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ 442 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~ 442 (582)
++|..|.+.+... ...++..+-..+.-||.. +|+|+||.++||++..++ +.++||||+..
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9988888888653 245566777778889998 999999999999998765 99999999875
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.2e-10 Score=101.96 Aligned_cols=140 Identities=21% Similarity=0.271 Sum_probs=105.5
Q ss_pred hhcCccCceEEEEEEeCCCcEEEEEEec-cCCC--------CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 299 DKLGQGGYGEVYKGELPDGQLVAVKVLK-NSRC--------NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~-~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
..|-||+-+.|+++.+ .|+.+.||.-. +... ....-.+|+..|.+++--.|....-++.+.....|+|||
T Consensus 13 ~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 5688999999999988 67777777532 2211 123467899999988766665555556677788899999
Q ss_pred cCC-CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC---ceEEeecccccc
Q 040604 370 MPN-GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF---CPKISDFGLAKQ 442 (582)
Q Consensus 370 ~~~-gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~---~vkl~DFGla~~ 442 (582)
++| .++.+++...-...........++.+|-+.+.-||.. +|+|+||..+||++..++ .+.++|||++..
T Consensus 92 ~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred ccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 966 3788888765433444444477888999999999998 999999999999996554 458999999865
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.3e-09 Score=115.67 Aligned_cols=166 Identities=20% Similarity=0.221 Sum_probs=124.1
Q ss_pred EeCCCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCChhhhhhcCCCcCCCHHH
Q 040604 313 ELPDGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKT 391 (582)
Q Consensus 313 ~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~ 391 (582)
+..++.+|.|.+.+.+.. ..+...+-+..|+.++||||+++++.+......|||+|.+ .-|..++.+.+ ...
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~-----~~~ 105 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG-----KEE 105 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH-----HHH
Confidence 445788999999876654 2345677888999999999999999999999999999998 35666665432 344
Q ss_pred HHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeecccCCccccccccccccc
Q 040604 392 MYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRF 471 (582)
Q Consensus 392 ~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 471 (582)
+.-.+.||+.||.+||..+ +++|++|.-..|+++..|..||++|.++........... ...--..|..|+.+...
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~--~~~~~~s~~~P~~~~~s- 180 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAK--SLYLIESFDDPEEIDPS- 180 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccc--cchhhhcccChhhcCcc-
Confidence 5556889999999999653 899999999999999999999999988755332211000 00111246677654321
Q ss_pred CCCCccchhHHHHHHHHHHhcC
Q 040604 472 GGVSHKSDVYSYGMMIIEMVGC 493 (582)
Q Consensus 472 ~~~s~~~DvwSlGvil~elltg 493 (582)
. -..|.|-||++++|++.|
T Consensus 181 -~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 -E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -c--cchhhhhHHHHHHHHhCc
Confidence 1 246999999999999998
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.4e-09 Score=101.42 Aligned_cols=125 Identities=27% Similarity=0.368 Sum_probs=83.0
Q ss_pred EEEEEEeCCCcEEEEEEeccCCCC---------------------------HHHHHHHHHHHhccCCC--ceEEEEeEEE
Q 040604 308 EVYKGELPDGQLVAVKVLKNSRCN---------------------------GEEFINEVASISRTSHV--NIVTFLGFCY 358 (582)
Q Consensus 308 ~Vy~~~~~~~~~vavK~~~~~~~~---------------------------~~~~~~E~~~l~~l~h~--niv~l~~~~~ 358 (582)
.||.|...+|..+|||+.+..... .....+|...|.++... ++.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 389999889999999997642110 01256899999999866 56777755
Q ss_pred eCCeeeEEEEecC--CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHH-HHhCCCCceEecCCCCCCEEEcCCCceEEe
Q 040604 359 ENKKNALIYELMP--NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEY-LHRGCQVRIVHFDIKPQNILLDEDFCPKIS 435 (582)
Q Consensus 359 ~~~~~~lv~E~~~--~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~y-LH~~~~~~ivH~Dikp~NILl~~~~~vkl~ 435 (582)
...+|||||++ |..+..+.... ++......++.+++..+.. +|+. ||+|+||.+.|||++++ .+.|+
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred --eCCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence 25689999998 55555443322 1123445667777775555 4676 99999999999999988 99999
Q ss_pred ecccccccc
Q 040604 436 DFGLAKQAQ 444 (582)
Q Consensus 436 DFGla~~~~ 444 (582)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999887644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.1e-10 Score=128.66 Aligned_cols=241 Identities=18% Similarity=0.196 Sum_probs=156.1
Q ss_pred hhcCccCceEEEEEEeC-CCcEEEEEEeccCCC----CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCC
Q 040604 299 DKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNG 373 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 373 (582)
+-+-+|+++.++.+.-. .|...++|+.+.... ..+....+-.++-..++|-+++..--+.-....+|+++|+.++
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~ 889 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG 889 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence 45678888888877432 455556665543221 1122223333333344566665554444556778999999999
Q ss_pred ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccc--------
Q 040604 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK-------- 445 (582)
Q Consensus 374 sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~-------- 445 (582)
+|...++..+ ..+..-....+..+..+++|||+. .+.|+|++|.|+|+..+++.+++|||+.....-
T Consensus 890 ~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~s 964 (1205)
T KOG0606|consen 890 DLPSKLHNSG--CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLS 964 (1205)
T ss_pred CchhhhhcCC--CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcCCcc
Confidence 9999988654 345455555677788899999986 699999999999999999999999984332110
Q ss_pred -------------c--------ccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCccc
Q 040604 446 -------------K--------ESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDT 504 (582)
Q Consensus 446 -------------~--------~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~ 504 (582)
. +.........||+.|.+||.+.+. .-...+|+|++|+.++|.++|..|+.......
T Consensus 965 g~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~--~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen 965 GPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR--RHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ 1042 (1205)
T ss_pred cccccCccccccccccccccccchhhccccccCCCcccCCcccccc--cCCCcchhhhhhhhhhhhhcCCCCCCCcchhh
Confidence 0 000111234599999999999874 56678999999999999999999997654332
Q ss_pred chhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHH
Q 040604 505 SICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMH 557 (582)
Q Consensus 505 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ 557 (582)
+.+-+..... ... ....+....+.+++.+.+..+|.+|-.|.
T Consensus 1043 ------~f~ni~~~~~-~~p----~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1043 ------IFENILNRDI-PWP----EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred ------hhhccccCCC-CCC----CCccccChhhhhhhhhhhccCchhccCcc
Confidence 1122222111 111 11112223334444556688999998776
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=8.6e-09 Score=101.97 Aligned_cols=134 Identities=18% Similarity=0.098 Sum_probs=96.9
Q ss_pred CceEEEEEEeCCCcEEEEEEeccCCC------------CHHHHHHHHHHHhccCCCc--eEEEEeEEEe-----CCeeeE
Q 040604 305 GYGEVYKGELPDGQLVAVKVLKNSRC------------NGEEFINEVASISRTSHVN--IVTFLGFCYE-----NKKNAL 365 (582)
Q Consensus 305 ~~g~Vy~~~~~~~~~vavK~~~~~~~------------~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~-----~~~~~l 365 (582)
....|.+... +|+.+.||....... ....+.+|...+.++...+ +..++++... ....+|
T Consensus 34 ~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L 112 (268)
T PRK15123 34 EGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI 112 (268)
T ss_pred CCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence 3344666665 678899997643321 1124778998888875433 3444555432 234679
Q ss_pred EEEecCCC-ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-------CCceEEeec
Q 040604 366 IYELMPNG-SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE-------DFCPKISDF 437 (582)
Q Consensus 366 v~E~~~~g-sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~-------~~~vkl~DF 437 (582)
|||++++. +|.+++........+......++.+++..+.-||.. ||+|+|+++.|||++. +..+.++||
T Consensus 113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl 189 (268)
T PRK15123 113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDL 189 (268)
T ss_pred EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence 99999875 798888543223456677788999999999999998 9999999999999975 468999999
Q ss_pred ccccc
Q 040604 438 GLAKQ 442 (582)
Q Consensus 438 Gla~~ 442 (582)
+.++.
T Consensus 190 ~r~~~ 194 (268)
T PRK15123 190 HRAQI 194 (268)
T ss_pred Ccccc
Confidence 98754
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=8.2e-09 Score=99.00 Aligned_cols=134 Identities=22% Similarity=0.233 Sum_probs=94.9
Q ss_pred HHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCC-----------------------HHHHHHHHHHHhccCCC--c
Q 040604 295 KSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCN-----------------------GEEFINEVASISRTSHV--N 349 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~E~~~l~~l~h~--n 349 (582)
+.+..+||-|--|.||.|...+|.++|||.-+..... .....+|..+|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 3456789999999999999999999999975432111 12356899999999755 6
Q ss_pred eEEEEeEEEeCCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC
Q 040604 350 IVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED 429 (582)
Q Consensus 350 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~ 429 (582)
|.+.+++ +..++|||+++|-.|...--. ......+ +..|++-+.-+-.. |+||+|+++-||+++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~~----~en~~~i---l~~il~~~~~~~~~---GiVHGDlSefNIlV~~d 238 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRLD----VENPDEI---LDKILEEVRKAYRR---GIVHGDLSEFNILVTED 238 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccCc----ccCHHHH---HHHHHHHHHHHHHc---CccccCCchheEEEecC
Confidence 7777655 466899999988777654311 1222232 33333333322233 99999999999999999
Q ss_pred CceEEeecccccc
Q 040604 430 FCPKISDFGLAKQ 442 (582)
Q Consensus 430 ~~vkl~DFGla~~ 442 (582)
|.+.++||--+..
T Consensus 239 g~~~vIDwPQ~v~ 251 (304)
T COG0478 239 GDIVVIDWPQAVP 251 (304)
T ss_pred CCEEEEeCccccc
Confidence 9999999975544
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.89 E-value=6e-08 Score=100.11 Aligned_cols=168 Identities=18% Similarity=0.288 Sum_probs=128.3
Q ss_pred CceEEEEEE-eCCCcEEEEEEeccCCCC-HHHHHHHHHHHhccCCCceEEEEeEEE----eCCeeeEEEEecCC-CChhh
Q 040604 305 GYGEVYKGE-LPDGQLVAVKVLKNSRCN-GEEFINEVASISRTSHVNIVTFLGFCY----ENKKNALIYELMPN-GSLDK 377 (582)
Q Consensus 305 ~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~E~~~~-gsL~~ 377 (582)
.-.+.|++. ..+|..|++|+++..+.. ...-..-++.++++.|.|||++..++. .+..++|||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 446789984 458999999999543322 122334578899999999999999887 34567899999875 56766
Q ss_pred hhhcC-------------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccc
Q 040604 378 FIHND-------------RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 378 ~i~~~-------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~ 444 (582)
+-... .+...++..+|.++.|+..||.++|+. |+.-+-|.|.+||++.+.+++|+..|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 54321 123578899999999999999999998 99999999999999999999999888877655
Q ss_pred ccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCC
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKN 496 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p 496 (582)
.+.. |.+.. -.+-|.=.||.+++.|.||...
T Consensus 445 ~d~~----------------~~le~-----~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPT----------------EPLES-----QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCC----------------cchhH-----HhhhhHHHHHHHHHHHhhcccc
Confidence 4431 11221 2467999999999999999765
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=4.9e-08 Score=104.52 Aligned_cols=144 Identities=19% Similarity=0.251 Sum_probs=97.0
Q ss_pred Hhh-hhcCccCceEEEEEEeCCCcEEEEEEeccCCCCH-------------------------------HH---------
Q 040604 296 SFR-DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNG-------------------------------EE--------- 334 (582)
Q Consensus 296 ~~~-~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------~~--------- 334 (582)
+|. +.|+.++-|.||+|++++|+.||||+.++.-... ++
T Consensus 127 eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~El 206 (517)
T COG0661 127 EFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREEL 206 (517)
T ss_pred HcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHh
Confidence 344 4699999999999999999999999987532110 01
Q ss_pred -HHHHHHHHhccC-----CCceEEEEeEEE-eCCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHH
Q 040604 335 -FINEVASISRTS-----HVNIVTFLGFCY-ENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH 407 (582)
Q Consensus 335 -~~~E~~~l~~l~-----h~niv~l~~~~~-~~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH 407 (582)
+.+|...+.+++ .++| ++=.++. -....+|+|||++|-.+.+...... ...+.+.+.....++..-.-+-|
T Consensus 207 Dy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~~~d 284 (517)
T COG0661 207 DYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQLLRD 284 (517)
T ss_pred CHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHHHhc
Confidence 345555555542 3333 3333333 3567799999999999988853322 34554444333333322222223
Q ss_pred hCCCCceEecCCCCCCEEEcCCCceEEeecccccccccc
Q 040604 408 RGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 408 ~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~ 446 (582)
|+.|.|.+|.||+++.+|.+-+.|||+.......
T Consensus 285 -----gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 285 -----GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred -----CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 8999999999999999999999999998876643
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.67 E-value=2.9e-07 Score=86.47 Aligned_cols=137 Identities=15% Similarity=0.125 Sum_probs=102.2
Q ss_pred cCccCceEEEEEEeCCCcEEEEEEeccC-------CCCHHHHHHHHHHHhccCCCc--eEEEEeEEEe-----CCeeeEE
Q 040604 301 LGQGGYGEVYKGELPDGQLVAVKVLKNS-------RCNGEEFINEVASISRTSHVN--IVTFLGFCYE-----NKKNALI 366 (582)
Q Consensus 301 lG~G~~g~Vy~~~~~~~~~vavK~~~~~-------~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~-----~~~~~lv 366 (582)
-|+||-+.|++-.+ +|..+-+|.-.+. ......|.+|+..|.++...+ +.+.+ ++.. ....+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 36699999999877 4457888875421 223467999999999986443 44444 3321 1235799
Q ss_pred EEecCC-CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc--eEEeecccccc
Q 040604 367 YELMPN-GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFC--PKISDFGLAKQ 442 (582)
Q Consensus 367 ~E~~~~-gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~--vkl~DFGla~~ 442 (582)
+|-++| -+|.+++....-.+.+......++.+++.++.-||+. |+.|+|+.+.|||++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998843 5788888654434567777889999999999999998 9999999999999986667 99999986654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.58 E-value=6.5e-07 Score=85.30 Aligned_cols=135 Identities=24% Similarity=0.320 Sum_probs=93.9
Q ss_pred hcCccCceEEEEEEeCCCcEEEEEEeccCCCCH--------------------HH-----HHHHHHHHhccC--CCceEE
Q 040604 300 KLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNG--------------------EE-----FINEVASISRTS--HVNIVT 352 (582)
Q Consensus 300 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------~~-----~~~E~~~l~~l~--h~niv~ 352 (582)
.|..|--+.||+|...++..+|||+.+...... .+ ...|+..|+++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 467788888999988889999999987532211 11 246788888874 445566
Q ss_pred EEeEEEeCCeeeEEEEecCCCCh-hhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc
Q 040604 353 FLGFCYENKKNALIYELMPNGSL-DKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFC 431 (582)
Q Consensus 353 l~~~~~~~~~~~lv~E~~~~gsL-~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~ 431 (582)
.+++. ...|||||+....+ .-.|. ..++.......+..++++.+.-|-.. .++||+||+.-|||+. ++.
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~Lk---Dv~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRLK---DVPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCcc---cCCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-CCe
Confidence 66654 56899999954311 11121 12233335666777787777777663 2999999999999999 889
Q ss_pred eEEeecccccccc
Q 040604 432 PKISDFGLAKQAQ 444 (582)
Q Consensus 432 vkl~DFGla~~~~ 444 (582)
+.|+|||-|....
T Consensus 205 p~iID~~QaV~~~ 217 (268)
T COG1718 205 PYIIDVSQAVTID 217 (268)
T ss_pred EEEEECccccccC
Confidence 9999999886654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.56 E-value=5.1e-07 Score=86.29 Aligned_cols=107 Identities=21% Similarity=0.253 Sum_probs=83.0
Q ss_pred HHHHHHHHHHHhccCCC--ceEEEEeEEEeCC----eeeEEEEecCCC-ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHH
Q 040604 332 GEEFINEVASISRTSHV--NIVTFLGFCYENK----KNALIYELMPNG-SLDKFIHNDRNIKLEWKTMYQIAIGIARGLE 404 (582)
Q Consensus 332 ~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~----~~~lv~E~~~~g-sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~ 404 (582)
.....+|...+.++... .+.+.+++..... ..+||+|++++. +|.+++..... .+......++.+++..+.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 34577888887777533 3455666655422 347999999874 79998876332 556677889999999999
Q ss_pred HHHhCCCCceEecCCCCCCEEEcCCC---ceEEeeccccccc
Q 040604 405 YLHRGCQVRIVHFDIKPQNILLDEDF---CPKISDFGLAKQA 443 (582)
Q Consensus 405 yLH~~~~~~ivH~Dikp~NILl~~~~---~vkl~DFGla~~~ 443 (582)
-||.. ||+|+|+++.|||++.++ .+.++||+-++..
T Consensus 133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99998 999999999999999887 8999999977653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.2e-08 Score=106.96 Aligned_cols=152 Identities=20% Similarity=0.303 Sum_probs=98.3
Q ss_pred HHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee-------ecccCCcccccccccc
Q 040604 396 AIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM-------LHARGTIGYIAPEVYS 468 (582)
Q Consensus 396 ~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~-------~~~~gt~~y~aPE~~~ 468 (582)
+.+++.||.|+|.. .++||+.|.|++|.++.++..||+.|+.+............ .-..-...|.|||++.
T Consensus 105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 34566999999986 59999999999999999999999999987654432111000 0112456899999997
Q ss_pred cccCCCCccchhHHHHHHHHHHhcCCCCC-CCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccc
Q 040604 469 RRFGGVSHKSDVYSYGMMIIEMVGCTKNL-DDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQ 547 (582)
Q Consensus 469 ~~~~~~s~~~DvwSlGvil~elltg~~p~-~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~ 547 (582)
.. ..+.++|+||+|++++.+..++++. ........+ +....... ....... ..++.++.+=+.+.+.
T Consensus 183 ~~--~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~--~~~~~~~~-~~~~~~s-------~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 183 GT--TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY--SFSRNLLN-AGAFGYS-------NNLPSELRESLKKLLN 250 (700)
T ss_pred cc--cccccccceeeeeEEEEEecCCcchhhccCCcchh--hhhhcccc-ccccccc-------ccCcHHHHHHHHHHhc
Confidence 73 6788999999999999999555544 333222211 01111000 0001111 2333444444445679
Q ss_pred cCCCCCCCHHHHHH
Q 040604 548 TNPSERPSMHKVLE 561 (582)
Q Consensus 548 ~dp~~RPt~~evl~ 561 (582)
.++.-||++.++..
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999998877754
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.49 E-value=2e-06 Score=83.28 Aligned_cols=139 Identities=15% Similarity=0.206 Sum_probs=86.2
Q ss_pred hhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCc--eEEEEeEEEeCCeeeEEEEecCCCC-h
Q 040604 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVN--IVTFLGFCYENKKNALIYELMPNGS-L 375 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~E~~~~gs-L 375 (582)
..||+|..+.||+. .|..+++|...... ......+|..+++.+.... +.+.+++....+...+|||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 57899999999984 24567888876533 4556789999998886443 4677777777777789999998863 2
Q ss_pred hhh---------------------hhcCCCcCCCHHHHH-HHHH----------HHHH-HHHHHHhC-CCCceEecCCCC
Q 040604 376 DKF---------------------IHNDRNIKLEWKTMY-QIAI----------GIAR-GLEYLHRG-CQVRIVHFDIKP 421 (582)
Q Consensus 376 ~~~---------------------i~~~~~~~l~~~~~~-~i~~----------qi~~-aL~yLH~~-~~~~ivH~Dikp 421 (582)
... ++.-........... ++.. .+.+ ...+|.+. ....++|+|+.|
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~ 162 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI 162 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence 111 111000011111100 0000 0111 11222211 123578999999
Q ss_pred CCEEEcCCCceEEeecccccc
Q 040604 422 QNILLDEDFCPKISDFGLAKQ 442 (582)
Q Consensus 422 ~NILl~~~~~vkl~DFGla~~ 442 (582)
.||++++++ +.|+||+.+..
T Consensus 163 ~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 163 GNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CcEEEcCCC-cEEEechhcCc
Confidence 999999888 99999987654
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.5e-06 Score=87.88 Aligned_cols=258 Identities=14% Similarity=0.148 Sum_probs=149.1
Q ss_pred hhhcCccCceEEEEE-EeCCCcEEEEEEeccCCCCHHHHHHHHHHHhcc-CCCceEE--------EEeEEEeCCeeeEEE
Q 040604 298 RDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFINEVASISRT-SHVNIVT--------FLGFCYENKKNALIY 367 (582)
Q Consensus 298 ~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~--------l~~~~~~~~~~~lv~ 367 (582)
...||+|+-+.+|-. ... -.+-|+.....-... .+.+..|... .||-+-. |+|- .......+.|
T Consensus 16 gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~--aqk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iGflm 89 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQ--AQKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVIGFLM 89 (637)
T ss_pred CccccCCccceeeecchhh---chhheeecCCCchHH--HHHHHHhccCCCCcchhhhhcccHHHhhCC-CccceeEEec
Confidence 467999999999964 221 224466654332211 1122233332 3443222 1111 1122356788
Q ss_pred EecCCCC-hhhhhh---c-CCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccc
Q 040604 368 ELMPNGS-LDKFIH---N-DRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ 442 (582)
Q Consensus 368 E~~~~gs-L~~~i~---~-~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~ 442 (582)
+.+++.. +..+.. + +.-...+|..+++.+..++.+.+-||.. |-+-+|+.++|+|+.+++.|.|.|=..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceee
Confidence 8886652 222221 1 1223478999999999999999999998 999999999999999999999988543333
Q ss_pred ccccccceeeecccCCcccccccccc-ccc--CCCCccchhHHHHHHHHHHhcC-CCCCCCCCcccc-------hhhH--
Q 040604 443 AQKKESAISMLHARGTIGYIAPEVYS-RRF--GGVSHKSDVYSYGMMIIEMVGC-TKNLDDEVTDTS-------ICHN-- 509 (582)
Q Consensus 443 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~--~~~s~~~DvwSlGvil~elltg-~~p~~~~~~~~~-------~~~~-- 509 (582)
..++ .....+.|.+.|.+||.-. ..+ ..-+..+|.|-|||++++||-| +.|+........ .+.+
T Consensus 167 ~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 167 NANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred ccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 2222 2334567999999999753 111 1346678999999999998866 788854321111 0100
Q ss_pred HHHH-hhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhcccc--CCCCCCCHHHHHHHHhcccCCC
Q 040604 510 LIYE-RIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQT--NPSERPSMHKVLEMLEGSIENL 570 (582)
Q Consensus 510 ~~~~-~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~--dp~~RPt~~evl~~Le~~~~~~ 570 (582)
+.+. ....+... .-......-+...+..|..+|+.. .+.-|||++..+..|...-++|
T Consensus 244 f~ya~~~~~g~~p---~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 244 FAYASDQRRGLKP---PPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred eeechhccCCCCC---CCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 1111 11111110 000111122233444455567654 3678999998887776544433
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=2.2e-06 Score=91.63 Aligned_cols=142 Identities=19% Similarity=0.220 Sum_probs=93.9
Q ss_pred hhcCccCceEEEEEEeCCCcEEEEEEeccCCCCH----------------------------H----------HHHHHHH
Q 040604 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNG----------------------------E----------EFINEVA 340 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------~----------~~~~E~~ 340 (582)
+.||.-+.|.||+|++++|+.||||+-++.-... + +|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5699999999999999999999999976532111 0 1455554
Q ss_pred HHhc----cCCCc---eEEEEeEEEe-CCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 040604 341 SISR----TSHVN---IVTFLGFCYE-NKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQV 412 (582)
Q Consensus 341 ~l~~----l~h~n---iv~l~~~~~~-~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~ 412 (582)
...+ +.|-+ -|++=.++++ ....+|+||||+|..+.++-.-.. ..++...+..-+.+...-+-+-|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~~~qIf~~----- 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAYLEQIFKT----- 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHHHHHHHhc-----
Confidence 4333 34555 2223333333 346789999999998877643221 24555544443333332222222
Q ss_pred ceEecCCCCCCEEEcC----CCceEEeecccccccccc
Q 040604 413 RIVHFDIKPQNILLDE----DFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 413 ~ivH~Dikp~NILl~~----~~~vkl~DFGla~~~~~~ 446 (582)
|++|.|-+|.||++.. ++.+.+.|||+.......
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 8999999999999984 678999999998876543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.32 E-value=5.7e-06 Score=78.15 Aligned_cols=129 Identities=16% Similarity=0.138 Sum_probs=80.1
Q ss_pred hhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHH----------HHHHHHHHhccCCC---ceEEEEeE-----EEeC
Q 040604 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEE----------FINEVASISRTSHV---NIVTFLGF-----CYEN 360 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------~~~E~~~l~~l~h~---niv~l~~~-----~~~~ 360 (582)
+.+-......|.+-.. +|..+++|..+......+. ..+.+..+.++... ....++.+ +...
T Consensus 37 kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~ 115 (229)
T PF06176_consen 37 KVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYT 115 (229)
T ss_pred EeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccce
Confidence 3444444455555554 6788999988654332221 22333333333222 22222221 1122
Q ss_pred CeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccc
Q 040604 361 KKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLA 440 (582)
Q Consensus 361 ~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla 440 (582)
...+|+|||++|..|.++.. +++ .++..+++++.-||+. |+.|+|..|.|+++++++ ++++||+..
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-i~iID~~~k 181 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-IRIIDTQGK 181 (229)
T ss_pred eEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-EEEEECccc
Confidence 34468999999988876532 222 2445677889999998 999999999999999655 999999866
Q ss_pred cc
Q 040604 441 KQ 442 (582)
Q Consensus 441 ~~ 442 (582)
+.
T Consensus 182 ~~ 183 (229)
T PF06176_consen 182 RM 183 (229)
T ss_pred cc
Confidence 54
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.27 E-value=4.7e-06 Score=80.87 Aligned_cols=142 Identities=22% Similarity=0.197 Sum_probs=84.1
Q ss_pred hhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCC--ceEEEEeEEEeC---CeeeEEEEecCCC
Q 040604 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHV--NIVTFLGFCYEN---KKNALIYELMPNG 373 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~---~~~~lv~E~~~~g 373 (582)
+.|+.|..+.||+....+ ..+++|+.... ...+.+.+|..+++.+... .+.+++...... ...+++|++++|.
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 468899999999998866 69999997655 3456777888888887533 356677654333 3468999999988
Q ss_pred Chhh----------------hh---hcC--CCcCCCHHH---------HHHH------------HHHHHH-HHHHHHh--
Q 040604 374 SLDK----------------FI---HND--RNIKLEWKT---------MYQI------------AIGIAR-GLEYLHR-- 408 (582)
Q Consensus 374 sL~~----------------~i---~~~--~~~~l~~~~---------~~~i------------~~qi~~-aL~yLH~-- 408 (582)
.+.. .+ +.. ...+..... .... ...+.+ .++.+++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 7776 11 111 001111100 0000 111222 2333332
Q ss_pred --CCCCceEecCCCCCCEEEc-CCCceEEeecccccc
Q 040604 409 --GCQVRIVHFDIKPQNILLD-EDFCPKISDFGLAKQ 442 (582)
Q Consensus 409 --~~~~~ivH~Dikp~NILl~-~~~~vkl~DFGla~~ 442 (582)
.....++|+|+.|.|||++ +++.+-|+||+.+..
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1345799999999999999 666678999986543
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.1e-05 Score=79.32 Aligned_cols=139 Identities=13% Similarity=0.128 Sum_probs=85.0
Q ss_pred cCccCc-eEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccC-CCceEEEEeEEEeCCeeeEEEEecCCCChhhh
Q 040604 301 LGQGGY-GEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTS-HVNIVTFLGFCYENKKNALIYELMPNGSLDKF 378 (582)
Q Consensus 301 lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~ 378 (582)
|-.|.. ..||+.... +..+.||+..... .....+|+.+++.+. +--+.+++++....+..++|||+++|.+|...
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 444555 789998764 4788888876543 345677888887774 33466778877666678999999998877643
Q ss_pred h-------------------hcCC--CcCCCH--HHHHHHHH--------------------HHHHHHHHHHh----CCC
Q 040604 379 I-------------------HNDR--NIKLEW--KTMYQIAI--------------------GIARGLEYLHR----GCQ 411 (582)
Q Consensus 379 i-------------------~~~~--~~~l~~--~~~~~i~~--------------------qi~~aL~yLH~----~~~ 411 (582)
. +... ..+... ........ .+...+..|-. ...
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 2 1110 001110 00000000 01111222211 113
Q ss_pred CceEecCCCCCCEEEcCCCceEEeecccccc
Q 040604 412 VRIVHFDIKPQNILLDEDFCPKISDFGLAKQ 442 (582)
Q Consensus 412 ~~ivH~Dikp~NILl~~~~~vkl~DFGla~~ 442 (582)
..++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 4699999999999999988889999986643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.19 E-value=4e-07 Score=96.34 Aligned_cols=182 Identities=20% Similarity=0.134 Sum_probs=130.4
Q ss_pred hhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCc-eEEEEeEEEeCCeeeEEEEecCCC-Ch
Q 040604 298 RDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVN-IVTFLGFCYENKKNALIYELMPNG-SL 375 (582)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~E~~~~g-sL 375 (582)
-..+++|++++++|.+-...+....|.+... ....-++++|.+++||| +++.++-+..+....++++++.++ +.
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 3457889999999886544444446655433 44556889999999999 777777777777888999999777 22
Q ss_pred hhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeecc
Q 040604 376 DKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHA 455 (582)
Q Consensus 376 ~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 455 (582)
...+. .....+..-+...+.+.-+++|++||+. .-+|+| ||+..+ +..|..||+.+..+.+.... ...
T Consensus 323 ~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~---~t~ 390 (829)
T KOG0576|consen 323 ALEMT-VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKP---RTA 390 (829)
T ss_pred cccCC-hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccccc---ccC
Confidence 22111 1112234444555667778899999986 458998 777665 68899999999887765422 234
Q ss_pred cCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCC
Q 040604 456 RGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNL 497 (582)
Q Consensus 456 ~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~ 497 (582)
.+|+.++|||+... +.+..+.|+|++|+-..+|.-|..|-
T Consensus 391 ~~~~~~~~pev~~~--~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 391 IGTPEPLAPEVIQE--NTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCCchhhcc--cccccCCCccCCCcchhhcCCCCCCC
Confidence 59999999998876 36788999999999777777666654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.13 E-value=6.1e-05 Score=70.96 Aligned_cols=129 Identities=26% Similarity=0.382 Sum_probs=90.5
Q ss_pred hhcCccCceEEEEEEeCCCcEEEEEEeccCC-----------------CCHHHHHHHHHHHhccC------CCceEEEEe
Q 040604 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSR-----------------CNGEEFINEVASISRTS------HVNIVTFLG 355 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------------~~~~~~~~E~~~l~~l~------h~niv~l~~ 355 (582)
..||+|+.-.||.- ++.....||+..... ....+..+|+.-..++. +.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 46999999999964 345567888887654 12345667776655555 788999999
Q ss_pred EEEeCCeeeEEEEecCC------CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC
Q 040604 356 FCYENKKNALIYELMPN------GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED 429 (582)
Q Consensus 356 ~~~~~~~~~lv~E~~~~------gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~ 429 (582)
+...+....+|+|.+.+ -+|.+++... .++. ...+. +-+-..||-+. .|+.+|++|+||++...
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~---L~~f~~~l~~~---~Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQA---LDEFKRYLLDH---HIVIRDLNPHNIVVQRR 154 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHH---HHHHHHHHHHc---CCeecCCCcccEEEEec
Confidence 99999999999999753 3577777543 3444 33333 33344566665 89999999999999543
Q ss_pred C----ceEEee-ccc
Q 040604 430 F----CPKISD-FGL 439 (582)
Q Consensus 430 ~----~vkl~D-FGl 439 (582)
. .+.|+| ||-
T Consensus 155 ~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 155 DSGEFRLVLIDGLGE 169 (199)
T ss_pred CCCceEEEEEeCCCC
Confidence 2 577777 453
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.2e-05 Score=75.47 Aligned_cols=105 Identities=21% Similarity=0.225 Sum_probs=83.4
Q ss_pred HHHHHHHhccCC-CceEEEEeEEEeCCeeeEEEEecCCCChhhhhhc-CCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 040604 336 INEVASISRTSH-VNIVTFLGFCYENKKNALIYELMPNGSLDKFIHN-DRNIKLEWKTMYQIAIGIARGLEYLHRGCQVR 413 (582)
Q Consensus 336 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~i~~-~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ 413 (582)
.+|..+++.+.+ +++.+++|.| ..++|.||...+++...... ..-...+|..+.+||.++++.+++|+......
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888888876 5999999999 45789999987766432100 01124689999999999999999999865446
Q ss_pred eEecCCCCCCEEEcCCCceEEeecccccccc
Q 040604 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 414 ivH~Dikp~NILl~~~~~vkl~DFGla~~~~ 444 (582)
+.-.|++++|+-+++++++|++|...+....
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 8889999999999999999999998765543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.04 E-value=8.8e-05 Score=75.06 Aligned_cols=75 Identities=13% Similarity=0.129 Sum_probs=57.0
Q ss_pred hhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCC---CceEEEEeEEEeC---CeeeEEEEecCC
Q 040604 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSH---VNIVTFLGFCYEN---KKNALIYELMPN 372 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~---~~~~lv~E~~~~ 372 (582)
+.||.|..+.||+....+++ +.+|..+. ......+.+|...|+.+.. ..|.++++++... +..+||||+++|
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~-~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGN-PMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred eecCCccceeEEEEEcCCCC-EEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 56999999999998765564 67777543 2245688999999988853 3678888887543 568999999988
Q ss_pred CCh
Q 040604 373 GSL 375 (582)
Q Consensus 373 gsL 375 (582)
+++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 765
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.02 E-value=8e-05 Score=86.04 Aligned_cols=77 Identities=12% Similarity=0.236 Sum_probs=56.8
Q ss_pred hhcCccCceEEEEEEeCCC---cEEEEEEeccCC--CCHHHHHHHHHHHhccC-CCce--EEEEeEEEeC---CeeeEEE
Q 040604 299 DKLGQGGYGEVYKGELPDG---QLVAVKVLKNSR--CNGEEFINEVASISRTS-HVNI--VTFLGFCYEN---KKNALIY 367 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv~ 367 (582)
++|+.|.++.+|+....++ ..+++|+..... .....+.+|+.+|+.+. |.+| .+++.++.+. ...++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 5789999999999876553 467777764332 23456889999999996 6654 7888887664 4678999
Q ss_pred EecCCCCh
Q 040604 368 ELMPNGSL 375 (582)
Q Consensus 368 E~~~~gsL 375 (582)
||++|..+
T Consensus 124 E~v~G~~~ 131 (822)
T PLN02876 124 EYLEGRIF 131 (822)
T ss_pred EecCCccc
Confidence 99987653
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.02 E-value=3.7e-05 Score=75.06 Aligned_cols=73 Identities=12% Similarity=0.149 Sum_probs=46.8
Q ss_pred hhcCccCce-EEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCC---ceEEEEeEEEeCC---eeeEEEEecC
Q 040604 299 DKLGQGGYG-EVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHV---NIVTFLGFCYENK---KNALIYELMP 371 (582)
Q Consensus 299 ~~lG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~---~~~lv~E~~~ 371 (582)
+.|+.||.. .||+. +..+++|..+. ......+.+|...+..+... -+.+.++.....+ ..+++||+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 457777776 58875 23567787654 23455788999998877532 3444454433222 3478999999
Q ss_pred CCChh
Q 040604 372 NGSLD 376 (582)
Q Consensus 372 ~gsL~ 376 (582)
|.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 87774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.01 E-value=6.9e-05 Score=73.11 Aligned_cols=74 Identities=20% Similarity=0.178 Sum_probs=48.8
Q ss_pred hhcCccCceEEEEEEeCC--CcEEEEEEeccCCCCHHHHHHHHHHHhccCCCc-eEEEEeEEEeCCeeeEEEEecCCCCh
Q 040604 299 DKLGQGGYGEVYKGELPD--GQLVAVKVLKNSRCNGEEFINEVASISRTSHVN-IVTFLGFCYENKKNALIYELMPNGSL 375 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~E~~~~gsL 375 (582)
+.|..|-...+|+....+ ++.|++|+........-...+|+.+++.+.... ..++++... ..++|||++|.++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l 79 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL 79 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence 457778888999997664 678999987643222223346888888875433 344544332 2489999988776
Q ss_pred h
Q 040604 376 D 376 (582)
Q Consensus 376 ~ 376 (582)
.
T Consensus 80 ~ 80 (235)
T cd05157 80 E 80 (235)
T ss_pred C
Confidence 3
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.99 E-value=7.6e-05 Score=67.58 Aligned_cols=126 Identities=22% Similarity=0.263 Sum_probs=86.9
Q ss_pred hhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceE-EEEeEEEeCCeeeEEEEecCCCChh
Q 040604 298 RDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIV-TFLGFCYENKKNALIYELMPNGSLD 376 (582)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~E~~~~gsL~ 376 (582)
.+.||+|.+|.||+|.+. |..+|+|+-+... ....+..|+++|..+.-.++- +++.+- ..++.|||+.|-.|.
T Consensus 27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds-~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L~ 100 (201)
T COG2112 27 EKELAKGTTSVVYLGEWR-GGEVALKVRRRDS-PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhcccccEEEEeecc-CceEEEEEecCCc-chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcchh
Confidence 467999999999999984 5588999876543 566788999999998877664 344442 234559999888887
Q ss_pred hhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC-CC-CEEEcCCCceEEeecccccc
Q 040604 377 KFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIK-PQ-NILLDEDFCPKISDFGLAKQ 442 (582)
Q Consensus 377 ~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dik-p~-NILl~~~~~vkl~DFGla~~ 442 (582)
+.-... +.+++ ..++++-.-|-.. ||-|+.|. |. ||++. ++.+-|+||..|+.
T Consensus 101 ~~~~~~-----~rk~l----~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~-~~~~~iIDFd~At~ 155 (201)
T COG2112 101 KLEIGG-----DRKHL----LRVLEKAYKLDRL---GIEHGELSRPWKNVLVN-DRDVYIIDFDSATF 155 (201)
T ss_pred hhhhcc-----cHHHH----HHHHHHHHHHHHh---ccchhhhcCCceeEEec-CCcEEEEEccchhh
Confidence 765421 22333 3444553334443 89999987 44 55554 44999999998874
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.87 E-value=2.8e-05 Score=88.03 Aligned_cols=197 Identities=18% Similarity=0.225 Sum_probs=136.7
Q ss_pred HHHHHHhccCCCceEEEEeEEEeCCeee----EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 040604 337 NEVASISRTSHVNIVTFLGFCYENKKNA----LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQV 412 (582)
Q Consensus 337 ~E~~~l~~l~h~niv~l~~~~~~~~~~~----lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~ 412 (582)
-|...+.++.|+|++.++.+-.+..... +..|++..-++...+.... .++....+.+..++.+||+|+|+.
T Consensus 231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~~--- 305 (1351)
T KOG1035|consen 231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHSL--- 305 (1351)
T ss_pred HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHHh---
Confidence 4667788899999999999988765443 3457788888888877544 577788888999999999999987
Q ss_pred ceEecCCCCC---CEEEcCCCceEEe--eccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHH
Q 040604 413 RIVHFDIKPQ---NILLDEDFCPKIS--DFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMI 487 (582)
Q Consensus 413 ~ivH~Dikp~---NILl~~~~~vkl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil 487 (582)
...|.-+..+ +...+..+.+.++ ||+.++........... .-+..+.++|....+....+...|+|.+|..+
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~---~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSD---LLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhh---cCccccccccccccccchhhhhhHHHHHHHHH
Confidence 4444444443 4445667778877 99988877665443222 24556888888776545555567999999999
Q ss_pred HHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 040604 488 IEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564 (582)
Q Consensus 488 ~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le 564 (582)
..+..|..+.........+ ++.. . ...+.+....|+..++++|+++.+++...-
T Consensus 383 ~~~~~~~~i~~~~~~~~~~----------------l~~~-~------~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSAVPVSL----------------LDVL-S------TSELLDALPKCLDEDSEERLSALELLTHPF 436 (1351)
T ss_pred hhhhhcCcccccccchhhh----------------hccc-c------chhhhhhhhhhcchhhhhccchhhhhhchh
Confidence 9999887654432221110 0000 0 013445556699999999999999987653
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00016 Score=67.57 Aligned_cols=124 Identities=27% Similarity=0.443 Sum_probs=86.9
Q ss_pred HHHHhhhhcCccCc-eEEEEEEeCCCcEEEEEEecc---C-------C------------CCHHHHHHHHHHHhccC---
Q 040604 293 MTKSFRDKLGQGGY-GEVYKGELPDGQLVAVKVLKN---S-------R------------CNGEEFINEVASISRTS--- 346 (582)
Q Consensus 293 ~~~~~~~~lG~G~~-g~Vy~~~~~~~~~vavK~~~~---~-------~------------~~~~~~~~E~~~l~~l~--- 346 (582)
...+|.+.||.|.- |.||++++ +|+.+|+|+++. . . ...+.|..|.....+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 34567789999999 99999998 788999999431 0 0 01124778888777764
Q ss_pred CCce--EEEEeEEEeC------------------CeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHH
Q 040604 347 HVNI--VTFLGFCYEN------------------KKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYL 406 (582)
Q Consensus 347 h~ni--v~l~~~~~~~------------------~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yL 406 (582)
+.++ |+.+|+..-. ....+|.||++... .+.... +.+|.+-|.-+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~~----~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIRD----IPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchhH----HHHHHHHHHHH
Confidence 4455 9999988422 12357888775433 122222 45677778889
Q ss_pred HhCCCCceEecCCCCCCEEEcCCCceEEeecccc
Q 040604 407 HRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLA 440 (582)
Q Consensus 407 H~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla 440 (582)
|.. ||+-+|+++.|.. .-||+|||.+
T Consensus 181 ~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHC---CeeeccCcccccc-----CCEEEecccC
Confidence 987 9999999999986 2389999864
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00024 Score=70.28 Aligned_cols=137 Identities=13% Similarity=0.102 Sum_probs=79.0
Q ss_pred hcCccCceEEEEEEeCCCcEEEEEEeccCCCCH-HHHHHHHHHHhccCCCce-EEEEeEEEeCCeeeEEEEecCCCChhh
Q 040604 300 KLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNG-EEFINEVASISRTSHVNI-VTFLGFCYENKKNALIYELMPNGSLDK 377 (582)
Q Consensus 300 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~gsL~~ 377 (582)
.+..|-.+.+|+... +++.+++|+........ -...+|..+++.+....+ .+++... ...+||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence 356677889998874 57788899865432211 235678888888864333 3444433 1369999998876642
Q ss_pred h-----------------hhcCC--CcCCCHHH-HHHHHHH---------HHHHHHHHHhC-----CCCceEecCCCCCC
Q 040604 378 F-----------------IHNDR--NIKLEWKT-MYQIAIG---------IARGLEYLHRG-----CQVRIVHFDIKPQN 423 (582)
Q Consensus 378 ~-----------------i~~~~--~~~l~~~~-~~~i~~q---------i~~aL~yLH~~-----~~~~ivH~Dikp~N 423 (582)
. ++... ..+++... ......+ +...++.+-.. ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11111 11122211 1111111 11112222111 12368999999999
Q ss_pred EEEcCCCceEEeecccccc
Q 040604 424 ILLDEDFCPKISDFGLAKQ 442 (582)
Q Consensus 424 ILl~~~~~vkl~DFGla~~ 442 (582)
|++++++ +.|+||+.|..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999987654
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00024 Score=72.11 Aligned_cols=140 Identities=28% Similarity=0.297 Sum_probs=83.8
Q ss_pred hhcCccCceEEEEEEeCC-------CcEEEEEEeccCCCCHHHHHHHHHHHhccCCCce-EEEEeEEEeCCeeeEEEEec
Q 040604 299 DKLGQGGYGEVYKGELPD-------GQLVAVKVLKNSRCNGEEFINEVASISRTSHVNI-VTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~ 370 (582)
+.|..|-...||+....+ ++.+++|+............+|..++..+....+ .++++++. ..+|+||+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~i 79 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEFI 79 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhee
Confidence 345667777999987654 5789999976654333455678888877754333 34555543 24689999
Q ss_pred CCCChhhh-----------------hhcCCCc-------CCC--HHHHHH--------------------------HHHH
Q 040604 371 PNGSLDKF-----------------IHNDRNI-------KLE--WKTMYQ--------------------------IAIG 398 (582)
Q Consensus 371 ~~gsL~~~-----------------i~~~~~~-------~l~--~~~~~~--------------------------i~~q 398 (582)
+|..+... +|+.... ..+ +..+.+ +..+
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 88776421 1111100 000 111111 1112
Q ss_pred HHHHHHHHHh------CCCCceEecCCCCCCEEEcCC----CceEEeecccccc
Q 040604 399 IARGLEYLHR------GCQVRIVHFDIKPQNILLDED----FCPKISDFGLAKQ 442 (582)
Q Consensus 399 i~~aL~yLH~------~~~~~ivH~Dikp~NILl~~~----~~vkl~DFGla~~ 442 (582)
+...+..|.. .....++|+|+.+.|||++++ +.+.++||..|..
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 2223334432 134579999999999999985 8899999987653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0015 Score=68.23 Aligned_cols=74 Identities=12% Similarity=0.156 Sum_probs=54.3
Q ss_pred hhcCccCceEEEEEEeCCC-cEEEEEEecc------C--CCCHHHHHHHHHHHhccC---CCceEEEEeEEEeCCeeeEE
Q 040604 299 DKLGQGGYGEVYKGELPDG-QLVAVKVLKN------S--RCNGEEFINEVASISRTS---HVNIVTFLGFCYENKKNALI 366 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~------~--~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 366 (582)
+.||.|.+..||++...+| +.++||.-.. . ....+.+..|...|+.+. ..++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5799999999999988777 5899998531 1 124466777888877753 3467778777 44667899
Q ss_pred EEecCCCC
Q 040604 367 YELMPNGS 374 (582)
Q Consensus 367 ~E~~~~gs 374 (582)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99997643
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00091 Score=67.66 Aligned_cols=141 Identities=16% Similarity=0.156 Sum_probs=85.3
Q ss_pred hhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCc--eEEEEeE------EEeCCeeeEEEEec
Q 040604 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVN--IVTFLGF------CYENKKNALIYELM 370 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~E~~ 370 (582)
+.|..|....+|+....+ ..+++|+... ...+....|+.++..+.+.. +.+++.. ....+..++|+||+
T Consensus 20 ~~i~~G~~n~~y~v~~~~-~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 20 EGISAGIENTNYFVTTDS-GRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred ecccCccccceEEEEeCC-CcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 467788888999987644 4788898765 34556677888777775433 4454432 12344568999999
Q ss_pred CCCChhh--------------hhhcCC-C--------cCCCHHHHH----------HHHHHHHHHHHHHHh----CCCCc
Q 040604 371 PNGSLDK--------------FIHNDR-N--------IKLEWKTMY----------QIAIGIARGLEYLHR----GCQVR 413 (582)
Q Consensus 371 ~~gsL~~--------------~i~~~~-~--------~~l~~~~~~----------~i~~qi~~aL~yLH~----~~~~~ 413 (582)
+|..+.. .++... . ....|.... .....+..++.++.+ ....+
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 8877532 011100 0 001111110 011123334444443 12347
Q ss_pred eEecCCCCCCEEEcCCCceEEeecccccc
Q 040604 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQ 442 (582)
Q Consensus 414 ivH~Dikp~NILl~~~~~vkl~DFGla~~ 442 (582)
++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 177 VIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 99999999999999987789999987643
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0017 Score=66.54 Aligned_cols=141 Identities=16% Similarity=0.221 Sum_probs=77.9
Q ss_pred hhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCc--eEEEEe------EEEeCCeeeEEEEec
Q 040604 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVN--IVTFLG------FCYENKKNALIYELM 370 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~------~~~~~~~~~lv~E~~ 370 (582)
+.|+.|...++|+....+| .+++|+.. ....+....|+..+..|.... +.+.+. +....+..++++||+
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 4577788889999876555 68889876 223444445555555553222 333332 122345678999999
Q ss_pred CCCChhh-----------h---hhcC-CCc--------CCCH-HHHHH------------HHHH-HHHHHHHHHhC----
Q 040604 371 PNGSLDK-----------F---IHND-RNI--------KLEW-KTMYQ------------IAIG-IARGLEYLHRG---- 409 (582)
Q Consensus 371 ~~gsL~~-----------~---i~~~-~~~--------~l~~-~~~~~------------i~~q-i~~aL~yLH~~---- 409 (582)
+|..+.. . ++.. ... .+.+ ..... .+.+ +...++.+.+.
T Consensus 105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 184 (319)
T PRK05231 105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA 184 (319)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence 8875421 1 1111 000 0111 11111 1111 11122222211
Q ss_pred CCCceEecCCCCCCEEEcCCCceEEeecccccc
Q 040604 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ 442 (582)
Q Consensus 410 ~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~ 442 (582)
...+++|+|+.|.|||++.+...-|+||+.+..
T Consensus 185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred CCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 234899999999999999776668999987654
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.003 Score=64.28 Aligned_cols=142 Identities=18% Similarity=0.255 Sum_probs=82.5
Q ss_pred hhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCc--eEEEEeEE------EeCCeeeEEEEec
Q 040604 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVN--IVTFLGFC------YENKKNALIYELM 370 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~------~~~~~~~lv~E~~ 370 (582)
+.++.|....+|+....+| .+++|+..... ..+....|+.++..|.... +.+++... ...+..+++|||+
T Consensus 28 ~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i 105 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL 105 (307)
T ss_pred cccCCccccceEEEEeCCC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence 4577777789999876555 57788875532 3445566777777764322 34444321 1245668999999
Q ss_pred CCCChhh--------------hhhcC-CCc--C-------CCHHHHH------------HHHHHHHHHHHHHHh----CC
Q 040604 371 PNGSLDK--------------FIHND-RNI--K-------LEWKTMY------------QIAIGIARGLEYLHR----GC 410 (582)
Q Consensus 371 ~~gsL~~--------------~i~~~-~~~--~-------l~~~~~~------------~i~~qi~~aL~yLH~----~~ 410 (582)
+|..+.. .++.. ... . -.|.... .....+...++++.. ..
T Consensus 106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~ 185 (307)
T TIGR00938 106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL 185 (307)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 8855421 11111 000 0 0111100 001123334555532 22
Q ss_pred CCceEecCCCCCCEEEcCCCceEEeecccccc
Q 040604 411 QVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ 442 (582)
Q Consensus 411 ~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~ 442 (582)
..+++|+|+++.||++++++.+.|+||+.+..
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 45899999999999999988778999987643
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0043 Score=64.19 Aligned_cols=139 Identities=19% Similarity=0.205 Sum_probs=80.6
Q ss_pred hcCccCceEEEEEEeCC-----CcEEEEEEeccCCCCHHHHHHHHHHHhccCCCce-EEEEeEEEeCCeeeEEEEecCCC
Q 040604 300 KLGQGGYGEVYKGELPD-----GQLVAVKVLKNSRCNGEEFINEVASISRTSHVNI-VTFLGFCYENKKNALIYELMPNG 373 (582)
Q Consensus 300 ~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~g 373 (582)
.|-.|-...+|+....+ ++.+++|+........-.-.+|..+++.+...++ .++++.+.. ..|+||+++.
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~----g~v~efi~g~ 118 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN----GRVEEFIHAR 118 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC----ceEEEeeCCC
Confidence 45557788999986532 3679999886543211122568888888765544 355565532 2689999877
Q ss_pred Chhhh-----------------hhcCC--C-c-CCCHHHHHHHHHHH-----------------HHHHHHH----Hh-CC
Q 040604 374 SLDKF-----------------IHNDR--N-I-KLEWKTMYQIAIGI-----------------ARGLEYL----HR-GC 410 (582)
Q Consensus 374 sL~~~-----------------i~~~~--~-~-~l~~~~~~~i~~qi-----------------~~aL~yL----H~-~~ 410 (582)
+|... +|... . . ...+.++.++..++ ...+..| .. ..
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~ 198 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ 198 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence 76421 11111 0 0 11122222222111 1112222 21 22
Q ss_pred CCceEecCCCCCCEEEcC-CCceEEeecccccc
Q 040604 411 QVRIVHFDIKPQNILLDE-DFCPKISDFGLAKQ 442 (582)
Q Consensus 411 ~~~ivH~Dikp~NILl~~-~~~vkl~DFGla~~ 442 (582)
...++|+|+++.|||+++ ++.+.++||..+..
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 347899999999999986 47899999987754
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.00056 Score=67.80 Aligned_cols=132 Identities=18% Similarity=0.217 Sum_probs=90.4
Q ss_pred HhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCH-----------------------HHHHHHHHHHhccCCC--ce
Q 040604 296 SFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNG-----------------------EEFINEVASISRTSHV--NI 350 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------------~~~~~E~~~l~~l~h~--ni 350 (582)
.+.++||-|--+-||.+...+|++.++|.-+..+..- -...+|.+.|+.|... -|
T Consensus 95 svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpV 174 (465)
T KOG2268|consen 95 SVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPV 174 (465)
T ss_pred hhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCC
Confidence 4567999999999999999899999999643211110 1245788888887542 34
Q ss_pred EEEEeEEEeCCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC
Q 040604 351 VTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF 430 (582)
Q Consensus 351 v~l~~~~~~~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~ 430 (582)
.+.+++ ...++|||++.|-.|...-+- .+..+++.-+.. -+.-|-.+ |+||+|..-=||++++++
T Consensus 175 PkpiD~----~RH~Vvmelv~g~Pl~~v~~v-----~d~~~ly~~lm~---~Iv~la~~---GlIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 175 PKPIDH----NRHCVVMELVDGYPLRQVRHV-----EDPPTLYDDLMG---LIVRLANH---GLIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCcccc----cceeeHHHhhcccceeeeeec-----CChHHHHHHHHH---HHHHHHHc---CceecccchheeEEecCC
Confidence 555544 356789999988888765432 223333332222 22333334 999999999999999999
Q ss_pred ceEEeecccccc
Q 040604 431 CPKISDFGLAKQ 442 (582)
Q Consensus 431 ~vkl~DFGla~~ 442 (582)
.++++||--...
T Consensus 240 ~i~vIDFPQmvS 251 (465)
T KOG2268|consen 240 KIVVIDFPQMVS 251 (465)
T ss_pred CEEEeechHhhc
Confidence 999999965443
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0039 Score=62.36 Aligned_cols=31 Identities=39% Similarity=0.524 Sum_probs=25.7
Q ss_pred CceEecCCCCCCEEEcCCCc-eEEeecccccc
Q 040604 412 VRIVHFDIKPQNILLDEDFC-PKISDFGLAKQ 442 (582)
Q Consensus 412 ~~ivH~Dikp~NILl~~~~~-vkl~DFGla~~ 442 (582)
..++|+|++|.|||+++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997554 56999998765
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.0074 Score=61.07 Aligned_cols=137 Identities=21% Similarity=0.237 Sum_probs=92.6
Q ss_pred hhcCccCceEEEEEEeCCCcEEEEEEeccCCC----------------------CHHH-----HHHHHHHHhccCCCceE
Q 040604 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRC----------------------NGEE-----FINEVASISRTSHVNIV 351 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~-----~~~E~~~l~~l~h~niv 351 (582)
.-|..|--+-||.+.-.+|..+|||+.+.+-. ..+. ...|+..|.+++...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 35778888899999888999999998764211 0011 24578888887644432
Q ss_pred EEEeEEEeCCeeeEEEEecCCCChh--hhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC
Q 040604 352 TFLGFCYENKKNALIYELMPNGSLD--KFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED 429 (582)
Q Consensus 352 ~l~~~~~~~~~~~lv~E~~~~gsL~--~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~ 429 (582)
-.--+.. ...+|||+|+. .+=+ -.| +...++...+..+-.|++.-|.-|-+.| ++||.||+--|+|+. +
T Consensus 230 ~PePIlL--k~hVLVM~FlG-rdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-d 300 (520)
T KOG2270|consen 230 CPEPILL--KNHVLVMEFLG-RDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-D 300 (520)
T ss_pred CCCceee--ecceEeeeecc-CCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-C
Confidence 1111111 24479999994 3321 122 2335666777777888888888887765 899999999999986 4
Q ss_pred CceEEeecccccccc
Q 040604 430 FCPKISDFGLAKQAQ 444 (582)
Q Consensus 430 ~~vkl~DFGla~~~~ 444 (582)
|.+.|+|-+-+....
T Consensus 301 G~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 301 GKLYIIDVSQSVEHD 315 (520)
T ss_pred CEEEEEEccccccCC
Confidence 689999988776543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.00041 Score=80.67 Aligned_cols=160 Identities=10% Similarity=-0.034 Sum_probs=110.4
Q ss_pred HHHHHHHHHhccCCCceEEEEeEEEe--CCeeeEEEEecCCCChhhhhhcCC--CcCCCHHHHHHHHHHHHHHHHHHHhC
Q 040604 334 EFINEVASISRTSHVNIVTFLGFCYE--NKKNALIYELMPNGSLDKFIHNDR--NIKLEWKTMYQIAIGIARGLEYLHRG 409 (582)
Q Consensus 334 ~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E~~~~gsL~~~i~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~ 409 (582)
..+.|...++...|+++.....-... ....+.+++++.+|.+.+.|-+.. ...++..-+.....+...+..-.|+.
T Consensus 1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 34456666677789988776554433 334578999999999999887542 22233333333333335555566654
Q ss_pred CC--CceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHH
Q 040604 410 CQ--VRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMI 487 (582)
Q Consensus 410 ~~--~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil 487 (582)
.+ .-.+|+++|+-|.+|..+..+|+.++|+.+......... ....+++.|+.|+....- .++.++|+|..|+-+
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~--Gl~l~sp~~v~qli~N~i--k~t~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFF--GLELCSPIYVLQLIKNEI--KFTKRSDILRRSLSL 1430 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccCchHhhh--hhhhCCHHHHHHHHHHHH--hhhhHHHHHHHHHHH
Confidence 32 236899999999999999999999999999433322221 123588899999987653 678889999999999
Q ss_pred HHHhcCCCCC
Q 040604 488 IEMVGCTKNL 497 (582)
Q Consensus 488 ~elltg~~p~ 497 (582)
+++-.|..++
T Consensus 1431 y~rs~~n~~f 1440 (2724)
T KOG1826|consen 1431 YLRSDGNAYF 1440 (2724)
T ss_pred HHHhcccHHH
Confidence 9988777665
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.02 Score=58.70 Aligned_cols=72 Identities=14% Similarity=0.155 Sum_probs=47.7
Q ss_pred hcCccCceEEEEEEeCCC-cEEEEEEec----c-C---CCCHHHHHHHHHHHhccC--CC-ceEEEEeEEEeCCeeeEEE
Q 040604 300 KLGQGGYGEVYKGELPDG-QLVAVKVLK----N-S---RCNGEEFINEVASISRTS--HV-NIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 300 ~lG~G~~g~Vy~~~~~~~-~~vavK~~~----~-~---~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~ 367 (582)
.||.|....||++...+| +.++||.-. . . ....+...-|...|+... -| .+.+++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 589999999999987654 689999742 1 1 223344556667665543 23 45666544 556667999
Q ss_pred EecCCC
Q 040604 368 ELMPNG 373 (582)
Q Consensus 368 E~~~~g 373 (582)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.022 Score=58.21 Aligned_cols=139 Identities=22% Similarity=0.368 Sum_probs=84.2
Q ss_pred hcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCce------EEEEe----EEEeCCeeeEEEEe
Q 040604 300 KLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNI------VTFLG----FCYENKKNALIYEL 369 (582)
Q Consensus 300 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni------v~l~~----~~~~~~~~~lv~E~ 369 (582)
.|.+ .-..||+....+|+. ++|+.... ...++...|...|..|.-..| ..+=| ........+-++||
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 3444 567799998877777 99999887 667777778887777642222 22211 11112366789999
Q ss_pred cCCCChhh-h--------------hhcC-CCc---------CCCHHH-------------HHHHHHHHHHHHHHHHhCC-
Q 040604 370 MPNGSLDK-F--------------IHND-RNI---------KLEWKT-------------MYQIAIGIARGLEYLHRGC- 410 (582)
Q Consensus 370 ~~~gsL~~-~--------------i~~~-~~~---------~l~~~~-------------~~~i~~qi~~aL~yLH~~~- 410 (582)
++|..+.. . ++.. ++. ...|.. -.....++...+..+.+..
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 98887772 0 1110 000 122320 0112334444455444321
Q ss_pred ----CCc--eEecCCCCCCEEEcCCCc-eEEeeccccc
Q 040604 411 ----QVR--IVHFDIKPQNILLDEDFC-PKISDFGLAK 441 (582)
Q Consensus 411 ----~~~--ivH~Dikp~NILl~~~~~-vkl~DFGla~ 441 (582)
..+ +||+|+.|.|||++.+.. +.++||+-+.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 123 999999999999998875 8999999654
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.0055 Score=58.67 Aligned_cols=122 Identities=20% Similarity=0.206 Sum_probs=60.4
Q ss_pred CcEEEEEEeccCCCCHHHHHHHHHHHhccCCCce-EEEEeEEEeCCeeeEEEEecCCCChhhh-h---------------
Q 040604 317 GQLVAVKVLKNSRCNGEEFINEVASISRTSHVNI-VTFLGFCYENKKNALIYELMPNGSLDKF-I--------------- 379 (582)
Q Consensus 317 ~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~gsL~~~-i--------------- 379 (582)
++.|+||+........-.-.+|..+++.+....+ .++++.+.+ .+|+||++|..|..- +
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~~ 77 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLAK 77 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHHH
Confidence 4678899887765444555678888888765444 456665422 367799977665321 0
Q ss_pred -hcCCC-----cCCCHHHHHHH----------------------HHHHHHHHHHHHh---C--CCCceEecCCCCCCEEE
Q 040604 380 -HNDRN-----IKLEWKTMYQI----------------------AIGIARGLEYLHR---G--CQVRIVHFDIKPQNILL 426 (582)
Q Consensus 380 -~~~~~-----~~l~~~~~~~i----------------------~~qi~~aL~yLH~---~--~~~~ivH~Dikp~NILl 426 (582)
|.... ...-+..+.++ ...+..-+..+.+ . ....+.|.|+.+.|||+
T Consensus 78 lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil~ 157 (211)
T PF01633_consen 78 LHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNILI 157 (211)
T ss_dssp HHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEEE
T ss_pred HhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEEe
Confidence 00000 00011111111 0111111222211 1 12368999999999999
Q ss_pred -cCCCceEEeecccccc
Q 040604 427 -DEDFCPKISDFGLAKQ 442 (582)
Q Consensus 427 -~~~~~vkl~DFGla~~ 442 (582)
+.++.++++||..|..
T Consensus 158 ~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 158 NNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp TSSSSCEEE--GTT-EE
T ss_pred ccCCCeEEEecHHHHhh
Confidence 8889999999987754
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.021 Score=58.66 Aligned_cols=140 Identities=16% Similarity=0.200 Sum_probs=78.3
Q ss_pred hhcCccCceEEEEEEeCC----CcEEEEEEeccCCCCHHHHHHHHHHHhccCCCce-EEEEeEEEeCCeeeEEEEecCCC
Q 040604 299 DKLGQGGYGEVYKGELPD----GQLVAVKVLKNSRCNGEEFINEVASISRTSHVNI-VTFLGFCYENKKNALIYELMPNG 373 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~g 373 (582)
+.|..|=...+|+....+ +..|++|+........=.-.+|..+++.+...++ .++++++. + .+|.+|+++.
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~---G~i~~fi~g~ 95 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-N---GMIQSFINAR 95 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-C---cEeehhhcCC
Confidence 345557777889886432 3478999886543221123578888888876555 45666552 2 2589999776
Q ss_pred Chhh-----------------hhhcCC--C-c-CCCHHHHHHHHHHH----------------------HHHHHH---HH
Q 040604 374 SLDK-----------------FIHNDR--N-I-KLEWKTMYQIAIGI----------------------ARGLEY---LH 407 (582)
Q Consensus 374 sL~~-----------------~i~~~~--~-~-~l~~~~~~~i~~qi----------------------~~aL~y---LH 407 (582)
.|.. .+|... . . .--+..+.++..++ ..-+.. +.
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 6531 011111 0 0 11122222222111 111111 11
Q ss_pred -h-CCCCceEecCCCCCCEEEcC-CCceEEeecccccc
Q 040604 408 -R-GCQVRIVHFDIKPQNILLDE-DFCPKISDFGLAKQ 442 (582)
Q Consensus 408 -~-~~~~~ivH~Dikp~NILl~~-~~~vkl~DFGla~~ 442 (582)
+ ....-++|.|+.+.|||+++ ++.++++||..|..
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 11234899999999999975 57899999987754
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.0061 Score=61.11 Aligned_cols=72 Identities=18% Similarity=0.322 Sum_probs=47.9
Q ss_pred hhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccC---CCceEEEEeEEEeCCeeeEEEEecCCC
Q 040604 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTS---HVNIVTFLGFCYENKKNALIYELMPNG 373 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~E~~~~g 373 (582)
+.++.|-...+|+.. .+++.+.||+-.. .....|..|..-|+.|. --.+.+.+++.......+|||||++.+
T Consensus 23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~~--~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD-TDGGSYFVKVNSE--SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEE--SSSSEEEEEE-TTS-EEEEEEEEG--GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred EecCCCChhheEEEE-CCCccEEEEecCh--hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 468888899999987 5788899998872 23456788888888773 445888999888777889999999766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.042 Score=55.58 Aligned_cols=133 Identities=20% Similarity=0.202 Sum_probs=80.2
Q ss_pred cCceEEEEEEeCCCcEEEEEEecc---CCCCHHHHHHHHHHHhccCC--CceEEEEeEEEeCC--eeeEEEEecCCCChh
Q 040604 304 GGYGEVYKGELPDGQLVAVKVLKN---SRCNGEEFINEVASISRTSH--VNIVTFLGFCYENK--KNALIYELMPNGSLD 376 (582)
Q Consensus 304 G~~g~Vy~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~E~~~~gsL~ 376 (582)
|....+|..... ++.+++. ... .........+|..+++.+.- .-+.+.++.|.++. ..+.||+|++|..+.
T Consensus 36 G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~ 113 (321)
T COG3173 36 GWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVW 113 (321)
T ss_pred CcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceecc
Confidence 333344554443 7778887 221 11123456678888888754 23556677777666 679999999875433
Q ss_pred hhhhcCCCcCCCHHHHHHHH-HHHHHHHHHHH------------------------------------------------
Q 040604 377 KFIHNDRNIKLEWKTMYQIA-IGIARGLEYLH------------------------------------------------ 407 (582)
Q Consensus 377 ~~i~~~~~~~l~~~~~~~i~-~qi~~aL~yLH------------------------------------------------ 407 (582)
....... . . .+++ ..+++.|+-||
T Consensus 114 ~~~~~~~---~--~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~W 186 (321)
T COG3173 114 SALPPES---L--G--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKW 186 (321)
T ss_pred CcCCccc---c--h--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHH
Confidence 2221100 0 0 0111 13333333333
Q ss_pred --hC-----CCCceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 408 --RG-----CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 408 --~~-----~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
.. ....++|+|+.+.|++++.++.+=|.||+++..-.+
T Consensus 187 l~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 187 LEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred HHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 32 124799999999999999999999999999877443
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.09 Score=53.96 Aligned_cols=71 Identities=17% Similarity=0.145 Sum_probs=46.4
Q ss_pred CceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCC--ceEEEE---e--EEEeCCeeeEEEEecCCCCh
Q 040604 305 GYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHV--NIVTFL---G--FCYENKKNALIYELMPNGSL 375 (582)
Q Consensus 305 ~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~---~--~~~~~~~~~lv~E~~~~gsL 375 (582)
.-..||+....++..+++|+.+......++...|+..+..|... .|+... | ....++..+.++++++|...
T Consensus 37 ~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 37 YENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred ccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 44679998887888999999876555667777788777666422 122211 1 12224566789999987643
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.056 Score=56.51 Aligned_cols=71 Identities=11% Similarity=0.072 Sum_probs=48.8
Q ss_pred hhcCccCceEEEEEEeCCCcEEEEEEec-----cCC---CCHHHHHHHHHHHhccC---CCceEEEEeEEEeCCeeeEEE
Q 040604 299 DKLGQGGYGEVYKGELPDGQLVAVKVLK-----NSR---CNGEEFINEVASISRTS---HVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~-----~~~---~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 367 (582)
+.||.|....||+... .+..++||.-. ... ...+.-..|+..|+.+. ..+|.+++.++. +..+++|
T Consensus 38 ~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvM 114 (418)
T PLN02756 38 KEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGM 114 (418)
T ss_pred EEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEE
Confidence 5789999999999876 45568999854 111 12333344566665553 357888888875 4568899
Q ss_pred EecCC
Q 040604 368 ELMPN 372 (582)
Q Consensus 368 E~~~~ 372 (582)
|++++
T Consensus 115 E~L~~ 119 (418)
T PLN02756 115 RYLEP 119 (418)
T ss_pred eecCC
Confidence 99976
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.023 Score=53.61 Aligned_cols=151 Identities=17% Similarity=0.197 Sum_probs=93.8
Q ss_pred cCceEEEEEEeCCCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCChhhhhhc
Q 040604 304 GGYGEVYKGELPDGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHN 381 (582)
Q Consensus 304 G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~i~~ 381 (582)
|+.++.-.++..-| +..+|++..... ....|.++..++++++ .|++|..= +.....++.|+|...
T Consensus 73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~-------- 139 (308)
T PF07387_consen 73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI-------- 139 (308)
T ss_pred CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc--------
Confidence 44555555543323 345566654433 3466788999998875 46777622 333556899998311
Q ss_pred CCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeecccCCccc
Q 040604 382 DRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGY 461 (582)
Q Consensus 382 ~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y 461 (582)
.... ..++..=+.+|.-.|+. +.+.+|+|..|+||+-|..|.+||.|=+.-- . .+..|
T Consensus 140 ------~i~~-~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--~------------~~V~~ 197 (308)
T PF07387_consen 140 ------KINF-SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--E------------NQVNM 197 (308)
T ss_pred ------ccch-hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhh--h------------heeeE
Confidence 1111 12222225678888976 4589999999999999999999999965321 1 11223
Q ss_pred ccccccccccCCCCccchhHHHHHHHHHHhcCC
Q 040604 462 IAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCT 494 (582)
Q Consensus 462 ~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~ 494 (582)
.--|+ ...+.++.+=+|=.-+++++...
T Consensus 198 vN~~Y-----~~lT~~aE~~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 198 VNIEY-----ESLTQEAEVKVFVKSCLKLVEKQ 225 (308)
T ss_pred Eeeec-----cccChHHHHHHHHHHHHHHHHHH
Confidence 33222 35678888888877778776544
|
The function of this family is unknown. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.041 Score=56.04 Aligned_cols=32 Identities=22% Similarity=0.198 Sum_probs=28.2
Q ss_pred CCceEecCCCCCCEEEcCCCceEEeecccccc
Q 040604 411 QVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ 442 (582)
Q Consensus 411 ~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~ 442 (582)
..+++|+|+.++|||+++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34799999999999999999999999987654
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.072 Score=54.15 Aligned_cols=29 Identities=28% Similarity=0.298 Sum_probs=25.4
Q ss_pred CceEecCCCCCCEEEcCCCceEEeeccccc
Q 040604 412 VRIVHFDIKPQNILLDEDFCPKISDFGLAK 441 (582)
Q Consensus 412 ~~ivH~Dikp~NILl~~~~~vkl~DFGla~ 441 (582)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 58999999999999988 678999998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.045 Score=56.95 Aligned_cols=72 Identities=15% Similarity=0.131 Sum_probs=48.8
Q ss_pred hhcCccCceEEEEEEeCC-CcEEEEEEec----cC---CCCHHHHHHHHHHHhccC--CC-ceEEEEeEEEeCCeeeEEE
Q 040604 299 DKLGQGGYGEVYKGELPD-GQLVAVKVLK----NS---RCNGEEFINEVASISRTS--HV-NIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~----~~---~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~ 367 (582)
+.||.|.-.-||++...+ ++.++||.-. .. ....+...-|...|+... -| ++.+++.+ +.+...+||
T Consensus 35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~vM 112 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCVM 112 (409)
T ss_pred eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHHH
Confidence 578999999999998743 6689999742 11 123455566777776653 23 56666654 556667899
Q ss_pred EecCC
Q 040604 368 ELMPN 372 (582)
Q Consensus 368 E~~~~ 372 (582)
|+++.
T Consensus 113 EdL~~ 117 (409)
T PRK12396 113 EDLSD 117 (409)
T ss_pred HhCcc
Confidence 99864
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.053 Score=53.19 Aligned_cols=78 Identities=21% Similarity=0.180 Sum_probs=56.2
Q ss_pred hhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec-CCCChhh
Q 040604 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM-PNGSLDK 377 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~-~~gsL~~ 377 (582)
..+-.|..+.|+.+...+|.++++|+.........+...+ ..|+.-+-...|++++.- .+...|++|.+ ++.+|.+
T Consensus 8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~E~~g~-~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g~~L~~ 84 (253)
T PF04655_consen 8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEHEARGE-AALRWWNGRGAVRLLAAD--PERGALLLERLDPGRSLAS 84 (253)
T ss_pred CCCCCCcceEEEEEEcCCCCeEEEEecCCcccchhhhhHH-hHhheeCCCCceeeeccc--cccchhhhhhccCCCchhh
Confidence 3466788999999999999999999987654333332222 447777888889998763 44667899999 5556765
Q ss_pred hh
Q 040604 378 FI 379 (582)
Q Consensus 378 ~i 379 (582)
+.
T Consensus 85 ~~ 86 (253)
T PF04655_consen 85 LP 86 (253)
T ss_pred cc
Confidence 44
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.14 Score=60.71 Aligned_cols=140 Identities=19% Similarity=0.232 Sum_probs=78.2
Q ss_pred hcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccC-------CCceEEEE-e----EEEe-CC--eee
Q 040604 300 KLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTS-------HVNIVTFL-G----FCYE-NK--KNA 364 (582)
Q Consensus 300 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-------h~niv~l~-~----~~~~-~~--~~~ 364 (582)
.|+ |..-.+|+....+|+.+++|+.+... .......|...|..|. -|.+++-. | .... +. ..+
T Consensus 32 ~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~v 109 (1013)
T PRK06148 32 PLD-GERDLNFRLTTDDGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRLL 109 (1013)
T ss_pred ecC-CcCCceEEEEeCCCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEEE
Confidence 464 35688899988788899999998643 3334444555554442 23333321 1 1111 22 456
Q ss_pred EEEEecCCCChhhh-----------------hhc----CC----CcCCCHHH-----------------HHHHHHHHHHH
Q 040604 365 LIYELMPNGSLDKF-----------------IHN----DR----NIKLEWKT-----------------MYQIAIGIARG 402 (582)
Q Consensus 365 lv~E~~~~gsL~~~-----------------i~~----~~----~~~l~~~~-----------------~~~i~~qi~~a 402 (582)
-+|+|++|..|.+. ++. .. ...+.|.. ...++.++++.
T Consensus 110 rLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~~ 189 (1013)
T PRK06148 110 RLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLAR 189 (1013)
T ss_pred EEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHHH
Confidence 78999998777541 110 00 01112211 11222233332
Q ss_pred HH-----HHHhCCCCceEecCCCCCCEEEcCCC--ceE-Eeecccccc
Q 040604 403 LE-----YLHRGCQVRIVHFDIKPQNILLDEDF--CPK-ISDFGLAKQ 442 (582)
Q Consensus 403 L~-----yLH~~~~~~ivH~Dikp~NILl~~~~--~vk-l~DFGla~~ 442 (582)
++ .+. ....++||+|+.+.|||++.++ .+. |+|||.+..
T Consensus 190 ~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 190 FERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 22 122 2234799999999999999875 555 999998765
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.19 Score=51.19 Aligned_cols=104 Identities=14% Similarity=0.151 Sum_probs=70.2
Q ss_pred CCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccc
Q 040604 360 NKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGL 439 (582)
Q Consensus 360 ~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGl 439 (582)
....|++|++- |+.|... . ...+++...|+.+.+..+.-+... .+.-|||+.-.||||+ +|.|-|+||-+
T Consensus 298 ~~y~yl~~kdh-gt~is~i-k-----~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 298 TLYLYLHFKDH-GTPISII-K-----ADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred ceEEEEEEecC-Cceeeee-e-----cccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeee
Confidence 34557788876 5555432 1 245678888888888877777765 5889999999999999 99999999999
Q ss_pred cccccccccceeeecccCCcccccccccccccCCCCccchhHHH
Q 040604 440 AKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSY 483 (582)
Q Consensus 440 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSl 483 (582)
++.-.. ...+... ..-.|-.+.+ .-+.+-+||-+
T Consensus 368 sRl~~~-q~~isy~------rldhp~lF~G---~dd~QFeIYrl 401 (488)
T COG5072 368 SRLSYS-QGIISYN------RLDHPDLFNG---VDDYQFEIYRL 401 (488)
T ss_pred eecccC-Cceeecc------ccCchhhhcC---ccceeeeHHHH
Confidence 995332 2222221 2334555554 22556677753
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.24 E-value=0.16 Score=53.17 Aligned_cols=74 Identities=18% Similarity=0.151 Sum_probs=45.1
Q ss_pred hhcCccCceEEEEEEeCCC--cE-----EEEEEeccCCCCHHHHHHHHHHHhccCCCce-EEEEeEEEeCCeeeEEEEec
Q 040604 299 DKLGQGGYGEVYKGELPDG--QL-----VAVKVLKNSRCNGEEFINEVASISRTSHVNI-VTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~--~~-----vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~ 370 (582)
+.|..|-...+|++...++ .. |.+++........-.-.+|+.+++.+...++ .++++.+. ..+|+||+
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~efI 131 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEWV 131 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEEe
Confidence 3565688889999865432 22 4444332211111123568889999876655 55666653 36999999
Q ss_pred CCCChh
Q 040604 371 PNGSLD 376 (582)
Q Consensus 371 ~~gsL~ 376 (582)
+|.+|.
T Consensus 132 eGr~l~ 137 (383)
T PTZ00384 132 EGNTMG 137 (383)
T ss_pred ccccCC
Confidence 988774
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 582 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-48 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-48 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-33 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-33 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-30 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-30 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-30 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-28 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-23 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-22 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-22 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-22 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-22 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-21 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-21 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-21 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-21 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-21 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-21 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-21 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-21 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-21 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-21 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-21 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-21 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-21 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-21 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-21 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-21 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-21 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-21 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-21 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-21 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-19 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-19 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-19 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-19 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-17 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-16 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 9e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-15 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-15 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-14 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-14 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-14 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-13 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 9e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-12 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-11 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 5e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 8e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 9e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 6e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-06 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 6e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 8e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 9e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 9e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-05 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 3e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-05 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 5e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 7e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 8e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 314 bits (807), Expect = e-103
Identities = 111/298 (37%), Positives = 160/298 (53%), Gaps = 20/298 (6%)
Query: 282 PKRYSYSDVKRMTKSFRD--KLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGE--EFIN 337
KR+S +++ + +F + LG+GG+G+VYKG L DG LVAVK LK R G +F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 338 EVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIH--NDRNIKLEWKTMYQI 395
EV IS H N++ GFC + L+Y M NGS+ + + L+W +I
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 396 AIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHA 455
A+G ARGL YLH C +I+H D+K NILLDE+F + DFGLAK K++ ++
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AV 195
Query: 456 RGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLI---Y 512
RGTIG+IAPE Y G S K+DV+ YG+M++E++ + D L+
Sbjct: 196 RGTIGHIAPE-YLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 513 ERIEPGN-----DFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565
++ D G +EE + +I V C Q++P ERP M +V+ MLEG
Sbjct: 254 GLLKEKKLEALVDVDLQGNYKDEE---VEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 1e-89
Identities = 89/319 (27%), Positives = 150/319 (47%), Gaps = 40/319 (12%)
Query: 271 EAFIRNHESLAPKRYSYSDVKRMTKSFRD--------KLGQGGYGEVYKGELPDGQLVAV 322
E +S+ ++K +T +F + K+G+GG+G VYKG + + VAV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 323 KVLKNSRCNG-----EEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDK 377
K L ++F E+ +++ H N+V LGF + L+Y MPNGSL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 378 FIHNDRNIK-LEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISD 436
+ L W +IA G A G+ +LH +H DIK NILLDE F KISD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 437 FGLAKQA-QKKESAIS---MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG 492
FGLA+ + + ++ ++ + GT Y+APE R G ++ KSD+YS+G++++E++
Sbjct: 177 FGLARASEKFAQTVMTSRIV----GTTAYMAPE-ALR--GEITPKSDIYSFGVVLLEIIT 229
Query: 493 CTKNLDDEVTDTSICHNLIYERIEP--GNDFQFDGVA----TEEEKKIAKMMILVGFWCI 546
+D+ L+ + E + + + + + M V C+
Sbjct: 230 GLPAVDEHREP----QLLL-DIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCL 284
Query: 547 QTNPSERPSMHKVLEMLEG 565
++RP + KV ++L+
Sbjct: 285 HEKKNKRPDIKKVQQLLQE 303
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 278 bits (714), Expect = 1e-89
Identities = 97/300 (32%), Positives = 153/300 (51%), Gaps = 25/300 (8%)
Query: 283 KRYSYSDVKRMTKSFRDK--LGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGE-EFINEV 339
R D++ T +F K +G G +G+VYKG L DG VA+K G EF E+
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86
Query: 340 ASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIH--NDRNIKLEWKTMYQIAI 397
++S H ++V+ +GFC E + LIY+ M NG+L + ++ + + + W+ +I I
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 398 GIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQA-QKKESAISMLHAR 456
G ARGL YLH I+H D+K NILLDE+F PKI+DFG++K+ + ++ +S +
Sbjct: 147 GAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST-VVK 202
Query: 457 GTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLI---YE 513
GT+GYI PE + + G ++ KSDVYS+G+++ E++ + + NL E
Sbjct: 203 GTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSAIVQ--SLPREMVNLAEWAVE 258
Query: 514 RIEPGN-----DFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568
G D E + C+ + +RPSM VL LE ++
Sbjct: 259 SHNNGQLEQIVDPNLADKIRPES---LRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 1e-69
Identities = 71/301 (23%), Positives = 113/301 (37%), Gaps = 45/301 (14%)
Query: 296 SFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLG 355
+ +G +G V+K + + VAVK+ + EV S+ H NI+ F+G
Sbjct: 27 QLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIG 85
Query: 356 FCYENKKNA----LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH---- 407
LI GSL F+ + + W + IA +ARGL YLH
Sbjct: 86 AEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIP 142
Query: 408 ---RGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAP 464
G + I H DIK +N+LL + I+DFGLA + + +SA GT Y+AP
Sbjct: 143 GLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAP 202
Query: 465 EVYSRRFGG---VSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDF 521
EV + D+Y+ G+++ E+ D V + + L +E E G
Sbjct: 203 EVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE----YMLPFEE-EIGQHP 257
Query: 522 QFDGVAT------------------EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEML 563
+ + + + + C + R S V E +
Sbjct: 258 SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEE----CWDHDAEARLSAGCVGERI 313
Query: 564 E 564
Sbjct: 314 T 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 2e-68
Identities = 80/297 (26%), Positives = 140/297 (47%), Gaps = 42/297 (14%)
Query: 297 FRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNG---EEFINEVASISRTSHVNIVTF 353
++K+G G +G V++ E G VAVK+L + EF+ EVA + R H NIV F
Sbjct: 41 IKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 354 LGFCYENKKNALIYELMPNGSLDKFIH-NDRNIKLEWKTMYQIAIGIARGLEYLHRGCQV 412
+G + +++ E + GSL + +H + +L+ + +A +A+G+ YLH
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNP 158
Query: 413 RIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFG 472
IVH ++K N+L+D+ + K+ DFGL++ K + +S A GT ++APEV R
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVL--RDE 214
Query: 473 GVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQF-DGVATEEE 531
+ KSDVYS+G+++ E+ + + P Q V + +
Sbjct: 215 PSNEKSDVYSFGVILWEL---------------ATLQQPWGNLNP---AQVVAAVGFKCK 256
Query: 532 ---------KKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQIPPKPSLF 579
++A ++ C P +RPS ++++L I++ PP S
Sbjct: 257 RLEIPRNLNPQVAAIIE----GCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 309
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 6e-67
Identities = 71/297 (23%), Positives = 122/297 (41%), Gaps = 42/297 (14%)
Query: 297 FRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGF 356
+ +G+G +G V K + + VA+K +++ + FI E+ +SR +H NIV G
Sbjct: 12 VEEVVGRGAFGVVCKAKW-RAKDVAIKQIESES-ERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 357 CYENKKNALIYELMPNGSLDKFIHNDRN-IKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
C L+ E GSL +H + ++G+ YLH ++
Sbjct: 70 CL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 416 HFDIKPQNILLDEDF-CPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGV 474
H D+KP N+LL KI DFG A Q M + +G+ ++APEV+
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HMTNNKGSAAWMAPEVFEGS--NY 180
Query: 475 SHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE--- 531
S K DV+S+G+++ E+ I ++ I G F+
Sbjct: 181 SEKCDVFSWGIILWEV---------------ITRRKPFDEIG-GPAFRIMWAVHNGTRPP 224
Query: 532 ------KKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQIPPKPSLFSAT 582
K I +M C +PS+RPSM ++++++ + +P +
Sbjct: 225 LIKNLPKPIESLMT----RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQ 277
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 1e-65
Identities = 65/291 (22%), Positives = 121/291 (41%), Gaps = 51/291 (17%)
Query: 297 FRDKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNG--------EEFINEVASISRTSH 347
+ ++G+GG+G V+KG + D +VA+K L G +EF EV +S +H
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 348 VNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH 407
NIV G + ++ E +P G L + + + ++W ++ + IA G+EY+
Sbjct: 83 PNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 408 RGCQVRIVHFDIKPQNILLDE-----DFCPKISDFGLAKQAQKKESAISMLHARGTIGYI 462
IVH D++ NI L C K++DFGL++Q+ S+ G ++
Sbjct: 140 -NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWM 193
Query: 463 APEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQ 522
APE + K+D YS+ M++ + + ++ G
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTI---------------LTGEGPFDEYSYGKIKF 238
Query: 523 FDGVATEEE---------KKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564
+ + E ++ ++ L C +P +RP +++ L
Sbjct: 239 INMIREEGLRPTIPEDCPPRLRNVIEL----CWSGDPKKRPHFSYIVKELS 285
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 210 bits (538), Expect = 3e-64
Identities = 62/278 (22%), Positives = 115/278 (41%), Gaps = 33/278 (11%)
Query: 296 SFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNG---EEFINEVASISRTSHVNIVT 352
+F KL + GE++KG G + VKVLK + +F E + SH N++
Sbjct: 13 NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 353 FLGFCYENKKN--ALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGC 410
LG C LI MP GSL +H N ++ + A+ +ARG+ +LH
Sbjct: 72 VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TL 130
Query: 411 QVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVY-SR 469
+ I + +++++DED +IS + Q ++APE +
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPG-------RMYAPAWVAPEALQKK 183
Query: 470 RFGGVSHKSDVYSYGMMIIEMVGCT---KNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526
+D++S+ +++ E+V +L + + + I PG
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGIS------ 237
Query: 527 ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564
++K+M + C+ +P++RP ++ +LE
Sbjct: 238 -----PHVSKLMKI----CMNEDPAKRPKFDMIVPILE 266
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 2e-61
Identities = 72/300 (24%), Positives = 124/300 (41%), Gaps = 38/300 (12%)
Query: 297 FRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNG---EEFINEVASISRTSHVNIVTF 353
+ +G+G +G+VY G G+ VA++++ R N + F EV + +T H N+V F
Sbjct: 37 IGELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 354 LGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVR 413
+G C A+I L +L + + I L+ QIA I +G+ YLH
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLH---AKG 150
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAK---QAQKKESAISMLHARGTIGYIAPEVYSRR 470
I+H D+K +N+ D I+DFGL Q + G + ++APE+ +
Sbjct: 151 ILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 471 FGGV-------SHKSDVYSYGMMIIEMVGCT---KNLDDEVTDTSICHNLIYERIEPGND 520
S SDV++ G + E+ K E + + + G
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMG 269
Query: 521 FQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQIPPKPSLFS 580
K+I+ +++ +C ERP+ K+++MLE + + P F
Sbjct: 270 -----------KEISDILL----FCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFW 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 205 bits (522), Expect = 3e-61
Identities = 74/325 (22%), Positives = 122/325 (37%), Gaps = 56/325 (17%)
Query: 296 SFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINE--VASISRTSHVNIVTF 353
+ +G+G YG VYKG L D + VAVKV + N + FINE + + H NI F
Sbjct: 16 KLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA--NRQNFINEKNIYRVPLMEHDNIARF 72
Query: 354 LGFCYENKKNA-----LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH- 407
+ + L+ E PNGSL K++ +W + ++A + RGL YLH
Sbjct: 73 IVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHT 129
Query: 408 -----RGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAK------QAQKKESAISMLHAR 456
+ I H D+ +N+L+ D ISDFGL+ + E + +
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 457 GTIGYIAPEVYSRRF-----GGVSHKSDVYSYGMMIIEMV-GCTKNLDDEVTDTSICHNL 510
GTI Y+APEV + D+Y+ G++ E+ CT E + +
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE---YQM 246
Query: 511 IYERIEPGNDFQFDGVATEEEKK------------------IAKMMILVGFWCIQTNPSE 552
++ + D +K + + + C +
Sbjct: 247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE----DCWDQDAEA 302
Query: 553 RPSMHKVLEMLEGSIENLQIPPKPS 577
R + E + + + S
Sbjct: 303 RLTAQXAEERMAELMMIWERNKSVS 327
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 3e-61
Identities = 81/276 (29%), Positives = 132/276 (47%), Gaps = 27/276 (9%)
Query: 297 FRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGE---EFINEVASISRTSHVNIVTF 353
++G G +G VYKG+ G VAVK+L + + F NEV + +T HVNI+ F
Sbjct: 28 VGQRIGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 354 LGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVR 413
+G+ + A++ + SL +H K E K + IA ARG++YLH
Sbjct: 86 MGYSTAPQL-AIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLH---AKS 140
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGG 473
I+H D+K NI L ED KI DFGLA + + + G+I ++APEV +
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 474 -VSHKSDVYSYGMMIIEMVGCT---KNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529
S +SDVY++G+++ E++ N++ + I E + G+
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNIN--------NRDQIIEMVGRGSLSPDLSKVRS 252
Query: 530 E-EKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564
K++ ++M C++ ERPS ++L +E
Sbjct: 253 NCPKRMKRLMA----ECLKKKRDERPSFPRILAEIE 284
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 4e-60
Identities = 74/291 (25%), Positives = 119/291 (40%), Gaps = 55/291 (18%)
Query: 297 FRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNG-----EEFINEVASISRTSHVNIV 351
+ +G GG+G+VY+ G VAVK ++ E E + H NI+
Sbjct: 11 LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 352 TFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQ 411
G C + L+ E G L++ + ++ + A+ IARG+ YLH
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 412 VRIVHFDIKPQNILLDEDFCP--------KISDFGLAKQAQKKESAISMLHARGTIGYIA 463
V I+H D+K NIL+ + KI+DFGLA++ + + A G ++A
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMA 182
Query: 464 PEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQF 523
PEV R S SDV+SYG+++ E+ + + + I+
Sbjct: 183 PEVI--RASMFSKGSDVWSYGVLLWEL---------------LTGEVPFRGIDG---LAV 222
Query: 524 -DGVATEEE---------KKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564
GVA + + AK+M C +P RPS +L+ L
Sbjct: 223 AYGVAMNKLALPIPSTCPEPFAKLME----DCWNPDPHSRPSFTNILDQLT 269
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 5e-58
Identities = 68/308 (22%), Positives = 116/308 (37%), Gaps = 53/308 (17%)
Query: 297 FRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKN-SRCNGEEFINEVASISRTSHVNIVTFL 354
+ LG+G +G+ K G+++ +K L F+ EV + H N++ F+
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 355 GFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRI 414
G Y++K+ I E + G+L I + + W A IA G+ YLH + I
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIK-SMDSQYPWSQRVSFAKDIASGMAYLH---SMNI 129
Query: 415 VHFDIKPQNILLDEDFCPKISDFGLAK------------QAQKKESAISMLHARGTIGYI 462
+H D+ N L+ E+ ++DFGLA+ ++ KK G ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 463 APEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQ 522
APE+ K DV+S+G+++ E++G P
Sbjct: 190 APEMI--NGRSYDEKVDVFSFGIVLCEIIGRVN---------------ADPDYLPRT--M 230
Query: 523 FDGVATEEE----------KKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENL-- 570
G+ + C +P +RPS K+ LE +L
Sbjct: 231 DFGLNVRGFLDRYCPPNCPPSFFPIT----VRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286
Query: 571 QIPPKPSL 578
+P P L
Sbjct: 287 HLPLGPQL 294
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 7e-57
Identities = 67/297 (22%), Positives = 121/297 (40%), Gaps = 39/297 (13%)
Query: 297 FRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGF 356
++G+G YGEV+ G+ G+ VAVKV + E+ H NI+ F+
Sbjct: 41 MVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 357 CYENKKN----ALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH----- 407
+ + LI + NGSL ++ + L+ K+M ++A GL +LH
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 408 RGCQVRIVHFDIKPQNILLDEDFCPKISDFGLA--KQAQKKESAISMLHARGTIGYIAPE 465
+ I H D+K +NIL+ ++ I+D GLA + E I GT Y+ PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 466 VYSRRFGGVS----HKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDF 521
V +D+YS+G+++ E+ + + + + +P +
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEV--ARRCVSGGIVEEYQLPYHDLVPSDPSYED 274
Query: 522 QFDGVATEEE--------------KKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564
+ V ++ +++ K+M C NP+ R + +V + L
Sbjct: 275 MREIVCIKKLRPSFPNRWSSDECLRQMGKLMT----ECWAHNPASRLTALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 9e-54
Identities = 63/300 (21%), Positives = 123/300 (41%), Gaps = 45/300 (15%)
Query: 297 FRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGF 356
++ +G+G +GEV++G+ G+ VAVK+ + E+ H NI+ F+
Sbjct: 46 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 357 CYENKKNA----LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH----- 407
++ L+ + +GSL +++ + + M ++A+ A GL +LH
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 408 RGCQVRIVHFDIKPQNILLDEDFCPKISDFGLA--KQAQKKESAISMLHARGTIGYIAPE 465
+ I H D+K +NIL+ ++ I+D GLA + I+ H GT Y+APE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 466 VYSRRFGG----VSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGN-- 519
V ++D+Y+ G++ E+ + + L Y + P +
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRC-----SIGGIHEDYQLPYYDLVPSDPS 276
Query: 520 -DFQFDGVATEEE--------------KKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564
+ V ++ + +AK+M C N + R + ++ + L
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR----ECWYANGAARLTALRIKKTLS 332
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 2e-53
Identities = 63/302 (20%), Positives = 122/302 (40%), Gaps = 49/302 (16%)
Query: 297 FRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINE--VASISRTSHVNIVTFL 354
+ +G+G YGEV++G G+ VAVK+ + + + + E + + H NI+ F+
Sbjct: 12 LLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFI 68
Query: 355 GFCYENKKNA----LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH--- 407
++ ++ LI GSL ++ L+ + +I + IA GL +LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 408 --RGCQVRIVHFDIKPQNILLDEDFCPKISDFGLA--KQAQKKESAISMLHARGTIGYIA 463
+ I H D+K +NIL+ ++ I+D GLA + + GT Y+A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 464 PEVYSRRFGGV----SHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGN 519
PEV + D++++G+++ E+ + + + P +
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM-----VSNGIVEDYKPPFYDVVPND 240
Query: 520 ---DFQFDGVATEEE--------------KKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562
+ V +++ +AK+M C NPS R + ++ +
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK----ECWYQNPSARLTALRIKKT 296
Query: 563 LE 564
L
Sbjct: 297 LT 298
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 5e-45
Identities = 84/314 (26%), Positives = 131/314 (41%), Gaps = 45/314 (14%)
Query: 260 KKKTREDDRNVEAFIRNHESLAPKRYSYSDVKRMTKSFRDKLGQGGYGEVYKG-ELPDGQ 318
+++ ++ D E L K S+ R K F ++G+G + VYKG +
Sbjct: 2 EERNQQQDDI--------EELETKAVGMSNDGRFLK-FDIEIGRGSFKTVYKGLDTETTV 52
Query: 319 LVAVKVLKNSRCNGEE---FINEVASISRTSHVNIVTFLGFCYENKKNA----LIYELMP 371
VA L++ + E F E + H NIV F K L+ ELM
Sbjct: 53 EVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT 112
Query: 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLD-EDF 430
+G+L ++ R ++ K + I +GL++LH I+H D+K NI +
Sbjct: 113 SGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTG 169
Query: 431 CPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEM 490
KI D GLA + + ++ GT ++APE+Y DVY++GM ++EM
Sbjct: 170 SVKIGDLGLATLKRASFAK-AV---IGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEM 222
Query: 491 VGCTKNLDDEVTDTSICHNL--IYERIEPGN-DFQFDGVATEEEKKIAKMMILVGFWCIQ 547
+ C N IY R+ G FD VA E K+I + CI+
Sbjct: 223 ATSEYPYSE-------CQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG-------CIR 268
Query: 548 TNPSERPSMHKVLE 561
N ER S+ +L
Sbjct: 269 QNKDERYSIKDLLN 282
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 9e-43
Identities = 71/295 (24%), Positives = 120/295 (40%), Gaps = 51/295 (17%)
Query: 297 FRDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLG 355
LGQG +G+V K D + A+K ++++ ++EV ++ +H +V +
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYA 69
Query: 356 F----------CYENKKNALIY---ELMPNGSLDKFIHNDRNIKLE----WKTMYQIAIG 398
KK + ++ E NG+L IH+ N+ + W+ QI
Sbjct: 70 AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQIL-- 126
Query: 399 IARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR-- 456
L Y+H I+H D+KP NI +DE KI DFGLAK + + +
Sbjct: 127 --EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 457 ----------GTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSI 506
GT Y+A EV G + K D+YS G++ EM+ + E
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMI-YPFSTGME------ 233
Query: 507 CHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561
I +++ +F + + K+ K +I I +P++RP +L
Sbjct: 234 -RVNILKKLRSV-SIEFPPDFDDNKMKVEKKIIR---LLIDHDPNKRPGARTLLN 283
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 6e-42
Identities = 69/306 (22%), Positives = 118/306 (38%), Gaps = 48/306 (15%)
Query: 299 DKLGQGGYGEVYKGE-LPDGQLVAVKV--LKNSRCNGEEFINEVASISRTSHVNIVTFLG 355
LG+GG+G V++ + D A+K L N E+ + EV ++++ H IV +
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 356 FCYEN---------KKNALIY---ELMPNGSLDKFIHNDRNIK-LEWKTMYQIAIGIARG 402
E +Y +L +L +++ I+ E I + IA
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 403 LEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR------ 456
+E+LH ++H D+KP NI D K+ DFGL + E ++L
Sbjct: 131 VEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 457 ----GTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIY 512
GT Y++PE SHK D++S G+++ E+ ++ ++
Sbjct: 188 TGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFEL--LYP-FSTQMERVRTLTDVRN 242
Query: 513 ERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQI 572
+ P F E + M+ +P ERP ++E E+L
Sbjct: 243 LKFPP----LFTQKYPCEYVMVQDML--------SPSPMERPEAINIIEN--AVFEDLDF 288
Query: 573 PPKPSL 578
P K L
Sbjct: 289 PGKTVL 294
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 9e-42
Identities = 64/297 (21%), Positives = 131/297 (44%), Gaps = 48/297 (16%)
Query: 286 SYSDVKRMTKSFR--DKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEFINEVASI 342
+++ KR F+ + +G GG+G+V+K + DG+ +K +K + E+ EV ++
Sbjct: 2 AHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKAL 58
Query: 343 SRTSHVNIVTFLGF-------------CYENKKNALIY---ELMPNGSLDKFIHNDRNIK 386
++ HVNIV + G K ++ E G+L+++I R K
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 387 LEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446
L+ ++ I +G++Y+H ++++ D+KP NI L + KI DFGL +
Sbjct: 119 LDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175
Query: 447 ESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSI 506
GT+ Y++PE S + + D+Y+ G+++ E++ +
Sbjct: 176 GKRTRSK---GTLRYMSPEQISSQ--DYGKEVDLYALGLILAELLHVCDTAFET------ 224
Query: 507 CHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEML 563
+ + + G + ++EK + + + + P +RP+ ++L L
Sbjct: 225 --SKFFTDLRDG---IISDIFDKKEKTLLQKL-------LSKKPEDRPNTSEILRTL 269
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 6e-41
Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 16/210 (7%)
Query: 290 VKRMTKSFRDKLGQGGYGEVYKGEL-PDGQ----LVAVKVLKN--SRCNGEEFINEVASI 342
+K LG G +G VYKG P+G+ VA+K L+ S +E ++E +
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 343 SRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARG 402
+ + ++ LG C LI +LMP G L ++ ++ + + + + IA+G
Sbjct: 72 ASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKG 129
Query: 403 LEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYI 462
+ YL R+VH D+ +N+L+ KI+DFGLAK +E + I ++
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 463 APE-VYSRRFGGVSHKSDVYSYGMMIIEMV 491
A E + R + +H+SDV+SYG+ + E++
Sbjct: 187 ALESILHRIY---THQSDVWSYGVTVWELM 213
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 7e-41
Identities = 69/286 (24%), Positives = 122/286 (42%), Gaps = 49/286 (17%)
Query: 296 SFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLK--NSRCNGEEFINEVASISRTSHVNIVT 352
+++G+G +GEV+ G L D LVAVK + +F+ E + + SH NIV
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 353 FLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQV 412
+G C + + ++ EL+ G F+ + +L KT+ Q+ A G+EYL
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA-RLRVKTLLQMVGDAAAGMEYLE---SK 232
Query: 413 RIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYI-----APEVY 467
+H D+ +N L+ E KISDFG++++ A G + + APE
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV-----YAASGGLRQVPVKWTAPEAL 287
Query: 468 S-RRFGGVSHKSDVYSYGMMIIEMV--------GCTKNLDDEVTDTSICHNLIYERIEPG 518
+ R+ S +SDV+S+G+++ E + + E +E G
Sbjct: 288 NYGRY---SSESDVWSFGILLWETFSLGASPYPNLSNQ---QT----------REFVEKG 331
Query: 519 NDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564
+ + + ++M C P +RPS + + L+
Sbjct: 332 GRLPCPELCPDA---VFRLME----QCWAYEPGQRPSFSTIYQELQ 370
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 7e-40
Identities = 72/274 (26%), Positives = 123/274 (44%), Gaps = 19/274 (6%)
Query: 297 FRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLG 355
+ KLG G YGEVY+G VAVK LK EEF+ E A + H N+V LG
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
C +I E M G+L ++ ++ + +A I+ +EYL + +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFI 340
Query: 416 HFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVS 475
H ++ +N L+ E+ K++DFGL++ A+ I + APE + S
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESL--AYNKFS 397
Query: 476 HKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIA 535
KSDV+++G+++ E+ + + + +YE +E + E+ +
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYELLEKDYRMERPEGCPEK---VY 449
Query: 536 KMMILVGFWCIQTNPSERPSMHKVLEMLEGSIEN 569
++M C Q NPS+RPS ++ + E +
Sbjct: 450 ELMR----ACWQWNPSDRPSFAEIHQAFETMFQE 479
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 57/284 (20%), Positives = 124/284 (43%), Gaps = 46/284 (16%)
Query: 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEE---FINEVASISRTSH--VNIVTF 353
++G GG +V++ Q+ A+K + + + + NE+A +++ I+
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 354 LGFCYENKKNALIYELM--PNGSLDKFIHNDRNIKLEW--KTMYQIAIGIARGLEYLHRG 409
+ + IY +M N L+ ++ ++I + + +H
Sbjct: 94 YDY-EITDQY--IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNML----EAVHTIH-- 144
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEV--- 466
Q IVH D+KP N L+ + K+ DFG+A Q Q +++ GT+ Y+ PE
Sbjct: 145 -QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 467 ------YSRRFGGVSHKSDVYSYGMMIIEMV-GCT--KNLDDEVTDTSICHNLIYERIEP 517
+ +S KSDV+S G ++ M G T + + +++ + ++ I+P
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-------SKLHAIIDP 255
Query: 518 GNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561
++ +F + ++ + ++ C++ +P +R S+ ++L
Sbjct: 256 NHEIEFPDIPEKD----LQDVLK---CCLKRDPKQRISIPELLA 292
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 57/284 (20%), Positives = 124/284 (43%), Gaps = 46/284 (16%)
Query: 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEE---FINEVASISRTSH--VNIVTF 353
++G GG +V++ Q+ A+K + + + + NE+A +++ I+
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 354 LGFCYENKKNALIYELM--PNGSLDKFIHNDRNIKLEW--KTMYQIAIGIARGLEYLHRG 409
+ + IY +M N L+ ++ ++I + + +H
Sbjct: 75 YDY-EITDQY--IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNML----EAVHTIH-- 125
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEV--- 466
Q IVH D+KP N L+ + K+ DFG+A Q Q +++ GT+ Y+ PE
Sbjct: 126 -QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 467 ------YSRRFGGVSHKSDVYSYGMMIIEMV-GCT--KNLDDEVTDTSICHNLIYERIEP 517
+ +S KSDV+S G ++ M G T + + +++ + ++ I+P
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-------SKLHAIIDP 236
Query: 518 GNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561
++ +F + ++ + ++ C++ +P +R S+ ++L
Sbjct: 237 NHEIEFPDIPEKD----LQDVLK---CCLKRDPKQRISIPELLA 273
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-39
Identities = 72/298 (24%), Positives = 126/298 (42%), Gaps = 40/298 (13%)
Query: 297 FRDKLGQGGYGEVYKGELP-----DGQLVAVKVLK-NSRCNGEEFINEVASISRTSHVNI 350
F +LG+G +G V G++VAVK L+ ++ + +F E+ + H NI
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 351 VTFLGFCYENKKNA--LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHR 408
V + G CY + LI E +P GSL ++ + +++ + Q I +G+EYL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLG- 131
Query: 409 GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ-AQKKESAISMLHARGTIGYIAPEVY 467
R +H D+ +NIL++ + KI DFGL K Q KE I + APE
Sbjct: 132 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 468 S-RRFGGVSHKSDVYSYGMMIIEMV-GCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525
+ +F S SDV+S+G+++ E+ K+ + N ++
Sbjct: 190 TESKF---SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM-IVFH----- 240
Query: 526 VATEEEK------------KIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQ 571
+ + +I +M C N ++RPS + ++ +N+
Sbjct: 241 LIELLKNNGRLPRPDGCPDEIYMIMTE----CWNNNVNQRPSFRDLALRVDQIRDNMA 294
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-39
Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 16/210 (7%)
Query: 290 VKRMTKSFRDKLGQGGYGEVYKGEL-PDGQ----LVAVKVLKN--SRCNGEEFINEVASI 342
+K LG G +G VYKG P+G+ VA+K L+ S +E ++E +
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 343 SRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARG 402
+ + ++ LG C LI +LMP G L ++ ++ + + + + IA+G
Sbjct: 72 ASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKG 129
Query: 403 LEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYI 462
+ YL R+VH D+ +N+L+ KI+DFGLAK +E + I ++
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 463 APE-VYSRRFGGVSHKSDVYSYGMMIIEMV 491
A E + R + +H+SDV+SYG+ + E++
Sbjct: 187 ALESILHRIY---THQSDVWSYGVTVWELM 213
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-39
Identities = 63/231 (27%), Positives = 110/231 (47%), Gaps = 20/231 (8%)
Query: 274 IRNHESLAPKRYSYSD---VKRMTKSFRDKLGQGGYGEVYKGELP-----DGQLVAVKVL 325
+ +H + Y+ D + + +LG+G +G V G LVAVK L
Sbjct: 1 MGHHHHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL 60
Query: 326 KNSRCNGE-EFINEVASISRTSHVNIVTFLGFCYENKKNA--LIYELMPNGSLDKFIHND 382
++S + + +F E+ + IV + G Y + + L+ E +P+G L F+
Sbjct: 61 QHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH 120
Query: 383 RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ 442
R +L+ + + I +G+EYL R VH D+ +NIL++ + KI+DFGLAK
Sbjct: 121 RA-RLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKL 176
Query: 443 -AQKKESAISMLHARGTIGYIAPE-VYSRRFGGVSHKSDVYSYGMMIIEMV 491
K+ + + I + APE + F S +SDV+S+G+++ E+
Sbjct: 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIF---SRQSDVWSFGVVLYELF 224
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 8e-39
Identities = 71/268 (26%), Positives = 119/268 (44%), Gaps = 19/268 (7%)
Query: 297 FRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGF 356
KLGQG +GEV+ G VA+K LK + E F+ E + + H +V
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 357 CYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVH 416
E + ++ E M GSL F+ + L + +A IA G+ Y+ R + VH
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 303
Query: 417 FDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSH 476
D++ NIL+ E+ K++DFGLA+ + E A+ I + APE +G +
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAA--LYGRFTI 360
Query: 477 KSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAK 536
KSDV+S+G+++ E+ + + + + +++E G E +
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQVERGYRMPCPPECPES---LHD 412
Query: 537 MMILVGFWCIQTNPSERPSMHKVLEMLE 564
+M C + P ERP+ + LE
Sbjct: 413 LMC----QCWRKEPEERPTFEYLQAFLE 436
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 1e-38
Identities = 71/268 (26%), Positives = 119/268 (44%), Gaps = 19/268 (7%)
Query: 297 FRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGF 356
KLGQG +GEV+ G VA+K LK + E F+ E + + H +V
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 357 CYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVH 416
E + ++ E M GSL F+ + L + +A IA G+ Y+ R + VH
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 386
Query: 417 FDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSH 476
D++ NIL+ E+ K++DFGLA+ + E A+ I + APE +G +
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAA--LYGRFTI 443
Query: 477 KSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAK 536
KSDV+S+G+++ E+ + + + + +++E G E +
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQVERGYRMPCPPECPES---LHD 495
Query: 537 MMILVGFWCIQTNPSERPSMHKVLEMLE 564
+M C + P ERP+ + LE
Sbjct: 496 LMC----QCWRKEPEERPTFEYLQAFLE 519
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-38
Identities = 60/224 (26%), Positives = 108/224 (48%), Gaps = 21/224 (9%)
Query: 282 PKRYSYSD---VKRMTKSFRDKLGQGGYGEVYKGELP-----DGQLVAVKVLK--NSRCN 331
K + D ++ LG+G +G+V G+ VAVK LK + +
Sbjct: 7 KKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH 66
Query: 332 GEEFINEVASISRTSHVNIVTFLGFCYENKKNA--LIYELMPNGSLDKFIHNDRNIKLEW 389
+ E+ + H NIV + G C E+ N LI E +P+GSL +++ ++N K+
Sbjct: 67 IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN-KINL 125
Query: 390 KTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449
K + A+ I +G++YL + VH D+ +N+L++ + KI DFGL K + +
Sbjct: 126 KQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY 182
Query: 450 ISM-LHARGTIGYIAPE-VYSRRFGGVSHKSDVYSYGMMIIEMV 491
++ + + APE + +F SDV+S+G+ + E++
Sbjct: 183 YTVKDDRDSPVFWYAPECLMQSKF---YIASDVWSFGVTLHELL 223
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-38
Identities = 65/289 (22%), Positives = 127/289 (43%), Gaps = 42/289 (14%)
Query: 299 DKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEE---FINEVASISRTSHVNIVTFL 354
K+G+G +G+ + DG+ +K + SR + +E EVA ++ H NIV +
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 355 GFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRI 414
EN ++ + G L K I+ + + + + + I L+++H +I
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KI 146
Query: 415 VHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES-AISMLHARGTIGYIAPEVYSRRFGG 473
+H DIK QNI L +D ++ DFG+A+ A + + GT Y++PE+ +
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI---GTPYYLSPEICENK--P 201
Query: 474 VSHKSDVYSYGMMIIEMVGCT-------KNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526
++KSD+++ G ++ E+ CT ++ ++ +I P
Sbjct: 202 YNNKSDIWALGCVLYEL--CTLKHAFEAGSMK------NLVLKIISGSFPP-----VSLH 248
Query: 527 ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM--LEGSIENLQIP 573
+ + + + + + NP +RPS++ +LE + IE P
Sbjct: 249 YSYDLRSLVSQL-------FKRNPRDRPSVNSILEKGFIAKRIEKFLSP 290
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 7e-38
Identities = 56/284 (19%), Positives = 123/284 (43%), Gaps = 46/284 (16%)
Query: 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEE---FINEVASISRTSH--VNIVTF 353
++G GG +V++ Q+ A+K + + + + NE+A +++ I+
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 354 LGFCYENKKNALIYELM--PNGSLDKFIHNDRNIKLEW--KTMYQIAIGIARGLEYLHRG 409
+ + IY +M N L+ ++ ++I + + +H
Sbjct: 122 YDY-EITDQY--IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNML----EAVHTIH-- 172
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEV--- 466
Q IVH D+KP N L+ + K+ DFG+A Q Q +++ G + Y+ PE
Sbjct: 173 -QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 467 ------YSRRFGGVSHKSDVYSYGMMIIEMV-GCT--KNLDDEVTDTSICHNLIYERIEP 517
+ +S KSDV+S G ++ M G T + + +++ + ++ I+P
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-------SKLHAIIDP 283
Query: 518 GNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561
++ +F + ++ + ++ C++ +P +R S+ ++L
Sbjct: 284 NHEIEFPDIPEKD----LQDVLK---CCLKRDPKQRISIPELLA 320
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-38
Identities = 52/197 (26%), Positives = 101/197 (51%), Gaps = 9/197 (4%)
Query: 296 SFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLG 355
+ +LG G +G V G+ VAVK++K + +EF E ++ + SH +V F G
Sbjct: 11 TLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
C + ++ E + NG L ++ + LE + ++ + G+ +L + +
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYLRSHGK-GLEPSQLLEMCYDVCEGMAFLES---HQFI 126
Query: 416 HFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYS-RRFGGV 474
H D+ +N L+D D C K+SDFG+ + + +S + + + + APEV+ ++
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPEVFHYFKY--- 182
Query: 475 SHKSDVYSYGMMIIEMV 491
S KSDV+++G+++ E+
Sbjct: 183 SSKSDVWAFGILMWEVF 199
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 7e-38
Identities = 71/298 (23%), Positives = 125/298 (41%), Gaps = 40/298 (13%)
Query: 297 FRDKLGQGGYGEVYKGELP-----DGQLVAVKVLK-NSRCNGEEFINEVASISRTSHVNI 350
F +LG+G +G V G++VAVK L+ ++ + +F E+ + H NI
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 351 VTFLGFCYENKKNA--LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHR 408
V + G CY + LI E +P GSL ++ + +++ + Q I +G+EYL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLG- 162
Query: 409 GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ-AQKKESAISMLHARGTIGYIAPEVY 467
R +H D+ +NIL++ + KI DFGL K Q KE I + APE
Sbjct: 163 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 220
Query: 468 S-RRFGGVSHKSDVYSYGMMIIEMV-GCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525
+ +F S SDV+S+G+++ E+ K+ + N ++
Sbjct: 221 TESKF---SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM-IVFH----- 271
Query: 526 VATEEEK------------KIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQ 571
+ + +I +M C N ++RPS + ++ + +
Sbjct: 272 LIELLKNNGRLPRPDGCPDEIYMIMTE----CWNNNVNQRPSFRDLALRVDQIRDQMA 325
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 8e-38
Identities = 51/203 (25%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 297 FRDKLGQGGYGEVYKGELPDGQL-----VAVKVLKN--SRCNGEEFINEVASISRTSHVN 349
LG G +G V+KG V +KV+++ R + + + + +I H +
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 350 IVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRG 409
IV LG C L+ + +P GSL + R L + + + IA+G+ YL
Sbjct: 77 IVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRG-ALGPQLLLNWGVQIAKGMYYLE-- 132
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYS- 468
+ +VH ++ +N+LL +++DFG+A + + A+ I ++A E
Sbjct: 133 -EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 469 RRFGGVSHKSDVYSYGMMIIEMV 491
++ +H+SDV+SYG+ + E++
Sbjct: 192 GKY---THQSDVWSYGVTVWELM 211
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 8e-38
Identities = 70/299 (23%), Positives = 128/299 (42%), Gaps = 43/299 (14%)
Query: 289 DVKRMTKSFRDKLGQGGYGEVYKGELPDG----QLVAVKVLKN--SRCNGEEFINEVASI 342
+ F + +G+G +G VY G L D AVK L +F+ E +
Sbjct: 21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 80
Query: 343 SRTSHVNIVTFLGFCYENKKNAL-IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIAR 401
SH N+++ LG C ++ + L + M +G L FI N+ + K + + +A+
Sbjct: 81 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAK 139
Query: 402 GLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE--SAISMLHARGTI 459
G++YL + VH D+ +N +LDE F K++DFGLA+ KE S + A+ +
Sbjct: 140 GMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 196
Query: 460 GYIAPE-VYSRRFGGVSHKSDVYSYGMMIIEMV--GCT-----KNLDDEVTDTSICHNLI 511
++A E + +++F + KSDV+S+G+++ E++ G D I
Sbjct: 197 KWMALESLQTQKF---TTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------------I 241
Query: 512 YERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENL 570
+ G + + ++M+ C RPS +++ +
Sbjct: 242 TVYLLQGRRLLQPEYCPDP---LYEVMLK----CWHPKAEMRPSFSELVSRISAIFSTF 293
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 9e-38
Identities = 72/303 (23%), Positives = 113/303 (37%), Gaps = 34/303 (11%)
Query: 268 RNVEAFIRNHESLAPKRYSYSDVK-RMTKSFR--DKLGQGGYGEVYKG-ELPDGQLVAVK 323
R V E+L Y S + +SF+ +LG G YGEV+K DG+L AVK
Sbjct: 29 RRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVK 88
Query: 324 VLKNSRCNGEE---FINEVASISR-TSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFI 379
+ ++ + EV S + H V E L EL SL +
Sbjct: 89 RSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC 147
Query: 380 HNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGL 439
L ++ L +LH +VH D+KP NI L K+ DFGL
Sbjct: 148 -EAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGL 203
Query: 440 AKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDD 499
+ + G Y+APE+ +G +DV+S G+ I+E+ C L
Sbjct: 204 LVELGTAGAGEVQE---GDPRYMAPELLQGSYG---TAADVFSLGLTILEVA-CNMELPH 256
Query: 500 EVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKV 559
+ + P +F + E + + MM ++ +P R + +
Sbjct: 257 GGEG----WQQLRQGYLPP---EFTAGLSSELRSVLVMM-------LEPDPKLRATAEAL 302
Query: 560 LEM 562
L +
Sbjct: 303 LAL 305
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-37
Identities = 53/197 (26%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 296 SFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLG 355
+F ++G G +G V+ G + VA+K ++ + E+FI E + + SH +V G
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
C E L+ E M +G L ++ R +T+ + + + G+ YL + ++
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYL---EEACVI 126
Query: 416 HFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYS-RRFGGV 474
H D+ +N L+ E+ K+SDFG+ + + S + + + +PEV+S R+
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST-GTKFPVKWASPEVFSFSRY--- 182
Query: 475 SHKSDVYSYGMMIIEMV 491
S KSDV+S+G+++ E+
Sbjct: 183 SSKSDVWSFGVLMWEVF 199
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-37
Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 9/198 (4%)
Query: 296 SFRDKLGQGGYGEVYKGELPDGQL-VAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFL 354
+ + KLG G YGEVY+G L VAVK LK EEF+ E A + H N+V L
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 355 GFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRI 414
G C +I E M G+L ++ ++ + +A I+ +EYL +
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 132
Query: 415 VHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYS-RRFGG 473
+H D+ +N L+ E+ K++DFGL++ A+ I + APE + +F
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAYNKF-- 189
Query: 474 VSHKSDVYSYGMMIIEMV 491
S KSDV+++G+++ E+
Sbjct: 190 -SIKSDVWAFGVLLWEIA 206
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-37
Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 296 SFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLG 355
++LG G +GEV+ G VAVK LK + + F+ E + + H +V
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 356 FCYENKKNALIY---ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQV 412
+ IY E M NGSL F+ IKL + +A IA G+ ++
Sbjct: 76 VVTQEP----IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---R 128
Query: 413 RIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYS-RRF 471
+H D++ NIL+ + KI+DFGLA+ + E A+ I + APE + F
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYGTF 187
Query: 472 GGVSHKSDVYSYGMMIIEMV 491
+ KSDV+S+G+++ E+V
Sbjct: 188 ---TIKSDVWSFGILLTEIV 204
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-37
Identities = 56/196 (28%), Positives = 92/196 (46%), Gaps = 9/196 (4%)
Query: 297 FRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGF 356
KLG G +GEV+ VAVK +K + E F+ E + H +V
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 357 CYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVH 416
+ + +I E M GSL F+ +D K + + IA G+ ++ + +H
Sbjct: 252 VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIH 307
Query: 417 FDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYS-RRFGGVS 475
D++ NIL+ KI+DFGLA+ + E A+ I + APE + F +
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTARE-GAKFPIKWTAPEAINFGSF---T 363
Query: 476 HKSDVYSYGMMIIEMV 491
KSDV+S+G++++E+V
Sbjct: 364 IKSDVWSFGILLMEIV 379
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 66/297 (22%), Positives = 117/297 (39%), Gaps = 40/297 (13%)
Query: 297 FRDKLGQGGYGEVYKGEL-----PDGQLVAVKVLK--NSRCNGEEFINEVASISRTSHVN 349
LG+G +G+V G++VAVK LK + + E+ + H +
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 350 IVTFLGFCYENKKNA--LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH 407
I+ + G C + + L+ E +P GSL ++ + + A I G+ YLH
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLH 151
Query: 408 RGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ-AQKKESAISMLHARGTIGYIAPE- 465
+H D+ +N+LLD D KI DFGLAK + E + + APE
Sbjct: 152 ---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 208
Query: 466 VYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525
+ +F + SDV+S+G+ + E++ + T + ++ +
Sbjct: 209 LKEYKF---YYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL- 264
Query: 526 VATEEE-----------KKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQ 571
E ++ +M C +T S RP+ ++ +L+ E Q
Sbjct: 265 ----ERGERLPRPDKCPAEVYHLMKN----CWETEASFRPTFENLIPILKTVHEKYQ 313
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-37
Identities = 66/300 (22%), Positives = 118/300 (39%), Gaps = 35/300 (11%)
Query: 275 RNHESLAPKRYSYSDVKRMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEE 334
+ + S V +++ +D LG G G + + D + VAVK + + +
Sbjct: 6 SLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD 65
Query: 335 FINEVASISRTS--HVNIVTFLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKT 391
EV + R S H N++ + ++++ + EL +L +++ L +
Sbjct: 66 --REVQ-LLRESDEHPNVIRYFCT-EKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEP 120
Query: 392 ---MYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE-----DFCPKISDFGLAKQA 443
+ Q GL +LH + IVH D+KP NIL+ ISDFGL K+
Sbjct: 121 ITLLQQ----TTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173
Query: 444 QKKESAISMLHAR-GTIGYIAPEVYSR-RFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEV 501
+ S GT G+IAPE+ S ++ D++S G + ++ + +
Sbjct: 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233
Query: 502 TDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561
+ + + E IA+ +I I +P +RPS VL+
Sbjct: 234 LQRQ-----ANILLGACSLDCLH--PEKHEDVIARELIE---KMIAMDPQKRPSAKHVLK 283
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 68/279 (24%), Positives = 124/279 (44%), Gaps = 40/279 (14%)
Query: 299 DKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNG----EEFINEVASISRTSHVNIVTF 353
K+G+G + EVY+ L DG VA+K ++ + I E+ + + +H N++ +
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 354 LGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLE------WKTMYQIAIGIARGLEYLH 407
E+ + ++ EL G L + I + + K WK Q+ LE++H
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA----LEHMH 153
Query: 408 RGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ-AQKKESAISMLHARGTIGYIAPEV 466
R++H DIKP N+ + K+ D GL + + K +A S++ GT Y++PE
Sbjct: 154 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV---GTPYYMSPER 207
Query: 467 YSRRFGGVSHKSDVYSYGMMIIEMVGCTKN---LDDEVTDTSICHNLIYERIEPGNDFQF 523
G + KSD++S G ++ EM D++ S+C + P +
Sbjct: 208 IHEN--GYNFKSDIWSLGCLLYEM--AALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHY 263
Query: 524 DGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562
+EE +++ CI +P +RP + V ++
Sbjct: 264 ----SEELRQLVN-------MCINPDPEKRPDVTYVYDV 291
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-37
Identities = 54/200 (27%), Positives = 99/200 (49%), Gaps = 15/200 (7%)
Query: 296 SFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLG 355
+F +LG G +G V G+ VA+K++K + +EFI E + SH +V G
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
C + + +I E M NG L ++ R+ + + + + ++ + +EYL + +
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLES---KQFL 142
Query: 416 HFDIKPQNILLDEDFCPKISDFGLAKQAQKKE---SAISMLHARGTIGYIAPEVYS-RRF 471
H D+ +N L+++ K+SDFGL++ E S S R + PEV +F
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLMYSKF 198
Query: 472 GGVSHKSDVYSYGMMIIEMV 491
S KSD++++G+++ E+
Sbjct: 199 ---SSKSDIWAFGVLMWEIY 215
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-37
Identities = 58/201 (28%), Positives = 101/201 (50%), Gaps = 15/201 (7%)
Query: 298 RDKLGQGGYGEVYKGEL--PDGQL-VAVKVLKN--SRCNGEEFINEVASISRTSHVNIVT 352
+LG G +G V +G Q+ VA+KVLK + + EE + E + + + IV
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 353 FLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQV 412
+G C + + L+ E+ G L KF+ R ++ + ++ ++ G++YL +
Sbjct: 75 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYL---EEK 129
Query: 413 RIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM-LHARGTIGYIAPEVYS-RR 470
VH D+ +N+LL KISDFGL+K +S + + + + APE + R+
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 189
Query: 471 FGGVSHKSDVYSYGMMIIEMV 491
F S +SDV+SYG+ + E +
Sbjct: 190 F---SSRSDVWSYGVTMWEAL 207
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-37
Identities = 66/254 (25%), Positives = 102/254 (40%), Gaps = 21/254 (8%)
Query: 244 AYSSSCHSRTVIQALIKKKTREDDRNVEAFIRNHESLAPKRYSYSDVKRMTKSFRDKLGQ 303
A+S + ++T K + + + E L P Y Y + + ++G+
Sbjct: 10 AHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMT-HQPRVGR 68
Query: 304 GGYGEVYKG-ELPDGQLVAVKV--LKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYEN 360
G +GEV++ + G AVK L+ R + E+ + + S IV G E
Sbjct: 69 GSFGEVHRMKDKQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYGAVREG 122
Query: 361 KKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIK 420
+ EL+ GSL + I L GLEYLH RI+H D+K
Sbjct: 123 PWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLH---TRRILHGDVK 177
Query: 421 PQNILLDEDFCP-KISDFGLAKQAQKKESAISMLHA---RGTIGYIAPEVYSRRFGGVSH 476
N+LL D + DFG A Q S+L GT ++APEV +
Sbjct: 178 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK--PCDA 235
Query: 477 KSDVYSYGMMIIEM 490
K D++S M++ M
Sbjct: 236 KVDIWSSCCMMLHM 249
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-37
Identities = 60/226 (26%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 276 NHESLAPKRYSYSDVKRMTKSFRDKLGQGGYGEVYKGELPDG----QLVAVKVLKN--SR 329
N E + ++ + F + +G+G +G VY G L D AVK L
Sbjct: 72 NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI 131
Query: 330 CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNAL-IYELMPNGSLDKFIHNDRNIKLE 388
+F+ E + SH N+++ LG C ++ + L + M +G L FI N+ +
Sbjct: 132 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPT 190
Query: 389 WKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448
K + + +A+G+++L + VH D+ +N +LDE F K++DFGLA+ KE
Sbjct: 191 VKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247
Query: 449 AISMLHARGT--IGYIAPE-VYSRRFGGVSHKSDVYSYGMMIIEMV 491
+ ++A E + +++F + KSDV+S+G+++ E++
Sbjct: 248 DSVHNKTGAKLPVKWMALESLQTQKF---TTKSDVWSFGVLLWELM 290
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 1e-36
Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 15/198 (7%)
Query: 296 SFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLG 355
+G+G +G+V G+ G VAVK +KN + F+ E + +++ H N+V LG
Sbjct: 24 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLG 81
Query: 356 FCYENKKNALI-YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRI 414
E K I E M GSL ++ + L + + ++ + +EYL
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 138
Query: 415 VHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYS-RRFGG 473
VH D+ +N+L+ ED K+SDFGL K+A + + + + APE ++F
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREKKF-- 191
Query: 474 VSHKSDVYSYGMMIIEMV 491
S KSDV+S+G+++ E+
Sbjct: 192 -STKSDVWSFGILLWEIY 208
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 15/209 (7%)
Query: 292 RMTKSFRDKLGQGGYGEVYKGELPDG----QLVAVKVLKN--SRCNGEEFINEVASISRT 345
R+ +G+G +G VY GE D A+K L E F+ E +
Sbjct: 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL 79
Query: 346 SHVNIVTFLGFCYENKKNALI-YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLE 404
+H N++ +G + + M +G L +FI + + K + + +ARG+E
Sbjct: 80 NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR-NPTVKDLISFGLQVARGME 138
Query: 405 YLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGT--IGYI 462
YL + + VH D+ +N +LDE F K++DFGLA+ +E H + +
Sbjct: 139 YLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT 195
Query: 463 APEVYSRRFGGVSHKSDVYSYGMMIIEMV 491
A E S + + KSDV+S+G+++ E++
Sbjct: 196 ALE--SLQTYRFTTKSDVWSFGVLLWELL 222
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 18/206 (8%)
Query: 296 SFRDKLGQGGYGEVYKGEL--PDGQL--VAVKVLK----NSRCNGEEFINEVASISRTSH 347
+KLG G +G V +GE P G+ VAVK LK + ++FI EV ++ H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 348 VNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH 407
N++ G ++ EL P GSL + + T+ + A+ +A G+ YL
Sbjct: 81 RNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLE 138
Query: 408 RGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA-ISMLHARGTIGYIAPEV 466
R +H D+ +N+LL KI DFGL + + + + H + + APE
Sbjct: 139 ---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195
Query: 467 YS-RRFGGVSHKSDVYSYGMMIIEMV 491
R F SH SD + +G+ + EM
Sbjct: 196 LKTRTF---SHASDTWMFGVTLWEMF 218
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-36
Identities = 45/352 (12%), Positives = 94/352 (26%), Gaps = 62/352 (17%)
Query: 255 IQALIKKKTREDDRNVEAFIRNH-ESLAPKRYSY---SDVKRMTKSFR--DKLGQGGYGE 308
+ LI E + A + ++ P+ S + + + + + L G
Sbjct: 18 EEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSV 77
Query: 309 VYKG-ELPDGQLVAVKVL----KNSRCNGEEFINEVASISRTSHVNIVTFLGFC------ 357
V+ ++ + A+KV +NSR E + +R +
Sbjct: 78 VFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPS 137
Query: 358 -----------------YENKKNALIYELMP--NGSLDKFIHNDRNI-----KLEWKTMY 393
++ A LMP + L+ + ++
Sbjct: 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALH 197
Query: 394 QIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISML 453
+ + R L +VH P N+ + D + D + + A S
Sbjct: 198 ILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASS-- 252
Query: 454 HARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTK---NLDDEVTDTSICHNL 510
+ Y E + +H + + G+ I + C L S
Sbjct: 253 ---VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW-CLFLPFGLVTPGIKGSWKRPS 308
Query: 511 IYERIEPGNDFQFDGVATEEEKK-IAKMMILVGFWCIQTNPSERPSMHKVLE 561
+ F + K I + + + R + +E
Sbjct: 309 LRVPGTDSLAFGSCTPLPDFVKTLIGRF--------LNFDRRRRLLPLEAME 352
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 9e-36
Identities = 60/200 (30%), Positives = 103/200 (51%), Gaps = 17/200 (8%)
Query: 300 KLGQGGYGEVYKGELPDGQL---VAVKVLKN---SRCNGEEFINEVASISRTSHVNIVTF 353
+LG G +G V KG ++ VAVK+LKN +E + E + + + IV
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 354 LGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVR 413
+G C E + L+ E+ G L+K++ +R++K K + ++ ++ G++YL
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD--KNIIELVHQVSMGMKYLEE---SN 137
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM-LHARGTIGYIAPEVYS-RRF 471
VH D+ +N+LL KISDFGL+K + E+ H + + + APE + +F
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 197
Query: 472 GGVSHKSDVYSYGMMIIEMV 491
S KSDV+S+G+++ E
Sbjct: 198 ---SSKSDVWSFGVLMWEAF 214
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 16/203 (7%)
Query: 296 SFRDKLGQGGYGEVYKGEL--PDGQ--LVAVKVLKN--SRCNGEEFINEVASISRTSHVN 349
LG+G +GEVY+G G+ VAVK K + N E+F++E + H +
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 74
Query: 350 IVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRG 409
IV +G E + +I EL P G L ++ ++N L+ T+ ++ I + + YL
Sbjct: 75 IVKLIGII-EEEPTWIIMELYPYGELGHYLERNKN-SLKVLTLVLYSLQICKAMAYLE-- 130
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYS- 468
+ VH DI +NIL+ C K+ DFGL++ + ++ R I +++PE +
Sbjct: 131 -SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED-YYKASVTRLPIKWMSPESINF 188
Query: 469 RRFGGVSHKSDVYSYGMMIIEMV 491
RRF + SDV+ + + + E++
Sbjct: 189 RRF---TTASDVWMFAVCMWEIL 208
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-35
Identities = 57/197 (28%), Positives = 99/197 (50%), Gaps = 15/197 (7%)
Query: 297 FRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGF 356
+G+G +G+V G+ G VAVK +KN + F+ E + +++ H N+V LG
Sbjct: 197 LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 357 CYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
E K ++ E M GSL ++ + L + + ++ + +EYL V
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFV 311
Query: 416 HFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYS-RRFGGV 474
H D+ +N+L+ ED K+SDFGL K+A + + + + APE ++F
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREKKF--- 363
Query: 475 SHKSDVYSYGMMIIEMV 491
S KSDV+S+G+++ E+
Sbjct: 364 STKSDVWSFGILLWEIY 380
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 65/206 (31%), Positives = 105/206 (50%), Gaps = 20/206 (9%)
Query: 297 FRDKLGQGGYGEVYKGEL--PDGQ---LVAVKVLKN--SRCNGEEFINEVASISRTSHVN 349
+ +G G +GEVYKG L G+ VA+K LK + +F+ E + + SH N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 350 IVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRG 409
I+ G + K +I E M NG+LDKF+ + + + GIA G++YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKYLAN- 165
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGT---IGYIAPEV 466
+ VH D+ +NIL++ + K+SDFGL++ + A G I + APE
Sbjct: 166 --MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY--TTSGGKIPIRWTAPEA 221
Query: 467 YS-RRFGGVSHKSDVYSYGMMIIEMV 491
S R+F + SDV+S+G+++ E++
Sbjct: 222 ISYRKF---TSASDVWSFGIVMWEVM 244
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-35
Identities = 67/199 (33%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 298 RDKLGQGGYGEVYKG-ELPDGQLVAVKV--LKNSRCNGEEFINEVASISRTSHVNIVTFL 354
R LG+G YG VY G +L + +A+K ++SR + E+A H NIV +L
Sbjct: 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY-SQPLHEEIALHKHLKHKNIVQYL 85
Query: 355 GFCYENKKNALIYELMPNGSLDKFIHNDRN-IKLEWKTMYQIAIGIARGLEYLHRGCQVR 413
G EN + E +P GSL + + +K +T+ I GL+YLH +
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQ 142
Query: 414 IVHFDIKPQNILLD-EDFCPKISDFGLAKQ-AQKKESAISMLHARGTIGYIAPEVYSRRF 471
IVH DIK N+L++ KISDFG +K+ A + GT+ Y+APE+ +
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF---TGTLQYMAPEIIDKGP 199
Query: 472 GGVSHKSDVYSYGMMIIEM 490
G +D++S G IIEM
Sbjct: 200 RGYGKAADIWSLGCTIIEM 218
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 296 SFRDKLGQGGYGEVYKGEL--PDGQ--LVAVKVLKN--SRCNGEEFINEVASISRTSHVN 349
+G+G +G+V++G P+ VA+K KN S E+F+ E ++ + H +
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 77
Query: 350 IVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRG 409
IV +G EN +I EL G L F+ + L+ ++ A ++ L YL
Sbjct: 78 IVKLIGVITENP-VWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLE-- 133
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYS- 468
R VH DI +N+L+ + C K+ DFGL++ + + + I ++APE +
Sbjct: 134 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINF 191
Query: 469 RRFGGVSHKSDVYSYGMMIIEMV 491
RRF + SDV+ +G+ + E++
Sbjct: 192 RRF---TSASDVWMFGVCMWEIL 211
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 69/301 (22%), Positives = 110/301 (36%), Gaps = 64/301 (21%)
Query: 297 FRDKLGQGGYGEVYKGE-LPDGQLVAVK-VLKNSRCNGEEFINEVASISRTSHVNIVTFL 354
F KLG+GG+ V E L DG A+K +L + + + EE E +H NI+ +
Sbjct: 33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 355 GFCYENKKNA----LIYELMPNGSLDKFI--HNDRNIKLEWKTMYQIAIGIARGLEYLHR 408
+C + L+ G+L I D+ L + + +GI RGLE +H
Sbjct: 93 AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH- 151
Query: 409 GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHA-------RGTIGY 461
H D+KP NILL ++ P + D G QA R TI Y
Sbjct: 152 --AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 462 IAPEVYS-RRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND 520
APE++S + + ++DV+S G ++ M P
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAM--MFGEG-------------------P--- 245
Query: 521 FQFDGVATEEEKKIAKMMILVGF-----------------WCIQTNPSERPSMHKVLEML 563
+D V + + + + +P +RP + +L L
Sbjct: 246 --YDMVFQKGDSVALA--VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301
Query: 564 E 564
E
Sbjct: 302 E 302
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-35
Identities = 61/234 (26%), Positives = 106/234 (45%), Gaps = 18/234 (7%)
Query: 269 NVEAFIRNHESLAPKRYSYSDVKRMTKS---FRDKLGQGGYGEVYKGELPDG----QLVA 321
+ + H P R S + + S +G G GEV G L VA
Sbjct: 22 EPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVA 81
Query: 322 VKVLKN--SRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFI 379
+K LK + +F++E + + + H NI+ G + ++ E M NGSLD F+
Sbjct: 82 IKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL 141
Query: 380 HNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGL 439
+ + + G+ G+ YL + VH D+ +N+L+D + K+SDFGL
Sbjct: 142 RTHDG-QFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGL 197
Query: 440 AKQ-AQKKESAISMLHARGTIGYIAPEVYS-RRFGGVSHKSDVYSYGMMIIEMV 491
++ ++A + + I + APE + R F S SDV+S+G+++ E++
Sbjct: 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTF---SSASDVWSFGVVMWEVL 248
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-35
Identities = 49/214 (22%), Positives = 98/214 (45%), Gaps = 24/214 (11%)
Query: 296 SFRDKLGQGGYGEVYKGELPDG----QLVAVKVLK---NSRCNGEEFINEVASISRTSHV 348
+ LG+G +G V + +L VAVK+LK + + EEF+ E A + H
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHP 85
Query: 349 NIVTFLGFCYENKKNA------LIYELMPNGSLDKFI----HNDRNIKLEWKTMYQIAIG 398
++ +G ++ +I M +G L F+ + L +T+ + +
Sbjct: 86 HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145
Query: 399 IARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGT 458
IA G+EYL +H D+ +N +L ED ++DFGL+++ + ++
Sbjct: 146 IACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLP 202
Query: 459 IGYIAPE-VYSRRFGGVSHKSDVYSYGMMIIEMV 491
+ ++A E + + + SDV+++G+ + E++
Sbjct: 203 VKWLALESLADNLY---TVHSDVWAFGVTMWEIM 233
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-35
Identities = 74/309 (23%), Positives = 132/309 (42%), Gaps = 67/309 (21%)
Query: 296 SFRDKLGQGGYGEVYKGELPDG----QLVAVKVLKN---SRCNGEEFINEVASISRTSHV 348
LG+G +G V +G L VAVK +K S+ EEF++E A + SH
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96
Query: 349 NIVTFLGFCYENKKNA-----LIYELMPNGSLDKFIHNDR----NIKLEWKTMYQIAIGI 399
N++ LG C E +I M G L ++ R + +T+ + + I
Sbjct: 97 NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156
Query: 400 ARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTI 459
A G+EYL +H D+ +N +L +D ++DFGL+K+ + A+ +
Sbjct: 157 ALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 213
Query: 460 GYIAPE-VYSRRFGGVSHKSDVYSYGMMIIEMV--GCT-----KNLDDEVTDTSICHNLI 511
+IA E + R + + KSDV+++G+ + E+ G T +N + +
Sbjct: 214 KWIAIESLADRVY---TSKSDVWAFGVTMWEIATRGMTPYPGVQNHE------------M 258
Query: 512 YERIEPGN---------DFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562
Y+ + G+ D ++ ++M C +T+P +RP+ +
Sbjct: 259 YDYLLHGHRLKQPEDCLD------------ELYEIMYS----CWRTDPLDRPTFSVLRLQ 302
Query: 563 LEGSIENLQ 571
LE +E+L
Sbjct: 303 LEKLLESLP 311
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 60/248 (24%), Positives = 111/248 (44%), Gaps = 30/248 (12%)
Query: 268 RNVEAFIRNHESLAPKRYSYSDVK---RMTKSFRDKLGQGGYGEVYKGELPDG------Q 318
+ ++ H P+ +S + V R + +LG+G +G+V+ E +
Sbjct: 13 EGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKM 72
Query: 319 LVAVKVLKN-SRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDK 377
LVAVK LK S ++F E ++ H +IV F G C E + +++E M +G L++
Sbjct: 73 LVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNR 132
Query: 378 F-------------IHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNI 424
F + L + +A +A G+ YL + VH D+ +N
Sbjct: 133 FLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNC 189
Query: 425 LLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPE-VYSRRFGGVSHKSDVYSY 483
L+ + KI DFG+++ + I ++ PE + R+F + +SDV+S+
Sbjct: 190 LVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF---TTESDVWSF 246
Query: 484 GMMIIEMV 491
G+++ E+
Sbjct: 247 GVVLWEIF 254
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-34
Identities = 63/285 (22%), Positives = 107/285 (37%), Gaps = 51/285 (17%)
Query: 300 KLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEE---FINEVASISRTSHVNIVTFLG 355
+G G YG K DG+++ K L E ++EV + H NIV +
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 356 FCYENKKNAL--IYELMPNGSLDKFIHNDRNIKLE------WKTMYQIAIGIARGLEYLH 407
+ L + E G L I + + M Q+ + L+ H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA----LKECH 128
Query: 408 --RGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES-AISMLHARGTIGYIAP 464
++H D+KP N+ LD K+ DFGLA+ S A + + GT Y++P
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV---GTPYYMSP 185
Query: 465 EVYSRRFGGVSHKSDVYSYGMMIIEMVGCT-------KNLDDEVTDTSICHNLIYERIEP 517
E +R + KSD++S G ++ E+ C + + + +I
Sbjct: 186 EQMNRM--SYNEKSDIWSLGCLLYEL--CALMPPFTAFSQKE-----------LAGKIRE 230
Query: 518 GNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562
G + ++E +I M + RPS+ ++LE
Sbjct: 231 GKFRRIPYRYSDELNEIITRM-------LNLKDYHRPSVEEILEN 268
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 48/215 (22%), Positives = 93/215 (43%), Gaps = 32/215 (14%)
Query: 296 SFRDKLGQGGYGEVYKGEL--------PDGQLVAVKVLKN-SRCNGEEFINEVASISRTS 346
F + LGQG + +++KG V +KVL R E F + +S+ S
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70
Query: 347 HVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYL 406
H ++V G C +N L+ E + GSLD ++ ++N + ++A +A + +L
Sbjct: 71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN-CINILWKLEVAKQLAAAMHFL 129
Query: 407 HRGCQVRIVHFDIKPQNILLDEDFCP--------KISDFGLAKQAQKKESAISMLHARGT 458
+ ++H ++ +NILL + K+SD G++ K+ +
Sbjct: 130 E---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI------LQER 180
Query: 459 IGYIAPEV--YSRRFGGVSHKSDVYSYGMMIIEMV 491
I ++ PE + + +D +S+G + E+
Sbjct: 181 IPWVPPECIENPKNL---NLATDKWSFGTTLWEIC 212
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 297 FRDKLGQGGYGEVYKGELPDG------QLVAVKVLKNSRCNGE--EFINEVASISRTSHV 348
+LGQG +G VY+G VA+K + + E EF+NE + + +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 349 NIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDR--------NIKLEWKTMYQIAIGIA 400
++V LG + + +I ELM G L ++ + R M Q+A IA
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 401 RGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIG 460
G+ YL+ + VH D+ +N ++ EDF KI DFG+ + + + +
Sbjct: 149 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 461 YIAPEVYSRRFGGVSHKSDVYSYGMMIIEMV 491
+++PE S + G + SDV+S+G+++ E+
Sbjct: 206 WMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 234
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 79/328 (24%), Positives = 135/328 (41%), Gaps = 56/328 (17%)
Query: 276 NHESLAPKRYSYSD---VKRMTKSFRDKLGQGGYGEVYKGELPD------GQLVAVKVLK 326
N+ + P + Y R SF LG G +G+V + VAVK+LK
Sbjct: 3 NYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK 62
Query: 327 NSRCNGE--EFINEVASISR-TSHVNIVTFLGFCYENKKNALIYELMPNGSLDKF----- 378
S E ++E+ +S +H+NIV LG C +I E G L F
Sbjct: 63 PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKR 122
Query: 379 -----------IHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLD 427
I D + L+ + + + +A+G+ +L +H D+ +NILL
Sbjct: 123 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLT 179
Query: 428 EDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMI 487
KI DFGLA+ + + + +AR + ++APE S + +SDV+SYG+ +
Sbjct: 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPE--SIFNCVYTFESDVWSYGIFL 237
Query: 488 IEMV--GCT----KNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILV 541
E+ G + +D + Y+ I+ G A E + +M
Sbjct: 238 WELFSLGSSPYPGMPVDSKF----------YKMIKEGFRMLSPEHAPAE---MYDIMKT- 283
Query: 542 GFWCIQTNPSERPSMHKVLEMLEGSIEN 569
C +P +RP+ ++++++E I
Sbjct: 284 ---CWDADPLKRPTFKQIVQLIEKQISE 308
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 68/200 (34%), Positives = 98/200 (49%), Gaps = 17/200 (8%)
Query: 299 DKLGQGGYGEVYKGELPDGQL---VAVKVLKNSRCNGEEFI----NEVASISRTSHVNIV 351
DKLG GG VY E D L VA+K + EE + EV + S+ SH NIV
Sbjct: 17 DKLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 352 TFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQ 411
+ + E+ L+ E + +L ++I + L T I G+++ H
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYIE--SHGPLSVDTAINFTNQILDGIKHAHD--- 129
Query: 412 VRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRF 471
+RIVH DIKPQNIL+D + KI DFG+AK A + S H GT+ Y +PE
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAK-ALSETSLTQTNHVLGTVQYFSPEQAKG-- 186
Query: 472 GGVSHKSDVYSYGMMIIEMV 491
+D+YS G+++ EM+
Sbjct: 187 EATDECTDIYSIGIVLYEML 206
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-34
Identities = 65/276 (23%), Positives = 120/276 (43%), Gaps = 47/276 (17%)
Query: 301 LGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNG----EEFINEVASISRTSHVNIVTFLG 355
LG+G + VY+ + G VA+K++ + NEV + H +I+
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKT---MYQIAIGIARGLEYLHRGCQV 412
+ ++ L+ E+ NG +++++ N E + M+QI G+ YLH
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII----TGMLYLHS---H 131
Query: 413 RIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR-GTIGYIAPEVYSRRF 471
I+H D+ N+LL + KI+DFGLA Q + + GT YI+PE+ +R
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH---EKHYTLCGTPNYISPEIATRS- 187
Query: 472 GGVSHKSDVYSYGMMIIEM-VGC----TKNLDDEVTDTSICHNLIYERIEPGNDFQF-DG 525
+SDV+S G M + +G T + + ++ D++
Sbjct: 188 -AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-----------TLNKVV-LADYEMPSF 234
Query: 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561
++ E + I +++ + NP++R S+ VL+
Sbjct: 235 LSIEAKDLIHQLL--------RRNPADRLSLSSVLD 262
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 15/204 (7%)
Query: 296 SFRDKLGQGGYGEVYKGELP----DGQLVAVKVLKN--SRCNGEEFINEVASISRTSHVN 349
S +G G +GEV G L VA+K LK + +F+ E + + + H N
Sbjct: 48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 350 IVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRG 409
I+ G ++K ++ E M NGSLD F+ + + + GIA G++YL
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSD- 165
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK-ESAISMLHARGTIGYIAPEVYS 468
+ VH D+ +NIL++ + K+SDFGL + + E+A + + I + +PE +
Sbjct: 166 --MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 469 -RRFGGVSHKSDVYSYGMMIIEMV 491
R+F + SDV+SYG+++ E++
Sbjct: 224 YRKF---TSASDVWSYGIVLWEVM 244
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 61/239 (25%), Positives = 110/239 (46%), Gaps = 30/239 (12%)
Query: 274 IRNHESLAPKRYSYSDVKRMTKSFRDKLGQGGYGEVYKGELPDG---QLVAVKVLKN--S 328
+H P Y + F+D +G+G +G+V K + A+K +K S
Sbjct: 6 HHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS 65
Query: 329 RCNGEEFINEVASISR-TSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNI-- 385
+ + +F E+ + + H NI+ LG C L E P+G+L F+ R +
Sbjct: 66 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLET 125
Query: 386 ------------KLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPK 433
L + + A +ARG++YL Q + +H D+ +NIL+ E++ K
Sbjct: 126 DPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAK 182
Query: 434 ISDFGLAKQAQKKESAISMLHARGTIGYIAPE-VYSRRFGGVSHKSDVYSYGMMIIEMV 491
I+DFGL++ +E + R + ++A E + + + SDV+SYG+++ E+V
Sbjct: 183 IADFGLSR---GQEVYVKKTMGRLPVRWMAIESLNYSVY---TTNSDVWSYGVLLWEIV 235
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-34
Identities = 55/308 (17%), Positives = 96/308 (31%), Gaps = 55/308 (17%)
Query: 296 SFRDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEE--FINEVASISRTSHVNIVT 352
D LGQG V++G G L A+KV N + E + + +H NIV
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 353 FLGFCYENKKNALIY---ELMPNGSLDKFIH-NDRNIKLEWKTMYQIAIGIARGLEYLHR 408
E E P GSL + L + + G+ +L
Sbjct: 72 LFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR- 129
Query: 409 GCQVRIVHFDIKPQNILL----DEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAP 464
+ IVH +IKP NI+ D K++DFG A++ + E +S+ GT Y+ P
Sbjct: 130 --ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY---GTEEYLHP 184
Query: 465 EVYSRRFGGV------SHKSDVYSYGMMIIEMV-----------------------GCTK 495
++Y R D++S G+
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 496 NLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPS 555
+ + + + P + G+ +A ++ + + +
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANIL--------EADQEKCWG 296
Query: 556 MHKVLEML 563
+
Sbjct: 297 FDQFFAET 304
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-34
Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 15/199 (7%)
Query: 300 KLGQGGYGEVYKGEL--PDGQL-VAVKVLKN--SRCNGEEFINEVASISRTSHVNIVTFL 354
+LG G +G V +G Q+ VA+KVLK + + EE + E + + + IV +
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 355 GFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRI 414
G C + + L+ E+ G L KF+ R ++ + ++ ++ G++YL +
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYL---EEKNF 457
Query: 415 VHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM-LHARGTIGYIAPEVYS-RRFG 472
VH ++ +N+LL KISDFGL+K +S + + + + APE + R+F
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF- 516
Query: 473 GVSHKSDVYSYGMMIIEMV 491
S +SDV+SYG+ + E +
Sbjct: 517 --SSRSDVWSYGVTMWEAL 533
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 73/276 (26%), Positives = 126/276 (45%), Gaps = 48/276 (17%)
Query: 301 LGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNG----EEFINEVASISRTSHVNIVTFLG 355
LG+GG+ + ++ + ++ A K++ S E+ E++ +H ++V F G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKT---MYQIAIGIARGLEYLHRGCQV 412
F +N ++ EL SL + + + E + + QI G +YLH +
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALT-EPEARYYLRQIV----LGCQYLH---RN 160
Query: 413 RIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR-GTIGYIAPEVYSRRF 471
R++H D+K N+ L+ED KI DFGLA + + GT YIAPEV S++
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG---ERKKVLCGTPNYIAPEVLSKK- 216
Query: 472 GGVSHKSDVYSYGMMIIEM-VGC----TKNLDDEVTDTSICHNLIYERIEPGNDFQF-DG 525
G S + DV+S G ++ + VG T L + Y RI+ N++
Sbjct: 217 -GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-----------TYLRIK-KNEYSIPKH 263
Query: 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561
+ I KM+ QT+P+ RP+++++L
Sbjct: 264 INPVAASLIQKML--------QTDPTARPTINELLN 291
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-34
Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 29/219 (13%)
Query: 296 SFRDKLGQGGYGEVYKGELPDG------QLVAVKVLKN--SRCNGEEFINEVASISRTSH 347
F ++LG+ +G+VYKG L Q VA+K LK+ EEF +E +R H
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71
Query: 348 VNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDR--------------NIKLEWKTMY 393
N+V LG +++ ++I+ +G L +F+ LE
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 394 QIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISML 453
+ IA G+EYL +VH D+ +N+L+ + KISD GL ++ + +
Sbjct: 132 HLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188
Query: 454 HARGTIGYIAPE-VYSRRFGGVSHKSDVYSYGMMIIEMV 491
++ I ++APE + +F S SD++SYG+++ E+
Sbjct: 189 NSLLPIRWMAPEAIMYGKF---SIDSDIWSYGVVLWEVF 224
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-34
Identities = 89/333 (26%), Positives = 142/333 (42%), Gaps = 65/333 (19%)
Query: 274 IRNHESLAPKRYSYSDVKRMTK--SFRDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRC 330
+ +H + R + + + LG+G +GEV K + Q AVKV+ +
Sbjct: 1 MHHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA 60
Query: 331 NGEE---FINEVASISRTSHVNIVTFLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIK 386
++ + EV + + H NI+ E+ + ++ EL G L F D IK
Sbjct: 61 KNKDTSTILREVELLKKLDHPNIMKLFEI-LEDSSSFYIVGELYTGGEL--F---DEIIK 114
Query: 387 LEW-------KTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL---DEDFCPKISD 436
+ + + Q+ G+ Y+H + IVH D+KP+NILL ++D KI D
Sbjct: 115 RKRFSEHDAARIIKQVF----SGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIID 167
Query: 437 FGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMI-IEMVGCT- 494
FGL+ Q+ + GT YIAPEV + K DV+S G+++ I + G
Sbjct: 168 FGLSTCFQQNTKMKDRI---GTAYYIAPEVLRGTYD---EKCDVWSAGVILYILLSGTPP 221
Query: 495 ---KNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKI---AKMMILVGFWCIQT 548
KN D I +R+E G + FD + + I AK +I +
Sbjct: 222 FYGKNEYD-----------ILKRVETG-KYAFDL---PQWRTISDDAKDLIRK---MLTF 263
Query: 549 NPSERPSMHKVLE---MLEGSIENLQIPPKPSL 578
+PS R + + LE + + S E I PSL
Sbjct: 264 HPSLRITATQCLEHPWIQKYSSETPTISDLPSL 296
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 59/229 (25%), Positives = 102/229 (44%), Gaps = 38/229 (16%)
Query: 290 VKRMTKSFRDKLGQGGYGEVYKGELPDG------QLVAVKVLKN-SRCNGEEFINEVASI 342
+KR + +LG+G +G+V+ E + LVAVK LK+ + ++F E +
Sbjct: 12 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELL 71
Query: 343 SRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKF--------------IHNDRNIKLE 388
+ H +IV F G C + +++E M +G L+KF +L
Sbjct: 72 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 389 WKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448
M IA IA G+ YL VH D+ +N L+ + KI DFG+++ +
Sbjct: 132 LSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD- 187
Query: 449 AISMLHARGTIGYI-----APE-VYSRRFGGVSHKSDVYSYGMMIIEMV 491
+ G + PE + R+F + +SDV+S+G+++ E+
Sbjct: 188 ----YYRVGGHTMLPIRWMPPESIMYRKF---TTESDVWSFGVILWEIF 229
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 74/276 (26%), Positives = 126/276 (45%), Gaps = 48/276 (17%)
Query: 301 LGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNG----EEFINEVASISRTSHVNIVTFLG 355
LG+GG+ + ++ + ++ A K++ S E+ E++ +H ++V F G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKT---MYQIAIGIARGLEYLHRGCQV 412
F +N ++ EL SL + + + E + + QI G +YLHR
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRKALT-EPEARYYLRQIV----LGCQYLHRN--- 134
Query: 413 RIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR-GTIGYIAPEVYSRRF 471
R++H D+K N+ L+ED KI DFGLA + + GT YIAPEV S++
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG---ERKKVLCGTPNYIAPEVLSKK- 190
Query: 472 GGVSHKSDVYSYGMMIIEM-VGC----TKNLDDEVTDTSICHNLIYERIEPGNDFQF-DG 525
G S + DV+S G ++ + VG T L + Y RI+ N++
Sbjct: 191 -GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-----------TYLRIK-KNEYSIPKH 237
Query: 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561
+ I KM+ QT+P+ RP+++++L
Sbjct: 238 INPVAASLIQKML--------QTDPTARPTINELLN 265
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 61/301 (20%), Positives = 111/301 (36%), Gaps = 60/301 (19%)
Query: 292 RMTKSFR--DKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEE---FINEVASISRT 345
R T F +K+G G +G V+K + DG + A+K K + + EV + +
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 346 S-HVNIVTFLGFCYENKKNALIYELMPNGSLDKFI--HNDRNIKLEWKTMYQIAIGIARG 402
H ++V + E+ + E GSL I + + + + + + RG
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 403 LEYLHRGCQVRIVHFDIKPQNILLDEDFCP-------------------KISDFGLAKQA 443
L Y+H + +VH DIKP NI + P KI D G +
Sbjct: 128 LRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 444 QKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCT---KNLDDE 500
+ G ++A EV + K+D+++ + ++ G +N D
Sbjct: 185 SSPQVEE------GDSRFLANEVLQENYTH-LPKADIFALALTVVCAAGAEPLPRNGDQ- 236
Query: 501 VTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVL 560
+ I G + V ++E ++ K+ I +P RPS ++
Sbjct: 237 -----------WHEIRQGRLPRIPQVLSQEFTELLKV-------MIHPDPERRPSAMALV 278
Query: 561 E 561
+
Sbjct: 279 K 279
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 51/207 (24%), Positives = 84/207 (40%), Gaps = 25/207 (12%)
Query: 299 DKLGQGGYGEVYKGELPDGQL---VAVKVLKNSRCNGEEFI----NEVASISRTSHVNIV 351
+ LG GG EV+ D + VAVKVL+ F E + + +H IV
Sbjct: 18 EILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 352 TFLGFCYENKKNALIY----ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH 407
+ E + +L +H + K ++ + L + H
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSH 133
Query: 408 RGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR---GTIGYIAP 464
+ I+H D+KP NI++ K+ DFG+A+ +S S+ GT Y++P
Sbjct: 134 Q---NGIIHRDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQYLSP 188
Query: 465 EVYSRRFGGVSHKSDVYSYGMMIIEMV 491
E V +SDVYS G ++ E++
Sbjct: 189 EQARG--DSVDARSDVYSLGCVLYEVL 213
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 75/342 (21%), Positives = 136/342 (39%), Gaps = 65/342 (19%)
Query: 260 KKKTREDDRNVEAFIRNH-ESLAPKRYSYSD---VKRMTKSFRDKLGQGGYGEVYKGELP 315
K K + + +E++ N + P + Y++ R F LG G +G+V +
Sbjct: 9 KPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAF 68
Query: 316 D------GQLVAVKVLKNSRCNGE--EFINEVASISR-TSHVNIVTFLGFCYENKKNALI 366
VAVK+LK++ E ++E+ +S H NIV LG C +I
Sbjct: 69 GLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVI 128
Query: 367 YELMPNGSLDKFIHNDR------------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRI 414
E G L F+ N + + + +A+G+ +L
Sbjct: 129 TEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNC 185
Query: 415 VHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPE-VYSRRFGG 473
+H D+ +N+LL KI DFGLA+ + I +AR + ++APE ++ +
Sbjct: 186 IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY-- 243
Query: 474 VSHKSDVYSYGMMIIEMV--GCT----KNLDDEVTDTSICHNLIYERIEPGN-----DFQ 522
+ +SDV+SYG+++ E+ G ++ + Y+ ++ G F
Sbjct: 244 -TVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF----------YKLVKDGYQMAQPAF- 291
Query: 523 FDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564
A + I +M C P+ RP+ ++ L+
Sbjct: 292 ----APKN---IYSIMQ----ACWALEPTHRPTFQQICSFLQ 322
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 5e-33
Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 296 SFRDKLGQGGYGEVYKGEL--PDGQ--LVAVKVLKN--SRCNGEEFINEVASISRTSHVN 349
+G+G +G+V++G P+ VA+K KN S E+F+ E ++ + H +
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 452
Query: 350 IVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRG 409
IV +G +I EL G L F+ + L+ ++ A ++ L YL
Sbjct: 453 IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKF-SLDLASLILYAYQLSTALAYLE-- 508
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSR 469
R VH DI +N+L+ + C K+ DFGL++ + + + I ++APE S
Sbjct: 509 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPE--SI 564
Query: 470 RFGGVSHKSDVYSYGMMIIEMV 491
F + SDV+ +G+ + E++
Sbjct: 565 NFRRFTSASDVWMFGVCMWEIL 586
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-33
Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 33/218 (15%)
Query: 296 SFRDKLGQGGYGEVYKGEL------PDGQLVAVKVLKNSRCNGE--EFINEVASISRTSH 347
+ LG G +GEVY+G++ P VAVK L + +F+ E IS+ +H
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 92
Query: 348 VNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDR-----NIKLEWKTMYQIAIGIARG 402
NIV +G ++ ++ ELM G L F+ R L + +A IA G
Sbjct: 93 QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 403 LEYLHRGCQVRIVHFDIKPQNILLD---EDFCPKISDFGLAKQAQKKESAISMLHARGTI 459
+YL + +H DI +N LL KI DFG+A+ + + +G
Sbjct: 153 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS-----YYRKGGC 204
Query: 460 GYI-----APE-VYSRRFGGVSHKSDVYSYGMMIIEMV 491
+ PE F + K+D +S+G+++ E+
Sbjct: 205 AMLPVKWMPPEAFMEGIF---TSKTDTWSFGVLLWEIF 239
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-33
Identities = 82/317 (25%), Positives = 135/317 (42%), Gaps = 69/317 (21%)
Query: 274 IRNHESLAPKRYSYSDVKRMTKSFRD------KLGQGGYGEVYKG-ELPDGQLVAVKVLK 326
+ +H P + V+ T F D LG+G +GEV + GQ AVKV+
Sbjct: 5 MMDHLHATPGMF----VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS 60
Query: 327 NSRCNGEE----FINEVASISRTSHVNIVTFLGFCYENKKNA-LIYELMPNGSLDKFIHN 381
+ + + EV + + H NI+ F +E+K L+ E+ G L F
Sbjct: 61 KRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF-FEDKGYFYLVGEVYTGGEL--F--- 114
Query: 382 DRNIKLEW-------KTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL---DEDFC 431
D I + + + Q + G+ Y+H + +IVH D+KP+N+LL +D
Sbjct: 115 DEIISRKRFSEVDAARIIRQ----VLSGITYMH---KNKIVHRDLKPENLLLESKSKDAN 167
Query: 432 PKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMI-IEM 490
+I DFGL+ + + + GT YIAPEV + K DV+S G+++ I +
Sbjct: 168 IRIIDFGLSTHFEASKKMKDKI---GTAYYIAPEVLHGTYD---EKCDVWSTGVILYILL 221
Query: 491 VGC---TKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKI---AKMMILVGFW 544
GC + + I +++E G + F+ + KK+ AK +I
Sbjct: 222 SGCPPFNGANEYD----------ILKKVEKG-KYTFEL---PQWKKVSESAKDLIRK--- 264
Query: 545 CIQTNPSERPSMHKVLE 561
+ PS R S L+
Sbjct: 265 MLTYVPSMRISARDALD 281
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 8e-33
Identities = 63/298 (21%), Positives = 116/298 (38%), Gaps = 54/298 (18%)
Query: 297 FRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTS-HVNIVTFLG 355
LG G G V G+ VAVK + C + + E+ ++ + H N++ +
Sbjct: 19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC--DIALMEIKLLTESDDHPNVIRYYC 76
Query: 356 FCYENKKNA-LIYELMPNGSLDKFI-----HNDRNIKLEWKTMYQIAIGIARGLEYLHRG 409
+ + EL N +L + ++ + + IA G+ +LH
Sbjct: 77 S-ETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH-- 132
Query: 410 CQVRIVHFDIKPQNILLD-------------EDFCPKISDFGLAKQAQKKESAIS--MLH 454
++I+H D+KPQNIL+ E+ ISDFGL K+ +S+ + +
Sbjct: 133 -SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 455 ARGTIGYIAPEV-----YSRRFGGVSHKSDVYSYGMMIIEMVGCTKNL---DDEVTDTSI 506
GT G+ APE+ + ++ D++S G + ++ D +++I
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL-SKGKHPFGDKYSRESNI 250
Query: 507 CHNLIYERIEPGNDFQFDGVATEEEKKI---AKMMILVGFWCIQTNPSERPSMHKVLE 561
F D + ++ + A +I I +P +RP+ KVL
Sbjct: 251 IR----------GIFSLDEMKCLHDRSLIAEATDLIS---QMIDHDPLKRPTAMKVLR 295
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 9e-33
Identities = 76/276 (27%), Positives = 124/276 (44%), Gaps = 50/276 (18%)
Query: 301 LGQGGYGEVYKG-ELPDGQLVAVKVLKNS---RCNGEEFIN-EVASISRTSHVNIVTFLG 355
LG+G +G VY E ++A+KVL + + E + EV S H NI+ G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKT---MYQIAIGIARGLEYLHRGCQV 412
+ ++ + LI E P G++ + + E +T + ++A L Y H
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQKLSKFD-EQRTATYITELA----NALSYCHSK--- 128
Query: 413 RIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR-----GTIGYIAPEVY 467
R++H DIKP+N+LL KI+DFG + A +R GT+ Y+ PE+
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---------SSRRTDLCGTLDYLPPEMI 179
Query: 468 SRRFGGVSHKSDVYSYGMMIIEM-VGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526
R K D++S G++ E VG + +T Y+RI +F F
Sbjct: 180 EGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-------YKRISRV-EFTFPDF 229
Query: 527 ATEEEKK-IAKMMILVGFWCIQTNPSERPSMHKVLE 561
TE + I+++ ++ NPS+RP + +VLE
Sbjct: 230 VTEGARDLISRL--------LKHNPSQRPMLREVLE 257
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 55/309 (17%), Positives = 96/309 (31%), Gaps = 52/309 (16%)
Query: 299 DKLGQG--GYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEF---INEVASISRTSHVNIVT 352
+G+G V P G+ V V+ + C+ E E+ +H NIV
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 353 FLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAI---GIARGLEYLHRG 409
+ + + ++ M GS I + IA G+ + L+Y+H
Sbjct: 91 YRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNEL---AIAYILQGVLKALDYIHH- 146
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ---AQKKESAISMLHAR--GTIGYIAP 464
+ VH +K +IL+ D +S +++ + + +++P
Sbjct: 147 --MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
Query: 465 EVYSRRFGGVSHKSDVYSYGMMIIEMV--------------------GCTKNLDDEVTDT 504
EV + G KSD+YS G+ E+ G L D T
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 264
Query: 505 SICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGF------------WCIQTNPSE 552
+ + R + + C+Q NP
Sbjct: 265 AEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDA 324
Query: 553 RPSMHKVLE 561
RPS +L
Sbjct: 325 RPSASTLLN 333
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-32
Identities = 81/288 (28%), Positives = 124/288 (43%), Gaps = 58/288 (20%)
Query: 296 SFRDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEE---FINEVASISRTSHVNIV 351
KLG G YGEV + A+K+++ + + + EVA + H NI+
Sbjct: 40 QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99
Query: 352 TFLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEW-------KTMYQIAIGIARGL 403
F +E+K+N L+ E G L F D I + Q+ G+
Sbjct: 100 KLYDF-FEDKRNYYLVMECYKGGEL--F---DEIIHRMKFNEVDAAVIIKQVL----SGV 149
Query: 404 EYLHRGCQVRIVHFDIKPQNILL---DEDFCPKISDFGLAKQAQKKESAISMLHARGTIG 460
YLH + IVH D+KP+N+LL ++D KI DFGL+ + ++ L GT
Sbjct: 150 TYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL---GTAY 203
Query: 461 YIAPEVYSRRFGGVSHKSDVYSYGMMI-IEMVG---CTKNLDDEVTDTSICHNLIYERIE 516
YIAPEV +++ K DV+S G+++ I + G D E I ++E
Sbjct: 204 YIAPEVLRKKYD---EKCDVWSIGVILFILLAGYPPFGGQTDQE----------ILRKVE 250
Query: 517 PGNDFQFDGVATEEEKKI---AKMMILVGFWCIQTNPSERPSMHKVLE 561
G + FD E K + AK +I +Q + R S + LE
Sbjct: 251 KG-KYTFDS---PEWKNVSEGAKDLIKQ---MLQFDSQRRISAQQALE 291
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 57/317 (17%), Positives = 99/317 (31%), Gaps = 56/317 (17%)
Query: 296 SFRDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEE--FINEVASISRTSHVNIVT 352
D LGQG V++G G L A+KV N + E + + +H NIV
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 353 FLGFCYENKKNALIY---ELMPNGSL-DKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHR 408
E E P GSL L + + G+ +L
Sbjct: 72 LFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR- 129
Query: 409 GCQVRIVHFDIKPQNILL----DEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAP 464
+ IVH +IKP NI+ D K++DFG A++ + E +S+ GT Y+ P
Sbjct: 130 --ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY---GTEEYLHP 184
Query: 465 EVYSRRFGGVSH------KSDVYSYGMMIIEMV-----------------------GCTK 495
++Y R H D++S G+
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 496 NLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPS 555
+ + + + P + G+ +A ++ + + +
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANIL--------EADQEKCWG 296
Query: 556 MHKVLEMLEGSIENLQI 572
+ I + +
Sbjct: 297 FDQFFAETS-DILHRMV 312
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 69/304 (22%), Positives = 118/304 (38%), Gaps = 61/304 (20%)
Query: 296 SFRDKLGQGGYGEVYKGELPDG------QLVAVKVLKNSRCNGE--EFINEVASISRTSH 347
+ LG G +GEVY+G++ VAVK L + +F+ E IS+ +H
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133
Query: 348 VNIVTFLGFCYENKKNALIYELMPNGSLDKFI-----HNDRNIKLEWKTMYQIAIGIARG 402
NIV +G ++ ++ ELM G L F+ + L + +A IA G
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 403 LEYLHRGCQVRIVHFDIKPQNILLD---EDFCPKISDFGLAKQAQKKESAISMLHARGTI 459
+YL + +H DI +N LL KI DFG+A+ + + +G
Sbjct: 194 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY-----YRKGGC 245
Query: 460 GYI-----APE-VYSRRFGGVSHKSDVYSYGMMIIEMV--------GCTKNLDDEVTDTS 505
+ PE F + K+D +S+G+++ E+ + + EV
Sbjct: 246 AMLPVKWMPPEAFMEGIF---TSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEV---- 295
Query: 506 ICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565
E + G + ++M C Q P +RP+ +LE +E
Sbjct: 296 ------LEFVTSGGRMDPPKNCPGP---VYRIMTQ----CWQHQPEDRPNFAIILERIEY 342
Query: 566 SIEN 569
++
Sbjct: 343 CTQD 346
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-32
Identities = 69/211 (32%), Positives = 103/211 (48%), Gaps = 32/211 (15%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFINEVASISRTS-HVNIVTFLGF 356
+ +G G YG+VYKG + GQL A+KV+ + EE E+ + + S H NI T+ G
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYG- 88
Query: 357 CYENKKNA-------LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAI---GIARGLEYL 406
+ K L+ E GS+ I N + L+ + IA I RGL +L
Sbjct: 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE---WIAYICREILRGLSHL 145
Query: 407 HRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ----AQKKESAISMLHARGTIGYI 462
H Q +++H DIK QN+LL E+ K+ DFG++ Q ++ + I GT ++
Sbjct: 146 H---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTPYWM 196
Query: 463 APEV---YSRRFGGVSHKSDVYSYGMMIIEM 490
APEV KSD++S G+ IEM
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEM 227
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-32
Identities = 82/304 (26%), Positives = 137/304 (45%), Gaps = 55/304 (18%)
Query: 282 PKRYSYSDVKRMTKSFRDK--------LGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNG 332
P + + V + LG G +G+V+K E G +A K++K
Sbjct: 70 PAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD 129
Query: 333 -EEFINEVASISRTSHVNIVTFLGFCYENKKN-ALIYELMPNGSL-DKFIHNDRNIKL-E 388
EE NE++ +++ H N++ +E+K + L+ E + G L D+ I D + L E
Sbjct: 130 KEEVKNEISVMNQLDHANLIQLYDA-FESKNDIVLVMEYVDGGELFDRII--DESYNLTE 186
Query: 389 WKT---MYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL--DEDFCPKISDFGLAKQA 443
T M QI G+ ++H Q+ I+H D+KP+NIL + KI DFGLA++
Sbjct: 187 LDTILFMKQIC----EGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239
Query: 444 QKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMI-IEMVGCTKNLDDEVT 502
+ +E GT ++APEV + F VS +D++S G++ + + G + L D
Sbjct: 240 KPREKLKVNF---GTPEFLAPEVVNYDF--VSFPTDMWSVGVIAYMLLSGLSPFLGD--N 292
Query: 503 DTSICHNLIYERIEPGN-DF---QFDGVATEEEKK-IAKMMILVGFWCIQTNPSERPSMH 557
D I D +F + +EE K+ I+K++I S R S
Sbjct: 293 DAE-----TLNNILACRWDLEDEEFQDI-SEEAKEFISKLLIK--------EKSWRISAS 338
Query: 558 KVLE 561
+ L+
Sbjct: 339 EALK 342
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 55/201 (27%), Positives = 88/201 (43%), Gaps = 23/201 (11%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEE----FINEVASISRTSHVNIVTF 353
++G G +G VY ++ + ++VA+K + S E I EV + + H N + +
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 354 LGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAI---GIARGLEYLHRGC 410
G L+ E + D + + ++ +IA G +GL YLH
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV-----EIAAVTHGALQGLAYLH--- 171
Query: 411 QVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEV-YSR 469
++H D+K NILL E K+ DFG A S + GT ++APEV +
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVILAM 225
Query: 470 RFGGVSHKSDVYSYGMMIIEM 490
G K DV+S G+ IE+
Sbjct: 226 DEGQYDGKVDVWSLGITCIEL 246
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 80/309 (25%), Positives = 131/309 (42%), Gaps = 54/309 (17%)
Query: 274 IRNHESLAPKRYSYSDVKRMTK--SFRDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRC 330
+ +H + R + + + LG+G +GEV K + Q AVKV+ +
Sbjct: 1 MHHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA 60
Query: 331 NGEE---FINEVASISRTSHVNIVTFLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIK 386
++ + EV + + H NI+ E+ + ++ EL G L F D IK
Sbjct: 61 KNKDTSTILREVELLKKLDHPNIMKLFEI-LEDSSSFYIVGELYTGGEL--F---DEIIK 114
Query: 387 LEW-------KTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL---DEDFCPKISD 436
+ + + Q+ G+ Y+H + IVH D+KP+NILL ++D KI D
Sbjct: 115 RKRFSEHDAARIIKQVF----SGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIID 167
Query: 437 FGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYG-MMIIEMVGCTK 495
FGL+ Q+ + GT YIAPEV + K DV+S G ++ I + G
Sbjct: 168 FGLSTCFQQNTKMKDRI---GTAYYIAPEVLRGTYD---EKCDVWSAGVILYILLSGTPP 221
Query: 496 NLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKI---AKMMILVGFWCIQTNPSE 552
+ I +R+E G + FD + + I AK +I + +PS
Sbjct: 222 FYGK--NEYD-----ILKRVETG-KYAFDL---PQWRTISDDAKDLIRK---MLTFHPSL 267
Query: 553 RPSMHKVLE 561
R + + LE
Sbjct: 268 RITATQCLE 276
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 26/202 (12%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFI-NEVASISRTSHVNIVTFLGF 356
K+G+G G V E G+ VAVK++ + E + NEV + H N+V
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 357 CYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAI---GIARGLEYLHRGCQVR 413
++ ++ E + G+L + R QIA + + L YLH
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQVR------LNEEQIATVCEAVLQALAYLH---AQG 161
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQ----AQKKESAISMLHARGTIGYIAPEVYSR 469
++H DIK +ILL D K+SDFG Q K++S + GT ++APEV SR
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV------GTPYWMAPEVISR 215
Query: 470 RFGGVSHKSDVYSYGMMIIEMV 491
+ + D++S G+M+IEMV
Sbjct: 216 --SLYATEVDIWSLGIMVIEMV 235
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 70/322 (21%), Positives = 126/322 (39%), Gaps = 77/322 (23%)
Query: 296 SFRDKLGQGGYGEVYKGELPDG------QLVAVKVLKNSRCNGE--EFINEVASISRTSH 347
+ +G+G +G V++ P +VAVK+LK +F E A ++ +
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 348 VNIVTFLGFCYENKKNALIYELMPNGSLDKF----------------------IHNDRNI 385
NIV LG C K L++E M G L++F + +
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 386 KLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445
L IA +A G+ YL + + VH D+ +N L+ E+ KI+DFGL++
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 446 KESAISMLHARGTIGYIAPE-VYSRRFGGVSHKSDVYSYGMMIIEMV--------GCTKN 496
+ + + I ++ PE ++ R+ + +SDV++YG+++ E+ G
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNRY---TTESDVWAYGVVLWEIFSYGLQPYYGMA-- 281
Query: 497 LDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK------KIAKMMILVGFWCIQTNP 550
+EV + GN ++ +M L C P
Sbjct: 282 -HEEV----------IYYVRDGNIL---------ACPENCPLELYNLMRL----CWSKLP 317
Query: 551 SERPSMHKVLEMLEGSIENLQI 572
++RPS + +L+ E +
Sbjct: 318 ADRPSFCSIHRILQRMCERAEG 339
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 76/340 (22%), Positives = 132/340 (38%), Gaps = 59/340 (17%)
Query: 243 GAYSSSCHSRTVIQALIKKKTREDDRNVEAFIRNHESLAPKRYSYSDVKRMTKSFRD--- 299
G++ H V K + D+ E K+Y V+ S D
Sbjct: 3 GSHHHHHHGSKVRGKYDGPKINDYDKFYEDI--------WKKYVPQPVEVKQGSVYDYYD 54
Query: 300 ---KLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNG-EEFINEVASISRTSHVNIVTFL 354
+LG G +G V++ E G++ K + NE++ +++ H ++
Sbjct: 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 114
Query: 355 GFCYENKKN-ALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIAR----GLEYLHRG 409
+E+K LI E + G L F DR ++K I R GL+++H
Sbjct: 115 DA-FEDKYEMVLILEFLSGGEL--F---DRIAAEDYKMSEAEVINYMRQACEGLKHMH-- 166
Query: 410 CQVRIVHFDIKPQNILL--DEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVY 467
+ IVH DIKP+NI+ + KI DFGLA + E T + APE+
Sbjct: 167 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIV 222
Query: 468 SRRFGGVSHKSDVYSYGMMI-IEMVGCTKNLDDEVTDTSICHNLIYERIEPGN-DF---Q 522
R V +D+++ G++ + + G + + D + ++ + +F
Sbjct: 223 DRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGE--DDLE-----TLQNVKRCDWEFDEDA 273
Query: 523 FDGVATEEEKK-IAKMMILVGFWCIQTNPSERPSMHKVLE 561
F V + E K I ++ P +R ++H LE
Sbjct: 274 FSSV-SPEAKDFIKNLLQK--------EPRKRLTVHDALE 304
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 25/204 (12%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLK-NSRCNGEEFINEVASISRTSHVNIVTFLGF 356
+LG G +G+VYK G L A KV++ S E++I E+ ++ H IV LG
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 357 CYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAI---GIARGLEYLHRGCQVR 413
Y + K ++ E P G++D + E QI + + L +LH R
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTE----PQIQVVCRQMLEALNFLH---SKR 137
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQ----AQKKESAISMLHARGTIGYIAPEV--- 466
I+H D+K N+L+ + +++DFG++ + QK++S I GT ++APEV
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAPEVVMC 191
Query: 467 YSRRFGGVSHKSDVYSYGMMIIEM 490
+ + +K+D++S G+ +IEM
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEM 215
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 24/201 (11%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFC 357
+KLG+G YG VYK GQ+VA+K + + +E I E++ + + ++V + G
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSY 93
Query: 358 YENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAI---GIARGLEYLHRGCQVRI 414
++N ++ E GS+ I E +IA +GLEYLH +R
Sbjct: 94 FKNTDLWIVMEYCGAGSVSDIIRLRNKTLTE----DEIATILQSTLKGLEYLH---FMRK 146
Query: 415 VHFDIKPQNILLDEDFCPKISDFGLAKQ----AQKKESAISMLHARGTIGYIAPEVYSRR 470
+H DIK NILL+ + K++DFG+A Q K+ + I GT ++APEV
Sbjct: 147 IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI------GTPFWMAPEVIQE- 199
Query: 471 FGGVSHKSDVYSYGMMIIEMV 491
G + +D++S G+ IEM
Sbjct: 200 -IGYNCVADIWSLGITAIEMA 219
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 70/302 (23%), Positives = 129/302 (42%), Gaps = 58/302 (19%)
Query: 296 SFRDKLGQGGYGEVYKGEL------PDGQLVAVKVLKNSRCNGE--EFINEVASISR-TS 346
LG+G +G+V + + + VAVK+LK + E ++E+ +
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 347 HVNIVTFLGFC-YENKKNALIYELMPNGSLDKFIHNDRNI--------------KLEWKT 391
H+N+V LG C +I E G+L ++ + RN L +
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 392 MYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451
+ + +A+G+E+L + +H D+ +NILL E KI DFGLA+ K +
Sbjct: 150 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206
Query: 452 MLHARGTIGYIAPE-VYSRRFGGVSHKSDVYSYGMMIIEMV--------GCTKNLDDEVT 502
AR + ++APE ++ R + + +SDV+S+G+++ E+ G + +
Sbjct: 207 KGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---- 259
Query: 503 DTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562
R++ G + T E + + M+ C PS+RP+ +++E
Sbjct: 260 --------FCRRLKEGTRMRAPDYTTPE---MYQTMLD----CWHGEPSQRPTFSELVEH 304
Query: 563 LE 564
L
Sbjct: 305 LG 306
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 30/203 (14%)
Query: 300 KLGQGGYGEVYKG-ELPDGQLVAVKVLK-NSRCNGEEFINEVASISRTSHVNIVTFLGFC 357
K+GQG G VY ++ GQ VA++ + + E INE+ + + NIV +L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 358 YENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTM--YQIAI---GIARGLEYLHRGCQV 412
+ ++ E + GSL + M QIA + LE+LH
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLH---SN 135
Query: 413 RIVHFDIKPQNILLDEDFCPKISDFGLAKQ----AQKKESAISMLHARGTIGYIAPEVYS 468
+++H DIK NILL D K++DFG Q K+ + + GT ++APEV +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV------GTPYWMAPEVVT 189
Query: 469 RRFGGVSHKSDVYSYGMMIIEMV 491
R K D++S G+M IEM+
Sbjct: 190 R--KAYGPKVDIWSLGIMAIEMI 210
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-31
Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 20/206 (9%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKV--LKNSRCNGEEFINEVASISRTSHVNIVTFLG 355
+ +G G V P + VA+K L+ + + +E + E+ ++S+ H NIV++
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 356 FCYENKKNALIYELMPNGSLD---KFIHNDRNIKLEWKTMYQIAI---GIARGLEYLHRG 409
+ L+ +L+ GS+ K I K IA + GLEYLH+
Sbjct: 81 SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR-----GTIGYIAP 464
+H D+K NILL ED +I+DFG++ A + GT ++AP
Sbjct: 141 ---GQIHRDVKAGNILLGEDGSVQIADFGVS--AFLATGGDITRNKVRKTFVGTPCWMAP 195
Query: 465 EVYSRRFGGVSHKSDVYSYGMMIIEM 490
EV + G K+D++S+G+ IE+
Sbjct: 196 EVMEQV-RGYDFKADIWSFGITAIEL 220
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 64/276 (23%), Positives = 128/276 (46%), Gaps = 35/276 (12%)
Query: 242 NGAYSSSCHSRTVIQALIKKKTREDDRNVEAFIRNHESLAPKRYSYSDVKRMTKSFRDKL 301
+ SSS +S T + + + + D + A + +E ++ + R + L
Sbjct: 33 SAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKW---EFPRDKLTLGKPL 89
Query: 302 GQGGYGEVYKGEL--------PDGQLVAVKVLKNSRCNGE--EFINEVASISR-TSHVNI 350
G+G +G+V E + VAVK+LK+ + + ++E+ + H NI
Sbjct: 90 GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 149
Query: 351 VTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNI--------------KLEWKTMYQIA 396
+ LG C ++ +I E G+L +++ R ++ +K +
Sbjct: 150 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 209
Query: 397 IGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR 456
+ARG+EYL + +H D+ +N+L+ E+ KI+DFGLA+ + + R
Sbjct: 210 YQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 266
Query: 457 GTIGYIAPE-VYSRRFGGVSHKSDVYSYGMMIIEMV 491
+ ++APE ++ R + +H+SDV+S+G+++ E+
Sbjct: 267 LPVKWMAPEALFDRVY---THQSDVWSFGVLMWEIF 299
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 76/312 (24%), Positives = 125/312 (40%), Gaps = 62/312 (19%)
Query: 296 SFRDKLGQGGYGEVYKGELPDG------QLVAVKVLKNSRCNGE--EFINEVASISR-TS 346
F LG G +G+V VAVK+LK + E ++E+ +++ S
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 107
Query: 347 HVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNI--------------------- 385
H NIV LG C + LI+E G L ++ + R
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 386 KLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445
L ++ + A +A+G+E+L VH D+ +N+L+ KI DFGLA+
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 446 KESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMV--------GCTKNL 497
+ + +AR + ++APE S G + KSDV+SYG+++ E+ G +
Sbjct: 225 DSNYVVRGNARLPVKWMAPE--SLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282
Query: 498 DDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMH 557
+ Y+ I+ G ATEE I +M C + +RPS
Sbjct: 283 N------------FYKLIQNGFKMDQPFYATEE---IYIIMQS----CWAFDSRKRPSFP 323
Query: 558 KVLEMLEGSIEN 569
+ L + +
Sbjct: 324 NLTSFLGCQLAD 335
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-31
Identities = 58/202 (28%), Positives = 101/202 (50%), Gaps = 27/202 (13%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKV--LKNSRCNGEEFINEVASISRTSHVNIVTFLG 355
+K+G+G +GEV+KG + ++VA+K+ L+ + E+ E+ +S+ + + G
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAI---GIARGLEYLHRGCQV 412
++ K +I E + GS + L+ QIA I +GL+YLH
Sbjct: 88 SYLKDTKLWIIMEYLGGGSALDLLEPG---PLDET---QIATILREILKGLDYLHSE--- 138
Query: 413 RIVHFDIKPQNILLDEDFCPKISDFGLAKQ----AQKKESAISMLHARGTIGYIAPEVYS 468
+ +H DIK N+LL E K++DFG+A Q K+ + + GT ++APEV
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEVIK 192
Query: 469 RRFGGVSHKSDVYSYGMMIIEM 490
+ K+D++S G+ IE+
Sbjct: 193 Q--SAYDSKADIWSLGITAIEL 212
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 66/297 (22%), Positives = 118/297 (39%), Gaps = 45/297 (15%)
Query: 299 DKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNGE--EFINEVASISRTSHVNIVTFLG 355
+LG G G V+K P G ++A K++ + I E+ + + IV F G
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
Y + + ++ E M GSLD+ + I + + +++I + +GL YL + +I+
Sbjct: 99 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI--LGKVSIAVIKGLTYLRE--KHKIM 154
Query: 416 HFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR-GTIGYIAPEVYSRRFGGV 474
H D+KP NIL++ K+ DFG++ Q SM ++ GT Y++PE
Sbjct: 155 HRDVKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPERLQG--THY 207
Query: 475 SHKSDVYSYGMMIIEMVG----CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530
S +SD++S G+ ++EM E+ C P +
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267
Query: 531 EKKIAKMMIL----------------VGFW----------CIQTNPSERPSMHKVLE 561
M + G + C+ NP+ER + +++
Sbjct: 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 55/222 (24%), Positives = 106/222 (47%), Gaps = 32/222 (14%)
Query: 296 SFRDKLGQGGYGEVYKGELPD--------GQLVAVKVLKNSRCNGE--EFINEVASISR- 344
+ LG+G +G+V E VAVK+LK+ + + ++E+ +
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 345 TSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNI--------------KLEWK 390
H NI+ LG C ++ +I E G+L +++ R ++ +K
Sbjct: 98 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 391 TMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450
+ +ARG+EYL + +H D+ +N+L+ E+ KI+DFGLA+ +
Sbjct: 158 DLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 451 SMLHARGTIGYIAPE-VYSRRFGGVSHKSDVYSYGMMIIEMV 491
+ R + ++APE ++ R + +H+SDV+S+G+++ E+
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEIF 253
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 70/304 (23%), Positives = 118/304 (38%), Gaps = 47/304 (15%)
Query: 298 RDKLGQGGYGEVYKGE-LPDGQLVAVK-VLKNSRCNGEEFINEVASISR-TSHVNIVTFL 354
R L +GG+ VY+ + + G+ A+K +L N I EV + + + H NIV F
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 355 GFCYENK-----KNALIYELM---PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYL 406
K A L ++ + L T+ +I R ++++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 407 HRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLA----------KQAQKKESAISMLHAR 456
HR + I+H D+K +N+LL K+ DFG A AQ++ +
Sbjct: 153 HR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 457 GTIGYIAPEV---YSRRFGGVSHKSDVYSYGMMIIEMVGCTKNL--DDEVTDTSICHNLI 511
T Y PE+ YS + K D+++ G ++ + C + +D I N
Sbjct: 212 TTPMYRTPEIIDLYSNF--PIGEKQDIWALGCILYLL--CFRQHPFEDGAK-LRIV-NGK 265
Query: 512 YERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQ 571
Y P +D Q+ +I +Q NP ER S+ +V+ L+
Sbjct: 266 YS--IPPHDTQYTVF---------HSLIR---AMLQVNPEERLSIAEVVHQLQEIAAARN 311
Query: 572 IPPK 575
+ PK
Sbjct: 312 VNPK 315
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 63/353 (17%), Positives = 127/353 (35%), Gaps = 60/353 (16%)
Query: 268 RNVEAFIRNHESLAPKRYSYSDVKRMTKSFR--DKLGQGGYGEVYKGELPDGQLVAVKVL 325
+++ + N+ +L + + +R L QG + ++ E D + A+K
Sbjct: 4 GSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALKKY 62
Query: 326 KNSRCNGEEFI------------------NEVASISRTSHVNIVTFLGFCYENKKNALIY 367
+ S + NE+ I+ + +T G + +IY
Sbjct: 63 EKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIY 122
Query: 368 ELMPNGSLDKFIHNDRNIKLEWKTMY------QIAIGIARGLEYLHRGCQVRIVHFDIKP 421
E M N S+ KF + + I + Y+H + I H D+KP
Sbjct: 123 EYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKP 180
Query: 422 QNILLDEDFCPKISDFGLAKQAQKKESAISMLH-ARGTIGYIAPEVYSRRFGGVSHKSDV 480
NIL+D++ K+SDFG ++ + +RGT ++ PE +S K D+
Sbjct: 181 SNILMDKNGRVKLSDFGESEYMVD-----KKIKGSRGTYEFMPPEFFSNESSYNGAKVDI 235
Query: 481 YSYGMMIIEMVGCTKNL--DDEVTDTSICHNLIYERIEPGNDFQF-DGVATEEEKKIAKM 537
+S G+ + M + +++ ++ I + ++ K
Sbjct: 236 WSLGICLYVMF--YNVVPFSLKIS-----LVELFNNIRTK-NIEYPLDRNHFLYPLTNKK 287
Query: 538 MILVGFWC-----------IQTNPSERPSMHKVLE---MLEGSIENLQIPPKP 576
+ ++ NP+ER + L+ + + +IE+L+ K
Sbjct: 288 STCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKE 340
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 78/281 (27%), Positives = 133/281 (47%), Gaps = 48/281 (17%)
Query: 297 FRDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFI-NEVASISRTSHVNIVTFL 354
F + LG G + EV+ + G+L A+K +K S + + NE+A + + H NIVT
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 355 GFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMY------QIAIGIARGLEYLH 407
YE+ + L+ +L+ G L F DR ++ + +Y + + ++YLH
Sbjct: 73 DI-YESTTHYYLVMQLVSGGEL--F---DRILE---RGVYTEKDASLVIQQVLSAVKYLH 123
Query: 408 RGCQVRIVHFDIKPQNILL---DEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAP 464
+ IVH D+KP+N+L +E+ I+DFGL+K Q M A GT GY+AP
Sbjct: 124 ---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACGTPGYVAP 176
Query: 465 EVYSRRFGGVSHKSDVYSYG-MMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQF 523
EV +++ S D +S G + I + G ++ + ++E+I+ G ++F
Sbjct: 177 EVLAQK--PYSKAVDCWSIGVITYILLCGYPPFYEETESK-------LFEKIKEG-YYEF 226
Query: 524 DGVATEEEKKI---AKMMILVGFWCIQTNPSERPSMHKVLE 561
+ I AK I ++ +P+ER + K L
Sbjct: 227 ES---PFWDDISESAKDFIC---HLLEKDPNERYTCEKALS 261
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 59/201 (29%), Positives = 102/201 (50%), Gaps = 15/201 (7%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGE--EFINEVASISRTS-HVNIVTFL 354
++G+G YG V K P GQ++AVK ++++ E + + ++ + R+S IV F
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87
Query: 355 GFCYENKKNALIYELMPNGSLDKF---IHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQ 411
G + + ELM + S DKF +++ + + + + +I + + L +L
Sbjct: 88 GALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--N 144
Query: 412 VRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEV--YSR 469
++I+H DIKP NILLD K+ DFG++ Q +I+ G Y+APE S
Sbjct: 145 LKIIHRDIKPSNILLDRSGNIKLCDFGISGQL---VDSIAKTRDAGCRPYMAPERIDPSA 201
Query: 470 RFGGVSHKSDVYSYGMMIIEM 490
G +SDV+S G+ + E+
Sbjct: 202 SRQGYDVRSDVWSLGITLYEL 222
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 62/282 (21%), Positives = 116/282 (41%), Gaps = 38/282 (13%)
Query: 242 NGAYSSSCHSRTVIQALIKKKTREDDRNVEAFIR---NHESLAPKRYSYSD---VKRMTK 295
++ + + D + ++ + R
Sbjct: 12 YDIPTTENLYFNGMGYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRL 71
Query: 296 SFRDKLGQGGYGEVYKGELPD--------GQLVAVKVLKNSRCNGE--EFINEVASISR- 344
LG+G +G+V E VAVK+LK+ + + I+E+ +
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 131
Query: 345 TSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEW--------------K 390
H NI+ LG C ++ +I E G+L +++ R LE+ K
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 391 TMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450
+ A +ARG+EYL + +H D+ +N+L+ ED KI+DFGLA+ +
Sbjct: 192 DLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248
Query: 451 SMLHARGTIGYIAPE-VYSRRFGGVSHKSDVYSYGMMIIEMV 491
+ R + ++APE ++ R + +H+SDV+S+G+++ E+
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEIF 287
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 56/226 (24%), Positives = 106/226 (46%), Gaps = 37/226 (16%)
Query: 297 FRDKLGQGGYGEVYKGELPDG------QLVAVKVLKNSRCNGE--EFINEVASISRTSHV 348
LG+G +G+V K VAVK+LK + E + ++E + + +H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 349 NIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNI----------------------K 386
+++ G C ++ LI E GSL F+ R +
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 387 LEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446
L + A I++G++YL ++++VH D+ +NIL+ E KISDFGL++ ++
Sbjct: 147 LTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 447 ESAISMLHARGTIGYIAPE-VYSRRFGGVSHKSDVYSYGMMIIEMV 491
+S + R + ++A E ++ + + +SDV+S+G+++ E+V
Sbjct: 204 DSYVKRSQGRIPVKWMAIESLFDHIY---TTQSDVWSFGVLLWEIV 246
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-30
Identities = 87/327 (26%), Positives = 134/327 (40%), Gaps = 71/327 (21%)
Query: 290 VKRMTKSFRD------KLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNG---------- 332
V++ + KLG G YGEV E A+KV+K S+ +
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 333 ----EEFINEVASISRTSHVNIVTFLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKL 387
EE NE++ + H NI+ +E+KK L+ E G L F ++ I
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDV-FEDKKYFYLVTEFYEGGEL--F---EQIINR 140
Query: 388 EW---KTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL---DEDFCPKISDFGLAK 441
I I G+ YLH + IVH DIKP+NILL + KI DFGL+
Sbjct: 141 HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS 197
Query: 442 QAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMI-IEMVGCT----KN 496
K L GT YIAPEV +++ K DV+S G+++ I + G +N
Sbjct: 198 FFSKDYKLRDRL---GTAYYIAPEVLKKKYN---EKCDVWSCGVIMYILLCGYPPFGGQN 251
Query: 497 LDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKI---AKMMILVGFWCIQTNPSER 553
D I +++E G + FD + K I AK +I + + ++R
Sbjct: 252 DQD-----------IIKKVEKG-KYYFDF---NDWKNISDEAKELIK---LMLTYDYNKR 293
Query: 554 PSMHKVLEM--LEGSIENLQIPPKPSL 578
+ + L ++ N+ + +L
Sbjct: 294 CTAEEALNSRWIKKYANNINKSDQKTL 320
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 70/300 (23%), Positives = 116/300 (38%), Gaps = 63/300 (21%)
Query: 290 VKRMTKSFRDK------LGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFINEVASI 342
+ R + F D +G G Y + AVK++ S+ + E E+ +
Sbjct: 13 LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE---EIEIL 69
Query: 343 SRTS-HVNIVTFLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEW-------KTMY 393
R H NI+T Y++ K ++ ELM G L D+ ++ ++ ++
Sbjct: 70 LRYGQHPNIITLKDV-YDDGKYVYVVTELMKGGEL--L---DKILRQKFFSEREASAVLF 123
Query: 394 QIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL---DEDFCP-KISDFGLAKQAQKKESA 449
I + +EYLH +VH D+KP NIL + +I DFG AKQ + +
Sbjct: 124 TIT----KTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176
Query: 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYG-MMIIEMVGCT----KNLDDEVTDT 504
+ T ++APEV R+ G D++S G ++ + G T D
Sbjct: 177 LMTPC--YTANFVAPEVLERQ--GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP---- 228
Query: 505 SICHNLIYERIEPGNDFQFDGVATEEEKKI---AKMMILVGFWCIQTNPSERPSMHKVLE 561
I RI G F G + AK ++ + +P +R + VL
Sbjct: 229 ----EEILARIGSG-KFSLSG---GYWNSVSDTAKDLVS---KMLHVDPHQRLTAALVLR 277
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 68/313 (21%), Positives = 122/313 (38%), Gaps = 60/313 (19%)
Query: 274 IRNHESLAPKRYSYSDVKRMTK--SFRDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRC 330
+ +H + R + + F+ KLG G +G+V+ E G +K + R
Sbjct: 1 MHHHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS 60
Query: 331 NG--EEFINEVASISRTSHVNIVTFLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKL 387
E+ E+ + H NI+ +E+ N ++ E G L +R +
Sbjct: 61 QVPMEQIEAEIEVLKSLDHPNIIKIFEV-FEDYHNMYIVMETCEGGEL--L---ERIVSA 114
Query: 388 EWKTMY-------QIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL---DEDFCPKISDF 437
+ + ++ + L Y H +VH D+KP+NIL KI DF
Sbjct: 115 QARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDF 171
Query: 438 GLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYG-MMIIEMVGCT-- 494
GLA+ + E +A GT Y+APEV+ R K D++S G +M + GC
Sbjct: 172 GLAELFKSDE---HSTNAAGTALYMAPEVFKRDVT---FKCDIWSAGVVMYFLLTGCLPF 225
Query: 495 --KNLDDEVTDTSICHNLIYERIEPGN-DF--QFDGVATEEEKK-IAKMMILVGFWCIQT 548
+L++ + ++ ++ + + T + + +M+
Sbjct: 226 TGTSLEE-----------VQQKATYKEPNYAVECRPL-TPQAVDLLKQML--------TK 265
Query: 549 NPSERPSMHKVLE 561
+P RPS +VL
Sbjct: 266 DPERRPSAAQVLH 278
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 67/272 (24%), Positives = 117/272 (43%), Gaps = 42/272 (15%)
Query: 301 LGQGGYGEVYKG-ELPDGQLVAVKVLKNS---RCNGEEFIN-EVASISRTSHVNIVTFLG 355
LG+G +G VY E + ++A+KVL S + E + E+ S H NI+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKT---MYQIAIGIARGLEYLHRGCQV 412
+ ++ K+ L+ E P G L K + E ++ M ++A L Y H
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGRFD-EQRSATFMEELA----DALHYCHE---R 133
Query: 413 RIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR-GTIGYIAPEVYSRRF 471
+++H DIKP+N+L+ KI+DFG + A GT+ Y+ PE+ +
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-----LRRRTMCGTLDYLPPEMIEGK- 187
Query: 472 GGVSHKSDVYSYGMMIIEM-VGCTKNLDDEVTDTSICHNLIYERIEPGNDFQF-DGVATE 529
K D++ G++ E VG T+T + RI D +F ++
Sbjct: 188 -THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET-------HRRIVNV-DLKFPPFLSDG 238
Query: 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561
+ I+K+ ++ +P +R + V+E
Sbjct: 239 SKDLISKL--------LRYHPPQRLPLKGVME 262
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-30
Identities = 47/206 (22%), Positives = 85/206 (41%), Gaps = 32/206 (15%)
Query: 298 RDKLGQGGYGEVYKGE---LPDGQLVAVKVLKNSRCNGEE----FINEVASISRTSHVNI 350
+ + GG G +Y + +G+ V +K L +S E + E ++ H +I
Sbjct: 85 KGCIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSI 141
Query: 351 VTFL--GFCYENKKNALIY---ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEY 405
V + + + Y E + SL + KL + I L Y
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSY 197
Query: 406 LHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPE 465
LH + +V+ D+KP+NI+L E+ K+ D G + ++ L+ GT G+ APE
Sbjct: 198 LHS---IGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRI----NSFGYLY--GTPGFQAPE 247
Query: 466 VYSRRFGGVSHKSDVYSYGMMIIEMV 491
+ G + +D+Y+ G + +
Sbjct: 248 IVR---TGPTVATDIYTVGRTLAALT 270
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 75/292 (25%), Positives = 123/292 (42%), Gaps = 60/292 (20%)
Query: 296 SFRDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNG-------EEFINEVASISRTSH 347
++LG G + V K E G A K +K + EE EV+ + + H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 348 VNIVTFLGFCYENKKN-ALIYELMPNGSLDKFIHNDRNIKLEWKT-------MYQIAIGI 399
NI+T YEN+ + LI EL+ G L F D + E + + QI
Sbjct: 75 PNIITLHDV-YENRTDVVLILELVSGGEL--F---DFLAQKESLSEEEATSFIKQIL--- 125
Query: 400 ARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCP----KISDFGLAKQAQKKESAISMLHA 455
G+ YLH +I HFD+KP+NI+L + P K+ DFGLA + + ++
Sbjct: 126 -DGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-- 179
Query: 456 RGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMI-IEMVGCTKNLDDEVTDTSICHNLIYER 514
GT ++APE+ + + ++D++S G++ I + G + L D T
Sbjct: 180 -GTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGD--TKQE-----TLAN 229
Query: 515 IEPGN-DFQ---FDGVATEEEKK-IAKMMILVGFWCIQTNPSERPSMHKVLE 561
I + DF F +E K I K+++ +R ++ + L
Sbjct: 230 ITAVSYDFDEEFFSQT-SELAKDFIRKLLVK--------ETRKRLTIQEALR 272
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKV--LKNSRCNGEEFINEVASISRTS-HVNIVTFL 354
+LG+G YG V K +P GQ++AVK + + + ++ RT VTF
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 355 GFCYENKKNALIYELMPNGSLDKFIHN--DRNIKLEWKTMYQIAIGIARGLEYLHRGCQV 412
G + + ELM + SLDKF D+ + + +IA+ I + LE+LH ++
Sbjct: 73 GALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KL 129
Query: 413 RIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEV--YSRR 470
++H D+KP N+L++ K+ DFG++ ++ G Y+APE
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGISGYL---VDDVAKDIDAGCKPYMAPERINPELN 186
Query: 471 FGGVSHKSDVYSYGMMIIEM 490
G S KSD++S G+ +IE+
Sbjct: 187 QKGYSVKSDIWSLGITMIEL 206
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-30
Identities = 71/290 (24%), Positives = 120/290 (41%), Gaps = 56/290 (19%)
Query: 296 SFRDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNG-------EEFINEVASISRTSH 347
++LG G + V K E G A K +K + EE EV+ + + H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 348 VNIVTFLGFCYENKKN-ALIYELMPNGSL-----DKFIHNDRNIKLEWKTMYQIAIGIAR 401
N++T YEN+ + LI EL+ G L K ++ + QI
Sbjct: 75 HNVITLHDV-YENRTDVVLILELVSGGELFDFLAQKESLSEEEAT---SFIKQIL----D 126
Query: 402 GLEYLHRGCQVRIVHFDIKPQNILL---DEDFCP-KISDFGLAKQAQKKESAISMLHARG 457
G+ YLH +I HFD+KP+NI+L + K+ DFGLA + + ++ G
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF---G 180
Query: 458 TIGYIAPEVYSRRFGGVSHKSDVYSYGMMI-IEMVGCTKNLDDEVTDTSICHNLIYERIE 516
T ++APE+ + + ++D++S G++ I + G + L D T I
Sbjct: 181 TPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGD--TKQE-----TLANIT 231
Query: 517 PGN-DFQ---FDGVATEEEKK-IAKMMILVGFWCIQTNPSERPSMHKVLE 561
+ DF F +E K I K+++ +R ++ + L
Sbjct: 232 SVSYDFDEEFFSHT-SELAKDFIRKLLVK--------ETRKRLTIQEALR 272
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 68/297 (22%), Positives = 118/297 (39%), Gaps = 52/297 (17%)
Query: 298 RDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEE-FINEVASISR-TSHVNIVTFL 354
D LG+G + V L Q AVK+++ + EV + + H N++ +
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 355 GFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMY------QIAIGIARGLEYLH 407
F +E + L++E M GS+ K + + + +A L++LH
Sbjct: 78 EF-FEEEDRFYLVFEKMRGGSI--L---SHIHK---RRHFNELEASVVVQDVASALDFLH 128
Query: 408 RGCQVRIVHFDIKPQNILL---DEDFCPKISDFGLAK-----QAQKKESAISMLHARGTI 459
I H D+KP+NIL ++ KI DF L S +L G+
Sbjct: 129 ---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 460 GYIAPEVYSRRFGGVSH---KSDVYSYG-MMIIEMVGC--------TKNLDDEVTDTSIC 507
Y+APEV S + D++S G ++ I + G + D C
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245
Query: 508 HNLIYERIEPGNDFQFDGVATEEEKKI---AKMMILVGFWCIQTNPSERPSMHKVLE 561
N+++E I+ G ++F ++ I AK +I + + +R S +VL+
Sbjct: 246 QNMLFESIQEG-KYEFPD---KDWAHISCAAKDLIS---KLLVRDAKQRLSAAQVLQ 295
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 76/292 (26%), Positives = 124/292 (42%), Gaps = 60/292 (20%)
Query: 296 SFRDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNG-------EEFINEVASISRTSH 347
++LG G + V K + G+ A K +K R + EE EV + H
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 348 VNIVTFLGFCYENKKN-ALIYELMPNGSLDKFIHNDRNIKLEWKT-------MYQIAIGI 399
NI+T +ENK + LI EL+ G L F D + E T + QI
Sbjct: 68 PNIITLHDI-FENKTDVVLILELVSGGEL--F---DFLAEKESLTEDEATQFLKQIL--- 118
Query: 400 ARGLEYLHRGCQVRIVHFDIKPQNILL----DEDFCPKISDFGLAKQAQKKESAISMLHA 455
G+ YLH RI HFD+KP+NI+L + K+ DFG+A + + ++
Sbjct: 119 -DGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF-- 172
Query: 456 RGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMI-IEMVGCTKNLDDEVTDTSICHNLIYER 514
GT ++APE+ + + ++D++S G++ I + G + L + T
Sbjct: 173 -GTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGE--TKQE-----TLTN 222
Query: 515 IEPGN-DFQ---FDGVATEEEKK-IAKMMILVGFWCIQTNPSERPSMHKVLE 561
I N DF F +E K I ++++ +P R ++ + LE
Sbjct: 223 ISAVNYDFDEEYFSNT-SELAKDFIRRLLV--------KDPKRRMTIAQSLE 265
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 71/318 (22%), Positives = 128/318 (40%), Gaps = 67/318 (21%)
Query: 281 APKRYSYSDVK-----RMTKSFRDK------LGQGGYGEVYKG-ELPDGQLVAVKVLKNS 328
K + + D+ K+ RD+ LG G GEV E + VA++++
Sbjct: 112 RNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKR 171
Query: 329 RCNGEE---------FINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSL-DKF 378
+ E+ + + +H I+ F ++ + ++ ELM G L DK
Sbjct: 172 KFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKV 230
Query: 379 IHND-------RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL---DE 428
+ N + YQ+ ++YLH + I+H D+KP+N+LL +E
Sbjct: 231 VGNKRLKEATCKLY------FYQML----LAVQYLH---ENGIIHRDLKPENVLLSSQEE 277
Query: 429 DFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEV-YSRRFGGVSHKSDVYSYGMMI 487
D KI+DFG +K + ++ GT Y+APEV S G + D +S G+++
Sbjct: 278 DCLIKITDFGHSKILGETSLMRTLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
Query: 488 -IEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKI---AKMMILVGF 543
I + G + T S + ++I G + F E ++ A ++
Sbjct: 335 FICLSGYPP-FSEHRTQVS-----LKDQITSG-KYNFI---PEVWAEVSEKALDLVK--- 381
Query: 544 WCIQTNPSERPSMHKVLE 561
+ +P R + + L
Sbjct: 382 KLLVVDPKARFTTEEALR 399
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 67/295 (22%), Positives = 118/295 (40%), Gaps = 61/295 (20%)
Query: 294 TKSFRDK------LGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEE---FINEVASIS 343
+ F D LG+G + V + G A K++ + + + E
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 344 RTSHVNIVTFLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEW-------KTMYQI 395
+ H NIV + + L+++L+ G L F + + E+ + QI
Sbjct: 61 KLQHPNIVRLHDS-IQEESFHYLVFDLVTGGEL--F---EDIVAREFYSEADASHCIQQI 114
Query: 396 AIGIARGLEYLHRGCQVRIVHFDIKPQNILL---DEDFCPKISDFGLAKQAQKKESAISM 452
+ Y H IVH ++KP+N+LL + K++DFGLA + E+
Sbjct: 115 L----ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 167
Query: 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYG-MMIIEMVGCTKNLDDEVTDTSICHNLI 511
GT GY++PEV + D+++ G ++ I +VG D+ +
Sbjct: 168 A---GTPGYLSPEVLKKDPYS--KPVDIWACGVILYILLVGYPPFWDE--DQHR-----L 215
Query: 512 YERIEPGN-DF---QFDGVATEEEKK-IAKMMILVGFWCIQTNPSERPSMHKVLE 561
Y +I+ G D+ ++D V T E K I M+ NP +R + + L+
Sbjct: 216 YAQIKAGAYDYPSPEWDTV-TPEAKSLIDSML--------TVNPKKRITADQALK 261
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 49/204 (24%), Positives = 86/204 (42%), Gaps = 23/204 (11%)
Query: 298 RDKLGQGGYGEVYKGELPDGQL---VAVKVLKNSRCNGEEFI----NEVASISRTSHVNI 350
R +G+GG G+VY+ E D VA+K++ + + F E + R ++
Sbjct: 39 RRLVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHV 96
Query: 351 VTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGC 410
V F + + + L+ L + R L I I L+ H
Sbjct: 97 VPIHDFGEIDGQLYVDMRLINGVDLAAMLR--RQGPLAPPRAVAIVRQIGSALDAAHA-- 152
Query: 411 QVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR-GTIGYIAPEVYSR 469
H D+KP+NIL+ D + DFG+A + ++ L GT+ Y+APE
Sbjct: 153 -AGATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPE---- 205
Query: 470 RFGG--VSHKSDVYSYGMMIIEMV 491
RF ++++D+Y+ ++ E +
Sbjct: 206 RFSESHATYRADIYALTCVLYECL 229
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-29
Identities = 73/323 (22%), Positives = 131/323 (40%), Gaps = 51/323 (15%)
Query: 260 KKKTREDDRNVEAFIRNHESLAPKRYSYSDVKRMTKSFRD------KLGQGGYGEVYKG- 312
+ K V + N+ K+Y V+ D +LG G +G V++
Sbjct: 118 QGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVT 177
Query: 313 ELPDGQLVAVKVLKNSRCNGEEFI-NEVASISRTSHVNIVTFLGFCYENKKN-ALIYELM 370
E G A K + + +E + E+ ++S H +V +E+ +IYE M
Sbjct: 178 ERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-FEDDNEMVMIYEFM 236
Query: 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIAR----GLEYLHRGCQVRIVHFDIKPQNILL 426
G L F ++ K A+ R GL ++H + VH D+KP+NI+
Sbjct: 237 SGGEL--F---EKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMF 288
Query: 427 --DEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYG 484
K+ DFGL K+ S+ GT + APEV + V + +D++S G
Sbjct: 289 TTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGK--PVGYYTDMWSVG 343
Query: 485 MMI-IEMVGCTKNLDDEVTDTSICHNLIYERIEPGN-DFQ---FDGVATEEEKK-IAKMM 538
++ I + G + + D ++ + + F G+ +E+ K I K++
Sbjct: 344 VLSYILLSGLSPFGGE--NDDE-----TLRNVKSCDWNMDDSAFSGI-SEDGKDFIRKLL 395
Query: 539 ILVGFWCIQTNPSERPSMHKVLE 561
+ +P+ R ++H+ LE
Sbjct: 396 LA--------DPNTRMTIHQALE 410
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 55/280 (19%), Positives = 111/280 (39%), Gaps = 44/280 (15%)
Query: 296 SFRDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFL 354
+ LG+G +G V++ E + K +K + E++ ++ H NI+
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLH 67
Query: 355 GFCYENKKN-ALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIAR----GLEYLHRG 409
+E+ + +I+E + + F +R ++ + + L++LH
Sbjct: 68 ES-FESMEELVMIFEFISGLDI--F---ERINTSAFELNEREIVSYVHQVCEALQFLH-- 119
Query: 410 CQVRIVHFDIKPQNILL--DEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVY 467
I HFDI+P+NI+ KI +FG A+Q + ++ + Y APEV+
Sbjct: 120 -SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPEYYAPEVH 175
Query: 468 SRRFGGVSHKSDVYSYGMMI-IEMVGCTKNLDDEVTDTSICHNLIYERIEPGN-DFQ--- 522
VS +D++S G ++ + + G L + T+ I E I F
Sbjct: 176 QHD--VVSTATDMWSLGTLVYVLLSGINPFLAE--TNQQ-----IIENIMNAEYTFDEEA 226
Query: 523 FDGVATEEEKK-IAKMMILVGFWCIQTNPSERPSMHKVLE 561
F + + E + ++++ R + + L+
Sbjct: 227 FKEI-SIEAMDFVDRLLVK--------ERKSRMTASEALQ 257
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 3e-29
Identities = 40/218 (18%), Positives = 75/218 (34%), Gaps = 32/218 (14%)
Query: 297 FRDKLGQGGYGEVYKGE------LPDGQLVAVKVLKNSRCNGEEF---INEVASISRTSH 347
LG+G + +VY+ + Q +KV K + N EF + + +
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQ 126
Query: 348 VNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIK----LEWKTMYQIAIGIARGL 403
+ F + L+ EL G+L I+ +N + + A+ + +
Sbjct: 127 HMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS-FAMRMLYMI 185
Query: 404 EYLHRGCQVRIVHFDIKPQNILLDEDFCP-----------KISDFGLAKQAQKKESAISM 452
E +H I+H DIKP N +L F + D G + +
Sbjct: 186 EQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242
Query: 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEM 490
T G+ E+ S + +++ D + + M
Sbjct: 243 TAKCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCM 278
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-29
Identities = 60/282 (21%), Positives = 111/282 (39%), Gaps = 50/282 (17%)
Query: 297 FRDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEE-FINEVASISRTSHVNIVTFL 354
+ +G+G +GEV + A K + + F E+ + H NI+
Sbjct: 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 72
Query: 355 GFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEW-------KTMYQIAIGIARGLEYL 406
+E+ + L+ EL G L F +R + + M + + Y
Sbjct: 73 ET-FEDNTDIYLVMELCTGGEL--F---ERVVHKRVFRESDAARIMKDVL----SAVAYC 122
Query: 407 HRGCQVRIVHFDIKPQNILL---DEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIA 463
H ++ + H D+KP+N L D K+ DFGLA + + + + + GT Y++
Sbjct: 123 H---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV---GTPYYVS 176
Query: 464 PEVYSRRFGGVSHKSDVYSYG-MMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQ 522
P+V +G + D +S G MM + + G TD+ + +I G F
Sbjct: 177 PQVLEGLYG---PECDEWSAGVMMYVLLCGYPPFSAP--TDSE-----VMLKIREG-TFT 225
Query: 523 FDGVATEEEKKI---AKMMILVGFWCIQTNPSERPSMHKVLE 561
F ++ + A+ +I + +P +R + + LE
Sbjct: 226 FPE---KDWLNVSPQAESLIRR---LLTKSPKQRITSLQALE 261
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 60/293 (20%), Positives = 105/293 (35%), Gaps = 62/293 (21%)
Query: 297 FRDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFI------NEVASISRTSHVN 349
+ +G+G + V + GQ AVK++ ++ + E + H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 350 IVTFLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKT-----------MYQIAI 397
IV L Y + +++E M L +K M QI
Sbjct: 88 IVELLET-YSSDGMLYMVFEFMDGADL--C---FEIVKRADAGFVYSEAVASHYMRQIL- 140
Query: 398 GIARGLEYLHRGCQVRIVHFDIKPQNILL---DEDFCPKISDFGLAKQAQKKESAISMLH 454
L Y H I+H D+KP +LL + K+ FG+A Q +
Sbjct: 141 ---EALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV--AGG 192
Query: 455 ARGTIGYIAPEVYSRRFGGVSHKSDVYSYG-MMIIEMVGCTKNLDDEVTDTSICHNLIYE 513
GT ++APEV R DV+ G ++ I + GC + ++E
Sbjct: 193 RVGTPHFMAPEVVKRE--PYGKPVDVWGCGVILFILLSGCLPFYGTK--------ERLFE 242
Query: 514 RIEPGN-DF---QFDGVATEEEKK-IAKMMILVGFWCIQTNPSERPSMHKVLE 561
I G Q+ + +E K + +M+ +P+ER ++++ L
Sbjct: 243 GIIKGKYKMNPRQWSHI-SESAKDLVRRML--------MLDPAERITVYEALN 286
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 75/337 (22%), Positives = 130/337 (38%), Gaps = 62/337 (18%)
Query: 275 RNHESLAPKRYSYSDVKRMTKSFRDK-------LGQGGYGEVYKG-ELPDGQLVAVKVLK 326
+H S + + + ++F + LG+G + V + GQ A K LK
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK 63
Query: 327 NSRCNG---EEFINEVASISRTSHV-NIVTFLGFCYENKKN-ALIYELMPNGSLDKFIHN 381
R E ++E+A + ++ YEN LI E G + F
Sbjct: 64 KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV-YENTSEIILILEYAAGGEI--F--- 117
Query: 382 DRNIKLEWKTMY--QIAIGIAR----GLEYLHRGCQVRIVHFDIKPQNILL---DEDFCP 432
E M I + + G+ YLH Q IVH D+KPQNILL
Sbjct: 118 SL-CLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDI 173
Query: 433 KISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMI-IEMV 491
KI DFG++++ ++ GT Y+APE+ + ++ +D+++ G++ + +
Sbjct: 174 KIVDFGMSRKIGHACELREIM---GTPEYLAPEILNYD--PITTATDMWNIGIIAYMLLT 228
Query: 492 GCTKNLDDEVTDTSICHNLIYERIEPGN-DFQ---FDGVATEEEKK-IAKMMILVGFWCI 546
+ + + + Y I N D+ F V ++ I +++
Sbjct: 229 HTSPFVGE--DNQE-----TYLNISQVNVDYSEETFSSV-SQLATDFIQSLLVK------ 274
Query: 547 QTNPSERPSMHKVLE---MLEGSIENLQIPPKPSLFS 580
NP +RP+ L + + ENL P + S S
Sbjct: 275 --NPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSS 309
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 72/291 (24%), Positives = 121/291 (41%), Gaps = 58/291 (19%)
Query: 296 SFRDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNG-------EEFINEVASISRTSH 347
++LG G + V K E G A K +K R E+ EV+ + H
Sbjct: 14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 348 VNIVTFLGFCYENKKN-ALIYELMPNGSLDKFIHNDRNIKLEWKTMY--QIAIGIAR--- 401
N++T YENK + LI EL+ G L F D + K + A +
Sbjct: 74 PNVITLHEV-YENKTDVILILELVAGGEL--F---DFLAE---KESLTEEEATEFLKQIL 124
Query: 402 -GLEYLHRGCQVRIVHFDIKPQNILL----DEDFCPKISDFGLAKQAQKKESAISMLHAR 456
G+ YLH ++I HFD+KP+NI+L KI DFGLA + ++
Sbjct: 125 NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 178
Query: 457 GTIGYIAPEVYSRRFGGVSHKSDVYSYGMMI-IEMVGCTKNLDDEVTDTSICHNLIYERI 515
GT ++APE+ + + ++D++S G++ I + G + L D T +
Sbjct: 179 GTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGD--TKQE-----TLANV 229
Query: 516 EPGN-DFQ---FDGVATEEEKK-IAKMMILVGFWCIQTNPSERPSMHKVLE 561
N +F+ F + K I ++++ +P +R ++ L+
Sbjct: 230 SAVNYEFEDEYFSNT-SALAKDFIRRLLVK--------DPKKRMTIQDSLQ 271
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 66/286 (23%), Positives = 119/286 (41%), Gaps = 55/286 (19%)
Query: 297 FRDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEE---FINEVASISRTSHVNIVT 352
+++LG+G + V + G A K++ + + + E + H NIV
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 353 FLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEW-------KTMYQIAIGIARGLE 404
+ + L+++L+ G L F + + E+ + QI +
Sbjct: 93 LHDS-IQEESFHYLVFDLVTGGEL--F---EDIVAREFYSEADASHCIQQIL----ESIA 142
Query: 405 YLHRGCQVRIVHFDIKPQNILL---DEDFCPKISDFGLAKQAQKKESAISMLHARGTIGY 461
Y H IVH ++KP+N+LL + K++DFGLA + E+ GT GY
Sbjct: 143 YCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTPGY 196
Query: 462 IAPEVYSRRFGGVSHKSDVYSYG-MMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGN- 519
++PEV + S D+++ G ++ I +VG D+ +Y +I+ G
Sbjct: 197 LSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDE--DQHR-----LYAQIKAGAY 247
Query: 520 DF---QFDGVATEEEKK-IAKMMILVGFWCIQTNPSERPSMHKVLE 561
D+ ++D V T E K I M+ NP +R + + L+
Sbjct: 248 DYPSPEWDTV-TPEAKSLIDSML--------TVNPKKRITADQALK 284
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 9e-29
Identities = 39/307 (12%), Positives = 89/307 (28%), Gaps = 74/307 (24%)
Query: 301 LGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFINEV-------------------- 339
LGQ + + G+ V V + I ++
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 340 --------ASISRTSHVNIVTFLGFCYENKKNALIYELMP--NGSLDKFI-----HNDRN 384
+ + + + + + L P +L F H+ +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 385 IKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444
L Q+ + + R L LH +VH ++P +I+LD+ ++ F +
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 445 KKESAISMLHARGTIGYIAPEVYSRRFG---------GVSHKSDVYSYGMMIIEMV-GCT 494
+ + + G+ PE+ +RR ++ D ++ G++I +
Sbjct: 258 ARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 495 KNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERP 554
D E I F+ + + ++ ++ +R
Sbjct: 312 PITKDAALGG-------SEWI-----FRSCKNIPQP----VRALLE---GFLRYPKEDRL 352
Query: 555 SMHKVLE 561
+ +E
Sbjct: 353 LPLQAME 359
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-28
Identities = 61/306 (19%), Positives = 122/306 (39%), Gaps = 56/306 (18%)
Query: 297 FRDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTF 353
+++LG GG+G V + G+ VA+K + N E + E+ + + +H N+V+
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS- 76
Query: 354 LGFCYENKKNA-------LIYELMPNGSLDKFIH-NDRNIKLEWKTMYQIAIGIARGLEY 405
+ + L E G L K+++ + L+ + + I+ L Y
Sbjct: 77 AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRY 136
Query: 406 LHRGCQVRIVHFDIKPQNILLD---EDFCPKISDFGLAKQAQKKESAISMLHARGTIGYI 462
LH + RI+H D+KP+NI+L + KI D G AK+ + E + GT+ Y+
Sbjct: 137 LH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV---GTLQYL 190
Query: 463 APEVYSRRFGGVSHKSDVYSYGMMIIEMVGC-------------------TKNLDDEVTD 503
APE+ ++ + D +S+G + E + K+ + V
Sbjct: 191 APELLEQK--KYTVTVDYWSFGTLAFECI-TGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247
Query: 504 TSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSM-----HK 558
+ + + + P + +A + E+ + M+ + +R +
Sbjct: 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCML--------MWHQRQRGTDPQNPNVG 299
Query: 559 VLEMLE 564
+ L+
Sbjct: 300 CFQALD 305
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 69/307 (22%), Positives = 115/307 (37%), Gaps = 68/307 (22%)
Query: 291 KRMTKSFRDK------LGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNG----------E 333
T F + LG+G V + P + AVK++ + E
Sbjct: 9 SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 334 EFINEVASISRTS-HVNIVTFLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEW-- 389
+ EV + + S H NI+ YE L+++LM G L F D +
Sbjct: 69 ATLKEVDILRKVSGHPNIIQLKDT-YETNTFFFLVFDLMKKGEL--F---DYLTEKVTLS 122
Query: 390 -----KTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444
K M + + LH ++ IVH D+KP+NILLD+D K++DFG + Q
Sbjct: 123 EKETRKIMRALL----EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175
Query: 445 KKESAISMLHARGTIGYIAPEVYSRRFGGVSH----KSDVYSYG-MMIIEMVGCTKNLDD 499
E + GT Y+APE+ + D++S G +M + G
Sbjct: 176 PGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 232
Query: 500 EVTDTSICHNLIYERIEPGN-DF---QFDGVATEEEKK-IAKMMILVGFWCIQTNPSERP 554
+ L+ I GN F ++D ++ K +++ + P +R
Sbjct: 233 K-------QMLMLRMIMSGNYQFGSPEWDDY-SDTVKDLVSRFL--------VVQPQKRY 276
Query: 555 SMHKVLE 561
+ + L
Sbjct: 277 TAEEALA 283
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 65/354 (18%), Positives = 114/354 (32%), Gaps = 90/354 (25%)
Query: 274 IRNHESLAPKRYSYSDVKRMTKSFRDK------LGQGGYGEVYKG-ELPDGQLVAVKVLK 326
+ +H + R + + K +GQG YG V E + A+K++
Sbjct: 1 MHHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60
Query: 327 NSRCNG------EEFINEVASISRTSHVNIVTFLGFCYENKKNA-LIYELMPNGSLDKFI 379
++ E EV + + H NI YE+++ L+ EL G L +
Sbjct: 61 KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYE-VYEDEQYICLVMELCHGGHLLDKL 119
Query: 380 HNDRNIKLEWKTMYQIAIG--------------------------------------IAR 401
+ + M + I
Sbjct: 120 NVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179
Query: 402 GLEYLHRGCQVRIVHFDIKPQNILL--DEDFCPKISDFGLAK--QAQKKESAISMLHARG 457
L YLH I H DIKP+N L ++ F K+ DFGL+K M G
Sbjct: 180 ALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAG 236
Query: 458 TIGYIAPEVYSRRFGGVSHKSDVYSYG-MMIIEMVGCT----KNLDDEVTDTSICHNLIY 512
T ++APEV + K D +S G ++ + ++G N D
Sbjct: 237 TPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD-----------TI 285
Query: 513 ERIEPGN-DF---QFDGVATEEEKK-IAKMMILVGFWCIQTNPSERPSMHKVLE 561
++ F ++ + + + ++ ++ N ER + L+
Sbjct: 286 SQVLNKKLCFENPNYNVL-SPLARDLLSNLL--------NRNVDERFDAMRALQ 330
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 70/299 (23%), Positives = 122/299 (40%), Gaps = 62/299 (20%)
Query: 295 KSFRDK------LGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEE---------FINE 338
K+ RD+ LG G GEV E + VA+K++ + E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 339 VASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSL-DKFIHND-------RNIKLEWK 390
+ + + +H I+ F ++ + ++ ELM G L DK + N +
Sbjct: 66 IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY----- 119
Query: 391 TMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL---DEDFCPKISDFGLAKQAQKKE 447
YQ+ ++YLH I+H D+KP+N+LL +ED KI+DFG +K +
Sbjct: 120 -FYQML----LAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 171
Query: 448 SAISMLHARGTIGYIAPEV-YSRRFGGVSHKSDVYSYGMMI-IEMVGCTKNLDDEVTDTS 505
++ GT Y+APEV S G + D +S G+++ I + G + T S
Sbjct: 172 LMRTLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP-FSEHRTQVS 227
Query: 506 ICHNLIYERIEPGNDFQFDGVATEEEKKI---AKMMILVGFWCIQTNPSERPSMHKVLE 561
+ ++I G + F E ++ A ++ + +P R + + L
Sbjct: 228 -----LKDQITSG-KYNFI---PEVWAEVSEKALDLVKK---LLVVDPKARFTTEEALR 274
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 43/325 (13%), Positives = 89/325 (27%), Gaps = 72/325 (22%)
Query: 278 ESLAPKRYSYSDVKRMTKSFRDKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEFI 336
ES +R + LGQ + G+ V V + I
Sbjct: 70 ESELGERPRTLVRGTV-------LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAI 122
Query: 337 NE----------------------------VASISRTSHVNIVTFLGFCYENKKNALIYE 368
+ + + + + + +
Sbjct: 123 KQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFF 182
Query: 369 LMP--NGSLDKFI-----HNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKP 421
L P +L F H+ + L Q+ + + R L LH +VH ++P
Sbjct: 183 LYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRP 239
Query: 422 QNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR-GTIGYIAPEVYSRRFGG---VSHK 477
+I+LD+ ++ F + SA+S + A + ++
Sbjct: 240 VDIVLDQRGGVFLTGFEHLVRDG--ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFA 297
Query: 478 SDVYSYGMMIIEMV-GCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAK 536
D ++ G+ I + N DD E I F+ + +
Sbjct: 298 FDTWTLGLAIYWIWCADLPNTDDAALGG-------SEWI-----FRSCKNIPQP----VR 341
Query: 537 MMILVGFWCIQTNPSERPSMHKVLE 561
++ ++ +R + +E
Sbjct: 342 ALLE---GFLRYPKEDRLLPLQAME 363
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-28
Identities = 64/285 (22%), Positives = 124/285 (43%), Gaps = 50/285 (17%)
Query: 296 SFRDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNG---EEFINEVASISRTSHVNIV 351
++LG+G + V + ++ GQ A ++ + + ++ E H NIV
Sbjct: 14 QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 352 TFLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEW-------KTMYQIAIGIARGL 403
+ + LI++L+ G L F + + E+ + QI +
Sbjct: 74 RLHDS-ISEEGHHYLIFDLVTGGEL--F---EDIVAREYYSEADASHCIQQIL----EAV 123
Query: 404 EYLHRGCQVRIVHFDIKPQNILL---DEDFCPKISDFGLAKQAQKKESAISMLHARGTIG 460
+ H Q+ +VH ++KP+N+LL + K++DFGLA + + ++ A GT G
Sbjct: 124 LHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA--WFGFAGTPG 178
Query: 461 YIAPEVYSRRFGGVSHKSDVYSYG-MMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGN 519
Y++PEV + G D+++ G ++ I +VG D+ +Y++I+ G
Sbjct: 179 YLSPEVLRKDPYG--KPVDLWACGVILYILLVGYPPFWDE--DQHR-----LYQQIKAG- 228
Query: 520 DFQFDGVATEEEKKI---AKMMILVGFWCIQTNPSERPSMHKVLE 561
+ F + E + AK +I + NPS+R + + L+
Sbjct: 229 AYDFP---SPEWDTVTPEAKDLIN---KMLTINPSKRITAAEALK 267
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 65/296 (21%), Positives = 118/296 (39%), Gaps = 50/296 (16%)
Query: 283 KRYSYSDVKRMTKSFRDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFINEVAS 341
+ Y + LG+G + K Q AVK++ E+ +
Sbjct: 8 QHYDLDLKDK-------PLGEGSFSICRKCVHKKSNQAFAVKIISKRME--ANTQKEITA 58
Query: 342 ISRTS-HVNIVTFLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEW-------KTM 392
+ H NIV + ++ + L+ EL+ G L F +R K + M
Sbjct: 59 LKLCEGHPNIVKLHEV-FHDQLHTFLVMELLNGGEL--F---ERIKKKKHFSETEASYIM 112
Query: 393 YQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL---DEDFCPKISDFGLAKQAQKKESA 449
++ + ++H V +VH D+KP+N+L +++ KI DFG A+ K
Sbjct: 113 RKLV----SAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR--LKPPDN 163
Query: 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYG-MMIIEMVGCTKNLDDEVTDTSICH 508
+ T+ Y APE+ ++ G D++S G ++ + G + + T
Sbjct: 164 QPLKTPCFTLHYAAPELLNQN--GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSA 221
Query: 509 NLIYERIEPGNDFQFDGVATEEEKKI---AKMMILVGFWCIQTNPSERPSMHKVLE 561
I ++I+ G DF F+G E K + AK +I + +P++R M +
Sbjct: 222 VEIMKKIKKG-DFSFEG---EAWKNVSQEAKDLIQ---GLLTVDPNKRLKMSGLRY 270
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 51/247 (20%), Positives = 90/247 (36%), Gaps = 33/247 (13%)
Query: 328 SRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIK- 386
S + ++ + S N V L + +L +L +++ +++
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 387 LEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446
E I I IA +E+LH ++H D+KP NI D K+ DFGL +
Sbjct: 161 REHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 447 ESAISMLHAR----------GTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKN 496
E ++L GT Y++PE SHK D++S G+++ E+
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGN--NYSHKVDIFSLGLILFEL--LYS- 272
Query: 497 LDDEVTDTSICHNLIYERIEPGN-DFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPS 555
T + I + F +E + M+ +P+ERP
Sbjct: 273 -----FSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDML--------SPSPTERPE 319
Query: 556 MHKVLEM 562
++E
Sbjct: 320 ATDIIEN 326
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 71/314 (22%), Positives = 121/314 (38%), Gaps = 59/314 (18%)
Query: 276 NHESLAPKRYSYSDVKRMTKSFRDK-------LGQGGYGEVYKG-ELPDGQLVAVKVLKN 327
+H + + + + D LG G G+V + GQ A+K+L +
Sbjct: 5 HHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD 64
Query: 328 SRCNGEEFINEVASISRTS-HVNIVTFLGFCYENKKNA-----LIYELMPNGSL-DKFIH 380
S +E V + S +IV L YEN + +I E M G L +
Sbjct: 65 SPKARQE----VDHHWQASGGPHIVCILDV-YENMHHGKRCLLIIMECMEGGELFSRIQE 119
Query: 381 NDRNIKLEW---KTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL---DEDFCPKI 434
E + M I +++LH I H D+KP+N+L ++D K+
Sbjct: 120 RGDQAFTEREAAEIMRDIG----TAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKL 172
Query: 435 SDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYG-MMIIEMVGC 493
+DFG AK+ + + T Y+APEV D++S G +M I + G
Sbjct: 173 TDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGF 226
Query: 494 T---KNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKI---AKMMILVGFWCIQ 547
N ++ + RI G + F E ++ AK +I ++
Sbjct: 227 PPFYSNTGQAISPG------MKRRIRLG-QYGFPN---PEWSEVSEDAKQLIR---LLLK 273
Query: 548 TNPSERPSMHKVLE 561
T+P+ER ++ + +
Sbjct: 274 TDPTERLTITQFMN 287
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 70/281 (24%), Positives = 121/281 (43%), Gaps = 48/281 (17%)
Query: 297 FRDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLG 355
+LG+G VY+ + + A+KVLK + + + E+ + R SH NI+
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKE 115
Query: 356 FCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEW-------KTMYQIAIGIARGLEYLH 407
+E L+ EL+ G L F DR ++ + + QI + YLH
Sbjct: 116 I-FETPTEISLVLELVTGGEL--F---DRIVEKGYYSERDAADAVKQIL----EAVAYLH 165
Query: 408 RGCQVRIVHFDIKPQNILL---DEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAP 464
+ IVH D+KP+N+L D KI+DFGL+K + + ++ GT GY AP
Sbjct: 166 ---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC---GTPGYCAP 219
Query: 465 EVYSRRFGGVSHKSDVYSYGMMI-IEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQF 523
E+ + D++S G++ I + G DE D ++ RI ++ F
Sbjct: 220 EILRGC--AYGPEVDMWSVGIITYILLCGFEP-FYDERGDQF-----MFRRILNC-EYYF 270
Query: 524 DGVATEEEKKI---AKMMILVGFWCIQTNPSERPSMHKVLE 561
+ ++ AK ++ I +P +R + + L+
Sbjct: 271 I---SPWWDEVSLNAKDLVR---KLIVLDPKKRLTTFQALQ 305
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 48/199 (24%), Positives = 89/199 (44%), Gaps = 14/199 (7%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGE--EFINEVASISRTS-HVNIVTFL 354
++G G G+V+K G ++AVK ++ S E + ++ + ++ IV
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90
Query: 355 GFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRI 414
G N + ELM +K + E + + ++ + I + L YL + +
Sbjct: 91 GTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPE-RILGKMTVAIVKALYYLKE--KHGV 146
Query: 415 VHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEV---YSRRF 471
+H D+KP NILLDE K+ DFG++ + + + G Y+APE
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRL---VDDKAKDRSAGCAAYMAPERIDPPDPTK 203
Query: 472 GGVSHKSDVYSYGMMIIEM 490
++DV+S G+ ++E+
Sbjct: 204 PDYDIRADVWSLGISLVEL 222
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 64/306 (20%), Positives = 114/306 (37%), Gaps = 67/306 (21%)
Query: 291 KRMTKSFRDK------LGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNG---------EE 334
K F K +G+G V + G AVK+++ + E
Sbjct: 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREA 145
Query: 335 FINEVASISRTS-HVNIVTFLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEW--- 389
E + + + H +I+T + YE+ L+++LM G L F D +
Sbjct: 146 TRRETHILRQVAGHPHIITLIDS-YESSSFMFLVFDLMRKGEL--F---DYLTEKVALSE 199
Query: 390 ----KTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445
M + + +LH IVH D+KP+NILLD++ ++SDFG + +
Sbjct: 200 KETRSIMRSLL----EAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252
Query: 446 KESAISMLHARGTIGYIAPEVYSRRFGGV----SHKSDVYSYG-MMIIEMVGCTKNLDDE 500
E + GT GY+APE+ + D+++ G ++ + G
Sbjct: 253 GE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309
Query: 501 VTDTSICHNLIYERIEPGNDFQFDG----VATEEEKK-IAKMMILVGFWCIQTNPSERPS 555
L+ I G +QF + K I++++ Q +P R +
Sbjct: 310 -------QILMLRMIMEG-QYQFSSPEWDDRSSTVKDLISRLL--------QVDPEARLT 353
Query: 556 MHKVLE 561
+ L+
Sbjct: 354 AEQALQ 359
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 67/287 (23%), Positives = 114/287 (39%), Gaps = 49/287 (17%)
Query: 295 KSFRDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFINEVASISRTS-HVNIVT 352
K LG G G+V + + A+K+L++ + EV R S +IV
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVR 119
Query: 353 FLGFCYENKKNA-----LIYELMPNGSLDKFIHNDRNIKLEWKTMY------QIAIGIAR 401
+ YEN ++ E + G L F R I+ + +I I
Sbjct: 120 IVDV-YENLYAGRKCLLIVMECLDGGEL--F---SR-IQDRGDQAFTEREASEIMKSIGE 172
Query: 402 GLEYLHRGCQVRIVHFDIKPQNILL---DEDFCPKISDFGLAKQAQKKESAISMLHARGT 458
++YLH + I H D+KP+N+L + K++DFG AK+ S+ T
Sbjct: 173 AIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYT 226
Query: 459 IGYIAPEVYSRRFGGVSHKSDVYSYG-MMIIEMVGCTKNLDDEVTDTSICHNLIYERIEP 517
Y+APEV D++S G +M I + G + S + RI
Sbjct: 227 PYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIRM 281
Query: 518 GNDFQFDGVATEEEKKI---AKMMILVGFWCIQTNPSERPSMHKVLE 561
G ++F E ++ KM+I ++T P++R ++ + +
Sbjct: 282 G-QYEFPN---PEWSEVSEEVKMLIR---NLLKTEPTQRMTITEFMN 321
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-25
Identities = 66/203 (32%), Positives = 97/203 (47%), Gaps = 26/203 (12%)
Query: 301 LGQGGYGEVYKGELPD-GQLVAVKVLKNSRC---NGEEF-INE---VASISRTSHVNIVT 352
+G+GG+GEVY D G++ A+K L R GE +NE ++ +S IV
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 353 FLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQ 411
+ + + I +LM G L + Y A I GLE++H
Sbjct: 257 -MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY--AAEIILGLEHMH---N 310
Query: 412 VRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR-GTIGYIAPEVYSRR 470
+V+ D+KP NILLDE +ISD GLA KK+ HA GT GY+APEV +
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HASVGTHGYMAPEVLQK- 364
Query: 471 FGGVSHKSDV--YSYGMMIIEMV 491
GV++ S +S G M+ +++
Sbjct: 365 --GVAYDSSADWFSLGCMLFKLL 385
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 26/202 (12%)
Query: 301 LGQGGYGEVYKGELPD-GQLVAVKVLKNSRCNGEEFINEVASI-------SRTSHVNIVT 352
+G+G +G+V + D ++ A+K + +C NEV ++ H +V
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVER---NEVRNVFKELQIMQGLEHPFLVN 79
Query: 353 FLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKL-EWKTMYQIA-IGIARGLEYLHRG 409
L + ++++++ ++ +L+ G L H +N+ E I + +A L+YL
Sbjct: 80 -LWYSFQDEEDMFMVVDLLLGGDL--RYHLQQNVHFKEETVKLFICELVMA--LDYLQ-- 132
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSR 469
RI+H D+KP NILLDE I+DF +A ++ +M GT Y+APE++S
Sbjct: 133 -NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GTKPYMAPEMFSS 188
Query: 470 RFG-GVSHKSDVYSYGMMIIEM 490
R G G S D +S G+ E+
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYEL 210
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 64/197 (32%), Positives = 98/197 (49%), Gaps = 15/197 (7%)
Query: 301 LGQGGYGEVYKGELPD-GQLVAVKVLKNSRC---NGEEF-INEVASISRTSHVNIVTFLG 355
LG+GG+GEV ++ G++ A K L+ R GE +NE + + + +V+ L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS-LA 250
Query: 356 FCYENK-KNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRI 414
+ YE K L+ LM G L I++ A I GLE LHR RI
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERI 307
Query: 415 VHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGV 474
V+ D+KP+NILLD+ +ISD GLA + ++ + GT+GY+APEV
Sbjct: 308 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV---GTVGYMAPEVVKNE--RY 362
Query: 475 SHKSDVYSYGMMIIEMV 491
+ D ++ G ++ EM+
Sbjct: 363 TFSPDWWALGCLLYEMI 379
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 66/275 (24%), Positives = 113/275 (41%), Gaps = 46/275 (16%)
Query: 301 LGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEFIN---------EVASISRTSHVNI 350
LG G +G V+ + V VK +K + + +I E+A +SR H NI
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 351 VTFLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRG 409
+ L +EN+ L+ E +G LD F DR+ +L+ I + + YL
Sbjct: 92 IKVLDI-FENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK 149
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR-GTIGYIAPEVYS 468
I+H DIK +NI++ EDF K+ DFG A ++ + + + GTI Y APEV
Sbjct: 150 ---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK----LFYTFCGTIEYCAPEVLM 202
Query: 469 RR-FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQF-DGV 526
+ G + +++S G+ + +V + E V
Sbjct: 203 GNPYRG--PELEMWSLGVTLYTLVFEENPFCE------------LEETVEA-AIHPPYLV 247
Query: 527 ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561
+ E ++ + +Q P R ++ K++
Sbjct: 248 SKELMSLVSGL--------LQPVPERRTTLEKLVT 274
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 64/268 (23%), Positives = 111/268 (41%), Gaps = 56/268 (20%)
Query: 247 SSCHSRTVIQALIKKKTREDDRNVEAFIRNHESLAPKRYSYSDVKRMTKSFRDKLGQGGY 306
S S + + + ++ ++ + ++ + +Y++ K +G G +
Sbjct: 2 SFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCK--------VIGNGSF 53
Query: 307 GEVYKGELPDGQLVAVK-VLKNSRCNGEEFIN-EVASISRTSHVNIVTFLGFCYENKKNA 364
G V++ +L + VA+K VL++ R F N E+ + H N+V F Y N
Sbjct: 54 GVVFQAKLVESDEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKK 108
Query: 365 ------LIYELMPNGSLDKFI--HNDRNIKLEWKT----MYQIAIGIARGLEYLHRGCQV 412
L+ E +P ++ + + + MYQ+ R L Y+H +
Sbjct: 109 DEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLL----RSLAYIH---SI 160
Query: 413 RIVHFDIKPQNILLDEDFCP-KISDFGLAKQAQKKESAISMLHARGTIGYI------APE 465
I H DIKPQN+LLD K+ DFG AK E +S YI APE
Sbjct: 161 GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS---------YICSRYYRAPE 211
Query: 466 VYSRRFGGV--SHKSDVYSYGMMIIEMV 491
+ FG + D++S G ++ E++
Sbjct: 212 LI---FGATNYTTNIDIWSTGCVMAELM 236
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 3e-23
Identities = 56/168 (33%), Positives = 83/168 (49%), Gaps = 26/168 (15%)
Query: 289 DVKRMTKSFR--DKLGQGGYGEVYKG-ELPDGQLVAVKVLK-NSRCNGEEFIN-----EV 339
DVK K + D LG+G + VYK + Q+VA+K +K R ++ IN E+
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 340 ASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDR------NIKLEWKTMY 393
+ SH NI+ L +L+++ M L+ I ++ +IK M
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIK---AYML 119
Query: 394 QIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAK 441
+GLEYLH Q I+H D+KP N+LLDE+ K++DFGLAK
Sbjct: 120 MTL----QGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 64/274 (23%), Positives = 106/274 (38%), Gaps = 40/274 (14%)
Query: 301 LGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYE 359
+G G +G +LVAVK ++ E E+ + H NIV F E
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRF----KE 83
Query: 360 ----NKKNALIYELMPNGSL-DKFIHNDR-NIKLEWKTMYQIAIGIARGLEYLHRGCQVR 413
A+I E G L ++ + R + Q+ G+ Y H ++
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGV----SYCHS---MQ 136
Query: 414 IVHFDIKPQNILLDEDFCP--KISDFGLAKQAQKKESAISMLHAR-GTIGYIAPEVYSRR 470
I H D+K +N LLD P KI DFG +K + S + GT YIAPEV R+
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLRQ 192
Query: 471 FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQF---DGVA 527
+DV+S G+ + M+ +D + + +RI + ++
Sbjct: 193 -EYDGKIADVWSCGVTLYVMLVGAYPFEDP--EEPRDYRKTIQRILSV-KYSIPDDIRIS 248
Query: 528 TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561
E I+++ +P+ R S+ ++
Sbjct: 249 PECCHLISRI--------FVADPATRISIPEIKT 274
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 55/232 (23%), Positives = 94/232 (40%), Gaps = 53/232 (22%)
Query: 286 SYSDVKRMTKSFRDKLGQGGYGEVYKG-ELPDGQLVAVK-VLKNSR-CNGEEFINEVASI 342
+ + GQG +G V G E G VA+K V+++ R N E + + +
Sbjct: 24 RFQVER--------MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE--LQIMQDL 73
Query: 343 SRTSHVNIVTFLGFCYENKKNA-------LIYELMPNGSLDKFIHNDRNIKLEWKT---- 391
+ H NIV + Y + ++ E +P+ +L + N ++
Sbjct: 74 AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIK 132
Query: 392 --MYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCP-KISDFGLAKQAQKKES 448
++Q+ R + LH + H DIKP N+L++E K+ DFG AK+ E
Sbjct: 133 VFLFQLI----RSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP 187
Query: 449 AISMLHARGTIGYI------APEVYSRRFGGV--SHKSDVYSYGMMIIEMVG 492
++ YI APE+ FG + D++S G + EM+
Sbjct: 188 NVA---------YICSRYYRAPELI---FGNQHYTTAVDIWSVGCIFAEMML 227
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 72/238 (30%), Positives = 108/238 (45%), Gaps = 63/238 (26%)
Query: 282 PKRYSYSDVKRMTKSFRDKLGQGGYGEVYKGEL-PDGQLVAVK-VLKNSRCNGEEFIN-E 338
P+ SY+D K +G G +G VY+ +L G+LVA+K VL++ R F N E
Sbjct: 51 PQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRE 97
Query: 339 VASISRTSHVNIVTFLGFCYENKKNA------LIYELMPNGSLDKFIHNDRN-------- 384
+ + + H NIV F Y + + L+ + +P ++ + +
Sbjct: 98 LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVI 156
Query: 385 -IKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCP-KISDFGLAKQ 442
+KL MYQ+ R L Y+H I H DIKPQN+LLD D K+ DFG AKQ
Sbjct: 157 YVKL---YMYQLF----RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206
Query: 443 AQKKESAISMLHARGTIGYI------APEVYSRRFGGV--SHKSDVYSYGMMIIEMVG 492
+ E +S YI APE+ FG + DV+S G ++ E++
Sbjct: 207 LVRGEPNVS---------YICSRYYRAPELI---FGATDYTSSIDVWSAGCVLAELLL 252
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 63/190 (33%), Positives = 89/190 (46%), Gaps = 15/190 (7%)
Query: 301 LGQGGYGEVYKGE-LPDGQLVAVKVL-KNSRCNGEEFIN-EVASISRTSHVNIVTFLGFC 357
LG+G YGEV + VAVK++ + E I E+ +H N+V F G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 358 YENKKNALIYELMPNGSL-DKFIHNDR-NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
E L E G L D+ + + +Q+ +A G+ YLH + I
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL---MA-GVVYLHG---IGIT 127
Query: 416 HFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR-GTIGYIAPEVYSRRFGGV 474
H DIKP+N+LLDE KISDFGLA + +L+ GT+ Y+APE+ RR
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-RLLNKMCGTLPYVAPELLKRR-EFH 185
Query: 475 SHKSDVYSYG 484
+ DV+S G
Sbjct: 186 AEPVDVWSCG 195
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 64/296 (21%), Positives = 110/296 (37%), Gaps = 43/296 (14%)
Query: 301 LGQGGYGEVYKGE-LPDGQLVAVKVLKNSR----CNGEEFIN-EVASISRTSHVNIVTFL 354
LG+G YG+V + AVK+LK + NGE + E+ + R H N++ +
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 355 GFCYENKKNA--LIYELMPNGS---LDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRG 409
Y +K ++ E G LD + Q+ I GLEYLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQL---ID-GLEYLHS- 127
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLH-ARGTIGYIAPEVYS 468
IVH DIKP N+LL KIS G+A+ + ++G+ + PE+ +
Sbjct: 128 --QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD-DTCRTSQGSPAFQPPEIAN 184
Query: 469 RRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLI--YERIEPGNDFQF-DG 525
K D++S G+ + + + + N+ +E I G +
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD--------NIYKLFENIGKG-SYAIPGD 235
Query: 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE---MLEGSIENLQIPPKPSL 578
+ M ++ P++R S+ ++ + + P P
Sbjct: 236 CGPPLSDLLKGM--------LEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPS 283
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-22
Identities = 49/178 (27%), Positives = 93/178 (52%), Gaps = 24/178 (13%)
Query: 275 RNHESLAPKRYSYSDVKRMTKSFR--DKLGQGGYGEVYKGELPDGQLVAVKVLK-NSRCN 331
+H + + Y + + + ++ +K+G+G YG VYK + G++VA+K ++ ++
Sbjct: 3 HHHHHSSGRENLYF--QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDE 60
Query: 332 GEEF--INEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDR------ 383
G I E++ + H NIV+ + + + L++E M L K + ++
Sbjct: 61 GIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDS 119
Query: 384 NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAK 441
IK +YQ+ RG+ + H+ RI+H D+KPQN+L++ D K++DFGLA+
Sbjct: 120 QIK---IYLYQLL----RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-22
Identities = 73/288 (25%), Positives = 119/288 (41%), Gaps = 33/288 (11%)
Query: 301 LGQGGYGEVYKGE-LPDGQLVAVKVL-KNSRCNGEEFIN-EVASISRTSHVNIVTFLGFC 357
LG+G YGEV + VAVK++ + E I E+ +H N+V F G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 358 YENKKNALIYELMPNGSL-DKFIHNDR-NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
E L E G L D+ + + +Q+ +A G+ YLH + I
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL---MA-GVVYLHG---IGIT 127
Query: 416 HFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR-GTIGYIAPEVYSRRFGGV 474
H DIKP+N+LLDE KISDFGLA + + +L+ GT+ Y+APE+ RR
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYN-NRERLLNKMCGTLPYVAPELLKRR-EFH 185
Query: 475 SHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQ--FDGVATEEEK 532
+ DV+S G+++ M+ D Y + + + + +
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-----EYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 533 KIAKMMILVGFWCIQTNPSERPSMHKVLE---MLEGSIENLQIPPKPS 577
+ K+ + NPS R ++ + + + + + P S
Sbjct: 241 LLHKI--------LVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS 280
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 7e-22
Identities = 44/151 (29%), Positives = 79/151 (52%), Gaps = 16/151 (10%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLK-NSRCNGEEF--INEVASISRTSHVNIVTFL 354
+K+G+G YG VYK G++VA+K ++ ++ G I E++ + +H NIV L
Sbjct: 9 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 355 GFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKT----MYQIAIGIARGLEYLHRGC 410
+ K L++E + L KF+ + ++Q+ +GL + H
Sbjct: 69 DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCHSH- 122
Query: 411 QVRIVHFDIKPQNILLDEDFCPKISDFGLAK 441
R++H D+KPQN+L++ + K++DFGLA+
Sbjct: 123 --RVLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 7e-22
Identities = 35/152 (23%), Positives = 68/152 (44%), Gaps = 17/152 (11%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCN-GEEFIN--EVASISRTSHVNIVTFL 354
K+G+G YG V+K GQ+VA+K S + + I E+ + + H N+V L
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 355 GFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKT----MYQIAIGIARGLEYLHRGC 410
++ L++E + ++ + + + +Q + + + H+
Sbjct: 69 EVFRRKRRLHLVFEYCDH-TVLHEL-DRYQRGVPEHLVKSITWQTL----QAVNFCHK-- 120
Query: 411 QVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ 442
+H D+KP+NIL+ + K+ DFG A+
Sbjct: 121 -HNCIHRDVKPENILITKHSVIKLCDFGFARL 151
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 9e-22
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 42/217 (19%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLK-NSRCNGEEFIN-----EVA---SISRTSHV 348
++G G YG VYK + G VA+K ++ + G + EVA + H
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 349 NIVTFLGFCYENKKNA-----LIYELMPNGSLDKFIHNDRNIKLEWKT----MYQIAIGI 399
N+V + C ++ + L++E + L ++ L +T M Q
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFL--- 130
Query: 400 ARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTI 459
RGL++LH IVH D+KP+NIL+ K++DFGLA+ +++ T+
Sbjct: 131 -RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALTPVVVTL 183
Query: 460 GYIAPEV-----YSRRFGGVSHKSDVYSYGMMIIEMV 491
Y APEV Y+ V D++S G + EM
Sbjct: 184 WYRAPEVLLQSTYA---TPV----DMWSVGCIFAEMF 213
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 63/269 (23%), Positives = 119/269 (44%), Gaps = 35/269 (13%)
Query: 301 LGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEFIN---EVASISRTSHVNIVTFLGF 356
+G+G + +V + G+ VA+K++ ++ N EV + +H NIV L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK-LFE 81
Query: 357 CYENKKNA-LIYELMPNGSL-DKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRI 414
E +K LI E G + D + + R ++ K I ++Y H+ I
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGR---MKEKEARSKFRQIVSAVQYCHQKR---I 135
Query: 415 VHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR-GTIGYIAPEVYSRRFGG 473
VH D+K +N+LLD D KI+DFG + + L A G Y APE++ +
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGG----KLDAFCGAPPYAAPELFQGK-KY 190
Query: 474 VSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQF-DGVATEEEK 532
+ DV+S G+++ +V + D + + ER+ G ++ ++T+ E
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKE------LRERVLRG-KYRIPFYMSTDCEN 243
Query: 533 KIAKMMILVGFWCIQTNPSERPSMHKVLE 561
+ + + NP +R ++ ++++
Sbjct: 244 LLKRFL--------VLNPIKRGTLEQIMK 264
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 2e-21
Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 22/202 (10%)
Query: 301 LGQGGYGEVYKGELPD-GQLVAVKVLKNSRC---NGEEF-INEVASISRTSHVNIVTFLG 355
LG+GG+GEV+ ++ G+L A K L R G + + E +++ IV+ L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS-LA 251
Query: 356 FCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAI----GIARGLEYLHRGC 410
+ +E K + L+ +M G + H + AI I GLE+LH
Sbjct: 252 YAFETKTDLCLVMTIMNGGDI--RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH--- 306
Query: 411 QVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR-GTIGYIAPEVYSR 469
Q I++ D+KP+N+LLD+D +ISD GLA + + ++ GT G++APE+
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT---KGYAGTPGFMAPELLLG 363
Query: 470 RFGGVSHKSDVYSYGMMIIEMV 491
D ++ G+ + EM+
Sbjct: 364 E--EYDFSVDYFALGVTLYEMI 383
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 31/159 (19%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFIN-----EVASISRTSHVNIVT 352
+KLG G Y VYKG G VA+K + + + EE E++ + H NIV
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEV---KLDSEEGTPSTAIREISLMKELKHENIVR 67
Query: 353 FLGFCYENKKNALIYELMPNGSLDKFIHNDR-----------NIKLEWKTMYQIAIGIAR 401
+ K L++E M N L K++ + +K +Q+ +
Sbjct: 68 LYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVK---YFQWQLL----Q 119
Query: 402 GLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLA 440
GL + H +I+H D+KPQN+L+++ K+ DFGLA
Sbjct: 120 GLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 60/303 (19%), Positives = 111/303 (36%), Gaps = 65/303 (21%)
Query: 301 LGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEFINEVASISR-----------TSHV 348
LG+GG+G V+ G L D VA+KV+ +R G +++ + H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 349 NIVTFLGFCYENKKNALIYELM----PNGSLDKFIHNDRNIK--LEWKTMYQIAIGIARG 402
++ L + +E ++ ++ P L +I + Q+
Sbjct: 99 GVIRLLDW-FETQEG--FMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV----AA 151
Query: 403 LEYLHRGCQVRIVHFDIKPQNILLDEDFCP-KISDFGLAKQAQKKESAISMLH-ARGTIG 460
+++ H +VH DIK +NIL+D K+ DFG GT
Sbjct: 152 IQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD-----EPYTDFDGTRV 203
Query: 461 YIAPEVYS-RRFGGVSHKSDVYSYGMMIIEMVGCTKNL--DDEVTDTSICHNLIYERIEP 517
Y PE S ++ + V+S G+++ +MV ++ + + + I
Sbjct: 204 YSPPEWISRHQYHA--LPATVWSLGILLYDMV--CGDIPFERD------------QEILE 247
Query: 518 GNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE---MLEGSIENLQIPP 574
+ F + + +I C+ PS RPS+ ++L M + + P
Sbjct: 248 A-ELHFPAHVSPD----CCALIR---RCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPS 299
Query: 575 KPS 577
K
Sbjct: 300 KGG 302
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 62/283 (21%), Positives = 113/283 (39%), Gaps = 62/283 (21%)
Query: 301 LGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEFIN-------EVASISRTSHV--NI 350
LG GG+G VY G + D VA+K ++ R + + EV + + S +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 351 VTFLGFCYENKKNALIYELM----PNGSLDKFIHNDRNIK--LEWKTMYQIAIGIARGLE 404
+ L + +E + ++ P L FI ++ L +Q+ +
Sbjct: 111 IRLLDW-FERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVL----EAVR 163
Query: 405 YLHRGCQVRIVHFDIKPQNILLDEDFCP-KISDFGLAKQAQKKESAISMLHAR-GTIGYI 462
+ H ++H DIK +NIL+D + K+ DFG + ++ GT Y
Sbjct: 164 HCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-----TVYTDFDGTRVYS 215
Query: 463 APEVYS-RRFGGVSHKSDVYSYGMMIIEMVGCTKNL--DDEVTDTSICHNLIYERIEPGN 519
PE R+ G + V+S G+++ +MV ++ + + E I G
Sbjct: 216 PPEWIRYHRYHG--RSAAVWSLGILLYDMV--CGDIPFEHD------------EEIIRG- 258
Query: 520 DFQF-DGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561
F V++E + +I WC+ PS+RP+ ++
Sbjct: 259 QVFFRQRVSSE-----CQHLIR---WCLALRPSDRPTFEEIQN 293
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 5e-21
Identities = 63/308 (20%), Positives = 113/308 (36%), Gaps = 79/308 (25%)
Query: 299 DKLGQGGYGEVYKGE-LPDGQLVAVKVL--------------------KNSRCNGEEFIN 337
D++G+G YG V D A+KVL + + +
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 338 EVASISR-------TSHVNIVTFLGFCYE---NKKNALIY---ELMPNGSLDKFIHNDR- 383
+ + + H N+V E + +Y EL+ G + +
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKL----VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPL 134
Query: 384 NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQA 443
+ + GI EYLH +I+H DIKP N+L+ ED KI+DFG++ +
Sbjct: 135 SEDQARFYFQDLIKGI----EYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 444 QKKESAISMLH-ARGTIGYIAPEVYSRRFGGVS-HKSDVYSYGMMIIEMV-GCTKNL--D 498
+ + ++L GT ++APE S S DV++ G+ + V G
Sbjct: 188 KGSD---ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ---CPFM 241
Query: 499 DEVTDTSICHNL--IYERIEPGNDFQF---DGVATEEEKKIAKMMILVGFWCIQTNPSER 553
DE + ++ +I+ +F +A + + I +M+ NP R
Sbjct: 242 DE--------RIMCLHSKIKSQ-ALEFPDQPDIAEDLKDLITRML--------DKNPESR 284
Query: 554 PSMHKVLE 561
+ ++
Sbjct: 285 IVVPEIKL 292
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 5e-21
Identities = 43/154 (27%), Positives = 73/154 (47%), Gaps = 24/154 (15%)
Query: 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFIN-----EVASISRTSHVNIVTF 353
+K+G+G YG VYK + G+ A+K ++ +E I E++ + H NIV
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLE--KEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 354 LGFCYENKKNALIYELMPNGSLDKFIHNDR------NIKLEWKTMYQIAIGIARGLEYLH 407
+ K+ L++E + L K + K + Q+ G+ Y H
Sbjct: 66 YDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK---SFLLQLL----NGIAYCH 117
Query: 408 RGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAK 441
R++H D+KPQN+L++ + KI+DFGLA+
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 6e-21
Identities = 39/153 (25%), Positives = 75/153 (49%), Gaps = 21/153 (13%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLK-NSRCNGEEF--INEVASISRTSHVNIVTFL 354
+K+G+G YG V+K ++VA+K ++ + G + E+ + H NIV
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 355 GFCYENKKNALIYELMPNGSLDKFIHNDR------NIKLEWKTMYQIAIGIARGLEYLHR 408
+ +KK L++E L K+ + +K ++Q+ +GL + H
Sbjct: 68 DVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVK---SFLFQLL----KGLGFCHS 119
Query: 409 GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAK 441
++H D+KPQN+L++ + K+++FGLA+
Sbjct: 120 R---NVLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 52/155 (33%), Positives = 80/155 (51%), Gaps = 26/155 (16%)
Query: 299 DKLGQGGYGEVYKGELPD-GQLVAVKVLKNSRCNGEE-----FINEVASISRTSHVNIVT 352
DKLG+G Y VYKG+ LVA+K + R EE I EV+ + H NIVT
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKDLKHANIVT 64
Query: 353 FLGFCYENKKNALIYELMPNGSLDKFIHN------DRNIKLEWKTMYQIAIGIARGLEYL 406
+ K L++E + L +++ + N+K ++Q+ RGL Y
Sbjct: 65 LHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVK---LFLFQLL----RGLAYC 116
Query: 407 HRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAK 441
HR +++H D+KPQN+L++E K++DFGLA+
Sbjct: 117 HRQ---KVLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEF----INEVASISRTSHVNIVTF 353
+G+G YG V K G++VA+K S + + + E+ + + H N+V
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD-KMVKKIAMREIKLLKQLRHENLVNL 89
Query: 354 LGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKT----MYQIAIGIARGLEYLHRG 409
L C + K+ L++E + + ++ + L+++ ++QI G+ + H
Sbjct: 90 LEVCKKKKRWYLVFEFVDH-TILDDL-ELFPNGLDYQVVQKYLFQII----NGIGFCHS- 142
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVY-- 467
I+H DIKP+NIL+ + K+ DFG A+ T Y APE+
Sbjct: 143 --HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD--DEVATRWYRAPELLVG 198
Query: 468 SRRFG-GVSHKSDVYSYGMMIIEMV 491
++G V DV++ G ++ EM
Sbjct: 199 DVKYGKAV----DVWAIGCLVTEMF 219
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 68/274 (24%), Positives = 115/274 (41%), Gaps = 44/274 (16%)
Query: 301 LGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEFIN----EVASISRTSHVNIVTFLG 355
LG G +G+V GE G VAVK+L + + + E+ ++ H +I+
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL-- 76
Query: 356 FCYE----NKKNALIYELMPNGSL-DKFIHNDR-NIKLEWKTMYQIAIGIARGLEYLHRG 409
Y+ ++ E + G L D + R + QI + +Y HR
Sbjct: 77 --YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAV----DYCHR- 129
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR-GTIGYIAPEVYS 468
+VH D+KP+N+LLD KI+DFGL+ E L G+ Y APEV S
Sbjct: 130 --HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE----FLRTSCGSPNYAAPEVIS 183
Query: 469 RRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQF-DGVA 527
R + D++S G+++ ++ T DDE T ++++I G F + +
Sbjct: 184 GR-LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT------LFKKIRGG-VFYIPEYLN 235
Query: 528 TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561
+ M +Q +P +R ++ + E
Sbjct: 236 RSVATLLMHM--------LQVDPLKRATIKDIRE 261
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 30/208 (14%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEF----INEVASISRTSHVNIVTF 353
KLG+G YGEVYK + + VA+K ++ E I EV+ + H NI+
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSLLKELQHRNIIEL 98
Query: 354 LGFCYENKKNALIYELMPNGSLDKFIHNDRNIKL-EWKT-MYQIAIGIARGLEYLHRGCQ 411
+ N + LI+E N L K++ + ++ + K+ +YQ+ G+ + H
Sbjct: 99 KSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLI----NGVNFCHSR-- 151
Query: 412 VRIVHFDIKPQNILLDEDFCP-----KISDFGLAKQAQKKESAISMLHARGTIGYIAPEV 466
R +H D+KPQN+LL KI DFGLA+ + H T+ Y PE+
Sbjct: 152 -RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFT--HEIITLWYRPPEI 208
Query: 467 Y--SRRFG-GVSHKSDVYSYGMMIIEMV 491
SR + V D++S + EM+
Sbjct: 209 LLGSRHYSTSV----DIWSIACIWAEML 232
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 60/287 (20%), Positives = 106/287 (36%), Gaps = 70/287 (24%)
Query: 295 KSFRDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFINEVASISRTS-HVNIVT 352
K LG G G+V + + A+K+L++ + EV R S +IV
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVR 75
Query: 353 FLGFCYENKKNA-----LIYELMPNGSLDKFIHNDRNIKLEWKTMY------QIAIGIAR 401
+ YEN ++ E + G L F R I+ + +I I
Sbjct: 76 IVDV-YENLYAGRKCLLIVMECLDGGEL--F---SR-IQDRGDQAFTEREASEIMKSIGE 128
Query: 402 GLEYLHRGCQVRIVHFDIKPQNILL---DEDFCPKISDFGLAKQAQKKESAISMLHARGT 458
++YLH + I H D+KP+N+L + K++DFG
Sbjct: 129 AIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF------------------- 166
Query: 459 IGYIAPEVYSRRFGGVSHKSDVYSYG-MMIIEMVGCTKNLDDEVTDTSICHNLIYERIEP 517
A E ++ D++S G +M I + G + S + RI
Sbjct: 167 ----AKETTGEKYD---KSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIRM 216
Query: 518 GNDFQFDGVATEEEKKI---AKMMILVGFWCIQTNPSERPSMHKVLE 561
G ++F E ++ KM+I ++T P++R ++ + +
Sbjct: 217 G-QYEFPN---PEWSEVSEEVKMLIR---NLLKTEPTQRMTITEFMN 256
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 9e-20
Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 46/218 (21%)
Query: 299 DKLGQGGYGEVYKG--ELPDGQLVAVKVLKNSRCNGEE------FINEVA---SISRTSH 347
++G+G YG+V+K G+ VA LK R E I EVA + H
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVA---LKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 73
Query: 348 VNIVTFLGFCYENKKNA-----LIYELMPNGSLDKFIHNDRNIKLEWKT----MYQIAIG 398
N+V C ++ + L++E + L ++ + +T M+Q+
Sbjct: 74 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLL-- 130
Query: 399 IARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGT 458
RGL++LH R+VH D+KPQNIL+ K++DFGLA+ +++ T
Sbjct: 131 --RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVT 182
Query: 459 IGYIAPEV-----YSRRFGGVSHKSDVYSYGMMIIEMV 491
+ Y APEV Y+ V D++S G + EM
Sbjct: 183 LWYRAPEVLLQSSYAT---PV----DLWSVGCIFAEMF 213
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 1e-19
Identities = 69/274 (25%), Positives = 117/274 (42%), Gaps = 44/274 (16%)
Query: 301 LGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEFIN----EVASISRTSHVNIVTFLG 355
LG G +G+V G+ G VAVK+L + + + E+ ++ H +I+
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL-- 81
Query: 356 FCYE----NKKNALIYELMPNGSL-DKFIHNDR-NIKLEWKTMYQIAIGIARGLEYLHRG 409
Y+ ++ E + G L D N R + K + QI G+ +Y HR
Sbjct: 82 --YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGV----DYCHR- 134
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR-GTIGYIAPEVYS 468
+VH D+KP+N+LLD KI+DFGL+ E L G+ Y APEV S
Sbjct: 135 --HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE----FLRTSCGSPNYAAPEVIS 188
Query: 469 RRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQF-DGVA 527
R + D++S G+++ ++ T DD+ T ++++I G F +
Sbjct: 189 GR-LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT------LFKKICDG-IFYTPQYLN 240
Query: 528 TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561
+ M +Q +P +R ++ + E
Sbjct: 241 PSVISLLKHM--------LQVDPMKRATIKDIRE 266
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 59/246 (23%), Positives = 101/246 (41%), Gaps = 31/246 (12%)
Query: 267 DRNVEAFIRNHESLAPKRYSYSDVKRMTKS---FRDKLGQGGYGEVYKGELPD-GQLVAV 322
D+ V F++ E + + R+ + +G+G + EV ++ GQ+ A+
Sbjct: 36 DKYVADFLQWAEPIVVRLKE----VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAM 91
Query: 323 KVLKN----SRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNA-LIYELMPNGSLDK 377
K++ R F E + I L F ++++ L+ E G L
Sbjct: 92 KIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ-LHFAFQDENYLYLVMEYYVGGDL-- 148
Query: 378 FIH---NDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKI 434
I E Y I +A ++ +H ++ VH DIKP NILLD ++
Sbjct: 149 LTLLSKFGERIPAEMARFYLAEIVMA--IDSVH---RLGYVHRDIKPDNILLDRCGHIRL 203
Query: 435 SDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKS-----DVYSYGMMIIE 489
+DFG + + + S++ A GT Y++PE+ GG S D ++ G+ E
Sbjct: 204 ADFGSCLKLRADGTVRSLV-AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYE 262
Query: 490 M-VGCT 494
M G T
Sbjct: 263 MFYGQT 268
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 62/272 (22%), Positives = 111/272 (40%), Gaps = 41/272 (15%)
Query: 301 LGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEFIN----EVASISRTSHVNIVTFLG 355
LG+G +G+V Q VA+K + + E++ + H +I+ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIK-LY 75
Query: 356 FCYENKKNALIYELM--PNGSL-DKFIHNDR-NIKLEWKTMYQIAIGIARGLEYLHRGCQ 411
+ I ++ G L D + R + QI I EY HR
Sbjct: 76 DVITTPTD--IVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAI----EYCHR--- 126
Query: 412 VRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR-GTIGYIAPEVYSRR 470
+IVH D+KP+N+LLD++ KI+DFGL+ L G+ Y APEV + +
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN----FLKTSCGSPNYAAPEVINGK 182
Query: 471 FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQF-DGVATE 529
+ DV+S G+++ M+ DDE +++++ + D ++
Sbjct: 183 -LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN------LFKKVNSC-VYVMPDFLSPG 234
Query: 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561
+ I +M I +P +R ++ ++
Sbjct: 235 AQSLIRRM--------IVADPMQRITIQEIRR 258
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-19
Identities = 55/242 (22%), Positives = 109/242 (45%), Gaps = 31/242 (12%)
Query: 265 EDDRNVEAFIRNHESLAPK----RYSYSD--VKRMTKSFRDKLGQGGYGEVYK-GELPDG 317
++N++ F+ ++ K R D V ++ +G+G +GEV
Sbjct: 42 RKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKV-------IGRGAFGEVQLVRHKSTR 94
Query: 318 QLVAVKVLKNS----RCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNA-LIYELMPN 372
++ A+K+L R + F E ++ + +V L + +++ + ++ E MP
Sbjct: 95 KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ-LFYAFQDDRYLYMVMEYMPG 153
Query: 373 GSLDKFIH-NDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFC 431
G L ++ ++ +W Y + +A L+ +H + +H D+KP N+LLD+
Sbjct: 154 GDL--VNLMSNYDVPEKWARFYTAEVVLA--LDAIH---SMGFIHRDVKPDNMLLDKSGH 206
Query: 432 PKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDV--YSYGMMIIE 489
K++DFG + K+ A GT YI+PEV + G + + +S G+ + E
Sbjct: 207 LKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 265
Query: 490 MV 491
M+
Sbjct: 266 ML 267
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 21/202 (10%), Positives = 51/202 (25%), Gaps = 49/202 (24%)
Query: 298 RDKLGQGGYGEVYKGELPDGQL---VAVKVLKNSRCNG----EEFINEVASISRTSHVNI 350
G + ++ D L VA+ + +E ++ +SR +
Sbjct: 36 LIFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGV 93
Query: 351 VTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHR-G 409
L + ++ E + GSL + + +A + HR G
Sbjct: 94 ARVLDVVHTRAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRAG 149
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSR 469
+ P + + D ++ +
Sbjct: 150 ----VALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPD----- 178
Query: 470 RFGGVSHKSDVYSYGMMIIEMV 491
+ + D+ G + ++
Sbjct: 179 ----ANPQDDIRGIGASLYALL 196
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 57/242 (23%), Positives = 103/242 (42%), Gaps = 34/242 (14%)
Query: 267 DRNVEAFIRNHESLAPK----RYSYSD--VKRMTKSFRDKLGQGGYGEVYKGELPD-GQL 319
++N+ ++ + K R D + ++ +G+G +GEV +L + ++
Sbjct: 49 EKNILEYLEWAKPFTSKVKQMRLHREDFEILKV-------IGRGAFGEVAVVKLKNADKV 101
Query: 320 VAVKVLKNS----RCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNA-LIYELMPNGS 374
A+K+L R F E + I T L + +++ N L+ + G
Sbjct: 102 FAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT-LHYAFQDDNNLYLVMDYYVGGD 160
Query: 375 LDKFIH---NDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFC 431
L + + E Y + IA ++ +H Q+ VH DIKP NIL+D +
Sbjct: 161 L--LTLLSKFEDRLPEEMARFYLAEMVIA--IDSVH---QLHYVHRDIKPDNILMDMNGH 213
Query: 432 PKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSH--KS-DVYSYGMMII 488
+++DFG + + + S + A GT YI+PE+ GG D +S G+ +
Sbjct: 214 IRLADFGSCLKLMEDGTVQSSV-AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMY 272
Query: 489 EM 490
EM
Sbjct: 273 EM 274
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 21/224 (9%)
Query: 275 RNHESLAPKRYSYSDVKRMTKSFRDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNS---RC 330
P++ D K F LG+G + V EL + A+K+L+ +
Sbjct: 17 HAQPPPQPRKKRPEDFK-----FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE 71
Query: 331 NGEEFIN-EVASISRTSHVNIVTFLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKL- 387
N ++ E +SR H V L F +++ + NG L + +
Sbjct: 72 NKVPYVTRERDVMSRLDHPFFVK-LYFTFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFD 128
Query: 388 EWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447
E T + A I LEYLH I+H D+KP+NILL+ED +I+DFG AK +
Sbjct: 129 ETCTRFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 184
Query: 448 SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMV 491
GT Y++PE+ + + SD+++ G +I ++V
Sbjct: 185 KQARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLV 226
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 51/189 (26%), Positives = 79/189 (41%), Gaps = 33/189 (17%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEE--F----INEVASISRTSHVNIV 351
K+GQG +GEV+K GQ VA LK E+ F + E+ + H N+V
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVA---LKKVLMENEKEGFPITALREIKILQLLKHENVV 79
Query: 352 TFLGFCYENKKNA--------LIYELMPNGSLDKFIHNDRNIKL---EWKT-MYQIAIGI 399
+ C L+++ + L + N +K E K M +
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN-VLVKFTLSEIKRVMQMLL--- 134
Query: 400 ARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ--AQKKESAISMLHARG 457
GL Y+HR +I+H D+K N+L+ D K++DFGLA+ K +
Sbjct: 135 -NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 190
Query: 458 TIGYIAPEV 466
T+ Y PE+
Sbjct: 191 TLWYRPPEL 199
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 6e-18
Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 39/208 (18%)
Query: 300 KLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFINEVASISR--TSHVNIVTFLGF 356
KLG+G Y EV++ + + + V VK+LK + ++ E+ I NI+T
Sbjct: 43 KLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREI-KILENLRGGPNIITLADI 99
Query: 357 CY--ENKKNALIYELMPNGSLDKFIH--NDRNIKLEWKTMYQIAIGIARGLEYLHRGCQV 412
++ AL++E + N + D +I+ MY+I + L+Y H
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR---FYMYEIL----KALDYCHSM--- 149
Query: 413 RIVHFDIKPQNILLDEDFCP-KISDFGLAKQAQKKESAISMLHARGTIGYIAPEV----- 466
I+H D+KP N+++D + ++ D+GLA+ + + + PE+
Sbjct: 150 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQ 206
Query: 467 -YSRRFGGVSHKS-DVYSYGMMIIEMVG 492
Y S D++S G M+ M+
Sbjct: 207 MYD--------YSLDMWSLGCMLASMIF 226
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 8e-18
Identities = 54/253 (21%), Positives = 96/253 (37%), Gaps = 87/253 (34%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVK-VLKNSRCNGEEFIN-EVASISRTSHVNIVTFLG 355
LG G +G V + ++ G+ A+K VL++ R + N E+ + HVNI+ +
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVD 67
Query: 356 FCYENKKNA--------------------------------------LIYELMPNGSLDK 377
+ Y +I E +P+ +L K
Sbjct: 68 YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHK 126
Query: 378 FIHNDRN---------IKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE 428
+ + I + +YQ+ R + ++H + I H DIKPQN+L++
Sbjct: 127 VLKSFIRSGRSIPMNLISI---YIYQLF----RAVGFIH---SLGICHRDIKPQNLLVNS 176
Query: 429 DFCP-KISDFGLAKQAQKKESAISMLHARGTIGYI------APEVYSRRFGGV--SHKSD 479
K+ DFG AK+ E +++ YI APE+ G + D
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVA---------YICSRFYRAPELM---LGATEYTPSID 224
Query: 480 VYSYGMMIIEMVG 492
++S G + E++
Sbjct: 225 LWSIGCVFGELIL 237
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 9e-18
Identities = 53/242 (21%), Positives = 101/242 (41%), Gaps = 46/242 (19%)
Query: 274 IRNHESLAPKRYSYSDVKRMTKSFRDKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNG 332
E RY + R KLG G + V+ + + + VA+K+++ +
Sbjct: 10 AFKGEPYKDARYI---LVR-------KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT 59
Query: 333 EEFINEV--------ASISRTSHV---NIVTFLG-FCYENKKNA---LIYELMPNGSLDK 377
E +E+ A ++ + +I+ L F ++ +++E++ +L
Sbjct: 60 EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLA 118
Query: 378 FIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCP----- 432
I + + + QI+ + GL+Y+HR C I+H DIKP+N+L++ P
Sbjct: 119 LIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQ 176
Query: 433 -KISDFGLAKQAQKKESA-ISMLHARGTIGYIAPEVYSRRFG-GVSHKSDVYSYGMMIIE 489
KI+D G A + + I Y +PEV G +D++S +I E
Sbjct: 177 IKIADLGNACWYDEHYTNSIQTRE------YRSPEVL---LGAPWGCGADIWSTACLIFE 227
Query: 490 MV 491
++
Sbjct: 228 LI 229
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 5e-17
Identities = 50/205 (24%), Positives = 82/205 (40%), Gaps = 37/205 (18%)
Query: 288 SDVKRMTKSF---RDKLGQGGYGEVYKG---ELPDGQLVAVKVLKNSRCNGEEF--INEV 339
S+ +R+ F K+G+G YG VYK + D + A+K ++ G E+
Sbjct: 13 SERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG---TGISMSACREI 69
Query: 340 ASISRTSHVNIVTFLGFCYENKKNA--LIYELMPNGSLDKFIHNDRNIKLEWKT------ 391
A + H N+++ + L+++ + L I R K K
Sbjct: 70 ALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRG 128
Query: 392 -----MYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF----CPKISDFGLAKQ 442
+YQI G+ YLH ++H D+KP NIL+ + KI+D G A+
Sbjct: 129 MVKSLLYQIL----DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
Query: 443 AQKKESAISMLHAR-GTIGYIAPEV 466
++ L T Y APE+
Sbjct: 182 FNSPLKPLADLDPVVVTFWYRAPEL 206
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 9e-17
Identities = 65/201 (32%), Positives = 106/201 (52%), Gaps = 24/201 (11%)
Query: 301 LGQGGYGEVY---KGELPD-GQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTF 353
LGQG +G+V+ K D QL A+KVLK + + E + +H IV
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK- 90
Query: 354 LGFCYENK-KNALIYELMPNGSLDKFIH--NDRNIKLEWKTMYQIAIGIARGLEYLHRGC 410
L + ++ + K LI + + G L F + E Y +A L++LH
Sbjct: 91 LHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFY--LAELALALDHLH--- 143
Query: 411 QVRIVHFDIKPQNILLDEDFCPKISDFGLAKQA-QKKESAISMLHARGTIGYIAPEVYSR 469
+ I++ D+KP+NILLDE+ K++DFGL+K++ ++ A S GT+ Y+APEV +R
Sbjct: 144 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC---GTVEYMAPEVVNR 200
Query: 470 RFGGVSHKSDVYSYGMMIIEM 490
R G + +D +S+G+++ EM
Sbjct: 201 R--GHTQSADWWSFGVLMFEM 219
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 27/202 (13%)
Query: 301 LGQGGYGEVYKGELPD-GQLVAVKVLKNSRCNGEEFI---NEVASI-------SRTSHVN 349
LG+G +G+V + G+ A+K+LK +E I +EVA + H
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILK------KEVIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 350 IVTFLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHR 408
+ L + ++ + E G L + +R + Y I L+YLH
Sbjct: 210 LTA-LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY--GAEIVSALDYLHS 266
Query: 409 GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYS 468
+ +V+ D+K +N++LD+D KI+DFGL K+ K + + GT Y+APEV
Sbjct: 267 --EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC--GTPEYLAPEVLE 322
Query: 469 RRFGGVSHKSDVYSYGMMIIEM 490
D + G+++ EM
Sbjct: 323 DN--DYGRAVDWWGLGVVMYEM 342
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 30/205 (14%)
Query: 301 LGQGGYGEVY---KGELPD-GQLVAVKVLKNSRCNGEEFINEVASI-------SRTSHVN 349
LG+GGYG+V+ K + G++ A+KVLK + + A H
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNA--KDTAHTKAERNILEEVKHPF 82
Query: 350 IVTFLGFCYENK-KNALIYELMPNGSLDKFIH--NDRNIKLEWKTMYQIAIGIARGLEYL 406
IV L + ++ K LI E + G L F+ + + Y I+ L +L
Sbjct: 83 IVD-LIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFY--LAEISMALGHL 137
Query: 407 HRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQA-QKKESAISMLHARGTIGYIAPE 465
H Q I++ D+KP+NI+L+ K++DFGL K++ + GTI Y+APE
Sbjct: 138 H---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC---GTIEYMAPE 191
Query: 466 VYSRRFGGVSHKSDVYSYGMMIIEM 490
+ R G + D +S G ++ +M
Sbjct: 192 ILMRS--GHNRAVDWWSLGALMYDM 214
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 59/231 (25%), Positives = 95/231 (41%), Gaps = 30/231 (12%)
Query: 301 LGQGGYGEVY---KGELPD-GQLVAVKVLKNSRCNGEEFINEVASI-------SRTSHVN 349
LG G YG+V+ K D G+L A+KVLK + +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA--KTTEHTRTERQVLEHIRQSP 119
Query: 350 IVTFLGFCYENKKNA-LIYELMPNGSLDKFIH--NDRNIKLEWKTMYQIAIGIARGLEYL 406
+ L + ++ + LI + + G L F H +Y I LE+L
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIY--VGEIVLALEHL 175
Query: 407 HRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES--AISMLHARGTIGYIAP 464
H ++ I++ DIK +NILLD + ++DFGL+K+ E+ A GTI Y+AP
Sbjct: 176 H---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC---GTIEYMAP 229
Query: 465 EVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERI 515
++ G D +S G+++ E++ + S I RI
Sbjct: 230 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRI 278
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 6e-16
Identities = 55/202 (27%), Positives = 86/202 (42%), Gaps = 28/202 (13%)
Query: 301 LGQGGYGEVYKGELPD-GQLVAVKVLKNSRCNGEEFI---NEVASI-------SRTSHVN 349
LG+G +G+V G+ A+K+L+ +E I +EVA T H
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILR------KEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 350 IVTFLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHR 408
+ L + ++ + E G L + +R E Y I LEYLH
Sbjct: 67 LTA-LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY--GAEIVSALEYLH- 122
Query: 409 GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYS 468
+V+ DIK +N++LD+D KI+DFGL K+ + + GT Y+APEV
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC--GTPEYLAPEVLE 178
Query: 469 RRFGGVSHKSDVYSYGMMIIEM 490
D + G+++ EM
Sbjct: 179 DN--DYGRAVDWWGLGVVMYEM 198
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 47/201 (23%), Positives = 91/201 (45%), Gaps = 25/201 (12%)
Query: 301 LGQGGYGEVYKGELPD-GQLVAVKVLKNSRCNGEEFINEVASI--------SRTSHVNIV 351
+G+G Y +V L ++ A+KV+K N + ++ + ++H +V
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD---EDIDWVQTEKHVFEQASNHPFLV 73
Query: 352 TFLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGC 410
L C++ + + E + G L + R + E Y + I+ L YLH
Sbjct: 74 G-LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY--SAEISLALNYLH--- 127
Query: 411 QVRIVHFDIKPQNILLDEDFCPKISDFGLAKQA-QKKESAISMLHARGTIGYIAPEVYSR 469
+ I++ D+K N+LLD + K++D+G+ K+ + ++ + GT YIAPE+
Sbjct: 128 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYIAPEILRG 184
Query: 470 RFGGVSHKSDVYSYGMMIIEM 490
D ++ G+++ EM
Sbjct: 185 E--DYGFSVDWWALGVLMFEM 203
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 33/205 (16%)
Query: 301 LGQGGYGEVYKGELPD-GQLVAVKVLKNSRCNGEEFI---NEVASI--------SRTSHV 348
LG+G +G+V+ E Q A+K LK ++ + ++V H
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALK------KDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 349 NIVTFLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH 407
+ + ++ K+N + E + G L I + L T Y A I GL++LH
Sbjct: 79 FLTH-MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY--AAEIILGLQFLH 135
Query: 408 RGCQVRIVHFDIKPQNILLDED-FCPKISDFGLAKQA-QKKESAISMLHARGTIGYIAPE 465
IV+ D+K NILLD+D KI+DFG+ K+ + GT YIAPE
Sbjct: 136 ---SKGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFC---GTPDYIAPE 188
Query: 466 VYSRRFGGVSHKSDVYSYGMMIIEM 490
+ + +H D +S+G+++ EM
Sbjct: 189 ILLGQ--KYNHSVDWWSFGVLLYEM 211
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 52/204 (25%), Positives = 85/204 (41%), Gaps = 31/204 (15%)
Query: 301 LGQGGYGEVYKGELPD-GQLVAVKVLKNSRCNGEEFI---NEVASI--------SRTSHV 348
LG+G +G+V + + G L AVKVLK ++ I ++V +H
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLK------KDVILQDDDVECTMTEKRILSLARNHP 84
Query: 349 NIVTFLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH 407
+ L C++ + E + G L I R Y A I L +LH
Sbjct: 85 FLTQ-LFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFY--AAEIISALMFLH 141
Query: 408 RGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQA-QKKESAISMLHARGTIGYIAPEV 466
I++ D+K N+LLD + K++DFG+ K+ + + GT YIAPE+
Sbjct: 142 ---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC---GTPDYIAPEI 195
Query: 467 YSRRFGGVSHKSDVYSYGMMIIEM 490
D ++ G+++ EM
Sbjct: 196 LQEM--LYGPAVDWWAMGVLLYEM 217
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 46/204 (22%), Positives = 92/204 (45%), Gaps = 31/204 (15%)
Query: 301 LGQGGYGEVYKGELPD-GQLVAVKVLKNSRCNGEEFI---NEVASI--------SRTSHV 348
+G+G Y +V L ++ A++V+K +E + ++ + ++H
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVK------KELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 349 NIVTFLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH 407
+V L C++ + + E + G L + R + E Y + I+ L YLH
Sbjct: 114 FLVG-LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY--SAEISLALNYLH 170
Query: 408 RGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQA-QKKESAISMLHARGTIGYIAPEV 466
+ I++ D+K N+LLD + K++D+G+ K+ + ++ + GT YIAPE+
Sbjct: 171 ---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYIAPEI 224
Query: 467 YSRRFGGVSHKSDVYSYGMMIIEM 490
D ++ G+++ EM
Sbjct: 225 LRGE--DYGFSVDWWALGVLMFEM 246
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 36/166 (21%), Positives = 64/166 (38%), Gaps = 30/166 (18%)
Query: 300 KLGQGGYGEVYKGE-LPDGQLVAVKVLKN---------------SRCNGEEFINEVASIS 343
K+G GG+G +Y + A V+K R ++ I +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 344 RTSHVNIVTFLGF----CYENKKNALIYELMPNG-SLDKFIHNDRNIKLEWKTMYQIAIG 398
+ ++ I F G ++ E + G L K + + T+ Q+ I
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNG--TFKKSTVLQLGIR 159
Query: 399 IARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKI--SDFGLAKQ 442
+ LEY+H + VH DIK N+LL ++ +D+GL+ +
Sbjct: 160 MLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 38/169 (22%), Positives = 67/169 (39%), Gaps = 33/169 (19%)
Query: 300 KLGQGGYGEVYKG------ELPDGQLVAVKVLKNS------------RCNGEEFINEVAS 341
+GQGG+G +Y + VKV + R E I +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 342 ISRTSHVNIVTFLGFCYENKK----NALIYELMPNG-SL-DKFIHNDRNIKLEWKTMYQI 395
+ ++ + + G +K +I + G L + N + + KT+ Q+
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAK--RFSRKTVLQL 157
Query: 396 AIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKI--SDFGLAKQ 442
++ I LEY+H + VH DIK N+LL+ ++ D+GLA +
Sbjct: 158 SLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 41/209 (19%)
Query: 301 LGQGGYGEVYKGELPD-GQLVAVKVLKNSRCNGEEFI---NEVASI--------SRTSHV 348
LG+G +G+V E +L AVK+LK ++ + ++V
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILK------KDVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 349 NIVTFLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH 407
+ L C++ + E + G L I K Y A IA GL +L
Sbjct: 82 FLTQ-LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY--AAEIAIGLFFLQ 138
Query: 408 RGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR------GTIGY 461
I++ D+K N++LD + KI+DFG+ K+ ++ GT Y
Sbjct: 139 ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--------NIWDGVTTKTFCGTPDY 187
Query: 462 IAPEVYSRRFGGVSHKSDVYSYGMMIIEM 490
IAPE+ + + D +++G+++ EM
Sbjct: 188 IAPEIIAYQ--PYGKSVDWWAFGVLLYEM 214
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 57/264 (21%), Positives = 107/264 (40%), Gaps = 30/264 (11%)
Query: 262 KTREDDRNVEAFIRNHESLAPKRYSYSDVKRMTKS---FRDKLGQGGYGEVYKGEL-PDG 317
K + +V+ F+ + K++ LG G +G V + G
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66
Query: 318 QLVAVKVLKNSRC----NGEEFINEVASISRTSHVNIVTFLGFCYENKKNA-LIYELMPN 372
A+K+L + E +NE + + +V L F +++ N ++ E +
Sbjct: 67 NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK-LEFSFKDNSNLYMVMEYVAG 125
Query: 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCP 432
G + + Y A I EYLH + +++ D+KP+N+L+D+
Sbjct: 126 GEMFSHLRRIGRFSEPHARFY--AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 180
Query: 433 KISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEM-V 491
+++DFG AK+ + + + GT +APE+ + G + D ++ G++I EM
Sbjct: 181 QVTDFGFAKRVKGRTWTLC-----GTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAA 233
Query: 492 GCTKNLDDEVTDTSICHNLIYERI 515
G D+ IYE+I
Sbjct: 234 GYPPFFADQ-------PIQIYEKI 250
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 5e-15
Identities = 55/206 (26%), Positives = 85/206 (41%), Gaps = 35/206 (16%)
Query: 301 LGQGGYGEVYKGELPD-GQLVAVKVLKNSRCNGEEFI---NEVASI--------SRTSHV 348
+G+G +G+V AVKVL+ ++ I E I H
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQ------KKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 349 NIVTFLGFCYENKKNA-LIYELMPNGSLDKFIH--NDRNIKLEWKTMYQIAIGIARGLEY 405
+V L F ++ + + + G L F H +R Y A IA L Y
Sbjct: 100 FLVG-LHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFY--AAEIASALGY 154
Query: 406 LHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQA-QKKESAISMLHARGTIGYIAP 464
LH + IV+ D+KP+NILLD ++DFGL K+ + + + GT Y+AP
Sbjct: 155 LH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC---GTPEYLAP 208
Query: 465 EVYSRRFGGVSHKSDVYSYGMMIIEM 490
EV ++ D + G ++ EM
Sbjct: 209 EVLHKQ--PYDRTVDWWCLGAVLYEM 232
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 33/168 (19%), Positives = 70/168 (41%), Gaps = 31/168 (18%)
Query: 300 KLGQGGYGEVYKGE---------LPDGQLVAVKV-LKNSRCNGE----------EFINEV 339
+ G +Y+ P Q ++K+ K+ R E +N+
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 340 ASISRTSHVNIVTFLGF-CYENKKNALIYELMPNG-SL-DKFIHNDRNIKLEWKTMYQIA 396
+ T + I T +GF +++K L+ + G SL + ++ L +++ Q+A
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKH-VLSERSVLQVA 165
Query: 397 IGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKI--SDFGLAKQ 442
+ LE+LH + VH ++ +NI +D + ++ + +G A +
Sbjct: 166 CRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 75.8 bits (186), Expect = 2e-14
Identities = 50/203 (24%), Positives = 84/203 (41%), Gaps = 29/203 (14%)
Query: 301 LGQGGYGEVYKGELPD-GQLVAVKVLKNSRCNGEEFI---NEVASI--------SRTSHV 348
LG+G +G+V E +L AVK+LK ++ + ++V
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILK------KDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 349 NIVTFLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH 407
+ L C++ + E + G L I K Y A IA GL +L
Sbjct: 403 FLTQ-LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY--AAEIAIGLFFLQ 459
Query: 408 RGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVY 467
I++ D+K N++LD + KI+DFG+ K+ GT YIAPE+
Sbjct: 460 ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC--GTPDYIAPEII 514
Query: 468 SRRFGGVSHKSDVYSYGMMIIEM 490
+ + D +++G+++ EM
Sbjct: 515 AYQ--PYGKSVDWWAFGVLLYEM 535
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 46/152 (30%), Positives = 67/152 (44%), Gaps = 17/152 (11%)
Query: 300 KLGQGGYGEVYKGE-LPDGQLVAVKVLK-NSRCNGEEFINEVASISRTSHVNIVTFLGFC 357
K+G G +GE+ G+ L + VA+K+ SR S I F
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQ-LGSGDGIPQVYYFG 74
Query: 358 YENKKNALIYELMPNG-SL-DKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
K NA++ EL+ G SL D F DR KT+ IAI + +EY+H ++
Sbjct: 75 PCGKYNAMVLELL--GPSLEDLFDLCDR--TFSLKTVLMIAIQLISRMEYVHS---KNLI 127
Query: 416 HFDIKPQNILLDEDFCPK-----ISDFGLAKQ 442
+ D+KP+N L+ I DF LAK+
Sbjct: 128 YRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 45/203 (22%), Positives = 90/203 (44%), Gaps = 34/203 (16%)
Query: 376 DKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKIS 435
++ + L + + + +A+G+E+L + +H D+ +NILL E KI
Sbjct: 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKIC 235
Query: 436 DFGLAKQAQKKESAISMLHARGTIGYIAPE-VYSRRFGGVSHKSDVYSYGMMIIEMV--- 491
DFGLA+ K + AR + ++APE ++ R + + +SDV+S+G+++ E+
Sbjct: 236 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEIFSLG 292
Query: 492 -----GCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCI 546
G + + R++ G + T E + + M+ C
Sbjct: 293 ASPYPGVKIDEE------------FCRRLKEGTRMRAPDYTTPE---MYQTMLD----CW 333
Query: 547 QTNPSERPSMHKVLEMLEGSIEN 569
PS+RP+ +++E L ++
Sbjct: 334 HGEPSQRPTFSELVEHLGNLLQA 356
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 26/99 (26%), Positives = 45/99 (45%), Gaps = 10/99 (10%)
Query: 296 SFRDKLGQGGYGEVYKGEL------PDGQLVAVKVLKNSRCNGE--EFINEVAS-ISRTS 346
LG+G +G+V + + + VAVK+LK + E ++E+ I
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 84
Query: 347 HVNIVTFLGFCYENKKNA-LIYELMPNGSLDKFIHNDRN 384
H+N+V LG C + +I E G+L ++ + RN
Sbjct: 85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN 123
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 34/168 (20%), Positives = 65/168 (38%), Gaps = 33/168 (19%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFINEVASISRT----------SH 347
+G G YG V + + + ++VA+K + F + + R +H
Sbjct: 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILR------VFEDLIDC-KRILREIAILNRLNH 111
Query: 348 VNIVTFLGFCYENKKNA-----LIYELMPNGSLDKFIHNDRNIKLEWKT--MYQIAIGIA 400
++V L ++ E+ + K + +Y +
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLL---- 166
Query: 401 RGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448
G++Y+H I+H D+KP N L+++D K+ DFGLA+ E+
Sbjct: 167 VGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 56/220 (25%), Positives = 87/220 (39%), Gaps = 44/220 (20%)
Query: 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEE---FIN---------EVASISRTS 346
+ G YG V G +G VA+K + N+ +G + E+ ++
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 347 HVNIVT----FLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKT---MYQIAIG 398
H NI+ F+ F L+ ELM L + IH+ R + MY I
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHIL-- 144
Query: 399 IARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGT 458
GL LH +VH D+ P NILL ++ I DF LA++ + H
Sbjct: 145 --LGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTH 196
Query: 459 IGYIAPEV------YSRRFGGVSHKSDVYSYGMMIIEMVG 492
Y APE+ +++ V D++S G ++ EM
Sbjct: 197 RWYRAPELVMQFKGFTK---LV----DMWSAGCVMAEMFN 229
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 57/257 (22%), Positives = 92/257 (35%), Gaps = 76/257 (29%)
Query: 300 KLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEFINEVA-----SISRTSHVN---I 350
KLG G + V+ + + VA+KV+K++ E ++E+ S + N +
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 351 VTFLG-FCYENKKNA---LIYELMPNG-SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEY 405
V L F +++E++ G L K+I L + +I + +GL+Y
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDY 161
Query: 406 LHRGCQVRIVHFDIKPQNILL--------------------------------------- 426
LH C+ I+H DIKP+NILL
Sbjct: 162 LHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGN 219
Query: 427 ----------DEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFG-GVS 475
E KI+D G A K + T Y + EV G G +
Sbjct: 220 FLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ-----TRQYRSLEV---LIGSGYN 271
Query: 476 HKSDVYSYGMMIIEMVG 492
+D++S M E+
Sbjct: 272 TPADIWSTACMAFELAT 288
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 4e-13
Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 33/203 (16%)
Query: 301 LGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNGEEFI--NEVASI-------SRTSHVNI 350
LG G +G V+ +G+ A+KVLK E + +V S +H I
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKK-----EIVVRLKQVEHTNDERLMLSIVTHPFI 68
Query: 351 VTFLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTM--YQIAIGIARGLEYLH 407
+ + +++ + +I + + G L F ++ + Y A + LEYLH
Sbjct: 69 IR-MWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFY--AAEVCLALEYLH 123
Query: 408 RGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVY 467
I++ D+KP+NILLD++ KI+DFG AK + GT YIAPEV
Sbjct: 124 ---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTPDYIAPEVV 175
Query: 468 SRRFGGVSHKSDVYSYGMMIIEM 490
S + + D +S+G++I EM
Sbjct: 176 STK--PYNKSIDWWSFGILIYEM 196
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 38/152 (25%), Positives = 64/152 (42%), Gaps = 17/152 (11%)
Query: 300 KLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEFINEVASI-SRTSHVNIVTFLGFC 357
++G+G +G +++G L + Q VA+K R + + +E + I F
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 358 YENKKNALIYELMPNG-SL-DKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
E N L+ +L+ G SL D R K KT+ A + ++ +H +V
Sbjct: 76 QEGLHNVLVIDLL--GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHE---KSLV 128
Query: 416 HFDIKPQNILLDEDFCPK-----ISDFGLAKQ 442
+ DIKP N L+ + DFG+ K
Sbjct: 129 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 53/236 (22%), Positives = 97/236 (41%), Gaps = 35/236 (14%)
Query: 266 DDRNVEAFIRNHESLAPKRYSYSDVKRMTKSFRDKLGQGGYGEVYKGE-LPDGQLVAVKV 324
DD H+ +A RY +G+G +G+V K Q VA+K+
Sbjct: 81 DDDQGSYVQVPHDHVA-YRYE----------VLKVIGKGSFGQVVKAYDHKVHQHVALKM 129
Query: 325 LKNSRCNGEEFINEVASISR------TSHVNIVTFLGFCYENKKNALIYELMPNGSLDKF 378
++N + + E+ + + +N++ L + +EL+ + +L +
Sbjct: 130 VRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYEL 188
Query: 379 IHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCP--KISD 436
I ++ + + A I + L+ LH+ RI+H D+KP+NILL + K+ D
Sbjct: 189 IKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVID 245
Query: 437 FGLAKQAQKKESA-ISMLHARGTIGYIAPEVYSRRFG-GVSHKSDVYSYGMMIIEM 490
FG + ++ I Y APEV G D++S G ++ E+
Sbjct: 246 FGSSCYEHQRVYTYIQSRF------YRAPEVI---LGARYGMPIDMWSLGCILAEL 292
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 40/232 (17%), Positives = 74/232 (31%), Gaps = 47/232 (20%)
Query: 260 KKKTREDDRNVEAFIRNHESLAPKRYSYSDVKRMTKSFRDKLGQGGYGEVYKG-ELPDGQ 318
R F P Y + +G+G YG VY + +
Sbjct: 3 HHHHHSSGRENLYFQGIKNVHVPDNYI----------IKHLIGRGSYGYVYLAYDKNTEK 52
Query: 319 LVAVKVLKNSRCNGEEFIN---------EVASISRTSHVNIVTFLGFCYENKKNA----- 364
VA+K + F + E+ ++R I+ +
Sbjct: 53 NVAIKKVNRM------FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY 106
Query: 365 LIYELMPNGSLDKFIH-----NDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDI 419
++ E+ + L K + +IK +Y + G ++H I+H D+
Sbjct: 107 IVLEIADS-DLKKLFKTPIFLTEEHIKT---ILYNLL----LGENFIHES---GIIHRDL 155
Query: 420 KPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRF 471
KP N LL++D K+ DFGLA+ ++ + ++
Sbjct: 156 KPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQ 207
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 44/150 (29%), Positives = 66/150 (44%), Gaps = 15/150 (10%)
Query: 300 KLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEFINEVASISRTSH-VNIVTFLGFC 357
K+G G +G++Y G + G+ VA+K+ + + E V I T
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECV-KTKHPQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 358 YENKKNALIYELMPNG-SL-DKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
E N ++ EL+ G SL D F R K KT+ +A + +EY+H +
Sbjct: 75 AEGDYNVMVMELL--GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIH---SKNFI 127
Query: 416 HFDIKPQNILLDEDFCPK---ISDFGLAKQ 442
H D+KP N L+ I DFGLAK+
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.8 bits (162), Expect = 4e-12
Identities = 28/191 (14%), Positives = 57/191 (29%), Gaps = 56/191 (29%)
Query: 300 KLGQGGYGEVYKGELPDGQLVAVKVL---------KNSRCNGEEFINEVA---------S 341
K+G+G +GEV++ D VA+K++ + + EE + E+
Sbjct: 27 KIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85
Query: 342 ISRTSHVNIVTFLGFC----------------YENKKNA--------------LIYELMP 371
+ Y + K + ++ E
Sbjct: 86 EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145
Query: 372 NG-SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF 430
G L++ ++ ++Q+ +A L H D+ N+LL +
Sbjct: 146 GGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR------FEHRDLHWGNVLLKKTS 199
Query: 431 CPKISDFGLAK 441
K+ K
Sbjct: 200 LKKLHYTLNGK 210
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 6e-12
Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 39/212 (18%)
Query: 301 LGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFIN---------EVASISRTSHVNI 350
+G+G YG V + + VA+K + F + E+ + R H NI
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISP-------FEHQTYCQRTLREIKILLRFRHENI 87
Query: 351 VT----FLGFCYENKKNA-LIYELMPNGSLDKFIH----NDRNIKLEWKTMYQIAIGIAR 401
+ E K+ ++ +LM L K + ++ +I +YQI R
Sbjct: 88 IGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICY---FLYQIL----R 139
Query: 402 GLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISML-HARGTIG 460
GL+Y+H ++H D+KP N+LL+ KI DFGLA+ A L T
Sbjct: 140 GLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 461 YIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG 492
Y APE+ G + D++S G ++ EM+
Sbjct: 197 YRAPEIML-NSKGYTKSIDIWSVGCILAEMLS 227
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 6e-12
Identities = 57/212 (26%), Positives = 88/212 (41%), Gaps = 43/212 (20%)
Query: 301 LGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFIN---------EVASISRTSHVNI 350
+G G YG V + G VA+K L F + E+ + H N+
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRP------FQSELFAKRAYRELRLLKHMRHENV 86
Query: 351 VTFLG-FCYENKKNA-----LIYELMPNGSLDKFIHNDRNIKLEWKT----MYQIAIGIA 400
+ L F + + L+ M L K + ++ KL +YQ+
Sbjct: 87 IGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHE---KLGEDRIQFLVYQML---- 138
Query: 401 RGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIG 460
+GL Y+H I+H D+KP N+ ++ED KI DFGLA+QA M T
Sbjct: 139 KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS-----EMTGYVVTRW 190
Query: 461 YIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG 492
Y APEV + + D++S G ++ EM+
Sbjct: 191 YRAPEVIL-NWMRYTQTVDIWSVGCIMAEMIT 221
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 9e-12
Identities = 57/211 (27%), Positives = 89/211 (42%), Gaps = 41/211 (19%)
Query: 301 LGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFIN---------EVASISRTSHVNI 350
+G G G V + + VA+K K SR F N E+ + +H NI
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIK--KLSRP----FQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 351 VTFLG-FCYENKKNA-----LIYELMPNGSLDKFIH---NDRNIKLEWKTMYQIAIGIAR 401
+ L F + ++ ELM +L + I + + +YQ+
Sbjct: 87 IGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSY---LLYQML----C 138
Query: 402 GLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGY 461
G+++LH I+H D+KP NI++ D KI DFGLA+ A ++ M T Y
Sbjct: 139 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 192
Query: 462 IAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG 492
APEV G D++S G ++ EM+
Sbjct: 193 RAPEVILGM--GYKENVDIWSVGCIMGEMIK 221
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 42/212 (19%)
Query: 300 KLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFIN---------EVASISRTSHVN 349
+G G YG V + G+ VA+K L F + E+ + H N
Sbjct: 31 HVGSGAYGSVCSAIDKRSGEKVAIKKLSRP------FQSEIFAKRAYRELLLLKHMQHEN 84
Query: 350 IVTFL-----GFCYENKKNA-LIYELMPNGSLDKFIH---NDRNIKLEWKTMYQIAIGIA 400
++ L N + L+ M L K + ++ I+ +YQ+
Sbjct: 85 VIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQY---LVYQML---- 136
Query: 401 RGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIG 460
+GL+Y+H +VH D+KP N+ ++ED KI DFGLA+ A M T
Sbjct: 137 KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRW 188
Query: 461 YIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG 492
Y APEV + + D++S G ++ EM+
Sbjct: 189 YRAPEVIL-SWMHYNQTVDIWSVGCIMAEMLT 219
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 66/279 (23%), Positives = 112/279 (40%), Gaps = 47/279 (16%)
Query: 236 FICYCPNGAYSSSCHSRTVIQALIKKKTREDDRNVEAFIRNHESLAPKRYSYSDVK---R 292
F+ YC S + K + + + + + + YS
Sbjct: 5 FLYYC-----SEPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFT 59
Query: 293 MTKSFRD--KLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFIN---------EVA 340
+ K +++ +G G G V + + VA+K K SR F N E+
Sbjct: 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRP----FQNQTHAKRAYRELV 113
Query: 341 SISRTSHVNIVTFL-----GFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLEWKTMYQ 394
+ +H NI++ L E ++ L+ ELM +L + I + + + +YQ
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQ 172
Query: 395 IAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLH 454
+ G+++LH I+H D+KP NI++ D KI DFGLA+ A ++ M
Sbjct: 173 ML----CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTP 222
Query: 455 ARGTIGYIAPEV-YSRRFGGVSHKSDVYSYGMMIIEMVG 492
T Y APEV + D++S G ++ EMV
Sbjct: 223 YVVTRYYRAPEVILGMGY---KENVDIWSVGCIMGEMVR 258
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 43/149 (28%), Positives = 65/149 (43%), Gaps = 13/149 (8%)
Query: 300 KLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEFINEVASISR-TSHVNIVTFLGFC 357
K+G G +GE+Y G + + VA+K+ + + + E I F
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENV-KTKHPQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 358 YENKKNALIYELMPNGSL-DKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVH 416
E N L+ +L+ SL D F R KL KT+ +A + +E++H +H
Sbjct: 73 VEGDYNVLVMDLLGP-SLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH---SKSFLH 126
Query: 417 FDIKPQNILLDEDFCPK---ISDFGLAKQ 442
DIKP N L+ I DFGLAK+
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 49/195 (25%), Positives = 81/195 (41%), Gaps = 45/195 (23%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFIN---------EVASISRTSHV 348
LG+G YG V P G++VA+K ++ F E+ + H
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEP-------FDKPLFALRTLREIKILKHFKHE 69
Query: 349 NIVT----FLGFCYENKKNA-LIYELMPNGSLDKFIHN----DRNIKLEWKTMYQIAIGI 399
NI+T +EN +I ELM L + I D +I+ +YQ
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQY---FIYQTL--- 122
Query: 400 ARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTI 459
R ++ LH ++H D+KP N+L++ + K+ DFGLA+ + + S + +
Sbjct: 123 -RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 460 --GYI------APEV 466
++ APEV
Sbjct: 179 MVEFVATRWYRAPEV 193
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 54/236 (22%), Positives = 94/236 (39%), Gaps = 33/236 (13%)
Query: 266 DDRNVEAFIRNHESLAPKRYSYSDVKRMTKSFRDKLGQGGYGEVYKGE-LPDGQLVAVKV 324
DD N + ++N E RY +G+G +G+V K + + VA+K+
Sbjct: 38 DDDNYDYIVKNGEKWM-DRYE----------IDSLIGKGSFGQVVKAYDRVEQEWVAIKI 86
Query: 325 LKNSRCNGEEFINEVASISR------TSHVNIVTFLGFCYENKKNALIYELMPNGSLDKF 378
+KN + + EV + IV L++E++ + +L
Sbjct: 87 IKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDL 145
Query: 379 IHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCP--KISD 436
+ N + + A + L +L ++ I+H D+KP+NILL KI D
Sbjct: 146 LRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD 204
Query: 437 FGLA-KQAQKKESAISMLHARGTIGYIAPEVYSRRFG-GVSHKSDVYSYGMMIIEM 490
FG + + Q+ I Y +PEV G D++S G +++EM
Sbjct: 205 FGSSCQLGQRIYQYIQSRF------YRSPEVL---LGMPYDLAIDMWSLGCILVEM 251
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 7e-11
Identities = 51/229 (22%), Positives = 86/229 (37%), Gaps = 62/229 (27%)
Query: 300 KLGQGGYGEVYKG-ELPDGQLVAVK--VLKNS-------RCNGEEFINEVASISRTSHVN 349
LG GG G V+ + + VA+K VL + R E+ I R H N
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR--------EIKIIRRLDHDN 69
Query: 350 IVTFLG-FCYENKKNA-------------LIYELMPNGSLDKFIHN----DRNIKLEWKT 391
IV + ++ E M L + + + +L
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARL---F 125
Query: 392 MYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCP-KISDFGLAKQA-QKKESA 449
MYQ+ RGL+Y+H ++H D+KP N+ ++ + KI DFGLA+
Sbjct: 126 MYQLL----RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178
Query: 450 ISMLHARGTIGYIAPEV------YSRRFGGVSHKSDVYSYGMMIIEMVG 492
+ T Y +P + Y++ + D+++ G + EM+
Sbjct: 179 GHLSEGLVTKWYRSPRLLLSPNNYTK---AI----DMWAAGCIFAEMLT 220
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 47/160 (29%), Positives = 74/160 (46%), Gaps = 36/160 (22%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFINEVASISRT-----------S 346
KLG+G YG V+K + G++VAVK K F N + RT
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVK--KIFDA----FQNSTDA-QRTFREIMILTELSG 67
Query: 347 HVNIVTFLG-FCYENKKNA-LIYELMPNGSLDKFIHN----DRNIKLEWKTMYQIAIGIA 400
H NIV L +N ++ L+++ M L I + + +YQ+
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQY---VVYQLI---- 119
Query: 401 RGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLA 440
+ ++YLH G ++H D+KP NILL+ + K++DFGL+
Sbjct: 120 KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS 156
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 56/212 (26%), Positives = 88/212 (41%), Gaps = 43/212 (20%)
Query: 301 LGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFIN---------EVASISRTSHVNI 350
+G G YG V + G VAVK L F + E+ + H N+
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP------FQSIIHAKRTYRELRLLKHMKHENV 90
Query: 351 VTFL-----GFCYENKKNA-LIYELMPNGSLDKFIH----NDRNIKLEWKTMYQIAIGIA 400
+ L E + L+ LM L+ + D +++ +YQI
Sbjct: 91 IGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQF---LIYQIL---- 142
Query: 401 RGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIG 460
RGL+Y+H I+H D+KP N+ ++ED KI DFGLA+ A M T
Sbjct: 143 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT-----ADEMTGYVATRW 194
Query: 461 YIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG 492
Y APE+ + + D++S G ++ E++
Sbjct: 195 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLT 225
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 9e-08
Identities = 48/262 (18%), Positives = 90/262 (34%), Gaps = 67/262 (25%)
Query: 265 EDDRNVEAFIRNHESLAPKRYSYSDVKRMTKSFRDKLGQGGYGEVYKG--ELPDGQLVAV 322
EDD+ R + L RY LG+G +G+V + VA+
Sbjct: 2 EDDKEGHLVCRIGDWLQE-RYE----------IVGNLGEGTFGKVVECLDHARGKSQVAL 50
Query: 323 KVLKNSRCNGEEFINEVASISR------TSHVNIVTFLG-FCYENKKN--ALIYELMPNG 373
K+++N E E+ + + + V F + + +EL+
Sbjct: 51 KIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF---HGHMCIAFELL-GK 106
Query: 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCP- 432
+ +F+ + + +A + L +LH ++ H D+KP+NIL
Sbjct: 107 NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFET 163
Query: 433 ------------------KISDFGLAKQAQKKESA-ISMLHARGTIGYIAPEV-----YS 468
+++DFG A + + ++ H Y PEV +
Sbjct: 164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRH------YRPPEVILELGW- 216
Query: 469 RRFGGVSHKSDVYSYGMMIIEM 490
+ DV+S G ++ E
Sbjct: 217 ------AQPCDVWSIGCILFEY 232
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 57/267 (21%), Positives = 99/267 (37%), Gaps = 71/267 (26%)
Query: 264 REDDRNVEAFIRNHESLAPKRYSYSDVKRMTKSFRDKLGQGGYGEVYKGE-LPDGQLVAV 322
+ DD V + L + K+G G +G V + + + + AV
Sbjct: 17 QGDDEIVHFSWKKGMLLNN-AFL----------VIRKMGDGTFGRVLLCQHIDNKKYYAV 65
Query: 323 KVLKNSRCNGEEFINEVASISR-----TSHVNIVTFLG-FCYENKKN--ALIYELMPNGS 374
KV++N + E + + ++ NIV + G F Y + LI+E + S
Sbjct: 66 KVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY---YDHMCLIFEPL-GPS 121
Query: 375 LDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCP-- 432
L + I + + + I I + L YL + + + H D+KP+NILLD+ +
Sbjct: 122 LYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKS 178
Query: 433 -----------------------KISDFGLAKQAQKKESA-ISMLHARGTIGYIAPEV-- 466
K+ DFG A + I+ Y APEV
Sbjct: 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQ------YRAPEVIL 232
Query: 467 ---YSRRFGGVSHKSDVYSYGMMIIEM 490
+ SD++S+G ++ E+
Sbjct: 233 NLGW-------DVSSDMWSFGCVLAEL 252
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 55/226 (24%), Positives = 90/226 (39%), Gaps = 52/226 (23%)
Query: 299 DKLGQGGYGEVYKG--ELPDGQLVAVKVLKNSRCNGEEFINEVASISR------TSHVNI 350
D LG+G +G+V + G+ VAVK++KN E +E+ + S
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79
Query: 351 VTFLG-FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRG 409
V L F + +++EL+ S FI + + + ++A I + + +LH
Sbjct: 80 VQMLEWFEHHGHI-CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS- 136
Query: 410 CQVRIVHFDIKPQNILLDEDFCP-------------------KISDFGLAKQAQKKESA- 449
++ H D+KP+NIL + K+ DFG A + S
Sbjct: 137 --NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTL 194
Query: 450 ISMLHARGTIGYIAPEV-----YSRRFGGVSHKSDVYSYGMMIIEM 490
+S H R APEV + S DV+S G ++IE
Sbjct: 195 VSTRHYR------APEVILALGW-------SQPCDVWSIGCILIEY 227
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 5e-05
Identities = 68/459 (14%), Positives = 135/459 (29%), Gaps = 134/459 (29%)
Query: 38 SNRPEHCGYPGFELDCAGDVPEITIMDRAYK-VLHINNESWRINVAREDYWDYNCP---- 92
++R +H + + + Y+ L + + ++ +C
Sbjct: 214 TSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW--NAFNLSCKILLT 271
Query: 93 ---ANLSNSLLNFSIFNYASDTQNLTLYYSCPASFMNNISGIL---LP------NRFNCS 140
+++ L + + + D ++TL S + LP N S
Sbjct: 272 TRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLS 331
Query: 141 I------DGKNTNSYYFSWDSNSFNSSIRSAIGA--------YFRSCANSAVIPVWQSTL 186
I DG T + + + + I S++ F +V
Sbjct: 332 IIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRL---SVF------- 381
Query: 187 RYMVNNPNSVNLTCALRVGFGLQWHANNRLCEE------CKQSNGNCGYIAKTGEFICYC 240
P S ++ L L W + K S + K +
Sbjct: 382 ------PPSAHIPTIL---LSLIWFDVIKSDVMVVVNKLHKYS-----LVEKQPK----- 422
Query: 241 PNGAYSSSCHSRTVIQALIKKKTREDDRNVEAFIRNHESLAPKRYSYSDVKRMTKSFRDK 300
+ S S I +K K E++ + I +H ++ PK + D + + D
Sbjct: 423 ---ESTISIPS---IYLELKVK-LENEYALHRSIVDHYNI-PKTFDSDD---LIPPYLD- 470
Query: 301 LGQGGYGEVYKG------ELPDGQLVAVKVLKNSRCNGEEFI------NEVASISRTSHV 348
Y + G E P+ + V + R F+ + A + S +
Sbjct: 471 ----QYFYSHIGHHLKNIEHPERMTLFRMVFLDFR-----FLEQKIRHDSTAWNASGSIL 521
Query: 349 NIVTFLGFCYEN--KKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYL 406
N + L F Y+ N YE + N ++ F+ K+E E L
Sbjct: 522 NTLQQLKF-YKPYICDNDPKYERLVN-AILDFLP-----KIE---------------ENL 559
Query: 407 HRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445
++ + ++ + E+ KQ Q+
Sbjct: 560 ICSKYTDLLRIALMAEDEAIFEE---------AHKQVQR 589
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.3 bits (101), Expect = 2e-04
Identities = 56/343 (16%), Positives = 106/343 (30%), Gaps = 103/343 (30%)
Query: 259 IKKKTREDDRNVEAFIRNHESL--APKRYSYSDVKR--MTKSFRDKL------------G 302
IK + R+ +I + L + ++ +V R R L G
Sbjct: 98 IKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDG 157
Query: 303 QGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYE--- 359
G G K VA+ V + + + ++ ++ L C
Sbjct: 158 VLGSG---K------TWVALDVCLSYKVQ-CKMDFKIFWLN----------LKNCNSPET 197
Query: 360 --NKKNALIYELMPNGSLDKFIHNDRNIKL------EWKTMYQIAIGIARGLEYLHRGCQ 411
L+Y++ PN + NIKL + L L
Sbjct: 198 VLEMLQKLLYQIDPN--WTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQN 255
Query: 412 VRIV-HFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRR 470
+ F++ + +L +++DF A + IS+ H EV S
Sbjct: 256 AKAWNAFNLSCKILLTTRF--KQVTDFLSAA----TTTHISLDHHSM--TLTPDEVKS-- 305
Query: 471 FGGVSHKSDVYSYGMMIIEMVGC-TKNLDDEVTDTS-ICHNLIYERIEPGNDFQFDGVAT 528
++++ + C ++L EV T+ ++I E I DG+AT
Sbjct: 306 ---------------LLLKYLDCRPQDLPREVLTTNPRRLSIIAESIR-------DGLAT 343
Query: 529 EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQ 571
+ W + + K+ ++E S+ L+
Sbjct: 344 WD------------NW-------KHVNCDKLTTIIESSLNVLE 367
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 582 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.68 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.12 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.99 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.65 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.5 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.48 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.43 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.4 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.34 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.09 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.07 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.94 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.69 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.67 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.54 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.48 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.48 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.45 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.42 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.38 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.32 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.27 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.81 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.71 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.5 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.47 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.72 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 87.57 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.17 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 81.84 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-56 Score=447.49 Aligned_cols=257 Identities=26% Similarity=0.388 Sum_probs=212.2
Q ss_pred HHHHHhhhhcCccCceEEEEEEeC------CCcEEEEEEeccCC--CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCee
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELP------DGQLVAVKVLKNSR--CNGEEFINEVASISRTSHVNIVTFLGFCYENKKN 363 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 363 (582)
..+.+|.++||+|+||+||+|.+. +++.||||+++... ...++|.+|+.++++++|||||+++|+|.++...
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 344567899999999999999762 57899999997543 2457899999999999999999999999999999
Q ss_pred eEEEEecCCCChhhhhhcCC--------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC
Q 040604 364 ALIYELMPNGSLDKFIHNDR--------------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED 429 (582)
Q Consensus 364 ~lv~E~~~~gsL~~~i~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~ 429 (582)
+||||||++|+|.++|.... ...+++..+++|+.|||.||+|||+. +||||||||+||||+++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDK 181 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCC
Confidence 99999999999999996532 23589999999999999999999998 99999999999999999
Q ss_pred CceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhh
Q 040604 430 FCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICH 508 (582)
Q Consensus 430 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~ 508 (582)
+.+||+|||+|+...............||+.|||||++.+ +.++.++|||||||+||||+| |+.||......
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~--~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~----- 254 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ----- 254 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH-----
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH-----
Confidence 9999999999997765443333345679999999999976 489999999999999999998 78898765332
Q ss_pred HHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 040604 509 NLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGS 566 (582)
Q Consensus 509 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~ 566 (582)
.+.+.+..+.....+.. ++..+.+|+.+||+.||++||||+||++.|+..
T Consensus 255 -~~~~~i~~~~~~~~p~~-------~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 255 -DVVEMIRNRQVLPCPDD-------CPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp -HHHHHHHTTCCCCCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred -HHHHHHHcCCCCCCccc-------chHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 13344444443333322 335577888899999999999999999999874
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-55 Score=445.40 Aligned_cols=256 Identities=24% Similarity=0.398 Sum_probs=203.4
Q ss_pred HhhhhcCccCceEEEEEEeC------CCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEE
Q 040604 296 SFRDKLGQGGYGEVYKGELP------DGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 368 (582)
.+.++||+|+||+||+|.+. +++.||||+++.... ..++|.+|+.+|++++|||||+++|+|.+....+||||
T Consensus 44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 123 (329)
T 4aoj_A 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123 (329)
T ss_dssp EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 45688999999999999764 478999999976443 24679999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCC-------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEe
Q 040604 369 LMPNGSLDKFIHNDR-------------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKIS 435 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~-------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~ 435 (582)
||++|+|.++++... ..+++|.++++|+.||+.||+|||+. +||||||||+||||++++.+||+
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEEC
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEc
Confidence 999999999997642 23689999999999999999999998 99999999999999999999999
Q ss_pred eccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHh
Q 040604 436 DFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYER 514 (582)
Q Consensus 436 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 514 (582)
|||+|+...............||+.|||||++.+ ..++.++|||||||+||||+| |+.||....... +...
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~--~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~------~~~~ 272 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY--RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE------AIDC 272 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH------HHHH
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcC--CCCCccccccchHHHHHHHHcCCCCCCCCCCHHH------HHHH
Confidence 9999997655443333345679999999999986 478999999999999999999 899997653322 2233
Q ss_pred hcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCC
Q 040604 515 IEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIEN 569 (582)
Q Consensus 515 i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~ 569 (582)
+..+..+..+.. ++..+.+|+.+||+.||++||||+||++.|+.+.++
T Consensus 273 i~~g~~~~~p~~-------~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 273 ITQGRELERPRA-------CPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHTCCCCCCTT-------CCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHcCCCCCCccc-------ccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 333333333332 234577888899999999999999999999997664
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-55 Score=439.12 Aligned_cols=261 Identities=30% Similarity=0.454 Sum_probs=203.5
Q ss_pred HHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 295 KSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
..+.++||+|+||+||+|.+.+ .||||+++..... .+.|.+|+.+|++++|||||+++|++.+ +..+||||||+
T Consensus 38 l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~ 114 (307)
T 3omv_A 38 VMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCE 114 (307)
T ss_dssp CCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCS
T ss_pred eEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCC
Confidence 3567899999999999998743 5999999765443 3568999999999999999999998854 56899999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
||+|.++++... ..+++..+++|+.|||.||+|||++ +||||||||+||||++++.+||+|||+|+..........
T Consensus 115 gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~ 190 (307)
T 3omv_A 115 GSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ 190 (307)
T ss_dssp SCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC---------
T ss_pred CCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCccee
Confidence 999999997543 4699999999999999999999998 999999999999999999999999999987665433333
Q ss_pred eecccCCcccccccccccc-cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCC-CCCCCCcCcH
Q 040604 452 MLHARGTIGYIAPEVYSRR-FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGN-DFQFDGVATE 529 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~-~~~~~~~~~~ 529 (582)
.....||+.|||||++... .+.++.++|||||||+||||+||+.||........ +...+..+. .+.+...
T Consensus 191 ~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~-----~~~~~~~~~~~p~~~~~--- 262 (307)
T 3omv_A 191 VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ-----IIFMVGRGYASPDLSKL--- 262 (307)
T ss_dssp ---CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-----HHHHHHTTCCCCCSTTS---
T ss_pred ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH-----HHHHHhcCCCCCCcccc---
Confidence 3456799999999998643 24689999999999999999999999976543221 222222221 1111111
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCC
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQ 571 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~ 571 (582)
...++..+.+|+.+||+.||++||||+||++.|+..-.+++
T Consensus 263 -~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 263 -YKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp -CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred -cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 11234567788889999999999999999999987666553
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=444.78 Aligned_cols=256 Identities=27% Similarity=0.426 Sum_probs=209.9
Q ss_pred HHhhhhcCccCceEEEEEEeC------CCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP------DGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 367 (582)
+.+.++||+|+||+||+|.+. +++.||||+++.... ..++|.+|+.+|++++|||||+++|+|.+++..+|||
T Consensus 15 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~ 94 (299)
T 4asz_A 15 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF 94 (299)
T ss_dssp EEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 346689999999999999763 478999999976433 2467999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCC-----------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEee
Q 040604 368 ELMPNGSLDKFIHNDR-----------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISD 436 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~-----------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~D 436 (582)
|||++|+|.++++..+ ...++|.++++|+.||+.||+|||++ +|+||||||+|||+++++.+||+|
T Consensus 95 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~D 171 (299)
T 4asz_A 95 EYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGD 171 (299)
T ss_dssp ECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred EcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECC
Confidence 9999999999997542 34699999999999999999999998 999999999999999999999999
Q ss_pred ccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhh
Q 040604 437 FGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERI 515 (582)
Q Consensus 437 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i 515 (582)
||+|+...............||+.|||||++.+ ..++.++|||||||+||||+| |+.||....... +...+
T Consensus 172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~--~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~------~~~~i 243 (299)
T 4asz_A 172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------VIECI 243 (299)
T ss_dssp CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHH
T ss_pred cccceecCCCCceeecCceecChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHH
Confidence 999987655444333334569999999999987 479999999999999999999 899997653321 23333
Q ss_pred cCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 516 EPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
..+..+..+.. ++..+.+|+.+||+.||++||||++|++.|++..+
T Consensus 244 ~~~~~~~~p~~-------~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 244 TQGRVLQRPRT-------CPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHTCCCCCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCCCCCCcc-------chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 33333333322 23457788889999999999999999999998654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-53 Score=433.51 Aligned_cols=247 Identities=24% Similarity=0.347 Sum_probs=200.2
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
|.+.++||+|+||+||+|... +|+.||||+++..... .+.+.+|+.+|++++|||||++++++.+++..+||||||
T Consensus 26 Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~ 105 (350)
T 4b9d_A 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYC 105 (350)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 456789999999999999764 7999999999765543 356889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
+||+|.++|...+...+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+........
T Consensus 106 ~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~- 181 (350)
T 4b9d_A 106 EGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL- 181 (350)
T ss_dssp TTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH-
T ss_pred CCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCccc-
Confidence 999999999877666789999999999999999999998 9999999999999999999999999999987543221
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHH
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 530 (582)
....+||+.|||||++.+. .++.++|||||||+||||++|+.||....... +...+..+....+...
T Consensus 182 -~~~~~GT~~YmAPE~l~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i~~~~~~~~~~~---- 248 (350)
T 4b9d_A 182 -ARACIGTPYYLSPEICENK--PYNNKSDIWALGCVLYELCTLKHAFEAGSMKN------LVLKIISGSFPPVSLH---- 248 (350)
T ss_dssp -HHHHHSCCTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHTCCCCCCTT----
T ss_pred -ccccCCCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHHcCCCCCCCcc----
Confidence 1234699999999999874 78999999999999999999999997653322 1222222222222222
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 531 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
+...+.+|+.+||+.||++|||++|+++
T Consensus 249 ---~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 249 ---YSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2345677888899999999999999985
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-53 Score=431.04 Aligned_cols=253 Identities=23% Similarity=0.275 Sum_probs=202.8
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCC
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGS 374 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 374 (582)
.+.++||+|+||+||+|... +|+.||||+++..... .+|+.+|++++|||||++++++.++...+||||||+||+
T Consensus 61 ~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~ 136 (336)
T 4g3f_A 61 THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136 (336)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred EeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence 34578999999999999764 7999999999765432 469999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-ceEEeeccccccccccccc---e
Q 040604 375 LDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF-CPKISDFGLAKQAQKKESA---I 450 (582)
Q Consensus 375 L~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~-~vkl~DFGla~~~~~~~~~---~ 450 (582)
|.++++..+ .+++..+..++.||+.||+|||++ +||||||||+||||+.+| .+||+|||+|+........ .
T Consensus 137 L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~ 211 (336)
T 4g3f_A 137 LGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211 (336)
T ss_dssp HHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred HHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence 999998654 699999999999999999999998 999999999999999988 6999999999987543221 1
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCC-CCCCCcCcH
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND-FQFDGVATE 529 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~ 529 (582)
.....+||+.|||||++.+. .++.++|||||||+||||++|+.||........ ... ....... ..++.
T Consensus 212 ~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~----i~~~~~~~~~~~~---- 280 (336)
T 4g3f_A 212 TGDYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-CLK----IASEPPPIREIPP---- 280 (336)
T ss_dssp --CCCCCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-HHH----HHHSCCGGGGSCT----
T ss_pred cCCccccCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHH----HHcCCCCchhcCc----
Confidence 22235799999999999874 789999999999999999999999976544331 111 1111111 11111
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCC
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQ 571 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~ 571 (582)
.+...+.+++.+||+.||++|||++||++.|...+..+.
T Consensus 281 ---~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 281 ---SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp ---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred ---cCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 234556778888999999999999999999887665443
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-53 Score=430.33 Aligned_cols=246 Identities=24% Similarity=0.335 Sum_probs=203.5
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC-CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR-CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
+++.++||+|+||+||+|... +|+.||||+++... ...+.+.+|+.+|++++|||||++++++.+++..+||||||+|
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 155 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 445678999999999999765 79999999996543 3456789999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
|+|.+++.+. .+++..+..++.||+.||+|||++ +||||||||+||||+.+|.+||+|||+|+........ .
T Consensus 156 g~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~--~ 227 (346)
T 4fih_A 156 GALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--R 227 (346)
T ss_dssp EEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--B
T ss_pred CcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc--c
Confidence 9999999753 589999999999999999999998 9999999999999999999999999999987654332 2
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
...+||+.|||||++.+. .++.++|||||||++|||++|+.||....... +...+.......+.. ..
T Consensus 228 ~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~i~~~~~~~~~~-----~~ 294 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK------AMKMIRDNLPPRLKN-----LH 294 (346)
T ss_dssp CCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSSCCCCSC-----GG
T ss_pred cccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHHcCCCCCCCc-----cc
Confidence 245799999999999764 78999999999999999999999997643322 122222221111111 12
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 533 KIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.+...+.+|+.+||+.||++|||++|+++
T Consensus 295 ~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 295 KVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 23456677888999999999999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=417.93 Aligned_cols=244 Identities=29% Similarity=0.423 Sum_probs=196.8
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEe----CCeeeEEE
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYE----NKKNALIY 367 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 367 (582)
.+.++||+|+||+||+|.+. +++.||+|++...... .+.|.+|+.+|++++|||||++++++.+ ....+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 35578999999999999765 7899999999765433 3568999999999999999999999875 34579999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc-CCCceEEeecccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLD-EDFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~-~~~~vkl~DFGla~~~~~~ 446 (582)
|||+||+|.+++.+.+ .+++..+..|+.||+.||+|||++ .++|+||||||+||||+ .++.+||+|||+|+.....
T Consensus 109 Ey~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~ 185 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence 9999999999997643 689999999999999999999987 12399999999999998 4799999999999864432
Q ss_pred ccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCC-CCCC
Q 040604 447 ESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDF-QFDG 525 (582)
Q Consensus 447 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~-~~~~ 525 (582)
. ....+||+.|||||++.+ .++.++|||||||+||||+||+.||....... .+...+..+..+ .++.
T Consensus 186 ~----~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-----~~~~~i~~~~~~~~~~~ 253 (290)
T 3fpq_A 186 F----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYRRVTSGVKPASFDK 253 (290)
T ss_dssp S----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHHHHHTTTCCCGGGGG
T ss_pred c----cCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-----HHHHHHHcCCCCCCCCc
Confidence 2 123579999999999864 58999999999999999999999997543322 233444443221 1222
Q ss_pred cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 526 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.. ...+.+|+.+||+.||++|||++|+++
T Consensus 254 ~~-------~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 254 VA-------IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CC-------CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cC-------CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22 234677888999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=423.67 Aligned_cols=267 Identities=22% Similarity=0.276 Sum_probs=201.8
Q ss_pred HhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCC----eeeEEEEecC
Q 040604 296 SFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENK----KNALIYELMP 371 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~E~~~ 371 (582)
.+.++||+|+||+||+|.+ +|+.||||+++........+..|+..+.+++|||||+++|++.++. ..+||||||+
T Consensus 6 ~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~ 84 (303)
T 3hmm_A 6 VLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84 (303)
T ss_dssp EEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred EEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCC
Confidence 3568899999999999988 6899999999765433333445677778899999999999998654 5689999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhC-----CCCceEecCCCCCCEEEcCCCceEEeecccccccccc
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRG-----CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-----~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~ 446 (582)
+|+|.++++.. ++++..+.+|+.|++.||+|||++ +.++|+||||||+||||+.++.+||+|||+|+.....
T Consensus 85 ~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 161 (303)
T 3hmm_A 85 HGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 161 (303)
T ss_dssp TCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred CCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCC
Confidence 99999999764 589999999999999999999975 2458999999999999999999999999999876544
Q ss_pred ccce--eeecccCCccccccccccccc----CCCCccchhHHHHHHHHHHhcCCCCCCCCCcccc----------hhhHH
Q 040604 447 ESAI--SMLHARGTIGYIAPEVYSRRF----GGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTS----------ICHNL 510 (582)
Q Consensus 447 ~~~~--~~~~~~gt~~y~aPE~~~~~~----~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~----------~~~~~ 510 (582)
.... ......||+.|||||++.+.. +.++.++|||||||+||||+||+.|+........ .....
T Consensus 162 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~ 241 (303)
T 3hmm_A 162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241 (303)
T ss_dssp TTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred CCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHH
Confidence 3321 122356999999999986531 2467899999999999999999877643322111 11111
Q ss_pred HHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 511 IYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 511 ~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
.........++.++... ...+..+.+.+|+.+||+.||++||||+||++.|+++.+
T Consensus 242 ~~~~~~~~~rp~~p~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 242 RKVVCEQKLRPNIPNRW--QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHTTSCCCCCCCGGG--GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhcccCCCCCCccc--cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 11222222222222211 122456678899999999999999999999999987543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-53 Score=423.28 Aligned_cols=245 Identities=23% Similarity=0.295 Sum_probs=204.7
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccC----CCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNS----RCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
|++.++||+|+||+||+|... +|+.||||++.+. ....+.+.+|+.+|++++|||||++++++.+++..+|||||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy 113 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 113 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 567789999999999999754 7999999999643 33557799999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
++||+|.+++.+.+ .+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.+......
T Consensus 114 ~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 114 AKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp CTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 99999999997644 699999999999999999999998 9999999999999999999999999999987654433
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
......+||+.|||||++.+. .++.++||||+||+||||++|+.||....... +.+.+..+. ..++...
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~i~~~~-~~~p~~~-- 257 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNEGL------IFAKIIKLE-YDFPEKF-- 257 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHS--CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTC-CCCCTTC--
T ss_pred ccccCcccCcccCCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHcCC-CCCCccc--
Confidence 333456799999999999874 68999999999999999999999997643221 222222221 2233222
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVL 560 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl 560 (582)
...+.+|+.+||+.||++|||++|++
T Consensus 258 -----s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 258 -----FPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -----CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -----CHHHHHHHHHHccCCHhHCcChHHHc
Confidence 34567788889999999999999863
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=429.39 Aligned_cols=263 Identities=25% Similarity=0.428 Sum_probs=213.9
Q ss_pred HHHHHHHHhhhhcCccCceEEEEEEeC------CCcEEEEEEeccCCCC--HHHHHHHHHHHhccCC-CceEEEEeEEEe
Q 040604 289 DVKRMTKSFRDKLGQGGYGEVYKGELP------DGQLVAVKVLKNSRCN--GEEFINEVASISRTSH-VNIVTFLGFCYE 359 (582)
Q Consensus 289 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h-~niv~l~~~~~~ 359 (582)
|+.+..+++.++||+|+||+||+|.+. .++.||||+++..... .+.|.+|+.+|+++.| ||||+++|+|.+
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 344556677889999999999999753 2468999999765433 3568999999999965 899999999976
Q ss_pred C-CeeeEEEEecCCCChhhhhhcCC--------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCE
Q 040604 360 N-KKNALIYELMPNGSLDKFIHNDR--------------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNI 424 (582)
Q Consensus 360 ~-~~~~lv~E~~~~gsL~~~i~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NI 424 (582)
. ...+||||||++|+|.++|+... ...+++..++.++.|||+||+|||++ +||||||||+||
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NI 216 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI 216 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccce
Confidence 5 56899999999999999997542 23489999999999999999999998 999999999999
Q ss_pred EEcCCCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcc
Q 040604 425 LLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTD 503 (582)
Q Consensus 425 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~ 503 (582)
|+++++.+||+|||+|+...............||+.|||||++.+ ..++.++|||||||+||||+| |+.||......
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~--~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc--CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999998766554444445679999999999987 479999999999999999998 89999765433
Q ss_pred cchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 504 TSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 504 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
.. +...+..+..+..+... ...+.+++.+||+.||++|||++||++.|+..++
T Consensus 295 ~~-----~~~~i~~g~~~~~p~~~-------~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 295 EE-----FCRRLKEGTRMRAPDYT-------TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp HH-----HHHHHHHTCCCCCCTTC-------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH-----HHHHHHcCCCCCCCccC-------CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 32 23334444333333333 3456677888999999999999999999988765
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=431.48 Aligned_cols=246 Identities=24% Similarity=0.335 Sum_probs=203.3
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC-CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR-CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
|++.++||+|+||+||+|... +|+.||||++.... ...+.+.+|+.+|++++|||||++++++.+.+..+||||||+|
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 456689999999999999765 79999999997544 3456789999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
|+|.+++... .+++..+..|+.||+.||+|||++ +||||||||+||||+.+|.+||+|||+|+.+...... .
T Consensus 233 G~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~--~ 304 (423)
T 4fie_A 233 GALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--R 304 (423)
T ss_dssp EEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC--B
T ss_pred CcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc--c
Confidence 9999999753 589999999999999999999998 9999999999999999999999999999987554322 2
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
...+||+.|||||++.+. .++.++|||||||++|||++|+.||....... +...+.......+.. ..
T Consensus 305 ~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~i~~~~~~~~~~-----~~ 371 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK------AMKMIRDNLPPRLKN-----LH 371 (423)
T ss_dssp CCCEECTTTCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSCCCCCSC-----TT
T ss_pred cccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHHcCCCCCCcc-----cc
Confidence 245699999999999764 78999999999999999999999997643322 122222221111111 11
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 533 KIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.+...+.+|+.+||+.||++|||++|+++
T Consensus 372 ~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 372 KVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp SSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 23355677888999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=409.13 Aligned_cols=244 Identities=25% Similarity=0.370 Sum_probs=189.6
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 368 (582)
.|++.++||+|+||+||+|... +|+.||||++++.. ...+.+.+|+.+|++++|||||++++++.+.+..++|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4567789999999999999764 79999999997543 234578999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
|+ +|+|.+++.+.+ .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.......
T Consensus 94 y~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 94 YA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp CC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred CC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence 99 789999987654 699999999999999999999998 999999999999999999999999999987654332
Q ss_pred ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc
Q 040604 449 AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528 (582)
Q Consensus 449 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 528 (582)
. ....||+.|||||++.+. ...+.++||||+||++|||++|+.||....... +.+.+..+. ..++...
T Consensus 168 ~---~~~~GT~~Y~APE~~~~~-~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~------~~~~i~~~~-~~~p~~~- 235 (275)
T 3hyh_A 168 L---KTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV------LFKNISNGV-YTLPKFL- 235 (275)
T ss_dssp ----------CTTSCHHHHSSS-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTC-CCCCTTS-
T ss_pred c---CCeeECcccCChhhhcCC-CCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHcCC-CCCCCCC-
Confidence 2 235699999999999874 345689999999999999999999997643221 222332222 1222222
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
...+.+|+.+||+.||++|||++|+++
T Consensus 236 ------s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 236 ------SPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ------CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ------CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 345667888899999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=411.61 Aligned_cols=244 Identities=26% Similarity=0.336 Sum_probs=192.0
Q ss_pred HHhhhhcCccCceEEEEEEeC----CCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP----DGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 367 (582)
|++.++||+|+||+||+|+.. +++.||||++++... ....+.+|+.+|++++|||||++++++.+++..+|||
T Consensus 26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 105 (304)
T 3ubd_A 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL 105 (304)
T ss_dssp EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 467789999999999999652 578999999975432 2346889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
||++||+|.+++.+.+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 106 Ey~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 106 DFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp CCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 9999999999998644 699999999999999999999998 99999999999999999999999999998754433
Q ss_pred cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcC
Q 040604 448 SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 527 (582)
.. .....||+.|||||++.+. .++.++|||||||+||||++|+.||....... +...+..+. ..++..
T Consensus 181 ~~--~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i~~~~-~~~p~~- 248 (304)
T 3ubd_A 181 KK--AYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE------TMTMILKAK-LGMPQF- 248 (304)
T ss_dssp CC--CCSCCCCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC-CCCCTT-
T ss_pred cc--ccccccCcccCCHHHhccC--CCCCCCcccchHHHHHHHHhCCCCCCCcCHHH------HHHHHHcCC-CCCCCc-
Confidence 22 2235799999999999764 78999999999999999999999997653322 122222221 122222
Q ss_pred cHHHHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 040604 528 TEEEKKIAKMMILVGFWCIQTNPSERPSM-----HKVLE 561 (582)
Q Consensus 528 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~-----~evl~ 561 (582)
+...+.+|+.+||+.||++|||+ +|+++
T Consensus 249 ------~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 249 ------LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ------SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ------CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 23456778888999999999984 66664
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-50 Score=403.95 Aligned_cols=258 Identities=22% Similarity=0.349 Sum_probs=188.9
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeCC----------
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYENK---------- 361 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---------- 361 (582)
+++.+.||+|+||+||+|... +|+.||||+++..... .+.+.+|+.+|++++|||||++++++.+.+
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~ 86 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP 86 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence 456689999999999999764 7999999999754432 356899999999999999999999987544
Q ss_pred --eeeEEEEecCCCChhhhhhcCCC-cCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecc
Q 040604 362 --KNALIYELMPNGSLDKFIHNDRN-IKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFG 438 (582)
Q Consensus 362 --~~~lv~E~~~~gsL~~~i~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFG 438 (582)
..++||||+++|+|.+++..... ...++..++.|+.||++||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 87 ~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 87 KVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred CcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccCc
Confidence 36899999999999999986543 2456778899999999999999998 99999999999999999999999999
Q ss_pred ccccccccccce----------eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhh
Q 040604 439 LAKQAQKKESAI----------SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICH 508 (582)
Q Consensus 439 la~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~ 508 (582)
+|+......... .....+||+.|||||++.+. .++.++|||||||++|||++ ||..... ..
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyell~---Pf~~~~~---~~- 234 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFELLY---PFSTQME---RV- 234 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHS---CCSSHHH---HH-
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCC--CCCCHHHHHHHHHHHHHHcc---CCCCccH---HH-
Confidence 998865432211 12234699999999999874 78999999999999999996 6643211 11
Q ss_pred HHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCCCCC
Q 040604 509 NLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQIPP 574 (582)
Q Consensus 509 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~~p~ 574 (582)
. ....+.... .+.........+.+|+.+||+.||++|||+.|+++. .-++.++.|.
T Consensus 235 ~-~~~~~~~~~-------~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h--~~~~~~~~p~ 290 (299)
T 4g31_A 235 R-TLTDVRNLK-------FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN--AVFEDLDFPG 290 (299)
T ss_dssp H-HHHHHHTTC-------CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS--GGGCCC----
T ss_pred H-HHHHHhcCC-------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC--HhhCCCCCCC
Confidence 1 111222211 122333444556778899999999999999999872 3344454444
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=399.43 Aligned_cols=258 Identities=22% Similarity=0.296 Sum_probs=197.3
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEe------CCeee
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYE------NKKNA 364 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~~ 364 (582)
|++.++||+|+||+||+|... +|+.||||+++..... .+.+.+|+.+|++++|||||++++++.. ....+
T Consensus 56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ 135 (398)
T 4b99_A 56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY 135 (398)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence 456789999999999999764 7999999999765443 3467899999999999999999999864 35679
Q ss_pred EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccc
Q 040604 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~ 444 (582)
|||||| +|+|.+++...+ .+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+.
T Consensus 136 ivmE~~-~g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 136 VVLDLM-ESDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEECC-SEEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEeCC-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 999999 578999997643 799999999999999999999998 99999999999999999999999999998764
Q ss_pred cccc--ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCC
Q 040604 445 KKES--AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQ 522 (582)
Q Consensus 445 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~ 522 (582)
.... .......+||+.|||||++.+. ..++.++||||+||++|||++|+.||........ + ..+...........
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~-l-~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ-L-QLIMMVLGTPSPAV 286 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-H-HHHHHHHCCCCGGG
T ss_pred cCccccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH-H-HHHHHhcCCCChHH
Confidence 4321 1122345799999999998764 4679999999999999999999999976543221 1 11111111110000
Q ss_pred ---------------CCCcCcHHH----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 523 ---------------FDGVATEEE----KKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 523 ---------------~~~~~~~~~----~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
+........ ..+...+.+|+.+||+.||++|||++|+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000000 112356778899999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=391.58 Aligned_cols=199 Identities=20% Similarity=0.337 Sum_probs=169.0
Q ss_pred HHhhhhcCccCceEEEEEEeC----CCcEEEEEEeccCCCCHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP----DGQLVAVKVLKNSRCNGEEFINEVASISRT-SHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
|++.++||+|+||+||+|..+ +++.||||++.... ....+.+|+.+|+++ +|||||++++++.+.++.++||||
T Consensus 23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~ 101 (361)
T 4f9c_A 23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPY 101 (361)
T ss_dssp CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEEC
T ss_pred EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeC
Confidence 556789999999999999642 57899999986654 456788999999998 699999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-CceEEeecccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED-FCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~-~~vkl~DFGla~~~~~~~~ 448 (582)
++||+|.+++. .+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 102 ~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 102 LEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI 173 (361)
T ss_dssp CCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred CCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence 99999999984 489999999999999999999998 99999999999999877 8999999999986543211
Q ss_pred c--------------------------eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCc
Q 040604 449 A--------------------------ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVT 502 (582)
Q Consensus 449 ~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~ 502 (582)
. ......+||+.|+|||++.+. ..++.++||||+||++|||++|+.||.....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 0 011234699999999999764 4689999999999999999999999976544
Q ss_pred c
Q 040604 503 D 503 (582)
Q Consensus 503 ~ 503 (582)
.
T Consensus 253 ~ 253 (361)
T 4f9c_A 253 D 253 (361)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=405.87 Aligned_cols=249 Identities=22% Similarity=0.337 Sum_probs=204.3
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
.|++.++||+|+||+||+|... +|+.||||+++.... ..+.+.+|+.+|++++|||||++++++.+....+||||||+
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 3567789999999999999764 799999999976543 34668899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC--CceEEeeccccccccccccc
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED--FCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~--~~vkl~DFGla~~~~~~~~~ 449 (582)
||+|.++|.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+......
T Consensus 238 gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~ 313 (573)
T 3uto_A 238 GGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313 (573)
T ss_dssp CCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE
T ss_pred CCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCce
Confidence 999999986533 3689999999999999999999998 99999999999999854 89999999999987655432
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
...+||+.|||||++.+. .++.++|||||||++|||++|+.||....... ....+..... .+. ..
T Consensus 314 ---~~~~GT~~y~APEv~~~~--~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~------~~~~i~~~~~-~~~---~~ 378 (573)
T 3uto_A 314 ---KVTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TLRNVKSCDW-NMD---DS 378 (573)
T ss_dssp ---EEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHTTCC-CCC---SG
T ss_pred ---eeeEECccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHHhCCC-CCC---cc
Confidence 234699999999999874 78999999999999999999999997654322 2222322211 111 11
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
....+...+.+|+.+||+.||++|||++|+++
T Consensus 379 ~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 379 AFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11223455678888999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=400.89 Aligned_cols=246 Identities=27% Similarity=0.333 Sum_probs=195.9
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccC----CCCHHHHHHH---HHHHhccCCCceEEEEeEEEeCCeeeEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNS----RCNGEEFINE---VASISRTSHVNIVTFLGFCYENKKNALI 366 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~~lv 366 (582)
+++.+.||+|+||+||+|... +|+.||||++++. ......+.+| +.+++.++|||||++++++.+.+..+||
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV 270 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 270 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence 455678999999999999765 7999999999643 2233334444 6677788999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccc
Q 040604 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~ 446 (582)
|||++||+|.++|.+.+ .+++..+..++.||+.||+|||++ +||||||||+||||+.+|++||+|||+|+.....
T Consensus 271 mEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 271 LDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp ECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 99999999999998643 699999999999999999999998 9999999999999999999999999999887654
Q ss_pred ccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCc
Q 040604 447 ESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526 (582)
Q Consensus 447 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 526 (582)
.. ...+||+.|||||++.+. ..++.++|||||||+||||++|+.||........ .. +...+... ...++..
T Consensus 346 ~~----~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~--~~-i~~~i~~~-~~~~p~~ 416 (689)
T 3v5w_A 346 KP----HASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HE-IDRMTLTM-AVELPDS 416 (689)
T ss_dssp CC----CSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH--HH-HHHHHHHC-CCCCCTT
T ss_pred CC----CCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HH-HHHhhcCC-CCCCCcc
Confidence 32 235799999999999643 3689999999999999999999999976433221 11 12222111 1122222
Q ss_pred CcHHHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 040604 527 ATEEEKKIAKMMILVGFWCIQTNPSERPS-----MHKVLE 561 (582)
Q Consensus 527 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~evl~ 561 (582)
. ...+.+|+.+||+.||++|++ ++||++
T Consensus 417 ~-------S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 417 F-------SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp S-------CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred C-------CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 2 345667788899999999998 677763
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=363.91 Aligned_cols=269 Identities=33% Similarity=0.568 Sum_probs=214.8
Q ss_pred HhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCC
Q 040604 296 SFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGS 374 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 374 (582)
.+.+.||+|+||+||+|.+.+++.||||++..... ..+.+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 42 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 121 (321)
T 2qkw_B 42 DHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121 (321)
T ss_dssp SCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCB
T ss_pred CccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCc
Confidence 34578999999999999988899999999876543 34678999999999999999999999999999999999999999
Q ss_pred hhhhhhcCC--CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 375 LDKFIHNDR--NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 375 L~~~i~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...........
T Consensus 122 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 198 (321)
T 2qkw_B 122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198 (321)
T ss_dssp TGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCB
T ss_pred HHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 999997543 23589999999999999999999998 9999999999999999999999999999875543322222
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccc-hhhHHHHHhhcCCCCCC-C-CCcCcH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTS-ICHNLIYERIEPGNDFQ-F-DGVATE 529 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~i~~~~~~~-~-~~~~~~ 529 (582)
....||+.|+|||++.+ +.++.++||||||+++|||++|+.||........ ....+.......+.... . ......
T Consensus 199 ~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (321)
T 2qkw_B 199 TVVKGTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADK 276 (321)
T ss_dssp CCCEEETTTCCHHHHHH--CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTC
T ss_pred cccCCCccccCHHHhcC--CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccc
Confidence 33458999999999876 4789999999999999999999999976544332 12222222222211110 1 111112
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCC
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIEN 569 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~ 569 (582)
........+.+++.+||+.||++|||++||++.|+..+..
T Consensus 277 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 277 IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 2345677888999999999999999999999999986653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=364.19 Aligned_cols=263 Identities=27% Similarity=0.473 Sum_probs=200.0
Q ss_pred HHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCH---HHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 294 TKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNG---EEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
.+++.++||+|+||+||+|.. +|+.||||++....... +.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 38 ~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 116 (309)
T 3p86_A 38 DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYL 116 (309)
T ss_dssp GEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECC
T ss_pred HceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecC
Confidence 345668999999999999987 68899999997655443 46889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCC-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCc--eEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 371 PNGSLDKFIHNDR-NIKLEWKTMYQIAIGIARGLEYLHRGCQVR--IVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 371 ~~gsL~~~i~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~--ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
++|+|.+++.... ...+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++......
T Consensus 117 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 117 SRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193 (309)
T ss_dssp TTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred CCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence 9999999998643 23489999999999999999999998 7 9999999999999999999999999998654432
Q ss_pred cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcC
Q 040604 448 SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 527 (582)
.. .....||+.|+|||++.+. .++.++||||||+++|||++|+.||....... .............+...
T Consensus 194 ~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~~- 263 (309)
T 3p86_A 194 LS--SKSAAGTPEWMAPEVLRDE--PSNEKSDVYSFGVILWELATLQQPWGNLNPAQ-----VVAAVGFKCKRLEIPRN- 263 (309)
T ss_dssp ----------CCTTSCHHHHTTC--CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH-----HHHHHHHSCCCCCCCTT-
T ss_pred cc--cccCCCCccccChhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhcCCCCCCCcc-
Confidence 21 2234699999999999763 67999999999999999999999997653322 11111112222222222
Q ss_pred cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCCCCCCC
Q 040604 528 TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQIPPKP 576 (582)
Q Consensus 528 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~~p~~p 576 (582)
+...+.+++.+||+.||++|||+++|++.|+..+.....||.+
T Consensus 264 ------~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~~ 306 (309)
T 3p86_A 264 ------LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNR 306 (309)
T ss_dssp ------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--------
T ss_pred ------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCCc
Confidence 2345677888999999999999999999999988877655544
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=364.77 Aligned_cols=281 Identities=37% Similarity=0.649 Sum_probs=220.3
Q ss_pred CcccHHHHHHHHHH--hhhhcCccCceEEEEEEeCCCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEE
Q 040604 283 KRYSYSDVKRMTKS--FRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCY 358 (582)
Q Consensus 283 ~~~~~~~~~~~~~~--~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~ 358 (582)
..++..++...+.+ +.+.||+|+||+||+|...+|+.||||+++.... ....+.+|+.++++++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 45677777655544 4578999999999999888899999999976432 2346899999999999999999999999
Q ss_pred eCCeeeEEEEecCCCChhhhhhcCC--CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEee
Q 040604 359 ENKKNALIYELMPNGSLDKFIHNDR--NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISD 436 (582)
Q Consensus 359 ~~~~~~lv~E~~~~gsL~~~i~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~D 436 (582)
+....++||||+++|+|.+++.... ...+++..++.|+.|++.||+|||+.+..+|+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 9999999999999999999998653 33599999999999999999999997666999999999999999999999999
Q ss_pred ccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCC---cccchhhHHHHH
Q 040604 437 FGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEV---TDTSICHNLIYE 513 (582)
Q Consensus 437 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~---~~~~~~~~~~~~ 513 (582)
||+++......... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.... ........++..
T Consensus 178 fg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 178 FGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp CSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHH--SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred CccccccCcccccc-cccccCCcCccCHHHhcc--CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 99998775443332 233469999999999876 368999999999999999999999996321 111122233322
Q ss_pred hhcCCCCCCC--CCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 040604 514 RIEPGNDFQF--DGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGS 566 (582)
Q Consensus 514 ~i~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~ 566 (582)
.+.......+ ..............+.+++.+||+.||++|||++||+++|++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 2222211111 1111122345567889999999999999999999999999873
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=367.85 Aligned_cols=257 Identities=24% Similarity=0.452 Sum_probs=208.4
Q ss_pred HHHhhhhcCccCceEEEEEEe--------CCCcEEEEEEeccCCCC--HHHHHHHHHHHhcc-CCCceEEEEeEEEeCCe
Q 040604 294 TKSFRDKLGQGGYGEVYKGEL--------PDGQLVAVKVLKNSRCN--GEEFINEVASISRT-SHVNIVTFLGFCYENKK 362 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 362 (582)
.+.+.+.||+|+||+||+|.. .++..||||+++..... .+.+.+|+.+++++ +||||+++++++.+...
T Consensus 82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 161 (370)
T 2psq_A 82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 161 (370)
T ss_dssp GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSS
T ss_pred HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCC
Confidence 345668899999999999965 24568999999765432 35689999999999 89999999999999999
Q ss_pred eeEEEEecCCCChhhhhhcCC--------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC
Q 040604 363 NALIYELMPNGSLDKFIHNDR--------------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE 428 (582)
Q Consensus 363 ~~lv~E~~~~gsL~~~i~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~ 428 (582)
.++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.
T Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~ 238 (370)
T 2psq_A 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTE 238 (370)
T ss_dssp CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECC
Confidence 999999999999999997643 23588999999999999999999998 9999999999999999
Q ss_pred CCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchh
Q 040604 429 DFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSIC 507 (582)
Q Consensus 429 ~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~ 507 (582)
++.+||+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--- 313 (370)
T 2psq_A 239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 313 (370)
T ss_dssp TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence 99999999999987655433222334468899999999876 478999999999999999999 888887643322
Q ss_pred hHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 508 HNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 508 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
+...+..+.....+.. +...+.+++.+||+.||++|||++|+++.|+.++.
T Consensus 314 ---~~~~~~~~~~~~~~~~-------~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 314 ---LFKLLKEGHRMDKPAN-------CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp ---HHHHHHTTCCCCCCTT-------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHhcCCCCCCCCC-------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 2223333322222222 23457778889999999999999999999998664
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=352.04 Aligned_cols=255 Identities=24% Similarity=0.457 Sum_probs=212.3
Q ss_pred HHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCC
Q 040604 294 TKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNG 373 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 373 (582)
.+.+.++||+|+||+||+|...++..||+|+++......+++.+|+.++++++||||+++++++.+....++||||++++
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (268)
T 3sxs_A 9 EITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNG 88 (268)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred heeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCC
Confidence 44567899999999999999888889999999888778889999999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeee
Q 040604 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISML 453 (582)
Q Consensus 374 sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 453 (582)
+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........ ...
T Consensus 89 ~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~ 163 (268)
T 3sxs_A 89 CLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-SSV 163 (268)
T ss_dssp BHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE-ECC
T ss_pred cHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhh-ccc
Confidence 9999997642 3589999999999999999999998 9999999999999999999999999999876554332 223
Q ss_pred cccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 454 HARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 454 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
...||+.|+|||.+.+ ..++.++||||||++++||++ |+.||....... ....+..+.....+...
T Consensus 164 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~----- 230 (268)
T 3sxs_A 164 GTKFPVKWSAPEVFHY--FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE------VVLKVSQGHRLYRPHLA----- 230 (268)
T ss_dssp SCCCCGGGCCHHHHHH--SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHHHTTCCCCCCTTS-----
T ss_pred CCCcCcccCCHHHHhc--cCCchhhhhHHHHHHHHHHHcCCCCCccccChHH------HHHHHHcCCCCCCCCcC-----
Confidence 4457888999999876 368899999999999999999 888987543322 12222222222222222
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 533 KIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
...+.+++.+||+.||++|||++++++.|+...+
T Consensus 231 --~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 231 --SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp --CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred --hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 2456778889999999999999999999998654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=352.39 Aligned_cols=254 Identities=25% Similarity=0.474 Sum_probs=210.8
Q ss_pred HHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCC
Q 040604 295 KSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGS 374 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 374 (582)
+.+.++||+|+||+||+|...+++.||+|+++......+.+.+|+.++++++||||+++++++.+....++||||+++++
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 91 (269)
T 4hcu_A 12 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 91 (269)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred ceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCc
Confidence 45568999999999999998889999999999887788899999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeec
Q 040604 375 LDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLH 454 (582)
Q Consensus 375 L~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 454 (582)
|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........ ....
T Consensus 92 L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~ 166 (269)
T 4hcu_A 92 LSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTG 166 (269)
T ss_dssp HHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-STTS
T ss_pred HHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccc-cccC
Confidence 999997543 3689999999999999999999998 9999999999999999999999999999876543221 1223
Q ss_pred ccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHH
Q 040604 455 ARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKK 533 (582)
Q Consensus 455 ~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 533 (582)
..||+.|+|||.+.. ..++.++||||||++++||++ |+.||....... +...+..+.....+...
T Consensus 167 ~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~------ 232 (269)
T 4hcu_A 167 TKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------VVEDISTGFRLYKPRLA------ 232 (269)
T ss_dssp TTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTTCCCCCCTTS------
T ss_pred cccccccCCHHHhcC--CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH------HHHHHhcCccCCCCCcC------
Confidence 457889999999876 478999999999999999999 888887543321 22223332222222222
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 534 IAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 534 ~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
...+.+++.+||+.||++|||++++++.|+...+
T Consensus 233 -~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 233 -STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp -CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 3456778888999999999999999999987543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=354.60 Aligned_cols=277 Identities=32% Similarity=0.551 Sum_probs=221.5
Q ss_pred CCcccHHHHHHHHHHhh--------hhcCccCceEEEEEEeCCCcEEEEEEeccCC-----CCHHHHHHHHHHHhccCCC
Q 040604 282 PKRYSYSDVKRMTKSFR--------DKLGQGGYGEVYKGELPDGQLVAVKVLKNSR-----CNGEEFINEVASISRTSHV 348 (582)
Q Consensus 282 ~~~~~~~~~~~~~~~~~--------~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~ 348 (582)
...+++.++.+++.+|. ++||+|+||.||+|.. +++.||||++.... ...+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 45688999999998886 4599999999999987 68899999986532 1246788999999999999
Q ss_pred ceEEEEeEEEeCCeeeEEEEecCCCChhhhhhcC-CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc
Q 040604 349 NIVTFLGFCYENKKNALIYELMPNGSLDKFIHND-RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLD 427 (582)
Q Consensus 349 niv~l~~~~~~~~~~~lv~E~~~~gsL~~~i~~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~ 427 (582)
||+++++++.+....++||||+++++|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+|||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEc
Confidence 9999999999999999999999999999998753 234699999999999999999999998 999999999999999
Q ss_pred CCCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchh
Q 040604 428 EDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSIC 507 (582)
Q Consensus 428 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~ 507 (582)
.++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|+|++|+.|+........ .
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~ 243 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-L 243 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB-T
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcchHH-H
Confidence 999999999999987665433333334569999999998864 578999999999999999999999976544332 1
Q ss_pred hHHHHHhhcCCCC---CCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 040604 508 HNLIYERIEPGND---FQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSI 567 (582)
Q Consensus 508 ~~~~~~~i~~~~~---~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~ 567 (582)
..+. +.+..... ..+..............+.+++.+||+.||++|||+++|++.|+++.
T Consensus 244 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 244 LDIK-EEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp THHH-HHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHH-HHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 1111 11111100 00111112223445677888999999999999999999999999854
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=363.46 Aligned_cols=267 Identities=25% Similarity=0.328 Sum_probs=207.2
Q ss_pred HHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCC----eeeEEEEec
Q 040604 295 KSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENK----KNALIYELM 370 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~E~~ 370 (582)
+.+.++||+|+||+||+|... ++.||||+++........+.+|+.++++++||||+++++++.+.. ..++||||+
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~ 104 (322)
T 3soc_A 26 LQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFH 104 (322)
T ss_dssp EEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred chhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecC
Confidence 456689999999999999874 899999999766555566778999999999999999999998754 368999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhC-------CCCceEecCCCCCCEEEcCCCceEEeeccccccc
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRG-------CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQA 443 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-------~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~ 443 (582)
++|+|.+++... .+++..++.++.|++.||+|||+. +..+|+||||||+|||++.++.+||+|||+++..
T Consensus 105 ~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~ 181 (322)
T 3soc_A 105 EKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181 (322)
T ss_dssp TTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEE
T ss_pred CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccccc
Confidence 999999999764 489999999999999999999975 1238999999999999999999999999999876
Q ss_pred cccccceeeecccCCccccccccccccc---CCCCccchhHHHHHHHHHHhcCCCCCCCCCcccc-----------hhhH
Q 040604 444 QKKESAISMLHARGTIGYIAPEVYSRRF---GGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTS-----------ICHN 509 (582)
Q Consensus 444 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~-----------~~~~ 509 (582)
.............||+.|+|||++.+.. ..++.++||||||+++|||++|+.||........ ....
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (322)
T 3soc_A 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLED 261 (322)
T ss_dssp CTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHH
T ss_pred ccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhh
Confidence 6544333333456999999999987521 2456789999999999999999999975433211 0111
Q ss_pred HHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 040604 510 LIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSI 567 (582)
Q Consensus 510 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~ 567 (582)
+............+.... ........+.+|+.+||+.||++|||++||++.|+.+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 262 MQEVVVHKKKRPVLRDYW--QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp HHHHHTTSCCCCCCCGGG--GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhhhhhcccCCCCccccc--cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111112222222222111 11234566888999999999999999999999998753
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=382.80 Aligned_cols=262 Identities=27% Similarity=0.427 Sum_probs=217.4
Q ss_pred HHHHHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEE
Q 040604 290 VKRMTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 290 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 368 (582)
+....+.+.++||+|+||.||+|.+. ++..||||+++......+.|.+|+.+|++++||||+++++++.+....++|||
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34445567789999999999999876 48899999998877778899999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
|+++|+|.+++.......+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 99999999999876666799999999999999999999998 999999999999999999999999999987654322
Q ss_pred ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcC
Q 040604 449 AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527 (582)
Q Consensus 449 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 527 (582)
. ......+|+.|+|||++.. ..++.++|||||||++|||++ |+.|+....... +.+.+..+.....+..
T Consensus 374 ~-~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~- 443 (495)
T 1opk_A 374 T-AHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKDYRMERPEG- 443 (495)
T ss_dssp E-CCTTCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG------HHHHHHTTCCCCCCTT-
T ss_pred e-ecCCCcCCcceeCHhHHhc--CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCCCCCCC-
Confidence 1 2223457789999999876 478999999999999999999 888887653322 2333333322222222
Q ss_pred cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCC
Q 040604 528 TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENL 570 (582)
Q Consensus 528 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~ 570 (582)
+...+.+|+.+||+.||++|||+++|++.|+..++..
T Consensus 444 ------~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~ 480 (495)
T 1opk_A 444 ------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 480 (495)
T ss_dssp ------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred ------CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence 2355677888999999999999999999999977643
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=377.05 Aligned_cols=265 Identities=27% Similarity=0.435 Sum_probs=211.9
Q ss_pred HHHHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
...+.+.++||+|+||.||+|.+.++..||||+++......+.|.+|+.+|++++||||+++++++.+ +..++||||++
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 34455678999999999999998888889999998877778899999999999999999999999865 67899999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
+|+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........ .
T Consensus 262 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~ 337 (452)
T 1fmk_A 262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-A 337 (452)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCcee-c
Confidence 99999999765445689999999999999999999998 9999999999999999999999999999876543221 1
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHH
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 530 (582)
.....+|+.|+|||.+.. +.++.++||||||+++|||++ |+.|+....... +...+..+.....+..
T Consensus 338 ~~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~------~~~~i~~~~~~~~~~~---- 405 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVERGYRMPCPPE---- 405 (452)
T ss_dssp -----CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCCCCCCTT----
T ss_pred ccCCcccccccCHhHHhc--CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCCCCCCC----
Confidence 223457889999999876 478999999999999999999 888887543221 2233333332222222
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCCCCCCC
Q 040604 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQIPPKP 576 (582)
Q Consensus 531 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~~p~~p 576 (582)
++..+.+++.+||+.||++|||+++|++.|+..+.+.+....|
T Consensus 406 ---~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~~ 448 (452)
T 1fmk_A 406 ---CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 448 (452)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred ---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccccc
Confidence 2355777888999999999999999999999988776544433
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=354.45 Aligned_cols=259 Identities=24% Similarity=0.388 Sum_probs=205.0
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC-CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR-CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
+.+.++||+|+||+||+|... +++.||+|++.... ...+.+.+|+.++++++||||+++++++.++...++||||+++
T Consensus 12 ~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 91 (310)
T 3s95_A 12 LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKG 91 (310)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCC
Confidence 345688999999999999765 79999999986533 2346789999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce--
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI-- 450 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~-- 450 (582)
|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 92 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (310)
T 3s95_A 92 GTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167 (310)
T ss_dssp CBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence 99999998643 4689999999999999999999998 99999999999999999999999999998765432211
Q ss_pred ----------eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCC
Q 040604 451 ----------SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND 520 (582)
Q Consensus 451 ----------~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~ 520 (582)
......||+.|+|||++.+ ..++.++||||||+++|||++|..|+.....................
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~-- 243 (310)
T 3s95_A 168 LRSLKKPDRKKRYTVVGNPYWMAPEMING--RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY-- 243 (310)
T ss_dssp ------------CCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT--
T ss_pred cccccccccccccccCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc--
Confidence 0113469999999999976 47899999999999999999999988764433221111111111110
Q ss_pred CCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCC
Q 040604 521 FQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENL 570 (582)
Q Consensus 521 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~ 570 (582)
... .+...+.+++.+||+.||++|||+++|++.|+.....+
T Consensus 244 --~~~-------~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 244 --CPP-------NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp --CCT-------TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --CCC-------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 011 11234677888999999999999999999998765443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=359.32 Aligned_cols=259 Identities=24% Similarity=0.406 Sum_probs=207.1
Q ss_pred HHHhhhhcCccCceEEEEEEeC----CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP----DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 367 (582)
++.+.+.||+|+||+||+|.+. .+..||||+++.... ..+.+.+|+.++++++||||+++++++.+....++||
T Consensus 50 ~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 129 (325)
T 3kul_A 50 RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVT 129 (325)
T ss_dssp GEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEE
T ss_pred HeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEe
Confidence 4455678999999999999764 455699999976433 2357899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
||+++|+|.+++.... ..+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 130 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 130 EYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp ECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred eCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 9999999999997543 4689999999999999999999998 99999999999999999999999999998765543
Q ss_pred cc-eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCC
Q 040604 448 SA-ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525 (582)
Q Consensus 448 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 525 (582)
.. .......+|+.|+|||++.+ ..++.++||||||+++|||++ |+.||....... +...+..+.......
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~ 277 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAF--RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD------VISSVEEGYRLPAPM 277 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH------HHHHHHTTCCCCCCT
T ss_pred cceeeccCCCCcccccCHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH------HHHHHHcCCCCCCCC
Confidence 22 22223457889999999976 468999999999999999999 999987653322 222333322222222
Q ss_pred cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCC
Q 040604 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQ 571 (582)
Q Consensus 526 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~ 571 (582)
.+...+.+++.+||+.||++|||+++|++.|+..+...+
T Consensus 278 -------~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 278 -------GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp -------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred -------CcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 223567788889999999999999999999999877654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=351.36 Aligned_cols=245 Identities=27% Similarity=0.383 Sum_probs=201.5
Q ss_pred HHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccC-CCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNS-RCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
+.+.++||+|+||+||+|.. .+++.||||++... ....+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 22 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 101 (297)
T 3fxz_A 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (297)
T ss_dssp BCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCC
Confidence 45568899999999999975 47999999998654 34567789999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..........
T Consensus 102 ~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-- 173 (297)
T 3fxz_A 102 GSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-- 173 (297)
T ss_dssp CBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB--
T ss_pred CCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccccc--
Confidence 9999999764 589999999999999999999998 99999999999999999999999999998765543322
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhc-CCCCCCCCCcCcHHH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIE-PGNDFQFDGVATEEE 531 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~ 531 (582)
....||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ...... ........
T Consensus 174 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~~------- 239 (297)
T 3fxz_A 174 STMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-----LYLIATNGTPELQNP------- 239 (297)
T ss_dssp CCCCSCGGGCCHHHHHC--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHHCSCCCSCG-------
T ss_pred CCccCCcCccChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhCCCCCCCCc-------
Confidence 23469999999999976 4789999999999999999999999976533221 111111 11111111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 532 KKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
..+...+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 123455778888999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=350.68 Aligned_cols=255 Identities=24% Similarity=0.427 Sum_probs=209.1
Q ss_pred HHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCC
Q 040604 294 TKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNG 373 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 373 (582)
.+.+.++||+|+||+||++...++..||||+++......+++.+|+.++++++|+||+++++++.+....++||||++++
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 104 (283)
T 3gen_A 25 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG 104 (283)
T ss_dssp GEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTC
T ss_pred HHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCC
Confidence 44567899999999999999988999999999988778889999999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeee
Q 040604 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISML 453 (582)
Q Consensus 374 sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 453 (582)
+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........ ...
T Consensus 105 ~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-~~~ 179 (283)
T 3gen_A 105 CLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSV 179 (283)
T ss_dssp BHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH-STT
T ss_pred cHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccc-ccc
Confidence 9999997632 3699999999999999999999998 9999999999999999999999999999876543221 122
Q ss_pred cccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 454 HARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 454 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
...||+.|+|||++.. ..++.++||||||+++|||++ |+.||....... ..+.+..+.....+...
T Consensus 180 ~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~----- 246 (283)
T 3gen_A 180 GSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQGLRLYRPHLA----- 246 (283)
T ss_dssp STTSCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHHHTTCCCCCCTTC-----
T ss_pred CCccCcccCCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccChhH------HHHHHhcccCCCCCCcC-----
Confidence 3457889999999876 368999999999999999998 999987654322 22233333222222222
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 533 KIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
...+.+++.+||+.||++|||++++++.|+..++
T Consensus 247 --~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 247 --SEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp --CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 2456778889999999999999999999987653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=376.68 Aligned_cols=260 Identities=25% Similarity=0.419 Sum_probs=213.8
Q ss_pred HHHHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
...+.+.++||+|+||+||+|.+.++..||||+++......+.|.+|+.+|++++||||+++++++. .+..++||||++
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~ 265 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMA 265 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecC
Confidence 3445667899999999999999988899999999887777889999999999999999999999986 667899999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
+|+|.+++.......+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........ .
T Consensus 266 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~-~ 341 (454)
T 1qcf_A 266 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-A 341 (454)
T ss_dssp TCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH-T
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee-c
Confidence 99999999865555789999999999999999999998 9999999999999999999999999999876543211 1
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHH
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 530 (582)
.....+|+.|+|||++.. +.++.++||||||+++|||++ |+.||....... +...+..+.....+.
T Consensus 342 ~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~------~~~~i~~~~~~~~~~----- 408 (454)
T 1qcf_A 342 REGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE------VIRALERGYRMPRPE----- 408 (454)
T ss_dssp TCSSSSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHHHHHTCCCCCCT-----
T ss_pred cCCCcccccccCHHHhcc--CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCCCCCC-----
Confidence 123347889999999975 478999999999999999999 999987643221 122222222221221
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCC
Q 040604 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQ 571 (582)
Q Consensus 531 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~ 571 (582)
.++..+.+|+.+||+.||++|||+++|++.|+....+.+
T Consensus 409 --~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~ 447 (454)
T 1qcf_A 409 --NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447 (454)
T ss_dssp --TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred --CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence 234567788889999999999999999999999776543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=358.68 Aligned_cols=248 Identities=21% Similarity=0.267 Sum_probs=204.5
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCC
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNG 373 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 373 (582)
+.+.++||+|+||+||+|... +++.+|+|+++......+.+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 7 y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~ 86 (321)
T 1tki_A 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred eEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCC
Confidence 446688999999999999765 7899999999876555677899999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC--CCceEEeecccccccccccccee
Q 040604 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE--DFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 374 sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~--~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++........
T Consensus 87 ~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~-- 160 (321)
T 1tki_A 87 DIFERINTS-AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF-- 160 (321)
T ss_dssp BHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE--
T ss_pred CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc--
Confidence 999999753 24689999999999999999999998 9999999999999987 789999999999887654432
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHH
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 531 (582)
....||+.|+|||++.+. .++.++||||||+++|||++|+.||....... +.+.+..+.. .......
T Consensus 161 -~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~----~~~~~~~ 227 (321)
T 1tki_A 161 -RLLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNAEY----TFDEEAF 227 (321)
T ss_dssp -EEEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTCC----CCCHHHH
T ss_pred -ccccCChhhcCcHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH------HHHHHHcCCC----CCChhhh
Confidence 234599999999998763 57899999999999999999999997653321 1111211110 0111222
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 532 KKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
..+...+.+++.+||+.||++|||++|+++
T Consensus 228 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 228 KEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 345567888999999999999999999986
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=359.65 Aligned_cols=245 Identities=23% Similarity=0.346 Sum_probs=200.8
Q ss_pred HHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
+.+.+.||+|+||.||+|.. .+|+.||||++...... .+.+.+|+.++++++||||+++++++......++||||+
T Consensus 17 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 96 (328)
T 3fe3_A 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYA 96 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECC
Confidence 44568999999999999976 58999999999765443 346789999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
++|+|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 97 ~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~- 170 (328)
T 3fe3_A 97 SGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL- 170 (328)
T ss_dssp TTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGG-
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcc-
Confidence 9999999997643 589999999999999999999998 9999999999999999999999999999876544322
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHH
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 530 (582)
....||+.|+|||++.+. ...+.++|||||||++|||++|+.||....... +.+.+..+. ..++...
T Consensus 171 --~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~i~~~~-~~~p~~~--- 237 (328)
T 3fe3_A 171 --DAFCGAPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE------LRERVLRGK-YRIPFYM--- 237 (328)
T ss_dssp --GTTSSSGGGCCHHHHHTC-CCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC-CCCCTTS---
T ss_pred --ccccCCcceeCcccccCC-CcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC-CCCCCCC---
Confidence 245699999999999764 234589999999999999999999997653322 222222221 1122222
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 531 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
...+.+++.+||+.||++|||++|+++.
T Consensus 238 ----s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 238 ----STDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ----CHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 3446677888999999999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=354.46 Aligned_cols=259 Identities=24% Similarity=0.337 Sum_probs=207.7
Q ss_pred CcccHHHHHHHHHH------------hhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCC
Q 040604 283 KRYSYSDVKRMTKS------------FRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC-NGEEFINEVASISRTSHV 348 (582)
Q Consensus 283 ~~~~~~~~~~~~~~------------~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~ 348 (582)
..+++++++.++.. +.++||+|+||.||+|... +|+.||||++..... ..+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34666666666543 2357999999999999876 799999999975443 457789999999999999
Q ss_pred ceEEEEeEEEeCCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC
Q 040604 349 NIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE 428 (582)
Q Consensus 349 niv~l~~~~~~~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~ 428 (582)
||+++++++......++||||+++++|.+++... .+++..++.++.|++.||+|||+. +|+||||||+|||++.
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTL 176 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECC
Confidence 9999999999999999999999999999998643 589999999999999999999998 9999999999999999
Q ss_pred CCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhh
Q 040604 429 DFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICH 508 (582)
Q Consensus 429 ~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~ 508 (582)
++.+||+|||++......... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~---- 248 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISR--SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---- 248 (321)
T ss_dssp TCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----
T ss_pred CCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----
Confidence 999999999999876543322 123469999999999976 478999999999999999999999997643221
Q ss_pred HHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 509 NLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 509 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
....+.......+.. ...+...+.+++.+||+.||++|||++++++.
T Consensus 249 --~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 249 --AMKRLRDSPPPKLKN-----SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp --HHHHHHHSSCCCCTT-----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --HHHHHhcCCCCCcCc-----cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111222111111111 11234557778889999999999999999874
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=359.19 Aligned_cols=251 Identities=28% Similarity=0.341 Sum_probs=200.7
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
+.+.++||+|+||+||+|... +++.||||++..... ..+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 9 y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 88 (323)
T 3tki_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88 (323)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred ceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCC
Confidence 345688999999999999765 799999999865432 23668899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
+|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..........
T Consensus 89 ~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 89 GGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp TEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred CCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence 999999997543 589999999999999999999998 999999999999999999999999999987654433322
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHH
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 531 (582)
.....||+.|+|||++.+. ...+.++||||||+++|||++|+.||............+ ........ ..
T Consensus 164 ~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~----~~~~~~~~-------~~ 231 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW----KEKKTYLN-------PW 231 (323)
T ss_dssp BCSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHH----HTTCTTST-------TG
T ss_pred cCCCccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH----hcccccCC-------cc
Confidence 3345799999999998764 234789999999999999999999997654433222211 11111111 01
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 532 KKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
..+...+.+|+.+||+.||++|||++|+++.
T Consensus 232 ~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 232 KKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 2234556778889999999999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=360.43 Aligned_cols=247 Identities=23% Similarity=0.336 Sum_probs=202.7
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC-------CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC-------NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALI 366 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 366 (582)
+.+.+.||+|+||+||++... +|+.||+|+++.... ..+.+.+|+.++++++||||+++++++.+....++|
T Consensus 14 y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 93 (361)
T 2yab_A 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLI 93 (361)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEE
Confidence 456789999999999999765 799999999976432 246789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC----ceEEeecccccc
Q 040604 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF----CPKISDFGLAKQ 442 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~----~vkl~DFGla~~ 442 (582)
|||++||+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++.
T Consensus 94 ~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 94 LELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 99999999999997543 689999999999999999999998 999999999999998877 799999999988
Q ss_pred ccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCC
Q 040604 443 AQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQ 522 (582)
Q Consensus 443 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~ 522 (582)
....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... ....+..+.. .
T Consensus 169 ~~~~~~~---~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~------~~~~i~~~~~-~ 236 (361)
T 2yab_A 169 IEDGVEF---KNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANITAVSY-D 236 (361)
T ss_dssp CCTTCCC---CCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHTTCC-C
T ss_pred cCCCCcc---ccCCCCccEECchHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcCC-C
Confidence 6654322 23469999999999876 368999999999999999999999997653322 1222222211 1
Q ss_pred CCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 523 FDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 523 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
+ .......+...+.+++.+||+.||++|||++|+++
T Consensus 237 ~---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 237 F---DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp C---CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred C---CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1 11122234566788889999999999999999984
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=351.31 Aligned_cols=260 Identities=23% Similarity=0.332 Sum_probs=199.9
Q ss_pred HHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhc--cCCCceEEEEeEEEeC----CeeeEEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISR--TSHVNIVTFLGFCYEN----KKNALIYE 368 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~lv~E 368 (582)
+.+.++||+|+||+||+|.. +++.||||++... ..+.+.+|.+++.. ++||||+++++++.+. ...++|||
T Consensus 10 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e 86 (301)
T 3q4u_A 10 ITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH 86 (301)
T ss_dssp CEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred EEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehh
Confidence 45668999999999999987 7899999999754 34555666666655 8999999999997653 45789999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceEecCCCCCCEEEcCCCceEEeecccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH--------RGCQVRIVHFDIKPQNILLDEDFCPKISDFGLA 440 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH--------~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla 440 (582)
|+++|+|.++++.. .+++..++.++.|++.||+||| +. +|+||||||+|||++.++.+||+|||++
T Consensus 87 ~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 160 (301)
T 3q4u_A 87 YHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLGLA 160 (301)
T ss_dssp CCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred hccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence 99999999999643 5899999999999999999999 66 9999999999999999999999999999
Q ss_pred cccccccccee--eecccCCcccccccccccccC----CCCccchhHHHHHHHHHHhcC----------CCCCCCCCccc
Q 040604 441 KQAQKKESAIS--MLHARGTIGYIAPEVYSRRFG----GVSHKSDVYSYGMMIIEMVGC----------TKNLDDEVTDT 504 (582)
Q Consensus 441 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~----~~s~~~DvwSlGvil~elltg----------~~p~~~~~~~~ 504 (582)
+.......... .....||+.|+|||++.+... .++.++||||||+++|||++| +.||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~ 240 (301)
T 3q4u_A 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240 (301)
T ss_dssp EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence 87654433211 123469999999999876311 345799999999999999999 77876544433
Q ss_pred chhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 505 SICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 505 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
..................++.. .........+.+++.+||+.||++|||+++|++.|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 241 PSFEDMRKVVCVDQQRPNIPNR--WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGG--GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cchhhhhHHHhccCCCCCCChh--hccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 3222222222222222222111 1123456778899999999999999999999999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=366.32 Aligned_cols=260 Identities=26% Similarity=0.438 Sum_probs=207.7
Q ss_pred HHHHHhhhhcCccCceEEEEEEe------CCCcEEEEEEeccCCCC--HHHHHHHHHHHhcc-CCCceEEEEeEEEeCCe
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGEL------PDGQLVAVKVLKNSRCN--GEEFINEVASISRT-SHVNIVTFLGFCYENKK 362 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 362 (582)
...+.+.++||+|+||.||+|.+ .+++.||||+++..... .+.+.+|+.+++++ +||||+++++++.+...
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 100 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 100 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC
Confidence 44556678999999999999963 25689999999765432 35689999999999 79999999999987654
Q ss_pred -eeEEEEecCCCChhhhhhcCCC---------------------------------------------------------
Q 040604 363 -NALIYELMPNGSLDKFIHNDRN--------------------------------------------------------- 384 (582)
Q Consensus 363 -~~lv~E~~~~gsL~~~i~~~~~--------------------------------------------------------- 384 (582)
.++||||+++|+|.+++.....
T Consensus 101 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (359)
T 3vhe_A 101 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 180 (359)
T ss_dssp CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------------
T ss_pred ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcc
Confidence 8999999999999999976532
Q ss_pred -------cCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeecccC
Q 040604 385 -------IKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARG 457 (582)
Q Consensus 385 -------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 457 (582)
..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...............|
T Consensus 181 ~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp ---CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred cccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence 1288999999999999999999998 999999999999999999999999999987655444333445568
Q ss_pred CcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHH
Q 040604 458 TIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAK 536 (582)
Q Consensus 458 t~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 536 (582)
|+.|+|||++.+ ..++.++||||||+++|||++ |+.||........ +...+..+......... ..
T Consensus 258 t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~-------~~ 323 (359)
T 3vhe_A 258 PLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-----FCRRLKEGTRMRAPDYT-------TP 323 (359)
T ss_dssp CGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-----HHHHHHHTCCCCCCTTC-------CH
T ss_pred CceeEChhhhcC--CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-----HHHHHHcCCCCCCCCCC-------CH
Confidence 999999999876 478999999999999999998 9999976543332 12222222222222222 24
Q ss_pred HHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 537 MMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 537 ~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
.+.+++.+||+.||++|||++||++.|+..++
T Consensus 324 ~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 324 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 56778888999999999999999999998654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=363.90 Aligned_cols=265 Identities=25% Similarity=0.419 Sum_probs=213.5
Q ss_pred HHHHHhhhhcCccCceEEEEEEeC--------CCcEEEEEEeccCCCC--HHHHHHHHHHHhcc-CCCceEEEEeEEEeC
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELP--------DGQLVAVKVLKNSRCN--GEEFINEVASISRT-SHVNIVTFLGFCYEN 360 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 360 (582)
...+.+.++||+|+||+||+|... .+..||||+++..... .+.+.+|+.+++++ +||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 345566789999999999999752 3468999999765432 25688999999999 999999999999999
Q ss_pred CeeeEEEEecCCCChhhhhhcCC--------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE
Q 040604 361 KKNALIYELMPNGSLDKFIHNDR--------------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL 426 (582)
Q Consensus 361 ~~~~lv~E~~~~gsL~~~i~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl 426 (582)
...++||||+++|+|.+++.... ...+++..++.|+.|++.||+|||+. +|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence 99999999999999999998653 23589999999999999999999998 99999999999999
Q ss_pred cCCCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccc
Q 040604 427 DEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTS 505 (582)
Q Consensus 427 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~ 505 (582)
+.++.+||+|||+++...............||+.|+|||++.+ ..++.++||||||++++||++ |+.|+.......
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~- 301 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE- 301 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence 9999999999999987665433333334568899999999876 478999999999999999999 888887543221
Q ss_pred hhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCCCCC
Q 040604 506 ICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQIPP 574 (582)
Q Consensus 506 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~~p~ 574 (582)
+.+.+..+........ +...+.+++.+||+.||++|||++||++.|+..+.......
T Consensus 302 -----~~~~~~~~~~~~~~~~-------~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 302 -----LFKLLKEGHRMDKPSN-------CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp -----HHHHHHTTCCCCCCSS-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred -----HHHHHHcCCCCCCCcc-------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 2233333332222222 23457778889999999999999999999998776554333
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=350.78 Aligned_cols=260 Identities=28% Similarity=0.379 Sum_probs=204.9
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC----HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN----GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.+.++||+|+||.||+|... +++.||+|++...... .+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 92 (294)
T 4eqm_A 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEY 92 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeC
Confidence 456789999999999999754 7899999998654332 25688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++++|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 93 ~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 93 IEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp CCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 99999999997643 689999999999999999999998 9999999999999999999999999999876543222
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
......||+.|+|||.+.+. .++.++||||||+++|||++|+.||....... .....+..... .....
T Consensus 168 -~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-----~~~~~~~~~~~----~~~~~ 235 (294)
T 4eqm_A 168 -QTNHVLGTVQYFSPEQAKGE--ATDECTDIYSIGIVLYEMLVGEPPFNGETAVS-----IAIKHIQDSVP----NVTTD 235 (294)
T ss_dssp --------CCSSCCHHHHHTC--CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH-----HHHHHHSSCCC----CHHHH
T ss_pred -ccCccccCccccCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHhhccCC----Ccchh
Confidence 12234699999999998763 67899999999999999999999997654322 11222222111 00001
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhcccCCCC
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERP-SMHKVLEMLEGSIENLQ 571 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RP-t~~evl~~Le~~~~~~~ 571 (582)
....++..+.+++.+||+.||++|| +++++.+.|+..+..-.
T Consensus 236 ~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 236 VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 1123456678888999999999999 89999999998776554
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=366.83 Aligned_cols=258 Identities=26% Similarity=0.419 Sum_probs=205.7
Q ss_pred HHHhhhhcCccCceEEEEEEeC------CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP------DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNAL 365 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 365 (582)
.+.+.++||+|+||+||+|.+. +++.||||+++.... ....+.+|+.++++++||||+++++++.+....++
T Consensus 72 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 151 (367)
T 3l9p_A 72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI 151 (367)
T ss_dssp GEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEE
Confidence 3456689999999999999742 567899999975433 23468899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcCC-----CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC---ceEEeec
Q 040604 366 IYELMPNGSLDKFIHNDR-----NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF---CPKISDF 437 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~---~vkl~DF 437 (582)
||||+++|+|.+++...+ ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++ .+||+||
T Consensus 152 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DF 228 (367)
T 3l9p_A 152 LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDF 228 (367)
T ss_dssp EEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred EEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECCC
Confidence 999999999999997643 23589999999999999999999998 999999999999999555 5999999
Q ss_pred cccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhc
Q 040604 438 GLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIE 516 (582)
Q Consensus 438 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~ 516 (582)
|+++...............||+.|+|||++.+ ..++.++|||||||++|||++ |..||....... +.+.+.
T Consensus 229 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~------~~~~i~ 300 (367)
T 3l9p_A 229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE------VLEFVT 300 (367)
T ss_dssp HHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHHHH
T ss_pred ccccccccccccccCCCcCCcccEECHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHH
Confidence 99986543322222234468999999999876 478999999999999999998 888887643221 223333
Q ss_pred CCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCC
Q 040604 517 PGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIEN 569 (582)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~ 569 (582)
.+........ +...+.+|+.+||+.||++|||+++|++.|+...+.
T Consensus 301 ~~~~~~~~~~-------~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 301 SGGRMDPPKN-------CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp TTCCCCCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCCCCCCCcc-------CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 3322222222 234567788899999999999999999999876553
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=366.05 Aligned_cols=256 Identities=27% Similarity=0.442 Sum_probs=206.5
Q ss_pred HHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
..+.+.++||+|+||.||+|.+. +++.||||+++..... .+.|.+|+.++++++||||+++++++.+.+..++||||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 193 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence 34456789999999999999876 7999999999754322 24688999999999999999999999998999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++|+|.+++...+ ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 194 VQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp CTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 99999999997532 3589999999999999999999998 9999999999999999999999999999875443221
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 528 (582)
.......+++.|+|||.+.. +.++.++||||||+++|||++ |+.|+....... +.+.+..+.....+...
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~- 340 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNY--GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ------TREFVEKGGRLPCPELC- 340 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH------HHHHHHTTCCCCCCTTC-
T ss_pred ecCCCCCCCcCcCCHhHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCCCCCCCC-
Confidence 11112236778999999875 478999999999999999998 888887653321 22333333333232222
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSI 567 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~ 567 (582)
+..+.+++.+||+.||++|||+++|++.|+...
T Consensus 341 ------~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 341 ------PDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp ------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 345677888999999999999999999998753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=350.83 Aligned_cols=259 Identities=28% Similarity=0.434 Sum_probs=214.3
Q ss_pred HHHHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 291 KRMTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 291 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
....+.+.++||+|+||+||+|... +++.||+|+++......+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 3344566789999999999999765 588999999987776778899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++++|.+++.......+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 91 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 167 (288)
T 3kfa_A 91 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 167 (288)
T ss_dssp CTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE
T ss_pred CCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCccc
Confidence 9999999999876666799999999999999999999998 9999999999999999999999999999876644322
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 528 (582)
......||+.|+|||.+.+ ..++.++||||||+++|+|++ |..|+....... +.+.+...........
T Consensus 168 -~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~-- 236 (288)
T 3kfa_A 168 -AHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKDYRMERPEG-- 236 (288)
T ss_dssp -EETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG------HHHHHHTTCCCCCCTT--
T ss_pred -cccCCccccCcCChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHhccCCCCCCCC--
Confidence 2233457889999999876 478999999999999999999 888886543322 2222322222222222
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
+...+.+++.+||+.||++|||++++++.|+..+.
T Consensus 237 -----~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 237 -----CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp -----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 23557788889999999999999999999987654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=351.83 Aligned_cols=258 Identities=24% Similarity=0.413 Sum_probs=210.0
Q ss_pred HHHhhhhcCccCceEEEEEEe------CCCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeE
Q 040604 294 TKSFRDKLGQGGYGEVYKGEL------PDGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNAL 365 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 365 (582)
.+.+.+.||+|+||.||+|.. .+++.||||+++.... ..+.+.+|+.++++++||||+++++++.+....++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 103 (314)
T 2ivs_A 24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLL 103 (314)
T ss_dssp GEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred heeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEE
Confidence 345668899999999999965 2458999999976443 23568899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcCCC----------------------cCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCC
Q 040604 366 IYELMPNGSLDKFIHNDRN----------------------IKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQN 423 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~----------------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~N 423 (582)
||||+++++|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+|
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~N 180 (314)
T 2ivs_A 104 IVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARN 180 (314)
T ss_dssp EEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGG
T ss_pred EEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchhe
Confidence 9999999999999986432 2488999999999999999999998 99999999999
Q ss_pred EEEcCCCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCc
Q 040604 424 ILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVT 502 (582)
Q Consensus 424 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~ 502 (582)
||++.++.+||+|||+++...............||+.|+|||.+.+ ..++.++||||||+++|||++ |+.||.....
T Consensus 181 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp EEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC--CCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999987765544333344568899999999876 368999999999999999999 9899876543
Q ss_pred ccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCC
Q 040604 503 DTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIEN 569 (582)
Q Consensus 503 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~ 569 (582)
.. +.+.+..+........ +...+.+++.+||+.||++|||+++|++.|++.+..
T Consensus 259 ~~------~~~~~~~~~~~~~~~~-------~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 259 ER------LFNLLKTGHRMERPDN-------CSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GG------HHHHHHTTCCCCCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HH------HHHHhhcCCcCCCCcc-------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 22 2233333322222222 235577788899999999999999999999987653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=346.47 Aligned_cols=258 Identities=26% Similarity=0.435 Sum_probs=211.4
Q ss_pred HHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCC
Q 040604 294 TKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNG 373 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 373 (582)
++.+.+.||+|+||.||+|...+++.||||+++......+.+.+|+.++++++||||+++++++. .+..++||||++++
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~ 92 (279)
T 1qpc_A 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENG 92 (279)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTC
T ss_pred hhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCC
Confidence 45567899999999999999888889999999887777889999999999999999999999986 45689999999999
Q ss_pred ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeee
Q 040604 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISML 453 (582)
Q Consensus 374 sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 453 (582)
+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++......... ...
T Consensus 93 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~ 168 (279)
T 1qpc_A 93 SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-ARE 168 (279)
T ss_dssp BHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-CCT
T ss_pred CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc-ccc
Confidence 999999765445799999999999999999999998 9999999999999999999999999999876543321 122
Q ss_pred cccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 454 HARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 454 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
...+|+.|+|||.+.+ +.++.++||||||++++||++ |+.|+....... +...+..+........
T Consensus 169 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~------ 234 (279)
T 1qpc_A 169 GAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------VIQNLERGYRMVRPDN------ 234 (279)
T ss_dssp TCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCCCCCCTT------
T ss_pred CCCCccCccChhhhcc--CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH------HHHHHhcccCCCCccc------
Confidence 3457889999999875 468899999999999999999 888886543221 2222333222222222
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCC
Q 040604 533 KIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQ 571 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~ 571 (582)
+...+.+++.+||+.||++|||++++++.|+..+....
T Consensus 235 -~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 235 -CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp -CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred -ccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 23567788889999999999999999999998776554
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=356.77 Aligned_cols=260 Identities=25% Similarity=0.409 Sum_probs=208.2
Q ss_pred HHHhhhhcCccCceEEEEEEeC------CCcEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP------DGQLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYENKKNAL 365 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 365 (582)
.+.+.+.||+|+||.||+|... +++.||||+++..... .+.+.+|+.++++++||||+++++++.+....++
T Consensus 48 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 127 (343)
T 1luf_A 48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 127 (343)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEE
Confidence 3456688999999999999764 3589999999765432 3568999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcCC----------------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCC
Q 040604 366 IYELMPNGSLDKFIHNDR----------------------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQN 423 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~----------------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~N 423 (582)
||||+++|+|.+++.... ...+++..++.++.||+.||+|||+. +|+||||||+|
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~N 204 (343)
T 1luf_A 128 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRN 204 (343)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred EEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcce
Confidence 999999999999997642 14689999999999999999999998 99999999999
Q ss_pred EEEcCCCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCc
Q 040604 424 ILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVT 502 (582)
Q Consensus 424 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~ 502 (582)
||++.++.+||+|||+++...............||+.|+|||++.+ ..++.++||||||+++|||++ |+.||.....
T Consensus 205 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 282 (343)
T 1luf_A 205 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282 (343)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred EEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc--CCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence 9999999999999999987654433222334568999999999876 468999999999999999999 8889875432
Q ss_pred ccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCC
Q 040604 503 DTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQ 571 (582)
Q Consensus 503 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~ 571 (582)
.. +...+..+........ +...+.+++.+||+.||++|||+++|++.|++..+..+
T Consensus 283 ~~------~~~~~~~~~~~~~~~~-------~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 283 EE------VIYYVRDGNILACPEN-------CPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp HH------HHHHHHTTCCCCCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred HH------HHHHHhCCCcCCCCCC-------CCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 21 2223333322222222 23457778889999999999999999999999877654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=354.65 Aligned_cols=255 Identities=25% Similarity=0.422 Sum_probs=198.4
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcE----EEEEEeccCC--CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQL----VAVKVLKNSR--CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALI 366 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 366 (582)
.+.+.++||+|+||+||+|.+. +++. ||+|.++... ...+.+.+|+.++++++||||+++++++.+.. .++|
T Consensus 16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v 94 (327)
T 3poz_A 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLI 94 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEE
T ss_pred HcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEE
Confidence 3456689999999999999754 4544 5788775432 34578999999999999999999999998754 7899
Q ss_pred EEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccc
Q 040604 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~ 446 (582)
|||+++|+|.+++.... ..+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 95 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 95 TQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred EEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 99999999999997643 4689999999999999999999998 9999999999999999999999999999877655
Q ss_pred ccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCC
Q 040604 447 ESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525 (582)
Q Consensus 447 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 525 (582)
..........||+.|+|||++.+ ..++.++||||||+++|||++ |+.||....... +...+..+.......
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~~~~~~~ 242 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------ISSILEKGERLPQPP 242 (327)
T ss_dssp CC-------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------HHHHHHTTCCCCCCT
T ss_pred cccccccCCCccccccChHHhcc--CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH------HHHHHHcCCCCCCCc
Confidence 44333344568899999999976 478999999999999999999 999987653322 223333332222222
Q ss_pred cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 526 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
. ....+.+++.+||+.||++||++++|++.|+....
T Consensus 243 ~-------~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 243 I-------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp T-------BCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred c-------CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 2 23456778889999999999999999999987654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=352.39 Aligned_cols=249 Identities=24% Similarity=0.343 Sum_probs=202.6
Q ss_pred HHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC-------CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeee
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC-------NGEEFINEVASISRTSHVNIVTFLGFCYENKKNA 364 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 364 (582)
..+.+.+.||+|+||.||++... +|+.||+|+++.... ..+.+.+|+.++++++||||+++++++.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34566789999999999999765 799999999875432 3577999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC----ceEEeecccc
Q 040604 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF----CPKISDFGLA 440 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~----~vkl~DFGla 440 (582)
+||||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||++
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999999999754 3689999999999999999999998 999999999999999887 8999999999
Q ss_pred ccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCC
Q 040604 441 KQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND 520 (582)
Q Consensus 441 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~ 520 (582)
+........ ....||+.|+|||++.. ..++.++||||||+++|+|++|+.||....... .+ ..+....
T Consensus 166 ~~~~~~~~~---~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~-~~~~~~~- 233 (326)
T 2y0a_A 166 HKIDFGNEF---KNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQE-----TL-ANVSAVN- 233 (326)
T ss_dssp EECCTTSCC---CCCCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-----HH-HHHHHTC-
T ss_pred eECCCCCcc---ccccCCcCcCCceeecC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-----HH-HHHHhcC-
Confidence 877544322 23469999999999875 468999999999999999999999997643221 11 1111110
Q ss_pred CCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 521 FQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 521 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
..+ ...........+.+++.+||+.||++|||++++++
T Consensus 234 ~~~---~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 234 YEF---EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CCC---CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCc---CccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 001 11112234456778889999999999999999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=348.23 Aligned_cols=257 Identities=24% Similarity=0.347 Sum_probs=198.9
Q ss_pred HHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 295 KSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
|.+.++||+|+||+||+|...+|+.||+|+++..... .+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 23 y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 102 (311)
T 3niz_A 23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME 102 (311)
T ss_dssp EEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS
T ss_pred hHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC
Confidence 4556899999999999999888999999999754332 3578899999999999999999999999999999999996
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 103 -~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~-- 175 (311)
T 3niz_A 103 -KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS-- 175 (311)
T ss_dssp -EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---
T ss_pred -CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCccc--
Confidence 58888776543 4689999999999999999999998 9999999999999999999999999999876543322
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCC------
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG------ 525 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~------ 525 (582)
.....||+.|+|||++.+. ..++.++||||||+++|||++|+.||........ ... +...+..........
T Consensus 176 ~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~-i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ-LPK-IFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp --CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH-HHH-HHHHHCCCCTTTSGGGTTSHH
T ss_pred ccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH-HHH-HHHHHCCCChHHhhhhhccch
Confidence 2234689999999998753 4689999999999999999999999976544332 111 122222111110000
Q ss_pred -----------cC-cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 526 -----------VA-TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 526 -----------~~-~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.. ......+...+.+++.+||+.||++|||++|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00 0001123356778899999999999999999986
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=353.33 Aligned_cols=245 Identities=23% Similarity=0.326 Sum_probs=200.4
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccC----CCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNS----RCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+++.+.||+|+||+||++... +|+.||||++++. ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~ 86 (337)
T 1o6l_A 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeC
Confidence 455688999999999999765 7999999999653 34567789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
++||+|..++...+ .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 87 ~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 161 (337)
T 1o6l_A 87 ANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp CTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence 99999999987543 689999999999999999999998 9999999999999999999999999999864332221
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... +.+.+... ...++..
T Consensus 162 --~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~~~-~~~~p~~--- 227 (337)
T 1o6l_A 162 --MKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELILME-EIRFPRT--- 227 (337)
T ss_dssp --BCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHC-CCCCCTT---
T ss_pred --ccccccChhhCChhhhcC--CCCCchhhcccchhHHHHHhcCCCCCCCCCHHH------HHHHHHcC-CCCCCCC---
Confidence 223469999999999976 368999999999999999999999997643221 11222111 1122222
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERP-----SMHKVLEM 562 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~~ 562 (582)
+...+.+++.+||+.||++|| +++||++.
T Consensus 228 ----~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 228 ----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 234567778889999999999 89999753
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=366.95 Aligned_cols=248 Identities=27% Similarity=0.450 Sum_probs=204.7
Q ss_pred HHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCC-eeeEEEEecCCC
Q 040604 295 KSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENK-KNALIYELMPNG 373 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~E~~~~g 373 (582)
+.+.++||+|+||.||+|.. .|+.||||+++... ..+.|.+|+.+|++++||||+++++++.+.. ..++||||+++|
T Consensus 195 ~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g 272 (450)
T 1k9a_A 195 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 272 (450)
T ss_dssp EEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTC
T ss_pred eEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCC
Confidence 34567899999999999988 47899999998654 5678999999999999999999999988765 789999999999
Q ss_pred ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeee
Q 040604 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISML 453 (582)
Q Consensus 374 sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 453 (582)
+|.+++...+...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 273 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~----- 344 (450)
T 1k9a_A 273 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD----- 344 (450)
T ss_dssp BHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC---------
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccccc-----
Confidence 999999876555689999999999999999999998 999999999999999999999999999986543221
Q ss_pred cccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 454 HARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 454 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
...+|+.|+|||++.. ..++.++||||||+++|||++ |+.|+....... +...+..+.....+..
T Consensus 345 ~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~------~~~~i~~~~~~~~p~~------ 410 (450)
T 1k9a_A 345 TGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYKMDAPDG------ 410 (450)
T ss_dssp --CCCTTTSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT------HHHHHHTTCCCCCCTT------
T ss_pred CCCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCCCCCCc------
Confidence 2357899999999976 478999999999999999998 999987654332 2233333333322222
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 040604 533 KIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSI 567 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~ 567 (582)
....+.+|+.+||+.||++|||+++|++.|+...
T Consensus 411 -~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 411 -CPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp -CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 2356777888999999999999999999998754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=349.66 Aligned_cols=266 Identities=21% Similarity=0.315 Sum_probs=208.5
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC--CCHHHHHHHHHHHhccCCCceEEEEeEEEeCC--eeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR--CNGEEFINEVASISRTSHVNIVTFLGFCYENK--KNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~E~ 369 (582)
+.+.++||+|+||+||+|... +++.||||+++... ...+.+.+|+.++++++||||+++++++.+.. ..++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (319)
T 4euu_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (319)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred EEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeC
Confidence 345689999999999999765 69999999997533 34577889999999999999999999998765 67999999
Q ss_pred cCCCChhhhhhcCC-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE----cCCCceEEeecccccccc
Q 040604 370 MPNGSLDKFIHNDR-NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL----DEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 370 ~~~gsL~~~i~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl----~~~~~vkl~DFGla~~~~ 444 (582)
+++++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp CTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred CCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 99999999998643 23499999999999999999999998 99999999999999 888899999999998876
Q ss_pred ccccceeeecccCCcccccccccccc------cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCC
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRR------FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPG 518 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~ 518 (582)
...... ...||+.|+|||++... ...++.++||||||+++|||++|+.||........ ....+...+...
T Consensus 168 ~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~ 243 (319)
T 4euu_A 168 DDEQFV---SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR-NKEVMYKIITGK 243 (319)
T ss_dssp TTCCBC---CCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG-CHHHHHHHHHHC
T ss_pred CCCcee---ecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch-hHHHHHHHhcCC
Confidence 544322 34599999999998521 24788999999999999999999999975433222 112222222111
Q ss_pred CCCC-------------CC---CcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 040604 519 NDFQ-------------FD---GVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSI 567 (582)
Q Consensus 519 ~~~~-------------~~---~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~ 567 (582)
.... +. .........+...+.+++.+||+.||++|||++|+++......
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 1000 00 0011123456677888999999999999999999999887643
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=349.51 Aligned_cols=275 Identities=24% Similarity=0.311 Sum_probs=204.4
Q ss_pred HHHHHHHHHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhc--cCCCceEEEEeEEEeC----
Q 040604 287 YSDVKRMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISR--TSHVNIVTFLGFCYEN---- 360 (582)
Q Consensus 287 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~---- 360 (582)
..+.....+.+.++||+|+||.||+|... ++.||||++.... ...+..|.+++.. ++||||+++++++.+.
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 33444556777899999999999999874 8999999996543 3445555555555 4999999999999887
Q ss_pred CeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceEecCCCCCCEEEcCCCceEEe
Q 040604 361 KKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGC-----QVRIVHFDIKPQNILLDEDFCPKIS 435 (582)
Q Consensus 361 ~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-----~~~ivH~Dikp~NILl~~~~~vkl~ 435 (582)
...++||||+++|+|.+++... .+++..++.++.|++.||+|||+.. ..+|+||||||+|||++.++.+||+
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 6789999999999999999754 5899999999999999999999751 2389999999999999999999999
Q ss_pred ecccccccccccccee--eecccCCcccccccccccccCCCCc------cchhHHHHHHHHHHhcC----------CCCC
Q 040604 436 DFGLAKQAQKKESAIS--MLHARGTIGYIAPEVYSRRFGGVSH------KSDVYSYGMMIIEMVGC----------TKNL 497 (582)
Q Consensus 436 DFGla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~s~------~~DvwSlGvil~elltg----------~~p~ 497 (582)
|||+++.......... .....||+.|+|||++.+. ..+. ++|||||||++|||++| +.|+
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES--LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTC--CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccc--cCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 9999987654432211 1234699999999998763 2333 49999999999999999 5666
Q ss_pred CCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCC
Q 040604 498 DDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQ 571 (582)
Q Consensus 498 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~ 571 (582)
.........................++.. .........+.+++.+||+.||++|||+++|++.|++..++.+
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNR--WSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGG--GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred hhhcCCCCchhhhHHHHhhhccCcccccc--chhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 54433322222221111111111111111 1123566778899999999999999999999999998776543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=353.41 Aligned_cols=262 Identities=26% Similarity=0.416 Sum_probs=207.9
Q ss_pred HHHHhhhhcCccCceEEEEEEe------CCCcEEEEEEeccCC--CCHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCee
Q 040604 293 MTKSFRDKLGQGGYGEVYKGEL------PDGQLVAVKVLKNSR--CNGEEFINEVASISRT-SHVNIVTFLGFCYENKKN 363 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 363 (582)
..+.+.+.||+|+||+||+|.. .+++.||||+++... ...+.+.+|+.+++++ +||||+++++++......
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 124 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 124 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence 3445678999999999999975 246789999997543 2346789999999999 899999999999999999
Q ss_pred eEEEEecCCCChhhhhhcCCC---------------------cCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCC
Q 040604 364 ALIYELMPNGSLDKFIHNDRN---------------------IKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQ 422 (582)
Q Consensus 364 ~lv~E~~~~gsL~~~i~~~~~---------------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~ 422 (582)
++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+. +|+||||||+
T Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~ 201 (344)
T 1rjb_A 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 201 (344)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChh
Confidence 999999999999999976432 2379999999999999999999998 9999999999
Q ss_pred CEEEcCCCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCC
Q 040604 423 NILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEV 501 (582)
Q Consensus 423 NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~ 501 (582)
|||++.++.+||+|||++................||+.|+|||.+.+ +.++.++||||||+++|||++ |..||....
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc--CCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999999987665544333334568899999999876 478999999999999999998 999987654
Q ss_pred cccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCC
Q 040604 502 TDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQ 571 (582)
Q Consensus 502 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~ 571 (582)
.... +...+..+.....+.. ....+.+++.+||+.||++|||+.+|++.|+..+...+
T Consensus 280 ~~~~-----~~~~~~~~~~~~~~~~-------~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 280 VDAN-----FYKLIQNGFKMDQPFY-------ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp CSHH-----HHHHHHTTCCCCCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred cHHH-----HHHHHhcCCCCCCCCC-------CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 3321 2222222222222222 23557778889999999999999999999999777553
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=353.75 Aligned_cols=260 Identities=24% Similarity=0.405 Sum_probs=193.0
Q ss_pred HHHhhhhcCccCceEEEEEEeCC-C---cEEEEEEeccCC---CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCee---
Q 040604 294 TKSFRDKLGQGGYGEVYKGELPD-G---QLVAVKVLKNSR---CNGEEFINEVASISRTSHVNIVTFLGFCYENKKN--- 363 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 363 (582)
.+.+.+.||+|+||+||+|.... + ..||||+++... ...+.+.+|+.++++++||||+++++++......
T Consensus 24 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (323)
T 3qup_A 24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRL 103 (323)
T ss_dssp -CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC------
T ss_pred HeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCC
Confidence 45567899999999999997653 3 289999997643 2346789999999999999999999999877655
Q ss_pred ---eEEEEecCCCChhhhhhcCC----CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEee
Q 040604 364 ---ALIYELMPNGSLDKFIHNDR----NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISD 436 (582)
Q Consensus 364 ---~lv~E~~~~gsL~~~i~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~D 436 (582)
++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 104 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~D 180 (323)
T 3qup_A 104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVAD 180 (323)
T ss_dssp -CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECC
T ss_pred CccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEee
Confidence 89999999999999986432 23589999999999999999999998 999999999999999999999999
Q ss_pred ccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhh
Q 040604 437 FGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERI 515 (582)
Q Consensus 437 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i 515 (582)
||+++...............+|+.|+|||.+.+ ..++.++||||||+++|||++ |+.||....... +...+
T Consensus 181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------~~~~~ 252 (323)
T 3qup_A 181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLAD--NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE------IYNYL 252 (323)
T ss_dssp CCC-----------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------HHHHH
T ss_pred ccccccccccccccccccccCcccccCchhhcC--CCCCCccchhhHHHHHHHHHhCCCCCccccChHH------HHHHH
Confidence 999987655443333334457889999999876 368999999999999999999 888887654332 22222
Q ss_pred cCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCC
Q 040604 516 EPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQ 571 (582)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~ 571 (582)
..+........ +...+.+++.+||+.||++|||+.++++.|++.+..+.
T Consensus 253 ~~~~~~~~~~~-------~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 253 IGGNRLKQPPE-------CMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp HTTCCCCCCTT-------CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred hcCCCCCCCCc-------cCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 22222222222 23457788889999999999999999999998777553
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=361.84 Aligned_cols=257 Identities=25% Similarity=0.440 Sum_probs=194.6
Q ss_pred HHHhhhhcCccCceEEEEEEeC----CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP----DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 367 (582)
.+.+.+.||+|+||.||+|... ++..||||+++.... ..+.|.+|+.++++++||||+++++++.+....++||
T Consensus 46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 125 (373)
T 2qol_A 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125 (373)
T ss_dssp GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEE
Confidence 3455688999999999999764 577899999976532 2357899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
||+++|+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 126 e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 126 EYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp ECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred eCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 999999999999754 34689999999999999999999998 99999999999999999999999999998765443
Q ss_pred cc-eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCC
Q 040604 448 SA-ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525 (582)
Q Consensus 448 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 525 (582)
.. .......+|+.|+|||++.. ..++.++||||||+++|||++ |+.||....... +...+..+.......
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~------~~~~i~~~~~~~~~~ 273 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD------VIKAVDEGYRLPPPM 273 (373)
T ss_dssp ------------CTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH------HHHHHHTTEECCCCT
T ss_pred ccceeccCCCcCCCccChhhhcc--CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCCCCCc
Confidence 22 11222346788999999876 478999999999999999998 999987543221 222222221111111
Q ss_pred cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCC
Q 040604 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIEN 569 (582)
Q Consensus 526 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~ 569 (582)
.....+.+++.+||+.||++||++++|++.|+..+..
T Consensus 274 -------~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 274 -------DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp -------TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -------cccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 2335677888899999999999999999999876543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=344.71 Aligned_cols=258 Identities=21% Similarity=0.289 Sum_probs=198.1
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
+++.++||+|+||+||+|... +++.||||+++..... .+.+.+|+.++++++||||+++++++.++...++||||+
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecC
Confidence 345689999999999999765 7899999999754432 367889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
++ +|.+.+... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 157 (292)
T 3o0g_A 84 DQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC- 157 (292)
T ss_dssp SE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC-
T ss_pred CC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc-
Confidence 65 665555442 24699999999999999999999998 9999999999999999999999999999876543322
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCC------
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFD------ 524 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~------ 524 (582)
.....||+.|+|||++.+. ..++.++||||||++++||++|+.|+.............. +...........
T Consensus 158 -~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 158 -YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF-RLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp -CCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHH-HHHCCCCTTTCTTGGGST
T ss_pred -ccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH-HHhCCCChhhhhhhcccc
Confidence 1234689999999998764 3479999999999999999999988755444332222221 111111100000
Q ss_pred -----------CcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 525 -----------GVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 525 -----------~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.........+...+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000111123456778889999999999999999986
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=356.97 Aligned_cols=250 Identities=22% Similarity=0.339 Sum_probs=201.7
Q ss_pred HHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCH---HHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEE
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNG---EEFINEVASISRTSHVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 368 (582)
..+.+.++||+|+||.||+|... +|+.||+|+++...... +.+.+|+.++++++||||+++++++.+....++|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 34566789999999999999765 79999999997655433 467899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC---ceEEeeccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF---CPKISDFGLAKQAQK 445 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~---~vkl~DFGla~~~~~ 445 (582)
|+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||++.....
T Consensus 109 ~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 109 LVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp CCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred cCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 999999999887543 689999999999999999999998 999999999999998654 599999999987664
Q ss_pred cccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCC
Q 040604 446 KESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525 (582)
Q Consensus 446 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 525 (582)
.... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... +...+..+.. .++
T Consensus 184 ~~~~---~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~------~~~~i~~~~~-~~~- 250 (362)
T 2bdw_A 184 SEAW---HGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHR------LYAQIKAGAY-DYP- 250 (362)
T ss_dssp CCSC---CCSCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCC-CCC-
T ss_pred Cccc---ccCCCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhCCC-CCC-
Confidence 4322 23469999999999876 368999999999999999999999997653321 1122222111 011
Q ss_pred cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 526 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
......+...+.+++.+||+.||++|||+.++++.
T Consensus 251 --~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 251 --SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp --TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred --cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 01112334567788889999999999999998753
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=376.43 Aligned_cols=262 Identities=27% Similarity=0.431 Sum_probs=215.5
Q ss_pred HHHHHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 291 KRMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 291 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
....+.+.++||+|+||.||+|.+.++..||||+++......+.|.+|+.+|++++|+||+++++++.+ +..++||||+
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 344456678999999999999999888889999998877778899999999999999999999999865 6789999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
++|+|.+++.......+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~- 419 (535)
T 2h8h_A 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 419 (535)
T ss_dssp TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH-
T ss_pred cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee-
Confidence 999999999765445689999999999999999999998 9999999999999999999999999999876543211
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
......+|+.|+|||++.. +.++.++|||||||+||||++ |+.||....... +.+.+..+........
T Consensus 420 ~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~------~~~~i~~~~~~~~~~~--- 488 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVERGYRMPCPPE--- 488 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH------HHHHHHTTCCCCCCTT---
T ss_pred cccCCcCcccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCCCCCCC---
Confidence 1123457889999999876 478999999999999999999 888887543221 2233333332222222
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCCC
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQI 572 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~~ 572 (582)
+...+.+|+.+||+.||++|||+++|++.|+..+...+.
T Consensus 489 ----~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 489 ----CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp ----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred ----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 235577788899999999999999999999998876653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=364.69 Aligned_cols=250 Identities=22% Similarity=0.301 Sum_probs=200.3
Q ss_pred HHHHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEE
Q 040604 293 MTKSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 368 (582)
..|.+.++||+|+||+||+|.. .+|+.+|+|++...... .+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 3456678999999999999965 47999999999765532 3468899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc---CCCceEEeeccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLD---EDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~---~~~~vkl~DFGla~~~~~ 445 (582)
|+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+++....
T Consensus 91 ~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 91 LVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp CCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred eCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 999999999987654 589999999999999999999998 999999999999998 567899999999987655
Q ss_pred cccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCC
Q 040604 446 KESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525 (582)
Q Consensus 446 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 525 (582)
.... .....||+.|+|||++.+ ..++.++||||+||++|+|++|..||....... +...+..+... ++.
T Consensus 166 ~~~~--~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~~~~-~~~ 234 (444)
T 3soa_A 166 EQQA--WFGFAGTPGYLSPEVLRK--DPYGKPVDLWACGVILYILLVGYPPFWDEDQHR------LYQQIKAGAYD-FPS 234 (444)
T ss_dssp TCCB--CCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHTCCC-CCT
T ss_pred CCce--eecccCCcccCCHHHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCccHHH------HHHHHHhCCCC-CCc
Confidence 4332 223569999999999976 368999999999999999999999997653322 12222221110 110
Q ss_pred cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 526 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.....+...+.+++.+||+.||++|||++|+++
T Consensus 235 ---~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 235 ---PEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp ---TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 011123455677888899999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=340.05 Aligned_cols=254 Identities=25% Similarity=0.464 Sum_probs=209.7
Q ss_pred HHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCC
Q 040604 295 KSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGS 374 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 374 (582)
+.+.+.||+|+||.||+|...+++.||+|+++......+.+.+|+.++++++||||+++++++.+....++||||+++++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (267)
T 3t9t_A 10 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGC 89 (267)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCB
T ss_pred eeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCc
Confidence 34568899999999999998889999999998877778899999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeec
Q 040604 375 LDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLH 454 (582)
Q Consensus 375 L~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 454 (582)
|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++........ ....
T Consensus 90 L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~ 164 (267)
T 3t9t_A 90 LSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTG 164 (267)
T ss_dssp HHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-STTS
T ss_pred HHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccc-cccc
Confidence 999997643 3689999999999999999999998 9999999999999999999999999999876443211 1123
Q ss_pred ccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHH
Q 040604 455 ARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKK 533 (582)
Q Consensus 455 ~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 533 (582)
..||+.|+|||++.+ ..++.++||||||+++|||++ |+.|+....... +.+.+..+.....+...
T Consensus 165 ~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~i~~~~~~~~~~~~------ 230 (267)
T 3t9t_A 165 TKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------VVEDISTGFRLYKPRLA------ 230 (267)
T ss_dssp TTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTTCCCCCCTTS------
T ss_pred ccccccccChhhhcC--CCccchhchhhhHHHHHHHhccCCCCCCCCCHHH------HHHHHhcCCcCCCCccC------
Confidence 457889999999876 468999999999999999999 888886543221 22223332222222222
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 534 IAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 534 ~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
...+.+++.+||+.||++|||++++++.|++..+
T Consensus 231 -~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 231 -STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp -CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -cHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 3456778889999999999999999999987543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=353.81 Aligned_cols=251 Identities=21% Similarity=0.263 Sum_probs=201.8
Q ss_pred HHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccC------CCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeE
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNS------RCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNAL 365 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 365 (582)
..|++.+.||+|+||+||+|... +|+.||||++... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 45667789999999999999764 7999999998532 2246789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcC--CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc---eEEeecccc
Q 040604 366 IYELMPNGSLDKFIHND--RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFC---PKISDFGLA 440 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~---vkl~DFGla 440 (582)
||||+++++|.+++... ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999998887643 234589999999999999999999998 9999999999999987654 999999999
Q ss_pred ccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCC
Q 040604 441 KQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND 520 (582)
Q Consensus 441 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~ 520 (582)
+........ .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... . +.+.+..+..
T Consensus 181 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~-----~~~~i~~~~~ 249 (351)
T 3c0i_A 181 IQLGESGLV--AGGRVGTPHFMAPEVVKRE--PYGKPVDVWGCGVILFILLSGCLPFYGTKE--R-----LFEGIIKGKY 249 (351)
T ss_dssp EECCTTSCB--CCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--H-----HHHHHHHTCC
T ss_pred eEecCCCee--ecCCcCCcCccCHHHHcCC--CCCchHhhHHHHHHHHHHHHCCCCCCCcHH--H-----HHHHHHcCCC
Confidence 876554321 2234699999999999763 689999999999999999999999976421 1 1122211111
Q ss_pred CCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 521 FQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 521 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
. ........+...+.+++.+||+.||++|||+.++++
T Consensus 250 -~---~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 -K---MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp -C---CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -C---CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 111122234567788899999999999999999985
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=346.30 Aligned_cols=265 Identities=25% Similarity=0.420 Sum_probs=203.1
Q ss_pred HHHHhhhhcCccCceEEEEEEe-----CCCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeC--Ceee
Q 040604 293 MTKSFRDKLGQGGYGEVYKGEL-----PDGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYEN--KKNA 364 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 364 (582)
..+++.++||+|+||+||+|.+ .+++.||||+++.... ..+.+.+|+.++++++||||+++++++... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 3455678999999999999974 3689999999975432 235788999999999999999999998654 4579
Q ss_pred EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccc
Q 040604 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~ 444 (582)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 90 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 9999999999999997653 3589999999999999999999998 99999999999999999999999999998765
Q ss_pred ccccc-eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcc----------cchhhHHHHH
Q 040604 445 KKESA-ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTD----------TSICHNLIYE 513 (582)
Q Consensus 445 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~----------~~~~~~~~~~ 513 (582)
..... .......||+.|+|||.+.+ ..++.++||||||+++|||++|..|+...... .......+.+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcC--CCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 44322 11223457888999999876 37899999999999999999999987643111 0011112222
Q ss_pred hhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCC
Q 040604 514 RIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENL 570 (582)
Q Consensus 514 ~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~ 570 (582)
.+........... +...+.+++.+||+.||++|||++||++.|+...+.+
T Consensus 244 ~~~~~~~~~~~~~-------~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 244 LLKNNGRLPRPDG-------CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHTTCCCCCCTT-------CCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHhccCcCCCCcC-------cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 3333222222222 2356778888999999999999999999999877655
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=357.80 Aligned_cols=265 Identities=18% Similarity=0.253 Sum_probs=203.4
Q ss_pred HHHhhhhcCcc--CceEEEEEEeC-CCcEEEEEEeccCCCCH---HHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEE
Q 040604 294 TKSFRDKLGQG--GYGEVYKGELP-DGQLVAVKVLKNSRCNG---EEFINEVASISRTSHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 294 ~~~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 367 (582)
.|++.++||+| +||+||+|... +|+.||||+++...... +.+.+|+.++++++|||||++++++.+....++||
T Consensus 26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 105 (389)
T 3gni_B 26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 105 (389)
T ss_dssp GEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEE
Confidence 34567899999 99999999775 79999999997654333 46778999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
||+++|+|.+++.......+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 106 SFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp ECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred EccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 999999999999876556799999999999999999999998 99999999999999999999999999987543321
Q ss_pred cc-----eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcC----C
Q 040604 448 SA-----ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEP----G 518 (582)
Q Consensus 448 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~----~ 518 (582)
.. .......||+.|+|||++.+....++.++|||||||++|||++|+.||.......... ..+...... .
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~ 261 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL-EKLNGTVPCLLDTS 261 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH-HC------------
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH-HHhcCCCCcccccc
Confidence 11 1112236999999999997643468999999999999999999999997654433211 100000000 0
Q ss_pred C----CCC-----------C--------------CCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 519 N----DFQ-----------F--------------DGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 519 ~----~~~-----------~--------------~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
. ... + ..........+...+.+|+.+||+.||++|||++|+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0 000 0 000001112344668889999999999999999999854
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=348.39 Aligned_cols=261 Identities=27% Similarity=0.438 Sum_probs=211.1
Q ss_pred HHHHhhhhcCccCceEEEEEEe------CCCcEEEEEEeccCCC--CHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCee
Q 040604 293 MTKSFRDKLGQGGYGEVYKGEL------PDGQLVAVKVLKNSRC--NGEEFINEVASISRT-SHVNIVTFLGFCYENKKN 363 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 363 (582)
..+.+.+.||+|+||+||+|.. .+++.||||+++.... ..+.+.+|+.+++++ +||||+++++++.+....
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 3455678999999999999974 3578999999976543 236789999999999 999999999999999999
Q ss_pred eEEEEecCCCChhhhhhcCCC----------------cCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc
Q 040604 364 ALIYELMPNGSLDKFIHNDRN----------------IKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLD 427 (582)
Q Consensus 364 ~lv~E~~~~gsL~~~i~~~~~----------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~ 427 (582)
++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+|||++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEc
Confidence 999999999999999976542 2489999999999999999999998 999999999999999
Q ss_pred CCCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccch
Q 040604 428 EDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSI 506 (582)
Q Consensus 428 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~ 506 (582)
.++.+||+|||+++...............||+.|+|||++.+ ..++.++||||||+++|||++ |+.||........
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~- 256 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 256 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-
T ss_pred CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-
Confidence 999999999999988766544333334558899999999876 478999999999999999999 8888876543322
Q ss_pred hhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCC
Q 040604 507 CHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENL 570 (582)
Q Consensus 507 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~ 570 (582)
....+.+ ........ .....+.+++.+||+.||++|||++++++.|++.+...
T Consensus 257 ~~~~~~~----~~~~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 257 FYKMIKE----GFRMLSPE-------HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HHHHHHH----TCCCCCCT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHhcc----CCCCCCcc-------cCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 1111211 11111111 12355777888999999999999999999999876543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=355.80 Aligned_cols=256 Identities=21% Similarity=0.233 Sum_probs=203.9
Q ss_pred HHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCCHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNGEEFINEVASISRT-SHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
+.+.++||+|+||+||+|.. .+|+.||||++.... ..+.+.+|+.+++++ +||||+++++++.+....++||||+ +
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (330)
T 2izr_A 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-G 88 (330)
T ss_dssp EEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-C
T ss_pred eEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-C
Confidence 34568899999999999975 589999999987543 234688999999999 9999999999999999999999999 9
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc-----eEEeeccccccccccc
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFC-----PKISDFGLAKQAQKKE 447 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~-----vkl~DFGla~~~~~~~ 447 (582)
++|.+++... ...+++..++.|+.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++......
T Consensus 89 ~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 89 PSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp CBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 9999999864 34799999999999999999999998 9999999999999999887 9999999998765433
Q ss_pred cce-----eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccc--hhhHHHHHhhcCCCC
Q 040604 448 SAI-----SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTS--ICHNLIYERIEPGND 520 (582)
Q Consensus 448 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~--~~~~~~~~~i~~~~~ 520 (582)
... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ............
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~--- 239 (330)
T 2izr_A 165 TKKHIPYREHKSLTGTARYMSINTHLG--KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT--- 239 (330)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS---
T ss_pred CCccccccccCCcCCCccccChHHHcC--CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC---
Confidence 211 1124569999999999987 4689999999999999999999999986543321 111111111100
Q ss_pred CCCCCcCcHH-HHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 521 FQFDGVATEE-EKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 521 ~~~~~~~~~~-~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
..+. ....+ .+.+++.+||+.||.+||++++|++.|+...+
T Consensus 240 ------~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~ 281 (330)
T 2izr_A 240 ------PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD 281 (330)
T ss_dssp ------CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred ------CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 0000 01123 68888899999999999999999999986554
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=357.12 Aligned_cols=245 Identities=24% Similarity=0.332 Sum_probs=196.2
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccC----CCCHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeeeEEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNS----RCNGEEFINEVASISRT-SHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 367 (582)
.+++.+.||+|+||+||+|... +|+.||||++++. ....+.+.+|..+++++ +||||+++++++.+....++||
T Consensus 24 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~ 103 (353)
T 3txo_A 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVM 103 (353)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEE
Confidence 4556789999999999999765 6899999999753 23456788999999988 7999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
||++||+|..++...+ .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 104 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 104 EFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence 9999999999997643 689999999999999999999998 99999999999999999999999999998644332
Q ss_pred cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcC
Q 040604 448 SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 527 (582)
.. ....+||+.|+|||++.+. .++.++|||||||++|||++|+.||....... +.+.+..+. ..++..
T Consensus 179 ~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~~~-~~~p~~- 246 (353)
T 3txo_A 179 VT--TATFCGTPDYIAPEILQEM--LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD------LFEAILNDE-VVYPTW- 246 (353)
T ss_dssp ---------CCGGGCCHHHHHHH--HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC-CCCCTT-
T ss_pred cc--ccccCCCcCeEChhhcCCC--CcCCccCCCcchHHHHHHHhCCCCCCCCCHHH------HHHHHHcCC-CCCCCC-
Confidence 21 2245699999999999764 68999999999999999999999997654322 222222211 112222
Q ss_pred cHHHHHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 040604 528 TEEEKKIAKMMILVGFWCIQTNPSERPSM------HKVLE 561 (582)
Q Consensus 528 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~------~evl~ 561 (582)
+...+.+++.+||+.||++||++ +++++
T Consensus 247 ------~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 247 ------LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ------SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ------CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 23446677888999999999998 77764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=356.26 Aligned_cols=246 Identities=20% Similarity=0.294 Sum_probs=195.3
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC----CHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeeeEEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEVASISRT-SHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 367 (582)
.+.+.++||+|+||+||+|... +++.||||++++... ..+.+.+|..++.++ +||||+++++++.+....++||
T Consensus 53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~ 132 (396)
T 4dc2_A 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 132 (396)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEE
Confidence 3456689999999999999765 688999999976432 234578899999887 8999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
||+++|+|..++...+ .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 133 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 133 EYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence 9999999999997643 689999999999999999999998 99999999999999999999999999998643322
Q ss_pred cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccc---hhhHHHHHhhcCCCCCCCC
Q 040604 448 SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTS---ICHNLIYERIEPGNDFQFD 524 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~---~~~~~~~~~i~~~~~~~~~ 524 (582)
.. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||........ .....+.+.+.... ..++
T Consensus 208 ~~--~~~~~gt~~Y~aPE~l~~~--~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-~~~p 282 (396)
T 4dc2_A 208 DT--TSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-IRIP 282 (396)
T ss_dssp CC--BCCCCBCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-CCCC
T ss_pred Cc--cccccCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc-cCCC
Confidence 21 2245799999999999874 789999999999999999999999965422211 11222233332221 1222
Q ss_pred CcCcHHHHHHHHHHHHHHHhccccCCCCCCCH
Q 040604 525 GVATEEEKKIAKMMILVGFWCIQTNPSERPSM 556 (582)
Q Consensus 525 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~ 556 (582)
.. +...+.+|+.+||+.||++||++
T Consensus 283 ~~-------~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 283 RS-------LSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp TT-------SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred Cc-------CCHHHHHHHHHHhcCCHhHcCCC
Confidence 22 23456677888999999999996
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=346.02 Aligned_cols=259 Identities=26% Similarity=0.420 Sum_probs=198.9
Q ss_pred HHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCC
Q 040604 295 KSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGS 374 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 374 (582)
+++.+.||+|+||+||+|.. .++.||||++... ...+.+.+|+.++++++||||+++++++. +..++||||+++|+
T Consensus 10 ~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~ 85 (307)
T 2eva_A 10 IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGS 85 (307)
T ss_dssp EEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCB
T ss_pred eeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCC
Confidence 34568899999999999987 4788999999643 24567899999999999999999999876 35789999999999
Q ss_pred hhhhhhcCCC-cCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc-eEEeeccccccccccccceee
Q 040604 375 LDKFIHNDRN-IKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFC-PKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 375 L~~~i~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~-vkl~DFGla~~~~~~~~~~~~ 452 (582)
|.+++..... ..+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||++.......
T Consensus 86 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~----- 160 (307)
T 2eva_A 86 LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM----- 160 (307)
T ss_dssp HHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------
T ss_pred HHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc-----
Confidence 9999986543 24789999999999999999999943348999999999999998886 7999999997654322
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......... +...+..+....+...
T Consensus 161 ~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~------ 228 (307)
T 2eva_A 161 TNNKGSAAWMAPEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR----IMWAVHNGTRPPLIKN------ 228 (307)
T ss_dssp ----CCTTSSCHHHHTC--CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH----HHHHHHTTCCCCCBTT------
T ss_pred ccCCCCCceEChhhhCC--CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH----HHHHHhcCCCCCcccc------
Confidence 12359999999999876 47899999999999999999999999754332211 1111222222222222
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCCCCCC
Q 040604 533 KIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQIPPK 575 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~~p~~ 575 (582)
+...+.+++.+||+.||++|||++++++.|+.....++.+..
T Consensus 229 -~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~ 270 (307)
T 2eva_A 229 -LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270 (307)
T ss_dssp -CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTS
T ss_pred -cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCC
Confidence 234567788899999999999999999999987765544333
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=344.68 Aligned_cols=257 Identities=26% Similarity=0.332 Sum_probs=197.1
Q ss_pred HHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 295 KSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
+.+.++||+|+||+||+|...+|+.||+|+++.... ..+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred chhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence 345688999999999999888899999999965432 23678899999999999999999999999999999999996
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 84 -~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 156 (288)
T 1ob3_A 84 -QDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-- 156 (288)
T ss_dssp -EEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred -CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccccc--
Confidence 59988887542 4689999999999999999999998 9999999999999999999999999999876433221
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCC---------
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQ--------- 522 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~--------- 522 (582)
.....||+.|+|||++.+. ..++.++||||||+++|||++|+.||........ ... +...+.......
T Consensus 157 ~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMR-IFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp -----CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHH-HHHHHCCCCTTTSTTGGGSTT
T ss_pred cccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH-HHHHHCCCChhhchhhhcccc
Confidence 1234689999999998653 4689999999999999999999999976533221 111 111111110000
Q ss_pred ----CC---Cc-CcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 523 ----FD---GV-ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 523 ----~~---~~-~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
+. .. .......+...+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 00 00001123456778889999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=337.69 Aligned_cols=251 Identities=24% Similarity=0.380 Sum_probs=203.5
Q ss_pred HHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEeC--CeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYEN--KKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~E~ 369 (582)
+.+.++||+|+||+||+|.. +++.||||+++..... .+.+.+|+.++++++||||+++++++.+. ...++||||
T Consensus 12 y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (271)
T 3kmu_A 12 LNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHW 90 (271)
T ss_dssp CEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEEC
T ss_pred hHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecc
Confidence 45668999999999999988 4889999999865543 35688999999999999999999999877 678999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCc--eEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVR--IVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~--ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
+++|+|.+++.......+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||.|||++......
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~~- 166 (271)
T 3kmu_A 91 MPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP- 166 (271)
T ss_dssp CTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSCT-
T ss_pred cCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeeccc-
Confidence 9999999999877666799999999999999999999987 7 999999999999999999999999887653322
Q ss_pred cceeeecccCCcccccccccccc-cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCc
Q 040604 448 SAISMLHARGTIGYIAPEVYSRR-FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 526 (582)
...||+.|+|||.+.+. ...++.++||||||+++|||++|+.||....... .............+...
T Consensus 167 ------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~ 235 (271)
T 3kmu_A 167 ------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME-----IGMKVALEGLRPTIPPG 235 (271)
T ss_dssp ------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH-----HHHHHHHSCCCCCCCTT
T ss_pred ------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH-----HHHHHHhcCCCCCCCCC
Confidence 23589999999998753 1233458999999999999999999997653322 11222222222222222
Q ss_pred CcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 527 ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 527 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
+...+.+++.+||+.||++|||++++++.|+...+
T Consensus 236 -------~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 236 -------ISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 23456778888999999999999999999998543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=356.44 Aligned_cols=266 Identities=18% Similarity=0.239 Sum_probs=201.1
Q ss_pred HHHhhhhcCccCceEEEEEEeCC------CcEEEEEEeccCCCC------------HHHHHHHHHHHhccCCCceEEEEe
Q 040604 294 TKSFRDKLGQGGYGEVYKGELPD------GQLVAVKVLKNSRCN------------GEEFINEVASISRTSHVNIVTFLG 355 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~------------~~~~~~E~~~l~~l~h~niv~l~~ 355 (582)
.+.+.++||+|+||+||+|.+.. ++.||||++...... ...+..|+..+++++|+||+++++
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 115 (364)
T 3op5_A 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115 (364)
T ss_dssp EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence 45667899999999999997754 478999998754321 123455667778889999999999
Q ss_pred EEEeC----CeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc--CC
Q 040604 356 FCYEN----KKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLD--ED 429 (582)
Q Consensus 356 ~~~~~----~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~--~~ 429 (582)
++... ...++||||+ +++|.+++... ...+++..++.|+.||+.||+|||+. +|+||||||+|||++ .+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp EEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCT
T ss_pred eeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCC
Confidence 99865 4579999999 99999999764 34699999999999999999999998 999999999999999 88
Q ss_pred CceEEeecccccccccccccee-----eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCccc
Q 040604 430 FCPKISDFGLAKQAQKKESAIS-----MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDT 504 (582)
Q Consensus 430 ~~vkl~DFGla~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~ 504 (582)
+.+||+|||+++.......... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.......
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV--APSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 9999999999987654332211 1233599999999999764 68999999999999999999999998543332
Q ss_pred chhhHHHHHhhcCCCCCCCCCcCcHH--HHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCC
Q 040604 505 SICHNLIYERIEPGNDFQFDGVATEE--EKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQ 571 (582)
Q Consensus 505 ~~~~~~~~~~i~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~ 571 (582)
...... ....... +....... ....+..+.+++.+||+.||++||++++|++.|+..+..+.
T Consensus 269 ~~~~~~-~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 269 KYVRDS-KIRYREN----IASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp HHHHHH-HHHHHHC----HHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHH-HHHhhhh----HHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 211111 1100000 00000000 01124567888899999999999999999999998776554
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=346.44 Aligned_cols=264 Identities=30% Similarity=0.464 Sum_probs=194.4
Q ss_pred HHHHHHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCH---HHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEE
Q 040604 290 VKRMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNG---EEFINEVASISRTSHVNIVTFLGFCYENKKNALI 366 (582)
Q Consensus 290 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 366 (582)
+....+.+.++||+|+||+||+|... ..+|||+++...... +.+.+|+.++++++||||++++++. .....++|
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 33444566789999999999999864 359999997655433 5688999999999999999999965 55678999
Q ss_pred EEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccc
Q 040604 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~ 446 (582)
|||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 98 TQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp EECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccc
Confidence 9999999999999654 34689999999999999999999998 9999999999999999999999999999876543
Q ss_pred ccceeeecccCCcccccccccccc-cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCC
Q 040604 447 ESAISMLHARGTIGYIAPEVYSRR-FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525 (582)
Q Consensus 447 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 525 (582)
..........||+.|+|||++... ...++.++||||||+++|||++|+.||......... ...+..... ...+..
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~~---~~~~~~ 249 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-IEMVGRGSL---SPDLSK 249 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH-HHHHHHTSC---CCCTTS
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH-HHHhccccc---Ccchhh
Confidence 332233345699999999998621 246788999999999999999999999765443221 111111111 111111
Q ss_pred cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 526 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
.. ..+...+.+++.+||+.||++|||++++++.|+....
T Consensus 250 ~~----~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 250 VR----SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp SC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cc----ccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 11 1234567788889999999999999999999998654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=352.44 Aligned_cols=251 Identities=24% Similarity=0.289 Sum_probs=193.0
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
+|.+.++||+|+||+||++... +++.||||++.......+.+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 100 (361)
T 3uc3_A 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASG 100 (361)
T ss_dssp TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCC
Confidence 3556789999999999999765 799999999987766678899999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc--eEEeeccccccccccccce
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFC--PKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~--vkl~DFGla~~~~~~~~~~ 450 (582)
|+|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++........
T Consensus 101 ~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~- 174 (361)
T 3uc3_A 101 GELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 174 (361)
T ss_dssp CBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCC-
Confidence 99999987543 689999999999999999999998 9999999999999987765 999999999854333221
Q ss_pred eeecccCCcccccccccccccCCCC-ccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVS-HKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s-~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
....||+.|+|||++.+. .++ .++||||||+++|+|++|+.||........ ....+..............
T Consensus 175 --~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~---- 245 (361)
T 3uc3_A 175 --KSTVGTPAYIAPEVLLRQ--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQRILSVKYSIPDDI---- 245 (361)
T ss_dssp --------CTTSCHHHHHCS--SCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHHHHHHTTCCCCCTTS----
T ss_pred --CCCcCCCCcCChhhhcCC--CCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHHHHHhcCCCCCCCcC----
Confidence 234599999999998764 444 458999999999999999999976544332 2222222222211111111
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
.+...+.+|+.+||+.||++|||++|+++.
T Consensus 246 ---~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 246 ---RISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ---CCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ---CCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 123456778889999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=347.88 Aligned_cols=248 Identities=21% Similarity=0.302 Sum_probs=182.9
Q ss_pred hhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhccC-CCceEEEEeEEEeCCeeeEEEEecCCCChh
Q 040604 299 DKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRTS-HVNIVTFLGFCYENKKNALIYELMPNGSLD 376 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 376 (582)
++||+|+||+||+|... +++.||||++... ....+.+|+.+++++. ||||+++++++.+....++||||+++|+|.
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF 94 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence 57999999999999765 7899999999653 3567789999999997 999999999999999999999999999999
Q ss_pred hhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC---ceEEeeccccccccccccceeee
Q 040604 377 KFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF---CPKISDFGLAKQAQKKESAISML 453 (582)
Q Consensus 377 ~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~---~vkl~DFGla~~~~~~~~~~~~~ 453 (582)
+++.... .+++..++.|+.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++........ ..
T Consensus 95 ~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~ 167 (325)
T 3kn6_A 95 ERIKKKK--HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--LK 167 (325)
T ss_dssp HHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred HHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc--cc
Confidence 9998653 689999999999999999999998 999999999999998765 8999999999876543322 22
Q ss_pred cccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccc-hhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 454 HARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTS-ICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 454 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
...||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ .....+.+.+..+.. ....+...
T Consensus 168 ~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~----~~~~~~~~ 241 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQ--NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF----SFEGEAWK 241 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC----CCCSHHHH
T ss_pred ccCCCcCccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC----CCCccccc
Confidence 3468999999999976 3789999999999999999999999976533211 111123334443321 11223334
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 533 KIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.+...+.+|+.+||+.||++|||++++++
T Consensus 242 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp TSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 45677888999999999999999999874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=347.35 Aligned_cols=263 Identities=17% Similarity=0.212 Sum_probs=208.9
Q ss_pred HHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCCHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNGEEFINEVASISRT-SHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
+.+.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+.+++++ +|+|++++++++.+....++||||+ +
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 89 (298)
T 1csn_A 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-G 89 (298)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred eEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-C
Confidence 44568899999999999975 589999999986543 345678899999999 7999999999999999999999999 9
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc-----eEEeeccccccccccc
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFC-----PKISDFGLAKQAQKKE 447 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~-----vkl~DFGla~~~~~~~ 447 (582)
++|.+++...+ ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++......
T Consensus 90 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~ 165 (298)
T 1csn_A 90 PSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165 (298)
T ss_dssp CBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred CCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence 99999998643 3689999999999999999999998 9999999999999987776 9999999998765543
Q ss_pred cc-----eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccc--hhhHHHHHhhcCCCC
Q 040604 448 SA-----ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTS--ICHNLIYERIEPGND 520 (582)
Q Consensus 448 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~--~~~~~~~~~i~~~~~ 520 (582)
.. .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ .............
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 241 (298)
T 1csn_A 166 TKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP-- 241 (298)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC--
T ss_pred ccccccccCccCCCCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc--
Confidence 21 11234569999999999876 3689999999999999999999999976543221 1111111111000
Q ss_pred CCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCCCC
Q 040604 521 FQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQIP 573 (582)
Q Consensus 521 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~~p 573 (582)
.......+...+.+++.+||+.||++||++++|++.|++.+..+...
T Consensus 242 ------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~ 288 (298)
T 1csn_A 242 ------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 288 (298)
T ss_dssp ------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred ------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence 00111123466788889999999999999999999999987766543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=344.14 Aligned_cols=259 Identities=24% Similarity=0.337 Sum_probs=199.1
Q ss_pred HHHHHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCC------CCHHHHHHHHHHHhccC---CCceEEEEeEEEeCC
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSR------CNGEEFINEVASISRTS---HVNIVTFLGFCYENK 361 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~ 361 (582)
..++.+.++||+|+||+||+|.. .+++.||||+++... .....+.+|+.++++++ ||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 34556778999999999999986 479999999986432 12356778888777664 999999999998755
Q ss_pred -----eeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEee
Q 040604 362 -----KNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISD 436 (582)
Q Consensus 362 -----~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~D 436 (582)
..++||||+. ++|.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEECS
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEee
Confidence 4789999995 7999999877666699999999999999999999998 999999999999999999999999
Q ss_pred ccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhc
Q 040604 437 FGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIE 516 (582)
Q Consensus 437 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~ 516 (582)
||+++........ ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .. .+.+.+.
T Consensus 164 fg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~-~i~~~~~ 236 (308)
T 3g33_A 164 FGLARIYSYQMAL---TPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-LG-KIFDLIG 236 (308)
T ss_dssp CSCTTTSTTCCCS---GGGGCCCSSCCHHHHHT--SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH-HH-HHHHHHC
T ss_pred CccccccCCCccc---CCccccccccCchHHcC--CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HH-HHHHHhC
Confidence 9999876543322 23469999999999876 4689999999999999999999999976543221 11 1222222
Q ss_pred CCCCCCCCC-----------cC----cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 517 PGNDFQFDG-----------VA----TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 517 ~~~~~~~~~-----------~~----~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
......+.. .. .....++...+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 111110000 00 0011134466788899999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=351.29 Aligned_cols=254 Identities=22% Similarity=0.372 Sum_probs=200.6
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcE----EEEEEeccCC--CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQL----VAVKVLKNSR--CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 367 (582)
+.+.++||+|+||+||+|.+. +++. ||+|++.... ...+.+.+|+.++++++||||+++++++. +...++||
T Consensus 15 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~ 93 (325)
T 3kex_A 15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVT 93 (325)
T ss_dssp EEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEE
T ss_pred ceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEE
Confidence 345688999999999999754 4544 7888775433 22356788999999999999999999885 56788999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 94 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 169 (325)
T 3kex_A 94 QYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169 (325)
T ss_dssp ECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred EeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence 999999999999764 24688899999999999999999998 99999999999999999999999999999876554
Q ss_pred cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCc
Q 040604 448 SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 526 (582)
.........||+.|+|||++.+ +.++.++||||||+++|||++ |+.||....... +...+..+........
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~ 241 (325)
T 3kex_A 170 KQLLYSEAKTPIKWMALESIHF--GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE------VPDLLEKGERLAQPQI 241 (325)
T ss_dssp TCCC-----CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH------HHHHHHTTCBCCCCTT
T ss_pred ccccccCCCCcccccChHHhcc--CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH------HHHHHHcCCCCCCCCc
Confidence 4333344568899999999976 478999999999999999999 999997654322 2223333322222222
Q ss_pred CcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 527 ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 527 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
. ...+.+++.+||+.||++|||++++++.|+....
T Consensus 242 ~-------~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 242 C-------TIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp B-------CTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred C-------cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 2 2345667788999999999999999999988654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=352.79 Aligned_cols=243 Identities=23% Similarity=0.349 Sum_probs=198.0
Q ss_pred HHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccC----CCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNS----RCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
|.+.+.||+|+||+||+|.. .+++.||||++... ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 11 Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 90 (336)
T 3h4j_B 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY 90 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEEC
Confidence 45668999999999999976 58999999998643 22346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+ +|+|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++.........
T Consensus 91 ~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~ 164 (336)
T 3h4j_B 91 A-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL 164 (336)
T ss_dssp C-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTT
T ss_pred C-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCccc
Confidence 9 789988887543 689999999999999999999998 9999999999999999999999999999876554332
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
....||+.|+|||++.+. ...+.++||||||+++|+|++|+.||........ ...+..+. ..++..
T Consensus 165 ---~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~------~~~i~~~~-~~~p~~--- 230 (336)
T 3h4j_B 165 ---KTSCGSPNYAAPEVINGK-LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL------FKKVNSCV-YVMPDF--- 230 (336)
T ss_dssp ---CCCTTSTTTSCGGGSCCS-GGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC------BCCCCSSC-CCCCTT---
T ss_pred ---ccccCCcCcCCHHHHcCC-CCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH------HHHHHcCC-CCCccc---
Confidence 234699999999999764 2347899999999999999999999976533221 11111111 112222
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
+...+.+++.+||+.||.+|||++|+++
T Consensus 231 ----~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 231 ----LSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp ----SCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred ----CCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 2345677888999999999999999985
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=350.47 Aligned_cols=261 Identities=24% Similarity=0.443 Sum_probs=208.3
Q ss_pred HHHHHhhhhcCccCceEEEEEEeC--------CCcEEEEEEeccCCC--CHHHHHHHHHHHhcc-CCCceEEEEeEEEeC
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELP--------DGQLVAVKVLKNSRC--NGEEFINEVASISRT-SHVNIVTFLGFCYEN 360 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 360 (582)
...+.+.+.||+|+||+||+|... +++.||||+++.... ..+.+.+|+.+++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 345566789999999999999763 567899999976543 235688999999999 899999999999999
Q ss_pred CeeeEEEEecCCCChhhhhhcCCC--------------cCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE
Q 040604 361 KKNALIYELMPNGSLDKFIHNDRN--------------IKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL 426 (582)
Q Consensus 361 ~~~~lv~E~~~~gsL~~~i~~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl 426 (582)
...++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+. +|+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 999999999999999999976532 2489999999999999999999998 99999999999999
Q ss_pred cCCCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccc
Q 040604 427 DEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTS 505 (582)
Q Consensus 427 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~ 505 (582)
+.++.+||+|||+++...............+|+.|+|||++.+ ..++.++||||||+++|||++ |+.|+.......
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~- 267 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE- 267 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC--CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH-
Confidence 9999999999999987765443333334568899999999876 368899999999999999999 888886543221
Q ss_pred hhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCC
Q 040604 506 ICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENL 570 (582)
Q Consensus 506 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~ 570 (582)
+...+..+........ +...+.+++.+||+.||++|||+++|++.|++.+...
T Consensus 268 -----~~~~~~~~~~~~~~~~-------~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 268 -----LFKLLKEGHRMDKPAN-------CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp -----HHHHHHHTCCCCCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----HHHHHhcCCCCCCCcc-------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 1222222221222221 2345677888999999999999999999999876533
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=351.49 Aligned_cols=249 Identities=22% Similarity=0.346 Sum_probs=200.9
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccC----CCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNS----RCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 368 (582)
.+.+.+.||+|+||.||++... +++.||+|++... ....+.+.+|+.++++++|||||++++++.+....++|||
T Consensus 16 ~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 95 (384)
T 4fr4_A 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVD 95 (384)
T ss_dssp GEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 3456789999999999999765 6899999998643 3355778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
|+.||+|..++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 96 ~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 170 (384)
T 4fr4_A 96 LLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170 (384)
T ss_dssp CCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCCc
Confidence 999999999997643 689999999999999999999998 999999999999999999999999999987654432
Q ss_pred ceeeecccCCcccccccccccc-cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcC
Q 040604 449 AISMLHARGTIGYIAPEVYSRR-FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527 (582)
Q Consensus 449 ~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 527 (582)
. ....||+.|+|||++... ...++.++|||||||++|||++|+.||........ .. +...+.... ..++..
T Consensus 171 ~---~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~--~~-~~~~~~~~~-~~~p~~- 242 (384)
T 4fr4_A 171 I---TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS--KE-IVHTFETTV-VTYPSA- 242 (384)
T ss_dssp B---CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH--HH-HHHHHHHCC-CCCCTT-
T ss_pred e---eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH--HH-HHHHHhhcc-cCCCCc-
Confidence 2 245699999999998642 13588999999999999999999999975433221 11 111111111 112222
Q ss_pred cHHHHHHHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 040604 528 TEEEKKIAKMMILVGFWCIQTNPSERPS-MHKVLE 561 (582)
Q Consensus 528 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-~~evl~ 561 (582)
+...+.+|+.+||+.||++||+ +++|++
T Consensus 243 ------~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 243 ------WSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ------SCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ------CCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 2355777888899999999998 777764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=344.94 Aligned_cols=241 Identities=28% Similarity=0.348 Sum_probs=199.4
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccC----CCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNS----RCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.+.+.||+|+||+||++... +|+.||+|++++. ....+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 8 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~ 87 (318)
T 1fot_A 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 87 (318)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeC
Confidence 445689999999999999765 7999999999653 23557788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 88 ~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~-- 160 (318)
T 1fot_A 88 IEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-- 160 (318)
T ss_dssp CCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB--
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCcc--
Confidence 99999999998644 689999999999999999999998 99999999999999999999999999998765432
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
....||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ..+.+.... ..++...
T Consensus 161 ---~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~i~~~~-~~~p~~~-- 226 (318)
T 1fot_A 161 ---YTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TYEKILNAE-LRFPPFF-- 226 (318)
T ss_dssp ---CCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHCC-CCCCTTS--
T ss_pred ---ccccCCccccCHhHhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC-CCCCCCC--
Confidence 23469999999999876 368999999999999999999999997653322 112221111 1222222
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERP-----SMHKVLE 561 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~ 561 (582)
...+.+++.+||+.||++|| ++++|++
T Consensus 227 -----~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 227 -----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -----CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 34566778889999999999 8899884
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=337.29 Aligned_cols=250 Identities=26% Similarity=0.421 Sum_probs=199.7
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC--H------HHHHHHHHHHhccCCCceEEEEeEEEeCCeeeE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN--G------EEFINEVASISRTSHVNIVTFLGFCYENKKNAL 365 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 365 (582)
+.+.+.||+|+||+||+|... +++.||||++...... . +.+.+|+.++++++||||+++++++.+.. ++
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~l 98 (287)
T 4f0f_A 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RM 98 (287)
T ss_dssp EEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EE
T ss_pred ceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eE
Confidence 456688999999999999764 7999999998654322 1 57889999999999999999999986544 79
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCc--eEecCCCCCCEEEcCCCc-----eEEeecc
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVR--IVHFDIKPQNILLDEDFC-----PKISDFG 438 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~--ivH~Dikp~NILl~~~~~-----vkl~DFG 438 (582)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. + |+||||||+|||++.++. +||+|||
T Consensus 99 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 99 VMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp EEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred EEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 999999999998887543 4699999999999999999999998 7 999999999999988776 9999999
Q ss_pred ccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCC
Q 040604 439 LAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPG 518 (582)
Q Consensus 439 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~ 518 (582)
+++..... .....||+.|+|||++......++.++||||||+++|||++|+.||............ ......
T Consensus 175 ~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~---~~~~~~ 246 (287)
T 4f0f_A 175 LSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN---MIREEG 246 (287)
T ss_dssp TCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHH---HHHHSC
T ss_pred cccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHH---HHhccC
Confidence 99864432 2235699999999998543356789999999999999999999999765443321111 111222
Q ss_pred CCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 519 NDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
....+... +...+.+++.+||+.||++|||+++|++.|++
T Consensus 247 ~~~~~~~~-------~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 247 LRPTIPED-------CPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp CCCCCCTT-------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CCCCCCcc-------cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 22222222 23557788888999999999999999999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=348.67 Aligned_cols=248 Identities=23% Similarity=0.331 Sum_probs=195.1
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCC---------
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENK--------- 361 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------- 361 (582)
.+++.++||+|+||.||+|... +|+.||||+++.... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 86 (332)
T 3qd2_B 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMD 86 (332)
T ss_dssp HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHH
T ss_pred cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhh
Confidence 3456689999999999999876 899999999975432 3467899999999999999999999986643
Q ss_pred ------------------------------------------------eeeEEEEecCCCChhhhhhcCCC-cCCCHHHH
Q 040604 362 ------------------------------------------------KNALIYELMPNGSLDKFIHNDRN-IKLEWKTM 392 (582)
Q Consensus 362 ------------------------------------------------~~~lv~E~~~~gsL~~~i~~~~~-~~l~~~~~ 392 (582)
..++||||+++++|.+++..... ...++..+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 166 (332)
T 3qd2_B 87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166 (332)
T ss_dssp C--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHH
T ss_pred hhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHH
Confidence 27899999999999999986532 34677788
Q ss_pred HHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc----------eeeecccCCcccc
Q 040604 393 YQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA----------ISMLHARGTIGYI 462 (582)
Q Consensus 393 ~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~----------~~~~~~~gt~~y~ 462 (582)
+.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........ .......||+.|+
T Consensus 167 ~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 167 LHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 99999999999999998 9999999999999999999999999999887654221 1112346999999
Q ss_pred cccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHH
Q 040604 463 APEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVG 542 (582)
Q Consensus 463 aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~ 542 (582)
|||++.+ ..++.++||||||+++|||++|..|+... . .....+... ..+.........+.+++
T Consensus 244 aPE~~~~--~~~~~~~Di~slG~il~el~~~~~~~~~~-------~-~~~~~~~~~-------~~~~~~~~~~~~~~~li 306 (332)
T 3qd2_B 244 SPEQIHG--NNYSHKVDIFSLGLILFELLYSFSTQMER-------V-RIITDVRNL-------KFPLLFTQKYPQEHMMV 306 (332)
T ss_dssp CHHHHHC--CCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------H-HHHHHHHTT-------CCCHHHHHHCHHHHHHH
T ss_pred ChHHhcC--CCCcchhhHHHHHHHHHHHHHcCCChhHH-------H-HHHHHhhcc-------CCCcccccCChhHHHHH
Confidence 9999876 37899999999999999999987653211 0 111112211 12233344556678899
Q ss_pred HhccccCCCCCCCHHHHHH
Q 040604 543 FWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 543 ~~Cl~~dp~~RPt~~evl~ 561 (582)
.+||+.||++|||++|+++
T Consensus 307 ~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 307 QDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHCSSGGGSCCHHHHHH
T ss_pred HHHccCCCCcCCCHHHHhh
Confidence 9999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=346.28 Aligned_cols=273 Identities=22% Similarity=0.325 Sum_probs=211.2
Q ss_pred cHHHHHHHHHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhc--cCCCceEEEEeEEEeCC--
Q 040604 286 SYSDVKRMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISR--TSHVNIVTFLGFCYENK-- 361 (582)
Q Consensus 286 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~-- 361 (582)
...+.....+.+.+.||+|+||+||+|.. +|+.||||+++.. ..+.+.+|+.++.. ++||||+++++++....
T Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 35 LVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred eecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 33445556677789999999999999988 6899999999654 34667888888877 79999999999998776
Q ss_pred --eeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceEecCCCCCCEEEcCCCc
Q 040604 362 --KNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH--------RGCQVRIVHFDIKPQNILLDEDFC 431 (582)
Q Consensus 362 --~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH--------~~~~~~ivH~Dikp~NILl~~~~~ 431 (582)
..++||||+++|+|.+++... .+++..++.++.|++.||+||| +. +|+||||||+|||++.++.
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSC
T ss_pred cceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCC
Confidence 789999999999999999753 5899999999999999999999 65 9999999999999999999
Q ss_pred eEEeeccccccccccccce--eeecccCCcccccccccccccC----CCCccchhHHHHHHHHHHhcC----------CC
Q 040604 432 PKISDFGLAKQAQKKESAI--SMLHARGTIGYIAPEVYSRRFG----GVSHKSDVYSYGMMIIEMVGC----------TK 495 (582)
Q Consensus 432 vkl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~----~~s~~~DvwSlGvil~elltg----------~~ 495 (582)
+||+|||++.......... ......||+.|+|||++.+... .++.++||||||+++|||++| ..
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 9999999998765543221 1233469999999999875311 233689999999999999999 66
Q ss_pred CCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCC
Q 040604 496 NLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIEN 569 (582)
Q Consensus 496 p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~ 569 (582)
||............+............+.... ...+....+.+|+.+||+.||++|||+++|++.|+...+.
T Consensus 266 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 266 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW--QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG--GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CccccCcCcccHHHHHHHHHHHHhCCCCcccc--cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 77654333222222222222222222221111 1234567788899999999999999999999999986654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=339.66 Aligned_cols=247 Identities=24% Similarity=0.350 Sum_probs=192.5
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC---------------------------CHHHHHHHHHHHhccC
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC---------------------------NGEEFINEVASISRTS 346 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------------------------~~~~~~~E~~~l~~l~ 346 (582)
+.+.++||+|+||.||+|... +++.||||++..... ..+.+.+|+.++++++
T Consensus 15 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 94 (298)
T 2zv2_A 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLD 94 (298)
T ss_dssp EEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCC
T ss_pred eEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCC
Confidence 456689999999999999764 789999999865431 1256889999999999
Q ss_pred CCceEEEEeEEEe--CCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCE
Q 040604 347 HVNIVTFLGFCYE--NKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNI 424 (582)
Q Consensus 347 h~niv~l~~~~~~--~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NI 424 (582)
||||+++++++.+ ....++||||+++++|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+||
T Consensus 95 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 95 HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNL 168 (298)
T ss_dssp CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHE
Confidence 9999999999987 5678999999999999987643 3699999999999999999999998 999999999999
Q ss_pred EEcCCCceEEeeccccccccccccceeeecccCCcccccccccccccC-CCCccchhHHHHHHHHHHhcCCCCCCCCCcc
Q 040604 425 LLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFG-GVSHKSDVYSYGMMIIEMVGCTKNLDDEVTD 503 (582)
Q Consensus 425 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~s~~~DvwSlGvil~elltg~~p~~~~~~~ 503 (582)
|++.++.+||+|||+++........ .....||+.|+|||++.+... ..+.++||||||+++|||++|+.||......
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 9999999999999999876554322 223569999999999875321 1478899999999999999999999764321
Q ss_pred cchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 504 TSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 504 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
. +...+.... ..++.. ..+...+.+++.+||+.||++|||++|+++
T Consensus 247 ~------~~~~~~~~~-~~~~~~-----~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 247 C------LHSKIKSQA-LEFPDQ-----PDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp H------HHHHHHHCC-CCCCSS-----SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred H------HHHHHhccc-CCCCCc-----cccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1 111111111 011110 112345778888999999999999999875
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=345.83 Aligned_cols=246 Identities=24% Similarity=0.286 Sum_probs=194.7
Q ss_pred HHHHHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCH---HHHHHHHHHHhcc-CCCceEEEEeEEEeCCeee
Q 040604 290 VKRMTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNG---EEFINEVASISRT-SHVNIVTFLGFCYENKKNA 364 (582)
Q Consensus 290 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 364 (582)
+....+.+.++||+|+||+||+|... +|+.||||++....... ..+..|+..+.++ +|+||+++++++.+....+
T Consensus 54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~ 133 (311)
T 3p1a_A 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133 (311)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence 34455667789999999999999776 79999999987654333 3455566665555 8999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccc
Q 040604 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~ 444 (582)
+||||+ +++|.+++...+ ..+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 134 lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred EEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 999999 789998887543 4699999999999999999999998 99999999999999999999999999998765
Q ss_pred ccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCC
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFD 524 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 524 (582)
..... ....||+.|+|||++.+ .++.++|||||||++|||++|..++..... ...+..+.
T Consensus 209 ~~~~~---~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~~---------~~~~~~~~----- 268 (311)
T 3p1a_A 209 TAGAG---EVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGEG---------WQQLRQGY----- 268 (311)
T ss_dssp ---------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---------HHHHTTTC-----
T ss_pred cCCCC---cccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCccH---------HHHHhccC-----
Confidence 43322 23459999999999864 689999999999999999999877654211 11222211
Q ss_pred CcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 525 GVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 525 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
........+...+.+++.+||+.||++|||++|+++
T Consensus 269 -~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 269 -LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp -CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111222334567888899999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=343.56 Aligned_cols=263 Identities=24% Similarity=0.402 Sum_probs=205.3
Q ss_pred HHHHHhhhhcCccCceEEEEEEe-----CCCcEEEEEEeccCC--CCHHHHHHHHHHHhccCCCceEEEEeEEEeC--Ce
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGEL-----PDGQLVAVKVLKNSR--CNGEEFINEVASISRTSHVNIVTFLGFCYEN--KK 362 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 362 (582)
+..+++.++||+|+||.||+|.+ .+++.||||+++... ...+.+.+|+.++++++||||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 33456678999999999999973 378999999997543 3457889999999999999999999999876 56
Q ss_pred eeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccc
Q 040604 363 NALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ 442 (582)
Q Consensus 363 ~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~ 442 (582)
.++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccccc
Confidence 789999999999999996543 3589999999999999999999998 999999999999999999999999999988
Q ss_pred ccccccc-eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCc---------ccchhhHHHH
Q 040604 443 AQKKESA-ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVT---------DTSICHNLIY 512 (582)
Q Consensus 443 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~---------~~~~~~~~~~ 512 (582)
....... .......||..|+|||++.+ ..++.++||||||+++|||++|+.|+..... ........+.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQ--SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecC--CCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 7654432 12223468899999999876 3678999999999999999999987543210 0001111122
Q ss_pred HhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 040604 513 ERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSI 567 (582)
Q Consensus 513 ~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~ 567 (582)
..+..+........ +...+.+++.+||+.||++|||++++++.|+..+
T Consensus 254 ~~~~~~~~~~~~~~-------~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 254 NTLKEGKRLPCPPN-------CPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHTTCCCCCCTT-------CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhccCCCCCCCC-------CCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 22333222222222 2356778888999999999999999999999865
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=352.93 Aligned_cols=244 Identities=25% Similarity=0.336 Sum_probs=198.9
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccC----CCCHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeeeEEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNS----RCNGEEFINEVASISRT-SHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 367 (582)
.+.+.+.||+|+||+||+|... +|+.||||++++. ....+.+..|..++.++ +||||+++++++.+....++||
T Consensus 18 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~ 97 (345)
T 1xjd_A 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 97 (345)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEE
Confidence 3456689999999999999765 7899999999753 34566788999999887 9999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
||++||+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 98 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 98 EYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172 (345)
T ss_dssp ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence 9999999999997643 689999999999999999999998 99999999999999999999999999998654322
Q ss_pred cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcC
Q 040604 448 SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 527 (582)
.. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... +.+.+.... ..++..
T Consensus 173 ~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~~~~-~~~p~~- 240 (345)
T 1xjd_A 173 AK--TNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------LFHSIRMDN-PFYPRW- 240 (345)
T ss_dssp CC--BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC-CCCCTT-
T ss_pred Cc--ccCCCCCcccCChhhhcCC--CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHHhCC-CCCCcc-
Confidence 21 2245699999999999763 68999999999999999999999997653321 222222211 122222
Q ss_pred cHHHHHHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 040604 528 TEEEKKIAKMMILVGFWCIQTNPSERPSMH-KVL 560 (582)
Q Consensus 528 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~-evl 560 (582)
+...+.+++.+||+.||++||++. +|+
T Consensus 241 ------~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 241 ------LEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ------SCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ------cCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 234567778889999999999997 664
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=360.00 Aligned_cols=251 Identities=26% Similarity=0.396 Sum_probs=204.6
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.+.+.||+|+||.||+|... +|+.||||+++... ...+.+.+|+.++++++||||+++++++......++||||
T Consensus 18 Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~ 97 (476)
T 2y94_A 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEY 97 (476)
T ss_dssp EEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 445688999999999999765 79999999996532 3456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 98 ~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~ 172 (476)
T 2y94_A 98 VSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 172 (476)
T ss_dssp CSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCB
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccccc
Confidence 9999999999754 3689999999999999999999998 9999999999999999999999999999886554322
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
....||+.|+|||++.+. ...+.++|||||||++|||++|+.||....... +...+..+.. ..+..
T Consensus 173 ---~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~------~~~~i~~~~~-~~p~~--- 238 (476)
T 2y94_A 173 ---RTSCGSPNYAAPEVISGR-LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT------LFKKICDGIF-YTPQY--- 238 (476)
T ss_dssp ---CCCCSCSTTCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH------HHHHHHTTCC-CCCTT---
T ss_pred ---cccCCCcCeEChhhccCC-CCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH------HHHHHhcCCc-CCCcc---
Confidence 234699999999999764 234789999999999999999999997653322 2223322221 11122
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcccC
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLE--MLEGSIE 568 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~--~Le~~~~ 568 (582)
+...+.+++.+||+.||++|||++++++ .+.+.+.
T Consensus 239 ----~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 275 (476)
T 2y94_A 239 ----LNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLP 275 (476)
T ss_dssp ----CCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTCC
T ss_pred ----CCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcCc
Confidence 2245677888899999999999999986 4555443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=338.85 Aligned_cols=254 Identities=24% Similarity=0.408 Sum_probs=193.2
Q ss_pred HHHhhhhcCccCceEEEEEEeC----CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP----DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 367 (582)
.+.+.+.||+|+||.||+|... .+..||+|+++.... ..+.+.+|+.++++++||||+++++++ .+...++||
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 94 (281)
T 1mp8_A 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIM 94 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred HeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEEE
Confidence 4556789999999999999764 356799999876433 235688999999999999999999997 456789999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 95 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 95 ELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp ECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred ecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCccc
Confidence 9999999999997543 4689999999999999999999998 99999999999999999999999999998765433
Q ss_pred cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCc
Q 040604 448 SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 526 (582)
.. ......+|+.|+|||++.. ..++.++||||||+++|||++ |..||....... +...+..+....+...
T Consensus 171 ~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~------~~~~i~~~~~~~~~~~ 241 (281)
T 1mp8_A 171 YY-KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERLPMPPN 241 (281)
T ss_dssp ---------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------HHHHHHTTCCCCCCTT
T ss_pred cc-ccccCCCcccccChhhccc--CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH------HHHHHHcCCCCCCCCC
Confidence 22 1123357889999999875 478999999999999999996 888987654322 2223333322222222
Q ss_pred CcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 527 ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 527 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
+...+.+++.+||+.||++|||+++|++.|+..++
T Consensus 242 -------~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 242 -------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp -------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 23556778889999999999999999999987653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=348.40 Aligned_cols=250 Identities=22% Similarity=0.365 Sum_probs=194.9
Q ss_pred HHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCH---HHHHHHHHHHhccCC--CceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNG---EEFINEVASISRTSH--VNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~E~ 369 (582)
|.+.++||+|+||.||++...+++.||||++....... +.+.+|+.++++++| +||+++++++.+....++|||+
T Consensus 11 y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~ 90 (343)
T 3dbq_A 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC 90 (343)
T ss_dssp EEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC
Confidence 44668999999999999988889999999997654433 568899999999987 9999999999999999999995
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
.+++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++ ++.+||+|||+++........
T Consensus 91 -~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 91 -GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp -CSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred -CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 5899999998653 689999999999999999999998 999999999999997 578999999999887654433
Q ss_pred eeeecccCCcccccccccccc---------cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCC
Q 040604 450 ISMLHARGTIGYIAPEVYSRR---------FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND 520 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~---------~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~ 520 (582)
.......||+.|+|||++.+. ...++.++|||||||++|||++|+.||........ .+...+.....
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----~~~~~~~~~~~ 239 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS----KLHAIIDPNHE 239 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH----HHHHHHCTTSC
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH----HHHHHhcCCcc
Confidence 333345699999999998541 14688999999999999999999999975433221 12222333222
Q ss_pred CCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 521 FQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 521 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
..++...+ ..+.+++.+||+.||++|||++|+++.
T Consensus 240 ~~~~~~~~-------~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 240 IEFPDIPE-------KDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CCCCCCSC-------HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCcccCC-------HHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 23333322 346678888999999999999999854
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=352.99 Aligned_cols=248 Identities=25% Similarity=0.309 Sum_probs=186.2
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCC
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNG 373 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 373 (582)
+.+.++||+|+||+||+|... +++.||||+++... ..+.+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 55 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 133 (349)
T 2w4o_A 55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGG 133 (349)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCC
Confidence 445688999999999999876 68899999997653 4467889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---CCceEEeeccccccccccccce
Q 040604 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE---DFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 374 sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~---~~~vkl~DFGla~~~~~~~~~~ 450 (582)
+|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++........
T Consensus 134 ~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~- 207 (349)
T 2w4o_A 134 ELFDRIVEKG--YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM- 207 (349)
T ss_dssp BHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCccccc-
Confidence 9999987543 589999999999999999999998 9999999999999975 889999999999876543221
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHH
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 530 (582)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ +...+.......... .
T Consensus 208 --~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~~i~~~~~~~~~~----~ 274 (349)
T 2w4o_A 208 --KTVCGTPGYCAPEILRG--CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF-----MFRRILNCEYYFISP----W 274 (349)
T ss_dssp -------CGGGSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH-----HHHHHHTTCCCCCTT----T
T ss_pred --ccccCCCCccCHHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH-----HHHHHHhCCCccCCc----h
Confidence 23469999999999876 3689999999999999999999999976543321 222222221111111 1
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 531 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
...+...+.+++.+||+.||++|||+.++++.
T Consensus 275 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 275 WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11234567788899999999999999999873
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=353.36 Aligned_cols=245 Identities=25% Similarity=0.318 Sum_probs=194.4
Q ss_pred hhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCCh
Q 040604 298 RDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSL 375 (582)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 375 (582)
.+.||+|+||.||+|... +|+.||+|+++.... ..+.+.+|+.++++++||||+++++++.+....++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 357999999999999764 799999999976542 346789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE--cCCCceEEeeccccccccccccceeee
Q 040604 376 DKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL--DEDFCPKISDFGLAKQAQKKESAISML 453 (582)
Q Consensus 376 ~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl--~~~~~vkl~DFGla~~~~~~~~~~~~~ 453 (582)
.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++........ .
T Consensus 174 ~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~---~ 246 (373)
T 2x4f_A 174 FDRIIDES-YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL---K 246 (373)
T ss_dssp HHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC---C
T ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc---c
Confidence 99887542 4689999999999999999999998 99999999999999 56789999999999887554332 2
Q ss_pred cccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHH
Q 040604 454 HARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKK 533 (582)
Q Consensus 454 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 533 (582)
...||+.|+|||++.. ..++.++|||||||++|||++|+.||....... . +.+.+...... .......
T Consensus 247 ~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~----~~~i~~~~~~~-----~~~~~~~ 314 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNY--DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE-T----LNNILACRWDL-----EDEEFQD 314 (373)
T ss_dssp CCCSSCTTCCHHHHTT--CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-H----HHHHHHTCCCS-----CSGGGTT
T ss_pred cccCCCcEeChhhccC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-H----HHHHHhccCCC-----Chhhhcc
Confidence 3459999999999875 478999999999999999999999997654322 1 11111111111 0111123
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 534 IAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 534 ~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
+...+.+++.+||+.||++|||++|+++
T Consensus 315 ~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 315 ISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 3466788899999999999999999986
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=345.40 Aligned_cols=259 Identities=25% Similarity=0.362 Sum_probs=190.0
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
.+.+.++||+|+||+||+|... +|+.||||+++.... ..+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85 (317)
T ss_dssp -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence 3566789999999999999765 789999999975432 3467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCC----CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccc
Q 040604 371 PNGSLDKFIHNDR----NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 371 ~~gsL~~~i~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~ 446 (582)
+ |+|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 6 69998886432 23589999999999999999999998 9999999999999999999999999999876543
Q ss_pred ccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCC-----
Q 040604 447 ESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDF----- 521 (582)
Q Consensus 447 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~----- 521 (582)
... .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||........ . ..+.+.+......
T Consensus 162 ~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~-~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 162 VNT--FSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ-L-KLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp CCC--CCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-H-HHHHHHHCSCCTTTCGGG
T ss_pred ccc--CCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-H-HHHHHHhCCCChhHhhhh
Confidence 221 1234699999999998753 3689999999999999999999999976543221 1 1111111111000
Q ss_pred --------CCCCcCcHH---------HHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 522 --------QFDGVATEE---------EKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 522 --------~~~~~~~~~---------~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.+....... ...+...+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000000000 0123456788999999999999999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=349.39 Aligned_cols=241 Identities=22% Similarity=0.291 Sum_probs=200.2
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccC----CCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNS----RCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.+.+.||+|+||.||++... +|+.||||+++.. ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 43 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 122 (350)
T 1rdq_E 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcC
Confidence 456689999999999999765 7999999999643 23457789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++|+|.+++...+ .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 123 ~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~-- 195 (350)
T 1rdq_E 123 VAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-- 195 (350)
T ss_dssp CTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB--
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCCc--
Confidence 99999999997643 589999999999999999999998 99999999999999999999999999998765432
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... +.+.+..+. ..++..
T Consensus 196 ---~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~~~~-~~~p~~--- 260 (350)
T 1rdq_E 196 ---WTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSGK-VRFPSH--- 260 (350)
T ss_dssp ---CCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC-CCCCTT---
T ss_pred ---ccccCCccccCHHHhcCC--CCCCcCCEecccHhHhHHhhCCCCCCCCCHHH------HHHHHHcCC-CCCCCC---
Confidence 134699999999999763 68999999999999999999999997653221 222222221 122222
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPS-----MHKVLE 561 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~evl~ 561 (582)
+...+.+++.+||+.||++||+ +++|++
T Consensus 261 ----~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 261 ----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 2345677888899999999998 888874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=351.88 Aligned_cols=265 Identities=18% Similarity=0.200 Sum_probs=198.4
Q ss_pred HHHHhhhhcCccCceEEEEEEeC----CCcEEEEEEeccCCCC------------HHHHHHHHHHHhccCCCceEEEEeE
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELP----DGQLVAVKVLKNSRCN------------GEEFINEVASISRTSHVNIVTFLGF 356 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~------------~~~~~~E~~~l~~l~h~niv~l~~~ 356 (582)
..+.+.++||+|+||+||+|... ++..+|||++...... .+.+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 34556789999999999999765 5788999998765321 1346788889999999999999999
Q ss_pred EEe----CCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC--
Q 040604 357 CYE----NKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF-- 430 (582)
Q Consensus 357 ~~~----~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~-- 430 (582)
+.. ....++||||+ +++|.+++...+ .+++..++.|+.||+.||+|||+. +|+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTT
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCC
Confidence 988 67889999999 999999997654 799999999999999999999998 999999999999999887
Q ss_pred ceEEeeccccccccccccce-----eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccc
Q 040604 431 CPKISDFGLAKQAQKKESAI-----SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTS 505 (582)
Q Consensus 431 ~vkl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~ 505 (582)
.+||+|||+++......... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG--VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 99999999998765432211 1123469999999999876 3689999999999999999999999965333222
Q ss_pred hhhHHHHHhhcCCCCCCCCCcCcHH--HHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCC
Q 040604 506 ICHNLIYERIEPGNDFQFDGVATEE--EKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENL 570 (582)
Q Consensus 506 ~~~~~~~~~i~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~ 570 (582)
............ ++...... ...+...+.+++.+||+.||++|||+++|++.|+.....+
T Consensus 269 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 330 (345)
T 2v62_A 269 AVQTAKTNLLDE-----LPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPL 330 (345)
T ss_dssp HHHHHHHHHHHT-----TTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCC
T ss_pred HHHHHHHhhccc-----ccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcc
Confidence 111111111111 00000000 0023456888889999999999999999999999855433
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=342.88 Aligned_cols=249 Identities=23% Similarity=0.327 Sum_probs=203.4
Q ss_pred HHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC-------CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeee
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC-------NGEEFINEVASISRTSHVNIVTFLGFCYENKKNA 364 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 364 (582)
..+.+.+.||+|+||.||+|... +|+.||||+++.... ..+.+.+|+.++++++||||+++++++.+....+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34567789999999999999765 799999999975432 3567999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC----ceEEeecccc
Q 040604 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF----CPKISDFGLA 440 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~----~vkl~DFGla 440 (582)
+||||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 9999999999999997643 689999999999999999999998 999999999999999888 7999999999
Q ss_pred ccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCC
Q 040604 441 KQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND 520 (582)
Q Consensus 441 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~ 520 (582)
+........ ....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....... ....+.....
T Consensus 167 ~~~~~~~~~---~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~i~~~~~ 235 (321)
T 2a2a_A 167 HEIEDGVEF---KNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANITSVSY 235 (321)
T ss_dssp EECCTTCCC---CCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHTTCC
T ss_pred eecCccccc---cccCCCCCccCcccccC--CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhccc
Confidence 876654322 23459999999999876 468999999999999999999999997643221 1112222111
Q ss_pred CCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 521 FQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 521 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.+ ...........+.+++.+||+.||++|||++|+++
T Consensus 236 -~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 -DF---DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp -CC---CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred -cc---ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 01 11112234456788999999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=335.33 Aligned_cols=249 Identities=27% Similarity=0.436 Sum_probs=191.0
Q ss_pred HHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCC-----CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRC-----NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.+.++||+|+||.||+|.+ .++.||||+++.... ..+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 9 ~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (271)
T 3dtc_A 9 LTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEF 87 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEEC
T ss_pred eeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEc
Confidence 34568999999999999987 488999999865432 246788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC--------CCceEEeeccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE--------DFCPKISDFGLAK 441 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~--------~~~vkl~DFGla~ 441 (582)
+++++|.+++.. ..+++..++.++.|++.||+|||+....+|+||||||+|||++. ++.+||+|||+++
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~ 164 (271)
T 3dtc_A 88 ARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164 (271)
T ss_dssp CTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred CCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence 999999999864 36899999999999999999999982223999999999999986 7789999999998
Q ss_pred cccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCC
Q 040604 442 QAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDF 521 (582)
Q Consensus 442 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~ 521 (582)
........ ...||+.|+|||.+.+ ..++.++||||||+++++|++|+.||....... ............
T Consensus 165 ~~~~~~~~----~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~ 233 (271)
T 3dtc_A 165 EWHRTTKM----SAAGAYAWMAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA-----VAYGVAMNKLAL 233 (271)
T ss_dssp ---------------CCGGGSCHHHHHH--CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH-----HHHHHHTSCCCC
T ss_pred cccccccc----CCCCccceeCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHhhhcCCCCC
Confidence 76543322 3459999999999876 468999999999999999999999997643322 111122222112
Q ss_pred CCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 522 QFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 522 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
..... ....+.+++.+||+.||++|||++|+++.|+.
T Consensus 234 ~~~~~-------~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 234 PIPST-------CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp CCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCcc-------cCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 22222 23457788889999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=347.66 Aligned_cols=255 Identities=25% Similarity=0.422 Sum_probs=196.4
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcE----EEEEEeccC--CCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQL----VAVKVLKNS--RCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 367 (582)
+.+.++||+|+||+||+|.+. +++. ||+|.++.. ....+.+.+|+.++++++||||+++++++.... .++||
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~ 95 (327)
T 3lzb_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT 95 (327)
T ss_dssp EEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEE
T ss_pred ceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEE
Confidence 456689999999999999754 4554 577776543 335678999999999999999999999998654 78999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
|++.+|+|.+++.... ..+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 96 ~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~ 171 (327)
T 3lzb_A 96 QLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp CCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred EecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence 9999999999997643 3689999999999999999999998 99999999999999999999999999998875544
Q ss_pred cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCc
Q 040604 448 SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 526 (582)
.........||+.|+|||.+.+ ..++.++||||||+++|||++ |+.||....... +...+..+........
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~ 243 (327)
T 3lzb_A 172 KEYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------ISSILEKGERLPQPPI 243 (327)
T ss_dssp --------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------HHHHHHTTCCCCCCTT
T ss_pred ccccccCCCccccccCHHHHcC--CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH------HHHHHHcCCCCCCCcc
Confidence 3333334457889999999976 478999999999999999999 999987654332 2223333322222222
Q ss_pred CcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCC
Q 040604 527 ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIEN 569 (582)
Q Consensus 527 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~ 569 (582)
. ...+.+++.+||+.||++|||++|+++.|+.....
T Consensus 244 ~-------~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 244 C-------TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp B-------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred C-------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 2 33567788889999999999999999999987654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=362.83 Aligned_cols=251 Identities=21% Similarity=0.273 Sum_probs=199.2
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccC----CCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNS----RCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.+.++||+|+||+||+|... +++.||+|++++. ....+.+.+|+.+++.++|||||++++++.+....++||||
T Consensus 71 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~ 150 (410)
T 3v8s_A 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY 150 (410)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 445578999999999999765 6899999999652 23345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
++||+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 151 ~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~ 224 (410)
T 3v8s_A 151 MPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224 (410)
T ss_dssp CTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred CCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence 9999999999753 589999999999999999999998 9999999999999999999999999999876544321
Q ss_pred eeeecccCCcccccccccccccC--CCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcC
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFG--GVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~--~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 527 (582)
......||+.|+|||++.+..+ .++.++|||||||++|||++|+.||....... .+...+.... ...++..
T Consensus 225 -~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~~----~~~~p~~- 297 (410)
T 3v8s_A 225 -RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKIMNHKN----SLTFPDD- 297 (410)
T ss_dssp -ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTHHH----HCCCCTT-
T ss_pred -cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh-HHHHHHhccc----cccCCCc-
Confidence 2234579999999999875421 27889999999999999999999997654322 1111111110 0111110
Q ss_pred cHHHHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 040604 528 TEEEKKIAKMMILVGFWCIQTNPSE--RPSMHKVLEM 562 (582)
Q Consensus 528 ~~~~~~~~~~l~~l~~~Cl~~dp~~--RPt~~evl~~ 562 (582)
..+...+.+|+.+||+.+|.+ ||+++||++.
T Consensus 298 ----~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 298 ----NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ----CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ----ccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 112345667778899999988 9999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=346.07 Aligned_cols=260 Identities=26% Similarity=0.438 Sum_probs=207.7
Q ss_pred HHHHHhhhhcCccCceEEEEEEe------CCCcEEEEEEeccCCCC--HHHHHHHHHHHhcc-CCCceEEEEeEEEeCC-
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGEL------PDGQLVAVKVLKNSRCN--GEEFINEVASISRT-SHVNIVTFLGFCYENK- 361 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~- 361 (582)
...+.+.+.||+|+||+||+|.. .+++.||||+++..... .+.+.+|+.+++++ +||||+++++++....
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 105 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence 33455678999999999999963 35789999999765432 34688999999999 7999999999998755
Q ss_pred eeeEEEEecCCCChhhhhhcCCC--------------cCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc
Q 040604 362 KNALIYELMPNGSLDKFIHNDRN--------------IKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLD 427 (582)
Q Consensus 362 ~~~lv~E~~~~gsL~~~i~~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~ 427 (582)
..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+|||++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 182 (316)
T ss_dssp CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEEC
Confidence 48999999999999999986542 1278999999999999999999998 999999999999999
Q ss_pred CCCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccch
Q 040604 428 EDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSI 506 (582)
Q Consensus 428 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~ 506 (582)
.++.+||+|||+++...............||+.|+|||++.+ ..++.++||||||+++|||++ |+.||.........
T Consensus 183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 260 (316)
T 2xir_A 183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260 (316)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred CCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc--ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence 999999999999987765544333344568999999999876 478999999999999999998 88898765433321
Q ss_pred hhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 507 CHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 507 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
...+..+......... ...+.+++.+||+.||++|||+++|++.|+..++
T Consensus 261 -----~~~~~~~~~~~~~~~~-------~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 261 -----CRRLKEGTRMRAPDYT-------TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp -----HHHHHHTCCCCCCTTC-------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHhccCccCCCCCCC-------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1222222222222222 3456778888999999999999999999998664
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=335.17 Aligned_cols=251 Identities=29% Similarity=0.349 Sum_probs=202.0
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
.+.+.+.||+|+||.||+|... +++.||||+++.... ..+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (276)
T 2yex_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (276)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEec
Confidence 3456689999999999999765 799999999865432 3467899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 88 ~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 88 SGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp TTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred CCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 999999998754 3689999999999999999999998 99999999999999999999999999998765433222
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHH
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 530 (582)
......||+.|+|||.+.+. ...+.++||||||++++||++|+.||............+. ........
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~------- 230 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK----EKKTYLNP------- 230 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHH----TTCTTSTT-------
T ss_pred cccCCccccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhh----hcccccCc-------
Confidence 22345699999999998763 2347899999999999999999999976544332222211 11111100
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 531 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
...+...+.+++.+||+.||++|||++++++
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 231 WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 1123455677888999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=346.56 Aligned_cols=262 Identities=25% Similarity=0.367 Sum_probs=207.0
Q ss_pred HhhhhcCccCceEEEEEEeC-----CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeC--CeeeEE
Q 040604 296 SFRDKLGQGGYGEVYKGELP-----DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYEN--KKNALI 366 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 366 (582)
.+.++||+|+||+||++.+. +++.||||+++.... ..+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 56689999999999988542 688999999976542 235689999999999999999999999874 567899
Q ss_pred EEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccc
Q 040604 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~ 446 (582)
|||+++|+|.+++... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 114 ~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp ECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 9999999999999764 489999999999999999999998 9999999999999999999999999999887654
Q ss_pred ccce-eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCccc---------chhhHHHHHhhc
Q 040604 447 ESAI-SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDT---------SICHNLIYERIE 516 (582)
Q Consensus 447 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~---------~~~~~~~~~~i~ 516 (582)
.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.|+....... ......+.+.+.
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKE--YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccCCCCCceeeChHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 3321 1223458889999999976 367899999999999999999999986432110 000111222233
Q ss_pred CCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCCC
Q 040604 517 PGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQI 572 (582)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~~ 572 (582)
.+........ +...+.+++.+||+.||++|||+++|++.|+...+.++.
T Consensus 266 ~~~~~~~~~~-------~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 266 RGERLPRPDK-------CPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp TTCCCCCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred cccCCCCCcc-------ccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 3322222222 235677888899999999999999999999987776653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=352.42 Aligned_cols=250 Identities=22% Similarity=0.355 Sum_probs=195.8
Q ss_pred HHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCC---HHHHHHHHHHHhccC--CCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCN---GEEFINEVASISRTS--HVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
|.+.++||+|+||+||++...+++.||||++...... .+.+.+|+.++++++ |+||+++++++......++|||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E- 136 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 136 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence 4566899999999999998888999999999765433 356889999999996 5999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+.+++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++........
T Consensus 137 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 137 CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 55899999998654 688999999999999999999998 999999999999995 589999999999887654433
Q ss_pred eeeecccCCcccccccccccc---------cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCC
Q 040604 450 ISMLHARGTIGYIAPEVYSRR---------FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND 520 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~---------~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~ 520 (582)
.......||+.|+|||++.+. ...++.++|||||||++|||++|+.||........ .+...+.....
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~----~~~~~~~~~~~ 286 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS----KLHAIIDPNHE 286 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH----HHHHHHCTTSC
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH----HHHHHhCcccc
Confidence 223345699999999998641 13588999999999999999999999975432211 12223333222
Q ss_pred CCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 521 FQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 521 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
..++... ...+.+|+.+||+.||++|||++||++.
T Consensus 287 ~~~~~~~-------~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 287 IEFPDIP-------EKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CCCCCCS-------CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCccc-------hHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 2233322 2356778888999999999999999853
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=356.32 Aligned_cols=268 Identities=21% Similarity=0.308 Sum_probs=209.7
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC--CCHHHHHHHHHHHhccCCCceEEEEeEEEeCC--eeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR--CNGEEFINEVASISRTSHVNIVTFLGFCYENK--KNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~E~ 369 (582)
+.+.++||+|+||+||+|... +|+.||||+++... ...+.+.+|+.++++++||||+++++++.+.. ..++||||
T Consensus 11 y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~ 90 (396)
T 4eut_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECC
T ss_pred eEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEec
Confidence 345689999999999999765 69999999997543 34577889999999999999999999998765 67999999
Q ss_pred cCCCChhhhhhcCC-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE----cCCCceEEeecccccccc
Q 040604 370 MPNGSLDKFIHNDR-NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL----DEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 370 ~~~gsL~~~i~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl----~~~~~vkl~DFGla~~~~ 444 (582)
+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 91 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp CTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred CCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 99999999997643 23499999999999999999999998 99999999999999 788889999999998765
Q ss_pred ccccceeeecccCCcccccccccccc------cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCC
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRR------FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPG 518 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~ 518 (582)
..... ....||+.|+|||++.+. ...++.++||||||+++|||++|+.||........ ....+...+...
T Consensus 168 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~-~~~~~~~~~~~~ 243 (396)
T 4eut_A 168 DDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR-NKEVMYKIITGK 243 (396)
T ss_dssp CGGGS---SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT-CHHHHHHHHHSC
T ss_pred CCCcc---ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc-hHHHHHHHhcCC
Confidence 54332 234599999999998541 02567899999999999999999999965433222 122222222221
Q ss_pred CCCCC-------------C---CcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCC
Q 040604 519 NDFQF-------------D---GVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIEN 569 (582)
Q Consensus 519 ~~~~~-------------~---~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~ 569 (582)
..... . .........+...+.+++.+||+.||++||+++++++.|+.+++.
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 11000 0 001111245667788899999999999999999999999887653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=335.24 Aligned_cols=247 Identities=20% Similarity=0.271 Sum_probs=201.9
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccC-CCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNS-RCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
.+.+.++||+|+||+||+|... ++..+|+|++... ....+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (277)
T 3f3z_A 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCT 89 (277)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccC
Confidence 4556789999999999999765 6789999998654 3456789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE---cCCCceEEeecccccccccccc
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL---DEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl---~~~~~vkl~DFGla~~~~~~~~ 448 (582)
+++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||++........
T Consensus 90 ~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 90 GGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164 (277)
T ss_dssp SCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence 999999887643 589999999999999999999998 99999999999999 7889999999999987655433
Q ss_pred ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc
Q 040604 449 AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528 (582)
Q Consensus 449 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 528 (582)
. ....||+.|+|||++.+ .++.++||||||++++||++|+.||....... +...+..+.. ....
T Consensus 165 ~---~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~----~~~~ 228 (277)
T 3f3z_A 165 M---RTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE------VMLKIREGTF----TFPE 228 (277)
T ss_dssp B---CCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCC----CCCH
T ss_pred h---hccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhCCC----CCCc
Confidence 2 23459999999999864 58899999999999999999999997643322 1112221111 0111
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.....+...+.+++.+||+.||++|||+.++++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 229 KDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111234567788899999999999999999985
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=348.40 Aligned_cols=258 Identities=21% Similarity=0.315 Sum_probs=194.1
Q ss_pred HHHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCCH----HHHHHHHHHHhccCCCceEEEEeEEEeCCee----e
Q 040604 294 TKSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNG----EEFINEVASISRTSHVNIVTFLGFCYENKKN----A 364 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----~ 364 (582)
.+.+.++||+|+||.||+|.. .+++.||||+++...... +.+.+|+.++++++||||+++++++...... +
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 92 (311)
T 3ork_A 13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 92 (311)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence 345678999999999999975 579999999997654322 4678999999999999999999998765543 8
Q ss_pred EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccc
Q 040604 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~ 444 (582)
+||||+++++|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 93 lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 93 IVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred EEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 9999999999999997643 689999999999999999999998 99999999999999999999999999998765
Q ss_pred ccccc-eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCC
Q 040604 445 KKESA-ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQF 523 (582)
Q Consensus 445 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~ 523 (582)
..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... .....+.......
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-----~~~~~~~~~~~~~- 239 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-----VAYQHVREDPIPP- 239 (311)
T ss_dssp --------------CCTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHCCCCCH-
T ss_pred ccccccccccccCcCcccCCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHhcCCCCCc-
Confidence 43222 12223459999999999976 378999999999999999999999997654322 1122222211100
Q ss_pred CCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHH-HHHHHHhcccC
Q 040604 524 DGVATEEEKKIAKMMILVGFWCIQTNPSERPSMH-KVLEMLEGSIE 568 (582)
Q Consensus 524 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~-evl~~Le~~~~ 568 (582)
......+...+.+++.+||+.||++||++. ++.+.|.....
T Consensus 240 ----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 240 ----SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp ----HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred ----ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 001112446677888999999999999654 45566665444
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=349.61 Aligned_cols=256 Identities=23% Similarity=0.266 Sum_probs=198.6
Q ss_pred HHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccC------CCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeE
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNS------RCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNAL 365 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 365 (582)
..+.+.++||+|+||+||+|... +++.||+|++... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 44666789999999999999764 7899999998643 2334678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcC--------------------------------------CCcCCCHHHHHHHHHHHHHHHHHHH
Q 040604 366 IYELMPNGSLDKFIHND--------------------------------------RNIKLEWKTMYQIAIGIARGLEYLH 407 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~--------------------------------------~~~~l~~~~~~~i~~qi~~aL~yLH 407 (582)
||||+++|+|.+++... ....+++..++.|+.|++.||+|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 99999999999988521 0122467788899999999999999
Q ss_pred hCCCCceEecCCCCCCEEEcCCC--ceEEeeccccccccccccc--eeeecccCCcccccccccccccCCCCccchhHHH
Q 040604 408 RGCQVRIVHFDIKPQNILLDEDF--CPKISDFGLAKQAQKKESA--ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSY 483 (582)
Q Consensus 408 ~~~~~~ivH~Dikp~NILl~~~~--~vkl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSl 483 (582)
+. +|+||||||+|||++.++ .+||+|||+++........ .......||+.|+|||++.+....++.++|||||
T Consensus 186 ~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 186 NQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 98 999999999999998776 8999999999875432221 1223456999999999987543578899999999
Q ss_pred HHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 484 GMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 484 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
|+++|||++|+.||....... .+...+........ .....+...+.+++.+||+.||++|||+.++++
T Consensus 263 G~il~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDAD-----TISQVLNKKLCFEN-----PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHH-----HHHHHHHCCCCTTS-----GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHHHHCCCCCCCCChHH-----HHHHHHhcccccCC-----cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 999999999999997654322 11222222111111 111223456778888999999999999999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=354.16 Aligned_cols=250 Identities=22% Similarity=0.321 Sum_probs=201.1
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
.+.+.++||+|+||+||+|... +|+.||+|++..... ....+.+|+.++++++||||+++++++.+....++||||++
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 131 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence 3556789999999999999765 789999999976432 34568899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC--CCceEEeeccccccccccccc
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE--DFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~--~~~vkl~DFGla~~~~~~~~~ 449 (582)
+|+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++........
T Consensus 132 gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 207 (387)
T 1kob_A 132 GGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 207 (387)
T ss_dssp CCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred CCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCcce
Confidence 99999998754 34689999999999999999999998 9999999999999974 578999999999887654332
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
. ...||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... . + ..+..... .+.. .
T Consensus 208 ~---~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-~----~-~~i~~~~~-~~~~---~ 272 (387)
T 1kob_A 208 K---VTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-T----L-QNVKRCDW-EFDE---D 272 (387)
T ss_dssp E---EECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-H----H-HHHHHCCC-CCCS---S
T ss_pred e---eeccCCCccCchhccC--CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH-H----H-HHHHhCCC-CCCc---c
Confidence 2 2369999999999976 368999999999999999999999997653321 1 1 11111110 0110 0
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
....+...+.+++.+||+.||++|||++|+++.
T Consensus 273 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 273 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 011234567788899999999999999999874
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=344.02 Aligned_cols=253 Identities=22% Similarity=0.353 Sum_probs=199.9
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CC-------cEEEEEEeccCC-CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeee
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DG-------QLVAVKVLKNSR-CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNA 364 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 364 (582)
.+.+.++||+|+||+||+|... ++ ..||+|++.... ...+.+.+|+.++++++||||+++++++.+....+
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (289)
T 4fvq_A 9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENI 88 (289)
T ss_dssp GEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCE
T ss_pred HeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCE
Confidence 4456789999999999999654 33 579999996543 34577999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc--------eEEee
Q 040604 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFC--------PKISD 436 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~--------vkl~D 436 (582)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|
T Consensus 89 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 89 LVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp EEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred EEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeecc
Confidence 9999999999999998643 3489999999999999999999998 9999999999999998887 99999
Q ss_pred ccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhc
Q 040604 437 FGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIE 516 (582)
Q Consensus 437 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~ 516 (582)
||++....... ...||+.|+|||++.+. ..++.++||||||+++|||++|+.|+......... .....
T Consensus 165 fg~~~~~~~~~------~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-----~~~~~ 232 (289)
T 4fvq_A 165 PGISITVLPKD------ILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-----LQFYE 232 (289)
T ss_dssp CCSCTTTSCHH------HHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-----HHHHH
T ss_pred CcccccccCcc------ccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH-----HHHhh
Confidence 99997654332 23489999999998753 46899999999999999999976655443322211 11111
Q ss_pred CCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCC
Q 040604 517 PGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQ 571 (582)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~ 571 (582)
... .+.... ...+.+++.+||+.||++|||++++++.|+..+..-.
T Consensus 233 ~~~--~~~~~~-------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 233 DRH--QLPAPK-------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp TTC--CCCCCS-------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred ccC--CCCCCC-------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 111 111111 2346678888999999999999999999999777443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=338.82 Aligned_cols=259 Identities=25% Similarity=0.426 Sum_probs=201.1
Q ss_pred HHhhhhcCccCceEEEEEEeCC----CcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEe-CCeeeEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELPD----GQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYE-NKKNALIY 367 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~ 367 (582)
+.+.++||+|+||+||+|...+ +..+|+|.++.... ..+.+.+|+.++++++||||+++++++.+ +...++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 3456899999999999997542 33689999876443 23568899999999999999999999754 45779999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 107 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 182 (298)
T 3f66_A 107 PYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182 (298)
T ss_dssp ECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred eCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccccc
Confidence 999999999999753 34689999999999999999999998 99999999999999999999999999998765433
Q ss_pred c--ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCC
Q 040604 448 S--AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525 (582)
Q Consensus 448 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 525 (582)
. ........||+.|+|||.+.+ ..++.++||||||++++||++|..|+......... ...+..+.....+.
T Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ 255 (298)
T 3f66_A 183 YYSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-----TVYLLQGRRLLQPE 255 (298)
T ss_dssp GCBC-----CCBCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH-----HHHHHTTCCCCCCT
T ss_pred hhccccccCCCCCccccChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH-----HHHHhcCCCCCCCc
Confidence 2 112233458899999999876 47899999999999999999965544333322221 11222222222222
Q ss_pred cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCC
Q 040604 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQ 571 (582)
Q Consensus 526 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~ 571 (582)
.. ...+.+++.+||+.||++|||++++++.|++.+..+.
T Consensus 256 ~~-------~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 256 YC-------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp TC-------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred cC-------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 22 2457778889999999999999999999999887665
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=346.23 Aligned_cols=245 Identities=21% Similarity=0.298 Sum_probs=194.7
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC----HHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeeeEEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN----GEEFINEVASISRT-SHVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 368 (582)
+.+.+.||+|+||.||++... +++.||||++++.... .+.+.+|+.++.++ +||||+++++++.+....++|||
T Consensus 11 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e 90 (345)
T 3a8x_A 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 90 (345)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEe
Confidence 445688999999999999765 6899999999765432 24578899999887 89999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
|+++|+|.+++...+ .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 91 ~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~ 165 (345)
T 3a8x_A 91 YVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165 (345)
T ss_dssp CCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence 999999999997643 689999999999999999999998 999999999999999999999999999986433222
Q ss_pred ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccc---hhhHHHHHhhcCCCCCCCCC
Q 040604 449 AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTS---ICHNLIYERIEPGNDFQFDG 525 (582)
Q Consensus 449 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~---~~~~~~~~~i~~~~~~~~~~ 525 (582)
. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||........ .....+.+.+.... ..++.
T Consensus 166 ~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~-~~~p~ 240 (345)
T 3a8x_A 166 T--TSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-IRIPR 240 (345)
T ss_dssp C--BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-CCCCT
T ss_pred c--ccccCCCccccCccccCCC--CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-CCCCC
Confidence 1 2245699999999999763 689999999999999999999999965322111 11122222222221 12222
Q ss_pred cCcHHHHHHHHHHHHHHHhccccCCCCCCCH
Q 040604 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSM 556 (582)
Q Consensus 526 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~ 556 (582)
. +...+.+++.+||+.||++||++
T Consensus 241 ~-------~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 241 S-------LSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp T-------SCHHHHHHHHHHTCSSTTTSTTC
T ss_pred C-------CCHHHHHHHHHHhcCCHhHCCCC
Confidence 2 23456778888999999999996
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=352.52 Aligned_cols=257 Identities=26% Similarity=0.429 Sum_probs=193.3
Q ss_pred HhhhhcCccCceEEEEEEeC--CC--cEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEe-CCeeeEEEE
Q 040604 296 SFRDKLGQGGYGEVYKGELP--DG--QLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYE-NKKNALIYE 368 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~E 368 (582)
.+.+.||+|+||+||+|.+. ++ ..||||.++..... .+.+.+|+.++++++||||+++++++.+ +...++|||
T Consensus 92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e 171 (373)
T 3c1x_A 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 171 (373)
T ss_dssp EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEE
T ss_pred ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEE
Confidence 45678999999999999653 32 46899998754432 4678999999999999999999999765 457799999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
|+++|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 172 YMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp CCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred CCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 999999999997543 4688999999999999999999998 999999999999999999999999999987644322
Q ss_pred c--eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCC
Q 040604 449 A--ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525 (582)
Q Consensus 449 ~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 525 (582)
. .......||+.|+|||++.+ ..++.++||||||+++|||++ |..|+....... . ...+..+.....+.
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~-~-----~~~~~~~~~~~~p~ 319 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-I-----TVYLLQGRRLLQPE 319 (373)
T ss_dssp ----------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC-H-----HHHHHTTCCCCCCT
T ss_pred ccccccCCCCCcccccChHHhcC--CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH-H-----HHHHHcCCCCCCCC
Confidence 1 11223458889999999876 478999999999999999999 555665443322 1 12222222222222
Q ss_pred cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCC
Q 040604 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQ 571 (582)
Q Consensus 526 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~ 571 (582)
. +...+.+++.+||+.||++|||+++|++.|+..+..+.
T Consensus 320 ~-------~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 320 Y-------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp T-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred C-------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 2 23457778889999999999999999999999887665
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=338.22 Aligned_cols=249 Identities=25% Similarity=0.365 Sum_probs=195.8
Q ss_pred HHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC--CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR--CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
..+.+.++||+|+||+||++... +++.+|+|++.... ...+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 45667789999999999999764 78999999986543 3457899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcC--CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE---cCCCceEEeecccccccc
Q 040604 370 MPNGSLDKFIHND--RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL---DEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 370 ~~~gsL~~~i~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl---~~~~~vkl~DFGla~~~~ 444 (582)
+++|+|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999988643 235699999999999999999999998 99999999999999 456889999999998765
Q ss_pred ccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCC
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFD 524 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 524 (582)
..... ....||+.|+|||++.+ .++.++||||||++++||++|+.||....... ..............
T Consensus 179 ~~~~~---~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~-----~~~~~~~~~~~~~~- 246 (285)
T 3is5_A 179 SDEHS---TNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE-----VQQKATYKEPNYAV- 246 (285)
T ss_dssp -----------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHCCCCCCC-
T ss_pred CcccC---cCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCHHH-----HHhhhccCCccccc-
Confidence 44322 23459999999999864 67899999999999999999999997653222 11111111111111
Q ss_pred CcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 525 GVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 525 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
....+...+.+++.+||+.||++|||++||++
T Consensus 247 -----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 -----ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -----ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01112345677888999999999999999985
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=350.48 Aligned_cols=256 Identities=24% Similarity=0.302 Sum_probs=201.4
Q ss_pred HHHHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCCHHHHHHHHHHHhccC-----CCceEEEEeEEEeCCeeeEE
Q 040604 293 MTKSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNGEEFINEVASISRTS-----HVNIVTFLGFCYENKKNALI 366 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv 366 (582)
..+.+.++||+|+||+||+|.. .+++.||||+++......+.+..|+.+++++. ||||+++++++......++|
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv 114 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLI 114 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEE
T ss_pred CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEE
Confidence 3456678999999999999976 47899999999865545567888999999986 99999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC------------------
Q 040604 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE------------------ 428 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~------------------ 428 (582)
|||+ +++|.+++.......+++..++.++.||+.||+|||+. +|+||||||+|||++.
T Consensus 115 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~ 190 (360)
T 3llt_A 115 FEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190 (360)
T ss_dssp ECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCE
T ss_pred EcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhccccccc
Confidence 9999 99999999877666799999999999999999999998 9999999999999975
Q ss_pred -------CCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCC
Q 040604 429 -------DFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEV 501 (582)
Q Consensus 429 -------~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~ 501 (582)
++.+||+|||+++....... ...||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 191 ~~~~~~~~~~~kl~DFG~a~~~~~~~~-----~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 191 IQIYRTKSTGIKLIDFGCATFKSDYHG-----SIINTRQYRAPEVILN--LGWDVSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp EEEEEESCCCEEECCCTTCEETTSCCC-----SCCSCGGGCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccCCCCEEEEeccCceecCCCCc-----CccCcccccCcHHHcC--CCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence 78999999999987544322 3469999999999986 378999999999999999999999997643
Q ss_pred cccchhhHHHHHhhcCCC---------------------CCCCCCcCc-------------HHHHHHHHHHHHHHHhccc
Q 040604 502 TDTSICHNLIYERIEPGN---------------------DFQFDGVAT-------------EEEKKIAKMMILVGFWCIQ 547 (582)
Q Consensus 502 ~~~~~~~~~~~~~i~~~~---------------------~~~~~~~~~-------------~~~~~~~~~l~~l~~~Cl~ 547 (582)
.... . ..+...+.... ...++.... .........+.+++.+||+
T Consensus 264 ~~~~-~-~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 341 (360)
T 3llt_A 264 HMEH-L-AMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ 341 (360)
T ss_dssp HHHH-H-HHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred HHHH-H-HHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence 3221 1 11111111000 000000000 0000111567789999999
Q ss_pred cCCCCCCCHHHHHH
Q 040604 548 TNPSERPSMHKVLE 561 (582)
Q Consensus 548 ~dp~~RPt~~evl~ 561 (582)
.||++|||++|+++
T Consensus 342 ~dP~~Rpta~elL~ 355 (360)
T 3llt_A 342 IDPTLRPSPAELLK 355 (360)
T ss_dssp SSGGGSCCHHHHTT
T ss_pred CChhhCCCHHHHhc
Confidence 99999999999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=337.55 Aligned_cols=254 Identities=25% Similarity=0.374 Sum_probs=205.7
Q ss_pred hcCccCceEEEEEEeC---CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCC
Q 040604 300 KLGQGGYGEVYKGELP---DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGS 374 (582)
Q Consensus 300 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 374 (582)
.||+|+||.||+|.+. +++.||||+++.... ..+.+.+|+.++++++||||+++++++ +.+..++||||+++++
T Consensus 17 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~ 95 (287)
T 1u59_A 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP 95 (287)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEE
T ss_pred cccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCC
Confidence 8999999999999753 678899999986533 346788999999999999999999999 5667899999999999
Q ss_pred hhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce-eee
Q 040604 375 LDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI-SML 453 (582)
Q Consensus 375 L~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~-~~~ 453 (582)
|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......... ...
T Consensus 96 L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 171 (287)
T 1u59_A 96 LHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 171 (287)
T ss_dssp HHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCC
T ss_pred HHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccc
Confidence 99999753 34689999999999999999999998 99999999999999999999999999998775443321 122
Q ss_pred cccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 454 HARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 454 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
...||+.|+|||++.+ ..++.++||||||+++|||++ |+.||....... +...+..+....++..
T Consensus 172 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~i~~~~~~~~~~~------ 237 (287)
T 1u59_A 172 AGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIEQGKRMECPPE------ 237 (287)
T ss_dssp SSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH------HHHHHHTTCCCCCCTT------
T ss_pred cccccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH------HHHHHhcCCcCCCCCC------
Confidence 3457899999999875 368899999999999999998 999987654322 2233333332222222
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCCCC
Q 040604 533 KIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQIP 573 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~~p 573 (582)
+...+.+++.+||+.||++||++++|++.|++.+.+...+
T Consensus 238 -~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 238 -CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp -CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred -cCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 2356777888999999999999999999999877655443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=347.83 Aligned_cols=258 Identities=26% Similarity=0.420 Sum_probs=205.8
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CC-----cEEEEEEeccCCC--CHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeee
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DG-----QLVAVKVLKNSRC--NGEEFINEVASISRT-SHVNIVTFLGFCYENKKNA 364 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~-----~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 364 (582)
.+.+.+.||+|+||+||+|... ++ ..||+|+++.... ..+.+.+|+.+++++ +||||+++++++.+....+
T Consensus 47 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 126 (333)
T 2i1m_A 47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVL 126 (333)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceE
Confidence 3456689999999999999764 23 4899999976543 235688999999999 8999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCC------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCce
Q 040604 365 LIYELMPNGSLDKFIHNDR------------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCP 432 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~v 432 (582)
+||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 127 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~ 203 (333)
T 2i1m_A 127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVA 203 (333)
T ss_dssp EEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGEE
T ss_pred EEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCeE
Confidence 9999999999999987532 23579999999999999999999998 99999999999999999999
Q ss_pred EEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHH
Q 040604 433 KISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLI 511 (582)
Q Consensus 433 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~ 511 (582)
||+|||+++...............||+.|+|||++.+ ..++.++||||||+++|||++ |..|+........ ....+
T Consensus 204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~~~~~ 280 (333)
T 2i1m_A 204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-FYKLV 280 (333)
T ss_dssp EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-HHHHH
T ss_pred EECccccccccccccceeecCCCCCCccccCHHHhcc--CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-HHHHH
Confidence 9999999987655443333334558889999999876 478999999999999999998 8888876543321 12222
Q ss_pred HHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 512 YERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 512 ~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
.. +......... ...+.+++.+||+.||++|||+++|++.|+....
T Consensus 281 ~~----~~~~~~~~~~-------~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 281 KD----GYQMAQPAFA-------PKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp HH----TCCCCCCTTC-------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hc----CCCCCCCCCC-------CHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 21 1111111212 3456778889999999999999999999987543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=352.69 Aligned_cols=246 Identities=22% Similarity=0.285 Sum_probs=187.7
Q ss_pred hhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHh-ccCCCceEEEEeEEEe----CCeeeEEEEecCC
Q 040604 299 DKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASIS-RTSHVNIVTFLGFCYE----NKKNALIYELMPN 372 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~----~~~~~lv~E~~~~ 372 (582)
+.||+|+||+||++... +|+.||||+++. ...+.+|+.++. ..+||||+++++++.. ....++||||++|
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~g 143 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 143 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCC
Confidence 57999999999999765 789999999964 346778888874 4589999999999875 5678999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---CCceEEeeccccccccccccc
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE---DFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~---~~~vkl~DFGla~~~~~~~~~ 449 (582)
|+|.+++.......+++..++.|+.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 144 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~- 219 (400)
T 1nxk_A 144 GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS- 219 (400)
T ss_dssp EEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----
T ss_pred CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCCCc-
Confidence 9999999876656799999999999999999999998 9999999999999997 78999999999987654332
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .. +...+..+.. .+.. .
T Consensus 220 --~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~-~~~~i~~~~~-~~~~---~ 289 (400)
T 1nxk_A 220 --LTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-PG-MKTRIRMGQY-EFPN---P 289 (400)
T ss_dssp ---------CTTCCGGGSCC--CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC-CS-HHHHHHHTCC-CCCT---T
T ss_pred --cccCCCCCCccCHhhcCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc-HH-HHHHHHcCcc-cCCC---c
Confidence 224569999999999876 47899999999999999999999999765432210 00 1111111111 1110 0
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
....+...+.+|+.+||+.||++|||++|+++.
T Consensus 290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111234567788899999999999999999874
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=348.12 Aligned_cols=245 Identities=23% Similarity=0.309 Sum_probs=198.5
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccC----CCCHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeeeEEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNS----RCNGEEFINEVASISRT-SHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 367 (582)
.+++.+.||+|+||+||+|... +|+.||||++++. ....+.+.+|..++..+ +||||+++++++.+....++||
T Consensus 21 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 100 (353)
T 2i0e_A 21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 100 (353)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEE
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEE
Confidence 3456689999999999999775 5889999999753 34557788999999987 8999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
||++||+|.+++...+ .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 101 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 101 EYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence 9999999999997643 589999999999999999999998 99999999999999999999999999998643322
Q ss_pred cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcC
Q 040604 448 SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 527 (582)
.. .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... +.+.+.... ..++..
T Consensus 176 ~~--~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~~~-~~~p~~- 243 (353)
T 2i0e_A 176 VT--TKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------LFQSIMEHN-VAYPKS- 243 (353)
T ss_dssp CC--BCCCCSCGGGCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC-CCCCTT-
T ss_pred cc--cccccCCccccChhhhcC--CCcCCcccccchHHHHHHHHcCCCCCCCCCHHH------HHHHHHhCC-CCCCCC-
Confidence 21 224569999999999976 368999999999999999999999997643321 122222211 122222
Q ss_pred cHHHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 040604 528 TEEEKKIAKMMILVGFWCIQTNPSERPS-----MHKVLE 561 (582)
Q Consensus 528 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~evl~ 561 (582)
+...+.+++.+||+.||++||+ +++|++
T Consensus 244 ------~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 244 ------MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ------SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ------CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 2345677888899999999995 466664
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=344.31 Aligned_cols=258 Identities=25% Similarity=0.422 Sum_probs=206.2
Q ss_pred HHHHhhhhcCccCceEEEEEEeC------CCcEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeCCeee
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELP------DGQLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYENKKNA 364 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 364 (582)
..+.+.+.||+|+||.||+|... +++.||||++...... ...+.+|+.++++++||||+++++++.+....+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 104 (322)
T 1p4o_A 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 104 (322)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence 34556789999999999999653 4788999999755432 346889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCC--------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEee
Q 040604 365 LIYELMPNGSLDKFIHNDR--------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISD 436 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~--------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~D 436 (582)
+||||+++|+|.+++...+ ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~D 181 (322)
T 1p4o_A 105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 181 (322)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECc
Confidence 9999999999999987532 13578999999999999999999998 999999999999999999999999
Q ss_pred ccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhh
Q 040604 437 FGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERI 515 (582)
Q Consensus 437 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i 515 (582)
||+++...............||+.|+|||++.+ ..++.++||||||+++|||++ |+.|+....... +...+
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~~~ 253 (322)
T 1p4o_A 182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ------VLRFV 253 (322)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH------HHHHH
T ss_pred CccccccccccccccccCCCCCCCccChhhhcc--CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH------HHHHH
Confidence 999987654433222223457899999999876 468999999999999999999 778886543221 22222
Q ss_pred cCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 516 EPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
..+....... .+...+.+++.+||+.||++|||+.++++.|++.+.
T Consensus 254 ~~~~~~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 254 MEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HTTCCCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HcCCcCCCCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 2222211222 223456778889999999999999999999998655
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=353.66 Aligned_cols=267 Identities=16% Similarity=0.213 Sum_probs=207.1
Q ss_pred HHHhhhhcCccCceEEEEEEeCC---------CcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEE------------
Q 040604 294 TKSFRDKLGQGGYGEVYKGELPD---------GQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVT------------ 352 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 352 (582)
.+.+.+.||+|+||+||+|.... ++.||||++... +.+.+|+.++++++||||++
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 118 (352)
T 2jii_A 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA 118 (352)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence 45567899999999999997653 789999999754 46889999999999999887
Q ss_pred ---EEeEEEe-CCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC
Q 040604 353 ---FLGFCYE-NKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE 428 (582)
Q Consensus 353 ---l~~~~~~-~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~ 428 (582)
+++++.. +...++||||+ +++|.+++.......+++..++.|+.||+.||+|||+. +|+||||||+|||++.
T Consensus 119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDP 194 (352)
T ss_dssp CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEET
T ss_pred ccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcC
Confidence 6777776 67889999999 99999999876556799999999999999999999998 9999999999999999
Q ss_pred CC--ceEEeeccccccccccccce-----eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCC
Q 040604 429 DF--CPKISDFGLAKQAQKKESAI-----SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEV 501 (582)
Q Consensus 429 ~~--~vkl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~ 501 (582)
++ .+||+|||+++......... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG--CGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 98 99999999998765433211 1123469999999999876 378999999999999999999999997654
Q ss_pred cccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCCCC
Q 040604 502 TDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQIP 573 (582)
Q Consensus 502 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~~p 573 (582)
..................... .... ....+...+.+++.+||+.||++|||+++|++.|++.++.....
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 273 PNTEDIMKQKQKFVDKPGPFV-GPCG--HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp TCHHHHHHHHHHHHHSCCCEE-CTTS--CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred cCHHHHHHHHHhccCChhhhh-hhcc--ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 332222222221111111110 0000 00112355777888899999999999999999999988766543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=336.35 Aligned_cols=255 Identities=24% Similarity=0.423 Sum_probs=203.6
Q ss_pred HHHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEe-----------
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYE----------- 359 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----------- 359 (582)
...+.+.+.||+|+||.||+|... +++.||+|+++... +.+.+|+.++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 344566789999999999999875 79999999997643 467789999999999999999998864
Q ss_pred -----CCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEE
Q 040604 360 -----NKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKI 434 (582)
Q Consensus 360 -----~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl 434 (582)
....++||||+++++|.+++.......+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEE
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEEE
Confidence 34578999999999999999876556799999999999999999999998 9999999999999999999999
Q ss_pred eeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHh
Q 040604 435 SDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYER 514 (582)
Q Consensus 435 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 514 (582)
+|||++......... ....||+.|+|||++.+ ..++.++||||||+++|||++|..|+.... . ....
T Consensus 164 ~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~-------~-~~~~ 230 (284)
T 2a19_B 164 GDFGLVTSLKNDGKR---TRSKGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCDTAFETS-------K-FFTD 230 (284)
T ss_dssp CCCTTCEESSCCSCC---CCCCSCCTTSCHHHHHC--SCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-------H-HHHH
T ss_pred Ccchhheeccccccc---cccCCcccccChhhhcc--CCCcchhhhHHHHHHHHHHHhcCCcchhHH-------H-HHHH
Confidence 999999876654322 23459999999999876 468999999999999999999998764211 1 1122
Q ss_pred hcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCCCCCC
Q 040604 515 IEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQIPPK 575 (582)
Q Consensus 515 i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~~p~~ 575 (582)
+.... +.... ...+.+++.+||+.||++|||+.|+++.|+...++.+...+
T Consensus 231 ~~~~~---~~~~~-------~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~~ 281 (284)
T 2a19_B 231 LRDGI---ISDIF-------DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNER 281 (284)
T ss_dssp HHTTC---CCTTS-------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-------
T ss_pred hhccc---ccccC-------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcccc
Confidence 22211 11222 23466778889999999999999999999987776665443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=336.87 Aligned_cols=257 Identities=25% Similarity=0.391 Sum_probs=203.9
Q ss_pred hhhhcCccCceEEEEEEeC-C---CcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCee-eEEEEe
Q 040604 297 FRDKLGQGGYGEVYKGELP-D---GQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKN-ALIYEL 369 (582)
Q Consensus 297 ~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv~E~ 369 (582)
..++||+|+||+||+|.+. + +..+|+|+++.... ..+.+.+|+.++++++||||+++++++.+.+.. ++||||
T Consensus 25 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 104 (298)
T 3pls_A 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY 104 (298)
T ss_dssp EEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECC
T ss_pred cCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEec
Confidence 3478999999999999643 2 33799999976443 236788999999999999999999999876655 899999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc-
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES- 448 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~- 448 (582)
+.+|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 105 ~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 180 (298)
T 3pls_A 105 MCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180 (298)
T ss_dssp CTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred ccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence 9999999999763 34689999999999999999999998 999999999999999999999999999986644321
Q ss_pred -ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcC
Q 040604 449 -AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527 (582)
Q Consensus 449 -~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 527 (582)
........||+.|+|||.+.+ ..++.++||||||+++|||++|+.|+........ +...+...........
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~- 252 (298)
T 3pls_A 181 SVQQHRHARLPVKWTALESLQT--YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-----LTHFLAQGRRLPQPEY- 252 (298)
T ss_dssp CSCCSSCTTCGGGGSCHHHHTT--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-----HHHHHHTTCCCCCCTT-
T ss_pred ccccCcCCCCCccccChhhhcc--CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-----HHHHhhcCCCCCCCcc-
Confidence 112223468999999999976 4789999999999999999997776654433322 1222222222222222
Q ss_pred cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCC
Q 040604 528 TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQ 571 (582)
Q Consensus 528 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~ 571 (582)
....+.+++.+||+.||++|||++++++.|++.+..+.
T Consensus 253 ------~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 253 ------CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp ------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred ------chHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 23457778889999999999999999999999877664
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=348.22 Aligned_cols=241 Identities=25% Similarity=0.315 Sum_probs=198.0
Q ss_pred HHHHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCC---------CHHHHHHHHHHHhccCCCceEEEEeEEEeCCe
Q 040604 293 MTKSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRC---------NGEEFINEVASISRTSHVNIVTFLGFCYENKK 362 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 362 (582)
..|.+.++||+|+||+||+|.. .+++.||||+++.... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 3455668899999999999975 4799999999976542 22357789999999999999999999999999
Q ss_pred eeEEEEecCCC-ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccc
Q 040604 363 NALIYELMPNG-SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAK 441 (582)
Q Consensus 363 ~~lv~E~~~~g-sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~ 441 (582)
.++||||+.+| +|.+++.... .+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 99999999776 9999997654 689999999999999999999998 99999999999999999999999999998
Q ss_pred cccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCC
Q 040604 442 QAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDF 521 (582)
Q Consensus 442 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~ 521 (582)
......... ...||+.|+|||++.+. ...+.++||||||+++|||++|+.||...... .... .
T Consensus 179 ~~~~~~~~~---~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------~~~~--~ 241 (335)
T 3dls_A 179 YLERGKLFY---TFCGTIEYCAPEVLMGN-PYRGPELEMWSLGVTLYTLVFEENPFCELEET-----------VEAA--I 241 (335)
T ss_dssp ECCTTCCBC---EECSCGGGCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------TTTC--C
T ss_pred ECCCCCcee---ccCCCccccChhhhcCC-CCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------Hhhc--c
Confidence 776544322 34599999999998764 23488999999999999999999999653211 1110 0
Q ss_pred CCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 522 QFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 522 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
..+.. +...+.+++.+||+.||++|||++++++.
T Consensus 242 ~~~~~-------~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 242 HPPYL-------VSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp CCSSC-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred CCCcc-------cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111 23456778888999999999999999975
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=341.28 Aligned_cols=260 Identities=26% Similarity=0.425 Sum_probs=194.9
Q ss_pred HHHhhhhcCccCceEEEEEEeC----CCcEEEEEEeccCCCCH---HHHHHHHHHHhccCCCceEEEEeEEEeCC-----
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP----DGQLVAVKVLKNSRCNG---EEFINEVASISRTSHVNIVTFLGFCYENK----- 361 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 361 (582)
.+.+.+.||+|+||.||+|... +++.||||+++...... +.+.+|+.++++++||||+++++++.+..
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 114 (313)
T 3brb_A 35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIP 114 (313)
T ss_dssp GEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------
T ss_pred HeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCc
Confidence 3456688999999999999653 35589999997654433 56889999999999999999999998755
Q ss_pred eeeEEEEecCCCChhhhhhcC----CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeec
Q 040604 362 KNALIYELMPNGSLDKFIHND----RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDF 437 (582)
Q Consensus 362 ~~~lv~E~~~~gsL~~~i~~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DF 437 (582)
..++||||+++|+|.+++... ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 115 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 115 KPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSC
T ss_pred ccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeec
Confidence 348999999999999998532 335699999999999999999999998 9999999999999999999999999
Q ss_pred cccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhc
Q 040604 438 GLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIE 516 (582)
Q Consensus 438 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~ 516 (582)
|+++...............+++.|+|||.+.+ ..++.++||||||+++|||++ |..|+....... +...+.
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~~~~ 263 (313)
T 3brb_A 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE------MYDYLL 263 (313)
T ss_dssp SCC----------------CCGGGSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG------HHHHHH
T ss_pred CcceecccccccCcccccCCCccccCchhhcC--CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HHHHHH
Confidence 99987655433222233458889999999876 478999999999999999999 777886543322 122222
Q ss_pred CCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCC
Q 040604 517 PGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQ 571 (582)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~ 571 (582)
.+........ +...+.+++.+||+.||++|||+++|++.|+..++.++
T Consensus 264 ~~~~~~~~~~-------~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 264 HGHRLKQPED-------CLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp TTCCCCCBTT-------CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred cCCCCCCCcc-------ccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 2222222222 23457788889999999999999999999999877653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=343.44 Aligned_cols=245 Identities=24% Similarity=0.311 Sum_probs=189.6
Q ss_pred HHHhhhhcCccCceEEEEEEe----CCCcEEEEEEeccCC-----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeee
Q 040604 294 TKSFRDKLGQGGYGEVYKGEL----PDGQLVAVKVLKNSR-----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNA 364 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 364 (582)
.+.+.+.||+|+||.||++.. .+|+.||+|+++... .....+.+|+.++++++||||+++++++.+....+
T Consensus 18 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 97 (327)
T 3a62_A 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLY 97 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEE
T ss_pred HeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEE
Confidence 345678999999999999976 478999999997643 22355788999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccc
Q 040604 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~ 444 (582)
+||||+++++|.+++...+ .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 98 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 98 LILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp EEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred EEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 9999999999999997543 588999999999999999999998 99999999999999999999999999998654
Q ss_pred ccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCC
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFD 524 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 524 (582)
..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... . +...+... ..++
T Consensus 173 ~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~----~~~i~~~~--~~~p 241 (327)
T 3a62_A 173 HDGTV--THTFCGTIEYMAPEILMR--SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK-T----IDKILKCK--LNLP 241 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-H----HHHHHHTC--CCCC
T ss_pred cCCcc--ccccCCCcCccCHhhCcC--CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH-H----HHHHHhCC--CCCC
Confidence 33221 223469999999999876 368999999999999999999999997653322 1 11111111 1122
Q ss_pred CcCcHHHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 040604 525 GVATEEEKKIAKMMILVGFWCIQTNPSERP-----SMHKVLE 561 (582)
Q Consensus 525 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~ 561 (582)
.. +...+.+++.+||+.||++|| +++++++
T Consensus 242 ~~-------~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 242 PY-------LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp TT-------SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CC-------CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 22 234567788889999999999 7778775
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=346.47 Aligned_cols=271 Identities=25% Similarity=0.358 Sum_probs=198.9
Q ss_pred HHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHH--HHhccCCCceEEEEeEEEe-----CCeeeEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVA--SISRTSHVNIVTFLGFCYE-----NKKNALIY 367 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~--~l~~l~h~niv~l~~~~~~-----~~~~~lv~ 367 (582)
+.+.++||+|+||+||+|.. +++.||||+++... ...+..|.. .+..++|+||+++++.+.. ....++||
T Consensus 15 y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 91 (336)
T 3g2f_A 15 LKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM 91 (336)
T ss_dssp EEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred hheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEE
Confidence 34568999999999999977 78999999997543 334444444 4556899999999986643 22568999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCC------CCceEecCCCCCCEEEcCCCceEEeeccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGC------QVRIVHFDIKPQNILLDEDFCPKISDFGLAK 441 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------~~~ivH~Dikp~NILl~~~~~vkl~DFGla~ 441 (582)
||+++|+|.+++.... .++..++.++.||+.||+|||+.. ..+|+||||||+|||++.++.+||+|||+++
T Consensus 92 e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~ 168 (336)
T 3g2f_A 92 EYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168 (336)
T ss_dssp CCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCE
T ss_pred ecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecccee
Confidence 9999999999997643 588999999999999999999752 2289999999999999999999999999998
Q ss_pred ccccccc------ceeeecccCCccccccccccccc-----CCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchh---
Q 040604 442 QAQKKES------AISMLHARGTIGYIAPEVYSRRF-----GGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSIC--- 507 (582)
Q Consensus 442 ~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~-----~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~--- 507 (582)
....... ........||+.|+|||++.+.. ..++.++||||||+++|||++|+.|+..........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~ 248 (336)
T 3g2f_A 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248 (336)
T ss_dssp ECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTT
T ss_pred ecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhh
Confidence 7654321 11122346999999999986521 245678999999999999999988765443322110
Q ss_pred ----------hHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCCC
Q 040604 508 ----------HNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQI 572 (582)
Q Consensus 508 ----------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~~ 572 (582)
...............++.... ........+.+++.+||+.||++|||++||++.|++.+...+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~ 322 (336)
T 3g2f_A 249 QTEVGNHPTFEDMQVLVSREKQRPKFPEAWK-ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER 322 (336)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCCCCCCCTTCC-CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC
T ss_pred hcccCCCchHHHHHhhhcccccCCCCCcccc-cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHh
Confidence 011001111111122221111 1223456788999999999999999999999999998877653
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=373.87 Aligned_cols=249 Identities=27% Similarity=0.412 Sum_probs=199.3
Q ss_pred hhcCccCceEEEEEEeC---CCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 299 DKLGQGGYGEVYKGELP---DGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
++||+|+||+||+|.+. +++.||||+++.... ..+++.+|+.+|++++|||||++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 37999999999999542 568899999976433 2478999999999999999999999986 4568899999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc-ee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA-IS 451 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~-~~ 451 (582)
|+|.+++.... .+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........ ..
T Consensus 454 g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 99999997543 689999999999999999999998 9999999999999999999999999999876544321 12
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHH
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 530 (582)
.....||+.|+|||++.. ..++.++|||||||++|||++ |+.||....... +.+.+..+.....+..
T Consensus 529 ~~~~~~t~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~------~~~~i~~~~~~~~p~~---- 596 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VTAMLEKGERMGCPAG---- 596 (635)
T ss_dssp ------CGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCCCCCCTT----
T ss_pred ccCCCCceeeeChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCCCCCCC----
Confidence 223457889999999976 478999999999999999998 999997654322 3334444433333222
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 531 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
+...+.+|+.+||+.||++||++++|++.|+....
T Consensus 597 ---~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 597 ---CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp ---CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 23567778889999999999999999999987554
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=359.24 Aligned_cols=254 Identities=20% Similarity=0.239 Sum_probs=199.0
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccC----CCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNS----RCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+++.++||+|+||+||+|... +++.||||++++. ....+.+.+|+.++.+++||||+++++++.+....+|||||
T Consensus 76 y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey 155 (437)
T 4aw2_A 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDY 155 (437)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEec
Confidence 345578999999999999876 5889999999652 22334588999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
++||+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 156 ~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 231 (437)
T 4aw2_A 156 YVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231 (437)
T ss_dssp CTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred CCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc
Confidence 9999999999763 24699999999999999999999998 9999999999999999999999999999876554332
Q ss_pred eeeecccCCcccccccccccc---cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCc
Q 040604 450 ISMLHARGTIGYIAPEVYSRR---FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 526 (582)
......||+.|+|||++... .+.++.++|||||||++|||++|+.||........ ....+.... ...++..
T Consensus 232 -~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-~~~i~~~~~----~~~~p~~ 305 (437)
T 4aw2_A 232 -QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YGKIMNHKE----RFQFPTQ 305 (437)
T ss_dssp -ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTHHH----HCCCCSS
T ss_pred -ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH-HHhhhhccc----cccCCcc
Confidence 22235799999999998621 24689999999999999999999999986543221 111111110 0111111
Q ss_pred CcHHHHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 040604 527 ATEEEKKIAKMMILVGFWCIQTNPSE--RPSMHKVLEM 562 (582)
Q Consensus 527 ~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPt~~evl~~ 562 (582)
. ..+...+.+|+.+||+.+|++ ||+++|+++.
T Consensus 306 ~----~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 306 V----TDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp C----CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred c----ccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0 112344566777888888887 9999999863
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=368.68 Aligned_cols=252 Identities=25% Similarity=0.378 Sum_probs=201.6
Q ss_pred hcCccCceEEEEEEeC---CCcEEEEEEeccCC--CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCC
Q 040604 300 KLGQGGYGEVYKGELP---DGQLVAVKVLKNSR--CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGS 374 (582)
Q Consensus 300 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 374 (582)
+||+|+||.||+|.+. ++..||||+++... ...+++.+|+.+|++++|||||++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999653 56789999997643 356789999999999999999999999975 56899999999999
Q ss_pred hhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce-eee
Q 040604 375 LDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI-SML 453 (582)
Q Consensus 375 L~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~-~~~ 453 (582)
|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......... ...
T Consensus 422 L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 497 (613)
T 2ozo_A 422 LHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497 (613)
T ss_dssp HHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence 99999754 34689999999999999999999998 99999999999999999999999999998765433221 112
Q ss_pred cccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 454 HARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 454 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
...+|+.|+|||++.. +.++.++|||||||++|||++ |+.||....... +...+..+.....+..
T Consensus 498 ~~~~~~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~------~~~~i~~~~~~~~p~~------ 563 (613)
T 2ozo_A 498 AGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIEQGKRMECPPE------ 563 (613)
T ss_dssp ----CCTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH------HHHHHHTTCCCCCCTT------
T ss_pred CCCCccceeCHhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH------HHHHHHcCCCCCCCCc------
Confidence 2346789999999975 478999999999999999998 999997654322 3334444433333322
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCC
Q 040604 533 KIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQ 571 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~ 571 (582)
+...+.+|+.+||+.||++||++++|++.|+....++.
T Consensus 564 -~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 564 -CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp -CCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred -CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 33567778889999999999999999999998655443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=355.31 Aligned_cols=250 Identities=22% Similarity=0.319 Sum_probs=191.6
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC---------CHHHHHHHHHHHhccCCCceEEEEeEEEeCCee
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC---------NGEEFINEVASISRTSHVNIVTFLGFCYENKKN 363 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 363 (582)
.+.+.++||+|+||+||+|... +++.||||++..... ....+.+|+.+|++++||||+++++++. .+..
T Consensus 136 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~ 214 (419)
T 3i6u_A 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDY 214 (419)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEE
T ss_pred cEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCce
Confidence 4556789999999999999654 789999999865321 1234789999999999999999999975 5567
Q ss_pred eEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC---ceEEeecccc
Q 040604 364 ALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF---CPKISDFGLA 440 (582)
Q Consensus 364 ~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~---~vkl~DFGla 440 (582)
++||||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||++
T Consensus 215 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 215 YIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp EEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred EEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecccc
Confidence 99999999999999887543 689999999999999999999998 999999999999997544 5999999999
Q ss_pred ccccccccceeeecccCCccccccccccc-ccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCC
Q 040604 441 KQAQKKESAISMLHARGTIGYIAPEVYSR-RFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGN 519 (582)
Q Consensus 441 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~ 519 (582)
+........ ....||+.|+|||++.. ....++.++||||||+++|||++|+.||......... .+.+..+.
T Consensus 290 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~-----~~~i~~~~ 361 (419)
T 3i6u_A 290 KILGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-----KDQITSGK 361 (419)
T ss_dssp TSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH-----HHHHHTTC
T ss_pred eecCCCccc---cccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH-----HHHHhcCC
Confidence 886543322 23469999999999853 1246788999999999999999999999765443321 22222221
Q ss_pred CCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 520 DFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
. ...+.....+...+.+++.+||+.||++|||++|+++
T Consensus 362 ~----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 362 Y----NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp C----CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred C----CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1 1112222345567888999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=333.26 Aligned_cols=249 Identities=25% Similarity=0.354 Sum_probs=200.4
Q ss_pred HHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC-------CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeee
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC-------NGEEFINEVASISRTSHVNIVTFLGFCYENKKNA 364 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 364 (582)
..+.+.++||+|+||.||++... +|+.||+|+++.... ..+.+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 34567789999999999999775 799999999875432 3577999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC----ceEEeecccc
Q 040604 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF----CPKISDFGLA 440 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~----~vkl~DFGla 440 (582)
+||||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||++
T Consensus 85 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 9999999999999997543 689999999999999999999998 999999999999998877 8999999999
Q ss_pred ccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCC
Q 040604 441 KQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND 520 (582)
Q Consensus 441 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~ 520 (582)
......... ....||+.|+|||++.. ..++.++||||||+++++|++|+.||....... ....+.....
T Consensus 160 ~~~~~~~~~---~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~ 228 (283)
T 3bhy_A 160 HKIEAGNEF---KNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGETKQE------TLTNISAVNY 228 (283)
T ss_dssp EECC-----------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTTCC
T ss_pred eeccCCCcc---cccCCCcCccCcceecC--CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH------HHHHhHhccc
Confidence 876543322 23459999999999876 468999999999999999999999997653321 1112211110
Q ss_pred CCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 521 FQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 521 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.............+.+++.+||+.||++|||+.++++
T Consensus 229 ----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 229 ----DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp ----CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0111122234566788999999999999999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=335.94 Aligned_cols=247 Identities=23% Similarity=0.331 Sum_probs=198.6
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCH---HHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNG---EEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
+.+.++||+|+||.||+|... +++.||+|++....... +.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 87 (284)
T 3kk8_A 8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 87 (284)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred hhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecC
Confidence 445688999999999999765 68999999997654433 56789999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc---eEEeeccccccccccc
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFC---PKISDFGLAKQAQKKE 447 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~---vkl~DFGla~~~~~~~ 447 (582)
++++|.+.+.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||++.......
T Consensus 88 ~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (284)
T 3kk8_A 88 TGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162 (284)
T ss_dssp CSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence 9999988887543 689999999999999999999998 9999999999999986655 9999999998765543
Q ss_pred cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcC
Q 040604 448 SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 527 (582)
.. ....||+.|+|||++.+ ..++.++||||||+++++|++|+.||....... ....+..+... ...
T Consensus 163 ~~---~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~~~-~~~-- 228 (284)
T 3kk8_A 163 AW---HGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHR------LYAQIKAGAYD-YPS-- 228 (284)
T ss_dssp BC---CCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCCC-CCT--
T ss_pred cc---cCCCCCcCCcCchhhcC--CCCCcccchHHHHHHHHHHHHCCCCCCCCchhH------HHHHHHhcccc-CCc--
Confidence 32 23469999999999876 368999999999999999999999997653322 11111111100 000
Q ss_pred cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 528 TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 528 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.....+...+.+++.+||+.||++|||++|+++
T Consensus 229 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 229 -PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp -TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 011122355678888999999999999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=349.76 Aligned_cols=244 Identities=23% Similarity=0.288 Sum_probs=188.9
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC----CHHHHHHHHHH-HhccCCCceEEEEeEEEeCCeeeEEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEVAS-ISRTSHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~ 367 (582)
.+++.+.||+|+||+||++... +++.||||++++... ..+.+.+|..+ ++.++||||+++++++.+....++||
T Consensus 39 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~ 118 (373)
T 2r5t_A 39 DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 118 (373)
T ss_dssp GEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEE
Confidence 3556789999999999999765 689999999976432 23456677776 57789999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
||++||+|.+++...+ .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 119 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 119 DYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 9999999999997643 688999999999999999999998 99999999999999999999999999998643322
Q ss_pred cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcC
Q 040604 448 SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 527 (582)
.. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... +.+.+... ...+....
T Consensus 194 ~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~~-~~~~~~~~ 262 (373)
T 2r5t_A 194 ST--TSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MYDNILNK-PLQLKPNI 262 (373)
T ss_dssp CC--CCSBSCCCCCCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH------HHHHHHHS-CCCCCSSS
T ss_pred Cc--cccccCCccccCHHHhCCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHhc-ccCCCCCC
Confidence 21 2245699999999999763 68999999999999999999999997653322 12222111 11222222
Q ss_pred cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 040604 528 TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVL 560 (582)
Q Consensus 528 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl 560 (582)
...+.+++.+||+.||++||++.+.+
T Consensus 263 -------~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 263 -------TNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp -------CHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred -------CHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 34566778889999999999985433
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=335.51 Aligned_cols=247 Identities=27% Similarity=0.449 Sum_probs=196.2
Q ss_pred HHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeC-CeeeEEEEecCCC
Q 040604 295 KSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYEN-KKNALIYELMPNG 373 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~E~~~~g 373 (582)
+.+.+.||+|+||+||++.. +|+.||||+++... ..+.+.+|+.++++++||||+++++++.+. ...++||||++++
T Consensus 23 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~ 100 (278)
T 1byg_A 23 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 100 (278)
T ss_dssp EEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred ceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCC
Confidence 45668999999999999987 58899999997654 557789999999999999999999997655 4789999999999
Q ss_pred ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeee
Q 040604 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISML 453 (582)
Q Consensus 374 sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 453 (582)
+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 101 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~----- 172 (278)
T 1byg_A 101 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD----- 172 (278)
T ss_dssp EHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------------
T ss_pred CHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccccc-----
Confidence 999999765444589999999999999999999998 999999999999999999999999999986544322
Q ss_pred cccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 454 HARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 454 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
...+|+.|+|||.+.+ ..++.++||||||++++||++ |+.|+....... +...+..+........
T Consensus 173 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~------ 238 (278)
T 1byg_A 173 TGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYKMDAPDG------ 238 (278)
T ss_dssp ---CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG------HHHHHTTTCCCCCCTT------
T ss_pred CCCccccccCHHHhCC--CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHhcCCCCCCccc------
Confidence 2358899999999876 478999999999999999998 898887643322 2233333322222222
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 040604 533 KIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGS 566 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~ 566 (582)
....+.+++.+||+.||++|||++++++.|+..
T Consensus 239 -~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 239 -CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp -CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 235567788889999999999999999999874
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=336.89 Aligned_cols=258 Identities=21% Similarity=0.309 Sum_probs=196.5
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
+.+.++||+|+||+||+|... +|+.||||++...... .+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 5 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (311)
T 4agu_A 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC 84 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeC
Confidence 345689999999999999765 6999999998765543 356789999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
++++|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..........
T Consensus 85 ~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (311)
T 4agu_A 85 DHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY 159 (311)
T ss_dssp SEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccccc
Confidence 9999999887543 589999999999999999999998 99999999999999999999999999998765433221
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcC-------------
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEP------------- 517 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~------------- 517 (582)
....||+.|+|||++.+. ..++.++||||||++++||++|+.||......... ..+.+.+..
T Consensus 160 --~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 160 --DDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL--YLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp --------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCSCCHHHHHHHHTCG
T ss_pred --CCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhccccccccccccccc
Confidence 234699999999998753 46799999999999999999999999765433211 011111110
Q ss_pred ---CCCCC-CCCcCcH--HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 518 ---GNDFQ-FDGVATE--EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 518 ---~~~~~-~~~~~~~--~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
+.... ....... ....+...+.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 0000000 112344567889999999999999999999853
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=342.98 Aligned_cols=264 Identities=26% Similarity=0.384 Sum_probs=205.3
Q ss_pred HHHhhhhcCccCceEEEEEEe-----CCCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEe--CCeeeE
Q 040604 294 TKSFRDKLGQGGYGEVYKGEL-----PDGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYE--NKKNAL 365 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 365 (582)
.+.+.++||+|+||.||++.+ .+++.||||++..... ..+.+.+|+.++++++|+||+++++++.. ....++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 103 (327)
T 3lxl_A 24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRL 103 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEE
T ss_pred hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEE
Confidence 445678999999999999973 3688999999976543 23568999999999999999999999874 456789
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 104 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 104 VMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 999999999999997643 3589999999999999999999998 999999999999999999999999999987754
Q ss_pred cccce-eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCccc---------chhhHHHHHhh
Q 040604 446 KESAI-SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDT---------SICHNLIYERI 515 (582)
Q Consensus 446 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~---------~~~~~~~~~~i 515 (582)
..... ......||+.|+|||++.+ ..++.++||||||+++++|++|+.|+....... ......+.+.+
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSD--NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred CCccceeeccCCccccccCHHHhcc--CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 43321 2223458899999999876 367899999999999999999999986432210 00011122223
Q ss_pred cCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCC
Q 040604 516 EPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENL 570 (582)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~ 570 (582)
..+....... .+...+.+++.+||+.||++|||+++|++.|+......
T Consensus 258 ~~~~~~~~~~-------~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 258 EEGQRLPAPP-------ACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HTTCCCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred hcccCCCCCC-------cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 3322222222 22355778888999999999999999999999876544
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=342.87 Aligned_cols=264 Identities=23% Similarity=0.342 Sum_probs=196.5
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCH--HHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNG--EEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
|.+.++||+|+||+||+|... +++.||||+++...... ..+.+|+.++++++||||+++++++.+....++||||++
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 83 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred eEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc
Confidence 345688999999999999765 79999999997543222 245679999999999999999999999999999999995
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 84 -~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~-- 156 (324)
T 3mtl_A 84 -KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT-- 156 (324)
T ss_dssp -EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred -cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCccc--
Confidence 68988887643 3689999999999999999999998 9999999999999999999999999999865543322
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc---
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT--- 528 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~--- 528 (582)
.....||+.|+|||++.+. ..++.++||||||+++|||++|+.||........ ...+...+.......+.....
T Consensus 157 ~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ--LHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred cccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHhchhhhcchh
Confidence 1234689999999998753 4689999999999999999999999976543221 111222222211111111110
Q ss_pred ---------------HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcccC
Q 040604 529 ---------------EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE--MLEGSIE 568 (582)
Q Consensus 529 ---------------~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~--~Le~~~~ 568 (582)
.....+...+.+++.+||+.||++|||++|+++ .+.+..+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 011123456788999999999999999999986 3444333
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=337.35 Aligned_cols=255 Identities=24% Similarity=0.356 Sum_probs=195.1
Q ss_pred hhcCccCceEEEEEEeC-CCcEEEEEEeccCC-CCHHHHHHHHHHHhc-cCCCceEEEEeEEEeCCeeeEEEEecCCCCh
Q 040604 299 DKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR-CNGEEFINEVASISR-TSHVNIVTFLGFCYENKKNALIYELMPNGSL 375 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 375 (582)
+.||+|+||+||+|... +++.||||+++... ...+.+.+|+.++.+ ++||||+++++++.+....++||||+++|+|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 57999999999999754 79999999997654 346788999999988 5799999999999999999999999999999
Q ss_pred hhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc---eEEeecccccccccccc----
Q 040604 376 DKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFC---PKISDFGLAKQAQKKES---- 448 (582)
Q Consensus 376 ~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~---vkl~DFGla~~~~~~~~---- 448 (582)
.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||++........
T Consensus 99 ~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 173 (316)
T 2ac3_A 99 LSHIHKRR--HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPI 173 (316)
T ss_dssp HHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----------
T ss_pred HHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccc
Confidence 99997643 689999999999999999999998 9999999999999998776 99999999986543211
Q ss_pred -ceeeecccCCcccccccccccc---cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccc---------hhhHHHHHhh
Q 040604 449 -AISMLHARGTIGYIAPEVYSRR---FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTS---------ICHNLIYERI 515 (582)
Q Consensus 449 -~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~---------~~~~~~~~~i 515 (582)
........||+.|+|||++... ...++.++||||||+++|||++|+.||........ .....+.+.+
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i 253 (316)
T 2ac3_A 174 STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESI 253 (316)
T ss_dssp --------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHH
T ss_pred cccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHH
Confidence 1112234599999999998641 12478899999999999999999999976543221 0011122222
Q ss_pred cCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 516 EPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
..+.. .+ .......+...+.+++.+||+.||++|||++|+++.
T Consensus 254 ~~~~~-~~---~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 254 QEGKY-EF---PDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHCCC-CC---CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hccCc-cc---CchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 22211 11 111122345678889999999999999999999873
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=334.36 Aligned_cols=255 Identities=27% Similarity=0.431 Sum_probs=202.2
Q ss_pred HHhhh-hcCccCceEEEEEEe---CCCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEE
Q 040604 295 KSFRD-KLGQGGYGEVYKGEL---PDGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 295 ~~~~~-~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 367 (582)
+.+.+ .||+|+||+||+|.+ .+++.||||+++..... .+.+.+|+.++++++||||+++++++ +.+..++||
T Consensus 18 y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~ 96 (291)
T 1xbb_A 18 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVM 96 (291)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred hhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEE
Confidence 34445 899999999999954 25789999999765332 46789999999999999999999999 667789999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 97 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 97 EMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171 (291)
T ss_dssp ECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred EeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence 9999999999998643 589999999999999999999998 99999999999999999999999999998765543
Q ss_pred cce-eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCC
Q 040604 448 SAI-SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525 (582)
Q Consensus 448 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 525 (582)
... ......||+.|+|||.+.+ ..++.++||||||+++|||++ |+.||....... +...+..+.......
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~ 243 (291)
T 1xbb_A 172 NYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VTAMLEKGERMGCPA 243 (291)
T ss_dssp SEEEC----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCCCCCCT
T ss_pred CcccccccCCCCceeeChHHhcc--CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHHcCCCCCCCC
Confidence 321 1223347889999999876 367899999999999999999 999987643321 223333333222222
Q ss_pred cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCC
Q 040604 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENL 570 (582)
Q Consensus 526 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~ 570 (582)
. +...+.+++.+||+.||++||++.+|++.|++.+...
T Consensus 244 ~-------~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 244 G-------CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp T-------CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred C-------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 2 2355777888999999999999999999999866543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=341.22 Aligned_cols=258 Identities=27% Similarity=0.466 Sum_probs=204.2
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcE--EEEEEeccCC--CCHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeeeEEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQL--VAVKVLKNSR--CNGEEFINEVASISRT-SHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~--vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 367 (582)
.+.+.+.||+|+||.||+|... ++.. +|+|.++... ...+.+.+|+.+++++ +||||+++++++.+....++||
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 105 (327)
T 1fvr_A 26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 105 (327)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEE
Confidence 3456789999999999999754 5664 4999987532 2346789999999999 9999999999999999999999
Q ss_pred EecCCCChhhhhhcCC--------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceE
Q 040604 368 ELMPNGSLDKFIHNDR--------------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPK 433 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vk 433 (582)
||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+|
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~k 182 (327)
T 1fvr_A 106 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 182 (327)
T ss_dssp CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEE
T ss_pred ecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEE
Confidence 9999999999997643 24689999999999999999999998 999999999999999999999
Q ss_pred EeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHH
Q 040604 434 ISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIY 512 (582)
Q Consensus 434 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 512 (582)
|+|||+++........ ....+|+.|+|||++.+ ..++.++||||||+++|||++ |+.||....... +.
T Consensus 183 L~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------~~ 251 (327)
T 1fvr_A 183 IADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LY 251 (327)
T ss_dssp ECCTTCEESSCEECCC-------CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HH
T ss_pred EcccCcCccccccccc---cCCCCCccccChhhhcc--ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH------HH
Confidence 9999999754332211 22357889999999876 367899999999999999998 999987643221 22
Q ss_pred HhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCCC
Q 040604 513 ERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQI 572 (582)
Q Consensus 513 ~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~~ 572 (582)
+.+..+........ +...+.+++.+||+.||++|||++++++.|+..+.....
T Consensus 252 ~~~~~~~~~~~~~~-------~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 252 EKLPQGYRLEKPLN-------CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp HHGGGTCCCCCCTT-------BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred HHhhcCCCCCCCCC-------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 33333322222221 234577888899999999999999999999987765543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=362.58 Aligned_cols=249 Identities=26% Similarity=0.332 Sum_probs=203.2
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccC----CCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNS----RCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.+.+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.+|++++|||||++++++.+....++||||
T Consensus 186 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy 265 (576)
T 2acx_A 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 265 (576)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEc
Confidence 344578999999999999765 7999999999643 33456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
++||+|.+++.......+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 266 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~ 342 (576)
T 2acx_A 266 MNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 342 (576)
T ss_dssp CCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCE
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCccc
Confidence 9999999999876656699999999999999999999998 9999999999999999999999999999887654332
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...+...+.... ..+...
T Consensus 343 ---~~~~GT~~Y~APEvl~~--~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~--~~~i~~~i~~~~-~~~p~~--- 411 (576)
T 2acx_A 343 ---KGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REEVERLVKEVP-EEYSER--- 411 (576)
T ss_dssp ---ECCCSCGGGCCHHHHTT--CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC--HHHHHHHHHHCC-CCCCTT---
T ss_pred ---cccCCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCcccccchh--HHHHHHHhhccc-ccCCcc---
Confidence 23469999999999976 3689999999999999999999999976543221 111222222111 112222
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERP-----SMHKVLE 561 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~ 561 (582)
+...+.+|+.+||+.||++|| +++||++
T Consensus 412 ----~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 412 ----FSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ----CCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 234567788889999999999 7888874
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=349.73 Aligned_cols=259 Identities=24% Similarity=0.321 Sum_probs=187.6
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC---HHHHHHHHHHHhccC-CCceEEEEeEEEeCC--eeeEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN---GEEFINEVASISRTS-HVNIVTFLGFCYENK--KNALI 366 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~lv 366 (582)
.+.+.++||+|+||.||+|... +|+.||||++...... ...+.+|+.+++++. ||||+++++++...+ ..++|
T Consensus 10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 89 (388)
T 3oz6_A 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLV 89 (388)
T ss_dssp TEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEE
T ss_pred ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEE
Confidence 3456689999999999999754 7999999998654332 345789999999997 999999999997544 67999
Q ss_pred EEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccc
Q 040604 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~ 446 (582)
|||++ ++|..++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 90 ~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 90 FDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp EECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred ecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 99995 7899988753 589999999999999999999998 9999999999999999999999999999875431
Q ss_pred c-------------------cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchh
Q 040604 447 E-------------------SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSIC 507 (582)
Q Consensus 447 ~-------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~ 507 (582)
. .........||+.|+|||++.+. ..++.++|||||||+++||++|+.||........ +
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~ 240 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ-L 240 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-H
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H
Confidence 1 01112335699999999998763 4689999999999999999999999976543221 1
Q ss_pred hHHHHHhhcCCCC--------------------------CCCCCcCcHHHH---------HHHHHHHHHHHhccccCCCC
Q 040604 508 HNLIYERIEPGND--------------------------FQFDGVATEEEK---------KIAKMMILVGFWCIQTNPSE 552 (582)
Q Consensus 508 ~~~~~~~i~~~~~--------------------------~~~~~~~~~~~~---------~~~~~l~~l~~~Cl~~dp~~ 552 (582)
.. +.+.+..... ............ .....+.+|+.+||+.||++
T Consensus 241 ~~-i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~ 319 (388)
T 3oz6_A 241 ER-IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319 (388)
T ss_dssp HH-HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred HH-HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence 11 1111111100 000000000000 12346788999999999999
Q ss_pred CCCHHHHHHH
Q 040604 553 RPSMHKVLEM 562 (582)
Q Consensus 553 RPt~~evl~~ 562 (582)
|||++|+++.
T Consensus 320 R~t~~e~l~H 329 (388)
T 3oz6_A 320 RISANDALKH 329 (388)
T ss_dssp SCCHHHHTTS
T ss_pred CCCHHHHhCC
Confidence 9999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=358.25 Aligned_cols=193 Identities=24% Similarity=0.401 Sum_probs=151.5
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEeC-----Ceee
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYEN-----KKNA 364 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 364 (582)
.+.+.++||+|+||+||+|... +++.||||++...... .+.+.+|+.+|++++|||||++++++... ...+
T Consensus 54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 133 (458)
T 3rp9_A 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133 (458)
T ss_dssp TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence 3456789999999999999755 7999999999764333 35688999999999999999999999543 4679
Q ss_pred EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccc
Q 040604 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~ 444 (582)
+||||+ +++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 134 lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 134 VVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 999998 68999998754 3699999999999999999999998 99999999999999999999999999998764
Q ss_pred ccccc-------------------------eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcC
Q 040604 445 KKESA-------------------------ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGC 493 (582)
Q Consensus 445 ~~~~~-------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg 493 (582)
..... .......||+.|+|||++... ..++.++|||||||+||||++|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTT
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHh
Confidence 32110 112345689999999987543 4689999999999999999994
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=345.66 Aligned_cols=249 Identities=25% Similarity=0.362 Sum_probs=196.1
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRT-SHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
.+.+.+.||+|+||+||++... +|+.||||+++..... ..+|+.++.++ +||||+++++++.+....++||||++
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 99 (342)
T 2qr7_A 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMK 99 (342)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCC
Confidence 4566789999999999999765 7899999999765432 35688888887 79999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC----CceEEeeccccccccccc
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED----FCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~----~~vkl~DFGla~~~~~~~ 447 (582)
||+|.+++...+ .+++..+..++.||+.||+|||+. +|+||||||+|||+.++ +.+||+|||+++......
T Consensus 100 gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 100 GGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp SCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 999999997643 689999999999999999999998 99999999999998443 359999999998765443
Q ss_pred cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcC
Q 040604 448 SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 527 (582)
.. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ...+...+..+... +...
T Consensus 175 ~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~~~~i~~~~~~-~~~~- 245 (342)
T 2qr7_A 175 GL--LMTPCYTANFVAPEVLERQ--GYDAACDIWSLGVLLYTMLTGYTPFANGPDDT---PEEILARIGSGKFS-LSGG- 245 (342)
T ss_dssp CC--BCCSSCCSSCCCHHHHHHH--HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC---HHHHHHHHHHCCCC-CCST-
T ss_pred Cc--eeccCCCccccCHHHhcCC--CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC---HHHHHHHHccCCcc-cCcc-
Confidence 22 1235699999999998763 57889999999999999999999997543221 11122223222211 1110
Q ss_pred cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 528 TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 528 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
....+...+.+++.+||+.||++|||++++++
T Consensus 246 --~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 246 --YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp --TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 01123455677888899999999999999985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=349.54 Aligned_cols=249 Identities=18% Similarity=0.178 Sum_probs=199.6
Q ss_pred HHhhhhcCccCceEEEEEE------eCCCcEEEEEEeccCCCCHHHHHHHHHHHhccC---CCceEEEEeEEEeCCeeeE
Q 040604 295 KSFRDKLGQGGYGEVYKGE------LPDGQLVAVKVLKNSRCNGEEFINEVASISRTS---HVNIVTFLGFCYENKKNAL 365 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l 365 (582)
+.+.++||+|+||+||+|. ..+++.||||+++.. ...++.+|+.++++++ |+||+++++++......++
T Consensus 67 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~l 144 (365)
T 3e7e_A 67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVL 144 (365)
T ss_dssp EEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEE
T ss_pred EEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEE
Confidence 4456789999999999993 447899999999754 4667888888888887 9999999999999999999
Q ss_pred EEEecCCCChhhhhhcC---CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-----------CCc
Q 040604 366 IYELMPNGSLDKFIHND---RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE-----------DFC 431 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~-----------~~~ 431 (582)
||||+++|+|.+++... ....+++..++.|+.||+.||+|||+. +|+||||||+|||++. ++.
T Consensus 145 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~~ 221 (365)
T 3e7e_A 145 VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221 (365)
T ss_dssp EECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------CTT
T ss_pred EEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccccCC
Confidence 99999999999999742 234699999999999999999999998 9999999999999998 899
Q ss_pred eEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHH
Q 040604 432 PKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLI 511 (582)
Q Consensus 432 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~ 511 (582)
+||+|||+|+...............||+.|+|||++.+. .++.++|||||||++|||++|+.||.........
T Consensus 222 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----- 294 (365)
T 3e7e_A 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK----- 294 (365)
T ss_dssp EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-----
T ss_pred EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC--CCCccccHHHHHHHHHHHHhCCCccccCCCCcee-----
Confidence 999999999865543333344456799999999999874 6899999999999999999999998543322110
Q ss_pred HHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCC-CCHHHHHHHHhcccC
Q 040604 512 YERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSER-PSMHKVLEMLEGSIE 568 (582)
Q Consensus 512 ~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~R-Pt~~evl~~Le~~~~ 568 (582)
+.. .+.... ..+.+.+++..||+.+|.+| |+++++.+.|+..+.
T Consensus 295 ---~~~----~~~~~~------~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 295 ---PEG----LFRRLP------HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp ---ECS----CCTTCS------SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred ---ech----hccccC------cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 000 011111 12345567777999999999 578888888887654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=342.45 Aligned_cols=255 Identities=27% Similarity=0.435 Sum_probs=197.1
Q ss_pred HhhhhcCccCceEEEEEEeCC-----CcEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEE
Q 040604 296 SFRDKLGQGGYGEVYKGELPD-----GQLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 368 (582)
.+.+.||+|+||+||+|.... +..||||+++..... ...+.+|+.++++++||||+++++++.+....++|||
T Consensus 47 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 126 (333)
T 1mqb_A 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 126 (333)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEe
Confidence 345789999999999996542 346999999764432 3468899999999999999999999999899999999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
|+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 127 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 202 (333)
T 1mqb_A 127 YMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 202 (333)
T ss_dssp CCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred CCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhccccc
Confidence 999999999997642 4689999999999999999999998 999999999999999999999999999987654322
Q ss_pred c-eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCc
Q 040604 449 A-ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526 (582)
Q Consensus 449 ~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 526 (582)
. .......+|+.|+|||++.. ..++.++||||||+++|||++ |+.||....... +...+..+.......
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------~~~~~~~~~~~~~~~- 273 (333)
T 1mqb_A 203 ATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------VMKAINDGFRLPTPM- 273 (333)
T ss_dssp --------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTTCCCCCCT-
T ss_pred cccccCCCCccccccCchhccc--CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH------HHHHHHCCCcCCCcc-
Confidence 1 11223347889999999875 478999999999999999999 999986543221 223333332222221
Q ss_pred CcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCC
Q 040604 527 ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIEN 569 (582)
Q Consensus 527 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~ 569 (582)
.+...+.+++.+||+.||++||++.+|++.|++.+..
T Consensus 274 ------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 274 ------DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp ------TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 2235577788899999999999999999999875543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=358.84 Aligned_cols=244 Identities=22% Similarity=0.324 Sum_probs=190.0
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccC----CCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNS----RCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.+.++||+|+||.||+|... +|+.||||+++.. ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 229 (446)
T 4ejn_A 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 229 (446)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECC
T ss_pred cEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEee
Confidence 455689999999999999754 7999999999753 22345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHR-GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
+++|+|.+++.... .+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++.......
T Consensus 230 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 304 (446)
T 4ejn_A 230 ANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 304 (446)
T ss_dssp CSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc
Confidence 99999999987643 68999999999999999999998 6 999999999999999999999999999986443322
Q ss_pred ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc
Q 040604 449 AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528 (582)
Q Consensus 449 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 528 (582)
. .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... +.+.+... ...++..
T Consensus 305 ~--~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~~~-~~~~p~~-- 371 (446)
T 4ejn_A 305 T--MKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILME-EIRFPRT-- 371 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHC-CCCCCTT--
T ss_pred c--cccccCCccccCHhhcCC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH------HHHHHHhC-CCCCCcc--
Confidence 2 234579999999999976 478999999999999999999999997653322 11111111 1112222
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERP-----SMHKVLE 561 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~ 561 (582)
+...+.+|+.+||+.||++|| +++|+++
T Consensus 372 -----~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 372 -----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 234567788889999999999 9999985
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=342.70 Aligned_cols=260 Identities=22% Similarity=0.300 Sum_probs=201.9
Q ss_pred ccHHHHHHHHHHhh-hhcCccCceEEEEEEeC-CCcEEEEEEeccCC---CCHHHHHHHHHHHhcc-CCCceEEEEeEEE
Q 040604 285 YSYSDVKRMTKSFR-DKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR---CNGEEFINEVASISRT-SHVNIVTFLGFCY 358 (582)
Q Consensus 285 ~~~~~~~~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 358 (582)
+...+.....+.+. ++||+|+||+||+|... +++.||||+++... .....+.+|+.+++++ +||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 33334444445555 78999999999999765 79999999987543 2357889999999998 4699999999999
Q ss_pred eCCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---CCceEEe
Q 040604 359 ENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE---DFCPKIS 435 (582)
Q Consensus 359 ~~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~---~~~vkl~ 435 (582)
+....++||||+++|+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEe
Confidence 999999999999999999999766556799999999999999999999998 9999999999999988 7899999
Q ss_pred eccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhh
Q 040604 436 DFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERI 515 (582)
Q Consensus 436 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i 515 (582)
|||+++........ ....||+.|+|||++.. ..++.++||||||+++|||++|+.||........ ... +. ..
T Consensus 177 Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~-i~-~~ 248 (327)
T 3lm5_A 177 DFGMSRKIGHACEL---REIMGTPEYLAPEILNY--DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET-YLN-IS-QV 248 (327)
T ss_dssp CGGGCEEC------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH-HH-HT
T ss_pred eCccccccCCcccc---ccccCCcCccCCeeecC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-HHH-HH-hc
Confidence 99999876544322 23469999999999876 4789999999999999999999999976543221 111 11 11
Q ss_pred cCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 516 EPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
...... .....+...+.+++.+||+.||++|||++++++.
T Consensus 249 ~~~~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 249 NVDYSE-------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CCCCCT-------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ccccCc-------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 111000 1111234557788889999999999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=360.97 Aligned_cols=246 Identities=30% Similarity=0.366 Sum_probs=198.7
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC--------------CCHHHHHHHHHHHhccCCCceEEEEeEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR--------------CNGEEFINEVASISRTSHVNIVTFLGFCYE 359 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 359 (582)
|.+.++||+|+||+||+|... +++.||||+++... ...+.+.+|+.++++++||||+++++++.+
T Consensus 38 Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 117 (504)
T 3q5i_A 38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED 117 (504)
T ss_dssp EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred eEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 456689999999999999765 68999999997543 234678999999999999999999999999
Q ss_pred CCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC---ceEEee
Q 040604 360 NKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF---CPKISD 436 (582)
Q Consensus 360 ~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~---~vkl~D 436 (582)
....++||||+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++ .+||+|
T Consensus 118 ~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 118 KKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred CCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 999999999999999999887543 689999999999999999999998 999999999999998776 699999
Q ss_pred ccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhc
Q 040604 437 FGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIE 516 (582)
Q Consensus 437 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~ 516 (582)
||+++........ ....||+.|+|||++.+ .++.++||||+||++|+|++|..||....... +...+.
T Consensus 193 fg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~ 260 (504)
T 3q5i_A 193 FGLSSFFSKDYKL---RDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD------IIKKVE 260 (504)
T ss_dssp CTTCEECCTTSCB---CCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH
T ss_pred CCCCEEcCCCCcc---ccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHH
Confidence 9999877654322 23469999999999864 68899999999999999999999997654322 222222
Q ss_pred CCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 517 PGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.+.. .+ .......+...+.+++.+||+.||.+|||++|+++
T Consensus 261 ~~~~-~~---~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 261 KGKY-YF---DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HCCC-CC---CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCCC-CC---CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 2211 01 11122334567788899999999999999999985
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=341.09 Aligned_cols=261 Identities=19% Similarity=0.280 Sum_probs=197.0
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC----HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN----GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.+.+.||+|+||.||+|... +++.||||++...... .+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 2h34_A 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRL 115 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEe
Confidence 456689999999999999765 7899999999754322 25688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 116 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 190 (309)
T 2h34_A 116 INGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190 (309)
T ss_dssp CCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence 99999999997643 689999999999999999999998 9999999999999999999999999999876543221
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... .+...+...... .. .
T Consensus 191 -~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~~-~~----~ 256 (309)
T 2h34_A 191 -QLGNTVGTLYYMAPERFSE--SHATYRADIYALTCVLYECLTGSPPYQGDQLS------VMGAHINQAIPR-PS----T 256 (309)
T ss_dssp -------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHHH------HHHHHHHSCCCC-GG----G
T ss_pred -cccccCCCcCccCHHHHcC--CCCCchHhHHHHHHHHHHHHHCCCCCCCchHH------HHHHHhccCCCC-cc----c
Confidence 1123469999999999876 47889999999999999999999999754321 122222221110 00 0
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhcccCCCCCCC
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERP-SMHKVLEMLEGSIENLQIPP 574 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RP-t~~evl~~Le~~~~~~~~p~ 574 (582)
....+...+.+++.+||+.||++|| +++++++.|+..+.......
T Consensus 257 ~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~~ 302 (309)
T 2h34_A 257 VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDR 302 (309)
T ss_dssp TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC------
T ss_pred cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcccc
Confidence 0112334567788889999999999 99999999999887665433
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=359.84 Aligned_cols=248 Identities=27% Similarity=0.386 Sum_probs=197.1
Q ss_pred HHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC---CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEE
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR---CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 368 (582)
..|.+.++||+|+||+||+|... +++.||||+++... ...+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 45667789999999999999765 78999999997543 235678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC---CceEEeeccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED---FCPKISDFGLAKQAQK 445 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~---~~vkl~DFGla~~~~~ 445 (582)
|+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.. +.+||+|||+++....
T Consensus 117 ~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 117 CYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp CCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 999999998887543 689999999999999999999998 99999999999999764 5599999999987665
Q ss_pred cccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCC
Q 040604 446 KESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525 (582)
Q Consensus 446 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 525 (582)
.... ....||+.|+|||++.+ .++.++||||+||++|+|++|..||....... +...+..+... +.
T Consensus 192 ~~~~---~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~~-~~- 257 (494)
T 3lij_A 192 QKKM---KERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQE------ILRKVEKGKYT-FD- 257 (494)
T ss_dssp TBCB---CCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCCC-CC-
T ss_pred Cccc---cccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCCC-CC-
Confidence 4332 23469999999999864 68999999999999999999999997654322 12222222111 10
Q ss_pred cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 526 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
......+...+.+++.+||+.||++|||++++++
T Consensus 258 --~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 258 --SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp --SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --chhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 1111233456778888999999999999999984
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=343.35 Aligned_cols=260 Identities=26% Similarity=0.425 Sum_probs=201.7
Q ss_pred HHHHhhhhcCccCceEEEEEEe------CCCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeee
Q 040604 293 MTKSFRDKLGQGGYGEVYKGEL------PDGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNA 364 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 364 (582)
..+.+.+.||+|+||.||+|.. .+++.||||++..... ....+.+|+.++++++||||+++++++.+....+
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 109 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence 3455678999999999999973 2577999999965432 2356889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCC-----cCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---CCceEEee
Q 040604 365 LIYELMPNGSLDKFIHNDRN-----IKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE---DFCPKISD 436 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~---~~~vkl~D 436 (582)
+||||+++++|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+|||++. +..+||+|
T Consensus 110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~D 186 (327)
T 2yfx_A 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD 186 (327)
T ss_dssp EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEECc
Confidence 99999999999999986532 3589999999999999999999998 9999999999999984 45699999
Q ss_pred ccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhh
Q 040604 437 FGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERI 515 (582)
Q Consensus 437 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i 515 (582)
||+++...............||+.|+|||++.+ ..++.++||||||+++|||++ |+.|+....... +.+.+
T Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~ 258 (327)
T 2yfx_A 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE------VLEFV 258 (327)
T ss_dssp CHHHHHHHC------CCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHHH
T ss_pred cccccccccccccccCCCcCCCcceeCHhHhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH------HHHHH
Confidence 999986544332222234468999999999876 478999999999999999998 888886543211 22233
Q ss_pred cCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCC
Q 040604 516 EPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENL 570 (582)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~ 570 (582)
..+........ +...+.+++.+||+.||++||++.+|++.|+......
T Consensus 259 ~~~~~~~~~~~-------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 259 TSGGRMDPPKN-------CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp HTTCCCCCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred hcCCCCCCCCC-------CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 33222222222 2345677888999999999999999999998765543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=332.84 Aligned_cols=252 Identities=25% Similarity=0.404 Sum_probs=197.7
Q ss_pred HHhhhhcCccCceEEEEEEeC----CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP----DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 368 (582)
+.+.+.||+|+||+||+|... ++..||+|+++.... ..+.+.+|+.++++++||||+++++++.+ ...++|||
T Consensus 14 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 92 (281)
T 3cc6_A 14 VVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIME 92 (281)
T ss_dssp EEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEE
T ss_pred eEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEe
Confidence 445688999999999999753 234699999976532 34678999999999999999999999764 56789999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
|+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 93 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 168 (281)
T 3cc6_A 93 LYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 168 (281)
T ss_dssp CCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred cCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccccccc
Confidence 999999999997543 3589999999999999999999998 999999999999999999999999999987654332
Q ss_pred ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcC
Q 040604 449 AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527 (582)
Q Consensus 449 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 527 (582)
. ......||+.|+|||++.+ ..++.++||||||+++|||++ |+.||....... +...+..+........
T Consensus 169 ~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~- 238 (281)
T 3cc6_A 169 Y-KASVTRLPIKWMSPESINF--RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD------VIGVLEKGDRLPKPDL- 238 (281)
T ss_dssp -----CCCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG------HHHHHHHTCCCCCCTT-
T ss_pred c-ccccCCCCcceeCchhhcc--CCCCchhccHHHHHHHHHHHhCCCCCcccCChHH------HHHHHhcCCCCCCCCC-
Confidence 2 1223457889999999875 478999999999999999998 999987543322 1122222211222222
Q ss_pred cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 040604 528 TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSI 567 (582)
Q Consensus 528 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~ 567 (582)
+...+.+++.+||+.||++|||+.++++.|+...
T Consensus 239 ------~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 239 ------CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp ------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 2345777888999999999999999999998754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=340.82 Aligned_cols=245 Identities=26% Similarity=0.356 Sum_probs=196.5
Q ss_pred HHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCCH----HHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNG----EEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+...++||+|+||+||+|.. .+|+.||||++....... +.+.+|+.++++++||||+++++++.+....++||||
T Consensus 56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 135 (348)
T 1u5q_A 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 135 (348)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEec
Confidence 45567899999999999975 589999999997654332 4688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+. |+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 136 ~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~-- 208 (348)
T 1u5q_A 136 CL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-- 208 (348)
T ss_dssp CS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC--
T ss_pred CC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCCC--
Confidence 96 78888775432 4689999999999999999999998 99999999999999999999999999998765432
Q ss_pred eeeecccCCccccccccccc-ccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc
Q 040604 450 ISMLHARGTIGYIAPEVYSR-RFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~-~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 528 (582)
...||+.|+|||++.. ..+.++.++||||||+++|||++|+.||....... .+...............
T Consensus 209 ----~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~-- 277 (348)
T 1u5q_A 209 ----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----ALYHIAQNESPALQSGH-- 277 (348)
T ss_dssp ----CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHSCCCCCCCTT--
T ss_pred ----cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHhcCCCCCCCCC--
Confidence 2459999999999853 12468999999999999999999999997653322 12222222111111111
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
....+.+++.+||+.||++|||++++++.
T Consensus 278 -----~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 278 -----WSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp -----SCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -----CCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 23456778888999999999999999853
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=332.93 Aligned_cols=250 Identities=22% Similarity=0.307 Sum_probs=197.5
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccC-----CCCHHHHHHHHHHHhccCCCceEEEEeEEE--eCCeeeEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNS-----RCNGEEFINEVASISRTSHVNIVTFLGFCY--ENKKNALI 366 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv 366 (582)
+.+.+.||+|+||.||++... +++.||+|+++.. ....+.+.+|+.++++++||||+++++++. +....++|
T Consensus 7 y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (305)
T 2wtk_C 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMV 86 (305)
T ss_dssp BCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEE
T ss_pred eeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEE
Confidence 456689999999999999764 7899999999653 223467899999999999999999999985 34578999
Q ss_pred EEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccc
Q 040604 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~ 446 (582)
|||++++ |.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 87 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 87 MEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred ehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999766 77777766566799999999999999999999998 9999999999999999999999999999876543
Q ss_pred ccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCc
Q 040604 447 ESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526 (582)
Q Consensus 447 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 526 (582)
..........||+.|+|||++.+.....+.++||||||+++|||++|+.||....... +.+.+..+. ..+...
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~i~~~~-~~~~~~ 235 (305)
T 2wtk_C 163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK------LFENIGKGS-YAIPGD 235 (305)
T ss_dssp CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCC-CCCCSS
T ss_pred ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH------HHHHHhcCC-CCCCCc
Confidence 3333333456999999999987532345789999999999999999999997643211 122222221 112222
Q ss_pred CcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 527 ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 527 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
. ...+.+++.+||+.||++|||++++++.
T Consensus 236 ~-------~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 236 C-------GPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp S-------CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred c-------CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2 3456678888999999999999999964
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=344.47 Aligned_cols=249 Identities=23% Similarity=0.353 Sum_probs=200.1
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC---------HHHHHHHHHHHhcc-CCCceEEEEeEEEeCCee
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN---------GEEFINEVASISRT-SHVNIVTFLGFCYENKKN 363 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 363 (582)
+.+.+.||+|+||.||+|.+. +|+.||||+++..... .+.+.+|+.+++++ +||||+++++++......
T Consensus 96 y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 175 (365)
T 2y7j_A 96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175 (365)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEE
T ss_pred cccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEE
Confidence 445578999999999999875 7999999999765421 24578899999999 799999999999999999
Q ss_pred eEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccc
Q 040604 364 ALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQA 443 (582)
Q Consensus 364 ~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~ 443 (582)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 176 ~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 176 FLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp EEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 9999999999999999754 3689999999999999999999998 9999999999999999999999999999877
Q ss_pred cccccceeeecccCCcccccccccccc----cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCC
Q 040604 444 QKKESAISMLHARGTIGYIAPEVYSRR----FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGN 519 (582)
Q Consensus 444 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~ 519 (582)
...... ....||+.|+|||++.+. ...++.++||||||+++|||++|+.||....... ....+..+.
T Consensus 251 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~------~~~~i~~~~ 321 (365)
T 2y7j_A 251 EPGEKL---RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL------MLRMIMEGQ 321 (365)
T ss_dssp CTTCCB---CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTC
T ss_pred CCCccc---ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhCC
Confidence 654332 235699999999998642 1357889999999999999999999997643221 111121111
Q ss_pred CCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 520 DFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
. . ............+.+++.+||+.||++|||++++++
T Consensus 322 ~-~---~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 322 Y-Q---FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp C-C---CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred C-C---CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 0 011111233456788889999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=355.85 Aligned_cols=253 Identities=19% Similarity=0.208 Sum_probs=198.4
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+++.+.||+|+||+||++... +|+.||||++++.. ...+.+.+|..++.+++||||+++++++.+....++||||
T Consensus 63 f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~ 142 (412)
T 2vd5_A 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEY 142 (412)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcC
Confidence 344578999999999999765 79999999996532 1234578999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
++||+|.+++.+.+ ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++++||+|||+++........
T Consensus 143 ~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~ 218 (412)
T 2vd5_A 143 YVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218 (412)
T ss_dssp CCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCCcc
Confidence 99999999997542 3689999999999999999999998 9999999999999999999999999999876554332
Q ss_pred eeeecccCCcccccccccccc-----cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCC
Q 040604 450 ISMLHARGTIGYIAPEVYSRR-----FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFD 524 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~-----~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 524 (582)
......||+.|+|||++... ...++.++|||||||++|||++|+.||........ ....+.... ...++
T Consensus 219 -~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~i~~~~~----~~~~p 292 (412)
T 2vd5_A 219 -RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET-YGKIVHYKE----HLSLP 292 (412)
T ss_dssp -ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTHHH----HCCCC
T ss_pred -ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH-HHHHHhccc----CcCCC
Confidence 12235799999999998631 13578999999999999999999999976543221 111111000 00111
Q ss_pred CcCcHHHHHHHHHHHHHHHhccccCCCCC---CCHHHHHHH
Q 040604 525 GVATEEEKKIAKMMILVGFWCIQTNPSER---PSMHKVLEM 562 (582)
Q Consensus 525 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~R---Pt~~evl~~ 562 (582)
.....+...+.+++.+||+ +|++| |+++|+++.
T Consensus 293 ----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 293 ----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp --------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 0112234567788889999 99998 589998753
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=340.89 Aligned_cols=261 Identities=25% Similarity=0.315 Sum_probs=199.4
Q ss_pred HHHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCC-CCHHHHHHHHHHHhccCCCceEEEEeEEEe----CCeeeEEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSR-CNGEEFINEVASISRTSHVNIVTFLGFCYE----NKKNALIY 367 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 367 (582)
.+.+.++||+|+||.||++.. .+++.||||++.... ...+.+.+|+.++++++||||+++++++.. ....++||
T Consensus 30 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 109 (317)
T 2buj_A 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL 109 (317)
T ss_dssp EEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred EEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEE
Confidence 345678999999999999976 589999999986543 234678899999999999999999999873 34678999
Q ss_pred EecCCCChhhhhhcC--CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 368 ELMPNGSLDKFIHND--RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 368 E~~~~gsL~~~i~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
||+++|+|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 186 (317)
T 2buj_A 110 PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186 (317)
T ss_dssp ECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred EeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence 999999999998752 345699999999999999999999998 999999999999999999999999999876543
Q ss_pred cccc-------eeeecccCCccccccccccccc-CCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcC
Q 040604 446 KESA-------ISMLHARGTIGYIAPEVYSRRF-GGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEP 517 (582)
Q Consensus 446 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~-~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~ 517 (582)
.... .......||+.|+|||++.... ..++.++||||||+++|||++|+.||............. +..
T Consensus 187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~----~~~ 262 (317)
T 2buj_A 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA----VQN 262 (317)
T ss_dssp EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH----HHC
T ss_pred ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH----hhc
Confidence 2110 0011234899999999986531 236889999999999999999999985422111111111 111
Q ss_pred CCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 518 GNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
........ .+...+.+++.+||+.||++|||+++|++.|+....
T Consensus 263 ~~~~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 263 QLSIPQSP-------RHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp C--CCCCT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred cCCCCccc-------cCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 11111111 123457788889999999999999999999998544
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=335.81 Aligned_cols=263 Identities=22% Similarity=0.381 Sum_probs=196.1
Q ss_pred HHHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCC----CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRC----NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 368 (582)
.+.+.++||+|+||.||+|.. .+|+.||||+++.... ..+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 112 (310)
T 2wqm_A 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112 (310)
T ss_dssp GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence 355678999999999999976 4799999999975332 23568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcC--CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccc
Q 040604 369 LMPNGSLDKFIHND--RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 369 ~~~~gsL~~~i~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~ 446 (582)
|+++++|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 99999999998642 334689999999999999999999998 9999999999999999999999999999876543
Q ss_pred ccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCc
Q 040604 447 ESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526 (582)
Q Consensus 447 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 526 (582)
.... ....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......... +...+.......+..
T Consensus 190 ~~~~--~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~- 260 (310)
T 2wqm_A 190 TTAA--HSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS----LCKKIEQCDYPPLPS- 260 (310)
T ss_dssp -----------CCSSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH----HHHHHHTTCSCCCCT-
T ss_pred Cccc--cccCCCeeEeChHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH----HHHHhhcccCCCCcc-
Confidence 3221 23459999999999876 47899999999999999999999999754332211 112222222111110
Q ss_pred CcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCCCC
Q 040604 527 ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQIP 573 (582)
Q Consensus 527 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~~p 573 (582)
..+...+.+++.+||+.||++|||+++|++.|+........|
T Consensus 261 -----~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 261 -----DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp -----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred -----cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 122345777888999999999999999999999865544433
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=332.12 Aligned_cols=242 Identities=29% Similarity=0.432 Sum_probs=195.3
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEe----CCeeeEEE
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYE----NKKNALIY 367 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 367 (582)
.+.++||+|+||+||+|... ++..||+|++...... .+.+.+|+.++++++||||+++++++.. ....++||
T Consensus 29 ~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 108 (290)
T 1t4h_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEE
Confidence 45578999999999999764 7889999999765433 3568899999999999999999999875 34578999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCc--eEecCCCCCCEEEc-CCCceEEeecccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVR--IVHFDIKPQNILLD-EDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~--ivH~Dikp~NILl~-~~~~vkl~DFGla~~~~ 444 (582)
||+++++|.+++.... .+++..++.++.|++.||+|||+. + |+||||||+|||++ .++.+||+|||++....
T Consensus 109 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 109 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 9999999999997643 689999999999999999999997 6 99999999999997 78999999999997654
Q ss_pred ccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCC-CCC
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND-FQF 523 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~-~~~ 523 (582)
.... ....||+.|+|||++.+ .++.++||||||+++++|++|+.||........ +...+..+.. ..+
T Consensus 184 ~~~~----~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~ 251 (290)
T 1t4h_A 184 ASFA----KAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IYRRVTSGVKPASF 251 (290)
T ss_dssp TTSB----EESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----HHHHHTTTCCCGGG
T ss_pred cccc----ccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH-----HHHHHhccCCcccc
Confidence 4322 23459999999998864 589999999999999999999999976443322 2222222211 111
Q ss_pred CCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 524 DGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 524 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
... ....+.+++.+||+.||++|||+++|++
T Consensus 252 ~~~-------~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 252 DKV-------AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGC-------CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCC-------CCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 111 2245778888999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=358.11 Aligned_cols=249 Identities=28% Similarity=0.371 Sum_probs=201.9
Q ss_pred HHHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEecc---CCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEE
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKN---SRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 367 (582)
...|.+.++||+|+||+||+|... +++.||||++.. .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 445677899999999999999765 799999999854 2345678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc---CCCceEEeecccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLD---EDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~---~~~~vkl~DFGla~~~~ 444 (582)
||+++|+|.+++.... .+++..++.++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||+++...
T Consensus 101 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 9999999999887543 689999999999999999999998 999999999999995 45679999999998765
Q ss_pred ccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCC-CCCC
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGN-DFQF 523 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~-~~~~ 523 (582)
..... ....||+.|+|||++.+ .++.++|||||||++|+|++|+.||....... +...+..+. ....
T Consensus 176 ~~~~~---~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~~~~~ 243 (486)
T 3mwu_A 176 QNTKM---KDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD------ILKRVETGKYAFDL 243 (486)
T ss_dssp CC-------CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCCCSCS
T ss_pred CCCcc---CCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCCCCCC
Confidence 44322 23469999999999864 58999999999999999999999997653322 112222211 1111
Q ss_pred CCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 524 DGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 524 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
+....+...+.+++.+||+.||++|||+.++++.
T Consensus 244 -----~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 244 -----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -----GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -----cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1112344567788889999999999999999874
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=353.38 Aligned_cols=196 Identities=22% Similarity=0.372 Sum_probs=162.6
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEeC-----CeeeE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYEN-----KKNAL 365 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~l 365 (582)
+.+.+.||+|+||.||+|... +++.||||+++..... .+.+.+|+.+|++++|+||+++++++... ...++
T Consensus 28 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 107 (432)
T 3n9x_A 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYI 107 (432)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred EEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEE
Confidence 456689999999999999764 7899999999764333 35688999999999999999999999766 56899
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
||||+ +++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 108 v~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 108 VLEIA-DSDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp EEECC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred EEecC-CcCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 99999 57999999754 3689999999999999999999998 999999999999999999999999999987654
Q ss_pred cccc--------------------eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCC
Q 040604 446 KESA--------------------ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNL 497 (582)
Q Consensus 446 ~~~~--------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~ 497 (582)
.... .......||+.|+|||++... ..++.++|||||||++|||++|..|+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhccccc
Confidence 3211 112345799999999987543 46899999999999999999865544
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=360.32 Aligned_cols=248 Identities=27% Similarity=0.389 Sum_probs=203.2
Q ss_pred HHHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccC----CCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEE
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNS----RCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALI 366 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 366 (582)
...|.+.++||+|+||+||+|... +|+.||||++... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 345667789999999999999765 7999999999654 23467899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE---cCCCceEEeeccccccc
Q 040604 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL---DEDFCPKISDFGLAKQA 443 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl---~~~~~vkl~DFGla~~~ 443 (582)
|||+.+|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 105 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp ECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999987643 689999999999999999999998 99999999999999 56789999999999876
Q ss_pred cccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCC-CCC
Q 040604 444 QKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGN-DFQ 522 (582)
Q Consensus 444 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~-~~~ 522 (582)
...... ....||+.|+|||++.+ .++.++|||||||++|+|++|+.||....... +...+..+. ...
T Consensus 180 ~~~~~~---~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~~~~ 247 (484)
T 3nyv_A 180 EASKKM---KDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANEYD------ILKKVEKGKYTFE 247 (484)
T ss_dssp CCCCSH---HHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCCCC
T ss_pred cccccc---ccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHcCCCCCC
Confidence 554322 23469999999999864 68899999999999999999999997653322 122222221 111
Q ss_pred CCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 523 FDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 523 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
. .....+...+.+++.+||+.||++|||++|+++
T Consensus 248 ~-----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 248 L-----PQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp S-----GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C-----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 1 111234456778888999999999999999985
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=356.84 Aligned_cols=254 Identities=25% Similarity=0.279 Sum_probs=190.8
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeC------Ceee
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYEN------KKNA 364 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 364 (582)
|.+.++||+|+||+||+|... +|+.||||++..... ..+.+.+|+.++++++||||+++++++... ...+
T Consensus 64 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 143 (464)
T 3ttj_A 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 143 (464)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEE
Confidence 455688999999999999654 799999999975432 245688999999999999999999999754 3569
Q ss_pred EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccc
Q 040604 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~ 444 (582)
+||||+++ +|.+.+.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+...
T Consensus 144 lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 144 LVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp EEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred EEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 99999964 56666643 488999999999999999999998 99999999999999999999999999998765
Q ss_pred ccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHH-------------
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLI------------- 511 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~------------- 511 (582)
.... .....||+.|+|||++.+. .++.++|||||||+++||++|+.||........ +...+
T Consensus 216 ~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~-~~~i~~~lg~p~~~~~~~ 289 (464)
T 3ttj_A 216 TSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKK 289 (464)
T ss_dssp -CCC---C----CCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCSCCHHHHTT
T ss_pred CCcc---cCCCcccccccCHHHHcCC--CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHH
Confidence 4322 2235699999999999874 789999999999999999999999976543211 11100
Q ss_pred -----HHhhcCCCC---CCC--------CCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 512 -----YERIEPGND---FQF--------DGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 512 -----~~~i~~~~~---~~~--------~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
...+..... ..+ ..............+.+|+.+||+.||++|||++|+++.
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 001111000 000 011122233446678899999999999999999999863
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=330.85 Aligned_cols=243 Identities=27% Similarity=0.409 Sum_probs=195.2
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.+.+.||+|+||+||+|... +++.||||++.... ...+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (279)
T 3fdn_A 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 90 (279)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEec
Confidence 345688999999999999765 67899999986432 2346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 91 ~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~- 164 (279)
T 3fdn_A 91 APLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR- 164 (279)
T ss_dssp CTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcccc-
Confidence 99999999987543 589999999999999999999988 999999999999999999999999999866544322
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
....||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ....+.... ..++..
T Consensus 165 ---~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~-~~~~~~--- 229 (279)
T 3fdn_A 165 ---TDLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TYKRISRVE-FTFPDF--- 229 (279)
T ss_dssp ------CCCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTC-CCCCTT---
T ss_pred ---cccCCCCCccCHhHhcc--CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH------HHHHHHhCC-CCCCCc---
Confidence 23469999999999876 367899999999999999999999997543221 111221111 112222
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
....+.+++.+||+.||++|||++||++.
T Consensus 230 ----~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 230 ----VTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ----SCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ----CCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 23456678888999999999999999964
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=335.83 Aligned_cols=252 Identities=23% Similarity=0.310 Sum_probs=196.4
Q ss_pred HHHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC---------CHHHHHHHHHHHhccCCCceEEEEeEEEeCC
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC---------NGEEFINEVASISRTSHVNIVTFLGFCYENK 361 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 361 (582)
...+.+.+.||+|+||.||+|... +++.||||++..... ....+.+|+.++++++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 345667789999999999999765 689999999865431 1234789999999999999999999986554
Q ss_pred eeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc---eEEeecc
Q 040604 362 KNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFC---PKISDFG 438 (582)
Q Consensus 362 ~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~---vkl~DFG 438 (582)
.++||||+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++. +||+|||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred -eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 89999999999999988754 3689999999999999999999998 9999999999999987664 9999999
Q ss_pred ccccccccccceeeecccCCccccccccccc-ccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcC
Q 040604 439 LAKQAQKKESAISMLHARGTIGYIAPEVYSR-RFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEP 517 (582)
Q Consensus 439 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~ 517 (582)
+++........ ....||+.|+|||++.. ....++.++||||||+++|+|++|+.||.......... ..+..
T Consensus 163 ~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-----~~~~~ 234 (322)
T 2ycf_A 163 HSKILGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK-----DQITS 234 (322)
T ss_dssp TCEECCCCHHH---HHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHH-----HHHHH
T ss_pred cceeccccccc---ccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHH-----HHHHh
Confidence 99876543221 12459999999999742 12468899999999999999999999997654433211 11111
Q ss_pred CCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 518 GNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
+.. ...+.....+...+.+++.+||+.||++|||++++++
T Consensus 235 ~~~----~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 235 GKY----NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp TCC----CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred Ccc----ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 111 1111222334567888999999999999999999873
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=345.61 Aligned_cols=253 Identities=23% Similarity=0.285 Sum_probs=199.9
Q ss_pred HHhhhhcCccCceEEEEEEe----CCCcEEEEEEeccCC-----CCHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeee
Q 040604 295 KSFRDKLGQGGYGEVYKGEL----PDGQLVAVKVLKNSR-----CNGEEFINEVASISRT-SHVNIVTFLGFCYENKKNA 364 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 364 (582)
+.+.++||+|+||+||++.. .+++.||||+++... ...+.+.+|+.+++++ +||||+++++++......+
T Consensus 56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 135 (355)
T 1vzo_A 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 135 (355)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEE
Confidence 45668999999999999976 378999999986532 2346677899999999 6999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccc
Q 040604 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~ 444 (582)
+||||+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 136 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 136 LILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp EEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred EEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 9999999999999997643 689999999999999999999998 99999999999999999999999999998765
Q ss_pred ccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCC
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFD 524 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 524 (582)
...... .....||+.|+|||++.+....++.++||||||+++|||++|+.||........ ............ ..+.
T Consensus 211 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~--~~~~ 286 (355)
T 1vzo_A 211 ADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILKSE--PPYP 286 (355)
T ss_dssp GGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHHCC--CCCC
T ss_pred cCCCCc-ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HHHHHHHHhccC--CCCC
Confidence 433221 223469999999999975434578999999999999999999999975433222 111111111111 1111
Q ss_pred CcCcHHHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 040604 525 GVATEEEKKIAKMMILVGFWCIQTNPSERP-----SMHKVLEML 563 (582)
Q Consensus 525 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~~L 563 (582)
. .+...+.+|+.+||+.||++|| +++|+++..
T Consensus 287 ~-------~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 287 Q-------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp T-------TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred c-------ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 1 1234567788899999999999 999998654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=328.17 Aligned_cols=242 Identities=22% Similarity=0.342 Sum_probs=195.2
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC---CHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeeeEEEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC---NGEEFINEVASISRT-SHVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 368 (582)
.+.+.++||+|+||+||+|... +++.||||+++.... ....+.+|+..+.++ +||||+++++++.+....++|||
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e 91 (289)
T 1x8b_A 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNE 91 (289)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEE
Confidence 4556689999999999999775 799999999976432 345688999999998 99999999999999999999999
Q ss_pred ecCCCChhhhhhcCC--CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-----------------
Q 040604 369 LMPNGSLDKFIHNDR--NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED----------------- 429 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~----------------- 429 (582)
|+++++|.+++.... ...+++..++.|+.||+.||+|||+. +|+||||||+|||++.+
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 92 YCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp CCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-------------------
T ss_pred ecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 999999999997642 24689999999999999999999998 99999999999999844
Q ss_pred --CceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchh
Q 040604 430 --FCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSIC 507 (582)
Q Consensus 430 --~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~ 507 (582)
..+||+|||++........ ..||+.|+|||++.+. ..++.++||||||++++||++|..++.....
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~~------~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----- 236 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISSPQV------EEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGDQ----- 236 (289)
T ss_dssp -CCCEEECCCTTCEETTCSCC------CCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-----
T ss_pred CceEEEEcccccccccCCccc------cCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchhH-----
Confidence 4799999999987654332 3499999999998764 3567899999999999999999887643211
Q ss_pred hHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 508 HNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 508 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
...+..+....+.... ...+.+++.+||+.||++|||++++++
T Consensus 237 ----~~~~~~~~~~~~~~~~-------~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 ----WHEIRQGRLPRIPQVL-------SQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ----HHHHHTTCCCCCSSCC-------CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HHHHHcCCCCCCCccc-------CHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1122222222222222 345677888899999999999999975
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=342.35 Aligned_cols=257 Identities=25% Similarity=0.331 Sum_probs=191.5
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
.+.+.++||+|+||+||+|... +++.||||+++..... .+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 114 (329)
T 3gbz_A 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY 114 (329)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEec
Confidence 3556689999999999999754 7999999999754332 34678999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE-----cCCCceEEeecccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL-----DEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl-----~~~~~vkl~DFGla~~~~ 444 (582)
++ |+|.+++.... .+++..++.|+.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 115 ~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 115 AE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp CS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred CC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 96 69999997654 589999999999999999999998 99999999999999 455569999999998765
Q ss_pred ccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCC--
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQ-- 522 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~-- 522 (582)
..... .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||........ ... +.+.+.......
T Consensus 189 ~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~-~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 189 IPIRQ--FTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ-LFK-IFEVLGLPDDTTWP 263 (329)
T ss_dssp -------------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH-HHHHHCCCCTTTST
T ss_pred Ccccc--cCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH-HHH-HHHHhCCCchhhhh
Confidence 43222 1234589999999998763 3589999999999999999999999976543221 111 111111111100
Q ss_pred -----------CCCcCcHHH-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 523 -----------FDGVATEEE-----KKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 523 -----------~~~~~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
+........ ..+...+.+++.+||+.||++|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000000001 113456788999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=331.38 Aligned_cols=262 Identities=19% Similarity=0.251 Sum_probs=204.0
Q ss_pred HHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEE-EeCCeeeEEEEecCC
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFC-YENKKNALIYELMPN 372 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~E~~~~ 372 (582)
+.+.+.||+|+||.||+|.. .+|+.||||++.... ..+.+.+|+.++++++|++++..+..+ .+....++||||+ +
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (296)
T 3uzp_A 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G 88 (296)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-C
Confidence 34568899999999999976 589999999987654 335688999999999988866555555 5667789999999 9
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE---cCCCceEEeeccccccccccccc
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL---DEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl---~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++........
T Consensus 89 ~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (296)
T 3uzp_A 89 PSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp CBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence 99999997433 3699999999999999999999998 99999999999999 58899999999999876554321
Q ss_pred e-----eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccc--hhhHHHHHhhcCCCCCC
Q 040604 450 I-----SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTS--ICHNLIYERIEPGNDFQ 522 (582)
Q Consensus 450 ~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~--~~~~~~~~~i~~~~~~~ 522 (582)
. ......||+.|+|||++.+. .++.++||||||+++|||++|+.||........ .............
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---- 238 (296)
T 3uzp_A 165 QHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP---- 238 (296)
T ss_dssp CBCCCCCSCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC----
T ss_pred cccccccccccccccccCChhhhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc----
Confidence 1 11234699999999998763 689999999999999999999999976433221 1111111111110
Q ss_pred CCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCCC
Q 040604 523 FDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQI 572 (582)
Q Consensus 523 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~~ 572 (582)
.......+...+.+++.+||+.||++|||+++|++.|+........
T Consensus 239 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 239 ----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp ----HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ----hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 0000112345678888999999999999999999999987766543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=335.11 Aligned_cols=248 Identities=28% Similarity=0.401 Sum_probs=198.4
Q ss_pred HHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
..+.+.+.||+|+||+||++... +|+.||+|+++.... ..+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 34566789999999999999765 799999999976543 3456889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE---cCCCceEEeeccccccccccc
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL---DEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl---~~~~~vkl~DFGla~~~~~~~ 447 (582)
++++|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++......
T Consensus 89 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 163 (304)
T 2jam_A 89 SGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163 (304)
T ss_dssp CSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred CCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence 9999999987543 689999999999999999999998 99999999999999 788999999999997654332
Q ss_pred cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcC
Q 040604 448 SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 527 (582)
. ....||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... +.+.+..+.. .+..
T Consensus 164 ~----~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~i~~~~~-~~~~-- 228 (304)
T 2jam_A 164 M----STACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVITYILLCGYPPFYEETESK------LFEKIKEGYY-EFES-- 228 (304)
T ss_dssp T----HHHHSCCCBCCTTTBSS--CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHCCC-CCCT--
T ss_pred c----ccccCCCCccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHcCCC-CCCc--
Confidence 1 12359999999999876 478999999999999999999999997643221 1122222111 0100
Q ss_pred cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 528 TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 528 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.....+...+.+++.+||+.||++|||++++++
T Consensus 229 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 229 -PFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp -TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred -cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001123456778888999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=327.68 Aligned_cols=248 Identities=23% Similarity=0.348 Sum_probs=201.6
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccC----CCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNS----RCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.+.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 16 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 95 (284)
T 2vgo_A 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEF 95 (284)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEe
Confidence 455689999999999999765 6889999998643 23456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++++|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 96 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 169 (284)
T 2vgo_A 96 APRGELYKELQKHG--RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR- 169 (284)
T ss_dssp CTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB-
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccccc-
Confidence 99999999997643 589999999999999999999998 999999999999999999999999999976544322
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....... ....+.... ..++..
T Consensus 170 ---~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~-~~~~~~--- 234 (284)
T 2vgo_A 170 ---RTMCGTLDYLPPEMIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE------THRRIVNVD-LKFPPF--- 234 (284)
T ss_dssp ---CCCCSCGGGCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTTC-CCCCTT---
T ss_pred ---ccccCCCCcCCHHHhcc--CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH------HHHHHhccc-cCCCCc---
Confidence 23469999999999876 367899999999999999999999997643322 111222111 112222
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhccc
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLE--MLEGSI 567 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~--~Le~~~ 567 (582)
+...+.+++.+||+.||++|||++++++ .+....
T Consensus 235 ----~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 235 ----LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp ----SCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred ----CCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 2345677888899999999999999986 444433
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=329.40 Aligned_cols=245 Identities=24% Similarity=0.399 Sum_probs=180.0
Q ss_pred HHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCC----CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSR----CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.+.+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 13 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 92 (278)
T 3cok_A 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEM 92 (278)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEec
Confidence 34568899999999999976 479999999996432 2346789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 93 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 168 (278)
T 3cok_A 93 CHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK 168 (278)
T ss_dssp CTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred CCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc
Confidence 9999999999754 24689999999999999999999998 9999999999999999999999999999876543221
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
. ....||+.|+|||.+.+. .++.++||||||++++||++|+.|+........ . ..+... ....+..
T Consensus 169 ~--~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~-~~~~~~-~~~~~~~--- 234 (278)
T 3cok_A 169 H--YTLCGTPNYISPEIATRS--AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-----L-NKVVLA-DYEMPSF--- 234 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCSS-CCCCCTT---
T ss_pred c--eeccCCCCcCCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-----H-HHHhhc-ccCCccc---
Confidence 1 234599999999998763 678999999999999999999999976533221 1 111111 1111111
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
+...+.+++.+||+.||++|||++++++
T Consensus 235 ----~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 235 ----LSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ----SCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ----cCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 2345677888999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=332.95 Aligned_cols=262 Identities=19% Similarity=0.245 Sum_probs=202.1
Q ss_pred HHHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEE-EeCCeeeEEEEecC
Q 040604 294 TKSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFC-YENKKNALIYELMP 371 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~E~~~ 371 (582)
.+.+.+.||+|+||+||+|.. .+++.||||++..... .+.+.+|+.++++++|++++..++.+ .+....++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 4hgt_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp -CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred ceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-
Confidence 355678999999999999975 5899999998765432 24578899999999988866666555 5667889999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE---cCCCceEEeecccccccccccc
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL---DEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl---~~~~~vkl~DFGla~~~~~~~~ 448 (582)
+++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 88 ~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 88 GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 999999997532 3699999999999999999999998 99999999999999 7889999999999987655432
Q ss_pred ce-----eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccc--hhhHHHHHhhcCCCCC
Q 040604 449 AI-----SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTS--ICHNLIYERIEPGNDF 521 (582)
Q Consensus 449 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~--~~~~~~~~~i~~~~~~ 521 (582)
.. ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||........ .............
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 238 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--- 238 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC---
T ss_pred CccCCCCcccccCCCccccchHHhcCC--CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch---
Confidence 11 11234699999999999764 689999999999999999999999976443321 1111111111110
Q ss_pred CCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCC
Q 040604 522 QFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQ 571 (582)
Q Consensus 522 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~ 571 (582)
.......+...+.+++.+||+.||++|||+++|++.|++.+....
T Consensus 239 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 239 -----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp -----HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -----hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 000011224567888899999999999999999999998776544
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=327.02 Aligned_cols=247 Identities=27% Similarity=0.377 Sum_probs=195.4
Q ss_pred hhcCccCceEEEEEEe-CCCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCChh
Q 040604 299 DKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLD 376 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 376 (582)
..||+|+||.||+|.. .+++.||||++..... ..+.+.+|+.++++++||||+++++++.+....++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 4799999999999975 4789999999976543 3567899999999999999999999999999999999999999999
Q ss_pred hhhhcC-CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-CCceEEeeccccccccccccceeeec
Q 040604 377 KFIHND-RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE-DFCPKISDFGLAKQAQKKESAISMLH 454 (582)
Q Consensus 377 ~~i~~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~-~~~vkl~DFGla~~~~~~~~~~~~~~ 454 (582)
+++... ....+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++........ ...
T Consensus 108 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~--~~~ 182 (295)
T 2clq_A 108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--TET 182 (295)
T ss_dssp HHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CC
T ss_pred HHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc--ccc
Confidence 999765 334577899999999999999999998 9999999999999987 899999999999876543221 123
Q ss_pred ccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHH
Q 040604 455 ARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKI 534 (582)
Q Consensus 455 ~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 534 (582)
..||+.|+|||++.+....++.++||||||+++|||++|+.||.......... ....... ....+... +
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~-~~~~~~~~-------~ 251 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM---FKVGMFK-VHPEIPES-------M 251 (295)
T ss_dssp CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH---HHHHHHC-CCCCCCTT-------S
T ss_pred cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH---Hhhcccc-cccccccc-------C
Confidence 46999999999987643347899999999999999999999996543222111 1111111 11112222 2
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 535 AKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 535 ~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
...+.+++.+||+.||++|||++++++
T Consensus 252 ~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 252 SAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 345677888999999999999999985
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=339.94 Aligned_cols=258 Identities=22% Similarity=0.353 Sum_probs=196.2
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCH---HHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNG---EEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
+.+.+.||+|+||.||+|... +|+.||||++....... +.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 106 (331)
T 4aaa_A 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV 106 (331)
T ss_dssp EEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred heeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecC
Confidence 445679999999999999765 69999999987655443 45789999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 107 ~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 180 (331)
T 4aaa_A 107 DHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV- 180 (331)
T ss_dssp SEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred CcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc-
Confidence 9999988876443 589999999999999999999998 9999999999999999999999999999876543322
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHH---------------hh
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYE---------------RI 515 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---------------~i 515 (582)
.....||+.|+|||++.+. ..++.++||||||+++|||++|+.||......... ...+.. ..
T Consensus 181 -~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 181 -YDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQL-YHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ----CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCSCCHHHHHHHHHCGG
T ss_pred -cCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHHHhCCCChhhhhHhhhccc
Confidence 1234699999999998763 36789999999999999999999999765433211 111000 00
Q ss_pred cCCC-CCCCCCcCc--HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 516 EPGN-DFQFDGVAT--EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 516 ~~~~-~~~~~~~~~--~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
..+. ...+..... .....+...+.+++.+||+.||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 000101111 111134567888999999999999999999875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=340.44 Aligned_cols=259 Identities=25% Similarity=0.331 Sum_probs=196.9
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC------HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN------GEEFINEVASISRTSHVNIVTFLGFCYENKKNALI 366 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 366 (582)
.+.+.+.||+|+||.||+|... +|+.||||+++..... .+.+.+|+.++++++||||+++++++.+....++|
T Consensus 11 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 90 (346)
T 1ua2_A 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLV 90 (346)
T ss_dssp --CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEE
T ss_pred ccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEE
Confidence 4556789999999999999765 6899999999753221 24688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccc
Q 040604 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~ 446 (582)
|||+++ +|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 91 ~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 91 FDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp EECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred EEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 999964 888888654 34688889999999999999999998 9999999999999999999999999999876543
Q ss_pred ccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCC-
Q 040604 447 ESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG- 525 (582)
Q Consensus 447 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~- 525 (582)
... .....||+.|+|||++.+. ..++.++||||||+++|||++|..|+....... .... +.+.........+..
T Consensus 166 ~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~-~~~~-i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 166 NRA--YTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTR-IFETLGTPTEEQWPDM 240 (346)
T ss_dssp CCC--CCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH-HHHHHCCCCTTTSSST
T ss_pred ccc--CCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHH-HHHHcCCCChhhhhhh
Confidence 322 2234699999999998653 357899999999999999999999887653322 1111 112111111100000
Q ss_pred -----------cC--c--HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 526 -----------VA--T--EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 526 -----------~~--~--~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
.. + .........+.+++.+||+.||++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 0 0012234667889999999999999999999875
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=334.13 Aligned_cols=254 Identities=19% Similarity=0.285 Sum_probs=198.0
Q ss_pred HHHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCCHHHHHHHHHHHhccC-CCceEEEEeEEEe--CCeeeEEEEe
Q 040604 294 TKSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNGEEFINEVASISRTS-HVNIVTFLGFCYE--NKKNALIYEL 369 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~E~ 369 (582)
.+.+.++||+|+||+||+|.. .+++.||||+++.. ..+.+.+|+.++++++ ||||+++++++.+ ....++||||
T Consensus 37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~ 114 (330)
T 3nsz_A 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114 (330)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred ceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence 345668999999999999965 57999999999743 4678999999999997 9999999999987 5678999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-ceEEeecccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF-CPKISDFGLAKQAQKKES 448 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~-~vkl~DFGla~~~~~~~~ 448 (582)
+++++|.+++. .+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++.......
T Consensus 115 ~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~ 186 (330)
T 3nsz_A 115 VNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 186 (330)
T ss_dssp CCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC
T ss_pred cCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc
Confidence 99999999885 388899999999999999999998 999999999999999776 899999999987655433
Q ss_pred ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHH--------HHhhcC---
Q 040604 449 AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLI--------YERIEP--- 517 (582)
Q Consensus 449 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~--------~~~i~~--- 517 (582)
. ....||+.|+|||++.+. ..++.++||||||++++||++|+.||.............. .+.+..
T Consensus 187 ~---~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 187 Y---NVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp C---CSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred c---ccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 2 234699999999998753 4689999999999999999999999965443322111100 000000
Q ss_pred ------------CCCCCCCCc-CcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 518 ------------GNDFQFDGV-ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 518 ------------~~~~~~~~~-~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.....+... .......+...+.+++.+||+.||++|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000000 00111124567888999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=338.22 Aligned_cols=261 Identities=21% Similarity=0.290 Sum_probs=197.5
Q ss_pred HHHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeC--------C
Q 040604 294 TKSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYEN--------K 361 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~ 361 (582)
.+.+.++||+|+||+||+|.. .+|+.||||++..... ....+.+|+.++++++||||+++++++... .
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (351)
T 3mi9_A 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 97 (351)
T ss_dssp GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence 345668999999999999976 4799999999865432 245788999999999999999999999873 4
Q ss_pred eeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccc
Q 040604 362 KNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAK 441 (582)
Q Consensus 362 ~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~ 441 (582)
..++||||++ ++|.+.+.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 98 ~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 98 SIYLVFDFCE-HDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp EEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eEEEEEeccC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 6789999996 57777776432 3689999999999999999999998 99999999999999999999999999998
Q ss_pred ccccccc--ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCC
Q 040604 442 QAQKKES--AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGN 519 (582)
Q Consensus 442 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~ 519 (582)
....... ........||+.|+|||++.+. ..++.++||||||++++||++|+.||........ ...+........
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~~~ 249 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ--LALISQLCGSIT 249 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCC
T ss_pred cccccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCC
Confidence 7653221 1122345689999999998753 4679999999999999999999999976543221 111111111111
Q ss_pred CCCCC---------------CcCcHHHHH-----HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 520 DFQFD---------------GVATEEEKK-----IAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 520 ~~~~~---------------~~~~~~~~~-----~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
..... ......... ....+.+|+.+||+.||++|||++|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00000 000001111 13457889999999999999999999863
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=327.69 Aligned_cols=245 Identities=27% Similarity=0.416 Sum_probs=192.4
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccC----CCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNS----RCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.+.+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 92 (276)
T 2h6d_A 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEY 92 (276)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEec
Confidence 445688999999999999875 7999999998643 23456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++++|.+++.... .+++..++.++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||++.........
T Consensus 93 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (276)
T 2h6d_A 93 VSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 167 (276)
T ss_dssp CCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred cCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCcce
Confidence 99999999997643 589999999999999999999998 9999999999999999999999999999876554322
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
....||+.|+|||.+.+. ...+.++||||||+++++|++|+.||....... +.+.+..+. ..++..
T Consensus 168 ---~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~-~~~~~~--- 233 (276)
T 2h6d_A 168 ---RTSCGSPNYAAPEVISGR-LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT------LFKKIRGGV-FYIPEY--- 233 (276)
T ss_dssp ------------CCTGGGTTS-CCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC-CCCCTT---
T ss_pred ---ecccCCccccCHHHHcCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH------HHHHhhcCc-ccCchh---
Confidence 234599999999998764 234689999999999999999999997643221 122222211 111111
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
+...+.+++.+||+.||++|||++++++.
T Consensus 234 ----~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 234 ----LNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----cCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 23456778889999999999999999874
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=350.17 Aligned_cols=197 Identities=24% Similarity=0.325 Sum_probs=171.6
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhcc------CCCceEEEEeEEEeCCeeeEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRT------SHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~~lv~ 367 (582)
+.+.++||+|+||+||+|... +++.||||+++......+.+.+|+.+++.+ +|+||+++++++......++||
T Consensus 99 y~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 178 (429)
T 3kvw_A 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTF 178 (429)
T ss_dssp EEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEE
T ss_pred EEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEE
Confidence 456689999999999999665 689999999987654556778888888877 5779999999999999999999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc--eEEeeccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFC--PKISDFGLAKQAQK 445 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~--vkl~DFGla~~~~~ 445 (582)
||+ +++|.+++.......+++..++.|+.||+.||+|||+. +|+||||||+|||++.++. +||+|||++.....
T Consensus 179 e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~ 254 (429)
T 3kvw_A 179 ELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ 254 (429)
T ss_dssp CCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred ecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceecCC
Confidence 999 57999999877666799999999999999999999998 9999999999999999887 99999999976543
Q ss_pred cccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCc
Q 040604 446 KESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVT 502 (582)
Q Consensus 446 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~ 502 (582)
.. ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 255 ~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 255 RV-----YTYIQSRFYRAPEVILGA--RYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp CC-----CSSCSCGGGCCHHHHHTB--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cc-----cccCCCCCccChHHHhCC--CCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 32 234699999999999764 689999999999999999999999976543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=355.20 Aligned_cols=247 Identities=23% Similarity=0.316 Sum_probs=199.1
Q ss_pred hhhhcCccCceEEEEEEeC-CCcEEEEEEeccC----CCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 297 FRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNS----RCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 297 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
+.+.||+|+||+||++... +|+.||||++++. ....+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 189 ~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~ 268 (543)
T 3c4z_A 189 DFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMN 268 (543)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEecc
Confidence 3467999999999999775 7999999999653 2345678999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCC--CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 372 NGSLDKFIHNDR--NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 372 ~gsL~~~i~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
||+|.+++.... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.+|.+||+|||+++........
T Consensus 269 gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~ 345 (543)
T 3c4z_A 269 GGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345 (543)
T ss_dssp TCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC
T ss_pred CCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc
Confidence 999999987643 44699999999999999999999998 9999999999999999999999999999876554322
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ... +.+.+.... ..++..
T Consensus 346 --~~~~~GT~~Y~APE~l~~--~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~-~~~-~~~~i~~~~-~~~p~~--- 415 (543)
T 3c4z_A 346 --TKGYAGTPGFMAPELLLG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKE-LKQRVLEQA-VTYPDK--- 415 (543)
T ss_dssp --BCCCCSCTTTSCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC-HHH-HHHHHHHCC-CCCCTT---
T ss_pred --cccccCCccccChhhhcC--CCCChHHhcCcchHHHHHHHhCCCCCCCCccchh-HHH-HHHHHhhcc-cCCCcc---
Confidence 123469999999999976 3789999999999999999999999976543221 111 222221111 112222
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCH-----HHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSM-----HKVL 560 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~-----~evl 560 (582)
+...+.+++.+||+.||++||++ ++|+
T Consensus 416 ----~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~ 447 (543)
T 3c4z_A 416 ----FSPASKDFCEALLQKDPEKRLGFRDGSCDGLR 447 (543)
T ss_dssp ----SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHH
T ss_pred ----cCHHHHHHHHHhccCCHhHCCCCcccCHHHHH
Confidence 23456677888999999999975 6665
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=348.23 Aligned_cols=260 Identities=23% Similarity=0.280 Sum_probs=200.0
Q ss_pred HHHHHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCCHHHHHHHHHHHhccC--------CCceEEEEeEEE----
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNGEEFINEVASISRTS--------HVNIVTFLGFCY---- 358 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~---- 358 (582)
..++.+.++||+|+||+||+|.. .+++.||||+++......+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 34566778999999999999975 47899999999866555677889999999985 788999999997
Q ss_pred eCCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC--------
Q 040604 359 ENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF-------- 430 (582)
Q Consensus 359 ~~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~-------- 430 (582)
+....++||||+ +++|.+.+.......+++..++.|+.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhh
Confidence 456789999999 777777776555557999999999999999999999852 899999999999999775
Q ss_pred -----------------------------------------ceEEeeccccccccccccceeeecccCCccccccccccc
Q 040604 431 -----------------------------------------CPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSR 469 (582)
Q Consensus 431 -----------------------------------------~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 469 (582)
.+||+|||+++...... ....||+.|+|||++.+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCSCGGGCCHHHHHT
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccCCCCCcccCChhhcC
Confidence 79999999998765432 23469999999999976
Q ss_pred ccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccch----hhHHHHHhhcCCC------------------C-CCCCCc
Q 040604 470 RFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSI----CHNLIYERIEPGN------------------D-FQFDGV 526 (582)
Q Consensus 470 ~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~----~~~~~~~~i~~~~------------------~-~~~~~~ 526 (582)
. .++.++|||||||++|||++|+.||......... ....+.+.+.... . ..+...
T Consensus 268 ~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 268 S--GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp S--CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred C--CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 3 6899999999999999999999999765432210 0111111111100 0 000000
Q ss_pred Cc-----------HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 527 AT-----------EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 527 ~~-----------~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.. .........+.+|+.+||+.||++|||++||++
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00 012345677889999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=338.55 Aligned_cols=263 Identities=23% Similarity=0.311 Sum_probs=185.9
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC-CHHHHHHHHHHHhccC-CCceEEEEeEEE--------eCCe
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC-NGEEFINEVASISRTS-HVNIVTFLGFCY--------ENKK 362 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~~~~ 362 (582)
++.+.++||+|+||.||+|... +++.||||++..... ..+.+.+|+.+++++. ||||+++++++. ....
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 108 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE 108 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence 3456789999999999999764 789999999865432 3456889999999996 999999999995 2345
Q ss_pred eeEEEEecCCCChhhhhhcC-CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCc--eEecCCCCCCEEEcCCCceEEeeccc
Q 040604 363 NALIYELMPNGSLDKFIHND-RNIKLEWKTMYQIAIGIARGLEYLHRGCQVR--IVHFDIKPQNILLDEDFCPKISDFGL 439 (582)
Q Consensus 363 ~~lv~E~~~~gsL~~~i~~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~--ivH~Dikp~NILl~~~~~vkl~DFGl 439 (582)
.++||||+ +|+|.+++... ....+++..++.++.||+.||+|||+. + |+||||||+|||++.++.+||+|||+
T Consensus 109 ~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 109 FLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred EEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 78999999 58998888642 334699999999999999999999997 7 99999999999999999999999999
Q ss_pred cccccccccce----------eeecccCCccccccccccc-ccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhh
Q 040604 440 AKQAQKKESAI----------SMLHARGTIGYIAPEVYSR-RFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICH 508 (582)
Q Consensus 440 a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~ 508 (582)
++......... ......||+.|+|||++.. ....++.++||||||+++|||++|+.||.......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---- 260 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---- 260 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----
Confidence 98765432211 1112359999999999832 12467899999999999999999999997543221
Q ss_pred HHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCCCCCCC
Q 040604 509 NLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQIPPKP 576 (582)
Q Consensus 509 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~~p~~p 576 (582)
.+..... ....... ...+.+++.+||+.||++|||++|+++.|+.........+.+
T Consensus 261 -~~~~~~~----~~~~~~~-------~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~ 316 (337)
T 3ll6_A 261 -IVNGKYS----IPPHDTQ-------YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKS 316 (337)
T ss_dssp ------CC----CCTTCCS-------SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTS
T ss_pred -hhcCccc----CCccccc-------chHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCc
Confidence 1111111 1111111 123567788899999999999999999999877655544443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=365.67 Aligned_cols=245 Identities=23% Similarity=0.310 Sum_probs=200.1
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccC----CCCHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeeeEEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNS----RCNGEEFINEVASISRT-SHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 367 (582)
.+++.+.||+|+||+||+|... +++.||||++++. ....+.+..|..++..+ +|+||+++++++.+.+..+|||
T Consensus 342 ~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~ 421 (674)
T 3pfq_A 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 421 (674)
T ss_dssp TEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEE
T ss_pred ceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEE
Confidence 3456678999999999999765 7899999999753 33456788999999987 7999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
||+++|+|.+++...+ .+++..++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 422 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 422 EYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred eCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 9999999999998643 689999999999999999999998 99999999999999999999999999998643332
Q ss_pred cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcC
Q 040604 448 SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 527 (582)
.. .....||+.|+|||++.+ ..++.++|||||||+||||++|+.||....... +.+.+.... ..++..
T Consensus 497 ~~--~~~~~GT~~Y~APE~l~~--~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~~-~~~p~~- 564 (674)
T 3pfq_A 497 VT--TKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------LFQSIMEHN-VAYPKS- 564 (674)
T ss_dssp CC--BCCCCSCSSSCCHHHHTC--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHSSC-CCCCTT-
T ss_pred cc--cccccCCCcccCHhhhcC--CCCCccceEechHHHHHHHHcCCCCCCCCCHHH------HHHHHHhCC-CCCCcc-
Confidence 21 234579999999999976 478999999999999999999999997653322 223332221 222222
Q ss_pred cHHHHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 040604 528 TEEEKKIAKMMILVGFWCIQTNPSERPSM-----HKVLE 561 (582)
Q Consensus 528 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~-----~evl~ 561 (582)
+...+.+|+.+||+.||++||++ +||++
T Consensus 565 ------~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 565 ------MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ------SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ------CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 33556778888999999999997 66663
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=340.88 Aligned_cols=249 Identities=22% Similarity=0.295 Sum_probs=190.0
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEeCC------eee
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYENK------KNA 364 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~ 364 (582)
|.+.+.||+|+||.||+|... +|+.||||++...... .+.+.+|+.++++++||||+++++++.... ..+
T Consensus 27 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 106 (367)
T 1cm8_A 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 106 (367)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEE
Confidence 345678999999999999764 7999999999654333 356789999999999999999999997653 459
Q ss_pred EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccc
Q 040604 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~ 444 (582)
+||||+ +++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 107 lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 107 LVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp EEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 999999 89999999763 589999999999999999999998 99999999999999999999999999998765
Q ss_pred ccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcC-------
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEP------- 517 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~------- 517 (582)
... ....||+.|+|||++.+. ..++.++||||+||+++||++|+.||........ +.. +.+....
T Consensus 180 ~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-l~~-i~~~~g~~~~~~~~ 251 (367)
T 1cm8_A 180 SEM-----TGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKE-IMKVTGTPPAEFVQ 251 (367)
T ss_dssp SSC-----CSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH-HHHHHCCCCHHHHH
T ss_pred ccc-----CcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH-HHHhcCCCCHHHHH
Confidence 432 234699999999998763 4689999999999999999999999976543221 111 1111100
Q ss_pred ----------------CCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 518 ----------------GNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 518 ----------------~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
.....+.... ......+.+|+.+||+.||++|||++|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 252 RLQSDEAKNYMKGLPELEKKDFASIL----TNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTC----TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhhhHHHHHHHHhCCCCCCCCHHHHC----CCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0000010000 1223557788889999999999999999873
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=327.12 Aligned_cols=245 Identities=27% Similarity=0.387 Sum_probs=199.5
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC----CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.+.+.||+|+||.||++... +++.+|+|++..... ..+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 96 (294)
T 2rku_A 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 96 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEec
Confidence 345688999999999999765 688999999865432 235688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 97 ~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 171 (294)
T 2rku_A 97 CRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 171 (294)
T ss_dssp CTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence 99999999887543 689999999999999999999998 9999999999999999999999999999876533222
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
.....||+.|+|||.+.+ ..++.++||||||+++++|++|+.||....... ....+.... ..+...
T Consensus 172 --~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~-~~~~~~--- 237 (294)
T 2rku_A 172 --KKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRIKKNE-YSIPKH--- 237 (294)
T ss_dssp --BCCCCSCCSSCCHHHHTT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTTC-CCCCTT---
T ss_pred --cccccCCCCcCCcchhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHhhcc-CCCccc---
Confidence 123469999999999876 367899999999999999999999997653322 111222211 112222
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
+...+.+++.+||+.||++|||++++++.
T Consensus 238 ----~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 238 ----INPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ----cCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 22456778888999999999999999863
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=333.53 Aligned_cols=261 Identities=25% Similarity=0.420 Sum_probs=204.2
Q ss_pred HHhhhhcCccCceEEEEEEe-----CCCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCC--eeeEE
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-----PDGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENK--KNALI 366 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 366 (582)
+.+.++||+|+||.||++.. .+++.||||++..... ..+.+.+|+.++++++||||+++++++.... ..++|
T Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 122 (326)
T 2w1i_A 43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 122 (326)
T ss_dssp EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEE
T ss_pred ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEE
Confidence 45668999999999999973 3689999999976443 2457899999999999999999999987654 67999
Q ss_pred EEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccc
Q 040604 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~ 446 (582)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 123 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~ 198 (326)
T 2w1i_A 123 MEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 198 (326)
T ss_dssp ECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCSS
T ss_pred EECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhcccc
Confidence 99999999999998653 3589999999999999999999998 9999999999999999999999999999887654
Q ss_pred cccee-eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCc----------ccchhhHHHHHhh
Q 040604 447 ESAIS-MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVT----------DTSICHNLIYERI 515 (582)
Q Consensus 447 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~----------~~~~~~~~~~~~i 515 (582)
..... .....+|..|+|||.+.+ ..++.++||||||+++|||++|..|+..... ........+.+.+
T Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (326)
T 2w1i_A 199 KEYYKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276 (326)
T ss_dssp CSEEECSSCCSCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred ccccccccCCCCceeEECchhhcC--CCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence 33211 123357888999999876 3678999999999999999999988753210 0001111122233
Q ss_pred cCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 516 EPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
.......... .+...+.+++.+||+.||++|||+++|++.|++..+
T Consensus 277 ~~~~~~~~~~-------~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 277 KNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HTTCCCCCCT-------TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCCCCCCCC-------cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 3322222221 123567788889999999999999999999987654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=341.21 Aligned_cols=253 Identities=24% Similarity=0.356 Sum_probs=201.9
Q ss_pred HHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCH------------------HHHHHHHHHHhccCCCceEEEEe
Q 040604 294 TKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNG------------------EEFINEVASISRTSHVNIVTFLG 355 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------~~~~~E~~~l~~l~h~niv~l~~ 355 (582)
.+.+.+.||+|+||.||+|.. +|+.||||++....... +.+.+|+.++++++||||+++++
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 110 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG 110 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred ceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 345668999999999999988 99999999986432111 78999999999999999999999
Q ss_pred EEEeCCeeeEEEEecCCCChhhh------hhcCCCcCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCCEEEcC
Q 040604 356 FCYENKKNALIYELMPNGSLDKF------IHNDRNIKLEWKTMYQIAIGIARGLEYLHR-GCQVRIVHFDIKPQNILLDE 428 (582)
Q Consensus 356 ~~~~~~~~~lv~E~~~~gsL~~~------i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~ivH~Dikp~NILl~~ 428 (582)
++.+.+..++||||+++++|.++ +.......+++..++.++.|++.||+|||+ . +|+||||||+|||++.
T Consensus 111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMDK 187 (348)
T ss_dssp EEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEECT
T ss_pred EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEcC
Confidence 99999999999999999999999 655445679999999999999999999998 7 9999999999999999
Q ss_pred CCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCc-cchhHHHHHHHHHHhcCCCCCCCCCcccchh
Q 040604 429 DFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSH-KSDVYSYGMMIIEMVGCTKNLDDEVTDTSIC 507 (582)
Q Consensus 429 ~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~-~~DvwSlGvil~elltg~~p~~~~~~~~~~~ 507 (582)
++.+||+|||++...... ......||+.|+|||++.+. ..++. ++||||||++++||++|+.||........
T Consensus 188 ~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-- 260 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE-- 260 (348)
T ss_dssp TSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH--
T ss_pred CCcEEEeccccccccccc----cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--
Confidence 999999999999876543 22345699999999998763 24555 99999999999999999999976544222
Q ss_pred hHHHHHhhcCCCCCCCCC--------cC----cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 508 HNLIYERIEPGNDFQFDG--------VA----TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 508 ~~~~~~~i~~~~~~~~~~--------~~----~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
+.+.+..+.. .++. .. ......+...+.+++.+||+.||++|||++|+++
T Consensus 261 ---~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 261 ---LFNNIRTKNI-EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp ---HHHHHTSCCC-CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ---HHHHHhccCc-CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1222222211 1110 00 0011234466788899999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=328.22 Aligned_cols=245 Identities=26% Similarity=0.372 Sum_probs=200.8
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC--CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR--CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
+.+.++||+|+||.||+|... +++.||||++.... ...+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 103 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence 445688999999999999754 79999999997543 345789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
+++|.+++.. ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 104 ~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 175 (303)
T 3a7i_A 104 GGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-- 175 (303)
T ss_dssp TEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC--
T ss_pred CCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccccc--
Confidence 9999999864 3689999999999999999999998 9999999999999999999999999999876543322
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHH
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 531 (582)
.....||+.|+|||++.+ ..++.++||||||+++|||++|+.|+....... ....+.......+....
T Consensus 176 ~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~---- 243 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELARGEPPHSELHPMK------VLFLIPKNNPPTLEGNY---- 243 (303)
T ss_dssp BCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSCCCCCCSSC----
T ss_pred cCccCCCcCccCHHHHhc--CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH------HHHHhhcCCCCCCcccc----
Confidence 123469999999999876 468899999999999999999999987543221 11112112222222222
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 532 KKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
...+.+++.+||+.||++|||++++++.
T Consensus 244 ---~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 244 ---SKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp ---CHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ---CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 3456778888999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=330.29 Aligned_cols=251 Identities=23% Similarity=0.309 Sum_probs=199.0
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEe--CCeeeEEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYE--NKKNALIYE 368 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E 368 (582)
+.+.+.||+|+||+||++... +++.||+|++...... .+.+.+|+.++++++||||+++++++.+ ....++|||
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 87 (279)
T 2w5a_A 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 87 (279)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEE
T ss_pred eeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEe
Confidence 445688999999999999765 7999999999765433 3568899999999999999999998864 457899999
Q ss_pred ecCCCChhhhhhcC--CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCc-----eEecCCCCCCEEEcCCCceEEeeccccc
Q 040604 369 LMPNGSLDKFIHND--RNIKLEWKTMYQIAIGIARGLEYLHRGCQVR-----IVHFDIKPQNILLDEDFCPKISDFGLAK 441 (582)
Q Consensus 369 ~~~~gsL~~~i~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~-----ivH~Dikp~NILl~~~~~vkl~DFGla~ 441 (582)
|+++++|.+++... ....+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 88 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp CCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred CCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999753 234589999999999999999999997 6 9999999999999999999999999998
Q ss_pred cccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCC
Q 040604 442 QAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDF 521 (582)
Q Consensus 442 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~ 521 (582)
......... ....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....... +.+.+..+...
T Consensus 165 ~~~~~~~~~--~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~i~~~~~~ 234 (279)
T 2w5a_A 165 ILNHDTSFA--KTFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------LAGKIREGKFR 234 (279)
T ss_dssp HC---CHHH--HHHHSCCTTCCHHHHHC--C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCCC
T ss_pred eeccccccc--cccCCCccccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH------HHHHHhhcccc
Confidence 765432211 12359999999999876 368899999999999999999999997653221 22222222222
Q ss_pred CCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 522 QFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 522 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
.+... ....+.+++.+||+.||++|||++||++.+..
T Consensus 235 ~~~~~-------~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 235 RIPYR-------YSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CCCTT-------SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cCCcc-------cCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 22222 23557778889999999999999999987654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=338.55 Aligned_cols=257 Identities=22% Similarity=0.288 Sum_probs=197.2
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeC-----CeeeEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYEN-----KKNALI 366 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv 366 (582)
+.+.++||+|+||.||+|... +++.||||++...... .+.+.+|+.++++++||||+++++++... ...++|
T Consensus 29 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv 108 (364)
T 3qyz_A 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIV 108 (364)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred EEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEE
Confidence 456689999999999999765 7889999999754432 25688999999999999999999999754 367899
Q ss_pred EEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccc
Q 040604 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~ 446 (582)
|||+. |+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 109 ~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 109 QDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp EECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 99995 6999988753 589999999999999999999998 9999999999999999999999999999876544
Q ss_pred cccee-eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCC---
Q 040604 447 ESAIS-MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQ--- 522 (582)
Q Consensus 447 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~--- 522 (582)
..... .....||+.|+|||++.+. ..++.++||||||+++|||++|+.||........ ... +...+.......
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~-i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNH-ILGILGSPSQEDLNC 258 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH-HHH-HHHHHCSCCHHHHHT
T ss_pred CCccccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH-HHH-HHHHhCCCCHHHHHH
Confidence 32211 1234699999999987653 4589999999999999999999999976543321 111 111111100000
Q ss_pred --------------CCCcCc--HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 523 --------------FDGVAT--EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 523 --------------~~~~~~--~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
...... .....+...+.+|+.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 000123456788999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=337.46 Aligned_cols=254 Identities=25% Similarity=0.265 Sum_probs=188.4
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEeCC------eee
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYENK------KNA 364 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~ 364 (582)
+.+.+.||+|+||.||+|... +++.||||++...... .+.+.+|+.++++++||||+++++++.... ..+
T Consensus 27 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 106 (371)
T 2xrw_A 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 106 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEE
T ss_pred eeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceE
Confidence 445688999999999999754 7899999999764333 356789999999999999999999997654 679
Q ss_pred EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccc
Q 040604 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~ 444 (582)
+||||++ ++|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 107 lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 107 IVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp EEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred EEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 9999995 678888753 488999999999999999999998 99999999999999999999999999998765
Q ss_pred ccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHH-------------
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLI------------- 511 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~------------- 511 (582)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ....+
T Consensus 179 ~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 179 TSFM---MTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFMKK 252 (371)
T ss_dssp --------------CTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHC-CCCCCHHHHTT
T ss_pred cccc---cCCceecCCccCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHH
Confidence 4322 123469999999999976 3689999999999999999999999976543211 00000
Q ss_pred -----HHhhcCCCCC---C--------CCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 512 -----YERIEPGNDF---Q--------FDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 512 -----~~~i~~~~~~---~--------~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
...+...... . ..+...+........+.+|+.+||+.||++|||++|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000000000 0 0011122233456778999999999999999999999863
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=331.18 Aligned_cols=250 Identities=29% Similarity=0.382 Sum_probs=195.2
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhcc-CCCceEEEEeEEEe------CCeeeEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRT-SHVNIVTFLGFCYE------NKKNALI 366 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~~~~~lv 366 (582)
+.+.+.||+|+||.||+|... +|+.||||++.......+.+.+|+.+++++ +||||+++++++.. ....++|
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv 105 (326)
T 2x7f_A 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV 105 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEE
T ss_pred EEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEE
Confidence 345689999999999999764 799999999987766778899999999999 89999999999987 4578999
Q ss_pred EEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccc
Q 040604 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~ 446 (582)
|||+++++|.+++.......+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 182 (326)
T 2x7f_A 106 MEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182 (326)
T ss_dssp EECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC-----
T ss_pred EEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecCcC
Confidence 9999999999999876656799999999999999999999998 9999999999999999999999999999876543
Q ss_pred ccceeeecccCCcccccccccccc---cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCC
Q 040604 447 ESAISMLHARGTIGYIAPEVYSRR---FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQF 523 (582)
Q Consensus 447 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~ 523 (582)
... .....||+.|+|||++... ...++.++||||||+++|+|++|+.||........ +............
T Consensus 183 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~ 255 (326)
T 2x7f_A 183 VGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-----LFLIPRNPAPRLK 255 (326)
T ss_dssp ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHSCCCCCS
T ss_pred ccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-----HHHhhcCccccCC
Confidence 221 1234599999999998621 24688999999999999999999999975433221 1111111111111
Q ss_pred CCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 524 DGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 524 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
... +...+.+++.+||+.||++||+++++++
T Consensus 256 ~~~-------~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 256 SKK-------WSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CSC-------SCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccc-------cCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111 2345677888999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=342.96 Aligned_cols=259 Identities=21% Similarity=0.291 Sum_probs=181.0
Q ss_pred hhhcCccCceEEEEEEeC---CCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEe--CCeeeEEEEecCC
Q 040604 298 RDKLGQGGYGEVYKGELP---DGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYE--NKKNALIYELMPN 372 (582)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E~~~~ 372 (582)
.++||+|+||+||+|... +++.||||++.... ..+.+.+|+.+|++++||||+++++++.. ....++||||+.
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~- 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-
Confidence 357999999999999864 57899999997654 34578899999999999999999999965 567899999995
Q ss_pred CChhhhhhcC-------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE----cCCCceEEeeccccc
Q 040604 373 GSLDKFIHND-------RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL----DEDFCPKISDFGLAK 441 (582)
Q Consensus 373 gsL~~~i~~~-------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl----~~~~~vkl~DFGla~ 441 (582)
++|.+++... ....+++..++.|+.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 104 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 180 (405)
T 3rgf_A 104 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180 (405)
T ss_dssp EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC
T ss_pred CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCce
Confidence 6888777532 223589999999999999999999998 99999999999999 778999999999998
Q ss_pred cccccccc-eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccc-------hhhHHHHH
Q 040604 442 QAQKKESA-ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTS-------ICHNLIYE 513 (582)
Q Consensus 442 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~-------~~~~~~~~ 513 (582)
........ .......||+.|+|||++.+. ..++.++|||||||++|||++|+.||........ .....+.+
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~ 259 (405)
T 3rgf_A 181 LFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 259 (405)
T ss_dssp ----------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred ecCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence 76543211 122235699999999998763 3589999999999999999999999975433210 00111111
Q ss_pred hhcCCCCCCCCCc--CcHH-----------------HH-------HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 514 RIEPGNDFQFDGV--ATEE-----------------EK-------KIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 514 ~i~~~~~~~~~~~--~~~~-----------------~~-------~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
.+.......+... .... .. .....+.+|+.+||+.||++|||++|+++.
T Consensus 260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 1211111111000 0000 00 003456788999999999999999999863
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=352.60 Aligned_cols=258 Identities=19% Similarity=0.254 Sum_probs=202.7
Q ss_pred HHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCCHHHHHHHHHHHhccCC-CceEEEEeEEEeCCeeeEEEEecCC
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNGEEFINEVASISRTSH-VNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
+.+.++||+|+||.||+|.. .+++.||||++..... .+.+.+|+.+++.++| +++..+..++.+....+|||||+ +
T Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g 86 (483)
T 3sv0_A 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (483)
T ss_dssp EECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-C
Confidence 45668999999999999975 5799999999865442 3457899999999987 55666777777888899999999 9
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE---cCCCceEEeeccccccccccccc
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL---DEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl---~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
++|.+++.... ..+++..++.|+.||+.||+|||+. +|+||||||+|||| +.++.+||+|||+++........
T Consensus 87 ~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (483)
T 3sv0_A 87 PSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (483)
T ss_dssp CBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence 99999997532 3699999999999999999999998 99999999999999 68899999999999876654322
Q ss_pred e-----eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccc--hhhHHHHHhhcCCCCCC
Q 040604 450 I-----SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTS--ICHNLIYERIEPGNDFQ 522 (582)
Q Consensus 450 ~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~--~~~~~~~~~i~~~~~~~ 522 (582)
. ......||+.|+|||++.+. .++.++|||||||+||||++|+.||........ .+.......+..
T Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~----- 235 (483)
T 3sv0_A 163 QHIPYRENKNLTGTARYASVNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT----- 235 (483)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS-----
T ss_pred cccccccccccCCCccccCHHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc-----
Confidence 1 11245699999999999763 789999999999999999999999976544321 111111111111
Q ss_pred CCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 523 FDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 523 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
........+...+.+++.+||+.||++||++++|+++|+..+.
T Consensus 236 ---~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 236 ---SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp ---CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred ---cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 0011112334678889999999999999999999999987643
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=329.94 Aligned_cols=249 Identities=25% Similarity=0.334 Sum_probs=199.1
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC----------CHHHHHHHHHHHhccC-CCceEEEEeEEEeCCe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----------NGEEFINEVASISRTS-HVNIVTFLGFCYENKK 362 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 362 (582)
+.+.+.||+|+||.||+|... +|+.||||+++.... ..+.+.+|+.+++++. ||||+++++++.+...
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 98 (298)
T 1phk_A 19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 98 (298)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred cceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCe
Confidence 445688999999999999765 789999999975431 1245789999999996 9999999999999999
Q ss_pred eeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccc
Q 040604 363 NALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ 442 (582)
Q Consensus 363 ~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~ 442 (582)
.++||||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 99 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 99 FFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 99999999999999999764 3689999999999999999999998 999999999999999999999999999987
Q ss_pred ccccccceeeecccCCcccccccccccc----cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCC
Q 040604 443 AQKKESAISMLHARGTIGYIAPEVYSRR----FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPG 518 (582)
Q Consensus 443 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~ 518 (582)
....... ....||+.|+|||++... ...++.++||||||++++||++|+.|+....... ....+..+
T Consensus 174 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~ 244 (298)
T 1phk_A 174 LDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------MLRMIMSG 244 (298)
T ss_dssp CCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHT
T ss_pred cCCCccc---ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH------HHHHHhcC
Confidence 6554322 234699999999998521 2467889999999999999999999997643221 11111111
Q ss_pred CCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 519 NDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.. .+. ......+...+.+++.+||+.||++|||++++++
T Consensus 245 ~~-~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 245 NY-QFG---SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CC-CCC---TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred Cc-ccC---cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11 010 0111233456788889999999999999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=344.17 Aligned_cols=255 Identities=24% Similarity=0.311 Sum_probs=190.3
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeC------CeeeEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYEN------KKNALIY 367 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv~ 367 (582)
+.+.+.||+|+||.||+|.+. +|+.||||++..... .+.+|+.+|++++|||||++++++... ...++||
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 132 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence 345688999999999999875 699999999865432 234799999999999999999998642 2357999
Q ss_pred EecCCCChhhhhhc--CCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-CceEEeecccccccc
Q 040604 368 ELMPNGSLDKFIHN--DRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED-FCPKISDFGLAKQAQ 444 (582)
Q Consensus 368 E~~~~gsL~~~i~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~-~~vkl~DFGla~~~~ 444 (582)
||++ ++|.+++.. .....+++..++.++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||+++...
T Consensus 133 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 133 DYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp ECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred hccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 9996 466665543 2335799999999999999999999998 99999999999999955 678999999998765
Q ss_pred ccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHH----------h
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYE----------R 514 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~----------~ 514 (582)
..... ....||+.|+|||++.+. ..++.++|||||||++|||++|+.||........ +...+.. .
T Consensus 209 ~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~-l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 209 RGEPN---VSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp TTCCC---CSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCSCCHHHHHH
T ss_pred cCCCc---eeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHh
Confidence 44332 234699999999998653 3689999999999999999999999976543221 1111110 0
Q ss_pred hc-CCCCCCCCCcCcHHH-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 515 IE-PGNDFQFDGVATEEE-----KKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 515 i~-~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
+. ......+........ ......+.+|+.+||+.||++|||+.|+++
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00 001111111111001 122456788999999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=338.27 Aligned_cols=265 Identities=25% Similarity=0.393 Sum_probs=196.0
Q ss_pred HHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 295 KSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
+.+.+.||+|+||.||+|...+ .+|+|+++.... ..+.+.+|+.++++++|+||+++++++.+....++||||++
T Consensus 35 ~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~ 112 (319)
T 2y4i_B 35 LEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCK 112 (319)
T ss_dssp EECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCC
T ss_pred eEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeeccc
Confidence 4566899999999999998753 499999875432 23567889999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc---
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES--- 448 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~--- 448 (582)
+++|.+++...+ ..+++..++.++.|++.||+|||+. +|+||||||+|||++ ++.+||+|||+++.......
T Consensus 113 ~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~ 187 (319)
T 2y4i_B 113 GRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR 187 (319)
T ss_dssp SEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC----------
T ss_pred CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccccccccc
Confidence 999999997643 4688999999999999999999998 999999999999998 67999999999876532211
Q ss_pred ceeeecccCCcccccccccccc-------cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCC
Q 040604 449 AISMLHARGTIGYIAPEVYSRR-------FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDF 521 (582)
Q Consensus 449 ~~~~~~~~gt~~y~aPE~~~~~-------~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~ 521 (582)
........||+.|+|||++... ...++.++||||||+++|||++|+.||....... +...+..+...
T Consensus 188 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~ 261 (319)
T 2y4i_B 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA------IIWQMGTGMKP 261 (319)
T ss_dssp CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH------HHHHHHTTCCC
T ss_pred ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHhccCCCC
Confidence 1112234599999999998642 1357889999999999999999999997543321 12222222222
Q ss_pred CCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCCCCCCCCC
Q 040604 522 QFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQIPPKPSL 578 (582)
Q Consensus 522 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~~p~~p~~ 578 (582)
..... .+...+.+++.+||+.||++|||+++|+++|+.........+.|..
T Consensus 262 ~~~~~------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~ 312 (319)
T 2y4i_B 262 NLSQI------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGH 312 (319)
T ss_dssp CCCCS------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------------
T ss_pred CCCcC------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcc
Confidence 11110 1223467788889999999999999999999998887766555544
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=338.03 Aligned_cols=260 Identities=23% Similarity=0.301 Sum_probs=186.6
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCe-------eeE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKK-------NAL 365 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------~~l 365 (582)
.+.+.++||+|+||+||+|... +|+.||||++.........+.+|+..++.++||||+++++++..... .++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~l 103 (360)
T 3e3p_A 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNV 103 (360)
T ss_dssp TEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEE
Confidence 4556689999999999999764 79999999997766566677889999999999999999999976433 789
Q ss_pred EEEecCCCChhhhhhc--CCCcCCCHHHHHHHHHHHHHHHHHHH--hCCCCceEecCCCCCCEEEcC-CCceEEeecccc
Q 040604 366 IYELMPNGSLDKFIHN--DRNIKLEWKTMYQIAIGIARGLEYLH--RGCQVRIVHFDIKPQNILLDE-DFCPKISDFGLA 440 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~--~~~~~l~~~~~~~i~~qi~~aL~yLH--~~~~~~ivH~Dikp~NILl~~-~~~vkl~DFGla 440 (582)
||||+++ +|...+.. .....+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.+||+|||++
T Consensus 104 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a 179 (360)
T 3e3p_A 104 VMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGSA 179 (360)
T ss_dssp EEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred Eeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence 9999965 55444432 23456899999999999999999999 66 9999999999999997 899999999999
Q ss_pred ccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHH--------
Q 040604 441 KQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIY-------- 512 (582)
Q Consensus 441 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~-------- 512 (582)
+........ ....||+.|+|||++.+. ..++.++||||||+++|||++|+.||........ ....+.
T Consensus 180 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~ 254 (360)
T 3e3p_A 180 KKLSPSEPN---VAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ-LHEIVRVLGCPSRE 254 (360)
T ss_dssp BCCCTTSCC---CSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHH
T ss_pred eecCCCCCc---ccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH-HHHHHHHcCCCCHH
Confidence 877654432 234689999999998653 4589999999999999999999999976543221 111111
Q ss_pred --HhhcCC-CCCCCC---C-----cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 513 --ERIEPG-NDFQFD---G-----VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 513 --~~i~~~-~~~~~~---~-----~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
..+... ....+. . ............+.+|+.+||+.||++|||++|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 001000 000000 0 0000001135678889999999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=335.85 Aligned_cols=244 Identities=26% Similarity=0.378 Sum_probs=198.7
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC----CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC----NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.+.+.||+|+||.||++... +++.+|+|++..... ..+.+.+|+.++++++|+||+++++++.+....++||||
T Consensus 43 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 122 (335)
T 2owb_A 43 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 122 (335)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEec
Confidence 445688999999999999765 688999999875432 235688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 123 ~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 197 (335)
T 2owb_A 123 CRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 197 (335)
T ss_dssp CTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence 99999999987543 689999999999999999999998 9999999999999999999999999999876533222
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
.....||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ . ..+.... ..+....
T Consensus 198 --~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~-~~~~~~~-~~~~~~~-- 264 (335)
T 2owb_A 198 --KKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-----Y-LRIKKNE-YSIPKHI-- 264 (335)
T ss_dssp --BCCCCSCCSSCCHHHHHT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----H-HHHHHTC-CCCCTTS--
T ss_pred --ccccCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH-----H-HHHhcCC-CCCCccC--
Confidence 123469999999999876 3678999999999999999999999976432221 1 1111111 1122222
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
...+.+++.+||+.||++|||++|+++
T Consensus 265 -----~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 265 -----NPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -----CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 244667888899999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=335.62 Aligned_cols=257 Identities=25% Similarity=0.359 Sum_probs=182.4
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC--CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR--CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
+.+.+.||+|+||.||+|... +++.||||++.... ...+.+.+|+.++++++||||+++++++......++||||++
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 96 (303)
T 2vwi_A 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLS 96 (303)
T ss_dssp CEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCT
T ss_pred hhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhcc
Confidence 456689999999999999754 78999999986543 234678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcC------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 372 NGSLDKFIHND------RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 372 ~gsL~~~i~~~------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
+++|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 97 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 173 (303)
T 2vwi_A 97 GGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLAT 173 (303)
T ss_dssp TCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC-
T ss_pred CCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheecc
Confidence 99999998641 234689999999999999999999998 999999999999999999999999999987654
Q ss_pred cccc---eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCC
Q 040604 446 KESA---ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQ 522 (582)
Q Consensus 446 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~ 522 (582)
.... .......||+.|+|||++.+. ..++.++||||||+++|||++|+.||........ ....+..... .
T Consensus 174 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~~~~-~ 246 (303)
T 2vwi_A 174 GGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPMKV-----LMLTLQNDPP-S 246 (303)
T ss_dssp --------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-----HHHHHTSSCC-C
T ss_pred CCCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH-----HHHHhccCCC-c
Confidence 3211 111234699999999998652 3578999999999999999999999976543321 1111111110 0
Q ss_pred CCCcC--cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 523 FDGVA--TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 523 ~~~~~--~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
..... ..........+.+++.+||+.||++|||++++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00000 0000122345778888999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=329.84 Aligned_cols=251 Identities=26% Similarity=0.347 Sum_probs=183.5
Q ss_pred HHHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCCH---HHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 294 TKSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNG---EEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
.+++.++||+|+||+||+|.. .+|+.||||+++...... +.+.++...++.++||||+++++++.+....++||||
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~ 87 (290)
T 3fme_A 8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMEL 87 (290)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEEC
T ss_pred hhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEeh
Confidence 345668999999999999976 479999999997654322 2344555568889999999999999999999999999
Q ss_pred cCCCChhhhhhcC--CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 370 MPNGSLDKFIHND--RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 370 ~~~gsL~~~i~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
++ |+|.+++... ....+++..++.++.|++.||+|||+. .+|+||||||+|||++.++.+||+|||+++......
T Consensus 88 ~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 164 (290)
T 3fme_A 88 MD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV 164 (290)
T ss_dssp CS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC----------
T ss_pred hc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccccc
Confidence 96 6888777542 345799999999999999999999984 289999999999999999999999999998765543
Q ss_pred cceeeecccCCccccccccccc--ccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCC
Q 040604 448 SAISMLHARGTIGYIAPEVYSR--RFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 525 (582)
.. ....||+.|+|||++.. ....++.++||||||+++|||++|+.||........... ..+..........
T Consensus 165 ~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~ 237 (290)
T 3fme_A 165 AK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK----QVVEEPSPQLPAD 237 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHH----HHHHSCCCCCCTT
T ss_pred cc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHH----HHhccCCCCcccc
Confidence 22 22359999999999731 114688999999999999999999999976433322222 2222211111111
Q ss_pred cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 526 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.+...+.+++.+||+.||++|||++|+++
T Consensus 238 -------~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 238 -------KFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -------TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -------cCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 12345778888999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=351.22 Aligned_cols=238 Identities=16% Similarity=0.149 Sum_probs=182.4
Q ss_pred HhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCC----CCHHHHHHHH---HHHhccCCCceEEEE-------eEEEeC
Q 040604 296 SFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSR----CNGEEFINEV---ASISRTSHVNIVTFL-------GFCYEN 360 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~---~~l~~l~h~niv~l~-------~~~~~~ 360 (582)
.+.++||+|+||+||+|.. .+|+.||||+++... ...+.+.+|+ .++++++|||||+++ +++.+.
T Consensus 76 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~ 155 (377)
T 3byv_A 76 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 155 (377)
T ss_dssp EEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECT
T ss_pred EEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhcc
Confidence 4457899999999999986 479999999997432 2346788999 556666899999998 666554
Q ss_pred C-----------------eeeEEEEecCCCChhhhhhcCCC-----cCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecC
Q 040604 361 K-----------------KNALIYELMPNGSLDKFIHNDRN-----IKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFD 418 (582)
Q Consensus 361 ~-----------------~~~lv~E~~~~gsL~~~i~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~D 418 (582)
+ ..++||||+ +|+|.+++...+. ..+++..++.|+.||+.||+|||+. +|+|||
T Consensus 156 ~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrD 231 (377)
T 3byv_A 156 QKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTY 231 (377)
T ss_dssp TSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred CCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 3 278999999 7899999975421 2234588889999999999999998 999999
Q ss_pred CCCCCEEEcCCCceEEeeccccccccccccceeeecccCCcccccccccccc---------cCCCCccchhHHHHHHHHH
Q 040604 419 IKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRR---------FGGVSHKSDVYSYGMMIIE 489 (582)
Q Consensus 419 ikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~s~~~DvwSlGvil~e 489 (582)
|||+|||++.++.+||+|||+++..... .....| +.|+|||++.+. ...++.++|||||||++||
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGAR-----VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTCE-----EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecCCc-----ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 9999999999999999999999864331 223457 999999998753 0158899999999999999
Q ss_pred HhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 490 MVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 490 lltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
|++|+.||........ ...+.... . .+...+.+++.+||+.||++|||+.++++
T Consensus 306 lltg~~Pf~~~~~~~~------~~~~~~~~-----~-------~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 306 IWCADLPITKDAALGG------SEWIFRSC-----K-------NIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHSSCCC------CC------SGGGGSSC-----C-------CCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHCCCCCcccccccc------hhhhhhhc-----c-------CCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999975433221 01111110 1 12345777888999999999999999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=337.65 Aligned_cols=198 Identities=26% Similarity=0.390 Sum_probs=171.1
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
.+.+.++||+|+||+||++... +++.||+|+++.... ..+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 34 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 113 (360)
T 3eqc_A 34 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 113 (360)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECC
Confidence 3456689999999999999765 789999999976532 2356889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
++++|.+++...+ .+++..+..++.|++.||+|||+. .+|+||||||+|||++.++.+||+|||++........
T Consensus 114 ~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 187 (360)
T 3eqc_A 114 DGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-- 187 (360)
T ss_dssp TTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC---
T ss_pred CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcccccccc--
Confidence 9999999997643 589999999999999999999983 1799999999999999999999999999976543221
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCC
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEV 501 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~ 501 (582)
....||+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 188 --~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 188 --NSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp -----CCCCTTCCHHHHTT--CCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred --cCCCCCCCeECHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 23469999999999976 478999999999999999999999997543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=329.37 Aligned_cols=249 Identities=28% Similarity=0.394 Sum_probs=196.7
Q ss_pred HHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
..+.+.+.||+|+||.||+|... +|+.||||++.... ..+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (314)
T 3com_A 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCG 107 (314)
T ss_dssp -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCC
Confidence 34556689999999999999765 69999999997654 45678999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
+++|.+++... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.........
T Consensus 108 ~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~-- 181 (314)
T 3com_A 108 AGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK-- 181 (314)
T ss_dssp TEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC--
T ss_pred CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc--
Confidence 99999998642 24689999999999999999999998 9999999999999999999999999999876543221
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHH
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 531 (582)
.....||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||........ +. .+.......+.. .
T Consensus 182 ~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~-~~~~~~~~~~~~-----~ 248 (314)
T 3com_A 182 RNTVIGTPFWMAPEVIQE--IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA-----IF-MIPTNPPPTFRK-----P 248 (314)
T ss_dssp BCCCCSCGGGCCHHHHSS--SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HH-HHHHSCCCCCSS-----G
T ss_pred cCccCCCCCccChhhcCC--CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH-----HH-HHhcCCCcccCC-----c
Confidence 123469999999999876 3688999999999999999999999976433221 11 111111111100 1
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 532 KKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
..+...+.+++.+||+.||++|||++++++
T Consensus 249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 112355778888999999999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=341.35 Aligned_cols=255 Identities=21% Similarity=0.282 Sum_probs=192.1
Q ss_pred HHHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeC------------
Q 040604 294 TKSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYEN------------ 360 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------------ 360 (582)
++.+.++||+|+||+||+|.. .+|+.||||++..... ...+|+.++++++||||+++++++...
T Consensus 8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~ 84 (383)
T 3eb0_A 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD 84 (383)
T ss_dssp TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHTTCCCTTBCCEEEEEEEC------------
T ss_pred eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHHcCCCCccchhheeeecCccccccccccc
Confidence 345678999999999999975 5899999999865432 234799999999999999999998543
Q ss_pred --------------------------CeeeEEEEecCCCChhhhhhc--CCCcCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 040604 361 --------------------------KKNALIYELMPNGSLDKFIHN--DRNIKLEWKTMYQIAIGIARGLEYLHRGCQV 412 (582)
Q Consensus 361 --------------------------~~~~lv~E~~~~gsL~~~i~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~ 412 (582)
...++||||++ |+|.+.+.. .....+++..+..++.||+.||+|||+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--- 160 (383)
T 3eb0_A 85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL--- 160 (383)
T ss_dssp -------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 34789999996 688777753 2345799999999999999999999988
Q ss_pred ceEecCCCCCCEEEc-CCCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHh
Q 040604 413 RIVHFDIKPQNILLD-EDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMV 491 (582)
Q Consensus 413 ~ivH~Dikp~NILl~-~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ell 491 (582)
+|+||||||+|||++ .++.+||+|||+++......... ...||+.|+|||++.+. ..++.++||||+||++|||+
T Consensus 161 gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell 236 (383)
T 3eb0_A 161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV---AYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFGELI 236 (383)
T ss_dssp TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCC---CCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHHHHH
T ss_pred cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCc---CcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHHHHH
Confidence 999999999999998 68999999999998765544322 34589999999998764 45899999999999999999
Q ss_pred cCCCCCCCCCcccchhhHHHHHhhcCC------------CCCCCCCcCcHHH-----HHHHHHHHHHHHhccccCCCCCC
Q 040604 492 GCTKNLDDEVTDTSICHNLIYERIEPG------------NDFQFDGVATEEE-----KKIAKMMILVGFWCIQTNPSERP 554 (582)
Q Consensus 492 tg~~p~~~~~~~~~~~~~~~~~~i~~~------------~~~~~~~~~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RP 554 (582)
+|+.||........ ....+ +.+... ....++....... ......+.+|+.+||+.||++||
T Consensus 237 ~g~~pf~~~~~~~~-~~~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 314 (383)
T 3eb0_A 237 LGKPLFSGETSIDQ-LVRII-QIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI 314 (383)
T ss_dssp HSSCSSCCSSHHHH-HHHHH-HHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred hCCCCCCCCChHHH-HHHHH-HHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC
Confidence 99999976543221 11111 111100 0011111111101 11345578889999999999999
Q ss_pred CHHHHHH
Q 040604 555 SMHKVLE 561 (582)
Q Consensus 555 t~~evl~ 561 (582)
|+.|+++
T Consensus 315 t~~e~l~ 321 (383)
T 3eb0_A 315 NPYEAMA 321 (383)
T ss_dssp CHHHHHT
T ss_pred CHHHHhc
Confidence 9999983
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=334.10 Aligned_cols=256 Identities=23% Similarity=0.334 Sum_probs=200.8
Q ss_pred HHHhhhhcCccCceEEEEEEe--CCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCc------eEEEEeEEEeCCeeeE
Q 040604 294 TKSFRDKLGQGGYGEVYKGEL--PDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVN------IVTFLGFCYENKKNAL 365 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~~~l 365 (582)
++.+.++||+|+||+||+|.. .+++.||||+++......+.+.+|+.++++++|++ ++++++++.+....++
T Consensus 15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~l 94 (339)
T 1z57_A 15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICI 94 (339)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEE
Confidence 455678999999999999976 37899999999865545577889999999887664 9999999999999999
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-----------------
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE----------------- 428 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~----------------- 428 (582)
||||+ +++|.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||++.
T Consensus 95 v~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 95 VFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred EEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 99999 99999999877666799999999999999999999998 9999999999999987
Q ss_pred --CCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccch
Q 040604 429 --DFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSI 506 (582)
Q Consensus 429 --~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~ 506 (582)
++.+||+|||+++....... ...||+.|+|||++.+ ..++.++||||||+++|||++|+.||........
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~- 242 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDDEHHS-----TLVSTRHYRAPEVILA--LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH- 242 (339)
T ss_dssp ESCCCEEECCCSSCEETTSCCC-----SSCSCGGGCCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH-
T ss_pred ccCCCceEeeCcccccCccccc-----cccCCccccChHHhhC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH-
Confidence 66899999999987544322 3469999999999976 3689999999999999999999999976543221
Q ss_pred hhHHHHHhhcCCCC----------------CCCCCcCc----------------HHHHHHHHHHHHHHHhccccCCCCCC
Q 040604 507 CHNLIYERIEPGND----------------FQFDGVAT----------------EEEKKIAKMMILVGFWCIQTNPSERP 554 (582)
Q Consensus 507 ~~~~~~~~i~~~~~----------------~~~~~~~~----------------~~~~~~~~~l~~l~~~Cl~~dp~~RP 554 (582)
...+......... ........ .........+.+++.+||+.||++||
T Consensus 243 -~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 243 -LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp -HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred -HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 1111111110000 00000000 00112356788999999999999999
Q ss_pred CHHHHHHH
Q 040604 555 SMHKVLEM 562 (582)
Q Consensus 555 t~~evl~~ 562 (582)
|++|+++.
T Consensus 322 t~~ell~h 329 (339)
T 1z57_A 322 TLREALKH 329 (339)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999853
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=338.82 Aligned_cols=253 Identities=22% Similarity=0.273 Sum_probs=178.9
Q ss_pred HHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEeC------Ceee
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYEN------KKNA 364 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 364 (582)
+.+.+.||+|+||.||+|.. .+|+.||||++...... .+.+.+|+.++++++||||+++++++... ...+
T Consensus 31 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~ 110 (367)
T 2fst_X 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 110 (367)
T ss_dssp EEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred eEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEE
Confidence 44568899999999999975 47999999999764332 35678999999999999999999999754 4578
Q ss_pred EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccc
Q 040604 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~ 444 (582)
+|||++ +++|.+++.. ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 111 lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 111 LVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp EEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred EEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 999999 8999998865 3599999999999999999999998 99999999999999999999999999998754
Q ss_pred ccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCC
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFD 524 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 524 (582)
... ....||+.|+|||++.+. ..++.++|||||||+++||++|+.||........ +. .+.+.+.......+.
T Consensus 184 ~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-l~-~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 184 DEM-----TGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LK-LILRLVGTPGAELLK 255 (367)
T ss_dssp ------------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HH-HHHHHHCSCCHHHHT
T ss_pred ccC-----CCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HH-HHHHHhCCCCHHHHH
Confidence 321 234699999999998763 4689999999999999999999999976543221 11 111111111000000
Q ss_pred CcCcH-------------------HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 525 GVATE-------------------EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 525 ~~~~~-------------------~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
..... ........+.+|+.+||+.||++|||++|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00000 001123557888999999999999999999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=329.38 Aligned_cols=251 Identities=26% Similarity=0.410 Sum_probs=189.7
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEe-------------
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYE------------- 359 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------------- 359 (582)
.+.+.+.||+|+||.||+|... +++.||||+++......+.+.+|+.++++++||||+++++++.+
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 86 (303)
T 1zy4_A 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKK 86 (303)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------C
T ss_pred cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccccc
Confidence 3456689999999999999764 79999999997655455778999999999999999999999865
Q ss_pred CCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccc
Q 040604 360 NKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGL 439 (582)
Q Consensus 360 ~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGl 439 (582)
....++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 87 KSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp EEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred CCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 346789999999999999998643 4678899999999999999999998 999999999999999999999999999
Q ss_pred ccccccccc------------ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchh
Q 040604 440 AKQAQKKES------------AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSIC 507 (582)
Q Consensus 440 a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~ 507 (582)
++....... ........||+.|+|||++.+. +.++.++||||||+++|||++ |+.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~~~~~~~--- 235 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFSTGMERV--- 235 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH---
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccCCchhHH---
Confidence 987643211 1112234699999999998753 468999999999999999998 443221111
Q ss_pred hHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 508 HNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 508 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.+...+.... ..++.... ......+.+++.+||+.||++|||++++++
T Consensus 236 --~~~~~~~~~~-~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 236 --NILKKLRSVS-IEFPPDFD---DNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp --HHHHHHHSTT-CCCCTTCC---TTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --HHHHhccccc-cccCcccc---ccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 1112222211 11111111 122345677888999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=327.17 Aligned_cols=249 Identities=27% Similarity=0.363 Sum_probs=200.7
Q ss_pred HHHHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccC---CCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEE
Q 040604 291 KRMTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNS---RCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALI 366 (582)
Q Consensus 291 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 366 (582)
...++.+.++||+|+||.||+|... +++.||||++... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3445667789999999999999765 7999999998653 23567899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC---CceEEeeccccccc
Q 040604 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED---FCPKISDFGLAKQA 443 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~---~~vkl~DFGla~~~ 443 (582)
|||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.+ +.+||+|||++...
T Consensus 100 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 99999999998886543 689999999999999999999998 99999999999999764 46999999999876
Q ss_pred cccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCC-CCC
Q 040604 444 QKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGN-DFQ 522 (582)
Q Consensus 444 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~-~~~ 522 (582)
...... ....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||....... +...+..+. ...
T Consensus 175 ~~~~~~---~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~ 242 (287)
T 2wei_A 175 QQNTKM---KDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD------ILKRVETGKYAFD 242 (287)
T ss_dssp CCCSSC---SCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCCCC
T ss_pred cCCCcc---ccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHcCCCCCC
Confidence 544322 12348999999999864 58899999999999999999999997653221 112222211 111
Q ss_pred CCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 523 FDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 523 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
. .....+...+.+++.+||+.||++|||++++++
T Consensus 243 ~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 243 L-----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp S-----GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred c-----hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 1 111223456778888999999999999999987
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=340.36 Aligned_cols=256 Identities=22% Similarity=0.269 Sum_probs=190.9
Q ss_pred HHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCe------eeEEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKK------NALIYE 368 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~lv~E 368 (582)
|.+.++||+|+||+||+|....+..+|+|++...... ..+|+.++++++||||+++++++..... .++|||
T Consensus 42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e 118 (394)
T 4e7w_A 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118 (394)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence 4566899999999999999877777999988653322 2369999999999999999999965433 789999
Q ss_pred ecCCCChhhhhhc-CCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc-CCCceEEeecccccccccc
Q 040604 369 LMPNGSLDKFIHN-DRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLD-EDFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 369 ~~~~gsL~~~i~~-~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~-~~~~vkl~DFGla~~~~~~ 446 (582)
|++++.+...... .....+++..++.++.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+++.....
T Consensus 119 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 119 YVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp CCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred ccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 9976544433321 1234689999999999999999999998 999999999999999 7999999999999876554
Q ss_pred ccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCC--------
Q 040604 447 ESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPG-------- 518 (582)
Q Consensus 447 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~-------- 518 (582)
.... ...||+.|+|||++.+. ..++.++|||||||++|||++|+.||........ +...+ ..+...
T Consensus 196 ~~~~---~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-l~~i~-~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 196 EPNV---SYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ-LVEII-KVLGTPSREQIKTM 269 (394)
T ss_dssp CCCC---SSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHH-HHHCCCCHHHHHHH
T ss_pred CCCc---ccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH-HHhCCCCHHHHHhh
Confidence 4322 34589999999998653 4689999999999999999999999976543221 11111 110000
Q ss_pred ----CCCCCCCcCcHHH-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 519 ----NDFQFDGVATEEE-----KKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 519 ----~~~~~~~~~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
....+........ ......+.+|+.+||+.||++|||+.|+++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0001111110000 1134567889999999999999999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=345.04 Aligned_cols=251 Identities=11% Similarity=0.053 Sum_probs=176.6
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC----HHHHHHHHHHHhcc--CCCceEEEE-------eEEEeC
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN----GEEFINEVASISRT--SHVNIVTFL-------GFCYEN 360 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l--~h~niv~l~-------~~~~~~ 360 (582)
+.+.++||+|+||+||+|.+. +|+.||||+++..... .+.+.+|+.+++.+ +||||++++ +++...
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 345678999999999999765 7999999999876542 34567775444444 699988855 444433
Q ss_pred -----------------CeeeEEEEecCCCChhhhhhcCCCcCCCHHHH------HHHHHHHHHHHHHHHhCCCCceEec
Q 040604 361 -----------------KKNALIYELMPNGSLDKFIHNDRNIKLEWKTM------YQIAIGIARGLEYLHRGCQVRIVHF 417 (582)
Q Consensus 361 -----------------~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~------~~i~~qi~~aL~yLH~~~~~~ivH~ 417 (582)
...++||||++ |+|.+++.... ..+++..+ +.++.||+.||+|||+. +|+||
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHr 218 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHG 218 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccC
Confidence 33799999997 89999998642 23455555 67889999999999998 99999
Q ss_pred CCCCCCEEEcCCCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCC
Q 040604 418 DIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNL 497 (582)
Q Consensus 418 Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~ 497 (582)
||||+|||++.++.+||+|||+++...... ....||+.|+|||++.+....++.++|||||||++|||++|+.||
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999998764322 134578999999999752236899999999999999999999999
Q ss_pred CCCCcccch-hhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 498 DDEVTDTSI-CHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 498 ~~~~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
......... ...... .........+. ....+...+.+|+.+||+.||++|||++++++
T Consensus 294 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 294 GLVTPGIKGSWKRPSL-RVPGTDSLAFG-----SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TBCCTTCTTCCCBCCT-TSCCCCSCCCT-----TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCcCcccccchhhhhh-hhccccccchh-----hccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 765332210 000000 00000011111 11123456778888999999999999999874
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=326.80 Aligned_cols=250 Identities=22% Similarity=0.355 Sum_probs=193.3
Q ss_pred HHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCC---HHHHHHHHHHHhccC--CCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCN---GEEFINEVASISRTS--HVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.+.+.||+|+||.||++...+++.||||++...... .+.+.+|+.++++++ |+||+++++++.+....++|||
T Consensus 30 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e- 108 (313)
T 3cek_A 30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 108 (313)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-
T ss_pred EEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-
Confidence 4556899999999999998888999999999765443 356889999999997 5999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+.+++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||+++ +.+||+|||+++........
T Consensus 109 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~ 182 (313)
T 3cek_A 109 CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS 182 (313)
T ss_dssp CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-------
T ss_pred cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCcccc
Confidence 55899999998654 689999999999999999999998 9999999999999975 89999999999876554333
Q ss_pred eeeecccCCcccccccccccc---------cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCC
Q 040604 450 ISMLHARGTIGYIAPEVYSRR---------FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND 520 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~---------~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~ 520 (582)
.......||+.|+|||++... ...++.++||||||+++|||++|+.||........ .+...+.....
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~----~~~~~~~~~~~ 258 (313)
T 3cek_A 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS----KLHAIIDPNHE 258 (313)
T ss_dssp -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH----HHHHHHCTTSC
T ss_pred ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH----HHHHHHhcccc
Confidence 222344699999999998641 13678899999999999999999999975433221 12222333222
Q ss_pred CCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 521 FQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 521 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
..+.... ...+.+++.+||+.||++||+++|+++.
T Consensus 259 ~~~~~~~-------~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 259 IEFPDIP-------EKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp CCCCCCS-------CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCcccc-------hHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 2232222 2456778888999999999999999863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=337.84 Aligned_cols=257 Identities=23% Similarity=0.285 Sum_probs=188.8
Q ss_pred HHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCC------------HHHHHHHHHHHhccCCCceEEEEeEEEeC--
Q 040604 295 KSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCN------------GEEFINEVASISRTSHVNIVTFLGFCYEN-- 360 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------~~~~~~E~~~l~~l~h~niv~l~~~~~~~-- 360 (582)
+.+.+.||+|+||.||+|...+|+.||||++...... .+.+.+|+.++++++||||+++++++...
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 103 (362)
T 3pg1_A 24 YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEE 103 (362)
T ss_dssp CEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCT
T ss_pred eEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccC
Confidence 3456899999999999998888999999998653221 26789999999999999999999998643
Q ss_pred ---CeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeec
Q 040604 361 ---KKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDF 437 (582)
Q Consensus 361 ---~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DF 437 (582)
...++||||++ |+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 104 ~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 104 PAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp TTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCT
T ss_pred CCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEEEec
Confidence 35789999996 7888888753 34689999999999999999999998 9999999999999999999999999
Q ss_pred cccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcC
Q 040604 438 GLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEP 517 (582)
Q Consensus 438 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~ 517 (582)
|+++........ ....||+.|+|||++.+. ..++.++||||||+++|+|++|+.||........ ... +.+....
T Consensus 179 g~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~-i~~~~~~ 252 (362)
T 3pg1_A 179 NLAREDTADANK---THYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ-LNK-IVEVVGT 252 (362)
T ss_dssp TC------------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHH-HHHHHCC
T ss_pred Cccccccccccc---ceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH-HHH-HHHHcCC
Confidence 999865443322 234599999999998753 4689999999999999999999999976532211 111 1111110
Q ss_pred CC-------------------CCCCCC-cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 518 GN-------------------DFQFDG-VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 518 ~~-------------------~~~~~~-~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
.. ...... ............+.+++.+||+.||++|||++|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 00 000000 0000111224567888999999999999999999863
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=330.23 Aligned_cols=256 Identities=25% Similarity=0.359 Sum_probs=196.7
Q ss_pred HHhhhhcCccCceEEEEEEe--CCCcEEEEEEeccCCC---CHHHHHHHHHHHhcc---CCCceEEEEeEEE-----eCC
Q 040604 295 KSFRDKLGQGGYGEVYKGEL--PDGQLVAVKVLKNSRC---NGEEFINEVASISRT---SHVNIVTFLGFCY-----ENK 361 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~~~ 361 (582)
+.+.+.||+|+||+||+|.. .+|+.||||+++.... ....+.+|+.+++++ +||||+++++++. ...
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 92 (326)
T 1blx_A 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 92 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred eeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCc
Confidence 45568999999999999986 4689999999864332 234567788777766 8999999999987 456
Q ss_pred eeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccc
Q 040604 362 KNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAK 441 (582)
Q Consensus 362 ~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~ 441 (582)
..++||||+. |+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 93 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp EEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred eEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 7899999996 7999999876655699999999999999999999998 99999999999999999999999999998
Q ss_pred cccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCC
Q 040604 442 QAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDF 521 (582)
Q Consensus 442 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~ 521 (582)
........ ....||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... .... +.+.+......
T Consensus 169 ~~~~~~~~---~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~-i~~~~~~~~~~ 241 (326)
T 1blx_A 169 IYSFQMAL---TSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGK-ILDVIGLPGEE 241 (326)
T ss_dssp CCCGGGGG---CCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHH-HHHHHCCCCGG
T ss_pred cccCCCCc---cccccccceeCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHH-HHHHcCCCCcc
Confidence 76543322 23469999999999876 368999999999999999999999997654322 1111 11111110000
Q ss_pred CC-----------C----CcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 522 QF-----------D----GVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 522 ~~-----------~----~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.+ . .........+...+.+++.+||+.||++|||++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 0 0000111223456778889999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=324.74 Aligned_cols=256 Identities=25% Similarity=0.390 Sum_probs=192.7
Q ss_pred HHHhhhhcCccCceEEEEEEeC--CCc--EEEEEEeccCCC----CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP--DGQ--LVAVKVLKNSRC----NGEEFINEVASISRTSHVNIVTFLGFCYENKKNAL 365 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 365 (582)
.+.+.++||+|+||+||+|.+. +++ .||||+++.... ..+.+.+|+.++++++||||+++++++.+.. .++
T Consensus 19 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 97 (291)
T 1u46_A 19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKM 97 (291)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEE
T ss_pred HeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-cee
Confidence 3456689999999999999743 333 689999875432 2367889999999999999999999997654 889
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 98 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 98 VTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 999999999999987542 3589999999999999999999998 999999999999999999999999999988755
Q ss_pred cccce-eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCC
Q 040604 446 KESAI-SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQF 523 (582)
Q Consensus 446 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~ 523 (582)
..... ......+|+.|+|||++.+ ..++.++||||||+++|||++ |+.||....... .+............
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~ 246 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-----ILHKIDKEGERLPR 246 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHHHTSCCCCCC
T ss_pred cccchhhhccCCCCceeeCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH-----HHHHHHccCCCCCC
Confidence 43321 1223458889999999876 367899999999999999999 999987653321 12222222211111
Q ss_pred CCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 524 DGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 524 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
.. .+...+.+++.+||+.||++|||++++++.|++...
T Consensus 247 ~~-------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 247 PE-------DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred Cc-------CcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 11 234567788889999999999999999999987543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=328.74 Aligned_cols=250 Identities=25% Similarity=0.351 Sum_probs=194.2
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC-CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR-CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
+++.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 21 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 100 (302)
T 2j7t_A 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPG 100 (302)
T ss_dssp EEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTT
T ss_pred eeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCC
Confidence 456688999999999999775 68999999986543 3567899999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||++......... .
T Consensus 101 ~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~ 174 (302)
T 2j7t_A 101 GAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK--R 174 (302)
T ss_dssp EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC---
T ss_pred CcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccccc--c
Confidence 99999887532 3689999999999999999999998 9999999999999999999999999997643322111 1
Q ss_pred ecccCCccccccccccc---ccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 453 LHARGTIGYIAPEVYSR---RFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~---~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
....||+.|+|||++.. ....++.++||||||+++|||++|+.|+....... .......... ....
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~-~~~~----- 243 (302)
T 2j7t_A 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-----VLLKIAKSDP-PTLL----- 243 (302)
T ss_dssp ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHSCC-CCCS-----
T ss_pred ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-----HHHHHhccCC-cccC-----
Confidence 23459999999999841 12467899999999999999999999997653322 1111111111 1110
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
....+...+.+++.+||+.||++|||++++++
T Consensus 244 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 244 TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 01122345778888999999999999999875
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=334.00 Aligned_cols=252 Identities=21% Similarity=0.236 Sum_probs=191.4
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEeCCee------e
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYENKKN------A 364 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~------~ 364 (582)
+.+.+.||+|+||+||+|... +|+.||||+++..... .+.+.+|+.++++++||||+++++++...... +
T Consensus 44 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 123 (371)
T 4exu_A 44 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 123 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCE
T ss_pred EEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEE
Confidence 345678999999999999764 7999999999765433 35688999999999999999999999876654 9
Q ss_pred EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccc
Q 040604 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~ 444 (582)
+||||+. ++|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 124 lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 124 LVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp EEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred EEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 9999995 788887743 489999999999999999999998 99999999999999999999999999998654
Q ss_pred ccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCC-
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQF- 523 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~- 523 (582)
... ....||+.|+|||++.+. ..++.++||||||++++||++|+.||........ .... ............
T Consensus 196 ~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i-~~~~~~~~~~~~~ 267 (371)
T 4exu_A 196 AEM-----TGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQI-LKVTGVPGTEFVQ 267 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHH-HHHHCCCCHHHHT
T ss_pred cCc-----CCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHH-HHHhCCCcHHHHH
Confidence 332 234689999999998763 4689999999999999999999999976533221 1111 111100000000
Q ss_pred ------------------CCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 524 ------------------DGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 524 ------------------~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
..............+.+|+.+||+.||++|||++|+++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000000011234667889999999999999999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=335.32 Aligned_cols=199 Identities=23% Similarity=0.304 Sum_probs=169.5
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhccC-CC-----ceEEEEeEEEeCCeeeEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRTS-HV-----NIVTFLGFCYENKKNALI 366 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~~~lv 366 (582)
.+.+.++||+|+||+||+|... +++.||||+++......+++.+|+.+++.++ |+ +|+++++++......++|
T Consensus 55 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv 134 (382)
T 2vx3_A 55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLV 134 (382)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEE
T ss_pred eEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEE
Confidence 3456689999999999999765 7899999999865544567778888888875 44 499999999999999999
Q ss_pred EEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc--CCCceEEeecccccccc
Q 040604 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLD--EDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~--~~~~vkl~DFGla~~~~ 444 (582)
|||+ +++|.+++.......+++..+..++.|++.||.|||+. ..+|+||||||+|||++ .++.+||+|||+++...
T Consensus 135 ~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~ 212 (382)
T 2vx3_A 135 FEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 212 (382)
T ss_dssp EECC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred EecC-CCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceecc
Confidence 9999 56999999876656799999999999999999999953 24899999999999994 57889999999998765
Q ss_pred ccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCC
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEV 501 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~ 501 (582)
... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 213 ~~~-----~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 213 QRI-----YQYIQSRFYRSPEVLLGM--PYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CCC-----CSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccc-----ccccCCccccChHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 432 234699999999999874 68999999999999999999999998654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=331.39 Aligned_cols=250 Identities=23% Similarity=0.295 Sum_probs=170.1
Q ss_pred hhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEe----CCeeeEEEEecCCC
Q 040604 299 DKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYE----NKKNALIYELMPNG 373 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~E~~~~g 373 (582)
+.||+|+||+||+|... +|+.||||++.... ....+....++.++||||+++++++.. ....++||||+++|
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg 111 (336)
T 3fhr_A 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGG 111 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTE
T ss_pred eeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCC
Confidence 46999999999999765 79999999996532 222223344667799999999999976 44578999999999
Q ss_pred ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---CCceEEeeccccccccccccce
Q 040604 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE---DFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 374 sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~---~~~vkl~DFGla~~~~~~~~~~ 450 (582)
+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 112 ~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~~-- 186 (336)
T 3fhr_A 112 ELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL-- 186 (336)
T ss_dssp EHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-------
T ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceecccccc--
Confidence 999999877666799999999999999999999998 9999999999999976 45599999999987654322
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHH
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 530 (582)
....||+.|+|||++.. ..++.++||||||+++|+|++|+.||........ .......+..... .+. ...
T Consensus 187 --~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~-~~~---~~~ 256 (336)
T 3fhr_A 187 --QTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI--SPGMKRRIRLGQY-GFP---NPE 256 (336)
T ss_dssp ---------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------CCC---TTT
T ss_pred --ccCCCCcCccChhhhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh--hhhHHHhhhcccc-ccC---chh
Confidence 23458999999999865 4688999999999999999999999965433221 0001111111100 000 011
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 040604 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVLE--MLEGS 566 (582)
Q Consensus 531 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~--~Le~~ 566 (582)
...+...+.+++.+||+.||++|||++|+++ .+.+.
T Consensus 257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 257 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp STTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred hccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 1123456778888999999999999999997 45543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=334.30 Aligned_cols=257 Identities=21% Similarity=0.264 Sum_probs=196.8
Q ss_pred HHHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCCHHHHHHHHHHHhccC-----------CCceEEEEeEEEeCC
Q 040604 294 TKSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNGEEFINEVASISRTS-----------HVNIVTFLGFCYENK 361 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~~~ 361 (582)
.+.+.++||+|+||+||+|.. .+++.||||++.......+.+.+|+.++++++ |+||+++++++....
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~ 99 (373)
T 1q8y_A 20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 99 (373)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred eEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccC
Confidence 455678999999999999976 47999999999865555677889999998886 899999999998654
Q ss_pred ----eeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc------CCCc
Q 040604 362 ----KNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLD------EDFC 431 (582)
Q Consensus 362 ----~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~------~~~~ 431 (582)
..++|||++ +++|.+++.......+++..++.++.||+.||+|||++ .+|+||||||+|||++ ..+.
T Consensus 100 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~~~~~~~~ 176 (373)
T 1q8y_A 100 PNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQ 176 (373)
T ss_dssp TTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred CCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccCCCcCcce
Confidence 778999999 99999999876666799999999999999999999984 2899999999999994 4458
Q ss_pred eEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccc-----h
Q 040604 432 PKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTS-----I 506 (582)
Q Consensus 432 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~-----~ 506 (582)
+||+|||+++...... ....||+.|+|||++.+. .++.++||||||+++|||++|+.||........ .
T Consensus 177 ~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 177 IKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred EEEcccccccccCCCC-----CCCCCCccccCcHHHhCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 9999999998765432 234699999999999763 689999999999999999999999975532211 1
Q ss_pred hhHHHHHhhcCCCC-------------------CCCC--CcCc---------HHHHHHHHHHHHHHHhccccCCCCCCCH
Q 040604 507 CHNLIYERIEPGND-------------------FQFD--GVAT---------EEEKKIAKMMILVGFWCIQTNPSERPSM 556 (582)
Q Consensus 507 ~~~~~~~~i~~~~~-------------------~~~~--~~~~---------~~~~~~~~~l~~l~~~Cl~~dp~~RPt~ 556 (582)
... +.+.+..... .... .... .........+.+|+.+||+.||++|||+
T Consensus 250 ~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 250 IAQ-IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHH-HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHH-HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 111 1111111000 0000 0000 0113456788899999999999999999
Q ss_pred HHHHH
Q 040604 557 HKVLE 561 (582)
Q Consensus 557 ~evl~ 561 (582)
+||++
T Consensus 329 ~ell~ 333 (373)
T 1q8y_A 329 GGLVN 333 (373)
T ss_dssp HHHHT
T ss_pred HHHhh
Confidence 99987
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=357.43 Aligned_cols=256 Identities=25% Similarity=0.415 Sum_probs=201.0
Q ss_pred HHHHHhhhhcCccCceEEEEEEeC----CCcEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeE
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELP----DGQLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYENKKNAL 365 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 365 (582)
...+.+.+.||+|+||+||+|.+. .+..||||+++..... .+.+.+|+.++++++||||+++++++. +...++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 344556678999999999999764 3567999998764332 367899999999999999999999984 456899
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
||||+++|+|.+++...+ ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 468 v~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp EEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred EEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 999999999999997543 4689999999999999999999998 999999999999999999999999999987654
Q ss_pred cccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCC
Q 040604 446 KESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFD 524 (582)
Q Consensus 446 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 524 (582)
.... ......||+.|+|||++.. ..++.++||||||+++|||++ |..||....... +...+..+....++
T Consensus 544 ~~~~-~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~------~~~~i~~~~~~~~~ 614 (656)
T 2j0j_A 544 STYY-KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERLPMP 614 (656)
T ss_dssp -----------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHHTCCCCCC
T ss_pred Ccce-eccCCCCCcceeCHHHhcC--CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHcCCCCCCC
Confidence 3322 1223457889999999876 478999999999999999997 888887543321 12222222222222
Q ss_pred CcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 525 GVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 525 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
.. +...+.+++.+||+.||++|||+.+|++.|+..++
T Consensus 615 ~~-------~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 615 PN-------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp TT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cc-------ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 22 23556778889999999999999999999987653
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=328.13 Aligned_cols=257 Identities=23% Similarity=0.315 Sum_probs=194.7
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeC-----CeeeEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYEN-----KKNALI 366 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv 366 (582)
+.+.+.||+|+||+||+|... +|+.||||+++..... ...+.+|+.++++++||||+++++++... ...++|
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 92 (353)
T 2b9h_A 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYII 92 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEE
T ss_pred eEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEE
Confidence 345688999999999999765 7999999999754332 35678999999999999999999998754 567999
Q ss_pred EEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccc
Q 040604 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~ 446 (582)
|||+. ++|.+++... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 93 ~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 93 QELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp ECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 99995 7999988753 589999999999999999999998 9999999999999999999999999999876533
Q ss_pred ccce--------eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCC
Q 040604 447 ESAI--------SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPG 518 (582)
Q Consensus 447 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~ 518 (582)
.... ......||+.|+|||++... ..++.++||||||+++|||++|+.||......... ..+...+...
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~ 242 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL--LLIFGIIGTP 242 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCCC
T ss_pred cccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH--HHHHHHhCCC
Confidence 2111 11234689999999987643 46899999999999999999999999765432110 0111111110
Q ss_pred CC-CCCCCcC-------------------cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 519 ND-FQFDGVA-------------------TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 519 ~~-~~~~~~~-------------------~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.. ....... ......+...+.+++.+||+.||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00 0000000 0001134466788999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=340.45 Aligned_cols=249 Identities=24% Similarity=0.324 Sum_probs=185.1
Q ss_pred hhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeeeEEEEecCCCChh
Q 040604 298 RDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRT-SHVNIVTFLGFCYENKKNALIYELMPNGSLD 376 (582)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 376 (582)
.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++++ +||||+++++++.+....++||||+ +|+|.
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~-~gsL~ 96 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQ 96 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC-SEEHH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC-CCCHH
Confidence 3679999999998776668999999998653 245678999999886 8999999999999999999999999 57999
Q ss_pred hhhhcCCCcC-----CCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-------------CceEEeecc
Q 040604 377 KFIHNDRNIK-----LEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED-------------FCPKISDFG 438 (582)
Q Consensus 377 ~~i~~~~~~~-----l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~-------------~~vkl~DFG 438 (582)
+++....... .++..++.++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG 173 (434)
T 2rio_A 97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173 (434)
T ss_dssp HHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence 9998653221 12334578999999999999998 99999999999999754 489999999
Q ss_pred ccccccccccce--eeecccCCcccccccccccc-----cCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHH
Q 040604 439 LAKQAQKKESAI--SMLHARGTIGYIAPEVYSRR-----FGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNL 510 (582)
Q Consensus 439 la~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-----~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~ 510 (582)
+++......... ......||+.|+|||++.+. ...++.++|||||||++|||++ |+.||....... ...
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~i 250 (434)
T 2rio_A 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE---SNI 250 (434)
T ss_dssp TCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH---HHH
T ss_pred cceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH---HHH
Confidence 999876543221 12234699999999998651 1468899999999999999998 888986543221 111
Q ss_pred HHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 511 IYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 511 ~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
+.... . +..........+...+.+++.+||+.||++|||+.+|++
T Consensus 251 ~~~~~-~-----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 251 IRGIF-S-----LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHTCC-C-----CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hcCCC-C-----cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11111 1 111111112345677889999999999999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=330.23 Aligned_cols=255 Identities=18% Similarity=0.282 Sum_probs=197.6
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CC-cEEEEEEeccCCCCHHHHHHHHHHHhccCCCc------eEEEEeEEEeCCeeeE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DG-QLVAVKVLKNSRCNGEEFINEVASISRTSHVN------IVTFLGFCYENKKNAL 365 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~~~l 365 (582)
.+.+.++||+|+||+||+|... ++ +.||||+++......+.+.+|+.++++++|++ ++.+++++......++
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~l 99 (355)
T 2eu9_A 20 RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCI 99 (355)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEE
T ss_pred cEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEE
Confidence 4556789999999999999764 44 78999999865545677889999999987766 9999999999999999
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE-------------------
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL------------------- 426 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl------------------- 426 (582)
||||+ +++|.+++.......+++..++.++.||+.||+|||+. +|+||||||+|||+
T Consensus 100 v~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 100 AFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred EEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccccccc
Confidence 99999 77787777766556799999999999999999999998 99999999999999
Q ss_pred cCCCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccch
Q 040604 427 DEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSI 506 (582)
Q Consensus 427 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~ 506 (582)
+.++.+||+|||+++...... ....||+.|+|||++.+ ..++.++||||||+++|||++|+.||........
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~- 247 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILE--LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH- 247 (355)
T ss_dssp ESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-
T ss_pred cCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeec--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 678899999999998754432 23469999999999976 4789999999999999999999999976543221
Q ss_pred hhHHHHHhhcCCCC----------------CCCCCcCc----------------HHHHHHHHHHHHHHHhccccCCCCCC
Q 040604 507 CHNLIYERIEPGND----------------FQFDGVAT----------------EEEKKIAKMMILVGFWCIQTNPSERP 554 (582)
Q Consensus 507 ~~~~~~~~i~~~~~----------------~~~~~~~~----------------~~~~~~~~~l~~l~~~Cl~~dp~~RP 554 (582)
. ..+......... ........ .........+.+|+.+||+.||++||
T Consensus 248 ~-~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 248 L-VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp H-HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred H-HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 0 111111110000 00000000 00112245678899999999999999
Q ss_pred CHHHHHH
Q 040604 555 SMHKVLE 561 (582)
Q Consensus 555 t~~evl~ 561 (582)
|++|+++
T Consensus 327 t~~e~l~ 333 (355)
T 2eu9_A 327 TLAEALL 333 (355)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999984
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=325.09 Aligned_cols=257 Identities=22% Similarity=0.244 Sum_probs=187.5
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEE--------------
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCY-------------- 358 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~-------------- 358 (582)
+.+.+.||+|+||.||+|... +++.||||++..... ..+.+.+|+.++++++||||+++++++.
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 92 (320)
T 2i6l_A 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLT 92 (320)
T ss_dssp EEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CC
T ss_pred eeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccc
Confidence 345688999999999999776 599999999875432 3467889999999999999999999874
Q ss_pred eCCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc-CCCceEEeec
Q 040604 359 ENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLD-EDFCPKISDF 437 (582)
Q Consensus 359 ~~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~-~~~~vkl~DF 437 (582)
+....++||||++ |+|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+|||++ +++.+||+||
T Consensus 93 ~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 93 ELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp SCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred ccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccC
Confidence 3457789999996 799999864 3589999999999999999999998 999999999999997 5679999999
Q ss_pred cccccccccccc-eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhc
Q 040604 438 GLAKQAQKKESA-ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIE 516 (582)
Q Consensus 438 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~ 516 (582)
|+++........ .......||+.|+|||.+.+. ..++.++||||||+++|||++|+.||........ ... +.+.+.
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~-~~~~~~ 242 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ-MQL-ILESIP 242 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH-HHHHSC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH-HHH-HHHhcC
Confidence 999876533211 112234589999999988653 4689999999999999999999999976543221 111 111000
Q ss_pred CCCC-----------------CCCCC-cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 517 PGND-----------------FQFDG-VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 517 ~~~~-----------------~~~~~-~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.... ..... ........+...+.+++.+||+.||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0000 00000 000001124567888999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=330.59 Aligned_cols=241 Identities=25% Similarity=0.365 Sum_probs=189.0
Q ss_pred HHHHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC-------HHHHHHHHHHHhcc----CCCceEEEEeEEE
Q 040604 291 KRMTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN-------GEEFINEVASISRT----SHVNIVTFLGFCY 358 (582)
Q Consensus 291 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~E~~~l~~l----~h~niv~l~~~~~ 358 (582)
....+.+.+.||+|+||.||+|... +++.||||+++..... ...+.+|+.++.++ +|+||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 3445667789999999999999764 7899999999765432 23456799999988 8999999999999
Q ss_pred eCCeeeEEEEe-cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc-CCCceEEee
Q 040604 359 ENKKNALIYEL-MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLD-EDFCPKISD 436 (582)
Q Consensus 359 ~~~~~~lv~E~-~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~-~~~~vkl~D 436 (582)
+.+..++|||+ +.+++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++ .++.+||+|
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred cCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEEE
Confidence 99999999999 78999999997643 689999999999999999999998 999999999999999 889999999
Q ss_pred ccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhc
Q 040604 437 FGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIE 516 (582)
Q Consensus 437 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~ 516 (582)
||+++....... ....||+.|+|||++.+. ...+.++||||||+++|||++|+.||..... +..
T Consensus 184 fg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~--- 247 (312)
T 2iwi_A 184 FGSGALLHDEPY----TDFDGTRVYSPPEWISRH-QYHALPATVWSLGILLYDMVCGDIPFERDQE--------ILE--- 247 (312)
T ss_dssp CSSCEECCSSCB----CCCCSCTTTSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------HHH---
T ss_pred cchhhhcccCcc----cccCCcccccCceeeecC-CCCCccchHHHHHHHHHHHHHCCCCCCChHH--------Hhh---
Confidence 999987654332 234599999999998753 2335689999999999999999999864311 111
Q ss_pred CCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 517 PGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.. ..+... +...+.+++.+||+.||++|||++|+++
T Consensus 248 ~~--~~~~~~-------~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 248 AE--LHFPAH-------VSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp TC--CCCCTT-------SCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hc--cCCccc-------CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 111111 2345677888999999999999999997
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=326.84 Aligned_cols=249 Identities=21% Similarity=0.273 Sum_probs=190.7
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEeCCe------ee
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYENKK------NA 364 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~ 364 (582)
+.+.+.||+|+||.||+|... +|+.||||++...... .+.+.+|+.++++++||||+++++++..... .+
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 105 (353)
T 3coi_A 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 105 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred EEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEE
Confidence 345678999999999999764 7999999999765433 3568899999999999999999999987654 48
Q ss_pred EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccc
Q 040604 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~ 444 (582)
+||||+. ++|.+++.. .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 106 lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 106 LVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp EEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred EEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 9999995 788888743 489999999999999999999998 99999999999999999999999999998754
Q ss_pred ccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHH------------
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIY------------ 512 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~------------ 512 (582)
... ....||+.|+|||++.+. ..++.++||||||++++||++|+.||........ ....+.
T Consensus 178 ~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 178 AEM-----TGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp -----------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH-HHHHHHHHCBCCHHHHTT
T ss_pred CCc-----cccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHH
Confidence 332 234689999999998753 4688999999999999999999999976532211 111100
Q ss_pred ----------HhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 513 ----------ERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 513 ----------~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
..+.......+... .......+.+++.+||+.||++|||++++++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQL----FPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTT----CTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhhHHHHHHHHhCcCCCCccHHHh----cCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000000001110 11234567788889999999999999999853
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=331.07 Aligned_cols=237 Identities=24% Similarity=0.346 Sum_probs=193.1
Q ss_pred HHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCC-------HHHHHHHHHHHhccC--CCceEEEEeEEEeCCeee
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCN-------GEEFINEVASISRTS--HVNIVTFLGFCYENKKNA 364 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~ 364 (582)
+.+.+.||+|+||.||+|.. .+++.||||+++..... .+.+.+|+.++++++ |+||+++++++.+....+
T Consensus 45 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~ 124 (320)
T 3a99_A 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 124 (320)
T ss_dssp EEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEE
Confidence 45668999999999999975 47899999999754322 245678999999996 599999999999999999
Q ss_pred EEEEecCC-CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc-CCCceEEeecccccc
Q 040604 365 LIYELMPN-GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLD-EDFCPKISDFGLAKQ 442 (582)
Q Consensus 365 lv~E~~~~-gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~-~~~~vkl~DFGla~~ 442 (582)
+|||++.+ ++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++ +++.+||+|||+++.
T Consensus 125 lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~ 199 (320)
T 3a99_A 125 LILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL 199 (320)
T ss_dssp EEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence 99999976 89999987643 689999999999999999999998 999999999999999 789999999999987
Q ss_pred ccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCC
Q 040604 443 AQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQ 522 (582)
Q Consensus 443 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~ 522 (582)
...... ....||+.|+|||++.+. ...+.++||||||+++|||++|+.||..... .. ... ..
T Consensus 200 ~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------~~----~~~--~~ 261 (320)
T 3a99_A 200 LKDTVY----TDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------II----RGQ--VF 261 (320)
T ss_dssp CCSSCB----CCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HH----HCC--CC
T ss_pred cccccc----cCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCChhh-------hh----ccc--cc
Confidence 654322 234599999999998753 3347889999999999999999999864311 11 111 11
Q ss_pred CCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 523 FDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 523 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
+... +...+.+++.+||+.||++|||+++|++
T Consensus 262 ~~~~-------~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 262 FRQR-------VSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp CSSC-------CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cccc-------CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 2345677888999999999999999987
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=325.91 Aligned_cols=252 Identities=25% Similarity=0.374 Sum_probs=174.0
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC--HHHHHHHHH-HHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN--GEEFINEVA-SISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
.+.+.||+|+||.||+|... +|+.||||+++..... ...+..|+. +++.++||||+++++++.+.+..++||||++
T Consensus 25 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (327)
T 3aln_A 25 KDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS 104 (327)
T ss_dssp EC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred hehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC
Confidence 45678999999999999775 7999999999765432 234556665 7788899999999999999999999999996
Q ss_pred CCChhhhhhc---CCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 372 NGSLDKFIHN---DRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 372 ~gsL~~~i~~---~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
++|.+++.. .....+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 105 -~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 181 (327)
T 3aln_A 105 -TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA 181 (327)
T ss_dssp -EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC------
T ss_pred -CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecccccc
Confidence 588777653 2245689999999999999999999984 3899999999999999999999999999987654332
Q ss_pred ceeeecccCCcccccccccccc--cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCc
Q 040604 449 AISMLHARGTIGYIAPEVYSRR--FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526 (582)
Q Consensus 449 ~~~~~~~~gt~~y~aPE~~~~~--~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 526 (582)
. ....||+.|+|||++... ...++.++||||||+++|||++|+.||......... ...+..+....+...
T Consensus 182 ~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~~~~~~~~~~~~~ 253 (327)
T 3aln_A 182 K---TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-----LTQVVKGDPPQLSNS 253 (327)
T ss_dssp ---------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCCCSCCCCCCCC
T ss_pred c---ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-----HHHHhcCCCCCCCCc
Confidence 2 223599999999998421 146889999999999999999999999764322111 111111111111110
Q ss_pred CcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 527 ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 527 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
....+...+.+++.+||+.||++|||+++|++
T Consensus 254 ---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 254 ---EEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp ---SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---ccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 01123456778888999999999999999974
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=321.11 Aligned_cols=250 Identities=22% Similarity=0.326 Sum_probs=176.8
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCH---HHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNG---EEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
+.+.+.||+|+||.||+|... +|+.||||++....... +.+.++..+++.++||||+++++++.+....++||||+
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (318)
T 2dyl_A 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM 106 (318)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc
Confidence 345678999999999999775 79999999997654322 23444556788899999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
++.+..+... ....+++..++.++.|++.||+|||+. .+|+||||||+|||++.++.+||+|||++.........
T Consensus 107 -~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~- 181 (318)
T 2dyl_A 107 -GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK- 181 (318)
T ss_dssp -SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred -CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccc-
Confidence 5666655543 234689999999999999999999982 18999999999999999999999999999876543322
Q ss_pred eeecccCCccccccccccc---ccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcC
Q 040604 451 SMLHARGTIGYIAPEVYSR---RFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~---~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 527 (582)
....||+.|+|||++.. ....++.++||||||+++|||++|+.||.......... ...+.. ....+...
T Consensus 182 --~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~~~~~~-~~~~~~~~- 253 (318)
T 2dyl_A 182 --DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVL----TKVLQE-EPPLLPGH- 253 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH----HHHHHS-CCCCCCSS-
T ss_pred --cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHH----HHHhcc-CCCCCCcc-
Confidence 23459999999999853 12467899999999999999999999997643332221 111111 11111110
Q ss_pred cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 528 TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 528 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
..+...+.+++.+||+.||++|||++++++
T Consensus 254 ----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 254 ----MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ----SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 012345677888999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=333.47 Aligned_cols=249 Identities=23% Similarity=0.260 Sum_probs=183.5
Q ss_pred HHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeeeEEEEecCCC
Q 040604 295 KSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRT-SHVNIVTFLGFCYENKKNALIYELMPNG 373 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~g 373 (582)
+.+.+.||+|+||+|+.....+|+.||||++.... .+.+.+|+.+|+++ +|||||++++++.+....++||||+ +|
T Consensus 26 y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~-~g 102 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC--FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AA 102 (432)
T ss_dssp EEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT--EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC-SE
T ss_pred EecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC-CC
Confidence 34557899999999776656689999999996533 23456899999998 7999999999999999999999999 47
Q ss_pred ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-----CCceEEeecccccccccccc
Q 040604 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE-----DFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 374 sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~-----~~~vkl~DFGla~~~~~~~~ 448 (582)
+|.+++.... ..+.+..++.++.||+.||+|||+. +|+||||||+|||++. ...+||+|||+++.......
T Consensus 103 ~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 103 TLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp EHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred CHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 9999997653 2344456678999999999999998 9999999999999953 23588999999987764422
Q ss_pred c-eeeecccCCcccccccccccc-cCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCC
Q 040604 449 A-ISMLHARGTIGYIAPEVYSRR-FGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525 (582)
Q Consensus 449 ~-~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 525 (582)
. .......||+.|+|||++.+. ...++.++|||||||++|||++ |..||....... ....+.........
T Consensus 179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~------~~~~~~~~~~~~~~- 251 (432)
T 3p23_A 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ------ANILLGACSLDCLH- 251 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH------HHHHTTCCCCTTSC-
T ss_pred ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH------HHHHhccCCccccC-
Confidence 1 122345699999999998742 2467889999999999999999 888885432211 11111111111111
Q ss_pred cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 526 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
. .......+.+|+.+||+.||++|||+++|++
T Consensus 252 --~--~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 252 --P--EKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp --T--TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --c--cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1 1123345678889999999999999999983
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=308.04 Aligned_cols=231 Identities=19% Similarity=0.241 Sum_probs=180.2
Q ss_pred hhcCccCceEEEEEEe-CCCcEEEEEEeccCCCCHHHHHHHHHHH-hccCCCceEEEEeEEEe----CCeeeEEEEecCC
Q 040604 299 DKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNGEEFINEVASI-SRTSHVNIVTFLGFCYE----NKKNALIYELMPN 372 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~lv~E~~~~ 372 (582)
+.||+|+||.||++.. .+++.||||+++. ...+.+|+.++ +.++||||+++++++.. ....++||||+++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~ 99 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 99 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCS
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCC
Confidence 6799999999999976 4799999999964 35677888887 66699999999999987 6678999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---CCceEEeeccccccccccccc
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE---DFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~---~~~vkl~DFGla~~~~~~~~~ 449 (582)
|+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||++.....
T Consensus 100 ~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~---- 172 (299)
T 3m2w_A 100 GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG---- 172 (299)
T ss_dssp CBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT----
T ss_pred CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccccccccc----
Confidence 9999999887666799999999999999999999998 9999999999999998 78999999999865321
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
..++.++||||||+++|||++|+.||........ ...+..............
T Consensus 173 ----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~------~~~~~~~~~~~~~~~~~~ 224 (299)
T 3m2w_A 173 ----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------SPGMKTRIRMGQYEFPNP 224 (299)
T ss_dssp ----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------CCSCCSSCTTCCSSCHH
T ss_pred ----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh------hHHHHHHHhhccccCCch
Confidence 2467899999999999999999999965432210 000000000000111112
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcccC
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLE--MLEGSIE 568 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~--~Le~~~~ 568 (582)
....+...+.+++.+||+.||++|||++|+++ .+.+...
T Consensus 225 ~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 225 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred hcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 22345667888999999999999999999996 3454433
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=347.90 Aligned_cols=237 Identities=22% Similarity=0.285 Sum_probs=190.0
Q ss_pred HHHhhhhcCccCceEEEEEEeC--CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCe-----ee
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP--DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKK-----NA 364 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~ 364 (582)
.+.+.++||+|+||+||+|.+. +|+.||||++..... ..+.+.+|+.++++++||||+++++++..... .+
T Consensus 81 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~ 160 (681)
T 2pzi_A 81 QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGY 160 (681)
T ss_dssp TEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred ceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeE
Confidence 3456789999999999999765 689999999875432 23568899999999999999999999987655 69
Q ss_pred EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccc
Q 040604 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~ 444 (582)
|||||++|++|.+++.. .+++..++.|+.||+.||+|||+. +|+||||||+|||++.+ .+||+|||+++...
T Consensus 161 lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 161 IVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp EEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred EEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 99999999999987754 689999999999999999999998 99999999999999985 89999999998765
Q ss_pred ccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCC
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFD 524 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 524 (582)
.. ....||+.|+|||++.+ ..+.++|||||||++++|++|..|+....... +.
T Consensus 233 ~~------~~~~gt~~y~aPE~~~~---~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------------~~ 285 (681)
T 2pzi_A 233 SF------GYLYGTPGFQAPEIVRT---GPTVATDIYTVGRTLAALTLDLPTRNGRYVDG------------------LP 285 (681)
T ss_dssp CC------SCCCCCTTTSCTTHHHH---CSCHHHHHHHHHHHHHHHHSCCCEETTEECSS------------------CC
T ss_pred cC------CccCCCccccCHHHHcC---CCCCceehhhhHHHHHHHHhCCCCCccccccc------------------cc
Confidence 43 23459999999999865 34899999999999999999988775421110 00
Q ss_pred CcCcHHHHHHHHHHHHHHHhccccCCCCCCC-HHHHHHHHhccc
Q 040604 525 GVATEEEKKIAKMMILVGFWCIQTNPSERPS-MHKVLEMLEGSI 567 (582)
Q Consensus 525 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-~~evl~~Le~~~ 567 (582)
. ..........+.+++.+||+.||++||+ ++++.+.|.+.+
T Consensus 286 ~--~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 286 E--DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp T--TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred c--cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0 0112234466788999999999999995 677777776543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=310.37 Aligned_cols=230 Identities=11% Similarity=0.077 Sum_probs=181.5
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCH----HHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNG----EEFINEVASISRTSHVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 368 (582)
+|.+.++||+|+||.||+|... +++.||||+++...... +.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 32 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 111 (286)
T 3uqc_A 32 RYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAE 111 (286)
T ss_dssp TEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEE
Confidence 4566789999999999999765 59999999997654432 678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
|++|++|.+++... ....++.+|+.|++.||+|||+. +|+||||||+|||++.++.+||+++|
T Consensus 112 ~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 112 WIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp CCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred ecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 99999999999542 35567889999999999999998 99999999999999999999998443
Q ss_pred ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc
Q 040604 449 AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528 (582)
Q Consensus 449 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 528 (582)
|++ .++.++||||||+++|||++|+.||........... ....+.. ... ...
T Consensus 175 ------------~~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~--~~~~~~~-~~~----~~~ 226 (286)
T 3uqc_A 175 ------------TMP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP--AERDTAG-QPI----EPA 226 (286)
T ss_dssp ------------CCT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE--CCBCTTS-CBC----CHH
T ss_pred ------------ccC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH--HHHHhcc-CCC----Chh
Confidence 333 357899999999999999999999986544321100 0000000 000 000
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCC
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIEN 569 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~ 569 (582)
.....+...+.+++.+||+.||++| |++|+++.|+.....
T Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 227 DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 1112345667888999999999999 999999999975543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=341.57 Aligned_cols=258 Identities=23% Similarity=0.308 Sum_probs=192.6
Q ss_pred HHHHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEe------CCee
Q 040604 293 MTKSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYE------NKKN 363 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~ 363 (582)
..+.+.++||+|+||+||+|.. .+|+.||||+++.... ..+.+.+|+.++++++||||+++++++.. ....
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 3466779999999999999976 4789999999876432 23568899999999999999999998765 6677
Q ss_pred eEEEEecCCCChhhhhhcCC-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc---eEEeeccc
Q 040604 364 ALIYELMPNGSLDKFIHNDR-NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFC---PKISDFGL 439 (582)
Q Consensus 364 ~lv~E~~~~gsL~~~i~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~---vkl~DFGl 439 (582)
++||||+++|+|.+++.... ...+++..++.|+.|++.||+|||+. +|+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999998643 33588899999999999999999998 9999999999999997765 99999999
Q ss_pred cccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHH---HHHhhc
Q 040604 440 AKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNL---IYERIE 516 (582)
Q Consensus 440 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~---~~~~i~ 516 (582)
+......... ....||+.|+|||++.+ ..++.++||||||+++|||++|+.||............. ....+.
T Consensus 171 a~~~~~~~~~---~~~~gt~~Y~APE~l~~--~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~ 245 (676)
T 3qa8_A 171 AKELDQGELC---TEFVGTLQYLAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245 (676)
T ss_dssp CCBTTSCCCC---CCCCSCCTTCSSCSSCC--SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred cccccccccc---ccccCCcccCChHHhcc--CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence 9887554332 23469999999999876 478999999999999999999999997542211100000 000000
Q ss_pred --CC--CCCCCCC---cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHH
Q 040604 517 --PG--NDFQFDG---VATEEEKKIAKMMILVGFWCIQTNPSERPSMHK 558 (582)
Q Consensus 517 --~~--~~~~~~~---~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~e 558 (582)
.. ....+.. ........+...+.+++.+||+.||++|||+++
T Consensus 246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 00 0000100 011112235677888999999999999999966
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=324.74 Aligned_cols=236 Identities=17% Similarity=0.156 Sum_probs=174.5
Q ss_pred hhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCC----CHHHHHHHHHHHhccCC-Cc---------------eEE---
Q 040604 297 FRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRC----NGEEFINEVASISRTSH-VN---------------IVT--- 352 (582)
Q Consensus 297 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h-~n---------------iv~--- 352 (582)
..+.||+|+||+||+|.+ .+|+.||||+++.... ..+.+.+|+.+++.++| +| ++.
T Consensus 82 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (413)
T 3dzo_A 82 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 161 (413)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred EecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence 346899999999999975 4799999999874332 24678999999999987 22 111
Q ss_pred ---EEeEEEe-----CCeeeEEEEecCCCChhhhhh-----cCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCC
Q 040604 353 ---FLGFCYE-----NKKNALIYELMPNGSLDKFIH-----NDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDI 419 (582)
Q Consensus 353 ---l~~~~~~-----~~~~~lv~E~~~~gsL~~~i~-----~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Di 419 (582)
++.+... ....+++|+++ +++|.+++. ......+++..++.|+.|++.||+|||+. +|+||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDi 237 (413)
T 3dzo_A 162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYL 237 (413)
T ss_dssp ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCc
Confidence 1111111 12346777776 799999885 23344688889999999999999999998 9999999
Q ss_pred CCCCEEEcCCCceEEeeccccccccccccceeeecccCCcccccccccccc--------cCCCCccchhHHHHHHHHHHh
Q 040604 420 KPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRR--------FGGVSHKSDVYSYGMMIIEMV 491 (582)
Q Consensus 420 kp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~s~~~DvwSlGvil~ell 491 (582)
||+|||++.++.+||+|||+++..... .....| +.|+|||++... ...++.++|||||||++|||+
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 999999999999999999999875443 223468 999999998321 135788999999999999999
Q ss_pred cCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 040604 492 GCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVL 560 (582)
Q Consensus 492 tg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl 560 (582)
+|+.||........ .+.+.... . .++..+.+|+.+||+.||++||++.+++
T Consensus 312 tg~~Pf~~~~~~~~------~~~~~~~~-----~-------~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 312 CADLPNTDDAALGG------SEWIFRSC-----K-------NIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HSSCCCCTTGGGSC------SGGGGSSC-----C-------CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HCCCCCCCcchhhh------HHHHHhhc-----c-------cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 99999976543221 01111100 1 1235577888899999999999976653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=314.45 Aligned_cols=242 Identities=15% Similarity=0.128 Sum_probs=185.7
Q ss_pred HHHHHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCC---------CHHHHHHHHHHHhccC---------CCceEE
Q 040604 291 KRMTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRC---------NGEEFINEVASISRTS---------HVNIVT 352 (582)
Q Consensus 291 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~---------h~niv~ 352 (582)
....+.+.++||+|+||+||+|.. +|+.||||+++.... ..+.+.+|+.++++++ |+|||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 345677889999999999999987 789999999975432 2377889999998885 888888
Q ss_pred EEeEEE------------------------------eCCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHH
Q 040604 353 FLGFCY------------------------------ENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARG 402 (582)
Q Consensus 353 l~~~~~------------------------------~~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~a 402 (582)
+.+.+. +....++||||+++|++.+.+.+ ..+++..++.|+.||+.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHH
Confidence 887653 26788999999999977666643 358999999999999999
Q ss_pred HHHHH-hCCCCceEecCCCCCCEEEcCCC--------------------ceEEeeccccccccccccceeeecccCCccc
Q 040604 403 LEYLH-RGCQVRIVHFDIKPQNILLDEDF--------------------CPKISDFGLAKQAQKKESAISMLHARGTIGY 461 (582)
Q Consensus 403 L~yLH-~~~~~~ivH~Dikp~NILl~~~~--------------------~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y 461 (582)
|+||| +. +|+||||||+|||++.++ .+||+|||+|+..... ...||+.|
T Consensus 174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 87 999999999999999887 8999999999876532 23599999
Q ss_pred ccccccccccCCCCccchhHHHHHH-HHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHH
Q 040604 462 IAPEVYSRRFGGVSHKSDVYSYGMM-IIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMIL 540 (582)
Q Consensus 462 ~aPE~~~~~~~~~s~~~DvwSlGvi-l~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~ 540 (582)
+|||++.+. .+.++||||++++ .+++++|..|+.... ....+.+.+....... ..........+...+.+
T Consensus 244 ~aPE~~~g~---~~~~~Diwsl~~~~~~~~~~g~~p~~~~~-----~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~d 314 (336)
T 2vuw_A 244 MDEDLFTGD---GDYQFDIYRLMKKENNNRWGEYHPYSNVL-----WLHYLTDKMLKQMTFK-TKCNTPAMKQIKRKIQE 314 (336)
T ss_dssp TCSGGGCCC---SSHHHHHHHHHHHHHTTCTTSCCTHHHHH-----HHHHHHHHHHHTCCCS-SCCCSHHHHHHHHHHHH
T ss_pred cChhhhcCC---CccceehhhhhCCCCcccccccCCCcchh-----hhhHHHHhhhhhhccC-cccchhhhhhcCHHHHH
Confidence 999999864 3889999998777 788888988874310 0001111111100000 11223345567888999
Q ss_pred HHHhccccCCCCCCCHHHHH
Q 040604 541 VGFWCIQTNPSERPSMHKVL 560 (582)
Q Consensus 541 l~~~Cl~~dp~~RPt~~evl 560 (582)
|+.+||+.| |++|++
T Consensus 315 li~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 315 FHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHGGGSS-----SHHHHH
T ss_pred HHHHHhccC-----CHHHHH
Confidence 999999976 999988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-31 Score=287.75 Aligned_cols=185 Identities=16% Similarity=0.147 Sum_probs=130.9
Q ss_pred hhcCccCceEEEEEE-eCCCcEEEEEEeccCCC-----------CHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeeeE
Q 040604 299 DKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRC-----------NGEEFINEVASISRT-SHVNIVTFLGFCYENKKNAL 365 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-----------~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 365 (582)
..++.|+.|.+..++ ...|+.+|+|++..... ..++|.+|+++|+++ +|+||+++++++.++...||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 356777887777653 34689999999975421 124689999999999 79999999999999999999
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
||||++|++|.++|...+ +++.. +|+.||+.||+|||++ |||||||||+||||+++|.+||+|||+|+....
T Consensus 320 VMEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EEECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EEecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999998654 56654 5889999999999998 999999999999999999999999999987655
Q ss_pred cccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCC
Q 040604 446 KESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKN 496 (582)
Q Consensus 446 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p 496 (582)
.... .....||++|||||++.+ ....++|+||+|+++++|.++..+
T Consensus 392 ~~~~--~~t~vGTp~YmAPE~l~g---~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCSW--PTNLVQSFFVFVNELFAE---NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --CC--SHHHHHHHHHHHHHHC--------------------CCCCTTHHH
T ss_pred CCcc--ccCceechhhccHHHhCC---CCCCcccccccccchhhhccccch
Confidence 4332 223569999999999975 467789999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-27 Score=260.53 Aligned_cols=184 Identities=16% Similarity=0.177 Sum_probs=145.2
Q ss_pred hhhcCccCceEEEEEEeCCCcEEEEEEeccCCCC---------HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEE
Q 040604 298 RDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCN---------GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 368 (582)
.++||+|+||+||+|.. .++.+++|+....... .+.+.+|+.++++++||||+++..++......+||||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 46899999999999954 6788999987543221 2347899999999999999966666667788899999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
|+++++|.+++.. +..++.|+++||+|||++ +|+||||||+|||++. .+||+|||+++.......
T Consensus 420 ~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 420 YINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp CCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred CCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 9999999999875 457899999999999998 9999999999999998 999999999998765432
Q ss_pred ce-----eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCC
Q 040604 449 AI-----SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNL 497 (582)
Q Consensus 449 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~ 497 (582)
.. ......||+.|||||++......|+..+|+||..+-.++.+.++.++
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 11 11234699999999999764346788899999999998888776654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.9e-24 Score=211.99 Aligned_cols=140 Identities=18% Similarity=0.122 Sum_probs=113.8
Q ss_pred hhhcCccCceEEEEEEeCCCcEEEEEEeccCCC-------------------CHHHHHHHHHHHhccCCCceEEEEeEEE
Q 040604 298 RDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRC-------------------NGEEFINEVASISRTSHVNIVTFLGFCY 358 (582)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------------~~~~~~~E~~~l~~l~h~niv~l~~~~~ 358 (582)
.+.||+|+||.||+|...+|+.||||+++.... ....+.+|+.++++++ | +++.+++.
T Consensus 95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~ 171 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA 171 (282)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE
T ss_pred cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe
Confidence 378999999999999887899999999964321 1345889999999998 4 55555443
Q ss_pred eCCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecc
Q 040604 359 ENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFG 438 (582)
Q Consensus 359 ~~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFG 438 (582)
....++||||++|++|.+ +.. .....++.|++.||+|||+. +|+||||||+|||++ ++.+||+|||
T Consensus 172 -~~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 172 -WEGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp -EETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred -ccceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEECC
Confidence 356799999999999998 422 12446899999999999998 999999999999999 9999999999
Q ss_pred ccccccccccceeeecccCCccccccccccc
Q 040604 439 LAKQAQKKESAISMLHARGTIGYIAPEVYSR 469 (582)
Q Consensus 439 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 469 (582)
+|+. +..++|||++.+
T Consensus 238 ~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 238 QSVE---------------VGEEGWREILER 253 (282)
T ss_dssp TCEE---------------TTSTTHHHHHHH
T ss_pred CCeE---------------CCCCCHHHHHHH
Confidence 9863 345788998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=4.4e-20 Score=182.01 Aligned_cols=133 Identities=19% Similarity=0.215 Sum_probs=103.7
Q ss_pred hhhhcCccCceEEEEEEe-CCCcE--EEEEEeccCCCC-------------------------HHHHHHHHHHHhccCCC
Q 040604 297 FRDKLGQGGYGEVYKGEL-PDGQL--VAVKVLKNSRCN-------------------------GEEFINEVASISRTSHV 348 (582)
Q Consensus 297 ~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~-------------------------~~~~~~E~~~l~~l~h~ 348 (582)
+.+.||+|+||.||+|.. .+|+. ||||+++..... ...+.+|+.+|.+++|+
T Consensus 51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 130 (258)
T 1zth_A 51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA 130 (258)
T ss_dssp EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence 446899999999999987 68988 999997643211 12578899999999887
Q ss_pred ce--EEEEeEEEeCCeeeEEEEecCC-C----ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHH-hCCCCceEecCCC
Q 040604 349 NI--VTFLGFCYENKKNALIYELMPN-G----SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH-RGCQVRIVHFDIK 420 (582)
Q Consensus 349 ni--v~l~~~~~~~~~~~lv~E~~~~-g----sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~~~~~ivH~Dik 420 (582)
++ ..+++. ...+|||||+.+ | +|.++... .++..+..++.|++.||.||| +. +|+|||||
T Consensus 131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlk 198 (258)
T 1zth_A 131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA---ELVHADLS 198 (258)
T ss_dssp TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCS
T ss_pred CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCC
Confidence 53 444443 367899999942 4 66665432 223456789999999999999 77 99999999
Q ss_pred CCCEEEcCCCceEEeeccccccc
Q 040604 421 PQNILLDEDFCPKISDFGLAKQA 443 (582)
Q Consensus 421 p~NILl~~~~~vkl~DFGla~~~ 443 (582)
|+|||++. .++|+|||+|...
T Consensus 199 p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEET
T ss_pred HHHEEEcC--cEEEEECcccccC
Confidence 99999998 9999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.68 E-value=1.1e-17 Score=171.87 Aligned_cols=133 Identities=15% Similarity=0.167 Sum_probs=99.0
Q ss_pred HhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCC---------------CHHH--------HHHHHHHHhccCCCce--
Q 040604 296 SFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRC---------------NGEE--------FINEVASISRTSHVNI-- 350 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------------~~~~--------~~~E~~~l~~l~h~ni-- 350 (582)
.+.++||+|++|.||+|...+|+.||||+++.... .... ..+|...|.++.+.++
T Consensus 98 ~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~v 177 (397)
T 4gyi_A 98 SVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPV 177 (397)
T ss_dssp EEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSC
T ss_pred EecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 45578999999999999988999999999764211 0111 2346677777755543
Q ss_pred EEEEeEEEeCCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC
Q 040604 351 VTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF 430 (582)
Q Consensus 351 v~l~~~~~~~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~ 430 (582)
...++. ...+|||||++|++|.++... .....++.|++.+|.|||+. +||||||||.|||+++++
T Consensus 178 p~p~~~----~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 178 PEPIAQ----SRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEK 242 (397)
T ss_dssp CCEEEE----ETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEE
T ss_pred Ceeeec----cCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCC
Confidence 223322 234799999999888766432 12346789999999999998 999999999999998877
Q ss_pred ----------ceEEeeccccccc
Q 040604 431 ----------CPKISDFGLAKQA 443 (582)
Q Consensus 431 ----------~vkl~DFGla~~~ 443 (582)
.+.|+||+-+...
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEET
T ss_pred CcccccccccceEEEEeCCcccC
Confidence 3899999977654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=6.5e-12 Score=123.46 Aligned_cols=138 Identities=12% Similarity=0.054 Sum_probs=107.9
Q ss_pred hhhhcCccCceEEEEEEeCCCcEEEEEEeccCC-CCHHHHHHHHHHHhccC-CCceEEEEeEEEeCCeeeEEEEecCCCC
Q 040604 297 FRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSR-CNGEEFINEVASISRTS-HVNIVTFLGFCYENKKNALIYELMPNGS 374 (582)
Q Consensus 297 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gs 374 (582)
+...++.|+.+.||+... +++.+++|+..... .....+.+|+.+++.+. +..+.+++++..+....++||||++|.+
T Consensus 18 ~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~ 96 (263)
T 3tm0_A 18 CVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVL 96 (263)
T ss_dssp EEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEE
T ss_pred eEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCee
Confidence 345678888899999975 46899999986522 23346889999999885 6778899999988889999999999999
Q ss_pred hhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 040604 375 LDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRG--------------------------------------------- 409 (582)
Q Consensus 375 L~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--------------------------------------------- 409 (582)
|.+.+.. ......++.+++++|..||+.
T Consensus 97 l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (263)
T 3tm0_A 97 CSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRE 169 (263)
T ss_dssp HHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHH
T ss_pred hhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHH
Confidence 9876321 112346788999999999981
Q ss_pred -----------CCCceEecCCCCCCEEEcCCCceEEeecccccc
Q 040604 410 -----------CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ 442 (582)
Q Consensus 410 -----------~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~ 442 (582)
....++|+|++|.|||+++++.+.|+||+.+..
T Consensus 170 l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 170 LYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 014599999999999998876678999987643
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.21 E-value=4.1e-11 Score=117.17 Aligned_cols=131 Identities=17% Similarity=0.128 Sum_probs=99.5
Q ss_pred hcC-ccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCc--eEEEEeEEEeCCeeeEEEEecCCCChh
Q 040604 300 KLG-QGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVN--IVTFLGFCYENKKNALIYELMPNGSLD 376 (582)
Q Consensus 300 ~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~E~~~~gsL~ 376 (582)
.++ .|..+.||++...+|+.+++|+.... ....+.+|+.+++.+.+.+ +.+++++....+..++||||++|.+|.
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 354 55569999998777888999997654 2356788999998886544 566888888777889999999998884
Q ss_pred hhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------------
Q 040604 377 KFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGC---------------------------------------------- 410 (582)
Q Consensus 377 ~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---------------------------------------------- 410 (582)
... .+ ...++.++++.|..||+..
T Consensus 104 --~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (264)
T 1nd4_A 104 --SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 173 (264)
T ss_dssp --TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred --cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence 211 12 1256778888888888742
Q ss_pred ---------CCceEecCCCCCCEEEcCCCceEEeecccccc
Q 040604 411 ---------QVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ 442 (582)
Q Consensus 411 ---------~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~ 442 (582)
...++|+|++|.|||+++++.++|+|||.+..
T Consensus 174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998877778999997654
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.12 E-value=2.1e-10 Score=118.13 Aligned_cols=140 Identities=16% Similarity=0.180 Sum_probs=106.2
Q ss_pred hhcCccCceEEEEEEeCCCcEEEEEEec--cCC--CCHHHHHHHHHHHhccC--CCceEEEEeEEEeC---CeeeEEEEe
Q 040604 299 DKLGQGGYGEVYKGELPDGQLVAVKVLK--NSR--CNGEEFINEVASISRTS--HVNIVTFLGFCYEN---KKNALIYEL 369 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~--~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~E~ 369 (582)
+.|+.|.++.||+.... +..+++|+.. ... .....+.+|+.+++.+. +..+.+++.++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 57899999999999875 4678888876 332 12356788999999987 45578899988766 347899999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGC--------------------------------------- 410 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--------------------------------------- 410 (582)
++|..+.+... ..++......++.+++++|..||+..
T Consensus 123 v~G~~l~~~~~----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 123 VSGRVLWDQSL----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp CCCBCCCCTTC----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred cCCeecCCCcc----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 99888754221 23677888899999999999999731
Q ss_pred ----------------CCceEecCCCCCCEEEcCCCc--eEEeeccccccc
Q 040604 411 ----------------QVRIVHFDIKPQNILLDEDFC--PKISDFGLAKQA 443 (582)
Q Consensus 411 ----------------~~~ivH~Dikp~NILl~~~~~--vkl~DFGla~~~ 443 (582)
...++|+|+++.|||++.++. +.|+||+.+...
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 247999999999999997753 699999988753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.99 E-value=3.1e-10 Score=114.07 Aligned_cols=186 Identities=20% Similarity=0.186 Sum_probs=122.2
Q ss_pred hhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccC-CCc--eEEEEeEEEeCC---eeeEEEEecCC
Q 040604 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTS-HVN--IVTFLGFCYENK---KNALIYELMPN 372 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~E~~~~ 372 (582)
+.++.|....||+.. ..+++|+.... .....+.+|+.+|+.+. +.. +.+++....... ..++|||+++|
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 458999999999863 45888986532 23467889999998873 333 445555543333 34799999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRG------------------------------------------- 409 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~------------------------------------------- 409 (582)
.+|..... ..++..+...++.+++..|..||+.
T Consensus 101 ~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 101 VPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp EECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred eECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 88875432 2467777888888999998888861
Q ss_pred ------------CCCceEecCCCCCCEEEcC--CCceEEeeccccccccccccceeeecc------------cCCccccc
Q 040604 410 ------------CQVRIVHFDIKPQNILLDE--DFCPKISDFGLAKQAQKKESAISMLHA------------RGTIGYIA 463 (582)
Q Consensus 410 ------------~~~~ivH~Dikp~NILl~~--~~~vkl~DFGla~~~~~~~~~~~~~~~------------~gt~~y~a 463 (582)
....++|+|++|.||++++ +..+.|+||+.+............... ....+..+
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~ 256 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKD 256 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSC
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCC
Confidence 1135899999999999998 567899999988754321110000000 00001112
Q ss_pred -ccccccccCCCCccchhHHHHHHHHHHhcCCCCC
Q 040604 464 -PEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNL 497 (582)
Q Consensus 464 -PE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~ 497 (582)
|+.... .....+.|+++.+++++.+|..++
T Consensus 257 ~~~~~~r----~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 257 IPTVLEK----YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHH----HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cHHHHHH----HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 222211 122358999999999999998665
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=6.2e-07 Score=89.93 Aligned_cols=136 Identities=18% Similarity=0.142 Sum_probs=94.3
Q ss_pred hhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCC---ceEEEEeEEE-eCCeeeEEEEecCCCC
Q 040604 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHV---NIVTFLGFCY-ENKKNALIYELMPNGS 374 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~E~~~~gs 374 (582)
+.++.|....||+. |..+++|+-.. ......+.+|+.+|+.+.+. .|.+.+.+.. ..+..++|||+++|..
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 45788888899987 56788888532 12245688999999998753 3566776664 3456789999999988
Q ss_pred hhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 040604 375 LDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRG--------------------------------------------- 409 (582)
Q Consensus 375 L~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--------------------------------------------- 409 (582)
|...... .++......++.++++.|..||+.
T Consensus 100 l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 100 LGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp CHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred Cchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 8763211 234445555555555555555542
Q ss_pred ------------CCCceEecCCCCCCEEEcC---CCc-eEEeeccccccc
Q 040604 410 ------------CQVRIVHFDIKPQNILLDE---DFC-PKISDFGLAKQA 443 (582)
Q Consensus 410 ------------~~~~ivH~Dikp~NILl~~---~~~-vkl~DFGla~~~ 443 (582)
....++|+|++|.|||++. ++. +.|+||+.+...
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 1235799999999999987 345 589999987653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=1.1e-06 Score=86.10 Aligned_cols=135 Identities=17% Similarity=0.144 Sum_probs=96.9
Q ss_pred hcCccCce-EEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhccC-CCceEEEEeEEEeCCeeeEEEEecCCCChh
Q 040604 300 KLGQGGYG-EVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRTS-HVNIVTFLGFCYENKKNALIYELMPNGSLD 376 (582)
Q Consensus 300 ~lG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 376 (582)
.+..|..| .||+.... ++..+++|+-... ....+.+|...|+.+. +--|.++++++.+.+..++|||+++|.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 34445554 68987654 5678999986533 3456788999988875 334678889998889999999999998887
Q ss_pred hhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------------
Q 040604 377 KFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGC---------------------------------------------- 410 (582)
Q Consensus 377 ~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---------------------------------------------- 410 (582)
+...... .....++.+++..|.-||+..
T Consensus 109 ~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 109 QVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred ccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 6653221 123345666677777777420
Q ss_pred ---------CCceEecCCCCCCEEEcCCCceEEeecccccc
Q 040604 411 ---------QVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ 442 (582)
Q Consensus 411 ---------~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~ 442 (582)
...++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12389999999999999887778999987654
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=9.1e-07 Score=90.59 Aligned_cols=79 Identities=8% Similarity=-0.037 Sum_probs=55.9
Q ss_pred hhc-CccCceEEEEEEeC-------CCcEEEEEEeccCC---C-CHHHHHHHHHHHhccCC---CceEEEEeEEEeC---
Q 040604 299 DKL-GQGGYGEVYKGELP-------DGQLVAVKVLKNSR---C-NGEEFINEVASISRTSH---VNIVTFLGFCYEN--- 360 (582)
Q Consensus 299 ~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~-~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~--- 360 (582)
+.| +.|....+|+.... +++.+++|+..... . ....+.+|+.+++.+.. -.+.+++.+..+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 88889999998654 26788999875432 1 23457788888887743 3577788877654
Q ss_pred CeeeEEEEecCCCChhh
Q 040604 361 KKNALIYELMPNGSLDK 377 (582)
Q Consensus 361 ~~~~lv~E~~~~gsL~~ 377 (582)
...++|||+++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999998877653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.09 E-value=1.4e-05 Score=80.87 Aligned_cols=140 Identities=14% Similarity=0.137 Sum_probs=80.2
Q ss_pred hhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCC--CceEEEEe------EEEeCCeeeEEEEec
Q 040604 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSH--VNIVTFLG------FCYENKKNALIYELM 370 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~E~~ 370 (582)
+.|+.|..+.||+....+| .+++|+.... .+.+..|+.+++.|.. -.|.+++. +....+..+++|||+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 3466677899999987555 4899998752 3444455555555431 12333332 123456778999999
Q ss_pred CCCChh--------------hhhhcC-CCc-----------CCCHHHH-------------------------------H
Q 040604 371 PNGSLD--------------KFIHND-RNI-----------KLEWKTM-------------------------------Y 393 (582)
Q Consensus 371 ~~gsL~--------------~~i~~~-~~~-----------~l~~~~~-------------------------------~ 393 (582)
+|..+. ..++.. ... ...|... .
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 886542 111110 000 0122211 0
Q ss_pred HHHHHHHHHHHHHHh----------CCCCceEecCCCCCCEEEcCCCceEEeecccccc
Q 040604 394 QIAIGIARGLEYLHR----------GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ 442 (582)
Q Consensus 394 ~i~~qi~~aL~yLH~----------~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~ 442 (582)
.+..++..++.+|++ .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111223345666653 0235899999999999998888999999997643
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.07 E-value=1.3e-05 Score=83.17 Aligned_cols=73 Identities=10% Similarity=0.058 Sum_probs=49.8
Q ss_pred hhcCccCceEEEEEEeC-CCcEEEEEEeccCC--------CCHHHHHHHHHHHhccCC--C-ceEEEEeEEEeCCeeeEE
Q 040604 299 DKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR--------CNGEEFINEVASISRTSH--V-NIVTFLGFCYENKKNALI 366 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~lv 366 (582)
+.||.|..+.||++... +++.++||...... ...+.+..|..+++.+.. + .+.+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 57999999999999754 56889999864321 123456788888887642 3 45566654 45567899
Q ss_pred EEecCCC
Q 040604 367 YELMPNG 373 (582)
Q Consensus 367 ~E~~~~g 373 (582)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.94 E-value=4.7e-05 Score=76.16 Aligned_cols=136 Identities=18% Similarity=0.229 Sum_probs=92.2
Q ss_pred hhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccC---CCceEEEEeEEEeCCeeeEEEEecCCCCh
Q 040604 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTS---HVNIVTFLGFCYENKKNALIYELMPNGSL 375 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~E~~~~gsL 375 (582)
+.|+.|....+|+... ++..+++|+.... ....+..|+..|+.|. ...|.+++.+....+..++||||++|..+
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 4689999999999876 5678889987643 3567888999888874 35688899888877889999999998765
Q ss_pred hh-----------hhhcCCC---c-----------------CCCHHHHH---HHHH----------------HHHHHH-H
Q 040604 376 DK-----------FIHNDRN---I-----------------KLEWKTMY---QIAI----------------GIARGL-E 404 (582)
Q Consensus 376 ~~-----------~i~~~~~---~-----------------~l~~~~~~---~i~~----------------qi~~aL-~ 404 (582)
.. .++.... . .-+|...+ ++.. ++++.+ .
T Consensus 119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~ 198 (312)
T 3jr1_A 119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD 198 (312)
T ss_dssp CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence 21 1222111 0 12454432 1111 112112 2
Q ss_pred HHHh-CCCCceEecCCCCCCEEEcCCCceEEeecc
Q 040604 405 YLHR-GCQVRIVHFDIKPQNILLDEDFCPKISDFG 438 (582)
Q Consensus 405 yLH~-~~~~~ivH~Dikp~NILl~~~~~vkl~DFG 438 (582)
.|.. ...+.++|+|+.+.|++++.++ +-|.||.
T Consensus 199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 3421 2246899999999999999887 8888874
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00014 Score=76.16 Aligned_cols=80 Identities=9% Similarity=0.038 Sum_probs=46.9
Q ss_pred CceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeecccCCcccccccccccccC-CCCccchhHHHHHHHHHH
Q 040604 412 VRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFG-GVSHKSDVYSYGMMIIEM 490 (582)
Q Consensus 412 ~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~s~~~DvwSlGvil~el 490 (582)
..++|+|++|.|||++.++ ++|+||+.+............. ..-...|++|+......+ .-....++.+....+|++
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYL-GNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHH-HHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHH-HHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 4899999999999998876 9999999887644221110000 001134666655431100 111234455777777777
Q ss_pred hcC
Q 040604 491 VGC 493 (582)
Q Consensus 491 ltg 493 (582)
+.+
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00012 Score=72.44 Aligned_cols=73 Identities=19% Similarity=0.222 Sum_probs=54.5
Q ss_pred hhcCccCceEEEEEEeCCCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCC---ceEEEEeEEEeCCeeeEEEEecCCCC
Q 040604 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRC-NGEEFINEVASISRTSHV---NIVTFLGFCYENKKNALIYELMPNGS 374 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~lv~E~~~~gs 374 (582)
+.+|.|..+.||+....+|+.+++|+...... ....|..|+..|+.|... -+.+.++.. ..++||||++++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence 56899999999999999999999998754432 335678899988887422 345555542 3579999998765
Q ss_pred h
Q 040604 375 L 375 (582)
Q Consensus 375 L 375 (582)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00016 Score=75.84 Aligned_cols=72 Identities=15% Similarity=0.230 Sum_probs=50.7
Q ss_pred hhcCccCceEEEEEEeCC--------CcEEEEEEeccCCCCHHHHHHHHHHHhccCCCce-EEEEeEEEeCCeeeEEEEe
Q 040604 299 DKLGQGGYGEVYKGELPD--------GQLVAVKVLKNSRCNGEEFINEVASISRTSHVNI-VTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~ 369 (582)
+.|+.|....||+....+ ++.+++|+.... ...+.+.+|..+++.+...++ .++++.+.+ .+||||
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~ 153 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 153 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence 457888889999997653 578999998442 222667789998888754443 567766532 389999
Q ss_pred cCCCCh
Q 040604 370 MPNGSL 375 (582)
Q Consensus 370 ~~~gsL 375 (582)
++|.+|
T Consensus 154 l~G~~l 159 (429)
T 1nw1_A 154 IPSRPL 159 (429)
T ss_dssp CCEEEC
T ss_pred eCCccc
Confidence 986454
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00044 Score=69.46 Aligned_cols=140 Identities=14% Similarity=0.166 Sum_probs=83.5
Q ss_pred hcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCC--ceEEEEeE-----EEeCCeeeEEEEecCC
Q 040604 300 KLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHV--NIVTFLGF-----CYENKKNALIYELMPN 372 (582)
Q Consensus 300 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~E~~~~ 372 (582)
.|+ |....||+....+|+.+++|+........+.+..|..+++.+... .+++++.. ....+..+++||+++|
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G 111 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 111 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence 466 778899998776787899999975545667777888888777422 24444443 1224456789999987
Q ss_pred CChhh-----------h---hhc----CC---CcCCCHHHH----HHHH---------------HHHHHHHHHHHh----
Q 040604 373 GSLDK-----------F---IHN----DR---NIKLEWKTM----YQIA---------------IGIARGLEYLHR---- 408 (582)
Q Consensus 373 gsL~~-----------~---i~~----~~---~~~l~~~~~----~~i~---------------~qi~~aL~yLH~---- 408 (582)
..+.. . ++. .. ....++... ..++ ..+...++.+.+
T Consensus 112 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 191 (328)
T 1zyl_A 112 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE 191 (328)
T ss_dssp EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhh
Confidence 55421 0 111 00 011222211 0010 011112223322
Q ss_pred CCCCceEecCCCCCCEEEcCCCceEEeecccccc
Q 040604 409 GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ 442 (582)
Q Consensus 409 ~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~ 442 (582)
.....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 192 ~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 192 DFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred cCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1234789999999999999 4 899999987654
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00027 Score=72.59 Aligned_cols=140 Identities=17% Similarity=0.186 Sum_probs=83.3
Q ss_pred hhcCccCceEEEEEEeC--------CCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCc-eEEEEeEEEeCCeeeEEEEe
Q 040604 299 DKLGQGGYGEVYKGELP--------DGQLVAVKVLKNSRCNGEEFINEVASISRTSHVN-IVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~E~ 369 (582)
+.|..|-...+|+.... +++.+++|+..........+.+|..+++.+.... ..++++++.+ .+||||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 45777888899998764 3578999987543334566778999888875332 3566766543 399999
Q ss_pred cCCCChhhh-----------------hhcCC---CcCCC--HHHHHHHHHHHHH-------------------HHHHHH-
Q 040604 370 MPNGSLDKF-----------------IHNDR---NIKLE--WKTMYQIAIGIAR-------------------GLEYLH- 407 (582)
Q Consensus 370 ~~~gsL~~~-----------------i~~~~---~~~l~--~~~~~~i~~qi~~-------------------aL~yLH- 407 (582)
++|.+|..- ++... ..... +.++.++..++.. .+..|.
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 988665411 11110 11122 3444444433321 223332
Q ss_pred ---hC-CCCceEecCCCCCCEEEcCC----CceEEeecccccc
Q 040604 408 ---RG-CQVRIVHFDIKPQNILLDED----FCPKISDFGLAKQ 442 (582)
Q Consensus 408 ---~~-~~~~ivH~Dikp~NILl~~~----~~vkl~DFGla~~ 442 (582)
.. ....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 23479999999999999876 7899999987754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00022 Score=70.93 Aligned_cols=137 Identities=12% Similarity=0.114 Sum_probs=74.9
Q ss_pred hhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCce-EEEEeEEEeCCeeeEEEEec-CCCChh
Q 040604 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNI-VTFLGFCYENKKNALIYELM-PNGSLD 376 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~-~~gsL~ 376 (582)
+.|+.|....+|+. ..+++|+........-...+|+.+++.+....+ .+++++ +.+..++|+||+ +|.+|.
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l~ 96 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTMS 96 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEECC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccCC
Confidence 66888999999998 568889876532111123467777766643222 355544 344568999999 665553
Q ss_pred hh------------------hhcCCC---cCCC-HHHHHHHHH--------------HHHHHH----HHHHh-CCCCceE
Q 040604 377 KF------------------IHNDRN---IKLE-WKTMYQIAI--------------GIARGL----EYLHR-GCQVRIV 415 (582)
Q Consensus 377 ~~------------------i~~~~~---~~l~-~~~~~~i~~--------------qi~~aL----~yLH~-~~~~~iv 415 (582)
.. ++.... .... +..+..+.. .+.+.+ +.|.. .....++
T Consensus 97 ~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l~ 176 (301)
T 3dxq_A 97 PEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAAC 176 (301)
T ss_dssp HHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEEE
T ss_pred HhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCceee
Confidence 21 111100 0001 011111100 011111 11111 1234689
Q ss_pred ecCCCCCCEEEcCCCceEEeeccccccc
Q 040604 416 HFDIKPQNILLDEDFCPKISDFGLAKQA 443 (582)
Q Consensus 416 H~Dikp~NILl~~~~~vkl~DFGla~~~ 443 (582)
|+|+.+.||+ ..++.+.|+||..+...
T Consensus 177 HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 177 HCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred ccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 9999999999 66677899999987653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00021 Score=71.64 Aligned_cols=142 Identities=14% Similarity=0.180 Sum_probs=79.5
Q ss_pred hhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCc--eEEEEeE------EEeCCeeeEEEEec
Q 040604 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVN--IVTFLGF------CYENKKNALIYELM 370 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~E~~ 370 (582)
+.|+.|....+|+....+| .+++|+.... ...+.+..|+.++..+.... +.+++.. ....+..+++|||+
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 4577788899999987655 6789988653 12345566777776664222 2333321 12235678999999
Q ss_pred CCCChhh--------------hhhcC-CCc--C----C---CHHHHHH------------HHHHHHHHHHHHHhC----C
Q 040604 371 PNGSLDK--------------FIHND-RNI--K----L---EWKTMYQ------------IAIGIARGLEYLHRG----C 410 (582)
Q Consensus 371 ~~gsL~~--------------~i~~~-~~~--~----l---~~~~~~~------------i~~qi~~aL~yLH~~----~ 410 (582)
+|..+.. .++.. ... + . .|...+. +...+...++.++.. .
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 8865421 11111 000 0 1 1221110 001134445555532 2
Q ss_pred CCceEecCCCCCCEEEcCCCceEEeecccccc
Q 040604 411 QVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ 442 (582)
Q Consensus 411 ~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~ 442 (582)
..+++|+|+++.|||+++++.+.|+||+.+..
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 34799999999999999876668999986643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00066 Score=71.55 Aligned_cols=73 Identities=14% Similarity=-0.033 Sum_probs=48.0
Q ss_pred hhcCccCceEEEEEEeCC-CcEEEEEEeccCCCCHHHHHHHHHHHhccCCCce-EEEEeEEEeCCeeeEEEEecCCCCh
Q 040604 299 DKLGQGGYGEVYKGELPD-GQLVAVKVLKNSRCNGEEFINEVASISRTSHVNI-VTFLGFCYENKKNALIYELMPNGSL 375 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~gsL 375 (582)
+.|+.|-...+|+....+ +..+++|+........-...+|..+++.|...++ .++++.+. . .+||||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 468888889999998764 5788999875432111112578888888875554 56777762 2 359999987555
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.0011 Score=66.70 Aligned_cols=142 Identities=15% Similarity=0.134 Sum_probs=73.1
Q ss_pred hhcCccCceE-EEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCC--CceEEEEeEEEeCCeeeEEEEecCCCCh
Q 040604 299 DKLGQGGYGE-VYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSH--VNIVTFLGFCYENKKNALIYELMPNGSL 375 (582)
Q Consensus 299 ~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~E~~~~gsL 375 (582)
+.|+.|+... +|+....+|+.+++|...... .+.+..|+.+++.+.. -.+.+++.+.. ..-+++||++.+..+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~l 99 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDALF 99 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCBH
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcch
Confidence 3465565554 667765446778787654432 1233456666665532 23556666532 333789999976666
Q ss_pred hhhhhcCC-----------------------Cc-CCCHHHHH-------HH-------------HHHHHHHHHHHH---h
Q 040604 376 DKFIHNDR-----------------------NI-KLEWKTMY-------QI-------------AIGIARGLEYLH---R 408 (582)
Q Consensus 376 ~~~i~~~~-----------------------~~-~l~~~~~~-------~i-------------~~qi~~aL~yLH---~ 408 (582)
.+.+.... .. .++..... .+ ...+...++.+. .
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 44332110 00 11111110 00 001112222221 1
Q ss_pred CCCCceEecCCCCCCEEEcCC----CceEEeecccccccc
Q 040604 409 GCQVRIVHFDIKPQNILLDED----FCPKISDFGLAKQAQ 444 (582)
Q Consensus 409 ~~~~~ivH~Dikp~NILl~~~----~~vkl~DFGla~~~~ 444 (582)
.....++|+|+.+.|||++.+ +.+.|+||+.+....
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 123489999999999999875 689999999887643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00028 Score=72.37 Aligned_cols=73 Identities=14% Similarity=0.105 Sum_probs=43.9
Q ss_pred hhcCccCceEEEEEEeCC---------CcEEEEEEeccCCCCHHHHHHHHHHHhccCCCc-eEEEEeEEEeCCeeeEEEE
Q 040604 299 DKLGQGGYGEVYKGELPD---------GQLVAVKVLKNSRCNGEEFINEVASISRTSHVN-IVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~E 368 (582)
+.|+.|....+|+....+ ++.+++|+.............|..+++.+...+ +.++++.. ..++|||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEEE
Confidence 467888889999987654 268899987543211112356777777765333 34666543 2368999
Q ss_pred ecCCCCh
Q 040604 369 LMPNGSL 375 (582)
Q Consensus 369 ~~~~gsL 375 (582)
|++|..+
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987554
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0036 Score=58.08 Aligned_cols=107 Identities=14% Similarity=0.089 Sum_probs=69.1
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
-+|.+++... +.++++.++|.++.|.+.+|.-+-.+.. . ..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 3688888754 3589999999999999999877622111 1 1223446899999999988764 1111
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCC
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDE 500 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~ 500 (582)
.....+.+||... ...+.+.=|||||+++|..+--..|-...
T Consensus 98 ---~~~~~~~~pe~~~---~~~te~~~IysLG~tLY~ALDygL~e~eE 139 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY---SQCMETEVIESLGIIIYKALDYGLKENEE 139 (229)
T ss_dssp ------------CCSS---SSSCHHHHHHHHHHHHHHHHTTTCCTTEE
T ss_pred ---ccccCCCChhhcc---ccchHHHHHHHHHHHHHHHhhcCCCcccc
Confidence 0223467888764 25678899999999999999766655443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.71 E-value=0.012 Score=59.21 Aligned_cols=31 Identities=23% Similarity=0.265 Sum_probs=27.7
Q ss_pred CceEecCCCCCCEEEcCCCceEEeecccccc
Q 040604 412 VRIVHFDIKPQNILLDEDFCPKISDFGLAKQ 442 (582)
Q Consensus 412 ~~ivH~Dikp~NILl~~~~~vkl~DFGla~~ 442 (582)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.47 E-value=0.041 Score=57.14 Aligned_cols=73 Identities=10% Similarity=0.074 Sum_probs=47.3
Q ss_pred hhcCccCceEEEEEEeCC--------CcEEEEEEeccCCCCHHHHHHHHHHHhccCCCc-eEEEEeEEEeCCeeeEEEEe
Q 040604 299 DKLGQGGYGEVYKGELPD--------GQLVAVKVLKNSRCNGEEFINEVASISRTSHVN-IVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~E~ 369 (582)
+.|..|-...+|+....+ ++.+++|+........-...+|..+++.+...+ ..++++.+ ..++||||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~ef 151 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIEEF 151 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEEC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEEEE
Confidence 457778888999987653 578999987543221112356787777774322 34556533 23789999
Q ss_pred cCCCCh
Q 040604 370 MPNGSL 375 (582)
Q Consensus 370 ~~~gsL 375 (582)
++|..|
T Consensus 152 I~G~~l 157 (424)
T 3mes_A 152 IDGEPL 157 (424)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.72 E-value=0.45 Score=48.82 Aligned_cols=30 Identities=30% Similarity=0.315 Sum_probs=25.2
Q ss_pred ceEecCCCCCCEEE------cCCCceEEeecccccc
Q 040604 413 RIVHFDIKPQNILL------DEDFCPKISDFGLAKQ 442 (582)
Q Consensus 413 ~ivH~Dikp~NILl------~~~~~vkl~DFGla~~ 442 (582)
.++|+|+.+.|||+ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4567799999988764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=87.57 E-value=1.4 Score=40.87 Aligned_cols=116 Identities=11% Similarity=0.140 Sum_probs=75.7
Q ss_pred cCCCceEEEEeEEEeCCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHH-HHHhCCCCceEecCCCCCC
Q 040604 345 TSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLE-YLHRGCQVRIVHFDIKPQN 423 (582)
Q Consensus 345 l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~-yLH~~~~~~ivH~Dikp~N 423 (582)
..||++ -..+-.+++...+.++.-+++.=...++ .++...+++++.+|+.... +++ .-+|-=|.|+|
T Consensus 47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~N 114 (219)
T 4ano_A 47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPEN 114 (219)
T ss_dssp GSCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGG
T ss_pred ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCce
Confidence 368887 3344456666666666553333233332 4677889999998887766 555 45889999999
Q ss_pred EEEcCCCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCC
Q 040604 424 ILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLD 498 (582)
Q Consensus 424 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~ 498 (582)
|+++.++.++|.-.|+-. -++|.-+ +..-=.-++=+++..++.++..|+
T Consensus 115 L~f~~~~~p~i~hRGi~~-------------------~lpP~e~-------~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKE-------------------SLPPDEW-------DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EEECTTCCEEESCCEETT-------------------TBSSCSC-------CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEEeCCCcEEEEEcCCcc-------------------cCCCCCC-------CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999998776533 2334321 111223346678888887776654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.17 E-value=0.94 Score=41.81 Aligned_cols=117 Identities=14% Similarity=0.153 Sum_probs=76.9
Q ss_pred cCCCceEEEEeEEEeCCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCE
Q 040604 345 TSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNI 424 (582)
Q Consensus 345 l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NI 424 (582)
..||+++.. .+-.+.+...+.++.-+ ....+-. -..++....++++.+|+....++++. +|-=|.|+||
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~---ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL 110 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDN---IKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDEL 110 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGG---GGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGE
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCc--ccCCHHH---HHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceE
Confidence 368888865 44455555555555433 2222221 11467889999999999888777643 8899999999
Q ss_pred EEcCCCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCC
Q 040604 425 LLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLD 498 (582)
Q Consensus 425 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~ 498 (582)
+++.++.+++.--|+... ++|. ..+...=.-.+=+++..+++++..|+
T Consensus 111 ~f~~~~~p~i~~RGik~~-------------------l~P~-------~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNV-------------------VDPL-------PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTTSCEEESCCEETTT-------------------BSCC-------CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEcCCCCEEEEEccCccC-------------------CCCC-------CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999987665432 2332 11222223356788888998887764
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=81.84 E-value=0.12 Score=54.25 Aligned_cols=61 Identities=7% Similarity=0.034 Sum_probs=19.4
Q ss_pred HhhhhcCccCceEEEEEEeCC-CcEEEE------EEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEe
Q 040604 296 SFRDKLGQGGYGEVYKGELPD-GQLVAV------KVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYE 359 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~~-~~~vav------K~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~ 359 (582)
.+.++|| ||.||+|.+.. ..+||| |..+..... ...+.+|..++..++|+|+++.+++-..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 3456787 99999998754 467888 766543322 2467889999999999999999887753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 582 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-71 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-66 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-66 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-66 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-65 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-63 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-63 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-60 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-57 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-57 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-57 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-56 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-55 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-54 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-54 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-52 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-52 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-47 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-43 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-38 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-26 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (579), Expect = 9e-71
Identities = 75/283 (26%), Positives = 128/283 (45%), Gaps = 22/283 (7%)
Query: 297 FRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNG---EEFINEVASISRTSHVNIVTF 353
++G G +G VYKG+ VAVK+L + + F NEV + +T HVNI+ F
Sbjct: 12 VGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 354 LGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVR 413
+G+ + A++ + SL +H K E + IA A+G++YLH
Sbjct: 70 MGYSTAPQL-AIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAKS--- 124
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVY-SRRFG 472
I+H D+K NI L ED KI DFGLA + + G+I ++APEV +
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 473 GVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532
S +SDVY++G+++ E++ + + + ++ + + + K
Sbjct: 185 PYSFQSDVYAFGIVLYELM-TGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 243
Query: 533 KIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQIPPK 575
++ C++ ERP ++L +E +L PK
Sbjct: 244 RLMA-------ECLKKKRDERPLFPQILASIELLARSL---PK 276
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 1e-66
Identities = 70/268 (26%), Positives = 121/268 (45%), Gaps = 19/268 (7%)
Query: 297 FRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGF 356
++LG G +GEV+ G VAVK LK + + F+ E + + H +V
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 357 CYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVH 416
+ +I E M NGSL F+ IKL + +A IA G+ ++ +H
Sbjct: 77 VTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 417 FDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSH 476
D++ NIL+ + KI+DFGLA+ + E + A+ I + APE +G +
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAI--NYGTFTI 189
Query: 477 KSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAK 536
KSDV+S+G+++ E+V + +T+ + + +E G EE ++ +
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPE-----VIQNLERGYRMVRPDNCPEELYQLMR 244
Query: 537 MMILVGFWCIQTNPSERPSMHKVLEMLE 564
C + P +RP+ + +LE
Sbjct: 245 -------LCWKERPEDRPTFDYLRSVLE 265
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 1e-66
Identities = 69/281 (24%), Positives = 120/281 (42%), Gaps = 19/281 (6%)
Query: 297 FRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGF 356
KLGQG +GEV+ G VA+K LK + E F+ E + + H +V
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 357 CYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVH 416
+ ++ E M GSL F+ + L + +A IA G+ Y+ ++ VH
Sbjct: 81 V-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 136
Query: 417 FDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSH 476
D++ NIL+ E+ K++DFGLA+ + E + A+ I + APE G +
Sbjct: 137 RDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALY--GRFTI 193
Query: 477 KSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAK 536
KSDV+S+G+++ E+ + + + + +++E G E +
Sbjct: 194 KSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQVERGYRMPCPPECPESLHDLMC 248
Query: 537 MMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQIPPKPS 577
C + P ERP+ + LE + + +P
Sbjct: 249 -------QCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 4e-66
Identities = 65/273 (23%), Positives = 125/273 (45%), Gaps = 19/273 (6%)
Query: 297 FRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGF 356
F ++G G +G V+ G + VA+K ++ + E+FI E + + SH +V G
Sbjct: 9 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 357 CYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVH 416
C E L++E M +G L ++ + +T+ + + + G+ YL C ++H
Sbjct: 69 CLEQAPICLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 124
Query: 417 FDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSH 476
D+ +N L+ E+ K+SDFG+ + + S + + + +PEV+ F S
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST-GTKFPVKWASPEVF--SFSRYSS 181
Query: 477 KSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAK 536
KSDV+S+G+++ E+ K + +++ + E I G +A+ +I
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSE-----VVEDISTGFRLYKPRLASTHVYQIMN 236
Query: 537 MMILVGFWCIQTNPSERPSMHKVLEMLEGSIEN 569
C + P +RP+ ++L L E+
Sbjct: 237 -------HCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 2e-65
Identities = 64/268 (23%), Positives = 119/268 (44%), Gaps = 19/268 (7%)
Query: 297 FRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGF 356
F +LG G +G V G+ VA+K++K + +EFI E + SH +V G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 357 CYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVH 416
C + + +I E M NG L ++ R+ + + + + ++ + +EYL +H
Sbjct: 68 CTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQ---FLH 123
Query: 417 FDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSH 476
D+ +N L+++ K+SDFGL++ E S + ++ + + PEV S
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMY--SKFSS 180
Query: 477 KSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAK 536
KSD++++G+++ E+ K + T++ E I G +A+E+ I
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSE-----TAEHIAQGLRLYRPHLASEKVYTIMY 235
Query: 537 MMILVGFWCIQTNPSERPSMHKVLEMLE 564
C ERP+ +L +
Sbjct: 236 -------SCWHEKADERPTFKILLSNIL 256
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 2e-63
Identities = 68/269 (25%), Positives = 118/269 (43%), Gaps = 25/269 (9%)
Query: 297 FRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGF 356
+G+G +G+V G+ G VAVK +KN + F+ E + +++ H N+V LG
Sbjct: 11 LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGV 68
Query: 357 CYENKKN-ALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
E K ++ E M GSL ++ + L + + ++ + +EYL V
Sbjct: 69 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFV 125
Query: 416 HFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVS 475
H D+ +N+L+ ED K+SDFGL K+A + + + + APE R S
Sbjct: 126 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEAL--REKKFS 178
Query: 476 HKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIA 535
KSDV+S+G+++ E+ + + + R+E G ++
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVPRVEKGYKMDAPDGCPPAVYEVM 233
Query: 536 KMMILVGFWCIQTNPSERPSMHKVLEMLE 564
K C + + RPS ++ E LE
Sbjct: 234 K-------NCWHLDAAMRPSFLQLREQLE 255
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 206 bits (525), Expect = 9e-63
Identities = 76/298 (25%), Positives = 135/298 (45%), Gaps = 21/298 (7%)
Query: 279 SLAPKRYSYSD--VKRMTKSFRDKLGQGGYGEVYKGELPD-GQLVAVKVLKNSRCNGEEF 335
++ P +Y ++R + + KLG G YGEVY+G VAVK LK EEF
Sbjct: 1 AMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF 60
Query: 336 INEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQI 395
+ E A + H N+V LG C +I E M G+L ++ ++ + +
Sbjct: 61 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 120
Query: 396 AIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHA 455
A I+ +EYL + +H D+ +N L+ E+ K++DFGL++ ++ + A
Sbjct: 121 ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGA 176
Query: 456 RGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERI 515
+ I + APE + S KSDV+++G+++ E+ + + + +YE +
Sbjct: 177 KFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELL 229
Query: 516 EPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQIP 573
E + E+ ++ + C Q NPS+RPS ++ + E + I
Sbjct: 230 EKDYRMERPEGCPEKVYELMR-------ACWQWNPSDRPSFAEIHQAFETMFQESSIS 280
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 7e-60
Identities = 61/293 (20%), Positives = 114/293 (38%), Gaps = 31/293 (10%)
Query: 297 FRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGF 356
++ +G+G +GEV++G+ G+ VAVK+ + E+ H NI+ F+
Sbjct: 7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 357 CYENKKNA----LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQV 412
++ L+ + +GSL +++ + + M ++A+ A GL +LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 413 -----RIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISML--HARGTIGYIAPE 465
I H D+K +NIL+ ++ I+D GLA + I + H GT Y+APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 466 VYSRRF----GGVSHKSDVYSYGMMIIEMVGCTKN----------LDDEVTDTSICHNLI 511
V ++D+Y+ G++ E+ D V +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 512 YERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564
E E ++M + C N + R + ++ + L
Sbjct: 243 KVVCEQKLRPNIPNRWQSCE--ALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 198 bits (503), Expect = 2e-59
Identities = 69/305 (22%), Positives = 129/305 (42%), Gaps = 38/305 (12%)
Query: 285 YSYSDVKRMTKSFRD-----------KLGQGGYGEVYKGELP----DGQLVAVKVLKNSR 329
+++ D + F +G G +GEV G L VA+K LK+
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 330 CNG--EEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKL 387
+F++E + + + H N++ G ++ +I E M NGSLD F+ + +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ-NDGQF 125
Query: 388 EWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447
+ + GIA G++YL VH D+ +NIL++ + K+SDFGL++ +
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 448 SAISMLHA---RGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDT 504
S + A + I + APE ++ + SDV+SYG+++ E++ + ++T+
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAI--QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240
Query: 505 SICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564
+ IE ++ C Q + + RP +++ L+
Sbjct: 241 D-----VINAIEQDYRLPPPMDCPSALHQLML-------DCWQKDRNHRPKFGQIVNTLD 288
Query: 565 GSIEN 569
I N
Sbjct: 289 KMIRN 293
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 3e-59
Identities = 66/283 (23%), Positives = 115/283 (40%), Gaps = 25/283 (8%)
Query: 300 KLGQGGYGEVYKGEL---PDGQLVAVKVLKNSRCNG--EEFINEVASISRTSHVNIVTFL 354
+LG G +G V +G VA+KVLK EE + E + + + IV +
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75
Query: 355 GFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRI 414
G C + + L+ E+ G L KF+ R ++ + ++ ++ G++YL +
Sbjct: 76 GVC-QAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLE---EKNF 130
Query: 415 VHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHA-RGTIGYIAPEVYSRRFGG 473
VH D+ +N+LL KISDFGL+K +S + A + + + APE F
Sbjct: 131 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI--NFRK 188
Query: 474 VSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKK 533
S +SDV+SYG+ + E + + ++ + IE G + E
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-----VMAFIEQGKRMECPPECPPELYA 243
Query: 534 IAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQIPPKP 576
+ C +RP V + + +L +
Sbjct: 244 LMS-------DCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 279
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 8e-59
Identities = 77/322 (23%), Positives = 132/322 (40%), Gaps = 44/322 (13%)
Query: 275 RNHESLAPKRYSYSD---VKRMTKSFRDKLGQGGYGEVYKGEL------PDGQLVAVKVL 325
N+ + P + Y R SF LG G +G+V + VAVK+L
Sbjct: 2 NNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML 61
Query: 326 KNSRCNG--EEFINEVASISR-TSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHND 382
K S E ++E+ +S +H+NIV LG C +I E G L F+
Sbjct: 62 KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121
Query: 383 RN----------------IKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILL 426
R+ + L+ + + + +A+G+ +L +H D+ +NILL
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL 178
Query: 427 DEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMM 486
KI DFGLA+ + + + +AR + ++APE + +SDV+SYG+
Sbjct: 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIF 236
Query: 487 IIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCI 546
+ E+ + + S Y+ I+ G A E I K C
Sbjct: 237 LWELFSLGSSPYPGMPVDSK----FYKMIKEGFRMLSPEHAPAEMYDIMK-------TCW 285
Query: 547 QTNPSERPSMHKVLEMLEGSIE 568
+P +RP+ ++++++E I
Sbjct: 286 DADPLKRPTFKQIVQLIEKQIS 307
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (497), Expect = 2e-58
Identities = 67/276 (24%), Positives = 111/276 (40%), Gaps = 31/276 (11%)
Query: 294 TKSFRD--KLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEE----FINEVASISRTS 346
K F D ++G G +G VY + + ++VA+K + S E I EV + +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 347 HVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYL 406
H N + + G L+ E + D + + L+ + + G +GL YL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYL 131
Query: 407 HRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEV 466
H ++H D+K NILL E K+ DFG A S + GT ++APEV
Sbjct: 132 H---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEV 182
Query: 467 Y-SRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDG 525
+ G K DV+S G+ IE+ L + + +Y + + G
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQNESPALQSG 237
Query: 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561
+E + C+Q P +RP+ +L+
Sbjct: 238 HWSEYFRNFVD-------SCLQKIPQDRPTSEVLLK 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 7e-58
Identities = 66/272 (24%), Positives = 117/272 (43%), Gaps = 27/272 (9%)
Query: 300 KLGQGGYGEVYKGELPD---GQLVAVKVLKNSRCNG---EEFINEVASISRTSHVNIVTF 353
+LG G +G V KG + VAVK+LKN + +E + E + + + IV
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 354 LGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVR 413
+G C E + L+ E+ G L+K++ +R ++ K + ++ ++ G++YL +
Sbjct: 74 IGIC-EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLE---ESN 127
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI-SMLHARGTIGYIAPEVYSRRFG 472
VH D+ +N+LL KISDFGL+K + E+ + H + + + APE +
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY--Y 185
Query: 473 GVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532
S KSDV+S+G+++ E + + + + +E G E
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----VTAMLEKGERMGCPAGCPREMY 240
Query: 533 KIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564
+ C + RP V L
Sbjct: 241 DLMN-------LCWTYDVENRPGFAAVELRLR 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 1e-57
Identities = 74/275 (26%), Positives = 116/275 (42%), Gaps = 32/275 (11%)
Query: 297 FRDKLGQGGYGEVYKGELPD-GQLVAVKVLKNSRCNG---EEFINEVASISRTSHVNIVT 352
F ++G+G + VYKG + VA L++ + + F E + H NIV
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 353 FLGFCYENKKN----ALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHR 408
F K L+ ELM +G+L ++ R ++ K + I +GL++LH
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 409 GCQVRIVHFDIKPQNILL-DEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVY 467
I+H D+K NI + KI D GLA + + GT ++APE+Y
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFMAPEMY 185
Query: 468 SRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND-FQFDGV 526
++ DVY++GM ++EM + IY R+ G FD V
Sbjct: 186 EEKY---DESVDVYAFGMCMLEMATSEYPYSE-----CQNAAQIYRRVTSGVKPASFDKV 237
Query: 527 ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561
A E K+I + CI+ N ER S+ +L
Sbjct: 238 AIPEVKEIIE-------GCIRQNKDERYSIKDLLN 265
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (489), Expect = 2e-57
Identities = 65/302 (21%), Positives = 117/302 (38%), Gaps = 47/302 (15%)
Query: 297 FRDKLGQGGYGEVYKGELP------DGQLVAVKVLKNSRCNG--EEFINEVASISRTSHV 348
+ +G+G +G V++ P +VAVK+LK +F E A ++ +
Sbjct: 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76
Query: 349 NIVTFLGFCYENKKNALIYELMPNGSLDKFIHN----------------------DRNIK 386
NIV LG C K L++E M G L++F+ +
Sbjct: 77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136
Query: 387 LEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446
L IA +A G+ YL + + VH D+ +N L+ E+ KI+DFGL++
Sbjct: 137 LSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193
Query: 447 ESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSI 506
+ + + I ++ PE + +SDV++YG+++ E+ +
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE- 250
Query: 507 CHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGS 566
+ + GN E + + C P++RPS + +L+
Sbjct: 251 ----VIYYVRDGNILACPENCPLELYNLMR-------LCWSKLPADRPSFCSIHRILQRM 299
Query: 567 IE 568
E
Sbjct: 300 CE 301
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 5e-57
Identities = 60/275 (21%), Positives = 103/275 (37%), Gaps = 27/275 (9%)
Query: 297 FRDKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEE---FINEVASISRTSHVNIVT 352
+G G YG K DG+++ K L E ++EV + H NIV
Sbjct: 8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 67
Query: 353 FLGFCYENKKNAL--IYELMPNGSLDKFIHNDRNIK--LEWKTMYQIAIGIARGLEYLHR 408
+ + L + E G L I + L+ + + ++ + L+ HR
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127
Query: 409 --GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEV 466
++H D+KP N+ LD K+ DFGLA+ S GT Y++PE
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV--GTPYYMSPEQ 185
Query: 467 YSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526
+R + KSD++S G ++ E+ + +I G +
Sbjct: 186 MNR--MSYNEKSDIWSLGCLLYELCALMPPFTAF------SQKELAGKIREGKFRRIPYR 237
Query: 527 ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561
++E +I + RPS+ ++LE
Sbjct: 238 YSDELNEIIT-------RMLNLKDYHRPSVEEILE 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 8e-57
Identities = 69/284 (24%), Positives = 119/284 (41%), Gaps = 35/284 (12%)
Query: 283 KRYSYSDVKRMTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNG----EEFIN 337
++++ D + LG+G +G VY ++A+KVL ++ +
Sbjct: 1 RQWALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 55
Query: 338 EVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAI 397
EV S H NI+ G+ ++ + LI E P G++ + + K + +
Sbjct: 56 EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYIT 113
Query: 398 GIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARG 457
+A L Y H R++H DIKP+N+LL KI+DFG + A G
Sbjct: 114 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCG 166
Query: 458 TIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEP 517
T+ Y+ PE+ R K D++S G++ E + + + Y+RI
Sbjct: 167 TLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEAN------TYQETYKRISR 218
Query: 518 GNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561
+F F TE + + ++ NPS+RP + +VLE
Sbjct: 219 V-EFTFPDFVTEGARDLIS-------RLLKHNPSQRPMLREVLE 254
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 9e-57
Identities = 74/298 (24%), Positives = 120/298 (40%), Gaps = 46/298 (15%)
Query: 297 FRDKLGQGGYGEVYKGELPD------GQLVAVKVLKNSRCNGE--EFINEVASISR-TSH 347
F LG G +G+V VAVK+LK + E ++E+ +++ SH
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 348 VNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNI---------------------K 386
NIV LG C + LI+E G L ++ + R
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 387 LEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446
L ++ + A +A+G+E+L VH D+ +N+L+ KI DFGLA+
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 447 ESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSI 506
+ + +AR + ++APE G + KSDV+SYG+++ E+ N +
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV--- 272
Query: 507 CHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564
Y+ I+ G ATEE I + C + +RPS + L
Sbjct: 273 -DANFYKLIQNGFKMDQPFYATEEIYIIMQ-------SCWAFDSRKRPSFPNLTSFLG 322
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 3e-56
Identities = 60/296 (20%), Positives = 120/296 (40%), Gaps = 43/296 (14%)
Query: 299 DKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNG--EEFINEVASISRTSHVNIVTFLG 355
+LG G G V+K P G ++A K++ + I E+ + + IV F G
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
Y + + ++ E M GSLD+ + + ++ + + +++I + +GL YL +I+
Sbjct: 72 AFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTYLREKH--KIM 127
Query: 416 HFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVS 475
H D+KP NIL++ K+ DFG++ Q + GT Y++PE + S
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERL--QGTHYS 181
Query: 476 HKSDVYSYGMMIIEMV-------GCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528
+SD++S G+ ++EM + + + + P +
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241
Query: 529 EEEKKIAKMMILVGF-----------------------WCIQTNPSERPSMHKVLE 561
+ + + L+ + C+ NP+ER + +++
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 6e-56
Identities = 68/298 (22%), Positives = 125/298 (41%), Gaps = 27/298 (9%)
Query: 276 NHESLAPKRYSYSDVKRMTKSFRDKLGQGGYGEVYKGELPD----GQLVAVKVLKNSRCN 331
N E + ++ + F + +G+G +G VY G L D AVK L
Sbjct: 10 NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI 69
Query: 332 GE--EFINEVASISRTSHVNIVTFLGFCYENKKNA-LIYELMPNGSLDKFIHNDRNIKLE 388
GE +F+ E + SH N+++ LG C ++ + ++ M +G L FI N+ +
Sbjct: 70 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPT 128
Query: 389 WKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE- 447
K + + +A+G+ + VH D+ +N +LDE F K++DFGLA+ KE
Sbjct: 129 VKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185
Query: 448 -SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSI 506
S + A+ + ++A E + + KSDV+S+G+++ E++ +V
Sbjct: 186 DSVHNKTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD- 242
Query: 507 CHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564
I + G + ++ C RPS +++ +
Sbjct: 243 ----ITVYLLQGRRLLQPEYCPDPLYEVML-------KCWHPKAEMRPSFSELVSRIS 289
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 3e-55
Identities = 78/321 (24%), Positives = 142/321 (44%), Gaps = 48/321 (14%)
Query: 282 PKRY---SYSDVKRMTKSFRDKLGQGGYGEVYKGELPDGQL---VAVKVLK--NSRCNGE 333
P Y ++D+K F+D +G+G +G+V K + L A+K +K S+ +
Sbjct: 1 PTIYPVLDWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR 55
Query: 334 EFINEVASISR-TSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNI------- 385
+F E+ + + H NI+ LG C L E P+G+L F+ R +
Sbjct: 56 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 115
Query: 386 -------KLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFG 438
L + + A +ARG++YL Q + +H D+ +NIL+ E++ KI+DFG
Sbjct: 116 IANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG 172
Query: 439 LAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLD 498
L++ +E + R + ++A E + + SDV+SYG+++ E+V
Sbjct: 173 LSRG---QEVYVKKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPY 227
Query: 499 DEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHK 558
+T +YE++ G + +E + + C + P ERPS +
Sbjct: 228 CGMTCAE-----LYEKLPQGYRLEKPLNCDDEVYDLMR-------QCWREKPYERPSFAQ 275
Query: 559 VLEMLEGSIENLQIPPKPSLF 579
+L L +E + +L+
Sbjct: 276 ILVSLNRMLEERKTYVNTTLY 296
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 2e-54
Identities = 60/270 (22%), Positives = 109/270 (40%), Gaps = 22/270 (8%)
Query: 297 FRDKLGQGGYGEVYKGELPD-GQLVAVKVLKNSRCNG-EEFINEVASISRTSHVNIVTFL 354
+LG G +G+VYK + + L A KV+ E+++ E+ ++ H NIV L
Sbjct: 16 IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 75
Query: 355 GFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRI 414
Y ++ E G++D + + L + + L YLH +I
Sbjct: 76 DAFYYENNLWILIEFCAGGAVDAVML-ELERPLTESQIQVVCKQTLDALNYLH---DNKI 131
Query: 415 VHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEV---YSRRF 471
+H D+K NIL D K++DFG++ + + GT ++APEV + +
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKD 189
Query: 472 GGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531
+K+DV+S G+ +IEM + E+ + + +
Sbjct: 190 RPYDYKADVWSLGITLIEMA-EIEPPHHELNPMRVLLKIAKSEPPT---LAQPSRWSSNF 245
Query: 532 KKIAKMMILVGFWCIQTNPSERPSMHKVLE 561
K K C++ N R + ++L+
Sbjct: 246 KDFLK-------KCLEKNVDARWTTSQLLQ 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 2e-54
Identities = 69/266 (25%), Positives = 102/266 (38%), Gaps = 20/266 (7%)
Query: 299 DKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNG--EEFINEVASISRTSHVNIVTFLG 355
LG+G YGEV + VAVK++ R E E+ +H N+V F G
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
E L E G L I +I + + + G+ YLH + I
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 125
Query: 416 HFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVS 475
H DIKP+N+LLDE KISDFGLA + + GT+ Y+APE+ RR +
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR-EFHA 184
Query: 476 HKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIA 535
DV+S G+++ M+ D S + E +
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWDQP----SDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240
Query: 536 KMMILVGFWCIQTNPSERPSMHKVLE 561
+ NPS R ++ + +
Sbjct: 241 H-------KILVENPSARITIPDIKK 259
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 4e-54
Identities = 65/277 (23%), Positives = 108/277 (38%), Gaps = 27/277 (9%)
Query: 297 FRDKLGQGGYGEVYKGELP----DGQLVAVKVLKNSRCNG----EEFINEVASISRTSHV 348
+KLG G +G V +GE VAVK LK + ++FI EV ++ H
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 349 NIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHR 408
N++ G ++ EL P GSL + + T+ + A+ +A G+ YL
Sbjct: 72 NLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLES 129
Query: 409 GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISML-HARGTIGYIAPEVY 467
+H D+ +N+LL KI DFGL + + + M H + + APE
Sbjct: 130 KR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 468 SRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527
SH SD + +G+ + EM + + + I H + E
Sbjct: 187 KT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL---------- 234
Query: 528 TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564
+ + + V C P +RP+ + + L
Sbjct: 235 -PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 6e-54
Identities = 70/282 (24%), Positives = 126/282 (44%), Gaps = 26/282 (9%)
Query: 296 SFRDKLGQGGYGEVYKGELPDGQ-----LVAVKVLKNSRCNGE--EFINEVASISRTSHV 348
+ + +G G +GEVYKG L VA+K LK + +F+ E + + SH
Sbjct: 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 69
Query: 349 NIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHR 408
NI+ G + K +I E M NG+LDKF +++ + + + GIA G++YL
Sbjct: 70 NIIRLEGVISKYKPMMIITEYMENGALDKF-LREKDGEFSVLQLVGMLRGIAAGMKYLAN 128
Query: 409 GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK-KESAISMLHARGTIGYIAPEVY 467
VH D+ +NIL++ + K+SDFGL++ + E+ + + I + APE
Sbjct: 129 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 468 SRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527
S + SDV+S+G+++ E++ + E+++ + + I G
Sbjct: 186 SY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-----VMKAINDGFRLPTPMDC 238
Query: 528 TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIEN 569
++ C Q + RP ++ +L+ I
Sbjct: 239 PSAIYQLMM-------QCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 5e-53
Identities = 65/289 (22%), Positives = 125/289 (43%), Gaps = 33/289 (11%)
Query: 296 SFRDKLGQGGYGEVYKGEL------PDGQLVAVKVLKNSRCNGE--EFINEVASISRTSH 347
+ +LGQG +G VY+G VA+K + + E EF+NE + + +
Sbjct: 23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 82
Query: 348 VNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRN--------IKLEWKTMYQIAIGI 399
++V LG + + +I ELM G L ++ + R M Q+A I
Sbjct: 83 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 142
Query: 400 ARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTI 459
A G+ YL + VH D+ +N ++ EDF KI DFG+ + + + +
Sbjct: 143 ADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199
Query: 460 GYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGN 519
+++PE + G + SDV+S+G+++ E+ + +++ + ++
Sbjct: 200 RWMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM-------- 249
Query: 520 DFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568
+G ++ M+ + C Q NP RPS +++ ++ +E
Sbjct: 250 ----EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 3e-52
Identities = 66/278 (23%), Positives = 114/278 (41%), Gaps = 26/278 (9%)
Query: 297 FRDKLGQGGYGEVYKGELPD----GQLVAVKVLKNSRCNG--EEFINEVASISRTSHVNI 350
+G+G +G+V++G VA+K KN + E+F+ E ++ + H +I
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 351 VTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGC 410
V +G EN +I EL G L F+ R L+ ++ A ++ L YL
Sbjct: 71 VKLIGVITENPV-WIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLES-- 126
Query: 411 QVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRR 470
R VH DI +N+L+ + C K+ DFGL++ + + + I ++APE
Sbjct: 127 -KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS-KGKLPIKWMAPESI--N 182
Query: 471 FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530
F + SDV+ +G+ + E++ V + + RIE G
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----VIGRIENGERLPMPPNCPPT 237
Query: 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568
+ C +PS RP ++ L +E
Sbjct: 238 LYSLMT-------KCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 4e-52
Identities = 68/296 (22%), Positives = 124/296 (41%), Gaps = 40/296 (13%)
Query: 297 FRDKLGQGGYGEVYKG------ELPDGQLVAVKVLKNSRCNGE--EFINEVASISRTSH- 347
LG+G +G+V + + + VAVK+LK + E ++E+ + H
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 348 VNIVTFLGFCYE-NKKNALIYELMPNGSLDKFIHNDRN--------------IKLEWKTM 392
+N+V LG C + +I E G+L ++ + RN L + +
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 393 YQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452
+ +A+G+E+L + +H D+ +NILL E KI DFGLA+ K +
Sbjct: 137 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIY 512
AR + ++APE + +SDV+S+G+++ E+ + V
Sbjct: 194 GDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----DEEFC 247
Query: 513 ERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568
R++ G + T E + C PS+RP+ +++E L ++
Sbjct: 248 RRLKEGTRMRAPDYTTPEMYQTML-------DCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 5e-52
Identities = 67/279 (24%), Positives = 119/279 (42%), Gaps = 26/279 (9%)
Query: 300 KLGQGGYGEVYKGE-LPDGQL----VAVKVLKNSRCNG--EEFINEVASISRTSHVNIVT 352
LG G +G VYKG +P+G+ VA+K L+ + +E ++E ++ + ++
Sbjct: 16 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 353 FLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQV 412
LG C + LI +LMP G L + + + + + + IA+G+ YL
Sbjct: 76 LLGICLTSTVQ-LITQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKGMNYL---EDR 130
Query: 413 RIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFG 472
R+VH D+ +N+L+ KI+DFGLAK +E + I ++A E
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 188
Query: 473 GVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532
+H+SDV+SYG+ + E++ D + + I +E G + T +
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEISSILEKGERLPQPPICTIDVY 243
Query: 533 KIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQ 571
I C + RP +++ + Q
Sbjct: 244 MIMV-------KCWMIDADSRPKFRELIIEFSKMARDPQ 275
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 5e-52
Identities = 69/293 (23%), Positives = 127/293 (43%), Gaps = 42/293 (14%)
Query: 297 FRDKLGQGGYGEVYKGELP--------DGQLVAVKVLKNSRCNGE--EFINEVASISR-T 345
LG+G +G+V E VAVK+LK+ + + I+E+ +
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 346 SHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDR--------------NIKLEWKT 391
H NI+ LG C ++ +I E G+L +++ R +L K
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 392 MYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451
+ A +ARG+EYL + +H D+ +N+L+ ED KI+DFGLA+ +
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLI 511
+ R + ++APE +H+SDV+S+G+++ E+ + V +
Sbjct: 194 TTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-----L 246
Query: 512 YERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564
++ ++ G+ T E + + C PS+RP+ +++E L+
Sbjct: 247 FKLLKEGHRMDKPSNCTNELYMMMR-------DCWHAVPSQRPTFKQLVEDLD 292
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 6e-51
Identities = 63/265 (23%), Positives = 112/265 (42%), Gaps = 23/265 (8%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEE-FINEVASISRTSHVNIVTFLGF 356
+K+GQG G VY ++ GQ VA++ + + +E INE+ + + NIV +L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 357 CYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVH 416
+ ++ E + GSL + + + + + LE+LH +++H
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECLQALEFLH---SNQVIH 139
Query: 417 FDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSH 476
DIK NILL D K++DFG Q ++S S + GT ++APEV +R
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--GTPYWMAPEVVTR--KAYGP 195
Query: 477 KSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAK 536
K D++S G+M IEM+ + + + Q + +
Sbjct: 196 KVDIWSLGIMAIEMI-EGEPPYLNENPLRALYLIATNGTPE---LQNPEKLSAIFRDFLN 251
Query: 537 MMILVGFWCIQTNPSERPSMHKVLE 561
C+ + +R S ++L+
Sbjct: 252 -------RCLDMDVEKRGSAKELLQ 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 173 bits (440), Expect = 1e-49
Identities = 61/269 (22%), Positives = 115/269 (42%), Gaps = 23/269 (8%)
Query: 297 FRDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNG-EEFINEVASISRTSHVNIVTFL 354
++LG G +G V++ E G A K + + E E+ ++S H +V
Sbjct: 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 89
Query: 355 GFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRI 414
++ + +IYE M G L + + ++ N K+ + + +GL ++H
Sbjct: 90 DAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENN---Y 145
Query: 415 VHFDIKPQNILLDEDFCP--KISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFG 472
VH D+KP+NI+ K+ DFGL K+S GT + APEV +
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT---TGTAEFAAPEVAEGK-- 200
Query: 473 GVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532
V + +D++S G++ ++ + D N+ +D F G++ + +
Sbjct: 201 PVGYYTDMWSVGVLSYILL-SGLSPFGGENDDETLRNVKSCDWNM-DDSAFSGISEDGKD 258
Query: 533 KIAKMMILVGFWCIQTNPSERPSMHKVLE 561
I K++ +P+ R ++H+ LE
Sbjct: 259 FIRKLL--------LADPNTRMTIHQALE 279
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 1e-47
Identities = 59/273 (21%), Positives = 101/273 (36%), Gaps = 26/273 (9%)
Query: 297 FRDKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEE----FINEVASISRTSHVNIV 351
F LG+G + V EL + A+K+L+ E E +SR H V
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 352 TFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQ 411
+++K NG L K+I + I LEYLH
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKG- 128
Query: 412 VRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRF 471
I+H D+KP+NILL+ED +I+DFG AK + GT Y++PE+ +
Sbjct: 129 --IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-- 184
Query: 472 GGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531
SD+++ G +I ++V + I +I + F +
Sbjct: 185 KSACKSSDLWALGCIIYQLV-AGLPPFRAGNEYLIFQKIIKLEYDFPEKF------FPKA 237
Query: 532 KKIAKMMILVGFWCIQTNPSERPSMHKVLEMLE 564
+ + + + + ++R ++
Sbjct: 238 RDLVE-------KLLVLDATKRLGCEEMEGYGP 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 6e-47
Identities = 55/285 (19%), Positives = 116/285 (40%), Gaps = 24/285 (8%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFC 357
+ LG+G +G V++ E + K +K + E++ ++ H NI+
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 358 YENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHF 417
++ +I+E + + + I+ +L + + + L++LH I HF
Sbjct: 71 ESMEELVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLH---SHNIGHF 126
Query: 418 DIKPQNILLDEDFCP--KISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVS 475
DI+P+NI+ KI +FG A+Q + ++ + Y APEV+ VS
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL---FTAPEYYAPEVHQH--DVVS 181
Query: 476 HKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIA 535
+D++S G ++ ++ N T+ I N++ ++ F ++ E +
Sbjct: 182 TATDMWSLGTLVYVLL-SGINPFLAETNQQIIENIMNAEYTF-DEEAFKEISIEAMDFVD 239
Query: 536 KMMILVGFWCIQTNPSERPSMHKVLEM--LEGSIENLQIPPKPSL 578
+++ R + + L+ L+ IE + +L
Sbjct: 240 RLL--------VKERKSRMTASEALQHPWLKQKIERVSTKVIRTL 276
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 165 bits (419), Expect = 1e-46
Identities = 67/288 (23%), Positives = 117/288 (40%), Gaps = 25/288 (8%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNGEE-FINEVASISRTSHVNIVTFLGF 356
++LG G +G V++ E G++ K + + NE++ +++ H ++
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 357 CYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVH 416
+ + LI E + G L I + K+ + GL+++H IVH
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHE---HSIVH 150
Query: 417 FDIKPQNILLDEDFCP--KISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGV 474
DIKP+NI+ + KI DFGLA + E + T + APE+ R V
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDR--EPV 205
Query: 475 SHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKI 534
+D+++ G++ ++ + D N+ E D F V+ E
Sbjct: 206 GFYTDMWAIGVLGYVLL-SGLSPFAGEDDLETLQNVKRCDWEFDED-AFSSVSPE----- 258
Query: 535 AKMMILVGFWCIQTNPSERPSMHKVLEM--LEGSIENLQIPPKPSLFS 580
AK I +Q P +R ++H LE L+G NL S ++
Sbjct: 259 AKDFIK---NLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYN 303
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 161 bits (408), Expect = 5e-46
Identities = 59/281 (20%), Positives = 115/281 (40%), Gaps = 34/281 (12%)
Query: 297 FRDKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNG----------EEFINEVASISRT 345
++ LG+G V + P + AVK++ + E + EV + +
Sbjct: 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66
Query: 346 S-HVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLE 404
S H NI+ N L+++LM G L ++ + L K +I + +
Sbjct: 67 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKIMRALLEVIC 124
Query: 405 YLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAP 464
LH+ + IVH D+KP+NILLD+D K++DFG + Q E + GT Y+AP
Sbjct: 125 ALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAP 178
Query: 465 EVYS----RRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND 520
E+ G + D++S G+++ ++ + ++ + G+
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLL-AGSPPFWHRKQMLMLRMIMSGNYQFGSP 237
Query: 521 FQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561
++D + + +++ + P +R + + L
Sbjct: 238 -EWDDYSDTVKDLVSRFL--------VVQPQKRYTAEEALA 269
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (408), Expect = 1e-45
Identities = 64/268 (23%), Positives = 108/268 (40%), Gaps = 20/268 (7%)
Query: 297 FRDKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEE--FINEVASISRTSHVNIVTF 353
FRD LG G + EV E +LVA+K + G+E NE+A + + H NIV
Sbjct: 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVAL 72
Query: 354 LGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVR 413
LI +L+ G L I + ++ + ++YLH V
Sbjct: 73 DDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLGIVH 130
Query: 414 IVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGG 473
LDED ISDFGL+K + GT GY+APEV +++
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC---GTPGYVAPEVLAQK--P 185
Query: 474 VSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKK 533
S D +S G++ ++ C + D + ++ E + + +D ++ +
Sbjct: 186 YSKAVDCWSIGVIAYILL-CGYPPFYDENDAKLFEQILKAEYEFDSPY-WDDISDSAKDF 243
Query: 534 IAKMMILVGFWCIQTNPSERPSMHKVLE 561
I +M + +P +R + + L+
Sbjct: 244 IRHLM--------EKDPEKRFTCEQALQ 263
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 158 bits (400), Expect = 5e-44
Identities = 67/271 (24%), Positives = 111/271 (40%), Gaps = 29/271 (10%)
Query: 296 SFRDKLGQGGYGEVYKGELPD-GQLVAVKVLKNSRCNGEE-------FINEVASISRTSH 347
S +G+GG+GEVY D G++ A+K L R ++ ++ +S
Sbjct: 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66
Query: 348 VNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH 407
IV + K + I +LM G L + ++ M A I GLE++H
Sbjct: 67 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLEHMH 124
Query: 408 RGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVY 467
+V+ D+KP NILLDE +ISD GLA KK+ S+ GT GY+APEV
Sbjct: 125 ---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVL 177
Query: 468 SRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527
++ +D +S G M+ +++ T H + R+ +
Sbjct: 178 -QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH--KTKDKHEID--RMTLTMAVELPDSF 232
Query: 528 TEEEKKIAKMMILVGFWCIQTNPSERPSMHK 558
+ E + + + +Q + + R
Sbjct: 233 SPELRSLLE-------GLLQRDVNRRLGCLG 256
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 155 bits (392), Expect = 1e-43
Identities = 60/279 (21%), Positives = 112/279 (40%), Gaps = 28/279 (10%)
Query: 297 FRDKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEE----FINEVASISRTSHVNIV 351
+ LG GG EV+ L + VAVKVL+ F E + + +H IV
Sbjct: 11 LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 70
Query: 352 TFLGFCYENKKNA----LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH 407
++ E + +L +H + + K ++ + L +
Sbjct: 71 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFS- 127
Query: 408 RGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR-GTIGYIAPEV 466
Q I+H D+KP NI++ K+ DFG+A+ ++++ A GT Y++PE
Sbjct: 128 --HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 467 YSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526
R V +SDVYS G ++ E++ + + S+ + + E P + +G+
Sbjct: 186 A--RGDSVDARSDVYSLGCVLYEVLTGEPPFTGD-SPVSVAYQHVREDPIPPSAR-HEGL 241
Query: 527 ATEEEKKIAKMMILVGFWCIQTNPSERP-SMHKVLEMLE 564
+ + + + K + NP R + ++ L
Sbjct: 242 SADLDAVVLK--------ALAKNPENRYQTAAEMRADLV 272
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 1e-43
Identities = 55/270 (20%), Positives = 102/270 (37%), Gaps = 21/270 (7%)
Query: 298 RDKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEFINEVASISRTS-HVNIVTFLG 355
LG G G+V + + A+K+L++ + EV R S +IV +
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVD 72
Query: 356 FCY----ENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQ 411
K ++ E + G L I + + + +I I ++YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---S 129
Query: 412 VRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRF 471
+ I H D+KP+N+L I A++ S S+ T Y+APEV
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE- 188
Query: 472 GGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531
D++S G+++ ++ + RI G ++F E
Sbjct: 189 -KYDKSCDMWSLGVIMYILLCGYPPFYSN--HGLAISPGMKTRIRMG-QYEFPNPEWSEV 244
Query: 532 KKIAKMMILVGFWCIQTNPSERPSMHKVLE 561
+ KM+I ++T P++R ++ + +
Sbjct: 245 SEEVKMLIR---NLLKTEPTQRMTITEFMN 271
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 153 bits (386), Expect = 8e-43
Identities = 45/290 (15%), Positives = 101/290 (34%), Gaps = 26/290 (8%)
Query: 297 FRDKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLG 355
++G+G +G +++G L + Q VA+K R + + +E + + + +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTGIPNVY 67
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
+ + + ++ + SL+ + K KT+ A + ++ +H + +V
Sbjct: 68 YFGQEGLHNVLVIDLLGPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIH---EKSLV 123
Query: 416 HFDIKPQNILLDEDFCP-----KISDFGLAKQAQKKESAISMLHAR-----GTIGYIAPE 465
+ DIKP N L+ + DFG+ K + + + + GT Y++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 466 VYSRRFGGVSHKSDVYSYGMMIIEMV-GCTKNLDDEVTDTSICHNLIYERIEPGNDFQFD 524
+ R S + D+ + G + + + G + + I E+ + +
Sbjct: 184 THLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 525 GVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQIPP 574
EE K P + + +E L
Sbjct: 242 AGFPEEFYKYMHY-------ARNLAFDATPDYDYLQGLFSKVLERLNTTE 284
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-42
Identities = 79/331 (23%), Positives = 131/331 (39%), Gaps = 48/331 (14%)
Query: 282 PKRYSYSDVKRMTKSFRDKLGQGGYGEVYKGELPD-GQLVAVKVLKNSRCNGEEFINEVA 340
P+ SY+D K +G G +G VY+ +L D G+LVA+K + + E+
Sbjct: 17 PQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQ 65
Query: 341 SISRTSHVNIVTFLGFCYENKKN------ALIYELMPNGSLDKFIHNDR-NIKLEWKTMY 393
+ + H NIV F Y + + L+ + +P H R L +
Sbjct: 66 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125
Query: 394 QIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED-FCPKISDFGLAKQAQKKESAISM 452
+ R L Y+H I H DIKPQN+LLD D K+ DFG AKQ + E +S
Sbjct: 126 LYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 182
Query: 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMV-GCTKNLDDEVTDT------- 504
+ +R Y APE+ + DV+S G ++ E++ G D D
Sbjct: 183 ICSR---YYRAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238
Query: 505 --SICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGF-----WCIQTNPSERPSMH 557
+ I E +F+F + K+ + ++ P+ R +
Sbjct: 239 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298
Query: 558 KVL------EMLEGSIENLQIPPKPSLFSAT 582
+ E+ + +++ P+LF+ T
Sbjct: 299 EACAHSFFDELRDPNVKLPNGRDTPALFNFT 329
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-41
Identities = 61/270 (22%), Positives = 107/270 (39%), Gaps = 29/270 (10%)
Query: 297 FRDKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEE----FINEVASISRT-SHVNI 350
LG+G +G+V+ E Q A+K LK ++ + E +S H +
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 351 VTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGC 410
+ + E + G L I + K + A I GL++L
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFL---H 120
Query: 411 QVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRR 470
IV+ D+K NILLD+D KI+DFG+ K+ ++ + GT YIAPE+ +
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF--CGTPDYIAPEILLGQ 178
Query: 471 FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530
+H D +S+G+++ EM+ + + ++ I N F + E
Sbjct: 179 --KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------LFHSIRMDNPFYPRWLEKE- 229
Query: 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVL 560
AK +++ P +R + +
Sbjct: 230 ----AKDLLV---KLFVREPEKRLGVRGDI 252
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 3e-41
Identities = 65/287 (22%), Positives = 112/287 (39%), Gaps = 33/287 (11%)
Query: 299 DKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNG------EEFINEVASISRTSHVNIV 351
D LG+G + VYK Q+VA+K +K + + E+ + SH NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 352 TFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQ 411
L +L+++ M I D ++ L + + +GLEYLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 120
Query: 412 VRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRF 471
I+H D+KP N+LLDE+ K++DFGLAK + H T Y APE+
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFG--SPNRAYTHQVVTRWYRAPELL-FGA 175
Query: 472 GGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531
D+++ G ++ E++ +D I+E + + Q+ + + +
Sbjct: 176 RMYGVGVDMWAVGCILAELL-LRVPFLPGDSDLDQLTR-IFETLGTPTEEQWPDMCSLPD 233
Query: 532 KKIAKMMILVGF----------------WCIQTNPSERPSMHKVLEM 562
K + NP R + + L+M
Sbjct: 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (368), Expect = 4e-40
Identities = 50/286 (17%), Positives = 98/286 (34%), Gaps = 24/286 (8%)
Query: 299 DKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFC 357
K+G G +G++Y G + G+ VA+K+ + E + + +C
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 358 Y-ENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVH 416
E N ++ EL+ D F R K KT+ +A + +EY+H +H
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHS---KNFIH 126
Query: 417 FDIKPQNIL---LDEDFCPKISDFGLAKQAQKKESAISMLHAR-----GTIGYIAPEVYS 468
D+KP N L + I DFGLAK+ + + + + GT Y + +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 469 RRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528
S + D+ S G +++ + + ++ E ++ +
Sbjct: 187 G--IEQSRRDDLESLGYVLMYFNLGSLPWQG------LKAATKRQKYERISEKKMSTPIE 238
Query: 529 EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQIPP 574
K +C ++P + ++
Sbjct: 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 284
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 143 bits (362), Expect = 2e-39
Identities = 61/282 (21%), Positives = 113/282 (40%), Gaps = 28/282 (9%)
Query: 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNG---EEFINEVASISRTSHVNIVTFLG 355
+K+G+G YG VYK + G+ A+K ++ + + I E++ + H NIV
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 356 FCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIV 415
+ K+ L++E + + LE T + + G+ Y H R++
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCH---DRRVL 122
Query: 416 HFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVS 475
H D+KPQN+L++ + KI+DFGLA+ H T+ Y AP+V S
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVL-MGSKKYS 179
Query: 476 HKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIA 535
D++S G + EMV L V++ + P + + +
Sbjct: 180 TTIDIWSVGCIFAEMV-NGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 536 KMMILVGF----------------WCIQTNPSERPSMHKVLE 561
+ + + ++ +P++R + + LE
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 5e-39
Identities = 65/275 (23%), Positives = 110/275 (40%), Gaps = 32/275 (11%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNG-------EEFINEVASISRTSHVNI 350
++LG G + V K E G A K +K R E+ EV+ + H N+
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 351 VTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGC 410
+T LI EL+ G L F+ L + + I G+ YLH
Sbjct: 76 ITLHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHSLQ 133
Query: 411 QVRIVHFDIKPQNILLDEDFCP----KISDFGLAKQAQKKESAISMLHARGTIGYIAPEV 466
I HFD+KP+NI+L + P KI DFGLA + + GT ++APE+
Sbjct: 134 ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEI 187
Query: 467 YSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526
+ + ++D++S G++ ++ + T N+ E +++ F
Sbjct: 188 V--NYEPLGLEADMWSIGVITYILL-SGASPFLGDTKQETLANVSAVNYEFEDEY-FSNT 243
Query: 527 ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561
+ AK I + +P +R ++ L+
Sbjct: 244 SAL-----AKDFIR---RLLVKDPKKRMTIQDSLQ 270
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 1e-38
Identities = 59/288 (20%), Positives = 98/288 (34%), Gaps = 32/288 (11%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNG--EEFINEVASISRTSHVNIVTFLG 355
+G+G YG V + + VA+K + + + E+ + R H NI+
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 356 FC----YENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQ 411
E K+ + + L K + L + I RGL+Y+H
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQILRGLKYIH---S 127
Query: 412 VRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR-GTIGYIAPEVYSRR 470
++H D+KP N+LL+ KI DFGLA+ A L T Y APE+
Sbjct: 128 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187
Query: 471 FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530
G + D++S G ++ EM+ + + H L D
Sbjct: 188 KGY-TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246
Query: 531 EKKIAKMMILVGFW-----------------CIQTNPSERPSMHKVLE 561
++ W + NP +R + + L
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-38
Identities = 56/274 (20%), Positives = 97/274 (35%), Gaps = 40/274 (14%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRC-------NGEEFINEVASISRTS--HV 348
LG GG+G VY G + D VA+K ++ R NG EV + + S
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 349 NIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHR 408
++ L + LI E +R L+ + + + +
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHC-- 126
Query: 409 GCQVRIVHFDIKPQNILLDED-FCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVY 467
++H DIK +NIL+D + K+ DFG + GT Y PE
Sbjct: 127 -HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWI 181
Query: 468 SRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527
+ V+S G+++ +MV + D I ++ F
Sbjct: 182 RYH-RYHGRSAAVWSLGILLYDMVCGDIPFEH---DEEIIRGQVF----------FRQRV 227
Query: 528 TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561
+ E + + + WC+ PS+RP+ ++
Sbjct: 228 SSECQHLIR-------WCLALRPSDRPTFEEIQN 254
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 3e-38
Identities = 61/283 (21%), Positives = 110/283 (38%), Gaps = 28/283 (9%)
Query: 299 DKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNG---EEFINEVASISRTSHVNIVTFL 354
+K+G+G YG VYK G++VA+K ++ I E++ + +H NIV L
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 355 GFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRI 414
+ K L++E + + L KF+ + + + +GL + H +
Sbjct: 68 DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---V 123
Query: 415 VHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGV 474
+H D+KPQN+L++ + K++DFGLA+ + T+ Y APE+
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV--VTLWYRAPEILLGC-KYY 180
Query: 475 SHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKI 534
S D++S G + EMV + L ++ + P + + K
Sbjct: 181 STAVDIWSLGCIFAEMV-TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 535 AKMMILVGF----------------WCIQTNPSERPSMHKVLE 561
F + +P++R S L
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 3e-38
Identities = 66/289 (22%), Positives = 117/289 (40%), Gaps = 35/289 (12%)
Query: 299 DKLGQGGYGEVYKGE--LPDGQLVAVKVLKNSRCNG---EEFINEVA---SISRTSHVNI 350
++G+G YG+V+K G+ VA+K ++ I EVA + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 351 VTFLGFCYENKKNALIYELMPN----GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYL 406
V C ++ + + L ++ + +T+ + + RGL++L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 407 HRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEV 466
H +VH D+KPQNIL+ K++DFGLA+ + + S+ T+ Y APEV
Sbjct: 133 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV---VVTLWYRAPEV 186
Query: 467 YSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526
+ + D++S G + EM K L +D ++ PG + V
Sbjct: 187 LLQ--SSYATPVDLWSVGCIFAEMF-RRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 527 ATEEEKKIAKMMILVGFW--------------CIQTNPSERPSMHKVLE 561
A + +K + + C+ NP++R S + L
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 140 bits (355), Expect = 3e-38
Identities = 68/264 (25%), Positives = 109/264 (41%), Gaps = 31/264 (11%)
Query: 297 FRDKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNG----EEFINEVASISRTSHVNIV 351
LG G +G V+ +G+ A+KVLK E +E +S +H I+
Sbjct: 8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFII 67
Query: 352 TFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQ 411
G + ++ +I + + G L + + + A + LEYLH
Sbjct: 68 RMWGTFQDAQQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKD- 124
Query: 412 VRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRF 471
I++ D+KP+NILLD++ KI+DFG AK + GT YIAPEV S +
Sbjct: 125 --IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL-----CGTPDYIAPEVVSTK- 176
Query: 472 GGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531
+ D +S+G++I EM+ D T YE+I + +F E+
Sbjct: 177 -PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TYEKILNA-ELRFPPFFNEDV 228
Query: 532 KKIAKMMILVGFWCIQTNPSERPS 555
K + I + S+R
Sbjct: 229 KDLLSR-------LITRDLSQRLG 245
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 3e-36
Identities = 57/267 (21%), Positives = 103/267 (38%), Gaps = 28/267 (10%)
Query: 297 FRDKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEE----FINEVASISRTSHVNIV 351
+ LG+G +G+V G+ A+K+L+ ++ + E + T H +
Sbjct: 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 352 TFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQ 411
+ + + E G L + R + I LEYLH
Sbjct: 69 ALKYAFQTHDRLCFVMEYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLHS--- 123
Query: 412 VRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRF 471
+V+ DIK +N++LD+D KI+DFGL K+ + +M GT Y+APEV
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLED-- 179
Query: 472 GGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531
D + G+++ EM+ ++ H ++E I + +F + E
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ------DHERLFELILME-EIRFPRTLSPEA 232
Query: 532 KKIAKMMILVGFWCIQTNPSERPSMHK 558
K + ++ +P +R
Sbjct: 233 KSLLA-------GLLKKDPKQRLGGGP 252
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 1e-35
Identities = 53/283 (18%), Positives = 105/283 (37%), Gaps = 28/283 (9%)
Query: 299 DKLGQGGYGEVYKGE-LPDGQLVAVKVLK---NSRCNGEEFINEVASISRTSHVNIVTFL 354
+K+G+G YG V+K + ++VA+K ++ + + E+ + H NIV
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 355 GFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRI 414
+ +KK L++E F + ++ + + + +GL + H +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD--PEIVKSFLFQLLKGLGFCH---SRNV 122
Query: 415 VHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGV 474
+H D+KPQN+L++ + K+++FGLA+ S T+ Y P+V
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV--VTLWYRPPDVLFGA-KLY 179
Query: 475 SHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKI 534
S D++S G + E+ + L + P + + K
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 535 AKMMILVGF----------------WCIQTNPSERPSMHKVLE 561
++ NP +R S + L+
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 4e-35
Identities = 49/296 (16%), Positives = 110/296 (37%), Gaps = 40/296 (13%)
Query: 299 DKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNG---EEFINEVASISRTSHVNIVTFL 354
K+GQG +GEV+K GQ VA+K + + E+ + H N+V +
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 355 GFCYENKKNA--------LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYL 406
C L+++ + + ++ +K + ++ + GL Y+
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNVLVKFTLSEIKRVMQMLLNGLYYI 133
Query: 407 HRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHAR--GTIGYIAP 464
+ +I+H D+K N+L+ D K++DFGLA+ +++ + T+ Y P
Sbjct: 134 ---HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
Query: 465 EVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNL----------IYER 514
E+ D++ G ++ EM + T+ + ++
Sbjct: 191 ELL-LGERDYGPPIDLWGAGCIMAEMW-TRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 515 IEPGNDFQFDGVATEEEKKIAKMMILVGF---------WCIQTNPSERPSMHKVLE 561
++ ++ + +++K+ + + +P++R L
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 2e-33
Identities = 57/272 (20%), Positives = 100/272 (36%), Gaps = 26/272 (9%)
Query: 297 FRDKLGQGGYGEVYKGEL----PDGQLVAVKVLKNSRCNG-----EEFINEVASISRTSH 347
LG G YG+V+ G+L A+KVLK + E E +
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87
Query: 348 V-NIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYL 406
+VT K LI + + G L + + I + + L
Sbjct: 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-----VQIYVGEIVLAL 142
Query: 407 HRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEV 466
++ I++ DIK +NILLD + ++DFGL+K+ E+ + GTI Y+AP++
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY-DFCGTIEYMAPDI 201
Query: 467 YSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526
G D +S G+++ E++ + S I RI +
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKSEPPYPQEM 259
Query: 527 ATEEEKKIAKMMILVGFWCIQTNPSERPSMHK 558
+ + I +++ +P +R
Sbjct: 260 SALAKDLIQRLL--------MKDPKKRLGCGP 283
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (321), Expect = 4e-33
Identities = 57/301 (18%), Positives = 115/301 (38%), Gaps = 34/301 (11%)
Query: 262 KTREDDRNVEAFIRNHESLAPKRYSY-SDVKRMTKSFR--DKLGQGGYGEVYKGE-LPDG 317
K + +V+ F+ + K++ S F LG G +G V + G
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66
Query: 318 QLVAVKVLKNSRCNG----EEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNG 373
A+K+L + E +NE + + +V +N ++ E + G
Sbjct: 67 NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPK 433
+ + R + A I EYLH + +++ D+KP+N+L+D+ +
Sbjct: 127 EMFSHLR--RIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQ 181
Query: 434 ISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGC 493
++DFG AK+ + + + GT +APE+ + G + D ++ G++I EM
Sbjct: 182 VTDFGFAKRVKGRTWTL-----CGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMA-A 233
Query: 494 TKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSER 553
I ++ ++ + F D K ++ +Q + ++R
Sbjct: 234 GYPPFFADQPIQIYEKIVSGKVRFPSHFSSD----------LKDLLR---NLLQVDLTKR 280
Query: 554 P 554
Sbjct: 281 F 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 6e-33
Identities = 58/307 (18%), Positives = 106/307 (34%), Gaps = 40/307 (13%)
Query: 285 YSYSDVKRMTKSFRD------KLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNG---EE 334
+ +V + R +G G YG V + G VA+K L + +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 335 FINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHND--RNIKLEWKTM 392
E+ + H N++ L ++ + ++ KL +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 393 YQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452
+ + +GL Y+H + H D+KP N+ ++ED KI DFGLA+QA + M
Sbjct: 124 QFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSE-----M 175
Query: 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIY 512
T Y APEV + + D++S G ++ EM+ K L ++
Sbjct: 176 TGYVVTRWYRAPEVI-LNWMRYTQTVDIWSVGCIMAEMI-TGKTLFKGSDHLDQLKEIMK 233
Query: 513 ERIEPGNDFQFDGVATEEEKKIAKMMILVGF------------------WCIQTNPSERP 554
P +F + E + + + L + + +R
Sbjct: 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293
Query: 555 SMHKVLE 561
+ + L
Sbjct: 294 TAGEALA 300
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (310), Expect = 7e-32
Identities = 51/294 (17%), Positives = 110/294 (37%), Gaps = 43/294 (14%)
Query: 297 FRDKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEFINEVASISRTS-HVNIVTFL 354
KLG+G Y EV++ + + + V VK+LK + ++ E+ + NI+T
Sbjct: 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNIITLA 96
Query: 355 GFCYENKKN--ALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQV 412
+ AL++E + N + L + I + L+Y H +
Sbjct: 97 DIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCH---SM 148
Query: 413 RIVHFDIKPQNILLDEDFCP-KISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRF 471
I+H D+KP N+++D + ++ D+GLA+ + + + PE+ +
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELL-VDY 204
Query: 472 GGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLI--------YERIEPGN---D 520
+ D++S G M+ M+ + + + Y+ I+ N D
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 521 FQFDGVATEEEKKIAKMMILVGFW-------------CIQTNPSERPSMHKVLE 561
+F+ + +K + + ++ + R + + +E
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (292), Expect = 3e-29
Identities = 53/338 (15%), Positives = 115/338 (34%), Gaps = 58/338 (17%)
Query: 299 DKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVN-------- 349
KLG G + V+ + + + VA+K+++ + E +E+ + R + +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 350 ---IVTFLGFCYENKKNALIYELMPNGSL---DKFIHNDRNIKLEWKTMYQIAIGIARGL 403
I+ L N + ++ I + + + QI+ + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 404 EYLHRGCQVRIVHFDIKPQNILLD-EDFCPKISDFGLAKQAQKKESAISMLHARGTIGYI 462
+Y+H + I+H DIKP+N+L++ D + +A ++ T Y
Sbjct: 139 DYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 463 APEVYSRRFGGVSHKSDVYSYGMMIIEMV------------GCTKNLDDEVTDTSICHNL 510
+PEV +D++S +I E++ TK+ D + L
Sbjct: 197 SPEVL--LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 254
Query: 511 IYERIEPGNDFQFDGVATEEEKKIAKMMILVGF----------------------WCIQT 548
+ G + + + I+K+ +Q
Sbjct: 255 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314
Query: 549 NPSERPSMHKVLEM----LEGSIENLQIPPKPSLFSAT 582
+P +R ++ +E +++P + S +
Sbjct: 315 DPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGS 352
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 1e-27
Identities = 62/304 (20%), Positives = 108/304 (35%), Gaps = 57/304 (18%)
Query: 299 DKLGQGGYGEVYKG-ELPDGQLVAVKVLKNSRCNG---EEFINEVASISRTSHVNIVTFL 354
+G G G V + + VA+K L N + E+ + +H NI++ L
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 355 GFC------YENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHR 408
E + L+ ELM + + M + + G+++LH
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCGIKHLHS 137
Query: 409 GCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYS 468
+ H D+KP NI++ D KI DFGLA+ A M T Y APEV
Sbjct: 138 AGII---HRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVIL 191
Query: 469 RRFGGVSHKSDVYSYGMMIIEMV-------------------------------GCTKNL 497
G D++S G ++ EMV +
Sbjct: 192 GM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 498 DDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMH 557
+ V + L + ++ P + F D + + A+ ++ + +P++R S+
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS---KMLVIDPAKRISVD 306
Query: 558 KVLE 561
L+
Sbjct: 307 DALQ 310
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 2e-26
Identities = 52/290 (17%), Positives = 98/290 (33%), Gaps = 40/290 (13%)
Query: 299 DKLGQGGYGEVYKGE-LPDGQLVAVKVLKNSRCNG---EEFINEVASISRTSHVNIVTFL 354
+G G YG V G VAVK L + + E+ + H N++ L
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 355 GFCYENKK-----NALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRG 409
+ + + + L+ + + L + + I RGL+Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSA 140
Query: 410 CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSR 469
+ H D+KP N+ ++ED KI DFGLA+ + + T Y APE+
Sbjct: 141 DII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLN 192
Query: 470 RFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529
+ D++S G ++ E++ + L ++ PG + +
Sbjct: 193 W-MHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 530 EEKKIAKMMILVGF------------------WCIQTNPSERPSMHKVLE 561
I + + + + +R + + L
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 102 bits (255), Expect = 7e-26
Identities = 31/202 (15%), Positives = 60/202 (29%), Gaps = 27/202 (13%)
Query: 299 DKLGQGGYGEVYKGELPDGQLVAVKVLKNSR-----------CNGEEFINEVASISRTSH 347
+G+G V+ VK K F +R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 348 VNIVTFLGFCYENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLH 407
+ G +Y N L + I ++ + ++ I + +
Sbjct: 66 RALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 408 RGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVY 467
IVH D+ N+L+ + I DF + + +E +L + I +
Sbjct: 121 HRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVG-EEGWREIL--ERDVRNII-TYF 172
Query: 468 SRRFGGVSHKSDVYSYGMMIIE 489
SR + + D+ S I++
Sbjct: 173 SRTYR---TEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 582 | |||
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.29 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.01 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.62 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.38 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.03 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.22 | |
| d1tpga1 | 41 | Plasminogen activator (tissue-type), t-PA {Human ( | 83.09 | |
| d1nqlb_ | 48 | Epidermal growth factor, EGF {Human (Homo sapiens) | 80.32 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-53 Score=420.25 Aligned_cols=256 Identities=27% Similarity=0.445 Sum_probs=213.2
Q ss_pred HHHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
..+++.++||+|+||+||+|.+++++.||||+++......+.|.+|+.++++++|||||+++|++.+ +..++||||+++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~ 91 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 91 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCC
Confidence 3455678999999999999999888999999998877788899999999999999999999998754 567999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
|+|.+++.......+++..+++|+.||++||+|||+. +|+||||||+||||++++.+||+|||+|+........ ..
T Consensus 92 g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~-~~ 167 (272)
T d1qpca_ 92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AR 167 (272)
T ss_dssp CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-CC
T ss_pred CcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccc-cc
Confidence 9999988766656799999999999999999999998 9999999999999999999999999999987654322 22
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
....||+.|+|||++.. +.++.++|||||||++|||+||+.|+........ +...+..+..+..+..
T Consensus 168 ~~~~gt~~y~APE~~~~--~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~-----~~~~i~~~~~~~~p~~------ 234 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-----VIQNLERGYRMVRPDN------ 234 (272)
T ss_dssp TTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHHHHTTCCCCCCTT------
T ss_pred cccCCcccccChHHHhC--CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHhcCCCCCccc------
Confidence 34569999999999876 4789999999999999999998777654433222 2333444433333332
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 040604 533 KIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSI 567 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~ 567 (582)
++..+.+|+.+||+.||++||||++|++.|+...
T Consensus 235 -~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 235 -CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp -CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 2345778888999999999999999999998744
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-53 Score=415.72 Aligned_cols=254 Identities=25% Similarity=0.468 Sum_probs=201.9
Q ss_pred HhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCCh
Q 040604 296 SFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSL 375 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 375 (582)
++.++||+|+||+||+|.+.+++.||||+++......++|.+|+.++++++|||||+++|++.+++..++||||+++|+|
T Consensus 8 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L 87 (263)
T d1sm2a_ 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL 87 (263)
T ss_dssp EEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred EEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcH
Confidence 45688999999999999998899999999988777889999999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeecc
Q 040604 376 DKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHA 455 (582)
Q Consensus 376 ~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 455 (582)
.+++.... ..+++..++.|+.||+.||+|||+. +|+||||||+|||+++++.+||+|||+|+......... ....
T Consensus 88 ~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~-~~~~ 162 (263)
T d1sm2a_ 88 SDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGT 162 (263)
T ss_dssp HHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-----------------
T ss_pred HHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCcee-ecce
Confidence 99987543 4689999999999999999999998 99999999999999999999999999998765543322 2235
Q ss_pred cCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHH
Q 040604 456 RGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKIA 535 (582)
Q Consensus 456 ~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 535 (582)
.||+.|+|||++.+ ..++.++|||||||++|||+|++.|+........ +.+.+..+.....+... .
T Consensus 163 ~gt~~y~aPE~l~~--~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~-----~~~~i~~~~~~~~p~~~-------~ 228 (263)
T d1sm2a_ 163 KFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-----VVEDISTGFRLYKPRLA-------S 228 (263)
T ss_dssp --CTTSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH-----HHHHHHHTCCCCCCTTS-------C
T ss_pred ecCcccCChHHhcC--CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH-----HHHHHHhcCCCCCcccc-------C
Confidence 69999999999986 4789999999999999999997666554433222 22233333222222222 3
Q ss_pred HHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 536 KMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 536 ~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
..+.+|+.+||+.||++||||+||++.|+++.+
T Consensus 229 ~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 229 THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 456788889999999999999999999998653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-52 Score=419.23 Aligned_cols=262 Identities=27% Similarity=0.438 Sum_probs=219.8
Q ss_pred HHHHHHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEE
Q 040604 290 VKRMTKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 290 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 368 (582)
+....+++.++||+|+||+||+|.+. +|+.||||+++......++|.+|+.+|++++|||||++++++.++...++|||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 34445566789999999999999765 68999999998887788899999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
|+++|+|.+++.......+++..++.|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.......
T Consensus 94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 99999999999877667899999999999999999999998 999999999999999999999999999998665433
Q ss_pred ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc
Q 040604 449 AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528 (582)
Q Consensus 449 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 528 (582)
. ......||+.|+|||++.+ +.++.++|||||||++|||++|+.|+........ +.+.+..+..+..+...
T Consensus 171 ~-~~~~~~g~~~y~aPE~~~~--~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-----~~~~i~~~~~~~~~~~~- 241 (287)
T d1opja_ 171 T-AHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYELLEKDYRMERPEGC- 241 (287)
T ss_dssp E-EETTEEECGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----HHHHHHTTCCCCCCTTC-
T ss_pred e-eeccccccccccChHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH-----HHHHHhcCCCCCCCccc-
Confidence 2 2234568999999999876 4789999999999999999998887755433221 23344444333333222
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCC
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIEN 569 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~ 569 (582)
+..+.+|+.+||+.||++||||+||++.|+...+.
T Consensus 242 ------~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 242 ------PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp ------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred ------hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 34577888899999999999999999999987654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-52 Score=413.54 Aligned_cols=250 Identities=29% Similarity=0.350 Sum_probs=201.1
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
|++.++||+|+||+||+|... +|+.||||+++.... ..+.+.+|+.+|++++|||||++++++.++...++||||++
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 86 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence 456689999999999999764 799999999865432 34568999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
+|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+|+..........
T Consensus 87 gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 87 GGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp TEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred CCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence 99999999754 3699999999999999999999998 999999999999999999999999999998765443333
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHH
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 531 (582)
.....||+.|+|||++.+. ...+.++|||||||++|||++|+.||........... ........... .
T Consensus 162 ~~~~~GT~~Y~APE~~~~~-~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~----~~~~~~~~~~~-------~ 229 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS----DWKEKKTYLNP-------W 229 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH----HHHTTCTTSTT-------G
T ss_pred ccceeeCcCccCHhHhcCC-CCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH----HHhcCCCCCCc-------c
Confidence 3456799999999999764 2346789999999999999999999976543332111 11111111111 1
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 532 KKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
..+...+.+|+.+||+.||++|||++|+++
T Consensus 230 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 230 KKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 223355667888999999999999999865
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-52 Score=413.88 Aligned_cols=261 Identities=29% Similarity=0.439 Sum_probs=202.0
Q ss_pred HHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 295 KSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
+.+.++||+|+||+||+|+.. ..||||+++.... ..+.|.+|+.+|++++|||||++++++.+ ...++||||++
T Consensus 10 ~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~ 86 (276)
T d1uwha_ 10 ITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCE 86 (276)
T ss_dssp CCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCC
T ss_pred EEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCC
Confidence 345689999999999999864 3599999975432 34678999999999999999999998754 56899999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
+|+|.+++...+ ..+++..++.|+.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+..........
T Consensus 87 ~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~ 162 (276)
T d1uwha_ 87 GSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162 (276)
T ss_dssp EEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC---------
T ss_pred CCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCccc
Confidence 999999997543 3699999999999999999999998 999999999999999999999999999988765444333
Q ss_pred eecccCCcccccccccccc-cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCC-CCCCCcCcH
Q 040604 452 MLHARGTIGYIAPEVYSRR-FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND-FQFDGVATE 529 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~ 529 (582)
.....||+.|||||++... .+.++.++|||||||+||||+||+.||........ +...+..+.. +.+..
T Consensus 163 ~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-----~~~~~~~~~~~p~~~~---- 233 (276)
T d1uwha_ 163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-----IIFMVGRGYLSPDLSK---- 233 (276)
T ss_dssp ---CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-----HHHHHHHTSCCCCGGG----
T ss_pred ccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH-----HHHHHhcCCCCCcchh----
Confidence 3456799999999998643 23589999999999999999999999976543321 1122221111 11111
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCC
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQ 571 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~ 571 (582)
....+++.+.+|+.+||+.||++||||+||++.|+.+..+++
T Consensus 234 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 111234567788889999999999999999999998776653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-51 Score=413.70 Aligned_cols=253 Identities=27% Similarity=0.455 Sum_probs=194.9
Q ss_pred hhhcCccCceEEEEEEeC-CC---cEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 298 RDKLGQGGYGEVYKGELP-DG---QLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 298 ~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
.++||+|+||+||+|.+. ++ ..||||.+...... .+.|.+|+.+|++++|||||+++|++.+.+..++||||++
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~ 110 (299)
T d1jpaa_ 31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFME 110 (299)
T ss_dssp EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecC
Confidence 467999999999999764 33 36899998654432 3579999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce-
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI- 450 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~- 450 (582)
+|+|.+++.... ..+++.+++.|+.||++||+|||+. +|+||||||+|||++.++.+||+|||+|+.........
T Consensus 111 ~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~ 186 (299)
T d1jpaa_ 111 NGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 186 (299)
T ss_dssp TEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------------
T ss_pred CCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCCCCcce
Confidence 999999887643 3689999999999999999999998 99999999999999999999999999999766543321
Q ss_pred --eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcC
Q 040604 451 --SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527 (582)
Q Consensus 451 --~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 527 (582)
......||+.|+|||++.+ +.++.++|||||||++|||+| |+.||....... +...+..+..+..+.
T Consensus 187 ~~~~~~~~~t~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~------~~~~i~~~~~~~~~~-- 256 (299)
T d1jpaa_ 187 YTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD------VINAIEQDYRLPPPM-- 256 (299)
T ss_dssp ---------CGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTTCCCCCCT--
T ss_pred eeecccccCCccccCHHHHhc--CCCCcccccccchHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCCCCCc--
Confidence 1223458999999999876 478999999999999999998 788887643321 233343333322222
Q ss_pred cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCC
Q 040604 528 TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIEN 569 (582)
Q Consensus 528 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~ 569 (582)
..+..+.+|+.+||+.||++||||+||++.|++.+++
T Consensus 257 -----~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 257 -----DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp -----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 2345677888999999999999999999999987764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=411.49 Aligned_cols=261 Identities=26% Similarity=0.425 Sum_probs=211.1
Q ss_pred HHHHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
..+++.++||+|+||+||+|.+++++.||||+++......+.|.+|+.++++++|||||+++|++.+ +..++||||+++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence 3456778999999999999999888899999998887788899999999999999999999999854 567899999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
|+|..++.......+++..++.|+.||+.||+|||+. +|+||||||+||||++++.+||+|||+|+........ ..
T Consensus 96 g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~ 171 (285)
T d1fmka3 96 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-AR 171 (285)
T ss_dssp CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred CchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCce-ee
Confidence 9999998866555799999999999999999999998 9999999999999999999999999999876543322 22
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
....||+.|+|||++.. +.++.++||||||+++|||++|+.|+........ +...+..+........
T Consensus 172 ~~~~gt~~y~aPE~~~~--~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~-----~~~~i~~~~~~~~~~~------ 238 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQVERGYRMPCPPE------ 238 (285)
T ss_dssp ----CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHHHHTTCCCCCCTT------
T ss_pred ccccccccccChHHHhC--CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH-----HHHHHHhcCCCCCCcc------
Confidence 34569999999999976 5789999999999999999998877765443322 2223333332223322
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCCC
Q 040604 533 KIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQI 572 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~~ 572 (582)
+...+.+++.+||+.||++||||++|+++|+..+.+.+.
T Consensus 239 -~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 239 -CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp -SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred -cCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence 234577888899999999999999999999998877653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-51 Score=400.78 Aligned_cols=250 Identities=24% Similarity=0.432 Sum_probs=212.2
Q ss_pred HhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCCCh
Q 040604 296 SFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNGSL 375 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 375 (582)
++.++||+|+||+||+|++++++.||||+++......++|.+|+.++++++|||||+++|++.++...++||||+++|+|
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l 86 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 86 (258)
T ss_dssp CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEH
T ss_pred EEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcH
Confidence 46789999999999999998899999999998888889999999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeeecc
Q 040604 376 DKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISMLHA 455 (582)
Q Consensus 376 ~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 455 (582)
.+++.... ..+++..+++++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++........ .....
T Consensus 87 ~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~ 161 (258)
T d1k2pa_ 87 LNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGS 161 (258)
T ss_dssp HHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CCCCS
T ss_pred HHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCce-eeccc
Confidence 99976543 4689999999999999999999998 9999999999999999999999999999876554332 22345
Q ss_pred cCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHHHH
Q 040604 456 RGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEKKI 534 (582)
Q Consensus 456 ~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 534 (582)
.||+.|+|||.+.+ ..++.++|||||||++|||+| |+.||....... +...+..+.....+...
T Consensus 162 ~~t~~y~aPE~~~~--~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~------~~~~i~~~~~~~~p~~~------- 226 (258)
T d1k2pa_ 162 KFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQGLRLYRPHLA------- 226 (258)
T ss_dssp CCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH------HHHHHHTTCCCCCCTTC-------
T ss_pred CCCCCcCCcHHhcC--CCCCcceeecccchhhHhHHhcCCCCCCCCCHHH------HHHHHHhCCCCCCcccc-------
Confidence 69999999999986 478999999999999999998 788887654322 23344444333333332
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 535 AKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 535 ~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
...+.+|+.+||+.||++|||+++|++.|..
T Consensus 227 ~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 227 SEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 2457788889999999999999999999865
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-51 Score=401.31 Aligned_cols=242 Identities=27% Similarity=0.416 Sum_probs=202.9
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccC----CCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNS----RCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+++.+.||+|+||+||+|... +++.||+|++.+. ....+.+.+|+.++++++|||||++++++.++...++||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence 456789999999999999765 7899999998642 33467789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++|+|.+++...+ .+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 88 ~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~- 161 (263)
T d2j4za1 88 APLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR- 161 (263)
T ss_dssp CTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCC-
T ss_pred cCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCcc-
Confidence 99999999997643 689999999999999999999998 999999999999999999999999999987654332
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
....||+.|+|||++.+. .++.++|||||||+||||++|+.||....... +.+.+.... ..++..
T Consensus 162 ---~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~~-~~~p~~--- 226 (263)
T d2j4za1 162 ---TTLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TYKRISRVE-FTFPDF--- 226 (263)
T ss_dssp ---EETTEEGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTTC-CCCCTT---
T ss_pred ---cccCCCCcccCHHHHcCC--CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH------HHHHHHcCC-CCCCcc---
Confidence 235699999999999874 68999999999999999999999997643221 223333322 222222
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
+...+.+|+.+||+.||++|||++|+++
T Consensus 227 ----~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 227 ----VTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 2345677888899999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=401.74 Aligned_cols=247 Identities=27% Similarity=0.423 Sum_probs=199.1
Q ss_pred hhcCccCceEEEEEEeC---CCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 299 DKLGQGGYGEVYKGELP---DGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
++||+|+||+||+|.+. .++.||||+++..... .++|.+|+.+|++++|||||+++|++. .+..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-~~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-cCCEEEEEEcCCC
Confidence 46999999999999653 3578999999754332 357999999999999999999999985 4567899999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc-ee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA-IS 451 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~-~~ 451 (582)
|+|.+++.... .+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+........ ..
T Consensus 92 g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 99999998654 699999999999999999999998 9999999999999999999999999999976554332 22
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHH
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 530 (582)
.....||+.|+|||.+.+ +.++.++|||||||++|||+| |+.||...... .+...+..+..+..+..
T Consensus 167 ~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~------~~~~~i~~~~~~~~p~~---- 234 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------EVTAMLEKGERMGCPAG---- 234 (277)
T ss_dssp ----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHHTTCCCCCCTT----
T ss_pred ccccCCCceecCchhhcC--CCCCchhhhccchhhhhHHhhCCCCCCCCCCHH------HHHHHHHcCCCCCCCcc----
Confidence 234569999999999976 478999999999999999998 88998764322 13344444444434332
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 040604 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGS 566 (582)
Q Consensus 531 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~ 566 (582)
++..+.+|+.+||+.||++|||+++|++.|+..
T Consensus 235 ---~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 235 ---CPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp ---CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---cCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 235577788899999999999999999988753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-50 Score=401.35 Aligned_cols=245 Identities=27% Similarity=0.393 Sum_probs=202.6
Q ss_pred HHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCC-CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSR-CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
|.+.++||+|+||+||+|.. .+|+.||||+++... ...+.+.+|+.++++++|||||++++++.+.+..++||||++|
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g 101 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCC
Confidence 45668999999999999976 479999999987543 4567799999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
|+|.+++.+. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+........ .
T Consensus 102 g~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~--~ 173 (293)
T d1yhwa1 102 GSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--R 173 (293)
T ss_dssp CBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC--B
T ss_pred CcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccccc--c
Confidence 9999988753 589999999999999999999998 9999999999999999999999999999987544322 2
Q ss_pred ecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCC-CCCCCCcCcHHH
Q 040604 453 LHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGN-DFQFDGVATEEE 531 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~ 531 (582)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+...+.... ....+
T Consensus 174 ~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~------- 239 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-----ALYLIATNGTPELQNP------- 239 (293)
T ss_dssp CCCCSCGGGCCHHHHSS--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHHCSCCCSSG-------
T ss_pred cccccCCCccChhhhcC--CCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-----HHHHHHhCCCCCCCCc-------
Confidence 24569999999999987 468999999999999999999999997643322 1111211111 11111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 532 KKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
..+...+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 123455677888999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-50 Score=399.59 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=204.5
Q ss_pred hhh-hcCccCceEEEEEEeC---CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 297 FRD-KLGQGGYGEVYKGELP---DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 297 ~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
+.+ +||+|+||+||+|.+. ++..||||+++.... ..++|.+|+.+|++++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~ 90 (285)
T d1u59a_ 12 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMA 90 (285)
T ss_dssp EEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred ECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeC
Confidence 345 5999999999999653 456899999976543 23679999999999999999999999864 5689999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
++|+|.+++...+ ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.........
T Consensus 91 ~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 91 GGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp TTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred CCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence 9999999886533 4689999999999999999999998 99999999999999999999999999999876543322
Q ss_pred -eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc
Q 040604 451 -SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528 (582)
Q Consensus 451 -~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 528 (582)
......||+.|+|||++.. +.++.++|||||||++|||+| |+.||....... +...+..+..+..+...
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~------~~~~i~~~~~~~~p~~~- 237 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIEQGKRMECPPEC- 237 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH------HHHHHHTTCCCCCCTTC-
T ss_pred ccccccccCccccChHHHhC--CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCCCCCCcC-
Confidence 2223468999999999976 478999999999999999998 899997654321 33444455444443332
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSI 567 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~ 567 (582)
+..+.+|+.+||+.||++||||.+|++.|+...
T Consensus 238 ------~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 238 ------PPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp ------CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 355678888999999999999999999998644
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=398.30 Aligned_cols=244 Identities=28% Similarity=0.421 Sum_probs=196.5
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEe----CCeeeEEE
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYE----NKKNALIY 367 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 367 (582)
+|.++||+|+||+||+|.+. +++.||+|++...... .+.+.+|+.+|++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 35578999999999999765 7899999998765433 3568899999999999999999999875 34578999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc-CCCceEEeecccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLD-EDFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~-~~~~vkl~DFGla~~~~~~ 446 (582)
||+++|+|.+++.+.. .+++..++.++.||++||+|||++ ..+|+||||||+|||++ +++.+||+|||+|+.....
T Consensus 92 E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred eCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence 9999999999997643 689999999999999999999987 12399999999999996 5799999999999865443
Q ss_pred ccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCC-CCCC
Q 040604 447 ESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDF-QFDG 525 (582)
Q Consensus 447 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~-~~~~ 525 (582)
.. ....||+.|+|||++.+ .++.++|||||||++|||++|+.||....... .+.+.+..+..+ .++.
T Consensus 169 ~~----~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-----~~~~~i~~~~~~~~~~~ 236 (270)
T d1t4ha_ 169 FA----KAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYRRVTSGVKPASFDK 236 (270)
T ss_dssp SB----EESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHHHHHTTTCCCGGGGG
T ss_pred cc----CCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-----HHHHHHHcCCCCcccCc
Confidence 22 23469999999999864 58999999999999999999999997543322 233344433221 1222
Q ss_pred cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 526 VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 526 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
. ....+.+|+.+||+.||++|||++|+++
T Consensus 237 ~-------~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 237 V-------AIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp C-------CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c-------CCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 2 2344677888999999999999999976
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=400.47 Aligned_cols=250 Identities=23% Similarity=0.322 Sum_probs=190.6
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCH---HHHHHHHHHHhccCCCceEEEEeEEEe--CCeeeEEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNG---EEFINEVASISRTSHVNIVTFLGFCYE--NKKNALIYE 368 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E 368 (582)
|++.+.||+|+||+||+|... +|+.||||+++...... +.+.+|+.++++++|||||++++++.+ +...++|||
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE 85 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence 456789999999999999764 79999999997655433 458899999999999999999999975 346789999
Q ss_pred ecCCCChhhhhhcC--CCcCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecCCCCCCEEEcCCCceEEeecccccccc
Q 040604 369 LMPNGSLDKFIHND--RNIKLEWKTMYQIAIGIARGLEYLHRGC--QVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 369 ~~~~gsL~~~i~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~--~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~ 444 (582)
|+++|+|.+++... ....+++..++.++.||+.||+|||++. ..+|+||||||+|||++.++.+||+|||+|+...
T Consensus 86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 165 (269)
T d2java1 86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 165 (269)
T ss_dssp CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecc
Confidence 99999999998643 2346999999999999999999999862 1249999999999999999999999999999876
Q ss_pred ccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCC
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFD 524 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 524 (582)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... +...+..+....++
T Consensus 166 ~~~~~--~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~------~~~~i~~~~~~~~~ 235 (269)
T d2java1 166 HDTSF--AKAFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------LAGKIREGKFRRIP 235 (269)
T ss_dssp ------------CCCSCCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHTCCCCCC
T ss_pred cCCCc--cccCCCCcccCCHHHHcC--CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH------HHHHHHcCCCCCCC
Confidence 54332 123569999999999976 478999999999999999999999997643221 22333333222222
Q ss_pred CcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 525 GVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 525 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.. +...+.+|+.+||+.||++|||++|+++
T Consensus 236 ~~-------~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 236 YR-------YSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp TT-------SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cc-------cCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 22 2345677888999999999999999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-50 Score=409.01 Aligned_cols=256 Identities=27% Similarity=0.419 Sum_probs=206.9
Q ss_pred HHHHhhhhcCccCceEEEEEEeC-CC-----cEEEEEEeccCC--CCHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCee
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELP-DG-----QLVAVKVLKNSR--CNGEEFINEVASISRT-SHVNIVTFLGFCYENKKN 363 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~-~~-----~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 363 (582)
..+++.++||+|+||+||+|... .+ ..||||++.... .....+.+|+.+|+++ +|||||++++++.+....
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 34567789999999999999753 22 369999986543 2346789999999998 899999999999999999
Q ss_pred eEEEEecCCCChhhhhhcCCC---------------------cCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCC
Q 040604 364 ALIYELMPNGSLDKFIHNDRN---------------------IKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQ 422 (582)
Q Consensus 364 ~lv~E~~~~gsL~~~i~~~~~---------------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~ 422 (582)
++||||+++|+|.++++.... ..+++..++.++.||+.||+|||++ +|+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence 999999999999999976432 3589999999999999999999998 9999999999
Q ss_pred CEEEcCCCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCC
Q 040604 423 NILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEV 501 (582)
Q Consensus 423 NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~ 501 (582)
|||++.++.+||+|||+|+...............||+.|||||++.+ +.++.++|||||||++|||+| |+.||....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC--CCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999998766555444445568999999999876 478999999999999999998 788987654
Q ss_pred cccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 040604 502 TDTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEG 565 (582)
Q Consensus 502 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~ 565 (582)
.... +.+.+..+..+..+... +..+.+|+.+||+.||++||||+||++.|..
T Consensus 272 ~~~~-----~~~~~~~~~~~~~p~~~-------~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 272 VDAN-----FYKLIQNGFKMDQPFYA-------TEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CSHH-----HHHHHHTTCCCCCCTTC-------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHH-----HHHHHhcCCCCCCCCcC-------CHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 3321 23333343333333322 3457788889999999999999999999963
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=403.00 Aligned_cols=250 Identities=23% Similarity=0.320 Sum_probs=201.7
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC-CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR-CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
|++.++||+|+||+||+|... +|+.||||+++... ...+.+.+|+.+|++++|||||++++++.+.+..++||||+++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 445688999999999999764 79999999997543 3446789999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceee
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISM 452 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 452 (582)
|+|.+++.+.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+........ .
T Consensus 94 g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~--~ 167 (288)
T d2jfla1 94 GAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--R 167 (288)
T ss_dssp EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH--H
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCccc--c
Confidence 99999876532 3699999999999999999999998 9999999999999999999999999999875443221 1
Q ss_pred ecccCCcccccccccccc---cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 453 LHARGTIGYIAPEVYSRR---FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 453 ~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
....||+.|+|||++... ...++.++|||||||++|||++|+.||....... . +.. +..+....+..
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~----~~~-i~~~~~~~~~~---- 237 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-V----LLK-IAKSEPPTLAQ---- 237 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-H----HHH-HHHSCCCCCSS----
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-H----HHH-HHcCCCCCCCc----
Confidence 234699999999998431 2457899999999999999999999997654332 1 112 22221111110
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
...+...+.+|+.+||+.||++|||++|+++
T Consensus 238 -~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 238 -PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1123456778888999999999999999976
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=403.24 Aligned_cols=245 Identities=23% Similarity=0.298 Sum_probs=200.5
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccC----CCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNS----RCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+++.+.||+|+||+||+|... +|+.||||+++.. ....+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence 457789999999999999764 7999999998642 33557799999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
++||+|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+........
T Consensus 90 ~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 90 AKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 99999999987654 699999999999999999999998 9999999999999999999999999999987654433
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... +.+.+..+. ..++..
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~~~-~~~p~~--- 232 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNEYL------IFQKIIKLE-YDFPEK--- 232 (288)
T ss_dssp -----CCCCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHTTC-CCCCTT---
T ss_pred cccccccCCccccCceeeccC--CCCcccceehhhHHHHHHhhCCCCCCCcCHHH------HHHHHHcCC-CCCCcc---
Confidence 333345799999999999774 78999999999999999999999997643221 223333322 222222
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVL 560 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl 560 (582)
+...+.+|+.+||+.||++|||++|++
T Consensus 233 ----~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 233 ----FFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp ----CCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred ----CCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 234567888899999999999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-50 Score=399.16 Aligned_cols=255 Identities=27% Similarity=0.436 Sum_probs=199.1
Q ss_pred hhhhcCccCceEEEEEEeCC-C----cEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 297 FRDKLGQGGYGEVYKGELPD-G----QLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 297 ~~~~lG~G~~g~Vy~~~~~~-~----~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+.+.||+|+||+||+|.+++ + ..||||+++..... .++|.+|+.++++++|||||+++|++.+....++||||
T Consensus 11 ~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~ 90 (283)
T d1mqba_ 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY 90 (283)
T ss_dssp EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred eeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEe
Confidence 45789999999999997653 2 47999999754433 34689999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+.+++|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+........
T Consensus 91 ~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 166 (283)
T d1mqba_ 91 MENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166 (283)
T ss_dssp CTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred cccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence 99999998876543 4699999999999999999999998 9999999999999999999999999999886554322
Q ss_pred -eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc
Q 040604 450 -ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528 (582)
Q Consensus 450 -~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 528 (582)
.......||+.|+|||++.+ +.++.++|||||||++|||++++.|+........ +.+.+..+..+..+..
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~--~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~-----~~~~i~~~~~~~~~~~-- 237 (283)
T d1mqba_ 167 TYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-----VMKAINDGFRLPTPMD-- 237 (283)
T ss_dssp -------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHHHTTCCCCCCTT--
T ss_pred ceEeccCCCCccccCHHHHcc--CCCCCcccccccHHHHHHHHhCCCCccccCCHHH-----HHHHHhccCCCCCchh--
Confidence 22234468999999999976 4789999999999999999998777655433222 2333444333323222
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCC
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIEN 569 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~ 569 (582)
++..+.+|+.+||+.||++||||+||++.|++.+++
T Consensus 238 -----~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 238 -----CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -----CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----hHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 335677889999999999999999999999886653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=411.77 Aligned_cols=198 Identities=26% Similarity=0.390 Sum_probs=173.3
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
.|++.++||+|+||+||+|... +|+.||+|+++.... ..+.+.+|+.+|++++|||||++++++.+....++||||+
T Consensus 7 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~ 86 (322)
T d1s9ja_ 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 86 (322)
T ss_dssp GEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4556789999999999999764 799999999975432 2467899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
+||+|.+++.+.+ .+++..+..++.|++.||.|||++ .+|+||||||+|||+++++.+||+|||+|+.......
T Consensus 87 ~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~-- 160 (322)
T d1s9ja_ 87 DGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-- 160 (322)
T ss_dssp TTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC--
T ss_pred CCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCcc--
Confidence 9999999997644 689999999999999999999963 1799999999999999999999999999987654322
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCC
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEV 501 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~ 501 (582)
....||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 161 --~~~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 161 --NSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp -----CCSSCCCCHHHHHC--SCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred --ccccCCccccCchHHcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 23469999999999987 478999999999999999999999997654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-49 Score=398.36 Aligned_cols=244 Identities=25% Similarity=0.339 Sum_probs=199.5
Q ss_pred HHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCCH----HHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNG----EEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
++..++||+|+||+||+|.. .+|+.||||+++...... +.+.+|+.+|++++|||||++++++.++...++||||
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 96 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEe
Confidence 45568899999999999975 479999999997655433 4588999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
+++|+|..++... .++++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 97 ~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~-- 169 (309)
T d1u5ra_ 97 CLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-- 169 (309)
T ss_dssp CSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC--
T ss_pred cCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCCC--
Confidence 9999998776654 3699999999999999999999998 99999999999999999999999999998765432
Q ss_pred eeeecccCCcccccccccccc-cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc
Q 040604 450 ISMLHARGTIGYIAPEVYSRR-FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 528 (582)
...||+.|+|||++.+. .+.++.++|||||||++|||++|+.||....... .+...............
T Consensus 170 ----~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-----~~~~i~~~~~~~~~~~~-- 238 (309)
T d1u5ra_ 170 ----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----ALYHIAQNESPALQSGH-- 238 (309)
T ss_dssp ----CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHSCCCCCSCTT--
T ss_pred ----ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-----HHHHHHhCCCCCCCCCC--
Confidence 34699999999998642 2468999999999999999999999997643322 12222222211111111
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
+...+.+|+.+||+.||++|||++|+++
T Consensus 239 -----~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 239 -----WSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -----SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----CCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 2345677888999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.1e-50 Score=403.26 Aligned_cols=249 Identities=28% Similarity=0.358 Sum_probs=187.6
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
.|++.+.||+|+||+||+|... +|+.||||++..... ..+.+.+|+.+|++++|||||++++++.++...++||||+
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~ 89 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV 89 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 3567789999999999999765 799999999975432 3356789999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc---CCCceEEeeccccccccccc
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLD---EDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~---~~~~vkl~DFGla~~~~~~~ 447 (582)
+||+|.+++...+ .+++..+..++.||+.||+|||+. +|+||||||+|||+. +++.+||+|||+|+......
T Consensus 90 ~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 90 SGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp CSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred CCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 9999999997643 699999999999999999999998 999999999999994 57899999999998765443
Q ss_pred cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcC
Q 040604 448 SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVA 527 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 527 (582)
.. ....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... +...+..+... +..
T Consensus 165 ~~---~~~~GT~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~~~~~-~~~-- 230 (307)
T d1a06a_ 165 VL---STACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPFYDENDAK------LFEQILKAEYE-FDS-- 230 (307)
T ss_dssp -----------CTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHTTCCC-CCT--
T ss_pred ee---eeeeeCccccCcHHHcCC--CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHhccCCC-CCC--
Confidence 32 234699999999999874 68999999999999999999999997653322 12222222111 110
Q ss_pred cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 528 TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 528 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
.....+...+.+|+.+||+.||++|||++|+++.
T Consensus 231 -~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 231 -PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp -TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0111234557788889999999999999999873
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-49 Score=394.04 Aligned_cols=248 Identities=23% Similarity=0.332 Sum_probs=204.0
Q ss_pred HHHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCC-------CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeE
Q 040604 294 TKSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRC-------NGEEFINEVASISRTSHVNIVTFLGFCYENKKNAL 365 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 365 (582)
.|++.++||+|+||+||+|.. .+|+.||||++++... ..+.+.+|+.+|++++|||||++++++.+....++
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 356678999999999999976 4799999999865322 34679999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC----ceEEeeccccc
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF----CPKISDFGLAK 441 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~----~vkl~DFGla~ 441 (582)
||||+++|+|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+|+
T Consensus 91 v~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 91 ILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhh
Confidence 999999999999997644 699999999999999999999998 999999999999998876 49999999998
Q ss_pred cccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCC
Q 040604 442 QAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDF 521 (582)
Q Consensus 442 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~ 521 (582)
........ ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+.....
T Consensus 166 ~~~~~~~~---~~~~~t~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~~~~- 233 (293)
T d1jksa_ 166 KIDFGNEF---KNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANVSAVNY- 233 (293)
T ss_dssp ECTTSCBC---SCCCCCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHTTCC-
T ss_pred hcCCCccc---cccCCCCcccCHHHHcC--CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH------HHHHHHhcCC-
Confidence 87654332 23469999999999976 368999999999999999999999997653322 1222222211
Q ss_pred CCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 522 QFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 522 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
. ........+...+.+|+.+||+.||++|||++|+++
T Consensus 234 ~---~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 E---FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp C---CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C---CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 111122334566788999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-49 Score=396.93 Aligned_cols=256 Identities=25% Similarity=0.403 Sum_probs=207.2
Q ss_pred HHHhhhhcCccCceEEEEEEeC------CCcEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP------DGQLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYENKKNAL 365 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 365 (582)
.+++.++||+|+||+||+|+.. +++.||||+++..... .++|.+|+.+|++++||||+++++++.+....++
T Consensus 14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~ 93 (301)
T d1lufa_ 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 93 (301)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEE
Confidence 3456789999999999999753 4678999999764433 3569999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcCC----------------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCC
Q 040604 366 IYELMPNGSLDKFIHNDR----------------------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQN 423 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~----------------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~N 423 (582)
||||+++|+|.+++.... ...+++..++.|+.|++.||+|||+. +|+||||||+|
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~N 170 (301)
T d1lufa_ 94 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRN 170 (301)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred EEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccc
Confidence 999999999999986432 23488999999999999999999998 99999999999
Q ss_pred EEEcCCCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCC-CCCCCCc
Q 040604 424 ILLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTK-NLDDEVT 502 (582)
Q Consensus 424 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~-p~~~~~~ 502 (582)
||+|.++.+||+|||+|+...............||+.|+|||.+.+ ..++.++|||||||++|||++|.. |+.....
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc--CCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 9999999999999999987655444433445679999999999986 479999999999999999999975 5544322
Q ss_pred ccchhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 040604 503 DTSICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSI 567 (582)
Q Consensus 503 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~ 567 (582)
.. +...+..+..+..+.. ++..+.+|+.+||+.||++||||.||+++|+++.
T Consensus 249 -~e-----~~~~v~~~~~~~~p~~-------~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 249 -EE-----VIYYVRDGNILACPEN-------CPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp -HH-----HHHHHHTTCCCCCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -HH-----HHHHHHcCCCCCCCcc-------chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 21 2233444443333322 2345778889999999999999999999999865
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-49 Score=389.08 Aligned_cols=247 Identities=27% Similarity=0.452 Sum_probs=197.5
Q ss_pred HHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeC-CeeeEEEEecCCC
Q 040604 295 KSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYEN-KKNALIYELMPNG 373 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~E~~~~g 373 (582)
+++.++||+|+||.||+|.+ .|+.||||+++... ..+.|.+|+.++++++|||||+++|++.+. ...++||||+++|
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g 86 (262)
T d1byga_ 9 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86 (262)
T ss_dssp EEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred eEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCC
Confidence 34678899999999999998 57899999997643 457899999999999999999999999654 5679999999999
Q ss_pred ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccceeee
Q 040604 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAISML 453 (582)
Q Consensus 374 sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 453 (582)
+|.+++.......+++..+++|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 87 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~----- 158 (262)
T d1byga_ 87 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD----- 158 (262)
T ss_dssp EHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------------
T ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCCc-----
Confidence 999999866555699999999999999999999998 999999999999999999999999999987554322
Q ss_pred cccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHHH
Q 040604 454 HARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEEK 532 (582)
Q Consensus 454 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 532 (582)
...+|+.|+|||++.+ +.++.++||||||+++|||+| |+.|+....... +...+..+..+.++...
T Consensus 159 ~~~~~~~y~aPE~l~~--~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~------~~~~i~~~~~~~~~~~~----- 225 (262)
T d1byga_ 159 TGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYKMDAPDGC----- 225 (262)
T ss_dssp ---CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG------HHHHHTTTCCCCCCTTC-----
T ss_pred cccccccCCChHHHhC--CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH------HHHHHHcCCCCCCCccC-----
Confidence 3358999999999976 478999999999999999998 566665432221 33444444444443332
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 040604 533 KIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGS 566 (582)
Q Consensus 533 ~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~ 566 (582)
...+.+|+.+||+.||++||||++|+++|+.+
T Consensus 226 --~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 226 --PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp --CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 24567788899999999999999999999864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.7e-49 Score=402.95 Aligned_cols=250 Identities=22% Similarity=0.334 Sum_probs=203.2
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
.|++.++||+|+||+||+|... +|+.||||++..... ..+.+.+|+.+|++++|||||++++++.+....++||||++
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 4567789999999999999764 799999999976543 34568899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc--CCCceEEeeccccccccccccc
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLD--EDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~--~~~~vkl~DFGla~~~~~~~~~ 449 (582)
||+|.+++.... ..+++..+..|+.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+|+........
T Consensus 107 gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 182 (350)
T d1koaa2 107 GGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 182 (350)
T ss_dssp SCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE
T ss_pred CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccccc
Confidence 999999986543 3699999999999999999999998 999999999999995 4688999999999987655443
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
. ...||+.|||||++.+. .++.++|||||||++|||++|+.||....... . ...+..... .+. ..
T Consensus 183 ~---~~~gT~~Y~aPEv~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~-----~~~i~~~~~-~~~---~~ 247 (350)
T d1koaa2 183 K---VTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-T-----LRNVKSCDW-NMD---DS 247 (350)
T ss_dssp E---EECSCTTTCCHHHHHTC--CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-H-----HHHHHHTCC-CSC---CG
T ss_pred c---eecCcccccCHHHHcCC--CCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH-H-----HHHHHhCCC-CCC---cc
Confidence 2 34699999999999764 68899999999999999999999997543221 1 112211111 011 11
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
....+...+.+|+.+||+.||++|||++|+++.
T Consensus 248 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 248 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 112334567788889999999999999999874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1e-48 Score=401.36 Aligned_cols=252 Identities=22% Similarity=0.330 Sum_probs=204.3
Q ss_pred HHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCC-CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCC
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRC-NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
|++.++||+|+||+||+|.. .+|+.||||+++.... ..+.+.+|+.+|++++|||||++++++.++...++||||++|
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 110 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 110 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 56778999999999999976 4799999999976543 345678999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc--CCCceEEeeccccccccccccce
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLD--EDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~--~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
|+|.+++... ..++++..++.|+.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+|+.........
T Consensus 111 g~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~ 186 (352)
T d1koba_ 111 GELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 186 (352)
T ss_dssp CBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred ChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCCcee
Confidence 9999887653 34699999999999999999999998 999999999999998 67899999999999876654332
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHH
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEE 530 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 530 (582)
...||+.|+|||++.+. .++.++|||||||++|||++|+.||....... +...+..+.. .++.. .
T Consensus 187 ---~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~~~-~~~~~---~ 251 (352)
T d1koba_ 187 ---VTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------TLQNVKRCDW-EFDED---A 251 (352)
T ss_dssp ---EECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHHCCC-CCCSS---T
T ss_pred ---eccCcccccCHHHHcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCC-CCCcc---c
Confidence 34599999999999764 78999999999999999999999997653322 1122221111 01110 0
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--Hhc
Q 040604 531 EKKIAKMMILVGFWCIQTNPSERPSMHKVLEM--LEG 565 (582)
Q Consensus 531 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~--Le~ 565 (582)
...+...+.+|+.+||+.||++|||++|+++. +++
T Consensus 252 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 252 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 11234556788899999999999999999874 544
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=394.98 Aligned_cols=264 Identities=27% Similarity=0.418 Sum_probs=213.8
Q ss_pred HHHHHHHhhhhcCccCceEEEEEEe------CCCcEEEEEEeccCCCC--HHHHHHHHHHHhcc-CCCceEEEEeEEEeC
Q 040604 290 VKRMTKSFRDKLGQGGYGEVYKGEL------PDGQLVAVKVLKNSRCN--GEEFINEVASISRT-SHVNIVTFLGFCYEN 360 (582)
Q Consensus 290 ~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 360 (582)
+.+..+++.++||+|+||.||+|.+ .+++.||||+++..... ..+|.+|+.+++++ +|||||++++++.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 4445566788999999999999964 35678999999765433 34688999999999 699999999999999
Q ss_pred CeeeEEEEecCCCChhhhhhcCC----------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCE
Q 040604 361 KKNALIYELMPNGSLDKFIHNDR----------------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNI 424 (582)
Q Consensus 361 ~~~~lv~E~~~~gsL~~~i~~~~----------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NI 424 (582)
...++||||+++|+|.++++... ...+++..+.+++.||+.||+|||++ +++||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccc
Confidence 99999999999999999987543 23589999999999999999999998 999999999999
Q ss_pred EEcCCCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCccc
Q 040604 425 LLDEDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDT 504 (582)
Q Consensus 425 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~ 504 (582)
|++.++.+||+|||+++...............||+.|+|||++.+ +.++.++|||||||++|||+|++.|+.......
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC--CCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999998776555545555679999999999976 478999999999999999999666655443333
Q ss_pred chhhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCC
Q 040604 505 SICHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIEN 569 (582)
Q Consensus 505 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~ 569 (582)
..+...+ ..+..+..+.. ....+.+|+.+||+.||++||||++|+++|++.+.+
T Consensus 255 ~~~~~~i----~~~~~~~~~~~-------~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 255 SKFYKMI----KEGFRMLSPEH-------APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHHH----HHTCCCCCCTT-------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHH----hcCCCCCCccc-------ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 3222322 22222222222 235577888999999999999999999999986543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-49 Score=395.95 Aligned_cols=260 Identities=25% Similarity=0.423 Sum_probs=197.7
Q ss_pred HHHHHhhhhcCccCceEEEEEEeC------CCcEEEEEEeccCCC--CHHHHHHHHHHHhcc-CCCceEEEEeEEEeCC-
Q 040604 292 RMTKSFRDKLGQGGYGEVYKGELP------DGQLVAVKVLKNSRC--NGEEFINEVASISRT-SHVNIVTFLGFCYENK- 361 (582)
Q Consensus 292 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~- 361 (582)
+..+++.++||+|+||+||+|.+. +++.||||+++.... ..+.+.+|...+.++ +|+|||.+++++.+..
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 345667789999999999999642 357899999975443 235678888888776 6889999999987654
Q ss_pred eeeEEEEecCCCChhhhhhcCC--------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc
Q 040604 362 KNALIYELMPNGSLDKFIHNDR--------------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLD 427 (582)
Q Consensus 362 ~~~lv~E~~~~gsL~~~i~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~ 427 (582)
..++||||+++|+|.++++... ...+++..++.++.||++||+|||++ +|+||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeEC
Confidence 6789999999999999997543 23488999999999999999999998 999999999999999
Q ss_pred CCCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCC-CCCCCCcccch
Q 040604 428 EDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTK-NLDDEVTDTSI 506 (582)
Q Consensus 428 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~-p~~~~~~~~~~ 506 (582)
+++.+||+|||+|+...............||+.|+|||++.+ +.++.++|||||||++|||++|.. |+....... .
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-~ 245 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-E 245 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-H
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc--CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-H
Confidence 999999999999987665544433445679999999999976 478999999999999999999765 555433322 1
Q ss_pred hhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 507 CHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 507 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
+...+..+..+..+... ...+.+++.+||+.||++||||+||+++|+..++
T Consensus 246 ----~~~~~~~~~~~~~~~~~-------~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 246 ----FCRRLKEGTRMRAPDYT-------TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp ----HHHHHHHTCCCCCCTTC-------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHHhcCCCCCCCccC-------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 22333333333333222 3456778889999999999999999999998654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=394.20 Aligned_cols=253 Identities=25% Similarity=0.424 Sum_probs=198.8
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCc----EEEEEEeccCC--CCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQ----LVAVKVLKNSR--CNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 367 (582)
+++.++||+|+||+||+|.+. +|+ .||+|.++... ...++|.+|+.++++++|||||+++|++.++ ..+++|
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 456689999999999999764 454 58888886432 3457899999999999999999999999764 567889
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
|++.+|+|.+++... ...+++..+++++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 90 e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 90 QLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp ECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred EeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 999999999988764 34799999999999999999999998 99999999999999999999999999999876655
Q ss_pred cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCc
Q 040604 448 SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 526 (582)
.........||+.|+|||++.+ +.++.++|||||||++|||+| |+.|+....... +...+..+..+..+..
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~--~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~------~~~~i~~~~~~~~p~~ 237 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------ISSILEKGERLPQPPI 237 (317)
T ss_dssp C--------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG------HHHHHHHTCCCCCCTT
T ss_pred ccccccccccCccccChHHHhc--CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH------HHHHHHcCCCCCCCcc
Confidence 4444445569999999999976 478999999999999999998 677776543222 2333333333333322
Q ss_pred CcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 040604 527 ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSI 567 (582)
Q Consensus 527 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~ 567 (582)
. ...+.+|+.+||+.||++|||++||++.|+...
T Consensus 238 ~-------~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 238 C-------TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp B-------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred c-------CHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 2 345677888999999999999999999987653
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=387.73 Aligned_cols=254 Identities=24% Similarity=0.412 Sum_probs=195.4
Q ss_pred HHHhhhhcCccCceEEEEEEeCC----CcEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELPD----GQLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIY 367 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 367 (582)
.+++.+.||+|+||+||+|.+.. +..||||+++..... .+.|.+|+.++++++|||||+++|++. ....++||
T Consensus 8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~ 86 (273)
T d1mp8a_ 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM 86 (273)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEE
Confidence 45677899999999999997642 457899998754433 357899999999999999999999985 46789999
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
||+++|+|.+++.... ..+++..++.++.||++||+|||+. +|+||||||+|||+++++.+||+|||+|+......
T Consensus 87 E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp ECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 9999999999876543 4689999999999999999999998 99999999999999999999999999998765443
Q ss_pred cceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCc
Q 040604 448 SAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526 (582)
Q Consensus 448 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 526 (582)
... .....||+.|+|||++.+ +.++.++|||||||++|||++ |..|+....... +...+..+....++..
T Consensus 163 ~~~-~~~~~gt~~y~apE~l~~--~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~------~~~~i~~~~~~~~~~~ 233 (273)
T d1mp8a_ 163 YYK-ASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERLPMPPN 233 (273)
T ss_dssp ---------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------HHHHHHTTCCCCCCTT
T ss_pred cee-ccceecCcccchhhHhcc--CCCCCccccccchHHHHHHHhcCCCCCCCCCHHH------HHHHHHcCCCCCCCCC
Confidence 322 234568999999999976 478999999999999999998 777886654322 3334444443333333
Q ss_pred CcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 527 ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 527 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
. +..+.+|+.+||+.||++|||++||++.|+.+++
T Consensus 234 ~-------~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 234 C-------PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp C-------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C-------CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 2 3557778889999999999999999999987654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-48 Score=391.65 Aligned_cols=248 Identities=21% Similarity=0.276 Sum_probs=204.8
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecCCC
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMPNG 373 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 373 (582)
|.+.++||+|+||+||+|... +|+.||||+++........+.+|+.+|++++|||||++++++.++...++||||++||
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg 86 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCC
Confidence 456789999999999999765 7899999999877656667889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC--CceEEeecccccccccccccee
Q 040604 374 SLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDED--FCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 374 sL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~--~~vkl~DFGla~~~~~~~~~~~ 451 (582)
+|.+++...+ ..+++.++..|+.||+.||+|||+. +|+||||||+|||++.+ ..+||+|||+++.........
T Consensus 87 ~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~- 161 (321)
T d1tkia_ 87 DIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR- 161 (321)
T ss_dssp BHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE-
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCCccc-
Confidence 9999997543 4689999999999999999999998 99999999999999854 589999999998876544332
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcHHH
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATEEE 531 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 531 (582)
...||+.|+|||.+.+. .++.++||||+||++|||++|+.||....... +...+..+.. .+ .....
T Consensus 162 --~~~~t~~y~ape~~~~~--~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~------~~~~i~~~~~-~~---~~~~~ 227 (321)
T d1tkia_ 162 --LLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNAEY-TF---DEEAF 227 (321)
T ss_dssp --EEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTCC-CC---CHHHH
T ss_pred --ccccccccccchhccCC--CCCchhhcccHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCC-CC---Chhhc
Confidence 24599999999998764 68999999999999999999999997654322 2222222111 11 11122
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 532 KKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 532 ~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
..+...+.+|+.+||+.||++|||++|+++
T Consensus 228 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 228 KEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 234566788999999999999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-48 Score=388.31 Aligned_cols=258 Identities=25% Similarity=0.422 Sum_probs=205.0
Q ss_pred HhhhhcCccCceEEEEEEeCC----CcEEEEEEeccCCC--CHHHHHHHHHHHhccCCCceEEEEeEEEeC-CeeeEEEE
Q 040604 296 SFRDKLGQGGYGEVYKGELPD----GQLVAVKVLKNSRC--NGEEFINEVASISRTSHVNIVTFLGFCYEN-KKNALIYE 368 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~E 368 (582)
+|.++||+|+||+||+|.+.+ ...||||+++.... ..++|.+|+.+|++++|||||+++|++.+. ...++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 456789999999999997643 23699999975433 236799999999999999999999998765 57899999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
|+++|+|.+++.... ..+++..+++++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 110 ~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp CCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred EeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 999999999987543 4678889999999999999999998 999999999999999999999999999997655432
Q ss_pred ce--eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCc
Q 040604 449 AI--SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526 (582)
Q Consensus 449 ~~--~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 526 (582)
.. ......||+.|+|||.+.. +.++.++||||||+++|||++|+.|+......... ...+..+..+..+..
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~-----~~~i~~g~~~~~p~~ 258 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-----TVYLLQGRRLLQPEY 258 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCC------C-----HHHHHTTCCCCCCTT
T ss_pred ccceecccccccccccChHHHhc--CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH-----HHHHHcCCCCCCccc
Confidence 21 1223469999999999876 47899999999999999999988888655433321 222333333333222
Q ss_pred CcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCC
Q 040604 527 ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQ 571 (582)
Q Consensus 527 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~ 571 (582)
+...+.+|+.+||+.||++||+|+||++.|++.+.+..
T Consensus 259 -------~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 259 -------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296 (311)
T ss_dssp -------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred -------CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence 23457788899999999999999999999998776543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=390.89 Aligned_cols=246 Identities=22% Similarity=0.282 Sum_probs=197.0
Q ss_pred hhcCccCceEEEEEEe-CCCcEEEEEEeccCCCCHHHHHHHHHHHhcc-CCCceEEEEeEEEe----CCeeeEEEEecCC
Q 040604 299 DKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNGEEFINEVASISRT-SHVNIVTFLGFCYE----NKKNALIYELMPN 372 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~lv~E~~~~ 372 (582)
+.||+|+||+||+|.. .+++.||||+++. .+.+.+|+.++.++ +|||||++++++.+ +...++|||||+|
T Consensus 18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~g 93 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 93 (335)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred EEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCC
Confidence 4599999999999976 5799999999964 35678899987654 89999999999875 3567999999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---CCceEEeeccccccccccccc
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE---DFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~---~~~vkl~DFGla~~~~~~~~~ 449 (582)
|+|.+++...+...+++..++.|+.||+.||+|||+. +|+||||||+|||++. .+.+||+|||+|+........
T Consensus 94 g~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~ 170 (335)
T d2ozaa1 94 GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 170 (335)
T ss_dssp EEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCC
T ss_pred CcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccCCCcc
Confidence 9999999876666799999999999999999999998 9999999999999985 567999999999887654432
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
....||+.|+|||++.+. .++.++|||||||+||||++|+.||........ ...+...+..+. . .....
T Consensus 171 ---~~~~gt~~y~aPE~~~~~--~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~--~~~~~~~i~~~~-~---~~~~~ 239 (335)
T d2ozaa1 171 ---TTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGMKTRIRMGQ-Y---EFPNP 239 (335)
T ss_dssp ---CCCSCCCSSCCCCCCCGG--GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSCS-S---SCCTT
T ss_pred ---ccccCCcccCCcHHHcCC--CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH--HHHHHHHHhcCC-C---CCCCc
Confidence 245699999999999874 689999999999999999999999965433221 111112222211 1 11122
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
....+...+.+|+.+||+.||++|||++|+++.
T Consensus 240 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 334566778899999999999999999999873
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-48 Score=387.95 Aligned_cols=258 Identities=26% Similarity=0.435 Sum_probs=206.7
Q ss_pred HHHHhhhhcCccCceEEEEEEeC--------CCcEEEEEEeccCCC--CHHHHHHHHHHHhcc-CCCceEEEEeEEEeCC
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELP--------DGQLVAVKVLKNSRC--NGEEFINEVASISRT-SHVNIVTFLGFCYENK 361 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 361 (582)
..+++.++||+|+||.||+|+.. ++..||||+++.... ...++.+|+..+.++ +|||||++++++.++.
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 34566789999999999999653 234799999976543 236788899999888 7999999999999999
Q ss_pred eeeEEEEecCCCChhhhhhcCC--------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc
Q 040604 362 KNALIYELMPNGSLDKFIHNDR--------------NIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLD 427 (582)
Q Consensus 362 ~~~lv~E~~~~gsL~~~i~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~ 427 (582)
..++||||+++|+|.++|.... ...+++..+++++.||+.||+|||+. +|+||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeec
Confidence 9999999999999999997543 24589999999999999999999998 999999999999999
Q ss_pred CCCceEEeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccch
Q 040604 428 EDFCPKISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSI 506 (582)
Q Consensus 428 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~ 506 (582)
.++.+||+|||+++...............||+.|+|||.+.+ +.++.++|||||||++|||++ |+.|+......
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~--~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--- 244 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--- 244 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC--CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---
Confidence 999999999999998766554444445679999999999976 489999999999999999998 56676543322
Q ss_pred hhHHHHHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 507 CHNLIYERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 507 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
.+.+.+..+..+..+... +..+.+|+.+||+.||++||||+||++.|++++.
T Consensus 245 ---~~~~~i~~~~~~~~p~~~-------~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 245 ---ELFKLLKEGHRMDKPSNC-------TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp ---HHHHHHHTTCCCCCCSSC-------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHHHcCCCCCCCccc-------hHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 233444454444443332 3457788899999999999999999999998643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=389.53 Aligned_cols=244 Identities=23% Similarity=0.322 Sum_probs=202.3
Q ss_pred HHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccC----CCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNS----RCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+++.+.||+|+||+||+|+. .+|+.||||++++. ....+.+.+|+.+|++++|||||++++++.+....++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence 45678999999999999976 48999999999753 33567789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
++||+|.+++...+ .+++..++.++.||+.||+|||++ +|+||||||+|||++++|.+||+|||+|+........
T Consensus 87 ~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~ 161 (337)
T d1o6la_ 87 ANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp CTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred cCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence 99999999998654 689999999999999999999998 9999999999999999999999999999876543322
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
....+||+.|+|||++.+. .++.++|||||||++|||++|+.||....... +.+.+..+. ..++...
T Consensus 162 --~~~~~GT~~Y~aPE~~~~~--~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~------~~~~i~~~~-~~~p~~~-- 228 (337)
T d1o6la_ 162 --MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELILMEE-IRFPRTL-- 228 (337)
T ss_dssp --BCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC-CCCCTTS--
T ss_pred --cccceeCHHHhhhhhccCC--CCChhhcccchhhHHHHHHHCCCCCCCcCHHH------HHHHHhcCC-CCCCccC--
Confidence 2235699999999999874 78999999999999999999999997654322 222222221 2233333
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERPS-----MHKVLE 561 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~evl~ 561 (582)
...+.+|+.+||+.||++||+ ++|+++
T Consensus 229 -----s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 229 -----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----CHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 344567788899999999995 788875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-47 Score=387.36 Aligned_cols=241 Identities=28% Similarity=0.351 Sum_probs=200.6
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccC----CCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEe
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNS----RCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
+++.++||+|+||+||+|... +|+.||||++++. ....+.+.+|+.++++++|||||++++++.+....++||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence 456789999999999999764 7999999999642 33567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~ 449 (582)
++||+|..++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 86 ~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~- 159 (316)
T d1fota_ 86 IEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY- 159 (316)
T ss_dssp CCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC-
T ss_pred cCCccccccccccc--cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccccc-
Confidence 99999999987654 578889999999999999999998 999999999999999999999999999988654332
Q ss_pred eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCcH
Q 040604 450 ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVATE 529 (582)
Q Consensus 450 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 529 (582)
...||+.|+|||++.+. .++.++|||||||++|||++|+.||....... +...+..+. ..++...
T Consensus 160 ----~~~Gt~~Y~APE~l~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~i~~~~-~~~p~~~-- 224 (316)
T d1fota_ 160 ----TLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TYEKILNAE-LRFPPFF-- 224 (316)
T ss_dssp ----CCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHCC-CCCCTTS--
T ss_pred ----cccCcccccCHHHHcCC--CCCchhhccccchhHHHHHhCCCCCCCcCHHH------HHHHHHcCC-CCCCCCC--
Confidence 35699999999999764 68999999999999999999999997653322 222222221 1222222
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 040604 530 EEKKIAKMMILVGFWCIQTNPSERP-----SMHKVLE 561 (582)
Q Consensus 530 ~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~ 561 (582)
...+.+++.+||+.||.+|| |++++++
T Consensus 225 -----s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 225 -----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -----CHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 24466778889999999996 8999985
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-48 Score=388.35 Aligned_cols=255 Identities=27% Similarity=0.464 Sum_probs=203.9
Q ss_pred HhhhhcCccCceEEEEEEeC-CCc--EEEEEEeccCC--CCHHHHHHHHHHHhcc-CCCceEEEEeEEEeCCeeeEEEEe
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQ--LVAVKVLKNSR--CNGEEFINEVASISRT-SHVNIVTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~ 369 (582)
++.++||+|+||+||+|.+. +|. .||||.++... ...+.|.+|+.+|+++ +|||||+++|++.+....++||||
T Consensus 13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey 92 (309)
T d1fvra_ 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 92 (309)
T ss_dssp EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEe
Confidence 45688999999999999765 454 57888875432 2446799999999998 799999999999999999999999
Q ss_pred cCCCChhhhhhcC--------------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEe
Q 040604 370 MPNGSLDKFIHND--------------RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKIS 435 (582)
Q Consensus 370 ~~~gsL~~~i~~~--------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~ 435 (582)
+++|+|.++++.. ....+++..+++++.||+.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 93 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEEC
T ss_pred cCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEc
Confidence 9999999999754 235689999999999999999999998 99999999999999999999999
Q ss_pred eccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCC-CCCCCcccchhhHHHHHh
Q 040604 436 DFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKN-LDDEVTDTSICHNLIYER 514 (582)
Q Consensus 436 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p-~~~~~~~~~~~~~~~~~~ 514 (582)
|||+|+........ ....||..|+|||.+.+ +.++.++|||||||++|||++|..| +... ... .+.+.
T Consensus 170 DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~--~~~~~~sDvwSfGvil~ell~~~~~p~~~~-~~~-----~~~~~ 238 (309)
T d1fvra_ 170 DFGLSRGQEVYVKK---TMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCA-----ELYEK 238 (309)
T ss_dssp CTTCEESSCEECCC-------CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CHH-----HHHHH
T ss_pred cccccccccccccc---cceecCCcccchHHhcc--CCCCccceeehhHHHHHHHHhcCCCCCCCC-CHH-----HHHHH
Confidence 99999875543332 23459999999999976 4789999999999999999998764 5433 222 13344
Q ss_pred hcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCC
Q 040604 515 IEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQ 571 (582)
Q Consensus 515 i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~ 571 (582)
+..+..+..+.. +...+.+|+.+||+.||++||||+||++.|++.++...
T Consensus 239 i~~~~~~~~~~~-------~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 239 LPQGYRLEKPLN-------CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp GGGTCCCCCCTT-------BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HHhcCCCCCCcc-------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 444443333322 23567788889999999999999999999998776443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=385.53 Aligned_cols=265 Identities=22% Similarity=0.276 Sum_probs=199.4
Q ss_pred hhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeCC----eeeEEEEecCC
Q 040604 297 FRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYENK----KNALIYELMPN 372 (582)
Q Consensus 297 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~E~~~~ 372 (582)
+.++||+|+||+||+|++ +|+.||||+++........+..|+..+.+++|||||++++++.+.. ..++||||+++
T Consensus 7 l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~ 85 (303)
T d1vjya_ 7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 85 (303)
T ss_dssp EEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred EEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccC
Confidence 457899999999999987 6899999999765433333445666667899999999999998654 56899999999
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhC-----CCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRG-----CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-----~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
|+|.+++++. ++++..+++++.|++.||+|||+. ...+|+||||||+|||++.++.+||+|||+++......
T Consensus 86 g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~ 162 (303)
T d1vjya_ 86 GSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 162 (303)
T ss_dssp CBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTT
T ss_pred CCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCC
Confidence 9999999864 589999999999999999999973 13599999999999999999999999999999875543
Q ss_pred cce--eeecccCCccccccccccccc----CCCCccchhHHHHHHHHHHhcCCCCCCCCCcccc---------hhhHHHH
Q 040604 448 SAI--SMLHARGTIGYIAPEVYSRRF----GGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTS---------ICHNLIY 512 (582)
Q Consensus 448 ~~~--~~~~~~gt~~y~aPE~~~~~~----~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~---------~~~~~~~ 512 (582)
... ......||+.|+|||++.+.. ..++.++|||||||+||||+||..|+........ .....+.
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (303)
T d1vjya_ 163 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242 (303)
T ss_dssp TEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHH
T ss_pred cceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHH
Confidence 322 223457999999999986531 1257799999999999999999887643222111 1111122
Q ss_pred Hh-hcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 040604 513 ER-IEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSI 567 (582)
Q Consensus 513 ~~-i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~ 567 (582)
.. ......+.++.. ....+....+.+|+.+||+.||++||||.||++.|++..
T Consensus 243 ~~~~~~~~~p~~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 243 KVVCEQKLRPNIPNR--WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHHTTSCCCCCCCGG--GGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhccccCCCCCcc--cCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 22 222222222111 112345567888999999999999999999999998643
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.8e-48 Score=382.02 Aligned_cols=250 Identities=25% Similarity=0.339 Sum_probs=202.0
Q ss_pred HHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCC----------HHHHHHHHHHHhccC-CCceEEEEeEEEeCCe
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCN----------GEEFINEVASISRTS-HVNIVTFLGFCYENKK 362 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 362 (582)
|++.++||+|+||+||+|+. .+|+.||||+++..... .+.+.+|+.++++++ |||||++++++.++..
T Consensus 5 y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 84 (277)
T d1phka_ 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 84 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcc
Confidence 45678999999999999976 47999999999764322 135789999999997 9999999999999999
Q ss_pred eeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccc
Q 040604 363 NALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ 442 (582)
Q Consensus 363 ~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~ 442 (582)
.+|||||+++|+|.+++...+ .+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 85 FFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeE
Confidence 999999999999999997644 699999999999999999999998 999999999999999999999999999998
Q ss_pred ccccccceeeecccCCcccccccccccc----cCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCC
Q 040604 443 AQKKESAISMLHARGTIGYIAPEVYSRR----FGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPG 518 (582)
Q Consensus 443 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~ 518 (582)
....... ....||+.|+|||++.+. ...++.++||||+||+|+||++|+.||....... +.+.+..+
T Consensus 160 ~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~------~~~~i~~~ 230 (277)
T d1phka_ 160 LDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------MLRMIMSG 230 (277)
T ss_dssp CCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHT
T ss_pred ccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH------HHHHHHhC
Confidence 7654332 235699999999998632 1346889999999999999999999998654322 12222221
Q ss_pred CCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 519 NDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
.. .+. ......+...+.+++.+||+.||++|||++||++.
T Consensus 231 ~~-~~~---~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 231 NY-QFG---SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp CC-CCC---TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CC-CCC---CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11 011 01112344567788899999999999999998753
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-48 Score=389.57 Aligned_cols=258 Identities=24% Similarity=0.410 Sum_probs=209.0
Q ss_pred HHHHhhhhcCccCceEEEEEEeC------CCcEEEEEEeccCCCCH--HHHHHHHHHHhccCCCceEEEEeEEEeCCeee
Q 040604 293 MTKSFRDKLGQGGYGEVYKGELP------DGQLVAVKVLKNSRCNG--EEFINEVASISRTSHVNIVTFLGFCYENKKNA 364 (582)
Q Consensus 293 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 364 (582)
..+++.++||+|+||+||+|.+. +++.||||+++...... ..|.+|+.++++++|||||+++|++...+..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 34456789999999999999653 35789999997654332 45889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcC--------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEee
Q 040604 365 LIYELMPNGSLDKFIHND--------RNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISD 436 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~--------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~D 436 (582)
+||||+++|+|.+++... ....+++..+.+++.|+++||.|||+. +|+||||||+|||+++++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEee
Confidence 999999999999988643 123478999999999999999999998 999999999999999999999999
Q ss_pred ccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCC-CCCCCCcccchhhHHHHHhh
Q 040604 437 FGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTK-NLDDEVTDTSICHNLIYERI 515 (582)
Q Consensus 437 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~-p~~~~~~~~~~~~~~~~~~i 515 (582)
||+|+...............||+.|+|||.+.+ +.++.++||||||+++|||+||+. |+... .... +...+
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~--~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-~~~~-----~~~~i 248 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGL-SNEQ-----VLRFV 248 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-CHHH-----HHHHH
T ss_pred cccceeccCCcceeeccceecccccCCHHHHcc--CCCCcccccccHHHHHHHHHhCCCCCCCCC-CHHH-----HHHHH
Confidence 999997765544443444569999999999976 478999999999999999999865 55433 2221 22333
Q ss_pred cCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 040604 516 EPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIE 568 (582)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~ 568 (582)
..+..+..+.. ++..+.+|+.+||+.||++||||++|+++|++.++
T Consensus 249 ~~~~~~~~p~~-------~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 249 MEGGLLDKPDN-------CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HTTCCCCCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HhCCCCCCccc-------chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 34333322222 23467888889999999999999999999998766
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=379.95 Aligned_cols=253 Identities=25% Similarity=0.389 Sum_probs=192.7
Q ss_pred HHhhhhcCccCceEEEEEEeC--CC--cEEEEEEeccCCC----CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP--DG--QLVAVKVLKNSRC----NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALI 366 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 366 (582)
+++.++||+|+||+||+|++. ++ ..||||+++.... ..+.|.+|+.+|++++|||||+++|++.+ ...++|
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhee
Confidence 456789999999999999653 33 4789999875432 23578999999999999999999999965 567899
Q ss_pred EEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccc
Q 040604 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~ 446 (582)
|||+++|+|.+++.... ..+++..+++++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp EECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 99999999998877543 3699999999999999999999998 9999999999999999999999999999987654
Q ss_pred ccce-eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhc-CCCCCCCCCcccchhhHHHHHhhcCCCCCCCC
Q 040604 447 ESAI-SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVG-CTKNLDDEVTDTSICHNLIYERIEPGNDFQFD 524 (582)
Q Consensus 447 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 524 (582)
.... ......||..|+|||++.+ ..++.++|||||||++|||+| |+.||....... .+......+..+...
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~-----~~~~i~~~~~~~~~~ 237 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-----ILHKIDKEGERLPRP 237 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHHHTSCCCCCCC
T ss_pred CCcceecCccccCcccCCHHHHhC--CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH-----HHHHHHhCCCCCCCc
Confidence 3332 2233458889999999987 478999999999999999998 788986543322 122222333222222
Q ss_pred CcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 040604 525 GVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGS 566 (582)
Q Consensus 525 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~ 566 (582)
.. ++..+.+|+.+||+.||++||||+||++.|+++
T Consensus 238 ~~-------~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 238 ED-------CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp TT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cc-------ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 22 234577888999999999999999999999863
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.6e-47 Score=387.78 Aligned_cols=242 Identities=21% Similarity=0.286 Sum_probs=201.4
Q ss_pred HHHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccC----CCCHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEE
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNS----RCNGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 368 (582)
.+++.++||+|+||+||+|... +|+.||||++++. ....+.+.+|+.+|++++|||||++++++.+....++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 4566789999999999999764 7999999998642 3345778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
|+.+|+|..++...+ .+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 122 ~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~ 196 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196 (350)
T ss_dssp CCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred cccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccccc
Confidence 999999999987654 689999999999999999999998 999999999999999999999999999998754332
Q ss_pred ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc
Q 040604 449 AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528 (582)
Q Consensus 449 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 528 (582)
...||+.|||||++.+. .++.++|||||||++|||++|+.||....... +...+..+. ..++..
T Consensus 197 -----~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~i~~~~-~~~p~~-- 260 (350)
T d1rdqe_ 197 -----TLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSGK-VRFPSH-- 260 (350)
T ss_dssp -----CCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC-CCCCTT--
T ss_pred -----cccCccccCCHHHHcCC--CCCccccccchhHHHHHHHhCCCCCCCcCHHH------HHHHHhcCC-CCCCcc--
Confidence 34699999999999874 68999999999999999999999997643221 222222221 112222
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERP-----SMHKVLE 561 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~ 561 (582)
+...+.+++.+||+.||++|+ |++++++
T Consensus 261 -----~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 261 -----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -----CCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 234567788889999999994 8999985
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.5e-47 Score=381.10 Aligned_cols=255 Identities=21% Similarity=0.296 Sum_probs=197.6
Q ss_pred HHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCC----HHHHHHHHHHHhccCCCceEEEEeEEEeCC----eeeE
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCN----GEEFINEVASISRTSHVNIVTFLGFCYENK----KNAL 365 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l 365 (582)
|++.+.||+|+||+||+|.. .+|+.||||+++..... .+.+.+|+.++++++|||||++++++.... ..++
T Consensus 9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l 88 (277)
T d1o6ya_ 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence 55678999999999999975 47999999999765432 246889999999999999999999997644 3789
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
||||++|++|.+++...+ .+++.+++.|+.||+.||+|||+. +|+||||||+|||++.++.++|+|||.++....
T Consensus 89 vmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 89 VMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhcc
Confidence 999999999999887644 689999999999999999999998 999999999999999999999999999876544
Q ss_pred ccc-ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCC
Q 040604 446 KES-AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFD 524 (582)
Q Consensus 446 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 524 (582)
... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... .....+........
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-----~~~~~~~~~~~~~~- 235 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-----VAYQHVREDPIPPS- 235 (277)
T ss_dssp ---------------TTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHCCCCCGG-
T ss_pred ccccccccccccCcccccCHHHHcC--CCCCcceecccchHHHHHHHhCCCCCCCcCHHH-----HHHHHHhcCCCCCc-
Confidence 322 122334569999999999976 478999999999999999999999997643322 22233333221110
Q ss_pred CcCcHHHHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhcc
Q 040604 525 GVATEEEKKIAKMMILVGFWCIQTNPSERP-SMHKVLEMLEGS 566 (582)
Q Consensus 525 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-t~~evl~~Le~~ 566 (582)
.....++..+.+++.+||+.||++|| |++++++.|.+.
T Consensus 236 ----~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 236 ----ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp ----GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ----hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 00112345677888899999999999 899999998764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=382.92 Aligned_cols=253 Identities=25% Similarity=0.315 Sum_probs=194.2
Q ss_pred hhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC------HHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 299 DKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN------GEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
++||+|+||+||+|... +|+.||||+++..... .+.+.+|+.+|++++|||||++++++.++...++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 67999999999999764 7999999998654322 2468899999999999999999999999999999999998
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
++++..++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+........
T Consensus 84 ~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-- 156 (299)
T d1ua2a_ 84 TDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-- 156 (299)
T ss_dssp EEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC--
T ss_pred chHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc--
Confidence 88777666533 4688889999999999999999998 9999999999999999999999999999876554322
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCC----------
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDF---------- 521 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~---------- 521 (582)
.....||+.|+|||++... ..++.++|||||||++|||++|+.||........ .. .+.+.+......
T Consensus 157 ~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-l~-~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LT-RIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HH-HHHHHHCCCCTTTSSSTTSSTT
T ss_pred ccceecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH-HH-HHHHhcCCCChhhccchhccch
Confidence 1234699999999998653 4679999999999999999999999876533221 11 111111111000
Q ss_pred --CCCCcCcHHH----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 522 --QFDGVATEEE----KKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 522 --~~~~~~~~~~----~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.+........ ..+...+.+|+.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000000001 123456788999999999999999999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-46 Score=387.27 Aligned_cols=246 Identities=27% Similarity=0.317 Sum_probs=196.9
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCC----CCHHHHHH---HHHHHhccCCCceEEEEeEEEeCCeeeEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSR----CNGEEFIN---EVASISRTSHVNIVTFLGFCYENKKNALI 366 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~lv 366 (582)
|++.+.||+|+||+||+|... +|+.||||++.+.. .....+.+ |+.+++.++|||||++++++.+.+..++|
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence 456689999999999999765 79999999986432 22333444 46777888999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccc
Q 040604 367 YELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKK 446 (582)
Q Consensus 367 ~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~ 446 (582)
|||++||+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 mE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp ECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 99999999999997643 688999999999999999999998 9999999999999999999999999999977654
Q ss_pred ccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCc
Q 040604 447 ESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGV 526 (582)
Q Consensus 447 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 526 (582)
.. ....||+.|+|||++... ..++.++|||||||+||||++|+.||........ ..+...+... ...++..
T Consensus 161 ~~----~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~~~~~~~~-~~~~~~~ 231 (364)
T d1omwa3 161 KP----HASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMTLTM-AVELPDS 231 (364)
T ss_dssp CC----CSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH---HHHHHHSSSC-CCCCCSS
T ss_pred cc----cccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhcccC-CCCCCCC
Confidence 32 234699999999998653 3689999999999999999999999976543321 1122222221 2222222
Q ss_pred CcHHHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 040604 527 ATEEEKKIAKMMILVGFWCIQTNPSERPS-----MHKVLE 561 (582)
Q Consensus 527 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~evl~ 561 (582)
. ...+.+|+.+||+.||++||| ++|+++
T Consensus 232 ~-------s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 232 F-------SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp S-------CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred C-------CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 2 345677888899999999999 688874
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-47 Score=384.43 Aligned_cols=243 Identities=25% Similarity=0.330 Sum_probs=199.1
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccC----CCCHHHHHHHHHHHh-ccCCCceEEEEeEEEeCCeeeEEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNS----RCNGEEFINEVASIS-RTSHVNIVTFLGFCYENKKNALIYE 368 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv~E 368 (582)
+++.++||+|+||+||+|... +|+.||||++++. ....+.+..|..++. .++|||||++++++.++...++|||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence 456789999999999999765 7999999999642 334566777877765 6899999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccc
Q 040604 369 LMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKES 448 (582)
Q Consensus 369 ~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~ 448 (582)
|+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 84 y~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 84 YLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred ecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 999999999997644 688999999999999999999998 999999999999999999999999999987654433
Q ss_pred ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCCCcCc
Q 040604 449 AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFDGVAT 528 (582)
Q Consensus 449 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 528 (582)
. .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... +...+..+. +.++..
T Consensus 159 ~--~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i~~~~-~~~p~~-- 225 (320)
T d1xjda_ 159 K--TNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------LFHSIRMDN-PFYPRW-- 225 (320)
T ss_dssp C--BCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC-CCCCTT--
T ss_pred c--ccccCCCCCcCCHHHHcC--CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHHcCC-CCCCcc--
Confidence 2 223569999999999987 478999999999999999999999997653322 222232221 222222
Q ss_pred HHHHHHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 040604 529 EEEKKIAKMMILVGFWCIQTNPSERPSMH-KVL 560 (582)
Q Consensus 529 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~-evl 560 (582)
+...+.+|+.+||+.||++|||++ +|+
T Consensus 226 -----~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 226 -----LEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp -----SCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -----CCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 234567788889999999999995 675
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=377.80 Aligned_cols=259 Identities=24% Similarity=0.325 Sum_probs=198.4
Q ss_pred HHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
|.+.++||+|+||+||+|.. .+|+.||||+++.... ..+.+.+|+.+|++++|||||++++++.++...++||||+
T Consensus 4 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~ 83 (298)
T d1gz8a_ 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 83 (298)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeec
Confidence 34568999999999999976 5799999999965432 3467899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
. +.+..++.......+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+........
T Consensus 84 ~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~- 158 (298)
T d1gz8a_ 84 H-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT- 158 (298)
T ss_dssp S-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC-
T ss_pred C-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCccc-
Confidence 5 5555555544556799999999999999999999998 9999999999999999999999999999876543322
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCC----------
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND---------- 520 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~---------- 520 (582)
.....||+.|+|||.+... ...+.++||||+||++|||++|+.||........ ..... ........
T Consensus 159 -~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~-~~~i~-~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 159 -YTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRIF-RTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp -TTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHH-HHHCCCCTTTSTTGGGST
T ss_pred -ceeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCHHHH-HHHHH-HhcCCCchhhcccccccc
Confidence 2234699999999988764 4568999999999999999999999976533221 11111 11111000
Q ss_pred ---CCCCCcCc----HHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 521 ---FQFDGVAT----EEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 521 ---~~~~~~~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
..+..... .....+...+.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000000 0111234567888999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.1e-46 Score=372.50 Aligned_cols=257 Identities=25% Similarity=0.310 Sum_probs=197.5
Q ss_pred HHhhhhcCccCceEEEEEEeCCCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEecC
Q 040604 295 KSFRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELMP 371 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 371 (582)
|++.++||+|+||+||+|.+++|+.||||+++.... ..+.+.+|+.+|++++|||||++++++.+.+..+++||++.
T Consensus 4 Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~ 83 (286)
T d1ob3a_ 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (286)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred ceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeeh
Confidence 445688999999999999988999999999965432 34679999999999999999999999999999999999997
Q ss_pred CCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccccccccee
Q 040604 372 NGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAIS 451 (582)
Q Consensus 372 ~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 451 (582)
++.+..+.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|.........
T Consensus 84 ~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~-- 156 (286)
T d1ob3a_ 84 QDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-- 156 (286)
T ss_dssp EEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred hhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCccc--
Confidence 77776666543 4799999999999999999999998 9999999999999999999999999999876543222
Q ss_pred eecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCC-----------
Q 040604 452 MLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND----------- 520 (582)
Q Consensus 452 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~----------- 520 (582)
.....||+.|+|||.+.+. ..++.++|||||||+++||++|+.||........ .... ...+.....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~-~~~i-~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRI-FRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp -----CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHH-HHHHCCCCTTTSTTGGGSTT
T ss_pred cceecccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH-HHHH-HHhhCCCChhhccchhhhhh
Confidence 1234599999999998764 4679999999999999999999999976543221 1111 111111000
Q ss_pred --CCCC---Cc-CcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 521 --FQFD---GV-ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 521 --~~~~---~~-~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
..+. .. .......+...+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 00 00111123456778899999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-46 Score=368.84 Aligned_cols=237 Identities=24% Similarity=0.337 Sum_probs=191.5
Q ss_pred HHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCC-------HHHHHHHHHHHhccC--CCceEEEEeEEEeCCeee
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCN-------GEEFINEVASISRTS--HVNIVTFLGFCYENKKNA 364 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~ 364 (582)
|.+.++||+|+||+||+|.. .+|+.||||+++..... ...+.+|+.+|++++ |||||++++++.+.+..+
T Consensus 6 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~ 85 (273)
T d1xwsa_ 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 85 (273)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEE
Confidence 45678999999999999976 47999999998754321 234678999999987 899999999999999999
Q ss_pred EEEEecCC-CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-CCceEEeecccccc
Q 040604 365 LIYELMPN-GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE-DFCPKISDFGLAKQ 442 (582)
Q Consensus 365 lv~E~~~~-gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~-~~~vkl~DFGla~~ 442 (582)
+||||+.+ +++.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+|+.
T Consensus 86 lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 86 LILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccccee
Confidence 99999976 57777776543 689999999999999999999998 9999999999999985 47999999999987
Q ss_pred ccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCC
Q 040604 443 AQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQ 522 (582)
Q Consensus 443 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~ 522 (582)
...... ....||+.|+|||++.+. ..++.++|||||||++|||++|+.||..... .. ... ..
T Consensus 161 ~~~~~~----~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------i~----~~~--~~ 222 (273)
T d1xwsa_ 161 LKDTVY----TDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------II----RGQ--VF 222 (273)
T ss_dssp CCSSCB----CCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HH----HCC--CC
T ss_pred cccccc----cccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCCchH-------Hh----hcc--cC
Confidence 544321 235699999999998764 3456789999999999999999999965311 11 111 11
Q ss_pred CCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 523 FDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 523 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
+.... ...+.+++.+||+.||++|||++|+++
T Consensus 223 ~~~~~-------s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 223 FRQRV-------SSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CSSCC-------CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCC-------CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 22222 345677888899999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=365.28 Aligned_cols=258 Identities=25% Similarity=0.330 Sum_probs=191.9
Q ss_pred HHHhhhhcCccCceEEEEEEeC--CCcEEEEEEeccCC---CCHHHHHHHHHHHhcc---CCCceEEEEeEEEe-----C
Q 040604 294 TKSFRDKLGQGGYGEVYKGELP--DGQLVAVKVLKNSR---CNGEEFINEVASISRT---SHVNIVTFLGFCYE-----N 360 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~ 360 (582)
.|++.++||+|+||+||+|.+. +++.||||+++... .....+.+|+.+|+.+ +||||+++++++.. .
T Consensus 8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~ 87 (305)
T d1blxa_ 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 87 (305)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccC
Confidence 3456789999999999999763 46789999986432 2234567788777665 79999999999863 2
Q ss_pred CeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccc
Q 040604 361 KKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLA 440 (582)
Q Consensus 361 ~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla 440 (582)
...+++|||+.++.+..... .....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 88 TKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp EEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred ceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhh
Confidence 46789999998776654443 3445789999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCC
Q 040604 441 KQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND 520 (582)
Q Consensus 441 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~ 520 (582)
+........ ....||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... .+.. +.+.+.....
T Consensus 164 ~~~~~~~~~---~~~~gT~~Y~APE~~~~--~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~-i~~~~~~~~~ 236 (305)
T d1blxa_ 164 RIYSFQMAL---TSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGK-ILDVIGLPGE 236 (305)
T ss_dssp CCCCGGGGG---CCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHH-HHHHHCCCCG
T ss_pred hhhcccccC---CCcccChhhcCcchhcC--CCCChhehhhchHHHHHHHHHCCCCCCCCCHHH-HHHH-HHHhhCCCch
Confidence 876544332 24569999999999976 478999999999999999999999997654322 1111 1111111000
Q ss_pred CC-----------CC----CcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 521 FQ-----------FD----GVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 521 ~~-----------~~----~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
.. +. .........+...+.+|+.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 00 00000111233556778889999999999999999863
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=359.48 Aligned_cols=261 Identities=20% Similarity=0.271 Sum_probs=192.0
Q ss_pred HHHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEe--------CC
Q 040604 294 TKSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYE--------NK 361 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~~ 361 (582)
+|++.++||+|+||+||+|.+ .+|+.||||++..... ..+.+.+|+.+|++++||||+++++++.. ..
T Consensus 11 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~ 90 (318)
T d3blha1 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 90 (318)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------
T ss_pred CEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCc
Confidence 345678999999999999976 4899999999865432 34678999999999999999999999865 34
Q ss_pred eeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccc
Q 040604 362 KNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAK 441 (582)
Q Consensus 362 ~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~ 441 (582)
..++||||+.++.+..+... ...+++..++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 91 SIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred eEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceee
Confidence 57899999977766655443 34688899999999999999999998 99999999999999999999999999998
Q ss_pred cccccccc--eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCC
Q 040604 442 QAQKKESA--ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGN 519 (582)
Q Consensus 442 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~ 519 (582)
........ .......||+.|+|||++.+. ..++.++||||+||++|||++|+.||........ ...+.+.+....
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~ 242 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ--LALISQLCGSIT 242 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCC
T ss_pred ecccccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH--HHHHHHhcCCCC
Confidence 76543221 112234699999999998764 4689999999999999999999999975432221 111112111111
Q ss_pred CCCC---------------CCcCcHHHH-----HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 520 DFQF---------------DGVATEEEK-----KIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 520 ~~~~---------------~~~~~~~~~-----~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
.... ......... .....+.+|+.+||+.||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0000 000000111 112356788999999999999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=363.91 Aligned_cols=259 Identities=21% Similarity=0.269 Sum_probs=193.3
Q ss_pred HHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCC--HHHHHHHHHHHhccCCCceEEEEeEEEeCC----eeeEEE
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCN--GEEFINEVASISRTSHVNIVTFLGFCYENK----KNALIY 367 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 367 (582)
|++.++||+|+||+||+|.. .+|+.||||++++.... .+.+.+|+.+|++++||||+++++++.... ..++++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence 44568999999999999975 58999999999764432 357889999999999999999999997643 234555
Q ss_pred EecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccc
Q 040604 368 ELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 368 E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~ 447 (582)
+++.+|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 90 ~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 90 THLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 667799999999754 589999999999999999999998 99999999999999999999999999998765543
Q ss_pred cce-eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCC-------
Q 040604 448 SAI-SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGN------- 519 (582)
Q Consensus 448 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~------- 519 (582)
... ......||+.|+|||++... ..++.++||||+||+++||++|+.||......... .. ....+....
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~-~~-~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL-NH-ILGILGSPSQEDLNCI 240 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HH-HHHHHCSCCHHHHHTC
T ss_pred ccceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH-HH-HhhhccCCChhhhhhh
Confidence 321 22345699999999998654 46789999999999999999999999765332111 00 000000000
Q ss_pred -----------CCCCCCc-CcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 520 -----------DFQFDGV-ATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 520 -----------~~~~~~~-~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
....... .......+...+.+|+.+||+.||++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000 000011223457788999999999999999999974
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=364.61 Aligned_cols=254 Identities=22% Similarity=0.299 Sum_probs=191.9
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCC---HHHHHHHHHHHhccCCCceEEEEeEEEeCC------eee
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCN---GEEFINEVASISRTSHVNIVTFLGFCYENK------KNA 364 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~ 364 (582)
|.+.++||+|+||+||+|... +|+.||||+++..... .+.+.+|+.+|++++|||||++++++...+ ..+
T Consensus 20 Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 99 (346)
T d1cm8a_ 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 99 (346)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEE
Confidence 456688999999999999764 7999999999765433 346889999999999999999999998654 468
Q ss_pred EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccc
Q 040604 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~ 444 (582)
+||||+ +.+|..+++.. .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+|+...
T Consensus 100 lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 100 LVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp EEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceeccC
Confidence 999999 77888877643 599999999999999999999998 99999999999999999999999999998765
Q ss_pred ccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHH-------------
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLI------------- 511 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~------------- 511 (582)
... ....||+.|+|||++.+. ..++.++||||+||+++||++|+.||........ .....
T Consensus 173 ~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 173 SEM-----TGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp SSC-----CSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHT
T ss_pred Ccc-----ccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHHH-HHHHHhccCCCcHHHHhh
Confidence 433 235699999999998764 4678999999999999999999999976533221 00000
Q ss_pred ---------HHhhcCCCCCCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--Hhcc
Q 040604 512 ---------YERIEPGNDFQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM--LEGS 566 (582)
Q Consensus 512 ---------~~~i~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~--Le~~ 566 (582)
...+.......+... ...+...+.+|+.+||+.||++|||++|+++. |++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFASI----LTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGT----CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hcchhhhhhhccCCcccccchHHh----ccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 000001000001100 11223456778889999999999999999975 5553
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-44 Score=356.50 Aligned_cols=258 Identities=20% Similarity=0.260 Sum_probs=201.2
Q ss_pred HHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCC---CHHHHHHHHHHHhccCCCceEEEEeEEEeCCeeeEEEEec
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRC---NGEEFINEVASISRTSHVNIVTFLGFCYENKKNALIYELM 370 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 370 (582)
|++.++||+|+||+||+|++ .+|+.||||+++.... ..+.+.+|+.+|++++||||+++++++.+....++|||++
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~ 83 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeec
Confidence 45568999999999999976 4789999999975443 2467899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccccccce
Q 040604 371 PNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQKKESAI 450 (582)
Q Consensus 371 ~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 450 (582)
.+++|..++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.|+.........
T Consensus 84 ~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~ 158 (292)
T d1unla_ 84 DQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp SEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred cccccccccccc--cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence 999998887654 3688999999999999999999998 99999999999999999999999999999876543322
Q ss_pred eeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCC----------
Q 040604 451 SMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND---------- 520 (582)
Q Consensus 451 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~---------- 520 (582)
....+++.|+|||.+... ..++.++||||+||+++||++|+.|+.............. ........
T Consensus 159 --~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 159 --SAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF-RLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp --CSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHH-HHHCCCCTTTCTTGGGST
T ss_pred --eeeccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHH-hhcCCCChhhhhhhhhcc
Confidence 233588899999998764 4578999999999999999999999865544332222111 11111000
Q ss_pred -------CCCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 521 -------FQFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 521 -------~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.............+...+.+|+.+||+.||.+||||+||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000001111223455677888999999999999999876
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-44 Score=368.40 Aligned_cols=255 Identities=24% Similarity=0.300 Sum_probs=189.9
Q ss_pred HhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCceEEEEeEEEeC------CeeeEEEE
Q 040604 296 SFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNIVTFLGFCYEN------KKNALIYE 368 (582)
Q Consensus 296 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv~E 368 (582)
+..++||+|+||+||+|++. +|+.||||+++.... .+.+|+.+|++++|+||+++++++... .+.+||||
T Consensus 23 ~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E 99 (350)
T d1q5ka_ 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99 (350)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred EeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence 34578999999999999765 799999999976543 234799999999999999999998643 24689999
Q ss_pred ecCCCChhhhhhc-CCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-ceEEeecccccccccc
Q 040604 369 LMPNGSLDKFIHN-DRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF-CPKISDFGLAKQAQKK 446 (582)
Q Consensus 369 ~~~~gsL~~~i~~-~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~-~vkl~DFGla~~~~~~ 446 (582)
|++++.+..+... .....+++..++.++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++.....
T Consensus 100 y~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~ 176 (350)
T d1q5ka_ 100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176 (350)
T ss_dssp CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred ccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence 9976644444332 2345799999999999999999999998 999999999999999775 8999999999887654
Q ss_pred ccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHH-----------HHHhh
Q 040604 447 ESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNL-----------IYERI 515 (582)
Q Consensus 447 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~-----------~~~~i 515 (582)
.... ...||+.|+|||.+.+. ..++.++||||+||++|||++|+.||........ +... +....
T Consensus 177 ~~~~---~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~-l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 177 EPNV---SYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp SCCC---SCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHHHC
T ss_pred cccc---cccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHHH-HHHHHHHhCCChHHhhhhhc
Confidence 4332 34699999999988654 4689999999999999999999999976543221 1111 11110
Q ss_pred cCCCCCCCCCcC-----cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 516 EPGNDFQFDGVA-----TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 516 ~~~~~~~~~~~~-----~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
.......+.... ..........+.+|+.+||+.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000001111000 0001123445778888999999999999999985
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.3e-44 Score=357.43 Aligned_cols=262 Identities=18% Similarity=0.227 Sum_probs=203.8
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCHHHHHHHHHHHhccCC-CceEEEEeEEEeCCeeeEEEEecCC
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNGEEFINEVASISRTSH-VNIVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
|.+.++||+|+||+||+|.+. +|+.||||++.... ..+.+.+|+.+++.+.| +|++.+++++.++...++||||+ +
T Consensus 7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~ 84 (293)
T d1csna_ 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-G 84 (293)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-C
Confidence 456789999999999999765 79999999986543 33457788999999876 89999999999999999999999 8
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-----CCceEEeeccccccccccc
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE-----DFCPKISDFGLAKQAQKKE 447 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~-----~~~vkl~DFGla~~~~~~~ 447 (582)
++|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+|+......
T Consensus 85 ~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 85 PSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp CBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred CCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 99999887543 4689999999999999999999998 9999999999999974 5789999999998765432
Q ss_pred cc-----eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchh-hHHHHHhhcCCCCC
Q 040604 448 SA-----ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSIC-HNLIYERIEPGNDF 521 (582)
Q Consensus 448 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~-~~~~~~~i~~~~~~ 521 (582)
.. .......||+.|||||++.+. .++.++|||||||++|||++|+.||.......... ...+.+......
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~--~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~-- 236 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP-- 236 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC--
T ss_pred cccceeecccCceEEchhhcCHHHhcCC--CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC--
Confidence 21 112235699999999999874 78999999999999999999999997654433211 111111100000
Q ss_pred CCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCC
Q 040604 522 QFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSIENLQ 571 (582)
Q Consensus 522 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~~~~~ 571 (582)
. .+....+++.+.+++..|++.+|++||+++.+.+.|+..++...
T Consensus 237 -~----~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 237 -L----RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp -H----HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred -h----HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 0 00011234567778888999999999999999998887665443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.8e-44 Score=358.61 Aligned_cols=257 Identities=19% Similarity=0.223 Sum_probs=194.3
Q ss_pred HHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCc-eEEEEeEEEeCCeeeEEEEecCC
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVN-IVTFLGFCYENKKNALIYELMPN 372 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~E~~~~ 372 (582)
|++.++||+|+||+||+|.+ .+|+.||||++..... .+++..|+.++++++|+| |+.+.++..+....++||||+ +
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~ 86 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G 86 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-C
Confidence 55678999999999999976 4799999999876443 345788999999998776 455566667788889999999 6
Q ss_pred CChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---CCceEEeeccccccccccccc
Q 040604 373 GSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDE---DFCPKISDFGLAKQAQKKESA 449 (582)
Q Consensus 373 gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~---~~~vkl~DFGla~~~~~~~~~ 449 (582)
++|...+... ...+++..+..++.|++.||+|||++ +|+||||||+|||++. +..+||+|||+|+........
T Consensus 87 ~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 87 PSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp CBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred Cchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 7776666543 34699999999999999999999998 9999999999999864 557999999999986543322
Q ss_pred -----eeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchh--hHHHHHhhcCCCCCC
Q 040604 450 -----ISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSIC--HNLIYERIEPGNDFQ 522 (582)
Q Consensus 450 -----~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~--~~~~~~~i~~~~~~~ 522 (582)
.......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.......... ...........
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~---- 236 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP---- 236 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTTB--CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC----
T ss_pred cceeccccCCcCCCccccCHHHHhCC--CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC----
Confidence 112234699999999999874 68999999999999999999999997654433211 11111111100
Q ss_pred CCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 040604 523 FDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEMLEGSI 567 (582)
Q Consensus 523 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~Le~~~ 567 (582)
.......++..+.+++.+||+.+|++||+++++.+.|+...
T Consensus 237 ----~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 237 ----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp ----HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred ----hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 00011123456778888999999999999999988887643
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=357.13 Aligned_cols=251 Identities=23% Similarity=0.285 Sum_probs=199.3
Q ss_pred HHhhhhcCccCceEEEEEEeC----CCcEEEEEEeccCC-----CCHHHHHHHHHHHhccCC-CceEEEEeEEEeCCeee
Q 040604 295 KSFRDKLGQGGYGEVYKGELP----DGQLVAVKVLKNSR-----CNGEEFINEVASISRTSH-VNIVTFLGFCYENKKNA 364 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~ 364 (582)
|++.++||+|+||+||+|... +|+.||||+++... ...+.+.+|+.++++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 567789999999999999642 58899999986432 245678899999999976 89999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccc
Q 040604 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~ 444 (582)
++|||+.+|+|.+++...+ .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+...
T Consensus 106 ~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred eeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 9999999999999997654 567889999999999999999998 99999999999999999999999999998765
Q ss_pred ccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCCCCCC
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGNDFQFD 524 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 524 (582)
....... ....||+.|+|||.+......++.++|||||||+||||++|+.||........ ............ ..++
T Consensus 181 ~~~~~~~-~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-~~~i~~~~~~~~--~~~~ 256 (322)
T d1vzoa_ 181 ADETERA-YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILKSE--PPYP 256 (322)
T ss_dssp GGGGGGG-CGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHHCC--CCCC
T ss_pred ccccccc-cccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcccCC--CCCc
Confidence 5433322 23569999999999976544678899999999999999999999976644332 111111111111 1111
Q ss_pred CcCcHHHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 040604 525 GVATEEEKKIAKMMILVGFWCIQTNPSERP-----SMHKVLE 561 (582)
Q Consensus 525 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~evl~ 561 (582)
. .+...+.+++.+||+.||++|| |++|+++
T Consensus 257 ~-------~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 257 Q-------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp T-------TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred c-------cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 1 2345667788889999999999 4788886
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.3e-43 Score=357.43 Aligned_cols=254 Identities=19% Similarity=0.273 Sum_probs=196.0
Q ss_pred HHHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCCHHHHHHHHHHHhccC-CCceEEEEeEEEeC--CeeeEEEEe
Q 040604 294 TKSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNGEEFINEVASISRTS-HVNIVTFLGFCYEN--KKNALIYEL 369 (582)
Q Consensus 294 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~E~ 369 (582)
.+++.++||+|+||+||+|.. .+|+.||||+++.. ..+.+.+|+.+|++++ ||||+++++++... ...++||||
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~ 113 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence 456778999999999999976 47999999999754 4678899999999995 99999999999754 468899999
Q ss_pred cCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-ceEEeecccccccccccc
Q 040604 370 MPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF-CPKISDFGLAKQAQKKES 448 (582)
Q Consensus 370 ~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~-~vkl~DFGla~~~~~~~~ 448 (582)
+.+++|..+.+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+.......
T Consensus 114 ~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~ 185 (328)
T d3bqca1 114 VNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185 (328)
T ss_dssp CCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC
T ss_pred cCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCCc
Confidence 99999987643 589999999999999999999998 999999999999998654 699999999987765433
Q ss_pred ceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHH-----------HHhhcC
Q 040604 449 AISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLI-----------YERIEP 517 (582)
Q Consensus 449 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~-----------~~~i~~ 517 (582)
. ....||+.|+|||.+.+. ..++.++||||+||+++||++|+.||.............. ......
T Consensus 186 ~---~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 186 Y---NVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp C---CSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred c---cccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 2 234699999999998764 4579999999999999999999999976544322111000 000000
Q ss_pred CCC------------CCCCC-cCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 518 GND------------FQFDG-VATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 518 ~~~------------~~~~~-~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
... ..... ........+...+.+|+.+||+.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00000 001111223456778899999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-42 Score=352.51 Aligned_cols=253 Identities=21% Similarity=0.260 Sum_probs=191.4
Q ss_pred HHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCCH---HHHHHHHHHHhccCCCceEEEEeEEEeC-----CeeeE
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNG---EEFINEVASISRTSHVNIVTFLGFCYEN-----KKNAL 365 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~l 365 (582)
|++.++||+|+||+||+|.. .+|+.||||+++...... +.+.+|+.+|++++|||||++++++... ...++
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 99 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence 45668999999999999975 479999999997654433 4678999999999999999999998643 34567
Q ss_pred EEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeeccccccccc
Q 040604 366 IYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQK 445 (582)
Q Consensus 366 v~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~~ 445 (582)
+||++.+|+|.+++..+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++.....
T Consensus 100 i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 100 LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp EEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred EEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccCc
Confidence 77888899999999653 599999999999999999999998 999999999999999999999999999987654
Q ss_pred cccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHHHHHhhcCCCC-----
Q 040604 446 KESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNLIYERIEPGND----- 520 (582)
Q Consensus 446 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~i~~~~~----- 520 (582)
... ...||+.|+|||.+.+. ..++.++|||||||++|+|++|+.||........ ...+.........
T Consensus 174 ~~~-----~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~--~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 174 EMT-----GYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ--LKLILRLVGTPGAELLKK 245 (348)
T ss_dssp GGS-----SSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCHHHHTT
T ss_pred ccc-----cccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCChHHhhh
Confidence 332 34599999999987664 4578999999999999999999999976532211 1111111110000
Q ss_pred -------------CCCCCcC-cHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040604 521 -------------FQFDGVA-TEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLE 561 (582)
Q Consensus 521 -------------~~~~~~~-~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~ 561 (582)
....... ......+...+.+|+.+||+.||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0000000 0001123455678899999999999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=350.02 Aligned_cols=254 Identities=24% Similarity=0.270 Sum_probs=186.3
Q ss_pred HHhhhhcCccCceEEEEEEeC-CCcEEEEEEeccCCCCH---HHHHHHHHHHhccCCCceEEEEeEEEeC------Ceee
Q 040604 295 KSFRDKLGQGGYGEVYKGELP-DGQLVAVKVLKNSRCNG---EEFINEVASISRTSHVNIVTFLGFCYEN------KKNA 364 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 364 (582)
|++.++||+|+||+||+|.+. +|+.||||+++...... ..+.+|+.++++++|||||++++++... ...+
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~ 98 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence 445679999999999999765 79999999997654433 4578999999999999999999999643 5779
Q ss_pred EEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeecccccccc
Q 040604 365 LIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQAQ 444 (582)
Q Consensus 365 lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~~~ 444 (582)
+||||+.++.+ +.+. ..+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+|++|||+++...
T Consensus 99 iv~Ey~~~~l~-~~~~----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 99 LVMELMDANLC-QVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp EEEECCSEEHH-HHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEeccchHHH-Hhhh----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhccc
Confidence 99999965544 4443 2589999999999999999999998 99999999999999999999999999988765
Q ss_pred ccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccchhhHH--------------
Q 040604 445 KKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTSICHNL-------------- 510 (582)
Q Consensus 445 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~-------------- 510 (582)
..... ....||+.|+|||++.+. .++.++||||+||+++||++|+.||........ ....
T Consensus 171 ~~~~~---~~~~~t~~y~aPE~l~~~--~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~-~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 171 TSFMM---TPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp -------------CCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHTT
T ss_pred ccccc---ccccccccccChhhhcCC--CCCCCcccccccchHHHHhhCCCCCCCCCHHHH-HHHHHHhccCCCHHHHHH
Confidence 54332 234699999999999773 789999999999999999999999965432111 0000
Q ss_pred ----HHHhhcCCCCC-----------CCCCcCcHHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040604 511 ----IYERIEPGNDF-----------QFDGVATEEEKKIAKMMILVGFWCIQTNPSERPSMHKVLEM 562 (582)
Q Consensus 511 ----~~~~i~~~~~~-----------~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~evl~~ 562 (582)
..+........ ................+.+|+.+||+.||++|||++||++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00011110000 01111223344567788999999999999999999999854
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-38 Score=327.63 Aligned_cols=277 Identities=20% Similarity=0.243 Sum_probs=199.6
Q ss_pred HHhhhhcCccCceEEEEEEe-CCCcEEEEEEeccCCCCHHHHHHHHHHHhccC-----------CCceEEEEeEEEe--C
Q 040604 295 KSFRDKLGQGGYGEVYKGEL-PDGQLVAVKVLKNSRCNGEEFINEVASISRTS-----------HVNIVTFLGFCYE--N 360 (582)
Q Consensus 295 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~--~ 360 (582)
|.+.++||+|+||+||+|+. .+|+.||||++++.....+.+.+|+.++++++ |+||+++++++.. .
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~ 94 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP 94 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccc
Confidence 56779999999999999976 47999999999876555677888999888875 5789999988864 3
Q ss_pred CeeeEEEEecCCCCh-hhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC------ceE
Q 040604 361 KKNALIYELMPNGSL-DKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDF------CPK 433 (582)
Q Consensus 361 ~~~~lv~E~~~~gsL-~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~------~vk 433 (582)
...+++|+++..+.. ...........+++..+..++.||+.||+|||+. .+|+||||||+|||++.++ .+|
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~~~k 172 (362)
T d1q8ya_ 95 NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIK 172 (362)
T ss_dssp TEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred cceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccccceee
Confidence 455677777655443 3334444556789999999999999999999983 2899999999999998665 399
Q ss_pred EeeccccccccccccceeeecccCCcccccccccccccCCCCccchhHHHHHHHHHHhcCCCCCCCCCcccc-----hhh
Q 040604 434 ISDFGLAKQAQKKESAISMLHARGTIGYIAPEVYSRRFGGVSHKSDVYSYGMMIIEMVGCTKNLDDEVTDTS-----ICH 508 (582)
Q Consensus 434 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvil~elltg~~p~~~~~~~~~-----~~~ 508 (582)
++|||.|....... ....||+.|+|||++.. ..++.++||||+||+++||++|+.||........ ...
T Consensus 173 l~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 173 IADLGNACWYDEHY-----TNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp ECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred Eeeccccccccccc-----ccccccccccChhhccc--cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 99999998755432 23469999999999876 4789999999999999999999999865432211 000
Q ss_pred HHHHHhhcC------------------CCC-CCCCCc-----------CcHHHHHHHHHHHHHHHhccccCCCCCCCHHH
Q 040604 509 NLIYERIEP------------------GND-FQFDGV-----------ATEEEKKIAKMMILVGFWCIQTNPSERPSMHK 558 (582)
Q Consensus 509 ~~~~~~i~~------------------~~~-~~~~~~-----------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~e 558 (582)
..+ ..+.. ... ...... ...........+.+|+.+||+.||++|||++|
T Consensus 246 ~~~-~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 246 QII-ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHH-HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHH-HHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 000 00000 000 000000 00112345678899999999999999999999
Q ss_pred HHHH--Hhc--ccCCCCCCCCCCCCCC
Q 040604 559 VLEM--LEG--SIENLQIPPKPSLFSA 581 (582)
Q Consensus 559 vl~~--Le~--~~~~~~~p~~p~~~~~ 581 (582)
+++. ++. ..+..+.|++|...+.
T Consensus 325 ~L~Hp~f~~~~~~~~~~~p~~~~~~~~ 351 (362)
T d1q8ya_ 325 LVNHPWLKDTLGMEEIRVPDRELYGSG 351 (362)
T ss_dssp HHTCGGGTTCTTCTTCCCTTSCTTCBS
T ss_pred HhcCcccCCCCCcccCCCCCcccCCCC
Confidence 9974 553 3456677888776543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=1.5e-24 Score=201.83 Aligned_cols=162 Identities=18% Similarity=0.161 Sum_probs=120.3
Q ss_pred hhhhcCccCceEEEEEEeCCCcEEEEEEeccCCCC-------------------HHHHHHHHHHHhccCCCceEEEEeEE
Q 040604 297 FRDKLGQGGYGEVYKGELPDGQLVAVKVLKNSRCN-------------------GEEFINEVASISRTSHVNIVTFLGFC 357 (582)
Q Consensus 297 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------~~~~~~E~~~l~~l~h~niv~l~~~~ 357 (582)
+.++||+|+||+||+|...+|+.||||+++..... .....+|...+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 45789999999999998889999999987642110 12245688899999999999988663
Q ss_pred EeCCeeeEEEEecCCCChhhhhhcCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCceEEeec
Q 040604 358 YENKKNALIYELMPNGSLDKFIHNDRNIKLEWKTMYQIAIGIARGLEYLHRGCQVRIVHFDIKPQNILLDEDFCPKISDF 437 (582)
Q Consensus 358 ~~~~~~~lv~E~~~~gsL~~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ivH~Dikp~NILl~~~~~vkl~DF 437 (582)
..+++|||+++..+.+ ++.....+++.|+++||+|||+. +|+||||||+|||+++++ ++|+||
T Consensus 84 ----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~~-~~liDF 146 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEEG-IWIIDF 146 (191)
T ss_dssp ----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETTE-EEECCC
T ss_pred ----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCCC-EEEEEC
Confidence 3479999998765543 23344567899999999999998 999999999999999754 899999
Q ss_pred cccccccccccceeeecccCCccccc------ccccccccCCCCccchhHHHHHHHH
Q 040604 438 GLAKQAQKKESAISMLHARGTIGYIA------PEVYSRRFGGVSHKSDVYSYGMMII 488 (582)
Q Consensus 438 Gla~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~s~~~DvwSlGvil~ 488 (582)
|+|......... .|+. .+.+.+ .++.++|+||+.--++
T Consensus 147 G~a~~~~~~~~~----------~~l~rd~~~~~~~f~r---~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 147 PQSVEVGEEGWR----------EILERDVRNIITYFSR---TYRTEKDINSAIDRIL 190 (191)
T ss_dssp TTCEETTSTTHH----------HHHHHHHHHHHHHHHH---HHCCCCCHHHHHHHHH
T ss_pred CCcccCCCCCcH----------HHHHHHHHHHHHHHcC---CCCCcccHHHHHHHHh
Confidence 999775433211 1111 123332 5678999999765443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.29 E-value=2.9e-06 Score=80.33 Aligned_cols=131 Identities=13% Similarity=0.090 Sum_probs=90.3
Q ss_pred cCceEEEEEEeCCCcEEEEEEeccC-CCCHHHHHHHHHHHhccC-CCceEEEEeEEEeCCeeeEEEEecCCCChhhhhhc
Q 040604 304 GGYGEVYKGELPDGQLVAVKVLKNS-RCNGEEFINEVASISRTS-HVNIVTFLGFCYENKKNALIYELMPNGSLDKFIHN 381 (582)
Q Consensus 304 G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~i~~ 381 (582)
++.+.||+... ++..+++|+.... ......+.+|...+..+. +--+.+++.+..+++..++|||+++|.++.+....
T Consensus 25 ~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~ 103 (263)
T d1j7la_ 25 MSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED 103 (263)
T ss_dssp CSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred CCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence 33468998865 5556777877543 334456778888887764 33467788888888889999999999888655422
Q ss_pred CCCcCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------------
Q 040604 382 DRNIKLEWKTMYQIAIGIARGLEYLHRGC--------------------------------------------------- 410 (582)
Q Consensus 382 ~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--------------------------------------------------- 410 (582)
. . ....++.++++.|..||+..
T Consensus 104 ~----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 176 (263)
T d1j7la_ 104 E----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKT 176 (263)
T ss_dssp C----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHH
T ss_pred c----c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHh
Confidence 1 1 12234555666666666321
Q ss_pred -----CCceEecCCCCCCEEEcCCCceEEeecccccc
Q 040604 411 -----QVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ 442 (582)
Q Consensus 411 -----~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~ 442 (582)
...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 177 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 177 EKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999877778999987654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.01 E-value=1.1e-05 Score=75.66 Aligned_cols=131 Identities=18% Similarity=0.136 Sum_probs=86.6
Q ss_pred hcCccCc-eEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCC--ceEEEEeEEEeCCeeeEEEEecCCCChh
Q 040604 300 KLGQGGY-GEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHV--NIVTFLGFCYENKKNALIYELMPNGSLD 376 (582)
Q Consensus 300 ~lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~~~~lv~E~~~~gsL~ 376 (582)
.+..|.. +.||+....++..+++|...... ...+..|+..++.+... .+.+++.+..++...++|||+++|.++.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 3445543 67999988888889999876543 33466777777766433 3677888888888889999999887764
Q ss_pred hhhhcCCCcCCCHHHHHHHHHHHHHHHHHHH-------------------------------------------------
Q 040604 377 KFIHNDRNIKLEWKTMYQIAIGIARGLEYLH------------------------------------------------- 407 (582)
Q Consensus 377 ~~i~~~~~~~l~~~~~~~i~~qi~~aL~yLH------------------------------------------------- 407 (582)
+.. .... +++.+++..|.-||
T Consensus 95 ~~~-------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 95 SSH-------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp TSC-------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred ccc-------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence 321 1111 11223333333333
Q ss_pred --hC----CCCceEecCCCCCCEEEcCCCceEEeecccccc
Q 040604 408 --RG----CQVRIVHFDIKPQNILLDEDFCPKISDFGLAKQ 442 (582)
Q Consensus 408 --~~----~~~~ivH~Dikp~NILl~~~~~vkl~DFGla~~ 442 (582)
+. ....++|+|+.|.|||++++..+-|+||+.+..
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 11 112489999999999999887788999987643
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.62 E-value=8.6e-05 Score=74.42 Aligned_cols=75 Identities=9% Similarity=0.064 Sum_probs=49.1
Q ss_pred hhcCccCceEEEEEEeC-CCcEEEEEEecc----C----CCCHHHHHHHHHHHhccC---CCceEEEEeEEEeCCeeeEE
Q 040604 299 DKLGQGGYGEVYKGELP-DGQLVAVKVLKN----S----RCNGEEFINEVASISRTS---HVNIVTFLGFCYENKKNALI 366 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----~----~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 366 (582)
+.||.|....||+.... +++.++||.-.. . ....+....|...|+.+. ...+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 46899999999999765 467899997432 1 112344556887776653 2346666654 55677899
Q ss_pred EEecCCCCh
Q 040604 367 YELMPNGSL 375 (582)
Q Consensus 367 ~E~~~~gsL 375 (582)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999976543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.38 E-value=0.00028 Score=68.60 Aligned_cols=134 Identities=13% Similarity=0.186 Sum_probs=80.6
Q ss_pred eEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCce--EEEE-----eEEEeCCeeeEEEEecCCCChhh--
Q 040604 307 GEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNI--VTFL-----GFCYENKKNALIYELMPNGSLDK-- 377 (582)
Q Consensus 307 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~E~~~~gsL~~-- 377 (582)
-.||++...+|+.+++|+.+......+++..|...+..|....+ +..+ .........+.++++++|..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~ 115 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN 115 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCC
Confidence 57999999899999999998877788888899988877653322 1111 12233556788999997644321
Q ss_pred ---------h---hhc----C---CCcCCCHH----------------------HHHHHHHHHHHHHHHH-HhCCCCceE
Q 040604 378 ---------F---IHN----D---RNIKLEWK----------------------TMYQIAIGIARGLEYL-HRGCQVRIV 415 (582)
Q Consensus 378 ---------~---i~~----~---~~~~l~~~----------------------~~~~i~~qi~~aL~yL-H~~~~~~iv 415 (582)
. ++. . .....++. ....++.++...+.-+ .+....++|
T Consensus 116 ~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~li 195 (325)
T d1zyla1 116 IDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRL 195 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEEC
T ss_pred HHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceee
Confidence 0 010 0 00111111 1122222333222221 122245799
Q ss_pred ecCCCCCCEEEcCCCceEEeecccccc
Q 040604 416 HFDIKPQNILLDEDFCPKISDFGLAKQ 442 (582)
Q Consensus 416 H~Dikp~NILl~~~~~vkl~DFGla~~ 442 (582)
|+|+.+.|||++++ ..++||+-+..
T Consensus 196 HgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 196 HGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred cCCCCcccEEEeCC--ceEEechhccc
Confidence 99999999999754 45899997764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.03 E-value=0.00066 Score=67.76 Aligned_cols=73 Identities=15% Similarity=0.234 Sum_probs=50.8
Q ss_pred hhcCccCceEEEEEEeCC--------CcEEEEEEeccCCCCHHHHHHHHHHHhccCCCce-EEEEeEEEeCCeeeEEEEe
Q 040604 299 DKLGQGGYGEVYKGELPD--------GQLVAVKVLKNSRCNGEEFINEVASISRTSHVNI-VTFLGFCYENKKNALIYEL 369 (582)
Q Consensus 299 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~ 369 (582)
+.|+.|-.-.+|+....+ .+.|.+++.... ...-...+|..+++.+.-.++ .++++++. -.+||||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEEE
Confidence 568889999999997653 356777777633 233455678888888754444 57777763 2689999
Q ss_pred cCCCChh
Q 040604 370 MPNGSLD 376 (582)
Q Consensus 370 ~~~gsL~ 376 (582)
++|..|.
T Consensus 123 i~g~~l~ 129 (395)
T d1nw1a_ 123 IPSRPLS 129 (395)
T ss_dssp CCEEECC
T ss_pred eccccCC
Confidence 9876553
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.22 E-value=0.0047 Score=59.09 Aligned_cols=140 Identities=12% Similarity=0.056 Sum_probs=71.6
Q ss_pred hcCccCceEEEEEEeCCCcEEEEEEeccCCCCHHHHHHHHHHHhccCCCce--EEEEe------EEEeCCeeeEEEEecC
Q 040604 300 KLGQGGYGEVYKGELPDGQLVAVKVLKNSRCNGEEFINEVASISRTSHVNI--VTFLG------FCYENKKNALIYELMP 371 (582)
Q Consensus 300 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~------~~~~~~~~~lv~E~~~ 371 (582)
.|..|---+.|+....+|+ +++|+..... ..+++..|+..+..|...++ ...+. +.........++.++.
T Consensus 25 ~i~~G~~N~ny~v~t~~g~-yVLri~~~~~-~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~ 102 (316)
T d2ppqa1 25 GIAEGVENSNFLLHTTKDP-LILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE 102 (316)
T ss_dssp EECC---EEEEEEEESSCC-EEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred cCCCCcccCeEEEEECCCc-EEEEEcCCCC-CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeecc
Confidence 4667777889999876665 8999986532 33445556666666543221 11110 1112344556677765
Q ss_pred CCChhhh--------------hhc---C----CCcCCC------------------HHHHHHHHHHHHHHHHHHHh-CCC
Q 040604 372 NGSLDKF--------------IHN---D----RNIKLE------------------WKTMYQIAIGIARGLEYLHR-GCQ 411 (582)
Q Consensus 372 ~gsL~~~--------------i~~---~----~~~~l~------------------~~~~~~i~~qi~~aL~yLH~-~~~ 411 (582)
+...... ++. . ...... .......+..+...+.-.+. ...
T Consensus 103 g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~ 182 (316)
T d2ppqa1 103 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP 182 (316)
T ss_dssp CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred cccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccccc
Confidence 5433210 000 0 000000 00111112222222222222 124
Q ss_pred CceEecCCCCCCEEEcCCCceEEeeccccc
Q 040604 412 VRIVHFDIKPQNILLDEDFCPKISDFGLAK 441 (582)
Q Consensus 412 ~~ivH~Dikp~NILl~~~~~vkl~DFGla~ 441 (582)
.++||+|+.+.||+++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 589999999999999998877899999764
|
| >d1tpga1 g.3.11.1 (A:51-91) Plasminogen activator (tissue-type), t-PA {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Plasminogen activator (tissue-type), t-PA species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.09 E-value=0.41 Score=29.87 Aligned_cols=29 Identities=31% Similarity=0.791 Sum_probs=24.4
Q ss_pred CCCcccccCCCCceEEeCCCCCCcCCCch
Q 040604 223 SNGNCGYIAKTGEFICYCPNGAYSSSCHS 251 (582)
Q Consensus 223 ~~~~C~~~~~~~~~~C~c~~G~~~~~~~~ 251 (582)
.+|.|..+.....|.|.|+.||.|..|..
T Consensus 8 ngG~C~~~~~~~~y~C~C~~g~~G~~Ce~ 36 (41)
T d1tpga1 8 NGGTCQQALYFSDFVCQCPEGFAGKSCEI 36 (41)
T ss_dssp TTCEEEEESSSSCEEEECCTTCBSSSCCB
T ss_pred CCCEEecCCCCCCeEECCCCCCCCCCcCc
Confidence 48999876666789999999999998863
|
| >d1nqlb_ g.3.11.1 (B:) Epidermal growth factor, EGF {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Epidermal growth factor, EGF species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.32 E-value=0.4 Score=31.11 Aligned_cols=30 Identities=30% Similarity=0.748 Sum_probs=24.9
Q ss_pred CCCcccccCCCCceEEeCCCCCCcCCCchh
Q 040604 223 SNGNCGYIAKTGEFICYCPNGAYSSSCHSR 252 (582)
Q Consensus 223 ~~~~C~~~~~~~~~~C~c~~G~~~~~~~~~ 252 (582)
.+|.|........+.|.|+.||.|..|..+
T Consensus 14 ngG~C~~~~~~~~~~C~C~~gy~G~~Ce~~ 43 (48)
T d1nqlb_ 14 HDGVCMYIEALDKYACNCVVGYIGERCQYR 43 (48)
T ss_dssp TTCEEEEETTTTEEEEEECTTEESTTSCEE
T ss_pred CCcEEeeeCCCCCeEEeCCCCcccCCCCcC
Confidence 479998766667899999999999988643
|